data_2k78_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k78 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.849 0.357 . . . . 0.0 110.408 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.02 143.7 12.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 110.308 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.86 -178.77 43.94 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.96 103.47 16.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -1.155 . . . . 0.0 110.242 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.496 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -95.2 158.58 15.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 0.0 110.632 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.403 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 1.7 m120 -79.35 141.27 37.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 109.998 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -164.94 157.23 15.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 110.209 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 141' ' ' LYS . 1.1 tt0 -155.66 -175.93 5.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 110.094 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' CG2' ' A' ' 46' ' ' THR . 0.4 OUTLIER -140.31 172.47 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.941 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -148.55 159.07 44.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 110.568 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.431 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.3 OUTLIER -67.56 128.22 35.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.477 -0.764 . . . . 0.0 109.882 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.472 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -55.41 146.51 19.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 0.0 110.089 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.1 t-20 71.44 2.3 4.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.861 -0.524 . . . . 0.0 111.235 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.431 ' CG2' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -136.75 -165.73 1.78 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.822 -1.174 . . . . 0.0 109.679 179.155 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -133.65 15.68 4.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 0.0 110.344 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -135.48 117.66 15.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.986 . . . . 0.0 110.579 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.422 ' CG2' ' HB2' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -50.45 131.3 24.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.201 -0.937 . . . . 0.0 109.264 179.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.54 -17.32 3.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.014 -1.054 . . . . 0.0 112.051 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.5 mt -136.93 -70.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.867 -1.145 . . . . 0.0 110.808 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -46.61 -26.31 0.88 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.597 -0.689 . . . . 0.0 110.943 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.422 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER -63.39 -14.5 50.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -0.981 . . . . 0.0 110.803 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.413 ' C ' ' CG ' ' A' ' 52' ' ' TYR . 21.2 m-20 -95.24 14.85 20.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.074 -1.016 . . . . 0.0 110.832 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.413 ' CG ' ' C ' ' A' ' 51' ' ' ASP . 22.5 m-85 -142.91 15.73 1.93 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.992 -1.068 . . . . 0.0 110.737 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -131.3 105.85 7.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.183 -0.948 . . . . 0.0 110.205 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -72.3 169.76 15.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.947 . . . . 0.0 110.368 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -147.72 162.04 33.12 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.338 -0.851 . . . . 0.0 110.018 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 58.8 Cg_endo -81.25 -175.8 16.46 Favored 'Cis proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.399 -2.334 . . . . 0.0 110.596 -0.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . . . -103.5 171.3 7.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.325 -0.859 . . . . 0.0 109.885 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.437 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -105.2 116.25 31.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.001 . . . . 0.0 110.536 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.496 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 1.9 p90 -97.24 162.67 13.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.394 -0.816 . . . . 0.0 109.945 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -154.78 150.97 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.026 -1.046 . . . . 0.0 110.783 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 19.6 mtmt -134.39 173.65 11.4 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.247 -0.908 . . . . 0.0 110.737 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HB2' ' CD ' ' A' ' 65' ' ' LYS . 4.5 mttm -153.27 62.21 0.76 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.508 -0.745 . . . . 0.0 109.703 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.1 m120 46.98 82.44 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.369 -0.832 . . . . 0.0 111.105 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.53 19.82 28.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.434 ' CD ' ' HB2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -168.84 162.62 11.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.045 -1.267 . . . . 0.0 111.181 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 2.6 pt? -172.66 154.89 3.15 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.009 0.909 . . . . 0.0 111.477 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 1.1 m-85 -137.98 -153.7 0.49 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.43 HG12 ' CE1' ' A' ' 142' ' ' PHE . 1.1 t -170.73 135.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.073 -1.017 . . . . 0.0 110.287 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.437 ' HG2' ' CB ' ' A' ' 58' ' ' LYS . 1.8 pt20 -97.51 131.24 44.31 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.39 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.68 143.69 20.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.253 -0.905 . . . . 0.0 110.108 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.77 135.85 33.31 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.299 -0.876 . . . . 0.0 109.902 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.8 t -103.34 126.42 57.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.418 -0.802 . . . . 0.0 110.143 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -97.99 127.16 43.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.227 -0.921 . . . . 0.0 110.149 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 m80 55.04 99.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.827 . . . . 0.0 110.146 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.9 t -74.39 -35.75 63.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.189 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -51.57 -23.9 4.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.26 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -94.37 -53.53 3.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.48 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.413 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 13.6 tt -89.51 123.71 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.144 -0.973 . . . . 0.0 109.835 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -87.69 -27.02 22.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 110.982 -179.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.466 ' N ' HG22 ' A' ' 79' ' ' THR . . . 179.56 -176.47 47.67 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.046 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 63.3 mtm -151.95 165.5 34.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.384 -1.068 . . . . 0.0 110.145 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -155.29 140.58 17.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.323 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.479 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -130.19 140.18 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 110.245 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 71.65 0.85 3.65 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.637 -0.664 . . . . 0.0 111.385 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.09 21.79 9.25 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.644 -1.265 . . . . 0.0 111.292 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.472 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.74 158.71 43.78 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.52 -1.577 . . . . 0.0 110.31 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.14 175.29 5.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 110.485 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -104.06 170.29 8.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.371 -0.831 . . . . 0.0 110.32 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -110.6 131.51 54.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 110.463 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.427 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.4 pp -68.26 102.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 109.571 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.438 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.1 tt -95.21 -30.89 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 111.092 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.7 m -167.22 95.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.028 -1.045 . . . . 0.0 110.327 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -96.77 105.07 17.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.397 -0.814 . . . . 0.0 109.977 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.67 105.36 17.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.236 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -32.03 44.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 0.0 110.235 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.59 -44.71 95.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 109.987 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -96.8 8.54 44.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 110.704 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.02 53.33 13.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.037 -1.039 . . . . 0.0 110.071 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.38 119.01 7.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 110.519 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.475 ' CG ' ' N ' ' A' ' 101' ' ' THR . 38.2 ttt180 -114.98 167.27 10.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.43 -0.794 . . . . 0.0 109.619 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 100' ' ' ARG . 92.0 m -141.09 153.14 45.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.018 -1.051 . . . . 0.0 109.962 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.416 ' N ' HG21 ' A' ' 101' ' ' THR . 97.1 p -144.99 142.35 29.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.157 -0.964 . . . . 0.0 110.686 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.18 140.73 29.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.324 -0.86 . . . . 0.0 109.85 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -127.96 138.62 52.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.077 -1.014 . . . . 0.0 110.71 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.436 ' HG2' ' CD2' ' A' ' 67' ' ' TYR . 3.2 tm-20 -98.29 128.16 44.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.329 -0.857 . . . . 0.0 109.538 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.61 151.12 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 110.926 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -63.09 111.2 2.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -0.916 . . . . 0.0 109.195 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.464 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.21 -167.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.458 -0.776 . . . . 0.0 109.844 -178.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.44 ' HG ' ' CD1' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -150.25 70.98 1.05 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.96 -1.088 . . . . 0.0 110.86 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.2 67.48 1.19 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 0.0 110.243 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.53 -121.57 1.02 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.41 153.44 27.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -1.157 . . . . 0.0 110.115 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.1 mm -136.74 149.2 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.0 110.262 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -76.49 103.78 6.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 109.968 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.415 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -109.17 179.49 21.03 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.5 mttp -145.03 167.4 22.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -1.088 . . . . 0.0 109.824 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -158.07 153.17 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.016 -1.052 . . . . 0.0 110.792 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.425 ' HB2' ' CG2' ' A' ' 79' ' ' THR . 59.9 m-20 -111.65 157.88 19.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.522 -0.737 . . . . 0.0 109.297 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -141.61 151.57 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.999 -1.063 . . . . 0.0 110.528 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.408 ' CE1' ' HB3' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -151.51 117.07 5.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.411 -0.805 . . . . 0.0 110.069 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 31.4 mt -141.05 151.97 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.188 -0.945 . . . . 0.0 110.484 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.57 95.79 1.12 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.465 -0.772 . . . . 0.0 109.668 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -173.14 163.6 4.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 110.431 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -87.34 112.94 22.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.374 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.9 t -76.42 91.68 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.323 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.02 43.33 9.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.216 -0.927 . . . . 0.0 110.349 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.14 30.61 16.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -145.37 100.92 4.41 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.269 -1.136 . . . . 0.0 110.261 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -52.5 113.25 1.14 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.74 1.389 . . . . 0.0 110.286 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -112.39 120.13 40.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.0 110.391 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -103.95 142.67 34.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.338 -0.851 . . . . 0.0 110.077 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -156.67 121.23 4.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 109.988 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.408 ' HB3' ' CE1' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -168.01 86.66 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 110.367 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -153.43 -172.45 4.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 110.358 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -117.64 87.81 2.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 110.091 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -85.56 -178.39 6.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.328 -0.857 . . . . 0.0 110.242 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 2.6 p30 -149.4 169.94 19.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 110.461 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -157.11 163.79 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -0.918 . . . . 0.0 110.634 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 85.2 m -91.86 125.33 36.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.3 -0.875 . . . . 0.0 110.567 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.479 ' CD2' HD11 ' A' ' 83' ' ' ILE . 31.4 m-85 -90.13 154.02 20.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.601 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -142.06 102.86 4.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.055 -1.028 . . . . 0.0 110.427 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.43 ' CE1' HG12 ' A' ' 68' ' ' VAL . 17.1 m-85 -92.26 153.51 19.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.43 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 51.1 m-80 -142.62 97.91 3.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.446 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -155.21 -148.12 4.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 C--N 1.309 -1.536 0 O-C-N 123.795 1.418 . . . . 0.0 110.436 -179.934 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 120.918 0.39 . . . . 0.0 110.337 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 p -160.67 148.06 15.78 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.195 -0.941 . . . . 0.0 110.331 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 171.2 174.35 38.9 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.93 107.73 19.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.282 -1.128 . . . . 0.0 110.568 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.506 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -95.73 158.09 15.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.149 -0.97 . . . . 0.0 110.363 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 143' ' ' ASN . 2.1 m-20 -80.38 143.8 33.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 109.716 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.486 ' CE2' HD11 ' A' ' 70' ' ' ILE . 1.1 p90 -164.92 156.36 15.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.117 -0.989 . . . . 0.0 110.254 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.42 -175.76 5.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.314 -0.866 . . . . 0.0 109.958 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.423 ' O ' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.31 175.17 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 110.031 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -149.08 160.57 43.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 110.404 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.94 119.97 13.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.369 -0.832 . . . . 0.0 109.418 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.476 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -48.71 146.15 3.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.241 -0.912 . . . . 0.0 110.169 -179.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER 72.53 2.33 4.31 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.949 -0.47 . . . . 0.0 110.866 -179.328 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -135.34 -163.0 1.32 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.878 -1.138 . . . . 0.0 109.818 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.56 14.02 3.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 110.242 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -135.25 123.51 23.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 110.354 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -60.56 131.37 50.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.072 -1.018 . . . . 0.0 109.313 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.04 -17.14 4.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 111.781 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.404 HD11 HG21 ' A' ' 48' ' ' ILE . 62.2 mt -137.25 -65.59 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.8 -1.188 . . . . 0.0 110.895 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.403 ' O ' ' CD2' ' A' ' 53' ' ' PHE . . . -50.03 -22.99 1.8 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.508 -0.745 . . . . 0.0 111.205 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.431 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 0.1 OUTLIER -70.58 -9.41 56.77 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.039 -1.038 . . . . 0.0 110.965 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.407 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 30.1 m-20 -102.47 14.9 30.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.928 -1.107 . . . . 0.0 110.959 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 51' ' ' ASP . 31.5 m-85 -136.47 4.98 2.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.001 -1.062 . . . . 0.0 111.097 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 19.8 m-85 -125.75 111.64 15.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.038 -1.039 . . . . 0.0 110.291 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -72.01 165.69 23.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.993 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.427 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -147.24 164.55 22.52 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.215 -0.928 . . . . 0.0 110.196 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.427 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 58.0 Cg_endo -80.84 -175.57 16.27 Favored 'Cis proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.338 -2.359 . . . . 0.0 110.666 -0.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.48 168.85 9.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -0.885 . . . . 0.0 109.676 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.419 ' CB ' ' CG ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.89 121.33 41.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.031 -1.043 . . . . 0.0 110.783 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.506 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 9.2 p90 -98.26 158.73 15.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.327 -0.858 . . . . 0.0 109.873 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -155.08 147.65 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.076 -1.015 . . . . 0.0 110.442 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 7.2 mttt -131.87 174.11 10.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.457 -0.777 . . . . 0.0 110.444 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 2.6 mmtp -156.73 62.04 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.796 . . . . 0.0 109.731 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 m120 47.53 85.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.835 . . . . 0.0 110.992 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.73 17.45 48.5 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.555 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -165.31 163.51 19.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.936 -1.332 . . . . 0.0 111.119 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.2 pt? -174.6 154.83 2.09 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.017 0.913 . . . . 0.0 110.964 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.565 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -139.48 -155.46 0.59 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.441 ' CG2' ' HA ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -170.67 134.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.846 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.419 ' CG ' ' CB ' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -97.73 134.68 40.58 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.123 -0.986 . . . . 0.0 110.011 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.486 HD11 ' CE2' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -113.2 139.53 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.437 -0.789 . . . . 0.0 110.069 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.31 133.67 34.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 110.022 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.2 t -102.6 125.51 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.44 -0.787 . . . . 0.0 109.831 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -99.21 126.93 45.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.13 -0.981 . . . . 0.0 110.416 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 58.42 99.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 110.354 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.37 -25.55 59.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.168 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -59.39 -36.27 75.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.41 ' HA ' HG12 ' A' ' 121' ' ' ILE . 46.5 m0 -82.77 -52.11 7.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 12.8 tt -89.3 122.66 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.869 . . . . 0.0 109.838 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -87.2 -25.46 24.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 110.878 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.437 ' N ' HG23 ' A' ' 79' ' ' THR . . . -179.77 178.05 48.41 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.499 -1.334 . . . . 0.0 110.243 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 89.6 mtp -150.92 160.26 44.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.996 . . . . 0.0 109.787 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -154.95 161.16 41.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 110.253 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.493 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 1.3 mt -149.73 152.6 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 110.149 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.529 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 0.2 OUTLIER 62.77 12.51 5.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.093 -1.004 . . . . 0.0 111.058 179.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.17 20.42 52.8 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.436 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.529 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.2 p-80 -138.28 158.8 43.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.859 -1.377 . . . . 0.0 110.441 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.39 172.2 9.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.334 -0.854 . . . . 0.0 110.595 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.523 ' CB ' ' CZ ' ' A' ' 104' ' ' PHE . 4.4 pt-20 -100.54 170.53 8.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.342 -0.849 . . . . 0.0 110.373 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.3 129.49 53.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.347 -0.845 . . . . 0.0 110.483 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.76 101.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.111 -0.993 . . . . 0.0 109.569 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.438 HG21 ' N ' ' A' ' 92' ' ' SER . 1.1 tt -94.86 -26.38 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 110.857 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.438 ' N ' HG21 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -167.04 100.31 0.54 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.229 -0.92 . . . . 0.0 109.655 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.423 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 16.4 ttmt -95.93 147.94 23.15 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 110.191 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -143.02 84.2 1.82 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -0.938 . . . . 0.0 110.3 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 p -71.21 -29.39 65.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 110.207 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.95 -52.57 62.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.339 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -96.31 15.84 20.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.0 110.5 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.42 62.54 2.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.117 -0.989 . . . . 0.0 110.547 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 94' ' ' ASN . 22.3 mt-10 -148.14 160.86 42.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.158 -0.964 . . . . 0.0 110.165 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.423 ' CG ' ' HA ' ' A' ' 93' ' ' LYS . 7.3 ttm180 -166.83 161.47 15.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 110.155 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 102' ' ' SER . 74.3 m -143.07 152.0 41.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 109.61 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.414 ' N ' HG22 ' A' ' 101' ' ' THR . 18.2 p -146.33 143.46 29.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.988 -1.07 . . . . 0.0 110.871 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.82 147.96 22.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.374 -0.828 . . . . 0.0 109.693 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.523 ' CZ ' ' CB ' ' A' ' 88' ' ' GLU . 27.2 m-85 -130.16 135.79 48.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.088 -1.008 . . . . 0.0 111.117 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -97.19 125.17 41.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.393 -0.817 . . . . 0.0 109.117 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.433 ' CG2' ' N ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -149.25 161.02 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 0.0 110.782 -178.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.433 ' N ' ' CG2' ' A' ' 106' ' ' VAL . 11.0 p -70.13 113.0 6.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 108.82 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 44.83 -164.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.673 -0.642 . . . . 0.0 109.964 -178.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.425 ' HG ' HD11 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -150.64 68.22 0.96 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.876 -1.14 . . . . 0.0 110.933 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -146.97 87.97 1.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.05 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 148.05 -125.76 2.18 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.439 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.1 OUTLIER -156.91 150.39 24.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -1.067 . . . . 0.0 109.723 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.436 ' CA ' ' HE2' ' A' ' 112' ' ' LYS . 2.4 mt -135.55 152.19 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.316 -0.865 . . . . 0.0 110.04 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -75.93 100.0 4.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.919 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.415 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -99.99 179.31 29.92 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 82' ' ' SER . 17.0 mtpt -146.13 158.31 43.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -1.121 . . . . 0.0 110.054 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.421 HG12 ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -157.6 145.99 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.119 -0.988 . . . . 0.0 110.312 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.421 ' N ' HG12 ' A' ' 117' ' ' ILE . 1.0 OUTLIER -108.32 161.17 15.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.366 -0.833 . . . . 0.0 109.596 179.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.48 150.77 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.119 -0.988 . . . . 0.0 110.766 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -151.94 114.19 4.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.467 -0.771 . . . . 0.0 109.871 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.489 HD13 ' CD2' ' A' ' 132' ' ' TYR . 15.8 mt -141.51 153.29 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.164 -0.96 . . . . 0.0 110.806 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -159.44 100.01 1.48 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.587 -0.695 . . . . 0.0 109.424 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -172.97 178.25 2.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.24 -0.912 . . . . 0.0 110.396 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -101.21 118.85 37.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.333 -0.854 . . . . 0.0 110.324 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.2 t -76.91 92.26 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.0 110.306 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.431 ' N ' ' ND2' ' A' ' 126' ' ' ASN . 1.4 m120 57.39 36.18 26.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.878 . . . . 0.0 110.503 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.89 31.25 6.72 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.12 98.15 4.74 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.247 -1.149 . . . . 0.0 110.07 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -49.17 121.28 6.65 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.921 1.485 . . . . 0.0 110.327 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -126.32 124.63 40.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 110.195 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -103.61 140.59 37.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 110.351 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.489 ' CD2' HD13 ' A' ' 121' ' ' ILE . 2.5 t80 -150.85 123.22 8.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.091 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -175.83 87.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 109.935 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -153.58 -164.68 1.95 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.355 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.472 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -119.2 139.83 51.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.981 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 135' ' ' HIS . 47.5 m-85 -154.53 -179.82 8.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.93 . . . . 0.0 110.119 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.401 ' CB ' ' HA ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -152.39 178.89 9.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.161 -0.962 . . . . 0.0 110.51 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.8 pt -157.13 170.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.885 . . . . 0.0 110.058 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.439 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 96.8 m -91.6 121.84 33.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 110.647 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.415 ' CE1' ' HA3' ' A' ' 115' ' ' GLY . 28.6 m-85 -89.44 155.58 19.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.575 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.32 100.53 3.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.048 -1.033 . . . . 0.0 110.741 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.414 ' CE1' HG12 ' A' ' 68' ' ' VAL . 15.9 m-85 -91.7 129.14 37.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.652 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.449 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 56.1 m-80 -113.93 104.38 12.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.105 -0.997 . . . . 0.0 110.877 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.405 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -163.13 -159.03 10.15 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.408 ' HD2' ' CD1' ' A' ' 109' ' ' LEU . 16.4 Cg_endo . . . . . 0 C--N 1.305 -1.747 0 O-C-N 123.982 1.517 . . . . 0.0 110.278 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.014 0.435 . . . . 0.0 110.419 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -158.91 134.6 8.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 110.246 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.96 178.27 48.74 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.29 105.4 17.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.181 -1.187 . . . . 0.0 110.382 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.519 ' CB ' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -94.27 154.25 17.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.345 -0.847 . . . . 0.0 109.744 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.463 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 12.4 t-20 -78.73 144.7 35.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.12 -0.988 . . . . 0.0 109.989 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.455 ' CD1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -165.57 161.46 18.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.343 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.22 -173.44 4.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.425 -0.797 . . . . 0.0 109.746 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.55 174.61 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.169 -0.957 . . . . 0.0 110.146 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -147.47 151.37 36.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.377 -0.827 . . . . 0.0 109.839 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -67.43 127.12 31.51 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.419 -0.8 . . . . 0.0 110.066 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.471 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -52.94 146.98 9.9 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.091 -1.006 . . . . 0.0 109.493 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 12.5 t30 73.09 -1.17 3.14 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.944 -0.472 . . . . 0.0 110.914 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -136.95 -163.38 1.41 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.899 -1.126 . . . . 0.0 109.561 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.402 ' N ' ' OG1' ' A' ' 43' ' ' THR . 8.5 m120 -133.34 15.74 4.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 110.434 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -136.53 129.03 30.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.015 . . . . 0.0 110.681 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.43 ' CG2' ' HB3' ' A' ' 50' ' ' ASN . 0.3 OUTLIER -57.79 132.38 53.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.156 -0.965 . . . . 0.0 109.037 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.75 -16.8 4.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.102 -0.999 . . . . 0.0 112.035 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.2 mt -136.62 -64.94 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.803 -1.185 . . . . 0.0 110.598 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.6 -20.79 8.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.428 -0.795 . . . . 0.0 110.727 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.43 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 0.1 OUTLIER -63.38 -17.84 63.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.309 -0.87 . . . . 0.0 110.76 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -102.47 15.45 29.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.139 -0.976 . . . . 0.0 110.992 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -131.73 1.11 3.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.949 -1.094 . . . . 0.0 111.151 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -129.37 113.47 14.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.127 -0.983 . . . . 0.0 110.252 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -72.79 173.05 9.67 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.386 -0.821 . . . . 0.0 110.617 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.15 164.67 22.01 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.354 -0.841 . . . . 0.0 109.769 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -78.66 -174.84 15.55 Favored 'Cis proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.798 -2.167 . . . . 0.0 110.559 -0.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.455 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . . . -101.22 164.38 11.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.879 . . . . 0.0 110.007 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.418 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 2.2 tptt -101.91 109.55 21.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.131 -0.981 . . . . 0.0 110.314 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.519 ' CD1' ' CB ' ' A' ' 34' ' ' LEU . 6.5 p90 -98.0 165.75 11.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.332 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -155.6 157.81 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.296 -0.877 . . . . 0.0 110.537 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 3.1 mtmt -139.41 174.31 10.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.245 -0.909 . . . . 0.0 110.831 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.445 ' CB ' ' CD ' ' A' ' 65' ' ' LYS . 7.2 mttm -159.03 62.21 0.41 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.418 -0.801 . . . . 0.0 109.878 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 48.97 84.0 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.441 -0.787 . . . . 0.0 111.232 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.68 24.42 28.12 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.736 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.445 ' CD ' ' CB ' ' A' ' 62' ' ' LYS . 1.3 ptpp? -167.42 155.94 9.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.912 -1.346 . . . . 0.0 111.018 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -160.12 155.56 25.34 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.201 1.0 . . . . 0.0 111.843 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 6.2 m-85 -142.58 -164.14 1.76 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' A' ' 59' ' ' TYR . 1.1 t -170.47 135.98 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.998 -1.064 . . . . 0.0 110.554 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 4.7 pt20 -99.15 134.23 42.3 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 109.773 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -113.23 134.87 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 110.093 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.0 m -89.57 123.56 33.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 0.0 109.954 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.08 141.7 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.207 -0.933 . . . . 0.0 110.278 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -98.67 140.02 33.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.827 . . . . 0.0 110.207 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.2 m170 52.58 88.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 110.221 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.7 p -52.19 -25.91 10.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.378 -0.827 . . . . 0.0 110.298 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -65.37 -55.74 16.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 110.369 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.4 ' HA ' HG12 ' A' ' 121' ' ' ILE . 47.4 m0 -50.73 -59.56 3.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.19 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.1 tt -88.46 118.04 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.312 -0.868 . . . . 0.0 109.894 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.431 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -86.6 -23.02 25.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.316 -0.865 . . . . 0.0 110.956 -179.186 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.431 ' N ' HG21 ' A' ' 79' ' ' THR . . . -177.07 176.1 47.93 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.019 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.413 ' CE ' ' OH ' ' A' ' 140' ' ' TYR . 56.6 mtp -152.57 157.79 41.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.376 -1.073 . . . . 0.0 110.07 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -155.11 140.51 17.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.94 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.476 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.4 OUTLIER -132.94 139.38 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.143 -0.973 . . . . 0.0 110.726 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 70.73 1.86 3.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.588 -0.695 . . . . 0.0 111.629 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.49 22.06 9.37 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.327 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.465 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.88 159.64 41.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.685 -1.479 . . . . 0.0 110.059 179.217 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -70.16 -174.55 0.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.171 -0.956 . . . . 0.0 110.616 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -109.06 169.03 8.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 110.239 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -110.34 127.56 55.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 0.0 109.985 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.408 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 pp -67.08 102.89 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.062 -1.024 . . . . 0.0 109.661 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.447 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 0.9 OUTLIER -95.7 -31.5 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 111.007 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.427 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -167.24 100.4 0.52 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.036 -1.04 . . . . 0.0 110.162 -179.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -96.21 148.8 22.34 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.417 -0.802 . . . . 0.0 110.084 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.23 97.9 3.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 110.331 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.6 -32.56 58.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.049 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.89 -43.18 99.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 110.091 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.77 5.76 50.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 110.507 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.71 56.91 6.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.034 -1.041 . . . . 0.0 110.311 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -148.14 -177.32 5.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 110.357 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.404 ' CG ' ' N ' ' A' ' 101' ' ' THR . 4.8 ttp180 175.22 160.06 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.855 . . . . 0.0 110.009 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.447 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 85.8 m -137.3 156.19 48.55 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.314 -0.866 . . . . 0.0 109.812 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.416 ' N ' HG23 ' A' ' 101' ' ' THR . 6.1 p -144.2 143.12 30.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.038 -1.038 . . . . 0.0 110.785 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -92.92 150.15 20.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.816 . . . . 0.0 110.054 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -129.71 154.44 47.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.94 . . . . 0.0 110.687 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.51 127.37 53.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.321 -0.862 . . . . 0.0 109.742 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.0 m -149.88 -165.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.045 -1.034 . . . . 0.0 110.607 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -97.9 111.9 24.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.479 -0.763 . . . . 0.0 108.994 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.431 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 47.41 -166.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.48 -0.763 . . . . 0.0 109.554 -178.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.419 ' CD2' ' CD2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -151.0 62.75 0.91 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.078 -1.014 . . . . 0.0 110.931 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -146.11 70.48 1.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 110.23 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.23 -125.07 1.19 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.454 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.2 OUTLIER -157.38 139.35 14.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.343 -1.092 . . . . 0.0 109.715 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.421 ' CA ' ' HE2' ' A' ' 112' ' ' LYS . 6.0 mt -135.25 149.83 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.24 -0.913 . . . . 0.0 110.237 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -76.57 123.18 25.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.908 . . . . 0.0 110.15 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -119.82 -177.65 16.23 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 82' ' ' SER . 12.3 mttt -145.12 158.86 43.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.327 -1.102 . . . . 0.0 110.111 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.77 143.64 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.454 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.59 154.99 18.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.401 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.84 146.86 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.008 -1.057 . . . . 0.0 110.678 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.53 110.47 3.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.43 -0.794 . . . . 0.0 110.006 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.448 ' HB ' ' CB ' ' A' ' 132' ' ' TYR . 19.6 mt -139.92 153.71 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 110.573 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.0 95.1 1.26 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.498 -0.751 . . . . 0.0 109.436 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.476 ' O ' ' CD1' ' A' ' 130' ' ' PHE . 1.3 pt-20 -174.5 -164.73 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.387 -0.821 . . . . 0.0 109.928 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -113.63 115.04 27.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.101 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.429 ' CG2' ' CE1' ' A' ' 130' ' ' PHE . 3.1 t -76.61 94.56 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.264 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.415 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 2.4 m120 59.42 39.13 22.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.337 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 91.89 34.69 7.13 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.72 90.71 6.31 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.226 -1.161 . . . . 0.0 110.061 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -57.3 133.75 59.31 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.126 1.593 . . . . 0.0 110.63 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' A' ' 123' ' ' GLU . 9.3 p90 -157.39 132.7 9.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.056 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -103.24 99.71 9.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.397 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.448 ' CB ' ' HB ' ' A' ' 121' ' ' ILE . 3.7 t80 -90.49 129.53 36.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.831 . . . . 0.0 109.703 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -170.45 83.58 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.091 -1.005 . . . . 0.0 110.27 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.84 -166.04 2.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.885 . . . . 0.0 110.327 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -118.34 151.7 37.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 109.858 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -155.29 179.85 8.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.014 . . . . 0.0 110.405 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -152.23 169.54 22.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.572 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.4 pt -156.65 161.63 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 110.214 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.454 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 66.4 m -91.82 125.85 36.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.865 . . . . 0.0 110.73 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.486 ' CE1' ' HA3' ' A' ' 115' ' ' GLY . 47.7 m-85 -90.59 164.93 14.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.905 . . . . 0.0 110.016 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.98 103.3 3.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.954 . . . . 0.0 110.32 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -92.44 141.33 28.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.301 -0.874 . . . . 0.0 110.515 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.445 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 67.2 m-20 -133.12 98.43 4.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 110.022 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.52 -148.71 5.35 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.408 ' HD2' ' CD1' ' A' ' 109' ' ' LEU . 17.7 Cg_endo . . . . . 0 C--N 1.308 -1.6 0 O-C-N 123.773 1.407 . . . . 0.0 110.768 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 25.0 m-20 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 120.866 0.365 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 36.6 t -160.84 148.24 15.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 110.43 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.35 172.14 39.97 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.18 106.59 18.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -1.107 . . . . 0.0 110.229 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.489 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -94.45 156.21 16.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.319 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -79.62 143.9 34.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 110.017 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.456 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 1.6 p90 -165.99 159.05 15.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 0.0 110.03 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -155.15 -175.14 5.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.926 . . . . 0.0 109.947 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.463 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -141.43 174.5 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 110.476 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 18.6 m-85 -148.17 156.02 42.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -0.808 . . . . 0.0 109.926 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.431 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -67.66 127.87 34.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.106 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.445 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -54.37 147.92 12.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 109.869 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 9.7 m-20 71.11 2.42 4.23 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.812 -0.555 . . . . 0.0 110.952 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.413 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -135.93 -162.26 1.25 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.849 -1.157 . . . . 0.0 109.666 179.087 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.413 ' N ' ' OG1' ' A' ' 43' ' ' THR . 16.5 m-80 -132.57 11.91 4.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 110.194 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -136.56 143.76 43.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 110.69 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.45 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -68.58 131.49 45.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.088 179.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.25 -17.52 3.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.962 -1.087 . . . . 0.0 112.137 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -137.32 -71.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.789 -1.195 . . . . 0.0 110.581 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.457 ' N ' ' CG2' ' A' ' 48' ' ' ILE . . . -48.87 -24.69 1.55 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.499 -0.751 . . . . 0.0 110.853 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.45 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -61.73 -20.64 63.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.121 -0.987 . . . . 0.0 110.784 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.41 ' OD2' ' ND2' ' A' ' 50' ' ' ASN . 2.1 m-20 -94.68 14.12 22.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.086 -1.009 . . . . 0.0 110.858 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -141.3 9.51 2.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.062 . . . . 0.0 110.843 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -118.15 110.67 17.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.983 . . . . 0.0 110.171 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -72.77 155.67 39.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.298 -0.877 . . . . 0.0 110.693 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.52 163.27 28.58 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.333 -0.854 . . . . 0.0 109.833 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.41 -175.27 16.4 Favored 'Cis proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.862 -2.141 . . . . 0.0 110.472 -0.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.09 -172.0 2.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 109.889 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.52 119.19 27.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.015 -1.053 . . . . 0.0 110.577 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.489 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 8.3 p90 -97.11 165.59 11.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 109.877 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -155.58 122.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.135 -0.978 . . . . 0.0 110.608 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HG2' ' CB ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -136.77 131.76 33.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.199 -0.938 . . . . 0.0 110.775 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -110.25 62.25 0.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 110.35 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 48.45 97.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.374 -0.829 . . . . 0.0 111.28 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.91 11.71 52.25 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.96 152.63 4.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.012 -1.287 . . . . 0.0 110.325 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -156.92 153.46 28.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.09 -1.006 . . . . 0.0 111.504 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 4.5 m-85 -142.94 -157.92 0.82 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.391 -0.818 . . . . 0.0 109.257 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -170.16 167.49 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.197 -0.939 . . . . 0.0 110.345 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.28 134.51 29.47 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.403 -0.81 . . . . 0.0 109.676 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.434 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.3 OUTLIER -115.48 133.71 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 110.225 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.3 m -89.86 129.72 36.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.155 -0.966 . . . . 0.0 109.853 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -102.31 143.78 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 110.231 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -99.23 139.34 35.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.905 . . . . 0.0 110.254 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 54.34 99.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 110.346 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.01 -35.32 78.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.885 . . . . 0.0 110.222 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -57.95 -35.98 71.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 110.196 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.438 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 39.8 m0 -79.0 -51.04 10.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 110.213 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 3.8 tp -89.27 120.55 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.875 . . . . 0.0 109.835 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.435 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -86.4 -34.56 20.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.406 -0.809 . . . . 0.0 110.706 -179.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.435 ' N ' HG21 ' A' ' 79' ' ' THR . . . -175.62 -179.63 46.25 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.532 -1.318 . . . . 0.0 109.989 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -152.41 166.31 32.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -1.091 . . . . 0.0 110.133 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -155.21 147.3 23.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.859 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.474 HD13 ' CE2' ' A' ' 140' ' ' TYR . 1.2 mt -142.37 143.11 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 110.627 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 72.3 -0.41 3.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.614 -0.678 . . . . 0.0 111.604 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.0 20.27 9.99 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.458 -1.354 . . . . 0.0 111.285 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.461 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.02 161.41 36.13 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.735 -1.45 . . . . 0.0 110.199 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -172.16 0.6 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.006 -1.059 . . . . 0.0 110.739 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 0.1 OUTLIER -109.79 165.9 11.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 110.557 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.16 135.05 54.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.448 -0.783 . . . . 0.0 109.856 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.42 100.76 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.087 -1.008 . . . . 0.0 109.913 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.44 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.2 tt -96.0 -28.56 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 110.285 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -166.32 96.08 0.57 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.232 -0.918 . . . . 0.0 109.794 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -95.36 102.4 14.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.427 -0.796 . . . . 0.0 110.073 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.38 95.75 7.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.365 -0.835 . . . . 0.0 110.352 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -37.96 53.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.928 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.55 -38.48 90.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.034 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -96.19 10.55 37.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.62 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 50.91 56.17 8.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.048 -1.033 . . . . 0.0 110.282 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -148.04 169.85 19.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.156 -0.965 . . . . 0.0 110.395 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.404 ' HB3' HG21 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -166.62 157.63 12.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.333 -0.855 . . . . 0.0 109.954 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.44 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 86.8 m -141.98 158.38 43.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.396 -0.815 . . . . 0.0 109.759 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -145.04 142.97 30.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.045 -1.034 . . . . 0.0 110.728 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.98 138.77 31.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.363 -0.836 . . . . 0.0 109.943 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 102' ' ' SER . 88.6 m-85 -130.06 145.9 51.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.055 -1.028 . . . . 0.0 110.901 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -99.69 131.02 45.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.377 -0.827 . . . . 0.0 108.881 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.9 m -149.09 162.28 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.849 -1.157 . . . . 0.0 111.285 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 60.4 p -69.44 112.32 5.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.454 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.67 -157.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.51 -0.744 . . . . 0.0 109.418 -178.3 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.21 51.53 0.9 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.798 -1.189 . . . . 0.0 110.807 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -146.26 87.73 1.75 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.026 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.22 171.02 20.75 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.402 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 1.0 OUTLIER -81.63 144.01 31.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -1.169 . . . . 0.0 110.175 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mm -137.92 139.89 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.171 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -76.65 135.57 39.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 109.947 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -140.98 178.12 20.39 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 82' ' ' SER . 9.1 mtmm -143.6 158.06 43.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.426 -1.044 . . . . 0.0 109.837 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.7 142.62 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.959 -1.088 . . . . 0.0 110.592 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -106.2 164.47 11.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -0.764 . . . . 0.0 109.798 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.474 HG11 ' CE2' ' A' ' 132' ' ' TYR . 25.0 t -141.95 151.53 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 110.447 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -152.03 105.42 3.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.476 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.462 HD11 ' CD2' ' A' ' 132' ' ' TYR . 4.9 mt -125.46 152.79 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.243 -0.911 . . . . 0.0 110.073 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.73 102.41 1.33 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.798 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -173.7 -164.24 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 110.443 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 128' ' ' LYS . 2.3 ttmt -99.92 103.11 14.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.294 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.426 ' O ' ' CG1' ' A' ' 125' ' ' VAL . 2.1 t -76.63 103.0 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 110.15 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 63.16 34.47 13.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.451 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.09 31.52 28.4 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.427 ' N ' ' HG2' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -145.33 137.01 12.89 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.224 -1.162 . . . . 0.0 109.999 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.25 129.27 33.94 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.564 1.297 . . . . 0.0 109.838 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -129.14 118.1 21.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 110.583 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -105.2 137.78 42.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 109.847 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.474 ' CE2' HG11 ' A' ' 119' ' ' VAL . 6.3 t80 -157.17 123.62 4.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.212 -0.93 . . . . 0.0 110.006 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -173.35 87.55 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.905 . . . . 0.0 109.986 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.96 -161.46 1.29 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.892 . . . . 0.0 110.297 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -120.93 155.6 33.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.86 . . . . 0.0 110.256 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 32.4 m-85 -155.14 -179.26 7.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 109.831 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 6.3 p30 -151.2 168.98 23.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 110.608 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.3 pt -156.85 163.27 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.365 -0.835 . . . . 0.0 110.13 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.402 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 90.8 m -91.9 122.11 34.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.224 -0.923 . . . . 0.0 110.54 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.474 ' CE2' HD13 ' A' ' 83' ' ' ILE . 49.2 m-85 -90.25 157.96 17.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -0.877 . . . . 0.0 110.235 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 104.74 3.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.225 -0.922 . . . . 0.0 110.178 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -91.39 158.35 16.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.237 -0.914 . . . . 0.0 110.277 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.456 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 65.9 m-80 -143.13 99.56 3.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -157.52 -154.89 7.27 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo . . . . . 0 C--N 1.307 -1.624 0 O-C-N 123.988 1.52 . . . . 0.0 110.537 -179.911 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.411 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 7.7 m-20 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.988 0.423 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 p -159.48 147.69 17.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 0.0 110.428 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.37 175.67 44.8 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.68 104.87 17.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -1.113 . . . . 0.0 110.39 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.488 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -95.27 159.12 15.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.328 -0.857 . . . . 0.0 110.434 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.439 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 16.3 m-20 -78.71 139.6 38.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.116 -0.99 . . . . 0.0 109.982 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -165.51 152.22 10.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.982 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -155.13 -173.2 4.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.0 110.237 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.456 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -140.97 178.65 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.878 . . . . 0.0 110.369 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 39.7 m-85 -148.18 156.72 42.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.446 -0.784 . . . . 0.0 109.68 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.27 122.78 18.62 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.937 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -49.86 148.89 2.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.934 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.4 t-20 71.52 2.82 4.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.879 -0.513 . . . . 0.0 110.771 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.12 -157.84 0.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.948 -1.095 . . . . 0.0 109.533 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.12 8.27 3.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 110.209 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -135.11 150.76 50.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.07 -1.019 . . . . 0.0 110.563 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.441 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -77.53 133.86 38.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.239 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.3 t -129.03 -17.21 3.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.024 -1.048 . . . . 0.0 111.954 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.3 mp -136.94 -69.45 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.7 -1.25 . . . . 0.0 110.623 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.42 -24.09 1.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.549 -0.72 . . . . 0.0 110.9 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.441 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -65.9 -13.41 59.63 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.083 -1.011 . . . . 0.0 110.957 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -99.27 15.36 26.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.016 -1.052 . . . . 0.0 110.957 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -136.87 10.06 3.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.893 -1.129 . . . . 0.0 111.148 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -120.83 104.78 10.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.093 -1.004 . . . . 0.0 110.242 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -72.59 106.35 4.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.193 -0.942 . . . . 0.0 110.114 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.456 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -93.53 167.71 13.4 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.255 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.456 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 53.1 Cg_endo -77.93 -175.82 17.47 Favored 'Cis proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.67 -2.221 . . . . 0.0 110.843 -0.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -103.2 171.51 7.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 109.977 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -104.21 117.17 33.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.01 . . . . 0.0 110.792 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.7 p90 -96.42 163.0 13.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 109.324 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -154.96 118.82 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.925 -1.109 . . . . 0.0 111.028 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.4 mtmt -139.07 131.57 28.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.314 -0.866 . . . . 0.0 109.632 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HB3' ' CE ' ' A' ' 65' ' ' LYS . 4.9 tttm -115.91 65.39 0.7 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.113 -0.992 . . . . 0.0 110.78 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 46.39 95.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.465 -0.772 . . . . 0.0 111.201 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.17 13.24 36.89 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.421 ' CE ' ' HB3' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -173.18 149.71 1.84 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.054 -1.262 . . . . 0.0 109.876 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -158.83 144.13 16.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.969 . . . . 0.0 111.261 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.503 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 3.3 m-85 -141.02 -161.79 1.27 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.537 -0.727 . . . . 0.0 109.663 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.453 HG11 ' CE1' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -170.18 163.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.213 -0.93 . . . . 0.0 109.933 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 102' ' ' SER . 3.4 pt20 -141.61 144.63 34.31 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.171 -0.956 . . . . 0.0 110.58 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.474 ' CD1' ' N ' ' A' ' 70' ' ' ILE . 2.2 mp -116.68 147.47 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.509 -0.744 . . . . 0.0 109.856 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.6 m -89.19 134.68 33.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 0.0 109.887 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.31 119.63 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 0.0 110.332 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -100.11 137.32 38.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.212 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.6 92.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.203 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 m -76.47 -25.49 54.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.155 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -60.4 -17.2 42.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.253 -0.904 . . . . 0.0 110.325 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.408 ' HA ' HG12 ' A' ' 121' ' ' ILE . 45.6 m0 -106.31 -51.45 2.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -0.956 . . . . 0.0 110.488 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.4 tt -89.52 125.25 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 109.886 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.434 HG23 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -86.83 -33.46 19.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.398 -0.814 . . . . 0.0 110.765 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 79' ' ' THR . . . 178.06 -174.9 47.16 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.139 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.403 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 0.6 OUTLIER -152.4 170.84 19.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -1.064 . . . . 0.0 110.259 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' LYS . 2.2 t -154.36 146.21 23.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 109.758 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.474 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 2.9 mt -140.95 144.44 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.619 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.474 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 71.33 2.29 4.19 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.632 -0.667 . . . . 0.0 111.204 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.33 21.47 13.14 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.73 -1.224 . . . . 0.0 111.103 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.47 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.0 160.14 40.13 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.655 -1.497 . . . . 0.0 110.193 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.11 -174.28 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.042 -1.036 . . . . 0.0 110.544 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 8.3 pt-20 -109.97 170.06 8.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.357 -0.839 . . . . 0.0 110.309 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.13 130.59 54.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 0.0 110.266 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.402 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 pp -67.56 103.63 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.074 -1.016 . . . . 0.0 109.59 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.43 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -95.13 -27.69 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.366 -0.834 . . . . 0.0 110.971 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.0 m -167.26 94.64 0.46 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.146 -0.971 . . . . 0.0 109.898 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -97.35 147.97 23.64 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 110.284 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.85 101.18 3.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 109.973 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -74.21 -32.37 63.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 0.0 110.312 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.47 -44.8 95.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 110.171 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.55 -3.36 43.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 110.729 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t0 59.97 50.37 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.96 -1.088 . . . . 0.0 110.13 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -147.44 128.45 14.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 110.091 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.77 172.37 12.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 110.444 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.43 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 97.2 m -141.11 157.1 45.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.447 -0.783 . . . . 0.0 109.458 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.43 ' N ' HG21 ' A' ' 101' ' ' THR . 0.7 OUTLIER -145.24 138.01 26.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.068 -1.02 . . . . 0.0 110.721 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -92.9 144.9 24.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.436 -0.79 . . . . 0.0 110.12 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.482 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 98.4 m-85 -130.76 145.5 51.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.142 -0.974 . . . . 0.0 110.845 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -95.59 126.59 40.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.338 -0.851 . . . . 0.0 109.295 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.78 177.55 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.974 -1.079 . . . . 0.0 111.038 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.5 t -89.4 110.91 21.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.48 -0.763 . . . . 0.0 109.258 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.438 ' CA ' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 49.65 -158.3 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.652 -178.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.31 50.92 0.83 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.983 -1.073 . . . . 0.0 111.066 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -144.85 84.35 1.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 110.137 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.43 170.44 19.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.72 145.87 30.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.171 . . . . 0.0 110.416 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 mt -137.28 139.34 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 0.0 109.838 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -76.19 121.2 22.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.27 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -129.15 178.16 17.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -144.63 165.84 26.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -1.154 . . . . 0.0 109.456 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.1 OUTLIER -157.79 150.52 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.869 -1.145 . . . . 0.0 111.171 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.404 ' O ' HG23 ' A' ' 79' ' ' THR . 1.1 m-20 -109.02 161.38 15.22 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.564 -0.71 . . . . 0.0 109.348 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 t -143.56 151.67 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.118 -0.989 . . . . 0.0 110.113 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 5.1 t80 -151.71 118.89 5.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 110.672 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.408 HG12 ' HA ' ' A' ' 77' ' ' TRP . 30.2 mt -142.63 151.62 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.969 . . . . 0.0 110.145 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.39 95.65 1.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.348 -0.845 . . . . 0.0 109.615 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -173.28 166.26 4.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.259 -0.901 . . . . 0.0 110.414 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -90.25 113.72 25.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.114 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -76.52 90.36 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.2 50.13 3.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.907 . . . . 0.0 110.388 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.71 29.96 45.88 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.21 101.21 4.44 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.175 -1.191 . . . . 0.0 110.27 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.12 136.49 24.03 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.819 1.431 . . . . 0.0 110.293 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 5.8 t80 -136.63 114.71 11.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.174 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -103.43 130.35 50.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 110.112 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . 1.6 t80 -145.21 113.84 6.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.763 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -162.81 92.15 0.77 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.929 . . . . 0.0 110.224 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -153.84 -169.75 3.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 110.433 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -119.63 86.29 2.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.318 -0.863 . . . . 0.0 110.022 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -84.59 -178.96 7.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.255 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 5.7 p30 -150.49 170.51 18.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 110.055 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.7 pt -156.92 165.63 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.076 -1.015 . . . . 0.0 110.754 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.409 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 98.8 m -91.76 117.91 30.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.499 -0.75 . . . . 0.0 110.33 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.422 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 30.6 m-85 -89.91 151.3 21.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 0.0 110.126 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -144.0 106.1 4.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.145 -0.972 . . . . 0.0 110.339 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.453 ' CE1' HG11 ' A' ' 68' ' ' VAL . 80.3 m-85 -91.46 148.6 22.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.91 . . . . 0.0 109.962 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.439 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 32.7 m-80 -131.1 105.03 7.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.271 -0.893 . . . . 0.0 110.508 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.72 -161.56 11.65 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo . . . . . 0 C--N 1.305 -1.748 0 O-C-N 123.919 1.483 . . . . 0.0 110.291 179.816 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 10.3 m-20 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 120.764 0.316 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.1 t -159.23 171.36 20.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.083 -1.011 . . . . 0.0 110.889 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.98 177.64 27.62 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.05 107.12 18.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -1.128 . . . . 0.0 110.204 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.479 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -94.3 155.4 17.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 110.091 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 143' ' ' ASN . 33.6 m-80 -79.92 138.62 37.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.77 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.4 OUTLIER -166.0 159.24 15.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.117 -0.989 . . . . 0.0 110.117 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -155.76 -170.33 3.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -0.86 . . . . 0.0 110.247 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.437 ' O ' ' CG2' ' A' ' 46' ' ' THR . 0.1 OUTLIER -140.06 173.09 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 109.943 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -150.41 160.94 43.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.192 -0.943 . . . . 0.0 110.197 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.416 ' CD ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -68.35 126.33 29.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.473 -0.767 . . . . 0.0 110.168 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.484 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -57.11 146.13 28.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 109.813 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 6.5 t30 72.93 -0.59 3.32 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.878 -0.514 . . . . 0.0 110.926 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -139.08 -168.62 2.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.976 -1.078 . . . . 0.0 109.556 179.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.422 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.9 OUTLIER -135.57 25.26 3.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.002 . . . . 0.0 110.558 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -135.37 123.69 23.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.147 -0.971 . . . . 0.0 111.035 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.437 ' CG2' ' O ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -52.54 122.1 8.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.46 -0.775 . . . . 0.0 109.313 179.046 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.59 -18.65 3.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.901 -1.125 . . . . 0.0 112.219 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.416 HD13 ' CD ' ' A' ' 40' ' ' LYS . 1.4 mp -138.47 -76.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.621 -1.299 . . . . 0.0 110.971 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.07 -27.02 0.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.735 -0.603 . . . . 0.0 111.116 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.424 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -63.16 -13.64 39.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.075 -1.016 . . . . 0.0 110.689 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.442 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 31.3 m-20 -98.68 10.63 40.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.07 -1.019 . . . . 0.0 110.752 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 16.6 m-85 -144.91 15.86 1.56 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.995 -1.066 . . . . 0.0 110.261 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.485 ' CZ ' ' HE2' ' A' ' 81' ' ' MET . 0.1 OUTLIER -113.44 108.75 17.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 110.369 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -72.21 147.76 46.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.153 -0.967 . . . . 0.0 110.19 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 20.6 pttt -146.38 163.35 30.36 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 109.957 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.401 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 50.9 Cg_endo -76.07 -177.11 19.92 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.84 -2.15 . . . . 0.0 110.918 0.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.451 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . . . -101.08 166.27 10.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.885 . . . . 0.0 110.005 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.454 ' CB ' ' CG ' ' A' ' 69' ' ' GLN . 1.2 mttm -103.39 112.44 25.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 0.0 110.364 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.479 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 1.9 p90 -95.83 163.33 13.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 109.682 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 1.1 tt -155.23 130.49 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.058 -1.026 . . . . 0.0 110.907 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -138.83 114.64 9.98 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.436 -0.79 . . . . 0.0 109.932 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -97.32 62.19 1.74 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 110.654 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 46.08 99.3 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.544 -0.723 . . . . 0.0 111.616 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.8 -21.67 43.92 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.16 166.09 23.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -1.182 . . . . 0.0 110.46 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.477 ' CD1' ' HA ' ' A' ' 108' ' ' LYS . 1.1 pt? -171.25 145.76 2.24 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.614 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.3 OUTLIER -141.41 -160.1 1.04 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.2 t -170.22 128.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.991 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.454 ' CG ' ' CB ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -98.79 132.49 44.11 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.033 -1.042 . . . . 0.0 109.704 179.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -112.62 128.16 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.85 . . . . 0.0 110.017 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 m -88.57 126.74 35.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.06 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.425 HG22 ' CB ' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -102.92 144.74 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.79 143.94 28.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 0.0 110.357 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 56.59 90.44 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.256 -0.902 . . . . 0.0 110.191 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -29.73 63.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.211 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -67.12 -53.08 34.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.848 . . . . 0.0 110.201 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.43 ' HA ' HG12 ' A' ' 121' ' ' ILE . 46.8 m0 -57.72 -56.06 26.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 9.3 tp -87.69 116.58 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.443 -0.786 . . . . 0.0 109.928 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.43 HG23 ' N ' ' A' ' 80' ' ' GLY . 0.5 OUTLIER -86.37 -23.98 25.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.477 -0.764 . . . . 0.0 110.67 -179.254 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.43 ' N ' HG23 ' A' ' 79' ' ' THR . . . 177.16 179.48 47.52 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.485 ' HE2' ' CZ ' ' A' ' 53' ' ' PHE . 17.3 mtt -151.52 165.79 33.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.395 -1.062 . . . . 0.0 109.796 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -154.56 148.84 26.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 110.215 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.503 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 2.3 mt -139.27 153.43 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 110.059 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.489 ' HB2' ' CE1' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 61.59 13.67 5.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.02 -1.05 . . . . 0.0 110.912 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.85 21.86 54.6 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.726 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.503 ' CD2' ' O ' ' A' ' 83' ' ' ILE . 2.1 p-80 -136.81 162.72 32.43 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.751 -1.441 . . . . 0.0 110.677 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 171.47 10.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.345 -0.847 . . . . 0.0 111.023 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.481 ' CB ' ' CZ ' ' A' ' 104' ' ' PHE . 5.7 pt-20 -100.4 170.41 8.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.445 -0.784 . . . . 0.0 110.535 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 102' ' ' SER . 9.4 t-20 -108.38 138.14 45.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 109.975 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.4 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.1 pp -68.14 101.14 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.969 -1.082 . . . . 0.0 109.561 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 92' ' ' SER . 0.4 OUTLIER -94.63 -31.95 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.352 -0.842 . . . . 0.0 110.978 -179.045 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.436 ' N ' HG22 ' A' ' 91' ' ' ILE . 9.0 m -166.2 98.25 0.61 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.063 -1.023 . . . . 0.0 109.934 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -95.05 137.62 33.86 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.41 -0.806 . . . . 0.0 109.911 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.57 90.07 2.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.358 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -31.03 64.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.947 . . . . 0.0 109.979 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.81 -44.84 95.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 110.176 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -95.25 9.86 38.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 110.556 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 53.7 58.91 4.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.032 -1.043 . . . . 0.0 110.19 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -147.94 162.33 39.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 110.391 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.425 ' CB ' HG22 ' A' ' 72' ' ' VAL . 1.2 mtp180 -164.71 149.42 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 109.961 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.433 ' CG2' HG23 ' A' ' 91' ' ' ILE . 52.4 m -142.04 154.87 45.3 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 109.986 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 24.8 p -146.91 146.67 30.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.981 . . . . 0.0 110.589 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -91.73 147.14 23.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.361 -0.837 . . . . 0.0 110.078 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.481 ' CZ ' ' CB ' ' A' ' 88' ' ' GLU . 6.1 m-85 -130.14 140.14 50.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 110.846 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -97.34 126.82 42.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 108.991 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.7 147.75 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.003 -1.06 . . . . 0.0 111.277 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.09 99.98 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.477 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 55.61 170.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.494 -0.754 . . . . 0.0 109.409 -178.191 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.34 79.25 1.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.967 -1.083 . . . . 0.0 111.065 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -146.41 71.89 1.26 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.827 . . . . 0.0 110.032 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.79 -101.48 0.19 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.427 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.3 OUTLIER -157.51 145.71 19.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -1.143 . . . . 0.0 110.156 -179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.401 ' N ' ' HG2' ' A' ' 112' ' ' LYS . 5.3 mm -136.27 137.92 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 109.879 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.14 108.49 9.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 0.0 110.058 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -120.54 -176.36 15.62 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 5.3 mtmm -144.62 167.29 22.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.307 -1.113 . . . . 0.0 110.001 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -157.74 142.29 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.109 -0.995 . . . . 0.0 110.709 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.7 155.92 18.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.438 -0.789 . . . . 0.0 109.679 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.77 153.65 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 0.0 110.451 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -151.29 103.62 3.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.423 -0.798 . . . . 0.0 110.553 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.447 HG22 ' N ' ' A' ' 122' ' ' ASP . 75.3 mt -133.09 151.0 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 0.0 110.204 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.447 ' N ' HG22 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -159.08 100.02 1.53 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.411 -0.806 . . . . 0.0 109.518 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -173.33 169.62 4.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 110.491 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -82.89 90.64 6.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.378 -0.826 . . . . 0.0 110.344 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.419 ' O ' ' CG1' ' A' ' 125' ' ' VAL . 2.0 p -77.43 134.66 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 110.156 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.58 25.47 1.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -0.881 . . . . 0.0 110.26 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.59 30.97 31.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -144.62 139.11 15.13 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.238 -1.154 . . . . 0.0 110.017 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -62.49 119.7 6.91 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.709 1.373 . . . . 0.0 110.448 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 4.5 t80 -117.87 113.48 21.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 110.271 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -104.6 111.08 23.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.079 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . 2.0 t80 -123.51 114.04 19.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 109.834 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -160.66 87.36 0.75 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.158 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -154.46 -173.01 4.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.868 . . . . 0.0 110.379 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -118.02 85.75 2.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.376 -0.827 . . . . 0.0 109.712 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -85.68 -179.05 6.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.28 -0.888 . . . . 0.0 110.362 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 8.5 p30 -151.01 167.99 25.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 110.331 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.433 ' C ' ' CD1' ' A' ' 41' ' ' TYR . 1.4 pt -157.28 177.19 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 110.499 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.427 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 20.7 m -91.57 121.2 33.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.903 . . . . 0.0 110.188 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -89.51 99.96 12.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.58 154.84 24.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 110.244 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -148.65 148.11 29.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.858 . . . . 0.0 109.919 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 35' ' ' ASN . 42.4 m-80 -138.99 98.13 3.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.88 . . . . 0.0 110.345 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -149.76 -148.83 4.85 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo . . . . . 0 C--N 1.307 -1.639 0 O-C-N 123.93 1.49 . . . . 0.0 110.463 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.409 ' O ' HG13 ' A' ' 60' ' ' ILE . 2.5 m-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.921 0.391 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 3.7 p -158.86 146.01 17.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.948 . . . . 0.0 110.743 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -179.66 176.64 47.73 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.58 114.84 25.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.193 -1.181 . . . . 0.0 110.47 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.506 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 1.5 tt -94.79 148.25 22.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 110.319 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.1 t30 -80.64 139.8 36.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.96 . . . . 0.0 110.03 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.51 ' CD2' ' N ' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -167.11 174.18 8.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.026 -1.046 . . . . 0.0 110.658 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.51 ' N ' ' CD2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -155.58 -165.76 2.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.594 -0.691 . . . . 0.0 109.571 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.07 164.63 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.1 -1.0 . . . . 0.0 110.274 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -147.83 148.26 30.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.373 -0.83 . . . . 0.0 109.978 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -67.82 128.37 36.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 110.09 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.473 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -52.53 146.62 9.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.176 -0.953 . . . . 0.0 109.901 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.3 t30 71.74 1.54 3.93 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.851 -0.53 . . . . 0.0 111.161 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -135.24 -162.22 1.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.89 -1.131 . . . . 0.0 109.531 179.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.43 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.9 OUTLIER -132.82 12.07 4.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 110.332 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -136.43 137.62 40.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.749 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.439 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -64.23 134.23 54.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.326 179.123 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.58 -17.25 3.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.904 -1.122 . . . . 0.0 112.159 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.0 mt -137.37 -50.75 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.61 -1.306 . . . . 0.0 111.184 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.0 5.34 11.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.385 -0.822 . . . . 0.0 111.512 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.439 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -73.5 -29.21 62.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.852 -1.155 . . . . 0.0 110.679 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -99.47 12.47 36.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.102 -0.999 . . . . 0.0 110.896 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -118.76 -18.84 8.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.009 -1.057 . . . . 0.0 110.451 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CE2' HG12 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -101.43 113.86 27.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 109.848 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.14 155.21 40.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.967 . . . . 0.0 110.459 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.35 160.06 43.35 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.833 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.29 -177.04 19.91 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.588 -2.255 . . . . 0.0 110.649 -0.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.471 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . . . -103.86 170.4 7.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.143 -0.973 . . . . 0.0 110.095 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -104.32 119.47 39.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.789 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.506 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 29.1 p90 -97.01 165.81 11.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 109.525 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 0.6 OUTLIER -154.95 124.04 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.937 -1.102 . . . . 0.0 110.937 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HG2' ' CB ' ' A' ' 66' ' ' LEU . 1.2 mtmt -137.67 125.13 21.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.345 -0.847 . . . . 0.0 110.684 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -103.81 62.42 0.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.393 -0.817 . . . . 0.0 110.402 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 47.67 98.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.463 -0.773 . . . . 0.0 111.35 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.11 12.59 39.08 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -173.7 154.81 2.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.889 -1.359 . . . . 0.0 110.227 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.555 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -154.27 151.31 28.98 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.073 -1.017 . . . . 0.0 111.247 179.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 13.8 m-85 -141.92 -164.71 1.85 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.467 -0.771 . . . . 0.0 109.233 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.441 HG13 ' CE1' ' A' ' 142' ' ' PHE . 1.1 t -169.09 131.98 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.023 -1.048 . . . . 0.0 110.835 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -101.72 135.88 42.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.392 -0.817 . . . . 0.0 109.838 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.437 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -113.62 133.38 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.133 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -91.04 128.73 36.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.931 . . . . 0.0 110.422 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.471 ' CG2' ' CB ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -104.86 142.24 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.906 . . . . 0.0 110.055 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -99.98 138.84 36.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.129 -0.982 . . . . 0.0 110.507 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.449 ' CD2' ' CE2' ' A' ' 77' ' ' TRP . 2.3 t-80 55.98 102.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.357 -0.839 . . . . 0.0 110.447 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.3 p -62.57 -43.73 98.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.125 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.76 -48.83 59.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.91 . . . . 0.0 110.146 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.449 ' CE2' ' CD2' ' A' ' 74' ' ' HIS . 44.4 m0 -57.41 -67.69 0.3 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 110.323 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 17.9 tt -87.83 117.98 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.39 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.43 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -85.9 -21.71 27.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.423 -0.798 . . . . 0.0 110.898 -178.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.43 ' N ' HG21 ' A' ' 79' ' ' THR . . . -175.09 177.13 47.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.29 159.22 43.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.432 -1.04 . . . . 0.0 109.884 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -155.84 151.33 27.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 0.0 109.932 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.481 ' HB ' ' CD1' ' A' ' 104' ' ' PHE . 3.9 mt -147.12 157.71 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 110.13 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.511 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 0.6 OUTLIER 62.48 14.52 7.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.611 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.23 21.23 61.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.511 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.1 p-80 -136.77 160.17 39.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.035 -1.273 . . . . 0.0 110.563 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.85 163.68 27.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.393 -0.817 . . . . 0.0 110.403 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.524 ' CB ' ' CE1' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -92.22 170.27 9.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.158 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.67 134.81 51.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.184 -0.948 . . . . 0.0 110.066 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -67.4 101.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.957 . . . . 0.0 109.618 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.434 HG22 ' CG2' ' A' ' 101' ' ' THR . 0.7 OUTLIER -95.27 -29.89 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 111.001 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.421 ' N ' HG21 ' A' ' 91' ' ' ILE . 3.5 m -167.15 94.94 0.47 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.035 -1.041 . . . . 0.0 110.048 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.435 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 18.2 ttmt -96.28 139.19 32.78 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.428 -0.795 . . . . 0.0 110.036 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.79 99.03 3.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.161 -0.962 . . . . 0.0 110.237 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 p -78.37 -32.37 48.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.1 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.12 99.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.879 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.06 10.68 36.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 0.0 110.549 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.54 58.11 5.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.978 -1.076 . . . . 0.0 110.011 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -146.43 165.04 30.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 110.265 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.471 ' CB ' ' CG2' ' A' ' 72' ' ' VAL . 2.8 mtp180 -168.73 154.42 6.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.368 -0.833 . . . . 0.0 109.903 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.434 ' CG2' HG22 ' A' ' 91' ' ' ILE . 78.2 m -141.76 154.66 45.41 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 109.839 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB2' ' CG ' ' A' ' 88' ' ' GLU . 99.7 p -144.84 139.14 27.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.981 . . . . 0.0 110.341 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -92.97 130.42 38.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.948 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.524 ' CE1' ' CB ' ' A' ' 88' ' ' GLU . 48.0 m-85 -114.43 147.74 38.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 110.451 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -105.17 135.15 47.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.342 -0.849 . . . . 0.0 110.052 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.3 m -149.36 158.97 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.36 -0.837 . . . . 0.0 109.891 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.4 p -53.17 -35.03 59.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.421 ' CE ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.49 -150.96 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.596 -0.69 . . . . 0.0 109.184 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.435 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -148.56 54.18 1.01 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.849 -1.157 . . . . 0.0 110.567 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -145.28 57.64 1.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.22 -0.925 . . . . 0.0 110.222 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.44 176.97 44.14 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.41 ' CE ' HG22 ' A' ' 139' ' ' THR . 0.1 OUTLIER -81.6 146.66 29.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -1.183 . . . . 0.0 110.446 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.403 ' N ' ' O ' ' A' ' 140' ' ' TYR . 7.6 mm -136.36 129.43 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.841 . . . . 0.0 109.942 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -76.72 112.55 13.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.839 . . . . 0.0 110.367 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -121.09 -175.15 15.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 82' ' ' SER . 63.1 mttt -144.88 164.86 29.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -1.143 . . . . 0.0 110.035 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.417 HG12 ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -157.98 145.76 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -0.948 . . . . 0.0 110.668 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.418 ' HB2' ' CG2' ' A' ' 79' ' ' THR . 72.9 m-20 -107.26 155.7 19.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.496 -0.753 . . . . 0.0 109.492 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.55 146.32 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.965 -1.084 . . . . 0.0 110.609 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -152.3 104.2 2.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.372 -0.83 . . . . 0.0 110.178 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 122' ' ' ASP . 46.4 mt -128.24 152.46 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.118 -0.989 . . . . 0.0 110.448 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.427 ' N ' HG23 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -160.28 95.56 1.14 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.438 -0.789 . . . . 0.0 109.69 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -173.72 175.53 2.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.0 110.23 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -84.16 102.78 12.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 110.273 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.414 ' O ' ' CG1' ' A' ' 125' ' ' VAL . 2.1 t -76.68 103.39 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.091 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.66 43.51 7.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.049 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.37 33.53 56.25 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.28 109.46 4.59 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.278 -1.13 . . . . 0.0 110.193 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -47.42 113.5 0.76 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.66 1.347 . . . . 0.0 110.164 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -112.48 151.14 30.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.0 110.437 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.64 125.89 26.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.393 -0.817 . . . . 0.0 110.115 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -140.4 129.87 24.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 110.155 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -176.3 88.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 110.037 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.35 -163.57 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 110.403 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -118.24 145.03 45.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 110.172 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -154.97 -179.03 7.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.095 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 8.9 p30 -150.27 169.85 20.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.187 -0.945 . . . . 0.0 110.558 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.416 ' CD1' ' OH ' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -156.53 173.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.608 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.41 HG22 ' CE ' ' A' ' 112' ' ' LYS . 24.6 m -91.82 162.77 14.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.473 -0.767 . . . . 0.0 110.526 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.451 ' CE2' ' HA3' ' A' ' 115' ' ' GLY . 97.0 m-85 -144.19 104.87 4.16 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.368 -0.832 . . . . 0.0 109.714 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -103.28 104.37 14.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 110.68 -179.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.441 ' CE1' HG13 ' A' ' 68' ' ' VAL . 29.6 m-85 -91.66 135.27 34.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.896 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 3.7 m-80 -126.25 105.09 8.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.096 -1.003 . . . . 0.0 110.227 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -150.96 -149.8 5.14 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 C--N 1.31 -1.478 0 O-C-N 123.702 1.369 . . . . 0.0 110.907 -179.768 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.042 0.449 . . . . 0.0 109.874 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -160.76 144.48 13.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.266 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.87 -175.99 42.6 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.39 105.62 17.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.34 -1.094 . . . . 0.0 110.395 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.499 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -94.8 154.49 17.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.0 110.31 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -80.13 137.86 36.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.335 -0.853 . . . . 0.0 110.037 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.4 OUTLIER -165.96 161.91 17.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.04 -1.038 . . . . 0.0 110.273 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 141' ' ' LYS . 0.2 OUTLIER -156.11 -176.82 6.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 109.908 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.434 ' O ' ' CG2' ' A' ' 46' ' ' THR . 25.8 m -140.38 116.84 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.018 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -90.27 163.1 14.89 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.494 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.434 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.4 OUTLIER -67.36 126.84 30.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 109.942 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.485 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -51.01 141.91 12.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.031 . . . . 0.0 109.943 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER 73.09 0.59 3.73 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.851 -0.53 . . . . 0.0 110.981 -179.408 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.434 ' CG2' ' HB3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -136.83 -168.52 2.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.85 -1.156 . . . . 0.0 109.677 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -135.86 24.41 3.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.188 -0.945 . . . . 0.0 110.422 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -135.65 119.91 17.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.069 . . . . 0.0 111.101 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.447 HG22 ' CB ' ' A' ' 50' ' ' ASN . 0.7 OUTLIER -50.14 117.57 2.43 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.589 -0.694 . . . . 0.0 109.501 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.6 t -129.64 -18.98 3.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.811 -1.181 . . . . 0.0 112.18 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 48' ' ' ILE . 71.8 mt -138.54 -79.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.653 -1.28 . . . . 0.0 111.0 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.41 ' N ' HG23 ' A' ' 48' ' ' ILE . . . -45.19 -26.93 0.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.738 -0.601 . . . . 0.0 111.159 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.447 ' CB ' HG22 ' A' ' 46' ' ' THR . 0.2 OUTLIER -67.68 -18.12 64.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.013 -1.055 . . . . 0.0 110.655 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -95.77 14.31 23.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 110.771 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -134.49 2.71 3.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.062 -1.024 . . . . 0.0 111.109 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.443 ' CE1' ' SD ' ' A' ' 81' ' ' MET . 26.7 m-85 -123.37 120.49 33.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.959 -1.088 . . . . 0.0 110.298 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -72.47 160.04 32.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.346 -0.846 . . . . 0.0 110.569 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.73 164.36 24.31 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.895 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.71 -175.71 17.18 Favored 'Cis proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.583 -0.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.435 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . . . -103.4 169.17 8.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.958 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.75 110.32 22.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.198 -0.939 . . . . 0.0 109.998 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -96.02 161.8 13.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.328 -0.857 . . . . 0.0 109.91 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -155.3 151.09 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.095 -1.003 . . . . 0.0 110.997 -179.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 17.9 mtmt -134.53 173.86 11.19 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.331 -0.855 . . . . 0.0 110.595 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -158.26 63.51 0.44 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.364 -0.835 . . . . 0.0 110.153 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.0 m120 48.71 84.5 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 111.274 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.64 18.57 47.77 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.53 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.451 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 3.1 ptpt -165.83 162.86 18.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.964 -1.316 . . . . 0.0 111.294 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.7 pt? -173.42 155.8 2.91 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.962 0.887 . . . . 0.0 111.205 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 1.1 m-85 -139.0 -159.4 0.95 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.422 ' CG2' ' HA ' ' A' ' 59' ' ' TYR . 1.2 t -169.41 133.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.141 -0.974 . . . . 0.0 109.796 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.42 136.17 38.24 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.106 -0.997 . . . . 0.0 109.866 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.68 131.12 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 110.364 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m -88.76 123.89 33.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.418 ' CG2' ' CB ' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -103.29 136.77 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 110.499 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.8 144.6 29.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.365 -0.834 . . . . 0.0 110.007 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 58.33 89.08 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.178 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.2 p -55.22 -23.89 24.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.302 -0.874 . . . . 0.0 110.58 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -73.92 -55.64 5.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.976 . . . . 0.0 110.322 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.444 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 42.2 m0 -48.91 -62.33 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 0.0 110.466 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.4 tp -87.9 115.5 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.282 -0.886 . . . . 0.0 110.242 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.436 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -87.33 -26.68 23.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.389 -0.819 . . . . 0.0 110.83 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.436 ' N ' HG21 ' A' ' 79' ' ' THR . . . -172.5 176.86 45.34 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.443 ' SD ' ' CE1' ' A' ' 53' ' ' PHE . 33.6 mtm -151.92 160.13 43.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.358 -1.083 . . . . 0.0 110.063 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 116' ' ' LYS . 1.3 m -154.53 132.93 11.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.185 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 16.8 mt -130.17 141.96 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.354 -0.841 . . . . 0.0 110.321 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.463 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 1.1 tm-20 69.89 3.08 4.15 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.415 -0.803 . . . . 0.0 111.295 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.38 24.42 10.25 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.695 -1.241 . . . . 0.0 111.119 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.47 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.49 159.12 42.89 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.605 -1.526 . . . . 0.0 110.179 179.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -70.48 -178.44 1.76 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.347 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.92 168.46 9.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 110.203 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.83 129.44 56.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.168 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.407 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.1 pp -67.98 101.23 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.139 -0.975 . . . . 0.0 109.484 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.442 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -93.19 -26.88 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.441 -0.787 . . . . 0.0 110.525 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.81 148.72 6.24 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.293 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.43 ' HG3' ' CG ' ' A' ' 100' ' ' ARG . 15.5 ttmt -141.98 149.32 39.9 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 110.019 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.74 91.34 2.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 0.0 110.466 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.4 p -73.33 -18.71 61.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 110.121 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.6 -28.46 69.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 110.379 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.55 23.24 3.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.253 -0.904 . . . . 0.0 110.249 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.54 79.72 0.11 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 0.0 110.432 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -148.14 167.15 25.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.43 ' CG ' ' HG3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -172.46 157.53 4.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 110.209 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.442 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 90.8 m -141.44 152.82 44.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.435 -0.791 . . . . 0.0 109.651 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.24 145.22 31.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.084 -1.01 . . . . 0.0 110.694 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -93.57 143.37 26.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.433 -0.792 . . . . 0.0 109.886 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.408 ' CD1' ' HB ' ' A' ' 83' ' ' ILE . 44.2 m-85 -127.36 127.58 44.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.976 . . . . 0.0 110.663 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -93.27 125.2 37.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 109.792 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.0 m -149.33 163.9 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.022 -1.049 . . . . 0.0 110.887 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p -80.21 105.03 11.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.388 -0.82 . . . . 0.0 109.348 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.483 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 53.74 174.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 109.756 -178.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.454 ' HG ' ' CD1' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -149.91 73.7 1.18 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.004 -1.06 . . . . 0.0 110.898 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.439 ' ND2' HD11 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -144.41 66.76 1.26 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.066 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.39 -108.64 0.31 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.86 146.34 19.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -1.145 . . . . 0.0 110.342 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.9 mt -137.38 142.8 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.357 -0.839 . . . . 0.0 110.157 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -76.3 125.42 29.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.218 -0.926 . . . . 0.0 110.137 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -131.56 -177.04 14.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.5 mtmm -142.38 161.0 39.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.364 -1.08 . . . . 0.0 109.678 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.438 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -158.23 146.43 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.046 -1.034 . . . . 0.0 110.735 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.416 ' N ' HG12 ' A' ' 117' ' ' ILE . 89.0 m-20 -110.12 159.68 17.13 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.48 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -133.63 147.05 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.09 -1.006 . . . . 0.0 110.17 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -152.03 113.14 4.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 110.684 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.475 HD13 ' CD2' ' A' ' 132' ' ' TYR . 2.6 mp -138.75 152.21 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 0.0 109.856 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.15 98.43 1.3 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.953 . . . . 0.0 110.015 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -174.03 178.68 2.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 110.18 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -93.06 107.69 19.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 110.175 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.42 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 56.0 t -75.84 90.58 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.826 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.42 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 63.7 53.04 2.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.277 -0.89 . . . . 0.0 110.012 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.33 36.95 48.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -145.04 97.48 4.84 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.296 -1.12 . . . . 0.0 110.366 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.99 110.15 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.863 1.454 . . . . 0.0 110.15 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -116.63 153.1 32.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.341 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -136.68 112.19 9.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 110.13 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.48 ' CE2' ' HB ' ' A' ' 119' ' ' VAL . 3.7 t80 -115.71 128.24 55.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.004 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -167.49 86.69 0.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.404 -0.81 . . . . 0.0 109.948 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -153.33 -169.19 3.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.898 . . . . 0.0 110.391 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.401 ' ND1' ' OD1' ' A' ' 118' ' ' ASP . 13.4 t60 -119.61 148.39 43.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 109.99 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -154.79 -179.66 8.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.882 . . . . 0.0 110.136 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.471 ' ND2' ' CE2' ' A' ' 41' ' ' TYR . 42.9 p-10 -151.82 170.66 19.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.882 . . . . 0.0 110.261 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.438 HG12 ' CG2' ' A' ' 117' ' ' ILE . 0.3 OUTLIER -157.76 168.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.917 . . . . 0.0 110.348 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 87.0 m -91.63 117.53 29.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.335 -0.853 . . . . 0.0 109.82 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.458 ' CD2' HG12 ' A' ' 83' ' ' ILE . 10.4 m-85 -88.91 106.51 18.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 110.326 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -86.69 159.59 19.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.318 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -148.87 150.86 33.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.878 . . . . 0.0 110.125 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -143.84 96.32 2.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 110.234 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -135.73 -140.01 4.1 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.432 ' O ' ' ND2' ' A' ' 110' ' ' ASN . 39.2 Cg_exo . . . . . 0 C--N 1.309 -1.521 0 O-C-N 123.711 1.374 . . . . 0.0 110.422 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.027 0.442 . . . . 0.0 110.156 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.18 144.07 14.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.946 . . . . 0.0 110.264 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.61 -177.52 45.92 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.34 108.4 19.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.351 -1.087 . . . . 0.0 110.359 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.497 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -94.84 150.0 20.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.399 -0.813 . . . . 0.0 109.913 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.416 ' N ' HD11 ' A' ' 34' ' ' LEU . 5.1 m-80 -78.93 141.34 37.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.991 -1.068 . . . . 0.0 109.7 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -165.4 156.48 14.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 110.557 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 141' ' ' LYS . 5.2 tt0 -155.56 -175.85 5.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 0.0 109.946 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.63 173.22 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 110.449 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -147.79 161.07 41.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -0.805 . . . . 0.0 109.951 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.434 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -67.53 132.73 48.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 0.0 109.879 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.512 ' CE2' ' ND2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -57.45 146.04 30.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 110.052 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.4 t30 71.07 2.89 4.43 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.801 -0.562 . . . . 0.0 111.055 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.413 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -135.64 -164.48 1.55 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.828 -1.17 . . . . 0.0 109.767 179.268 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.413 ' N ' ' OG1' ' A' ' 43' ' ' THR . 2.2 t-20 -131.81 14.21 4.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 110.296 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.81 135.55 41.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.069 -1.019 . . . . 0.0 110.401 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -68.07 133.48 49.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.403 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.48 -17.45 3.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.017 -1.052 . . . . 0.0 112.184 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.6 mt -136.92 -58.6 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.607 -1.308 . . . . 0.0 111.121 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.09 -10.04 27.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.472 -0.768 . . . . 0.0 111.424 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.442 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -75.68 -18.15 59.72 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.843 -1.16 . . . . 0.0 110.787 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -102.06 15.41 29.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.0 110.731 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -129.12 3.37 5.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.049 -1.032 . . . . 0.0 110.985 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -128.94 117.54 21.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.994 -1.066 . . . . 0.0 110.293 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -72.83 166.71 22.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.341 -0.849 . . . . 0.0 110.494 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -146.92 160.35 40.69 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.304 -0.873 . . . . 0.0 109.834 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.13 -175.36 16.49 Favored 'Cis proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.752 -2.186 . . . . 0.0 110.725 -0.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.77 170.23 8.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -0.895 . . . . 0.0 109.96 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.437 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -107.97 111.67 23.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.11 -0.994 . . . . 0.0 110.693 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.497 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 2.7 p90 -97.84 165.24 12.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.262 -0.899 . . . . 0.0 110.132 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -155.52 154.15 6.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.254 -0.904 . . . . 0.0 110.66 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -133.35 170.64 15.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.424 -0.798 . . . . 0.0 110.479 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.427 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 0.7 OUTLIER -152.75 62.33 0.79 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -0.83 . . . . 0.0 110.12 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 50.47 82.86 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.353 -0.842 . . . . 0.0 111.067 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.51 21.93 35.91 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.427 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 6.2 ptpt -167.15 163.71 15.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.021 -1.282 . . . . 0.0 110.768 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.5 pt? -173.73 154.19 2.39 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.009 0.909 . . . . 0.0 111.034 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.565 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -139.61 -155.52 0.6 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.779 -0.575 . . . . 0.0 109.475 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -170.67 135.88 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.195 -0.94 . . . . 0.0 110.536 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.437 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -99.29 133.73 43.18 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.29 -0.881 . . . . 0.0 109.657 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.0 140.42 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.363 -0.836 . . . . 0.0 110.3 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.5 m -89.23 129.9 35.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.754 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.47 128.25 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 110.544 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -100.92 134.97 43.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.304 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 32.1 m170 54.76 94.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.345 -0.847 . . . . 0.0 110.245 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -27.85 61.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.942 . . . . 0.0 110.288 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -27.11 61.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.186 -0.946 . . . . 0.0 110.283 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.404 ' HA ' HG12 ' A' ' 121' ' ' ILE . 38.4 m0 -92.48 -52.27 4.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.2 -0.938 . . . . 0.0 110.057 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 1.5 tt -88.65 119.15 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.293 -0.88 . . . . 0.0 109.392 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -86.98 -23.83 24.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.42 -0.8 . . . . 0.0 111.389 -178.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.438 ' N ' HG23 ' A' ' 79' ' ' THR . . . -178.49 -178.84 48.15 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.064 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 19.0 mtm -152.24 162.73 40.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.464 -1.021 . . . . 0.0 110.103 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -155.2 141.26 18.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 0.0 109.935 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 7.1 mt -135.75 140.47 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 110.589 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 71.16 1.99 4.05 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.528 -0.733 . . . . 0.0 111.442 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.79 21.79 10.85 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.536 -1.316 . . . . 0.0 111.233 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.485 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.13 158.58 44.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.622 -1.517 . . . . 0.0 110.05 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -71.41 -177.6 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.141 -0.975 . . . . 0.0 110.337 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -109.95 170.21 8.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.322 -0.861 . . . . 0.0 110.182 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -115.4 134.73 54.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.294 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.48 102.29 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.976 . . . . 0.0 109.668 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.444 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -95.51 -27.52 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 111.008 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.413 ' N ' HG21 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -167.53 103.62 0.51 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.08 -1.013 . . . . 0.0 109.856 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -95.53 149.59 21.25 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.386 -0.821 . . . . 0.0 110.259 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.34 61.58 1.39 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 110.116 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 m -54.49 -30.58 53.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.214 -0.928 . . . . 0.0 110.148 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.09 -49.27 75.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.094 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -95.97 9.9 39.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.566 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.47 55.62 4.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.082 -1.011 . . . . 0.0 110.326 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -147.53 159.2 44.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.173 -0.954 . . . . 0.0 110.402 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -163.16 162.77 25.7 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.325 -0.86 . . . . 0.0 110.023 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.444 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 85.7 m -141.07 152.71 45.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.944 . . . . 0.0 109.655 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 101' ' ' THR . 70.1 p -145.71 143.4 29.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.977 -1.077 . . . . 0.0 110.725 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -93.07 143.87 25.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.381 -0.824 . . . . 0.0 109.843 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -125.64 145.46 50.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.108 -0.995 . . . . 0.0 110.561 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.45 130.61 47.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.363 -0.835 . . . . 0.0 110.141 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 107' ' ' SER . 12.5 p -148.9 150.56 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 110.292 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.422 ' N ' HG22 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -50.34 -39.63 46.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.449 ' CE ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.5 -157.56 0.33 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.445 -0.784 . . . . 0.0 109.591 179.168 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.43 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -148.19 62.77 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.96 -1.087 . . . . 0.0 110.612 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -145.81 62.92 1.25 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 110.078 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.82 -179.97 33.15 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -82.05 145.28 30.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -1.14 . . . . 0.0 110.57 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.1 mt -137.77 149.71 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.888 . . . . 0.0 109.923 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -76.04 120.96 22.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.0 110.183 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.485 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -124.71 171.21 16.78 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 82' ' ' SER . 47.1 mttt -146.37 159.94 42.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.276 -1.132 . . . . 0.0 110.033 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.41 HG12 ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -158.12 144.35 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.155 -0.965 . . . . 0.0 110.317 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.41 ' N ' HG12 ' A' ' 117' ' ' ILE . 11.9 m-20 -106.38 158.09 17.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.341 -0.849 . . . . 0.0 109.676 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.89 150.99 34.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.243 -0.911 . . . . 0.0 109.771 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -151.74 100.26 2.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 0.0 110.543 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 77' ' ' TRP . 54.7 mt -129.74 151.99 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 110.176 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.48 96.58 1.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.856 . . . . 0.0 110.012 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -173.76 -175.78 1.14 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.868 . . . . 0.0 110.394 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.91 104.15 16.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.338 -0.851 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.6 95.68 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 110.072 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.13 44.44 10.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 110.128 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.85 30.09 44.71 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -145.34 107.79 4.48 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.295 -1.12 . . . . 0.0 110.233 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -52.12 108.31 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.684 1.36 . . . . 0.0 110.214 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -110.66 119.33 38.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 0.0 110.46 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -106.33 117.22 33.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 110.138 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -126.45 121.22 31.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 0.0 110.078 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -166.69 90.47 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 110.415 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.03 -165.1 2.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.145 -0.972 . . . . 0.0 110.392 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -120.87 86.11 2.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 109.997 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -85.45 -179.17 6.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.881 . . . . 0.0 110.392 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.512 ' ND2' ' CE2' ' A' ' 41' ' ' TYR . 46.2 p30 -151.28 171.05 18.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 110.29 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.4 pt -156.5 162.22 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.2 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 62.2 m -91.67 121.24 33.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 110.61 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.485 ' CD1' ' HA3' ' A' ' 115' ' ' GLY . 21.9 m-85 -90.2 155.16 19.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.835 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -144.77 99.82 3.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.518 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -91.6 144.03 25.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.37 -0.831 . . . . 0.0 109.825 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.436 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 5.4 m-80 -132.96 100.96 5.05 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.158 -0.964 . . . . 0.0 110.51 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -163.21 -144.03 3.89 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo . . . . . 0 C--N 1.309 -1.521 0 O-C-N 123.779 1.41 . . . . 0.0 110.635 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.42 ' CA ' ' HD3' ' A' ' 61' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.944 0.402 . . . . 0.0 110.277 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.6 t -159.65 140.73 12.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 110.525 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 177.37 178.76 47.27 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.03 111.29 21.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -1.125 . . . . 0.0 110.389 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.512 ' CB ' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -94.16 151.12 19.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 109.665 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.431 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -79.06 131.5 36.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.178 -0.951 . . . . 0.0 110.538 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.507 ' CE1' ' CB ' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -166.11 158.14 14.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 111.034 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -155.53 -165.96 2.12 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.465 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -141.22 175.08 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 110.36 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 54.3 m-85 -148.32 163.99 35.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.475 -0.766 . . . . 0.0 109.813 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.24 128.46 36.64 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 109.895 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.474 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -54.97 146.37 17.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 110.112 -179.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.0 t-20 71.87 2.93 4.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.922 -0.487 . . . . 0.0 110.941 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.416 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -136.23 -162.35 1.26 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.888 -1.133 . . . . 0.0 109.706 179.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.416 ' N ' ' OG1' ' A' ' 43' ' ' THR . 22.9 m120 -133.05 15.74 4.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 110.445 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.5 139.03 43.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.16 -0.963 . . . . 0.0 110.361 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.437 ' CG2' ' HB2' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -74.08 133.06 42.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.994 . . . . 0.0 109.379 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.76 -16.97 4.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.046 -1.033 . . . . 0.0 111.82 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.8 mt -137.11 -64.63 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.831 -1.168 . . . . 0.0 110.623 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.4 -18.09 6.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.495 -0.753 . . . . 0.0 111.163 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.437 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 0.1 OUTLIER -68.35 -10.87 57.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.926 -1.108 . . . . 0.0 110.847 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -102.38 12.8 36.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.879 -1.138 . . . . 0.0 110.843 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -136.29 6.44 3.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.012 -1.055 . . . . 0.0 110.667 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -114.22 98.47 6.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.957 . . . . 0.0 109.845 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -72.03 103.28 3.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.522 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.432 ' HG3' ' N ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -93.05 165.06 19.38 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.204 -0.935 . . . . 0.0 109.879 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.432 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 50.1 Cg_endo -78.61 -176.36 18.53 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.468 -2.305 . . . . 0.0 110.524 -0.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' CB ' ' CE1' ' A' ' 36' ' ' TYR . . . -103.15 165.41 11.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.25 -0.906 . . . . 0.0 110.008 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.404 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.71 109.52 21.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 110.168 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.512 ' CD1' ' CB ' ' A' ' 34' ' ' LEU . 19.4 p90 -96.95 161.78 13.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.676 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -154.0 153.05 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.111 -0.993 . . . . 0.0 110.357 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -135.89 174.03 11.06 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.324 -0.86 . . . . 0.0 110.453 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -159.48 62.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.344 -0.848 . . . . 0.0 110.108 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 48.97 87.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.449 -0.782 . . . . 0.0 111.193 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.59 25.15 33.69 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.087 -1.054 . . . . 0.0 110.558 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -171.9 158.85 4.94 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.962 -1.317 . . . . 0.0 111.028 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.3 pt? -173.4 150.29 1.82 Allowed 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 122.068 0.937 . . . . 0.0 111.334 178.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.585 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -140.03 -161.06 1.14 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -167.15 142.89 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.578 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 8.7 pt20 -101.12 134.8 43.6 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.906 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.75 138.85 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.902 . . . . 0.0 109.842 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.6 m -89.03 135.87 33.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 110.469 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.42 122.69 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.865 . . . . 0.0 110.201 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -100.23 143.07 30.85 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.107 -0.995 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 62.03 74.53 0.44 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 110.029 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.4 m -64.35 -19.1 65.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.348 -0.845 . . . . 0.0 110.551 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.32 -45.11 57.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.089 -1.007 . . . . 0.0 110.315 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -77.19 -42.44 37.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 110.19 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 6.1 tp -88.14 118.82 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -0.92 . . . . 0.0 109.3 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.454 ' CG2' ' HB3' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -85.55 -24.06 27.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 111.029 -178.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 79' ' ' THR . . . 175.48 -179.16 46.85 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.006 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.408 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 28.5 mtm -151.35 158.55 43.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.458 -1.025 . . . . 0.0 109.791 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.33 154.87 34.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.087 -1.008 . . . . 0.0 110.17 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.499 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 12.9 mt -141.96 155.36 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 110.195 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.502 ' HB2' ' CE1' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 58.79 16.55 4.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.013 . . . . 0.0 110.791 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.19 21.65 60.41 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.92 -1.133 . . . . 0.0 110.424 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.502 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 2.2 p-80 -135.18 157.42 46.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.842 -1.387 . . . . 0.0 110.525 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 178.8 3.65 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.329 -0.857 . . . . 0.0 110.701 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.421 ' HG3' ' CB ' ' A' ' 102' ' ' SER . 2.7 pt-20 -108.5 166.65 10.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.362 -0.836 . . . . 0.0 110.221 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 102' ' ' SER . 1.4 t30 -105.22 130.89 53.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -0.919 . . . . 0.0 110.209 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.12 102.56 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -0.954 . . . . 0.0 110.081 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 92' ' ' SER . 1.3 tt -95.78 -26.83 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.88 . . . . 0.0 110.855 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.448 ' N ' HG22 ' A' ' 91' ' ' ILE . 1.4 m -167.5 99.02 0.49 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.148 -0.97 . . . . 0.0 109.874 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.422 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 7.7 ttmm -95.7 103.78 15.67 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.382 -0.824 . . . . 0.0 110.178 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.33 95.01 7.78 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.0 110.293 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.3 -29.86 61.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 110.109 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.09 94.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 110.354 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -95.69 14.56 22.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.206 -0.934 . . . . 0.0 110.593 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.6 t0 50.16 57.42 6.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.033 -1.042 . . . . 0.0 110.263 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -146.84 -176.74 5.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.166 -0.959 . . . . 0.0 110.318 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.422 ' HG3' ' CG ' ' A' ' 93' ' ' LYS . 4.9 ttm180 -176.75 162.45 2.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.438 -0.789 . . . . 0.0 109.989 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.434 HG23 ' N ' ' A' ' 102' ' ' SER . 86.8 m -142.68 150.6 40.38 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.86 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.434 ' N ' HG23 ' A' ' 101' ' ' THR . 19.5 p -146.33 148.72 32.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.045 -1.034 . . . . 0.0 110.711 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -92.99 146.92 23.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.322 -0.862 . . . . 0.0 110.088 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -131.15 144.15 51.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.109 -0.994 . . . . 0.0 110.76 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -99.37 128.42 45.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.882 . . . . 0.0 109.366 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.442 HG23 ' CD1' ' A' ' 113' ' ' ILE . 1.0 OUTLIER -149.73 143.09 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 110.825 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.4 113.21 2.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.111 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 47.23 -163.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.539 -0.726 . . . . 0.0 109.69 -178.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.423 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -151.66 64.61 0.87 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.861 -1.149 . . . . 0.0 110.753 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -146.2 58.78 1.22 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 110.308 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.8 171.05 38.6 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 113' ' ' ILE . 1.6 tmtt? -81.6 147.48 29.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -1.152 . . . . 0.0 110.326 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.442 ' CD1' HG23 ' A' ' 106' ' ' VAL . 1.4 mt -136.01 140.84 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.941 . . . . 0.0 110.021 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.24 112.32 12.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.129 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -111.21 178.24 19.45 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.409 ' HA ' ' CB ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -145.04 161.54 39.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -1.115 . . . . 0.0 109.854 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -157.02 140.96 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.121 -0.987 . . . . 0.0 110.392 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.454 ' HB3' ' CG2' ' A' ' 79' ' ' THR . 25.1 t0 -105.24 152.47 22.84 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.354 -0.841 . . . . 0.0 109.473 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.421 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -128.86 151.89 36.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.017 -1.052 . . . . 0.0 110.386 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.401 ' CB ' ' OG1' ' A' ' 79' ' ' THR . 27.0 t80 -151.39 100.63 2.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 110.621 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.473 HG23 ' CD2' ' A' ' 130' ' ' PHE . 4.3 mt -127.36 152.89 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.965 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -159.7 98.77 1.38 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.262 -0.899 . . . . 0.0 109.912 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 124' ' ' LYS . 12.5 pt-20 -173.75 -152.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 110.363 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -101.98 167.05 10.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.329 -0.857 . . . . 0.0 110.423 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' A' ' 126' ' ' ASN . 1.3 t -158.05 114.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 125' ' ' VAL . 3.0 t-20 56.26 25.92 9.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.441 -0.787 . . . . 0.0 109.826 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 86.04 37.32 9.28 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -148.92 145.91 20.59 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.11 -1.229 . . . . 0.0 110.189 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -66.83 130.31 22.89 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.861 1.453 . . . . 0.0 110.027 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.473 ' CD2' HG23 ' A' ' 121' ' ' ILE . 10.2 t80 -116.34 140.16 49.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.174 -0.954 . . . . 0.0 110.548 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.79 105.01 5.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.829 . . . . 0.0 109.943 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.47 ' CD2' HD11 ' A' ' 121' ' ' ILE . 4.0 t80 -120.71 128.57 53.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 110.046 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -170.82 88.45 0.12 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.089 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.44 -175.03 5.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.356 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -119.52 85.27 2.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 110.242 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -86.26 -178.83 6.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.354 -0.842 . . . . 0.0 110.078 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.409 ' CB ' ' HA ' ' A' ' 116' ' ' LYS . 4.2 p30 -150.87 178.42 9.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 110.281 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -156.69 168.88 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.382 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.403 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 48.9 m -92.03 119.59 31.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.342 -0.849 . . . . 0.0 110.931 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.485 ' CE1' ' HA3' ' A' ' 115' ' ' GLY . 28.3 m-85 -90.92 162.86 14.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.258 -0.902 . . . . 0.0 110.026 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.01 99.89 2.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.057 -1.027 . . . . 0.0 110.702 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -91.95 150.96 20.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.195 -0.94 . . . . 0.0 110.417 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.423 ' ND2' ' N ' ' A' ' 143' ' ' ASN . 2.3 m-80 -141.66 104.58 4.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -0.886 . . . . 0.0 110.449 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.423 ' HA3' HD11 ' A' ' 109' ' ' LEU . . . -157.28 -146.74 4.57 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.411 ' CD ' HD13 ' A' ' 109' ' ' LEU . 11.0 Cg_endo . . . . . 0 C--N 1.309 -1.552 0 O-C-N 123.697 1.367 . . . . 0.0 110.671 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 8.4 m-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.706 0.289 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -160.98 156.01 24.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.024 -1.048 . . . . 0.0 110.711 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' CD2' ' A' ' 59' ' ' TYR . . . 164.24 171.88 31.03 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.88 107.77 19.45 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.235 -1.156 . . . . 0.0 110.538 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.486 ' HB2' ' CD2' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -95.47 157.56 15.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.96 -1.088 . . . . 0.0 110.487 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 143' ' ' ASN . 49.2 m-20 -80.17 143.68 33.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 110.142 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.5 OUTLIER -166.22 156.42 12.36 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.948 . . . . 0.0 110.096 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -155.6 -178.58 7.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -0.984 . . . . 0.0 110.444 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.48 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -140.14 170.33 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 0.0 109.959 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 47.3 m-85 -147.27 159.45 43.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.344 -0.847 . . . . 0.0 110.192 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HE3' ' CB ' ' A' ' 47' ' ' SER . 9.4 tppt? -67.81 145.81 54.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.948 . . . . 0.0 109.979 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.62 140.91 53.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.074 -1.016 . . . . 0.0 110.311 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 61.59 26.26 16.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.925 . . . . 0.0 110.112 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.416 ' OG1' ' CG ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -133.14 -154.67 0.62 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.389 -0.819 . . . . 0.0 110.058 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -126.18 -28.62 3.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.18 -0.95 . . . . 0.0 110.741 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.93 172.92 12.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.068 -1.02 . . . . 0.0 110.973 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.433 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -75.54 142.24 42.83 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.507 -0.745 . . . . 0.0 109.352 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.436 ' CB ' ' HE3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -129.62 -17.9 3.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.06 -1.025 . . . . 0.0 112.122 -178.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 49' ' ' ALA . 12.2 mt -137.63 -71.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.757 -1.215 . . . . 0.0 110.781 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.421 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -47.25 -24.98 0.83 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.704 -0.623 . . . . 0.0 111.242 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.433 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -67.3 -13.99 62.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.995 -1.066 . . . . 0.0 110.89 -179.682 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.412 ' C ' ' CD1' ' A' ' 52' ' ' TYR . 27.3 m-20 -88.83 -11.11 45.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 110.785 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 0.6 OUTLIER -119.16 7.4 11.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.022 -1.049 . . . . 0.0 110.71 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.7 106.93 16.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.034 -1.041 . . . . 0.0 110.42 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -72.4 153.54 41.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.131 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.63 159.19 44.94 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.107 -0.996 . . . . 0.0 109.985 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.411 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 57.2 Cg_endo -78.97 -175.93 17.66 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.752 -2.187 . . . . 0.0 110.681 -0.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -104.23 173.38 6.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 110.251 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.477 ' CB ' ' CG ' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -103.59 120.61 41.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.887 . . . . 0.0 110.349 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.494 ' CD1' ' HD2' ' A' ' 61' ' ' LYS . 11.6 p90 -97.79 159.14 15.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.95 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 1.1 tt -155.85 114.5 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 110.469 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.494 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -128.1 127.88 43.87 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.153 -0.967 . . . . 0.0 110.549 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.06 62.11 0.69 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.402 -0.811 . . . . 0.0 110.128 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.4 OUTLIER 46.99 98.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.531 -0.73 . . . . 0.0 111.19 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.1 -11.65 58.72 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.64 162.82 36.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.028 -1.277 . . . . 0.0 110.296 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.6 pt? -168.32 144.99 3.92 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.151 -0.968 . . . . 0.0 111.358 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.489 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -139.44 -160.69 1.09 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.2 t -170.18 129.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.204 -0.935 . . . . 0.0 110.206 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.477 ' CG ' ' CB ' ' A' ' 58' ' ' LYS . 3.0 pp0? -96.37 126.54 41.64 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.229 -0.92 . . . . 0.0 109.254 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.73 139.33 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 110.283 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m -88.31 141.7 28.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.359 -0.838 . . . . 0.0 109.425 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.75 135.43 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 110.609 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -101.18 131.2 47.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.336 -0.852 . . . . 0.0 109.815 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 55.85 102.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.216 -0.928 . . . . 0.0 110.181 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -31.1 65.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.941 . . . . 0.0 110.537 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -54.11 -59.51 4.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.972 . . . . 0.0 110.178 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.445 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 20.0 m0 -53.35 -66.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.925 . . . . 0.0 110.31 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.434 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 19.2 tt -88.76 118.69 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.249 -0.907 . . . . 0.0 109.746 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.447 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -87.47 -24.79 24.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 111.662 -178.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.447 ' N ' HG21 ' A' ' 79' ' ' THR . . . -174.54 175.45 46.82 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.553 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 2.9 mpp? -150.95 111.3 4.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.595 -0.944 . . . . 0.0 110.16 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -86.23 159.94 19.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.031 -1.043 . . . . 0.0 109.603 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 1.2 mt -151.14 122.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -0.902 . . . . 0.0 110.534 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.463 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 70.49 3.31 4.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.484 -0.76 . . . . 0.0 111.424 179.598 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.09 20.36 9.32 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.548 -1.311 . . . . 0.0 111.092 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.477 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -136.66 157.32 47.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.699 -1.471 . . . . 0.0 110.148 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -171.05 0.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.519 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -110.42 170.56 8.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 110.108 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -119.12 121.11 39.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 110.156 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.401 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 pp -67.22 103.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.062 -1.024 . . . . 0.0 109.48 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.422 HG21 ' CG2' ' A' ' 101' ' ' THR . 1.8 tt -94.32 -27.76 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.444 -0.785 . . . . 0.0 110.767 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.9 m -166.71 98.54 0.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.164 -0.96 . . . . 0.0 109.879 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.41 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 14.7 ttmt -96.05 106.54 18.73 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.403 -0.81 . . . . 0.0 110.315 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.84 95.26 7.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 0.0 110.038 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.2 p -74.91 -26.05 59.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.28 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.17 -49.2 76.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.128 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -96.05 13.82 25.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.925 . . . . 0.0 110.447 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 53.16 63.16 2.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.096 -1.003 . . . . 0.0 110.128 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.93 173.8 12.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.331 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.41 ' HG3' ' CG ' ' A' ' 93' ' ' LYS . 3.5 ttm180 -169.37 165.16 10.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 0.0 110.236 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.422 ' CG2' HG21 ' A' ' 91' ' ' ILE . 94.9 m -143.99 151.9 40.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -0.845 . . . . 0.0 109.903 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 2.9 p -145.14 140.17 27.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.941 -1.1 . . . . 0.0 110.912 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.58 141.14 28.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 0.0 110.109 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.441 ' CG ' HD13 ' A' ' 83' ' ' ILE . 87.8 m-85 -131.45 145.41 51.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.131 -0.981 . . . . 0.0 110.851 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -104.33 130.36 52.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.316 -0.865 . . . . 0.0 109.471 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.426 HG23 ' CD1' ' A' ' 113' ' ' ILE . 1.0 OUTLIER -150.03 150.89 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.982 -1.074 . . . . 0.0 110.881 -179.194 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.1 t -66.13 113.2 4.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.189 -0.944 . . . . 0.0 109.027 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.481 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 51.88 -178.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.324 -178.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.428 HD11 ' O ' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -150.0 58.13 0.97 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 0.0 111.554 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 11.3 t30 -145.28 58.83 1.28 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.841 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.32 174.43 44.59 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -81.97 141.43 33.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -1.111 . . . . 0.0 110.659 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.426 ' CD1' HG23 ' A' ' 106' ' ' VAL . 72.6 mt -137.7 150.86 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.371 -0.831 . . . . 0.0 109.735 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -76.21 126.75 31.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.155 -0.966 . . . . 0.0 110.568 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -132.64 172.29 21.32 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 10.7 mttt -144.07 167.51 22.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.126 -1.22 . . . . 0.0 109.413 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.405 HD12 ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -158.5 145.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.983 -1.073 . . . . 0.0 110.52 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.427 ' HB2' ' CG2' ' A' ' 79' ' ' THR . 1.7 m-20 -108.2 160.34 15.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.429 -0.794 . . . . 0.0 109.225 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.49 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -134.41 147.85 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 110.642 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -151.34 109.86 3.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.426 -0.796 . . . . 0.0 110.569 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.445 ' CG1' ' HA ' ' A' ' 77' ' ' TRP . 2.3 mp -140.58 152.97 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.411 -0.805 . . . . 0.0 109.871 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -160.38 102.35 1.39 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.027 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -174.11 -170.72 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.454 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.74 109.4 21.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.85 . . . . 0.0 110.17 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.5 t -76.7 107.09 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.362 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.4 m120 50.37 42.42 25.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.877 . . . . 0.0 110.423 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.82 37.19 11.97 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -145.24 99.33 4.58 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.236 -1.155 . . . . 0.0 109.97 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -59.04 130.11 34.99 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.674 1.355 . . . . 0.0 110.392 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.482 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -158.62 128.67 5.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 110.029 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -105.9 142.61 35.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.225 -0.922 . . . . 0.0 110.785 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.49 ' CE2' ' HB ' ' A' ' 119' ' ' VAL . 5.5 t80 -127.2 121.49 31.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.48 -0.763 . . . . 0.0 109.704 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -158.77 84.44 0.82 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.201 -0.937 . . . . 0.0 110.11 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.0 -169.62 3.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 110.419 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.443 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 13.5 p-80 -120.28 159.29 25.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 110.309 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 57.4 m-85 -155.13 -178.82 7.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.347 -0.845 . . . . 0.0 109.907 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.43 ' O ' ' CG2' ' A' ' 138' ' ' ILE . 0.3 OUTLIER -150.66 161.2 43.06 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.039 -1.038 . . . . 0.0 110.885 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.43 ' CG2' ' O ' ' A' ' 137' ' ' ASN . 6.8 pt -155.59 173.34 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.544 -0.723 . . . . 0.0 109.642 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 43.3 m -91.79 116.36 28.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.162 -0.961 . . . . 0.0 111.089 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.429 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 7.4 m-85 -89.58 150.22 22.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 109.547 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -145.11 162.51 36.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.088 -1.007 . . . . 0.0 110.86 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -148.99 158.53 44.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.52 -0.738 . . . . 0.0 109.933 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 35' ' ' ASN . 32.8 m-80 -142.0 110.55 6.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.582 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -168.49 -145.95 4.78 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.419 ' HD2' HD13 ' A' ' 109' ' ' LEU . 11.3 Cg_endo . . . . . 0 C--N 1.309 -1.531 0 O-C-N 123.75 1.395 . . . . 0.0 109.986 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.009 0.433 . . . . 0.0 110.23 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -159.93 149.49 18.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.928 . . . . 0.0 110.292 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.7 176.83 39.21 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.95 103.05 15.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -1.13 . . . . 0.0 110.335 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.519 ' CB ' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -93.55 152.34 19.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 109.987 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.443 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 14.5 m-80 -78.35 144.86 35.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 110.125 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.5 OUTLIER -165.09 156.96 15.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 110.058 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.1 -177.93 6.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.9 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.58 176.2 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.241 -0.912 . . . . 0.0 110.034 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 56.9 m-85 -148.67 161.91 40.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.413 -0.804 . . . . 0.0 109.954 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.73 135.78 53.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 0.0 109.656 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.466 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -61.65 146.73 48.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 110.112 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 3.3 t-20 70.54 4.58 5.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.793 -0.567 . . . . 0.0 110.723 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -135.55 -164.52 1.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.92 -1.112 . . . . 0.0 109.576 179.286 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.422 ' N ' ' OG1' ' A' ' 43' ' ' THR . 6.3 m-80 -130.85 14.02 5.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 110.527 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -136.09 142.87 44.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.06 -1.025 . . . . 0.0 110.563 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -77.18 136.36 38.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.124 -0.985 . . . . 0.0 109.181 179.397 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.07 -17.78 3.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.01 -1.056 . . . . 0.0 112.048 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 51.8 mt -137.74 -68.81 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.79 -1.194 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -48.39 -24.5 1.26 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 111.201 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.421 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 0.1 OUTLIER -67.5 -14.15 62.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.961 -1.087 . . . . 0.0 110.891 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -102.19 15.16 29.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.056 -1.028 . . . . 0.0 110.902 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -127.51 -5.49 5.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.963 -1.086 . . . . 0.0 111.177 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 11.5 m-30 -110.39 112.85 25.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.948 -1.095 . . . . 0.0 110.518 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -72.77 109.75 6.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.284 -0.885 . . . . 0.0 110.129 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.401 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -93.39 164.06 22.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 110.161 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.401 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 56.2 Cg_endo -79.62 -175.82 17.2 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.452 -2.311 . . . . 0.0 110.693 -0.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.77 165.62 10.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 110.098 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -104.36 113.27 26.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.178 -0.951 . . . . 0.0 110.345 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.519 ' CD1' ' CB ' ' A' ' 34' ' ' LEU . 9.3 p90 -98.21 166.45 11.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.22 -0.925 . . . . 0.0 110.308 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.8 OUTLIER -155.67 158.93 3.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.585 -179.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 18.0 mtmt -138.86 173.1 11.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 0.0 110.985 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.435 ' HB2' ' CD ' ' A' ' 65' ' ' LYS . 19.2 mtpt -155.53 62.15 0.61 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.577 -0.702 . . . . 0.0 109.535 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 47.96 84.3 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.539 -0.726 . . . . 0.0 111.177 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.06 19.45 36.31 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.809 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.435 ' CD ' ' HB2' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -165.43 157.37 14.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.85 -1.383 . . . . 0.0 111.141 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -160.47 155.92 25.15 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.169 0.985 . . . . 0.0 111.755 178.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 3.7 m-85 -141.89 -162.06 1.33 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.452 ' CG2' ' HA ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -170.68 138.88 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 120.97 -1.081 . . . . 0.0 110.712 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 1.2 pt20 -99.65 134.84 41.95 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.776 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.74 128.4 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.992 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.3 122.36 31.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.826 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -103.28 150.41 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.404 -0.81 . . . . 0.0 110.508 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -102.28 133.44 47.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.343 -0.848 . . . . 0.0 110.005 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 57.38 99.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.119 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.3 t -62.54 -44.06 97.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.879 . . . . 0.0 110.465 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -52.58 -38.35 59.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.915 . . . . 0.0 110.392 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.418 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 45.5 m0 -68.46 -59.17 3.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -0.946 . . . . 0.0 110.243 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.6 tp -88.44 118.04 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -0.918 . . . . 0.0 109.772 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.46 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -86.97 -25.38 24.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 110.99 -179.099 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.46 ' N ' HG21 ' A' ' 79' ' ' THR . . . 175.4 174.92 42.4 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.238 -1.458 . . . . 0.0 110.526 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 0.7 OUTLIER -152.82 115.27 4.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.451 -1.029 . . . . 0.0 110.025 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.56 171.24 11.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 109.885 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.479 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.0 OUTLIER -171.76 131.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.135 -0.978 . . . . 0.0 110.816 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.469 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 0.9 OUTLIER 62.35 9.41 3.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.575 -0.703 . . . . 0.0 111.879 179.36 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.36 1.21 29.57 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.361 -1.399 . . . . 0.0 111.594 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.503 ' CD2' ' N ' ' A' ' 86' ' ' HIS . 3.3 p80 -135.6 154.17 51.43 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.577 -1.543 . . . . 0.0 110.847 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -167.17 0.17 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.454 -0.779 . . . . 0.0 110.421 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 8.1 pt-20 -107.68 170.22 8.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.193 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.34 134.32 55.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.246 -0.909 . . . . 0.0 110.396 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -67.83 103.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.126 -0.983 . . . . 0.0 109.514 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.431 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 2.0 tt -94.57 -29.49 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.865 . . . . 0.0 111.142 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.77 105.34 0.6 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.051 -1.03 . . . . 0.0 110.138 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -96.07 108.82 21.29 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.394 -0.816 . . . . 0.0 110.244 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.54 86.71 4.2 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.067 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.07 -24.54 62.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.37 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.56 -53.47 54.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.078 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -97.46 19.2 13.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -0.881 . . . . 0.0 110.255 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 50.76 65.72 1.38 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 110.123 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -147.7 158.41 44.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.223 -0.923 . . . . 0.0 110.314 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -153.98 160.84 42.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -0.896 . . . . 0.0 110.038 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.431 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 91.2 m -141.1 156.94 45.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.864 . . . . 0.0 109.856 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.425 ' N ' HG23 ' A' ' 101' ' ' THR . 84.7 p -145.65 143.41 29.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 110.699 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.08 135.98 33.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.354 -0.841 . . . . 0.0 109.912 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 39.1 m-85 -121.68 148.23 44.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.078 -1.014 . . . . 0.0 110.796 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -115.02 128.46 56.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.392 -0.818 . . . . 0.0 109.657 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.0 m -149.62 -175.37 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.605 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.32 113.44 22.31 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.44 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 47.48 -158.6 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.46 -0.775 . . . . 0.0 109.343 -178.345 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.459 ' CD2' ' CD2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -151.02 53.72 0.87 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.772 -1.205 . . . . 0.0 110.772 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -145.87 84.29 1.66 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.994 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.41 166.51 15.14 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.87 144.0 31.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -1.12 . . . . 0.0 110.429 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.1 mt -137.06 146.61 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 110.089 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -76.68 130.64 38.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.325 -0.859 . . . . 0.0 110.385 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -138.82 176.55 20.81 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 82' ' ' SER . 8.6 mttt -143.06 164.41 30.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -1.122 . . . . 0.0 109.42 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.432 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -158.65 142.36 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.912 -1.117 . . . . 0.0 110.921 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.418 ' HB2' ' CG2' ' A' ' 79' ' ' THR . 5.3 m-20 -112.08 162.77 15.04 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.551 -0.718 . . . . 0.0 109.182 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.76 153.63 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.137 -0.977 . . . . 0.0 110.37 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -151.82 107.31 3.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 110.541 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.49 HD11 ' CD2' ' A' ' 132' ' ' TYR . 7.7 mt -130.72 151.47 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.242 -0.911 . . . . 0.0 109.855 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.426 ' N ' HG23 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -159.15 104.37 1.68 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.217 -0.927 . . . . 0.0 109.855 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -172.66 -158.73 0.11 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 110.304 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -119.83 108.01 13.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.368 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.4 t -76.93 117.96 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.928 . . . . 0.0 110.223 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.48 29.06 2.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.396 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 90.98 35.77 7.0 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.49 116.52 5.46 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 110.125 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.12 135.36 30.39 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.638 1.336 . . . . 0.0 110.266 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -136.25 113.38 10.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 110.316 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -104.0 122.77 45.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 110.122 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.49 ' CD2' HD11 ' A' ' 121' ' ' ILE . 3.9 t80 -131.72 128.58 39.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 109.886 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -173.39 94.14 0.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.158 -0.964 . . . . 0.0 110.369 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.86 -175.0 5.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.256 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.55 86.43 2.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.941 . . . . 0.0 110.136 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -84.48 -178.77 7.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.361 -0.837 . . . . 0.0 110.02 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 18.9 p30 -149.5 167.67 25.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 0.0 110.204 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.432 HG12 ' CG2' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -156.45 163.3 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 110.718 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 81.9 m -92.15 125.41 36.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.489 -0.757 . . . . 0.0 110.406 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -90.39 165.11 14.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.204 -0.935 . . . . 0.0 110.371 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.21 101.54 1.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 110.315 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.417 ' CE1' HG12 ' A' ' 68' ' ' VAL . 59.3 m-85 -91.57 158.67 16.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.266 -0.897 . . . . 0.0 110.207 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.446 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 55.0 m-20 -143.46 96.98 3.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.223 -0.923 . . . . 0.0 110.604 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.414 ' HA3' HD11 ' A' ' 109' ' ' LEU . . . -154.23 -148.28 4.91 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo . . . . . 0 C--N 1.31 -1.491 0 O-C-N 123.804 1.423 . . . . 0.0 110.631 -179.786 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.932 0.396 . . . . 0.0 110.273 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 p -160.76 141.31 11.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.885 . . . . 0.0 110.347 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.25 -178.0 43.86 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.6 107.14 18.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.274 -1.133 . . . . 0.0 110.122 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.488 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -94.86 156.49 16.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.379 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -79.91 138.64 37.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.94 . . . . 0.0 110.369 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.448 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 1.2 p90 -164.91 150.75 10.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.349 -0.844 . . . . 0.0 110.006 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 38' ' ' VAL . 2.2 tt0 -155.02 156.46 35.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.869 . . . . 0.0 109.756 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.431 ' N ' ' HG3' ' A' ' 37' ' ' GLU . 28.1 m -101.08 174.71 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.17 -0.956 . . . . 0.0 110.638 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.433 ' HA ' ' CA ' ' A' ' 46' ' ' THR . 10.0 m-85 -148.12 156.18 42.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.516 -0.74 . . . . 0.0 109.746 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.429 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -67.59 133.59 49.68 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.221 -0.924 . . . . 0.0 109.592 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -63.73 147.14 52.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.991 -1.068 . . . . 0.0 109.864 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 5.5 t30 69.97 4.9 5.01 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.719 -0.613 . . . . 0.0 110.859 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.411 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -137.46 -167.23 2.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.94 -1.1 . . . . 0.0 109.718 179.422 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.411 ' N ' ' OG1' ' A' ' 43' ' ' THR . 24.7 m120 -130.56 14.34 5.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.109 -0.994 . . . . 0.0 110.426 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -135.03 116.86 15.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.083 -1.011 . . . . 0.0 110.402 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.456 ' CG2' ' CB ' ' A' ' 50' ' ' ASN . 0.5 OUTLIER -54.65 134.42 47.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.991 -1.068 . . . . 0.0 108.972 179.327 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.73 -17.66 3.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.826 -1.171 . . . . 0.0 112.299 -178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.505 HD11 HG22 ' A' ' 48' ' ' ILE . 23.4 mt -137.78 -64.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.634 -1.291 . . . . 0.0 111.304 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.479 ' O ' ' CD2' ' A' ' 53' ' ' PHE . . . -45.32 -27.92 0.74 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.619 -0.675 . . . . 0.0 111.43 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.456 ' CB ' ' CG2' ' A' ' 46' ' ' THR . 6.5 t-20 -71.91 -13.63 61.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.959 -1.088 . . . . 0.0 111.057 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.404 ' C ' ' CG ' ' A' ' 52' ' ' TYR . 8.7 m-20 -90.05 14.95 11.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.063 -1.023 . . . . 0.0 110.863 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.404 ' CG ' ' C ' ' A' ' 51' ' ' ASP . 24.0 m-85 -143.05 11.56 1.79 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.042 -1.036 . . . . 0.0 110.856 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 24.0 m-85 -129.76 113.37 14.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 109.991 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -72.17 164.92 25.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.166 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.413 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -146.75 164.21 25.08 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 110.07 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.413 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 49.6 Cg_endo -79.53 -175.65 16.91 Favored 'Cis proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.332 -2.362 . . . . 0.0 110.558 -0.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.0 167.94 9.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.287 -0.883 . . . . 0.0 109.873 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -103.57 111.35 23.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.116 -0.99 . . . . 0.0 110.745 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -96.35 162.85 13.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.001 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -154.28 155.93 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.085 -1.009 . . . . 0.0 110.528 -179.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.3 mtmp? -138.62 171.75 13.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.317 -0.865 . . . . 0.0 110.598 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . 12.1 mttp -162.03 61.66 0.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.394 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 60.91 91.66 0.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -0.839 . . . . 0.0 111.428 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.89 28.83 61.96 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.115 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.421 ' HD2' ' HB3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -170.59 162.71 8.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.892 -1.357 . . . . 0.0 111.207 179.434 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.4 pt? -172.51 149.45 2.13 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 122.084 0.945 . . . . 0.0 111.38 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 1.2 m-85 -138.02 172.19 13.3 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.72 142.09 26.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.933 -1.104 . . . . 0.0 110.441 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.426 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 6.3 pt20 -97.37 133.49 41.91 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.37 -0.831 . . . . 0.0 109.572 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.99 138.55 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -0.82 . . . . 0.0 110.153 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 m -88.36 129.48 35.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.244 -0.91 . . . . 0.0 109.769 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.99 127.21 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 110.405 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -99.42 133.25 44.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 110.017 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.0 m80 54.8 98.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.158 -0.964 . . . . 0.0 110.063 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.3 p -64.15 -25.8 68.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.392 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -65.37 -56.85 10.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -51.06 -65.11 0.61 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.21 -0.931 . . . . 0.0 110.177 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 10.0 tt -89.27 120.79 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.331 -0.856 . . . . 0.0 109.845 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.449 HG22 ' N ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -86.93 -23.09 25.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 110.867 -179.341 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.449 ' N ' HG22 ' A' ' 79' ' ' THR . . . -179.99 -179.36 48.8 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.509 -1.329 . . . . 0.0 109.99 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 58.8 mtm -152.34 171.07 18.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -1.073 . . . . 0.0 110.292 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 116' ' ' LYS . 10.3 t -155.18 172.04 18.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.295 -0.878 . . . . 0.0 109.909 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.47 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -168.01 140.05 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.092 -1.005 . . . . 0.0 110.763 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.481 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 2.0 mt-10 61.94 10.23 3.46 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.477 -0.764 . . . . 0.0 111.749 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.67 0.51 30.66 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.362 -1.399 . . . . 0.0 111.093 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.481 ' NE2' ' CB ' ' A' ' 84' ' ' GLU . 3.6 p80 -132.56 154.55 49.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.645 -1.503 . . . . 0.0 110.519 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -162.41 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.516 -0.74 . . . . 0.0 110.173 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.491 ' CB ' ' CZ ' ' A' ' 104' ' ' PHE . 12.1 pt-20 -107.61 169.27 8.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 110.107 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -106.0 127.32 53.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.152 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.76 102.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.139 -0.976 . . . . 0.0 109.673 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.434 HG21 ' CG2' ' A' ' 101' ' ' THR . 0.9 OUTLIER -94.74 -30.58 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 110.936 -179.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.409 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 54.4 p -167.15 103.89 0.54 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.091 -1.006 . . . . 0.0 109.986 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' HG3' ' CG ' ' A' ' 100' ' ' ARG . 21.4 ttmt -95.04 112.09 23.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 110.129 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.4 68.89 2.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.159 -0.963 . . . . 0.0 110.295 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.15 -29.05 56.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 110.266 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.51 -52.18 62.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.554 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -95.21 18.6 12.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -0.893 . . . . 0.0 110.552 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 51.0 61.32 3.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 110.21 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -147.14 169.89 18.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 110.024 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.431 ' CG ' ' HG3' ' A' ' 93' ' ' LYS . 0.8 OUTLIER -165.77 160.53 17.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.93 . . . . 0.0 110.328 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.434 ' CG2' HG21 ' A' ' 91' ' ' ILE . 87.6 m -141.31 147.22 37.81 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.568 -0.708 . . . . 0.0 109.393 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 3.7 p -145.53 141.8 28.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.034 -1.041 . . . . 0.0 110.842 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -92.49 145.48 24.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.531 -0.731 . . . . 0.0 109.682 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CZ ' ' CB ' ' A' ' 88' ' ' GLU . 30.4 m-85 -126.48 141.44 51.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.117 -0.989 . . . . 0.0 111.01 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -102.49 124.67 48.47 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.494 -0.754 . . . . 0.0 109.393 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 16.6 m -149.45 138.03 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.016 -1.053 . . . . 0.0 111.038 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.68 101.53 0.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 108.945 178.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.462 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 53.65 176.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.378 -178.607 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.462 ' HG ' ' CD1' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -150.18 83.22 1.38 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.85 -1.156 . . . . 0.0 111.218 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -144.71 75.42 1.45 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.953 . . . . 0.0 110.15 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.32 -109.26 0.41 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -157.58 150.91 23.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -1.171 . . . . 0.0 110.437 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -136.14 147.02 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.436 -0.79 . . . . 0.0 109.827 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -75.83 114.26 14.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.997 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.94 179.21 16.57 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 82' ' ' SER . 27.1 mttp -144.08 160.69 40.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 0.0 109.9 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.427 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.29 146.45 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.975 . . . . 0.0 110.4 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.426 ' N ' HG12 ' A' ' 117' ' ' ILE . 1.1 m-20 -105.57 156.3 18.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.414 -0.804 . . . . 0.0 109.405 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.97 146.0 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.159 -0.963 . . . . 0.0 110.44 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -151.6 109.3 3.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.37 -0.831 . . . . 0.0 110.246 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.486 HD13 ' CD2' ' A' ' 132' ' ' TYR . 54.8 mt -133.86 152.85 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.4 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 8.0 p-10 -160.46 95.28 1.11 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.81 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -174.26 -176.46 1.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 110.263 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -95.05 103.09 14.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 110.062 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.424 HG22 ' CB ' ' A' ' 130' ' ' PHE . 16.4 t -76.44 106.55 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.296 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.06 29.26 16.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 110.184 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.97 32.85 10.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.33 115.2 4.93 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.327 -1.102 . . . . 0.0 110.161 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -52.47 116.56 2.93 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.534 1.281 . . . . 0.0 110.187 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 5.7 t80 -116.0 122.51 45.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.691 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.83 122.02 44.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -0.879 . . . . 0.0 109.921 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.486 ' CD2' HD13 ' A' ' 121' ' ' ILE . 1.7 t80 -138.73 119.71 14.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.894 . . . . 0.0 110.169 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -168.53 85.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.127 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.25 -160.56 1.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.28 -0.887 . . . . 0.0 110.316 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.44 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -120.08 147.66 44.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.229 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 22.7 m-85 -155.68 -178.65 7.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.873 . . . . 0.0 109.997 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 9.7 p30 -149.82 169.18 21.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 0.0 110.671 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.427 HG12 ' CG2' ' A' ' 117' ' ' ILE . 0.5 OUTLIER -156.18 162.61 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 110.322 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 49.6 m -91.86 118.21 30.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.321 -0.862 . . . . 0.0 110.932 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.429 ' CD2' HG13 ' A' ' 83' ' ' ILE . 13.2 m-85 -90.91 101.43 14.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.274 -0.891 . . . . 0.0 110.017 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -87.74 103.49 15.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.087 -1.008 . . . . 0.0 110.526 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 140' ' ' TYR . 60.6 m-85 -92.67 153.28 19.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 110.186 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 9.8 m-80 -141.52 103.2 4.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.153 -0.967 . . . . 0.0 110.331 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.428 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -156.46 -149.74 5.45 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 C--N 1.309 -1.533 0 O-C-N 123.984 1.518 . . . . 0.0 110.43 -179.972 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.933 0.397 . . . . 0.0 110.41 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -160.43 139.82 10.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 110.486 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.93 178.05 43.58 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.58 109.03 19.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.293 -1.122 . . . . 0.0 110.252 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.487 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -94.99 153.21 17.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.266 -0.896 . . . . 0.0 110.805 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -81.05 135.56 35.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.85 . . . . 0.0 110.243 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.482 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -166.47 161.77 16.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.993 -1.067 . . . . 0.0 110.129 179.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -155.12 -165.61 2.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 0.0 110.356 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.533 ' CG2' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -139.06 169.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -148.32 159.82 43.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.316 -0.865 . . . . 0.0 109.907 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.97 135.74 52.83 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.336 -0.852 . . . . 0.0 109.734 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.467 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -64.52 146.89 53.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.074 -1.016 . . . . 0.0 109.762 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 5.2 t-20 70.91 4.12 4.92 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.84 -0.537 . . . . 0.0 110.71 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.442 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -138.61 -167.53 2.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.944 -1.097 . . . . 0.0 109.498 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.442 ' N ' ' OG1' ' A' ' 43' ' ' THR . 37.4 m-80 -133.27 18.42 4.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.989 -1.069 . . . . 0.0 110.464 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -136.37 117.61 14.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.55 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.8 134.49 36.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.066 . . . . 0.0 109.261 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.35 -18.01 3.68 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.169 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.405 HD12 HG22 ' A' ' 48' ' ' ILE . 30.2 mt -138.1 -50.29 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.634 -1.291 . . . . 0.0 111.194 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.443 ' CB ' HD13 ' A' ' 138' ' ' ILE . . . -80.95 7.71 10.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.49 -0.756 . . . . 0.0 111.532 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.459 ' O ' ' CE1' ' A' ' 53' ' ' PHE . 1.1 p-10 -69.32 -35.73 76.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.809 -1.182 . . . . 0.0 110.461 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -103.16 15.31 29.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.202 -0.936 . . . . 0.0 110.892 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.404 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -93.01 -8.38 43.14 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.966 -1.083 . . . . 0.0 111.021 -179.6 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.533 ' CE1' ' CG2' ' A' ' 38' ' ' VAL . 31.9 p90 -127.07 126.14 42.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.003 -1.061 . . . . 0.0 110.719 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -73.95 104.39 4.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.024 -1.047 . . . . 0.0 109.883 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.416 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 1.6 pttt -92.58 164.96 20.48 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 110.125 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.416 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 50.1 Cg_endo -77.92 -177.58 21.52 Favored 'Cis proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.519 -2.284 . . . . 0.0 110.569 -0.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -103.1 167.47 9.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.962 . . . . 0.0 110.25 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.436 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -102.95 114.51 28.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 110.09 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.0 p90 -96.98 162.21 13.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 110.056 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -154.97 155.13 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 110.311 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 24.6 mtmt -137.73 170.78 15.46 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.332 -0.855 . . . . 0.0 110.85 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.416 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -155.98 62.43 0.58 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.655 -0.653 . . . . 0.0 109.745 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.23 92.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.327 -0.858 . . . . 0.0 110.992 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.7 27.19 54.77 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.258 -0.972 . . . . 0.0 110.763 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.416 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 7.9 ptpt -171.81 158.51 4.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.972 -1.311 . . . . 0.0 111.0 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.7 pt? -170.72 147.11 2.75 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.166 0.984 . . . . 0.0 111.615 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -138.32 171.37 14.49 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.473 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.83 143.27 24.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.975 -1.078 . . . . 0.0 109.971 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.436 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -97.0 135.67 38.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.24 -0.913 . . . . 0.0 110.087 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.2 OUTLIER -110.9 140.14 31.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.388 -0.82 . . . . 0.0 109.63 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -87.86 138.4 31.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.132 -0.98 . . . . 0.0 110.223 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.436 ' CG1' HG23 ' A' ' 78' ' ' ILE . 15.5 t -103.16 122.28 55.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.462 -0.774 . . . . 0.0 109.991 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.98 130.37 46.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 110.268 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.8 t60 57.7 94.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.254 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t -71.79 -12.23 61.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.909 . . . . 0.0 110.593 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -74.64 -26.1 59.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.103 -0.998 . . . . 0.0 110.345 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -94.17 -47.34 6.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 0.0 110.39 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.436 HG23 ' CG1' ' A' ' 72' ' ' VAL . 6.8 tp -88.46 115.98 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.118 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.4 HG23 ' N ' ' A' ' 80' ' ' GLY . 0.5 OUTLIER -87.41 -23.06 24.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.356 -0.84 . . . . 0.0 110.442 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.4 ' N ' HG23 ' A' ' 79' ' ' THR . . . -179.55 178.17 48.54 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.426 ' CE ' ' HB3' ' A' ' 102' ' ' SER . 0.0 OUTLIER -152.9 161.14 42.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -1.074 . . . . 0.0 110.194 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 116' ' ' LYS . 2.4 t -155.12 149.67 26.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.032 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.471 HD12 ' CG ' ' A' ' 104' ' ' PHE . 4.8 mt -141.83 144.41 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 110.427 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 69.67 3.85 4.44 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.498 -0.751 . . . . 0.0 111.119 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.55 20.79 21.21 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.718 -1.23 . . . . 0.0 111.116 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.457 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.04 163.31 31.05 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.713 -1.463 . . . . 0.0 110.174 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -177.69 1.85 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.108 -0.995 . . . . 0.0 110.31 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -110.01 169.61 8.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.347 -0.846 . . . . 0.0 110.209 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.64 124.95 53.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.948 . . . . 0.0 110.191 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pp -67.43 102.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 109.796 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.411 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.8 tt -95.19 -28.12 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.388 -0.82 . . . . 0.0 110.784 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.9 m -166.77 101.04 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.194 -0.941 . . . . 0.0 109.734 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -94.96 152.09 18.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.444 -0.785 . . . . 0.0 110.336 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -144.38 83.46 1.72 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 110.16 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 p -70.55 -27.05 63.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 110.326 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.59 -52.75 62.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 0.0 110.064 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.5 mtmm -96.21 17.75 15.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.311 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 51.97 60.27 3.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 110.249 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 94' ' ' ASN . 34.0 mt-10 -148.28 167.39 25.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 110.47 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.473 ' CG ' ' N ' ' A' ' 101' ' ' THR . 33.7 ttt180 -174.56 167.45 3.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.388 -0.82 . . . . 0.0 109.682 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.473 ' N ' ' CG ' ' A' ' 100' ' ' ARG . 94.9 m -141.44 153.95 45.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.962 . . . . 0.0 109.837 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB3' ' CE ' ' A' ' 81' ' ' MET . 83.6 p -145.38 141.1 28.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.112 -0.992 . . . . 0.0 110.68 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.32 146.65 23.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.896 . . . . 0.0 109.991 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.471 ' CG ' HD12 ' A' ' 83' ' ' ILE . 45.8 m-85 -129.14 147.74 51.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 0.0 110.675 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -105.53 125.83 51.43 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.384 -0.823 . . . . 0.0 109.789 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.8 m -150.16 152.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.968 . . . . 0.0 110.956 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.2 m -71.95 105.93 4.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.276 -0.89 . . . . 0.0 109.291 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.458 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 50.23 -178.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.494 -0.754 . . . . 0.0 109.734 -178.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -151.22 81.93 1.31 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.824 -1.172 . . . . 0.0 110.996 -179.385 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.61 67.71 1.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 110.191 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 162.57 -109.91 0.41 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -157.19 148.1 21.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -1.118 . . . . 0.0 109.65 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 63.9 mt -136.27 150.74 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.902 . . . . 0.0 110.274 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.92 131.95 38.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.356 -0.84 . . . . 0.0 110.114 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.419 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -138.08 178.97 18.8 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 3.3 mtpp -144.6 164.46 30.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -1.179 . . . . 0.0 110.08 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.41 HG13 ' CD1' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.86 141.55 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.07 -1.019 . . . . 0.0 110.694 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -104.12 152.46 22.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.268 -0.895 . . . . 0.0 109.72 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -128.71 154.09 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.132 -0.98 . . . . 0.0 110.345 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -151.55 102.45 2.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.21 -0.931 . . . . 0.0 110.738 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.461 HG22 ' CZ ' ' A' ' 130' ' ' PHE . 3.8 mt -133.38 152.88 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.324 -0.86 . . . . 0.0 110.097 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.34 95.38 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.981 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -174.81 -156.38 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 110.248 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.412 ' HG2' ' CA ' ' A' ' 129' ' ' PRO . 11.7 mttt -122.46 120.99 35.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.28 -0.887 . . . . 0.0 110.25 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.463 HG23 ' CE1' ' A' ' 130' ' ' PHE . 89.6 t -76.91 92.33 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 110.363 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.31 31.48 11.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.269 -0.895 . . . . 0.0 110.302 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.23 35.58 2.29 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -145.43 85.44 7.94 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.358 -1.084 . . . . 0.0 110.124 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.412 ' CA ' ' HG2' ' A' ' 124' ' ' LYS . 11.3 Cg_endo -59.3 129.49 31.65 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.983 1.517 . . . . 0.0 110.287 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.463 ' CE1' HG23 ' A' ' 125' ' ' VAL . 7.6 p90 -156.14 139.85 16.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 110.452 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -105.36 131.9 52.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.391 -0.818 . . . . 0.0 110.007 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 119' ' ' VAL . 5.9 t80 -131.47 129.92 41.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.0 110.138 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -174.44 89.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.343 -0.848 . . . . 0.0 110.064 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.83 -168.42 3.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 110.188 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.17 85.93 2.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.407 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -85.01 -178.98 6.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 109.796 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 29.2 p30 -150.42 168.98 22.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.025 -1.047 . . . . 0.0 110.654 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.443 HD13 ' CB ' ' A' ' 49' ' ' ALA . 2.3 pt -157.83 173.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.324 -0.86 . . . . 0.0 110.784 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.8 m -92.01 163.6 13.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.622 -0.674 . . . . 0.0 110.282 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.524 ' CD1' ' CG1' ' A' ' 38' ' ' VAL . 97.3 m-85 -141.79 100.49 3.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 109.643 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 2.0 mttt -82.5 108.95 16.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 110.833 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -92.17 140.65 29.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.99 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.402 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 37.8 m-80 -129.64 96.04 4.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 110.339 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -149.14 -152.68 5.79 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo . . . . . 0 C--N 1.308 -1.582 0 O-C-N 123.943 1.496 . . . . 0.0 110.356 -179.908 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.405 ' O ' HG13 ' A' ' 60' ' ' ILE . 5.9 m-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.969 0.414 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -158.43 153.34 25.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.105 -0.997 . . . . 0.0 110.532 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.431 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 172.18 170.1 35.67 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.25 111.08 21.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -1.117 . . . . 0.0 110.152 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.476 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -94.78 155.39 16.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 0.0 110.646 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 3.0 t-20 -81.6 137.83 35.45 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.355 -0.84 . . . . 0.0 109.693 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -167.98 163.72 13.7 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.992 -1.067 . . . . 0.0 110.587 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.05 -168.33 2.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.37 -0.831 . . . . 0.0 109.823 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.429 ' O ' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER -139.82 -178.42 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.971 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -149.22 150.71 33.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 110.047 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.41 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.5 OUTLIER -67.56 127.83 34.19 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.397 -0.814 . . . . 0.0 109.87 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.471 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -55.9 147.27 19.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.142 -0.973 . . . . 0.0 109.921 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER 72.32 1.18 3.86 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.865 -0.522 . . . . 0.0 110.792 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.41 ' CG2' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -137.29 -166.49 1.94 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.873 -1.142 . . . . 0.0 109.559 179.192 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.408 ' N ' ' OG1' ' A' ' 43' ' ' THR . 23.0 m-80 -133.34 16.14 4.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -136.54 121.82 19.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.481 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.437 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -51.15 132.25 28.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 109.226 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.98 -17.58 3.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.889 -1.132 . . . . 0.0 111.926 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.8 mp -137.5 -75.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.827 -1.17 . . . . 0.0 110.572 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -47.48 -24.99 0.95 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.679 -0.638 . . . . 0.0 110.928 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.437 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.7 OUTLIER -46.65 -34.31 4.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.242 -0.911 . . . . 0.0 111.134 -179.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -102.19 15.76 28.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.044 -1.035 . . . . 0.0 110.986 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.453 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -99.25 -15.89 18.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.015 -1.053 . . . . 0.0 110.971 -179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.501 ' CG ' ' O ' ' A' ' 53' ' ' PHE . 21.3 p90 -118.6 128.39 54.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.928 -1.108 . . . . 0.0 110.993 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -74.97 114.42 13.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.095 -1.003 . . . . 0.0 109.91 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.75 159.64 35.8 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.036 . . . . 0.0 109.994 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -81.45 -175.28 15.37 Favored 'Cis proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.643 -2.232 . . . . 0.0 110.667 -0.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.487 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.45 172.81 6.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.197 -0.939 . . . . 0.0 110.041 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.31 116.6 32.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.25 -0.906 . . . . 0.0 111.076 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.476 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 6.9 p90 -98.14 161.77 13.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.237 -0.915 . . . . 0.0 109.523 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 0.6 OUTLIER -155.42 122.08 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.951 -1.093 . . . . 0.0 111.034 -179.551 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.6 mtmt -139.39 131.52 28.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.0 110.212 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -109.21 62.42 0.6 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.196 -0.94 . . . . 0.0 110.441 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 62' ' ' LYS . 14.0 t-20 49.62 100.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.402 -0.811 . . . . 0.0 111.119 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.26 -17.96 56.17 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.43 152.8 45.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.154 -1.203 . . . . 0.0 110.201 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -155.07 142.81 19.87 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.938 0.875 . . . . 0.0 111.012 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 5.7 m-85 -140.03 -170.15 2.89 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.54 -0.725 . . . . 0.0 109.352 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -162.06 165.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.098 -1.001 . . . . 0.0 109.882 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -140.45 143.66 35.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.198 -0.938 . . . . 0.0 110.472 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.56 128.51 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.335 -0.853 . . . . 0.0 110.258 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.7 m -88.83 124.33 34.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -102.68 138.93 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 110.386 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -101.0 135.03 43.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.325 -0.859 . . . . 0.0 110.238 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.1 m80 60.4 102.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.295 -0.878 . . . . 0.0 110.036 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 t -64.47 -33.44 75.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.887 . . . . 0.0 110.377 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -52.49 -57.78 8.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 110.257 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.452 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 13.2 m0 -55.62 -62.52 1.63 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 110.382 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.9 tp -88.78 114.01 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 109.97 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -86.79 -26.28 24.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 110.782 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.443 ' N ' HG22 ' A' ' 79' ' ' THR . . . -172.46 174.89 45.67 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.074 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.28 163.23 39.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -1.042 . . . . 0.0 109.962 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -155.66 167.62 29.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.824 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.506 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.2 OUTLIER -164.62 154.13 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 110.033 179.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.495 ' HB2' ' CE1' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 59.74 15.02 4.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.049 -1.032 . . . . 0.0 110.859 179.725 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.28 23.23 55.14 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.031 -1.081 . . . . 0.0 110.976 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.506 ' CD2' ' O ' ' A' ' 83' ' ' ILE . 2.0 p-80 -138.27 161.58 36.51 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.67 -1.488 . . . . 0.0 110.623 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.27 179.35 2.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.851 . . . . 0.0 110.971 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.419 ' HA ' ' CE1' ' A' ' 104' ' ' PHE . 2.1 pt-20 -99.39 170.13 8.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 110.663 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 102' ' ' SER . 2.2 t30 -116.78 133.73 55.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.476 -0.765 . . . . 0.0 109.468 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pp -67.45 101.53 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.954 -1.092 . . . . 0.0 109.871 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.43 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 0.5 OUTLIER -95.41 -31.22 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.838 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.425 ' N ' HG23 ' A' ' 91' ' ' ILE . 11.0 m -166.73 95.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.109 -0.994 . . . . 0.0 110.009 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -95.9 95.3 8.15 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.478 -0.763 . . . . 0.0 110.156 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.09 91.25 5.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.175 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.73 -27.64 60.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 110.202 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.61 -45.37 93.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -0.936 . . . . 0.0 110.129 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.93 18.7 12.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.31 -0.869 . . . . 0.0 110.23 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 t0 50.48 61.75 3.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 110.043 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -148.09 166.72 26.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 110.515 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.432 ' HB3' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -168.93 147.71 4.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.453 -0.779 . . . . 0.0 109.533 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 102' ' ' SER . 62.9 m -141.55 158.22 44.12 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.163 -0.96 . . . . 0.0 109.867 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.438 ' N ' HG22 ' A' ' 101' ' ' THR . 81.3 p -145.06 143.45 30.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 110.375 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 1.5 tm-20 -92.6 141.26 28.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 110.2 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.419 ' CE1' ' HA ' ' A' ' 88' ' ' GLU . 8.0 m-85 -123.81 148.65 46.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.279 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -98.3 132.29 43.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.37 -0.832 . . . . 0.0 110.075 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.421 HG23 ' CD1' ' A' ' 113' ' ' ILE . 8.9 p -149.08 166.88 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.202 -0.936 . . . . 0.0 110.245 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.5 t -69.63 -35.3 75.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 109.846 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.439 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -164.5 -148.9 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.503 -0.748 . . . . 0.0 109.325 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.444 ' CA ' ' HB3' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -150.06 51.92 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.726 -1.234 . . . . 0.0 111.232 -179.577 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 145' ' ' PRO . 12.9 t-20 -146.31 70.23 1.22 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.099 -1.001 . . . . 0.0 110.492 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.12 -129.25 1.7 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.44 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.0 OUTLIER -156.65 140.87 16.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.323 -1.104 . . . . 0.0 109.839 -179.771 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.421 ' CD1' HG23 ' A' ' 106' ' ' VAL . 2.5 mt -135.33 153.87 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.164 -0.96 . . . . 0.0 110.019 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -76.2 137.08 39.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.076 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -137.35 177.23 20.0 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 82' ' ' SER . 16.7 mttt -144.14 156.16 44.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -1.139 . . . . 0.0 109.76 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.452 HG12 ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -157.73 151.16 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.006 -1.059 . . . . 0.0 110.578 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.452 ' N ' HG12 ' A' ' 117' ' ' ILE . 0.9 OUTLIER -112.14 158.37 19.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.412 -0.805 . . . . 0.0 109.386 179.357 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.472 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -129.77 148.35 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -0.976 . . . . 0.0 110.053 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.78 102.24 2.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 110.769 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.452 ' CG1' ' HA ' ' A' ' 77' ' ' TRP . 2.6 mp -133.72 151.9 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -0.987 . . . . 0.0 110.162 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 1.2 p-10 -160.57 98.45 1.24 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.354 -0.842 . . . . 0.0 109.73 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -173.75 -156.95 0.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 110.553 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 125' ' ' VAL . 18.6 mtpt -91.27 165.22 13.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.416 -0.803 . . . . 0.0 110.608 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 47.6 t -157.88 99.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 67.18 25.83 8.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.531 -0.731 . . . . 0.0 109.611 -178.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 86.53 34.25 12.18 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -147.89 134.25 9.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.22 -1.165 . . . . 0.0 110.303 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -60.85 129.09 27.64 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.581 1.306 . . . . 0.0 110.141 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 132' ' ' TYR . 46.2 t80 -121.01 145.8 47.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.167 -0.958 . . . . 0.0 110.385 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -136.08 118.21 15.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.211 -0.931 . . . . 0.0 110.146 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.474 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . 3.7 t80 -129.73 131.47 46.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 109.804 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -177.37 87.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.04 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.66 -163.9 1.76 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 0.0 110.536 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.461 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 4.2 p80 -118.69 143.66 46.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 135' ' ' HIS . 13.0 m-85 -154.85 -179.45 8.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 110.117 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 1.7 p30 -152.1 172.11 16.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 0.0 110.584 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.9 pt -157.17 162.93 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.844 . . . . 0.0 110.173 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.44 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 45.1 m -92.0 126.92 37.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 110.594 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.464 ' CE2' HG13 ' A' ' 83' ' ' ILE . 14.4 m-85 -89.48 154.23 20.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -0.949 . . . . 0.0 109.654 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.89 105.52 5.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.041 -1.037 . . . . 0.0 110.397 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.444 ' HB3' ' CA ' ' A' ' 109' ' ' LEU . 31.7 m-85 -91.99 134.72 34.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 0.0 110.374 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 4.2 m-80 -132.11 103.56 6.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 0.0 110.311 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.403 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -164.71 -150.38 6.15 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.44 ' HG2' ' NZ ' ' A' ' 61' ' ' LYS . 9.4 Cg_endo . . . . . 0 C--N 1.308 -1.601 0 O-C-N 123.765 1.402 . . . . 0.0 110.457 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 25.4 m-20 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 120.816 0.341 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 15.1 t -160.39 169.68 22.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 110.789 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.9 171.71 25.06 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.69 105.18 17.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.1 -1.235 . . . . 0.0 110.217 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.482 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -94.21 156.05 16.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 110.414 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.411 ' O ' ' N ' ' A' ' 143' ' ' ASN . 14.9 m-20 -79.86 140.83 36.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.214 -0.929 . . . . 0.0 109.738 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.46 ' CD1' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -165.91 158.18 14.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.98 . . . . 0.0 110.181 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -155.37 -168.89 2.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.258 -0.901 . . . . 0.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.07 173.97 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 109.796 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -148.22 156.48 42.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 110.491 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 128.93 38.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.528 -0.732 . . . . 0.0 109.766 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.508 ' CE2' ' ND2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -58.18 148.26 27.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.098 -1.001 . . . . 0.0 109.879 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 11.0 m-20 71.08 2.44 4.24 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.816 -0.552 . . . . 0.0 110.961 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.409 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -136.96 -165.49 1.75 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.944 -1.098 . . . . 0.0 109.684 179.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.409 ' N ' ' OG1' ' A' ' 43' ' ' THR . 64.1 t30 -133.86 16.13 3.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 110.19 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -136.01 118.31 15.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 110.583 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.37 128.61 23.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.988 . . . . 0.0 109.099 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.49 -16.13 3.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.008 -1.058 . . . . 0.0 112.222 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.18 -64.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.792 -1.193 . . . . 0.0 110.907 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.39 -21.9 4.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.452 -0.78 . . . . 0.0 111.147 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -8.97 46.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.054 -1.029 . . . . 0.0 110.951 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.404 ' C ' ' CG ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -97.78 8.49 44.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.013 -1.055 . . . . 0.0 110.913 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.404 ' CG ' ' C ' ' A' ' 51' ' ' ASP . 7.1 m-85 -142.44 17.3 2.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.966 -1.084 . . . . 0.0 110.342 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -119.49 107.22 13.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.439 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -72.88 155.09 40.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 110.249 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.423 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -146.68 167.22 14.3 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.121 -0.987 . . . . 0.0 110.026 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.423 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 49.8 Cg_endo -77.06 -175.31 16.47 Favored 'Cis proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.681 -2.216 . . . . 0.0 110.481 -0.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.46 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . . . -100.4 162.43 12.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 109.975 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.409 ' CB ' ' CG ' ' A' ' 69' ' ' GLN . 0.5 OUTLIER -102.08 117.03 33.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.304 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.482 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.7 p90 -97.51 160.95 14.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 109.776 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -155.35 127.42 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.056 -1.028 . . . . 0.0 110.559 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.437 ' HG2' ' CB ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -136.61 119.36 16.15 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.206 -0.934 . . . . 0.0 110.783 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.2 OUTLIER -96.01 62.05 2.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.384 -0.822 . . . . 0.0 110.393 179.62 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.403 ' O ' ' O ' ' A' ' 62' ' ' LYS . 41.3 t30 46.62 99.17 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.58 -0.7 . . . . 0.0 111.407 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.83 5.03 54.15 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.436 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.58 158.91 16.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.894 -1.357 . . . . 0.0 110.199 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.555 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -155.13 149.81 26.46 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 122.171 0.986 . . . . 0.0 111.199 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.519 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 5.0 m-85 -142.74 -164.71 1.89 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.388 -0.82 . . . . 0.0 109.242 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.405 ' CG2' ' HA ' ' A' ' 59' ' ' TYR . 1.2 t -170.56 134.12 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.082 -1.011 . . . . 0.0 110.102 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.409 ' CG ' ' CB ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -97.59 134.15 41.18 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.157 -0.965 . . . . 0.0 109.568 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.1 OUTLIER -112.81 137.64 45.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.864 -179.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.5 m -88.6 135.17 33.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 109.972 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.409 ' CG1' HG21 ' A' ' 78' ' ' ILE . 3.4 t -102.38 123.98 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.283 -0.886 . . . . 0.0 109.943 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -98.31 126.85 43.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.247 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.36 99.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 110.328 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -32.62 66.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 110.09 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -58.95 -41.63 87.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.16 -0.963 . . . . 0.0 110.041 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.402 ' HA ' HG12 ' A' ' 121' ' ' ILE . 45.1 m0 -71.48 -62.11 1.53 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.375 -0.828 . . . . 0.0 110.128 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.409 HG21 ' CG1' ' A' ' 72' ' ' VAL . 9.9 tt -89.3 122.13 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 109.691 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.451 HG22 ' N ' ' A' ' 80' ' ' GLY . 1.0 OUTLIER -87.14 -23.25 24.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.385 -0.822 . . . . 0.0 111.114 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 79' ' ' THR . . . -178.38 179.94 48.47 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.017 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 47.5 mtm -152.45 171.12 18.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.346 -1.09 . . . . 0.0 109.94 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -155.21 164.45 38.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.214 -0.929 . . . . 0.0 110.233 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 7.4 mt -155.59 135.54 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.542 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 1.6 tm-20 69.54 3.44 4.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.406 -0.808 . . . . 0.0 111.428 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.64 21.5 12.52 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.136 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.477 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -136.95 159.05 43.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.722 -1.458 . . . . 0.0 110.138 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -178.98 2.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.083 -1.011 . . . . 0.0 110.354 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 1.7 pt-20 -106.6 167.59 9.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.34 -0.85 . . . . 0.0 110.043 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.28 129.79 55.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 110.349 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 1.4 pp -68.28 101.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.903 . . . . 0.0 109.671 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.439 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.8 tt -95.3 -28.87 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.384 -0.822 . . . . 0.0 110.716 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.9 p -167.33 107.41 0.59 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.022 -1.049 . . . . 0.0 109.935 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -95.41 110.33 22.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -0.869 . . . . 0.0 110.153 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.84 81.27 3.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 110.197 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.9 p -69.56 -26.56 64.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.254 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.62 -52.33 63.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.199 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -95.79 19.91 10.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 110.304 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 50.36 63.75 2.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 109.996 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -147.56 -177.98 6.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.858 . . . . 0.0 110.408 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -176.32 164.97 2.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.835 . . . . 0.0 109.715 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.439 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 93.3 m -142.6 154.86 44.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.158 -0.964 . . . . 0.0 109.755 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.42 ' N ' HG22 ' A' ' 101' ' ' THR . 1.5 p -145.53 144.25 30.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.905 -1.122 . . . . 0.0 110.721 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -92.69 140.34 29.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.299 -0.876 . . . . 0.0 109.792 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' A' ' 88' ' ' GLU . 32.6 m-85 -126.58 149.62 49.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.119 -0.988 . . . . 0.0 111.066 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -119.74 126.35 50.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.46 -0.775 . . . . 0.0 109.477 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.406 ' O ' HD22 ' A' ' 66' ' ' LEU . 22.9 m -149.97 -164.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.972 -1.08 . . . . 0.0 110.778 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.2 t -98.46 112.0 24.17 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.442 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.26 -165.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.521 -0.737 . . . . 0.0 109.661 -178.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.45 ' CD2' ' HB2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -151.91 60.2 0.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.87 -1.144 . . . . 0.0 111.188 -179.435 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -146.33 80.5 1.56 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.124 -0.985 . . . . 0.0 110.435 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.59 -117.19 0.75 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.478 ' CG ' ' CG2' ' A' ' 139' ' ' THR . 3.7 ttpt -157.52 145.27 18.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.346 -1.091 . . . . 0.0 110.041 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.6 mt -137.39 146.02 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.352 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -76.83 108.9 10.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.222 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.461 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -111.37 177.99 19.26 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 82' ' ' SER . 22.2 mttt -145.45 161.23 40.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -1.125 . . . . 0.0 109.89 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.44 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.8 147.15 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.095 -1.003 . . . . 0.0 110.682 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.439 ' N ' HG12 ' A' ' 117' ' ' ILE . 39.6 m-20 -106.39 159.32 16.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.394 -0.816 . . . . 0.0 109.149 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.92 147.29 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.027 -1.045 . . . . 0.0 110.684 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -153.34 113.89 4.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -0.872 . . . . 0.0 110.711 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.475 HD12 ' CD2' ' A' ' 132' ' ' TYR . 43.9 mt -137.69 152.94 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.103 -0.998 . . . . 0.0 110.386 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -160.08 95.43 1.16 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.376 -0.828 . . . . 0.0 109.85 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -173.81 -173.95 0.9 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.885 . . . . 0.0 110.354 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -104.47 121.35 43.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 110.263 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.3 95.04 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.102 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.05 39.02 30.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.29 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 96.45 31.46 7.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -145.33 100.39 4.46 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.316 -1.108 . . . . 0.0 110.134 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -50.4 132.84 35.83 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.869 1.457 . . . . 0.0 110.191 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -139.39 127.79 22.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 110.301 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.21 136.99 43.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.143 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.475 ' CD2' HD12 ' A' ' 121' ' ' ILE . 1.8 t80 -153.22 123.94 7.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 110.188 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -177.08 86.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -153.09 -165.31 2.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.9 . . . . 0.0 110.249 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -119.35 140.13 50.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.891 . . . . 0.0 110.283 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.463 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 61.4 m-85 -154.6 -179.17 7.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.874 . . . . 0.0 109.871 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.508 ' ND2' ' CE2' ' A' ' 41' ' ' TYR . 40.0 p30 -151.1 176.59 11.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 110.787 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.44 HG12 ' CG2' ' A' ' 117' ' ' ILE . 0.8 OUTLIER -156.35 171.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.476 -0.765 . . . . 0.0 109.673 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.478 ' CG2' ' CG ' ' A' ' 112' ' ' LYS . 26.1 m -91.76 118.04 30.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.976 . . . . 0.0 110.698 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.461 ' CD1' ' HA3' ' A' ' 115' ' ' GLY . 18.6 m-85 -89.68 108.11 19.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 109.61 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -97.48 161.67 13.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.723 -179.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -148.11 153.04 38.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.476 -0.765 . . . . 0.0 109.936 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 35' ' ' ASN . 31.4 m-80 -138.74 101.8 4.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 110.419 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -159.46 -154.5 7.29 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.423 ' HD2' ' CD1' ' A' ' 109' ' ' LEU . 19.7 Cg_endo . . . . . 0 C--N 1.307 -1.635 0 O-C-N 123.999 1.526 . . . . 0.0 110.707 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 2.1 m-20 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.921 0.391 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 p -159.58 147.87 17.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.019 . . . . 0.0 110.666 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.11 -179.33 45.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.04 119.68 28.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.176 -1.191 . . . . 0.0 110.26 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.439 ' CG ' ' HB3' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -94.4 131.83 39.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.427 -0.796 . . . . 0.0 110.893 -179.471 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -78.74 128.96 34.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.099 -1.0 . . . . 0.0 108.547 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -164.45 164.53 21.95 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.702 -1.249 . . . . 0.0 111.477 -178.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.98 -167.29 2.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.19 173.67 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.919 -1.113 . . . . 0.0 110.447 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -148.09 154.61 40.43 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.444 -0.785 . . . . 0.0 109.697 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.99 140.58 57.73 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.334 -0.853 . . . . 0.0 109.771 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -63.28 147.16 51.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.993 . . . . 0.0 110.205 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.4 OUTLIER 69.0 5.98 5.37 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.673 -0.642 . . . . 0.0 110.681 -179.452 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.44 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -137.01 -167.42 2.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.027 -1.045 . . . . 0.0 109.344 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.44 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.9 OUTLIER -131.62 13.77 4.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.0 110.147 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -136.44 133.62 36.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.15 -0.969 . . . . 0.0 110.715 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.441 ' CG2' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -62.18 136.49 57.96 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.252 -0.905 . . . . 0.0 109.087 179.29 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.28 -17.96 5.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.917 -1.114 . . . . 0.0 111.81 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 49' ' ' ALA . 1.2 mp -137.98 -74.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.897 -1.127 . . . . 0.0 110.532 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.455 ' N ' ' CG2' ' A' ' 48' ' ' ILE . . . -45.13 -26.63 0.49 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.769 -0.582 . . . . 0.0 111.238 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.441 ' CB ' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER -52.57 -23.64 6.78 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.094 -1.004 . . . . 0.0 111.102 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -102.73 15.41 29.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.969 -1.082 . . . . 0.0 111.026 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 52.7 m-85 -123.06 -10.64 8.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.039 -1.038 . . . . 0.0 110.967 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CZ ' ' CE ' ' A' ' 81' ' ' MET . 17.5 m-85 -119.52 115.33 23.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.063 -1.023 . . . . 0.0 110.309 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -72.24 169.47 16.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 110.6 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.413 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -147.54 161.96 33.76 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.428 -0.795 . . . . 0.0 109.76 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.413 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 60.6 Cg_endo -83.6 -175.07 13.46 Favored 'Cis proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.592 -2.253 . . . . 0.0 110.728 -0.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.487 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . . . -99.49 -171.46 2.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.369 -0.832 . . . . 0.0 109.752 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -127.63 121.16 29.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.055 -1.028 . . . . 0.0 110.372 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.517 ' CD1' ' CE ' ' A' ' 61' ' ' LYS . 38.6 p90 -96.36 161.28 14.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 0.0 109.893 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.478 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -155.19 121.03 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 110.609 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.517 ' CE ' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -130.88 117.91 19.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.089 -1.007 . . . . 0.0 110.654 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -93.61 61.57 3.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.25 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 49.62 101.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.555 -0.715 . . . . 0.0 111.431 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.1 56.99 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.466 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -142.49 158.62 43.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.056 -1.261 . . . . 0.0 110.08 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.574 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -158.86 138.28 11.59 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.988 0.899 . . . . 0.0 111.201 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -141.56 178.95 7.1 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.633 -0.667 . . . . 0.0 109.308 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.06 141.42 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 0.0 110.472 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -98.38 144.2 28.02 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 109.922 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.98 135.0 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.264 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.51 123.84 33.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.883 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.3 t -103.21 131.21 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.928 . . . . 0.0 110.381 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -100.26 134.01 43.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.219 -0.926 . . . . 0.0 110.049 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 62.14 116.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.3 -0.875 . . . . 0.0 110.036 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.92 -25.26 24.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.177 -0.952 . . . . 0.0 110.638 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -59.66 4.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.994 . . . . 0.0 110.357 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.481 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 39.8 m0 -53.58 -62.46 1.64 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.902 . . . . 0.0 110.436 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.408 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 0.8 OUTLIER -88.34 120.38 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.954 . . . . 0.0 109.964 179.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.424 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -87.05 -23.25 25.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.392 -0.818 . . . . 0.0 110.758 -179.3 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.424 ' N ' HG21 ' A' ' 79' ' ' THR . . . 175.13 -177.01 47.25 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.52 ' CE ' ' CZ ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -151.18 168.16 25.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -1.076 . . . . 0.0 110.185 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 116' ' ' LYS . 3.2 t -154.33 137.87 15.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 109.845 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.514 ' CD1' ' CD2' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -132.27 140.01 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.345 -179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 73.35 -1.07 3.17 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.809 -0.557 . . . . 0.0 111.224 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.62 21.92 8.42 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.632 -1.27 . . . . 0.0 111.121 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.443 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.37 162.99 32.1 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.637 -1.508 . . . . 0.0 110.269 179.285 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -171.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 110.547 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -109.07 170.22 8.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.341 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.6 122.02 44.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.319 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pt -67.39 103.59 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.168 -0.958 . . . . 0.0 109.911 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.446 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.5 tt -95.66 -28.51 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.886 . . . . 0.0 110.964 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.6 p -167.53 105.21 0.52 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.033 -1.042 . . . . 0.0 110.081 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm -95.29 107.72 19.84 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.277 -0.889 . . . . 0.0 110.017 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.65 95.99 8.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 110.385 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.67 -29.65 56.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.099 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -47.78 82.37 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.305 -0.872 . . . . 0.0 110.078 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -95.85 12.24 30.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 110.419 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.9 t0 51.33 56.95 7.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.019 -1.051 . . . . 0.0 110.152 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -148.14 154.75 40.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.202 -0.936 . . . . 0.0 110.442 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -143.68 166.14 25.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 109.941 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.446 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 87.0 m -141.35 150.69 42.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.382 -0.824 . . . . 0.0 109.636 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.423 ' N ' HG21 ' A' ' 101' ' ' THR . 79.9 p -145.31 141.48 28.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.036 -1.04 . . . . 0.0 110.733 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.04 144.1 25.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.842 . . . . 0.0 109.885 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -127.87 136.95 52.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.062 -1.024 . . . . 0.0 110.757 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -93.13 127.48 38.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -0.883 . . . . 0.0 109.449 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.3 m -149.68 171.36 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.017 -1.052 . . . . 0.0 110.954 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.79 110.47 18.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.33 -156.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 109.678 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.438 HD12 ' CA ' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -150.86 59.83 0.93 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.983 -1.073 . . . . 0.0 110.982 -179.267 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.12 104.19 3.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.293 -0.879 . . . . 0.0 110.337 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.35 -131.88 6.13 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.4 ' HB3' ' HG2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -157.0 152.42 26.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.299 -1.118 . . . . 0.0 110.0 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mt -135.78 145.24 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.882 . . . . 0.0 110.17 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -76.06 113.12 13.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.347 -0.845 . . . . 0.0 110.058 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.468 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -122.26 -170.4 13.69 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 82' ' ' SER . 4.1 mttp -147.66 171.95 14.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -1.155 . . . . 0.0 109.977 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -157.67 145.11 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -0.96 . . . . 0.0 110.453 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 117' ' ' ILE . 7.7 m-20 -105.63 155.04 19.61 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.473 -0.767 . . . . 0.0 109.535 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.482 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -132.4 146.47 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 110.127 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -151.76 115.02 4.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.89 . . . . 0.0 110.55 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.481 ' CG1' ' HA ' ' A' ' 77' ' ' TRP . 2.2 mp -141.51 152.57 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -0.95 . . . . 0.0 110.337 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.55 101.08 1.5 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 0.0 109.828 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -173.62 -176.93 1.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.378 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -97.61 105.18 17.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 110.391 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 t -76.29 99.24 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.0 109.898 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 55.5 50.46 14.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.32 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.31 33.28 44.75 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 106.31 4.33 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.085 -1.244 . . . . 0.0 110.233 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -58.04 128.01 27.19 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.541 1.285 . . . . 0.0 110.108 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -127.13 148.05 50.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.355 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.3 99.07 4.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.364 -0.835 . . . . 0.0 109.837 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.482 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 3.0 t80 -102.0 131.14 48.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 109.894 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -166.37 77.48 0.22 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.227 -0.92 . . . . 0.0 110.229 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -153.83 -173.82 4.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.291 -0.881 . . . . 0.0 110.339 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.449 ' O ' ' CD2' ' A' ' 136' ' ' TYR . 6.1 p80 -119.79 162.53 18.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 110.11 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 135' ' ' HIS . 54.7 m-85 -155.09 137.34 14.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.964 . . . . 0.0 110.423 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.441 ' OD1' ' CG ' ' A' ' 41' ' ' TYR . 28.1 p30 -88.63 159.23 17.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.315 -0.866 . . . . 0.0 110.267 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -156.69 155.92 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.269 -0.895 . . . . 0.0 110.051 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.2 m -91.81 123.06 34.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.265 -0.897 . . . . 0.0 111.074 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.514 ' CD2' ' CD1' ' A' ' 83' ' ' ILE . 62.7 m-85 -90.82 154.6 19.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.395 -0.816 . . . . 0.0 109.236 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -140.23 95.3 2.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.894 -1.129 . . . . 0.0 110.683 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -91.06 133.45 35.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.321 -0.862 . . . . 0.0 110.197 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.421 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 3.6 m-80 -137.58 102.08 4.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 110.451 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.438 ' CA ' HD12 ' A' ' 109' ' ' LEU . . . -146.07 -142.11 3.72 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.406 ' HD2' ' HA3' ' A' ' 144' ' ' GLY . 1.9 Cg_endo . . . . . 0 C--N 1.312 -1.369 0 O-C-N 123.576 1.303 . . . . 0.0 110.756 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 1.1 m-20 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.852 0.358 . . . . 0.0 110.373 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.6 p -161.81 150.4 15.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.841 . . . . 0.0 110.32 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 161.31 177.94 34.83 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.404 HG22 ' HG2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -88.18 104.9 17.14 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.358 -1.084 . . . . 0.0 110.321 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.486 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -94.61 158.6 15.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 110.499 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.431 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 3.6 m-20 -78.8 140.79 38.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.898 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.452 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -165.46 153.89 11.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 110.105 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.34 -177.06 6.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.235 -0.916 . . . . 0.0 110.352 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.436 ' O ' ' CG2' ' A' ' 46' ' ' THR . 1.6 m -140.04 178.09 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.348 -0.845 . . . . 0.0 109.843 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -149.39 162.8 39.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 110.481 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.3 OUTLIER -68.15 123.73 21.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.362 -0.836 . . . . 0.0 109.79 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -53.26 144.94 14.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.977 . . . . 0.0 109.955 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 6.1 m120 71.62 1.52 3.91 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.857 -0.527 . . . . 0.0 111.1 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.411 ' CG2' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -136.98 -166.86 1.98 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.829 -1.169 . . . . 0.0 109.827 179.15 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.74 21.4 3.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 110.443 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -133.15 126.06 30.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.122 -0.986 . . . . 0.0 110.956 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.445 ' CG2' ' HB2' ' A' ' 50' ' ' ASN . 0.7 OUTLIER -55.11 118.48 4.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.601 -0.687 . . . . 0.0 109.686 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.51 -18.58 3.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.8 -1.188 . . . . 0.0 112.078 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.0 mt -138.88 -76.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.789 -1.195 . . . . 0.0 111.122 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.434 ' O ' ' CD2' ' A' ' 53' ' ' PHE . . . -46.0 -26.41 0.72 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.622 -0.674 . . . . 0.0 111.176 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.445 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 16.9 t-20 -68.9 -13.4 62.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.075 -1.016 . . . . 0.0 110.792 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -102.59 15.13 30.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.974 -1.079 . . . . 0.0 111.123 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -136.42 11.33 3.24 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.008 -1.058 . . . . 0.0 110.808 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.434 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 25.2 m-85 -130.98 115.62 16.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.077 -1.014 . . . . 0.0 110.122 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -72.59 164.23 26.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.355 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.467 ' CD ' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -146.83 164.43 23.74 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.274 -0.891 . . . . 0.0 110.048 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.41 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 57.2 Cg_endo -78.86 -175.44 16.71 Favored 'Cis proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.438 -2.317 . . . . 0.0 110.45 -0.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.52 167.96 9.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.077 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.427 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -101.45 113.51 26.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.32 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.486 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 1.7 p90 -97.06 161.95 13.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 110.004 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 1.0 OUTLIER -154.81 156.99 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.089 -1.007 . . . . 0.0 110.465 179.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 34.6 mtmt -140.34 170.23 16.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.179 -0.95 . . . . 0.0 111.058 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 12.5 mtmt -157.05 62.15 0.51 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.549 -0.719 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t30 51.05 87.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.344 -0.848 . . . . 0.0 111.26 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.83 24.91 39.96 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.696 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 62' ' ' LYS . 2.8 ptpt -167.56 153.3 7.46 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.914 -1.345 . . . . 0.0 110.941 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -158.78 151.17 21.61 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 122.347 1.07 . . . . 0.0 111.696 178.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 6.3 m-85 -143.85 170.41 15.94 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.18 145.04 21.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.908 -1.12 . . . . 0.0 110.389 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.436 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 4.6 pt20 -97.84 132.77 43.15 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.355 -0.84 . . . . 0.0 109.593 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.38 137.57 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.942 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.08 128.45 35.75 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.209 -0.932 . . . . 0.0 109.939 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.84 126.37 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.977 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 74' ' ' HIS . 21.6 m-20 -99.18 128.03 45.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.363 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.414 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 0.1 OUTLIER 64.23 113.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.85 . . . . 0.0 110.198 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.58 -38.31 23.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.202 -0.937 . . . . 0.0 110.257 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -55.35 -42.45 73.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.212 -0.93 . . . . 0.0 110.182 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.439 ' HA ' HG12 ' A' ' 121' ' ' ILE . 34.4 m0 -67.4 -64.32 0.88 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 110.282 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.9 tt -88.81 126.3 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.379 -0.826 . . . . 0.0 110.007 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.438 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -87.88 -24.81 23.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.441 -0.787 . . . . 0.0 110.975 -179.298 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.438 ' N ' HG21 ' A' ' 79' ' ' THR . . . 178.16 -179.05 48.62 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.627 -1.273 . . . . 0.0 109.955 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.8 mtm -151.59 161.85 41.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.265 -1.138 . . . . 0.0 110.352 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -154.99 146.24 22.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.86 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 3.6 mt -139.17 142.77 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.903 . . . . 0.0 110.657 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 2.5 tm-20 72.26 -0.35 3.29 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.693 -0.63 . . . . 0.0 111.56 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.87 20.27 9.52 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.537 -1.316 . . . . 0.0 111.006 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.477 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.72 159.31 42.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.649 -1.5 . . . . 0.0 110.365 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -71.17 179.69 2.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 110.177 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -102.23 170.17 8.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.904 . . . . 0.0 110.083 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.2 129.7 56.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.938 . . . . 0.0 110.243 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.451 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 0.8 OUTLIER -67.65 102.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 109.767 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.434 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.5 tt -95.15 -25.86 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -0.861 . . . . 0.0 110.853 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.407 ' N ' HG21 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -167.35 104.88 0.53 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.122 -0.986 . . . . 0.0 109.659 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -96.34 145.69 25.39 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.399 -0.813 . . . . 0.0 110.265 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.22 78.98 1.62 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 110.115 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.25 -25.88 67.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 110.327 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.16 64.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 110.112 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -96.57 17.3 16.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.392 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 t0 50.41 63.13 2.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.975 . . . . 0.0 110.013 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -147.15 162.28 39.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.335 -0.853 . . . . 0.0 110.346 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -163.72 161.75 23.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.435 -0.791 . . . . 0.0 109.873 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.434 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 86.9 m -142.42 150.37 40.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.655 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.421 ' N ' HG23 ' A' ' 101' ' ' THR . 78.5 p -145.42 143.6 30.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.052 -1.03 . . . . 0.0 110.76 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -93.4 147.33 23.04 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.374 -0.829 . . . . 0.0 109.838 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -128.18 131.45 48.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.132 -0.98 . . . . 0.0 110.924 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -96.08 124.84 40.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.879 . . . . 0.0 109.474 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.6 m -149.28 -171.71 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.051 -1.031 . . . . 0.0 110.665 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.9 111.96 23.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.442 -0.786 . . . . 0.0 109.144 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.451 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.69 -162.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.456 -0.777 . . . . 0.0 109.969 -178.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.453 HD23 ' CD2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -149.84 56.92 0.97 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.015 -1.053 . . . . 0.0 110.644 -179.72 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -145.63 79.53 1.57 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.879 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.63 170.98 19.67 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.06 144.42 30.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -1.154 . . . . 0.0 110.482 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.476 HD12 ' CD2' ' A' ' 142' ' ' PHE . 5.3 mt -136.34 146.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 0.0 109.719 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.15 117.3 17.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.151 -0.968 . . . . 0.0 110.496 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.11 176.05 16.4 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 82' ' ' SER . 15.9 mttt -144.43 163.52 33.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -1.155 . . . . 0.0 109.945 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -157.89 140.64 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 110.43 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -101.56 154.35 18.93 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.366 -0.834 . . . . 0.0 109.254 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.468 HG12 ' CD2' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -133.4 151.05 32.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.999 -1.063 . . . . 0.0 110.781 -179.288 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -150.69 99.5 2.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.595 -0.69 . . . . 0.0 109.362 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 77' ' ' TRP . 20.1 mt -135.04 153.33 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.259 -0.9 . . . . 0.0 110.738 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -159.87 106.27 1.62 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.499 -0.75 . . . . 0.0 109.169 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.4 162.13 6.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.315 -0.866 . . . . 0.0 110.216 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -89.78 113.88 25.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 110.495 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.4 t -76.92 96.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.341 -0.849 . . . . 0.0 110.218 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.22 29.74 13.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.595 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.95 32.94 5.69 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -144.94 100.51 4.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.317 -1.107 . . . . 0.0 110.138 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.54 115.29 1.71 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.765 1.403 . . . . 0.0 110.468 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 8.2 t80 -111.95 125.63 54.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 110.17 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.2 139.39 37.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 110.147 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.468 ' CD2' HG12 ' A' ' 119' ' ' VAL . 1.6 t80 -153.43 113.83 3.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.809 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.403 ' O ' ' CG ' ' A' ' 134' ' ' HIS . 8.1 t0 -165.92 88.33 0.39 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.136 -0.977 . . . . 0.0 110.154 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.403 ' CG ' ' O ' ' A' ' 133' ' ' ASP . 74.1 m-70 -154.04 -168.26 2.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 110.282 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.6 85.46 2.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.796 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -85.86 -178.57 6.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.825 . . . . 0.0 110.416 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.42 ' OD1' ' CD2' ' A' ' 41' ' ' TYR . 11.6 p30 -150.33 174.27 13.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.938 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.4 ' C ' ' CD1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -155.92 165.34 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.135 -0.978 . . . . 0.0 110.614 -179.655 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 61.8 m -91.81 113.82 26.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.406 -0.809 . . . . 0.0 110.525 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.46 ' CD2' HD12 ' A' ' 83' ' ' ILE . 27.6 m-85 -89.63 155.15 19.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.979 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.79 112.77 5.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.946 . . . . 0.0 110.523 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.476 ' CD2' HD12 ' A' ' 113' ' ' ILE . 27.2 m-85 -91.98 155.78 17.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 110.313 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.431 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 61.3 m-80 -140.03 96.93 3.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -0.979 . . . . 0.0 110.332 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.5 -151.95 6.47 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo . . . . . 0 C--N 1.307 -1.625 0 O-C-N 123.889 1.468 . . . . 0.0 110.567 -179.981 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 120.807 0.337 . . . . 0.0 110.512 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.0 t -160.86 130.02 4.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.899 . . . . 0.0 110.29 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . -170.77 179.19 42.89 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.72 110.67 21.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.401 -1.058 . . . . 0.0 110.505 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.49 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -95.36 148.62 22.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 109.99 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.429 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -79.16 134.26 36.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.085 -1.01 . . . . 0.0 110.339 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.519 ' CE1' ' CB ' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -166.27 167.91 15.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.152 -0.968 . . . . 0.0 110.839 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.98 -172.93 4.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.542 -0.724 . . . . 0.0 109.764 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.435 ' CG1' ' CE1' ' A' ' 140' ' ' TYR . 0.6 OUTLIER -140.73 107.73 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.688 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.0 161.38 15.16 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.455 -0.778 . . . . 0.0 110.497 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.412 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -67.84 137.38 55.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.374 -0.829 . . . . 0.0 110.081 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.474 ' CD2' ' OD1' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -62.53 145.47 54.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.035 -1.041 . . . . 0.0 110.064 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 12.6 t30 70.42 3.49 4.5 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.763 -0.586 . . . . 0.0 110.771 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.423 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -139.25 -171.08 3.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.878 -1.139 . . . . 0.0 109.538 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.423 ' N ' ' OG1' ' A' ' 43' ' ' THR . 17.5 p30 -134.63 23.48 3.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.106 -0.996 . . . . 0.0 110.055 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.64 121.47 19.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 111.075 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.46 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -49.79 126.87 14.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.583 -0.698 . . . . 0.0 109.291 178.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.431 ' HB3' ' CD1' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -129.84 -19.36 3.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.74 -1.225 . . . . 0.0 112.449 -178.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.431 ' CD1' ' HB3' ' A' ' 47' ' ' SER . 1.4 mp -139.45 -78.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.65 -1.281 . . . . 0.0 111.296 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.429 ' N ' ' CG2' ' A' ' 48' ' ' ILE . . . -45.01 -26.42 0.43 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.853 -0.53 . . . . 0.0 111.337 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.46 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 4.7 p30 -60.92 -15.49 31.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.091 -1.006 . . . . 0.0 110.882 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.421 ' C ' ' CD1' ' A' ' 52' ' ' TYR . 6.2 m-20 -101.8 15.2 29.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.054 -1.029 . . . . 0.0 110.896 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 43.3 m-85 -140.08 10.39 2.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.004 -1.06 . . . . 0.0 110.554 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.417 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 30.7 m-85 -132.02 113.27 13.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 110.174 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.69 164.55 26.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.705 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -146.57 161.66 37.25 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.4 -0.812 . . . . 0.0 109.71 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -79.93 -175.39 16.27 Favored 'Cis proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.522 -2.282 . . . . 0.0 110.396 -0.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.519 ' CB ' ' CE1' ' A' ' 36' ' ' TYR . . . -101.14 166.29 10.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.933 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.54 116.0 31.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.948 . . . . 0.0 110.465 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 28.9 p90 -97.1 163.87 12.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 109.823 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -155.11 151.0 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.109 -0.994 . . . . 0.0 110.558 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 28.1 mtmt -134.5 174.0 11.03 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -0.9 . . . . 0.0 110.945 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 9.5 mttt -155.93 62.33 0.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.4 -0.813 . . . . 0.0 110.021 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m120 53.97 85.86 0.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.338 -0.851 . . . . 0.0 111.188 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.43 23.58 50.36 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.203 -0.999 . . . . 0.0 110.705 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 62' ' ' LYS . 8.6 ptpt -166.12 161.17 16.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.814 -1.404 . . . . 0.0 110.951 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 2.5 pt? -173.11 158.0 3.59 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.152 0.977 . . . . 0.0 111.555 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.566 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -139.27 -153.84 0.49 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 1.2 t -170.17 135.16 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 110.026 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 5.1 pt20 -97.39 133.66 41.69 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.63 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.2 142.93 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 110.099 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.18 129.59 35.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 110.199 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -104.1 127.29 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 110.159 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.0 137.9 37.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 110.341 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 52.42 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.339 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -73.52 -31.68 63.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 110.217 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -55.48 -36.93 67.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 110.31 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -83.6 -50.86 7.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 110.15 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.417 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 19.5 tt -89.75 125.34 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 109.942 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -87.1 -29.88 21.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 110.579 -179.577 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.448 ' N ' HG23 ' A' ' 79' ' ' THR . . . 174.15 -168.37 41.13 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.8 mtp -151.99 169.19 22.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -1.125 . . . . 0.0 110.469 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.36 131.62 11.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.871 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.3 mt -131.25 147.32 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.933 . . . . 0.0 110.344 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' OE1' ' CA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER 66.46 7.29 4.91 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.133 -0.979 . . . . 0.0 111.004 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.03 25.49 19.52 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.895 -1.145 . . . . 0.0 111.297 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.47 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -139.48 161.29 37.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.638 -1.507 . . . . 0.0 110.482 179.262 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.41 -173.74 0.95 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.13 -0.981 . . . . 0.0 110.561 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.475 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 1.8 pt-20 -110.24 170.05 8.34 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.368 -0.832 . . . . 0.0 110.278 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.14 127.46 54.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.274 -0.891 . . . . 0.0 110.268 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.29 103.95 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 0.0 109.597 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.437 HG23 ' CG2' ' A' ' 101' ' ' THR . 1.1 tt -95.92 -30.1 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 111.085 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.7 p -167.43 104.91 0.53 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.016 -1.052 . . . . 0.0 110.015 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -95.53 108.54 20.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 110.154 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.75 62.14 2.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.289 -0.882 . . . . 0.0 110.177 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.59 -21.93 30.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.297 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -18.69 62.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.211 -0.931 . . . . 0.0 110.288 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -136.31 22.19 3.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 110.278 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 55.89 64.42 1.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -0.868 . . . . 0.0 110.521 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -148.18 -179.51 6.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.278 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 179.22 162.32 0.81 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.2 -0.938 . . . . 0.0 110.135 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.437 ' CG2' HG23 ' A' ' 91' ' ' ILE . 97.2 m -141.48 152.46 44.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 109.651 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.4 p -144.36 139.59 28.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.008 -1.057 . . . . 0.0 110.548 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.28 141.14 28.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.388 -0.82 . . . . 0.0 110.01 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.475 ' CE1' ' HB2' ' A' ' 88' ' ' GLU . 68.3 m-85 -129.0 138.26 51.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.157 -0.964 . . . . 0.0 110.669 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -99.0 130.66 45.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.272 -0.892 . . . . 0.0 109.616 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.0 p -149.42 152.12 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.02 -1.05 . . . . 0.0 110.86 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.6 m -63.68 106.41 0.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -0.931 . . . . 0.0 109.145 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.471 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 48.4 -174.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.494 -0.753 . . . . 0.0 110.062 -178.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.449 ' HG ' ' CD1' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -150.13 75.45 1.24 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.977 -1.077 . . . . 0.0 110.691 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -146.09 43.22 1.23 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.86 . . . . 0.0 110.246 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.64 -169.62 38.21 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -81.71 151.59 27.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -1.181 . . . . 0.0 110.437 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 140' ' ' TYR . 13.9 mm -136.31 132.35 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.418 -0.801 . . . . 0.0 109.884 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.68 103.03 6.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 0.0 110.191 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.57 175.85 15.94 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -147.88 177.46 9.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -1.14 . . . . 0.0 109.532 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -157.21 149.48 10.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.103 -0.998 . . . . 0.0 111.099 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.433 ' HB2' ' CG2' ' A' ' 79' ' ' THR . 69.0 m-20 -106.83 156.14 18.99 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.447 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 2.2 t -140.45 149.44 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 110.142 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -151.01 116.36 5.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 0.0 110.381 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.491 HD12 ' CD2' ' A' ' 132' ' ' TYR . 3.9 mt -134.97 153.83 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.44 -0.788 . . . . 0.0 109.994 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.54 102.28 1.71 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.145 -0.972 . . . . 0.0 109.971 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -173.17 175.28 3.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.522 -0.736 . . . . 0.0 109.829 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 100.7 12.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.148 -0.97 . . . . 0.0 110.344 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.2 t -76.92 112.15 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.339 -0.851 . . . . 0.0 109.965 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 53.98 43.44 30.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 110.212 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.53 38.09 68.78 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -145.26 108.41 4.54 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.228 -1.16 . . . . 0.0 110.048 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -47.96 129.19 17.7 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.682 1.359 . . . . 0.0 110.377 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -135.38 139.91 44.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 110.132 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -135.08 121.45 20.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.0 110.262 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.491 ' CD2' HD12 ' A' ' 121' ' ' ILE . 3.2 t80 -114.2 141.45 47.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 109.617 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -175.99 81.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.085 -1.01 . . . . 0.0 110.298 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.19 178.77 9.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 0.0 110.589 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.406 ' ND1' ' N ' ' A' ' 135' ' ' HIS . 1.8 m80 -119.0 96.38 5.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.315 -0.866 . . . . 0.0 109.631 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.93 139.53 31.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 110.483 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.474 ' OD1' ' CD2' ' A' ' 41' ' ' TYR . 25.4 p30 -88.72 159.72 17.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.327 -0.858 . . . . 0.0 110.157 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.455 HG13 ' CE2' ' A' ' 140' ' ' TYR . 6.9 pt -156.35 166.28 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 110.1 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 88.6 m -91.76 161.27 14.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.359 -0.838 . . . . 0.0 110.572 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.455 ' CE2' HG13 ' A' ' 138' ' ' ILE . 19.3 m-85 -147.06 98.66 3.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.428 -0.795 . . . . 0.0 109.635 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 112' ' ' LYS . 9.6 mtpt -101.46 105.3 16.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.896 . . . . 0.0 110.874 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 140' ' ' TYR . 98.3 m-85 -92.2 140.34 29.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.889 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.458 ' N ' ' ND2' ' A' ' 143' ' ' ASN . 2.1 m-80 -124.02 98.67 5.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -0.99 . . . . 0.0 110.453 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.412 ' HA3' ' HD2' ' A' ' 145' ' ' PRO . . . -151.36 -148.67 4.87 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.416 ' HD2' ' CD1' ' A' ' 109' ' ' LEU . 10.3 Cg_endo . . . . . 0 C--N 1.309 -1.548 0 O-C-N 123.639 1.336 . . . . 0.0 110.077 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.962 0.41 . . . . 0.0 110.478 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.6 t -160.11 134.67 7.6 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 110.451 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.84 179.09 48.47 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.39 112.23 22.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -1.124 . . . . 0.0 110.335 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.513 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -94.73 146.83 23.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 110.431 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.404 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -80.7 133.15 35.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 109.779 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -165.88 162.69 18.45 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.154 -0.966 . . . . 0.0 110.716 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.47 -168.29 2.78 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.455 -0.778 . . . . 0.0 109.526 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.431 ' O ' ' CG2' ' A' ' 46' ' ' THR . 2.5 m -140.92 117.88 8.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.047 -1.033 . . . . 0.0 110.349 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -90.86 155.54 18.68 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.42 -0.8 . . . . 0.0 110.134 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.412 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.3 OUTLIER -67.44 126.83 30.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.401 -0.812 . . . . 0.0 110.111 -179.767 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.511 ' CD2' ' ND2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -56.96 147.37 24.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.913 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.8 t30 72.77 -0.01 3.5 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.963 -0.461 . . . . 0.0 110.811 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -138.73 -168.32 2.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.937 -1.102 . . . . 0.0 109.445 179.189 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.42 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.1 OUTLIER -136.28 25.27 3.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.014 -1.054 . . . . 0.0 110.357 179.667 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -135.62 118.63 16.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.057 -1.027 . . . . 0.0 111.354 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.443 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.6 OUTLIER -48.82 120.64 3.97 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.66 -18.06 3.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.709 -1.244 . . . . 0.0 112.466 -178.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 95.3 mt -137.98 -76.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.624 -1.298 . . . . 0.0 111.279 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -50.28 -21.94 1.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.742 -0.599 . . . . 0.0 111.593 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.443 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 59.8 t30 -59.08 -32.92 70.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.039 . . . . 0.0 111.388 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.18 15.89 27.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.016 -1.053 . . . . 0.0 111.025 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.461 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -98.65 -17.55 18.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.02 -1.05 . . . . 0.0 111.069 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.501 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 9.3 p90 -127.0 134.3 50.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.0 -1.062 . . . . 0.0 111.037 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.78 113.88 12.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.904 . . . . 0.0 109.937 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.72 162.34 29.48 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.015 -1.053 . . . . 0.0 110.005 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -83.09 -175.46 14.6 Favored 'Cis proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.55 -2.271 . . . . 0.0 110.526 -0.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.492 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . . . -102.53 -171.61 1.99 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 0.0 110.176 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.402 ' CB ' ' CG ' ' A' ' 69' ' ' GLN . 2.2 ttmt -125.29 113.35 17.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 0.0 110.251 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.513 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 10.0 p90 -97.26 165.42 12.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 110.31 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -155.48 156.81 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.363 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 19.8 mtmt -140.64 173.53 11.4 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.353 -0.842 . . . . 0.0 110.599 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.429 ' CB ' ' HD2' ' A' ' 65' ' ' LYS . 1.6 mtmm -158.53 62.23 0.43 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.843 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m120 45.11 82.6 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.661 -0.65 . . . . 0.0 111.195 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.91 14.78 33.06 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.608 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HD2' ' CB ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -165.77 163.17 18.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.96 -1.318 . . . . 0.0 110.982 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 2.4 pt? -172.68 144.67 1.43 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.015 0.912 . . . . 0.0 111.356 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -139.01 173.33 11.67 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.175 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -142.24 142.17 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.042 -1.036 . . . . 0.0 110.429 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.402 ' CG ' ' CB ' ' A' ' 58' ' ' LYS . 3.3 pp0? -97.66 132.35 43.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.398 -0.814 . . . . 0.0 109.641 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.49 132.63 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 110.457 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.54 125.2 35.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.679 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.438 ' CG2' ' HB3' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -103.15 134.22 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.901 . . . . 0.0 110.465 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -102.12 145.44 29.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.388 -0.82 . . . . 0.0 110.034 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 11.1 m170 50.61 87.39 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 110.141 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.2 p -57.21 -36.21 70.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.355 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -55.62 -32.8 63.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 110.353 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -76.3 -60.67 2.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 110.378 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.44 ' CD1' HG13 ' A' ' 117' ' ' ILE . 2.1 tp -88.41 117.2 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.437 -0.789 . . . . 0.0 110.058 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -86.82 -24.59 24.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -0.803 . . . . 0.0 110.836 -179.341 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 79' ' ' THR . . . 179.98 177.89 48.25 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.606 -1.283 . . . . 0.0 109.955 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.1 mtt -152.94 162.42 41.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -1.148 . . . . 0.0 109.969 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 t -154.81 153.48 31.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.958 . . . . 0.0 110.01 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.485 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.9 OUTLIER -151.77 147.21 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 110.896 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.478 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 61.07 10.65 2.98 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.488 -0.757 . . . . 0.0 111.944 179.204 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.75 2.16 34.59 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.313 -1.423 . . . . 0.0 111.39 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 83' ' ' ILE . 5.2 p80 -135.39 150.25 49.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.534 -1.568 . . . . 0.0 110.824 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -70.15 -164.23 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 110.437 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 9.6 pt-20 -106.79 170.24 8.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.857 . . . . 0.0 110.492 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.34 136.24 50.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.019 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -67.96 100.94 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.989 -1.07 . . . . 0.0 109.648 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.425 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.1 tt -96.26 -29.13 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.0 110.776 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.4 m -167.38 99.48 0.51 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.162 -0.961 . . . . 0.0 109.963 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -95.61 152.99 17.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.816 . . . . 0.0 110.041 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -142.79 73.66 1.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 110.172 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.57 -34.27 72.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.269 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -47.09 85.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.119 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -96.32 14.82 23.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.46 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 51.16 55.13 9.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.109 -0.995 . . . . 0.0 110.103 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 94' ' ' ASN . 54.3 mt-10 -146.32 168.1 21.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.327 -0.858 . . . . 0.0 110.168 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.438 ' HB3' ' CG2' ' A' ' 72' ' ' VAL . 4.2 ttt180 -172.96 163.23 4.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.212 -0.93 . . . . 0.0 109.93 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.438 ' N ' ' CG ' ' A' ' 100' ' ' ARG . 62.9 m -139.96 153.98 47.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.863 . . . . 0.0 110.122 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.432 ' N ' HG22 ' A' ' 101' ' ' THR . 5.1 p -145.59 143.93 30.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.427 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.99 147.51 22.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.283 -0.886 . . . . 0.0 109.965 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.475 ' CZ ' ' HB3' ' A' ' 88' ' ' GLU . 15.6 m-85 -128.02 135.84 50.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 110.683 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.11 131.13 51.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.721 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.0 m -149.22 159.12 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.14 -0.975 . . . . 0.0 110.558 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.8 t -50.44 -45.04 55.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 109.142 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.443 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.5 -165.43 0.85 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.658 -0.651 . . . . 0.0 109.485 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.441 ' CD2' ' HB2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -149.99 71.48 1.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.073 -1.017 . . . . 0.0 110.548 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -146.17 55.49 1.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.404 -0.81 . . . . 0.0 110.177 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 142' ' ' PHE . . . 169.37 -108.27 0.29 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.41 ' HG3' HG21 ' A' ' 139' ' ' THR . 1.5 tmtt? -156.44 135.15 11.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.35 -1.088 . . . . 0.0 109.902 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.2 mt -128.97 147.27 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.124 -0.985 . . . . 0.0 110.291 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.89 119.95 20.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.952 . . . . 0.0 110.407 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -124.71 178.79 16.38 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -146.49 158.51 43.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -1.088 . . . . 0.0 109.842 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.44 HG13 ' CD1' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.55 146.91 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.069 -1.019 . . . . 0.0 110.581 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.435 ' N ' HG12 ' A' ' 117' ' ' ILE . 1.4 m-20 -106.92 159.79 16.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.532 -0.73 . . . . 0.0 109.534 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -136.24 151.63 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 0.0 110.286 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.16 103.91 3.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.385 -0.822 . . . . 0.0 110.513 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.483 HD12 ' CD2' ' A' ' 132' ' ' TYR . 65.4 mt -132.34 153.18 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 110.136 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.42 ' N ' HG23 ' A' ' 121' ' ' ILE . 0.8 OUTLIER -159.29 97.16 1.35 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.384 -0.823 . . . . 0.0 109.851 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -173.54 -179.73 1.91 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 110.165 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -103.16 108.01 19.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.096 -1.003 . . . . 0.0 110.295 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.5 t -76.82 100.01 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.296 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.417 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 1.6 m120 62.65 42.08 8.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.222 -0.924 . . . . 0.0 110.519 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.1 36.49 24.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.08 106.21 4.48 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.155 -1.203 . . . . 0.0 110.12 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -51.18 115.19 1.89 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.695 1.366 . . . . 0.0 110.251 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -114.9 116.87 29.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 110.473 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.38 133.95 47.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.398 -0.814 . . . . 0.0 109.775 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.483 ' CD2' HD12 ' A' ' 121' ' ' ILE . 2.3 t80 -149.79 119.38 6.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.161 -0.962 . . . . 0.0 109.937 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -165.98 75.36 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.248 -0.908 . . . . 0.0 110.034 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.03 -165.24 2.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 110.448 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 1.6 p-80 -122.26 154.33 37.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 110.361 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 45.6 m-85 -154.94 135.06 13.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.31 -0.869 . . . . 0.0 110.033 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.511 ' ND2' ' CD2' ' A' ' 41' ' ' TYR . 50.8 p30 -87.77 166.45 14.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.325 -0.859 . . . . 0.0 110.525 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.409 ' CG2' ' O ' ' A' ' 137' ' ' ASN . 5.9 pt -156.48 167.25 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.12 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.41 HG21 ' HG3' ' A' ' 112' ' ' LYS . 85.0 m -91.76 115.44 28.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.323 -0.861 . . . . 0.0 111.059 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.464 ' CE2' HD11 ' A' ' 83' ' ' ILE . 15.6 m-85 -90.62 95.79 10.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 109.578 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -87.71 101.94 14.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.05 -1.031 . . . . 0.0 110.742 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 111' ' ' GLY . 22.8 m-85 -93.26 138.87 31.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.31 -0.869 . . . . 0.0 110.251 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.469 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 17.4 m-80 -132.38 99.48 4.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.11 -0.994 . . . . 0.0 110.333 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.406 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -159.77 -142.02 3.29 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo . . . . . 0 C--N 1.31 -1.485 0 O-C-N 123.598 1.315 . . . . 0.0 110.11 179.76 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 60.7 m-20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 120.904 0.383 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.25 141.05 13.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 110.569 -179.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -172.7 173.06 45.38 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.61 110.63 21.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.258 -1.142 . . . . 0.0 110.402 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.411 ' CD1' ' HA3' ' A' ' 144' ' ' GLY . 0.6 OUTLIER -95.61 155.34 16.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -0.915 . . . . 0.0 110.549 179.793 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.7 t-20 -81.86 135.69 35.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.111 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.493 ' CD1' ' HB1' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -167.09 159.52 13.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.864 -1.147 . . . . 0.0 110.969 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -154.69 -165.82 2.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.398 -0.814 . . . . 0.0 109.795 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.507 ' CG2' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -141.16 174.42 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 110.632 -179.914 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -148.56 157.29 43.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.401 -0.812 . . . . 0.0 109.889 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.445 ' HG3' ' CG2' ' A' ' 43' ' ' THR . 12.8 tppt? -67.73 136.4 54.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 110.223 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.467 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -61.46 146.54 48.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.178 -0.951 . . . . 0.0 109.354 179.577 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 8.3 t30 72.02 2.83 4.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.851 -0.53 . . . . 0.0 110.79 -179.141 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.445 ' CG2' ' HG3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -136.62 -166.65 1.93 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.932 -1.105 . . . . 0.0 109.559 179.207 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.445 ' N ' ' OG1' ' A' ' 43' ' ' THR . 25.6 t30 -130.93 15.87 5.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 110.302 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.59 139.07 41.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 110.843 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.465 ' CG2' ' CB ' ' A' ' 50' ' ' ASN . 0.3 OUTLIER -70.43 134.76 48.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.075 179.141 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.7 t -129.28 -18.26 3.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.009 -1.077 . . . . 0.0 112.193 -178.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.1 mp -138.19 -49.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.773 -1.204 . . . . 0.0 110.976 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.42 ' CB ' HD13 ' A' ' 138' ' ' ILE . . . -81.94 8.5 10.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.537 -0.727 . . . . 0.0 111.475 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.465 ' CB ' ' CG2' ' A' ' 46' ' ' THR . 0.5 OUTLIER -71.78 -33.93 69.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.901 -1.124 . . . . 0.0 110.492 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 71.5 m-20 -102.69 15.38 29.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.13 -0.981 . . . . 0.0 110.806 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.441 ' CD1' HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -91.13 -18.01 25.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.047 -1.033 . . . . 0.0 110.866 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.507 ' CE1' ' CG2' ' A' ' 38' ' ' VAL . 39.2 p90 -118.3 127.88 54.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.15 -0.969 . . . . 0.0 110.865 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -73.76 109.85 7.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.746 179.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -91.99 161.63 32.88 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.047 -1.033 . . . . 0.0 110.144 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.54 -175.58 16.77 Favored 'Cis proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.513 -2.286 . . . . 0.0 110.585 -0.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.493 ' HB1' ' CD1' ' A' ' 36' ' ' TYR . . . -101.8 168.06 9.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 0.0 109.894 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.5 116.01 31.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 110.795 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.4 ' HA ' ' CG2' ' A' ' 68' ' ' VAL . 3.9 p90 -96.3 160.96 14.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 0.0 109.355 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -154.72 124.62 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.942 -1.099 . . . . 0.0 110.967 -179.329 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.2 mtmt -137.62 129.29 28.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.349 -0.845 . . . . 0.0 110.173 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -108.37 63.63 0.61 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.903 . . . . 0.0 110.843 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 46.03 96.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.494 -0.754 . . . . 0.0 111.109 179.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.94 12.73 39.15 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -171.25 156.8 4.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.166 -1.196 . . . . 0.0 109.735 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.05 143.28 6.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.034 -1.041 . . . . 0.0 111.517 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -140.26 -160.59 1.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.613 -0.679 . . . . 0.0 109.436 179.94 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 59' ' ' TYR . 1.2 t -170.14 131.06 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.003 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.46 141.98 30.65 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.917 . . . . 0.0 110.322 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.69 141.27 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.438 -0.789 . . . . 0.0 110.067 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.18 134.42 34.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.985 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.36 124.87 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.867 . . . . 0.0 110.277 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.83 128.94 45.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.011 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.4 m80 62.72 113.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.311 -0.868 . . . . 0.0 110.107 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.2 t -76.47 -13.19 60.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.864 . . . . 0.0 110.677 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -84.0 -56.1 3.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.041 -1.037 . . . . 0.0 110.397 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.472 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 4.0 m0 -47.87 -68.07 0.22 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.325 -0.859 . . . . 0.0 110.646 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.441 HD11 ' CD1' ' A' ' 52' ' ' TYR . 0.6 OUTLIER -88.28 122.15 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.922 . . . . 0.0 110.041 -179.86 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.441 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -87.19 -27.42 23.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.847 . . . . 0.0 110.926 -179.204 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.441 ' N ' HG21 ' A' ' 79' ' ' THR . . . -175.18 -179.74 45.93 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.166 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.93 169.68 22.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.508 -0.995 . . . . 0.0 109.987 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -153.91 161.41 42.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.067 -1.021 . . . . 0.0 109.716 179.904 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.496 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -164.5 141.4 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 110.699 -179.672 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.48 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 0.4 OUTLIER 62.89 8.7 3.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.525 -0.734 . . . . 0.0 111.964 179.379 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.24 2.01 28.03 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.349 -1.405 . . . . 0.0 111.424 178.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.48 ' NE2' ' CB ' ' A' ' 84' ' ' GLU . 3.2 p80 -135.42 155.95 49.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.518 -1.577 . . . . 0.0 110.964 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -160.49 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.508 -0.745 . . . . 0.0 110.5 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -102.66 150.81 23.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.391 -0.818 . . . . 0.0 110.298 -179.863 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -99.89 125.55 45.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.599 179.519 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pp -67.24 103.11 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.005 -1.059 . . . . 0.0 109.884 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.436 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -95.63 -28.91 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.461 -0.774 . . . . 0.0 110.851 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.5 p -167.05 105.1 0.56 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.96 -1.087 . . . . 0.0 109.982 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.44 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 13.2 ttmt -95.24 106.48 18.52 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.327 -0.858 . . . . 0.0 110.19 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -96.59 95.01 7.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.9 p -77.31 -17.75 58.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 110.434 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.73 -53.67 50.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.025 -1.047 . . . . 0.0 110.101 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -98.0 15.07 25.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -0.88 . . . . 0.0 110.358 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.0 64.93 1.57 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.15 -0.969 . . . . 0.0 110.174 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.93 170.98 15.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.424 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.44 ' CD ' ' HG3' ' A' ' 93' ' ' LYS . 6.6 mtp180 -162.18 164.6 27.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.496 -0.752 . . . . 0.0 109.91 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.436 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 94.6 m -140.68 152.12 45.11 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.29 -0.881 . . . . 0.0 109.618 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 101' ' ' THR . 1.7 p -143.54 138.84 29.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.989 -1.069 . . . . 0.0 110.65 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -91.69 138.2 31.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.366 -0.834 . . . . 0.0 109.975 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 38.2 m-85 -128.59 129.71 46.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.157 -0.964 . . . . 0.0 110.807 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -90.31 127.53 36.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.392 -0.817 . . . . 0.0 109.395 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.459 ' CG2' ' N ' ' A' ' 107' ' ' SER . 2.7 p -149.28 168.52 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.001 -1.062 . . . . 0.0 110.832 -179.25 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.459 ' N ' ' CG2' ' A' ' 106' ' ' VAL . 39.5 t -78.2 110.54 13.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.05 178.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.439 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 47.41 -158.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.46 -0.775 . . . . 0.0 109.86 -178.834 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.401 ' CD1' ' HD2' ' A' ' 145' ' ' PRO . 0.3 OUTLIER -151.27 59.93 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.041 -1.037 . . . . 0.0 110.791 -179.678 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -146.22 56.96 1.19 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.239 -0.913 . . . . 0.0 110.31 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.33 178.96 48.66 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.57 148.32 29.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -1.135 . . . . 0.0 110.395 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.1 mm -137.84 150.08 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 110.114 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -76.07 124.63 27.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 109.986 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.48 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -131.88 116.82 1.94 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 82' ' ' SER . 30.8 mtpt -95.44 159.22 15.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -1.106 . . . . 0.0 109.471 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.431 HG13 ' CD1' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -158.24 140.55 5.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 120.845 -1.16 . . . . 0.0 111.194 -179.836 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -108.26 161.11 15.3 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.496 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -131.48 147.62 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.014 -1.054 . . . . 0.0 110.766 -179.434 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -152.12 106.45 3.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 110.281 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.472 ' CG1' ' HA ' ' A' ' 77' ' ' TRP . 2.4 mp -135.03 150.65 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.158 -0.964 . . . . 0.0 110.68 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 1.0 OUTLIER -160.94 96.8 1.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.46 -0.775 . . . . 0.0 109.863 179.856 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -173.9 -168.38 0.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 110.508 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.9 84.73 3.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.863 . . . . 0.0 110.346 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.0 m -77.52 136.62 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.932 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 50.39 28.01 3.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.812 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.32 34.21 41.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -145.09 128.82 8.63 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.238 -1.154 . . . . 0.0 110.139 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -68.95 110.5 2.4 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.658 1.346 . . . . 0.0 110.155 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 132' ' ' TYR . 49.1 t80 -116.15 156.08 27.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.124 -0.985 . . . . 0.0 110.453 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.79 110.39 9.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 109.935 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.496 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 1.6 t80 -112.8 127.28 56.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 110.041 -179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -163.4 84.59 0.49 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 110.052 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.45 -169.8 3.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.511 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.468 ' O ' ' CD2' ' A' ' 135' ' ' HIS . 0.7 OUTLIER -119.71 145.66 46.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 110.163 179.889 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 38.9 m-85 -155.16 -179.56 8.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 110.104 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -151.88 172.9 15.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.42 HD13 ' CB ' ' A' ' 49' ' ' ALA . 1.8 pt -155.8 166.72 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.305 -0.872 . . . . 0.0 110.132 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.6 m -91.83 122.24 34.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 111.063 -179.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.496 ' CD2' HD11 ' A' ' 83' ' ' ILE . 6.3 m-85 -90.02 162.5 15.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.302 -0.874 . . . . 0.0 109.625 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 101.31 2.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.055 -1.028 . . . . 0.0 110.819 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -91.34 133.85 35.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.299 -0.876 . . . . 0.0 109.518 179.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 2.9 m-80 -128.56 108.63 10.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 110.64 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.411 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -160.36 -145.5 4.3 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.419 ' HG2' ' NZ ' ' A' ' 61' ' ' LYS . 11.0 Cg_endo . . . . . 0 C--N 1.307 -1.638 0 O-C-N 123.626 1.33 . . . . 0.0 110.063 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 8.8 m-20 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.907 0.384 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 p -160.02 159.05 31.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -0.995 . . . . 0.0 110.529 -179.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.51 176.19 35.21 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.94 105.96 18.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.283 -1.128 . . . . 0.0 110.369 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.491 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -95.82 157.26 15.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.128 -0.982 . . . . 0.0 110.847 -179.844 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -80.24 138.45 36.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.344 -0.848 . . . . 0.0 110.483 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -165.24 155.53 13.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.209 179.498 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -155.52 -177.4 6.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.0 110.101 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 139' ' ' THR . 2.2 m -140.21 116.74 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 0.0 110.356 179.511 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -92.35 169.56 10.47 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.421 -0.799 . . . . 0.0 110.38 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 125.82 27.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.887 . . . . 0.0 109.716 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.487 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.5 OUTLIER -48.58 143.28 5.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.286 -0.884 . . . . 0.0 110.53 -179.46 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 18.6 t30 73.77 -2.47 2.76 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.038 -0.414 . . . . 0.0 111.468 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.47 -163.88 1.51 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.782 -1.199 . . . . 0.0 110.053 179.523 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -136.59 30.92 2.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.559 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -134.3 119.81 19.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.082 -1.011 . . . . 0.0 110.983 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.435 HG23 ' CB ' ' A' ' 50' ' ' ASN . 0.5 OUTLIER -57.95 121.61 10.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.472 -0.767 . . . . 0.0 109.63 179.245 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.73 -19.18 3.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.767 -1.208 . . . . 0.0 112.227 -179.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.92 -77.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.536 -1.353 . . . . 0.0 111.108 -179.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -46.17 -25.67 0.64 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.702 -0.623 . . . . 0.0 111.269 -179.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.462 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 1.3 p30 -66.34 -14.65 62.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.988 -1.07 . . . . 0.0 110.917 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.63 15.27 29.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.083 -1.011 . . . . 0.0 111.182 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -138.79 13.4 2.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.831 -1.168 . . . . 0.0 111.002 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.496 ' CG ' ' O ' ' A' ' 53' ' ' PHE . 4.8 p90 -125.81 129.18 48.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.019 . . . . 0.0 110.4 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -73.41 157.11 37.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 110.297 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -148.27 155.4 42.93 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 110.062 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.81 -174.97 15.52 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.762 -2.183 . . . . 0.0 110.351 -0.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.51 169.13 9.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -0.954 . . . . 0.0 110.164 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.436 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -103.15 115.84 31.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.498 -179.868 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.5 p90 -97.76 164.32 12.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.922 . . . . 0.0 109.916 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -155.45 129.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 110.275 179.903 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.2 mtmp? -140.05 112.74 7.99 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.485 -0.759 . . . . 0.0 110.196 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 62.23 2.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.109 -0.994 . . . . 0.0 110.593 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 46.03 99.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.604 -0.685 . . . . 0.0 111.63 179.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.05 -21.64 43.74 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.084 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.87 167.45 20.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -1.139 . . . . 0.0 110.35 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.495 ' CD1' ' HA ' ' A' ' 108' ' ' LYS . 1.1 pt? -171.62 145.46 2.02 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.553 179.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.553 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 1.1 m-85 -142.45 -167.1 2.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.68 -0.637 . . . . 0.0 109.43 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -165.28 129.63 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.126 -0.984 . . . . 0.0 110.419 179.374 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.436 ' HG2' ' CB ' ' A' ' 58' ' ' LYS . 12.1 pt20 -99.57 132.52 44.85 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.832 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.04 130.66 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 110.195 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.8 m -88.56 127.68 35.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.907 . . . . 0.0 109.797 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.439 HG23 ' N ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -102.01 141.9 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.829 . . . . 0.0 110.167 -179.663 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -99.72 148.48 24.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.323 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 7.9 m80 52.43 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.46 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.14 -29.82 61.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 0.0 110.104 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -53.3 14.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.395 -0.816 . . . . 0.0 110.118 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.457 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 35.0 m0 -51.71 -70.43 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.344 -0.847 . . . . 0.0 110.286 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.442 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 3.9 tt -88.23 116.91 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 109.927 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -87.3 -22.55 25.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -0.841 . . . . 0.0 110.937 -179.18 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 79' ' ' THR . . . -178.43 170.66 42.79 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.311 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.422 ' CE ' HD12 ' A' ' 78' ' ' ILE . 4.0 mtm -153.07 107.1 3.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.428 -1.042 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.84 163.91 17.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 110.136 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.507 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.5 OUTLIER -152.42 144.65 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.376 -0.827 . . . . 0.0 110.0 179.83 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.465 ' HB3' ' CE1' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 64.67 10.71 6.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.096 -1.002 . . . . 0.0 110.997 179.868 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.9 15.6 53.83 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.623 179.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 83' ' ' ILE . 2.2 p-80 -135.08 159.47 41.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.821 -1.399 . . . . 0.0 110.546 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 176.71 4.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.403 -0.811 . . . . 0.0 111.008 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 7.4 pt-20 -104.02 170.25 8.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 0.0 110.508 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.7 OUTLIER -112.06 128.34 56.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 110.157 -179.927 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.71 103.56 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.097 -1.002 . . . . 0.0 109.586 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.425 HG23 ' CG2' ' A' ' 101' ' ' THR . 1.4 tt -94.47 -27.24 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.344 -0.847 . . . . 0.0 110.872 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.409 ' N ' HG22 ' A' ' 91' ' ' ILE . 1.2 m -167.03 100.86 0.54 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.184 -0.947 . . . . 0.0 109.808 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.418 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 21.5 ttmt -95.67 107.17 19.35 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.327 -0.858 . . . . 0.0 110.211 -179.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.47 68.3 2.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.027 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.94 -27.52 44.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.282 -0.886 . . . . 0.0 110.229 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.42 -47.44 84.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 0.0 110.126 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -96.71 17.54 16.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.263 -0.898 . . . . 0.0 110.435 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 52.7 57.98 5.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 110.247 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -148.28 174.42 12.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.164 -0.96 . . . . 0.0 110.527 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.439 ' N ' HG23 ' A' ' 72' ' ' VAL . 3.2 ttm180 -170.16 162.65 8.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.356 -0.84 . . . . 0.0 110.207 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.43 HG23 ' N ' ' A' ' 102' ' ' SER . 91.0 m -142.13 153.78 44.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 109.801 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.43 ' N ' HG23 ' A' ' 101' ' ' THR . 0.7 OUTLIER -145.8 144.93 30.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.96 -1.088 . . . . 0.0 110.927 -179.818 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -93.43 141.8 28.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.353 -0.842 . . . . 0.0 109.719 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 97.9 m-85 -130.16 141.63 50.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.006 . . . . 0.0 111.18 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.32 127.89 50.54 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.435 HG21 ' CD1' ' A' ' 113' ' ' ILE . 2.6 p -149.89 149.59 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.036 -1.04 . . . . 0.0 111.351 -178.509 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 101.58 0.72 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.159 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.495 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 55.1 174.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 108.899 -177.919 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.96 70.66 1.11 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.782 -1.199 . . . . 0.0 111.004 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -147.32 64.39 1.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.469 -0.77 . . . . 0.0 110.191 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.54 -112.59 0.38 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.676 -1.25 . . . . 0.0 109.986 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.439 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.4 OUTLIER -157.35 137.58 12.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -1.165 . . . . 0.0 110.167 -179.628 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.435 ' CD1' HG21 ' A' ' 106' ' ' VAL . 12.0 mt -135.21 151.93 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.98 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -76.01 125.18 28.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.164 -0.96 . . . . 0.0 110.5 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.48 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -133.43 178.73 18.02 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 2.1 mtpp -142.34 166.89 23.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -1.186 . . . . 0.0 109.745 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.407 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -158.83 140.59 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.877 -1.14 . . . . 0.0 110.751 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.405 ' CB ' ' CG2' ' A' ' 79' ' ' THR . 1.2 m-20 -107.42 160.62 15.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.553 -0.717 . . . . 0.0 109.375 179.296 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.433 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -136.97 149.81 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.058 -1.026 . . . . 0.0 110.582 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.41 106.51 3.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.305 -0.872 . . . . 0.0 110.602 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.457 ' CG1' ' HA ' ' A' ' 77' ' ' TRP . 3.0 mp -137.99 148.68 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -0.901 . . . . 0.0 110.258 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.432 ' N ' HG22 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -159.9 95.69 1.19 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.351 -0.843 . . . . 0.0 109.738 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.47 -178.97 1.77 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.374 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -98.12 102.27 13.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 110.308 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.477 HG23 ' CD2' ' A' ' 130' ' ' PHE . 13.4 t -76.74 97.42 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 110.303 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.8 m120 57.48 50.84 10.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.268 -0.895 . . . . 0.0 110.423 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.9 36.63 57.35 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.408 ' CA ' ' HE3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -145.75 103.08 4.21 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.195 -1.179 . . . . 0.0 110.186 179.819 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -49.91 117.85 3.39 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.785 1.413 . . . . 0.0 110.227 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.477 ' CD2' HG23 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -111.81 110.3 20.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 110.453 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -106.08 107.48 18.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -0.886 . . . . 0.0 110.079 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.433 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 3.6 t80 -134.54 129.29 34.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.051 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -174.27 82.28 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.168 -0.957 . . . . 0.0 110.234 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -153.44 -160.54 1.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.169 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -122.5 148.46 45.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.257 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -155.14 -179.33 7.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.681 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 46.2 p-10 -151.67 173.02 15.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 110.984 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.407 HG12 ' CG2' ' A' ' 117' ' ' ILE . 1.5 pt -157.58 172.39 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 110.356 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.439 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 59.9 m -91.66 124.06 35.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.346 -0.846 . . . . 0.0 110.56 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.48 ' CE1' ' HA3' ' A' ' 115' ' ' GLY . 31.5 m-85 -91.2 104.47 17.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.233 -0.917 . . . . 0.0 109.996 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.62 105.7 17.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.202 -0.936 . . . . 0.0 110.741 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -92.45 158.8 15.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.285 -0.884 . . . . 0.0 110.519 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 38.2 m-80 -145.49 104.0 3.87 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.094 -1.004 . . . . 0.0 110.479 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -164.34 -146.77 4.87 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo . . . . . 0 C--N 1.308 -1.605 0 O-C-N 123.802 1.422 . . . . 0.0 110.412 -179.957 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 12.8 m-20 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 120.782 0.325 . . . . 0.0 110.308 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -159.36 155.23 26.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.037 -1.039 . . . . 0.0 110.589 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.79 171.76 35.66 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.67 111.14 21.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -1.12 . . . . 0.0 110.54 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.494 ' HB2' ' CD2' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -94.46 148.86 21.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 0.0 109.877 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.437 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 22.4 m-20 -79.56 137.94 37.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.224 -0.922 . . . . 0.0 110.199 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.42 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 1.8 p90 -166.57 164.01 17.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.187 -0.946 . . . . 0.0 110.83 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.25 -179.41 8.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.472 -0.768 . . . . 0.0 109.64 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.434 ' O ' ' CG2' ' A' ' 46' ' ' THR . 69.0 t -140.21 111.21 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.093 -1.004 . . . . 0.0 110.217 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -89.04 166.17 14.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.758 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.2 OUTLIER -67.18 125.15 25.15 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 110.109 -179.766 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.471 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -51.14 144.0 9.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 110.058 -179.906 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.9 OUTLIER 72.02 1.36 3.89 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.818 -0.551 . . . . 0.0 111.108 -179.536 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.429 ' CG2' ' HB3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -135.66 -166.69 1.9 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.894 -1.129 . . . . 0.0 109.752 179.233 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -135.18 18.7 3.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.937 . . . . 0.0 110.196 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -136.19 126.41 26.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.114 -0.991 . . . . 0.0 111.088 -179.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.444 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -53.9 124.95 16.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -0.834 . . . . 0.0 108.903 178.951 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.3 -18.77 3.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.73 -1.231 . . . . 0.0 112.202 -178.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.3 mt -138.55 -78.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.751 -1.218 . . . . 0.0 110.776 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.99 -25.68 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.696 -0.627 . . . . 0.0 111.24 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.444 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -56.48 -18.12 10.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.037 -1.039 . . . . 0.0 111.073 -179.597 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -101.91 15.21 29.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.976 -1.078 . . . . 0.0 111.006 -179.316 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -141.87 10.74 2.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.935 -1.103 . . . . 0.0 111.031 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -118.69 115.44 24.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.091 -1.006 . . . . 0.0 110.136 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.31 152.36 42.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 110.408 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.2 158.26 44.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 109.848 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.57 -175.65 16.9 Favored 'Cis proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.714 -2.203 . . . . 0.0 110.585 -0.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.47 164.05 11.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.062 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.424 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 1.4 mtpt -102.44 118.09 36.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.931 . . . . 0.0 110.524 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.494 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 27.2 p90 -97.3 164.47 12.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.862 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -156.31 117.03 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.033 -1.042 . . . . 0.0 110.632 -179.681 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -127.49 122.15 32.65 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.157 -0.965 . . . . 0.0 110.365 179.885 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 63' ' ' ASN . 1.7 mmmp? -101.46 61.97 0.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 0.0 110.155 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 62' ' ' LYS . 5.1 t-20 47.78 100.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.435 -0.791 . . . . 0.0 111.434 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.11 -15.53 57.83 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.461 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -144.28 169.36 18.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.009 -1.289 . . . . 0.0 110.532 179.827 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.6 pt? -169.58 144.26 2.91 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.367 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.541 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -137.47 -169.08 2.44 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.727 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.2 t -165.72 131.27 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 110.012 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.424 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -98.12 130.21 44.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 -179.932 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -111.61 135.01 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.69 179.94 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.6 m -89.68 125.52 35.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.082 -1.011 . . . . 0.0 110.067 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.59 143.41 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 110.207 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -100.57 128.52 46.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.354 -0.841 . . . . 0.0 110.615 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 61.24 115.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 0.0 110.499 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -43.08 57.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.0 110.037 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -50.82 -39.37 53.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 109.99 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.8 m0 -64.77 -73.45 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 110.062 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.31 119.13 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 109.987 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.45 ' CG2' ' CB ' ' A' ' 118' ' ' ASP . 3.7 t -86.88 -21.65 26.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 111.001 -179.346 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 79' ' ' THR . . . -172.17 169.93 42.98 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.451 -1.356 . . . . 0.0 110.125 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.5 mtm -151.87 106.11 3.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -1.106 . . . . 0.0 110.04 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -86.58 158.48 19.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 109.863 179.66 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.486 HD12 ' CE1' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -156.25 135.63 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.5 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.441 ' HB3' ' NE2' ' A' ' 86' ' ' HIS . 0.6 OUTLIER 65.29 6.22 3.51 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.451 -0.781 . . . . 0.0 112.018 179.489 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.18 -0.57 22.51 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.332 -1.413 . . . . 0.0 111.328 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.452 ' CD2' ' N ' ' A' ' 86' ' ' HIS . 2.6 p80 -131.72 158.08 42.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.557 -1.555 . . . . 0.0 110.881 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -70.55 -164.24 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.5 -0.75 . . . . 0.0 110.505 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 1.2 pm0 -104.61 164.07 12.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 110.544 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -115.38 133.96 55.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.913 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.427 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 1.2 pp -68.06 101.71 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.995 -1.065 . . . . 0.0 109.792 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.44 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 2.3 tt -95.71 -28.2 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.338 -0.851 . . . . 0.0 110.732 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.7 p -167.03 103.35 0.55 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 109.776 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -95.08 147.51 23.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.357 -0.84 . . . . 0.0 110.174 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.31 71.39 1.33 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 110.125 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.16 -32.7 62.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.372 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -42.78 99.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.224 -0.923 . . . . 0.0 110.16 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -95.98 10.38 37.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -0.904 . . . . 0.0 110.608 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 50.95 56.87 7.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.97 -1.081 . . . . 0.0 110.181 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -147.61 179.65 7.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.45 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -174.86 162.02 3.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.401 -0.812 . . . . 0.0 109.984 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.455 HG21 ' N ' ' A' ' 102' ' ' SER . 82.8 m -140.61 156.02 46.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.331 -0.855 . . . . 0.0 109.552 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.455 ' N ' HG21 ' A' ' 101' ' ' THR . 0.9 OUTLIER -143.23 140.02 30.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.982 -1.073 . . . . 0.0 110.82 -179.582 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -93.56 137.59 32.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.717 . . . . 0.0 110.194 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 81.7 m-85 -128.59 140.98 51.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.08 -1.012 . . . . 0.0 110.748 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -102.52 131.54 49.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.86 . . . . 0.0 109.335 179.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.7 m -149.16 147.63 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.135 -0.978 . . . . 0.0 110.833 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.51 108.25 1.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 109.141 179.12 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.483 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 54.39 176.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -0.95 . . . . 0.0 109.118 -178.646 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.409 ' CD1' ' HD2' ' A' ' 145' ' ' PRO . 0.3 OUTLIER -148.9 72.09 1.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.968 -1.082 . . . . 0.0 110.792 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -145.59 44.58 1.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.471 -0.768 . . . . 0.0 109.984 179.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.29 177.25 46.55 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . 0.6 OUTLIER -80.51 145.95 31.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.233 -1.157 . . . . 0.0 110.637 -179.701 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 74.9 mt -136.17 150.75 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.35 -0.844 . . . . 0.0 109.781 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -76.48 132.26 39.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.06 -1.025 . . . . 0.0 110.428 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.432 ' HA3' ' CD2' ' A' ' 140' ' ' TYR . . . -132.94 169.84 22.36 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 82' ' ' SER . 22.4 mtmt -144.01 162.23 36.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.069 -1.253 . . . . 0.0 109.529 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.442 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -159.31 153.44 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.907 -1.121 . . . . 0.0 111.034 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.45 ' CB ' ' CG2' ' A' ' 79' ' ' THR . 84.3 m-20 -115.31 154.23 29.52 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.63 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.493 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -129.48 143.76 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.058 -1.026 . . . . 0.0 110.55 -179.652 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.92 99.99 2.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -0.826 . . . . 0.0 110.118 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.487 HD11 ' CD2' ' A' ' 132' ' ' TYR . 20.7 mt -123.24 152.55 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.612 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.89 96.54 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.399 -0.813 . . . . 0.0 109.812 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -173.5 -170.67 0.62 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.945 . . . . 0.0 110.509 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.97 103.5 15.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 110.347 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.85 102.72 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 110.333 179.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.8 m120 53.86 43.14 31.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.311 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.23 32.17 44.43 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -145.5 102.3 4.31 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.228 -1.16 . . . . 0.0 110.116 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -46.68 120.73 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.702 1.369 . . . . 0.0 110.517 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -124.95 148.51 48.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 0.0 110.058 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -134.69 106.35 6.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.271 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.493 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 4.7 t80 -110.62 131.48 55.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 110.098 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.29 88.04 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.895 . . . . 0.0 110.069 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.34 -168.33 2.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.268 -0.895 . . . . 0.0 110.288 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -117.65 141.67 48.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.974 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -155.51 -179.26 7.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 110.195 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -151.18 176.38 11.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -0.951 . . . . 0.0 110.378 179.902 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.442 HG12 ' CG2' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -155.7 179.59 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 110.085 -179.761 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.5 m -91.06 161.5 15.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.817 . . . . 0.0 111.086 -179.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.486 ' CE1' HD12 ' A' ' 83' ' ' ILE . 23.1 m-85 -147.82 98.81 3.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.575 -0.703 . . . . 0.0 109.3 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 112' ' ' LYS . 10.9 tttt -116.86 110.19 18.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.244 -0.91 . . . . 0.0 110.955 -179.259 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -92.56 152.73 19.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.403 -0.811 . . . . 0.0 110.089 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.42 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 3.4 m-80 -128.98 104.64 7.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.922 . . . . 0.0 110.214 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -153.26 -144.52 3.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.409 ' HD2' ' CD1' ' A' ' 109' ' ' LEU . 10.1 Cg_endo . . . . . 0 C--N 1.309 -1.55 0 O-C-N 123.608 1.32 . . . . 0.0 110.644 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.11 0.481 . . . . 0.0 110.209 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 p -159.74 129.85 5.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.408 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.52 177.8 48.33 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.45 105.54 17.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.205 -1.173 . . . . 0.0 110.221 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.476 ' CB ' ' CD1' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -93.79 151.37 19.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.378 -0.826 . . . . 0.0 110.154 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.438 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 23.0 m120 -79.06 145.55 33.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.921 . . . . 0.0 110.14 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.455 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 1.5 p90 -163.92 156.01 17.07 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.189 -0.945 . . . . 0.0 110.177 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -155.44 -176.76 6.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 110.043 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.449 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -140.16 174.41 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.159 -0.963 . . . . 0.0 110.267 179.991 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.449 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 47.3 m-85 -147.96 160.19 43.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.416 -0.802 . . . . 0.0 110.153 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.81 121.33 15.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.859 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.476 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -48.75 148.97 1.91 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 -179.72 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 8.5 t30 72.47 1.43 3.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.968 -0.458 . . . . 0.0 111.085 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.05 -155.98 0.67 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.789 -1.195 . . . . 0.0 109.902 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -136.13 10.77 3.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.335 -0.853 . . . . 0.0 110.491 179.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -134.28 148.95 50.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.015 . . . . 0.0 110.845 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.403 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -79.83 138.44 37.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.319 179.547 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.97 -17.91 3.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.961 -1.087 . . . . 0.0 111.899 -179.041 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.5 mt -137.96 -71.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.764 -1.21 . . . . 0.0 110.709 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -46.11 -26.53 0.77 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.691 -0.631 . . . . 0.0 111.023 -179.426 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.403 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -59.7 -19.65 51.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.128 -0.983 . . . . 0.0 110.715 -179.595 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -102.32 14.82 30.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.97 -1.081 . . . . 0.0 110.868 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -128.79 6.15 5.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.984 -1.073 . . . . 0.0 111.075 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.421 ' CE1' ' HE3' ' A' ' 81' ' ' MET . 33.8 m-85 -129.76 117.01 19.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 110.34 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -72.77 166.82 22.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.97 . . . . 0.0 110.301 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 3.3 pttt -148.18 159.57 39.32 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 110.011 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 59.4 Cg_endo -82.48 -175.64 15.35 Favored 'Cis proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.648 -2.23 . . . . 0.0 110.394 -0.411 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.97 170.23 8.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 110.002 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -103.03 108.38 19.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 110.525 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.476 ' CD1' ' CB ' ' A' ' 34' ' ' LEU . 6.3 p90 -97.97 162.25 13.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 109.75 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.432 HG13 ' N ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -154.8 155.22 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.15 -0.969 . . . . 0.0 110.373 -179.665 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.7 mtpt -135.94 168.89 18.49 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.339 -0.851 . . . . 0.0 110.606 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.407 ' CB ' ' HG3' ' A' ' 65' ' ' LYS . 10.4 mttm -148.0 61.97 1.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 0.0 109.834 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 45.69 78.07 0.07 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.47 -0.769 . . . . 0.0 110.925 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.09 19.42 16.89 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.407 ' HG3' ' CB ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -168.07 162.83 13.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.146 -1.208 . . . . 0.0 110.38 179.546 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.3 pt? -173.42 150.18 1.8 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.2 1.0 . . . . 0.0 111.74 178.706 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.554 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -139.94 -164.83 1.77 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.023 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -170.17 144.01 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.0 110.692 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.419 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 1.6 pt20 -99.75 132.87 44.82 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.924 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -110.57 133.1 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.852 . . . . 0.0 109.8 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.27 123.08 33.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.145 -0.972 . . . . 0.0 110.26 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.29 147.09 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.357 -0.839 . . . . 0.0 109.857 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -99.49 141.91 31.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 0.0 110.49 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.444 ' HB3' ' CG ' ' A' ' 77' ' ' TRP . 9.6 m-70 53.62 92.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 m -52.35 -31.28 32.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 110.232 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -71.11 -45.53 63.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.219 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.444 ' CG ' ' HB3' ' A' ' 74' ' ' HIS . 45.6 m0 -55.64 -62.77 1.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.318 -0.864 . . . . 0.0 110.303 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 0.5 OUTLIER -88.37 120.26 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.448 -0.783 . . . . 0.0 109.915 -179.727 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.457 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -89.16 -27.21 20.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.347 -0.846 . . . . 0.0 111.073 -179.217 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.457 ' N ' HG21 ' A' ' 79' ' ' THR . . . -179.57 172.02 43.78 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.258 -1.449 . . . . 0.0 110.535 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.421 ' HE3' ' CE1' ' A' ' 53' ' ' PHE . 1.8 mtp -153.05 110.95 3.6 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.522 -0.987 . . . . 0.0 109.859 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -86.56 123.04 31.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.975 -1.078 . . . . 0.0 110.031 179.947 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 1.7 mt -113.1 131.07 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 110.259 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 2.3 tm-20 69.62 5.51 5.23 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.493 -0.755 . . . . 0.0 110.99 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.25 23.89 10.86 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.728 -1.225 . . . . 0.0 111.0 178.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.47 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.39 162.37 34.6 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.673 -1.486 . . . . 0.0 110.149 179.359 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -175.68 1.18 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.96 . . . . 0.0 110.199 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 5.1 pt-20 -110.17 167.03 10.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 110.341 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 102' ' ' SER . 3.5 t-20 -114.09 130.7 56.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.361 -0.837 . . . . 0.0 109.918 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.401 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 1.1 pp -67.69 100.89 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 0.0 109.674 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.441 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 2.4 tt -95.36 -23.3 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 110.566 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 91' ' ' ILE . 1.5 m -167.06 100.18 0.53 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -94.54 142.5 27.37 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.914 -179.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.59 74.12 1.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 110.33 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.0 p -65.07 -31.16 72.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.062 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.65 -50.07 72.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.852 . . . . 0.0 110.226 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -95.43 13.62 25.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.259 -0.9 . . . . 0.0 110.426 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.65 60.56 3.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 110.276 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -147.54 150.41 34.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 0.0 110.418 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.47 157.08 40.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.353 -0.842 . . . . 0.0 109.951 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.441 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 60.4 m -141.09 154.8 46.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.306 -0.871 . . . . 0.0 109.75 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 1.8 p -145.57 139.75 26.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.007 -1.058 . . . . 0.0 111.044 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -93.06 138.65 31.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.46 -0.775 . . . . 0.0 109.429 179.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 102' ' ' SER . 93.5 m-85 -128.5 145.72 51.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.883 -1.136 . . . . 0.0 111.34 -179.234 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -105.72 130.41 53.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.42 -0.8 . . . . 0.0 109.048 178.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.1 m -150.31 170.34 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.918 -1.113 . . . . 0.0 111.36 -178.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.3 m -74.59 111.02 9.36 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.444 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 45.7 -163.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.591 -0.693 . . . . 0.0 109.673 -178.355 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.454 ' CD2' ' CD2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -151.03 56.88 0.9 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.911 -1.118 . . . . 0.0 110.871 -179.549 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -145.58 70.2 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 0.0 110.001 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.89 176.57 38.0 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HE3' ' N ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -81.78 142.91 32.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -1.115 . . . . 0.0 110.34 -179.972 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.43 ' N ' ' HE3' ' A' ' 112' ' ' LYS . 53.0 mt -137.34 153.52 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 110.041 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.38 128.3 34.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.231 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.455 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -138.62 123.25 2.56 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 82' ' ' SER . 10.5 mttm -96.76 163.74 12.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -1.175 . . . . 0.0 109.703 179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.419 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -159.22 133.18 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.879 -1.138 . . . . 0.0 111.171 179.895 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.436 ' HB2' ' CG2' ' A' ' 79' ' ' THR . 93.6 m-20 -108.35 165.61 11.38 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.402 HG22 ' CE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -141.45 153.2 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.965 -1.085 . . . . 0.0 110.648 -179.644 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.421 ' CE1' ' OD2' ' A' ' 122' ' ' ASP . 6.4 t80 -151.82 109.63 3.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -0.806 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.499 HD11 ' CD2' ' A' ' 132' ' ' TYR . 46.2 mt -134.71 152.92 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.961 . . . . 0.0 110.349 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.421 ' OD2' ' CE1' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -160.48 98.07 1.24 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.389 -0.819 . . . . 0.0 109.622 179.602 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -173.2 -168.52 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 110.398 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -103.58 97.46 7.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 110.474 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.8 125.0 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.253 -0.905 . . . . 0.0 110.222 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 52.9 25.29 3.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.293 -0.879 . . . . 0.0 110.198 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 85.94 33.82 14.44 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -144.61 134.43 11.66 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.313 -1.11 . . . . 0.0 110.0 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.47 127.85 25.21 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.631 1.332 . . . . 0.0 110.474 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -131.07 113.18 13.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.357 -0.84 . . . . 0.0 110.123 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.25 104.45 14.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.187 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.499 ' CD2' HD11 ' A' ' 121' ' ' ILE . 3.1 t80 -114.93 124.27 51.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.905 . . . . 0.0 109.943 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 48.2 p-10 -171.03 86.47 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.328 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -153.3 -168.95 3.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.905 . . . . 0.0 110.189 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.4 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.3 OUTLIER -119.8 148.61 43.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.336 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.4 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 12.4 m-85 -155.67 -178.56 7.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 0.0 110.245 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -150.04 171.45 16.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.89 . . . . 0.0 110.275 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.419 HG12 ' CG2' ' A' ' 117' ' ' ILE . 0.4 OUTLIER -156.46 166.21 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 0.0 110.413 -179.739 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 59.8 m -91.77 120.45 32.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 0.0 110.437 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.455 ' CD1' ' HA3' ' A' ' 115' ' ' GLY . 11.6 m-85 -90.38 161.82 15.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.59 102.7 2.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.908 . . . . 0.0 110.388 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -91.72 154.91 18.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.922 . . . . 0.0 110.155 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.455 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 22.8 m-80 -143.0 98.45 3.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -153.62 -146.81 4.47 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo . . . . . 0 C--N 1.308 -1.581 0 O-C-N 123.776 1.408 . . . . 0.0 110.451 -179.922 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 9.8 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 120.766 0.317 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 22.7 t -160.14 159.76 32.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.021 -1.049 . . . . 0.0 110.911 -179.471 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 165.24 172.73 33.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.37 115.21 25.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.156 -1.202 . . . . 0.0 110.381 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.507 ' HB2' ' CD2' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -95.88 141.72 28.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.134 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -78.99 135.88 37.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 109.924 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.428 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -165.71 171.67 12.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 110.715 -179.948 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -155.23 -176.78 6.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.442 -0.786 . . . . 0.0 110.081 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 46' ' ' THR . 1.4 m -141.27 108.37 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 0.0 109.94 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -93.2 162.64 13.94 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 110.637 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.406 ' CG ' HG21 ' A' ' 43' ' ' THR . 12.7 tppt? -67.52 140.81 57.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.599 -0.688 . . . . 0.0 110.043 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.46 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -64.57 147.75 52.21 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.011 -1.056 . . . . 0.0 109.247 179.413 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.1 t-20 70.95 3.04 4.47 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.701 -0.625 . . . . 0.0 110.746 -179.046 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -137.36 -168.28 2.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.911 -1.118 . . . . 0.0 109.446 179.182 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.441 ' N ' ' OG1' ' A' ' 43' ' ' THR . 65.3 t30 -128.55 12.29 6.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.931 -1.106 . . . . 0.0 110.491 179.69 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -136.29 133.04 36.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.055 -1.028 . . . . 0.0 110.467 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.474 ' CG2' ' CB ' ' A' ' 50' ' ' ASN . 6.0 t -63.56 139.43 58.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.088 -1.007 . . . . 0.0 109.068 179.154 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.39 -17.53 3.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 112.015 -179.013 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.7 mt -137.94 -50.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.785 -1.197 . . . . 0.0 110.845 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.74 -54.72 43.69 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.567 -0.708 . . . . 0.0 111.717 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.474 ' CB ' ' CG2' ' A' ' 46' ' ' THR . 4.8 t-20 -47.47 -25.04 0.96 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.141 -0.974 . . . . 0.0 110.988 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -73.32 -2.44 22.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -0.988 . . . . 0.0 111.168 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -144.78 28.78 1.26 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.823 -1.173 . . . . 0.0 110.892 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.423 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 11.3 m-85 -130.97 109.47 10.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.944 . . . . 0.0 110.244 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -72.45 150.15 43.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.328 -0.857 . . . . 0.0 110.415 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.79 168.09 12.25 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.321 -0.862 . . . . 0.0 109.924 -179.994 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 44.6 Cg_endo -76.57 -175.66 17.04 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.692 -2.211 . . . . 0.0 110.683 -0.201 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.45 168.38 9.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 110.137 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.49 119.91 39.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.17 -0.956 . . . . 0.0 110.562 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.507 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 27.4 p90 -96.93 164.25 12.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 109.676 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 1.0 OUTLIER -156.37 116.4 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.951 -1.093 . . . . 0.0 111.165 -179.603 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.484 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -127.6 119.48 26.05 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.359 -0.838 . . . . 0.0 110.037 179.655 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.38 62.52 1.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.571 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.41 96.18 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.46 -0.775 . . . . 0.0 111.229 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.54 10.52 43.91 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.58 160.84 11.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.963 -1.316 . . . . 0.0 109.877 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.7 pt? -166.18 141.78 4.76 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.636 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.541 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -139.64 -178.03 5.22 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.496 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -156.11 131.92 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.986 -1.071 . . . . 0.0 110.341 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 7.8 pt20 -97.3 133.12 42.33 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.291 -0.881 . . . . 0.0 109.936 179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.411 HG23 ' CE ' ' A' ' 81' ' ' MET . 0.4 OUTLIER -114.73 131.22 67.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.179 -0.951 . . . . 0.0 109.502 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 m -87.52 116.57 25.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.131 -0.981 . . . . 0.0 110.481 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -104.01 143.62 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.403 -0.811 . . . . 0.0 109.996 179.883 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -101.05 156.26 17.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.161 -0.962 . . . . 0.0 110.348 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 51.49 86.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 110.324 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.426 ' HB2' ' CD ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -65.36 -30.12 70.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 0.0 110.054 179.907 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -63.78 -34.5 78.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.88 . . . . 0.0 110.319 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.41 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 27.4 m0 -77.74 -58.02 3.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.8 tt -88.87 121.07 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.911 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.46 HG21 ' N ' ' A' ' 80' ' ' GLY . 1.0 OUTLIER -86.66 -24.83 25.13 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.248 -0.908 . . . . 0.0 110.867 -179.344 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.46 ' N ' HG21 ' A' ' 79' ' ' THR . . . 178.55 -179.19 48.75 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.308 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.423 ' SD ' ' CZ ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -152.68 114.79 4.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.441 -1.035 . . . . 0.0 110.12 -179.989 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -85.78 156.34 20.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.146 -0.971 . . . . 0.0 110.406 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.442 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 1.4 mt -156.74 134.27 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.404 -0.81 . . . . 0.0 110.111 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 69.85 3.37 4.27 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.528 -0.732 . . . . 0.0 111.488 179.735 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.94 22.2 11.13 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.22 178.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.457 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.66 161.81 35.51 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.676 -1.485 . . . . 0.0 110.143 179.276 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -70.33 -169.54 0.31 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.127 -0.983 . . . . 0.0 110.475 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.23 169.71 8.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 110.259 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.05 128.66 49.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 110.236 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.427 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.6 pp -68.33 101.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.773 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.443 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.5 tt -94.84 -28.32 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 110.441 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.8 m -166.39 98.88 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.901 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -95.31 106.38 18.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.455 -0.778 . . . . 0.0 110.017 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.1 101.87 13.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 110.227 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -78.96 -28.99 43.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 110.22 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.44 -51.04 69.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.15 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -96.2 15.75 20.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 110.41 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.66 23.23 3.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.115 -0.991 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -92.77 177.91 5.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 110.461 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.436 ' HB3' ' CG2' ' A' ' 72' ' ' VAL . 0.6 OUTLIER -179.35 151.76 0.5 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.457 -0.777 . . . . 0.0 109.658 179.948 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.443 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 86.1 m -141.46 158.03 44.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 110.257 -179.568 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.436 ' N ' HG22 ' A' ' 101' ' ' THR . 9.5 p -145.24 143.16 30.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -0.98 . . . . 0.0 110.452 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -93.26 143.44 26.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.29 -0.881 . . . . 0.0 110.031 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -129.91 132.26 46.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.133 -0.98 . . . . 0.0 110.874 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -92.31 128.92 38.34 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.308 -0.87 . . . . 0.0 109.624 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.3 m -149.9 144.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.012 -1.055 . . . . 0.0 111.059 -179.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.36 109.8 1.71 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.928 . . . . 0.0 108.944 178.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.465 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 54.16 175.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 109.24 -178.585 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.437 ' CD1' ' HD2' ' A' ' 145' ' ' PRO . 0.3 OUTLIER -149.98 71.45 1.08 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.006 -1.059 . . . . 0.0 110.871 -179.853 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -146.14 40.33 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.387 -0.821 . . . . 0.0 110.185 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -169.42 -170.73 34.29 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -81.34 145.51 30.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -1.131 . . . . 0.0 110.476 -179.81 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mm -137.65 138.14 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.432 -0.793 . . . . 0.0 109.971 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -76.16 123.07 25.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.185 -0.947 . . . . 0.0 110.361 -179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.477 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -134.86 175.79 20.36 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 38.9 mttt -144.7 176.85 9.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -1.182 . . . . 0.0 109.886 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -158.47 144.45 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.922 -1.111 . . . . 0.0 111.157 179.926 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.441 ' CB ' ' CG2' ' A' ' 79' ' ' THR . 1.1 m-20 -108.98 156.89 19.2 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.441 -0.787 . . . . 0.0 109.041 178.522 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.458 HG12 ' CE2' ' A' ' 132' ' ' TYR . 2.6 t -141.72 151.86 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.016 -1.053 . . . . 0.0 110.705 -179.307 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.454 ' CZ ' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -151.14 104.37 3.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.436 -0.79 . . . . 0.0 110.268 179.97 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.432 HG23 ' CZ ' ' A' ' 130' ' ' PHE . 5.0 mt -133.06 153.25 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.134 -0.979 . . . . 0.0 110.084 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.69 95.93 1.23 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 110.12 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.463 ' HG2' ' CE1' ' A' ' 130' ' ' PHE . 7.6 pt-20 -174.48 -155.77 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.424 ' HG2' ' CA ' ' A' ' 129' ' ' PRO . 9.3 mtmt -122.59 127.21 49.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.445 HG22 ' CE1' ' A' ' 130' ' ' PHE . 80.8 t -76.18 90.65 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.145 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.7 m120 52.04 27.38 4.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 0.0 110.245 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 117.87 31.8 1.54 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -145.29 90.9 5.97 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.219 -1.166 . . . . 0.0 110.066 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.424 ' CA ' ' HG2' ' A' ' 124' ' ' LYS . 27.6 Cg_exo -56.86 123.14 13.13 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.014 1.534 . . . . 0.0 110.314 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.463 ' CE1' ' HG2' ' A' ' 123' ' ' GLU . 14.7 p90 -147.7 132.69 18.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.221 -0.924 . . . . 0.0 110.262 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -103.94 132.54 50.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 110.027 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.458 ' CE2' HG12 ' A' ' 119' ' ' VAL . 4.1 t80 -125.63 130.96 52.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.377 -0.827 . . . . 0.0 110.003 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.454 ' OD2' ' CZ ' ' A' ' 120' ' ' TYR . 62.5 t0 -169.43 84.62 0.13 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -0.931 . . . . 0.0 110.008 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.72 -177.03 6.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.384 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.455 ' O ' ' CD2' ' A' ' 135' ' ' HIS . 28.4 p-80 -120.49 89.52 3.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 110.294 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -84.76 -179.41 7.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 109.813 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 10.3 p30 -151.21 168.24 25.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.037 -1.039 . . . . 0.0 110.876 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -156.66 178.88 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -0.81 . . . . 0.0 110.845 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 94.8 m -91.53 162.7 14.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.538 -0.727 . . . . 0.0 110.586 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.477 ' CE2' ' HA3' ' A' ' 115' ' ' GLY . 96.4 m-85 -145.4 105.25 4.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.373 -0.829 . . . . 0.0 109.717 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -103.98 109.13 20.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 110.797 -179.484 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -91.79 145.84 24.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.603 179.361 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.427 ' N ' ' ND2' ' A' ' 143' ' ' ASN . 2.6 m-80 -133.81 109.17 8.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.035 -1.04 . . . . 0.0 110.63 -179.446 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -153.71 -135.47 2.13 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.437 ' HD2' ' CD1' ' A' ' 109' ' ' LEU . 6.1 Cg_endo . . . . . 0 C--N 1.312 -1.352 0 O-C-N 123.399 1.21 . . . . 0.0 110.025 179.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 6.7 m-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.983 0.42 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.72 153.86 23.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 110.325 -179.668 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.32 179.5 42.46 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.03 109.41 20.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.176 -1.19 . . . . 0.0 110.404 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -94.36 151.69 19.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.397 -0.815 . . . . 0.0 109.955 179.926 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.437 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 2.8 m-80 -79.4 136.6 37.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.152 -0.967 . . . . 0.0 109.509 179.626 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.436 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 0.6 OUTLIER -164.98 159.1 17.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.092 -1.005 . . . . 0.0 110.366 -179.852 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.37 -179.83 8.47 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.417 -0.802 . . . . 0.0 109.653 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.442 ' O ' ' CG2' ' A' ' 46' ' ' THR . 3.3 m -139.74 117.48 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.128 -0.982 . . . . 0.0 110.118 179.642 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -90.6 161.41 15.44 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.35 -0.843 . . . . 0.0 110.668 -179.629 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.0 OUTLIER -68.05 135.42 52.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.605 -0.684 . . . . 0.0 110.243 -179.75 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.473 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -61.56 144.76 53.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 110.082 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.4 t-20 70.7 3.21 4.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.789 -0.57 . . . . 0.0 110.728 -179.204 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.429 ' CG2' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -139.0 -169.72 2.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.033 -1.042 . . . . 0.0 109.638 179.48 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.404 ' N ' ' OG1' ' A' ' 43' ' ' THR . 1.6 m120 -136.08 24.59 3.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.112 -0.992 . . . . 0.0 110.295 179.677 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -136.13 120.65 18.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 111.146 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.442 ' CG2' ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -49.64 121.61 5.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.532 -0.73 . . . . 0.0 109.359 178.961 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.73 -18.83 3.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.833 -1.167 . . . . 0.0 112.293 -178.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.0 mt -138.99 -78.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.59 -1.319 . . . . 0.0 111.214 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.3 -26.65 0.54 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.634 -0.666 . . . . 0.0 111.508 -179.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.421 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -63.98 -16.33 61.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.029 -1.044 . . . . 0.0 110.765 -179.582 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -102.58 15.44 29.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.082 -1.011 . . . . 0.0 110.853 -179.65 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -130.38 12.14 5.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.072 -1.017 . . . . 0.0 111.014 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.427 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 23.8 m-85 -131.28 116.9 18.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.026 -1.046 . . . . 0.0 110.314 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -72.4 108.47 5.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.258 -0.901 . . . . 0.0 110.323 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.88 159.65 34.08 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 109.943 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -78.76 -175.78 17.38 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.753 -2.186 . . . . 0.0 110.65 -0.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.1 171.56 7.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 109.984 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.55 112.14 25.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.074 -1.016 . . . . 0.0 110.684 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.466 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 11.1 p90 -96.95 167.1 11.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.217 -0.927 . . . . 0.0 109.965 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -156.39 120.96 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.172 -0.955 . . . . 0.0 110.981 179.941 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.1 mtmp? -137.77 127.36 25.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.282 -0.886 . . . . 0.0 110.078 179.614 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -108.59 62.33 0.61 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 110.425 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.68 103.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.434 -0.791 . . . . 0.0 111.343 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.28 -20.3 50.81 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.003 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.39 154.96 48.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.026 -1.279 . . . . 0.0 110.661 -179.677 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.547 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -157.02 142.99 17.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 111.195 179.446 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.532 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 4.0 m-85 -139.36 -172.85 3.45 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.436 ' CG2' ' HA ' ' A' ' 59' ' ' TYR . 1.2 t -163.39 130.06 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.95 -1.093 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -98.59 136.28 38.91 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.589 179.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -114.76 132.61 63.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.15 -0.969 . . . . 0.0 110.172 -179.452 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.12 120.48 31.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.699 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 72' ' ' VAL . 0.8 OUTLIER -103.28 136.89 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 110.042 -179.72 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -99.92 147.15 25.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 110.335 -179.668 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.447 ' CD2' ' CZ3' ' A' ' 77' ' ' TRP . 62.0 m-70 58.1 92.12 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.433 -0.792 . . . . 0.0 110.231 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.77 -40.1 87.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 110.284 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.9 m170 -62.52 -27.7 69.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 110.266 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.447 ' CZ3' ' CD2' ' A' ' 74' ' ' HIS . 38.9 m0 -72.24 -73.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.998 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 6.9 tt -88.06 116.47 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.378 -0.826 . . . . 0.0 109.316 179.552 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 80' ' ' GLY . 1.6 t -86.56 -21.4 26.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.284 -0.885 . . . . 0.0 111.615 -178.573 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.426 ' N ' HG22 ' A' ' 79' ' ' THR . . . -173.52 168.74 41.74 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.307 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.431 ' CG ' ' HB ' ' A' ' 117' ' ' ILE . 1.8 mtm -153.17 105.21 2.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.375 -1.074 . . . . 0.0 109.993 179.717 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 116' ' ' LYS . 3.7 t -86.65 157.15 19.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 0.0 110.111 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.486 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.3 OUTLIER -153.88 151.75 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.132 179.805 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.524 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 1.3 mm-40 57.73 17.69 4.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.049 -1.032 . . . . 0.0 110.717 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.15 16.95 63.76 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.45 179.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.524 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.2 p-80 -137.59 159.69 41.26 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.8 -1.412 . . . . 0.0 110.829 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -71.7 169.99 14.45 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.544 -0.723 . . . . 0.0 110.802 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -89.28 168.12 12.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.344 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -111.48 127.2 55.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.288 -0.882 . . . . 0.0 110.248 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pp -67.99 104.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.144 -0.973 . . . . 0.0 109.623 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.442 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -95.89 -30.09 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 111.235 -179.15 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.7 p -166.86 101.75 0.56 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.936 -1.103 . . . . 0.0 110.49 -179.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -96.69 146.75 24.59 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.422 -0.799 . . . . 0.0 109.972 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.55 110.12 5.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.153 -0.967 . . . . 0.0 110.31 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.0 m -81.49 -40.49 23.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.861 . . . . 0.0 110.411 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.72 -33.41 75.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.216 -0.928 . . . . 0.0 110.284 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 0.3 OUTLIER -96.05 -10.68 27.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 110.541 179.926 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 97' ' ' LYS . 1.2 t0 62.31 53.99 2.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.041 -1.037 . . . . 0.0 110.046 -179.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -146.98 179.42 7.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 110.429 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -172.04 159.92 5.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.978 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.442 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 91.2 m -141.52 153.31 44.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 109.728 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.432 ' N ' HG22 ' A' ' 101' ' ' THR . 24.7 p -145.03 140.58 28.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.012 -1.055 . . . . 0.0 110.704 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -93.4 148.14 22.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 109.99 179.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.46 ' CD1' HD13 ' A' ' 83' ' ' ILE . 97.0 m-85 -128.8 150.38 50.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.141 -0.974 . . . . 0.0 110.721 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.403 ' OE2' ' N ' ' A' ' 106' ' ' VAL . 7.1 tp10 -110.99 123.88 51.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.381 -0.825 . . . . 0.0 109.792 179.626 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 108' ' ' LYS . 9.5 p -149.36 165.54 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.74 -41.27 77.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.133 -0.98 . . . . 0.0 109.795 179.604 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.441 ' CE ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -164.05 -146.23 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.353 179.403 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.45 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -151.81 56.35 0.85 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.809 -1.182 . . . . 0.0 110.647 -179.403 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 145' ' ' PRO . 10.5 t-20 -146.59 93.74 2.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -0.87 . . . . 0.0 110.232 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 148.51 -119.68 1.1 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.435 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.0 OUTLIER -156.72 112.68 2.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -1.139 . . . . 0.0 110.264 -179.688 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mm -102.73 139.93 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.231 -0.918 . . . . 0.0 110.023 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.21 123.36 25.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.035 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.473 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -132.57 179.73 17.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 28.6 mtmm -144.29 166.29 25.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -1.131 . . . . 0.0 109.707 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.431 ' HB ' ' CG ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -158.73 144.06 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.933 -1.105 . . . . 0.0 110.721 179.991 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.414 ' CB ' ' CG2' ' A' ' 79' ' ' THR . 5.8 m-20 -107.25 159.53 16.28 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.456 -0.778 . . . . 0.0 108.941 178.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.437 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -141.5 148.49 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.024 -1.047 . . . . 0.0 110.658 -179.464 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -152.09 104.02 2.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.381 -0.824 . . . . 0.0 110.045 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 132' ' ' TYR . 44.4 mt -128.96 152.54 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 110.117 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.423 ' N ' HG22 ' A' ' 121' ' ' ILE . 5.2 p-10 -159.94 97.33 1.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 0.0 109.735 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -173.55 -169.11 0.48 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 110.304 -179.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm -112.01 102.61 10.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.87 . . . . 0.0 110.184 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.69 118.22 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -0.877 . . . . 0.0 110.235 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.94 26.77 6.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.365 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.65 5.52 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.38 107.35 4.44 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.202 -1.175 . . . . 0.0 110.139 179.809 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -51.13 109.8 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.694 1.365 . . . . 0.0 110.368 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' A' ' 132' ' ' TYR . 11.3 t80 -110.02 146.25 35.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.175 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -133.62 99.18 4.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.284 -0.885 . . . . 0.0 110.214 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.482 ' CD2' HD11 ' A' ' 121' ' ' ILE . 2.5 t80 -115.12 129.1 56.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.125 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.62 81.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.953 . . . . 0.0 110.256 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -153.13 -165.28 2.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.16 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.42 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -118.3 143.43 46.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.109 -0.994 . . . . 0.0 110.29 179.866 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.42 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 32.2 m-85 -155.25 -179.47 8.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.381 -0.824 . . . . 0.0 109.826 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 20.6 p30 -151.27 178.64 9.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 110.345 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -156.98 167.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 110.764 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.435 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 94.1 m -91.75 121.25 33.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.46 -0.775 . . . . 0.0 110.37 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.476 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 43.2 m-85 -90.59 95.72 10.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.071 -1.018 . . . . 0.0 110.235 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.92 104.26 16.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.458 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 140' ' ' TYR . 67.9 m-85 -92.93 158.75 15.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.325 -0.859 . . . . 0.0 110.295 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.446 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 20.7 m-80 -139.72 97.36 3.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.105 -0.997 . . . . 0.0 110.651 -179.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.405 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -161.91 -152.66 6.78 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.437 ' HD2' ' CD1' ' A' ' 109' ' ' LEU . 18.8 Cg_endo . . . . . 0 C--N 1.309 -1.532 0 O-C-N 123.893 1.47 . . . . 0.0 110.241 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 13.3 m-20 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 16.2 t -160.46 153.24 21.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.983 -1.073 . . . . 0.0 110.853 -179.5 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' CD2' ' A' ' 59' ' ' TYR . . . 171.18 176.76 40.55 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.76 109.5 20.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -1.158 . . . . 0.0 110.601 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.495 ' HB2' ' CD2' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -95.78 156.77 16.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.97 -1.081 . . . . 0.0 110.442 179.663 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.432 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 33.8 m-20 -79.92 139.83 36.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 110.246 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -165.84 160.66 17.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.945 . . . . 0.0 110.015 179.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -155.59 -175.8 5.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 0.0 110.447 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.464 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -140.89 166.76 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.324 -0.86 . . . . 0.0 109.834 179.728 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.464 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 51.1 m-85 -147.56 161.55 40.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.084 -1.01 . . . . 0.0 110.545 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.437 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -68.34 135.12 51.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.371 -0.831 . . . . 0.0 109.896 179.96 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.45 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -60.71 146.8 44.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.201 -179.82 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER 70.55 4.63 5.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.789 -0.569 . . . . 0.0 110.892 -179.453 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -135.18 -163.86 1.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.868 -1.145 . . . . 0.0 109.764 179.377 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.414 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.1 OUTLIER -130.34 11.73 5.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.461 179.637 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -135.27 148.89 49.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.025 -1.047 . . . . 0.0 110.592 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.448 ' CG2' ' HB2' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -78.32 137.27 37.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.504 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.54 -17.54 3.68 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.037 -179.075 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.454 HD12 HG22 ' A' ' 48' ' ' ILE . 60.5 mt -137.57 -69.73 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.708 -1.245 . . . . 0.0 110.868 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.447 ' O ' ' CD2' ' A' ' 53' ' ' PHE . . . -45.48 -26.5 0.58 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.627 -0.671 . . . . 0.0 111.241 -179.347 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.448 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER -68.08 -9.13 43.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.076 -1.015 . . . . 0.0 110.823 -179.773 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.465 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 1.6 m-20 -99.26 14.8 28.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.029 -1.045 . . . . 0.0 110.852 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.465 ' CE2' ' HB2' ' A' ' 51' ' ' ASP . 36.6 m-85 -142.27 11.61 1.95 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.945 -1.097 . . . . 0.0 110.824 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 25.9 m-85 -132.62 107.46 8.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.06 -1.025 . . . . 0.0 110.584 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -72.72 167.91 19.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.14 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.408 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.42 164.73 22.91 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.955 . . . . 0.0 109.973 179.798 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.408 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 55.6 Cg_endo -78.23 -175.32 16.48 Favored 'Cis proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.565 -2.265 . . . . 0.0 110.588 -0.153 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.24 170.16 8.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 109.693 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.459 ' CB ' ' CG ' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -101.37 119.69 39.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 110.586 -179.644 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 13.7 p90 -97.81 162.97 13.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.118 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 1.9 tt -157.07 109.81 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.315 -0.866 . . . . 0.0 110.541 179.633 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -128.59 137.86 51.91 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.167 -0.958 . . . . 0.0 110.347 179.89 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.76 62.25 0.99 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 110.13 179.457 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 45.97 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.493 -0.754 . . . . 0.0 111.28 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.44 -8.42 58.6 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.458 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.19 158.54 44.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.916 -1.344 . . . . 0.0 110.428 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.482 ' CD1' ' HA ' ' A' ' 108' ' ' LYS . 1.2 pt? -169.49 148.54 3.79 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.156 -0.965 . . . . 0.0 111.233 179.191 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.547 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -140.73 -163.26 1.5 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.63 -0.669 . . . . 0.0 109.639 -179.638 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 67' ' ' TYR . 1.4 t -168.3 124.82 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 110.047 179.62 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.459 ' CG ' ' CB ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -97.3 130.97 44.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.212 -0.93 . . . . 0.0 109.789 179.758 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.48 141.54 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.83 . . . . 0.0 110.205 -179.344 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.5 m -89.69 123.52 33.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.794 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.4 t -102.3 131.8 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 110.358 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.47 143.85 30.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 110.382 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 55.97 97.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.299 -0.875 . . . . 0.0 110.388 179.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -69.53 -18.03 63.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -0.932 . . . . 0.0 110.338 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.97 -47.37 18.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.255 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.434 ' HA ' HG12 ' A' ' 121' ' ' ILE . 46.5 m0 -61.44 -59.33 5.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 110.569 -179.882 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.7 tt -88.67 122.69 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.09 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.432 HG23 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -86.99 -26.74 23.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.359 -0.838 . . . . 0.0 110.832 -179.368 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 79' ' ' THR . . . -176.9 180.0 47.58 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.625 -1.274 . . . . 0.0 109.921 -179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.437 ' SD ' ' CZ ' ' A' ' 53' ' ' PHE . 25.8 mtm -151.6 163.31 39.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.338 -1.096 . . . . 0.0 110.118 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 116' ' ' LYS . 23.1 t -155.4 137.47 14.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.365 -0.834 . . . . 0.0 110.02 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 1.6 mt -136.23 141.28 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.263 -0.898 . . . . 0.0 110.362 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 72.67 -0.25 3.4 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.755 -0.591 . . . . 0.0 111.399 179.972 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.12 22.39 8.8 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.589 -1.291 . . . . 0.0 111.288 178.8 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.47 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.42 159.52 41.85 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.628 -1.513 . . . . 0.0 110.215 179.353 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -173.53 0.92 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.142 -0.974 . . . . 0.0 110.448 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 1.2 pt-20 -108.76 170.13 8.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.0 110.267 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -120.6 125.41 47.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.933 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -67.52 102.55 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.962 -1.086 . . . . 0.0 109.749 179.967 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.424 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.2 tt -94.87 -28.11 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 0.0 110.553 -179.354 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.7 m -166.48 96.1 0.56 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.411 -0.805 . . . . 0.0 109.829 -179.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -95.99 109.99 22.29 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 110.292 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.04 83.86 3.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 110.281 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.8 p -65.32 -30.99 71.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -0.929 . . . . 0.0 110.322 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.21 84.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.936 . . . . 0.0 110.09 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.81 17.49 15.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.3 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 49.59 60.39 3.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.239 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -147.33 177.98 8.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 110.242 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 179.87 159.63 0.79 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.899 . . . . 0.0 110.072 -179.845 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.424 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 95.7 m -137.19 154.84 50.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.962 . . . . 0.0 109.808 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.7 p -145.11 139.45 27.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 110.712 -179.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -93.57 144.36 25.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 110.13 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 93.5 m-85 -128.94 146.7 50.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.19 -0.944 . . . . 0.0 110.534 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -101.88 129.84 48.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.364 -0.835 . . . . 0.0 109.607 179.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.42 ' CG2' HD13 ' A' ' 113' ' ' ILE . 9.0 p -149.49 139.41 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.094 -1.004 . . . . 0.0 111.022 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.9 t -63.96 102.25 0.46 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.143 -0.973 . . . . 0.0 108.5 178.527 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 56.58 171.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 108.833 -177.968 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.94 76.96 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.952 -1.093 . . . . 0.0 110.853 -179.427 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -146.01 64.17 1.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.447 -0.783 . . . . 0.0 109.846 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.08 -171.92 38.96 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.01 140.27 34.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.318 -1.107 . . . . 0.0 110.564 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.42 HD13 ' CG2' ' A' ' 106' ' ' VAL . 12.9 mt -136.0 150.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.321 -0.862 . . . . 0.0 109.739 179.623 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.33 127.46 32.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 -179.846 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -132.37 169.25 22.33 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -146.74 159.79 43.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -1.156 . . . . 0.0 110.096 179.981 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.99 143.66 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.105 -0.997 . . . . 0.0 110.591 179.84 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -106.53 159.76 15.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.433 -0.792 . . . . 0.0 109.263 179.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.06 149.31 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.04 -1.037 . . . . 0.0 110.814 -179.582 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.409 ' CZ ' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -151.72 107.63 3.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.46 -0.775 . . . . 0.0 109.859 179.715 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.463 HD12 ' CD2' ' A' ' 132' ' ' TYR . 28.6 mt -135.22 153.12 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.408 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.78 101.09 1.46 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.468 -0.77 . . . . 0.0 109.455 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -173.23 -165.14 0.26 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.235 -0.916 . . . . 0.0 110.442 -179.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -95.76 165.81 12.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.647 -179.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 6.8 t -158.41 93.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 65.53 30.5 10.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.386 -0.822 . . . . 0.0 109.603 -179.11 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.61 39.42 10.74 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -147.48 106.55 3.79 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.149 -1.206 . . . . 0.0 110.371 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.62 114.71 1.3 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.69 1.363 . . . . 0.0 109.953 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 10.5 t80 -97.78 141.36 30.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 110.451 -179.482 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -134.4 99.12 4.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 109.847 179.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . 1.7 t80 -112.91 124.27 52.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.064 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.409 ' OD2' ' CZ ' ' A' ' 120' ' ' TYR . 53.7 t0 -170.24 84.39 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 109.926 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -154.16 -165.02 1.99 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 110.555 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.47 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 74.2 m-70 -117.87 152.32 35.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.852 . . . . 0.0 109.692 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.47 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 66.0 m-85 -155.11 -178.97 7.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.938 . . . . 0.0 110.331 -179.761 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 2.1 p30 -150.16 164.93 34.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 110.166 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.2 pt -156.24 172.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.337 -0.852 . . . . 0.0 110.35 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 10.9 m -91.76 162.28 14.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.412 -0.805 . . . . 0.0 110.576 -179.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.463 ' CE1' ' CG1' ' A' ' 38' ' ' VAL . 12.0 m-85 -145.52 108.15 4.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.388 -0.82 . . . . 0.0 110.032 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.61 109.82 21.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.37 -0.831 . . . . 0.0 110.521 -179.726 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -91.22 157.02 17.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.082 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.432 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 59.1 m-80 -138.83 98.37 3.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.197 -0.939 . . . . 0.0 110.398 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -157.76 -147.24 4.75 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo . . . . . 0 C--N 1.309 -1.526 0 O-C-N 123.807 1.424 . . . . 0.0 110.733 -179.87 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 4.8 m-20 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.972 0.415 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 4.1 p -159.13 158.67 33.32 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.272 -0.892 . . . . 0.0 110.779 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 171.5 171.84 37.01 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.91 108.5 19.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -1.216 . . . . 0.0 110.355 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.485 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -94.45 152.52 18.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.0 109.995 179.855 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.449 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -78.82 139.57 38.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.139 -0.976 . . . . 0.0 110.425 -179.953 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -165.65 159.28 16.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.193 -0.942 . . . . 0.0 110.202 179.557 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -155.36 -171.63 3.87 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.338 -0.851 . . . . 0.0 109.699 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.519 ' CG1' ' CD1' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -140.85 172.06 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 110.231 179.781 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -147.52 157.24 43.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 110.09 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.423 ' NZ ' ' HA ' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -67.58 139.33 56.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.226 -179.864 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.455 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -63.64 147.04 52.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.942 179.853 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 28.3 t30 70.01 4.62 4.89 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.715 -0.616 . . . . 0.0 110.732 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.82 179.67 6.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.976 -1.078 . . . . 0.0 109.776 179.376 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -115.76 12.98 16.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 110.285 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.37 143.38 46.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.109 -0.994 . . . . 0.0 110.613 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.435 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -73.72 139.73 45.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.251 179.48 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -17.8 3.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.001 -1.062 . . . . 0.0 112.189 -178.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 49' ' ' ALA . 8.0 mt -137.46 -73.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.781 -1.2 . . . . 0.0 110.787 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.413 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -45.8 -26.13 0.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.612 -0.68 . . . . 0.0 111.14 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.455 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -60.02 -16.81 34.09 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.109 -0.995 . . . . 0.0 110.695 -179.83 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -102.33 15.54 28.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.031 -1.043 . . . . 0.0 111.009 -179.406 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 63.5 m-85 -133.27 7.63 3.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.839 -1.163 . . . . 0.0 111.384 -179.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' A' ' 53' ' ' PHE . 15.0 p90 -115.64 114.92 25.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.961 -1.087 . . . . 0.0 110.537 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -74.7 106.14 6.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.038 -1.039 . . . . 0.0 110.459 -179.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.41 ' HB3' ' CE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -94.3 160.38 32.03 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 110.228 179.844 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.69 -175.38 15.97 Favored 'Cis proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.548 -2.272 . . . . 0.0 110.733 -0.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.71 164.99 11.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 109.899 179.694 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.11 117.55 34.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.134 -0.978 . . . . 0.0 110.993 -179.536 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.485 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 31.5 p90 -98.47 165.63 11.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.319 -0.863 . . . . 0.0 109.799 179.385 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 0.5 OUTLIER -155.41 122.47 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.988 -1.07 . . . . 0.0 111.139 -179.739 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -140.19 131.86 27.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.258 -0.901 . . . . 0.0 110.331 179.735 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 63' ' ' ASN . 7.1 tttt -111.37 62.08 0.61 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 0.0 110.455 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 62' ' ' LYS . 4.5 m120 49.85 101.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.365 -0.834 . . . . 0.0 111.223 179.578 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.65 -18.48 55.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -140.55 160.19 40.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.248 . . . . 0.0 110.273 179.849 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.547 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -163.54 144.77 9.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 111.274 179.852 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 3.4 m-85 -141.57 -159.32 0.95 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.263 -0.898 . . . . 0.0 109.674 -179.771 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -169.92 165.28 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 110.322 179.613 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.414 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 2.0 pt20 -140.97 133.57 28.64 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.382 -0.824 . . . . 0.0 109.894 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.67 140.33 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 110.003 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.8 m -89.09 134.04 34.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.133 -0.979 . . . . 0.0 109.748 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.418 ' CG1' HG21 ' A' ' 78' ' ' ILE . 2.4 t -102.2 126.55 56.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.395 -0.816 . . . . 0.0 110.407 -179.507 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -99.5 127.9 45.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.263 -0.898 . . . . 0.0 110.046 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 63.32 69.93 0.55 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 109.871 -179.705 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.78 -27.49 63.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.467 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -55.99 -39.34 71.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 0.0 110.54 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.419 ' O ' ' CG1' ' A' ' 119' ' ' VAL . 24.8 m0 -81.2 -52.61 7.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.379 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.418 HG21 ' CG1' ' A' ' 72' ' ' VAL . 20.3 tt -88.87 123.18 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 109.658 179.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.471 HG22 ' N ' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -87.08 -29.79 21.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.215 -0.928 . . . . 0.0 111.266 -179.001 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 79' ' ' THR . . . -175.95 175.07 47.28 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 118.998 -1.573 . . . . 0.0 110.701 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.414 ' CG ' HD13 ' A' ' 117' ' ' ILE . 5.2 mtt -152.3 110.49 3.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.654 -0.909 . . . . 0.0 109.784 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 116' ' ' LYS . 1.0 OUTLIER -85.88 157.26 20.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.095 -1.003 . . . . 0.0 110.359 -179.98 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.485 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 1.0 OUTLIER -151.35 149.98 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.381 -0.825 . . . . 0.0 109.758 179.578 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.508 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 0.7 OUTLIER 61.77 14.09 5.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.124 -0.985 . . . . 0.0 110.783 -179.886 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.38 19.92 57.76 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.809 179.163 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.508 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.1 p-80 -137.47 161.24 36.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.72 -1.459 . . . . 0.0 110.692 179.591 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.76 174.33 7.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.468 -0.77 . . . . 0.0 110.838 -179.521 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 8.2 pt-20 -99.06 167.4 10.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 110.474 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -118.43 134.94 54.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.31 -0.869 . . . . 0.0 110.192 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.07 100.72 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 109.445 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.449 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 2.5 tt -96.32 -25.72 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 110.797 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -167.73 95.07 0.43 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.965 . . . . 0.0 110.138 -179.775 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.437 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 2.4 ttmt -96.34 144.03 26.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.83 93.62 2.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.129 -0.982 . . . . 0.0 110.331 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -76.81 -15.78 59.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.864 . . . . 0.0 110.357 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.83 -28.01 69.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 110.548 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -136.34 25.56 3.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.122 -0.986 . . . . 0.0 110.502 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.87 70.82 0.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.337 179.873 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -147.71 160.51 42.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.141 -0.975 . . . . 0.0 110.003 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.437 ' HG3' ' CG ' ' A' ' 93' ' ' LYS . 1.0 OUTLIER -168.92 162.87 11.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 110.356 -179.777 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.449 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 57.9 m -142.05 157.81 44.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.45 -0.781 . . . . 0.0 109.229 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 2.0 p -143.9 137.04 27.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.821 -1.174 . . . . 0.0 110.616 -179.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -93.0 136.48 33.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.426 -0.796 . . . . 0.0 109.995 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 102' ' ' SER . 88.6 m-85 -129.68 144.38 51.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.1 -1.0 . . . . 0.0 110.904 -179.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -101.11 127.96 47.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.481 -0.762 . . . . 0.0 109.091 179.041 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 19.9 m -147.98 163.02 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.914 -1.117 . . . . 0.0 111.075 -178.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.67 109.55 7.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.292 -0.88 . . . . 0.0 108.658 178.629 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.443 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 48.84 -159.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.341 -0.85 . . . . 0.0 109.563 -178.577 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.424 HD13 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -150.59 60.72 0.94 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.974 -1.079 . . . . 0.0 111.103 -179.489 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -146.08 82.12 1.6 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.339 -0.85 . . . . 0.0 109.799 179.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.57 170.82 22.09 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.43 146.14 29.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -1.056 . . . . 0.0 110.458 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.6 mt -139.35 149.9 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.942 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.48 142.66 40.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.12 -0.988 . . . . 0.0 110.525 -179.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -147.72 127.84 2.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 82' ' ' SER . 10.8 mttt -94.67 168.2 10.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.346 -1.09 . . . . 0.0 109.787 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.414 HD13 ' CG ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -158.9 133.95 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.993 -1.067 . . . . 0.0 110.858 179.481 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.437 ' HB2' ' CG2' ' A' ' 79' ' ' THR . 11.6 m-20 -107.47 163.32 13.15 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.482 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.464 HG13 ' CD2' ' A' ' 132' ' ' TYR . 3.8 t -144.14 152.67 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.899 -1.126 . . . . 0.0 110.475 -179.268 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.21 113.73 4.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.427 -0.796 . . . . 0.0 110.523 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.424 ' HB ' ' CB ' ' A' ' 132' ' ' TYR . 2.7 mp -138.15 153.71 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.347 -0.845 . . . . 0.0 110.082 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.74 96.99 1.41 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.125 -0.985 . . . . 0.0 110.208 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.43 ' O ' ' CD1' ' A' ' 130' ' ' PHE . 0.4 OUTLIER -174.12 -170.69 0.56 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.395 -0.815 . . . . 0.0 110.151 -179.957 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.31 111.49 23.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.213 -0.929 . . . . 0.0 110.22 -179.875 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.407 HG23 ' CE1' ' A' ' 130' ' ' PHE . 2.7 t -77.12 107.6 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.34 179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.28 38.07 12.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.892 . . . . 0.0 110.495 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 91.72 39.02 5.66 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -144.82 90.07 6.44 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.337 -1.096 . . . . 0.0 109.998 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.03 121.48 9.37 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.97 1.51 . . . . 0.0 110.715 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.43 ' CD1' ' O ' ' A' ' 123' ' ' GLU . 11.6 p90 -146.38 166.35 26.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.923 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.68 117.28 14.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 110.43 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.464 ' CD2' HG13 ' A' ' 119' ' ' VAL . 3.8 t80 -102.46 135.0 44.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.394 -0.817 . . . . 0.0 109.705 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -174.39 83.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 0.0 110.16 -179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.91 -162.32 1.41 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.902 . . . . 0.0 110.622 179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -120.28 157.09 29.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.445 -0.785 . . . . 0.0 110.062 179.852 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 34.4 m-85 -155.15 -179.05 7.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.048 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.78 165.74 32.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 110.521 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -156.38 159.34 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.464 -0.772 . . . . 0.0 109.815 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.9 m -91.61 119.9 31.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.18 -0.95 . . . . 0.0 110.655 -179.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.519 ' CD1' ' CG1' ' A' ' 38' ' ' VAL . 9.5 m-85 -90.39 165.73 13.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.322 -0.861 . . . . 0.0 109.909 179.518 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.89 103.92 1.9 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.467 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -92.2 154.23 18.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.274 -0.891 . . . . 0.0 110.236 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 48.8 m-80 -141.78 96.9 3.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 110.497 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.424 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -150.86 -151.72 5.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.735 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 C--N 1.307 -1.652 0 O-C-N 123.733 1.386 . . . . 0.0 110.287 -179.933 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 63.6 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.846 0.355 . . . . 0.0 110.386 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER -159.39 150.44 19.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.052 -1.03 . . . . 0.0 110.727 -179.374 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.37 -136.87 3.39 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.22 110.5 4.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.162 -1.199 . . . . 0.0 110.348 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.464 ' CD2' ' HB3' ' A' ' 59' ' ' TYR . 2.3 pp -95.06 156.08 16.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.434 -0.791 . . . . 0.0 110.365 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.422 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 1.4 t30 -79.33 141.69 36.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.37 -0.832 . . . . 0.0 110.068 179.749 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.475 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 1.6 p90 -164.01 162.81 23.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.068 -1.02 . . . . 0.0 110.682 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.36 -165.89 2.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.528 -0.732 . . . . 0.0 109.677 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.41 HG22 HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -139.92 174.58 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.15 -0.969 . . . . 0.0 110.154 179.703 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.422 ' CE2' ' HG3' ' A' ' 141' ' ' LYS . 14.0 m-85 -147.62 147.29 29.87 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.203 -0.935 . . . . 0.0 109.961 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.44 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -67.58 130.36 42.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.366 -0.834 . . . . 0.0 110.26 -179.592 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.455 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -52.45 145.75 10.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -0.887 . . . . 0.0 110.386 -179.809 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.8 t30 72.79 0.26 3.59 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.884 -0.51 . . . . 0.0 111.074 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.423 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -136.38 -161.99 1.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.871 -1.143 . . . . 0.0 109.749 179.298 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.423 ' N ' ' OG1' ' A' ' 43' ' ' THR . 12.0 p-10 -135.58 15.47 3.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.188 -0.945 . . . . 0.0 110.214 179.592 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -135.14 128.13 31.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 0.0 110.767 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.446 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -57.58 136.35 56.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.45 179.509 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.34 -17.85 4.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.064 -1.023 . . . . 0.0 111.675 -179.194 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 mp -137.78 -71.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.777 -1.202 . . . . 0.0 110.813 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -45.4 -26.14 0.51 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.693 -0.629 . . . . 0.0 111.27 -179.366 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.446 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -62.47 -13.02 25.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.06 -1.025 . . . . 0.0 111.044 -179.73 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -98.89 13.97 30.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.99 -1.069 . . . . 0.0 110.995 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -135.44 -1.55 2.55 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.907 -1.121 . . . . 0.0 111.574 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 49' ' ' ALA . 16.2 m-30 -111.91 101.12 9.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.961 -1.087 . . . . 0.0 110.249 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.19 113.67 10.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.314 -0.866 . . . . 0.0 110.539 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.451 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 1.0 OUTLIER -93.53 166.67 15.5 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 109.942 179.739 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.451 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 60.2 Cg_endo -82.79 -175.55 14.97 Favored 'Cis proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.784 -2.174 . . . . 0.0 110.595 -0.494 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -104.25 162.67 13.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.286 -0.884 . . . . 0.0 109.641 179.467 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -98.85 114.73 27.45 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.226 -0.922 . . . . 0.0 110.254 -179.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.464 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 10.7 p90 -97.68 161.64 13.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.123 -0.985 . . . . 0.0 110.609 -179.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.446 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -154.86 127.77 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.9 . . . . 0.0 110.543 -179.632 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 2.4 mtmt -137.82 119.42 14.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.183 -0.948 . . . . 0.0 110.438 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -94.74 62.12 2.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.657 -179.998 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.406 ' O ' ' O ' ' A' ' 62' ' ' LYS . 0.1 OUTLIER 49.16 101.54 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.404 -0.81 . . . . 0.0 111.376 179.44 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.56 -21.93 41.97 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.357 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.444 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -135.28 154.5 51.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.175 -1.191 . . . . 0.0 110.138 179.61 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -156.37 135.99 12.43 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.159 0.98 . . . . 0.0 111.308 179.878 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.516 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -142.17 176.39 9.01 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.417 -0.802 . . . . 0.0 109.144 179.985 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -150.01 141.58 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.931 -1.106 . . . . 0.0 110.872 179.983 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 6.0 pt20 -100.09 134.98 42.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.461 -0.774 . . . . 0.0 109.513 179.209 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 101' ' ' THR . 1.1 mm -110.51 131.22 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.725 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.6 m -87.75 127.67 35.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.185 -0.947 . . . . 0.0 110.023 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -103.33 144.4 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.833 . . . . 0.0 110.045 -179.644 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -99.36 146.78 25.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.112 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 53.94 84.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.078 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.8 p -50.35 -33.42 20.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.451 -179.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -41.17 74.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 110.384 -179.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.459 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 31.5 m0 -61.15 -63.14 1.39 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 0.0 110.444 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 16.4 tt -88.36 118.6 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.144 -0.973 . . . . 0.0 109.765 179.843 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.428 HG23 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -86.85 -23.67 25.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.87 . . . . 0.0 110.964 -179.2 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.428 ' N ' HG23 ' A' ' 79' ' ' THR . . . 179.38 173.83 44.9 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.447 -1.359 . . . . 0.0 110.153 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.47 ' HE2' ' CE1' ' A' ' 53' ' ' PHE . 1.2 mtm -153.32 113.58 3.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.339 -1.095 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.74 169.66 13.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.454 HG13 ' CE2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -169.24 141.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -0.867 . . . . 0.0 110.048 179.785 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.523 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 1.1 tm-20 64.52 11.91 7.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.274 -0.891 . . . . 0.0 110.69 -179.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.77 17.45 61.66 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.336 179.528 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.523 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.2 p-80 -137.75 160.19 39.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.971 -1.311 . . . . 0.0 110.576 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.91 162.15 29.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.418 -0.801 . . . . 0.0 110.492 -179.674 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.504 ' CB ' ' CE1' ' A' ' 104' ' ' PHE . 12.9 pt-20 -91.2 168.08 11.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.864 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.63 133.94 53.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.303 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.8 pt -68.01 142.41 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.034 -1.041 . . . . 0.0 109.402 179.463 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.409 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 3.0 tt -136.24 -29.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.151 -0.968 . . . . 0.0 111.43 -179.038 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 m -165.34 94.66 0.63 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.982 -1.074 . . . . 0.0 109.743 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -96.39 142.46 28.47 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.322 -0.861 . . . . 0.0 110.062 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -141.74 91.57 2.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 110.245 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 72.6 p -71.14 -23.34 62.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 110.245 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.41 54.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.093 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -97.72 13.48 30.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.904 . . . . 0.0 110.413 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.29 62.45 2.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.034 -1.042 . . . . 0.0 110.166 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -147.89 137.29 22.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 0.0 110.43 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.433 ' HG3' ' N ' ' A' ' 101' ' ' THR . 3.2 ttt180 -144.1 162.0 37.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.435 -0.791 . . . . 0.0 109.983 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 102' ' ' SER . 94.0 m -142.14 156.69 45.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 110.371 -179.781 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.436 ' N ' HG22 ' A' ' 101' ' ' THR . 2.4 p -145.29 145.35 31.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.183 -0.948 . . . . 0.0 110.271 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -91.55 144.21 25.78 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.296 -0.878 . . . . 0.0 110.041 -179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.504 ' CE1' ' CB ' ' A' ' 88' ' ' GLU . 37.2 m-85 -130.13 135.82 48.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 110.846 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.06 126.19 38.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.34 -0.85 . . . . 0.0 109.424 179.182 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.2 p -149.59 158.64 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.012 -1.055 . . . . 0.0 110.872 -179.101 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.4 p -69.87 108.88 4.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.937 . . . . 0.0 108.773 178.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.436 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 47.87 -153.51 0.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.366 -0.834 . . . . 0.0 109.488 -178.457 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.425 ' CD2' HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.41 61.23 0.89 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.657 -1.277 . . . . 0.0 111.251 -179.093 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -147.37 94.35 2.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.961 . . . . 0.0 110.458 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.58 -123.78 1.61 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.429 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.2 OUTLIER -156.86 150.23 24.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.299 -1.118 . . . . 0.0 109.513 -179.676 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.414 ' N ' ' HG2' ' A' ' 112' ' ' LYS . 1.5 mm -138.53 129.16 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.134 -179.715 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -76.35 131.36 39.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.206 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -142.7 -162.66 9.36 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -146.31 172.45 13.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.224 -1.162 . . . . 0.0 109.741 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.8 140.41 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.115 -0.991 . . . . 0.0 110.477 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.42 ' HB2' ' CG2' ' A' ' 79' ' ' THR . 23.2 m-20 -106.53 158.46 16.9 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.222 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.464 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -134.88 149.91 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.119 -0.988 . . . . 0.0 110.229 -179.749 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -151.27 106.8 3.36 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.646 -179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.459 ' CG1' ' HA ' ' A' ' 77' ' ' TRP . 2.5 mp -137.43 152.67 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.43 -0.794 . . . . 0.0 109.777 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.443 ' N ' HG21 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -160.31 106.65 1.54 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.289 -0.882 . . . . 0.0 109.723 -179.981 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -172.28 -179.48 2.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 110.258 -179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -85.08 96.64 9.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 110.491 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.402 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 2.5 t -76.45 106.78 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.996 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 64.15 26.2 13.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.174 -179.903 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.07 34.86 9.37 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.24 127.24 7.92 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.223 -1.163 . . . . 0.0 110.14 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -55.86 108.94 0.36 Allowed 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.504 1.265 . . . . 0.0 110.109 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 132' ' ' TYR . 52.0 t80 -114.93 144.24 43.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.363 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -135.44 118.07 15.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 110.243 -179.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.475 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . 5.0 t80 -115.11 127.92 55.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.123 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.83 82.56 0.38 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.869 . . . . 0.0 109.925 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -154.29 -172.72 4.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 110.534 -179.763 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.459 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 5.9 p-80 -122.53 161.75 23.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.483 -0.761 . . . . 0.0 109.918 179.698 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.459 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 47.2 m-85 -155.38 140.63 17.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.169 -0.957 . . . . 0.0 110.337 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.433 ' ND2' ' CD2' ' A' ' 41' ' ' TYR . 38.8 p30 -88.11 156.51 19.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.232 -0.917 . . . . 0.0 110.4 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 137' ' ' ASN . 4.2 pt -157.21 143.8 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 109.891 -179.945 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.429 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 81.4 m -91.62 128.35 37.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.197 -0.94 . . . . 0.0 110.944 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.454 ' CE2' HG13 ' A' ' 83' ' ' ILE . 51.8 m-85 -90.8 159.99 16.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.793 179.102 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.422 ' HG3' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -146.67 102.41 3.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.368 -179.965 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -93.17 152.14 19.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.279 -0.888 . . . . 0.0 110.386 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 51.3 m-80 -144.22 95.61 2.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.154 -0.966 . . . . 0.0 110.393 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.424 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -152.19 -154.77 6.76 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.793 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 C--N 1.305 -1.712 0 O-C-N 123.91 1.479 . . . . 0.0 110.644 -179.729 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.904 0.383 . . . . 0.0 110.281 . . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 t -161.31 140.81 10.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.86 . . . . 0.0 110.401 -179.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.0 179.38 47.36 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.28 111.99 22.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.317 -1.108 . . . . 0.0 110.051 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.492 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -95.4 154.3 17.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -0.905 . . . . 0.0 110.8 -179.739 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.4 m-20 -81.91 139.08 34.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.336 179.071 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.428 ' CE2' ' HB1' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -166.89 160.36 14.34 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.948 -1.095 . . . . 0.0 110.859 -179.924 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.57 -167.12 2.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.572 -0.705 . . . . 0.0 109.721 179.695 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.418 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -142.16 174.04 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.116 -0.99 . . . . 0.0 110.296 179.818 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.482 ' CE2' ' HG3' ' A' ' 141' ' ' LYS . 16.7 m-85 -147.73 152.69 38.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.838 . . . . 0.0 110.052 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 124.29 23.01 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.381 -0.824 . . . . 0.0 110.009 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.436 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -49.17 147.58 2.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.77 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 3.9 m120 72.33 0.79 3.72 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.934 -0.479 . . . . 0.0 110.91 -179.092 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.4 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -136.77 -160.38 1.05 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.818 -1.177 . . . . 0.0 109.729 179.092 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.4 ' N ' ' OG1' ' A' ' 43' ' ' THR . 3.2 t-20 -134.37 11.64 3.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 110.248 179.471 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -135.99 139.0 42.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.102 -0.999 . . . . 0.0 110.628 -179.685 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.434 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -63.71 133.44 53.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.206 179.264 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -128.7 -17.6 4.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.89 -1.132 . . . . 0.0 111.964 -178.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.2 mt -137.54 -71.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.815 -1.178 . . . . 0.0 110.76 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -50.99 -22.53 2.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.499 -0.751 . . . . 0.0 111.027 -179.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.434 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -55.59 -19.32 9.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.128 -0.982 . . . . 0.0 110.77 -179.793 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -94.29 15.29 17.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.015 -1.053 . . . . 0.0 110.922 -179.44 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -141.61 16.27 2.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.908 -1.12 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -123.1 106.17 10.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.141 -0.975 . . . . 0.0 110.255 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.96 152.45 41.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.899 . . . . 0.0 110.607 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.3 162.56 31.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 0.0 109.838 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.02 -176.68 19.18 Favored 'Cis proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.728 -2.197 . . . . 0.0 110.475 -0.127 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.428 ' HB1' ' CE2' ' A' ' 36' ' ' TYR . . . -105.23 166.33 10.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 110.091 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -101.49 113.78 27.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 110.088 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.492 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 8.7 p90 -96.27 163.54 13.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.924 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.4 OUTLIER -154.74 154.19 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.181 -0.95 . . . . 0.0 110.205 -179.925 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 29.7 mtpt -136.52 170.43 16.07 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.157 -0.965 . . . . 0.0 110.854 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.418 ' CB ' ' CD ' ' A' ' 65' ' ' LYS . 9.4 mttt -155.06 62.91 0.64 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.439 -0.788 . . . . 0.0 110.032 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t30 48.61 86.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.397 -0.815 . . . . 0.0 111.091 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.63 24.21 33.92 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.616 179.021 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.418 ' CD ' ' CB ' ' A' ' 62' ' ' LYS . 6.4 ptpt -170.39 161.19 7.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.042 -1.27 . . . . 0.0 110.947 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.6 pt? -172.19 149.49 2.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.1 0.952 . . . . 0.0 111.732 178.688 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -140.61 174.06 10.89 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.258 -179.268 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.57 143.04 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.988 -1.07 . . . . 0.0 110.15 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.4 ' O ' ' HG3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -99.69 133.65 43.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 110.329 179.87 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.12 141.08 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.796 179.823 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 m -89.13 130.21 35.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.875 . . . . 0.0 110.348 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.7 t -102.94 125.63 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.904 179.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -100.32 140.24 34.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.497 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.523 ' CE1' ' CE2' ' A' ' 77' ' ' TRP . 0.6 OUTLIER 62.14 77.32 0.33 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.93 . . . . 0.0 110.315 179.87 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.8 m -65.47 -35.06 79.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 110.057 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -52.95 -38.28 61.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.314 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.523 ' CE2' ' CE1' ' A' ' 74' ' ' HIS . 44.6 m0 -82.18 -61.27 1.95 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.947 . . . . 0.0 110.381 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.428 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 7.8 tt -87.76 122.03 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.372 -0.83 . . . . 0.0 109.808 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.458 ' CG2' ' HB3' ' A' ' 118' ' ' ASP . 1.3 t -87.6 -22.42 24.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.0 111.41 -178.87 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.456 ' N ' HG22 ' A' ' 79' ' ' THR . . . 179.79 176.98 47.68 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.303 -1.427 . . . . 0.0 110.381 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.403 ' SD ' ' CD1' ' A' ' 78' ' ' ILE . 2.1 mpp? -150.61 108.14 3.65 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.579 -0.954 . . . . 0.0 109.985 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.49 156.9 20.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.24 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.481 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 3.9 mt -148.19 153.28 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 110.073 179.758 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.524 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 1.9 tm-20 61.96 14.81 6.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 0.0 110.709 179.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.6 19.42 61.93 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.524 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.2 p-80 -136.2 159.85 40.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.274 . . . . 0.0 110.272 179.608 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -71.44 162.95 28.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.82 . . . . 0.0 110.604 -179.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -90.79 170.09 10.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 179.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.39 126.92 55.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.289 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pp -67.86 103.64 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.142 -0.973 . . . . 0.0 109.465 179.578 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.434 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -94.38 -28.41 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 0.0 110.978 -179.061 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.3 m -166.91 100.21 0.55 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.044 -1.035 . . . . 0.0 110.12 -179.644 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -95.72 102.64 14.46 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.396 -0.815 . . . . 0.0 110.041 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.47 94.3 7.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 110.211 -179.799 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 79.1 p -80.47 -17.34 51.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.356 -0.84 . . . . 0.0 110.368 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.48 -19.91 64.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.95 . . . . 0.0 110.11 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -136.44 22.44 3.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 110.105 179.887 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 52.74 67.97 0.9 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 0.0 110.093 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -147.72 176.23 10.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -0.898 . . . . 0.0 110.262 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -175.93 161.41 2.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.892 . . . . 0.0 110.189 -179.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.434 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 87.1 m -142.32 154.32 44.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.897 . . . . 0.0 109.814 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.4 p -145.88 142.01 28.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.034 -1.042 . . . . 0.0 110.759 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -92.74 146.16 23.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.456 -0.778 . . . . 0.0 109.716 179.472 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.469 ' CG ' HD12 ' A' ' 83' ' ' ILE . 46.4 m-85 -129.22 139.5 51.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.076 -1.015 . . . . 0.0 111.079 -179.398 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -105.75 122.06 45.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.462 -0.774 . . . . 0.0 109.225 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.4 m -149.02 147.91 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.069 -1.019 . . . . 0.0 110.91 -178.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.6 m -63.8 106.64 1.03 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.327 -0.858 . . . . 0.0 109.117 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.461 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.1 OUTLIER 50.45 -177.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.469 -0.77 . . . . 0.0 109.588 -178.729 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.459 ' HG ' ' CD1' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -150.42 82.49 1.36 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.907 -1.12 . . . . 0.0 111.191 -179.42 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -145.16 80.33 1.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.109 179.46 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.09 -113.61 0.61 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -157.11 152.93 27.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.161 -1.199 . . . . 0.0 110.055 179.847 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 57.4 mt -134.15 150.79 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 0.0 110.188 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -76.37 123.01 25.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.254 -0.904 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.458 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -128.83 177.75 17.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 82' ' ' SER . 8.8 mttt -143.45 171.79 13.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -1.079 . . . . 0.0 109.845 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.13 138.83 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.073 -1.017 . . . . 0.0 110.543 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.458 ' HB3' ' CG2' ' A' ' 79' ' ' THR . 42.4 t0 -107.96 158.06 17.69 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 108.896 179.047 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.406 ' CG1' ' HA ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -145.34 152.7 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 0.0 110.781 -179.244 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -152.44 107.36 3.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.462 -0.774 . . . . 0.0 110.457 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.474 HD11 ' CD2' ' A' ' 132' ' ' TYR . 20.0 mt -127.74 153.31 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.185 -0.947 . . . . 0.0 110.454 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.55 96.96 1.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.866 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.423 ' HG2' ' CE1' ' A' ' 130' ' ' PHE . 6.7 pt-20 -173.88 -149.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 110.261 -179.654 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.67 119.33 20.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.194 -0.941 . . . . 0.0 110.223 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.7 t -76.77 90.58 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.222 -0.924 . . . . 0.0 110.369 -179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.58 46.07 23.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 110.505 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.23 36.16 5.02 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.76 88.31 6.53 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.176 -1.19 . . . . 0.0 110.157 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -62.46 124.46 14.27 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.945 1.497 . . . . 0.0 110.274 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.423 ' CE1' ' HG2' ' A' ' 123' ' ' GLU . 6.2 p90 -154.25 161.86 41.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 110.183 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -135.42 106.18 6.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 110.17 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.474 ' CD2' HD11 ' A' ' 121' ' ' ILE . 3.6 t80 -91.79 131.31 37.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.01 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -166.68 89.63 0.37 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.917 . . . . 0.0 109.99 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 -177.06 6.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.152 -0.968 . . . . 0.0 110.593 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -118.22 93.06 3.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.372 -0.83 . . . . 0.0 109.758 179.753 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.472 ' CZ ' ' OH ' ' A' ' 132' ' ' TYR . 89.1 m-85 -85.55 -179.42 6.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.433 -0.792 . . . . 0.0 110.653 -179.476 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 12.4 p30 -151.09 161.77 42.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 110.111 179.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.5 pt -156.81 163.35 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.093 -1.004 . . . . 0.0 110.692 -179.596 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.0 m -91.97 121.6 33.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.386 -0.821 . . . . 0.0 110.736 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.458 ' CE1' ' HA3' ' A' ' 115' ' ' GLY . 55.4 m-85 -89.78 137.27 32.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -0.903 . . . . 0.0 109.407 179.088 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.482 ' HG3' ' CE2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -118.02 101.17 8.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.101 -1.0 . . . . 0.0 110.63 -179.725 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -92.6 130.3 38.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 0.0 109.83 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 3.7 m-80 -129.55 103.84 7.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 110.453 -179.761 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.426 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -152.62 -147.85 4.71 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.404 ' HD2' ' CD1' ' A' ' 109' ' ' LEU . 9.8 Cg_endo . . . . . 0 C--N 1.309 -1.533 0 O-C-N 123.793 1.417 . . . . 0.0 110.601 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.273 0.559 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.17 150.32 12.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 110.111 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.9 t30 63.0 24.34 14.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 109.952 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 178.87 53.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.411 -0.806 . . . . 0.0 110.092 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.3 -150.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.902 . . . . 0.0 110.347 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.8 OUTLIER 56.01 28.88 13.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.408 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.02 143.7 12.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 110.308 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.86 -178.77 43.94 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.96 103.47 16.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -1.155 . . . . 0.0 110.242 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.496 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -95.2 158.58 15.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 0.0 110.632 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.403 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 1.7 m120 -79.35 141.27 37.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 109.998 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -164.94 157.23 15.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 110.209 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 141' ' ' LYS . 1.1 tt0 -155.66 -175.93 5.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 110.094 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.421 ' O ' ' CG2' ' A' ' 46' ' ' THR . 0.4 OUTLIER -140.31 172.47 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.941 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -148.55 159.07 44.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 110.568 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.431 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.3 OUTLIER -67.56 128.22 35.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.477 -0.764 . . . . 0.0 109.882 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.472 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -55.41 146.51 19.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 0.0 110.089 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.1 t-20 71.44 2.3 4.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.861 -0.524 . . . . 0.0 111.235 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.431 ' CG2' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -136.75 -165.73 1.78 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.822 -1.174 . . . . 0.0 109.679 179.155 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -133.65 15.68 4.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 0.0 110.344 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -135.48 117.66 15.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.986 . . . . 0.0 110.579 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.422 ' CG2' ' HB2' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -50.45 131.3 24.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.201 -0.937 . . . . 0.0 109.264 179.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.54 -17.32 3.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.014 -1.054 . . . . 0.0 112.051 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.5 mt -136.93 -70.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.867 -1.145 . . . . 0.0 110.808 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -46.61 -26.31 0.88 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.597 -0.689 . . . . 0.0 110.943 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.422 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER -63.39 -14.5 50.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -0.981 . . . . 0.0 110.803 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.413 ' C ' ' CG ' ' A' ' 52' ' ' TYR . 21.2 m-20 -95.24 14.85 20.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.074 -1.016 . . . . 0.0 110.832 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.413 ' CG ' ' C ' ' A' ' 51' ' ' ASP . 22.5 m-85 -142.91 15.73 1.93 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.992 -1.068 . . . . 0.0 110.737 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -131.3 105.85 7.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.183 -0.948 . . . . 0.0 110.205 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -72.3 169.76 15.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.947 . . . . 0.0 110.368 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -147.72 162.04 33.12 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.338 -0.851 . . . . 0.0 110.018 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 58.8 Cg_endo -81.25 -175.8 16.46 Favored 'Cis proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.399 -2.334 . . . . 0.0 110.596 -0.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . . . -103.5 171.3 7.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.325 -0.859 . . . . 0.0 109.885 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.437 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -105.2 116.25 31.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.001 . . . . 0.0 110.536 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.496 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 1.9 p90 -97.24 162.67 13.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.394 -0.816 . . . . 0.0 109.945 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -154.78 150.97 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.026 -1.046 . . . . 0.0 110.783 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 19.6 mtmt -134.39 173.65 11.4 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.247 -0.908 . . . . 0.0 110.737 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HB2' ' CD ' ' A' ' 65' ' ' LYS . 4.5 mttm -153.27 62.21 0.76 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.508 -0.745 . . . . 0.0 109.703 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.1 m120 46.98 82.44 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.369 -0.832 . . . . 0.0 111.105 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.53 19.82 28.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.434 ' CD ' ' HB2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -168.84 162.62 11.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.045 -1.267 . . . . 0.0 111.181 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 2.6 pt? -172.66 154.89 3.15 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.009 0.909 . . . . 0.0 111.477 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 1.1 m-85 -137.98 -153.7 0.49 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.43 HG12 ' CE1' ' A' ' 142' ' ' PHE . 1.1 t -170.73 135.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.073 -1.017 . . . . 0.0 110.287 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.437 ' HG2' ' CB ' ' A' ' 58' ' ' LYS . 1.8 pt20 -97.51 131.24 44.31 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.39 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.68 143.69 20.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.253 -0.905 . . . . 0.0 110.108 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.77 135.85 33.31 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.299 -0.876 . . . . 0.0 109.902 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.8 t -103.34 126.42 57.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.418 -0.802 . . . . 0.0 110.143 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -97.99 127.16 43.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.227 -0.921 . . . . 0.0 110.149 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 m80 55.04 99.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.827 . . . . 0.0 110.146 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.9 t -74.39 -35.75 63.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.189 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -51.57 -23.9 4.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.26 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.473 ' CD2' HBB1 ' A' ' 151' ' ' ZNH . 45.4 m0 -94.37 -53.53 3.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.48 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.413 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 13.6 tt -89.51 123.71 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.144 -0.973 . . . . 0.0 109.835 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -87.69 -27.02 22.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 110.982 -179.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.466 ' N ' HG22 ' A' ' 79' ' ' THR . . . 179.56 -176.47 47.67 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.046 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 63.3 mtm -151.95 165.5 34.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.384 -1.068 . . . . 0.0 110.145 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -155.29 140.58 17.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.323 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.479 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -130.19 140.18 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 110.245 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 71.65 0.85 3.65 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.637 -0.664 . . . . 0.0 111.385 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.09 21.79 9.25 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.644 -1.265 . . . . 0.0 111.292 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.472 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.74 158.71 43.78 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.52 -1.577 . . . . 0.0 110.31 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.14 175.29 5.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 110.485 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -104.06 170.29 8.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.371 -0.831 . . . . 0.0 110.32 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -110.6 131.51 54.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 110.463 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.427 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.4 pp -68.26 102.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 109.571 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.438 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.1 tt -95.21 -30.89 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 111.092 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.7 m -167.22 95.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.028 -1.045 . . . . 0.0 110.327 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -96.77 105.07 17.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.397 -0.814 . . . . 0.0 109.977 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.67 105.36 17.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.236 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -32.03 44.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 0.0 110.235 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.59 -44.71 95.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 109.987 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -96.8 8.54 44.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 110.704 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.02 53.33 13.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.037 -1.039 . . . . 0.0 110.071 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.38 119.01 7.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 110.519 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.475 ' CG ' ' N ' ' A' ' 101' ' ' THR . 38.2 ttt180 -114.98 167.27 10.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.43 -0.794 . . . . 0.0 109.619 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 100' ' ' ARG . 92.0 m -141.09 153.14 45.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.018 -1.051 . . . . 0.0 109.962 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.416 ' N ' HG21 ' A' ' 101' ' ' THR . 97.1 p -144.99 142.35 29.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.157 -0.964 . . . . 0.0 110.686 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.18 140.73 29.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.324 -0.86 . . . . 0.0 109.85 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -127.96 138.62 52.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.077 -1.014 . . . . 0.0 110.71 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.436 ' HG2' ' CD2' ' A' ' 67' ' ' TYR . 3.2 tm-20 -98.29 128.16 44.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.329 -0.857 . . . . 0.0 109.538 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.61 151.12 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 110.926 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -63.09 111.2 2.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -0.916 . . . . 0.0 109.195 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.464 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.21 -167.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.458 -0.776 . . . . 0.0 109.844 -178.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.44 ' HG ' ' CD1' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -150.25 70.98 1.05 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.96 -1.088 . . . . 0.0 110.86 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.2 67.48 1.19 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 0.0 110.243 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.53 -121.57 1.02 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.41 153.44 27.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -1.157 . . . . 0.0 110.115 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.1 mm -136.74 149.2 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.0 110.262 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -76.49 103.78 6.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 109.968 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.415 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -109.17 179.49 21.03 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.5 mttp -145.03 167.4 22.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -1.088 . . . . 0.0 109.824 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.43 ' CD1' ' HAC' ' A' ' 151' ' ' ZNH . 0.1 OUTLIER -158.07 153.17 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.016 -1.052 . . . . 0.0 110.792 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.425 ' HB2' ' CG2' ' A' ' 79' ' ' THR . 59.9 m-20 -111.65 157.88 19.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.522 -0.737 . . . . 0.0 109.297 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -141.61 151.57 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.999 -1.063 . . . . 0.0 110.528 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.408 ' CE1' ' HB3' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -151.51 117.07 5.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.411 -0.805 . . . . 0.0 110.069 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 31.4 mt -141.05 151.97 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.188 -0.945 . . . . 0.0 110.484 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.57 95.79 1.12 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.465 -0.772 . . . . 0.0 109.668 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -173.14 163.6 4.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 110.431 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -87.34 112.94 22.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.374 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.9 t -76.42 91.68 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.323 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.02 43.33 9.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.216 -0.927 . . . . 0.0 110.349 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.14 30.61 16.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -145.37 100.92 4.41 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.269 -1.136 . . . . 0.0 110.261 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -52.5 113.25 1.14 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.74 1.389 . . . . 0.0 110.286 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -112.39 120.13 40.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.0 110.391 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -103.95 142.67 34.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.338 -0.851 . . . . 0.0 110.077 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -156.67 121.23 4.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 109.988 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.408 ' HB3' ' CE1' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -168.01 86.66 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 110.367 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -153.43 -172.45 4.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 110.358 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -117.64 87.81 2.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 110.091 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -85.56 -178.39 6.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.328 -0.857 . . . . 0.0 110.242 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 2.6 p30 -149.4 169.94 19.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 110.461 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -157.11 163.79 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -0.918 . . . . 0.0 110.634 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 85.2 m -91.86 125.33 36.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.3 -0.875 . . . . 0.0 110.567 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.479 ' CD2' HD11 ' A' ' 83' ' ' ILE . 31.4 m-85 -90.13 154.02 20.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.601 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -142.06 102.86 4.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.055 -1.028 . . . . 0.0 110.427 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.43 ' CE1' HG12 ' A' ' 68' ' ' VAL . 17.1 m-85 -92.26 153.51 19.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.43 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 51.1 m-80 -142.62 97.91 3.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.446 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -155.21 -148.12 4.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.57 -166.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.795 1.418 . . . . 0.0 110.436 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.2 p -149.84 -54.01 0.16 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.128 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -120.89 -76.71 0.58 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 110.244 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.6 t 56.25 59.4 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 110.406 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -157.98 28.79 0.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.882 . . . . 0.0 110.227 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.956 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.473 HBB1 ' CD2' ' A' ' 77' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.225 0.536 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -80.49 95.13 6.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.178 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 4.8 t-20 64.28 35.6 9.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -0.868 . . . . 0.0 110.089 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.86 79.44 1.73 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.406 -0.809 . . . . 0.0 110.234 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.38 -51.67 14.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 110.148 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER 53.2 34.5 17.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.239 -0.913 . . . . 0.0 110.337 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 p -160.67 148.06 15.78 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.195 -0.941 . . . . 0.0 110.331 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 171.2 174.35 38.9 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.93 107.73 19.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.282 -1.128 . . . . 0.0 110.568 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.506 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -95.73 158.09 15.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.149 -0.97 . . . . 0.0 110.363 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 143' ' ' ASN . 2.1 m-20 -80.38 143.8 33.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 109.716 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.486 ' CE2' HD11 ' A' ' 70' ' ' ILE . 1.1 p90 -164.92 156.36 15.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.117 -0.989 . . . . 0.0 110.254 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.42 -175.76 5.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.314 -0.866 . . . . 0.0 109.958 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.423 ' O ' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.31 175.17 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 110.031 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -149.08 160.57 43.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 110.404 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.94 119.97 13.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.369 -0.832 . . . . 0.0 109.418 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.476 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -48.71 146.15 3.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.241 -0.912 . . . . 0.0 110.169 -179.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER 72.53 2.33 4.31 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.949 -0.47 . . . . 0.0 110.866 -179.328 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -135.34 -163.0 1.32 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.878 -1.138 . . . . 0.0 109.818 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.56 14.02 3.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 110.242 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -135.25 123.51 23.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 110.354 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -60.56 131.37 50.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.072 -1.018 . . . . 0.0 109.313 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.04 -17.14 4.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 111.781 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.404 HD11 HG21 ' A' ' 48' ' ' ILE . 62.2 mt -137.25 -65.59 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.8 -1.188 . . . . 0.0 110.895 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.403 ' O ' ' CD2' ' A' ' 53' ' ' PHE . . . -50.03 -22.99 1.8 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.508 -0.745 . . . . 0.0 111.205 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.431 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 0.1 OUTLIER -70.58 -9.41 56.77 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.039 -1.038 . . . . 0.0 110.965 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.407 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 30.1 m-20 -102.47 14.9 30.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.928 -1.107 . . . . 0.0 110.959 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.492 ' CG ' HMC2 ' A' ' 151' ' ' ZNH . 31.5 m-85 -136.47 4.98 2.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.001 -1.062 . . . . 0.0 111.097 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 19.8 m-85 -125.75 111.64 15.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.038 -1.039 . . . . 0.0 110.291 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -72.01 165.69 23.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.993 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.427 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -147.24 164.55 22.52 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.215 -0.928 . . . . 0.0 110.196 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.427 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 58.0 Cg_endo -80.84 -175.57 16.27 Favored 'Cis proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.338 -2.359 . . . . 0.0 110.666 -0.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.48 168.85 9.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -0.885 . . . . 0.0 109.676 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.419 ' CB ' ' CG ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.89 121.33 41.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.031 -1.043 . . . . 0.0 110.783 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.506 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 9.2 p90 -98.26 158.73 15.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.327 -0.858 . . . . 0.0 109.873 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -155.08 147.65 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.076 -1.015 . . . . 0.0 110.442 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 7.2 mttt -131.87 174.11 10.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.457 -0.777 . . . . 0.0 110.444 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 2.6 mmtp -156.73 62.04 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.796 . . . . 0.0 109.731 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 m120 47.53 85.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.835 . . . . 0.0 110.992 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.73 17.45 48.5 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.555 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -165.31 163.51 19.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.936 -1.332 . . . . 0.0 111.119 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.2 pt? -174.6 154.83 2.09 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.017 0.913 . . . . 0.0 110.964 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.565 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -139.48 -155.46 0.59 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.441 ' CG2' ' HA ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -170.67 134.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.846 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.419 ' CG ' ' CB ' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -97.73 134.68 40.58 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.123 -0.986 . . . . 0.0 110.011 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.486 HD11 ' CE2' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -113.2 139.53 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.437 -0.789 . . . . 0.0 110.069 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.31 133.67 34.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 110.022 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.2 t -102.6 125.51 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.44 -0.787 . . . . 0.0 109.831 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -99.21 126.93 45.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.13 -0.981 . . . . 0.0 110.416 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 58.42 99.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 110.354 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.37 -25.55 59.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.168 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -59.39 -36.27 75.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.41 ' HA ' HG12 ' A' ' 121' ' ' ILE . 46.5 m0 -82.77 -52.11 7.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 12.8 tt -89.3 122.66 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.869 . . . . 0.0 109.838 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -87.2 -25.46 24.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 110.878 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.437 ' N ' HG23 ' A' ' 79' ' ' THR . . . -179.77 178.05 48.41 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.499 -1.334 . . . . 0.0 110.243 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 89.6 mtp -150.92 160.26 44.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.996 . . . . 0.0 109.787 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -154.95 161.16 41.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 110.253 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.493 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 1.3 mt -149.73 152.6 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 110.149 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.529 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 0.2 OUTLIER 62.77 12.51 5.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.093 -1.004 . . . . 0.0 111.058 179.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.17 20.42 52.8 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.436 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.529 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.2 p-80 -138.28 158.8 43.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.859 -1.377 . . . . 0.0 110.441 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.39 172.2 9.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.334 -0.854 . . . . 0.0 110.595 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.523 ' CB ' ' CZ ' ' A' ' 104' ' ' PHE . 4.4 pt-20 -100.54 170.53 8.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.342 -0.849 . . . . 0.0 110.373 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.3 129.49 53.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.347 -0.845 . . . . 0.0 110.483 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.76 101.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.111 -0.993 . . . . 0.0 109.569 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.438 HG21 ' N ' ' A' ' 92' ' ' SER . 1.1 tt -94.86 -26.38 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 110.857 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.438 ' N ' HG21 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -167.04 100.31 0.54 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.229 -0.92 . . . . 0.0 109.655 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.423 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 16.4 ttmt -95.93 147.94 23.15 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 110.191 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -143.02 84.2 1.82 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -0.938 . . . . 0.0 110.3 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 p -71.21 -29.39 65.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 110.207 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.95 -52.57 62.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.339 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -96.31 15.84 20.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.0 110.5 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.42 62.54 2.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.117 -0.989 . . . . 0.0 110.547 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 94' ' ' ASN . 22.3 mt-10 -148.14 160.86 42.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.158 -0.964 . . . . 0.0 110.165 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.423 ' CG ' ' HA ' ' A' ' 93' ' ' LYS . 7.3 ttm180 -166.83 161.47 15.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 110.155 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 102' ' ' SER . 74.3 m -143.07 152.0 41.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 109.61 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.414 ' N ' HG22 ' A' ' 101' ' ' THR . 18.2 p -146.33 143.46 29.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.988 -1.07 . . . . 0.0 110.871 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.82 147.96 22.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.374 -0.828 . . . . 0.0 109.693 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.523 ' CZ ' ' CB ' ' A' ' 88' ' ' GLU . 27.2 m-85 -130.16 135.79 48.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.088 -1.008 . . . . 0.0 111.117 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -97.19 125.17 41.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.393 -0.817 . . . . 0.0 109.117 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.433 ' CG2' ' N ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -149.25 161.02 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 0.0 110.782 -178.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.433 ' N ' ' CG2' ' A' ' 106' ' ' VAL . 11.0 p -70.13 113.0 6.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 108.82 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 44.83 -164.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.673 -0.642 . . . . 0.0 109.964 -178.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.425 ' HG ' HD11 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -150.64 68.22 0.96 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.876 -1.14 . . . . 0.0 110.933 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -146.97 87.97 1.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.05 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 148.05 -125.76 2.18 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.439 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.1 OUTLIER -156.91 150.39 24.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -1.067 . . . . 0.0 109.723 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.436 ' CA ' ' HE2' ' A' ' 112' ' ' LYS . 2.4 mt -135.55 152.19 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.316 -0.865 . . . . 0.0 110.04 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -75.93 100.0 4.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.919 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.415 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -99.99 179.31 29.92 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 82' ' ' SER . 17.0 mtpt -146.13 158.31 43.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -1.121 . . . . 0.0 110.054 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.421 HG12 ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -157.6 145.99 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.119 -0.988 . . . . 0.0 110.312 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.421 ' N ' HG12 ' A' ' 117' ' ' ILE . 1.0 OUTLIER -108.32 161.17 15.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.366 -0.833 . . . . 0.0 109.596 179.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.48 150.77 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.119 -0.988 . . . . 0.0 110.766 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -151.94 114.19 4.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.467 -0.771 . . . . 0.0 109.871 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.489 HD13 ' CD2' ' A' ' 132' ' ' TYR . 15.8 mt -141.51 153.29 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.164 -0.96 . . . . 0.0 110.806 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -159.44 100.01 1.48 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.587 -0.695 . . . . 0.0 109.424 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -172.97 178.25 2.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.24 -0.912 . . . . 0.0 110.396 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -101.21 118.85 37.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.333 -0.854 . . . . 0.0 110.324 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.2 t -76.91 92.26 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.0 110.306 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.431 ' N ' ' ND2' ' A' ' 126' ' ' ASN . 1.4 m120 57.39 36.18 26.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.878 . . . . 0.0 110.503 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.89 31.25 6.72 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.12 98.15 4.74 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.247 -1.149 . . . . 0.0 110.07 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -49.17 121.28 6.65 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.921 1.485 . . . . 0.0 110.327 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -126.32 124.63 40.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 110.195 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -103.61 140.59 37.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 110.351 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.489 ' CD2' HD13 ' A' ' 121' ' ' ILE . 2.5 t80 -150.85 123.22 8.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.091 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -175.83 87.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 109.935 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -153.58 -164.68 1.95 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.355 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.472 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -119.2 139.83 51.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.981 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 135' ' ' HIS . 47.5 m-85 -154.53 -179.82 8.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.93 . . . . 0.0 110.119 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.401 ' CB ' ' HA ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -152.39 178.89 9.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.161 -0.962 . . . . 0.0 110.51 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.8 pt -157.13 170.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.885 . . . . 0.0 110.058 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.439 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 96.8 m -91.6 121.84 33.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 110.647 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.415 ' CE1' ' HA3' ' A' ' 115' ' ' GLY . 28.6 m-85 -89.44 155.58 19.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.575 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.32 100.53 3.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.048 -1.033 . . . . 0.0 110.741 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.414 ' CE1' HG12 ' A' ' 68' ' ' VAL . 15.9 m-85 -91.7 129.14 37.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.652 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.449 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 56.1 m-80 -113.93 104.38 12.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.105 -0.997 . . . . 0.0 110.877 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.405 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -163.13 -159.03 10.15 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.408 ' HD2' ' CD1' ' A' ' 109' ' ' LEU . 16.4 Cg_endo -62.66 140.52 81.31 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.982 1.517 . . . . 0.0 110.278 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 m -90.59 -42.54 10.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.928 . . . . 0.0 110.401 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -175.4 -43.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.189 -0.944 . . . . 0.0 110.28 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.1 t 56.39 53.63 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 110.307 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.11 60.63 4.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.02 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.492 HMC2 ' CG ' ' A' ' 52' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.347 0.594 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.3 131.17 48.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.139 -0.975 . . . . 0.0 110.286 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.95 31.23 16.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.167 -0.958 . . . . 0.0 110.005 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.81 41.44 1.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.843 . . . . 0.0 110.277 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.55 -160.16 0.45 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 110.231 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER 56.69 27.33 12.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 110.419 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -158.91 134.6 8.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 110.246 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.96 178.27 48.74 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.29 105.4 17.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.181 -1.187 . . . . 0.0 110.382 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.519 ' CB ' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -94.27 154.25 17.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.345 -0.847 . . . . 0.0 109.744 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.463 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 12.4 t-20 -78.73 144.7 35.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.12 -0.988 . . . . 0.0 109.989 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.455 ' CD1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -165.57 161.46 18.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.343 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.22 -173.44 4.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.425 -0.797 . . . . 0.0 109.746 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.55 174.61 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.169 -0.957 . . . . 0.0 110.146 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -147.47 151.37 36.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.377 -0.827 . . . . 0.0 109.839 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -67.43 127.12 31.51 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.419 -0.8 . . . . 0.0 110.066 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.471 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -52.94 146.98 9.9 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.091 -1.006 . . . . 0.0 109.493 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 12.5 t30 73.09 -1.17 3.14 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.944 -0.472 . . . . 0.0 110.914 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -136.95 -163.38 1.41 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.899 -1.126 . . . . 0.0 109.561 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.402 ' N ' ' OG1' ' A' ' 43' ' ' THR . 8.5 m120 -133.34 15.74 4.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 110.434 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -136.53 129.03 30.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.015 . . . . 0.0 110.681 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.43 ' CG2' ' HB3' ' A' ' 50' ' ' ASN . 0.3 OUTLIER -57.79 132.38 53.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.156 -0.965 . . . . 0.0 109.037 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.75 -16.8 4.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.102 -0.999 . . . . 0.0 112.035 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.2 mt -136.62 -64.94 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.803 -1.185 . . . . 0.0 110.598 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.6 -20.79 8.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.428 -0.795 . . . . 0.0 110.727 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.43 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 0.1 OUTLIER -63.38 -17.84 63.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.309 -0.87 . . . . 0.0 110.76 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -102.47 15.45 29.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.139 -0.976 . . . . 0.0 110.992 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.477 ' CD2' HBC2 ' A' ' 151' ' ' ZNH . 66.9 m-85 -131.73 1.11 3.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.949 -1.094 . . . . 0.0 111.151 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -129.37 113.47 14.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.127 -0.983 . . . . 0.0 110.252 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -72.79 173.05 9.67 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.386 -0.821 . . . . 0.0 110.617 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.15 164.67 22.01 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.354 -0.841 . . . . 0.0 109.769 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -78.66 -174.84 15.55 Favored 'Cis proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.798 -2.167 . . . . 0.0 110.559 -0.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.455 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . . . -101.22 164.38 11.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.879 . . . . 0.0 110.007 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.418 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 2.2 tptt -101.91 109.55 21.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.131 -0.981 . . . . 0.0 110.314 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.519 ' CD1' ' CB ' ' A' ' 34' ' ' LEU . 6.5 p90 -98.0 165.75 11.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.332 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -155.6 157.81 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.296 -0.877 . . . . 0.0 110.537 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 3.1 mtmt -139.41 174.31 10.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.245 -0.909 . . . . 0.0 110.831 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.445 ' CB ' ' CD ' ' A' ' 65' ' ' LYS . 7.2 mttm -159.03 62.21 0.41 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.418 -0.801 . . . . 0.0 109.878 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 48.97 84.0 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.441 -0.787 . . . . 0.0 111.232 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.68 24.42 28.12 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.736 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' CD ' ' CB ' ' A' ' 62' ' ' LYS . 1.3 ptpp? -167.42 155.94 9.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.912 -1.346 . . . . 0.0 111.018 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -160.12 155.56 25.34 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.201 1.0 . . . . 0.0 111.843 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 6.2 m-85 -142.58 -164.14 1.76 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' A' ' 59' ' ' TYR . 1.1 t -170.47 135.98 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.998 -1.064 . . . . 0.0 110.554 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 4.7 pt20 -99.15 134.23 42.3 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 109.773 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -113.23 134.87 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 110.093 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.0 m -89.57 123.56 33.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 0.0 109.954 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.08 141.7 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.207 -0.933 . . . . 0.0 110.278 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -98.67 140.02 33.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.827 . . . . 0.0 110.207 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.2 m170 52.58 88.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 110.221 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.7 p -52.19 -25.91 10.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.378 -0.827 . . . . 0.0 110.298 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -65.37 -55.74 16.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 110.369 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.4 ' HA ' HG12 ' A' ' 121' ' ' ILE . 47.4 m0 -50.73 -59.56 3.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.19 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.1 tt -88.46 118.04 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.312 -0.868 . . . . 0.0 109.894 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.431 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -86.6 -23.02 25.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.316 -0.865 . . . . 0.0 110.956 -179.186 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.431 ' N ' HG21 ' A' ' 79' ' ' THR . . . -177.07 176.1 47.93 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.019 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.413 ' CE ' ' OH ' ' A' ' 140' ' ' TYR . 56.6 mtp -152.57 157.79 41.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.376 -1.073 . . . . 0.0 110.07 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -155.11 140.51 17.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.94 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.476 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.4 OUTLIER -132.94 139.38 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.143 -0.973 . . . . 0.0 110.726 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 70.73 1.86 3.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.588 -0.695 . . . . 0.0 111.629 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.49 22.06 9.37 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.327 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.465 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.88 159.64 41.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.685 -1.479 . . . . 0.0 110.059 179.217 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -70.16 -174.55 0.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.171 -0.956 . . . . 0.0 110.616 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -109.06 169.03 8.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 110.239 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -110.34 127.56 55.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 0.0 109.985 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.408 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 pp -67.08 102.89 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.062 -1.024 . . . . 0.0 109.661 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.447 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 0.9 OUTLIER -95.7 -31.5 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 111.007 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.427 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -167.24 100.4 0.52 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.036 -1.04 . . . . 0.0 110.162 -179.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -96.21 148.8 22.34 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.417 -0.802 . . . . 0.0 110.084 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.23 97.9 3.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 110.331 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.6 -32.56 58.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.049 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.89 -43.18 99.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 110.091 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.77 5.76 50.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 110.507 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.71 56.91 6.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.034 -1.041 . . . . 0.0 110.311 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -148.14 -177.32 5.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 110.357 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.404 ' CG ' ' N ' ' A' ' 101' ' ' THR . 4.8 ttp180 175.22 160.06 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.855 . . . . 0.0 110.009 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.447 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 85.8 m -137.3 156.19 48.55 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.314 -0.866 . . . . 0.0 109.812 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.416 ' N ' HG23 ' A' ' 101' ' ' THR . 6.1 p -144.2 143.12 30.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.038 -1.038 . . . . 0.0 110.785 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -92.92 150.15 20.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.816 . . . . 0.0 110.054 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -129.71 154.44 47.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.94 . . . . 0.0 110.687 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.51 127.37 53.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.321 -0.862 . . . . 0.0 109.742 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.0 m -149.88 -165.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.045 -1.034 . . . . 0.0 110.607 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -97.9 111.9 24.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.479 -0.763 . . . . 0.0 108.994 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.431 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 47.41 -166.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.48 -0.763 . . . . 0.0 109.554 -178.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.419 ' CD2' ' CD2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -151.0 62.75 0.91 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.078 -1.014 . . . . 0.0 110.931 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -146.11 70.48 1.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 110.23 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.23 -125.07 1.19 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.454 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.2 OUTLIER -157.38 139.35 14.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.343 -1.092 . . . . 0.0 109.715 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.421 ' CA ' ' HE2' ' A' ' 112' ' ' LYS . 6.0 mt -135.25 149.83 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.24 -0.913 . . . . 0.0 110.237 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -76.57 123.18 25.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.908 . . . . 0.0 110.15 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -119.82 -177.65 16.23 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 82' ' ' SER . 12.3 mttt -145.12 158.86 43.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.327 -1.102 . . . . 0.0 110.111 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.77 143.64 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.454 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.59 154.99 18.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.401 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.84 146.86 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.008 -1.057 . . . . 0.0 110.678 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.53 110.47 3.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.43 -0.794 . . . . 0.0 110.006 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.448 ' HB ' ' CB ' ' A' ' 132' ' ' TYR . 19.6 mt -139.92 153.71 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 110.573 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.0 95.1 1.26 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.498 -0.751 . . . . 0.0 109.436 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.476 ' O ' ' CD1' ' A' ' 130' ' ' PHE . 1.3 pt-20 -174.5 -164.73 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.387 -0.821 . . . . 0.0 109.928 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -113.63 115.04 27.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.101 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.429 ' CG2' ' CE1' ' A' ' 130' ' ' PHE . 3.1 t -76.61 94.56 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.264 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.415 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 2.4 m120 59.42 39.13 22.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.337 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 91.89 34.69 7.13 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.72 90.71 6.31 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.226 -1.161 . . . . 0.0 110.061 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -57.3 133.75 59.31 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.126 1.593 . . . . 0.0 110.63 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' A' ' 123' ' ' GLU . 9.3 p90 -157.39 132.7 9.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.056 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -103.24 99.71 9.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.397 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.453 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 3.7 t80 -90.49 129.53 36.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.831 . . . . 0.0 109.703 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -170.45 83.58 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.091 -1.005 . . . . 0.0 110.27 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.84 -166.04 2.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.885 . . . . 0.0 110.327 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -118.34 151.7 37.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 109.858 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -155.29 179.85 8.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.014 . . . . 0.0 110.405 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -152.23 169.54 22.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.572 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.4 pt -156.65 161.63 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 110.214 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.454 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 66.4 m -91.82 125.85 36.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.865 . . . . 0.0 110.73 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.486 ' CE1' ' HA3' ' A' ' 115' ' ' GLY . 47.7 m-85 -90.59 164.93 14.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.905 . . . . 0.0 110.016 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.98 103.3 3.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.954 . . . . 0.0 110.32 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -92.44 141.33 28.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.301 -0.874 . . . . 0.0 110.515 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.445 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 67.2 m-20 -133.12 98.43 4.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 110.022 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.52 -148.71 5.35 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.408 ' HD2' ' CD1' ' A' ' 109' ' ' LEU . 17.7 Cg_endo -63.22 -174.01 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.773 1.407 . . . . 0.0 110.768 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.47 -42.74 0.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 110.038 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -142.82 -49.16 0.34 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 110.155 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 30.4 t 56.01 29.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 110.322 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.55 24.67 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.291 -0.88 . . . . 0.0 110.19 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.915 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.477 HBC2 ' CD2' ' A' ' 52' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.286 0.565 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -131.85 142.21 49.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.164 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.78 27.99 17.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.262 -0.899 . . . . 0.0 109.88 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.08 114.17 10.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 0.0 110.24 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.74 -165.62 0.85 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.34 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 25.0 m-20 55.64 23.24 5.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.335 -0.853 . . . . 0.0 110.352 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 36.6 t -160.84 148.24 15.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 110.43 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.35 172.14 39.97 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.18 106.59 18.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -1.107 . . . . 0.0 110.229 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.489 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -94.45 156.21 16.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.319 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -79.62 143.9 34.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 110.017 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.456 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 1.6 p90 -165.99 159.05 15.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 0.0 110.03 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -155.15 -175.14 5.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.926 . . . . 0.0 109.947 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.463 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -141.43 174.5 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 110.476 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 18.6 m-85 -148.17 156.02 42.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -0.808 . . . . 0.0 109.926 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.431 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -67.66 127.87 34.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.106 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.445 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -54.37 147.92 12.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 109.869 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 9.7 m-20 71.11 2.42 4.23 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.812 -0.555 . . . . 0.0 110.952 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.413 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -135.93 -162.26 1.25 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.849 -1.157 . . . . 0.0 109.666 179.087 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.413 ' N ' ' OG1' ' A' ' 43' ' ' THR . 16.5 m-80 -132.57 11.91 4.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 110.194 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -136.56 143.76 43.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 110.69 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.45 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -68.58 131.49 45.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.088 179.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.25 -17.52 3.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.962 -1.087 . . . . 0.0 112.137 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -137.32 -71.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.789 -1.195 . . . . 0.0 110.581 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.457 ' N ' ' CG2' ' A' ' 48' ' ' ILE . . . -48.87 -24.69 1.55 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.499 -0.751 . . . . 0.0 110.853 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.45 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -61.73 -20.64 63.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.121 -0.987 . . . . 0.0 110.784 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.41 ' OD2' ' ND2' ' A' ' 50' ' ' ASN . 2.1 m-20 -94.68 14.12 22.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.086 -1.009 . . . . 0.0 110.858 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.406 ' CD2' HBC2 ' A' ' 151' ' ' ZNH . 61.1 m-85 -141.3 9.51 2.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.062 . . . . 0.0 110.843 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -118.15 110.67 17.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.983 . . . . 0.0 110.171 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -72.77 155.67 39.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.298 -0.877 . . . . 0.0 110.693 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.52 163.27 28.58 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.333 -0.854 . . . . 0.0 109.833 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.41 -175.27 16.4 Favored 'Cis proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.862 -2.141 . . . . 0.0 110.472 -0.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.09 -172.0 2.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 109.889 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.52 119.19 27.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.015 -1.053 . . . . 0.0 110.577 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.489 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 8.3 p90 -97.11 165.59 11.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 109.877 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -155.58 122.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.135 -0.978 . . . . 0.0 110.608 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HG2' ' CB ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -136.77 131.76 33.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.199 -0.938 . . . . 0.0 110.775 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -110.25 62.25 0.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 110.35 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 48.45 97.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.374 -0.829 . . . . 0.0 111.28 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.91 11.71 52.25 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.96 152.63 4.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.012 -1.287 . . . . 0.0 110.325 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -156.92 153.46 28.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.09 -1.006 . . . . 0.0 111.504 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 4.5 m-85 -142.94 -157.92 0.82 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.391 -0.818 . . . . 0.0 109.257 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -170.16 167.49 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.197 -0.939 . . . . 0.0 110.345 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.28 134.51 29.47 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.403 -0.81 . . . . 0.0 109.676 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.434 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.3 OUTLIER -115.48 133.71 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 110.225 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.3 m -89.86 129.72 36.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.155 -0.966 . . . . 0.0 109.853 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -102.31 143.78 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 110.231 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -99.23 139.34 35.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.905 . . . . 0.0 110.254 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 54.34 99.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 110.346 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.01 -35.32 78.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.885 . . . . 0.0 110.222 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -57.95 -35.98 71.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 110.196 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.438 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 39.8 m0 -79.0 -51.04 10.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 110.213 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 3.8 tp -89.27 120.55 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.875 . . . . 0.0 109.835 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.435 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -86.4 -34.56 20.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.406 -0.809 . . . . 0.0 110.706 -179.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.435 ' N ' HG21 ' A' ' 79' ' ' THR . . . -175.62 -179.63 46.25 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.532 -1.318 . . . . 0.0 109.989 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -152.41 166.31 32.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -1.091 . . . . 0.0 110.133 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -155.21 147.3 23.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.859 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.474 HD13 ' CE2' ' A' ' 140' ' ' TYR . 1.2 mt -142.37 143.11 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 110.627 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 72.3 -0.41 3.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.614 -0.678 . . . . 0.0 111.604 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.0 20.27 9.99 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.458 -1.354 . . . . 0.0 111.285 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.461 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.02 161.41 36.13 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.735 -1.45 . . . . 0.0 110.199 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -172.16 0.6 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.006 -1.059 . . . . 0.0 110.739 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 0.1 OUTLIER -109.79 165.9 11.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 110.557 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.16 135.05 54.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.448 -0.783 . . . . 0.0 109.856 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.42 100.76 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.087 -1.008 . . . . 0.0 109.913 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.44 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.2 tt -96.0 -28.56 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 110.285 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -166.32 96.08 0.57 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.232 -0.918 . . . . 0.0 109.794 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -95.36 102.4 14.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.427 -0.796 . . . . 0.0 110.073 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.38 95.75 7.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.365 -0.835 . . . . 0.0 110.352 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -37.96 53.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.928 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.55 -38.48 90.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.034 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -96.19 10.55 37.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.62 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 50.91 56.17 8.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.048 -1.033 . . . . 0.0 110.282 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -148.04 169.85 19.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.156 -0.965 . . . . 0.0 110.395 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.404 ' HB3' HG21 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -166.62 157.63 12.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.333 -0.855 . . . . 0.0 109.954 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.44 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 86.8 m -141.98 158.38 43.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.396 -0.815 . . . . 0.0 109.759 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -145.04 142.97 30.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.045 -1.034 . . . . 0.0 110.728 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.98 138.77 31.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.363 -0.836 . . . . 0.0 109.943 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 102' ' ' SER . 88.6 m-85 -130.06 145.9 51.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.055 -1.028 . . . . 0.0 110.901 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -99.69 131.02 45.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.377 -0.827 . . . . 0.0 108.881 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.9 m -149.09 162.28 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.849 -1.157 . . . . 0.0 111.285 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 60.4 p -69.44 112.32 5.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.454 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.67 -157.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.51 -0.744 . . . . 0.0 109.418 -178.3 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.21 51.53 0.9 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.798 -1.189 . . . . 0.0 110.807 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -146.26 87.73 1.75 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.026 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.22 171.02 20.75 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.402 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 1.0 OUTLIER -81.63 144.01 31.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -1.169 . . . . 0.0 110.175 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mm -137.92 139.89 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.171 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -76.65 135.57 39.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 109.947 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -140.98 178.12 20.39 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 82' ' ' SER . 9.1 mtmm -143.6 158.06 43.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.426 -1.044 . . . . 0.0 109.837 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.7 142.62 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.959 -1.088 . . . . 0.0 110.592 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -106.2 164.47 11.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -0.764 . . . . 0.0 109.798 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.474 HG11 ' CE2' ' A' ' 132' ' ' TYR . 25.0 t -141.95 151.53 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 110.447 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -152.03 105.42 3.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.476 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.462 HD11 ' CD2' ' A' ' 132' ' ' TYR . 4.9 mt -125.46 152.79 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.243 -0.911 . . . . 0.0 110.073 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.73 102.41 1.33 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.798 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -173.7 -164.24 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 110.443 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 128' ' ' LYS . 2.3 ttmt -99.92 103.11 14.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.294 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.426 ' O ' ' CG1' ' A' ' 125' ' ' VAL . 2.1 t -76.63 103.0 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 110.15 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 63.16 34.47 13.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.451 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.09 31.52 28.4 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.427 ' N ' ' HG2' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -145.33 137.01 12.89 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.224 -1.162 . . . . 0.0 109.999 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.25 129.27 33.94 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.564 1.297 . . . . 0.0 109.838 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -129.14 118.1 21.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 110.583 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -105.2 137.78 42.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 109.847 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.478 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 6.3 t80 -157.17 123.62 4.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.212 -0.93 . . . . 0.0 110.006 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -173.35 87.55 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.905 . . . . 0.0 109.986 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.96 -161.46 1.29 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.892 . . . . 0.0 110.297 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -120.93 155.6 33.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.86 . . . . 0.0 110.256 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 32.4 m-85 -155.14 -179.26 7.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 109.831 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 6.3 p30 -151.2 168.98 23.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 110.608 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.3 pt -156.85 163.27 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.365 -0.835 . . . . 0.0 110.13 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.402 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 90.8 m -91.9 122.11 34.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.224 -0.923 . . . . 0.0 110.54 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.474 ' CE2' HD13 ' A' ' 83' ' ' ILE . 49.2 m-85 -90.25 157.96 17.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -0.877 . . . . 0.0 110.235 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 104.74 3.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.225 -0.922 . . . . 0.0 110.178 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -91.39 158.35 16.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.237 -0.914 . . . . 0.0 110.277 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.456 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 65.9 m-80 -143.13 99.56 3.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -157.52 -154.89 7.27 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -60.36 -165.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.988 1.52 . . . . 0.0 110.537 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.8 p -149.74 -47.83 0.13 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.378 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.75 -58.89 2.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 110.444 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.2 t 57.12 54.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 110.229 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.58 75.72 8.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.293 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.478 ' NA ' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.294 0.569 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 27' ' ' ASN . . . -100.7 136.39 40.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.242 -0.911 . . . . 0.0 110.158 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 26' ' ' ALA . 68.7 m-20 56.87 27.77 13.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.381 -0.824 . . . . 0.0 109.762 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -149.36 47.25 0.97 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.477 -0.764 . . . . 0.0 110.367 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.13 -37.06 64.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.074 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.411 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 7.7 m-20 57.63 28.47 15.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 110.266 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 p -159.48 147.69 17.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 0.0 110.428 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.37 175.67 44.8 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.68 104.87 17.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -1.113 . . . . 0.0 110.39 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.488 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -95.27 159.12 15.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.328 -0.857 . . . . 0.0 110.434 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.439 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 16.3 m-20 -78.71 139.6 38.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.116 -0.99 . . . . 0.0 109.982 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -165.51 152.22 10.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.982 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -155.13 -173.2 4.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.0 110.237 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.456 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -140.97 178.65 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.878 . . . . 0.0 110.369 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 39.7 m-85 -148.18 156.72 42.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.446 -0.784 . . . . 0.0 109.68 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.27 122.78 18.62 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.937 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -49.86 148.89 2.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.934 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.4 t-20 71.52 2.82 4.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.879 -0.513 . . . . 0.0 110.771 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.12 -157.84 0.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.948 -1.095 . . . . 0.0 109.533 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.12 8.27 3.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 110.209 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -135.11 150.76 50.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.07 -1.019 . . . . 0.0 110.563 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.441 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -77.53 133.86 38.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.239 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.3 t -129.03 -17.21 3.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.024 -1.048 . . . . 0.0 111.954 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.3 mp -136.94 -69.45 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.7 -1.25 . . . . 0.0 110.623 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.42 -24.09 1.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.549 -0.72 . . . . 0.0 110.9 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.441 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -65.9 -13.41 59.63 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.083 -1.011 . . . . 0.0 110.957 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -99.27 15.36 26.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.016 -1.052 . . . . 0.0 110.957 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.488 ' CD1' HBC2 ' A' ' 151' ' ' ZNH . 58.1 m-85 -136.87 10.06 3.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.893 -1.129 . . . . 0.0 111.148 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -120.83 104.78 10.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.093 -1.004 . . . . 0.0 110.242 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -72.59 106.35 4.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.193 -0.942 . . . . 0.0 110.114 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.456 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -93.53 167.71 13.4 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.255 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.456 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 53.1 Cg_endo -77.93 -175.82 17.47 Favored 'Cis proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.67 -2.221 . . . . 0.0 110.843 -0.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -103.2 171.51 7.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 109.977 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -104.21 117.17 33.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.01 . . . . 0.0 110.792 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.7 p90 -96.42 163.0 13.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 109.324 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -154.96 118.82 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.925 -1.109 . . . . 0.0 111.028 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.4 mtmt -139.07 131.57 28.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.314 -0.866 . . . . 0.0 109.632 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HB3' ' CE ' ' A' ' 65' ' ' LYS . 4.9 tttm -115.91 65.39 0.7 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.113 -0.992 . . . . 0.0 110.78 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 46.39 95.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.465 -0.772 . . . . 0.0 111.201 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.17 13.24 36.89 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.421 ' CE ' ' HB3' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -173.18 149.71 1.84 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.054 -1.262 . . . . 0.0 109.876 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -158.83 144.13 16.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.969 . . . . 0.0 111.261 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.503 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 3.3 m-85 -141.02 -161.79 1.27 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.537 -0.727 . . . . 0.0 109.663 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.453 HG11 ' CE1' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -170.18 163.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.213 -0.93 . . . . 0.0 109.933 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 102' ' ' SER . 3.4 pt20 -141.61 144.63 34.31 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.171 -0.956 . . . . 0.0 110.58 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.474 ' CD1' ' N ' ' A' ' 70' ' ' ILE . 2.2 mp -116.68 147.47 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.509 -0.744 . . . . 0.0 109.856 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.6 m -89.19 134.68 33.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 0.0 109.887 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.31 119.63 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 0.0 110.332 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -100.11 137.32 38.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.212 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.6 92.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.203 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 m -76.47 -25.49 54.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.155 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -60.4 -17.2 42.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.253 -0.904 . . . . 0.0 110.325 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.435 ' CG ' HBB1 ' A' ' 151' ' ' ZNH . 45.6 m0 -106.31 -51.45 2.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -0.956 . . . . 0.0 110.488 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.4 tt -89.52 125.25 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 109.886 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.434 HG23 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -86.83 -33.46 19.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.398 -0.814 . . . . 0.0 110.765 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 79' ' ' THR . . . 178.06 -174.9 47.16 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.139 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.403 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 0.6 OUTLIER -152.4 170.84 19.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -1.064 . . . . 0.0 110.259 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' LYS . 2.2 t -154.36 146.21 23.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 109.758 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.474 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 2.9 mt -140.95 144.44 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.619 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.474 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 71.33 2.29 4.19 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.632 -0.667 . . . . 0.0 111.204 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.33 21.47 13.14 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.73 -1.224 . . . . 0.0 111.103 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.47 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.0 160.14 40.13 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.655 -1.497 . . . . 0.0 110.193 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.11 -174.28 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.042 -1.036 . . . . 0.0 110.544 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 8.3 pt-20 -109.97 170.06 8.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.357 -0.839 . . . . 0.0 110.309 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.13 130.59 54.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 0.0 110.266 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.402 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 pp -67.56 103.63 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.074 -1.016 . . . . 0.0 109.59 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.43 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -95.13 -27.69 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.366 -0.834 . . . . 0.0 110.971 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.0 m -167.26 94.64 0.46 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.146 -0.971 . . . . 0.0 109.898 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -97.35 147.97 23.64 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 110.284 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.85 101.18 3.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 109.973 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -74.21 -32.37 63.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 0.0 110.312 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.47 -44.8 95.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 110.171 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.55 -3.36 43.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 110.729 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t0 59.97 50.37 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.96 -1.088 . . . . 0.0 110.13 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -147.44 128.45 14.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 110.091 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.77 172.37 12.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 110.444 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.43 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 97.2 m -141.11 157.1 45.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.447 -0.783 . . . . 0.0 109.458 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.43 ' N ' HG21 ' A' ' 101' ' ' THR . 0.7 OUTLIER -145.24 138.01 26.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.068 -1.02 . . . . 0.0 110.721 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -92.9 144.9 24.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.436 -0.79 . . . . 0.0 110.12 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.482 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 98.4 m-85 -130.76 145.5 51.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.142 -0.974 . . . . 0.0 110.845 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -95.59 126.59 40.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.338 -0.851 . . . . 0.0 109.295 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.78 177.55 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.974 -1.079 . . . . 0.0 111.038 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.5 t -89.4 110.91 21.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.48 -0.763 . . . . 0.0 109.258 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.438 ' CA ' HD23 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 49.65 -158.3 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.652 -178.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.31 50.92 0.83 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.983 -1.073 . . . . 0.0 111.066 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -144.85 84.35 1.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 110.137 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.43 170.44 19.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.72 145.87 30.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.171 . . . . 0.0 110.416 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 mt -137.28 139.34 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 0.0 109.838 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -76.19 121.2 22.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.27 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -129.15 178.16 17.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -144.63 165.84 26.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -1.154 . . . . 0.0 109.456 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.1 OUTLIER -157.79 150.52 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.869 -1.145 . . . . 0.0 111.171 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.404 ' O ' HG23 ' A' ' 79' ' ' THR . 1.1 m-20 -109.02 161.38 15.22 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.564 -0.71 . . . . 0.0 109.348 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 t -143.56 151.67 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.118 -0.989 . . . . 0.0 110.113 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 5.1 t80 -151.71 118.89 5.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 110.672 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.41 HD12 HBB2 ' A' ' 151' ' ' ZNH . 30.2 mt -142.63 151.62 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.969 . . . . 0.0 110.145 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.39 95.65 1.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.348 -0.845 . . . . 0.0 109.615 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -173.28 166.26 4.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.259 -0.901 . . . . 0.0 110.414 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -90.25 113.72 25.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.114 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -76.52 90.36 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.2 50.13 3.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.907 . . . . 0.0 110.388 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.71 29.96 45.88 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.21 101.21 4.44 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.175 -1.191 . . . . 0.0 110.27 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.12 136.49 24.03 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.819 1.431 . . . . 0.0 110.293 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 5.8 t80 -136.63 114.71 11.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.174 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -103.43 130.35 50.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 110.112 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . 1.6 t80 -145.21 113.84 6.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.763 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -162.81 92.15 0.77 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.929 . . . . 0.0 110.224 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -153.84 -169.75 3.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 110.433 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -119.63 86.29 2.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.318 -0.863 . . . . 0.0 110.022 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.411 ' CD1' HBD2 ' A' ' 151' ' ' ZNH . 43.2 m-85 -84.59 -178.96 7.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.255 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 5.7 p30 -150.49 170.51 18.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 110.055 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.7 pt -156.92 165.63 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.076 -1.015 . . . . 0.0 110.754 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.409 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 98.8 m -91.76 117.91 30.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.499 -0.75 . . . . 0.0 110.33 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.422 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 30.6 m-85 -89.91 151.3 21.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 0.0 110.126 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -144.0 106.1 4.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.145 -0.972 . . . . 0.0 110.339 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.453 ' CE1' HG11 ' A' ' 68' ' ' VAL . 80.3 m-85 -91.46 148.6 22.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.91 . . . . 0.0 109.962 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.439 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 32.7 m-80 -131.1 105.03 7.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.271 -0.893 . . . . 0.0 110.508 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.72 -161.56 11.65 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.411 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 7.3 Cg_endo -54.89 -168.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.919 1.483 . . . . 0.0 110.291 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.2 20.45 0.96 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.256 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.69 -61.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 109.71 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' A' ' 145' ' ' PRO . 5.8 t 56.94 52.95 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.36 -0.838 . . . . 0.0 110.376 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.51 110.98 17.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.488 HBC2 ' CD1' ' A' ' 52' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.22 0.533 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -112.51 76.09 0.96 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.336 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 2.2 t-20 62.83 23.0 13.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.03 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -97.8 101.19 12.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -0.883 . . . . 0.0 110.288 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.89 -155.5 0.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 110.273 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 10.3 m-20 55.1 24.55 6.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.862 . . . . 0.0 110.516 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.1 t -159.23 171.36 20.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.083 -1.011 . . . . 0.0 110.889 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.98 177.64 27.62 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.05 107.12 18.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -1.128 . . . . 0.0 110.204 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.479 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -94.3 155.4 17.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 110.091 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 143' ' ' ASN . 33.6 m-80 -79.92 138.62 37.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.77 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.4 OUTLIER -166.0 159.24 15.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.117 -0.989 . . . . 0.0 110.117 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -155.76 -170.33 3.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -0.86 . . . . 0.0 110.247 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.437 ' O ' ' CG2' ' A' ' 46' ' ' THR . 0.1 OUTLIER -140.06 173.09 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 109.943 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -150.41 160.94 43.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.192 -0.943 . . . . 0.0 110.197 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.416 ' CD ' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -68.35 126.33 29.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.473 -0.767 . . . . 0.0 110.168 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.484 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -57.11 146.13 28.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 109.813 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 6.5 t30 72.93 -0.59 3.32 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.878 -0.514 . . . . 0.0 110.926 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -139.08 -168.62 2.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.976 -1.078 . . . . 0.0 109.556 179.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.422 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.9 OUTLIER -135.57 25.26 3.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.002 . . . . 0.0 110.558 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -135.37 123.69 23.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.147 -0.971 . . . . 0.0 111.035 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.437 ' CG2' ' O ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -52.54 122.1 8.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.46 -0.775 . . . . 0.0 109.313 179.046 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.59 -18.65 3.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.901 -1.125 . . . . 0.0 112.219 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.416 HD13 ' CD ' ' A' ' 40' ' ' LYS . 1.4 mp -138.47 -76.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.621 -1.299 . . . . 0.0 110.971 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.07 -27.02 0.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.735 -0.603 . . . . 0.0 111.116 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.424 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -63.16 -13.64 39.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.075 -1.016 . . . . 0.0 110.689 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.442 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 31.3 m-20 -98.68 10.63 40.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.07 -1.019 . . . . 0.0 110.752 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.446 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 16.6 m-85 -144.91 15.86 1.56 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.995 -1.066 . . . . 0.0 110.261 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.485 ' CZ ' ' HE2' ' A' ' 81' ' ' MET . 0.1 OUTLIER -113.44 108.75 17.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 110.369 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -72.21 147.76 46.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.153 -0.967 . . . . 0.0 110.19 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 20.6 pttt -146.38 163.35 30.36 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 109.957 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.401 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 50.9 Cg_endo -76.07 -177.11 19.92 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.84 -2.15 . . . . 0.0 110.918 0.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.451 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . . . -101.08 166.27 10.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.885 . . . . 0.0 110.005 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.454 ' CB ' ' CG ' ' A' ' 69' ' ' GLN . 1.2 mttm -103.39 112.44 25.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 0.0 110.364 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.479 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 1.9 p90 -95.83 163.33 13.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 109.682 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 1.1 tt -155.23 130.49 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.058 -1.026 . . . . 0.0 110.907 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -138.83 114.64 9.98 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.436 -0.79 . . . . 0.0 109.932 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -97.32 62.19 1.74 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 110.654 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 46.08 99.3 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.544 -0.723 . . . . 0.0 111.616 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.8 -21.67 43.92 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.16 166.09 23.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -1.182 . . . . 0.0 110.46 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.477 ' CD1' ' HA ' ' A' ' 108' ' ' LYS . 1.1 pt? -171.25 145.76 2.24 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.614 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.3 OUTLIER -141.41 -160.1 1.04 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.2 t -170.22 128.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.991 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.454 ' CG ' ' CB ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -98.79 132.49 44.11 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.033 -1.042 . . . . 0.0 109.704 179.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -112.62 128.16 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.85 . . . . 0.0 110.017 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 m -88.57 126.74 35.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.06 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.425 HG22 ' CB ' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -102.92 144.74 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.79 143.94 28.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 0.0 110.357 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 56.59 90.44 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.256 -0.902 . . . . 0.0 110.191 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -29.73 63.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.211 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -67.12 -53.08 34.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.848 . . . . 0.0 110.201 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.43 ' HA ' HG12 ' A' ' 121' ' ' ILE . 46.8 m0 -57.72 -56.06 26.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 9.3 tp -87.69 116.58 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.443 -0.786 . . . . 0.0 109.928 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.43 HG23 ' N ' ' A' ' 80' ' ' GLY . 0.5 OUTLIER -86.37 -23.98 25.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.477 -0.764 . . . . 0.0 110.67 -179.254 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.43 ' N ' HG23 ' A' ' 79' ' ' THR . . . 177.16 179.48 47.52 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.485 ' HE2' ' CZ ' ' A' ' 53' ' ' PHE . 17.3 mtt -151.52 165.79 33.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.395 -1.062 . . . . 0.0 109.796 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -154.56 148.84 26.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 110.215 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.503 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 2.3 mt -139.27 153.43 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 110.059 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.489 ' HB2' ' CE1' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 61.59 13.67 5.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.02 -1.05 . . . . 0.0 110.912 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.85 21.86 54.6 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.726 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.503 ' CD2' ' O ' ' A' ' 83' ' ' ILE . 2.1 p-80 -136.81 162.72 32.43 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.751 -1.441 . . . . 0.0 110.677 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 171.47 10.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.345 -0.847 . . . . 0.0 111.023 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.481 ' CB ' ' CZ ' ' A' ' 104' ' ' PHE . 5.7 pt-20 -100.4 170.41 8.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.445 -0.784 . . . . 0.0 110.535 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 102' ' ' SER . 9.4 t-20 -108.38 138.14 45.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 109.975 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.4 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.1 pp -68.14 101.14 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.969 -1.082 . . . . 0.0 109.561 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 92' ' ' SER . 0.4 OUTLIER -94.63 -31.95 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.352 -0.842 . . . . 0.0 110.978 -179.045 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.436 ' N ' HG22 ' A' ' 91' ' ' ILE . 9.0 m -166.2 98.25 0.61 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.063 -1.023 . . . . 0.0 109.934 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -95.05 137.62 33.86 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.41 -0.806 . . . . 0.0 109.911 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.57 90.07 2.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.358 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -31.03 64.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.947 . . . . 0.0 109.979 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.81 -44.84 95.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 110.176 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -95.25 9.86 38.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 110.556 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 53.7 58.91 4.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.032 -1.043 . . . . 0.0 110.19 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -147.94 162.33 39.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 110.391 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.425 ' CB ' HG22 ' A' ' 72' ' ' VAL . 1.2 mtp180 -164.71 149.42 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 109.961 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.433 ' CG2' HG23 ' A' ' 91' ' ' ILE . 52.4 m -142.04 154.87 45.3 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 109.986 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 24.8 p -146.91 146.67 30.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.981 . . . . 0.0 110.589 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -91.73 147.14 23.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.361 -0.837 . . . . 0.0 110.078 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.481 ' CZ ' ' CB ' ' A' ' 88' ' ' GLU . 6.1 m-85 -130.14 140.14 50.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 110.846 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -97.34 126.82 42.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 108.991 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.7 147.75 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.003 -1.06 . . . . 0.0 111.277 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.09 99.98 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.477 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 55.61 170.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.494 -0.754 . . . . 0.0 109.409 -178.191 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.34 79.25 1.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.967 -1.083 . . . . 0.0 111.065 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -146.41 71.89 1.26 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.827 . . . . 0.0 110.032 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.79 -101.48 0.19 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.427 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.3 OUTLIER -157.51 145.71 19.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -1.143 . . . . 0.0 110.156 -179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.401 ' N ' ' HG2' ' A' ' 112' ' ' LYS . 5.3 mm -136.27 137.92 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 109.879 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.14 108.49 9.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 0.0 110.058 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -120.54 -176.36 15.62 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 5.3 mtmm -144.62 167.29 22.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.307 -1.113 . . . . 0.0 110.001 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -157.74 142.29 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.109 -0.995 . . . . 0.0 110.709 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.7 155.92 18.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.438 -0.789 . . . . 0.0 109.679 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.77 153.65 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 0.0 110.451 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -151.29 103.62 3.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.423 -0.798 . . . . 0.0 110.553 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.447 HG22 ' N ' ' A' ' 122' ' ' ASP . 75.3 mt -133.09 151.0 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 0.0 110.204 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.447 ' N ' HG22 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -159.08 100.02 1.53 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.411 -0.806 . . . . 0.0 109.518 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -173.33 169.62 4.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 110.491 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -82.89 90.64 6.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.378 -0.826 . . . . 0.0 110.344 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.419 ' O ' ' CG1' ' A' ' 125' ' ' VAL . 2.0 p -77.43 134.66 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 110.156 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.58 25.47 1.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -0.881 . . . . 0.0 110.26 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.59 30.97 31.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -144.62 139.11 15.13 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.238 -1.154 . . . . 0.0 110.017 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -62.49 119.7 6.91 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.709 1.373 . . . . 0.0 110.448 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 4.5 t80 -117.87 113.48 21.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 110.271 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -104.6 111.08 23.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.079 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . 2.0 t80 -123.51 114.04 19.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 109.834 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -160.66 87.36 0.75 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.158 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -154.46 -173.01 4.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.868 . . . . 0.0 110.379 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -118.02 85.75 2.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.376 -0.827 . . . . 0.0 109.712 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -85.68 -179.05 6.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.28 -0.888 . . . . 0.0 110.362 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 8.5 p30 -151.01 167.99 25.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 110.331 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.433 ' C ' ' CD1' ' A' ' 41' ' ' TYR . 1.4 pt -157.28 177.19 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 110.499 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.427 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 20.7 m -91.57 121.2 33.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.903 . . . . 0.0 110.188 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -89.51 99.96 12.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.58 154.84 24.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 110.244 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -148.65 148.11 29.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.858 . . . . 0.0 109.919 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 35' ' ' ASN . 42.4 m-80 -138.99 98.13 3.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.88 . . . . 0.0 110.345 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -149.76 -148.83 4.85 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -66.5 -177.06 0.79 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.93 1.49 . . . . 0.0 110.463 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.45 -59.44 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 109.943 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.85 -148.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.867 . . . . 0.0 110.026 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.0 t 57.1 63.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 110.15 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.06 62.78 5.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.894 . . . . 0.0 110.241 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.403 HBB2 HD13 ' A' ' 121' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.187 0.517 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.65 133.48 38.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 110.167 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 62.41 22.7 13.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.951 . . . . 0.0 110.077 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -104.5 162.28 13.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.385 -0.822 . . . . 0.0 110.048 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.55 -172.5 2.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 110.283 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.409 ' O ' HG13 ' A' ' 60' ' ' ILE . 2.5 m-20 54.54 24.66 5.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 110.087 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 3.7 p -158.86 146.01 17.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.948 . . . . 0.0 110.743 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -179.66 176.64 47.73 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.58 114.84 25.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.193 -1.181 . . . . 0.0 110.47 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.506 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 1.5 tt -94.79 148.25 22.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 110.319 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.1 t30 -80.64 139.8 36.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.96 . . . . 0.0 110.03 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.51 ' CD2' ' N ' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -167.11 174.18 8.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.026 -1.046 . . . . 0.0 110.658 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.51 ' N ' ' CD2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -155.58 -165.76 2.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.594 -0.691 . . . . 0.0 109.571 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.07 164.63 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.1 -1.0 . . . . 0.0 110.274 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -147.83 148.26 30.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.373 -0.83 . . . . 0.0 109.978 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -67.82 128.37 36.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 110.09 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.473 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -52.53 146.62 9.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.176 -0.953 . . . . 0.0 109.901 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.3 t30 71.74 1.54 3.93 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.851 -0.53 . . . . 0.0 111.161 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -135.24 -162.22 1.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.89 -1.131 . . . . 0.0 109.531 179.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.43 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.9 OUTLIER -132.82 12.07 4.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 110.332 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -136.43 137.62 40.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.749 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.439 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -64.23 134.23 54.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.326 179.123 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.58 -17.25 3.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.904 -1.122 . . . . 0.0 112.159 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.0 mt -137.37 -50.75 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.61 -1.306 . . . . 0.0 111.184 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.0 5.34 11.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.385 -0.822 . . . . 0.0 111.512 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.439 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -73.5 -29.21 62.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.852 -1.155 . . . . 0.0 110.679 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -99.47 12.47 36.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.102 -0.999 . . . . 0.0 110.896 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.482 ' CG ' HMC2 ' A' ' 151' ' ' ZNH . 37.4 m-85 -118.76 -18.84 8.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.009 -1.057 . . . . 0.0 110.451 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CE2' HG12 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -101.43 113.86 27.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 109.848 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.14 155.21 40.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.967 . . . . 0.0 110.459 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.35 160.06 43.35 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.833 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.29 -177.04 19.91 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.588 -2.255 . . . . 0.0 110.649 -0.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.471 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . . . -103.86 170.4 7.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.143 -0.973 . . . . 0.0 110.095 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -104.32 119.47 39.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.789 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.506 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 29.1 p90 -97.01 165.81 11.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 109.525 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 0.6 OUTLIER -154.95 124.04 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.937 -1.102 . . . . 0.0 110.937 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HG2' ' CB ' ' A' ' 66' ' ' LEU . 1.2 mtmt -137.67 125.13 21.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.345 -0.847 . . . . 0.0 110.684 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -103.81 62.42 0.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.393 -0.817 . . . . 0.0 110.402 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 47.67 98.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.463 -0.773 . . . . 0.0 111.35 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.11 12.59 39.08 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -173.7 154.81 2.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.889 -1.359 . . . . 0.0 110.227 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.555 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -154.27 151.31 28.98 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.073 -1.017 . . . . 0.0 111.247 179.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 13.8 m-85 -141.92 -164.71 1.85 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.467 -0.771 . . . . 0.0 109.233 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.441 HG13 ' CE1' ' A' ' 142' ' ' PHE . 1.1 t -169.09 131.98 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.023 -1.048 . . . . 0.0 110.835 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -101.72 135.88 42.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.392 -0.817 . . . . 0.0 109.838 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.437 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -113.62 133.38 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.133 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -91.04 128.73 36.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.931 . . . . 0.0 110.422 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.471 ' CG2' ' CB ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -104.86 142.24 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.906 . . . . 0.0 110.055 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -99.98 138.84 36.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.129 -0.982 . . . . 0.0 110.507 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.449 ' CD2' ' CE2' ' A' ' 77' ' ' TRP . 2.3 t-80 55.98 102.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.357 -0.839 . . . . 0.0 110.447 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.3 p -62.57 -43.73 98.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.125 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.76 -48.83 59.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.91 . . . . 0.0 110.146 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.449 ' CE2' ' CD2' ' A' ' 74' ' ' HIS . 44.4 m0 -57.41 -67.69 0.3 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 110.323 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 17.9 tt -87.83 117.98 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.39 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.43 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -85.9 -21.71 27.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.423 -0.798 . . . . 0.0 110.898 -178.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.43 ' N ' HG21 ' A' ' 79' ' ' THR . . . -175.09 177.13 47.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.29 159.22 43.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.432 -1.04 . . . . 0.0 109.884 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -155.84 151.33 27.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 0.0 109.932 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.481 ' HB ' ' CD1' ' A' ' 104' ' ' PHE . 3.9 mt -147.12 157.71 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 110.13 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.511 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 0.6 OUTLIER 62.48 14.52 7.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.611 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.23 21.23 61.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.511 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.1 p-80 -136.77 160.17 39.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.035 -1.273 . . . . 0.0 110.563 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.85 163.68 27.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.393 -0.817 . . . . 0.0 110.403 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.524 ' CB ' ' CE1' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -92.22 170.27 9.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.158 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.67 134.81 51.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.184 -0.948 . . . . 0.0 110.066 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -67.4 101.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.957 . . . . 0.0 109.618 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.434 HG22 ' CG2' ' A' ' 101' ' ' THR . 0.7 OUTLIER -95.27 -29.89 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 111.001 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.421 ' N ' HG21 ' A' ' 91' ' ' ILE . 3.5 m -167.15 94.94 0.47 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.035 -1.041 . . . . 0.0 110.048 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.435 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 18.2 ttmt -96.28 139.19 32.78 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.428 -0.795 . . . . 0.0 110.036 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.79 99.03 3.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.161 -0.962 . . . . 0.0 110.237 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 p -78.37 -32.37 48.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.1 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.12 99.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.879 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.06 10.68 36.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 0.0 110.549 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.54 58.11 5.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.978 -1.076 . . . . 0.0 110.011 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -146.43 165.04 30.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 110.265 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.471 ' CB ' ' CG2' ' A' ' 72' ' ' VAL . 2.8 mtp180 -168.73 154.42 6.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.368 -0.833 . . . . 0.0 109.903 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.434 ' CG2' HG22 ' A' ' 91' ' ' ILE . 78.2 m -141.76 154.66 45.41 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 109.839 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB2' ' CG ' ' A' ' 88' ' ' GLU . 99.7 p -144.84 139.14 27.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.981 . . . . 0.0 110.341 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -92.97 130.42 38.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.948 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.524 ' CE1' ' CB ' ' A' ' 88' ' ' GLU . 48.0 m-85 -114.43 147.74 38.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 110.451 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -105.17 135.15 47.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.342 -0.849 . . . . 0.0 110.052 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.3 m -149.36 158.97 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.36 -0.837 . . . . 0.0 109.891 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.4 p -53.17 -35.03 59.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.421 ' CE ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.49 -150.96 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.596 -0.69 . . . . 0.0 109.184 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.435 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -148.56 54.18 1.01 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.849 -1.157 . . . . 0.0 110.567 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -145.28 57.64 1.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.22 -0.925 . . . . 0.0 110.222 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.44 176.97 44.14 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.41 ' CE ' HG22 ' A' ' 139' ' ' THR . 0.1 OUTLIER -81.6 146.66 29.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -1.183 . . . . 0.0 110.446 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.403 ' N ' ' O ' ' A' ' 140' ' ' TYR . 7.6 mm -136.36 129.43 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.841 . . . . 0.0 109.942 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -76.72 112.55 13.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.839 . . . . 0.0 110.367 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -121.09 -175.15 15.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 82' ' ' SER . 63.1 mttt -144.88 164.86 29.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -1.143 . . . . 0.0 110.035 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.417 HG12 ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -157.98 145.76 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -0.948 . . . . 0.0 110.668 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.418 ' HB2' ' CG2' ' A' ' 79' ' ' THR . 72.9 m-20 -107.26 155.7 19.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.496 -0.753 . . . . 0.0 109.492 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.55 146.32 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.965 -1.084 . . . . 0.0 110.609 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -152.3 104.2 2.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.372 -0.83 . . . . 0.0 110.178 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.429 HD11 HBB2 ' A' ' 151' ' ' ZNH . 46.4 mt -128.24 152.46 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.118 -0.989 . . . . 0.0 110.448 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.427 ' N ' HG23 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -160.28 95.56 1.14 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.438 -0.789 . . . . 0.0 109.69 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -173.72 175.53 2.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.0 110.23 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -84.16 102.78 12.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 110.273 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.414 ' O ' ' CG1' ' A' ' 125' ' ' VAL . 2.1 t -76.68 103.39 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.091 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.66 43.51 7.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.049 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.37 33.53 56.25 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.28 109.46 4.59 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.278 -1.13 . . . . 0.0 110.193 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -47.42 113.5 0.76 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.66 1.347 . . . . 0.0 110.164 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -112.48 151.14 30.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.0 110.437 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.64 125.89 26.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.393 -0.817 . . . . 0.0 110.115 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.462 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 4.2 t80 -140.4 129.87 24.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 110.155 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -176.3 88.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 110.037 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.35 -163.57 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 110.403 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -118.24 145.03 45.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 110.172 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -154.97 -179.03 7.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.095 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 8.9 p30 -150.27 169.85 20.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.187 -0.945 . . . . 0.0 110.558 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.416 ' CD1' ' OH ' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -156.53 173.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.608 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.41 HG22 ' CE ' ' A' ' 112' ' ' LYS . 24.6 m -91.82 162.77 14.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.473 -0.767 . . . . 0.0 110.526 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.451 ' CE2' ' HA3' ' A' ' 115' ' ' GLY . 97.0 m-85 -144.19 104.87 4.16 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.368 -0.832 . . . . 0.0 109.714 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -103.28 104.37 14.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 110.68 -179.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.441 ' CE1' HG13 ' A' ' 68' ' ' VAL . 29.6 m-85 -91.66 135.27 34.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.896 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 3.7 m-80 -126.25 105.09 8.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.096 -1.003 . . . . 0.0 110.227 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -150.96 -149.8 5.14 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -49.95 170.84 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.702 1.369 . . . . 0.0 110.907 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.8 p -149.3 -51.01 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.44 -0.787 . . . . 0.0 109.883 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.09 -59.76 1.96 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 110.102 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 149' ' ' ALA . 65.1 t 55.88 -102.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 0.0 110.247 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.425 ' N ' HG11 ' A' ' 148' ' ' VAL . . . -158.56 -58.69 0.07 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.008 -1.057 . . . . 0.0 110.173 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.974 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.482 HMC2 ' CG ' ' A' ' 52' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.239 0.543 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.9 130.46 36.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -0.937 . . . . 0.0 110.292 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 57.77 23.29 9.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.383 -0.823 . . . . 0.0 109.925 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.63 35.44 1.44 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.352 -0.843 . . . . 0.0 109.922 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.79 -60.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 110.308 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.4 OUTLIER 52.52 27.88 5.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.874 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -160.76 144.48 13.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.266 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.87 -175.99 42.6 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.39 105.62 17.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.34 -1.094 . . . . 0.0 110.395 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.499 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -94.8 154.49 17.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.0 110.31 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -80.13 137.86 36.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.335 -0.853 . . . . 0.0 110.037 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.4 OUTLIER -165.96 161.91 17.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.04 -1.038 . . . . 0.0 110.273 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 141' ' ' LYS . 0.2 OUTLIER -156.11 -176.82 6.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 109.908 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.434 ' O ' ' CG2' ' A' ' 46' ' ' THR . 25.8 m -140.38 116.84 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.018 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -90.27 163.1 14.89 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.494 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.434 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.4 OUTLIER -67.36 126.84 30.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 109.942 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.485 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -51.01 141.91 12.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.031 . . . . 0.0 109.943 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER 73.09 0.59 3.73 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.851 -0.53 . . . . 0.0 110.981 -179.408 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.434 ' CG2' ' HB3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -136.83 -168.52 2.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.85 -1.156 . . . . 0.0 109.677 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -135.86 24.41 3.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.188 -0.945 . . . . 0.0 110.422 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -135.65 119.91 17.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.069 . . . . 0.0 111.101 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.447 HG22 ' CB ' ' A' ' 50' ' ' ASN . 0.7 OUTLIER -50.14 117.57 2.43 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.589 -0.694 . . . . 0.0 109.501 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.6 t -129.64 -18.98 3.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.811 -1.181 . . . . 0.0 112.18 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 48' ' ' ILE . 71.8 mt -138.54 -79.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.653 -1.28 . . . . 0.0 111.0 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.41 ' N ' HG23 ' A' ' 48' ' ' ILE . . . -45.19 -26.93 0.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.738 -0.601 . . . . 0.0 111.159 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.447 ' CB ' HG22 ' A' ' 46' ' ' THR . 0.2 OUTLIER -67.68 -18.12 64.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.013 -1.055 . . . . 0.0 110.655 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -95.77 14.31 23.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 110.771 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.459 ' CD2' HBC2 ' A' ' 151' ' ' ZNH . 64.0 m-85 -134.49 2.71 3.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.062 -1.024 . . . . 0.0 111.109 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.443 ' CE1' ' SD ' ' A' ' 81' ' ' MET . 26.7 m-85 -123.37 120.49 33.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.959 -1.088 . . . . 0.0 110.298 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -72.47 160.04 32.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.346 -0.846 . . . . 0.0 110.569 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.73 164.36 24.31 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.895 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.71 -175.71 17.18 Favored 'Cis proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.583 -0.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.435 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . . . -103.4 169.17 8.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.958 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.75 110.32 22.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.198 -0.939 . . . . 0.0 109.998 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -96.02 161.8 13.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.328 -0.857 . . . . 0.0 109.91 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -155.3 151.09 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.095 -1.003 . . . . 0.0 110.997 -179.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 17.9 mtmt -134.53 173.86 11.19 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.331 -0.855 . . . . 0.0 110.595 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -158.26 63.51 0.44 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.364 -0.835 . . . . 0.0 110.153 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.0 m120 48.71 84.5 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 111.274 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.64 18.57 47.77 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.53 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.451 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 3.1 ptpt -165.83 162.86 18.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.964 -1.316 . . . . 0.0 111.294 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.7 pt? -173.42 155.8 2.91 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.962 0.887 . . . . 0.0 111.205 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 1.1 m-85 -139.0 -159.4 0.95 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.422 ' CG2' ' HA ' ' A' ' 59' ' ' TYR . 1.2 t -169.41 133.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.141 -0.974 . . . . 0.0 109.796 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.42 136.17 38.24 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.106 -0.997 . . . . 0.0 109.866 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.68 131.12 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 110.364 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m -88.76 123.89 33.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.418 ' CG2' ' CB ' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -103.29 136.77 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 110.499 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.8 144.6 29.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.365 -0.834 . . . . 0.0 110.007 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 58.33 89.08 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.178 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.2 p -55.22 -23.89 24.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.302 -0.874 . . . . 0.0 110.58 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -73.92 -55.64 5.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.976 . . . . 0.0 110.322 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.444 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 42.2 m0 -48.91 -62.33 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 0.0 110.466 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.4 tp -87.9 115.5 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.282 -0.886 . . . . 0.0 110.242 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.436 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -87.33 -26.68 23.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.389 -0.819 . . . . 0.0 110.83 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.436 ' N ' HG21 ' A' ' 79' ' ' THR . . . -172.5 176.86 45.34 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.443 ' SD ' ' CE1' ' A' ' 53' ' ' PHE . 33.6 mtm -151.92 160.13 43.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.358 -1.083 . . . . 0.0 110.063 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 116' ' ' LYS . 1.3 m -154.53 132.93 11.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.185 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 16.8 mt -130.17 141.96 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.354 -0.841 . . . . 0.0 110.321 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.463 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 1.1 tm-20 69.89 3.08 4.15 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.415 -0.803 . . . . 0.0 111.295 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.38 24.42 10.25 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.695 -1.241 . . . . 0.0 111.119 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.47 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.49 159.12 42.89 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.605 -1.526 . . . . 0.0 110.179 179.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -70.48 -178.44 1.76 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.347 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.92 168.46 9.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 110.203 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.83 129.44 56.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.168 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.407 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.1 pp -67.98 101.23 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.139 -0.975 . . . . 0.0 109.484 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.442 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -93.19 -26.88 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.441 -0.787 . . . . 0.0 110.525 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.81 148.72 6.24 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.293 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.43 ' HG3' ' CG ' ' A' ' 100' ' ' ARG . 15.5 ttmt -141.98 149.32 39.9 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 110.019 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.74 91.34 2.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 0.0 110.466 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.4 p -73.33 -18.71 61.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 110.121 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.6 -28.46 69.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 110.379 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.55 23.24 3.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.253 -0.904 . . . . 0.0 110.249 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.54 79.72 0.11 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 0.0 110.432 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -148.14 167.15 25.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.43 ' CG ' ' HG3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -172.46 157.53 4.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 110.209 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.442 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 90.8 m -141.44 152.82 44.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.435 -0.791 . . . . 0.0 109.651 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.24 145.22 31.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.084 -1.01 . . . . 0.0 110.694 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -93.57 143.37 26.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.433 -0.792 . . . . 0.0 109.886 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.408 ' CD1' ' HB ' ' A' ' 83' ' ' ILE . 44.2 m-85 -127.36 127.58 44.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.976 . . . . 0.0 110.663 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -93.27 125.2 37.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 109.792 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.0 m -149.33 163.9 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.022 -1.049 . . . . 0.0 110.887 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p -80.21 105.03 11.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.388 -0.82 . . . . 0.0 109.348 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.483 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 53.74 174.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 109.756 -178.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.454 ' HG ' ' CD1' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -149.91 73.7 1.18 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.004 -1.06 . . . . 0.0 110.898 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.439 ' ND2' HD11 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -144.41 66.76 1.26 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.066 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.39 -108.64 0.31 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.86 146.34 19.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -1.145 . . . . 0.0 110.342 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.9 mt -137.38 142.8 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.357 -0.839 . . . . 0.0 110.157 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -76.3 125.42 29.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.218 -0.926 . . . . 0.0 110.137 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -131.56 -177.04 14.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.5 mtmm -142.38 161.0 39.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.364 -1.08 . . . . 0.0 109.678 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.438 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -158.23 146.43 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.046 -1.034 . . . . 0.0 110.735 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.416 ' N ' HG12 ' A' ' 117' ' ' ILE . 89.0 m-20 -110.12 159.68 17.13 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.48 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -133.63 147.05 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.09 -1.006 . . . . 0.0 110.17 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -152.03 113.14 4.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 110.684 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.475 HD13 ' CD2' ' A' ' 132' ' ' TYR . 2.6 mp -138.75 152.21 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 0.0 109.856 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.15 98.43 1.3 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.953 . . . . 0.0 110.015 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -174.03 178.68 2.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 110.18 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -93.06 107.69 19.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 110.175 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.42 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 56.0 t -75.84 90.58 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.826 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.42 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 63.7 53.04 2.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.277 -0.89 . . . . 0.0 110.012 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.33 36.95 48.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -145.04 97.48 4.84 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.296 -1.12 . . . . 0.0 110.366 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.99 110.15 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.863 1.454 . . . . 0.0 110.15 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.478 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 52.4 t80 -116.63 153.1 32.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.341 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -136.68 112.19 9.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 110.13 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.495 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 3.7 t80 -115.71 128.24 55.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.004 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -167.49 86.69 0.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.404 -0.81 . . . . 0.0 109.948 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -153.33 -169.19 3.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.898 . . . . 0.0 110.391 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.401 ' ND1' ' OD1' ' A' ' 118' ' ' ASP . 13.4 t60 -119.61 148.39 43.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 109.99 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -154.79 -179.66 8.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.882 . . . . 0.0 110.136 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.471 ' ND2' ' CE2' ' A' ' 41' ' ' TYR . 42.9 p-10 -151.82 170.66 19.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.882 . . . . 0.0 110.261 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.438 HG12 ' CG2' ' A' ' 117' ' ' ILE . 0.3 OUTLIER -157.76 168.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.917 . . . . 0.0 110.348 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 87.0 m -91.63 117.53 29.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.335 -0.853 . . . . 0.0 109.82 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.458 ' CD2' HG12 ' A' ' 83' ' ' ILE . 10.4 m-85 -88.91 106.51 18.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 110.326 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -86.69 159.59 19.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.318 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -148.87 150.86 33.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.878 . . . . 0.0 110.125 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -143.84 96.32 2.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 110.234 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -135.73 -140.01 4.1 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.432 ' O ' ' ND2' ' A' ' 110' ' ' ASN . 39.2 Cg_exo -49.38 134.17 31.53 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.711 1.374 . . . . 0.0 110.422 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.28 -41.37 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.181 -0.949 . . . . 0.0 110.43 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.98 -72.76 0.67 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.917 . . . . 0.0 110.366 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.5 t 56.51 54.18 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.378 -0.826 . . . . 0.0 110.269 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.28 -19.99 41.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.307 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.814 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.495 ' NA ' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.41 ' CA ' ' HB1' ' A' ' 28' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.246 0.546 . . . . 0.0 110.201 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . 56.36 80.63 0.14 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.289 -0.882 . . . . 0.0 110.171 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 0.1 OUTLIER 62.82 20.46 12.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.304 -0.873 . . . . 0.0 110.192 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.41 ' HB1' ' CA ' ' A' ' 25' ' ' SER . . . -82.42 57.1 3.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 110.094 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.4 -35.05 63.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 110.376 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER 58.12 28.65 16.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.156 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.18 144.07 14.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.946 . . . . 0.0 110.264 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.61 -177.52 45.92 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.34 108.4 19.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.351 -1.087 . . . . 0.0 110.359 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.497 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -94.84 150.0 20.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.399 -0.813 . . . . 0.0 109.913 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.416 ' N ' HD11 ' A' ' 34' ' ' LEU . 5.1 m-80 -78.93 141.34 37.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.991 -1.068 . . . . 0.0 109.7 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -165.4 156.48 14.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 110.557 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 141' ' ' LYS . 5.2 tt0 -155.56 -175.85 5.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 0.0 109.946 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.63 173.22 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 110.449 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -147.79 161.07 41.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -0.805 . . . . 0.0 109.951 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.434 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -67.53 132.73 48.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 0.0 109.879 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.512 ' CE2' ' ND2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -57.45 146.04 30.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 110.052 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.4 t30 71.07 2.89 4.43 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.801 -0.562 . . . . 0.0 111.055 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.413 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -135.64 -164.48 1.55 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.828 -1.17 . . . . 0.0 109.767 179.268 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.413 ' N ' ' OG1' ' A' ' 43' ' ' THR . 2.2 t-20 -131.81 14.21 4.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 110.296 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.81 135.55 41.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.069 -1.019 . . . . 0.0 110.401 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -68.07 133.48 49.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.403 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.48 -17.45 3.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.017 -1.052 . . . . 0.0 112.184 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.6 mt -136.92 -58.6 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.607 -1.308 . . . . 0.0 111.121 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.09 -10.04 27.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.472 -0.768 . . . . 0.0 111.424 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.442 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -75.68 -18.15 59.72 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.843 -1.16 . . . . 0.0 110.787 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -102.06 15.41 29.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.0 110.731 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.434 ' CD2' HBC2 ' A' ' 151' ' ' ZNH . 49.4 m-85 -129.12 3.37 5.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.049 -1.032 . . . . 0.0 110.985 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -128.94 117.54 21.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.994 -1.066 . . . . 0.0 110.293 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -72.83 166.71 22.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.341 -0.849 . . . . 0.0 110.494 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -146.92 160.35 40.69 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.304 -0.873 . . . . 0.0 109.834 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.13 -175.36 16.49 Favored 'Cis proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.752 -2.186 . . . . 0.0 110.725 -0.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.77 170.23 8.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -0.895 . . . . 0.0 109.96 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.437 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -107.97 111.67 23.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.11 -0.994 . . . . 0.0 110.693 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.497 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 2.7 p90 -97.84 165.24 12.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.262 -0.899 . . . . 0.0 110.132 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -155.52 154.15 6.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.254 -0.904 . . . . 0.0 110.66 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -133.35 170.64 15.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.424 -0.798 . . . . 0.0 110.479 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.427 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 0.7 OUTLIER -152.75 62.33 0.79 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -0.83 . . . . 0.0 110.12 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 50.47 82.86 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.353 -0.842 . . . . 0.0 111.067 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.51 21.93 35.91 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.427 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 6.2 ptpt -167.15 163.71 15.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.021 -1.282 . . . . 0.0 110.768 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.5 pt? -173.73 154.19 2.39 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.009 0.909 . . . . 0.0 111.034 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.565 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -139.61 -155.52 0.6 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.779 -0.575 . . . . 0.0 109.475 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -170.67 135.88 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.195 -0.94 . . . . 0.0 110.536 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.437 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -99.29 133.73 43.18 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.29 -0.881 . . . . 0.0 109.657 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.0 140.42 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.363 -0.836 . . . . 0.0 110.3 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.5 m -89.23 129.9 35.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.754 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.47 128.25 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 110.544 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -100.92 134.97 43.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.304 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 32.1 m170 54.76 94.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.345 -0.847 . . . . 0.0 110.245 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -27.85 61.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.942 . . . . 0.0 110.288 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -27.11 61.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.186 -0.946 . . . . 0.0 110.283 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.404 ' HA ' HG12 ' A' ' 121' ' ' ILE . 38.4 m0 -92.48 -52.27 4.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.2 -0.938 . . . . 0.0 110.057 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 1.5 tt -88.65 119.15 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.293 -0.88 . . . . 0.0 109.392 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -86.98 -23.83 24.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.42 -0.8 . . . . 0.0 111.389 -178.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.438 ' N ' HG23 ' A' ' 79' ' ' THR . . . -178.49 -178.84 48.15 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.064 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 19.0 mtm -152.24 162.73 40.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.464 -1.021 . . . . 0.0 110.103 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -155.2 141.26 18.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 0.0 109.935 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 7.1 mt -135.75 140.47 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 110.589 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 71.16 1.99 4.05 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.528 -0.733 . . . . 0.0 111.442 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.79 21.79 10.85 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.536 -1.316 . . . . 0.0 111.233 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.485 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.13 158.58 44.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.622 -1.517 . . . . 0.0 110.05 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -71.41 -177.6 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.141 -0.975 . . . . 0.0 110.337 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -109.95 170.21 8.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.322 -0.861 . . . . 0.0 110.182 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -115.4 134.73 54.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.294 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.48 102.29 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.976 . . . . 0.0 109.668 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.444 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -95.51 -27.52 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 111.008 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.413 ' N ' HG21 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -167.53 103.62 0.51 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.08 -1.013 . . . . 0.0 109.856 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -95.53 149.59 21.25 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.386 -0.821 . . . . 0.0 110.259 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.34 61.58 1.39 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 110.116 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 m -54.49 -30.58 53.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.214 -0.928 . . . . 0.0 110.148 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.09 -49.27 75.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.094 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -95.97 9.9 39.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.566 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.47 55.62 4.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.082 -1.011 . . . . 0.0 110.326 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -147.53 159.2 44.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.173 -0.954 . . . . 0.0 110.402 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -163.16 162.77 25.7 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.325 -0.86 . . . . 0.0 110.023 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.444 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 85.7 m -141.07 152.71 45.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.944 . . . . 0.0 109.655 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 101' ' ' THR . 70.1 p -145.71 143.4 29.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.977 -1.077 . . . . 0.0 110.725 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -93.07 143.87 25.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.381 -0.824 . . . . 0.0 109.843 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -125.64 145.46 50.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.108 -0.995 . . . . 0.0 110.561 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.45 130.61 47.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.363 -0.835 . . . . 0.0 110.141 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 107' ' ' SER . 12.5 p -148.9 150.56 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 110.292 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.422 ' N ' HG22 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -50.34 -39.63 46.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.449 ' CE ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.5 -157.56 0.33 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.445 -0.784 . . . . 0.0 109.591 179.168 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.43 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -148.19 62.77 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.96 -1.087 . . . . 0.0 110.612 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -145.81 62.92 1.25 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 110.078 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.82 -179.97 33.15 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -82.05 145.28 30.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -1.14 . . . . 0.0 110.57 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 27.1 mt -137.77 149.71 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.888 . . . . 0.0 109.923 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -76.04 120.96 22.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.0 110.183 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.485 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -124.71 171.21 16.78 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 82' ' ' SER . 47.1 mttt -146.37 159.94 42.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.276 -1.132 . . . . 0.0 110.033 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.41 HG12 ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -158.12 144.35 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.155 -0.965 . . . . 0.0 110.317 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.41 ' N ' HG12 ' A' ' 117' ' ' ILE . 11.9 m-20 -106.38 158.09 17.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.341 -0.849 . . . . 0.0 109.676 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.89 150.99 34.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.243 -0.911 . . . . 0.0 109.771 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -151.74 100.26 2.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 0.0 110.543 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 77' ' ' TRP . 54.7 mt -129.74 151.99 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 110.176 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.48 96.58 1.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.856 . . . . 0.0 110.012 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -173.76 -175.78 1.14 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.868 . . . . 0.0 110.394 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.91 104.15 16.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.338 -0.851 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.6 95.68 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 110.072 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.13 44.44 10.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 110.128 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.85 30.09 44.71 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -145.34 107.79 4.48 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.295 -1.12 . . . . 0.0 110.233 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -52.12 108.31 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.684 1.36 . . . . 0.0 110.214 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -110.66 119.33 38.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 0.0 110.46 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -106.33 117.22 33.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 110.138 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.433 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 2.3 t80 -126.45 121.22 31.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 0.0 110.078 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -166.69 90.47 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 110.415 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.03 -165.1 2.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.145 -0.972 . . . . 0.0 110.392 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -120.87 86.11 2.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 109.997 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -85.45 -179.17 6.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.881 . . . . 0.0 110.392 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.512 ' ND2' ' CE2' ' A' ' 41' ' ' TYR . 46.2 p30 -151.28 171.05 18.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 110.29 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.4 pt -156.5 162.22 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.2 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 62.2 m -91.67 121.24 33.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 110.61 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.485 ' CD1' ' HA3' ' A' ' 115' ' ' GLY . 21.9 m-85 -90.2 155.16 19.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.835 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -144.77 99.82 3.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.518 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -91.6 144.03 25.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.37 -0.831 . . . . 0.0 109.825 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.436 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 5.4 m-80 -132.96 100.96 5.05 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.158 -0.964 . . . . 0.0 110.51 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -163.21 -144.03 3.89 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -63.28 138.31 65.62 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.779 1.41 . . . . 0.0 110.635 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.86 -52.01 4.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.0 110.045 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.53 -48.98 0.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 110.303 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 94.0 t 55.12 -102.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.219 -0.925 . . . . 0.0 110.158 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.51 -41.11 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.961 -1.087 . . . . 0.0 110.159 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.939 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.434 HBC2 ' CD2' ' A' ' 52' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.319 0.58 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.401 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -141.38 75.81 1.52 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 110.194 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 9.5 t30 63.51 38.5 9.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.99 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.49 119.01 18.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.794 . . . . 0.0 110.297 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.93 -167.01 1.0 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.121 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.42 ' CA ' ' HD3' ' A' ' 61' ' ' LYS . 0.3 OUTLIER 52.07 28.35 5.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.948 . . . . 0.0 110.277 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.6 t -159.65 140.73 12.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 110.525 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 177.37 178.76 47.27 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.03 111.29 21.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -1.125 . . . . 0.0 110.389 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.512 ' CB ' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -94.16 151.12 19.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 109.665 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.431 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -79.06 131.5 36.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.178 -0.951 . . . . 0.0 110.538 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.507 ' CE1' ' CB ' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -166.11 158.14 14.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 111.034 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -155.53 -165.96 2.12 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.465 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -141.22 175.08 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 110.36 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 54.3 m-85 -148.32 163.99 35.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.475 -0.766 . . . . 0.0 109.813 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.24 128.46 36.64 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 109.895 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.474 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -54.97 146.37 17.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 110.112 -179.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.0 t-20 71.87 2.93 4.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.922 -0.487 . . . . 0.0 110.941 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.416 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -136.23 -162.35 1.26 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.888 -1.133 . . . . 0.0 109.706 179.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.416 ' N ' ' OG1' ' A' ' 43' ' ' THR . 22.9 m120 -133.05 15.74 4.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 110.445 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.5 139.03 43.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.16 -0.963 . . . . 0.0 110.361 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.437 ' CG2' ' HB2' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -74.08 133.06 42.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.994 . . . . 0.0 109.379 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.76 -16.97 4.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.046 -1.033 . . . . 0.0 111.82 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.8 mt -137.11 -64.63 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.831 -1.168 . . . . 0.0 110.623 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.4 -18.09 6.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.495 -0.753 . . . . 0.0 111.163 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.437 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 0.1 OUTLIER -68.35 -10.87 57.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.926 -1.108 . . . . 0.0 110.847 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -102.38 12.8 36.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.879 -1.138 . . . . 0.0 110.843 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -136.29 6.44 3.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.012 -1.055 . . . . 0.0 110.667 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -114.22 98.47 6.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.957 . . . . 0.0 109.845 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -72.03 103.28 3.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.522 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.432 ' HG3' ' N ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -93.05 165.06 19.38 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.204 -0.935 . . . . 0.0 109.879 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.432 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 50.1 Cg_endo -78.61 -176.36 18.53 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.468 -2.305 . . . . 0.0 110.524 -0.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.507 ' CB ' ' CE1' ' A' ' 36' ' ' TYR . . . -103.15 165.41 11.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.25 -0.906 . . . . 0.0 110.008 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.404 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.71 109.52 21.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 110.168 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.512 ' CD1' ' CB ' ' A' ' 34' ' ' LEU . 19.4 p90 -96.95 161.78 13.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.676 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -154.0 153.05 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.111 -0.993 . . . . 0.0 110.357 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -135.89 174.03 11.06 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.324 -0.86 . . . . 0.0 110.453 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -159.48 62.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.344 -0.848 . . . . 0.0 110.108 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 48.97 87.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.449 -0.782 . . . . 0.0 111.193 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.59 25.15 33.69 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.087 -1.054 . . . . 0.0 110.558 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -171.9 158.85 4.94 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.962 -1.317 . . . . 0.0 111.028 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.3 pt? -173.4 150.29 1.82 Allowed 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 122.068 0.937 . . . . 0.0 111.334 178.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.585 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -140.03 -161.06 1.14 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -167.15 142.89 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.578 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 8.7 pt20 -101.12 134.8 43.6 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.906 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.75 138.85 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.902 . . . . 0.0 109.842 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.6 m -89.03 135.87 33.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 110.469 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.42 122.69 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.865 . . . . 0.0 110.201 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -100.23 143.07 30.85 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.107 -0.995 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 62.03 74.53 0.44 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 110.029 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.4 m -64.35 -19.1 65.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.348 -0.845 . . . . 0.0 110.551 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.32 -45.11 57.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.089 -1.007 . . . . 0.0 110.315 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -77.19 -42.44 37.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 110.19 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 6.1 tp -88.14 118.82 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -0.92 . . . . 0.0 109.3 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.454 ' CG2' ' HB3' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -85.55 -24.06 27.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 111.029 -178.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 79' ' ' THR . . . 175.48 -179.16 46.85 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.006 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.408 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 28.5 mtm -151.35 158.55 43.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.458 -1.025 . . . . 0.0 109.791 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.33 154.87 34.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.087 -1.008 . . . . 0.0 110.17 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.499 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 12.9 mt -141.96 155.36 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 110.195 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.502 ' HB2' ' CE1' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 58.79 16.55 4.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.013 . . . . 0.0 110.791 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.19 21.65 60.41 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.92 -1.133 . . . . 0.0 110.424 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.502 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 2.2 p-80 -135.18 157.42 46.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.842 -1.387 . . . . 0.0 110.525 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 178.8 3.65 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.329 -0.857 . . . . 0.0 110.701 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.421 ' HG3' ' CB ' ' A' ' 102' ' ' SER . 2.7 pt-20 -108.5 166.65 10.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.362 -0.836 . . . . 0.0 110.221 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 102' ' ' SER . 1.4 t30 -105.22 130.89 53.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -0.919 . . . . 0.0 110.209 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.12 102.56 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -0.954 . . . . 0.0 110.081 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 92' ' ' SER . 1.3 tt -95.78 -26.83 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.88 . . . . 0.0 110.855 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.448 ' N ' HG22 ' A' ' 91' ' ' ILE . 1.4 m -167.5 99.02 0.49 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.148 -0.97 . . . . 0.0 109.874 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.422 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 7.7 ttmm -95.7 103.78 15.67 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.382 -0.824 . . . . 0.0 110.178 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.33 95.01 7.78 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.0 110.293 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.3 -29.86 61.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 110.109 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.09 94.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 110.354 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -95.69 14.56 22.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.206 -0.934 . . . . 0.0 110.593 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.6 t0 50.16 57.42 6.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.033 -1.042 . . . . 0.0 110.263 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -146.84 -176.74 5.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.166 -0.959 . . . . 0.0 110.318 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.422 ' HG3' ' CG ' ' A' ' 93' ' ' LYS . 4.9 ttm180 -176.75 162.45 2.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.438 -0.789 . . . . 0.0 109.989 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.434 HG23 ' N ' ' A' ' 102' ' ' SER . 86.8 m -142.68 150.6 40.38 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.86 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.434 ' N ' HG23 ' A' ' 101' ' ' THR . 19.5 p -146.33 148.72 32.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.045 -1.034 . . . . 0.0 110.711 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -92.99 146.92 23.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.322 -0.862 . . . . 0.0 110.088 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -131.15 144.15 51.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.109 -0.994 . . . . 0.0 110.76 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -99.37 128.42 45.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.882 . . . . 0.0 109.366 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.442 HG23 ' CD1' ' A' ' 113' ' ' ILE . 1.0 OUTLIER -149.73 143.09 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 110.825 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.4 113.21 2.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.111 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 47.23 -163.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.539 -0.726 . . . . 0.0 109.69 -178.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.423 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -151.66 64.61 0.87 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.861 -1.149 . . . . 0.0 110.753 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -146.2 58.78 1.22 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 110.308 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.8 171.05 38.6 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 113' ' ' ILE . 1.6 tmtt? -81.6 147.48 29.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -1.152 . . . . 0.0 110.326 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.442 ' CD1' HG23 ' A' ' 106' ' ' VAL . 1.4 mt -136.01 140.84 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.941 . . . . 0.0 110.021 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.24 112.32 12.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.129 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -111.21 178.24 19.45 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.409 ' HA ' ' CB ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -145.04 161.54 39.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -1.115 . . . . 0.0 109.854 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -157.02 140.96 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.121 -0.987 . . . . 0.0 110.392 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.454 ' HB3' ' CG2' ' A' ' 79' ' ' THR . 25.1 t0 -105.24 152.47 22.84 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.354 -0.841 . . . . 0.0 109.473 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.421 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -128.86 151.89 36.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.017 -1.052 . . . . 0.0 110.386 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.401 ' CB ' ' OG1' ' A' ' 79' ' ' THR . 27.0 t80 -151.39 100.63 2.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 110.621 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.473 HG23 ' CD2' ' A' ' 130' ' ' PHE . 4.3 mt -127.36 152.89 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.965 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -159.7 98.77 1.38 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.262 -0.899 . . . . 0.0 109.912 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 124' ' ' LYS . 12.5 pt-20 -173.75 -152.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 110.363 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -101.98 167.05 10.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.329 -0.857 . . . . 0.0 110.423 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' A' ' 126' ' ' ASN . 1.3 t -158.05 114.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 125' ' ' VAL . 3.0 t-20 56.26 25.92 9.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.441 -0.787 . . . . 0.0 109.826 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 86.04 37.32 9.28 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.6 mtmm -148.92 145.91 20.59 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.11 -1.229 . . . . 0.0 110.189 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -66.83 130.31 22.89 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.861 1.453 . . . . 0.0 110.027 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.473 ' CD2' HG23 ' A' ' 121' ' ' ILE . 10.2 t80 -116.34 140.16 49.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.174 -0.954 . . . . 0.0 110.548 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.79 105.01 5.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.829 . . . . 0.0 109.943 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.477 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 4.0 t80 -120.71 128.57 53.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 110.046 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -170.82 88.45 0.12 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.089 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.44 -175.03 5.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.356 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -119.52 85.27 2.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 110.242 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.486 ' CD1' HBD2 ' A' ' 151' ' ' ZNH . 40.3 m-85 -86.26 -178.83 6.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.354 -0.842 . . . . 0.0 110.078 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.409 ' CB ' ' HA ' ' A' ' 116' ' ' LYS . 4.2 p30 -150.87 178.42 9.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 110.281 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -156.69 168.88 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.382 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.403 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 48.9 m -92.03 119.59 31.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.342 -0.849 . . . . 0.0 110.931 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.485 ' CE1' ' HA3' ' A' ' 115' ' ' GLY . 28.3 m-85 -90.92 162.86 14.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.258 -0.902 . . . . 0.0 110.026 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.01 99.89 2.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.057 -1.027 . . . . 0.0 110.702 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -91.95 150.96 20.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.195 -0.94 . . . . 0.0 110.417 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.423 ' ND2' ' N ' ' A' ' 143' ' ' ASN . 2.3 m-80 -141.66 104.58 4.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -0.886 . . . . 0.0 110.449 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.423 ' HA3' HD11 ' A' ' 109' ' ' LEU . . . -157.28 -146.74 4.57 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.411 ' CD ' HD13 ' A' ' 109' ' ' LEU . 11.0 Cg_endo -58.91 -172.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.697 1.367 . . . . 0.0 110.671 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.65 -58.53 0.2 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.296 -0.877 . . . . 0.0 110.056 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -168.84 -63.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 110.216 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.2 t 56.47 46.06 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.318 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.82 114.66 20.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.965 . . . . 0.0 110.176 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.955 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.486 HBD2 ' CD1' ' A' ' 136' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.203 0.525 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.66 87.15 1.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 110.252 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.64 26.88 16.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.9 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -114.27 177.9 4.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.863 . . . . 0.0 110.285 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 42.89 -164.0 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.364 0.602 . . . . 0.0 111.006 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 8.4 m-20 55.68 31.55 17.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 110.417 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -160.98 156.01 24.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.024 -1.048 . . . . 0.0 110.711 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' CD2' ' A' ' 59' ' ' TYR . . . 164.24 171.88 31.03 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.88 107.77 19.45 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.235 -1.156 . . . . 0.0 110.538 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.486 ' HB2' ' CD2' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -95.47 157.56 15.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.96 -1.088 . . . . 0.0 110.487 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 143' ' ' ASN . 49.2 m-20 -80.17 143.68 33.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 110.142 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.5 OUTLIER -166.22 156.42 12.36 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.948 . . . . 0.0 110.096 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -155.6 -178.58 7.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -0.984 . . . . 0.0 110.444 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.48 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -140.14 170.33 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 0.0 109.959 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 47.3 m-85 -147.27 159.45 43.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.344 -0.847 . . . . 0.0 110.192 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HE3' ' CB ' ' A' ' 47' ' ' SER . 9.4 tppt? -67.81 145.81 54.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.948 . . . . 0.0 109.979 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.62 140.91 53.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.074 -1.016 . . . . 0.0 110.311 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 61.59 26.26 16.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.925 . . . . 0.0 110.112 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.416 ' OG1' ' CG ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -133.14 -154.67 0.62 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.389 -0.819 . . . . 0.0 110.058 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -126.18 -28.62 3.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.18 -0.95 . . . . 0.0 110.741 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.93 172.92 12.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.068 -1.02 . . . . 0.0 110.973 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.433 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -75.54 142.24 42.83 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.507 -0.745 . . . . 0.0 109.352 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.436 ' CB ' ' HE3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -129.62 -17.9 3.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.06 -1.025 . . . . 0.0 112.122 -178.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 49' ' ' ALA . 12.2 mt -137.63 -71.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.757 -1.215 . . . . 0.0 110.781 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.421 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -47.25 -24.98 0.83 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.704 -0.623 . . . . 0.0 111.242 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.433 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -67.3 -13.99 62.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.995 -1.066 . . . . 0.0 110.89 -179.682 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.412 ' C ' ' CD1' ' A' ' 52' ' ' TYR . 27.3 m-20 -88.83 -11.11 45.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 110.785 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 0.6 OUTLIER -119.16 7.4 11.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.022 -1.049 . . . . 0.0 110.71 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.7 106.93 16.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.034 -1.041 . . . . 0.0 110.42 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -72.4 153.54 41.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.131 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.63 159.19 44.94 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.107 -0.996 . . . . 0.0 109.985 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.411 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 57.2 Cg_endo -78.97 -175.93 17.66 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.752 -2.187 . . . . 0.0 110.681 -0.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -104.23 173.38 6.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 110.251 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.477 ' CB ' ' CG ' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -103.59 120.61 41.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.887 . . . . 0.0 110.349 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.494 ' CD1' ' HD2' ' A' ' 61' ' ' LYS . 11.6 p90 -97.79 159.14 15.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.95 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 1.1 tt -155.85 114.5 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 110.469 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.494 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -128.1 127.88 43.87 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.153 -0.967 . . . . 0.0 110.549 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.06 62.11 0.69 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.402 -0.811 . . . . 0.0 110.128 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.4 OUTLIER 46.99 98.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.531 -0.73 . . . . 0.0 111.19 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.1 -11.65 58.72 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.64 162.82 36.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.028 -1.277 . . . . 0.0 110.296 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.6 pt? -168.32 144.99 3.92 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.151 -0.968 . . . . 0.0 111.358 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.489 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -139.44 -160.69 1.09 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.2 t -170.18 129.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.204 -0.935 . . . . 0.0 110.206 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.477 ' CG ' ' CB ' ' A' ' 58' ' ' LYS . 3.0 pp0? -96.37 126.54 41.64 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.229 -0.92 . . . . 0.0 109.254 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.73 139.33 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 110.283 -179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m -88.31 141.7 28.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.359 -0.838 . . . . 0.0 109.425 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.75 135.43 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 110.609 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -101.18 131.2 47.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.336 -0.852 . . . . 0.0 109.815 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 55.85 102.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.216 -0.928 . . . . 0.0 110.181 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -31.1 65.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.941 . . . . 0.0 110.537 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -54.11 -59.51 4.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.972 . . . . 0.0 110.178 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.445 ' CD1' HBB1 ' A' ' 151' ' ' ZNH . 20.0 m0 -53.35 -66.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.925 . . . . 0.0 110.31 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.434 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 19.2 tt -88.76 118.69 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.249 -0.907 . . . . 0.0 109.746 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.447 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -87.47 -24.79 24.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 111.662 -178.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.447 ' N ' HG21 ' A' ' 79' ' ' THR . . . -174.54 175.45 46.82 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.553 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 2.9 mpp? -150.95 111.3 4.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.595 -0.944 . . . . 0.0 110.16 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -86.23 159.94 19.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.031 -1.043 . . . . 0.0 109.603 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 1.2 mt -151.14 122.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -0.902 . . . . 0.0 110.534 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.463 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 70.49 3.31 4.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.484 -0.76 . . . . 0.0 111.424 179.598 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.09 20.36 9.32 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.548 -1.311 . . . . 0.0 111.092 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.477 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -136.66 157.32 47.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.699 -1.471 . . . . 0.0 110.148 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -171.05 0.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.519 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -110.42 170.56 8.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 110.108 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -119.12 121.11 39.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 110.156 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.401 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 pp -67.22 103.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.062 -1.024 . . . . 0.0 109.48 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.422 HG21 ' CG2' ' A' ' 101' ' ' THR . 1.8 tt -94.32 -27.76 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.444 -0.785 . . . . 0.0 110.767 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.9 m -166.71 98.54 0.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.164 -0.96 . . . . 0.0 109.879 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.41 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 14.7 ttmt -96.05 106.54 18.73 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.403 -0.81 . . . . 0.0 110.315 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.84 95.26 7.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 0.0 110.038 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.2 p -74.91 -26.05 59.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.28 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.17 -49.2 76.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.128 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -96.05 13.82 25.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.925 . . . . 0.0 110.447 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 53.16 63.16 2.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.096 -1.003 . . . . 0.0 110.128 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.93 173.8 12.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.331 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.41 ' HG3' ' CG ' ' A' ' 93' ' ' LYS . 3.5 ttm180 -169.37 165.16 10.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 0.0 110.236 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.422 ' CG2' HG21 ' A' ' 91' ' ' ILE . 94.9 m -143.99 151.9 40.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -0.845 . . . . 0.0 109.903 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 2.9 p -145.14 140.17 27.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.941 -1.1 . . . . 0.0 110.912 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.58 141.14 28.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 0.0 110.109 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.441 ' CG ' HD13 ' A' ' 83' ' ' ILE . 87.8 m-85 -131.45 145.41 51.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.131 -0.981 . . . . 0.0 110.851 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -104.33 130.36 52.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.316 -0.865 . . . . 0.0 109.471 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.426 HG23 ' CD1' ' A' ' 113' ' ' ILE . 1.0 OUTLIER -150.03 150.89 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.982 -1.074 . . . . 0.0 110.881 -179.194 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.1 t -66.13 113.2 4.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.189 -0.944 . . . . 0.0 109.027 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.481 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 51.88 -178.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.324 -178.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.428 HD11 ' O ' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -150.0 58.13 0.97 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 0.0 111.554 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 11.3 t30 -145.28 58.83 1.28 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.841 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.32 174.43 44.59 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -81.97 141.43 33.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -1.111 . . . . 0.0 110.659 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.426 ' CD1' HG23 ' A' ' 106' ' ' VAL . 72.6 mt -137.7 150.86 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.371 -0.831 . . . . 0.0 109.735 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -76.21 126.75 31.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.155 -0.966 . . . . 0.0 110.568 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -132.64 172.29 21.32 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 10.7 mttt -144.07 167.51 22.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.126 -1.22 . . . . 0.0 109.413 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.405 HD12 ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -158.5 145.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.983 -1.073 . . . . 0.0 110.52 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.427 ' HB2' ' CG2' ' A' ' 79' ' ' THR . 1.7 m-20 -108.2 160.34 15.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.429 -0.794 . . . . 0.0 109.225 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.49 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -134.41 147.85 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 110.642 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -151.34 109.86 3.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.426 -0.796 . . . . 0.0 110.569 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.445 ' CG1' ' HA ' ' A' ' 77' ' ' TRP . 2.3 mp -140.58 152.97 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.411 -0.805 . . . . 0.0 109.871 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -160.38 102.35 1.39 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.027 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -174.11 -170.72 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.454 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.74 109.4 21.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.85 . . . . 0.0 110.17 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.5 t -76.7 107.09 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.362 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.4 m120 50.37 42.42 25.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.877 . . . . 0.0 110.423 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.82 37.19 11.97 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -145.24 99.33 4.58 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.236 -1.155 . . . . 0.0 109.97 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -59.04 130.11 34.99 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.674 1.355 . . . . 0.0 110.392 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.482 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -158.62 128.67 5.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 110.029 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -105.9 142.61 35.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.225 -0.922 . . . . 0.0 110.785 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.508 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 5.5 t80 -127.2 121.49 31.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.48 -0.763 . . . . 0.0 109.704 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -158.77 84.44 0.82 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.201 -0.937 . . . . 0.0 110.11 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.0 -169.62 3.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 110.419 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.443 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 13.5 p-80 -120.28 159.29 25.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 110.309 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 57.4 m-85 -155.13 -178.82 7.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.347 -0.845 . . . . 0.0 109.907 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.43 ' O ' ' CG2' ' A' ' 138' ' ' ILE . 0.3 OUTLIER -150.66 161.2 43.06 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.039 -1.038 . . . . 0.0 110.885 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.43 ' CG2' ' O ' ' A' ' 137' ' ' ASN . 6.8 pt -155.59 173.34 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.544 -0.723 . . . . 0.0 109.642 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 43.3 m -91.79 116.36 28.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.162 -0.961 . . . . 0.0 111.089 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.429 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 7.4 m-85 -89.58 150.22 22.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 109.547 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -145.11 162.51 36.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.088 -1.007 . . . . 0.0 110.86 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -148.99 158.53 44.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.52 -0.738 . . . . 0.0 109.933 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 35' ' ' ASN . 32.8 m-80 -142.0 110.55 6.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.582 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -168.49 -145.95 4.78 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.419 ' HD2' HD13 ' A' ' 109' ' ' LEU . 11.3 Cg_endo -61.52 -177.25 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.75 1.395 . . . . 0.0 109.986 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.18 -56.92 0.2 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.154 -0.966 . . . . 0.0 110.305 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.72 -66.53 0.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.173 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.3 t 55.97 54.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.388 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.25 41.89 0.27 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.386 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.963 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.508 ' NA ' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.226 0.536 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.17 96.94 2.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 110.277 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 62.63 24.07 14.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.218 -0.926 . . . . 0.0 109.943 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.82 82.16 1.71 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 110.114 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.1 -161.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.154 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER 56.34 28.64 13.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.23 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -159.93 149.49 18.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.928 . . . . 0.0 110.292 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.7 176.83 39.21 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.95 103.05 15.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -1.13 . . . . 0.0 110.335 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.519 ' CB ' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -93.55 152.34 19.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 109.987 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.443 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 14.5 m-80 -78.35 144.86 35.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 110.125 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.5 OUTLIER -165.09 156.96 15.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 110.058 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.1 -177.93 6.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.9 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.58 176.2 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.241 -0.912 . . . . 0.0 110.034 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 56.9 m-85 -148.67 161.91 40.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.413 -0.804 . . . . 0.0 109.954 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.73 135.78 53.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 0.0 109.656 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.466 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -61.65 146.73 48.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 110.112 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 3.3 t-20 70.54 4.58 5.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.793 -0.567 . . . . 0.0 110.723 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -135.55 -164.52 1.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.92 -1.112 . . . . 0.0 109.576 179.286 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.422 ' N ' ' OG1' ' A' ' 43' ' ' THR . 6.3 m-80 -130.85 14.02 5.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 110.527 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -136.09 142.87 44.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.06 -1.025 . . . . 0.0 110.563 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -77.18 136.36 38.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.124 -0.985 . . . . 0.0 109.181 179.397 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.07 -17.78 3.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.01 -1.056 . . . . 0.0 112.048 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 51.8 mt -137.74 -68.81 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.79 -1.194 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -48.39 -24.5 1.26 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 111.201 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.421 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 0.1 OUTLIER -67.5 -14.15 62.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.961 -1.087 . . . . 0.0 110.891 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -102.19 15.16 29.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.056 -1.028 . . . . 0.0 110.902 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.444 ' CD2' HBC2 ' A' ' 151' ' ' ZNH . 95.7 m-85 -127.51 -5.49 5.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.963 -1.086 . . . . 0.0 111.177 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 11.5 m-30 -110.39 112.85 25.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.948 -1.095 . . . . 0.0 110.518 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -72.77 109.75 6.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.284 -0.885 . . . . 0.0 110.129 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.401 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -93.39 164.06 22.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 110.161 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.401 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 56.2 Cg_endo -79.62 -175.82 17.2 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.452 -2.311 . . . . 0.0 110.693 -0.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.77 165.62 10.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 110.098 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -104.36 113.27 26.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.178 -0.951 . . . . 0.0 110.345 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.519 ' CD1' ' CB ' ' A' ' 34' ' ' LEU . 9.3 p90 -98.21 166.45 11.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.22 -0.925 . . . . 0.0 110.308 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.8 OUTLIER -155.67 158.93 3.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.585 -179.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 18.0 mtmt -138.86 173.1 11.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 0.0 110.985 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.435 ' HB2' ' CD ' ' A' ' 65' ' ' LYS . 19.2 mtpt -155.53 62.15 0.61 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.577 -0.702 . . . . 0.0 109.535 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 47.96 84.3 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.539 -0.726 . . . . 0.0 111.177 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.06 19.45 36.31 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.809 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.435 ' CD ' ' HB2' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -165.43 157.37 14.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.85 -1.383 . . . . 0.0 111.141 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -160.47 155.92 25.15 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.169 0.985 . . . . 0.0 111.755 178.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 3.7 m-85 -141.89 -162.06 1.33 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.452 ' CG2' ' HA ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -170.68 138.88 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 120.97 -1.081 . . . . 0.0 110.712 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 1.2 pt20 -99.65 134.84 41.95 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.776 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.74 128.4 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.992 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.3 122.36 31.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.826 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -103.28 150.41 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.404 -0.81 . . . . 0.0 110.508 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -102.28 133.44 47.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.343 -0.848 . . . . 0.0 110.005 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 57.38 99.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.119 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.3 t -62.54 -44.06 97.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.879 . . . . 0.0 110.465 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -52.58 -38.35 59.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.915 . . . . 0.0 110.392 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.418 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 45.5 m0 -68.46 -59.17 3.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -0.946 . . . . 0.0 110.243 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.6 tp -88.44 118.04 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -0.918 . . . . 0.0 109.772 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.46 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -86.97 -25.38 24.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 110.99 -179.099 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.46 ' N ' HG21 ' A' ' 79' ' ' THR . . . 175.4 174.92 42.4 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.238 -1.458 . . . . 0.0 110.526 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 0.7 OUTLIER -152.82 115.27 4.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.451 -1.029 . . . . 0.0 110.025 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.56 171.24 11.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 109.885 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.479 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.0 OUTLIER -171.76 131.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.135 -0.978 . . . . 0.0 110.816 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.469 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 0.9 OUTLIER 62.35 9.41 3.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.575 -0.703 . . . . 0.0 111.879 179.36 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.36 1.21 29.57 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.361 -1.399 . . . . 0.0 111.594 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.503 ' CD2' ' N ' ' A' ' 86' ' ' HIS . 3.3 p80 -135.6 154.17 51.43 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.577 -1.543 . . . . 0.0 110.847 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -167.17 0.17 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.454 -0.779 . . . . 0.0 110.421 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 8.1 pt-20 -107.68 170.22 8.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.193 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.34 134.32 55.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.246 -0.909 . . . . 0.0 110.396 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -67.83 103.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.126 -0.983 . . . . 0.0 109.514 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.431 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 2.0 tt -94.57 -29.49 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.865 . . . . 0.0 111.142 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.77 105.34 0.6 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.051 -1.03 . . . . 0.0 110.138 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -96.07 108.82 21.29 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.394 -0.816 . . . . 0.0 110.244 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.54 86.71 4.2 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.067 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.07 -24.54 62.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.37 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.56 -53.47 54.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.078 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -97.46 19.2 13.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -0.881 . . . . 0.0 110.255 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 50.76 65.72 1.38 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 110.123 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -147.7 158.41 44.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.223 -0.923 . . . . 0.0 110.314 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -153.98 160.84 42.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -0.896 . . . . 0.0 110.038 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.431 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 91.2 m -141.1 156.94 45.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.864 . . . . 0.0 109.856 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.425 ' N ' HG23 ' A' ' 101' ' ' THR . 84.7 p -145.65 143.41 29.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 110.699 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.08 135.98 33.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.354 -0.841 . . . . 0.0 109.912 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 39.1 m-85 -121.68 148.23 44.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.078 -1.014 . . . . 0.0 110.796 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -115.02 128.46 56.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.392 -0.818 . . . . 0.0 109.657 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.0 m -149.62 -175.37 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.605 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.32 113.44 22.31 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.44 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 47.48 -158.6 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.46 -0.775 . . . . 0.0 109.343 -178.345 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.459 ' CD2' ' CD2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -151.02 53.72 0.87 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.772 -1.205 . . . . 0.0 110.772 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.417 ' CB ' HG21 ' A' ' 146' ' ' THR . 2.7 t30 -145.87 84.29 1.66 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.994 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.41 166.51 15.14 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.87 144.0 31.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -1.12 . . . . 0.0 110.429 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.1 mt -137.06 146.61 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 110.089 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -76.68 130.64 38.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.325 -0.859 . . . . 0.0 110.385 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -138.82 176.55 20.81 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 82' ' ' SER . 8.6 mttt -143.06 164.41 30.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -1.122 . . . . 0.0 109.42 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.432 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -158.65 142.36 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.912 -1.117 . . . . 0.0 110.921 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.418 ' HB2' ' CG2' ' A' ' 79' ' ' THR . 5.3 m-20 -112.08 162.77 15.04 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.551 -0.718 . . . . 0.0 109.182 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.76 153.63 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.137 -0.977 . . . . 0.0 110.37 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -151.82 107.31 3.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 110.541 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.49 HD11 ' CD2' ' A' ' 132' ' ' TYR . 7.7 mt -130.72 151.47 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.242 -0.911 . . . . 0.0 109.855 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.426 ' N ' HG23 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -159.15 104.37 1.68 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.217 -0.927 . . . . 0.0 109.855 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -172.66 -158.73 0.11 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 110.304 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -119.83 108.01 13.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.368 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.4 t -76.93 117.96 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.928 . . . . 0.0 110.223 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.48 29.06 2.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.396 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 90.98 35.77 7.0 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.49 116.52 5.46 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 110.125 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.12 135.36 30.39 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.638 1.336 . . . . 0.0 110.266 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.483 ' CE2' HMB1 ' A' ' 151' ' ' ZNH . 6.4 t80 -136.25 113.38 10.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 110.316 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -104.0 122.77 45.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 110.122 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.49 ' CD2' HD11 ' A' ' 121' ' ' ILE . 3.9 t80 -131.72 128.58 39.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 109.886 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -173.39 94.14 0.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.158 -0.964 . . . . 0.0 110.369 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.86 -175.0 5.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.256 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.55 86.43 2.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.941 . . . . 0.0 110.136 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.448 ' CD1' HBD2 ' A' ' 151' ' ' ZNH . 24.6 m-85 -84.48 -178.77 7.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.361 -0.837 . . . . 0.0 110.02 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 18.9 p30 -149.5 167.67 25.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 0.0 110.204 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.432 HG12 ' CG2' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -156.45 163.3 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 110.718 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 81.9 m -92.15 125.41 36.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.489 -0.757 . . . . 0.0 110.406 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -90.39 165.11 14.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.204 -0.935 . . . . 0.0 110.371 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.21 101.54 1.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 110.315 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.417 ' CE1' HG12 ' A' ' 68' ' ' VAL . 59.3 m-85 -91.57 158.67 16.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.266 -0.897 . . . . 0.0 110.207 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.446 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 55.0 m-20 -143.46 96.98 3.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.223 -0.923 . . . . 0.0 110.604 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.414 ' HA3' HD11 ' A' ' 109' ' ' LEU . . . -154.23 -148.28 4.91 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.45 172.86 1.74 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.804 1.423 . . . . 0.0 110.631 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.417 HG21 ' CB ' ' A' ' 110' ' ' ASN . 9.2 p -149.89 -60.12 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.361 -0.837 . . . . 0.0 110.242 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -108.78 -27.87 9.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.315 -0.866 . . . . 0.0 110.378 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 43.8 t 55.54 46.11 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.223 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.69 103.93 11.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 110.269 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.907 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.483 HMB1 ' CE2' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.288 0.566 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -139.25 38.4 2.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.994 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 60.58 23.52 13.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 109.883 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.01 127.79 33.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 109.946 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 43.32 -163.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.704 -0.623 . . . . 0.0 110.802 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER 55.53 27.53 10.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.143 -0.973 . . . . 0.0 110.273 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 p -160.76 141.31 11.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.885 . . . . 0.0 110.347 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.25 -178.0 43.86 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.6 107.14 18.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.274 -1.133 . . . . 0.0 110.122 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.488 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -94.86 156.49 16.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.379 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -79.91 138.64 37.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.94 . . . . 0.0 110.369 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.448 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 1.2 p90 -164.91 150.75 10.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.349 -0.844 . . . . 0.0 110.006 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 38' ' ' VAL . 2.2 tt0 -155.02 156.46 35.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.869 . . . . 0.0 109.756 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.431 ' N ' ' HG3' ' A' ' 37' ' ' GLU . 28.1 m -101.08 174.71 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.17 -0.956 . . . . 0.0 110.638 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.433 ' HA ' ' CA ' ' A' ' 46' ' ' THR . 10.0 m-85 -148.12 156.18 42.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.516 -0.74 . . . . 0.0 109.746 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.429 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -67.59 133.59 49.68 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.221 -0.924 . . . . 0.0 109.592 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -63.73 147.14 52.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.991 -1.068 . . . . 0.0 109.864 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 5.5 t30 69.97 4.9 5.01 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.719 -0.613 . . . . 0.0 110.859 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.411 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -137.46 -167.23 2.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.94 -1.1 . . . . 0.0 109.718 179.422 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.411 ' N ' ' OG1' ' A' ' 43' ' ' THR . 24.7 m120 -130.56 14.34 5.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.109 -0.994 . . . . 0.0 110.426 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -135.03 116.86 15.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.083 -1.011 . . . . 0.0 110.402 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.456 ' CG2' ' CB ' ' A' ' 50' ' ' ASN . 0.5 OUTLIER -54.65 134.42 47.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.991 -1.068 . . . . 0.0 108.972 179.327 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.73 -17.66 3.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.826 -1.171 . . . . 0.0 112.299 -178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.505 HD11 HG22 ' A' ' 48' ' ' ILE . 23.4 mt -137.78 -64.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.634 -1.291 . . . . 0.0 111.304 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.479 ' O ' ' CD2' ' A' ' 53' ' ' PHE . . . -45.32 -27.92 0.74 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.619 -0.675 . . . . 0.0 111.43 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.456 ' CB ' ' CG2' ' A' ' 46' ' ' THR . 6.5 t-20 -71.91 -13.63 61.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.959 -1.088 . . . . 0.0 111.057 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.404 ' C ' ' CG ' ' A' ' 52' ' ' TYR . 8.7 m-20 -90.05 14.95 11.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.063 -1.023 . . . . 0.0 110.863 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.404 ' CG ' ' C ' ' A' ' 51' ' ' ASP . 24.0 m-85 -143.05 11.56 1.79 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.042 -1.036 . . . . 0.0 110.856 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 24.0 m-85 -129.76 113.37 14.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 109.991 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -72.17 164.92 25.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.166 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.413 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -146.75 164.21 25.08 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 110.07 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.413 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 49.6 Cg_endo -79.53 -175.65 16.91 Favored 'Cis proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.332 -2.362 . . . . 0.0 110.558 -0.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.0 167.94 9.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.287 -0.883 . . . . 0.0 109.873 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -103.57 111.35 23.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.116 -0.99 . . . . 0.0 110.745 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -96.35 162.85 13.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.001 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -154.28 155.93 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.085 -1.009 . . . . 0.0 110.528 -179.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.3 mtmp? -138.62 171.75 13.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.317 -0.865 . . . . 0.0 110.598 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . 12.1 mttp -162.03 61.66 0.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.394 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 60.91 91.66 0.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -0.839 . . . . 0.0 111.428 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.89 28.83 61.96 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.115 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.421 ' HD2' ' HB3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -170.59 162.71 8.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.892 -1.357 . . . . 0.0 111.207 179.434 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.4 pt? -172.51 149.45 2.13 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 122.084 0.945 . . . . 0.0 111.38 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 1.2 m-85 -138.02 172.19 13.3 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.72 142.09 26.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.933 -1.104 . . . . 0.0 110.441 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.426 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 6.3 pt20 -97.37 133.49 41.91 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.37 -0.831 . . . . 0.0 109.572 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.99 138.55 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -0.82 . . . . 0.0 110.153 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 m -88.36 129.48 35.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.244 -0.91 . . . . 0.0 109.769 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.99 127.21 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 110.405 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -99.42 133.25 44.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 110.017 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.0 m80 54.8 98.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.158 -0.964 . . . . 0.0 110.063 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.3 p -64.15 -25.8 68.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.392 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -65.37 -56.85 10.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -51.06 -65.11 0.61 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.21 -0.931 . . . . 0.0 110.177 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 10.0 tt -89.27 120.79 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.331 -0.856 . . . . 0.0 109.845 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.449 HG22 ' N ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -86.93 -23.09 25.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 110.867 -179.341 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.449 ' N ' HG22 ' A' ' 79' ' ' THR . . . -179.99 -179.36 48.8 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.509 -1.329 . . . . 0.0 109.99 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 58.8 mtm -152.34 171.07 18.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -1.073 . . . . 0.0 110.292 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 116' ' ' LYS . 10.3 t -155.18 172.04 18.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.295 -0.878 . . . . 0.0 109.909 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.47 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -168.01 140.05 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.092 -1.005 . . . . 0.0 110.763 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.481 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 2.0 mt-10 61.94 10.23 3.46 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.477 -0.764 . . . . 0.0 111.749 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.67 0.51 30.66 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.362 -1.399 . . . . 0.0 111.093 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.481 ' NE2' ' CB ' ' A' ' 84' ' ' GLU . 3.6 p80 -132.56 154.55 49.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.645 -1.503 . . . . 0.0 110.519 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -162.41 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.516 -0.74 . . . . 0.0 110.173 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.491 ' CB ' ' CZ ' ' A' ' 104' ' ' PHE . 12.1 pt-20 -107.61 169.27 8.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 110.107 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -106.0 127.32 53.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.152 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.76 102.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.139 -0.976 . . . . 0.0 109.673 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.434 HG21 ' CG2' ' A' ' 101' ' ' THR . 0.9 OUTLIER -94.74 -30.58 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 110.936 -179.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.409 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 54.4 p -167.15 103.89 0.54 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.091 -1.006 . . . . 0.0 109.986 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.431 ' HG3' ' CG ' ' A' ' 100' ' ' ARG . 21.4 ttmt -95.04 112.09 23.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 110.129 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.4 68.89 2.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.159 -0.963 . . . . 0.0 110.295 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.15 -29.05 56.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 110.266 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.51 -52.18 62.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.554 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -95.21 18.6 12.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -0.893 . . . . 0.0 110.552 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 51.0 61.32 3.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 110.21 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -147.14 169.89 18.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 110.024 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.431 ' CG ' ' HG3' ' A' ' 93' ' ' LYS . 0.8 OUTLIER -165.77 160.53 17.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.93 . . . . 0.0 110.328 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.434 ' CG2' HG21 ' A' ' 91' ' ' ILE . 87.6 m -141.31 147.22 37.81 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.568 -0.708 . . . . 0.0 109.393 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 3.7 p -145.53 141.8 28.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.034 -1.041 . . . . 0.0 110.842 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -92.49 145.48 24.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.531 -0.731 . . . . 0.0 109.682 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CZ ' ' CB ' ' A' ' 88' ' ' GLU . 30.4 m-85 -126.48 141.44 51.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.117 -0.989 . . . . 0.0 111.01 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -102.49 124.67 48.47 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.494 -0.754 . . . . 0.0 109.393 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 16.6 m -149.45 138.03 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.016 -1.053 . . . . 0.0 111.038 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.68 101.53 0.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 108.945 178.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.462 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 53.65 176.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.378 -178.607 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.462 ' HG ' ' CD1' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -150.18 83.22 1.38 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.85 -1.156 . . . . 0.0 111.218 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -144.71 75.42 1.45 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.953 . . . . 0.0 110.15 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.32 -109.26 0.41 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -157.58 150.91 23.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -1.171 . . . . 0.0 110.437 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -136.14 147.02 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.436 -0.79 . . . . 0.0 109.827 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -75.83 114.26 14.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.997 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.94 179.21 16.57 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 82' ' ' SER . 27.1 mttp -144.08 160.69 40.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 0.0 109.9 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.427 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.29 146.45 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.975 . . . . 0.0 110.4 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.426 ' N ' HG12 ' A' ' 117' ' ' ILE . 1.1 m-20 -105.57 156.3 18.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.414 -0.804 . . . . 0.0 109.405 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.97 146.0 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.159 -0.963 . . . . 0.0 110.44 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -151.6 109.3 3.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.37 -0.831 . . . . 0.0 110.246 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.486 HD13 ' CD2' ' A' ' 132' ' ' TYR . 54.8 mt -133.86 152.85 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.4 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 8.0 p-10 -160.46 95.28 1.11 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.81 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -174.26 -176.46 1.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 110.263 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -95.05 103.09 14.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 110.062 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.424 HG22 ' CB ' ' A' ' 130' ' ' PHE . 16.4 t -76.44 106.55 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.296 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.06 29.26 16.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 110.184 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.97 32.85 10.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.33 115.2 4.93 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.327 -1.102 . . . . 0.0 110.161 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -52.47 116.56 2.93 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.534 1.281 . . . . 0.0 110.187 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 5.7 t80 -116.0 122.51 45.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.691 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.83 122.02 44.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -0.879 . . . . 0.0 109.921 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.486 ' CD2' HD13 ' A' ' 121' ' ' ILE . 1.7 t80 -138.73 119.71 14.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.894 . . . . 0.0 110.169 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -168.53 85.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.127 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.25 -160.56 1.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.28 -0.887 . . . . 0.0 110.316 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.44 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -120.08 147.66 44.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.229 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 22.7 m-85 -155.68 -178.65 7.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.873 . . . . 0.0 109.997 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 9.7 p30 -149.82 169.18 21.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 0.0 110.671 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.427 HG12 ' CG2' ' A' ' 117' ' ' ILE . 0.5 OUTLIER -156.18 162.61 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 110.322 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 49.6 m -91.86 118.21 30.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.321 -0.862 . . . . 0.0 110.932 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.429 ' CD2' HG13 ' A' ' 83' ' ' ILE . 13.2 m-85 -90.91 101.43 14.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.274 -0.891 . . . . 0.0 110.017 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -87.74 103.49 15.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.087 -1.008 . . . . 0.0 110.526 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 140' ' ' TYR . 60.6 m-85 -92.67 153.28 19.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 110.186 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 9.8 m-80 -141.52 103.2 4.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.153 -0.967 . . . . 0.0 110.331 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.428 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -156.46 -149.74 5.45 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -62.76 -170.44 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.984 1.518 . . . . 0.0 110.43 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.08 -42.6 0.14 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 110.105 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -144.75 -53.6 0.31 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.886 . . . . 0.0 109.905 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.8 t 56.55 51.75 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 110.272 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.67 107.39 14.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 0.0 110.121 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.891 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.429 ' NA ' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.274 0.559 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -171.92 61.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.142 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.0 t30 60.86 28.69 18.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.378 -0.826 . . . . 0.0 109.989 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.02 72.36 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -0.825 . . . . 0.0 109.968 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.05 -56.65 4.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 110.081 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 1.0 OUTLIER 56.16 33.67 22.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.119 -0.988 . . . . 0.0 110.41 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -160.43 139.82 10.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 110.486 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.93 178.05 43.58 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.58 109.03 19.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.293 -1.122 . . . . 0.0 110.252 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.487 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -94.99 153.21 17.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.266 -0.896 . . . . 0.0 110.805 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -81.05 135.56 35.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.85 . . . . 0.0 110.243 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.482 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -166.47 161.77 16.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.993 -1.067 . . . . 0.0 110.129 179.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -155.12 -165.61 2.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 0.0 110.356 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.533 ' CG2' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -139.06 169.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -148.32 159.82 43.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.316 -0.865 . . . . 0.0 109.907 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.97 135.74 52.83 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.336 -0.852 . . . . 0.0 109.734 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.467 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -64.52 146.89 53.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.074 -1.016 . . . . 0.0 109.762 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 5.2 t-20 70.91 4.12 4.92 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.84 -0.537 . . . . 0.0 110.71 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.442 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -138.61 -167.53 2.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.944 -1.097 . . . . 0.0 109.498 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.442 ' N ' ' OG1' ' A' ' 43' ' ' THR . 37.4 m-80 -133.27 18.42 4.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.989 -1.069 . . . . 0.0 110.464 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -136.37 117.61 14.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.55 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.8 134.49 36.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.066 . . . . 0.0 109.261 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.35 -18.01 3.68 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.169 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.405 HD12 HG22 ' A' ' 48' ' ' ILE . 30.2 mt -138.1 -50.29 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.634 -1.291 . . . . 0.0 111.194 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.443 ' CB ' HD13 ' A' ' 138' ' ' ILE . . . -80.95 7.71 10.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.49 -0.756 . . . . 0.0 111.532 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.459 ' O ' ' CE1' ' A' ' 53' ' ' PHE . 1.1 p-10 -69.32 -35.73 76.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.809 -1.182 . . . . 0.0 110.461 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -103.16 15.31 29.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.202 -0.936 . . . . 0.0 110.892 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.404 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -93.01 -8.38 43.14 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.966 -1.083 . . . . 0.0 111.021 -179.6 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.533 ' CE1' ' CG2' ' A' ' 38' ' ' VAL . 31.9 p90 -127.07 126.14 42.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.003 -1.061 . . . . 0.0 110.719 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -73.95 104.39 4.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.024 -1.047 . . . . 0.0 109.883 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.416 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 1.6 pttt -92.58 164.96 20.48 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 110.125 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.416 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 50.1 Cg_endo -77.92 -177.58 21.52 Favored 'Cis proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.519 -2.284 . . . . 0.0 110.569 -0.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -103.1 167.47 9.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.962 . . . . 0.0 110.25 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.436 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -102.95 114.51 28.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 110.09 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.0 p90 -96.98 162.21 13.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 110.056 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -154.97 155.13 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 110.311 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 24.6 mtmt -137.73 170.78 15.46 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.332 -0.855 . . . . 0.0 110.85 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.416 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -155.98 62.43 0.58 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.655 -0.653 . . . . 0.0 109.745 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.23 92.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.327 -0.858 . . . . 0.0 110.992 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.7 27.19 54.77 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.258 -0.972 . . . . 0.0 110.763 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.416 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 7.9 ptpt -171.81 158.51 4.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.972 -1.311 . . . . 0.0 111.0 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.7 pt? -170.72 147.11 2.75 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.166 0.984 . . . . 0.0 111.615 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -138.32 171.37 14.49 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.473 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.83 143.27 24.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.975 -1.078 . . . . 0.0 109.971 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.436 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -97.0 135.67 38.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.24 -0.913 . . . . 0.0 110.087 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.2 OUTLIER -110.9 140.14 31.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.388 -0.82 . . . . 0.0 109.63 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -87.86 138.4 31.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.132 -0.98 . . . . 0.0 110.223 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.436 ' CG1' HG23 ' A' ' 78' ' ' ILE . 15.5 t -103.16 122.28 55.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.462 -0.774 . . . . 0.0 109.991 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.98 130.37 46.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 110.268 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.8 t60 57.7 94.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.254 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t -71.79 -12.23 61.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.909 . . . . 0.0 110.593 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -74.64 -26.1 59.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.103 -0.998 . . . . 0.0 110.345 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -94.17 -47.34 6.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 0.0 110.39 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.436 HG23 ' CG1' ' A' ' 72' ' ' VAL . 6.8 tp -88.46 115.98 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.118 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.4 HG23 ' N ' ' A' ' 80' ' ' GLY . 0.5 OUTLIER -87.41 -23.06 24.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.356 -0.84 . . . . 0.0 110.442 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.4 ' N ' HG23 ' A' ' 79' ' ' THR . . . -179.55 178.17 48.54 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.426 ' CE ' ' HB3' ' A' ' 102' ' ' SER . 0.0 OUTLIER -152.9 161.14 42.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -1.074 . . . . 0.0 110.194 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 116' ' ' LYS . 2.4 t -155.12 149.67 26.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.032 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.471 HD12 ' CG ' ' A' ' 104' ' ' PHE . 4.8 mt -141.83 144.41 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 110.427 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 69.67 3.85 4.44 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.498 -0.751 . . . . 0.0 111.119 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.55 20.79 21.21 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.718 -1.23 . . . . 0.0 111.116 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.457 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.04 163.31 31.05 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.713 -1.463 . . . . 0.0 110.174 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -177.69 1.85 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.108 -0.995 . . . . 0.0 110.31 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -110.01 169.61 8.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.347 -0.846 . . . . 0.0 110.209 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.64 124.95 53.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.948 . . . . 0.0 110.191 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pp -67.43 102.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 109.796 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.411 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.8 tt -95.19 -28.12 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.388 -0.82 . . . . 0.0 110.784 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.9 m -166.77 101.04 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.194 -0.941 . . . . 0.0 109.734 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -94.96 152.09 18.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.444 -0.785 . . . . 0.0 110.336 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -144.38 83.46 1.72 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 110.16 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 p -70.55 -27.05 63.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 110.326 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.59 -52.75 62.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 0.0 110.064 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.5 mtmm -96.21 17.75 15.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.311 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 51.97 60.27 3.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 110.249 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 94' ' ' ASN . 34.0 mt-10 -148.28 167.39 25.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 110.47 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.473 ' CG ' ' N ' ' A' ' 101' ' ' THR . 33.7 ttt180 -174.56 167.45 3.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.388 -0.82 . . . . 0.0 109.682 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.473 ' N ' ' CG ' ' A' ' 100' ' ' ARG . 94.9 m -141.44 153.95 45.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.962 . . . . 0.0 109.837 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB3' ' CE ' ' A' ' 81' ' ' MET . 83.6 p -145.38 141.1 28.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.112 -0.992 . . . . 0.0 110.68 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.32 146.65 23.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.896 . . . . 0.0 109.991 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.471 ' CG ' HD12 ' A' ' 83' ' ' ILE . 45.8 m-85 -129.14 147.74 51.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 0.0 110.675 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -105.53 125.83 51.43 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.384 -0.823 . . . . 0.0 109.789 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.8 m -150.16 152.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.968 . . . . 0.0 110.956 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.2 m -71.95 105.93 4.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.276 -0.89 . . . . 0.0 109.291 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.458 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 50.23 -178.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.494 -0.754 . . . . 0.0 109.734 -178.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -151.22 81.93 1.31 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.824 -1.172 . . . . 0.0 110.996 -179.385 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.61 67.71 1.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 110.191 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 162.57 -109.91 0.41 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -157.19 148.1 21.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -1.118 . . . . 0.0 109.65 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 63.9 mt -136.27 150.74 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.902 . . . . 0.0 110.274 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.92 131.95 38.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.356 -0.84 . . . . 0.0 110.114 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.419 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -138.08 178.97 18.8 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 3.3 mtpp -144.6 164.46 30.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -1.179 . . . . 0.0 110.08 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.41 HG13 ' CD1' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.86 141.55 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.07 -1.019 . . . . 0.0 110.694 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -104.12 152.46 22.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.268 -0.895 . . . . 0.0 109.72 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -128.71 154.09 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.132 -0.98 . . . . 0.0 110.345 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -151.55 102.45 2.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.21 -0.931 . . . . 0.0 110.738 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.461 HG22 ' CZ ' ' A' ' 130' ' ' PHE . 3.8 mt -133.38 152.88 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.324 -0.86 . . . . 0.0 110.097 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.34 95.38 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.981 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -174.81 -156.38 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 110.248 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.412 ' HG2' ' CA ' ' A' ' 129' ' ' PRO . 11.7 mttt -122.46 120.99 35.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.28 -0.887 . . . . 0.0 110.25 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.463 HG23 ' CE1' ' A' ' 130' ' ' PHE . 89.6 t -76.91 92.33 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 110.363 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.31 31.48 11.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.269 -0.895 . . . . 0.0 110.302 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.23 35.58 2.29 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -145.43 85.44 7.94 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.358 -1.084 . . . . 0.0 110.124 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.412 ' CA ' ' HG2' ' A' ' 124' ' ' LYS . 11.3 Cg_endo -59.3 129.49 31.65 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.983 1.517 . . . . 0.0 110.287 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.463 ' CE1' HG23 ' A' ' 125' ' ' VAL . 7.6 p90 -156.14 139.85 16.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 110.452 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -105.36 131.9 52.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.391 -0.818 . . . . 0.0 110.007 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.497 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 5.9 t80 -131.47 129.92 41.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.0 110.138 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -174.44 89.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.343 -0.848 . . . . 0.0 110.064 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.83 -168.42 3.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 110.188 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.17 85.93 2.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.407 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.416 ' CD1' HAD2 ' A' ' 151' ' ' ZNH . 30.5 m-85 -85.01 -178.98 6.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 109.796 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 29.2 p30 -150.42 168.98 22.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.025 -1.047 . . . . 0.0 110.654 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.443 HD13 ' CB ' ' A' ' 49' ' ' ALA . 2.3 pt -157.83 173.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.324 -0.86 . . . . 0.0 110.784 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.8 m -92.01 163.6 13.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.622 -0.674 . . . . 0.0 110.282 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.524 ' CD1' ' CG1' ' A' ' 38' ' ' VAL . 97.3 m-85 -141.79 100.49 3.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 109.643 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 2.0 mttt -82.5 108.95 16.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 110.833 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -92.17 140.65 29.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.99 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.402 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 37.8 m-80 -129.64 96.04 4.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 110.339 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -149.14 -152.68 5.79 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -62.49 139.17 74.86 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.943 1.496 . . . . 0.0 110.356 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.12 -36.37 14.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.473 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -133.82 -155.03 0.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 110.417 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.8 t 56.99 86.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 110.122 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.72 -22.21 37.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 0.0 110.223 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.497 ' NA ' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.428 ' N ' ' HB2' ' A' ' 28' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.279 0.561 . . . . 0.0 110.252 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 60.64 103.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.375 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 t30 62.74 29.48 16.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.941 . . . . 0.0 109.994 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.428 ' HB2' ' N ' ' A' ' 25' ' ' SER . . . -65.38 100.03 0.45 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.9 -72.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.192 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.405 ' O ' HG13 ' A' ' 60' ' ' ILE . 5.9 m-20 56.67 25.97 10.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.185 -0.947 . . . . 0.0 110.31 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -158.43 153.34 25.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.105 -0.997 . . . . 0.0 110.532 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.431 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 172.18 170.1 35.67 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.25 111.08 21.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -1.117 . . . . 0.0 110.152 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.476 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -94.78 155.39 16.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 0.0 110.646 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 3.0 t-20 -81.6 137.83 35.45 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.355 -0.84 . . . . 0.0 109.693 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -167.98 163.72 13.7 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.992 -1.067 . . . . 0.0 110.587 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.05 -168.33 2.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.37 -0.831 . . . . 0.0 109.823 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.429 ' O ' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER -139.82 -178.42 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.971 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -149.22 150.71 33.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 110.047 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.41 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.5 OUTLIER -67.56 127.83 34.19 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.397 -0.814 . . . . 0.0 109.87 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.471 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -55.9 147.27 19.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.142 -0.973 . . . . 0.0 109.921 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER 72.32 1.18 3.86 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.865 -0.522 . . . . 0.0 110.792 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.41 ' CG2' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -137.29 -166.49 1.94 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.873 -1.142 . . . . 0.0 109.559 179.192 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.408 ' N ' ' OG1' ' A' ' 43' ' ' THR . 23.0 m-80 -133.34 16.14 4.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -136.54 121.82 19.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.481 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.437 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -51.15 132.25 28.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 109.226 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.98 -17.58 3.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.889 -1.132 . . . . 0.0 111.926 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.8 mp -137.5 -75.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.827 -1.17 . . . . 0.0 110.572 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -47.48 -24.99 0.95 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.679 -0.638 . . . . 0.0 110.928 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.437 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.7 OUTLIER -46.65 -34.31 4.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.242 -0.911 . . . . 0.0 111.134 -179.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -102.19 15.76 28.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.044 -1.035 . . . . 0.0 110.986 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.453 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -99.25 -15.89 18.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.015 -1.053 . . . . 0.0 110.971 -179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.501 ' CG ' ' O ' ' A' ' 53' ' ' PHE . 21.3 p90 -118.6 128.39 54.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.928 -1.108 . . . . 0.0 110.993 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -74.97 114.42 13.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.095 -1.003 . . . . 0.0 109.91 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.75 159.64 35.8 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.036 . . . . 0.0 109.994 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -81.45 -175.28 15.37 Favored 'Cis proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.643 -2.232 . . . . 0.0 110.667 -0.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.487 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.45 172.81 6.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.197 -0.939 . . . . 0.0 110.041 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.31 116.6 32.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.25 -0.906 . . . . 0.0 111.076 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.476 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 6.9 p90 -98.14 161.77 13.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.237 -0.915 . . . . 0.0 109.523 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 0.6 OUTLIER -155.42 122.08 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.951 -1.093 . . . . 0.0 111.034 -179.551 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.6 mtmt -139.39 131.52 28.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.0 110.212 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -109.21 62.42 0.6 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.196 -0.94 . . . . 0.0 110.441 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 62' ' ' LYS . 14.0 t-20 49.62 100.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.402 -0.811 . . . . 0.0 111.119 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.26 -17.96 56.17 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.43 152.8 45.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.154 -1.203 . . . . 0.0 110.201 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -155.07 142.81 19.87 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.938 0.875 . . . . 0.0 111.012 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 5.7 m-85 -140.03 -170.15 2.89 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.54 -0.725 . . . . 0.0 109.352 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -162.06 165.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.098 -1.001 . . . . 0.0 109.882 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -140.45 143.66 35.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.198 -0.938 . . . . 0.0 110.472 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.56 128.51 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.335 -0.853 . . . . 0.0 110.258 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.7 m -88.83 124.33 34.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -102.68 138.93 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 110.386 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -101.0 135.03 43.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.325 -0.859 . . . . 0.0 110.238 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.1 m80 60.4 102.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.295 -0.878 . . . . 0.0 110.036 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 t -64.47 -33.44 75.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.887 . . . . 0.0 110.377 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -52.49 -57.78 8.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 110.257 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.454 ' CD2' ' HAB' ' A' ' 151' ' ' ZNH . 13.2 m0 -55.62 -62.52 1.63 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 110.382 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.9 tp -88.78 114.01 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 109.97 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -86.79 -26.28 24.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 110.782 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.443 ' N ' HG22 ' A' ' 79' ' ' THR . . . -172.46 174.89 45.67 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.074 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.28 163.23 39.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -1.042 . . . . 0.0 109.962 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -155.66 167.62 29.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.824 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.506 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.2 OUTLIER -164.62 154.13 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 110.033 179.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.495 ' HB2' ' CE1' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 59.74 15.02 4.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.049 -1.032 . . . . 0.0 110.859 179.725 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.28 23.23 55.14 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.031 -1.081 . . . . 0.0 110.976 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.506 ' CD2' ' O ' ' A' ' 83' ' ' ILE . 2.0 p-80 -138.27 161.58 36.51 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.67 -1.488 . . . . 0.0 110.623 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.27 179.35 2.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.851 . . . . 0.0 110.971 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.419 ' HA ' ' CE1' ' A' ' 104' ' ' PHE . 2.1 pt-20 -99.39 170.13 8.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 110.663 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 102' ' ' SER . 2.2 t30 -116.78 133.73 55.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.476 -0.765 . . . . 0.0 109.468 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pp -67.45 101.53 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.954 -1.092 . . . . 0.0 109.871 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.43 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 0.5 OUTLIER -95.41 -31.22 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.838 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.425 ' N ' HG23 ' A' ' 91' ' ' ILE . 11.0 m -166.73 95.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.109 -0.994 . . . . 0.0 110.009 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -95.9 95.3 8.15 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.478 -0.763 . . . . 0.0 110.156 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.09 91.25 5.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.175 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.73 -27.64 60.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 110.202 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.61 -45.37 93.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -0.936 . . . . 0.0 110.129 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.93 18.7 12.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.31 -0.869 . . . . 0.0 110.23 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 t0 50.48 61.75 3.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 110.043 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -148.09 166.72 26.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 110.515 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.432 ' HB3' ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -168.93 147.71 4.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.453 -0.779 . . . . 0.0 109.533 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 102' ' ' SER . 62.9 m -141.55 158.22 44.12 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.163 -0.96 . . . . 0.0 109.867 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.438 ' N ' HG22 ' A' ' 101' ' ' THR . 81.3 p -145.06 143.45 30.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 110.375 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 1.5 tm-20 -92.6 141.26 28.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 110.2 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.419 ' CE1' ' HA ' ' A' ' 88' ' ' GLU . 8.0 m-85 -123.81 148.65 46.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.279 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -98.3 132.29 43.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.37 -0.832 . . . . 0.0 110.075 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.421 HG23 ' CD1' ' A' ' 113' ' ' ILE . 8.9 p -149.08 166.88 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.202 -0.936 . . . . 0.0 110.245 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.5 t -69.63 -35.3 75.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 109.846 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.439 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -164.5 -148.9 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.503 -0.748 . . . . 0.0 109.325 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.444 ' CA ' ' HB3' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -150.06 51.92 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.726 -1.234 . . . . 0.0 111.232 -179.577 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 145' ' ' PRO . 12.9 t-20 -146.31 70.23 1.22 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.099 -1.001 . . . . 0.0 110.492 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.12 -129.25 1.7 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.44 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.0 OUTLIER -156.65 140.87 16.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.323 -1.104 . . . . 0.0 109.839 -179.771 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.421 ' CD1' HG23 ' A' ' 106' ' ' VAL . 2.5 mt -135.33 153.87 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.164 -0.96 . . . . 0.0 110.019 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -76.2 137.08 39.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.076 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -137.35 177.23 20.0 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 82' ' ' SER . 16.7 mttt -144.14 156.16 44.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -1.139 . . . . 0.0 109.76 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.452 HG12 ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -157.73 151.16 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.006 -1.059 . . . . 0.0 110.578 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.452 ' N ' HG12 ' A' ' 117' ' ' ILE . 0.9 OUTLIER -112.14 158.37 19.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.412 -0.805 . . . . 0.0 109.386 179.357 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.472 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -129.77 148.35 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -0.976 . . . . 0.0 110.053 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.78 102.24 2.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 110.769 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.452 ' CG1' ' HA ' ' A' ' 77' ' ' TRP . 2.6 mp -133.72 151.9 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -0.987 . . . . 0.0 110.162 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 1.2 p-10 -160.57 98.45 1.24 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.354 -0.842 . . . . 0.0 109.73 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -173.75 -156.95 0.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 110.553 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 125' ' ' VAL . 18.6 mtpt -91.27 165.22 13.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.416 -0.803 . . . . 0.0 110.608 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 47.6 t -157.88 99.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 67.18 25.83 8.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.531 -0.731 . . . . 0.0 109.611 -178.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 86.53 34.25 12.18 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -147.89 134.25 9.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.22 -1.165 . . . . 0.0 110.303 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -60.85 129.09 27.64 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.581 1.306 . . . . 0.0 110.141 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 132' ' ' TYR . 46.2 t80 -121.01 145.8 47.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.167 -0.958 . . . . 0.0 110.385 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -136.08 118.21 15.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.211 -0.931 . . . . 0.0 110.146 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.494 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 3.7 t80 -129.73 131.47 46.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 109.804 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -177.37 87.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.04 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.66 -163.9 1.76 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 0.0 110.536 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.461 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 4.2 p80 -118.69 143.66 46.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 135' ' ' HIS . 13.0 m-85 -154.85 -179.45 8.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 110.117 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 1.7 p30 -152.1 172.11 16.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 0.0 110.584 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.9 pt -157.17 162.93 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.844 . . . . 0.0 110.173 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.44 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 45.1 m -92.0 126.92 37.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 110.594 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.464 ' CE2' HG13 ' A' ' 83' ' ' ILE . 14.4 m-85 -89.48 154.23 20.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -0.949 . . . . 0.0 109.654 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.89 105.52 5.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.041 -1.037 . . . . 0.0 110.397 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.444 ' HB3' ' CA ' ' A' ' 109' ' ' LEU . 31.7 m-85 -91.99 134.72 34.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 0.0 110.374 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 4.2 m-80 -132.11 103.56 6.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 0.0 110.311 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.403 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -164.71 -150.38 6.15 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.44 ' HG2' ' NZ ' ' A' ' 61' ' ' LYS . 9.4 Cg_endo -57.56 -165.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.765 1.402 . . . . 0.0 110.457 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.2 p -149.54 -52.58 0.16 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -0.946 . . . . 0.0 110.09 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.62 -60.12 1.93 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.048 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.2 t 56.77 51.95 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.359 -0.838 . . . . 0.0 110.335 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.88 -5.4 58.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.2 -0.938 . . . . 0.0 110.67 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.987 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.494 ' NA ' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.3 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.262 0.553 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.6 65.75 0.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.908 . . . . 0.0 110.092 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 62.15 21.37 12.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.929 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.66 135.51 49.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.291 -0.88 . . . . 0.0 109.934 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 43.72 -160.54 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.71 -0.618 . . . . 0.0 110.419 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 25.4 m-20 54.66 31.33 15.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 110.196 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 15.1 t -160.39 169.68 22.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 110.789 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.9 171.71 25.06 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.69 105.18 17.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.1 -1.235 . . . . 0.0 110.217 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.482 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -94.21 156.05 16.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 110.414 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.411 ' O ' ' N ' ' A' ' 143' ' ' ASN . 14.9 m-20 -79.86 140.83 36.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.214 -0.929 . . . . 0.0 109.738 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.46 ' CD1' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -165.91 158.18 14.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.98 . . . . 0.0 110.181 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -155.37 -168.89 2.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.258 -0.901 . . . . 0.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.07 173.97 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 109.796 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -148.22 156.48 42.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 110.491 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 128.93 38.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.528 -0.732 . . . . 0.0 109.766 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.508 ' CE2' ' ND2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -58.18 148.26 27.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.098 -1.001 . . . . 0.0 109.879 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 11.0 m-20 71.08 2.44 4.24 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.816 -0.552 . . . . 0.0 110.961 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.409 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -136.96 -165.49 1.75 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.944 -1.098 . . . . 0.0 109.684 179.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' N ' ' OG1' ' A' ' 43' ' ' THR . 64.1 t30 -133.86 16.13 3.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 110.19 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -136.01 118.31 15.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 110.583 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.37 128.61 23.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.988 . . . . 0.0 109.099 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.49 -16.13 3.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.008 -1.058 . . . . 0.0 112.222 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.408 HG21 ' ND ' ' A' ' 151' ' ' ZNH . 2.4 mt -136.18 -64.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.792 -1.193 . . . . 0.0 110.907 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.39 -21.9 4.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.452 -0.78 . . . . 0.0 111.147 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -8.97 46.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.054 -1.029 . . . . 0.0 110.951 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.404 ' C ' ' CG ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -97.78 8.49 44.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.013 -1.055 . . . . 0.0 110.913 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.453 ' CG ' HMC2 ' A' ' 151' ' ' ZNH . 7.1 m-85 -142.44 17.3 2.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.966 -1.084 . . . . 0.0 110.342 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -119.49 107.22 13.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.439 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -72.88 155.09 40.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 110.249 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.423 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -146.68 167.22 14.3 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.121 -0.987 . . . . 0.0 110.026 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.423 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 49.8 Cg_endo -77.06 -175.31 16.47 Favored 'Cis proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.681 -2.216 . . . . 0.0 110.481 -0.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.46 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . . . -100.4 162.43 12.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 109.975 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.409 ' CB ' ' CG ' ' A' ' 69' ' ' GLN . 0.5 OUTLIER -102.08 117.03 33.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.304 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.482 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.7 p90 -97.51 160.95 14.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 109.776 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -155.35 127.42 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.056 -1.028 . . . . 0.0 110.559 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.437 ' HG2' ' CB ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -136.61 119.36 16.15 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.206 -0.934 . . . . 0.0 110.783 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.2 OUTLIER -96.01 62.05 2.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.384 -0.822 . . . . 0.0 110.393 179.62 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.403 ' O ' ' O ' ' A' ' 62' ' ' LYS . 41.3 t30 46.62 99.17 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.58 -0.7 . . . . 0.0 111.407 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.83 5.03 54.15 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.436 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.58 158.91 16.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.894 -1.357 . . . . 0.0 110.199 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.555 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -155.13 149.81 26.46 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 122.171 0.986 . . . . 0.0 111.199 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.519 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 5.0 m-85 -142.74 -164.71 1.89 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.388 -0.82 . . . . 0.0 109.242 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.405 ' CG2' ' HA ' ' A' ' 59' ' ' TYR . 1.2 t -170.56 134.12 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.082 -1.011 . . . . 0.0 110.102 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.409 ' CG ' ' CB ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -97.59 134.15 41.18 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.157 -0.965 . . . . 0.0 109.568 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.1 OUTLIER -112.81 137.64 45.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.864 -179.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.5 m -88.6 135.17 33.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 109.972 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.409 ' CG1' HG21 ' A' ' 78' ' ' ILE . 3.4 t -102.38 123.98 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.283 -0.886 . . . . 0.0 109.943 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -98.31 126.85 43.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.247 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.36 99.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 110.328 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -32.62 66.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 110.09 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -58.95 -41.63 87.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.16 -0.963 . . . . 0.0 110.041 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.409 ' HB3' HMC1 ' A' ' 151' ' ' ZNH . 45.1 m0 -71.48 -62.11 1.53 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.375 -0.828 . . . . 0.0 110.128 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.409 HG21 ' CG1' ' A' ' 72' ' ' VAL . 9.9 tt -89.3 122.13 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 109.691 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.451 HG22 ' N ' ' A' ' 80' ' ' GLY . 1.0 OUTLIER -87.14 -23.25 24.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.385 -0.822 . . . . 0.0 111.114 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 79' ' ' THR . . . -178.38 179.94 48.47 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.017 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 47.5 mtm -152.45 171.12 18.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.346 -1.09 . . . . 0.0 109.94 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -155.21 164.45 38.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.214 -0.929 . . . . 0.0 110.233 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 7.4 mt -155.59 135.54 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.542 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 1.6 tm-20 69.54 3.44 4.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.406 -0.808 . . . . 0.0 111.428 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.64 21.5 12.52 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.136 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.477 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -136.95 159.05 43.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.722 -1.458 . . . . 0.0 110.138 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -178.98 2.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.083 -1.011 . . . . 0.0 110.354 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 1.7 pt-20 -106.6 167.59 9.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.34 -0.85 . . . . 0.0 110.043 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.28 129.79 55.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 110.349 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 1.4 pp -68.28 101.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.903 . . . . 0.0 109.671 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.439 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.8 tt -95.3 -28.87 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.384 -0.822 . . . . 0.0 110.716 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.9 p -167.33 107.41 0.59 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.022 -1.049 . . . . 0.0 109.935 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -95.41 110.33 22.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -0.869 . . . . 0.0 110.153 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.84 81.27 3.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 110.197 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.9 p -69.56 -26.56 64.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.254 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.62 -52.33 63.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.199 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -95.79 19.91 10.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 110.304 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 50.36 63.75 2.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 109.996 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -147.56 -177.98 6.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.858 . . . . 0.0 110.408 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -176.32 164.97 2.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.835 . . . . 0.0 109.715 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.439 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 93.3 m -142.6 154.86 44.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.158 -0.964 . . . . 0.0 109.755 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.42 ' N ' HG22 ' A' ' 101' ' ' THR . 1.5 p -145.53 144.25 30.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.905 -1.122 . . . . 0.0 110.721 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -92.69 140.34 29.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.299 -0.876 . . . . 0.0 109.792 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' A' ' 88' ' ' GLU . 32.6 m-85 -126.58 149.62 49.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.119 -0.988 . . . . 0.0 111.066 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -119.74 126.35 50.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.46 -0.775 . . . . 0.0 109.477 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.406 ' O ' HD22 ' A' ' 66' ' ' LEU . 22.9 m -149.97 -164.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.972 -1.08 . . . . 0.0 110.778 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.2 t -98.46 112.0 24.17 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.442 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.26 -165.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.521 -0.737 . . . . 0.0 109.661 -178.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.45 ' CD2' ' HB2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -151.91 60.2 0.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.87 -1.144 . . . . 0.0 111.188 -179.435 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -146.33 80.5 1.56 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.124 -0.985 . . . . 0.0 110.435 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.59 -117.19 0.75 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' CG ' ' CG2' ' A' ' 139' ' ' THR . 3.7 ttpt -157.52 145.27 18.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.346 -1.091 . . . . 0.0 110.041 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.6 mt -137.39 146.02 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.352 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -76.83 108.9 10.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.222 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.461 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -111.37 177.99 19.26 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 82' ' ' SER . 22.2 mttt -145.45 161.23 40.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -1.125 . . . . 0.0 109.89 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.44 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.8 147.15 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.095 -1.003 . . . . 0.0 110.682 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.439 ' N ' HG12 ' A' ' 117' ' ' ILE . 39.6 m-20 -106.39 159.32 16.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.394 -0.816 . . . . 0.0 109.149 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.92 147.29 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.027 -1.045 . . . . 0.0 110.684 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -153.34 113.89 4.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -0.872 . . . . 0.0 110.711 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.475 HD12 ' CD2' ' A' ' 132' ' ' TYR . 43.9 mt -137.69 152.94 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.103 -0.998 . . . . 0.0 110.386 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -160.08 95.43 1.16 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.376 -0.828 . . . . 0.0 109.85 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -173.81 -173.95 0.9 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.885 . . . . 0.0 110.354 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -104.47 121.35 43.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 110.263 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.3 95.04 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.102 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.05 39.02 30.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.29 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 96.45 31.46 7.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -145.33 100.39 4.46 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.316 -1.108 . . . . 0.0 110.134 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -50.4 132.84 35.83 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.869 1.457 . . . . 0.0 110.191 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.428 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 2.9 t80 -139.39 127.79 22.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 110.301 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.21 136.99 43.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.143 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.475 ' CD2' HD12 ' A' ' 121' ' ' ILE . 1.8 t80 -153.22 123.94 7.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 110.188 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -177.08 86.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -153.09 -165.31 2.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.9 . . . . 0.0 110.249 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -119.35 140.13 50.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.891 . . . . 0.0 110.283 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.463 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 61.4 m-85 -154.6 -179.17 7.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.874 . . . . 0.0 109.871 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.508 ' ND2' ' CE2' ' A' ' 41' ' ' TYR . 40.0 p30 -151.1 176.59 11.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 110.787 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.44 HG12 ' CG2' ' A' ' 117' ' ' ILE . 0.8 OUTLIER -156.35 171.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.476 -0.765 . . . . 0.0 109.673 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.478 ' CG2' ' CG ' ' A' ' 112' ' ' LYS . 26.1 m -91.76 118.04 30.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.976 . . . . 0.0 110.698 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.461 ' CD1' ' HA3' ' A' ' 115' ' ' GLY . 18.6 m-85 -89.68 108.11 19.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 109.61 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -97.48 161.67 13.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.723 -179.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -148.11 153.04 38.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.476 -0.765 . . . . 0.0 109.936 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 35' ' ' ASN . 31.4 m-80 -138.74 101.8 4.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 110.419 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -159.46 -154.5 7.29 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.423 ' HD2' ' CD1' ' A' ' 109' ' ' LEU . 19.7 Cg_endo -64.44 -175.68 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.999 1.526 . . . . 0.0 110.707 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.13 -61.47 0.23 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.401 -0.812 . . . . 0.0 110.209 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.3 -71.62 0.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.294 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 38.6 t 56.18 42.85 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.357 -0.839 . . . . 0.0 110.078 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.74 86.77 6.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.361 -0.837 . . . . 0.0 110.255 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.454 HBD2 ' CD1' ' A' ' 136' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.138 0.494 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -106.53 116.46 31.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.086 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 0.1 OUTLIER 63.86 20.96 12.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.318 -0.864 . . . . 0.0 110.109 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.58 74.5 4.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 110.193 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.45 -153.97 0.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.335 -0.853 . . . . 0.0 110.213 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 2.1 m-20 54.99 30.24 13.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 110.187 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 p -159.58 147.87 17.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.019 . . . . 0.0 110.666 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.11 -179.33 45.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.04 119.68 28.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.176 -1.191 . . . . 0.0 110.26 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.439 ' CG ' ' HB3' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -94.4 131.83 39.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.427 -0.796 . . . . 0.0 110.893 -179.471 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -78.74 128.96 34.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.099 -1.0 . . . . 0.0 108.547 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -164.45 164.53 21.95 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.702 -1.249 . . . . 0.0 111.477 -178.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.98 -167.29 2.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.19 173.67 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.919 -1.113 . . . . 0.0 110.447 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -148.09 154.61 40.43 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.444 -0.785 . . . . 0.0 109.697 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.99 140.58 57.73 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.334 -0.853 . . . . 0.0 109.771 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -63.28 147.16 51.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.993 . . . . 0.0 110.205 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.4 OUTLIER 69.0 5.98 5.37 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.673 -0.642 . . . . 0.0 110.681 -179.452 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.44 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -137.01 -167.42 2.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.027 -1.045 . . . . 0.0 109.344 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.44 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.9 OUTLIER -131.62 13.77 4.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.0 110.147 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -136.44 133.62 36.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.15 -0.969 . . . . 0.0 110.715 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.441 ' CG2' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -62.18 136.49 57.96 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.252 -0.905 . . . . 0.0 109.087 179.29 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.28 -17.96 5.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.917 -1.114 . . . . 0.0 111.81 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 49' ' ' ALA . 1.2 mp -137.98 -74.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.897 -1.127 . . . . 0.0 110.532 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.455 ' N ' ' CG2' ' A' ' 48' ' ' ILE . . . -45.13 -26.63 0.49 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.769 -0.582 . . . . 0.0 111.238 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.441 ' CB ' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER -52.57 -23.64 6.78 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.094 -1.004 . . . . 0.0 111.102 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -102.73 15.41 29.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.969 -1.082 . . . . 0.0 111.026 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 52.7 m-85 -123.06 -10.64 8.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.039 -1.038 . . . . 0.0 110.967 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CZ ' ' CE ' ' A' ' 81' ' ' MET . 17.5 m-85 -119.52 115.33 23.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.063 -1.023 . . . . 0.0 110.309 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -72.24 169.47 16.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 110.6 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.413 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -147.54 161.96 33.76 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.428 -0.795 . . . . 0.0 109.76 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.413 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 60.6 Cg_endo -83.6 -175.07 13.46 Favored 'Cis proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.592 -2.253 . . . . 0.0 110.728 -0.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.487 ' HB2' ' CD1' ' A' ' 36' ' ' TYR . . . -99.49 -171.46 2.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.369 -0.832 . . . . 0.0 109.752 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -127.63 121.16 29.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.055 -1.028 . . . . 0.0 110.372 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.517 ' CD1' ' CE ' ' A' ' 61' ' ' LYS . 38.6 p90 -96.36 161.28 14.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 0.0 109.893 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.478 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -155.19 121.03 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 110.609 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.517 ' CE ' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -130.88 117.91 19.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.089 -1.007 . . . . 0.0 110.654 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -93.61 61.57 3.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.25 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 49.62 101.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.555 -0.715 . . . . 0.0 111.431 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.1 56.99 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.466 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -142.49 158.62 43.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.056 -1.261 . . . . 0.0 110.08 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.574 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -158.86 138.28 11.59 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.988 0.899 . . . . 0.0 111.201 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -141.56 178.95 7.1 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.633 -0.667 . . . . 0.0 109.308 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.06 141.42 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 0.0 110.472 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -98.38 144.2 28.02 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 109.922 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.98 135.0 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.264 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.51 123.84 33.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.883 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.3 t -103.21 131.21 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.928 . . . . 0.0 110.381 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -100.26 134.01 43.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.219 -0.926 . . . . 0.0 110.049 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 62.14 116.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.3 -0.875 . . . . 0.0 110.036 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.92 -25.26 24.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.177 -0.952 . . . . 0.0 110.638 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -59.66 4.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.994 . . . . 0.0 110.357 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.481 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 39.8 m0 -53.58 -62.46 1.64 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.902 . . . . 0.0 110.436 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.408 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 0.8 OUTLIER -88.34 120.38 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.954 . . . . 0.0 109.964 179.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.424 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -87.05 -23.25 25.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.392 -0.818 . . . . 0.0 110.758 -179.3 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.424 ' N ' HG21 ' A' ' 79' ' ' THR . . . 175.13 -177.01 47.25 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.52 ' CE ' ' CZ ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -151.18 168.16 25.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -1.076 . . . . 0.0 110.185 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 116' ' ' LYS . 3.2 t -154.33 137.87 15.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 109.845 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.514 ' CD1' ' CD2' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -132.27 140.01 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.345 -179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 73.35 -1.07 3.17 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.809 -0.557 . . . . 0.0 111.224 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.62 21.92 8.42 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.632 -1.27 . . . . 0.0 111.121 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.443 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.37 162.99 32.1 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.637 -1.508 . . . . 0.0 110.269 179.285 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -171.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 110.547 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -109.07 170.22 8.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.341 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.6 122.02 44.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.319 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pt -67.39 103.59 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.168 -0.958 . . . . 0.0 109.911 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.446 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.5 tt -95.66 -28.51 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.886 . . . . 0.0 110.964 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.6 p -167.53 105.21 0.52 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.033 -1.042 . . . . 0.0 110.081 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm -95.29 107.72 19.84 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.277 -0.889 . . . . 0.0 110.017 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.65 95.99 8.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 110.385 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.67 -29.65 56.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.099 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -47.78 82.37 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.305 -0.872 . . . . 0.0 110.078 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -95.85 12.24 30.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 110.419 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.9 t0 51.33 56.95 7.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.019 -1.051 . . . . 0.0 110.152 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -148.14 154.75 40.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.202 -0.936 . . . . 0.0 110.442 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -143.68 166.14 25.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 109.941 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.446 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 87.0 m -141.35 150.69 42.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.382 -0.824 . . . . 0.0 109.636 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.423 ' N ' HG21 ' A' ' 101' ' ' THR . 79.9 p -145.31 141.48 28.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.036 -1.04 . . . . 0.0 110.733 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.04 144.1 25.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.842 . . . . 0.0 109.885 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -127.87 136.95 52.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.062 -1.024 . . . . 0.0 110.757 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -93.13 127.48 38.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -0.883 . . . . 0.0 109.449 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.3 m -149.68 171.36 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.017 -1.052 . . . . 0.0 110.954 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.79 110.47 18.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.33 -156.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 109.678 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.438 HD12 ' CA ' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -150.86 59.83 0.93 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.983 -1.073 . . . . 0.0 110.982 -179.267 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.439 ' HB2' ' CG2' ' A' ' 146' ' ' THR . 0.6 OUTLIER -146.12 104.19 3.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.293 -0.879 . . . . 0.0 110.337 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.35 -131.88 6.13 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.4 ' HB3' ' HG2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -157.0 152.42 26.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.299 -1.118 . . . . 0.0 110.0 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mt -135.78 145.24 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.882 . . . . 0.0 110.17 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -76.06 113.12 13.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.347 -0.845 . . . . 0.0 110.058 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.468 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -122.26 -170.4 13.69 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 82' ' ' SER . 4.1 mttp -147.66 171.95 14.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -1.155 . . . . 0.0 109.977 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -157.67 145.11 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -0.96 . . . . 0.0 110.453 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 117' ' ' ILE . 7.7 m-20 -105.63 155.04 19.61 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.473 -0.767 . . . . 0.0 109.535 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.482 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -132.4 146.47 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 110.127 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -151.76 115.02 4.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.89 . . . . 0.0 110.55 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.481 ' CG1' ' HA ' ' A' ' 77' ' ' TRP . 2.2 mp -141.51 152.57 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -0.95 . . . . 0.0 110.337 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.55 101.08 1.5 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 0.0 109.828 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -173.62 -176.93 1.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.378 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -97.61 105.18 17.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 110.391 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 t -76.29 99.24 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.0 109.898 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 55.5 50.46 14.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.32 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.31 33.28 44.75 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 106.31 4.33 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.085 -1.244 . . . . 0.0 110.233 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -58.04 128.01 27.19 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.541 1.285 . . . . 0.0 110.108 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -127.13 148.05 50.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.355 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.3 99.07 4.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.364 -0.835 . . . . 0.0 109.837 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.482 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 3.0 t80 -102.0 131.14 48.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 109.894 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -166.37 77.48 0.22 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.227 -0.92 . . . . 0.0 110.229 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -153.83 -173.82 4.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.291 -0.881 . . . . 0.0 110.339 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.449 ' O ' ' CD2' ' A' ' 136' ' ' TYR . 6.1 p80 -119.79 162.53 18.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 110.11 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 135' ' ' HIS . 54.7 m-85 -155.09 137.34 14.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.964 . . . . 0.0 110.423 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.441 ' OD1' ' CG ' ' A' ' 41' ' ' TYR . 28.1 p30 -88.63 159.23 17.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.315 -0.866 . . . . 0.0 110.267 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -156.69 155.92 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.269 -0.895 . . . . 0.0 110.051 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.2 m -91.81 123.06 34.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.265 -0.897 . . . . 0.0 111.074 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.514 ' CD2' ' CD1' ' A' ' 83' ' ' ILE . 62.7 m-85 -90.82 154.6 19.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.395 -0.816 . . . . 0.0 109.236 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -140.23 95.3 2.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.894 -1.129 . . . . 0.0 110.683 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -91.06 133.45 35.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.321 -0.862 . . . . 0.0 110.197 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.421 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 3.6 m-80 -137.58 102.08 4.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 110.451 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.438 ' CA ' HD12 ' A' ' 109' ' ' LEU . . . -146.07 -142.11 3.72 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.406 ' HD2' ' HA3' ' A' ' 144' ' ' GLY . 1.9 Cg_endo -49.18 141.0 24.45 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.576 1.303 . . . . 0.0 110.756 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.439 ' CG2' ' HB2' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -150.49 30.44 0.67 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.166 179.714 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -121.85 -52.22 2.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 110.415 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.9 t 58.11 35.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.368 -0.832 . . . . 0.0 110.325 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.83 82.25 7.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.988 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.483 HMC2 ' CD2' ' A' ' 52' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.276 0.56 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -98.83 55.61 1.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -0.897 . . . . 0.0 110.236 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 24.2 t30 63.23 22.07 13.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.909 . . . . 0.0 110.15 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -110.6 56.11 0.64 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 110.284 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 42.15 -162.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.761 -0.587 . . . . 0.0 111.076 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 1.1 m-20 54.87 29.85 12.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 110.373 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.6 p -161.81 150.4 15.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.841 . . . . 0.0 110.32 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 161.31 177.94 34.83 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.404 HG22 ' HG2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -88.18 104.9 17.14 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.358 -1.084 . . . . 0.0 110.321 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.486 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -94.61 158.6 15.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 110.499 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.431 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 3.6 m-20 -78.8 140.79 38.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.898 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.452 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -165.46 153.89 11.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 110.105 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.34 -177.06 6.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.235 -0.916 . . . . 0.0 110.352 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.436 ' O ' ' CG2' ' A' ' 46' ' ' THR . 1.6 m -140.04 178.09 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.348 -0.845 . . . . 0.0 109.843 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -149.39 162.8 39.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 110.481 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.3 OUTLIER -68.15 123.73 21.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.362 -0.836 . . . . 0.0 109.79 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -53.26 144.94 14.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.977 . . . . 0.0 109.955 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 6.1 m120 71.62 1.52 3.91 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.857 -0.527 . . . . 0.0 111.1 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.411 ' CG2' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -136.98 -166.86 1.98 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.829 -1.169 . . . . 0.0 109.827 179.15 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.74 21.4 3.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 110.443 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -133.15 126.06 30.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.122 -0.986 . . . . 0.0 110.956 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.445 ' CG2' ' HB2' ' A' ' 50' ' ' ASN . 0.7 OUTLIER -55.11 118.48 4.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.601 -0.687 . . . . 0.0 109.686 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.51 -18.58 3.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.8 -1.188 . . . . 0.0 112.078 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.0 mt -138.88 -76.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.789 -1.195 . . . . 0.0 111.122 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.434 ' O ' ' CD2' ' A' ' 53' ' ' PHE . . . -46.0 -26.41 0.72 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.622 -0.674 . . . . 0.0 111.176 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.445 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 16.9 t-20 -68.9 -13.4 62.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.075 -1.016 . . . . 0.0 110.792 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -102.59 15.13 30.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.974 -1.079 . . . . 0.0 111.123 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -136.42 11.33 3.24 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.008 -1.058 . . . . 0.0 110.808 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.434 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 25.2 m-85 -130.98 115.62 16.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.077 -1.014 . . . . 0.0 110.122 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -72.59 164.23 26.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.355 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.467 ' CD ' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -146.83 164.43 23.74 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.274 -0.891 . . . . 0.0 110.048 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.41 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 57.2 Cg_endo -78.86 -175.44 16.71 Favored 'Cis proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.438 -2.317 . . . . 0.0 110.45 -0.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.52 167.96 9.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.077 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.427 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -101.45 113.51 26.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.32 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.486 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 1.7 p90 -97.06 161.95 13.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 110.004 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 1.0 OUTLIER -154.81 156.99 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.089 -1.007 . . . . 0.0 110.465 179.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 34.6 mtmt -140.34 170.23 16.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.179 -0.95 . . . . 0.0 111.058 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 12.5 mtmt -157.05 62.15 0.51 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.549 -0.719 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t30 51.05 87.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.344 -0.848 . . . . 0.0 111.26 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.83 24.91 39.96 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.696 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 62' ' ' LYS . 2.8 ptpt -167.56 153.3 7.46 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.914 -1.345 . . . . 0.0 110.941 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -158.78 151.17 21.61 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 122.347 1.07 . . . . 0.0 111.696 178.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 6.3 m-85 -143.85 170.41 15.94 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.18 145.04 21.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.908 -1.12 . . . . 0.0 110.389 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.436 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 4.6 pt20 -97.84 132.77 43.15 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.355 -0.84 . . . . 0.0 109.593 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.38 137.57 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.942 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.08 128.45 35.75 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.209 -0.932 . . . . 0.0 109.939 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.84 126.37 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.977 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 74' ' ' HIS . 21.6 m-20 -99.18 128.03 45.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.363 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.414 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 0.1 OUTLIER 64.23 113.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.85 . . . . 0.0 110.198 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.58 -38.31 23.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.202 -0.937 . . . . 0.0 110.257 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -55.35 -42.45 73.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.212 -0.93 . . . . 0.0 110.182 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.486 ' CD1' HBB1 ' A' ' 151' ' ' ZNH . 34.4 m0 -67.4 -64.32 0.88 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 110.282 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.9 tt -88.81 126.3 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.379 -0.826 . . . . 0.0 110.007 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.438 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -87.88 -24.81 23.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.441 -0.787 . . . . 0.0 110.975 -179.298 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.438 ' N ' HG21 ' A' ' 79' ' ' THR . . . 178.16 -179.05 48.62 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.627 -1.273 . . . . 0.0 109.955 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.8 mtm -151.59 161.85 41.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.265 -1.138 . . . . 0.0 110.352 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -154.99 146.24 22.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.86 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 3.6 mt -139.17 142.77 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.903 . . . . 0.0 110.657 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 2.5 tm-20 72.26 -0.35 3.29 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.693 -0.63 . . . . 0.0 111.56 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.87 20.27 9.52 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.537 -1.316 . . . . 0.0 111.006 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.477 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.72 159.31 42.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.649 -1.5 . . . . 0.0 110.365 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -71.17 179.69 2.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 110.177 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -102.23 170.17 8.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.904 . . . . 0.0 110.083 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.2 129.7 56.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.938 . . . . 0.0 110.243 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.451 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 0.8 OUTLIER -67.65 102.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 109.767 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.434 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.5 tt -95.15 -25.86 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -0.861 . . . . 0.0 110.853 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.407 ' N ' HG21 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -167.35 104.88 0.53 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.122 -0.986 . . . . 0.0 109.659 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -96.34 145.69 25.39 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.399 -0.813 . . . . 0.0 110.265 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.22 78.98 1.62 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 110.115 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.25 -25.88 67.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 110.327 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.16 64.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 110.112 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -96.57 17.3 16.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.392 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 t0 50.41 63.13 2.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.975 . . . . 0.0 110.013 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -147.15 162.28 39.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.335 -0.853 . . . . 0.0 110.346 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -163.72 161.75 23.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.435 -0.791 . . . . 0.0 109.873 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.434 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 86.9 m -142.42 150.37 40.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.655 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.421 ' N ' HG23 ' A' ' 101' ' ' THR . 78.5 p -145.42 143.6 30.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.052 -1.03 . . . . 0.0 110.76 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -93.4 147.33 23.04 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.374 -0.829 . . . . 0.0 109.838 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -128.18 131.45 48.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.132 -0.98 . . . . 0.0 110.924 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -96.08 124.84 40.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.879 . . . . 0.0 109.474 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.6 m -149.28 -171.71 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.051 -1.031 . . . . 0.0 110.665 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.9 111.96 23.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.442 -0.786 . . . . 0.0 109.144 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.451 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.69 -162.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.456 -0.777 . . . . 0.0 109.969 -178.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.453 HD23 ' CD2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -149.84 56.92 0.97 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.015 -1.053 . . . . 0.0 110.644 -179.72 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -145.63 79.53 1.57 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.879 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.63 170.98 19.67 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.06 144.42 30.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -1.154 . . . . 0.0 110.482 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.476 HD12 ' CD2' ' A' ' 142' ' ' PHE . 5.3 mt -136.34 146.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 0.0 109.719 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.15 117.3 17.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.151 -0.968 . . . . 0.0 110.496 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.11 176.05 16.4 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 82' ' ' SER . 15.9 mttt -144.43 163.52 33.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -1.155 . . . . 0.0 109.945 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -157.89 140.64 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 110.43 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -101.56 154.35 18.93 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.366 -0.834 . . . . 0.0 109.254 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.468 HG12 ' CD2' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -133.4 151.05 32.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.999 -1.063 . . . . 0.0 110.781 -179.288 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -150.69 99.5 2.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.595 -0.69 . . . . 0.0 109.362 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 77' ' ' TRP . 20.1 mt -135.04 153.33 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.259 -0.9 . . . . 0.0 110.738 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -159.87 106.27 1.62 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.499 -0.75 . . . . 0.0 109.169 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.4 162.13 6.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.315 -0.866 . . . . 0.0 110.216 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -89.78 113.88 25.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 110.495 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.4 t -76.92 96.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.341 -0.849 . . . . 0.0 110.218 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.22 29.74 13.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.595 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.95 32.94 5.69 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -144.94 100.51 4.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.317 -1.107 . . . . 0.0 110.138 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.54 115.29 1.71 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.765 1.403 . . . . 0.0 110.468 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 8.2 t80 -111.95 125.63 54.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 110.17 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.2 139.39 37.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 110.147 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.468 ' CD2' HG12 ' A' ' 119' ' ' VAL . 1.6 t80 -153.43 113.83 3.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.809 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.403 ' O ' ' CG ' ' A' ' 134' ' ' HIS . 8.1 t0 -165.92 88.33 0.39 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.136 -0.977 . . . . 0.0 110.154 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.403 ' CG ' ' O ' ' A' ' 133' ' ' ASP . 74.1 m-70 -154.04 -168.26 2.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 110.282 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.6 85.46 2.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.796 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -85.86 -178.57 6.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.825 . . . . 0.0 110.416 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.42 ' OD1' ' CD2' ' A' ' 41' ' ' TYR . 11.6 p30 -150.33 174.27 13.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.938 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.4 ' C ' ' CD1' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -155.92 165.34 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.135 -0.978 . . . . 0.0 110.614 -179.655 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 61.8 m -91.81 113.82 26.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.406 -0.809 . . . . 0.0 110.525 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.46 ' CD2' HD12 ' A' ' 83' ' ' ILE . 27.6 m-85 -89.63 155.15 19.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.979 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.79 112.77 5.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.946 . . . . 0.0 110.523 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.476 ' CD2' HD12 ' A' ' 113' ' ' ILE . 27.2 m-85 -91.98 155.78 17.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 110.313 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.431 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 61.3 m-80 -140.03 96.93 3.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -0.979 . . . . 0.0 110.332 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.5 -151.95 6.47 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -63.19 -172.09 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.889 1.468 . . . . 0.0 110.567 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.37 -46.28 0.14 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.214 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -132.04 -48.58 0.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 110.082 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.2 t 56.37 54.17 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.1 25.74 0.26 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.188 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.486 HBB1 ' CD1' ' A' ' 77' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.26 0.552 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.418 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -123.62 94.28 4.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.21 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 0.7 OUTLIER 63.95 40.09 7.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 0.0 110.037 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.36 150.11 37.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.381 -0.824 . . . . 0.0 110.445 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.02 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.368 -0.833 . . . . 0.0 110.197 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER 54.99 28.16 10.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.263 -0.898 . . . . 0.0 110.512 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.0 t -160.86 130.02 4.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.899 . . . . 0.0 110.29 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . -170.77 179.19 42.89 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.72 110.67 21.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.401 -1.058 . . . . 0.0 110.505 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.49 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -95.36 148.62 22.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 109.99 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.429 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -79.16 134.26 36.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.085 -1.01 . . . . 0.0 110.339 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.519 ' CE1' ' CB ' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -166.27 167.91 15.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.152 -0.968 . . . . 0.0 110.839 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.98 -172.93 4.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.542 -0.724 . . . . 0.0 109.764 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.435 ' CG1' ' CE1' ' A' ' 140' ' ' TYR . 0.6 OUTLIER -140.73 107.73 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.688 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.0 161.38 15.16 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.455 -0.778 . . . . 0.0 110.497 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.412 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -67.84 137.38 55.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.374 -0.829 . . . . 0.0 110.081 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.474 ' CD2' ' OD1' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -62.53 145.47 54.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.035 -1.041 . . . . 0.0 110.064 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 12.6 t30 70.42 3.49 4.5 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.763 -0.586 . . . . 0.0 110.771 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.423 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -139.25 -171.08 3.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.878 -1.139 . . . . 0.0 109.538 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.423 ' N ' ' OG1' ' A' ' 43' ' ' THR . 17.5 p30 -134.63 23.48 3.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.106 -0.996 . . . . 0.0 110.055 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.64 121.47 19.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 111.075 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.46 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER -49.79 126.87 14.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.583 -0.698 . . . . 0.0 109.291 178.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.431 ' HB3' ' CD1' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -129.84 -19.36 3.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.74 -1.225 . . . . 0.0 112.449 -178.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.431 ' CD1' ' HB3' ' A' ' 47' ' ' SER . 1.4 mp -139.45 -78.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.65 -1.281 . . . . 0.0 111.296 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.429 ' N ' ' CG2' ' A' ' 48' ' ' ILE . . . -45.01 -26.42 0.43 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.853 -0.53 . . . . 0.0 111.337 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.46 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 4.7 p30 -60.92 -15.49 31.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.091 -1.006 . . . . 0.0 110.882 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.421 ' C ' ' CD1' ' A' ' 52' ' ' TYR . 6.2 m-20 -101.8 15.2 29.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.054 -1.029 . . . . 0.0 110.896 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.473 ' CD1' HBC2 ' A' ' 151' ' ' ZNH . 43.3 m-85 -140.08 10.39 2.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.004 -1.06 . . . . 0.0 110.554 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.417 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 30.7 m-85 -132.02 113.27 13.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 110.174 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.69 164.55 26.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.705 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -146.57 161.66 37.25 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.4 -0.812 . . . . 0.0 109.71 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -79.93 -175.39 16.27 Favored 'Cis proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.522 -2.282 . . . . 0.0 110.396 -0.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.519 ' CB ' ' CE1' ' A' ' 36' ' ' TYR . . . -101.14 166.29 10.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.933 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.54 116.0 31.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.948 . . . . 0.0 110.465 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 28.9 p90 -97.1 163.87 12.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 109.823 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -155.11 151.0 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.109 -0.994 . . . . 0.0 110.558 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 28.1 mtmt -134.5 174.0 11.03 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -0.9 . . . . 0.0 110.945 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 9.5 mttt -155.93 62.33 0.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.4 -0.813 . . . . 0.0 110.021 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m120 53.97 85.86 0.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.338 -0.851 . . . . 0.0 111.188 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.43 23.58 50.36 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.203 -0.999 . . . . 0.0 110.705 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 62' ' ' LYS . 8.6 ptpt -166.12 161.17 16.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.814 -1.404 . . . . 0.0 110.951 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 2.5 pt? -173.11 158.0 3.59 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.152 0.977 . . . . 0.0 111.555 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.566 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -139.27 -153.84 0.49 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 1.2 t -170.17 135.16 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 110.026 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 5.1 pt20 -97.39 133.66 41.69 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.63 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.2 142.93 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 110.099 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.18 129.59 35.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 110.199 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -104.1 127.29 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 110.159 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.0 137.9 37.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 110.341 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 52.42 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.339 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -73.52 -31.68 63.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 110.217 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -55.48 -36.93 67.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 110.31 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -83.6 -50.86 7.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 110.15 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.417 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 19.5 tt -89.75 125.34 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 109.942 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -87.1 -29.88 21.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 110.579 -179.577 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.448 ' N ' HG23 ' A' ' 79' ' ' THR . . . 174.15 -168.37 41.13 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.8 mtp -151.99 169.19 22.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -1.125 . . . . 0.0 110.469 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.36 131.62 11.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.871 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.3 mt -131.25 147.32 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.933 . . . . 0.0 110.344 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' OE1' ' CA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER 66.46 7.29 4.91 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.133 -0.979 . . . . 0.0 111.004 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.03 25.49 19.52 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.895 -1.145 . . . . 0.0 111.297 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.47 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -139.48 161.29 37.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.638 -1.507 . . . . 0.0 110.482 179.262 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.41 -173.74 0.95 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.13 -0.981 . . . . 0.0 110.561 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.475 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 1.8 pt-20 -110.24 170.05 8.34 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.368 -0.832 . . . . 0.0 110.278 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.14 127.46 54.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.274 -0.891 . . . . 0.0 110.268 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.29 103.95 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 0.0 109.597 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.437 HG23 ' CG2' ' A' ' 101' ' ' THR . 1.1 tt -95.92 -30.1 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 111.085 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.7 p -167.43 104.91 0.53 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.016 -1.052 . . . . 0.0 110.015 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -95.53 108.54 20.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 110.154 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.75 62.14 2.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.289 -0.882 . . . . 0.0 110.177 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.59 -21.93 30.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.297 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -18.69 62.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.211 -0.931 . . . . 0.0 110.288 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -136.31 22.19 3.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 110.278 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 55.89 64.42 1.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -0.868 . . . . 0.0 110.521 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -148.18 -179.51 6.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.278 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 179.22 162.32 0.81 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.2 -0.938 . . . . 0.0 110.135 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.437 ' CG2' HG23 ' A' ' 91' ' ' ILE . 97.2 m -141.48 152.46 44.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 109.651 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.4 p -144.36 139.59 28.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.008 -1.057 . . . . 0.0 110.548 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.28 141.14 28.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.388 -0.82 . . . . 0.0 110.01 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.475 ' CE1' ' HB2' ' A' ' 88' ' ' GLU . 68.3 m-85 -129.0 138.26 51.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.157 -0.964 . . . . 0.0 110.669 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -99.0 130.66 45.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.272 -0.892 . . . . 0.0 109.616 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.0 p -149.42 152.12 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.02 -1.05 . . . . 0.0 110.86 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.6 m -63.68 106.41 0.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -0.931 . . . . 0.0 109.145 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.471 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 48.4 -174.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.494 -0.753 . . . . 0.0 110.062 -178.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.449 ' HG ' ' CD1' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -150.13 75.45 1.24 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.977 -1.077 . . . . 0.0 110.691 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -146.09 43.22 1.23 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.86 . . . . 0.0 110.246 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.64 -169.62 38.21 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -81.71 151.59 27.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -1.181 . . . . 0.0 110.437 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 140' ' ' TYR . 13.9 mm -136.31 132.35 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.418 -0.801 . . . . 0.0 109.884 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.68 103.03 6.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 0.0 110.191 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.57 175.85 15.94 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -147.88 177.46 9.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -1.14 . . . . 0.0 109.532 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -157.21 149.48 10.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.103 -0.998 . . . . 0.0 111.099 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.433 ' HB2' ' CG2' ' A' ' 79' ' ' THR . 69.0 m-20 -106.83 156.14 18.99 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.447 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 2.2 t -140.45 149.44 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 110.142 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -151.01 116.36 5.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 0.0 110.381 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.491 HD12 ' CD2' ' A' ' 132' ' ' TYR . 3.9 mt -134.97 153.83 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.44 -0.788 . . . . 0.0 109.994 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.54 102.28 1.71 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.145 -0.972 . . . . 0.0 109.971 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -173.17 175.28 3.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.522 -0.736 . . . . 0.0 109.829 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 100.7 12.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.148 -0.97 . . . . 0.0 110.344 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.2 t -76.92 112.15 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.339 -0.851 . . . . 0.0 109.965 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 53.98 43.44 30.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 110.212 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.53 38.09 68.78 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -145.26 108.41 4.54 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.228 -1.16 . . . . 0.0 110.048 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -47.96 129.19 17.7 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.682 1.359 . . . . 0.0 110.377 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.487 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 36.6 t80 -135.38 139.91 44.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 110.132 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -135.08 121.45 20.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.0 110.262 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.491 ' CD2' HD12 ' A' ' 121' ' ' ILE . 3.2 t80 -114.2 141.45 47.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 109.617 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -175.99 81.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.085 -1.01 . . . . 0.0 110.298 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.19 178.77 9.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 0.0 110.589 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.406 ' ND1' ' N ' ' A' ' 135' ' ' HIS . 1.8 m80 -119.0 96.38 5.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.315 -0.866 . . . . 0.0 109.631 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.93 139.53 31.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 110.483 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.474 ' OD1' ' CD2' ' A' ' 41' ' ' TYR . 25.4 p30 -88.72 159.72 17.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.327 -0.858 . . . . 0.0 110.157 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.455 HG13 ' CE2' ' A' ' 140' ' ' TYR . 6.9 pt -156.35 166.28 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 110.1 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 88.6 m -91.76 161.27 14.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.359 -0.838 . . . . 0.0 110.572 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.455 ' CE2' HG13 ' A' ' 138' ' ' ILE . 19.3 m-85 -147.06 98.66 3.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.428 -0.795 . . . . 0.0 109.635 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 112' ' ' LYS . 9.6 mtpt -101.46 105.3 16.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.896 . . . . 0.0 110.874 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 140' ' ' TYR . 98.3 m-85 -92.2 140.34 29.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.889 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.458 ' N ' ' ND2' ' A' ' 143' ' ' ASN . 2.1 m-80 -124.02 98.67 5.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -0.99 . . . . 0.0 110.453 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.412 ' HA3' ' HD2' ' A' ' 145' ' ' PRO . . . -151.36 -148.67 4.87 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.416 ' HD2' ' CD1' ' A' ' 109' ' ' LEU . 10.3 Cg_endo -56.77 150.28 54.89 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.639 1.336 . . . . 0.0 110.077 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.4 p -90.5 -46.08 8.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.959 . . . . 0.0 110.313 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -155.29 -43.81 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.375 -0.828 . . . . 0.0 110.066 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.5 t 56.36 41.9 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.207 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.19 75.55 8.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 110.17 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.921 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.487 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.218 0.532 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.12 101.52 3.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.288 -0.882 . . . . 0.0 110.267 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 63.34 35.46 12.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 110.077 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -177.06 160.36 1.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 110.35 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.67 -160.61 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.231 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER 54.34 25.32 5.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.268 -0.895 . . . . 0.0 110.478 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.6 t -160.11 134.67 7.6 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 110.451 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.84 179.09 48.47 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.39 112.23 22.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -1.124 . . . . 0.0 110.335 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.513 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -94.73 146.83 23.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 110.431 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.404 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -80.7 133.15 35.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 109.779 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -165.88 162.69 18.45 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.154 -0.966 . . . . 0.0 110.716 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.47 -168.29 2.78 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.455 -0.778 . . . . 0.0 109.526 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.431 ' O ' ' CG2' ' A' ' 46' ' ' THR . 2.5 m -140.92 117.88 8.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.047 -1.033 . . . . 0.0 110.349 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -90.86 155.54 18.68 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.42 -0.8 . . . . 0.0 110.134 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.412 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.3 OUTLIER -67.44 126.83 30.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.401 -0.812 . . . . 0.0 110.111 -179.767 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.511 ' CD2' ' ND2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -56.96 147.37 24.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.913 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.8 t30 72.77 -0.01 3.5 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.963 -0.461 . . . . 0.0 110.811 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -138.73 -168.32 2.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.937 -1.102 . . . . 0.0 109.445 179.189 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.42 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.1 OUTLIER -136.28 25.27 3.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.014 -1.054 . . . . 0.0 110.357 179.667 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -135.62 118.63 16.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.057 -1.027 . . . . 0.0 111.354 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.443 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.6 OUTLIER -48.82 120.64 3.97 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.66 -18.06 3.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.709 -1.244 . . . . 0.0 112.466 -178.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 95.3 mt -137.98 -76.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.624 -1.298 . . . . 0.0 111.279 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -50.28 -21.94 1.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.742 -0.599 . . . . 0.0 111.593 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.443 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 59.8 t30 -59.08 -32.92 70.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.039 . . . . 0.0 111.388 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.18 15.89 27.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.016 -1.053 . . . . 0.0 111.025 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.461 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -98.65 -17.55 18.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.02 -1.05 . . . . 0.0 111.069 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.501 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 9.3 p90 -127.0 134.3 50.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.0 -1.062 . . . . 0.0 111.037 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.78 113.88 12.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.904 . . . . 0.0 109.937 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.72 162.34 29.48 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.015 -1.053 . . . . 0.0 110.005 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -83.09 -175.46 14.6 Favored 'Cis proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.55 -2.271 . . . . 0.0 110.526 -0.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.492 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . . . -102.53 -171.61 1.99 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 0.0 110.176 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.402 ' CB ' ' CG ' ' A' ' 69' ' ' GLN . 2.2 ttmt -125.29 113.35 17.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 0.0 110.251 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.513 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 10.0 p90 -97.26 165.42 12.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 110.31 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -155.48 156.81 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.363 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.576 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 19.8 mtmt -140.64 173.53 11.4 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.353 -0.842 . . . . 0.0 110.599 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.429 ' CB ' ' HD2' ' A' ' 65' ' ' LYS . 1.6 mtmm -158.53 62.23 0.43 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.843 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m120 45.11 82.6 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.661 -0.65 . . . . 0.0 111.195 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.91 14.78 33.06 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.608 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HD2' ' CB ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -165.77 163.17 18.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.96 -1.318 . . . . 0.0 110.982 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 2.4 pt? -172.68 144.67 1.43 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.015 0.912 . . . . 0.0 111.356 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -139.01 173.33 11.67 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.175 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -142.24 142.17 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.042 -1.036 . . . . 0.0 110.429 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.402 ' CG ' ' CB ' ' A' ' 58' ' ' LYS . 3.3 pp0? -97.66 132.35 43.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.398 -0.814 . . . . 0.0 109.641 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.49 132.63 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 110.457 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.54 125.2 35.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.679 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.438 ' CG2' ' HB3' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -103.15 134.22 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.901 . . . . 0.0 110.465 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -102.12 145.44 29.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.388 -0.82 . . . . 0.0 110.034 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 11.1 m170 50.61 87.39 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 110.141 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.2 p -57.21 -36.21 70.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.355 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -55.62 -32.8 63.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 110.353 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.483 ' CE2' HBB1 ' A' ' 151' ' ' ZNH . 35.7 m0 -76.3 -60.67 2.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 110.378 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.44 ' CD1' HG13 ' A' ' 117' ' ' ILE . 2.1 tp -88.41 117.2 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.437 -0.789 . . . . 0.0 110.058 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -86.82 -24.59 24.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -0.803 . . . . 0.0 110.836 -179.341 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 79' ' ' THR . . . 179.98 177.89 48.25 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.606 -1.283 . . . . 0.0 109.955 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.1 mtt -152.94 162.42 41.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -1.148 . . . . 0.0 109.969 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 t -154.81 153.48 31.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.958 . . . . 0.0 110.01 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.485 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.9 OUTLIER -151.77 147.21 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 110.896 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 61.07 10.65 2.98 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.488 -0.757 . . . . 0.0 111.944 179.204 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.75 2.16 34.59 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.313 -1.423 . . . . 0.0 111.39 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 83' ' ' ILE . 5.2 p80 -135.39 150.25 49.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.534 -1.568 . . . . 0.0 110.824 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -70.15 -164.23 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 110.437 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 9.6 pt-20 -106.79 170.24 8.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.857 . . . . 0.0 110.492 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.34 136.24 50.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.019 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -67.96 100.94 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.989 -1.07 . . . . 0.0 109.648 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.425 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.1 tt -96.26 -29.13 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.0 110.776 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.4 m -167.38 99.48 0.51 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.162 -0.961 . . . . 0.0 109.963 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -95.61 152.99 17.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.816 . . . . 0.0 110.041 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -142.79 73.66 1.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 110.172 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.57 -34.27 72.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.269 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -47.09 85.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.119 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -96.32 14.82 23.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.46 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 51.16 55.13 9.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.109 -0.995 . . . . 0.0 110.103 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 94' ' ' ASN . 54.3 mt-10 -146.32 168.1 21.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.327 -0.858 . . . . 0.0 110.168 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.438 ' HB3' ' CG2' ' A' ' 72' ' ' VAL . 4.2 ttt180 -172.96 163.23 4.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.212 -0.93 . . . . 0.0 109.93 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.438 ' N ' ' CG ' ' A' ' 100' ' ' ARG . 62.9 m -139.96 153.98 47.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.863 . . . . 0.0 110.122 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.432 ' N ' HG22 ' A' ' 101' ' ' THR . 5.1 p -145.59 143.93 30.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.427 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.99 147.51 22.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.283 -0.886 . . . . 0.0 109.965 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.475 ' CZ ' ' HB3' ' A' ' 88' ' ' GLU . 15.6 m-85 -128.02 135.84 50.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 110.683 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.11 131.13 51.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.721 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.0 m -149.22 159.12 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.14 -0.975 . . . . 0.0 110.558 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.8 t -50.44 -45.04 55.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 109.142 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.443 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.5 -165.43 0.85 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.658 -0.651 . . . . 0.0 109.485 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.441 ' CD2' ' HB2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -149.99 71.48 1.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.073 -1.017 . . . . 0.0 110.548 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -146.17 55.49 1.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.404 -0.81 . . . . 0.0 110.177 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 142' ' ' PHE . . . 169.37 -108.27 0.29 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.41 ' HG3' HG21 ' A' ' 139' ' ' THR . 1.5 tmtt? -156.44 135.15 11.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.35 -1.088 . . . . 0.0 109.902 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.2 mt -128.97 147.27 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.124 -0.985 . . . . 0.0 110.291 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.89 119.95 20.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.952 . . . . 0.0 110.407 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -124.71 178.79 16.38 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -146.49 158.51 43.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -1.088 . . . . 0.0 109.842 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.44 HG13 ' CD1' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.55 146.91 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.069 -1.019 . . . . 0.0 110.581 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.435 ' N ' HG12 ' A' ' 117' ' ' ILE . 1.4 m-20 -106.92 159.79 16.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.532 -0.73 . . . . 0.0 109.534 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.461 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -136.24 151.63 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 0.0 110.286 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.16 103.91 3.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.385 -0.822 . . . . 0.0 110.513 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.483 HD12 ' CD2' ' A' ' 132' ' ' TYR . 65.4 mt -132.34 153.18 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 110.136 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.42 ' N ' HG23 ' A' ' 121' ' ' ILE . 0.8 OUTLIER -159.29 97.16 1.35 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.384 -0.823 . . . . 0.0 109.851 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -173.54 -179.73 1.91 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 110.165 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -103.16 108.01 19.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.096 -1.003 . . . . 0.0 110.295 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.5 t -76.82 100.01 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.296 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.417 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 1.6 m120 62.65 42.08 8.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.222 -0.924 . . . . 0.0 110.519 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.1 36.49 24.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.08 106.21 4.48 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.155 -1.203 . . . . 0.0 110.12 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -51.18 115.19 1.89 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.695 1.366 . . . . 0.0 110.251 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.47 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 6.1 t80 -114.9 116.87 29.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 110.473 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.38 133.95 47.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.398 -0.814 . . . . 0.0 109.775 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.483 ' CD2' HD12 ' A' ' 121' ' ' ILE . 2.3 t80 -149.79 119.38 6.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.161 -0.962 . . . . 0.0 109.937 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -165.98 75.36 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.248 -0.908 . . . . 0.0 110.034 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.03 -165.24 2.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 110.448 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 1.6 p-80 -122.26 154.33 37.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 110.361 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 45.6 m-85 -154.94 135.06 13.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.31 -0.869 . . . . 0.0 110.033 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.511 ' ND2' ' CD2' ' A' ' 41' ' ' TYR . 50.8 p30 -87.77 166.45 14.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.325 -0.859 . . . . 0.0 110.525 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.409 ' CG2' ' O ' ' A' ' 137' ' ' ASN . 5.9 pt -156.48 167.25 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.12 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.41 HG21 ' HG3' ' A' ' 112' ' ' LYS . 85.0 m -91.76 115.44 28.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.323 -0.861 . . . . 0.0 111.059 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.464 ' CE2' HD11 ' A' ' 83' ' ' ILE . 15.6 m-85 -90.62 95.79 10.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 109.578 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -87.71 101.94 14.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.05 -1.031 . . . . 0.0 110.742 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 111' ' ' GLY . 22.8 m-85 -93.26 138.87 31.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.31 -0.869 . . . . 0.0 110.251 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.469 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 17.4 m-80 -132.38 99.48 4.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.11 -0.994 . . . . 0.0 110.333 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.406 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -159.77 -142.02 3.29 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -61.54 133.73 47.33 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.598 1.315 . . . . 0.0 110.11 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.1 m -91.19 -52.12 4.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 110.165 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -165.02 29.28 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.852 . . . . 0.0 110.421 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.5 t 58.55 39.0 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.897 . . . . 0.0 110.358 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.13 56.73 3.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 0.0 110.295 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.979 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.483 HBB1 ' CE2' ' A' ' 77' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.229 0.538 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -170.3 134.58 1.19 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 110.33 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 6.2 t30 63.35 35.97 11.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.032 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.86 87.03 2.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.34 -0.85 . . . . 0.0 110.356 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.54 -164.58 0.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 110.236 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 60.7 m-20 53.29 27.97 6.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 110.341 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.25 141.05 13.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 110.569 -179.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -172.7 173.06 45.38 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.61 110.63 21.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.258 -1.142 . . . . 0.0 110.402 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.411 ' CD1' ' HA3' ' A' ' 144' ' ' GLY . 0.6 OUTLIER -95.61 155.34 16.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -0.915 . . . . 0.0 110.549 179.793 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.7 t-20 -81.86 135.69 35.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.111 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.493 ' CD1' ' HB1' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -167.09 159.52 13.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.864 -1.147 . . . . 0.0 110.969 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -154.69 -165.82 2.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.398 -0.814 . . . . 0.0 109.795 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.507 ' CG2' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -141.16 174.42 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 110.632 -179.914 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -148.56 157.29 43.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.401 -0.812 . . . . 0.0 109.889 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.445 ' HG3' ' CG2' ' A' ' 43' ' ' THR . 12.8 tppt? -67.73 136.4 54.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 110.223 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.467 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -61.46 146.54 48.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.178 -0.951 . . . . 0.0 109.354 179.577 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 8.3 t30 72.02 2.83 4.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.851 -0.53 . . . . 0.0 110.79 -179.141 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.445 ' CG2' ' HG3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -136.62 -166.65 1.93 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.932 -1.105 . . . . 0.0 109.559 179.207 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.445 ' N ' ' OG1' ' A' ' 43' ' ' THR . 25.6 t30 -130.93 15.87 5.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 110.302 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.59 139.07 41.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 110.843 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.465 ' CG2' ' CB ' ' A' ' 50' ' ' ASN . 0.3 OUTLIER -70.43 134.76 48.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.075 179.141 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.7 t -129.28 -18.26 3.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.009 -1.077 . . . . 0.0 112.193 -178.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.1 mp -138.19 -49.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.773 -1.204 . . . . 0.0 110.976 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.42 ' CB ' HD13 ' A' ' 138' ' ' ILE . . . -81.94 8.5 10.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.537 -0.727 . . . . 0.0 111.475 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.465 ' CB ' ' CG2' ' A' ' 46' ' ' THR . 0.5 OUTLIER -71.78 -33.93 69.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.901 -1.124 . . . . 0.0 110.492 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 71.5 m-20 -102.69 15.38 29.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.13 -0.981 . . . . 0.0 110.806 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.441 ' CD1' HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -91.13 -18.01 25.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.047 -1.033 . . . . 0.0 110.866 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.507 ' CE1' ' CG2' ' A' ' 38' ' ' VAL . 39.2 p90 -118.3 127.88 54.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.15 -0.969 . . . . 0.0 110.865 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -73.76 109.85 7.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.746 179.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -91.99 161.63 32.88 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.047 -1.033 . . . . 0.0 110.144 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.54 -175.58 16.77 Favored 'Cis proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.513 -2.286 . . . . 0.0 110.585 -0.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.493 ' HB1' ' CD1' ' A' ' 36' ' ' TYR . . . -101.8 168.06 9.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 0.0 109.894 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.5 116.01 31.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 110.795 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.4 ' HA ' ' CG2' ' A' ' 68' ' ' VAL . 3.9 p90 -96.3 160.96 14.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 0.0 109.355 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -154.72 124.62 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.942 -1.099 . . . . 0.0 110.967 -179.329 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.2 mtmt -137.62 129.29 28.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.349 -0.845 . . . . 0.0 110.173 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -108.37 63.63 0.61 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.903 . . . . 0.0 110.843 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 46.03 96.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.494 -0.754 . . . . 0.0 111.109 179.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.94 12.73 39.15 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -171.25 156.8 4.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.166 -1.196 . . . . 0.0 109.735 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.05 143.28 6.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.034 -1.041 . . . . 0.0 111.517 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -140.26 -160.59 1.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.613 -0.679 . . . . 0.0 109.436 179.94 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 59' ' ' TYR . 1.2 t -170.14 131.06 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.003 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.46 141.98 30.65 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.917 . . . . 0.0 110.322 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.69 141.27 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.438 -0.789 . . . . 0.0 110.067 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.18 134.42 34.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.985 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.36 124.87 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.867 . . . . 0.0 110.277 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.83 128.94 45.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.011 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.4 m80 62.72 113.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.311 -0.868 . . . . 0.0 110.107 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.2 t -76.47 -13.19 60.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.864 . . . . 0.0 110.677 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -84.0 -56.1 3.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.041 -1.037 . . . . 0.0 110.397 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.486 ' CD1' HBB1 ' A' ' 151' ' ' ZNH . 4.0 m0 -47.87 -68.07 0.22 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.325 -0.859 . . . . 0.0 110.646 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.441 HD11 ' CD1' ' A' ' 52' ' ' TYR . 0.6 OUTLIER -88.28 122.15 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.922 . . . . 0.0 110.041 -179.86 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.441 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -87.19 -27.42 23.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.847 . . . . 0.0 110.926 -179.204 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.441 ' N ' HG21 ' A' ' 79' ' ' THR . . . -175.18 -179.74 45.93 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.166 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.93 169.68 22.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.508 -0.995 . . . . 0.0 109.987 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -153.91 161.41 42.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.067 -1.021 . . . . 0.0 109.716 179.904 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.496 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -164.5 141.4 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 110.699 -179.672 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 0.4 OUTLIER 62.89 8.7 3.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.525 -0.734 . . . . 0.0 111.964 179.379 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.24 2.01 28.03 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.349 -1.405 . . . . 0.0 111.424 178.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.48 ' NE2' ' CB ' ' A' ' 84' ' ' GLU . 3.2 p80 -135.42 155.95 49.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.518 -1.577 . . . . 0.0 110.964 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -160.49 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.508 -0.745 . . . . 0.0 110.5 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -102.66 150.81 23.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.391 -0.818 . . . . 0.0 110.298 -179.863 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -99.89 125.55 45.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.599 179.519 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pp -67.24 103.11 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.005 -1.059 . . . . 0.0 109.884 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.436 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -95.63 -28.91 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.461 -0.774 . . . . 0.0 110.851 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.5 p -167.05 105.1 0.56 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.96 -1.087 . . . . 0.0 109.982 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.44 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 13.2 ttmt -95.24 106.48 18.52 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.327 -0.858 . . . . 0.0 110.19 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -96.59 95.01 7.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.9 p -77.31 -17.75 58.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 110.434 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.73 -53.67 50.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.025 -1.047 . . . . 0.0 110.101 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -98.0 15.07 25.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -0.88 . . . . 0.0 110.358 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.0 64.93 1.57 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.15 -0.969 . . . . 0.0 110.174 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.93 170.98 15.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.424 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.44 ' CD ' ' HG3' ' A' ' 93' ' ' LYS . 6.6 mtp180 -162.18 164.6 27.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.496 -0.752 . . . . 0.0 109.91 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.436 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 94.6 m -140.68 152.12 45.11 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.29 -0.881 . . . . 0.0 109.618 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 101' ' ' THR . 1.7 p -143.54 138.84 29.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.989 -1.069 . . . . 0.0 110.65 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -91.69 138.2 31.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.366 -0.834 . . . . 0.0 109.975 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 38.2 m-85 -128.59 129.71 46.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.157 -0.964 . . . . 0.0 110.807 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -90.31 127.53 36.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.392 -0.817 . . . . 0.0 109.395 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.459 ' CG2' ' N ' ' A' ' 107' ' ' SER . 2.7 p -149.28 168.52 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.001 -1.062 . . . . 0.0 110.832 -179.25 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.459 ' N ' ' CG2' ' A' ' 106' ' ' VAL . 39.5 t -78.2 110.54 13.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.05 178.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.439 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 47.41 -158.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.46 -0.775 . . . . 0.0 109.86 -178.834 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.401 ' CD1' ' HD2' ' A' ' 145' ' ' PRO . 0.3 OUTLIER -151.27 59.93 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.041 -1.037 . . . . 0.0 110.791 -179.678 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -146.22 56.96 1.19 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.239 -0.913 . . . . 0.0 110.31 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.33 178.96 48.66 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.57 148.32 29.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -1.135 . . . . 0.0 110.395 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.1 mm -137.84 150.08 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 110.114 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -76.07 124.63 27.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 109.986 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.48 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -131.88 116.82 1.94 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 82' ' ' SER . 30.8 mtpt -95.44 159.22 15.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -1.106 . . . . 0.0 109.471 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.434 ' CD1' ' HAC' ' A' ' 151' ' ' ZNH . 0.0 OUTLIER -158.24 140.55 5.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 120.845 -1.16 . . . . 0.0 111.194 -179.836 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -108.26 161.11 15.3 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.496 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -131.48 147.62 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.014 -1.054 . . . . 0.0 110.766 -179.434 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -152.12 106.45 3.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 110.281 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.472 ' CG1' ' HA ' ' A' ' 77' ' ' TRP . 2.4 mp -135.03 150.65 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.158 -0.964 . . . . 0.0 110.68 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 1.0 OUTLIER -160.94 96.8 1.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.46 -0.775 . . . . 0.0 109.863 179.856 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -173.9 -168.38 0.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 110.508 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.9 84.73 3.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.863 . . . . 0.0 110.346 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.0 m -77.52 136.62 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.932 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 50.39 28.01 3.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.812 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.32 34.21 41.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -145.09 128.82 8.63 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.238 -1.154 . . . . 0.0 110.139 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -68.95 110.5 2.4 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.658 1.346 . . . . 0.0 110.155 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 132' ' ' TYR . 49.1 t80 -116.15 156.08 27.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.124 -0.985 . . . . 0.0 110.453 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.79 110.39 9.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 109.935 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.496 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 1.6 t80 -112.8 127.28 56.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 110.041 -179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -163.4 84.59 0.49 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 110.052 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.45 -169.8 3.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.511 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.468 ' O ' ' CD2' ' A' ' 135' ' ' HIS . 0.7 OUTLIER -119.71 145.66 46.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 110.163 179.889 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 38.9 m-85 -155.16 -179.56 8.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 110.104 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -151.88 172.9 15.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.42 HD13 ' CB ' ' A' ' 49' ' ' ALA . 1.8 pt -155.8 166.72 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.305 -0.872 . . . . 0.0 110.132 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.6 m -91.83 122.24 34.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 111.063 -179.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.496 ' CD2' HD11 ' A' ' 83' ' ' ILE . 6.3 m-85 -90.02 162.5 15.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.302 -0.874 . . . . 0.0 109.625 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 101.31 2.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.055 -1.028 . . . . 0.0 110.819 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -91.34 133.85 35.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.299 -0.876 . . . . 0.0 109.518 179.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 2.9 m-80 -128.56 108.63 10.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 110.64 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.411 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -160.36 -145.5 4.3 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.419 ' HG2' ' NZ ' ' A' ' 61' ' ' LYS . 11.0 Cg_endo -60.27 -169.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.626 1.33 . . . . 0.0 110.063 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.55 -43.5 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.0 110.231 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -110.9 -61.76 1.64 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.159 -0.963 . . . . 0.0 110.172 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.417 ' CG2' ' HB2' ' A' ' 145' ' ' PRO . 50.2 t 55.57 48.97 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -0.833 . . . . 0.0 110.23 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.3 47.88 0.36 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 110.09 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.835 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.486 HBB1 ' CD1' ' A' ' 77' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.204 0.526 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.405 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -132.27 133.43 44.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.914 . . . . 0.0 110.053 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 1.2 t-20 62.56 24.15 14.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.931 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.1 146.52 23.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.416 -0.803 . . . . 0.0 110.186 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.47 -160.11 0.45 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 110.189 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 8.8 m-20 56.94 27.37 13.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 110.259 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 p -160.02 159.05 31.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -0.995 . . . . 0.0 110.529 -179.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.51 176.19 35.21 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.94 105.96 18.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.283 -1.128 . . . . 0.0 110.369 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.491 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -95.82 157.26 15.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.128 -0.982 . . . . 0.0 110.847 -179.844 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -80.24 138.45 36.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.344 -0.848 . . . . 0.0 110.483 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -165.24 155.53 13.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.209 179.498 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -155.52 -177.4 6.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.0 110.101 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 139' ' ' THR . 2.2 m -140.21 116.74 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 0.0 110.356 179.511 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -92.35 169.56 10.47 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.421 -0.799 . . . . 0.0 110.38 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 125.82 27.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.887 . . . . 0.0 109.716 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.487 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.5 OUTLIER -48.58 143.28 5.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.286 -0.884 . . . . 0.0 110.53 -179.46 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 18.6 t30 73.77 -2.47 2.76 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.038 -0.414 . . . . 0.0 111.468 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.47 -163.88 1.51 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.782 -1.199 . . . . 0.0 110.053 179.523 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -136.59 30.92 2.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.559 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -134.3 119.81 19.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.082 -1.011 . . . . 0.0 110.983 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.435 HG23 ' CB ' ' A' ' 50' ' ' ASN . 0.5 OUTLIER -57.95 121.61 10.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.472 -0.767 . . . . 0.0 109.63 179.245 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.73 -19.18 3.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.767 -1.208 . . . . 0.0 112.227 -179.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.92 -77.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.536 -1.353 . . . . 0.0 111.108 -179.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -46.17 -25.67 0.64 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.702 -0.623 . . . . 0.0 111.269 -179.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.462 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 1.3 p30 -66.34 -14.65 62.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.988 -1.07 . . . . 0.0 110.917 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.63 15.27 29.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.083 -1.011 . . . . 0.0 111.182 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -138.79 13.4 2.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.831 -1.168 . . . . 0.0 111.002 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.496 ' CG ' ' O ' ' A' ' 53' ' ' PHE . 4.8 p90 -125.81 129.18 48.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.019 . . . . 0.0 110.4 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -73.41 157.11 37.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 110.297 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -148.27 155.4 42.93 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 110.062 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -79.81 -174.97 15.52 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.762 -2.183 . . . . 0.0 110.351 -0.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.51 169.13 9.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -0.954 . . . . 0.0 110.164 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.436 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -103.15 115.84 31.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.498 -179.868 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.5 p90 -97.76 164.32 12.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.922 . . . . 0.0 109.916 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -155.45 129.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 110.275 179.903 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.2 mtmp? -140.05 112.74 7.99 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.485 -0.759 . . . . 0.0 110.196 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 62.23 2.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.109 -0.994 . . . . 0.0 110.593 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 46.03 99.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.604 -0.685 . . . . 0.0 111.63 179.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.05 -21.64 43.74 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.084 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.87 167.45 20.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -1.139 . . . . 0.0 110.35 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.495 ' CD1' ' HA ' ' A' ' 108' ' ' LYS . 1.1 pt? -171.62 145.46 2.02 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.553 179.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.553 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 1.1 m-85 -142.45 -167.1 2.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.68 -0.637 . . . . 0.0 109.43 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -165.28 129.63 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.126 -0.984 . . . . 0.0 110.419 179.374 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.436 ' HG2' ' CB ' ' A' ' 58' ' ' LYS . 12.1 pt20 -99.57 132.52 44.85 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.832 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.04 130.66 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 110.195 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.8 m -88.56 127.68 35.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.907 . . . . 0.0 109.797 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.439 HG23 ' N ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -102.01 141.9 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.829 . . . . 0.0 110.167 -179.663 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -99.72 148.48 24.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.323 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 7.9 m80 52.43 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.46 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.14 -29.82 61.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 0.0 110.104 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -53.3 14.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.395 -0.816 . . . . 0.0 110.118 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.457 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 35.0 m0 -51.71 -70.43 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.344 -0.847 . . . . 0.0 110.286 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.442 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 3.9 tt -88.23 116.91 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 109.927 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 80' ' ' GLY . 0.7 OUTLIER -87.3 -22.55 25.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -0.841 . . . . 0.0 110.937 -179.18 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 79' ' ' THR . . . -178.43 170.66 42.79 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.311 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.422 ' CE ' HD12 ' A' ' 78' ' ' ILE . 4.0 mtm -153.07 107.1 3.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.428 -1.042 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.84 163.91 17.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 110.136 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.507 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.5 OUTLIER -152.42 144.65 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.376 -0.827 . . . . 0.0 110.0 179.83 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.465 ' HB3' ' CE1' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 64.67 10.71 6.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.096 -1.002 . . . . 0.0 110.997 179.868 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.9 15.6 53.83 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.623 179.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 83' ' ' ILE . 2.2 p-80 -135.08 159.47 41.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.821 -1.399 . . . . 0.0 110.546 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 176.71 4.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.403 -0.811 . . . . 0.0 111.008 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 7.4 pt-20 -104.02 170.25 8.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 0.0 110.508 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.7 OUTLIER -112.06 128.34 56.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 110.157 -179.927 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.71 103.56 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.097 -1.002 . . . . 0.0 109.586 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.425 HG23 ' CG2' ' A' ' 101' ' ' THR . 1.4 tt -94.47 -27.24 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.344 -0.847 . . . . 0.0 110.872 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.409 ' N ' HG22 ' A' ' 91' ' ' ILE . 1.2 m -167.03 100.86 0.54 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.184 -0.947 . . . . 0.0 109.808 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.418 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 21.5 ttmt -95.67 107.17 19.35 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.327 -0.858 . . . . 0.0 110.211 -179.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.47 68.3 2.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.027 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.94 -27.52 44.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.282 -0.886 . . . . 0.0 110.229 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.42 -47.44 84.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 0.0 110.126 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -96.71 17.54 16.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.263 -0.898 . . . . 0.0 110.435 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 52.7 57.98 5.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 110.247 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -148.28 174.42 12.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.164 -0.96 . . . . 0.0 110.527 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.439 ' N ' HG23 ' A' ' 72' ' ' VAL . 3.2 ttm180 -170.16 162.65 8.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.356 -0.84 . . . . 0.0 110.207 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.43 HG23 ' N ' ' A' ' 102' ' ' SER . 91.0 m -142.13 153.78 44.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 109.801 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.43 ' N ' HG23 ' A' ' 101' ' ' THR . 0.7 OUTLIER -145.8 144.93 30.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.96 -1.088 . . . . 0.0 110.927 -179.818 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -93.43 141.8 28.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.353 -0.842 . . . . 0.0 109.719 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 97.9 m-85 -130.16 141.63 50.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.006 . . . . 0.0 111.18 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.32 127.89 50.54 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.435 HG21 ' CD1' ' A' ' 113' ' ' ILE . 2.6 p -149.89 149.59 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.036 -1.04 . . . . 0.0 111.351 -178.509 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 101.58 0.72 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.159 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.495 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 55.1 174.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 108.899 -177.919 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.96 70.66 1.11 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.782 -1.199 . . . . 0.0 111.004 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -147.32 64.39 1.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.469 -0.77 . . . . 0.0 110.191 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.54 -112.59 0.38 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.676 -1.25 . . . . 0.0 109.986 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.439 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.4 OUTLIER -157.35 137.58 12.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -1.165 . . . . 0.0 110.167 -179.628 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.435 ' CD1' HG21 ' A' ' 106' ' ' VAL . 12.0 mt -135.21 151.93 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.98 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -76.01 125.18 28.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.164 -0.96 . . . . 0.0 110.5 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.48 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -133.43 178.73 18.02 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 2.1 mtpp -142.34 166.89 23.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -1.186 . . . . 0.0 109.745 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.407 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -158.83 140.59 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.877 -1.14 . . . . 0.0 110.751 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.405 ' CB ' ' CG2' ' A' ' 79' ' ' THR . 1.2 m-20 -107.42 160.62 15.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.553 -0.717 . . . . 0.0 109.375 179.296 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.433 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -136.97 149.81 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.058 -1.026 . . . . 0.0 110.582 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.41 106.51 3.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.305 -0.872 . . . . 0.0 110.602 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.457 ' CG1' ' HA ' ' A' ' 77' ' ' TRP . 3.0 mp -137.99 148.68 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -0.901 . . . . 0.0 110.258 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.432 ' N ' HG22 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -159.9 95.69 1.19 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.351 -0.843 . . . . 0.0 109.738 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.47 -178.97 1.77 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.374 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -98.12 102.27 13.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 110.308 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.477 HG23 ' CD2' ' A' ' 130' ' ' PHE . 13.4 t -76.74 97.42 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 110.303 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.8 m120 57.48 50.84 10.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.268 -0.895 . . . . 0.0 110.423 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.9 36.63 57.35 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.408 ' CA ' ' HE3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -145.75 103.08 4.21 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.195 -1.179 . . . . 0.0 110.186 179.819 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -49.91 117.85 3.39 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.785 1.413 . . . . 0.0 110.227 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.477 ' CD2' HG23 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -111.81 110.3 20.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 110.453 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -106.08 107.48 18.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -0.886 . . . . 0.0 110.079 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.465 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 3.6 t80 -134.54 129.29 34.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.051 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -174.27 82.28 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.168 -0.957 . . . . 0.0 110.234 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -153.44 -160.54 1.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.169 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -122.5 148.46 45.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.257 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -155.14 -179.33 7.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.681 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 46.2 p-10 -151.67 173.02 15.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 110.984 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.407 HG12 ' CG2' ' A' ' 117' ' ' ILE . 1.5 pt -157.58 172.39 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 110.356 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.439 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 59.9 m -91.66 124.06 35.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.346 -0.846 . . . . 0.0 110.56 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.48 ' CE1' ' HA3' ' A' ' 115' ' ' GLY . 31.5 m-85 -91.2 104.47 17.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.233 -0.917 . . . . 0.0 109.996 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.62 105.7 17.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.202 -0.936 . . . . 0.0 110.741 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -92.45 158.8 15.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.285 -0.884 . . . . 0.0 110.519 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 38.2 m-80 -145.49 104.0 3.87 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.094 -1.004 . . . . 0.0 110.479 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -164.34 -146.77 4.87 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -66.48 122.43 9.87 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.802 1.422 . . . . 0.0 110.412 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.65 -34.48 15.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 110.21 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -154.64 -65.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.374 -0.829 . . . . 0.0 110.197 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.7 t 57.31 40.3 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.367 -0.833 . . . . 0.0 110.379 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.72 59.85 4.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.957 . . . . 0.0 110.213 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.863 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.465 ' NA ' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.233 0.54 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -158.55 145.3 17.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.174 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 0.6 OUTLIER 62.56 28.0 16.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.965 -179.872 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -107.59 106.98 17.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.421 -0.799 . . . . 0.0 110.186 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.74 -46.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.329 -0.857 . . . . 0.0 110.306 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 12.8 m-20 57.55 31.14 19.85 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.934 . . . . 0.0 110.308 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -159.36 155.23 26.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.037 -1.039 . . . . 0.0 110.589 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.79 171.76 35.66 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.67 111.14 21.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -1.12 . . . . 0.0 110.54 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.494 ' HB2' ' CD2' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -94.46 148.86 21.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 0.0 109.877 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.437 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 22.4 m-20 -79.56 137.94 37.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.224 -0.922 . . . . 0.0 110.199 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.42 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 1.8 p90 -166.57 164.01 17.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.187 -0.946 . . . . 0.0 110.83 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.25 -179.41 8.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.472 -0.768 . . . . 0.0 109.64 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.434 ' O ' ' CG2' ' A' ' 46' ' ' THR . 69.0 t -140.21 111.21 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.093 -1.004 . . . . 0.0 110.217 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -89.04 166.17 14.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.758 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.2 OUTLIER -67.18 125.15 25.15 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 110.109 -179.766 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.471 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -51.14 144.0 9.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 110.058 -179.906 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.9 OUTLIER 72.02 1.36 3.89 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.818 -0.551 . . . . 0.0 111.108 -179.536 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.429 ' CG2' ' HB3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -135.66 -166.69 1.9 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.894 -1.129 . . . . 0.0 109.752 179.233 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -135.18 18.7 3.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.937 . . . . 0.0 110.196 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -136.19 126.41 26.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.114 -0.991 . . . . 0.0 111.088 -179.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.444 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -53.9 124.95 16.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -0.834 . . . . 0.0 108.903 178.951 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.3 -18.77 3.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.73 -1.231 . . . . 0.0 112.202 -178.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.3 mt -138.55 -78.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.751 -1.218 . . . . 0.0 110.776 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.99 -25.68 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.696 -0.627 . . . . 0.0 111.24 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.444 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -56.48 -18.12 10.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.037 -1.039 . . . . 0.0 111.073 -179.597 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -101.91 15.21 29.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.976 -1.078 . . . . 0.0 111.006 -179.316 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -141.87 10.74 2.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.935 -1.103 . . . . 0.0 111.031 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -118.69 115.44 24.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.091 -1.006 . . . . 0.0 110.136 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.31 152.36 42.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 110.408 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.2 158.26 44.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 109.848 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.57 -175.65 16.9 Favored 'Cis proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.714 -2.203 . . . . 0.0 110.585 -0.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.47 164.05 11.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.062 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.424 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 1.4 mtpt -102.44 118.09 36.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.931 . . . . 0.0 110.524 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.494 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 27.2 p90 -97.3 164.47 12.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.862 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -156.31 117.03 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.033 -1.042 . . . . 0.0 110.632 -179.681 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -127.49 122.15 32.65 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.157 -0.965 . . . . 0.0 110.365 179.885 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 63' ' ' ASN . 1.7 mmmp? -101.46 61.97 0.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 0.0 110.155 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 62' ' ' LYS . 5.1 t-20 47.78 100.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.435 -0.791 . . . . 0.0 111.434 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.11 -15.53 57.83 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.461 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -144.28 169.36 18.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.009 -1.289 . . . . 0.0 110.532 179.827 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.6 pt? -169.58 144.26 2.91 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.367 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.541 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -137.47 -169.08 2.44 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.727 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.2 t -165.72 131.27 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 110.012 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.424 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -98.12 130.21 44.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 -179.932 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -111.61 135.01 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.69 179.94 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.6 m -89.68 125.52 35.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.082 -1.011 . . . . 0.0 110.067 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.59 143.41 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 110.207 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -100.57 128.52 46.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.354 -0.841 . . . . 0.0 110.615 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 61.24 115.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 0.0 110.499 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -43.08 57.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.0 110.037 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -50.82 -39.37 53.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 109.99 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.8 m0 -64.77 -73.45 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 110.062 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.31 119.13 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 109.987 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.45 ' CG2' ' CB ' ' A' ' 118' ' ' ASP . 3.7 t -86.88 -21.65 26.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 111.001 -179.346 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 79' ' ' THR . . . -172.17 169.93 42.98 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.451 -1.356 . . . . 0.0 110.125 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.5 mtm -151.87 106.11 3.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -1.106 . . . . 0.0 110.04 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -86.58 158.48 19.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 109.863 179.66 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.486 HD12 ' CE1' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -156.25 135.63 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.5 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.441 ' HB3' ' NE2' ' A' ' 86' ' ' HIS . 0.6 OUTLIER 65.29 6.22 3.51 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.451 -0.781 . . . . 0.0 112.018 179.489 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.18 -0.57 22.51 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.332 -1.413 . . . . 0.0 111.328 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.452 ' CD2' ' N ' ' A' ' 86' ' ' HIS . 2.6 p80 -131.72 158.08 42.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.557 -1.555 . . . . 0.0 110.881 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -70.55 -164.24 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.5 -0.75 . . . . 0.0 110.505 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 1.2 pm0 -104.61 164.07 12.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 110.544 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -115.38 133.96 55.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.913 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.427 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 1.2 pp -68.06 101.71 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.995 -1.065 . . . . 0.0 109.792 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.44 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 2.3 tt -95.71 -28.2 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.338 -0.851 . . . . 0.0 110.732 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.7 p -167.03 103.35 0.55 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 109.776 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -95.08 147.51 23.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.357 -0.84 . . . . 0.0 110.174 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.31 71.39 1.33 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 110.125 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.16 -32.7 62.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.372 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -42.78 99.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.224 -0.923 . . . . 0.0 110.16 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -95.98 10.38 37.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -0.904 . . . . 0.0 110.608 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 50.95 56.87 7.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.97 -1.081 . . . . 0.0 110.181 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -147.61 179.65 7.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.45 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -174.86 162.02 3.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.401 -0.812 . . . . 0.0 109.984 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.455 HG21 ' N ' ' A' ' 102' ' ' SER . 82.8 m -140.61 156.02 46.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.331 -0.855 . . . . 0.0 109.552 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.455 ' N ' HG21 ' A' ' 101' ' ' THR . 0.9 OUTLIER -143.23 140.02 30.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.982 -1.073 . . . . 0.0 110.82 -179.582 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -93.56 137.59 32.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.717 . . . . 0.0 110.194 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 81.7 m-85 -128.59 140.98 51.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.08 -1.012 . . . . 0.0 110.748 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -102.52 131.54 49.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.86 . . . . 0.0 109.335 179.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.7 m -149.16 147.63 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.135 -0.978 . . . . 0.0 110.833 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.51 108.25 1.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 109.141 179.12 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.483 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 54.39 176.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -0.95 . . . . 0.0 109.118 -178.646 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.409 ' CD1' ' HD2' ' A' ' 145' ' ' PRO . 0.3 OUTLIER -148.9 72.09 1.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.968 -1.082 . . . . 0.0 110.792 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -145.59 44.58 1.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.471 -0.768 . . . . 0.0 109.984 179.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -174.29 177.25 46.55 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . 0.6 OUTLIER -80.51 145.95 31.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.233 -1.157 . . . . 0.0 110.637 -179.701 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 74.9 mt -136.17 150.75 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.35 -0.844 . . . . 0.0 109.781 179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -76.48 132.26 39.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.06 -1.025 . . . . 0.0 110.428 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.432 ' HA3' ' CD2' ' A' ' 140' ' ' TYR . . . -132.94 169.84 22.36 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 82' ' ' SER . 22.4 mtmt -144.01 162.23 36.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.069 -1.253 . . . . 0.0 109.529 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.442 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -159.31 153.44 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.907 -1.121 . . . . 0.0 111.034 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.45 ' CB ' ' CG2' ' A' ' 79' ' ' THR . 84.3 m-20 -115.31 154.23 29.52 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.63 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.493 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -129.48 143.76 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.058 -1.026 . . . . 0.0 110.55 -179.652 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.92 99.99 2.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -0.826 . . . . 0.0 110.118 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.487 HD11 ' CD2' ' A' ' 132' ' ' TYR . 20.7 mt -123.24 152.55 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.612 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.89 96.54 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.399 -0.813 . . . . 0.0 109.812 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -173.5 -170.67 0.62 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.945 . . . . 0.0 110.509 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.97 103.5 15.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 110.347 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.85 102.72 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 110.333 179.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.8 m120 53.86 43.14 31.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.311 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.23 32.17 44.43 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -145.5 102.3 4.31 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.228 -1.16 . . . . 0.0 110.116 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -46.68 120.73 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.702 1.369 . . . . 0.0 110.517 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.463 ' CE2' HMB1 ' A' ' 151' ' ' ZNH . 35.8 t80 -124.95 148.51 48.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 0.0 110.058 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -134.69 106.35 6.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.271 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.504 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 4.7 t80 -110.62 131.48 55.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 110.098 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.29 88.04 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.895 . . . . 0.0 110.069 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.34 -168.33 2.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.268 -0.895 . . . . 0.0 110.288 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -117.65 141.67 48.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.974 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CD1' HAD2 ' A' ' 151' ' ' ZNH . 30.6 m-85 -155.51 -179.26 7.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 110.195 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -151.18 176.38 11.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -0.951 . . . . 0.0 110.378 179.902 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.442 HG12 ' CG2' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -155.7 179.59 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 110.085 -179.761 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.5 m -91.06 161.5 15.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.817 . . . . 0.0 111.086 -179.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.486 ' CE1' HD12 ' A' ' 83' ' ' ILE . 23.1 m-85 -147.82 98.81 3.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.575 -0.703 . . . . 0.0 109.3 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 112' ' ' LYS . 10.9 tttt -116.86 110.19 18.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.244 -0.91 . . . . 0.0 110.955 -179.259 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -92.56 152.73 19.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.403 -0.811 . . . . 0.0 110.089 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.42 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 3.4 m-80 -128.98 104.64 7.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.922 . . . . 0.0 110.214 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -153.26 -144.52 3.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.409 ' HD2' ' CD1' ' A' ' 109' ' ' LEU . 10.1 Cg_endo -59.03 -173.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.608 1.32 . . . . 0.0 110.644 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 -42.41 0.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 110.414 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -160.77 -40.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 110.212 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 29.5 t 56.25 43.59 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.836 . . . . 0.0 110.198 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.77 128.72 34.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.869 . . . . 0.0 110.15 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.993 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.504 ' NA ' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.27 0.557 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -144.61 54.15 1.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.002 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.5 m120 61.08 24.87 14.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 109.862 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.92 -179.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -0.845 . . . . 0.0 110.036 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.67 -69.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 0.0 110.356 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER 56.18 23.37 6.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.374 -0.829 . . . . 0.0 110.209 -179.854 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 p -159.74 129.85 5.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.408 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.52 177.8 48.33 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.45 105.54 17.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.205 -1.173 . . . . 0.0 110.221 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.476 ' CB ' ' CD1' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -93.79 151.37 19.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.378 -0.826 . . . . 0.0 110.154 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.438 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 23.0 m120 -79.06 145.55 33.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.921 . . . . 0.0 110.14 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.455 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 1.5 p90 -163.92 156.01 17.07 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.189 -0.945 . . . . 0.0 110.177 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -155.44 -176.76 6.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 110.043 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.449 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -140.16 174.41 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.159 -0.963 . . . . 0.0 110.267 179.991 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.449 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 47.3 m-85 -147.96 160.19 43.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.416 -0.802 . . . . 0.0 110.153 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.81 121.33 15.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.859 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.476 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -48.75 148.97 1.91 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 -179.72 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 8.5 t30 72.47 1.43 3.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.968 -0.458 . . . . 0.0 111.085 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.05 -155.98 0.67 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.789 -1.195 . . . . 0.0 109.902 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -136.13 10.77 3.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.335 -0.853 . . . . 0.0 110.491 179.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -134.28 148.95 50.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.015 . . . . 0.0 110.845 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.403 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -79.83 138.44 37.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.319 179.547 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.97 -17.91 3.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.961 -1.087 . . . . 0.0 111.899 -179.041 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.5 mt -137.96 -71.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.764 -1.21 . . . . 0.0 110.709 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -46.11 -26.53 0.77 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.691 -0.631 . . . . 0.0 111.023 -179.426 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.403 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -59.7 -19.65 51.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.128 -0.983 . . . . 0.0 110.715 -179.595 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -102.32 14.82 30.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.97 -1.081 . . . . 0.0 110.868 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.484 ' CD1' HMC2 ' A' ' 151' ' ' ZNH . 86.6 m-85 -128.79 6.15 5.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.984 -1.073 . . . . 0.0 111.075 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.421 ' CE1' ' HE3' ' A' ' 81' ' ' MET . 33.8 m-85 -129.76 117.01 19.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 110.34 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -72.77 166.82 22.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.97 . . . . 0.0 110.301 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 3.3 pttt -148.18 159.57 39.32 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 110.011 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HA ' ' HB2' ' A' ' 55' ' ' LYS . 59.4 Cg_endo -82.48 -175.64 15.35 Favored 'Cis proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.648 -2.23 . . . . 0.0 110.394 -0.411 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.97 170.23 8.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 110.002 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -103.03 108.38 19.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 110.525 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.476 ' CD1' ' CB ' ' A' ' 34' ' ' LEU . 6.3 p90 -97.97 162.25 13.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 109.75 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.432 HG13 ' N ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -154.8 155.22 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.15 -0.969 . . . . 0.0 110.373 -179.665 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.7 mtpt -135.94 168.89 18.49 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.339 -0.851 . . . . 0.0 110.606 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.407 ' CB ' ' HG3' ' A' ' 65' ' ' LYS . 10.4 mttm -148.0 61.97 1.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 0.0 109.834 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 45.69 78.07 0.07 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.47 -0.769 . . . . 0.0 110.925 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.09 19.42 16.89 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.407 ' HG3' ' CB ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -168.07 162.83 13.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.146 -1.208 . . . . 0.0 110.38 179.546 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.3 pt? -173.42 150.18 1.8 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.2 1.0 . . . . 0.0 111.74 178.706 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.554 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -139.94 -164.83 1.77 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.023 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -170.17 144.01 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.0 110.692 179.356 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.419 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 1.6 pt20 -99.75 132.87 44.82 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.924 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -110.57 133.1 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.852 . . . . 0.0 109.8 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.27 123.08 33.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.145 -0.972 . . . . 0.0 110.26 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -104.29 147.09 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.357 -0.839 . . . . 0.0 109.857 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -99.49 141.91 31.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 0.0 110.49 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.444 ' HB3' ' CG ' ' A' ' 77' ' ' TRP . 9.6 m-70 53.62 92.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 m -52.35 -31.28 32.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 110.232 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -71.11 -45.53 63.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.219 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.444 ' CG ' ' HB3' ' A' ' 74' ' ' HIS . 45.6 m0 -55.64 -62.77 1.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.318 -0.864 . . . . 0.0 110.303 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 0.5 OUTLIER -88.37 120.26 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.448 -0.783 . . . . 0.0 109.915 -179.727 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.457 HG21 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -89.16 -27.21 20.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.347 -0.846 . . . . 0.0 111.073 -179.217 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.457 ' N ' HG21 ' A' ' 79' ' ' THR . . . -179.57 172.02 43.78 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.258 -1.449 . . . . 0.0 110.535 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.421 ' HE3' ' CE1' ' A' ' 53' ' ' PHE . 1.8 mtp -153.05 110.95 3.6 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.522 -0.987 . . . . 0.0 109.859 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -86.56 123.04 31.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.975 -1.078 . . . . 0.0 110.031 179.947 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 1.7 mt -113.1 131.07 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 110.259 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 2.3 tm-20 69.62 5.51 5.23 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.493 -0.755 . . . . 0.0 110.99 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.25 23.89 10.86 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.728 -1.225 . . . . 0.0 111.0 178.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.47 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.39 162.37 34.6 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.673 -1.486 . . . . 0.0 110.149 179.359 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -175.68 1.18 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.96 . . . . 0.0 110.199 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 5.1 pt-20 -110.17 167.03 10.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 110.341 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 102' ' ' SER . 3.5 t-20 -114.09 130.7 56.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.361 -0.837 . . . . 0.0 109.918 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.401 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 1.1 pp -67.69 100.89 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 0.0 109.674 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.441 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 2.4 tt -95.36 -23.3 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 110.566 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 91' ' ' ILE . 1.5 m -167.06 100.18 0.53 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -94.54 142.5 27.37 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.914 -179.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.59 74.12 1.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 110.33 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.0 p -65.07 -31.16 72.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.062 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.65 -50.07 72.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.852 . . . . 0.0 110.226 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -95.43 13.62 25.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.259 -0.9 . . . . 0.0 110.426 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.65 60.56 3.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 110.276 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -147.54 150.41 34.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 0.0 110.418 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.47 157.08 40.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.353 -0.842 . . . . 0.0 109.951 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.441 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 60.4 m -141.09 154.8 46.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.306 -0.871 . . . . 0.0 109.75 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 1.8 p -145.57 139.75 26.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.007 -1.058 . . . . 0.0 111.044 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -93.06 138.65 31.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.46 -0.775 . . . . 0.0 109.429 179.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 102' ' ' SER . 93.5 m-85 -128.5 145.72 51.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.883 -1.136 . . . . 0.0 111.34 -179.234 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -105.72 130.41 53.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.42 -0.8 . . . . 0.0 109.048 178.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.1 m -150.31 170.34 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.918 -1.113 . . . . 0.0 111.36 -178.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.3 m -74.59 111.02 9.36 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.444 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 45.7 -163.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.591 -0.693 . . . . 0.0 109.673 -178.355 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.454 ' CD2' ' CD2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -151.03 56.88 0.9 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.911 -1.118 . . . . 0.0 110.871 -179.549 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -145.58 70.2 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 0.0 110.001 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.89 176.57 38.0 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HE3' ' N ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -81.78 142.91 32.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -1.115 . . . . 0.0 110.34 -179.972 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.43 ' N ' ' HE3' ' A' ' 112' ' ' LYS . 53.0 mt -137.34 153.52 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 110.041 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.38 128.3 34.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.231 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.455 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -138.62 123.25 2.56 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 82' ' ' SER . 10.5 mttm -96.76 163.74 12.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -1.175 . . . . 0.0 109.703 179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.419 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -159.22 133.18 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.879 -1.138 . . . . 0.0 111.171 179.895 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.436 ' HB2' ' CG2' ' A' ' 79' ' ' THR . 93.6 m-20 -108.35 165.61 11.38 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.402 HG22 ' CE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -141.45 153.2 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.965 -1.085 . . . . 0.0 110.648 -179.644 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.421 ' CE1' ' OD2' ' A' ' 122' ' ' ASP . 6.4 t80 -151.82 109.63 3.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -0.806 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.499 HD11 ' CD2' ' A' ' 132' ' ' TYR . 46.2 mt -134.71 152.92 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.961 . . . . 0.0 110.349 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.421 ' OD2' ' CE1' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -160.48 98.07 1.24 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.389 -0.819 . . . . 0.0 109.622 179.602 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -173.2 -168.52 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 110.398 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -103.58 97.46 7.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 110.474 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.8 125.0 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.253 -0.905 . . . . 0.0 110.222 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 52.9 25.29 3.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.293 -0.879 . . . . 0.0 110.198 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 85.94 33.82 14.44 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -144.61 134.43 11.66 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.313 -1.11 . . . . 0.0 110.0 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.47 127.85 25.21 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.631 1.332 . . . . 0.0 110.474 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -131.07 113.18 13.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.357 -0.84 . . . . 0.0 110.123 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.25 104.45 14.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.187 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.499 ' CD2' HD11 ' A' ' 121' ' ' ILE . 3.1 t80 -114.93 124.27 51.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.905 . . . . 0.0 109.943 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 48.2 p-10 -171.03 86.47 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.328 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -153.3 -168.95 3.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.905 . . . . 0.0 110.189 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.4 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.3 OUTLIER -119.8 148.61 43.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.336 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.48 ' CD1' HBD2 ' A' ' 151' ' ' ZNH . 12.4 m-85 -155.67 -178.56 7.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 0.0 110.245 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -150.04 171.45 16.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.89 . . . . 0.0 110.275 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.419 HG12 ' CG2' ' A' ' 117' ' ' ILE . 0.4 OUTLIER -156.46 166.21 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 0.0 110.413 -179.739 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 59.8 m -91.77 120.45 32.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 0.0 110.437 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.455 ' CD1' ' HA3' ' A' ' 115' ' ' GLY . 11.6 m-85 -90.38 161.82 15.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.59 102.7 2.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.908 . . . . 0.0 110.388 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -91.72 154.91 18.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.922 . . . . 0.0 110.155 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.455 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 22.8 m-80 -143.0 98.45 3.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -153.62 -146.81 4.47 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.43 143.73 99.62 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.776 1.408 . . . . 0.0 110.451 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.5 p -90.94 -44.81 9.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.325 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -154.35 -46.6 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.228 -0.92 . . . . 0.0 110.143 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 15.4 t 56.88 48.17 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 110.281 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.59 82.81 7.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.186 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.979 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.484 HMC2 ' CD1' ' A' ' 52' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.291 0.567 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 179.59 172.2 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.39 29.27 15.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.068 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -140.68 105.63 4.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.419 -0.801 . . . . 0.0 110.213 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.61 -39.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.235 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 9.8 m-20 57.05 29.27 16.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.887 . . . . 0.0 110.439 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 22.7 t -160.14 159.76 32.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.021 -1.049 . . . . 0.0 110.911 -179.471 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 165.24 172.73 33.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.37 115.21 25.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.156 -1.202 . . . . 0.0 110.381 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.507 ' HB2' ' CD2' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -95.88 141.72 28.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.134 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -78.99 135.88 37.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 109.924 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.428 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -165.71 171.67 12.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 110.715 -179.948 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -155.23 -176.78 6.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.442 -0.786 . . . . 0.0 110.081 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 46' ' ' THR . 1.4 m -141.27 108.37 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 0.0 109.94 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -93.2 162.64 13.94 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 110.637 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.406 ' CG ' HG21 ' A' ' 43' ' ' THR . 12.7 tppt? -67.52 140.81 57.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.599 -0.688 . . . . 0.0 110.043 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.46 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -64.57 147.75 52.21 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.011 -1.056 . . . . 0.0 109.247 179.413 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.1 t-20 70.95 3.04 4.47 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.701 -0.625 . . . . 0.0 110.746 -179.046 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -137.36 -168.28 2.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.911 -1.118 . . . . 0.0 109.446 179.182 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.441 ' N ' ' OG1' ' A' ' 43' ' ' THR . 65.3 t30 -128.55 12.29 6.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.931 -1.106 . . . . 0.0 110.491 179.69 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -136.29 133.04 36.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.055 -1.028 . . . . 0.0 110.467 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.474 ' CG2' ' CB ' ' A' ' 50' ' ' ASN . 6.0 t -63.56 139.43 58.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.088 -1.007 . . . . 0.0 109.068 179.154 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.39 -17.53 3.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 112.015 -179.013 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.7 mt -137.94 -50.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.785 -1.197 . . . . 0.0 110.845 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.74 -54.72 43.69 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.567 -0.708 . . . . 0.0 111.717 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.474 ' CB ' ' CG2' ' A' ' 46' ' ' THR . 4.8 t-20 -47.47 -25.04 0.96 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.141 -0.974 . . . . 0.0 110.988 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -73.32 -2.44 22.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -0.988 . . . . 0.0 111.168 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -144.78 28.78 1.26 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.823 -1.173 . . . . 0.0 110.892 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.481 ' CE2' HBC1 ' A' ' 151' ' ' ZNH . 11.3 m-85 -130.97 109.47 10.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.944 . . . . 0.0 110.244 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -72.45 150.15 43.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.328 -0.857 . . . . 0.0 110.415 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.79 168.09 12.25 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.321 -0.862 . . . . 0.0 109.924 -179.994 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 44.6 Cg_endo -76.57 -175.66 17.04 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.692 -2.211 . . . . 0.0 110.683 -0.201 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.45 168.38 9.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 110.137 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.49 119.91 39.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.17 -0.956 . . . . 0.0 110.562 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.507 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 27.4 p90 -96.93 164.25 12.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 109.676 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 1.0 OUTLIER -156.37 116.4 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.951 -1.093 . . . . 0.0 111.165 -179.603 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.484 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -127.6 119.48 26.05 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.359 -0.838 . . . . 0.0 110.037 179.655 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.38 62.52 1.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.571 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.41 96.18 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.46 -0.775 . . . . 0.0 111.229 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.54 10.52 43.91 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.58 160.84 11.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.963 -1.316 . . . . 0.0 109.877 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.7 pt? -166.18 141.78 4.76 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.636 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.541 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -139.64 -178.03 5.22 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.496 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -156.11 131.92 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.986 -1.071 . . . . 0.0 110.341 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 7.8 pt20 -97.3 133.12 42.33 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.291 -0.881 . . . . 0.0 109.936 179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.411 HG23 ' CE ' ' A' ' 81' ' ' MET . 0.4 OUTLIER -114.73 131.22 67.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.179 -0.951 . . . . 0.0 109.502 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 m -87.52 116.57 25.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.131 -0.981 . . . . 0.0 110.481 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -104.01 143.62 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.403 -0.811 . . . . 0.0 109.996 179.883 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -101.05 156.26 17.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.161 -0.962 . . . . 0.0 110.348 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 51.49 86.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 110.324 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.426 ' HB2' ' CD ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -65.36 -30.12 70.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 0.0 110.054 179.907 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -63.78 -34.5 78.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.88 . . . . 0.0 110.319 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.41 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 27.4 m0 -77.74 -58.02 3.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.8 tt -88.87 121.07 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.911 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.46 HG21 ' N ' ' A' ' 80' ' ' GLY . 1.0 OUTLIER -86.66 -24.83 25.13 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.248 -0.908 . . . . 0.0 110.867 -179.344 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.46 ' N ' HG21 ' A' ' 79' ' ' THR . . . 178.55 -179.19 48.75 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.308 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.423 ' SD ' ' CZ ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -152.68 114.79 4.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.441 -1.035 . . . . 0.0 110.12 -179.989 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -85.78 156.34 20.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.146 -0.971 . . . . 0.0 110.406 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.442 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 1.4 mt -156.74 134.27 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.404 -0.81 . . . . 0.0 110.111 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 69.85 3.37 4.27 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.528 -0.732 . . . . 0.0 111.488 179.735 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.94 22.2 11.13 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.22 178.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.457 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.66 161.81 35.51 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.676 -1.485 . . . . 0.0 110.143 179.276 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -70.33 -169.54 0.31 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.127 -0.983 . . . . 0.0 110.475 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.23 169.71 8.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 110.259 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.05 128.66 49.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 110.236 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.427 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.6 pp -68.33 101.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.773 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.443 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.5 tt -94.84 -28.32 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 110.441 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.8 m -166.39 98.88 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.901 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -95.31 106.38 18.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.455 -0.778 . . . . 0.0 110.017 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.1 101.87 13.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 110.227 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -78.96 -28.99 43.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 110.22 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.44 -51.04 69.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.15 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -96.2 15.75 20.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 110.41 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.66 23.23 3.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.115 -0.991 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -92.77 177.91 5.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 110.461 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.436 ' HB3' ' CG2' ' A' ' 72' ' ' VAL . 0.6 OUTLIER -179.35 151.76 0.5 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.457 -0.777 . . . . 0.0 109.658 179.948 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.443 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 86.1 m -141.46 158.03 44.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 110.257 -179.568 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.436 ' N ' HG22 ' A' ' 101' ' ' THR . 9.5 p -145.24 143.16 30.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -0.98 . . . . 0.0 110.452 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -93.26 143.44 26.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.29 -0.881 . . . . 0.0 110.031 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -129.91 132.26 46.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.133 -0.98 . . . . 0.0 110.874 -179.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -92.31 128.92 38.34 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.308 -0.87 . . . . 0.0 109.624 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.3 m -149.9 144.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.012 -1.055 . . . . 0.0 111.059 -179.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.36 109.8 1.71 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.928 . . . . 0.0 108.944 178.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.465 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 54.16 175.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 109.24 -178.585 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.437 ' CD1' ' HD2' ' A' ' 145' ' ' PRO . 0.3 OUTLIER -149.98 71.45 1.08 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.006 -1.059 . . . . 0.0 110.871 -179.853 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -146.14 40.33 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.387 -0.821 . . . . 0.0 110.185 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -169.42 -170.73 34.29 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -81.34 145.51 30.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -1.131 . . . . 0.0 110.476 -179.81 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mm -137.65 138.14 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.432 -0.793 . . . . 0.0 109.971 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -76.16 123.07 25.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.185 -0.947 . . . . 0.0 110.361 -179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.477 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -134.86 175.79 20.36 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 38.9 mttt -144.7 176.85 9.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -1.182 . . . . 0.0 109.886 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -158.47 144.45 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.922 -1.111 . . . . 0.0 111.157 179.926 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.441 ' CB ' ' CG2' ' A' ' 79' ' ' THR . 1.1 m-20 -108.98 156.89 19.2 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.441 -0.787 . . . . 0.0 109.041 178.522 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.458 HG12 ' CE2' ' A' ' 132' ' ' TYR . 2.6 t -141.72 151.86 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.016 -1.053 . . . . 0.0 110.705 -179.307 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.454 ' CZ ' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -151.14 104.37 3.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.436 -0.79 . . . . 0.0 110.268 179.97 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.432 HG23 ' CZ ' ' A' ' 130' ' ' PHE . 5.0 mt -133.06 153.25 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.134 -0.979 . . . . 0.0 110.084 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.69 95.93 1.23 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 110.12 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.463 ' HG2' ' CE1' ' A' ' 130' ' ' PHE . 7.6 pt-20 -174.48 -155.77 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.424 ' HG2' ' CA ' ' A' ' 129' ' ' PRO . 9.3 mtmt -122.59 127.21 49.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.445 HG22 ' CE1' ' A' ' 130' ' ' PHE . 80.8 t -76.18 90.65 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.145 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.7 m120 52.04 27.38 4.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 0.0 110.245 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 117.87 31.8 1.54 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -145.29 90.9 5.97 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.219 -1.166 . . . . 0.0 110.066 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.424 ' CA ' ' HG2' ' A' ' 124' ' ' LYS . 27.6 Cg_exo -56.86 123.14 13.13 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.014 1.534 . . . . 0.0 110.314 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.463 ' CE1' ' HG2' ' A' ' 123' ' ' GLU . 14.7 p90 -147.7 132.69 18.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.221 -0.924 . . . . 0.0 110.262 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -103.94 132.54 50.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 110.027 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.491 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 4.1 t80 -125.63 130.96 52.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.377 -0.827 . . . . 0.0 110.003 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.454 ' OD2' ' CZ ' ' A' ' 120' ' ' TYR . 62.5 t0 -169.43 84.62 0.13 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -0.931 . . . . 0.0 110.008 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.72 -177.03 6.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.384 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.455 ' O ' ' CD2' ' A' ' 135' ' ' HIS . 28.4 p-80 -120.49 89.52 3.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 110.294 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -84.76 -179.41 7.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 109.813 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 10.3 p30 -151.21 168.24 25.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.037 -1.039 . . . . 0.0 110.876 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -156.66 178.88 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -0.81 . . . . 0.0 110.845 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 94.8 m -91.53 162.7 14.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.538 -0.727 . . . . 0.0 110.586 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.477 ' CE2' ' HA3' ' A' ' 115' ' ' GLY . 96.4 m-85 -145.4 105.25 4.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.373 -0.829 . . . . 0.0 109.717 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -103.98 109.13 20.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 110.797 -179.484 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -91.79 145.84 24.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.603 179.361 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.427 ' N ' ' ND2' ' A' ' 143' ' ' ASN . 2.6 m-80 -133.81 109.17 8.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.035 -1.04 . . . . 0.0 110.63 -179.446 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -153.71 -135.47 2.13 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.437 ' HD2' ' CD1' ' A' ' 109' ' ' LEU . 6.1 Cg_endo -54.72 -173.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.399 1.21 . . . . 0.0 110.025 179.743 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 62.9 p -150.18 -58.06 0.18 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 110.514 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -121.44 -65.29 1.15 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 110.417 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 44.7 t 55.59 46.42 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 110.222 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.71 118.49 22.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.923 . . . . 0.0 110.295 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.951 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.491 ' NA ' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.301 0.572 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -150.5 80.67 1.35 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 110.276 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 62.2 28.8 17.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.961 . . . . 0.0 109.866 -179.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.9 -179.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.412 -0.805 . . . . 0.0 110.325 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.73 -68.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 110.199 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 6.7 m-20 54.58 27.41 8.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.093 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.72 153.86 23.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 110.325 -179.668 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.32 179.5 42.46 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.03 109.41 20.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.176 -1.19 . . . . 0.0 110.404 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -94.36 151.69 19.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.397 -0.815 . . . . 0.0 109.955 179.926 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.437 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 2.8 m-80 -79.4 136.6 37.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.152 -0.967 . . . . 0.0 109.509 179.626 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.436 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 0.6 OUTLIER -164.98 159.1 17.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.092 -1.005 . . . . 0.0 110.366 -179.852 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.37 -179.83 8.47 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.417 -0.802 . . . . 0.0 109.653 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.442 ' O ' ' CG2' ' A' ' 46' ' ' THR . 3.3 m -139.74 117.48 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.128 -0.982 . . . . 0.0 110.118 179.642 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -90.6 161.41 15.44 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.35 -0.843 . . . . 0.0 110.668 -179.629 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.429 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.0 OUTLIER -68.05 135.42 52.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.605 -0.684 . . . . 0.0 110.243 -179.75 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.473 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -61.56 144.76 53.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 110.082 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.4 t-20 70.7 3.21 4.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.789 -0.57 . . . . 0.0 110.728 -179.204 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.429 ' CG2' ' HB3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -139.0 -169.72 2.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.033 -1.042 . . . . 0.0 109.638 179.48 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.404 ' N ' ' OG1' ' A' ' 43' ' ' THR . 1.6 m120 -136.08 24.59 3.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.112 -0.992 . . . . 0.0 110.295 179.677 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -136.13 120.65 18.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 111.146 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.442 ' CG2' ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -49.64 121.61 5.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.532 -0.73 . . . . 0.0 109.359 178.961 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.73 -18.83 3.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.833 -1.167 . . . . 0.0 112.293 -178.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.0 mt -138.99 -78.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.59 -1.319 . . . . 0.0 111.214 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.3 -26.65 0.54 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.634 -0.666 . . . . 0.0 111.508 -179.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.421 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -63.98 -16.33 61.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.029 -1.044 . . . . 0.0 110.765 -179.582 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -102.58 15.44 29.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.082 -1.011 . . . . 0.0 110.853 -179.65 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.482 ' CD1' HMC2 ' A' ' 151' ' ' ZNH . 91.3 m-85 -130.38 12.14 5.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.072 -1.017 . . . . 0.0 111.014 -179.675 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.427 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 23.8 m-85 -131.28 116.9 18.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.026 -1.046 . . . . 0.0 110.314 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -72.4 108.47 5.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.258 -0.901 . . . . 0.0 110.323 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.88 159.65 34.08 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 109.943 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -78.76 -175.78 17.38 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.753 -2.186 . . . . 0.0 110.65 -0.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.1 171.56 7.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 109.984 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.55 112.14 25.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.074 -1.016 . . . . 0.0 110.684 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.466 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 11.1 p90 -96.95 167.1 11.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.217 -0.927 . . . . 0.0 109.965 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -156.39 120.96 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.172 -0.955 . . . . 0.0 110.981 179.941 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.1 mtmp? -137.77 127.36 25.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.282 -0.886 . . . . 0.0 110.078 179.614 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -108.59 62.33 0.61 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 110.425 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.68 103.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.434 -0.791 . . . . 0.0 111.343 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.28 -20.3 50.81 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.003 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.39 154.96 48.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.026 -1.279 . . . . 0.0 110.661 -179.677 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.547 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -157.02 142.99 17.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 111.195 179.446 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.532 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 4.0 m-85 -139.36 -172.85 3.45 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.436 ' CG2' ' HA ' ' A' ' 59' ' ' TYR . 1.2 t -163.39 130.06 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.95 -1.093 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -98.59 136.28 38.91 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.589 179.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -114.76 132.61 63.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.15 -0.969 . . . . 0.0 110.172 -179.452 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.12 120.48 31.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.699 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 72' ' ' VAL . 0.8 OUTLIER -103.28 136.89 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 110.042 -179.72 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -99.92 147.15 25.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 110.335 -179.668 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.447 ' CD2' ' CZ3' ' A' ' 77' ' ' TRP . 62.0 m-70 58.1 92.12 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.433 -0.792 . . . . 0.0 110.231 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.77 -40.1 87.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 110.284 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.9 m170 -62.52 -27.7 69.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 110.266 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.447 ' CZ3' ' CD2' ' A' ' 74' ' ' HIS . 38.9 m0 -72.24 -73.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.998 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 6.9 tt -88.06 116.47 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.378 -0.826 . . . . 0.0 109.316 179.552 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 80' ' ' GLY . 1.6 t -86.56 -21.4 26.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.284 -0.885 . . . . 0.0 111.615 -178.573 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.426 ' N ' HG22 ' A' ' 79' ' ' THR . . . -173.52 168.74 41.74 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.307 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.431 ' CG ' ' HB ' ' A' ' 117' ' ' ILE . 1.8 mtm -153.17 105.21 2.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.375 -1.074 . . . . 0.0 109.993 179.717 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 116' ' ' LYS . 3.7 t -86.65 157.15 19.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 0.0 110.111 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.486 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.3 OUTLIER -153.88 151.75 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.132 179.805 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.524 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 1.3 mm-40 57.73 17.69 4.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.049 -1.032 . . . . 0.0 110.717 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.15 16.95 63.76 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.45 179.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.524 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.2 p-80 -137.59 159.69 41.26 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.8 -1.412 . . . . 0.0 110.829 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -71.7 169.99 14.45 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.544 -0.723 . . . . 0.0 110.802 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -89.28 168.12 12.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.344 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -111.48 127.2 55.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.288 -0.882 . . . . 0.0 110.248 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pp -67.99 104.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.144 -0.973 . . . . 0.0 109.623 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.442 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -95.89 -30.09 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 111.235 -179.15 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.7 p -166.86 101.75 0.56 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.936 -1.103 . . . . 0.0 110.49 -179.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -96.69 146.75 24.59 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.422 -0.799 . . . . 0.0 109.972 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.55 110.12 5.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.153 -0.967 . . . . 0.0 110.31 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.0 m -81.49 -40.49 23.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.861 . . . . 0.0 110.411 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.72 -33.41 75.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.216 -0.928 . . . . 0.0 110.284 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 0.3 OUTLIER -96.05 -10.68 27.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 110.541 179.926 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 97' ' ' LYS . 1.2 t0 62.31 53.99 2.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.041 -1.037 . . . . 0.0 110.046 -179.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -146.98 179.42 7.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 110.429 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -172.04 159.92 5.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.978 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.442 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 91.2 m -141.52 153.31 44.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 109.728 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.432 ' N ' HG22 ' A' ' 101' ' ' THR . 24.7 p -145.03 140.58 28.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.012 -1.055 . . . . 0.0 110.704 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -93.4 148.14 22.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 109.99 179.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.46 ' CD1' HD13 ' A' ' 83' ' ' ILE . 97.0 m-85 -128.8 150.38 50.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.141 -0.974 . . . . 0.0 110.721 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.403 ' OE2' ' N ' ' A' ' 106' ' ' VAL . 7.1 tp10 -110.99 123.88 51.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.381 -0.825 . . . . 0.0 109.792 179.626 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 108' ' ' LYS . 9.5 p -149.36 165.54 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.74 -41.27 77.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.133 -0.98 . . . . 0.0 109.795 179.604 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.441 ' CE ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -164.05 -146.23 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.353 179.403 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.45 ' CD2' ' HG ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -151.81 56.35 0.85 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.809 -1.182 . . . . 0.0 110.647 -179.403 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 145' ' ' PRO . 10.5 t-20 -146.59 93.74 2.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -0.87 . . . . 0.0 110.232 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 148.51 -119.68 1.1 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.435 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.0 OUTLIER -156.72 112.68 2.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -1.139 . . . . 0.0 110.264 -179.688 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mm -102.73 139.93 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.231 -0.918 . . . . 0.0 110.023 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.21 123.36 25.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.035 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.473 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -132.57 179.73 17.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 28.6 mtmm -144.29 166.29 25.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -1.131 . . . . 0.0 109.707 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.431 ' HB ' ' CG ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -158.73 144.06 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.933 -1.105 . . . . 0.0 110.721 179.991 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.414 ' CB ' ' CG2' ' A' ' 79' ' ' THR . 5.8 m-20 -107.25 159.53 16.28 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.456 -0.778 . . . . 0.0 108.941 178.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.437 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -141.5 148.49 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.024 -1.047 . . . . 0.0 110.658 -179.464 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -152.09 104.02 2.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.381 -0.824 . . . . 0.0 110.045 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 132' ' ' TYR . 44.4 mt -128.96 152.54 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 110.117 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.423 ' N ' HG22 ' A' ' 121' ' ' ILE . 5.2 p-10 -159.94 97.33 1.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 0.0 109.735 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -173.55 -169.11 0.48 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 110.304 -179.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm -112.01 102.61 10.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.87 . . . . 0.0 110.184 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.69 118.22 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -0.877 . . . . 0.0 110.235 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.94 26.77 6.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.365 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.65 5.52 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.38 107.35 4.44 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.202 -1.175 . . . . 0.0 110.139 179.809 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -51.13 109.8 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.694 1.365 . . . . 0.0 110.368 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' A' ' 132' ' ' TYR . 11.3 t80 -110.02 146.25 35.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.175 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -133.62 99.18 4.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.284 -0.885 . . . . 0.0 110.214 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.482 ' CD2' HD11 ' A' ' 121' ' ' ILE . 2.5 t80 -115.12 129.1 56.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.125 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.62 81.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.953 . . . . 0.0 110.256 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -153.13 -165.28 2.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.16 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.42 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -118.3 143.43 46.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.109 -0.994 . . . . 0.0 110.29 179.866 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.42 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 32.2 m-85 -155.25 -179.47 8.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.381 -0.824 . . . . 0.0 109.826 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 20.6 p30 -151.27 178.64 9.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 110.345 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -156.98 167.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 110.764 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.435 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 94.1 m -91.75 121.25 33.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.46 -0.775 . . . . 0.0 110.37 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.476 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 43.2 m-85 -90.59 95.72 10.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.071 -1.018 . . . . 0.0 110.235 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.92 104.26 16.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.458 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 140' ' ' TYR . 67.9 m-85 -92.93 158.75 15.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.325 -0.859 . . . . 0.0 110.295 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.446 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 20.7 m-80 -139.72 97.36 3.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.105 -0.997 . . . . 0.0 110.651 -179.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.405 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -161.91 -152.66 6.78 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.437 ' HD2' ' CD1' ' A' ' 109' ' ' LEU . 18.8 Cg_endo -64.92 -161.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.893 1.47 . . . . 0.0 110.241 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.7 p -148.44 -47.91 0.15 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.121 -0.987 . . . . 0.0 110.069 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.41 -49.59 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.315 -0.866 . . . . 0.0 110.016 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.2 t 56.21 38.73 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.393 -0.817 . . . . 0.0 110.296 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.34 44.81 0.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.227 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.98 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.482 HMC2 ' CD1' ' A' ' 52' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.283 0.563 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.28 100.28 0.35 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.897 . . . . 0.0 110.122 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.93 22.7 13.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.288 -0.882 . . . . 0.0 110.009 -179.854 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -162.61 109.67 1.27 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 110.267 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.94 -49.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.362 -0.836 . . . . 0.0 110.124 -179.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 13.3 m-20 56.76 33.54 23.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 110.36 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 16.2 t -160.46 153.24 21.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.983 -1.073 . . . . 0.0 110.853 -179.5 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' CD2' ' A' ' 59' ' ' TYR . . . 171.18 176.76 40.55 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.76 109.5 20.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -1.158 . . . . 0.0 110.601 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.495 ' HB2' ' CD2' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -95.78 156.77 16.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.97 -1.081 . . . . 0.0 110.442 179.663 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.432 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 33.8 m-20 -79.92 139.83 36.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 110.246 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -165.84 160.66 17.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.945 . . . . 0.0 110.015 179.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -155.59 -175.8 5.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 0.0 110.447 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.464 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -140.89 166.76 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.324 -0.86 . . . . 0.0 109.834 179.728 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.464 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 51.1 m-85 -147.56 161.55 40.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.084 -1.01 . . . . 0.0 110.545 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.437 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -68.34 135.12 51.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.371 -0.831 . . . . 0.0 109.896 179.96 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.45 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -60.71 146.8 44.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.201 -179.82 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER 70.55 4.63 5.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.789 -0.569 . . . . 0.0 110.892 -179.453 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -135.18 -163.86 1.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.868 -1.145 . . . . 0.0 109.764 179.377 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.414 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.1 OUTLIER -130.34 11.73 5.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.461 179.637 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -135.27 148.89 49.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.025 -1.047 . . . . 0.0 110.592 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.448 ' CG2' ' HB2' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -78.32 137.27 37.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.504 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.54 -17.54 3.68 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.037 -179.075 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.454 HD12 HG22 ' A' ' 48' ' ' ILE . 60.5 mt -137.57 -69.73 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.708 -1.245 . . . . 0.0 110.868 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.447 ' O ' ' CD2' ' A' ' 53' ' ' PHE . . . -45.48 -26.5 0.58 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.627 -0.671 . . . . 0.0 111.241 -179.347 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.448 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER -68.08 -9.13 43.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.076 -1.015 . . . . 0.0 110.823 -179.773 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.465 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 1.6 m-20 -99.26 14.8 28.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.029 -1.045 . . . . 0.0 110.852 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.465 ' CE2' ' HB2' ' A' ' 51' ' ' ASP . 36.6 m-85 -142.27 11.61 1.95 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.945 -1.097 . . . . 0.0 110.824 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 25.9 m-85 -132.62 107.46 8.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.06 -1.025 . . . . 0.0 110.584 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -72.72 167.91 19.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.14 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.408 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.42 164.73 22.91 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.955 . . . . 0.0 109.973 179.798 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.408 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 55.6 Cg_endo -78.23 -175.32 16.48 Favored 'Cis proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.565 -2.265 . . . . 0.0 110.588 -0.153 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.24 170.16 8.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 109.693 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.459 ' CB ' ' CG ' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -101.37 119.69 39.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 110.586 -179.644 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 13.7 p90 -97.81 162.97 13.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.118 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 1.9 tt -157.07 109.81 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.315 -0.866 . . . . 0.0 110.541 179.633 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -128.59 137.86 51.91 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.167 -0.958 . . . . 0.0 110.347 179.89 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.76 62.25 0.99 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 110.13 179.457 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 45.97 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.493 -0.754 . . . . 0.0 111.28 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.44 -8.42 58.6 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.458 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.19 158.54 44.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.916 -1.344 . . . . 0.0 110.428 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.482 ' CD1' ' HA ' ' A' ' 108' ' ' LYS . 1.2 pt? -169.49 148.54 3.79 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.156 -0.965 . . . . 0.0 111.233 179.191 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.547 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -140.73 -163.26 1.5 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.63 -0.669 . . . . 0.0 109.639 -179.638 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 67' ' ' TYR . 1.4 t -168.3 124.82 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 110.047 179.62 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.459 ' CG ' ' CB ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -97.3 130.97 44.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.212 -0.93 . . . . 0.0 109.789 179.758 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.48 141.54 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.83 . . . . 0.0 110.205 -179.344 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.5 m -89.69 123.52 33.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.794 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.4 t -102.3 131.8 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 110.358 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.47 143.85 30.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 110.382 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 55.97 97.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.299 -0.875 . . . . 0.0 110.388 179.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -69.53 -18.03 63.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -0.932 . . . . 0.0 110.338 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.97 -47.37 18.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.255 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.47 ' CD1' HBB1 ' A' ' 151' ' ' ZNH . 46.5 m0 -61.44 -59.33 5.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 110.569 -179.882 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.7 tt -88.67 122.69 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.09 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.432 HG23 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -86.99 -26.74 23.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.359 -0.838 . . . . 0.0 110.832 -179.368 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 79' ' ' THR . . . -176.9 180.0 47.58 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.625 -1.274 . . . . 0.0 109.921 -179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.437 ' SD ' ' CZ ' ' A' ' 53' ' ' PHE . 25.8 mtm -151.6 163.31 39.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.338 -1.096 . . . . 0.0 110.118 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 116' ' ' LYS . 23.1 t -155.4 137.47 14.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.365 -0.834 . . . . 0.0 110.02 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 1.6 mt -136.23 141.28 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.263 -0.898 . . . . 0.0 110.362 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 72.67 -0.25 3.4 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.755 -0.591 . . . . 0.0 111.399 179.972 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.12 22.39 8.8 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.589 -1.291 . . . . 0.0 111.288 178.8 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.47 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.42 159.52 41.85 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.628 -1.513 . . . . 0.0 110.215 179.353 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -173.53 0.92 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.142 -0.974 . . . . 0.0 110.448 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 1.2 pt-20 -108.76 170.13 8.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.0 110.267 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -120.6 125.41 47.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.933 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -67.52 102.55 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.962 -1.086 . . . . 0.0 109.749 179.967 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.424 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.2 tt -94.87 -28.11 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 0.0 110.553 -179.354 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.7 m -166.48 96.1 0.56 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.411 -0.805 . . . . 0.0 109.829 -179.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -95.99 109.99 22.29 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 110.292 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.04 83.86 3.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 110.281 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.8 p -65.32 -30.99 71.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -0.929 . . . . 0.0 110.322 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.21 84.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.936 . . . . 0.0 110.09 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.81 17.49 15.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.3 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 49.59 60.39 3.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.239 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -147.33 177.98 8.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 110.242 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 179.87 159.63 0.79 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.899 . . . . 0.0 110.072 -179.845 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.424 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 95.7 m -137.19 154.84 50.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.962 . . . . 0.0 109.808 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.7 p -145.11 139.45 27.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 110.712 -179.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -93.57 144.36 25.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 110.13 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 93.5 m-85 -128.94 146.7 50.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.19 -0.944 . . . . 0.0 110.534 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -101.88 129.84 48.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.364 -0.835 . . . . 0.0 109.607 179.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.42 ' CG2' HD13 ' A' ' 113' ' ' ILE . 9.0 p -149.49 139.41 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.094 -1.004 . . . . 0.0 111.022 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.9 t -63.96 102.25 0.46 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.143 -0.973 . . . . 0.0 108.5 178.527 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 56.58 171.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 108.833 -177.968 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.94 76.96 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.952 -1.093 . . . . 0.0 110.853 -179.427 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -146.01 64.17 1.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.447 -0.783 . . . . 0.0 109.846 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.08 -171.92 38.96 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.01 140.27 34.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.318 -1.107 . . . . 0.0 110.564 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.42 HD13 ' CG2' ' A' ' 106' ' ' VAL . 12.9 mt -136.0 150.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.321 -0.862 . . . . 0.0 109.739 179.623 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.33 127.46 32.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 -179.846 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -132.37 169.25 22.33 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -146.74 159.79 43.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -1.156 . . . . 0.0 110.096 179.981 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.99 143.66 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.105 -0.997 . . . . 0.0 110.591 179.84 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -106.53 159.76 15.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.433 -0.792 . . . . 0.0 109.263 179.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.06 149.31 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.04 -1.037 . . . . 0.0 110.814 -179.582 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.409 ' CZ ' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -151.72 107.63 3.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.46 -0.775 . . . . 0.0 109.859 179.715 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.463 HD12 ' CD2' ' A' ' 132' ' ' TYR . 28.6 mt -135.22 153.12 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.408 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.78 101.09 1.46 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.468 -0.77 . . . . 0.0 109.455 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -173.23 -165.14 0.26 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.235 -0.916 . . . . 0.0 110.442 -179.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -95.76 165.81 12.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.647 -179.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 6.8 t -158.41 93.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 65.53 30.5 10.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.386 -0.822 . . . . 0.0 109.603 -179.11 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.61 39.42 10.74 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -147.48 106.55 3.79 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.149 -1.206 . . . . 0.0 110.371 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.62 114.71 1.3 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.69 1.363 . . . . 0.0 109.953 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 10.5 t80 -97.78 141.36 30.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 110.451 -179.482 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -134.4 99.12 4.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 109.847 179.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . 1.7 t80 -112.91 124.27 52.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.064 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.409 ' OD2' ' CZ ' ' A' ' 120' ' ' TYR . 53.7 t0 -170.24 84.39 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 109.926 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -154.16 -165.02 1.99 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 110.555 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.47 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 74.2 m-70 -117.87 152.32 35.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.852 . . . . 0.0 109.692 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.47 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 66.0 m-85 -155.11 -178.97 7.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.938 . . . . 0.0 110.331 -179.761 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 2.1 p30 -150.16 164.93 34.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 110.166 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.2 pt -156.24 172.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.337 -0.852 . . . . 0.0 110.35 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 10.9 m -91.76 162.28 14.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.412 -0.805 . . . . 0.0 110.576 -179.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.463 ' CE1' ' CG1' ' A' ' 38' ' ' VAL . 12.0 m-85 -145.52 108.15 4.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.388 -0.82 . . . . 0.0 110.032 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.61 109.82 21.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.37 -0.831 . . . . 0.0 110.521 -179.726 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -91.22 157.02 17.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.082 179.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.432 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 59.1 m-80 -138.83 98.37 3.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.197 -0.939 . . . . 0.0 110.398 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -157.76 -147.24 4.75 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -71.99 152.15 56.91 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.807 1.424 . . . . 0.0 110.733 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 p -91.48 -24.31 19.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 110.076 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -165.24 -79.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.302 -0.874 . . . . 0.0 110.031 -179.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.0 t 56.89 35.94 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 110.344 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.51 -44.62 17.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.258 -0.901 . . . . 0.0 110.181 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.961 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.47 HBB1 ' CD1' ' A' ' 77' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.243 0.544 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.51 106.58 17.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 0.0 110.384 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 62.15 23.44 13.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.93 . . . . 0.0 110.02 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.84 65.58 8.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.359 -0.838 . . . . 0.0 110.089 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.39 -62.18 1.61 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.318 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 4.8 m-20 56.41 27.55 12.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.0 110.215 -179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 4.1 p -159.13 158.67 33.32 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.272 -0.892 . . . . 0.0 110.779 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 171.5 171.84 37.01 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.91 108.5 19.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -1.216 . . . . 0.0 110.355 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.485 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -94.45 152.52 18.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.0 109.995 179.855 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.449 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -78.82 139.57 38.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.139 -0.976 . . . . 0.0 110.425 -179.953 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -165.65 159.28 16.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.193 -0.942 . . . . 0.0 110.202 179.557 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -155.36 -171.63 3.87 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.338 -0.851 . . . . 0.0 109.699 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.519 ' CG1' ' CD1' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -140.85 172.06 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 110.231 179.781 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -147.52 157.24 43.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 110.09 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.423 ' NZ ' ' HA ' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -67.58 139.33 56.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.226 -179.864 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.455 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.2 OUTLIER -63.64 147.04 52.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.942 179.853 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 28.3 t30 70.01 4.62 4.89 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.715 -0.616 . . . . 0.0 110.732 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.82 179.67 6.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.976 -1.078 . . . . 0.0 109.776 179.376 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -115.76 12.98 16.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 110.285 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.37 143.38 46.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.109 -0.994 . . . . 0.0 110.613 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.435 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -73.72 139.73 45.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.251 179.48 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -17.8 3.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.001 -1.062 . . . . 0.0 112.189 -178.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 49' ' ' ALA . 8.0 mt -137.46 -73.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.781 -1.2 . . . . 0.0 110.787 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.413 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -45.8 -26.13 0.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.612 -0.68 . . . . 0.0 111.14 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.455 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -60.02 -16.81 34.09 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.109 -0.995 . . . . 0.0 110.695 -179.83 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -102.33 15.54 28.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.031 -1.043 . . . . 0.0 111.009 -179.406 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.479 ' CD1' HBC2 ' A' ' 151' ' ' ZNH . 63.5 m-85 -133.27 7.63 3.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.839 -1.163 . . . . 0.0 111.384 -179.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' A' ' 53' ' ' PHE . 15.0 p90 -115.64 114.92 25.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.961 -1.087 . . . . 0.0 110.537 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -74.7 106.14 6.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.038 -1.039 . . . . 0.0 110.459 -179.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.41 ' HB3' ' CE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -94.3 160.38 32.03 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 110.228 179.844 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.69 -175.38 15.97 Favored 'Cis proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.548 -2.272 . . . . 0.0 110.733 -0.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.71 164.99 11.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 109.899 179.694 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.11 117.55 34.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.134 -0.978 . . . . 0.0 110.993 -179.536 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.485 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 31.5 p90 -98.47 165.63 11.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.319 -0.863 . . . . 0.0 109.799 179.385 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 31' ' ' SER . 0.5 OUTLIER -155.41 122.47 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.988 -1.07 . . . . 0.0 111.139 -179.739 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -140.19 131.86 27.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.258 -0.901 . . . . 0.0 110.331 179.735 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 63' ' ' ASN . 7.1 tttt -111.37 62.08 0.61 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 0.0 110.455 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 62' ' ' LYS . 4.5 m120 49.85 101.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.365 -0.834 . . . . 0.0 111.223 179.578 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.65 -18.48 55.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -140.55 160.19 40.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.248 . . . . 0.0 110.273 179.849 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.547 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -163.54 144.77 9.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 111.274 179.852 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 3.4 m-85 -141.57 -159.32 0.95 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.263 -0.898 . . . . 0.0 109.674 -179.771 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -169.92 165.28 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 110.322 179.613 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.414 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 2.0 pt20 -140.97 133.57 28.64 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.382 -0.824 . . . . 0.0 109.894 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.67 140.33 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 110.003 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.8 m -89.09 134.04 34.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.133 -0.979 . . . . 0.0 109.748 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.418 ' CG1' HG21 ' A' ' 78' ' ' ILE . 2.4 t -102.2 126.55 56.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.395 -0.816 . . . . 0.0 110.407 -179.507 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -99.5 127.9 45.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.263 -0.898 . . . . 0.0 110.046 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 63.32 69.93 0.55 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 109.871 -179.705 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.78 -27.49 63.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.467 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -55.99 -39.34 71.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 0.0 110.54 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.419 ' O ' ' CG1' ' A' ' 119' ' ' VAL . 24.8 m0 -81.2 -52.61 7.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.379 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.418 HG21 ' CG1' ' A' ' 72' ' ' VAL . 20.3 tt -88.87 123.18 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 109.658 179.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.471 HG22 ' N ' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -87.08 -29.79 21.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.215 -0.928 . . . . 0.0 111.266 -179.001 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 79' ' ' THR . . . -175.95 175.07 47.28 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 118.998 -1.573 . . . . 0.0 110.701 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.414 ' CG ' HD13 ' A' ' 117' ' ' ILE . 5.2 mtt -152.3 110.49 3.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.654 -0.909 . . . . 0.0 109.784 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 116' ' ' LYS . 1.0 OUTLIER -85.88 157.26 20.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.095 -1.003 . . . . 0.0 110.359 -179.98 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.485 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 1.0 OUTLIER -151.35 149.98 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.381 -0.825 . . . . 0.0 109.758 179.578 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.508 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 0.7 OUTLIER 61.77 14.09 5.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.124 -0.985 . . . . 0.0 110.783 -179.886 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.38 19.92 57.76 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.809 179.163 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.508 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.1 p-80 -137.47 161.24 36.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.72 -1.459 . . . . 0.0 110.692 179.591 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.76 174.33 7.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.468 -0.77 . . . . 0.0 110.838 -179.521 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 8.2 pt-20 -99.06 167.4 10.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 110.474 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -118.43 134.94 54.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.31 -0.869 . . . . 0.0 110.192 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.07 100.72 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 109.445 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.449 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 2.5 tt -96.32 -25.72 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 110.797 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -167.73 95.07 0.43 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.965 . . . . 0.0 110.138 -179.775 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.437 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 2.4 ttmt -96.34 144.03 26.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.83 93.62 2.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.129 -0.982 . . . . 0.0 110.331 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -76.81 -15.78 59.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.864 . . . . 0.0 110.357 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.83 -28.01 69.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 110.548 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -136.34 25.56 3.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.122 -0.986 . . . . 0.0 110.502 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.87 70.82 0.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.337 179.873 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -147.71 160.51 42.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.141 -0.975 . . . . 0.0 110.003 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.437 ' HG3' ' CG ' ' A' ' 93' ' ' LYS . 1.0 OUTLIER -168.92 162.87 11.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 110.356 -179.777 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.449 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 57.9 m -142.05 157.81 44.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.45 -0.781 . . . . 0.0 109.229 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 2.0 p -143.9 137.04 27.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.821 -1.174 . . . . 0.0 110.616 -179.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -93.0 136.48 33.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.426 -0.796 . . . . 0.0 109.995 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 102' ' ' SER . 88.6 m-85 -129.68 144.38 51.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.1 -1.0 . . . . 0.0 110.904 -179.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -101.11 127.96 47.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.481 -0.762 . . . . 0.0 109.091 179.041 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 19.9 m -147.98 163.02 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.914 -1.117 . . . . 0.0 111.075 -178.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.67 109.55 7.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.292 -0.88 . . . . 0.0 108.658 178.629 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.443 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 48.84 -159.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.341 -0.85 . . . . 0.0 109.563 -178.577 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.424 HD13 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -150.59 60.72 0.94 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.974 -1.079 . . . . 0.0 111.103 -179.489 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -146.08 82.12 1.6 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.339 -0.85 . . . . 0.0 109.799 179.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.57 170.82 22.09 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.43 146.14 29.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -1.056 . . . . 0.0 110.458 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 82.6 mt -139.35 149.9 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.942 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.48 142.66 40.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.12 -0.988 . . . . 0.0 110.525 -179.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -147.72 127.84 2.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 82' ' ' SER . 10.8 mttt -94.67 168.2 10.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.346 -1.09 . . . . 0.0 109.787 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.414 HD13 ' CG ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -158.9 133.95 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.993 -1.067 . . . . 0.0 110.858 179.481 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.437 ' HB2' ' CG2' ' A' ' 79' ' ' THR . 11.6 m-20 -107.47 163.32 13.15 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.482 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.464 HG13 ' CD2' ' A' ' 132' ' ' TYR . 3.8 t -144.14 152.67 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.899 -1.126 . . . . 0.0 110.475 -179.268 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.21 113.73 4.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.427 -0.796 . . . . 0.0 110.523 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.424 ' HB ' ' CB ' ' A' ' 132' ' ' TYR . 2.7 mp -138.15 153.71 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.347 -0.845 . . . . 0.0 110.082 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.74 96.99 1.41 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.125 -0.985 . . . . 0.0 110.208 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.43 ' O ' ' CD1' ' A' ' 130' ' ' PHE . 0.4 OUTLIER -174.12 -170.69 0.56 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.395 -0.815 . . . . 0.0 110.151 -179.957 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.31 111.49 23.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.213 -0.929 . . . . 0.0 110.22 -179.875 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.407 HG23 ' CE1' ' A' ' 130' ' ' PHE . 2.7 t -77.12 107.6 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.34 179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.28 38.07 12.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.892 . . . . 0.0 110.495 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 91.72 39.02 5.66 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -144.82 90.07 6.44 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.337 -1.096 . . . . 0.0 109.998 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.03 121.48 9.37 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.97 1.51 . . . . 0.0 110.715 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.43 ' CD1' ' O ' ' A' ' 123' ' ' GLU . 11.6 p90 -146.38 166.35 26.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.923 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.68 117.28 14.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 110.43 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.481 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 3.8 t80 -102.46 135.0 44.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.394 -0.817 . . . . 0.0 109.705 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -174.39 83.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 0.0 110.16 -179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.91 -162.32 1.41 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.902 . . . . 0.0 110.622 179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -120.28 157.09 29.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.445 -0.785 . . . . 0.0 110.062 179.852 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 34.4 m-85 -155.15 -179.05 7.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.048 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.78 165.74 32.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 110.521 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -156.38 159.34 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.464 -0.772 . . . . 0.0 109.815 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.9 m -91.61 119.9 31.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.18 -0.95 . . . . 0.0 110.655 -179.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.519 ' CD1' ' CG1' ' A' ' 38' ' ' VAL . 9.5 m-85 -90.39 165.73 13.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.322 -0.861 . . . . 0.0 109.909 179.518 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.89 103.92 1.9 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.467 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -92.2 154.23 18.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.274 -0.891 . . . . 0.0 110.236 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 48.8 m-80 -141.78 96.9 3.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 110.497 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.424 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -150.86 -151.72 5.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.735 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.96 178.13 0.29 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.733 1.386 . . . . 0.0 110.287 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.61 -60.38 0.24 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.273 -0.892 . . . . 0.0 110.005 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.76 -63.12 1.36 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.095 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 24.2 t 55.99 55.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 110.305 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.75 -22.57 37.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 110.255 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.997 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.481 ' NA ' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.326 0.584 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.46 78.96 0.73 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.937 . . . . 0.0 110.155 -179.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 t30 62.12 23.96 14.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.915 -179.763 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.46 90.01 4.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.377 -0.827 . . . . 0.0 110.245 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.87 -73.5 0.22 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.289 -0.882 . . . . 0.0 109.885 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 63.6 m-20 52.74 28.22 6.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 110.386 179.657 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER -159.39 150.44 19.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.052 -1.03 . . . . 0.0 110.727 -179.374 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.37 -136.87 3.39 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.22 110.5 4.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.162 -1.199 . . . . 0.0 110.348 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.464 ' CD2' ' HB3' ' A' ' 59' ' ' TYR . 2.3 pp -95.06 156.08 16.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.434 -0.791 . . . . 0.0 110.365 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.422 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 1.4 t30 -79.33 141.69 36.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.37 -0.832 . . . . 0.0 110.068 179.749 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.475 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 1.6 p90 -164.01 162.81 23.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.068 -1.02 . . . . 0.0 110.682 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.36 -165.89 2.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.528 -0.732 . . . . 0.0 109.677 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.41 HG22 HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -139.92 174.58 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.15 -0.969 . . . . 0.0 110.154 179.703 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.422 ' CE2' ' HG3' ' A' ' 141' ' ' LYS . 14.0 m-85 -147.62 147.29 29.87 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.203 -0.935 . . . . 0.0 109.961 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.44 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -67.58 130.36 42.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.366 -0.834 . . . . 0.0 110.26 -179.592 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.455 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -52.45 145.75 10.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -0.887 . . . . 0.0 110.386 -179.809 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.8 t30 72.79 0.26 3.59 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.884 -0.51 . . . . 0.0 111.074 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.423 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -136.38 -161.99 1.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.871 -1.143 . . . . 0.0 109.749 179.298 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.423 ' N ' ' OG1' ' A' ' 43' ' ' THR . 12.0 p-10 -135.58 15.47 3.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.188 -0.945 . . . . 0.0 110.214 179.592 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -135.14 128.13 31.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 0.0 110.767 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.446 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -57.58 136.35 56.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.45 179.509 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.34 -17.85 4.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.064 -1.023 . . . . 0.0 111.675 -179.194 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 mp -137.78 -71.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.777 -1.202 . . . . 0.0 110.813 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -45.4 -26.14 0.51 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.693 -0.629 . . . . 0.0 111.27 -179.366 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.446 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -62.47 -13.02 25.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.06 -1.025 . . . . 0.0 111.044 -179.73 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -98.89 13.97 30.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.99 -1.069 . . . . 0.0 110.995 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -135.44 -1.55 2.55 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.907 -1.121 . . . . 0.0 111.574 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 49' ' ' ALA . 16.2 m-30 -111.91 101.12 9.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.961 -1.087 . . . . 0.0 110.249 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.19 113.67 10.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.314 -0.866 . . . . 0.0 110.539 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.451 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 1.0 OUTLIER -93.53 166.67 15.5 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 109.942 179.739 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.451 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 60.2 Cg_endo -82.79 -175.55 14.97 Favored 'Cis proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.784 -2.174 . . . . 0.0 110.595 -0.494 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -104.25 162.67 13.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.286 -0.884 . . . . 0.0 109.641 179.467 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -98.85 114.73 27.45 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.226 -0.922 . . . . 0.0 110.254 -179.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.464 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 10.7 p90 -97.68 161.64 13.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.123 -0.985 . . . . 0.0 110.609 -179.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.446 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -154.86 127.77 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.9 . . . . 0.0 110.543 -179.632 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 2.4 mtmt -137.82 119.42 14.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.183 -0.948 . . . . 0.0 110.438 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -94.74 62.12 2.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.657 -179.998 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.406 ' O ' ' O ' ' A' ' 62' ' ' LYS . 0.1 OUTLIER 49.16 101.54 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.404 -0.81 . . . . 0.0 111.376 179.44 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.56 -21.93 41.97 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.357 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.444 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -135.28 154.5 51.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.175 -1.191 . . . . 0.0 110.138 179.61 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -156.37 135.99 12.43 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.159 0.98 . . . . 0.0 111.308 179.878 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.516 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -142.17 176.39 9.01 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.417 -0.802 . . . . 0.0 109.144 179.985 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -150.01 141.58 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.931 -1.106 . . . . 0.0 110.872 179.983 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 6.0 pt20 -100.09 134.98 42.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.461 -0.774 . . . . 0.0 109.513 179.209 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 101' ' ' THR . 1.1 mm -110.51 131.22 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.725 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.6 m -87.75 127.67 35.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.185 -0.947 . . . . 0.0 110.023 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -103.33 144.4 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.833 . . . . 0.0 110.045 -179.644 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -99.36 146.78 25.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.112 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 53.94 84.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.078 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.8 p -50.35 -33.42 20.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.451 -179.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -41.17 74.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 110.384 -179.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.489 ' CD1' HBB1 ' A' ' 151' ' ' ZNH . 31.5 m0 -61.15 -63.14 1.39 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 0.0 110.444 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 16.4 tt -88.36 118.6 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.144 -0.973 . . . . 0.0 109.765 179.843 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.428 HG23 ' N ' ' A' ' 80' ' ' GLY . 0.6 OUTLIER -86.85 -23.67 25.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.87 . . . . 0.0 110.964 -179.2 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.428 ' N ' HG23 ' A' ' 79' ' ' THR . . . 179.38 173.83 44.9 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.447 -1.359 . . . . 0.0 110.153 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.47 ' HE2' ' CE1' ' A' ' 53' ' ' PHE . 1.2 mtm -153.32 113.58 3.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.339 -1.095 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.74 169.66 13.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.454 HG13 ' CE2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -169.24 141.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -0.867 . . . . 0.0 110.048 179.785 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.523 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 1.1 tm-20 64.52 11.91 7.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.274 -0.891 . . . . 0.0 110.69 -179.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.77 17.45 61.66 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.336 179.528 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.523 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.2 p-80 -137.75 160.19 39.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.971 -1.311 . . . . 0.0 110.576 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.91 162.15 29.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.418 -0.801 . . . . 0.0 110.492 -179.674 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.504 ' CB ' ' CE1' ' A' ' 104' ' ' PHE . 12.9 pt-20 -91.2 168.08 11.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.864 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.63 133.94 53.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.303 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.8 pt -68.01 142.41 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.034 -1.041 . . . . 0.0 109.402 179.463 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.409 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 3.0 tt -136.24 -29.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.151 -0.968 . . . . 0.0 111.43 -179.038 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 m -165.34 94.66 0.63 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.982 -1.074 . . . . 0.0 109.743 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -96.39 142.46 28.47 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.322 -0.861 . . . . 0.0 110.062 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -141.74 91.57 2.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 110.245 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 72.6 p -71.14 -23.34 62.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 110.245 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.41 54.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.093 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -97.72 13.48 30.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.904 . . . . 0.0 110.413 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.29 62.45 2.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.034 -1.042 . . . . 0.0 110.166 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -147.89 137.29 22.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 0.0 110.43 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.433 ' HG3' ' N ' ' A' ' 101' ' ' THR . 3.2 ttt180 -144.1 162.0 37.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.435 -0.791 . . . . 0.0 109.983 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 102' ' ' SER . 94.0 m -142.14 156.69 45.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 110.371 -179.781 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.436 ' N ' HG22 ' A' ' 101' ' ' THR . 2.4 p -145.29 145.35 31.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.183 -0.948 . . . . 0.0 110.271 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -91.55 144.21 25.78 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.296 -0.878 . . . . 0.0 110.041 -179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.504 ' CE1' ' CB ' ' A' ' 88' ' ' GLU . 37.2 m-85 -130.13 135.82 48.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 110.846 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.06 126.19 38.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.34 -0.85 . . . . 0.0 109.424 179.182 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.2 p -149.59 158.64 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.012 -1.055 . . . . 0.0 110.872 -179.101 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.4 p -69.87 108.88 4.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.937 . . . . 0.0 108.773 178.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.436 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 47.87 -153.51 0.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.366 -0.834 . . . . 0.0 109.488 -178.457 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.425 ' CD2' HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.41 61.23 0.89 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.657 -1.277 . . . . 0.0 111.251 -179.093 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -147.37 94.35 2.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.961 . . . . 0.0 110.458 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.58 -123.78 1.61 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.429 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.2 OUTLIER -156.86 150.23 24.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.299 -1.118 . . . . 0.0 109.513 -179.676 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.414 ' N ' ' HG2' ' A' ' 112' ' ' LYS . 1.5 mm -138.53 129.16 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.134 -179.715 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -76.35 131.36 39.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.206 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -142.7 -162.66 9.36 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -146.31 172.45 13.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.224 -1.162 . . . . 0.0 109.741 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.8 140.41 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.115 -0.991 . . . . 0.0 110.477 179.972 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.42 ' HB2' ' CG2' ' A' ' 79' ' ' THR . 23.2 m-20 -106.53 158.46 16.9 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.222 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.464 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -134.88 149.91 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.119 -0.988 . . . . 0.0 110.229 -179.749 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -151.27 106.8 3.36 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.646 -179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.459 ' CG1' ' HA ' ' A' ' 77' ' ' TRP . 2.5 mp -137.43 152.67 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.43 -0.794 . . . . 0.0 109.777 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.443 ' N ' HG21 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -160.31 106.65 1.54 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.289 -0.882 . . . . 0.0 109.723 -179.981 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -172.28 -179.48 2.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 110.258 -179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -85.08 96.64 9.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 110.491 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.402 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 2.5 t -76.45 106.78 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.996 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 64.15 26.2 13.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.174 -179.903 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.07 34.86 9.37 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.24 127.24 7.92 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.223 -1.163 . . . . 0.0 110.14 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -55.86 108.94 0.36 Allowed 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.504 1.265 . . . . 0.0 110.109 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 132' ' ' TYR . 52.0 t80 -114.93 144.24 43.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.363 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -135.44 118.07 15.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 110.243 -179.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.495 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 5.0 t80 -115.11 127.92 55.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.123 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.83 82.56 0.38 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.869 . . . . 0.0 109.925 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -154.29 -172.72 4.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 110.534 -179.763 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.459 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 5.9 p-80 -122.53 161.75 23.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.483 -0.761 . . . . 0.0 109.918 179.698 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.459 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 47.2 m-85 -155.38 140.63 17.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.169 -0.957 . . . . 0.0 110.337 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.433 ' ND2' ' CD2' ' A' ' 41' ' ' TYR . 38.8 p30 -88.11 156.51 19.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.232 -0.917 . . . . 0.0 110.4 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 137' ' ' ASN . 4.2 pt -157.21 143.8 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 109.891 -179.945 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.429 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 81.4 m -91.62 128.35 37.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.197 -0.94 . . . . 0.0 110.944 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.454 ' CE2' HG13 ' A' ' 83' ' ' ILE . 51.8 m-85 -90.8 159.99 16.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.793 179.102 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.422 ' HG3' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -146.67 102.41 3.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.368 -179.965 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -93.17 152.14 19.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.279 -0.888 . . . . 0.0 110.386 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 51.3 m-80 -144.22 95.61 2.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.154 -0.966 . . . . 0.0 110.393 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.424 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -152.19 -154.77 6.76 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.793 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -61.15 178.39 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.91 1.479 . . . . 0.0 110.644 -179.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.7 p -149.49 -62.48 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 110.117 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -120.37 -60.81 1.65 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 110.169 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.1 t 56.73 42.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 0.0 110.307 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.96 -47.26 12.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 0.0 110.264 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.972 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.495 ' NA ' ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.29 0.567 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.53 88.3 2.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 110.241 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.91 32.23 17.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.267 -0.896 . . . . 0.0 109.954 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.47 118.35 19.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.851 . . . . 0.0 110.383 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 43.04 -164.78 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.667 -0.646 . . . . 0.0 111.044 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER 56.31 28.69 13.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.897 . . . . 0.0 110.281 -179.82 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 t -161.31 140.81 10.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.86 . . . . 0.0 110.401 -179.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.0 179.38 47.36 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.28 111.99 22.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.317 -1.108 . . . . 0.0 110.051 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.492 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -95.4 154.3 17.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -0.905 . . . . 0.0 110.8 -179.739 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.4 m-20 -81.91 139.08 34.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.336 179.071 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.428 ' CE2' ' HB1' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -166.89 160.36 14.34 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.948 -1.095 . . . . 0.0 110.859 -179.924 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.57 -167.12 2.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.572 -0.705 . . . . 0.0 109.721 179.695 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.418 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -142.16 174.04 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.116 -0.99 . . . . 0.0 110.296 179.818 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.482 ' CE2' ' HG3' ' A' ' 141' ' ' LYS . 16.7 m-85 -147.73 152.69 38.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.838 . . . . 0.0 110.052 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 124.29 23.01 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.381 -0.824 . . . . 0.0 110.009 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.436 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -49.17 147.58 2.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.77 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 3.9 m120 72.33 0.79 3.72 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.934 -0.479 . . . . 0.0 110.91 -179.092 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.4 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -136.77 -160.38 1.05 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.818 -1.177 . . . . 0.0 109.729 179.092 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.4 ' N ' ' OG1' ' A' ' 43' ' ' THR . 3.2 t-20 -134.37 11.64 3.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 110.248 179.471 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -135.99 139.0 42.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.102 -0.999 . . . . 0.0 110.628 -179.685 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.434 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -63.71 133.44 53.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.206 179.264 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -128.7 -17.6 4.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.89 -1.132 . . . . 0.0 111.964 -178.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.2 mt -137.54 -71.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.815 -1.178 . . . . 0.0 110.76 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -50.99 -22.53 2.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.499 -0.751 . . . . 0.0 111.027 -179.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.434 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -55.59 -19.32 9.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.128 -0.982 . . . . 0.0 110.77 -179.793 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -94.29 15.29 17.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.015 -1.053 . . . . 0.0 110.922 -179.44 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -141.61 16.27 2.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.908 -1.12 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -123.1 106.17 10.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.141 -0.975 . . . . 0.0 110.255 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.96 152.45 41.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.899 . . . . 0.0 110.607 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.3 162.56 31.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 0.0 109.838 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -78.02 -176.68 19.18 Favored 'Cis proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.728 -2.197 . . . . 0.0 110.475 -0.127 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.428 ' HB1' ' CE2' ' A' ' 36' ' ' TYR . . . -105.23 166.33 10.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 110.091 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -101.49 113.78 27.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 110.088 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.492 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 8.7 p90 -96.27 163.54 13.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.924 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.4 OUTLIER -154.74 154.19 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.181 -0.95 . . . . 0.0 110.205 -179.925 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 29.7 mtpt -136.52 170.43 16.07 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.157 -0.965 . . . . 0.0 110.854 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.418 ' CB ' ' CD ' ' A' ' 65' ' ' LYS . 9.4 mttt -155.06 62.91 0.64 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.439 -0.788 . . . . 0.0 110.032 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t30 48.61 86.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.397 -0.815 . . . . 0.0 111.091 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.63 24.21 33.92 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.616 179.021 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.418 ' CD ' ' CB ' ' A' ' 62' ' ' LYS . 6.4 ptpt -170.39 161.19 7.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.042 -1.27 . . . . 0.0 110.947 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 61' ' ' LYS . 1.6 pt? -172.19 149.49 2.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.1 0.952 . . . . 0.0 111.732 178.688 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -140.61 174.06 10.89 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.258 -179.268 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.57 143.04 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.988 -1.07 . . . . 0.0 110.15 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.4 ' O ' ' HG3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -99.69 133.65 43.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 110.329 179.87 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.12 141.08 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.796 179.823 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 m -89.13 130.21 35.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.875 . . . . 0.0 110.348 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.7 t -102.94 125.63 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.904 179.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -100.32 140.24 34.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.497 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.523 ' CE1' ' CE2' ' A' ' 77' ' ' TRP . 0.6 OUTLIER 62.14 77.32 0.33 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.93 . . . . 0.0 110.315 179.87 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.8 m -65.47 -35.06 79.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 110.057 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -52.95 -38.28 61.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.314 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.523 ' CE2' ' CE1' ' A' ' 74' ' ' HIS . 44.6 m0 -82.18 -61.27 1.95 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.947 . . . . 0.0 110.381 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.428 ' O ' ' CG2' ' A' ' 78' ' ' ILE . 7.8 tt -87.76 122.03 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.372 -0.83 . . . . 0.0 109.808 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.458 ' CG2' ' HB3' ' A' ' 118' ' ' ASP . 1.3 t -87.6 -22.42 24.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.0 111.41 -178.87 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.456 ' N ' HG22 ' A' ' 79' ' ' THR . . . 179.79 176.98 47.68 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.303 -1.427 . . . . 0.0 110.381 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.403 ' SD ' ' CD1' ' A' ' 78' ' ' ILE . 2.1 mpp? -150.61 108.14 3.65 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.579 -0.954 . . . . 0.0 109.985 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.49 156.9 20.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.24 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.481 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 3.9 mt -148.19 153.28 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 110.073 179.758 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.524 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 1.9 tm-20 61.96 14.81 6.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 0.0 110.709 179.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.6 19.42 61.93 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.524 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.2 p-80 -136.2 159.85 40.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.274 . . . . 0.0 110.272 179.608 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -71.44 162.95 28.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.82 . . . . 0.0 110.604 -179.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -90.79 170.09 10.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 179.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.39 126.92 55.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.289 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pp -67.86 103.64 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.142 -0.973 . . . . 0.0 109.465 179.578 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.434 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -94.38 -28.41 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 0.0 110.978 -179.061 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.3 m -166.91 100.21 0.55 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.044 -1.035 . . . . 0.0 110.12 -179.644 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -95.72 102.64 14.46 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.396 -0.815 . . . . 0.0 110.041 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.47 94.3 7.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 110.211 -179.799 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 79.1 p -80.47 -17.34 51.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.356 -0.84 . . . . 0.0 110.368 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.48 -19.91 64.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.95 . . . . 0.0 110.11 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -136.44 22.44 3.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 110.105 179.887 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 52.74 67.97 0.9 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 0.0 110.093 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -147.72 176.23 10.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -0.898 . . . . 0.0 110.262 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -175.93 161.41 2.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.892 . . . . 0.0 110.189 -179.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.434 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 87.1 m -142.32 154.32 44.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.897 . . . . 0.0 109.814 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.4 p -145.88 142.01 28.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.034 -1.042 . . . . 0.0 110.759 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -92.74 146.16 23.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.456 -0.778 . . . . 0.0 109.716 179.472 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.469 ' CG ' HD12 ' A' ' 83' ' ' ILE . 46.4 m-85 -129.22 139.5 51.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.076 -1.015 . . . . 0.0 111.079 -179.398 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -105.75 122.06 45.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.462 -0.774 . . . . 0.0 109.225 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.4 m -149.02 147.91 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.069 -1.019 . . . . 0.0 110.91 -178.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.6 m -63.8 106.64 1.03 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.327 -0.858 . . . . 0.0 109.117 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.461 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 0.1 OUTLIER 50.45 -177.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.469 -0.77 . . . . 0.0 109.588 -178.729 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.459 ' HG ' ' CD1' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -150.42 82.49 1.36 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.907 -1.12 . . . . 0.0 111.191 -179.42 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.432 ' CB ' HG21 ' A' ' 146' ' ' THR . 15.2 t-20 -145.16 80.33 1.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.109 179.46 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.09 -113.61 0.61 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -157.11 152.93 27.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.161 -1.199 . . . . 0.0 110.055 179.847 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 57.4 mt -134.15 150.79 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 0.0 110.188 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -76.37 123.01 25.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.254 -0.904 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.458 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -128.83 177.75 17.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 82' ' ' SER . 8.8 mttt -143.45 171.79 13.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -1.079 . . . . 0.0 109.845 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.13 138.83 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.073 -1.017 . . . . 0.0 110.543 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.458 ' HB3' ' CG2' ' A' ' 79' ' ' THR . 42.4 t0 -107.96 158.06 17.69 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 108.896 179.047 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.406 ' CG1' ' HA ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -145.34 152.7 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 0.0 110.781 -179.244 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -152.44 107.36 3.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.462 -0.774 . . . . 0.0 110.457 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.474 HD11 ' CD2' ' A' ' 132' ' ' TYR . 20.0 mt -127.74 153.31 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.185 -0.947 . . . . 0.0 110.454 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.55 96.96 1.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.866 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.423 ' HG2' ' CE1' ' A' ' 130' ' ' PHE . 6.7 pt-20 -173.88 -149.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 110.261 -179.654 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.67 119.33 20.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.194 -0.941 . . . . 0.0 110.223 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.7 t -76.77 90.58 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.222 -0.924 . . . . 0.0 110.369 -179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.58 46.07 23.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 110.505 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.23 36.16 5.02 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.76 88.31 6.53 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.176 -1.19 . . . . 0.0 110.157 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -62.46 124.46 14.27 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.945 1.497 . . . . 0.0 110.274 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.423 ' CE1' ' HG2' ' A' ' 123' ' ' GLU . 6.2 p90 -154.25 161.86 41.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 110.183 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -135.42 106.18 6.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 110.17 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.474 ' CD2' HD11 ' A' ' 121' ' ' ILE . 3.6 t80 -91.79 131.31 37.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.01 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -166.68 89.63 0.37 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.917 . . . . 0.0 109.99 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 -177.06 6.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.152 -0.968 . . . . 0.0 110.593 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -118.22 93.06 3.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.372 -0.83 . . . . 0.0 109.758 179.753 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.472 ' CZ ' ' OH ' ' A' ' 132' ' ' TYR . 89.1 m-85 -85.55 -179.42 6.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.433 -0.792 . . . . 0.0 110.653 -179.476 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 12.4 p30 -151.09 161.77 42.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 110.111 179.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.5 pt -156.81 163.35 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.093 -1.004 . . . . 0.0 110.692 -179.596 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.0 m -91.97 121.6 33.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.386 -0.821 . . . . 0.0 110.736 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.458 ' CE1' ' HA3' ' A' ' 115' ' ' GLY . 55.4 m-85 -89.78 137.27 32.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -0.903 . . . . 0.0 109.407 179.088 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.482 ' HG3' ' CE2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -118.02 101.17 8.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.101 -1.0 . . . . 0.0 110.63 -179.725 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -92.6 130.3 38.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 0.0 109.83 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 3.7 m-80 -129.55 103.84 7.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 110.453 -179.761 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.426 ' HA3' ' CD1' ' A' ' 34' ' ' LEU . . . -152.62 -147.85 4.71 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.404 ' HD2' ' CD1' ' A' ' 109' ' ' LEU . 9.8 Cg_endo -58.5 -172.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.793 1.417 . . . . 0.0 110.601 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.432 HG21 ' CB ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -149.15 -51.92 0.16 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.304 -0.873 . . . . 0.0 110.263 -179.921 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -131.23 -51.25 1.02 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.319 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.5 t 56.83 32.42 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.368 -0.833 . . . . 0.0 110.324 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.31 30.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.273 -0.892 . . . . 0.0 110.261 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.976 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' ZNH . . . . . 0.405 ' HHC' HBB2 ' A' ' 151' ' ' ZNH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.849 0.357 . . . . 0.0 110.408 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.02 143.7 12.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 110.308 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.86 -178.77 43.94 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.96 103.47 16.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -1.155 . . . . 0.0 110.242 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.743 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -95.2 158.58 15.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 0.0 110.632 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' A' ' 143' ' ' ASN . 1.7 m120 -79.35 141.27 37.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 109.998 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.586 ' HE2' HD11 ' A' ' 70' ' ' ILE . 0.6 OUTLIER -164.94 157.23 15.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 110.209 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 141' ' ' LYS . 1.1 tt0 -155.66 -175.93 5.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 110.094 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 46' ' ' THR . 0.4 OUTLIER -140.31 172.47 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.941 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.408 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 39.1 m-85 -148.55 159.07 44.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 110.568 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.439 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.3 OUTLIER -67.56 128.22 35.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.477 -0.764 . . . . 0.0 109.882 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.479 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -55.41 146.51 19.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 0.0 110.089 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.1 t-20 71.44 2.3 4.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.861 -0.524 . . . . 0.0 111.235 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.75 -165.73 1.78 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.822 -1.174 . . . . 0.0 109.679 179.155 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -133.65 15.68 4.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 0.0 110.344 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -135.48 117.66 15.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.986 . . . . 0.0 110.579 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -50.45 131.3 24.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.201 -0.937 . . . . 0.0 109.264 179.274 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.54 -17.32 3.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.014 -1.054 . . . . 0.0 112.051 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.5 mt -136.93 -70.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.867 -1.145 . . . . 0.0 110.808 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.428 ' HB1' ' HE2' ' A' ' 53' ' ' PHE . . . -46.61 -26.31 0.88 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.597 -0.689 . . . . 0.0 110.943 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.453 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -63.39 -14.5 50.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -0.981 . . . . 0.0 110.803 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.413 ' C ' ' CG ' ' A' ' 52' ' ' TYR . 21.2 m-20 -95.24 14.85 20.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.074 -1.016 . . . . 0.0 110.832 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.413 ' CG ' ' C ' ' A' ' 51' ' ' ASP . 22.5 m-85 -142.91 15.73 1.93 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.992 -1.068 . . . . 0.0 110.737 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.428 ' HE2' ' HB1' ' A' ' 49' ' ' ALA . 19.4 m-85 -131.3 105.85 7.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.183 -0.948 . . . . 0.0 110.205 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.476 ' HB2' HG21 ' A' ' 71' ' ' THR . 22.7 m120 -72.3 169.76 15.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.947 . . . . 0.0 110.368 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.72 162.04 33.12 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.338 -0.851 . . . . 0.0 110.018 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.25 -175.8 16.46 Favored 'Cis proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.399 -2.334 . . . . 0.0 110.596 -0.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.58 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -103.5 171.3 7.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.325 -0.859 . . . . 0.0 109.885 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.438 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -105.2 116.25 31.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.001 . . . . 0.0 110.536 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.507 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 1.9 p90 -97.24 162.67 13.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.394 -0.816 . . . . 0.0 109.945 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -154.78 150.97 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.026 -1.046 . . . . 0.0 110.783 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 19.6 mtmt -134.39 173.65 11.4 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.247 -0.908 . . . . 0.0 110.737 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.457 ' HB2' ' CD ' ' A' ' 65' ' ' LYS . 4.5 mttm -153.27 62.21 0.76 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.508 -0.745 . . . . 0.0 109.703 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.1 m120 46.98 82.44 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.369 -0.832 . . . . 0.0 111.105 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.53 19.82 28.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.457 ' CD ' ' HB2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -168.84 162.62 11.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.045 -1.267 . . . . 0.0 111.181 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' A' ' 108' ' ' LYS . 2.6 pt? -172.66 154.89 3.15 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.009 0.909 . . . . 0.0 111.477 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 1.1 m-85 -137.98 -153.7 0.49 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.439 HG11 ' CE1' ' A' ' 142' ' ' PHE . 1.1 t -170.73 135.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.073 -1.017 . . . . 0.0 110.287 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.438 ' HG2' ' CB ' ' A' ' 58' ' ' LYS . 1.8 pt20 -97.51 131.24 44.31 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.39 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.586 HD11 ' HE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -110.68 143.69 20.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.253 -0.905 . . . . 0.0 110.108 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.476 HG21 ' HB2' ' A' ' 54' ' ' ASN . 0.5 OUTLIER -88.77 135.85 33.31 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.299 -0.876 . . . . 0.0 109.902 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.642 ' CG1' HG21 ' A' ' 78' ' ' ILE . 22.8 t -103.34 126.42 57.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.418 -0.802 . . . . 0.0 110.143 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -97.99 127.16 43.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.227 -0.921 . . . . 0.0 110.149 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 m80 55.04 99.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.827 . . . . 0.0 110.146 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.9 t -74.39 -35.75 63.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.189 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -51.57 -23.9 4.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.26 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.449 ' O ' HG12 ' A' ' 119' ' ' VAL . 45.4 m0 -94.37 -53.53 3.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.48 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.642 HG21 ' CG1' ' A' ' 72' ' ' VAL . 13.6 tt -89.51 123.71 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.144 -0.973 . . . . 0.0 109.835 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -87.69 -27.02 22.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 110.982 -179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.56 -176.47 47.67 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.046 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.415 ' HE1' HG22 ' A' ' 72' ' ' VAL . 63.3 mtm -151.95 165.5 34.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.384 -1.068 . . . . 0.0 110.145 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -155.29 140.58 17.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.323 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.688 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -130.19 140.18 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 110.245 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 71.65 0.85 3.65 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.637 -0.664 . . . . 0.0 111.385 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.09 21.79 9.25 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.644 -1.265 . . . . 0.0 111.292 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.472 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.74 158.71 43.78 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.52 -1.577 . . . . 0.0 110.31 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.14 175.29 5.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 110.485 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -104.06 170.29 8.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.371 -0.831 . . . . 0.0 110.32 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -110.6 131.51 54.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 110.463 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 90' ' ' ILE . 1.4 pp -68.26 102.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 109.571 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.492 HG21 HG22 ' A' ' 101' ' ' THR . 1.1 tt -95.21 -30.89 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 111.092 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.7 m -167.22 95.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.028 -1.045 . . . . 0.0 110.327 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -96.77 105.07 17.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.397 -0.814 . . . . 0.0 109.977 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.67 105.36 17.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.236 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -32.03 44.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 0.0 110.235 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.59 -44.71 95.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 109.987 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -96.8 8.54 44.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 110.704 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.02 53.33 13.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.037 -1.039 . . . . 0.0 110.071 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.38 119.01 7.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 110.519 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.475 ' CG ' ' N ' ' A' ' 101' ' ' THR . 38.2 ttt180 -114.98 167.27 10.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.43 -0.794 . . . . 0.0 109.619 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.492 HG22 HG21 ' A' ' 91' ' ' ILE . 92.0 m -141.09 153.14 45.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.018 -1.051 . . . . 0.0 109.962 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.1 p -144.99 142.35 29.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.157 -0.964 . . . . 0.0 110.686 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.18 140.73 29.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.324 -0.86 . . . . 0.0 109.85 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -127.96 138.62 52.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.077 -1.014 . . . . 0.0 110.71 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.456 ' HG2' ' CD2' ' A' ' 67' ' ' TYR . 3.2 tm-20 -98.29 128.16 44.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.329 -0.857 . . . . 0.0 109.538 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.61 151.12 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 110.926 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -63.09 111.2 2.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -0.916 . . . . 0.0 109.195 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.792 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.21 -167.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.458 -0.776 . . . . 0.0 109.844 -178.917 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.468 HD22 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.25 70.98 1.05 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.96 -1.088 . . . . 0.0 110.86 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 144' ' ' GLY . 9.5 t-20 -146.2 67.48 1.19 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 0.0 110.243 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 164.53 -121.57 1.02 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -157.41 153.44 27.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -1.157 . . . . 0.0 110.115 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.1 mm -136.74 149.2 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.0 110.262 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -76.49 103.78 6.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 109.968 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -109.17 179.49 21.03 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.5 mttp -145.03 167.4 22.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -1.088 . . . . 0.0 109.824 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -158.07 153.17 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.016 -1.052 . . . . 0.0 110.792 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.652 ' O ' HG22 ' A' ' 79' ' ' THR . 59.9 m-20 -111.65 157.88 19.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.522 -0.737 . . . . 0.0 109.297 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.455 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.7 OUTLIER -141.61 151.57 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.999 -1.063 . . . . 0.0 110.528 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -151.51 117.07 5.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.411 -0.805 . . . . 0.0 110.069 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 77' ' ' TRP . 31.4 mt -141.05 151.97 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.188 -0.945 . . . . 0.0 110.484 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.57 95.79 1.12 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.465 -0.772 . . . . 0.0 109.668 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -173.14 163.6 4.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 110.431 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -87.34 112.94 22.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.374 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 130' ' ' PHE . 60.9 t -76.42 91.68 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.323 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.02 43.33 9.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.216 -0.927 . . . . 0.0 110.349 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.14 30.61 16.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -145.37 100.92 4.41 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.269 -1.136 . . . . 0.0 110.261 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -52.5 113.25 1.14 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.74 1.389 . . . . 0.0 110.286 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.4 ' HB3' HG23 ' A' ' 125' ' ' VAL . 3.3 t80 -112.39 120.13 40.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.0 110.391 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -103.95 142.67 34.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.338 -0.851 . . . . 0.0 110.077 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.455 ' HE2' HG11 ' A' ' 119' ' ' VAL . 2.5 t80 -156.67 121.23 4.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 109.988 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.429 ' HB3' ' CE1' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -168.01 86.66 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 110.367 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -153.43 -172.45 4.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 110.358 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -117.64 87.81 2.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 110.091 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -85.56 -178.39 6.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.328 -0.857 . . . . 0.0 110.242 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 138' ' ' ILE . 2.6 p30 -149.4 169.94 19.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 110.461 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.0 OUTLIER -157.11 163.79 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -0.918 . . . . 0.0 110.634 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.408 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 85.2 m -91.86 125.33 36.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.3 -0.875 . . . . 0.0 110.567 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.688 ' CD2' HD11 ' A' ' 83' ' ' ILE . 31.4 m-85 -90.13 154.02 20.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.601 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.0 OUTLIER -142.06 102.86 4.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.055 -1.028 . . . . 0.0 110.427 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.439 ' CE1' HG11 ' A' ' 68' ' ' VAL . 17.1 m-85 -92.26 153.51 19.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.524 ' C ' HD21 ' A' ' 34' ' ' LEU . 51.1 m-80 -142.62 97.91 3.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.446 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.743 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -155.21 -148.12 4.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.463 ' HD2' HD11 ' A' ' 34' ' ' LEU . 9.4 Cg_endo . . . . . 0 C--N 1.309 -1.536 0 O-C-N 123.795 1.418 . . . . 0.0 110.436 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 120.918 0.39 . . . . 0.0 110.337 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 p -160.67 148.06 15.78 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.195 -0.941 . . . . 0.0 110.331 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 171.2 174.35 38.9 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.93 107.73 19.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.282 -1.128 . . . . 0.0 110.568 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.699 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.7 OUTLIER -95.73 158.09 15.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.149 -0.97 . . . . 0.0 110.363 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 143' ' ' ASN . 2.1 m-20 -80.38 143.8 33.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 109.716 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.472 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 1.1 p90 -164.92 156.36 15.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.117 -0.989 . . . . 0.0 110.254 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.42 -175.76 5.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.314 -0.866 . . . . 0.0 109.958 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -140.31 175.17 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 110.031 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -149.08 160.57 43.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 110.404 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.426 ' HG3' ' HB2' ' A' ' 47' ' ' SER . 0.1 OUTLIER -67.94 119.97 13.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.369 -0.832 . . . . 0.0 109.418 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.546 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -48.71 146.15 3.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.241 -0.912 . . . . 0.0 110.169 -179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER 72.53 2.33 4.31 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.949 -0.47 . . . . 0.0 110.866 -179.328 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -135.34 -163.0 1.32 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.878 -1.138 . . . . 0.0 109.818 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.56 14.02 3.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 110.242 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -135.25 123.51 23.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 110.354 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.556 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -60.56 131.37 50.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.072 -1.018 . . . . 0.0 109.313 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.426 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -128.04 -17.14 4.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 111.781 -178.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.2 mt -137.25 -65.59 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.8 -1.188 . . . . 0.0 110.895 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HB1' ' HE2' ' A' ' 53' ' ' PHE . . . -50.03 -22.99 1.8 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.508 -0.745 . . . . 0.0 111.205 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.514 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.1 OUTLIER -70.58 -9.41 56.77 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.039 -1.038 . . . . 0.0 110.965 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.407 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 30.1 m-20 -102.47 14.9 30.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.928 -1.107 . . . . 0.0 110.959 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 51' ' ' ASP . 31.5 m-85 -136.47 4.98 2.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.001 -1.062 . . . . 0.0 111.097 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.579 ' HE2' ' HB1' ' A' ' 49' ' ' ALA . 19.8 m-85 -125.75 111.64 15.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.038 -1.039 . . . . 0.0 110.291 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -72.01 165.69 23.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.993 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.438 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -147.24 164.55 22.52 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.215 -0.928 . . . . 0.0 110.196 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.438 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 58.0 Cg_endo -80.84 -175.57 16.27 Favored 'Cis proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.338 -2.359 . . . . 0.0 110.666 -0.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.48 168.85 9.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -0.885 . . . . 0.0 109.676 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.441 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.89 121.33 41.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.031 -1.043 . . . . 0.0 110.783 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.511 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 9.2 p90 -98.26 158.73 15.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.327 -0.858 . . . . 0.0 109.873 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.8 OUTLIER -155.08 147.65 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.076 -1.015 . . . . 0.0 110.442 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 7.2 mttt -131.87 174.11 10.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.457 -0.777 . . . . 0.0 110.444 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . 2.6 mmtp -156.73 62.04 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.796 . . . . 0.0 109.731 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 m120 47.53 85.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.835 . . . . 0.0 110.992 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.73 17.45 48.5 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.555 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HD2' ' HB3' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -165.31 163.51 19.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.936 -1.332 . . . . 0.0 111.119 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.584 HD11 ' HA ' ' A' ' 108' ' ' LYS . 1.2 pt? -174.6 154.83 2.09 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.017 0.913 . . . . 0.0 110.964 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.565 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -139.48 -155.46 0.59 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -170.67 134.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.846 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.441 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -97.73 134.68 40.58 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.123 -0.986 . . . . 0.0 110.011 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 101' ' ' THR . 1.0 OUTLIER -113.2 139.53 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.437 -0.789 . . . . 0.0 110.069 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.31 133.67 34.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 110.022 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.842 HG13 HD13 ' A' ' 78' ' ' ILE . 5.2 t -102.6 125.51 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.44 -0.787 . . . . 0.0 109.831 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -99.21 126.93 45.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.13 -0.981 . . . . 0.0 110.416 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.599 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER 58.42 99.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 110.354 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.37 -25.55 59.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.168 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -59.39 -36.27 75.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.498 ' O ' HG12 ' A' ' 119' ' ' VAL . 46.5 m0 -82.77 -52.11 7.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.842 HD13 HG13 ' A' ' 72' ' ' VAL . 12.8 tt -89.3 122.66 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.869 . . . . 0.0 109.838 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.667 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.2 -25.46 24.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 110.878 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.77 178.05 48.41 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.499 -1.334 . . . . 0.0 110.243 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.706 ' SD ' HD11 ' A' ' 78' ' ' ILE . 89.6 mtp -150.92 160.26 44.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.996 . . . . 0.0 109.787 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -154.95 161.16 41.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 110.253 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.567 ' O ' ' CE1' ' A' ' 86' ' ' HIS . 1.3 mt -149.73 152.6 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 110.149 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.556 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 0.2 OUTLIER 62.77 12.51 5.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.093 -1.004 . . . . 0.0 111.058 179.706 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.17 20.42 52.8 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.436 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 83' ' ' ILE . 3.1 p80 -138.28 158.8 43.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.859 -1.377 . . . . 0.0 110.441 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.39 172.2 9.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.334 -0.854 . . . . 0.0 110.595 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.523 ' CB ' ' CZ ' ' A' ' 104' ' ' PHE . 4.4 pt-20 -100.54 170.53 8.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.342 -0.849 . . . . 0.0 110.373 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.3 129.49 53.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.347 -0.845 . . . . 0.0 110.483 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.76 101.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.111 -0.993 . . . . 0.0 109.569 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 101' ' ' THR . 1.1 tt -94.86 -26.38 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 110.857 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.501 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -167.04 100.31 0.54 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.229 -0.92 . . . . 0.0 109.655 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.406 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 16.4 ttmt -95.93 147.94 23.15 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 110.191 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -143.02 84.2 1.82 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -0.938 . . . . 0.0 110.3 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 p -71.21 -29.39 65.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 110.207 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.95 -52.57 62.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.339 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -96.31 15.84 20.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.0 110.5 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.42 62.54 2.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.117 -0.989 . . . . 0.0 110.547 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 94' ' ' ASN . 22.3 mt-10 -148.14 160.86 42.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.158 -0.964 . . . . 0.0 110.165 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 92' ' ' SER . 7.3 ttm180 -166.83 161.47 15.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 110.155 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.578 ' O ' HG22 ' A' ' 91' ' ' ILE . 74.3 m -143.07 152.0 41.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 109.61 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 18.2 p -146.33 143.46 29.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.988 -1.07 . . . . 0.0 110.871 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.82 147.96 22.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.374 -0.828 . . . . 0.0 109.693 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.523 ' CZ ' ' CB ' ' A' ' 88' ' ' GLU . 27.2 m-85 -130.16 135.79 48.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.088 -1.008 . . . . 0.0 111.117 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -97.19 125.17 41.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.393 -0.817 . . . . 0.0 109.117 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.478 ' O ' HD21 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -149.25 161.02 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 0.0 110.782 -178.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.433 ' N ' ' CG2' ' A' ' 106' ' ' VAL . 11.0 p -70.13 113.0 6.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 108.82 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.584 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 44.83 -164.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.673 -0.642 . . . . 0.0 109.964 -178.716 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -150.64 68.22 0.96 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.876 -1.14 . . . . 0.0 110.933 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -146.97 87.97 1.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.05 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 148.05 -125.76 2.18 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.47 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.1 OUTLIER -156.91 150.39 24.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -1.067 . . . . 0.0 109.723 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.461 ' CD1' HG23 ' A' ' 106' ' ' VAL . 2.4 mt -135.55 152.19 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.316 -0.865 . . . . 0.0 110.04 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -75.93 100.0 4.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.919 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.413 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -99.99 179.31 29.92 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 82' ' ' SER . 17.0 mtpt -146.13 158.31 43.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -1.121 . . . . 0.0 110.054 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.46 ' O ' HD13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -157.6 145.99 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.119 -0.988 . . . . 0.0 110.312 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.667 ' C ' HG22 ' A' ' 79' ' ' THR . 1.0 OUTLIER -108.32 161.17 15.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.366 -0.833 . . . . 0.0 109.596 179.508 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -136.48 150.77 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.119 -0.988 . . . . 0.0 110.766 -179.549 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -151.94 114.19 4.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.467 -0.771 . . . . 0.0 109.871 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 77' ' ' TRP . 15.8 mt -141.51 153.29 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.164 -0.96 . . . . 0.0 110.806 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -159.44 100.01 1.48 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.587 -0.695 . . . . 0.0 109.424 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -172.97 178.25 2.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.24 -0.912 . . . . 0.0 110.396 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -101.21 118.85 37.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.333 -0.854 . . . . 0.0 110.324 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.2 t -76.91 92.26 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.0 110.306 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.431 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 1.4 m120 57.39 36.18 26.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.878 . . . . 0.0 110.503 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.89 31.25 6.72 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.12 98.15 4.74 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.247 -1.149 . . . . 0.0 110.07 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -49.17 121.28 6.65 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.921 1.485 . . . . 0.0 110.327 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -126.32 124.63 40.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 110.195 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -103.61 140.59 37.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 110.351 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.467 ' HE2' HG11 ' A' ' 119' ' ' VAL . 2.5 t80 -150.85 123.22 8.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.091 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -175.83 87.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 109.935 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -153.58 -164.68 1.95 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.355 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.472 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -119.2 139.83 51.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.981 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 135' ' ' HIS . 47.5 m-85 -154.53 -179.82 8.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.93 . . . . 0.0 110.119 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.638 ' O ' HG23 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -152.39 178.89 9.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.161 -0.962 . . . . 0.0 110.51 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.638 HG23 ' O ' ' A' ' 137' ' ' ASN . 3.8 pt -157.13 170.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.885 . . . . 0.0 110.058 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.47 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 96.8 m -91.6 121.84 33.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 110.647 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.567 ' HA ' HG12 ' A' ' 38' ' ' VAL . 28.6 m-85 -89.44 155.58 19.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.575 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.0 OUTLIER -143.32 100.53 3.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.048 -1.033 . . . . 0.0 110.741 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.425 ' CE1' HG11 ' A' ' 68' ' ' VAL . 15.9 m-85 -91.7 129.14 37.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.652 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.472 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 56.1 m-80 -113.93 104.38 12.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.105 -0.997 . . . . 0.0 110.877 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.699 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -163.13 -159.03 10.15 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo . . . . . 0 C--N 1.305 -1.747 0 O-C-N 123.982 1.517 . . . . 0.0 110.278 179.922 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.014 0.435 . . . . 0.0 110.419 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -158.91 134.6 8.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 110.246 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.96 178.27 48.74 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.29 105.4 17.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.181 -1.187 . . . . 0.0 110.382 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.839 HD13 HD22 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -94.27 154.25 17.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.345 -0.847 . . . . 0.0 109.744 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.475 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 12.4 t-20 -78.73 144.7 35.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.12 -0.988 . . . . 0.0 109.989 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -165.57 161.46 18.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.343 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.22 -173.44 4.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.425 -0.797 . . . . 0.0 109.746 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.78 HG23 HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.55 174.61 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.169 -0.957 . . . . 0.0 110.146 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.413 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 16.0 m-85 -147.47 151.37 36.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.377 -0.827 . . . . 0.0 109.839 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -67.43 127.12 31.51 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.419 -0.8 . . . . 0.0 110.066 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.477 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -52.94 146.98 9.9 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.091 -1.006 . . . . 0.0 109.493 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 12.5 t30 73.09 -1.17 3.14 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.944 -0.472 . . . . 0.0 110.914 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.95 -163.38 1.41 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.899 -1.126 . . . . 0.0 109.561 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.402 ' N ' ' OG1' ' A' ' 43' ' ' THR . 8.5 m120 -133.34 15.74 4.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 110.434 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -136.53 129.03 30.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.015 . . . . 0.0 110.681 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.78 HG21 HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -57.79 132.38 53.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.156 -0.965 . . . . 0.0 109.037 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.75 -16.8 4.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.102 -0.999 . . . . 0.0 112.035 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 49' ' ' ALA . 2.2 mt -136.62 -64.94 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.803 -1.185 . . . . 0.0 110.598 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.457 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -54.6 -20.79 8.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.428 -0.795 . . . . 0.0 110.727 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.456 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 0.1 OUTLIER -63.38 -17.84 63.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.309 -0.87 . . . . 0.0 110.76 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -102.47 15.45 29.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.139 -0.976 . . . . 0.0 110.992 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -131.73 1.11 3.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.949 -1.094 . . . . 0.0 111.151 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -129.37 113.47 14.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.127 -0.983 . . . . 0.0 110.252 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -72.79 173.05 9.67 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.386 -0.821 . . . . 0.0 110.617 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.15 164.67 22.01 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.354 -0.841 . . . . 0.0 109.769 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -78.66 -174.84 15.55 Favored 'Cis proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.798 -2.167 . . . . 0.0 110.559 -0.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.22 164.38 11.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.879 . . . . 0.0 110.007 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.415 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 2.2 tptt -101.91 109.55 21.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.131 -0.981 . . . . 0.0 110.314 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.519 ' CD1' ' CB ' ' A' ' 34' ' ' LEU . 6.5 p90 -98.0 165.75 11.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.332 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.8 OUTLIER -155.6 157.81 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.296 -0.877 . . . . 0.0 110.537 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 3.1 mtmt -139.41 174.31 10.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.245 -0.909 . . . . 0.0 110.831 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . 7.2 mttm -159.03 62.21 0.41 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.418 -0.801 . . . . 0.0 109.878 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 48.97 84.0 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.441 -0.787 . . . . 0.0 111.232 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.68 24.42 28.12 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.736 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.76 ' C ' HD13 ' A' ' 66' ' ' LEU . 1.3 ptpp? -167.42 155.94 9.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.912 -1.346 . . . . 0.0 111.018 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.76 HD13 ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -160.12 155.56 25.34 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.201 1.0 . . . . 0.0 111.843 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 6.2 m-85 -142.58 -164.14 1.76 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 103' ' ' GLU . 1.1 t -170.47 135.98 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.998 -1.064 . . . . 0.0 110.554 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 102' ' ' SER . 4.7 pt20 -99.15 134.23 42.3 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 109.773 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -113.23 134.87 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 110.093 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.0 m -89.57 123.56 33.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 0.0 109.954 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -103.08 141.7 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.207 -0.933 . . . . 0.0 110.278 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -98.67 140.02 33.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.827 . . . . 0.0 110.207 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.2 m170 52.58 88.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 110.221 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.7 p -52.19 -25.91 10.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.378 -0.827 . . . . 0.0 110.298 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -65.37 -55.74 16.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 110.369 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.429 ' HA ' HG12 ' A' ' 121' ' ' ILE . 47.4 m0 -50.73 -59.56 3.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.19 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.79 HD11 ' CG ' ' A' ' 81' ' ' MET . 6.1 tt -88.46 118.04 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.312 -0.868 . . . . 0.0 109.894 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.61 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.6 -23.02 25.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.316 -0.865 . . . . 0.0 110.956 -179.186 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.07 176.1 47.93 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.019 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.79 ' CG ' HD11 ' A' ' 78' ' ' ILE . 56.6 mtp -152.57 157.79 41.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.376 -1.073 . . . . 0.0 110.07 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -155.11 140.51 17.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.94 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.848 HD11 ' CE2' ' A' ' 140' ' ' TYR . 0.4 OUTLIER -132.94 139.38 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.143 -0.973 . . . . 0.0 110.726 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 70.73 1.86 3.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.588 -0.695 . . . . 0.0 111.629 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.49 22.06 9.37 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.327 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.587 ' HE1' ' HD1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -137.88 159.64 41.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.685 -1.479 . . . . 0.0 110.059 179.217 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -70.16 -174.55 0.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.171 -0.956 . . . . 0.0 110.616 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -109.06 169.03 8.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 110.239 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 102' ' ' SER . 22.4 m120 -110.34 127.56 55.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.408 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 pp -67.08 102.89 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.062 -1.024 . . . . 0.0 109.661 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.456 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 0.9 OUTLIER -95.7 -31.5 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 111.007 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.427 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -167.24 100.4 0.52 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.036 -1.04 . . . . 0.0 110.162 -179.76 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -96.21 148.8 22.34 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.417 -0.802 . . . . 0.0 110.084 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -143.23 97.9 3.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 110.331 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.6 -32.56 58.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.049 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.89 -43.18 99.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 110.091 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.77 5.76 50.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 110.507 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.71 56.91 6.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.034 -1.041 . . . . 0.0 110.311 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -148.14 -177.32 5.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 110.357 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.544 ' O ' HG22 ' A' ' 72' ' ' VAL . 4.8 ttp180 175.22 160.06 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.855 . . . . 0.0 110.009 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.456 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 85.8 m -137.3 156.19 48.55 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.314 -0.866 . . . . 0.0 109.812 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 6.1 p -144.2 143.12 30.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.038 -1.038 . . . . 0.0 110.785 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.2 tt0 -92.92 150.15 20.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.816 . . . . 0.0 110.054 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.682 ' CD2' HD12 ' A' ' 83' ' ' ILE . 15.5 m-85 -129.71 154.44 47.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.94 . . . . 0.0 110.687 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.459 ' C ' HG13 ' A' ' 106' ' ' VAL . 0.5 OUTLIER -118.51 127.37 53.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.321 -0.862 . . . . 0.0 109.742 179.563 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.496 ' O ' HD21 ' A' ' 66' ' ' LEU . 29.0 m -149.88 -165.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.045 -1.034 . . . . 0.0 110.607 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -97.9 111.9 24.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.479 -0.763 . . . . 0.0 108.994 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 47.41 -166.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.48 -0.763 . . . . 0.0 109.554 -178.66 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.839 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.0 62.75 0.91 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.078 -1.014 . . . . 0.0 110.931 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -146.11 70.48 1.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 110.23 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 170.23 -125.07 1.19 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.2 OUTLIER -157.38 139.35 14.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.343 -1.092 . . . . 0.0 109.715 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.427 ' CA ' ' HE2' ' A' ' 112' ' ' LYS . 6.0 mt -135.25 149.83 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.24 -0.913 . . . . 0.0 110.237 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -76.57 123.18 25.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.908 . . . . 0.0 110.15 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.483 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -119.82 -177.65 16.23 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 12.3 mttt -145.12 158.86 43.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.327 -1.102 . . . . 0.0 110.111 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -157.77 143.64 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.454 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.61 ' C ' HG22 ' A' ' 79' ' ' THR . 0.9 OUTLIER -103.59 154.99 18.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.401 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.408 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -129.84 146.86 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.008 -1.057 . . . . 0.0 110.678 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.53 110.47 3.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.43 -0.794 . . . . 0.0 110.006 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.462 ' HB ' ' CB ' ' A' ' 132' ' ' TYR . 19.6 mt -139.92 153.71 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 110.573 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.0 95.1 1.26 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.498 -0.751 . . . . 0.0 109.436 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.476 ' O ' ' CD1' ' A' ' 130' ' ' PHE . 1.3 pt-20 -174.5 -164.73 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.387 -0.821 . . . . 0.0 109.928 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -113.63 115.04 27.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.101 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.972 HG23 ' CE1' ' A' ' 130' ' ' PHE . 3.1 t -76.61 94.56 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.264 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 59.42 39.13 22.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.337 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 91.89 34.69 7.13 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.72 90.71 6.31 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.226 -1.161 . . . . 0.0 110.061 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -57.3 133.75 59.31 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.126 1.593 . . . . 0.0 110.63 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.972 ' CE1' HG23 ' A' ' 125' ' ' VAL . 9.3 p90 -157.39 132.7 9.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.056 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -103.24 99.71 9.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.397 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.462 ' CB ' ' HB ' ' A' ' 121' ' ' ILE . 3.7 t80 -90.49 129.53 36.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.831 . . . . 0.0 109.703 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -170.45 83.58 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.091 -1.005 . . . . 0.0 110.27 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.84 -166.04 2.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.885 . . . . 0.0 110.327 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -118.34 151.7 37.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 109.858 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -155.29 179.85 8.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.014 . . . . 0.0 110.405 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.574 ' O ' HG23 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -152.23 169.54 22.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.572 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.574 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.4 pt -156.65 161.63 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 110.214 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.478 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 66.4 m -91.82 125.85 36.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.865 . . . . 0.0 110.73 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.848 ' CE2' HD11 ' A' ' 83' ' ' ILE . 47.7 m-85 -90.59 164.93 14.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.905 . . . . 0.0 110.016 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.1 OUTLIER -147.98 103.3 3.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.954 . . . . 0.0 110.32 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -92.44 141.33 28.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.301 -0.874 . . . . 0.0 110.515 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 67.2 m-20 -133.12 98.43 4.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 110.022 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.523 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -160.52 -148.71 5.35 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo . . . . . 0 C--N 1.308 -1.6 0 O-C-N 123.773 1.407 . . . . 0.0 110.768 -179.903 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 25.0 m-20 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 120.866 0.365 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.6 t -160.84 148.24 15.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 110.43 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.35 172.14 39.97 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.18 106.59 18.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -1.107 . . . . 0.0 110.229 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.782 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.8 OUTLIER -94.45 156.21 16.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.319 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -79.62 143.9 34.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 110.017 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.634 ' HE2' HD11 ' A' ' 70' ' ' ILE . 1.6 p90 -165.99 159.05 15.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 0.0 110.03 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -155.15 -175.14 5.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.926 . . . . 0.0 109.947 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 46' ' ' THR . 0.1 OUTLIER -141.43 174.5 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 110.476 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 18.6 m-85 -148.17 156.02 42.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -0.808 . . . . 0.0 109.926 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.542 ' HZ2' ' HA ' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -67.66 127.87 34.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.106 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.538 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -54.37 147.92 12.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 109.869 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 9.7 m-20 71.11 2.42 4.23 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.812 -0.555 . . . . 0.0 110.952 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -135.93 -162.26 1.25 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.849 -1.157 . . . . 0.0 109.666 179.087 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.413 ' N ' ' OG1' ' A' ' 43' ' ' THR . 16.5 m-80 -132.57 11.91 4.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 110.194 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -136.56 143.76 43.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 110.69 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -68.58 131.49 45.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.088 179.2 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.558 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -129.25 -17.52 3.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.962 -1.087 . . . . 0.0 112.137 -178.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.713 HG22 ' N ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -137.32 -71.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.789 -1.195 . . . . 0.0 110.581 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.713 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -48.87 -24.69 1.55 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.499 -0.751 . . . . 0.0 110.853 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.455 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -61.73 -20.64 63.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.121 -0.987 . . . . 0.0 110.784 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.41 ' OD2' ' ND2' ' A' ' 50' ' ' ASN . 2.1 m-20 -94.68 14.12 22.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.086 -1.009 . . . . 0.0 110.858 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -141.3 9.51 2.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.062 . . . . 0.0 110.843 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -118.15 110.67 17.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.983 . . . . 0.0 110.171 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -72.77 155.67 39.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.298 -0.877 . . . . 0.0 110.693 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -147.52 163.27 28.58 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.333 -0.854 . . . . 0.0 109.833 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 50.5 Cg_endo -77.41 -175.27 16.4 Favored 'Cis proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.862 -2.141 . . . . 0.0 110.472 -0.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.513 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.09 -172.0 2.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 109.889 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.432 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -125.52 119.19 27.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.015 -1.053 . . . . 0.0 110.577 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 8.3 p90 -97.11 165.59 11.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 109.877 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.501 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -155.58 122.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.135 -0.978 . . . . 0.0 110.608 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.662 ' HD3' HD21 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -136.77 131.76 33.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.199 -0.938 . . . . 0.0 110.775 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.404 ' HB2' ' HD2' ' A' ' 65' ' ' LYS . 6.7 mttp -110.25 62.25 0.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 110.35 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 48.45 97.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.374 -0.829 . . . . 0.0 111.28 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.91 11.71 52.25 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.721 ' C ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -169.96 152.63 4.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.012 -1.287 . . . . 0.0 110.325 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.79 ' N ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -156.92 153.46 28.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.09 -1.006 . . . . 0.0 111.504 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 4.5 m-85 -142.94 -157.92 0.82 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.391 -0.818 . . . . 0.0 109.257 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -170.16 167.49 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.197 -0.939 . . . . 0.0 110.345 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.476 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -141.28 134.51 29.47 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.403 -0.81 . . . . 0.0 109.676 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.634 HD11 ' HE2' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -115.48 133.71 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 110.225 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.3 m -89.86 129.72 36.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.155 -0.966 . . . . 0.0 109.853 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.412 HG12 ' CE ' ' A' ' 81' ' ' MET . 1.0 OUTLIER -102.31 143.78 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 110.231 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -99.23 139.34 35.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.905 . . . . 0.0 110.254 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.655 ' O ' HG22 ' A' ' 78' ' ' ILE . 3.9 m-70 54.34 99.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 110.346 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.01 -35.32 78.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.885 . . . . 0.0 110.222 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -57.95 -35.98 71.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 110.196 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.681 ' O ' HG13 ' A' ' 119' ' ' VAL . 39.8 m0 -79.0 -51.04 10.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 110.213 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 74' ' ' HIS . 3.8 tp -89.27 120.55 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.875 . . . . 0.0 109.835 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.45 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.4 -34.56 20.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.406 -0.809 . . . . 0.0 110.706 -179.333 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.418 ' N ' ' CG2' ' A' ' 79' ' ' THR . . . -175.62 -179.63 46.25 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.532 -1.318 . . . . 0.0 109.989 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.442 ' CE ' HG21 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -152.41 166.31 32.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -1.091 . . . . 0.0 110.133 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -155.21 147.3 23.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.859 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.626 HD11 ' CD2' ' A' ' 140' ' ' TYR . 1.2 mt -142.37 143.11 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 110.627 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 72.3 -0.41 3.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.614 -0.678 . . . . 0.0 111.604 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.0 20.27 9.99 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.458 -1.354 . . . . 0.0 111.285 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.561 ' HE1' ' HD1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -137.02 161.41 36.13 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.735 -1.45 . . . . 0.0 110.199 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -172.16 0.6 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.006 -1.059 . . . . 0.0 110.739 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 0.1 OUTLIER -109.79 165.9 11.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 110.557 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.16 135.05 54.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.448 -0.783 . . . . 0.0 109.856 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.42 100.76 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.087 -1.008 . . . . 0.0 109.913 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.535 HG21 HG22 ' A' ' 101' ' ' THR . 1.2 tt -96.0 -28.56 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 110.285 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -166.32 96.08 0.57 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.232 -0.918 . . . . 0.0 109.794 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -95.36 102.4 14.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.427 -0.796 . . . . 0.0 110.073 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.38 95.75 7.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.365 -0.835 . . . . 0.0 110.352 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -37.96 53.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.928 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.55 -38.48 90.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.034 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -96.19 10.55 37.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.62 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 50.91 56.17 8.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.048 -1.033 . . . . 0.0 110.282 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -148.04 169.85 19.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.156 -0.965 . . . . 0.0 110.395 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.408 ' O ' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -166.62 157.63 12.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.333 -0.855 . . . . 0.0 109.954 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.535 HG22 HG21 ' A' ' 91' ' ' ILE . 86.8 m -141.98 158.38 43.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.396 -0.815 . . . . 0.0 109.759 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -145.04 142.97 30.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.045 -1.034 . . . . 0.0 110.728 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -92.98 138.77 31.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.363 -0.836 . . . . 0.0 109.943 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.561 ' HD1' ' HE1' ' A' ' 86' ' ' HIS . 88.6 m-85 -130.06 145.9 51.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.055 -1.028 . . . . 0.0 110.901 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.481 ' C ' HG13 ' A' ' 106' ' ' VAL . 3.2 tt0 -99.69 131.02 45.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.377 -0.827 . . . . 0.0 108.881 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 108' ' ' LYS . 22.9 m -149.09 162.28 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.849 -1.157 . . . . 0.0 111.285 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 60.4 p -69.44 112.32 5.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.0 OUTLIER 46.67 -157.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.51 -0.744 . . . . 0.0 109.418 -178.3 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.662 HD21 ' HD3' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -150.21 51.53 0.9 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.798 -1.189 . . . . 0.0 110.807 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -146.26 87.73 1.75 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.026 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.22 171.02 20.75 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.419 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 1.0 OUTLIER -81.63 144.01 31.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -1.169 . . . . 0.0 110.175 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mm -137.92 139.89 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.171 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -76.65 135.57 39.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 109.947 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -140.98 178.12 20.39 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 9.1 mtmm -143.6 158.06 43.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.426 -1.044 . . . . 0.0 109.837 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.56 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.7 142.62 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.959 -1.088 . . . . 0.0 110.592 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.45 ' C ' HG22 ' A' ' 79' ' ' THR . 40.5 m-20 -106.2 164.47 11.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -0.764 . . . . 0.0 109.798 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 77' ' ' TRP . 25.0 t -141.95 151.53 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 110.447 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -152.03 105.42 3.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.476 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.505 HG21 ' HE2' ' A' ' 130' ' ' PHE . 4.9 mt -125.46 152.79 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.243 -0.911 . . . . 0.0 110.073 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.73 102.41 1.33 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.798 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -173.7 -164.24 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 110.443 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 2.3 ttmt -99.92 103.11 14.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.294 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.667 ' O ' HG12 ' A' ' 125' ' ' VAL . 2.1 t -76.63 103.0 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 110.15 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 63.16 34.47 13.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.451 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.09 31.52 28.4 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -145.33 137.01 12.89 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.224 -1.162 . . . . 0.0 109.999 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.25 129.27 33.94 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.564 1.297 . . . . 0.0 109.838 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.505 ' HE2' HG21 ' A' ' 121' ' ' ILE . 8.7 t80 -129.14 118.1 21.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 110.583 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -105.2 137.78 42.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 109.847 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.483 ' CD2' HD12 ' A' ' 121' ' ' ILE . 6.3 t80 -157.17 123.62 4.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.212 -0.93 . . . . 0.0 110.006 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -173.35 87.55 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.905 . . . . 0.0 109.986 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.96 -161.46 1.29 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.892 . . . . 0.0 110.297 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -120.93 155.6 33.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.86 . . . . 0.0 110.256 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 32.4 m-85 -155.14 -179.26 7.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 109.831 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.563 ' O ' HG23 ' A' ' 138' ' ' ILE . 6.3 p30 -151.2 168.98 23.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 110.608 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.3 pt -156.85 163.27 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.365 -0.835 . . . . 0.0 110.13 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.419 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 90.8 m -91.9 122.11 34.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.224 -0.923 . . . . 0.0 110.54 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.626 ' CD2' HD11 ' A' ' 83' ' ' ILE . 49.2 m-85 -90.25 157.96 17.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -0.877 . . . . 0.0 110.235 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 104.74 3.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.225 -0.922 . . . . 0.0 110.178 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -91.39 158.35 16.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.237 -0.914 . . . . 0.0 110.277 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 29.7 m120 -143.13 99.56 3.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.782 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -157.52 -154.89 7.27 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.408 ' HD2' ' HA3' ' A' ' 144' ' ' GLY . 11.3 Cg_endo . . . . . 0 C--N 1.307 -1.624 0 O-C-N 123.988 1.52 . . . . 0.0 110.537 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 7.7 m-20 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.988 0.423 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 p -159.48 147.69 17.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 0.0 110.428 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.37 175.67 44.8 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.68 104.87 17.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -1.113 . . . . 0.0 110.39 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.583 HD13 HD22 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -95.27 159.12 15.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.328 -0.857 . . . . 0.0 110.434 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.455 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 16.3 m-20 -78.71 139.6 38.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.116 -0.99 . . . . 0.0 109.982 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.73 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -165.51 152.22 10.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.982 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -155.13 -173.2 4.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.0 110.237 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -140.97 178.65 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.878 . . . . 0.0 110.369 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 39.7 m-85 -148.18 156.72 42.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.446 -0.784 . . . . 0.0 109.68 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.27 122.78 18.62 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.937 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.58 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -49.86 148.89 2.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.934 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.4 t-20 71.52 2.82 4.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.879 -0.513 . . . . 0.0 110.771 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -135.12 -157.84 0.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.948 -1.095 . . . . 0.0 109.533 179.232 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.12 8.27 3.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 110.209 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -135.11 150.76 50.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.07 -1.019 . . . . 0.0 110.563 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.483 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -77.53 133.86 38.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.239 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.472 ' HB3' HD12 ' A' ' 48' ' ' ILE . 34.3 t -129.03 -17.21 3.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.024 -1.048 . . . . 0.0 111.954 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 47' ' ' SER . 3.3 mp -136.94 -69.45 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.7 -1.25 . . . . 0.0 110.623 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.484 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -49.42 -24.09 1.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.549 -0.72 . . . . 0.0 110.9 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.448 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -65.9 -13.41 59.63 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.083 -1.011 . . . . 0.0 110.957 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -99.27 15.36 26.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.016 -1.052 . . . . 0.0 110.957 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -136.87 10.06 3.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.893 -1.129 . . . . 0.0 111.148 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.484 ' CE2' ' HB1' ' A' ' 49' ' ' ALA . 23.1 m-30 -120.83 104.78 10.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.093 -1.004 . . . . 0.0 110.242 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -72.59 106.35 4.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.193 -0.942 . . . . 0.0 110.114 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.466 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -93.53 167.71 13.4 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.255 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.466 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 53.1 Cg_endo -77.93 -175.82 17.47 Favored 'Cis proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.67 -2.221 . . . . 0.0 110.843 -0.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.73 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -103.2 171.51 7.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 109.977 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -104.21 117.17 33.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.01 . . . . 0.0 110.792 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.59 ' HB2' HD23 ' A' ' 109' ' ' LEU . 3.7 p90 -96.42 163.0 13.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 109.324 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.518 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -154.96 118.82 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.925 -1.109 . . . . 0.0 111.028 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HD3' HD21 ' A' ' 109' ' ' LEU . 1.4 mtmt -139.07 131.57 28.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.314 -0.866 . . . . 0.0 109.632 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.437 ' HB3' ' CE ' ' A' ' 65' ' ' LYS . 4.9 tttm -115.91 65.39 0.7 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.113 -0.992 . . . . 0.0 110.78 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 46.39 95.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.465 -0.772 . . . . 0.0 111.201 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.17 13.24 36.89 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.437 ' CE ' ' HB3' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -173.18 149.71 1.84 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.054 -1.262 . . . . 0.0 109.876 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.792 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -158.83 144.13 16.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.969 . . . . 0.0 111.261 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.518 ' HB2' HG23 ' A' ' 60' ' ' ILE . 3.3 m-85 -141.02 -161.79 1.27 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.537 -0.727 . . . . 0.0 109.663 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.54 HG11 ' CE1' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -170.18 163.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.213 -0.93 . . . . 0.0 109.933 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.744 ' C ' HD12 ' A' ' 70' ' ' ILE . 3.4 pt20 -141.61 144.63 34.31 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.171 -0.956 . . . . 0.0 110.58 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.744 HD12 ' C ' ' A' ' 69' ' ' GLN . 2.2 mp -116.68 147.47 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.509 -0.744 . . . . 0.0 109.856 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.6 m -89.19 134.68 33.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 0.0 109.887 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.564 HG12 HG21 ' A' ' 78' ' ' ILE . 2.4 t -102.31 119.63 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 0.0 110.332 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -100.11 137.32 38.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.212 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.528 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER 57.6 92.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.203 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 m -76.47 -25.49 54.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.155 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -60.4 -17.2 42.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.253 -0.904 . . . . 0.0 110.325 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.45 ' HA ' HG12 ' A' ' 121' ' ' ILE . 45.6 m0 -106.31 -51.45 2.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -0.956 . . . . 0.0 110.488 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.845 HD11 ' SD ' ' A' ' 81' ' ' MET . 11.4 tt -89.52 125.25 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 109.886 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.83 -33.46 19.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.398 -0.814 . . . . 0.0 110.765 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.4 ' N ' ' CG2' ' A' ' 79' ' ' THR . . . 178.06 -174.9 47.16 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.139 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.845 ' SD ' HD11 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -152.4 170.84 19.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -1.064 . . . . 0.0 110.259 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' LYS . 2.2 t -154.36 146.21 23.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 109.758 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.474 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 2.9 mt -140.95 144.44 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.619 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.474 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 71.33 2.29 4.19 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.632 -0.667 . . . . 0.0 111.204 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.33 21.47 13.14 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.73 -1.224 . . . . 0.0 111.103 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.509 ' HE1' ' HD1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -138.0 160.14 40.13 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.655 -1.497 . . . . 0.0 110.193 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.11 -174.28 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.042 -1.036 . . . . 0.0 110.544 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 8.3 pt-20 -109.97 170.06 8.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.357 -0.839 . . . . 0.0 110.309 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -120.13 130.59 54.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 0.0 110.266 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.402 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 pp -67.56 103.63 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.074 -1.016 . . . . 0.0 109.59 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.437 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -95.13 -27.69 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.366 -0.834 . . . . 0.0 110.971 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.0 m -167.26 94.64 0.46 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.146 -0.971 . . . . 0.0 109.898 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -97.35 147.97 23.64 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 110.284 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -142.85 101.18 3.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 109.973 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -74.21 -32.37 63.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 0.0 110.312 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.47 -44.8 95.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 110.171 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.55 -3.36 43.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 110.729 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t0 59.97 50.37 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.96 -1.088 . . . . 0.0 110.13 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -147.44 128.45 14.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 110.091 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.77 172.37 12.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 110.444 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.437 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 97.2 m -141.11 157.1 45.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.447 -0.783 . . . . 0.0 109.458 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -145.24 138.01 26.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.068 -1.02 . . . . 0.0 110.721 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -92.9 144.9 24.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.436 -0.79 . . . . 0.0 110.12 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.509 ' HD1' ' HE1' ' A' ' 86' ' ' HIS . 98.4 m-85 -130.76 145.5 51.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.142 -0.974 . . . . 0.0 110.845 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.48 ' C ' HG13 ' A' ' 106' ' ' VAL . 15.7 tt0 -95.59 126.59 40.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.338 -0.851 . . . . 0.0 109.295 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.48 HG13 ' C ' ' A' ' 105' ' ' GLU . 34.6 m -149.78 177.55 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.974 -1.079 . . . . 0.0 111.038 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.5 t -89.4 110.91 21.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.48 -0.763 . . . . 0.0 109.258 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.454 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 49.65 -158.3 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.652 -178.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.617 HD21 ' HD3' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -151.31 50.92 0.83 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.983 -1.073 . . . . 0.0 111.066 -179.118 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 145' ' ' PRO . 18.4 t-20 -144.85 84.35 1.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 110.137 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.43 170.44 19.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.405 ' O ' ' HE3' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -81.72 145.87 30.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.171 . . . . 0.0 110.416 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 mt -137.28 139.34 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 0.0 109.838 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -76.19 121.2 22.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.27 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -129.15 178.16 17.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -144.63 165.84 26.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -1.154 . . . . 0.0 109.456 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.563 HD12 ' HG3' ' A' ' 81' ' ' MET . 0.1 OUTLIER -157.79 150.52 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.869 -1.145 . . . . 0.0 111.171 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.514 ' O ' HG22 ' A' ' 79' ' ' THR . 1.1 m-20 -109.02 161.38 15.22 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.564 -0.71 . . . . 0.0 109.348 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.425 HG11 ' CE2' ' A' ' 132' ' ' TYR . 3.0 t -143.56 151.67 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.118 -0.989 . . . . 0.0 110.113 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 5.1 t80 -151.71 118.89 5.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 110.672 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 77' ' ' TRP . 30.2 mt -142.63 151.62 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.969 . . . . 0.0 110.145 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.39 95.65 1.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.348 -0.845 . . . . 0.0 109.615 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -173.28 166.26 4.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.259 -0.901 . . . . 0.0 110.414 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -90.25 113.72 25.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.114 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -76.52 90.36 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.2 50.13 3.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.907 . . . . 0.0 110.388 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.71 29.96 45.88 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.21 101.21 4.44 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.175 -1.191 . . . . 0.0 110.27 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.12 136.49 24.03 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.819 1.431 . . . . 0.0 110.293 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 5.8 t80 -136.63 114.71 11.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.174 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -103.43 130.35 50.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 110.112 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 1.6 t80 -145.21 113.84 6.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.763 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 15.8 t0 -162.81 92.15 0.77 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.929 . . . . 0.0 110.224 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -153.84 -169.75 3.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 110.433 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -119.63 86.29 2.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.318 -0.863 . . . . 0.0 110.022 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -84.59 -178.96 7.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.255 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.611 ' O ' HG23 ' A' ' 138' ' ' ILE . 5.7 p30 -150.49 170.51 18.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 110.055 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.7 pt -156.92 165.63 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.076 -1.015 . . . . 0.0 110.754 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 98.8 m -91.76 117.91 30.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.499 -0.75 . . . . 0.0 110.33 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.571 ' HA ' HG12 ' A' ' 38' ' ' VAL . 30.6 m-85 -89.91 151.3 21.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 0.0 110.126 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -144.0 106.1 4.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.145 -0.972 . . . . 0.0 110.339 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.54 ' CE1' HG11 ' A' ' 68' ' ' VAL . 80.3 m-85 -91.46 148.6 22.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.91 . . . . 0.0 109.962 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.455 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 32.7 m-80 -131.1 105.03 7.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.271 -0.893 . . . . 0.0 110.508 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.441 ' HA3' HD21 ' A' ' 34' ' ' LEU . . . -160.72 -161.56 11.65 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.462 ' HD2' HD11 ' A' ' 34' ' ' LEU . 7.3 Cg_endo . . . . . 0 C--N 1.305 -1.748 0 O-C-N 123.919 1.483 . . . . 0.0 110.291 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 10.3 m-20 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 120.764 0.316 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.1 t -159.23 171.36 20.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.083 -1.011 . . . . 0.0 110.889 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.98 177.64 27.62 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.05 107.12 18.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -1.128 . . . . 0.0 110.204 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.855 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -94.3 155.4 17.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 110.091 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.443 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 33.6 m-80 -79.92 138.62 37.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.77 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.674 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -166.0 159.24 15.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.117 -0.989 . . . . 0.0 110.117 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -155.76 -170.33 3.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -0.86 . . . . 0.0 110.247 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 46' ' ' THR . 0.1 OUTLIER -140.06 173.09 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 109.943 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -150.41 160.94 43.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.192 -0.943 . . . . 0.0 110.197 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -68.35 126.33 29.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.473 -0.767 . . . . 0.0 110.168 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.484 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -57.11 146.13 28.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 109.813 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 6.5 t30 72.93 -0.59 3.32 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.878 -0.514 . . . . 0.0 110.926 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -139.08 -168.62 2.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.976 -1.078 . . . . 0.0 109.556 179.484 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.422 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.9 OUTLIER -135.57 25.26 3.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.002 . . . . 0.0 110.558 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -135.37 123.69 23.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.147 -0.971 . . . . 0.0 111.035 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -52.54 122.1 8.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.46 -0.775 . . . . 0.0 109.313 179.046 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.59 -18.65 3.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.901 -1.125 . . . . 0.0 112.219 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.603 HG22 ' N ' ' A' ' 49' ' ' ALA . 1.4 mp -138.47 -76.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.621 -1.299 . . . . 0.0 110.971 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.603 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -45.07 -27.02 0.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.735 -0.603 . . . . 0.0 111.116 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.437 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -63.16 -13.64 39.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.075 -1.016 . . . . 0.0 110.689 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.465 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 31.3 m-20 -98.68 10.63 40.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.07 -1.019 . . . . 0.0 110.752 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 51' ' ' ASP . 16.6 m-85 -144.91 15.86 1.56 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.995 -1.066 . . . . 0.0 110.261 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.44 108.75 17.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 110.369 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -72.21 147.76 46.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.153 -0.967 . . . . 0.0 110.19 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.456 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 20.6 pttt -146.38 163.35 30.36 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 109.957 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 50.9 Cg_endo -76.07 -177.11 19.92 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.84 -2.15 . . . . 0.0 110.918 0.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.674 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.08 166.27 10.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.885 . . . . 0.0 110.005 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 1.2 mttm -103.39 112.44 25.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 0.0 110.364 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 1.9 p90 -95.83 163.33 13.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 109.682 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 1.1 tt -155.23 130.49 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.058 -1.026 . . . . 0.0 110.907 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -138.83 114.64 9.98 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.436 -0.79 . . . . 0.0 109.932 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HB2' ' HD2' ' A' ' 65' ' ' LYS . 40.4 mttt -97.32 62.19 1.74 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 110.654 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 46.08 99.3 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.544 -0.723 . . . . 0.0 111.616 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.8 -21.67 43.92 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.421 ' HD2' ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -133.16 166.09 23.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -1.182 . . . . 0.0 110.46 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.741 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.1 pt? -171.25 145.76 2.24 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.614 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.3 OUTLIER -141.41 -160.1 1.04 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -170.22 128.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.991 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.497 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 0.6 OUTLIER -98.79 132.49 44.11 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.033 -1.042 . . . . 0.0 109.704 179.735 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -112.62 128.16 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.85 . . . . 0.0 110.017 -179.662 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 m -88.57 126.74 35.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.06 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -102.92 144.74 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.79 143.94 28.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 0.0 110.357 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.624 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.3 OUTLIER 56.59 90.44 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.256 -0.902 . . . . 0.0 110.191 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -29.73 63.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.211 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -67.12 -53.08 34.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.848 . . . . 0.0 110.201 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.541 ' O ' HG12 ' A' ' 119' ' ' VAL . 46.8 m0 -57.72 -56.06 26.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.648 HD11 HG13 ' A' ' 117' ' ' ILE . 9.3 tp -87.69 116.58 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.443 -0.786 . . . . 0.0 109.928 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -86.37 -23.98 25.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.477 -0.764 . . . . 0.0 110.67 -179.254 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.16 179.48 47.52 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.3 mtt -151.52 165.79 33.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.395 -1.062 . . . . 0.0 109.796 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -154.56 148.84 26.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 110.215 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.917 HD12 ' CD2' ' A' ' 104' ' ' PHE . 2.3 mt -139.27 153.43 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 110.059 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.487 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 61.59 13.67 5.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.02 -1.05 . . . . 0.0 110.912 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.85 21.86 54.6 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.726 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.569 ' CE1' ' O ' ' A' ' 83' ' ' ILE . 2.3 p80 -136.81 162.72 32.43 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.751 -1.441 . . . . 0.0 110.677 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 171.47 10.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.345 -0.847 . . . . 0.0 111.023 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.481 ' CB ' ' CZ ' ' A' ' 104' ' ' PHE . 5.7 pt-20 -100.4 170.41 8.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.445 -0.784 . . . . 0.0 110.535 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 102' ' ' SER . 9.4 t-20 -108.38 138.14 45.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 109.975 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.4 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.1 pp -68.14 101.14 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.969 -1.082 . . . . 0.0 109.561 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.504 HG21 HG22 ' A' ' 101' ' ' THR . 0.4 OUTLIER -94.63 -31.95 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.352 -0.842 . . . . 0.0 110.978 -179.045 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.413 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 9.0 m -166.2 98.25 0.61 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.063 -1.023 . . . . 0.0 109.934 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -95.05 137.62 33.86 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.41 -0.806 . . . . 0.0 109.911 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -142.57 90.07 2.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.358 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -31.03 64.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.947 . . . . 0.0 109.979 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.81 -44.84 95.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 110.176 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -95.25 9.86 38.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 110.556 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 53.7 58.91 4.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.032 -1.043 . . . . 0.0 110.19 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -147.94 162.33 39.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 110.391 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.607 ' O ' HG22 ' A' ' 72' ' ' VAL . 1.2 mtp180 -164.71 149.42 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 109.961 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.504 HG22 HG21 ' A' ' 91' ' ' ILE . 52.4 m -142.04 154.87 45.3 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 109.986 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 24.8 p -146.91 146.67 30.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.981 . . . . 0.0 110.589 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -91.73 147.14 23.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.361 -0.837 . . . . 0.0 110.078 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.917 ' CD2' HD12 ' A' ' 83' ' ' ILE . 6.1 m-85 -130.14 140.14 50.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 110.846 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -97.34 126.82 42.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 108.991 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.741 ' O ' HD21 ' A' ' 66' ' ' LEU . 14.5 p -149.7 147.75 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.003 -1.06 . . . . 0.0 111.277 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.09 99.98 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.667 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 55.61 170.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.494 -0.754 . . . . 0.0 109.409 -178.191 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.408 ' H ' HD12 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -149.34 79.25 1.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.967 -1.083 . . . . 0.0 111.065 -179.191 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -146.41 71.89 1.26 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.827 . . . . 0.0 110.032 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.79 -101.48 0.19 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.453 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.3 OUTLIER -157.51 145.71 19.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -1.143 . . . . 0.0 110.156 -179.627 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mm -136.27 137.92 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 109.879 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.14 108.49 9.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 0.0 110.058 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -120.54 -176.36 15.62 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 5.3 mtmm -144.62 167.29 22.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.307 -1.113 . . . . 0.0 110.001 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.648 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.74 142.29 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.109 -0.995 . . . . 0.0 110.709 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.58 ' O ' HG22 ' A' ' 79' ' ' THR . 1.0 OUTLIER -104.7 155.92 18.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.438 -0.789 . . . . 0.0 109.679 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.2 OUTLIER -135.77 153.65 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 0.0 110.451 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 15.6 t80 -151.29 103.62 3.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.423 -0.798 . . . . 0.0 110.553 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 77' ' ' TRP . 75.3 mt -133.09 151.0 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 0.0 110.204 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -159.08 100.02 1.53 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.411 -0.806 . . . . 0.0 109.518 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -173.33 169.62 4.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 110.491 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 2.2 mttt -82.89 90.64 6.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.378 -0.826 . . . . 0.0 110.344 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.419 ' O ' ' CG1' ' A' ' 125' ' ' VAL . 2.0 p -77.43 134.66 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 110.156 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.58 25.47 1.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -0.881 . . . . 0.0 110.26 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.59 30.97 31.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 3.3 mtmm -144.62 139.11 15.13 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.238 -1.154 . . . . 0.0 110.017 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -62.49 119.7 6.91 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.709 1.373 . . . . 0.0 110.448 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 4.5 t80 -117.87 113.48 21.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 110.271 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -104.6 111.08 23.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.079 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.466 ' HE2' HG11 ' A' ' 119' ' ' VAL . 2.0 t80 -123.51 114.04 19.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 109.834 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -160.66 87.36 0.75 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.158 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -154.46 -173.01 4.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.868 . . . . 0.0 110.379 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -118.02 85.75 2.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.376 -0.827 . . . . 0.0 109.712 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -85.68 -179.05 6.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.28 -0.888 . . . . 0.0 110.362 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.595 ' O ' HG23 ' A' ' 138' ' ' ILE . 8.5 p30 -151.01 167.99 25.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 110.331 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.4 pt -157.28 177.19 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 110.499 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.453 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 20.7 m -91.57 121.2 33.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.903 . . . . 0.0 110.188 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.677 ' CD2' HD11 ' A' ' 83' ' ' ILE . 12.6 m-85 -89.51 99.96 12.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.58 154.84 24.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 110.244 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.4 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 14.9 m-85 -148.65 148.11 29.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.858 . . . . 0.0 109.919 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.443 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 23.6 m120 -138.99 98.13 3.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.88 . . . . 0.0 110.345 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.855 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -149.76 -148.83 4.85 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo . . . . . 0 C--N 1.307 -1.639 0 O-C-N 123.93 1.49 . . . . 0.0 110.463 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 2.5 m-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.921 0.391 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 p -158.86 146.01 17.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.948 . . . . 0.0 110.743 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -179.66 176.64 47.73 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.58 114.84 25.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.193 -1.181 . . . . 0.0 110.47 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.52 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 1.5 tt -94.79 148.25 22.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 110.319 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.1 t30 -80.64 139.8 36.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.96 . . . . 0.0 110.03 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.51 ' CD2' ' N ' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -167.11 174.18 8.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.026 -1.046 . . . . 0.0 110.658 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.51 ' N ' ' CD2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -155.58 -165.76 2.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.594 -0.691 . . . . 0.0 109.571 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.671 ' C ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.07 164.63 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.1 -1.0 . . . . 0.0 110.274 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -147.83 148.26 30.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.373 -0.83 . . . . 0.0 109.978 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.441 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -67.82 128.37 36.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 110.09 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.536 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -52.53 146.62 9.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.176 -0.953 . . . . 0.0 109.901 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.3 t30 71.74 1.54 3.93 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.851 -0.53 . . . . 0.0 111.161 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -135.24 -162.22 1.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.89 -1.131 . . . . 0.0 109.531 179.159 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.43 ' N ' ' OG1' ' A' ' 43' ' ' THR . 6.2 p30 -132.82 12.07 4.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 110.332 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -136.43 137.62 40.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.749 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.671 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -64.23 134.23 54.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.326 179.123 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.58 -17.25 3.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.904 -1.122 . . . . 0.0 112.159 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.0 mt -137.37 -50.75 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.61 -1.306 . . . . 0.0 111.184 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.0 5.34 11.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.385 -0.822 . . . . 0.0 111.512 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.447 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -73.5 -29.21 62.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.852 -1.155 . . . . 0.0 110.679 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -99.47 12.47 36.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.102 -0.999 . . . . 0.0 110.896 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -118.76 -18.84 8.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.009 -1.057 . . . . 0.0 110.451 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.414 ' CE2' HG12 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -101.43 113.86 27.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 109.848 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.14 155.21 40.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.967 . . . . 0.0 110.459 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -146.35 160.06 43.35 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.833 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 55.6 Cg_endo -78.29 -177.04 19.91 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.588 -2.255 . . . . 0.0 110.649 -0.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.86 170.4 7.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.143 -0.973 . . . . 0.0 110.095 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -104.32 119.47 39.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.789 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 29.1 p90 -97.01 165.81 11.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 109.525 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.677 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -154.95 124.04 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.937 -1.102 . . . . 0.0 110.937 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.479 ' HD3' HD21 ' A' ' 109' ' ' LEU . 1.2 mtmt -137.67 125.13 21.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.345 -0.847 . . . . 0.0 110.684 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -103.81 62.42 0.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.393 -0.817 . . . . 0.0 110.402 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 47.67 98.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.463 -0.773 . . . . 0.0 111.35 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.11 12.59 39.08 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.707 ' C ' HD13 ' A' ' 66' ' ' LEU . 3.5 ptpt -173.7 154.81 2.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.889 -1.359 . . . . 0.0 110.227 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.811 ' N ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -154.27 151.31 28.98 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.073 -1.017 . . . . 0.0 111.247 179.15 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.677 ' HB2' HG23 ' A' ' 60' ' ' ILE . 13.8 m-85 -141.92 -164.71 1.85 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.467 -0.771 . . . . 0.0 109.233 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.1 t -169.09 131.98 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.023 -1.048 . . . . 0.0 110.835 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -101.72 135.88 42.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.392 -0.817 . . . . 0.0 109.838 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.437 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -113.62 133.38 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.133 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -91.04 128.73 36.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.931 . . . . 0.0 110.422 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.541 HG11 ' CE ' ' A' ' 81' ' ' MET . 0.9 OUTLIER -104.86 142.24 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.906 . . . . 0.0 110.055 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -99.98 138.84 36.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.129 -0.982 . . . . 0.0 110.507 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 55.98 102.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.357 -0.839 . . . . 0.0 110.447 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.3 p -62.57 -43.73 98.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.125 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.76 -48.83 59.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.91 . . . . 0.0 110.146 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.46 ' O ' HG12 ' A' ' 119' ' ' VAL . 44.4 m0 -57.41 -67.69 0.3 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 110.323 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 78' ' ' ILE . 17.9 tt -87.83 117.98 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.39 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.618 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -85.9 -21.71 27.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.423 -0.798 . . . . 0.0 110.898 -178.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.09 177.13 47.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.541 ' CE ' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -152.29 159.22 43.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.432 -1.04 . . . . 0.0 109.884 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -155.84 151.33 27.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 0.0 109.932 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.527 HD12 ' CD2' ' A' ' 104' ' ' PHE . 3.9 mt -147.12 157.71 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 110.13 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.657 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 0.6 OUTLIER 62.48 14.52 7.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.611 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.23 21.23 61.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.657 ' CD2' ' HB3' ' A' ' 84' ' ' GLU . 2.1 p80 -136.77 160.17 39.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.035 -1.273 . . . . 0.0 110.563 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.85 163.68 27.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.393 -0.817 . . . . 0.0 110.403 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.524 ' CB ' ' CE1' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -92.22 170.27 9.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.158 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.67 134.81 51.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.184 -0.948 . . . . 0.0 110.066 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -67.4 101.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.957 . . . . 0.0 109.618 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.523 HG21 HG22 ' A' ' 101' ' ' THR . 0.7 OUTLIER -95.27 -29.89 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 111.001 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 3.5 m -167.15 94.94 0.47 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.035 -1.041 . . . . 0.0 110.048 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 18.2 ttmt -96.28 139.19 32.78 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.428 -0.795 . . . . 0.0 110.036 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.79 99.03 3.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.161 -0.962 . . . . 0.0 110.237 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 p -78.37 -32.37 48.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.1 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.12 99.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.879 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.06 10.68 36.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 0.0 110.549 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.54 58.11 5.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.978 -1.076 . . . . 0.0 110.011 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -146.43 165.04 30.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 110.265 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.471 ' CB ' ' CG2' ' A' ' 72' ' ' VAL . 2.8 mtp180 -168.73 154.42 6.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.368 -0.833 . . . . 0.0 109.903 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.523 HG22 HG21 ' A' ' 91' ' ' ILE . 78.2 m -141.76 154.66 45.41 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 109.839 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.452 ' HB2' ' CG ' ' A' ' 88' ' ' GLU . 99.7 p -144.84 139.14 27.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.981 . . . . 0.0 110.341 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -92.97 130.42 38.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.948 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.527 ' CD2' HD12 ' A' ' 83' ' ' ILE . 48.0 m-85 -114.43 147.74 38.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 110.451 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -105.17 135.15 47.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.342 -0.849 . . . . 0.0 110.052 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.3 m -149.36 158.97 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.36 -0.837 . . . . 0.0 109.891 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.4 p -53.17 -35.03 59.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.426 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.49 -150.96 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.596 -0.69 . . . . 0.0 109.184 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.479 HD21 ' HD3' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -148.56 54.18 1.01 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.849 -1.157 . . . . 0.0 110.567 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 22.2 t-20 -145.28 57.64 1.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.22 -0.925 . . . . 0.0 110.222 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.44 176.97 44.14 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.419 ' CE ' HG23 ' A' ' 139' ' ' THR . 0.1 OUTLIER -81.6 146.66 29.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -1.183 . . . . 0.0 110.446 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.403 ' N ' ' O ' ' A' ' 140' ' ' TYR . 7.6 mm -136.36 129.43 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.841 . . . . 0.0 109.942 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -76.72 112.55 13.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.839 . . . . 0.0 110.367 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.432 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -121.09 -175.15 15.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 63.1 mttt -144.88 164.86 29.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -1.143 . . . . 0.0 110.035 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.632 HG21 HD11 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.98 145.76 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -0.948 . . . . 0.0 110.668 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.618 ' C ' HG22 ' A' ' 79' ' ' THR . 72.9 m-20 -107.26 155.7 19.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.496 -0.753 . . . . 0.0 109.492 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.2 OUTLIER -129.55 146.32 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.965 -1.084 . . . . 0.0 110.609 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.412 ' HB2' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -152.3 104.2 2.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.372 -0.83 . . . . 0.0 110.178 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 46.4 mt -128.24 152.46 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.118 -0.989 . . . . 0.0 110.448 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.28 95.56 1.14 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.438 -0.789 . . . . 0.0 109.69 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -173.72 175.53 2.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.0 110.23 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -84.16 102.78 12.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 110.273 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.664 ' O ' HG12 ' A' ' 125' ' ' VAL . 2.1 t -76.68 103.39 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.091 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.66 43.51 7.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.049 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.37 33.53 56.25 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.28 109.46 4.59 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.278 -1.13 . . . . 0.0 110.193 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -47.42 113.5 0.76 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.66 1.347 . . . . 0.0 110.164 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -112.48 151.14 30.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.0 110.437 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.64 125.89 26.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.393 -0.817 . . . . 0.0 110.115 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.418 ' HE2' HG11 ' A' ' 119' ' ' VAL . 4.2 t80 -140.4 129.87 24.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 110.155 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 0.8 OUTLIER -176.3 88.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 110.037 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.35 -163.57 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 110.403 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -118.24 145.03 45.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 110.172 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -154.97 -179.03 7.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.095 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 8.9 p30 -150.27 169.85 20.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.187 -0.945 . . . . 0.0 110.558 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.632 HD11 HG21 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -156.53 173.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.608 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.419 HG23 ' CE ' ' A' ' 112' ' ' LYS . 24.6 m -91.82 162.77 14.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.473 -0.767 . . . . 0.0 110.526 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.432 ' CE2' ' HA3' ' A' ' 115' ' ' GLY . 97.0 m-85 -144.19 104.87 4.16 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.368 -0.832 . . . . 0.0 109.714 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.28 104.37 14.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 110.68 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.435 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 29.6 m-85 -91.66 135.27 34.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.896 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.413 ' H ' HD21 ' A' ' 34' ' ' LEU . 8.9 m120 -126.25 105.09 8.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.096 -1.003 . . . . 0.0 110.227 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.448 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -150.96 -149.8 5.14 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.42 ' HD2' ' HA3' ' A' ' 144' ' ' GLY . 1.7 Cg_endo . . . . . 0 C--N 1.31 -1.478 0 O-C-N 123.702 1.369 . . . . 0.0 110.907 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.042 0.449 . . . . 0.0 109.874 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -160.76 144.48 13.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.266 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.87 -175.99 42.6 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.39 105.62 17.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.34 -1.094 . . . . 0.0 110.395 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.649 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -94.8 154.49 17.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.0 110.31 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -80.13 137.86 36.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.335 -0.853 . . . . 0.0 110.037 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.717 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -165.96 161.91 17.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.04 -1.038 . . . . 0.0 110.273 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 141' ' ' LYS . 0.2 OUTLIER -156.11 -176.82 6.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 109.908 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.792 ' O ' HG22 ' A' ' 46' ' ' THR . 25.8 m -140.38 116.84 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.018 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -90.27 163.1 14.89 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.494 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.441 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.4 OUTLIER -67.36 126.84 30.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 109.942 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.494 ' O ' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -51.01 141.91 12.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.031 . . . . 0.0 109.943 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER 73.09 0.59 3.73 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.851 -0.53 . . . . 0.0 110.981 -179.408 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -136.83 -168.52 2.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.85 -1.156 . . . . 0.0 109.677 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -135.86 24.41 3.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.188 -0.945 . . . . 0.0 110.422 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -135.65 119.91 17.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.069 . . . . 0.0 111.101 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.792 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.7 OUTLIER -50.14 117.57 2.43 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.589 -0.694 . . . . 0.0 109.501 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.6 t -129.64 -18.98 3.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.811 -1.181 . . . . 0.0 112.18 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 49' ' ' ALA . 71.8 mt -138.54 -79.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.653 -1.28 . . . . 0.0 111.0 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.672 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -45.19 -26.93 0.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.738 -0.601 . . . . 0.0 111.159 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.458 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -67.68 -18.12 64.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.013 -1.055 . . . . 0.0 110.655 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -95.77 14.31 23.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 110.771 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -134.49 2.71 3.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.062 -1.024 . . . . 0.0 111.109 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.443 ' CE1' ' SD ' ' A' ' 81' ' ' MET . 26.7 m-85 -123.37 120.49 33.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.959 -1.088 . . . . 0.0 110.298 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -72.47 160.04 32.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.346 -0.846 . . . . 0.0 110.569 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.73 164.36 24.31 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.895 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 53.5 Cg_endo -76.71 -175.71 17.18 Favored 'Cis proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.583 -0.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.717 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -103.4 169.17 8.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.958 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.75 110.32 22.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.198 -0.939 . . . . 0.0 109.998 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.618 ' CD2' HD13 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -96.02 161.8 13.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.328 -0.857 . . . . 0.0 109.91 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -155.3 151.09 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.095 -1.003 . . . . 0.0 110.997 -179.448 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 17.9 mtmt -134.53 173.86 11.19 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.331 -0.855 . . . . 0.0 110.595 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.479 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -158.26 63.51 0.44 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.364 -0.835 . . . . 0.0 110.153 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.0 m120 48.71 84.5 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 111.274 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.64 18.57 47.77 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.53 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.479 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 3.1 ptpt -165.83 162.86 18.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.964 -1.316 . . . . 0.0 111.294 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.83 HD21 ' H ' ' A' ' 108' ' ' LYS . 1.7 pt? -173.42 155.8 2.91 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.962 0.887 . . . . 0.0 111.205 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 1.1 m-85 -139.0 -159.4 0.95 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 67' ' ' TYR . 1.2 t -169.41 133.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.141 -0.974 . . . . 0.0 109.796 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 102' ' ' SER . 5.1 pt20 -97.42 136.17 38.24 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.106 -0.997 . . . . 0.0 109.866 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.435 ' O ' HG22 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -113.68 131.12 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 110.364 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m -88.76 123.89 33.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.637 HG12 ' HE1' ' A' ' 81' ' ' MET . 0.8 OUTLIER -103.29 136.77 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 110.499 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.8 144.6 29.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.365 -0.834 . . . . 0.0 110.007 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 58.33 89.08 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.178 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.2 p -55.22 -23.89 24.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.302 -0.874 . . . . 0.0 110.58 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -73.92 -55.64 5.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.976 . . . . 0.0 110.322 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.687 ' O ' HG12 ' A' ' 119' ' ' VAL . 42.2 m0 -48.91 -62.33 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 0.0 110.466 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.592 HG23 ' O ' ' A' ' 78' ' ' ILE . 6.4 tp -87.9 115.5 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.282 -0.886 . . . . 0.0 110.242 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.576 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.33 -26.68 23.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.389 -0.819 . . . . 0.0 110.83 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.5 176.86 45.34 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.637 ' HE1' HG12 ' A' ' 72' ' ' VAL . 33.6 mtm -151.92 160.13 43.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.358 -1.083 . . . . 0.0 110.063 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 116' ' ' LYS . 1.3 m -154.53 132.93 11.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.185 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.654 HD12 ' CG ' ' A' ' 104' ' ' PHE . 16.8 mt -130.17 141.96 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.354 -0.841 . . . . 0.0 110.321 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.463 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 1.1 tm-20 69.89 3.08 4.15 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.415 -0.803 . . . . 0.0 111.295 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.38 24.42 10.25 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.695 -1.241 . . . . 0.0 111.119 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.47 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.49 159.12 42.89 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.605 -1.526 . . . . 0.0 110.179 179.317 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -70.48 -178.44 1.76 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.347 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 0.6 OUTLIER -104.92 168.46 9.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 110.203 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.83 129.44 56.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.168 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.407 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.1 pp -67.98 101.23 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.139 -0.975 . . . . 0.0 109.484 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.548 HG21 HG22 ' A' ' 101' ' ' THR . 1.4 tt -93.19 -26.88 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.441 -0.787 . . . . 0.0 110.525 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.458 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -166.81 148.72 6.24 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.293 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.457 ' HG3' ' CG ' ' A' ' 100' ' ' ARG . 15.5 ttmt -141.98 149.32 39.9 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 110.019 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.74 91.34 2.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 0.0 110.466 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.4 p -73.33 -18.71 61.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 110.121 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.6 -28.46 69.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 110.379 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.55 23.24 3.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.253 -0.904 . . . . 0.0 110.249 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.54 79.72 0.11 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 0.0 110.432 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -148.14 167.15 25.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.457 ' CG ' ' HG3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -172.46 157.53 4.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 110.209 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.548 HG22 HG21 ' A' ' 91' ' ' ILE . 90.8 m -141.44 152.82 44.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.435 -0.791 . . . . 0.0 109.651 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 0.8 OUTLIER -145.24 145.22 31.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.084 -1.01 . . . . 0.0 110.694 -179.68 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -93.57 143.37 26.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.433 -0.792 . . . . 0.0 109.886 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.654 ' CG ' HD12 ' A' ' 83' ' ' ILE . 44.2 m-85 -127.36 127.58 44.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.976 . . . . 0.0 110.663 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.443 ' C ' HG13 ' A' ' 106' ' ' VAL . 2.7 tm-20 -93.27 125.2 37.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 109.792 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 105' ' ' GLU . 29.0 m -149.33 163.9 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.022 -1.049 . . . . 0.0 110.887 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p -80.21 105.03 11.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.388 -0.82 . . . . 0.0 109.348 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.83 ' H ' HD21 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 53.74 174.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 109.756 -178.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.542 HD21 ' HD2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -149.91 73.7 1.18 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.004 -1.06 . . . . 0.0 110.898 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.41 66.76 1.26 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.066 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.39 -108.64 0.31 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.86 146.34 19.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -1.145 . . . . 0.0 110.342 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.544 HD12 ' CE2' ' A' ' 142' ' ' PHE . 35.9 mt -137.38 142.8 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.357 -0.839 . . . . 0.0 110.157 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -76.3 125.42 29.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.218 -0.926 . . . . 0.0 110.137 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -131.56 -177.04 14.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.5 mtmm -142.38 161.0 39.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.364 -1.08 . . . . 0.0 109.678 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.483 HG21 HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -158.23 146.43 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.046 -1.034 . . . . 0.0 110.735 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.576 ' C ' HG22 ' A' ' 79' ' ' THR . 89.0 m-20 -110.12 159.68 17.13 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -133.63 147.05 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.09 -1.006 . . . . 0.0 110.17 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -152.03 113.14 4.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 110.684 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.617 HD11 ' HA ' ' A' ' 77' ' ' TRP . 2.6 mp -138.75 152.21 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 0.0 109.856 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.15 98.43 1.3 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.953 . . . . 0.0 110.015 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -174.03 178.68 2.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 110.18 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -93.06 107.69 19.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 110.175 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.42 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 56.0 t -75.84 90.58 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.826 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.42 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 63.7 53.04 2.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.277 -0.89 . . . . 0.0 110.012 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.33 36.95 48.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -145.04 97.48 4.84 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.296 -1.12 . . . . 0.0 110.366 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.99 110.15 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.863 1.454 . . . . 0.0 110.15 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -116.63 153.1 32.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.341 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -136.68 112.19 9.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 110.13 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.489 ' CE2' ' HB ' ' A' ' 119' ' ' VAL . 3.7 t80 -115.71 128.24 55.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.004 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -167.49 86.69 0.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.404 -0.81 . . . . 0.0 109.948 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -153.33 -169.19 3.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.898 . . . . 0.0 110.391 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.401 ' ND1' ' OD1' ' A' ' 118' ' ' ASP . 13.4 t60 -119.61 148.39 43.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 109.99 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -154.79 -179.66 8.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.882 . . . . 0.0 110.136 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.499 ' O ' HG23 ' A' ' 138' ' ' ILE . 42.9 p-10 -151.82 170.66 19.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.882 . . . . 0.0 110.261 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.672 HG21 ' HB2' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -157.76 168.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.917 . . . . 0.0 110.348 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 87.0 m -91.63 117.53 29.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.335 -0.853 . . . . 0.0 109.82 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.479 ' CD2' HG12 ' A' ' 83' ' ' ILE . 10.4 m-85 -88.91 106.51 18.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 110.326 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -86.69 159.59 19.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.318 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.544 ' CE2' HD12 ' A' ' 113' ' ' ILE . 41.4 m-85 -148.87 150.86 33.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.878 . . . . 0.0 110.125 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.56 ' C ' HD21 ' A' ' 34' ' ' LEU . 22.6 m120 -143.84 96.32 2.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 110.234 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.649 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -135.73 -140.01 4.1 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo . . . . . 0 C--N 1.309 -1.521 0 O-C-N 123.711 1.374 . . . . 0.0 110.422 179.919 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.027 0.442 . . . . 0.0 110.156 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.18 144.07 14.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.946 . . . . 0.0 110.264 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.61 -177.52 45.92 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.34 108.4 19.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.351 -1.087 . . . . 0.0 110.359 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.935 ' HG ' HD22 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -94.84 150.0 20.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.399 -0.813 . . . . 0.0 109.913 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.708 ' H ' HD13 ' A' ' 34' ' ' LEU . 5.1 m-80 -78.93 141.34 37.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.991 -1.068 . . . . 0.0 109.7 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -165.4 156.48 14.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 110.557 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 141' ' ' LYS . 5.2 tt0 -155.56 -175.85 5.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 0.0 109.946 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.659 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -141.63 173.22 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 110.449 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -147.79 161.07 41.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -0.805 . . . . 0.0 109.951 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.519 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.1 OUTLIER -67.53 132.73 48.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 0.0 109.879 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.512 ' CE2' ' ND2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -57.45 146.04 30.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 110.052 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.4 t30 71.07 2.89 4.43 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.801 -0.562 . . . . 0.0 111.055 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.519 HG21 ' HG2' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -135.64 -164.48 1.55 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.828 -1.17 . . . . 0.0 109.767 179.268 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.413 ' N ' ' OG1' ' A' ' 43' ' ' THR . 2.2 t-20 -131.81 14.21 4.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 110.296 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.81 135.55 41.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.069 -1.019 . . . . 0.0 110.401 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.531 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -68.07 133.48 49.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.403 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.48 -17.45 3.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.017 -1.052 . . . . 0.0 112.184 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.6 mt -136.92 -58.6 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.607 -1.308 . . . . 0.0 111.121 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.09 -10.04 27.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.472 -0.768 . . . . 0.0 111.424 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.461 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER -75.68 -18.15 59.72 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.843 -1.16 . . . . 0.0 110.787 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -102.06 15.41 29.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.0 110.731 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -129.12 3.37 5.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.049 -1.032 . . . . 0.0 110.985 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -128.94 117.54 21.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.994 -1.066 . . . . 0.0 110.293 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -72.83 166.71 22.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.341 -0.849 . . . . 0.0 110.494 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -146.92 160.35 40.69 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.304 -0.873 . . . . 0.0 109.834 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.13 -175.36 16.49 Favored 'Cis proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.752 -2.186 . . . . 0.0 110.725 -0.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.44 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.77 170.23 8.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -0.895 . . . . 0.0 109.96 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.462 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -107.97 111.67 23.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.11 -0.994 . . . . 0.0 110.693 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.666 ' CD2' HD21 ' A' ' 109' ' ' LEU . 2.7 p90 -97.84 165.24 12.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.262 -0.899 . . . . 0.0 110.132 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -155.52 154.15 6.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.254 -0.904 . . . . 0.0 110.66 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -133.35 170.64 15.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.424 -0.798 . . . . 0.0 110.479 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.455 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 0.7 OUTLIER -152.75 62.33 0.79 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -0.83 . . . . 0.0 110.12 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 50.47 82.86 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.353 -0.842 . . . . 0.0 111.067 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.51 21.93 35.91 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.455 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 6.2 ptpt -167.15 163.71 15.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.021 -1.282 . . . . 0.0 110.768 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.952 HD11 ' HA ' ' A' ' 108' ' ' LYS . 1.5 pt? -173.73 154.19 2.39 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.009 0.909 . . . . 0.0 111.034 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.565 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -139.61 -155.52 0.6 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.779 -0.575 . . . . 0.0 109.475 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 103' ' ' GLU . 1.0 OUTLIER -170.67 135.88 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.195 -0.94 . . . . 0.0 110.536 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.462 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -99.29 133.73 43.18 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.29 -0.881 . . . . 0.0 109.657 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.2 OUTLIER -113.0 140.42 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.363 -0.836 . . . . 0.0 110.3 -179.502 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.5 m -89.23 129.9 35.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.754 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.724 HG12 HG21 ' A' ' 78' ' ' ILE . 2.5 t -103.47 128.25 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 110.544 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -100.92 134.97 43.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.304 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.515 ' O ' HG22 ' A' ' 78' ' ' ILE . 32.1 m170 54.76 94.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.345 -0.847 . . . . 0.0 110.245 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -27.85 61.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.942 . . . . 0.0 110.288 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -27.11 61.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.186 -0.946 . . . . 0.0 110.283 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.556 ' O ' HG12 ' A' ' 119' ' ' VAL . 38.4 m0 -92.48 -52.27 4.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.2 -0.938 . . . . 0.0 110.057 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.724 HG21 HG12 ' A' ' 72' ' ' VAL . 1.5 tt -88.65 119.15 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.293 -0.88 . . . . 0.0 109.392 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.629 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.98 -23.83 24.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.42 -0.8 . . . . 0.0 111.389 -178.66 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.49 -178.84 48.15 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.064 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.432 ' HE2' HG13 ' A' ' 72' ' ' VAL . 19.0 mtm -152.24 162.73 40.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.464 -1.021 . . . . 0.0 110.103 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -155.2 141.26 18.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 0.0 109.935 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.569 HD12 ' CG ' ' A' ' 104' ' ' PHE . 7.1 mt -135.75 140.47 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 110.589 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 71.16 1.99 4.05 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.528 -0.733 . . . . 0.0 111.442 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.79 21.79 10.85 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.536 -1.316 . . . . 0.0 111.233 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.64 ' HE1' ' HD1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -137.13 158.58 44.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.622 -1.517 . . . . 0.0 110.05 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -71.41 -177.6 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.141 -0.975 . . . . 0.0 110.337 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -109.95 170.21 8.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.322 -0.861 . . . . 0.0 110.182 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -115.4 134.73 54.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.294 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.48 102.29 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.976 . . . . 0.0 109.668 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.587 HG22 ' O ' ' A' ' 101' ' ' THR . 1.4 tt -95.51 -27.52 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 111.008 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.448 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -167.53 103.62 0.51 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.08 -1.013 . . . . 0.0 109.856 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -95.53 149.59 21.25 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.386 -0.821 . . . . 0.0 110.259 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.34 61.58 1.39 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 110.116 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 m -54.49 -30.58 53.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.214 -0.928 . . . . 0.0 110.148 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.09 -49.27 75.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.094 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -95.97 9.9 39.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.566 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.47 55.62 4.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.082 -1.011 . . . . 0.0 110.326 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -147.53 159.2 44.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.173 -0.954 . . . . 0.0 110.402 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.415 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.5 ttm180 -163.16 162.77 25.7 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.325 -0.86 . . . . 0.0 110.023 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.587 ' O ' HG22 ' A' ' 91' ' ' ILE . 85.7 m -141.07 152.71 45.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.944 . . . . 0.0 109.655 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.1 p -145.71 143.4 29.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.977 -1.077 . . . . 0.0 110.725 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 5.3 tt0 -93.07 143.87 25.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.381 -0.824 . . . . 0.0 109.843 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.64 ' HD1' ' HE1' ' A' ' 86' ' ' HIS . 42.4 m-85 -125.64 145.46 50.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.108 -0.995 . . . . 0.0 110.561 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.45 130.61 47.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.363 -0.835 . . . . 0.0 110.141 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.551 ' O ' HD21 ' A' ' 66' ' ' LEU . 12.5 p -148.9 150.56 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 110.292 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.34 -39.63 46.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.952 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.5 -157.56 0.33 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.445 -0.784 . . . . 0.0 109.591 179.168 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.935 HD22 ' HG ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -148.19 62.77 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.96 -1.087 . . . . 0.0 110.612 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -145.81 62.92 1.25 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 110.078 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.82 -179.97 33.15 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.05 145.28 30.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -1.14 . . . . 0.0 110.57 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.521 HD13 HG21 ' A' ' 106' ' ' VAL . 27.1 mt -137.77 149.71 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.888 . . . . 0.0 109.923 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -76.04 120.96 22.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.0 110.183 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.489 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -124.71 171.21 16.78 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 82' ' ' SER . 47.1 mttt -146.37 159.94 42.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.276 -1.132 . . . . 0.0 110.033 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.402 HG12 ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -158.12 144.35 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.155 -0.965 . . . . 0.0 110.317 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.629 ' C ' HG22 ' A' ' 79' ' ' THR . 11.9 m-20 -106.38 158.09 17.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.341 -0.849 . . . . 0.0 109.676 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.1 OUTLIER -131.89 150.99 34.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.243 -0.911 . . . . 0.0 109.771 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 16.8 t80 -151.74 100.26 2.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 0.0 110.543 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.434 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 54.7 mt -129.74 151.99 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 110.176 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.48 96.58 1.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.856 . . . . 0.0 110.012 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -173.76 -175.78 1.14 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.868 . . . . 0.0 110.394 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.91 104.15 16.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.338 -0.851 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.541 ' O ' HG12 ' A' ' 125' ' ' VAL . 11.9 t -76.6 95.68 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 110.072 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.13 44.44 10.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 110.128 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.85 30.09 44.71 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -145.34 107.79 4.48 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.295 -1.12 . . . . 0.0 110.233 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -52.12 108.31 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.684 1.36 . . . . 0.0 110.214 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.527 ' HB3' HG23 ' A' ' 125' ' ' VAL . 24.4 t80 -110.66 119.33 38.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 0.0 110.46 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -106.33 117.22 33.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 110.138 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.488 ' HE2' HG11 ' A' ' 119' ' ' VAL . 2.3 t80 -126.45 121.22 31.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 0.0 110.078 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 35.4 t70 -166.69 90.47 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 110.415 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.03 -165.1 2.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.145 -0.972 . . . . 0.0 110.392 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -120.87 86.11 2.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 109.997 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -85.45 -179.17 6.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.881 . . . . 0.0 110.392 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.57 ' O ' HG23 ' A' ' 138' ' ' ILE . 46.2 p30 -151.28 171.05 18.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 110.29 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.4 pt -156.5 162.22 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 62.2 m -91.67 121.24 33.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 110.61 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.659 ' HA ' HG12 ' A' ' 38' ' ' VAL . 21.9 m-85 -90.2 155.16 19.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.835 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -144.77 99.82 3.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.518 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -91.6 144.03 25.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.37 -0.831 . . . . 0.0 109.825 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.436 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 5.3 m120 -132.96 100.96 5.05 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.158 -0.964 . . . . 0.0 110.51 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.917 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -163.21 -144.03 3.89 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.403 ' HG2' HD11 ' A' ' 109' ' ' LEU . 15.3 Cg_endo . . . . . 0 C--N 1.309 -1.521 0 O-C-N 123.779 1.41 . . . . 0.0 110.635 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.944 0.402 . . . . 0.0 110.277 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.6 t -159.65 140.73 12.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 110.525 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 177.37 178.76 47.27 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.03 111.29 21.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -1.125 . . . . 0.0 110.389 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.512 ' CB ' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -94.16 151.12 19.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 109.665 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.444 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -79.06 131.5 36.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.178 -0.951 . . . . 0.0 110.538 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.907 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -166.11 158.14 14.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 111.034 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -155.53 -165.96 2.12 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.559 ' C ' HG23 ' A' ' 46' ' ' THR . 0.1 OUTLIER -141.22 175.08 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 110.36 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 54.3 m-85 -148.32 163.99 35.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.475 -0.766 . . . . 0.0 109.813 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.427 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -68.24 128.46 36.64 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 109.895 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.515 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -54.97 146.37 17.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 110.112 -179.776 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.0 t-20 71.87 2.93 4.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.922 -0.487 . . . . 0.0 110.941 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -136.23 -162.35 1.26 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.888 -1.133 . . . . 0.0 109.706 179.216 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.416 ' N ' ' OG1' ' A' ' 43' ' ' THR . 22.9 m120 -133.05 15.74 4.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 110.445 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.5 139.03 43.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.16 -0.963 . . . . 0.0 110.361 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.559 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -74.08 133.06 42.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.994 . . . . 0.0 109.379 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.76 -16.97 4.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.046 -1.033 . . . . 0.0 111.82 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.8 mt -137.11 -64.63 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.831 -1.168 . . . . 0.0 110.623 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.4 -18.09 6.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.495 -0.753 . . . . 0.0 111.163 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.46 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 0.1 OUTLIER -68.35 -10.87 57.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.926 -1.108 . . . . 0.0 110.847 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -102.38 12.8 36.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.879 -1.138 . . . . 0.0 110.843 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -136.29 6.44 3.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.012 -1.055 . . . . 0.0 110.667 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -114.22 98.47 6.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.957 . . . . 0.0 109.845 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -72.03 103.28 3.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.522 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HG3' ' N ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -93.05 165.06 19.38 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.204 -0.935 . . . . 0.0 109.879 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.446 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 50.1 Cg_endo -78.61 -176.36 18.53 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.468 -2.305 . . . . 0.0 110.524 -0.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.907 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -103.15 165.41 11.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.25 -0.906 . . . . 0.0 110.008 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.405 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.71 109.52 21.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 110.168 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.512 ' CD1' ' CB ' ' A' ' 34' ' ' LEU . 19.4 p90 -96.95 161.78 13.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.676 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -154.0 153.05 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.111 -0.993 . . . . 0.0 110.357 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -135.89 174.03 11.06 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.324 -0.86 . . . . 0.0 110.453 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.437 ' HB2' ' HD3' ' A' ' 65' ' ' LYS . 9.8 mtmt -159.48 62.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.344 -0.848 . . . . 0.0 110.108 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 48.97 87.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.449 -0.782 . . . . 0.0 111.193 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.59 25.15 33.69 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.087 -1.054 . . . . 0.0 110.558 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.437 ' HD3' ' HB2' ' A' ' 62' ' ' LYS . 6.8 ptpt -171.9 158.85 4.94 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.962 -1.317 . . . . 0.0 111.028 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' A' ' 108' ' ' LYS . 1.3 pt? -173.4 150.29 1.82 Allowed 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 122.068 0.937 . . . . 0.0 111.334 178.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.586 ' C ' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -140.03 -161.06 1.14 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.586 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -167.15 142.89 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.578 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 102' ' ' SER . 8.7 pt20 -101.12 134.8 43.6 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.906 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -113.75 138.85 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.902 . . . . 0.0 109.842 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.6 m -89.03 135.87 33.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 110.469 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.663 HG12 HG21 ' A' ' 78' ' ' ILE . 2.0 t -107.42 122.69 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.865 . . . . 0.0 110.201 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -100.23 143.07 30.85 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.107 -0.995 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.909 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.5 OUTLIER 62.03 74.53 0.44 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 110.029 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.4 m -64.35 -19.1 65.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.348 -0.845 . . . . 0.0 110.551 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.32 -45.11 57.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.089 -1.007 . . . . 0.0 110.315 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -77.19 -42.44 37.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 110.19 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.909 HG22 ' O ' ' A' ' 74' ' ' HIS . 6.1 tp -88.14 118.82 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -0.92 . . . . 0.0 109.3 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -85.55 -24.06 27.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 111.029 -178.705 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.48 -179.16 46.85 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.006 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.552 ' HE1' HG22 ' A' ' 72' ' ' VAL . 28.5 mtm -151.35 158.55 43.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.458 -1.025 . . . . 0.0 109.791 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.33 154.87 34.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.087 -1.008 . . . . 0.0 110.17 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.76 HD12 ' CD2' ' A' ' 104' ' ' PHE . 12.9 mt -141.96 155.36 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 110.195 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.628 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 58.79 16.55 4.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.013 . . . . 0.0 110.791 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.19 21.65 60.41 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.92 -1.133 . . . . 0.0 110.424 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.628 ' CD2' ' HB3' ' A' ' 84' ' ' GLU . 2.7 p80 -135.18 157.42 46.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.842 -1.387 . . . . 0.0 110.525 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 178.8 3.65 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.329 -0.857 . . . . 0.0 110.701 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.407 ' HG3' ' CB ' ' A' ' 102' ' ' SER . 2.7 pt-20 -108.5 166.65 10.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.362 -0.836 . . . . 0.0 110.221 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 102' ' ' SER . 1.4 t30 -105.22 130.89 53.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -0.919 . . . . 0.0 110.209 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.12 102.56 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -0.954 . . . . 0.0 110.081 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 101' ' ' THR . 1.3 tt -95.78 -26.83 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.88 . . . . 0.0 110.855 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -167.5 99.02 0.49 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.148 -0.97 . . . . 0.0 109.874 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.437 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 7.7 ttmm -95.7 103.78 15.67 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.382 -0.824 . . . . 0.0 110.178 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -96.33 95.01 7.78 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.0 110.293 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.3 -29.86 61.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 110.109 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.09 94.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 110.354 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -95.69 14.56 22.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.206 -0.934 . . . . 0.0 110.593 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.6 t0 50.16 57.42 6.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.033 -1.042 . . . . 0.0 110.263 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -146.84 -176.74 5.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.166 -0.959 . . . . 0.0 110.318 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 72' ' ' VAL . 4.9 ttm180 -176.75 162.45 2.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.438 -0.789 . . . . 0.0 109.989 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.636 ' O ' HG22 ' A' ' 91' ' ' ILE . 86.8 m -142.68 150.6 40.38 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.86 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 19.5 p -146.33 148.72 32.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.045 -1.034 . . . . 0.0 110.711 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -92.99 146.92 23.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.322 -0.862 . . . . 0.0 110.088 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.76 ' CD2' HD12 ' A' ' 83' ' ' ILE . 8.7 m-85 -131.15 144.15 51.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.109 -0.994 . . . . 0.0 110.76 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -99.37 128.42 45.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.882 . . . . 0.0 109.366 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.73 143.09 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 110.825 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.4 113.21 2.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.111 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.616 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 47.23 -163.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.539 -0.726 . . . . 0.0 109.69 -178.609 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.428 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.66 64.61 0.87 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.861 -1.149 . . . . 0.0 110.753 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -146.2 58.78 1.22 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 110.308 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.8 171.05 38.6 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.441 ' HE3' HG23 ' A' ' 139' ' ' THR . 1.6 tmtt? -81.6 147.48 29.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -1.152 . . . . 0.0 110.326 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.41 ' N ' ' HG2' ' A' ' 112' ' ' LYS . 1.4 mt -136.01 140.84 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.941 . . . . 0.0 110.021 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.24 112.32 12.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.129 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.479 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -111.21 178.24 19.45 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -145.04 161.54 39.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -1.115 . . . . 0.0 109.854 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.669 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.02 140.96 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.121 -0.987 . . . . 0.0 110.392 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.549 ' O ' HG22 ' A' ' 79' ' ' THR . 25.1 t0 -105.24 152.47 22.84 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.354 -0.841 . . . . 0.0 109.473 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.464 HG22 HD11 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -128.86 151.89 36.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.017 -1.052 . . . . 0.0 110.386 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.401 ' CB ' ' OG1' ' A' ' 79' ' ' THR . 27.0 t80 -151.39 100.63 2.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 110.621 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.483 HD12 ' CD2' ' A' ' 132' ' ' TYR . 4.3 mt -127.36 152.89 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.965 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -159.7 98.77 1.38 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.262 -0.899 . . . . 0.0 109.912 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 124' ' ' LYS . 12.5 pt-20 -173.75 -152.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 110.363 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.47 ' O ' HG23 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -101.98 167.05 10.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.329 -0.857 . . . . 0.0 110.423 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 125' ' ' VAL . 1.3 t -158.05 114.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 125' ' ' VAL . 36.9 t30 56.26 25.92 9.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.441 -0.787 . . . . 0.0 109.826 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 86.04 37.32 9.28 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 3.6 mtmm -148.92 145.91 20.59 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.11 -1.229 . . . . 0.0 110.189 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -66.83 130.31 22.89 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.861 1.453 . . . . 0.0 110.027 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 10.2 t80 -116.34 140.16 49.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.174 -0.954 . . . . 0.0 110.548 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.79 105.01 5.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.829 . . . . 0.0 109.943 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.483 ' CD2' HD12 ' A' ' 121' ' ' ILE . 4.0 t80 -120.71 128.57 53.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 110.046 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -170.82 88.45 0.12 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.089 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.44 -175.03 5.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.356 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -119.52 85.27 2.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 110.242 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.402 ' HD2' HG21 ' A' ' 119' ' ' VAL . 40.3 m-85 -86.26 -178.83 6.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.354 -0.842 . . . . 0.0 110.078 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.472 ' HA ' HG22 ' A' ' 117' ' ' ILE . 4.2 p30 -150.87 178.42 9.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 110.281 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -156.69 168.88 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.382 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.441 HG23 ' HE3' ' A' ' 112' ' ' LYS . 48.9 m -92.03 119.59 31.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.342 -0.849 . . . . 0.0 110.931 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.526 ' CE2' HD11 ' A' ' 83' ' ' ILE . 28.3 m-85 -90.92 162.86 14.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.258 -0.902 . . . . 0.0 110.026 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.01 99.89 2.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.057 -1.027 . . . . 0.0 110.702 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.405 ' HA ' ' HB2' ' A' ' 36' ' ' TYR . 61.7 m-85 -91.95 150.96 20.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.195 -0.94 . . . . 0.0 110.417 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -141.66 104.58 4.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -0.886 . . . . 0.0 110.449 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.424 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -157.28 -146.74 4.57 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.41 ' CD ' HD11 ' A' ' 109' ' ' LEU . 11.0 Cg_endo . . . . . 0 C--N 1.309 -1.552 0 O-C-N 123.697 1.367 . . . . 0.0 110.671 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 8.4 m-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.706 0.289 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' TYR . 1.5 p -160.98 156.01 24.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.024 -1.048 . . . . 0.0 110.711 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' CD2' ' A' ' 59' ' ' TYR . . . 164.24 171.88 31.03 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -91.88 107.77 19.45 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.235 -1.156 . . . . 0.0 110.538 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.65 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.6 OUTLIER -95.47 157.56 15.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.96 -1.088 . . . . 0.0 110.487 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.4 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 49.2 m-20 -80.17 143.68 33.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 110.142 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.5 OUTLIER -166.22 156.42 12.36 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.948 . . . . 0.0 110.096 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -155.6 -178.58 7.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -0.984 . . . . 0.0 110.444 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.753 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -140.14 170.33 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 0.0 109.959 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 47.3 m-85 -147.27 159.45 43.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.344 -0.847 . . . . 0.0 110.192 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.47 ' HE3' ' CB ' ' A' ' 47' ' ' SER . 9.4 tppt? -67.81 145.81 54.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.948 . . . . 0.0 109.979 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.62 140.91 53.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.074 -1.016 . . . . 0.0 110.311 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 61.59 26.26 16.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.925 . . . . 0.0 110.112 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.422 ' OG1' ' HG3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -133.14 -154.67 0.62 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.389 -0.819 . . . . 0.0 110.058 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -126.18 -28.62 3.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.18 -0.95 . . . . 0.0 110.741 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.433 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -134.93 172.92 12.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.068 -1.02 . . . . 0.0 110.973 -179.63 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.481 HG21 ' HB2' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -75.54 142.24 42.83 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.507 -0.745 . . . . 0.0 109.352 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.47 ' CB ' ' HE3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -129.62 -17.9 3.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.06 -1.025 . . . . 0.0 112.122 -178.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 49' ' ' ALA . 12.2 mt -137.63 -71.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.757 -1.215 . . . . 0.0 110.781 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.552 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -47.25 -24.98 0.83 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.704 -0.623 . . . . 0.0 111.242 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.481 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.1 OUTLIER -67.3 -13.99 62.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.995 -1.066 . . . . 0.0 110.89 -179.682 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.412 ' C ' ' CD1' ' A' ' 52' ' ' TYR . 27.3 m-20 -88.83 -11.11 45.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 110.785 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 0.6 OUTLIER -119.16 7.4 11.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.022 -1.049 . . . . 0.0 110.71 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.402 ' CE2' HG12 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -109.7 106.93 16.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.034 -1.041 . . . . 0.0 110.42 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -72.4 153.54 41.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.131 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.63 159.19 44.94 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.107 -0.996 . . . . 0.0 109.985 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 57.2 Cg_endo -78.97 -175.93 17.66 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.752 -2.187 . . . . 0.0 110.681 -0.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -104.23 173.38 6.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 110.251 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.477 ' CB ' ' CG ' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -103.59 120.61 41.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.887 . . . . 0.0 110.349 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.524 ' CD1' ' HD2' ' A' ' 61' ' ' LYS . 11.6 p90 -97.79 159.14 15.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.95 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.587 HG23 ' HD1' ' A' ' 67' ' ' TYR . 1.1 tt -155.85 114.5 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 110.469 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.524 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -128.1 127.88 43.87 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.153 -0.967 . . . . 0.0 110.549 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.06 62.11 0.69 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.402 -0.811 . . . . 0.0 110.128 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.4 OUTLIER 46.99 98.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.531 -0.73 . . . . 0.0 111.19 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.1 -11.65 58.72 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -145.64 162.82 36.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.028 -1.277 . . . . 0.0 110.296 179.629 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.693 HD11 ' N ' ' A' ' 108' ' ' LYS . 1.6 pt? -168.32 144.99 3.92 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.151 -0.968 . . . . 0.0 111.358 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.587 ' HD1' HG23 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -139.44 -160.69 1.09 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 67' ' ' TYR . 1.2 t -170.18 129.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.204 -0.935 . . . . 0.0 110.206 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.477 ' CG ' ' CB ' ' A' ' 58' ' ' LYS . 3.0 pp0? -96.37 126.54 41.64 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.229 -0.92 . . . . 0.0 109.254 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -108.73 139.33 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 110.283 -179.121 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m -88.31 141.7 28.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.359 -0.838 . . . . 0.0 109.425 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.555 HG12 HG21 ' A' ' 78' ' ' ILE . 0.7 OUTLIER -119.75 135.43 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 110.609 -179.227 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -101.18 131.2 47.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.336 -0.852 . . . . 0.0 109.815 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.415 ' O ' HG22 ' A' ' 78' ' ' ILE . 3.8 m-70 55.85 102.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.216 -0.928 . . . . 0.0 110.181 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -31.1 65.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.941 . . . . 0.0 110.537 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -54.11 -59.51 4.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.972 . . . . 0.0 110.178 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.642 ' HA ' HD11 ' A' ' 121' ' ' ILE . 20.0 m0 -53.35 -66.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.925 . . . . 0.0 110.31 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 78' ' ' ILE . 19.2 tt -88.76 118.69 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.249 -0.907 . . . . 0.0 109.746 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.692 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -87.47 -24.79 24.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 111.662 -178.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 81' ' ' MET . . . -174.54 175.45 46.82 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.553 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.429 ' SD ' HD11 ' A' ' 78' ' ' ILE . 2.9 mpp? -150.95 111.3 4.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.595 -0.944 . . . . 0.0 110.16 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -86.23 159.94 19.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.031 -1.043 . . . . 0.0 109.603 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.672 HD12 ' CD1' ' A' ' 104' ' ' PHE . 1.2 mt -151.14 122.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -0.902 . . . . 0.0 110.534 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.463 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 70.49 3.31 4.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.484 -0.76 . . . . 0.0 111.424 179.598 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.09 20.36 9.32 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.548 -1.311 . . . . 0.0 111.092 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.483 ' HE1' ' HD1' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -136.66 157.32 47.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.699 -1.471 . . . . 0.0 110.148 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -171.05 0.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.519 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -110.42 170.56 8.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 110.108 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 102' ' ' SER . 3.9 t-20 -119.12 121.11 39.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 110.156 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.401 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 pp -67.22 103.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.062 -1.024 . . . . 0.0 109.48 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.433 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.8 tt -94.32 -27.76 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.444 -0.785 . . . . 0.0 110.767 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.9 m -166.71 98.54 0.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.164 -0.96 . . . . 0.0 109.879 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.425 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 14.7 ttmt -96.05 106.54 18.73 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.403 -0.81 . . . . 0.0 110.315 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.84 95.26 7.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 0.0 110.038 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.2 p -74.91 -26.05 59.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.28 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.17 -49.2 76.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.128 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -96.05 13.82 25.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.925 . . . . 0.0 110.447 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 53.16 63.16 2.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.096 -1.003 . . . . 0.0 110.128 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.93 173.8 12.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.331 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 72' ' ' VAL . 3.5 ttm180 -169.37 165.16 10.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 0.0 110.236 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 70' ' ' ILE . 94.9 m -143.99 151.9 40.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -0.845 . . . . 0.0 109.903 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.492 ' HG ' ' HZ ' ' A' ' 104' ' ' PHE . 2.9 p -145.14 140.17 27.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.941 -1.1 . . . . 0.0 110.912 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.58 141.14 28.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 0.0 110.109 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.672 ' CD1' HD12 ' A' ' 83' ' ' ILE . 87.8 m-85 -131.45 145.41 51.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.131 -0.981 . . . . 0.0 110.851 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -104.33 130.36 52.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.316 -0.865 . . . . 0.0 109.471 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.624 ' O ' HD21 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -150.03 150.89 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.982 -1.074 . . . . 0.0 110.881 -179.194 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.1 t -66.13 113.2 4.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.189 -0.944 . . . . 0.0 109.027 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.693 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 51.88 -178.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.324 -178.621 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.584 ' H ' HD12 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -150.0 58.13 0.97 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 0.0 111.554 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 11.3 t30 -145.28 58.83 1.28 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.841 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.32 174.43 44.59 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 141.43 33.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -1.111 . . . . 0.0 110.659 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 72.6 mt -137.7 150.86 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.371 -0.831 . . . . 0.0 109.735 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -76.21 126.75 31.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.155 -0.966 . . . . 0.0 110.568 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -132.64 172.29 21.32 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 82' ' ' SER . 10.7 mttt -144.07 167.51 22.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.126 -1.22 . . . . 0.0 109.413 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.524 ' O ' HD13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -158.5 145.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.983 -1.073 . . . . 0.0 110.52 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.692 ' C ' HG22 ' A' ' 79' ' ' THR . 1.7 m-20 -108.2 160.34 15.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.429 -0.794 . . . . 0.0 109.225 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -134.41 147.85 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 110.642 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 3.5 t80 -151.34 109.86 3.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.426 -0.796 . . . . 0.0 110.569 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.642 HD11 ' HA ' ' A' ' 77' ' ' TRP . 2.3 mp -140.58 152.97 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.411 -0.805 . . . . 0.0 109.871 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -160.38 102.35 1.39 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.027 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -174.11 -170.72 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.454 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.74 109.4 21.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.85 . . . . 0.0 110.17 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.5 t -76.7 107.09 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.362 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 50.37 42.42 25.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.877 . . . . 0.0 110.423 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.82 37.19 11.97 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 36.7 mtmt -145.24 99.33 4.58 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.236 -1.155 . . . . 0.0 109.97 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 128' ' ' LYS . 9.6 Cg_endo -59.04 130.11 34.99 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.674 1.355 . . . . 0.0 110.392 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -158.62 128.67 5.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 110.029 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -105.9 142.61 35.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.225 -0.922 . . . . 0.0 110.785 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.497 ' CE2' ' HB ' ' A' ' 119' ' ' VAL . 5.5 t80 -127.2 121.49 31.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.48 -0.763 . . . . 0.0 109.704 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -158.77 84.44 0.82 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.201 -0.937 . . . . 0.0 110.11 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.0 -169.62 3.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 110.419 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.443 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 13.4 p80 -120.28 159.29 25.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 110.309 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 57.4 m-85 -155.13 -178.82 7.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.347 -0.845 . . . . 0.0 109.907 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -150.66 161.2 43.06 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.039 -1.038 . . . . 0.0 110.885 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 137' ' ' ASN . 6.8 pt -155.59 173.34 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.544 -0.723 . . . . 0.0 109.642 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 43.3 m -91.79 116.36 28.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.162 -0.961 . . . . 0.0 111.089 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.753 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.4 m-85 -89.58 150.22 22.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 109.547 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.11 162.51 36.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.088 -1.007 . . . . 0.0 110.86 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.409 ' HB3' ' O ' ' A' ' 109' ' ' LEU . 26.9 m-85 -148.99 158.53 44.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.52 -0.738 . . . . 0.0 109.933 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.4 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 19.4 m120 -142.0 110.55 6.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.582 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.65 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -168.49 -145.95 4.78 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 11.3 Cg_endo . . . . . 0 C--N 1.309 -1.531 0 O-C-N 123.75 1.395 . . . . 0.0 109.986 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.009 0.433 . . . . 0.0 110.23 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -159.93 149.49 18.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.928 . . . . 0.0 110.292 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.7 176.83 39.21 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.95 103.05 15.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -1.13 . . . . 0.0 110.335 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.703 HD13 HD22 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -93.55 152.34 19.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 109.987 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.459 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 14.5 m-80 -78.35 144.86 35.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 110.125 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -165.09 156.96 15.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 110.058 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.1 -177.93 6.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.9 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.588 ' C ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.58 176.2 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.241 -0.912 . . . . 0.0 110.034 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 56.9 m-85 -148.67 161.91 40.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.413 -0.804 . . . . 0.0 109.954 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.2 OUTLIER -67.73 135.78 53.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 0.0 109.656 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.503 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -61.65 146.73 48.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 110.112 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER 70.54 4.58 5.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.793 -0.567 . . . . 0.0 110.723 -179.379 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -135.55 -164.52 1.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.92 -1.112 . . . . 0.0 109.576 179.286 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.422 ' N ' ' OG1' ' A' ' 43' ' ' THR . 6.3 m-80 -130.85 14.02 5.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 110.527 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -136.09 142.87 44.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.06 -1.025 . . . . 0.0 110.563 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.588 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -77.18 136.36 38.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.124 -0.985 . . . . 0.0 109.181 179.397 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.07 -17.78 3.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.01 -1.056 . . . . 0.0 112.048 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 51.8 mt -137.74 -68.81 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.79 -1.194 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -48.39 -24.5 1.26 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 111.201 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.531 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.1 OUTLIER -67.5 -14.15 62.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.961 -1.087 . . . . 0.0 110.891 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -102.19 15.16 29.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.056 -1.028 . . . . 0.0 110.902 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -127.51 -5.49 5.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.963 -1.086 . . . . 0.0 111.177 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 11.5 m-30 -110.39 112.85 25.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.948 -1.095 . . . . 0.0 110.518 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -72.77 109.75 6.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.284 -0.885 . . . . 0.0 110.129 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.402 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -93.39 164.06 22.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 110.161 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.402 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 56.2 Cg_endo -79.62 -175.82 17.2 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.452 -2.311 . . . . 0.0 110.693 -0.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -103.77 165.62 10.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 110.098 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -104.36 113.27 26.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.178 -0.951 . . . . 0.0 110.345 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.524 ' HA ' HG23 ' A' ' 68' ' ' VAL . 9.3 p90 -98.21 166.45 11.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.22 -0.925 . . . . 0.0 110.308 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.8 OUTLIER -155.67 158.93 3.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.585 -179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 18.0 mtmt -138.86 173.1 11.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 0.0 110.985 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.46 ' HB2' ' CD ' ' A' ' 65' ' ' LYS . 19.2 mtpt -155.53 62.15 0.61 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.577 -0.702 . . . . 0.0 109.535 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 47.96 84.3 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.539 -0.726 . . . . 0.0 111.177 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.06 19.45 36.31 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.809 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.758 ' C ' HD13 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -165.43 157.37 14.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.85 -1.383 . . . . 0.0 111.141 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.758 HD13 ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -160.47 155.92 25.15 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.169 0.985 . . . . 0.0 111.755 178.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 3.7 m-85 -141.89 -162.06 1.33 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.524 HG23 ' HA ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -170.68 138.88 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 120.97 -1.081 . . . . 0.0 110.712 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 7.0 pt20 -99.65 134.84 41.95 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.776 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -113.74 128.4 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.992 -179.739 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 71' ' ' THR . 0.9 OUTLIER -88.3 122.36 31.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.826 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -103.28 150.41 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.404 -0.81 . . . . 0.0 110.508 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -102.28 133.44 47.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.343 -0.848 . . . . 0.0 110.005 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 57.38 99.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.119 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.3 t -62.54 -44.06 97.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.879 . . . . 0.0 110.465 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -52.58 -38.35 59.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.915 . . . . 0.0 110.392 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.534 ' O ' HG12 ' A' ' 119' ' ' VAL . 45.5 m0 -68.46 -59.17 3.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -0.946 . . . . 0.0 110.243 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 78' ' ' ILE . 6.6 tp -88.44 118.04 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -0.918 . . . . 0.0 109.772 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.97 -25.38 24.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 110.99 -179.099 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.4 174.92 42.4 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.238 -1.458 . . . . 0.0 110.526 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -152.82 115.27 4.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.451 -1.029 . . . . 0.0 110.025 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.56 171.24 11.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 109.885 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.576 HD11 ' CZ ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -171.76 131.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.135 -0.978 . . . . 0.0 110.816 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HB3' ' NE2' ' A' ' 86' ' ' HIS . 0.9 OUTLIER 62.35 9.41 3.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.575 -0.703 . . . . 0.0 111.879 179.36 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.36 1.21 29.57 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.361 -1.399 . . . . 0.0 111.594 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.503 ' CD2' ' N ' ' A' ' 86' ' ' HIS . 3.3 p80 -135.6 154.17 51.43 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.577 -1.543 . . . . 0.0 110.847 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -167.17 0.17 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.454 -0.779 . . . . 0.0 110.421 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 8.1 pt-20 -107.68 170.22 8.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.193 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.34 134.32 55.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.246 -0.909 . . . . 0.0 110.396 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -67.83 103.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.126 -0.983 . . . . 0.0 109.514 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 92' ' ' SER . 2.0 tt -94.57 -29.49 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.865 . . . . 0.0 111.142 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.508 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -166.77 105.34 0.6 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.051 -1.03 . . . . 0.0 110.138 -179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.433 ' HG3' ' HG3' ' A' ' 100' ' ' ARG . 2.4 ttmm -96.07 108.82 21.29 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.394 -0.816 . . . . 0.0 110.244 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.54 86.71 4.2 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.067 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.07 -24.54 62.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.37 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.56 -53.47 54.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.078 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -97.46 19.2 13.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -0.881 . . . . 0.0 110.255 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 50.76 65.72 1.38 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 110.123 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -147.7 158.41 44.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.223 -0.923 . . . . 0.0 110.314 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.433 ' HG3' ' HG3' ' A' ' 93' ' ' LYS . 1.3 ttm180 -153.98 160.84 42.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -0.896 . . . . 0.0 110.038 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.501 ' O ' HG22 ' A' ' 91' ' ' ILE . 91.2 m -141.1 156.94 45.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.864 . . . . 0.0 109.856 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 84.7 p -145.65 143.41 29.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 110.699 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.08 135.98 33.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.354 -0.841 . . . . 0.0 109.912 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 39.1 m-85 -121.68 148.23 44.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.078 -1.014 . . . . 0.0 110.796 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.472 ' C ' HG13 ' A' ' 106' ' ' VAL . 3.9 mp0 -115.02 128.46 56.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.392 -0.818 . . . . 0.0 109.657 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.472 HG13 ' C ' ' A' ' 105' ' ' GLU . 35.0 m -149.62 -175.37 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.605 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.32 113.44 22.31 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.457 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 47.48 -158.6 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.46 -0.775 . . . . 0.0 109.343 -178.345 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.703 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.02 53.72 0.87 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.772 -1.205 . . . . 0.0 110.772 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -145.87 84.29 1.66 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.994 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.41 166.51 15.14 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -81.87 144.0 31.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -1.12 . . . . 0.0 110.429 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.1 mt -137.06 146.61 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 110.089 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -76.68 130.64 38.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.325 -0.859 . . . . 0.0 110.385 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -138.82 176.55 20.81 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.6 mttt -143.06 164.41 30.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -1.122 . . . . 0.0 109.42 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.477 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -158.65 142.36 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.912 -1.117 . . . . 0.0 110.921 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.683 ' O ' HG22 ' A' ' 79' ' ' THR . 5.3 m-20 -112.08 162.77 15.04 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.551 -0.718 . . . . 0.0 109.182 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -140.76 153.63 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.137 -0.977 . . . . 0.0 110.37 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -151.82 107.31 3.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 110.541 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' A' ' 132' ' ' TYR . 7.7 mt -130.72 151.47 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.242 -0.911 . . . . 0.0 109.855 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -159.15 104.37 1.68 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.217 -0.927 . . . . 0.0 109.855 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -172.66 -158.73 0.11 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 110.304 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -119.83 108.01 13.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.368 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 125' ' ' VAL . 1.4 t -76.93 117.96 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.928 . . . . 0.0 110.223 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.48 29.06 2.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.396 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 90.98 35.77 7.0 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.49 116.52 5.46 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 110.125 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.12 135.36 30.39 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.638 1.336 . . . . 0.0 110.266 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -136.25 113.38 10.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 110.316 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -104.0 122.77 45.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 110.122 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.507 ' CD2' HD12 ' A' ' 121' ' ' ILE . 3.9 t80 -131.72 128.58 39.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 109.886 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 55.4 t0 -173.39 94.14 0.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.158 -0.964 . . . . 0.0 110.369 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.86 -175.0 5.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.256 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -120.55 86.43 2.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.941 . . . . 0.0 110.136 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -84.48 -178.77 7.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.361 -0.837 . . . . 0.0 110.02 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 18.9 p30 -149.5 167.67 25.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 0.0 110.204 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.447 HG12 ' CG2' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -156.45 163.3 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 110.718 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.409 ' O ' HG12 ' A' ' 38' ' ' VAL . 81.9 m -92.15 125.41 36.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.489 -0.757 . . . . 0.0 110.406 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.576 ' CZ ' HD11 ' A' ' 83' ' ' ILE . 23.8 m-85 -90.39 165.11 14.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.204 -0.935 . . . . 0.0 110.371 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.21 101.54 1.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 110.315 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.427 ' CE1' HG11 ' A' ' 68' ' ' VAL . 59.3 m-85 -91.57 158.67 16.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.266 -0.897 . . . . 0.0 110.207 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.455 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 55.0 m-20 -143.46 96.98 3.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.223 -0.923 . . . . 0.0 110.604 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.597 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -154.23 -148.28 4.91 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo . . . . . 0 C--N 1.31 -1.491 0 O-C-N 123.804 1.423 . . . . 0.0 110.631 -179.786 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.932 0.396 . . . . 0.0 110.273 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 p -160.76 141.31 11.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.885 . . . . 0.0 110.347 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.25 -178.0 43.86 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.6 107.14 18.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.274 -1.133 . . . . 0.0 110.122 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.907 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -94.86 156.49 16.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.379 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 143' ' ' ASN . 2.8 m-20 -79.91 138.64 37.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.94 . . . . 0.0 110.369 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.687 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 1.2 p90 -164.91 150.75 10.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.349 -0.844 . . . . 0.0 110.006 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 38' ' ' VAL . 2.2 tt0 -155.02 156.46 35.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.869 . . . . 0.0 109.756 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.769 HG23 ' OG1' ' A' ' 46' ' ' THR . 28.1 m -101.08 174.71 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.17 -0.956 . . . . 0.0 110.638 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.471 ' HA ' ' CA ' ' A' ' 46' ' ' THR . 10.0 m-85 -148.12 156.18 42.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.516 -0.74 . . . . 0.0 109.746 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.433 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -67.59 133.59 49.68 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.221 -0.924 . . . . 0.0 109.592 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -63.73 147.14 52.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.991 -1.068 . . . . 0.0 109.864 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 5.5 t30 69.97 4.9 5.01 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.719 -0.613 . . . . 0.0 110.859 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.46 -167.23 2.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.94 -1.1 . . . . 0.0 109.718 179.422 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.411 ' N ' ' OG1' ' A' ' 43' ' ' THR . 24.7 m120 -130.56 14.34 5.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.109 -0.994 . . . . 0.0 110.426 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -135.03 116.86 15.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.083 -1.011 . . . . 0.0 110.402 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.769 ' OG1' HG23 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -54.65 134.42 47.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.991 -1.068 . . . . 0.0 108.972 179.327 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.73 -17.66 3.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.826 -1.171 . . . . 0.0 112.299 -178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.4 mt -137.78 -64.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.634 -1.291 . . . . 0.0 111.304 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.521 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -45.32 -27.92 0.74 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.619 -0.675 . . . . 0.0 111.43 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.456 ' CB ' ' CG2' ' A' ' 46' ' ' THR . 6.5 t-20 -71.91 -13.63 61.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.959 -1.088 . . . . 0.0 111.057 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.413 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 8.7 m-20 -90.05 14.95 11.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.063 -1.023 . . . . 0.0 110.863 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 51' ' ' ASP . 24.0 m-85 -143.05 11.56 1.79 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.042 -1.036 . . . . 0.0 110.856 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 24.0 m-85 -129.76 113.37 14.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 109.991 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -72.17 164.92 25.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.166 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -146.75 164.21 25.08 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 110.07 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.422 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 49.6 Cg_endo -79.53 -175.65 16.91 Favored 'Cis proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.332 -2.362 . . . . 0.0 110.558 -0.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.687 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.0 167.94 9.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.287 -0.883 . . . . 0.0 109.873 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -103.57 111.35 23.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.116 -0.99 . . . . 0.0 110.745 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.701 ' HA ' HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -96.35 162.85 13.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.001 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -154.28 155.93 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.085 -1.009 . . . . 0.0 110.528 -179.754 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.3 mtmp? -138.62 171.75 13.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.317 -0.865 . . . . 0.0 110.598 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.454 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . 12.1 mttp -162.03 61.66 0.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.394 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 60.91 91.66 0.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -0.839 . . . . 0.0 111.428 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.89 28.83 61.96 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.115 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.454 ' HD2' ' HB3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -170.59 162.71 8.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.892 -1.357 . . . . 0.0 111.207 179.434 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.865 HD21 ' H ' ' A' ' 108' ' ' LYS . 1.4 pt? -172.51 149.45 2.13 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 122.084 0.945 . . . . 0.0 111.38 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 1.2 m-85 -138.02 172.19 13.3 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.701 HG13 ' HA ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -142.72 142.09 26.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.933 -1.104 . . . . 0.0 110.441 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 102' ' ' SER . 6.3 pt20 -97.37 133.49 41.91 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.37 -0.831 . . . . 0.0 109.572 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.2 OUTLIER -111.99 138.55 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -0.82 . . . . 0.0 110.153 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 m -88.36 129.48 35.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.244 -0.91 . . . . 0.0 109.769 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.625 HG13 HD13 ' A' ' 78' ' ' ILE . 2.8 t -102.99 127.21 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 110.405 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -99.42 133.25 44.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 110.017 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.0 m80 54.8 98.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.158 -0.964 . . . . 0.0 110.063 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.3 p -64.15 -25.8 68.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.392 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -65.37 -56.85 10.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.48 ' O ' HG12 ' A' ' 119' ' ' VAL . 36.7 m0 -51.06 -65.11 0.61 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.21 -0.931 . . . . 0.0 110.177 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.631 HD11 ' HG3' ' A' ' 81' ' ' MET . 10.0 tt -89.27 120.79 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.331 -0.856 . . . . 0.0 109.845 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.668 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -86.93 -23.09 25.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 110.867 -179.341 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.99 -179.36 48.8 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.509 -1.329 . . . . 0.0 109.99 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.631 ' HG3' HD11 ' A' ' 78' ' ' ILE . 58.8 mtm -152.34 171.07 18.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -1.073 . . . . 0.0 110.292 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 116' ' ' LYS . 10.3 t -155.18 172.04 18.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.295 -0.878 . . . . 0.0 109.909 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.47 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -168.01 140.05 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.092 -1.005 . . . . 0.0 110.763 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.481 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 2.0 mt-10 61.94 10.23 3.46 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.477 -0.764 . . . . 0.0 111.749 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.67 0.51 30.66 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.362 -1.399 . . . . 0.0 111.093 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.481 ' NE2' ' CB ' ' A' ' 84' ' ' GLU . 3.6 p80 -132.56 154.55 49.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.645 -1.503 . . . . 0.0 110.519 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -162.41 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.516 -0.74 . . . . 0.0 110.173 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.491 ' CB ' ' CZ ' ' A' ' 104' ' ' PHE . 12.1 pt-20 -107.61 169.27 8.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 110.107 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -106.0 127.32 53.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.152 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.76 102.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.139 -0.976 . . . . 0.0 109.673 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 101' ' ' THR . 0.9 OUTLIER -94.74 -30.58 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 110.936 -179.201 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.409 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 54.4 p -167.15 103.89 0.54 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.091 -1.006 . . . . 0.0 109.986 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.456 ' HG3' ' CG ' ' A' ' 100' ' ' ARG . 21.4 ttmt -95.04 112.09 23.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 110.129 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -96.4 68.89 2.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.159 -0.963 . . . . 0.0 110.295 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.15 -29.05 56.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 110.266 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.51 -52.18 62.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.554 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -95.21 18.6 12.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -0.893 . . . . 0.0 110.552 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 51.0 61.32 3.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 110.21 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -147.14 169.89 18.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 110.024 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.456 ' CG ' ' HG3' ' A' ' 93' ' ' LYS . 0.8 OUTLIER -165.77 160.53 17.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.93 . . . . 0.0 110.328 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.502 ' O ' HG22 ' A' ' 91' ' ' ILE . 87.6 m -141.31 147.22 37.81 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.568 -0.708 . . . . 0.0 109.393 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 3.7 p -145.53 141.8 28.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.034 -1.041 . . . . 0.0 110.842 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 5.2 tt0 -92.49 145.48 24.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.531 -0.731 . . . . 0.0 109.682 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CZ ' ' CB ' ' A' ' 88' ' ' GLU . 30.4 m-85 -126.48 141.44 51.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.117 -0.989 . . . . 0.0 111.01 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.417 ' C ' HG13 ' A' ' 106' ' ' VAL . 38.0 tt0 -102.49 124.67 48.47 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.494 -0.754 . . . . 0.0 109.393 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.417 HG13 ' C ' ' A' ' 105' ' ' GLU . 16.6 m -149.45 138.03 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.016 -1.053 . . . . 0.0 111.038 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.68 101.53 0.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 108.945 178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.865 ' H ' HD21 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 53.65 176.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.378 -178.607 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.515 HD22 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.18 83.22 1.38 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.85 -1.156 . . . . 0.0 111.218 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 145' ' ' PRO . 13.6 t-20 -144.71 75.42 1.45 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.953 . . . . 0.0 110.15 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.32 -109.26 0.41 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HB3' ' HG2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -157.58 150.91 23.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -1.171 . . . . 0.0 110.437 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -136.14 147.02 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.436 -0.79 . . . . 0.0 109.827 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -75.83 114.26 14.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.997 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.94 179.21 16.57 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 27.1 mttp -144.08 160.69 40.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 0.0 109.9 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.675 HG21 HD11 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.29 146.45 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.975 . . . . 0.0 110.4 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.668 ' C ' HG22 ' A' ' 79' ' ' THR . 1.1 m-20 -105.57 156.3 18.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.414 -0.804 . . . . 0.0 109.405 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.583 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -131.97 146.0 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.159 -0.963 . . . . 0.0 110.44 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 1.1 t80 -151.6 109.3 3.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.37 -0.831 . . . . 0.0 110.246 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 54.8 mt -133.86 152.85 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.4 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 8.0 p-10 -160.46 95.28 1.11 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.81 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -174.26 -176.46 1.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 110.263 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -95.05 103.09 14.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 110.062 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.4 t -76.44 106.55 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.296 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.06 29.26 16.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 110.184 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.97 32.85 10.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.33 115.2 4.93 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.327 -1.102 . . . . 0.0 110.161 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -52.47 116.56 2.93 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.534 1.281 . . . . 0.0 110.187 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.473 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 5.7 t80 -116.0 122.51 45.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.691 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.83 122.02 44.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -0.879 . . . . 0.0 109.921 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.583 ' HE2' HG11 ' A' ' 119' ' ' VAL . 1.7 t80 -138.73 119.71 14.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.894 . . . . 0.0 110.169 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -168.53 85.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.127 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.25 -160.56 1.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.28 -0.887 . . . . 0.0 110.316 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.44 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -120.08 147.66 44.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.229 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 22.7 m-85 -155.68 -178.65 7.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.873 . . . . 0.0 109.997 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 9.7 p30 -149.82 169.18 21.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 0.0 110.671 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.675 HD11 HG21 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -156.18 162.61 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 110.322 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 49.6 m -91.86 118.21 30.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.321 -0.862 . . . . 0.0 110.932 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.484 ' HD1' HG12 ' A' ' 38' ' ' VAL . 13.2 m-85 -90.91 101.43 14.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.274 -0.891 . . . . 0.0 110.017 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.43 ' HG2' ' HB3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -87.74 103.49 15.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.087 -1.008 . . . . 0.0 110.526 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 140' ' ' TYR . 60.6 m-85 -92.67 153.28 19.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 110.186 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 5.2 m120 -141.52 103.2 4.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.153 -0.967 . . . . 0.0 110.331 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.907 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -156.46 -149.74 5.45 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.541 ' HD2' HD11 ' A' ' 34' ' ' LEU . 12.2 Cg_endo . . . . . 0 C--N 1.309 -1.533 0 O-C-N 123.984 1.518 . . . . 0.0 110.43 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.933 0.397 . . . . 0.0 110.41 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -160.43 139.82 10.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 110.486 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.93 178.05 43.58 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.58 109.03 19.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.293 -1.122 . . . . 0.0 110.252 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.819 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.6 OUTLIER -94.99 153.21 17.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.266 -0.896 . . . . 0.0 110.805 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -81.05 135.56 35.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.85 . . . . 0.0 110.243 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.933 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -166.47 161.77 16.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.993 -1.067 . . . . 0.0 110.129 179.379 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -155.12 -165.61 2.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 0.0 110.356 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 139' ' ' THR . 0.0 OUTLIER -139.06 169.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.419 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 31.3 m-85 -148.32 159.82 43.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.316 -0.865 . . . . 0.0 109.907 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.427 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.4 OUTLIER -67.97 135.74 52.83 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.336 -0.852 . . . . 0.0 109.734 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.467 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -64.52 146.89 53.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.074 -1.016 . . . . 0.0 109.762 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER 70.91 4.12 4.92 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.84 -0.537 . . . . 0.0 110.71 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.442 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -138.61 -167.53 2.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.944 -1.097 . . . . 0.0 109.498 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.442 ' N ' ' OG1' ' A' ' 43' ' ' THR . 37.4 m-80 -133.27 18.42 4.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.989 -1.069 . . . . 0.0 110.464 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -136.37 117.61 14.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.55 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.5 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -52.8 134.49 36.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.066 . . . . 0.0 109.261 179.352 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.35 -18.01 3.68 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.169 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.2 mt -138.1 -50.29 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.634 -1.291 . . . . 0.0 111.194 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HA ' ' HB3' ' A' ' 52' ' ' TYR . . . -80.95 7.71 10.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.49 -0.756 . . . . 0.0 111.532 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.459 ' O ' ' CE1' ' A' ' 53' ' ' PHE . 1.1 p-10 -69.32 -35.73 76.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.809 -1.182 . . . . 0.0 110.461 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -103.16 15.31 29.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.202 -0.936 . . . . 0.0 110.892 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.409 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -93.01 -8.38 43.14 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.966 -1.083 . . . . 0.0 111.021 -179.6 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.533 ' CE1' ' CG2' ' A' ' 38' ' ' VAL . 31.9 p90 -127.07 126.14 42.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.003 -1.061 . . . . 0.0 110.719 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.571 ' HB3' HG21 ' A' ' 71' ' ' THR . 19.7 t-20 -73.95 104.39 4.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.024 -1.047 . . . . 0.0 109.883 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 1.6 pttt -92.58 164.96 20.48 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 110.125 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.435 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 50.1 Cg_endo -77.92 -177.58 21.52 Favored 'Cis proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.519 -2.284 . . . . 0.0 110.569 -0.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.933 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -103.1 167.47 9.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.962 . . . . 0.0 110.25 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.461 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -102.95 114.51 28.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 110.09 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.0 p90 -96.98 162.21 13.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 110.056 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -154.97 155.13 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 110.311 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 24.6 mtmt -137.73 170.78 15.46 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.332 -0.855 . . . . 0.0 110.85 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.444 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -155.98 62.43 0.58 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.655 -0.653 . . . . 0.0 109.745 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.23 92.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.327 -0.858 . . . . 0.0 110.992 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.7 27.19 54.77 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.258 -0.972 . . . . 0.0 110.763 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.444 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 7.9 ptpt -171.81 158.51 4.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.972 -1.311 . . . . 0.0 111.0 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.868 HD21 ' H ' ' A' ' 108' ' ' LYS . 1.7 pt? -170.72 147.11 2.75 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.166 0.984 . . . . 0.0 111.615 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -138.32 171.37 14.49 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.473 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.83 143.27 24.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.975 -1.078 . . . . 0.0 109.971 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.461 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -97.0 135.67 38.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.24 -0.913 . . . . 0.0 110.087 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.2 OUTLIER -110.9 140.14 31.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.388 -0.82 . . . . 0.0 109.63 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.571 HG21 ' HB3' ' A' ' 54' ' ' ASN . 1.8 m -87.86 138.4 31.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.132 -0.98 . . . . 0.0 110.223 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.65 ' CG1' HG21 ' A' ' 78' ' ' ILE . 15.5 t -103.16 122.28 55.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.462 -0.774 . . . . 0.0 109.991 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.98 130.37 46.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 110.268 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.526 ' O ' HG22 ' A' ' 78' ' ' ILE . 4.8 t60 57.7 94.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.254 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t -71.79 -12.23 61.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.909 . . . . 0.0 110.593 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -74.64 -26.1 59.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.103 -0.998 . . . . 0.0 110.345 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.481 ' O ' HG12 ' A' ' 119' ' ' VAL . 21.3 m0 -94.17 -47.34 6.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 0.0 110.39 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.65 HG21 ' CG1' ' A' ' 72' ' ' VAL . 6.8 tp -88.46 115.98 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.118 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.585 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -87.41 -23.06 24.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.356 -0.84 . . . . 0.0 110.442 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.55 178.17 48.54 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.463 ' HE3' ' HB3' ' A' ' 102' ' ' SER . 0.0 OUTLIER -152.9 161.14 42.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -1.074 . . . . 0.0 110.194 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 116' ' ' LYS . 2.4 t -155.12 149.67 26.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.032 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.568 HD12 ' CD2' ' A' ' 104' ' ' PHE . 4.8 mt -141.83 144.41 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 110.427 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 69.67 3.85 4.44 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.498 -0.751 . . . . 0.0 111.119 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.55 20.79 21.21 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.718 -1.23 . . . . 0.0 111.116 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.665 ' HE1' ' HD1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -137.04 163.31 31.05 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.713 -1.463 . . . . 0.0 110.174 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -177.69 1.85 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.108 -0.995 . . . . 0.0 110.31 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -110.01 169.61 8.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.347 -0.846 . . . . 0.0 110.209 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.64 124.95 53.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.948 . . . . 0.0 110.191 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pp -67.43 102.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 109.796 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 101' ' ' THR . 1.8 tt -95.19 -28.12 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.388 -0.82 . . . . 0.0 110.784 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 3.9 m -166.77 101.04 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.194 -0.941 . . . . 0.0 109.734 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -94.96 152.09 18.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.444 -0.785 . . . . 0.0 110.336 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -144.38 83.46 1.72 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 110.16 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 p -70.55 -27.05 63.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 110.326 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.59 -52.75 62.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 0.0 110.064 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.5 mtmm -96.21 17.75 15.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.311 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 51.97 60.27 3.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 110.249 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 94' ' ' ASN . 34.0 mt-10 -148.28 167.39 25.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 110.47 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.473 ' CG ' ' N ' ' A' ' 101' ' ' THR . 33.7 ttt180 -174.56 167.45 3.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.388 -0.82 . . . . 0.0 109.682 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.473 ' N ' ' CG ' ' A' ' 100' ' ' ARG . 94.9 m -141.44 153.95 45.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.962 . . . . 0.0 109.837 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.463 ' HB3' ' HE3' ' A' ' 81' ' ' MET . 83.6 p -145.38 141.1 28.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.112 -0.992 . . . . 0.0 110.68 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.32 146.65 23.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.896 . . . . 0.0 109.991 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.665 ' HD1' ' HE1' ' A' ' 86' ' ' HIS . 45.8 m-85 -129.14 147.74 51.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 0.0 110.675 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.489 ' C ' HG13 ' A' ' 106' ' ' VAL . 35.7 tt0 -105.53 125.83 51.43 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.384 -0.823 . . . . 0.0 109.789 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.489 HG13 ' C ' ' A' ' 105' ' ' GLU . 33.8 m -150.16 152.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.968 . . . . 0.0 110.956 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.2 m -71.95 105.93 4.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.276 -0.89 . . . . 0.0 109.291 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.868 ' H ' HD21 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 50.23 -178.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.494 -0.754 . . . . 0.0 109.734 -178.682 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.742 HD22 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -151.22 81.93 1.31 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.824 -1.172 . . . . 0.0 110.996 -179.385 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.61 67.71 1.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 110.191 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 162.57 -109.91 0.41 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.417 ' HB2' ' HG2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -157.19 148.1 21.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -1.118 . . . . 0.0 109.65 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 63.9 mt -136.27 150.74 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.902 . . . . 0.0 110.274 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.92 131.95 38.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.356 -0.84 . . . . 0.0 110.114 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -138.08 178.97 18.8 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 3.3 mtpp -144.6 164.46 30.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -1.179 . . . . 0.0 110.08 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.547 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.86 141.55 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.07 -1.019 . . . . 0.0 110.694 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.585 ' C ' HG22 ' A' ' 79' ' ' THR . 6.1 m-20 -104.12 152.46 22.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.268 -0.895 . . . . 0.0 109.72 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.2 OUTLIER -128.71 154.09 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.132 -0.98 . . . . 0.0 110.345 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -151.55 102.45 2.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.21 -0.931 . . . . 0.0 110.738 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 3.8 mt -133.38 152.88 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.324 -0.86 . . . . 0.0 110.097 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.34 95.38 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.981 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 129' ' ' PRO . 19.1 pt-20 -174.81 -156.38 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 110.248 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.433 ' HG2' ' CA ' ' A' ' 129' ' ' PRO . 11.7 mttt -122.46 120.99 35.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.28 -0.887 . . . . 0.0 110.25 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.702 HG23 ' CE1' ' A' ' 130' ' ' PHE . 89.6 t -76.91 92.33 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 110.363 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.31 31.48 11.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.269 -0.895 . . . . 0.0 110.302 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.23 35.58 2.29 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 3.7 mtmt -145.43 85.44 7.94 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.358 -1.084 . . . . 0.0 110.124 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.433 ' CA ' ' HG2' ' A' ' 124' ' ' LYS . 11.3 Cg_endo -59.3 129.49 31.65 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.983 1.517 . . . . 0.0 110.287 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.702 ' CE1' HG23 ' A' ' 125' ' ' VAL . 7.6 p90 -156.14 139.85 16.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 110.452 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -105.36 131.9 52.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.391 -0.818 . . . . 0.0 110.007 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.445 ' HB3' ' HB ' ' A' ' 121' ' ' ILE . 5.9 t80 -131.47 129.92 41.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.0 110.138 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 16.6 t0 -174.44 89.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.343 -0.848 . . . . 0.0 110.064 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.83 -168.42 3.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 110.188 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.17 85.93 2.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.407 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -85.01 -178.98 6.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 109.796 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.65 ' O ' HG23 ' A' ' 138' ' ' ILE . 29.2 p30 -150.42 168.98 22.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.025 -1.047 . . . . 0.0 110.654 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 137' ' ' ASN . 2.3 pt -157.83 173.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.324 -0.86 . . . . 0.0 110.784 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.76 ' O ' HG12 ' A' ' 38' ' ' VAL . 90.8 m -92.01 163.6 13.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.622 -0.674 . . . . 0.0 110.282 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.524 ' CD1' ' CG1' ' A' ' 38' ' ' VAL . 97.3 m-85 -141.79 100.49 3.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 109.643 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 2.0 mttt -82.5 108.95 16.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 110.833 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -92.17 140.65 29.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.99 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -129.64 96.04 4.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 110.339 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.819 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -149.14 -152.68 5.79 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo . . . . . 0 C--N 1.308 -1.582 0 O-C-N 123.943 1.496 . . . . 0.0 110.356 -179.908 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 5.9 m-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.969 0.414 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.43 153.34 25.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.105 -0.997 . . . . 0.0 110.532 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.431 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 172.18 170.1 35.67 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.482 HG23 ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -88.25 111.08 21.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -1.117 . . . . 0.0 110.152 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.058 HD13 HD22 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -94.78 155.39 16.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 0.0 110.646 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 27.2 t30 -81.6 137.83 35.45 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.355 -0.84 . . . . 0.0 109.693 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.833 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -167.98 163.72 13.7 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.992 -1.067 . . . . 0.0 110.587 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.05 -168.33 2.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.37 -0.831 . . . . 0.0 109.823 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.748 ' O ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -139.82 -178.42 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.971 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.417 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 15.4 m-85 -149.22 150.71 33.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 110.047 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.413 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.5 OUTLIER -67.56 127.83 34.19 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.397 -0.814 . . . . 0.0 109.87 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.48 ' O ' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -55.9 147.27 19.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.142 -0.973 . . . . 0.0 109.921 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER 72.32 1.18 3.86 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.865 -0.522 . . . . 0.0 110.792 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.29 -166.49 1.94 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.873 -1.142 . . . . 0.0 109.559 179.192 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.408 ' N ' ' OG1' ' A' ' 43' ' ' THR . 23.0 m-80 -133.34 16.14 4.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -136.54 121.82 19.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.481 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.748 HG23 ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -51.15 132.25 28.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 109.226 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.459 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -128.98 -17.58 3.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.889 -1.132 . . . . 0.0 111.926 -178.746 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.459 HD12 ' HB3' ' A' ' 47' ' ' SER . 1.8 mp -137.5 -75.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.827 -1.17 . . . . 0.0 110.572 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 52' ' ' TYR . . . -47.48 -24.99 0.95 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.679 -0.638 . . . . 0.0 110.928 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.443 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.7 OUTLIER -46.65 -34.31 4.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.242 -0.911 . . . . 0.0 111.134 -179.597 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -102.19 15.76 28.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.044 -1.035 . . . . 0.0 110.986 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.52 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -99.25 -15.89 18.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.015 -1.053 . . . . 0.0 110.971 -179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.501 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 21.3 p90 -118.6 128.39 54.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.928 -1.108 . . . . 0.0 110.993 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -74.97 114.42 13.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.095 -1.003 . . . . 0.0 109.91 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.75 159.64 35.8 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.036 . . . . 0.0 109.994 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -81.45 -175.28 15.37 Favored 'Cis proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.643 -2.232 . . . . 0.0 110.667 -0.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.833 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.45 172.81 6.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.197 -0.939 . . . . 0.0 110.041 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HD2' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -106.31 116.6 32.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.25 -0.906 . . . . 0.0 111.076 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.48 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 6.9 p90 -98.14 161.77 13.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.237 -0.915 . . . . 0.0 109.523 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.537 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -155.42 122.08 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.951 -1.093 . . . . 0.0 111.034 -179.551 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.473 ' HD3' HD21 ' A' ' 109' ' ' LEU . 1.6 mtmt -139.39 131.52 28.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.0 110.212 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -109.21 62.42 0.6 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.196 -0.94 . . . . 0.0 110.441 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 62' ' ' LYS . 14.0 t-20 49.62 100.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.402 -0.811 . . . . 0.0 111.119 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.26 -17.96 56.17 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HB2' ' OH ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -140.43 152.8 45.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.154 -1.203 . . . . 0.0 110.201 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.812 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -155.07 142.81 19.87 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.938 0.875 . . . . 0.0 111.012 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.537 ' HB2' HG23 ' A' ' 60' ' ' ILE . 5.7 m-85 -140.03 -170.15 2.89 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.54 -0.725 . . . . 0.0 109.352 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -162.06 165.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.098 -1.001 . . . . 0.0 109.882 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 102' ' ' SER . 1.3 pt20 -140.45 143.66 35.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.198 -0.938 . . . . 0.0 110.472 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -115.56 128.51 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.335 -0.853 . . . . 0.0 110.258 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.7 m -88.83 124.33 34.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.482 HG11 ' CE ' ' A' ' 81' ' ' MET . 0.8 OUTLIER -102.68 138.93 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 110.386 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -101.0 135.03 43.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.325 -0.859 . . . . 0.0 110.238 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.439 ' O ' HG22 ' A' ' 78' ' ' ILE . 6.1 m80 60.4 102.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.295 -0.878 . . . . 0.0 110.036 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 t -64.47 -33.44 75.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.887 . . . . 0.0 110.377 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -52.49 -57.78 8.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 110.257 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.533 ' HA ' HD11 ' A' ' 121' ' ' ILE . 13.2 m0 -55.62 -62.52 1.63 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 110.382 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 78' ' ' ILE . 2.9 tp -88.78 114.01 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 109.97 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.79 -26.28 24.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 110.782 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.46 174.89 45.67 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.074 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.482 ' CE ' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -152.28 163.23 39.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -1.042 . . . . 0.0 109.962 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -155.66 167.62 29.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.824 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.601 HD11 ' CD1' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -164.62 154.13 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 110.033 179.825 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.454 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 59.74 15.02 4.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.049 -1.032 . . . . 0.0 110.859 179.725 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.28 23.23 55.14 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.031 -1.081 . . . . 0.0 110.976 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 83' ' ' ILE . 2.3 p80 -138.27 161.58 36.51 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.67 -1.488 . . . . 0.0 110.623 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.27 179.35 2.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.851 . . . . 0.0 110.971 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 2.1 pt-20 -99.39 170.13 8.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 110.663 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 102' ' ' SER . 2.2 t30 -116.78 133.73 55.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.476 -0.765 . . . . 0.0 109.468 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.589 HG22 ' NH2' ' A' ' 100' ' ' ARG . 1.1 pp -67.45 101.53 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.954 -1.092 . . . . 0.0 109.871 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.5 HG21 HG22 ' A' ' 101' ' ' THR . 0.5 OUTLIER -95.41 -31.22 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.838 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.418 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 11.0 m -166.73 95.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.109 -0.994 . . . . 0.0 110.009 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -95.9 95.3 8.15 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.478 -0.763 . . . . 0.0 110.156 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -97.09 91.25 5.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.175 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.73 -27.64 60.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 110.202 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.61 -45.37 93.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -0.936 . . . . 0.0 110.129 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.93 18.7 12.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.31 -0.869 . . . . 0.0 110.23 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 t0 50.48 61.75 3.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 110.043 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -148.09 166.72 26.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 110.515 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.589 ' NH2' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -168.93 147.71 4.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.453 -0.779 . . . . 0.0 109.533 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.5 HG22 HG21 ' A' ' 91' ' ' ILE . 62.9 m -141.55 158.22 44.12 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.163 -0.96 . . . . 0.0 109.867 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 81.3 p -145.06 143.45 30.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 110.375 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 1.5 tm-20 -92.6 141.26 28.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 110.2 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -123.81 148.65 46.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.279 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -98.3 132.29 43.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.37 -0.832 . . . . 0.0 110.075 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.558 HG13 HD21 ' A' ' 66' ' ' LEU . 8.9 p -149.08 166.88 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.202 -0.936 . . . . 0.0 110.245 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 106' ' ' VAL . 1.5 t -69.63 -35.3 75.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 109.846 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.461 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -164.5 -148.9 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.503 -0.748 . . . . 0.0 109.325 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 1.058 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.06 51.92 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.726 -1.234 . . . . 0.0 111.232 -179.577 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 12.9 t-20 -146.31 70.23 1.22 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.099 -1.001 . . . . 0.0 110.492 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 142' ' ' PHE . . . 172.12 -129.25 1.7 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.467 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.0 OUTLIER -156.65 140.87 16.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.323 -1.104 . . . . 0.0 109.839 -179.771 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.467 ' CD1' HG23 ' A' ' 106' ' ' VAL . 2.5 mt -135.33 153.87 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.164 -0.96 . . . . 0.0 110.019 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -76.2 137.08 39.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.076 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 83' ' ' ILE . . . -137.35 177.23 20.0 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 82' ' ' SER . 16.7 mttt -144.14 156.16 44.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -1.139 . . . . 0.0 109.76 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.585 ' O ' HD13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -157.73 151.16 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.006 -1.059 . . . . 0.0 110.578 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.621 ' O ' HG22 ' A' ' 79' ' ' THR . 0.9 OUTLIER -112.14 158.37 19.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.412 -0.805 . . . . 0.0 109.386 179.357 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.481 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -129.77 148.35 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -0.976 . . . . 0.0 110.053 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.78 102.24 2.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 110.769 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.533 HD11 ' HA ' ' A' ' 77' ' ' TRP . 2.6 mp -133.72 151.9 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -0.987 . . . . 0.0 110.162 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 1.2 p-10 -160.57 98.45 1.24 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.354 -0.842 . . . . 0.0 109.73 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -173.75 -156.95 0.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 110.553 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.586 ' O ' HG23 ' A' ' 125' ' ' VAL . 18.6 mtpt -91.27 165.22 13.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.416 -0.803 . . . . 0.0 110.608 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 124' ' ' LYS . 47.6 t -157.88 99.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 67.18 25.83 8.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.531 -0.731 . . . . 0.0 109.611 -178.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 86.53 34.25 12.18 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 0.6 OUTLIER -147.89 134.25 9.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.22 -1.165 . . . . 0.0 110.303 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 128' ' ' LYS . 20.5 Cg_exo -60.85 129.09 27.64 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.581 1.306 . . . . 0.0 110.141 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' A' ' 132' ' ' TYR . 46.2 t80 -121.01 145.8 47.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.167 -0.958 . . . . 0.0 110.385 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -136.08 118.21 15.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.211 -0.931 . . . . 0.0 110.146 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.485 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . 3.7 t80 -129.73 131.47 46.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 109.804 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -177.37 87.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.04 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.66 -163.9 1.76 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 0.0 110.536 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.461 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 4.2 p80 -118.69 143.66 46.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 135' ' ' HIS . 13.0 m-85 -154.85 -179.45 8.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 110.117 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.62 ' O ' HG23 ' A' ' 138' ' ' ILE . 1.7 p30 -152.1 172.11 16.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 0.0 110.584 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.62 HG23 ' O ' ' A' ' 137' ' ' ASN . 3.9 pt -157.17 162.93 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.844 . . . . 0.0 110.173 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.467 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 45.1 m -92.0 126.92 37.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 110.594 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.601 ' CD1' HD11 ' A' ' 83' ' ' ILE . 14.4 m-85 -89.48 154.23 20.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -0.949 . . . . 0.0 109.654 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -137.89 105.52 5.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.041 -1.037 . . . . 0.0 110.397 -179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.47 ' HB3' ' CA ' ' A' ' 109' ' ' LEU . 31.7 m-85 -91.99 134.72 34.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 0.0 110.374 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 8.7 m120 -132.11 103.56 6.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 0.0 110.311 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.898 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -164.71 -150.38 6.15 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.742 ' HD2' HD11 ' A' ' 34' ' ' LEU . 9.4 Cg_endo . . . . . 0 C--N 1.308 -1.601 0 O-C-N 123.765 1.402 . . . . 0.0 110.457 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 25.4 m-20 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 120.816 0.341 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 59' ' ' TYR . 15.1 t -160.39 169.68 22.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 110.789 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.9 171.71 25.06 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.69 105.18 17.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.1 -1.235 . . . . 0.0 110.217 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.838 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -94.21 156.05 16.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 110.414 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.411 ' O ' ' N ' ' A' ' 143' ' ' ASN . 14.9 m-20 -79.86 140.83 36.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.214 -0.929 . . . . 0.0 109.738 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.664 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -165.91 158.18 14.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.98 . . . . 0.0 110.181 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -155.37 -168.89 2.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.258 -0.901 . . . . 0.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.473 ' C ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.07 173.97 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 109.796 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.402 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 27.6 m-85 -148.22 156.48 42.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 110.491 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 128.93 38.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.528 -0.732 . . . . 0.0 109.766 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.508 ' CE2' ' ND2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -58.18 148.26 27.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.098 -1.001 . . . . 0.0 109.879 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 11.0 m-20 71.08 2.44 4.24 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.816 -0.552 . . . . 0.0 110.961 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.96 -165.49 1.75 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.944 -1.098 . . . . 0.0 109.684 179.221 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.409 ' N ' ' OG1' ' A' ' 43' ' ' THR . 64.1 t30 -133.86 16.13 3.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 110.19 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -136.01 118.31 15.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 110.583 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.473 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -51.37 128.61 23.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.988 . . . . 0.0 109.099 179.247 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.49 -16.13 3.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.008 -1.058 . . . . 0.0 112.222 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.18 -64.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.792 -1.193 . . . . 0.0 110.907 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.49 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -52.39 -21.9 4.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.452 -0.78 . . . . 0.0 111.147 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -8.97 46.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.054 -1.029 . . . . 0.0 110.951 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.404 ' C ' ' CG ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -97.78 8.49 44.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.013 -1.055 . . . . 0.0 110.913 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.404 ' CG ' ' C ' ' A' ' 51' ' ' ASP . 7.1 m-85 -142.44 17.3 2.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.966 -1.084 . . . . 0.0 110.342 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -119.49 107.22 13.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.439 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -72.88 155.09 40.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 110.249 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.425 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -146.68 167.22 14.3 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.121 -0.987 . . . . 0.0 110.026 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.425 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 49.8 Cg_endo -77.06 -175.31 16.47 Favored 'Cis proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.681 -2.216 . . . . 0.0 110.481 -0.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.664 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -100.4 162.43 12.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 109.975 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.463 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . 0.5 OUTLIER -102.08 117.03 33.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.304 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.489 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.7 p90 -97.51 160.95 14.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 109.776 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.504 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -155.35 127.42 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.056 -1.028 . . . . 0.0 110.559 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HG2' ' CB ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -136.61 119.36 16.15 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.206 -0.934 . . . . 0.0 110.783 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.2 OUTLIER -96.01 62.05 2.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.384 -0.822 . . . . 0.0 110.393 179.62 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.403 ' O ' ' O ' ' A' ' 62' ' ' LYS . 41.3 t30 46.62 99.17 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.58 -0.7 . . . . 0.0 111.407 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.83 5.03 54.15 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.436 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.714 ' C ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.58 158.91 16.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.894 -1.357 . . . . 0.0 110.199 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.803 ' N ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -155.13 149.81 26.46 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 122.171 0.986 . . . . 0.0 111.199 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.519 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 5.0 m-85 -142.74 -164.71 1.89 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.388 -0.82 . . . . 0.0 109.242 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.441 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -170.56 134.12 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.082 -1.011 . . . . 0.0 110.102 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -97.59 134.15 41.18 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.157 -0.965 . . . . 0.0 109.568 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.1 OUTLIER -112.81 137.64 45.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.864 -179.476 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.5 m -88.6 135.17 33.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 109.972 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.846 HG22 ' CE ' ' A' ' 81' ' ' MET . 3.4 t -102.38 123.98 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.283 -0.886 . . . . 0.0 109.943 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -98.31 126.85 43.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.247 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.637 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER 62.36 99.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 110.328 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -32.62 66.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 110.09 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -58.95 -41.63 87.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.16 -0.963 . . . . 0.0 110.041 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.656 ' O ' HG12 ' A' ' 119' ' ' VAL . 45.1 m0 -71.48 -62.11 1.53 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.375 -0.828 . . . . 0.0 110.128 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 74' ' ' HIS . 9.9 tt -89.3 122.13 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 109.691 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.709 HG22 ' C ' ' A' ' 118' ' ' ASP . 1.0 OUTLIER -87.14 -23.25 24.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.385 -0.822 . . . . 0.0 111.114 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.409 ' O ' HG12 ' A' ' 117' ' ' ILE . . . -178.38 179.94 48.47 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.017 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.846 ' CE ' HG22 ' A' ' 72' ' ' VAL . 47.5 mtm -152.45 171.12 18.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.346 -1.09 . . . . 0.0 109.94 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -155.21 164.45 38.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.214 -0.929 . . . . 0.0 110.233 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.683 HD12 ' CG ' ' A' ' 104' ' ' PHE . 7.4 mt -155.59 135.54 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.542 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 1.6 tm-20 69.54 3.44 4.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.406 -0.808 . . . . 0.0 111.428 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.64 21.5 12.52 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.136 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.477 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -136.95 159.05 43.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.722 -1.458 . . . . 0.0 110.138 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -178.98 2.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.083 -1.011 . . . . 0.0 110.354 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.447 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 1.7 pt-20 -106.6 167.59 9.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.34 -0.85 . . . . 0.0 110.043 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.28 129.79 55.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 110.349 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.519 HD12 ' O ' ' A' ' 90' ' ' ILE . 1.4 pp -68.28 101.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.903 . . . . 0.0 109.671 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.55 HG21 HG22 ' A' ' 101' ' ' THR . 1.8 tt -95.3 -28.87 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.384 -0.822 . . . . 0.0 110.716 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.9 p -167.33 107.41 0.59 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.022 -1.049 . . . . 0.0 109.935 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.419 ' HA ' ' HG3' ' A' ' 100' ' ' ARG . 24.3 ttmt -95.41 110.33 22.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -0.869 . . . . 0.0 110.153 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.84 81.27 3.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 110.197 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.9 p -69.56 -26.56 64.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.254 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.62 -52.33 63.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.199 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -95.79 19.91 10.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 110.304 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 50.36 63.75 2.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 109.996 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -147.56 -177.98 6.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.858 . . . . 0.0 110.408 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.419 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 3.9 ttm180 -176.32 164.97 2.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.835 . . . . 0.0 109.715 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.55 HG22 HG21 ' A' ' 91' ' ' ILE . 93.3 m -142.6 154.86 44.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.158 -0.964 . . . . 0.0 109.755 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 p -145.53 144.25 30.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.905 -1.122 . . . . 0.0 110.721 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -92.69 140.34 29.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.299 -0.876 . . . . 0.0 109.792 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.683 ' CG ' HD12 ' A' ' 83' ' ' ILE . 32.6 m-85 -126.58 149.62 49.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.119 -0.988 . . . . 0.0 111.066 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.456 ' C ' HG13 ' A' ' 106' ' ' VAL . 1.6 tt0 -119.74 126.35 50.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.46 -0.775 . . . . 0.0 109.477 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.472 ' O ' HD21 ' A' ' 66' ' ' LEU . 22.9 m -149.97 -164.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.972 -1.08 . . . . 0.0 110.778 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.2 t -98.46 112.0 24.17 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.451 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.26 -165.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.521 -0.737 . . . . 0.0 109.661 -178.343 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.469 ' CD2' ' HB2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -151.91 60.2 0.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.87 -1.144 . . . . 0.0 111.188 -179.435 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -146.33 80.5 1.56 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.124 -0.985 . . . . 0.0 110.435 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.59 -117.19 0.75 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.478 ' CG ' ' CG2' ' A' ' 139' ' ' THR . 3.7 ttpt -157.52 145.27 18.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.346 -1.091 . . . . 0.0 110.041 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.6 mt -137.39 146.02 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.352 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -76.83 108.9 10.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.222 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.461 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -111.37 177.99 19.26 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 82' ' ' SER . 22.2 mttt -145.45 161.23 40.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -1.125 . . . . 0.0 109.89 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.455 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.8 147.15 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.095 -1.003 . . . . 0.0 110.682 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.709 ' C ' HG22 ' A' ' 79' ' ' THR . 39.6 m-20 -106.39 159.32 16.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.394 -0.816 . . . . 0.0 109.149 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -140.92 147.29 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.027 -1.045 . . . . 0.0 110.684 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -153.34 113.89 4.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -0.872 . . . . 0.0 110.711 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 43.9 mt -137.69 152.94 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.103 -0.998 . . . . 0.0 110.386 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -160.08 95.43 1.16 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.376 -0.828 . . . . 0.0 109.85 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -173.81 -173.95 0.9 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.885 . . . . 0.0 110.354 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -104.47 121.35 43.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 110.263 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.3 95.04 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.102 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.05 39.02 30.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.29 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 96.45 31.46 7.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -145.33 100.39 4.46 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.316 -1.108 . . . . 0.0 110.134 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -50.4 132.84 35.83 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.869 1.457 . . . . 0.0 110.191 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -139.39 127.79 22.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 110.301 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.21 136.99 43.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.143 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.444 ' HB3' ' HB ' ' A' ' 121' ' ' ILE . 1.8 t80 -153.22 123.94 7.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 110.188 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -177.08 86.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -153.09 -165.31 2.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.9 . . . . 0.0 110.249 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -119.35 140.13 50.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.891 . . . . 0.0 110.283 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.463 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 61.4 m-85 -154.6 -179.17 7.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.874 . . . . 0.0 109.871 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.508 ' ND2' ' CE2' ' A' ' 41' ' ' TYR . 40.0 p30 -151.1 176.59 11.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 110.787 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.49 HG21 ' HB2' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -156.35 171.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.476 -0.765 . . . . 0.0 109.673 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.478 ' CG2' ' CG ' ' A' ' 112' ' ' LYS . 26.1 m -91.76 118.04 30.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.976 . . . . 0.0 110.698 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.461 ' CD1' ' HA3' ' A' ' 115' ' ' GLY . 18.6 m-85 -89.68 108.11 19.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 109.61 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -97.48 161.67 13.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.723 -179.592 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -148.11 153.04 38.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.476 -0.765 . . . . 0.0 109.936 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 35' ' ' ASN . 21.0 m120 -138.74 101.8 4.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 110.419 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.838 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -159.46 -154.5 7.29 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.56 ' HD2' HD11 ' A' ' 34' ' ' LEU . 19.7 Cg_endo . . . . . 0 C--N 1.307 -1.635 0 O-C-N 123.999 1.526 . . . . 0.0 110.707 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 2.1 m-20 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.921 0.391 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 p -159.58 147.87 17.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.019 . . . . 0.0 110.666 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.11 -179.33 45.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.04 119.68 28.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.176 -1.191 . . . . 0.0 110.26 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.87 HD11 ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -94.4 131.83 39.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.427 -0.796 . . . . 0.0 110.893 -179.471 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.445 ' N ' HD23 ' A' ' 34' ' ' LEU . 47.6 t30 -78.74 128.96 34.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.099 -1.0 . . . . 0.0 108.547 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.669 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -164.45 164.53 21.95 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.702 -1.249 . . . . 0.0 111.477 -178.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.98 -167.29 2.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.19 173.67 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.919 -1.113 . . . . 0.0 110.447 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -148.09 154.61 40.43 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.444 -0.785 . . . . 0.0 109.697 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.403 ' CE ' ' HA ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -66.99 140.58 57.73 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.334 -0.853 . . . . 0.0 109.771 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.507 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -63.28 147.16 51.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.993 . . . . 0.0 110.205 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.4 OUTLIER 69.0 5.98 5.37 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.673 -0.642 . . . . 0.0 110.681 -179.452 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.01 -167.42 2.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.027 -1.045 . . . . 0.0 109.344 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.44 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.9 OUTLIER -131.62 13.77 4.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.0 110.147 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -136.44 133.62 36.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.15 -0.969 . . . . 0.0 110.715 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.447 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -62.18 136.49 57.96 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.252 -0.905 . . . . 0.0 109.087 179.29 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.649 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -126.28 -17.96 5.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.917 -1.114 . . . . 0.0 111.81 -178.906 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.682 HG22 ' N ' ' A' ' 49' ' ' ALA . 1.2 mp -137.98 -74.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.897 -1.127 . . . . 0.0 110.532 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.682 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -45.13 -26.63 0.49 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.769 -0.582 . . . . 0.0 111.238 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.447 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -52.57 -23.64 6.78 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.094 -1.004 . . . . 0.0 111.102 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -102.73 15.41 29.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.969 -1.082 . . . . 0.0 111.026 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 52.7 m-85 -123.06 -10.64 8.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.039 -1.038 . . . . 0.0 110.967 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CZ ' ' CE ' ' A' ' 81' ' ' MET . 17.5 m-85 -119.52 115.33 23.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.063 -1.023 . . . . 0.0 110.309 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -72.24 169.47 16.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 110.6 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 161.96 33.76 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.428 -0.795 . . . . 0.0 109.76 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -83.6 -175.07 13.46 Favored 'Cis proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.592 -2.253 . . . . 0.0 110.728 -0.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.669 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -99.49 -171.46 2.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.369 -0.832 . . . . 0.0 109.752 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.413 ' HB2' ' NE2' ' A' ' 69' ' ' GLN . 3.8 mttp -127.63 121.16 29.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.055 -1.028 . . . . 0.0 110.372 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.527 ' HB3' HD12 ' A' ' 34' ' ' LEU . 38.6 p90 -96.36 161.28 14.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 0.0 109.893 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.638 HG23 ' HD1' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -155.19 121.03 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 110.609 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.517 ' CE ' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -130.88 117.91 19.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.089 -1.007 . . . . 0.0 110.654 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -93.61 61.57 3.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.25 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 49.62 101.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.555 -0.715 . . . . 0.0 111.431 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.1 56.99 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.466 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -142.49 158.62 43.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.056 -1.261 . . . . 0.0 110.08 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.853 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -158.86 138.28 11.59 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.988 0.899 . . . . 0.0 111.201 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.638 ' HD1' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.56 178.95 7.1 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.633 -0.667 . . . . 0.0 109.308 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.06 141.42 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 0.0 110.472 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 58' ' ' LYS . 11.2 pt20 -98.38 144.2 28.02 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 109.922 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.98 135.0 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.264 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 71' ' ' THR . 0.9 OUTLIER -89.51 123.84 33.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.883 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.653 HG12 HG21 ' A' ' 78' ' ' ILE . 1.3 t -103.21 131.21 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.928 . . . . 0.0 110.381 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -100.26 134.01 43.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.219 -0.926 . . . . 0.0 110.049 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.682 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER 62.14 116.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.3 -0.875 . . . . 0.0 110.036 -179.746 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.92 -25.26 24.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.177 -0.952 . . . . 0.0 110.638 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -59.66 4.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.994 . . . . 0.0 110.357 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.576 ' O ' HD11 ' A' ' 121' ' ' ILE . 39.8 m0 -53.58 -62.46 1.64 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.902 . . . . 0.0 110.436 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 74' ' ' HIS . 0.8 OUTLIER -88.34 120.38 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.954 . . . . 0.0 109.964 179.846 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.629 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.05 -23.25 25.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.392 -0.818 . . . . 0.0 110.758 -179.3 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.13 -177.01 47.25 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.52 ' CE ' ' CZ ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -151.18 168.16 25.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -1.076 . . . . 0.0 110.185 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 116' ' ' LYS . 3.2 t -154.33 137.87 15.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 109.845 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.898 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -132.27 140.01 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.345 -179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 73.35 -1.07 3.17 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.809 -0.557 . . . . 0.0 111.224 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.62 21.92 8.42 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.632 -1.27 . . . . 0.0 111.121 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.443 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.37 162.99 32.1 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.637 -1.508 . . . . 0.0 110.269 179.285 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -171.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 110.547 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -109.07 170.22 8.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.341 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.6 122.02 44.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.319 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pt -67.39 103.59 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.168 -0.958 . . . . 0.0 109.911 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 101' ' ' THR . 1.5 tt -95.66 -28.51 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.886 . . . . 0.0 110.964 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.6 p -167.53 105.21 0.52 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.033 -1.042 . . . . 0.0 110.081 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm -95.29 107.72 19.84 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.277 -0.889 . . . . 0.0 110.017 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.65 95.99 8.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 110.385 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.67 -29.65 56.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.099 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -47.78 82.37 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.305 -0.872 . . . . 0.0 110.078 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -95.85 12.24 30.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 110.419 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.9 t0 51.33 56.95 7.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.019 -1.051 . . . . 0.0 110.152 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -148.14 154.75 40.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.202 -0.936 . . . . 0.0 110.442 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -143.68 166.14 25.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 109.941 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.573 ' O ' HG22 ' A' ' 91' ' ' ILE . 87.0 m -141.35 150.69 42.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.382 -0.824 . . . . 0.0 109.636 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.9 p -145.31 141.48 28.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.036 -1.04 . . . . 0.0 110.733 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.04 144.1 25.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.842 . . . . 0.0 109.885 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -127.87 136.95 52.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.062 -1.024 . . . . 0.0 110.757 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.482 ' C ' HG13 ' A' ' 106' ' ' VAL . 3.5 mt-10 -93.13 127.48 38.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -0.883 . . . . 0.0 109.449 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.482 HG13 ' C ' ' A' ' 105' ' ' GLU . 35.3 m -149.68 171.36 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.017 -1.052 . . . . 0.0 110.954 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.79 110.47 18.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.33 -156.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 109.678 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.87 ' HB2' HD11 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -150.86 59.83 0.93 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.983 -1.073 . . . . 0.0 110.982 -179.267 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER -146.12 104.19 3.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.293 -0.879 . . . . 0.0 110.337 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 134.35 -131.88 6.13 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.432 ' HB3' ' HG2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -157.0 152.42 26.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.299 -1.118 . . . . 0.0 110.0 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mt -135.78 145.24 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.882 . . . . 0.0 110.17 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -76.06 113.12 13.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.347 -0.845 . . . . 0.0 110.058 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.456 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -122.26 -170.4 13.69 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 82' ' ' SER . 4.1 mttp -147.66 171.95 14.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -1.155 . . . . 0.0 109.977 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -157.67 145.11 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -0.96 . . . . 0.0 110.453 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.629 ' O ' HG22 ' A' ' 79' ' ' THR . 7.7 m-20 -105.63 155.04 19.61 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.473 -0.767 . . . . 0.0 109.535 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -132.4 146.47 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 110.127 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -151.76 115.02 4.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.89 . . . . 0.0 110.55 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.576 HD11 ' O ' ' A' ' 77' ' ' TRP . 2.2 mp -141.51 152.57 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -0.95 . . . . 0.0 110.337 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.55 101.08 1.5 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 0.0 109.828 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -173.62 -176.93 1.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.378 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -97.61 105.18 17.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 110.391 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 128' ' ' LYS . 21.9 t -76.29 99.24 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.0 109.898 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 55.5 50.46 14.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.32 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.31 33.28 44.75 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.453 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -145.6 106.31 4.33 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.085 -1.244 . . . . 0.0 110.233 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 128' ' ' LYS . 9.2 Cg_endo -58.04 128.01 27.19 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.541 1.285 . . . . 0.0 110.108 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -127.13 148.05 50.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.355 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.3 99.07 4.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.364 -0.835 . . . . 0.0 109.837 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.492 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 3.0 t80 -102.0 131.14 48.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 109.894 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -166.37 77.48 0.22 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.227 -0.92 . . . . 0.0 110.229 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -153.83 -173.82 4.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.291 -0.881 . . . . 0.0 110.339 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.449 ' O ' ' CD2' ' A' ' 136' ' ' TYR . 6.1 p80 -119.79 162.53 18.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 110.11 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 135' ' ' HIS . 54.7 m-85 -155.09 137.34 14.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.964 . . . . 0.0 110.423 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.462 ' O ' HG23 ' A' ' 138' ' ' ILE . 28.1 p30 -88.63 159.23 17.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.315 -0.866 . . . . 0.0 110.267 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -156.69 155.92 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.269 -0.895 . . . . 0.0 110.051 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.2 m -91.81 123.06 34.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.265 -0.897 . . . . 0.0 111.074 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.898 ' CD2' HD11 ' A' ' 83' ' ' ILE . 62.7 m-85 -90.82 154.6 19.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.395 -0.816 . . . . 0.0 109.236 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -140.23 95.3 2.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.894 -1.129 . . . . 0.0 110.683 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 110' ' ' ASN . 23.4 m-85 -91.06 133.45 35.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.321 -0.862 . . . . 0.0 110.197 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.421 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 8.6 m120 -137.58 102.08 4.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 110.451 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.442 ' CA ' HD13 ' A' ' 109' ' ' LEU . . . -146.07 -142.11 3.72 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.429 ' HD2' ' HA3' ' A' ' 144' ' ' GLY . 1.9 Cg_endo . . . . . 0 C--N 1.312 -1.369 0 O-C-N 123.576 1.303 . . . . 0.0 110.756 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 1.1 m-20 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.852 0.358 . . . . 0.0 110.373 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.6 p -161.81 150.4 15.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.841 . . . . 0.0 110.32 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 161.31 177.94 34.83 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.552 HG23 ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -88.18 104.9 17.14 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.358 -1.084 . . . . 0.0 110.321 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.783 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -94.61 158.6 15.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 110.499 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.448 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 3.6 m-20 -78.8 140.79 38.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.898 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.596 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -165.46 153.89 11.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 110.105 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.34 -177.06 6.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.235 -0.916 . . . . 0.0 110.352 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 140' ' ' TYR . 1.6 m -140.04 178.09 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.348 -0.845 . . . . 0.0 109.843 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -149.39 162.8 39.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 110.481 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.3 OUTLIER -68.15 123.73 21.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.362 -0.836 . . . . 0.0 109.79 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.502 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -53.26 144.94 14.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.977 . . . . 0.0 109.955 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 6.1 m120 71.62 1.52 3.91 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.857 -0.527 . . . . 0.0 111.1 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.98 -166.86 1.98 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.829 -1.169 . . . . 0.0 109.827 179.15 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.74 21.4 3.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 110.443 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -133.15 126.06 30.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.122 -0.986 . . . . 0.0 110.956 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.523 HG22 ' HB2' ' A' ' 50' ' ' ASN . 0.7 OUTLIER -55.11 118.48 4.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.601 -0.687 . . . . 0.0 109.686 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.51 -18.58 3.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.8 -1.188 . . . . 0.0 112.078 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.0 mt -138.88 -76.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.789 -1.195 . . . . 0.0 111.122 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.504 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -46.0 -26.41 0.72 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.622 -0.674 . . . . 0.0 111.176 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.523 ' HB2' HG22 ' A' ' 46' ' ' THR . 16.9 t-20 -68.9 -13.4 62.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.075 -1.016 . . . . 0.0 110.792 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -102.59 15.13 30.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.974 -1.079 . . . . 0.0 111.123 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -136.42 11.33 3.24 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.008 -1.058 . . . . 0.0 110.808 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.437 ' HE2' ' HB1' ' A' ' 49' ' ' ALA . 25.2 m-85 -130.98 115.62 16.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.077 -1.014 . . . . 0.0 110.122 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -72.59 164.23 26.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.355 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.467 ' CD ' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -146.83 164.43 23.74 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.274 -0.891 . . . . 0.0 110.048 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.42 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 57.2 Cg_endo -78.86 -175.44 16.71 Favored 'Cis proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.438 -2.317 . . . . 0.0 110.45 -0.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.596 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.52 167.96 9.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.077 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.552 ' HD2' HG23 ' A' ' 33' ' ' THR . 0.9 OUTLIER -101.45 113.51 26.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.32 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CD2' HD21 ' A' ' 109' ' ' LEU . 1.7 p90 -97.06 161.95 13.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 110.004 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 1.0 OUTLIER -154.81 156.99 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.089 -1.007 . . . . 0.0 110.465 179.646 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 34.6 mtmt -140.34 170.23 16.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.179 -0.95 . . . . 0.0 111.058 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 12.5 mtmt -157.05 62.15 0.51 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.549 -0.719 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t30 51.05 87.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.344 -0.848 . . . . 0.0 111.26 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.83 24.91 39.96 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.696 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.753 ' C ' HD13 ' A' ' 66' ' ' LEU . 2.8 ptpt -167.56 153.3 7.46 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.914 -1.345 . . . . 0.0 110.941 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.768 ' N ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -158.78 151.17 21.61 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 122.347 1.07 . . . . 0.0 111.696 178.534 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 6.3 m-85 -143.85 170.41 15.94 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 58' ' ' LYS . 1.1 m -145.18 145.04 21.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.908 -1.12 . . . . 0.0 110.389 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.436 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 4.6 pt20 -97.84 132.77 43.15 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.355 -0.84 . . . . 0.0 109.593 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -112.38 137.57 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.942 -179.67 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.08 128.45 35.75 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.209 -0.932 . . . . 0.0 109.939 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.686 HG12 HG21 ' A' ' 78' ' ' ILE . 2.0 t -101.84 126.37 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.977 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 74' ' ' HIS . 21.6 m-20 -99.18 128.03 45.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.363 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.669 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER 64.23 113.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.85 . . . . 0.0 110.198 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.58 -38.31 23.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.202 -0.937 . . . . 0.0 110.257 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -55.35 -42.45 73.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.212 -0.93 . . . . 0.0 110.182 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.486 ' HA ' HG12 ' A' ' 121' ' ' ILE . 34.4 m0 -67.4 -64.32 0.88 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 110.282 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.686 HG21 HG12 ' A' ' 72' ' ' VAL . 17.9 tt -88.81 126.3 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.379 -0.826 . . . . 0.0 110.007 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.88 -24.81 23.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.441 -0.787 . . . . 0.0 110.975 -179.298 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.402 ' O ' HG12 ' A' ' 117' ' ' ILE . . . 178.16 -179.05 48.62 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.627 -1.273 . . . . 0.0 109.955 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.448 ' HG3' HD11 ' A' ' 78' ' ' ILE . 2.8 mtm -151.59 161.85 41.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.265 -1.138 . . . . 0.0 110.352 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -154.99 146.24 22.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.86 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.624 HD11 ' CD2' ' A' ' 140' ' ' TYR . 3.6 mt -139.17 142.77 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.903 . . . . 0.0 110.657 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 2.5 tm-20 72.26 -0.35 3.29 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.693 -0.63 . . . . 0.0 111.56 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.87 20.27 9.52 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.537 -1.316 . . . . 0.0 111.006 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.477 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.72 159.31 42.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.649 -1.5 . . . . 0.0 110.365 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -71.17 179.69 2.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 110.177 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -102.23 170.17 8.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.904 . . . . 0.0 110.083 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.2 129.7 56.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.938 . . . . 0.0 110.243 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.451 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 0.8 OUTLIER -67.65 102.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 109.767 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 101' ' ' THR . 1.5 tt -95.15 -25.86 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -0.861 . . . . 0.0 110.853 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.517 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -167.35 104.88 0.53 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.122 -0.986 . . . . 0.0 109.659 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -96.34 145.69 25.39 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.399 -0.813 . . . . 0.0 110.265 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.22 78.98 1.62 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 110.115 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.25 -25.88 67.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 110.327 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.16 64.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 110.112 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -96.57 17.3 16.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.392 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 t0 50.41 63.13 2.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.975 . . . . 0.0 110.013 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -147.15 162.28 39.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.335 -0.853 . . . . 0.0 110.346 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.447 ' O ' HG23 ' A' ' 72' ' ' VAL . 2.1 mtp180 -163.72 161.75 23.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.435 -0.791 . . . . 0.0 109.873 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.593 ' O ' HG22 ' A' ' 91' ' ' ILE . 86.9 m -142.42 150.37 40.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.655 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.5 p -145.42 143.6 30.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.052 -1.03 . . . . 0.0 110.76 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 2.0 tm-20 -93.4 147.33 23.04 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.374 -0.829 . . . . 0.0 109.838 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.577 ' CD2' HD12 ' A' ' 83' ' ' ILE . 19.1 m-85 -128.18 131.45 48.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.132 -0.98 . . . . 0.0 110.924 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.464 ' C ' HG13 ' A' ' 106' ' ' VAL . 15.5 tt0 -96.08 124.84 40.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.879 . . . . 0.0 109.474 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.496 ' O ' HD21 ' A' ' 66' ' ' LEU . 29.6 m -149.28 -171.71 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.051 -1.031 . . . . 0.0 110.665 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.9 111.96 23.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.442 -0.786 . . . . 0.0 109.144 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.479 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.69 -162.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.456 -0.777 . . . . 0.0 109.969 -178.872 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.522 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -149.84 56.92 0.97 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.015 -1.053 . . . . 0.0 110.644 -179.72 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -145.63 79.53 1.57 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.879 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.63 170.98 19.67 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.06 144.42 30.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -1.154 . . . . 0.0 110.482 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.486 HD12 ' CD2' ' A' ' 142' ' ' PHE . 5.3 mt -136.34 146.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 0.0 109.719 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.15 117.3 17.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.151 -0.968 . . . . 0.0 110.496 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.11 176.05 16.4 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 15.9 mttt -144.43 163.52 33.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -1.155 . . . . 0.0 109.945 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.417 ' HB ' ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -157.89 140.64 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 110.43 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.581 ' O ' HG22 ' A' ' 79' ' ' THR . 52.9 m-20 -101.56 154.35 18.93 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.366 -0.834 . . . . 0.0 109.254 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.654 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -133.4 151.05 32.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.999 -1.063 . . . . 0.0 110.781 -179.288 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -150.69 99.5 2.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.595 -0.69 . . . . 0.0 109.362 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.501 HD12 ' CD2' ' A' ' 132' ' ' TYR . 20.1 mt -135.04 153.33 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.259 -0.9 . . . . 0.0 110.738 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -159.87 106.27 1.62 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.499 -0.75 . . . . 0.0 109.169 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.4 162.13 6.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.315 -0.866 . . . . 0.0 110.216 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 7.1 mtmt -89.78 113.88 25.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 110.495 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.4 t -76.92 96.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.341 -0.849 . . . . 0.0 110.218 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.22 29.74 13.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.595 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.95 32.94 5.69 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 46.6 mtmt -144.94 100.51 4.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.317 -1.107 . . . . 0.0 110.138 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.54 115.29 1.71 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.765 1.403 . . . . 0.0 110.468 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 8.2 t80 -111.95 125.63 54.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 110.17 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.2 139.39 37.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 110.147 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.654 ' HE2' HG11 ' A' ' 119' ' ' VAL . 1.6 t80 -153.43 113.83 3.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.809 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.403 ' O ' ' CG ' ' A' ' 134' ' ' HIS . 8.1 t0 -165.92 88.33 0.39 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.136 -0.977 . . . . 0.0 110.154 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.403 ' CG ' ' O ' ' A' ' 133' ' ' ASP . 74.1 m-70 -154.04 -168.26 2.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 110.282 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.6 85.46 2.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.796 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.476 ' HD2' HG21 ' A' ' 119' ' ' VAL . 25.0 m-85 -85.86 -178.57 6.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.825 . . . . 0.0 110.416 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 11.6 p30 -150.33 174.27 13.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.938 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.504 HG21 ' HB2' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -155.92 165.34 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.135 -0.978 . . . . 0.0 110.614 -179.655 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 61.8 m -91.81 113.82 26.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.406 -0.809 . . . . 0.0 110.525 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.674 ' HA ' HG12 ' A' ' 38' ' ' VAL . 27.6 m-85 -89.63 155.15 19.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.979 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.79 112.77 5.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.946 . . . . 0.0 110.523 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.486 ' CD2' HD12 ' A' ' 113' ' ' ILE . 27.2 m-85 -91.98 155.78 17.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 110.313 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.522 ' C ' HD21 ' A' ' 34' ' ' LEU . 27.2 m120 -140.03 96.93 3.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -0.979 . . . . 0.0 110.332 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.783 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -161.5 -151.95 6.47 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.497 ' HD2' HD11 ' A' ' 34' ' ' LEU . 15.1 Cg_endo . . . . . 0 C--N 1.307 -1.625 0 O-C-N 123.889 1.468 . . . . 0.0 110.567 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 120.807 0.337 . . . . 0.0 110.512 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.0 t -160.86 130.02 4.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.899 . . . . 0.0 110.29 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . -170.77 179.19 42.89 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.72 110.67 21.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.401 -1.058 . . . . 0.0 110.505 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.841 HD13 HD22 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -95.36 148.62 22.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 109.99 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.44 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -79.16 134.26 36.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.085 -1.01 . . . . 0.0 110.339 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.887 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -166.27 167.91 15.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.152 -0.968 . . . . 0.0 110.839 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.98 -172.93 4.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.542 -0.724 . . . . 0.0 109.764 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.707 ' O ' HG22 ' A' ' 46' ' ' THR . 0.6 OUTLIER -140.73 107.73 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.688 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.0 161.38 15.16 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.455 -0.778 . . . . 0.0 110.497 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.449 ' HD3' HD13 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -67.84 137.38 55.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.374 -0.829 . . . . 0.0 110.081 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.474 ' CD2' ' OD1' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -62.53 145.47 54.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.035 -1.041 . . . . 0.0 110.064 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 12.6 t30 70.42 3.49 4.5 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.763 -0.586 . . . . 0.0 110.771 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.423 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -139.25 -171.08 3.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.878 -1.139 . . . . 0.0 109.538 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.423 ' N ' ' OG1' ' A' ' 43' ' ' THR . 17.5 p30 -134.63 23.48 3.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.106 -0.996 . . . . 0.0 110.055 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.64 121.47 19.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 111.075 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.707 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -49.79 126.87 14.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.583 -0.698 . . . . 0.0 109.291 178.764 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.795 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -129.84 -19.36 3.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.74 -1.225 . . . . 0.0 112.449 -178.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 47' ' ' SER . 1.4 mp -139.45 -78.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.65 -1.281 . . . . 0.0 111.296 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.697 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -45.01 -26.42 0.43 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.853 -0.53 . . . . 0.0 111.337 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.478 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 4.7 p30 -60.92 -15.49 31.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.091 -1.006 . . . . 0.0 110.882 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.421 ' C ' ' CD1' ' A' ' 52' ' ' TYR . 6.2 m-20 -101.8 15.2 29.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.054 -1.029 . . . . 0.0 110.896 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 43.3 m-85 -140.08 10.39 2.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.004 -1.06 . . . . 0.0 110.554 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.417 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 30.7 m-85 -132.02 113.27 13.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 110.174 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.492 ' HB2' HG21 ' A' ' 71' ' ' THR . 0.8 OUTLIER -72.69 164.55 26.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.705 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -146.57 161.66 37.25 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.4 -0.812 . . . . 0.0 109.71 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.402 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 57.5 Cg_endo -79.93 -175.39 16.27 Favored 'Cis proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.522 -2.282 . . . . 0.0 110.396 -0.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.887 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.14 166.29 10.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.933 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.54 116.0 31.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.948 . . . . 0.0 110.465 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.514 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 28.9 p90 -97.1 163.87 12.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 109.823 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -155.11 151.0 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.109 -0.994 . . . . 0.0 110.558 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 28.1 mtmt -134.5 174.0 11.03 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -0.9 . . . . 0.0 110.945 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 9.5 mttt -155.93 62.33 0.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.4 -0.813 . . . . 0.0 110.021 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m120 53.97 85.86 0.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.338 -0.851 . . . . 0.0 111.188 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.43 23.58 50.36 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.203 -0.999 . . . . 0.0 110.705 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 62' ' ' LYS . 8.6 ptpt -166.12 161.17 16.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.814 -1.404 . . . . 0.0 110.951 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.786 HD11 ' HA ' ' A' ' 108' ' ' LYS . 2.5 pt? -173.11 158.0 3.59 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.152 0.977 . . . . 0.0 111.555 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.566 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -139.27 -153.84 0.49 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -170.17 135.16 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 110.026 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 5.1 pt20 -97.39 133.66 41.69 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.63 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -114.2 142.93 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 110.099 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.492 HG21 ' HB2' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -89.18 129.59 35.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 110.199 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.782 HG12 HG21 ' A' ' 78' ' ' ILE . 2.5 t -104.1 127.29 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 110.159 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.0 137.9 37.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 110.341 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.698 ' O ' HG22 ' A' ' 78' ' ' ILE . 63.4 m-70 52.42 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.339 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -73.52 -31.68 63.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 110.217 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -55.48 -36.93 67.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 110.31 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -83.6 -50.86 7.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 110.15 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.782 HG21 HG12 ' A' ' 72' ' ' VAL . 19.5 tt -89.75 125.34 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 109.942 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.612 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -87.1 -29.88 21.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 110.579 -179.577 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.15 -168.37 41.13 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.431 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.8 mtp -151.99 169.19 22.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -1.125 . . . . 0.0 110.469 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.36 131.62 11.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.871 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.3 mt -131.25 147.32 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.933 . . . . 0.0 110.344 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' OE1' ' CA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER 66.46 7.29 4.91 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.133 -0.979 . . . . 0.0 111.004 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.03 25.49 19.52 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.895 -1.145 . . . . 0.0 111.297 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.684 ' HE1' ' HD1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -139.48 161.29 37.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.638 -1.507 . . . . 0.0 110.482 179.262 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.41 -173.74 0.95 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.13 -0.981 . . . . 0.0 110.561 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 1.8 pt-20 -110.24 170.05 8.34 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.368 -0.832 . . . . 0.0 110.278 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.14 127.46 54.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.274 -0.891 . . . . 0.0 110.268 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.29 103.95 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 0.0 109.597 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.442 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.1 tt -95.92 -30.1 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 111.085 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.7 p -167.43 104.91 0.53 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.016 -1.052 . . . . 0.0 110.015 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -95.53 108.54 20.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 110.154 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 99' ' ' GLU . 3.9 t-20 -95.75 62.14 2.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.289 -0.882 . . . . 0.0 110.177 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.59 -21.93 30.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.297 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -18.69 62.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.211 -0.931 . . . . 0.0 110.288 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -136.31 22.19 3.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 110.278 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 55.89 64.42 1.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -0.868 . . . . 0.0 110.521 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 94' ' ' ASN . 15.6 mt-10 -148.18 -179.51 6.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.278 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 179.22 162.32 0.81 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.2 -0.938 . . . . 0.0 110.135 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.442 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 97.2 m -141.48 152.46 44.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 109.651 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 37.4 p -144.36 139.59 28.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.008 -1.057 . . . . 0.0 110.548 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.28 141.14 28.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.388 -0.82 . . . . 0.0 110.01 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.684 ' HD1' ' HE1' ' A' ' 86' ' ' HIS . 68.3 m-85 -129.0 138.26 51.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.157 -0.964 . . . . 0.0 110.669 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -99.0 130.66 45.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.272 -0.892 . . . . 0.0 109.616 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.0 p -149.42 152.12 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.02 -1.05 . . . . 0.0 110.86 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.6 m -63.68 106.41 0.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -0.931 . . . . 0.0 109.145 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.786 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 48.4 -174.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.494 -0.753 . . . . 0.0 110.062 -178.888 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.841 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.13 75.45 1.24 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.977 -1.077 . . . . 0.0 110.691 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -146.09 43.22 1.23 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.86 . . . . 0.0 110.246 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.64 -169.62 38.21 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 151.59 27.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -1.181 . . . . 0.0 110.437 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 140' ' ' TYR . 13.9 mm -136.31 132.35 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.418 -0.801 . . . . 0.0 109.884 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.68 103.03 6.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 0.0 110.191 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.57 175.85 15.94 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 18.9 mttt -147.88 177.46 9.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -1.14 . . . . 0.0 109.532 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.481 HG21 HD13 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -157.21 149.48 10.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.103 -0.998 . . . . 0.0 111.099 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.612 ' O ' HG22 ' A' ' 79' ' ' THR . 69.0 m-20 -106.83 156.14 18.99 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.452 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 2.2 t -140.45 149.44 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 110.142 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 2.1 t80 -151.01 116.36 5.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 0.0 110.381 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.498 HD12 ' CD2' ' A' ' 132' ' ' TYR . 3.9 mt -134.97 153.83 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.44 -0.788 . . . . 0.0 109.994 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.54 102.28 1.71 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.145 -0.972 . . . . 0.0 109.971 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -173.17 175.28 3.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.522 -0.736 . . . . 0.0 109.829 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 100.7 12.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.148 -0.97 . . . . 0.0 110.344 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.2 t -76.92 112.15 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.339 -0.851 . . . . 0.0 109.965 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 53.98 43.44 30.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 110.212 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.53 38.09 68.78 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -145.26 108.41 4.54 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.228 -1.16 . . . . 0.0 110.048 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -47.96 129.19 17.7 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.682 1.359 . . . . 0.0 110.377 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -135.38 139.91 44.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 110.132 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -135.08 121.45 20.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.0 110.262 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.498 ' CD2' HD12 ' A' ' 121' ' ' ILE . 3.2 t80 -114.2 141.45 47.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 109.617 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 3.7 p30 -175.99 81.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.085 -1.01 . . . . 0.0 110.298 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.19 178.77 9.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 0.0 110.589 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.406 ' ND1' ' N ' ' A' ' 135' ' ' HIS . 1.8 m80 -119.0 96.38 5.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.315 -0.866 . . . . 0.0 109.631 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.93 139.53 31.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 110.483 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.597 ' O ' HG23 ' A' ' 138' ' ' ILE . 25.4 p30 -88.72 159.72 17.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.327 -0.858 . . . . 0.0 110.157 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 137' ' ' ASN . 6.9 pt -156.35 166.28 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 110.1 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 88.6 m -91.76 161.27 14.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.359 -0.838 . . . . 0.0 110.572 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.457 ' CE2' HG13 ' A' ' 138' ' ' ILE . 19.3 m-85 -147.06 98.66 3.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.428 -0.795 . . . . 0.0 109.635 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -101.46 105.3 16.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.896 . . . . 0.0 110.874 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 140' ' ' TYR . 98.3 m-85 -92.2 140.34 29.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.889 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -124.02 98.67 5.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -0.99 . . . . 0.0 110.453 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.64 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -151.36 -148.67 4.87 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.418 ' HD2' HD11 ' A' ' 109' ' ' LEU . 10.3 Cg_endo . . . . . 0 C--N 1.309 -1.548 0 O-C-N 123.639 1.336 . . . . 0.0 110.077 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.962 0.41 . . . . 0.0 110.478 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.6 t -160.11 134.67 7.6 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 110.451 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.84 179.09 48.47 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.39 112.23 22.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -1.124 . . . . 0.0 110.335 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.86 HD13 HD22 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -94.73 146.83 23.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 110.431 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.412 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -80.7 133.15 35.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 109.779 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.749 ' CE2' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -165.88 162.69 18.45 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.154 -0.966 . . . . 0.0 110.716 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.47 -168.29 2.78 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.455 -0.778 . . . . 0.0 109.526 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.861 ' O ' HG22 ' A' ' 46' ' ' THR . 2.5 m -140.92 117.88 8.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.047 -1.033 . . . . 0.0 110.349 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -90.86 155.54 18.68 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.42 -0.8 . . . . 0.0 110.134 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.3 OUTLIER -67.44 126.83 30.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.401 -0.812 . . . . 0.0 110.111 -179.767 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.511 ' CD2' ' ND2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -56.96 147.37 24.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.913 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.8 t30 72.77 -0.01 3.5 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.963 -0.461 . . . . 0.0 110.811 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -138.73 -168.32 2.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.937 -1.102 . . . . 0.0 109.445 179.189 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.42 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.1 OUTLIER -136.28 25.27 3.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.014 -1.054 . . . . 0.0 110.357 179.667 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -135.62 118.63 16.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.057 -1.027 . . . . 0.0 111.354 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.861 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -48.82 120.64 3.97 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.849 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.66 -18.06 3.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.709 -1.244 . . . . 0.0 112.466 -178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 95.3 mt -137.98 -76.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.624 -1.298 . . . . 0.0 111.279 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -50.28 -21.94 1.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.742 -0.599 . . . . 0.0 111.593 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.462 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 59.8 t30 -59.08 -32.92 70.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.039 . . . . 0.0 111.388 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.18 15.89 27.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.016 -1.053 . . . . 0.0 111.025 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.461 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -98.65 -17.55 18.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.02 -1.05 . . . . 0.0 111.069 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.501 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 9.3 p90 -127.0 134.3 50.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.0 -1.062 . . . . 0.0 111.037 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -74.78 113.88 12.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.904 . . . . 0.0 109.937 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.72 162.34 29.48 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.015 -1.053 . . . . 0.0 110.005 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -83.09 -175.46 14.6 Favored 'Cis proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.55 -2.271 . . . . 0.0 110.526 -0.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.749 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . . . -102.53 -171.61 1.99 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 0.0 110.176 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 2.2 ttmt -125.29 113.35 17.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 0.0 110.251 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.607 ' HA ' HG13 ' A' ' 68' ' ' VAL . 10.0 p90 -97.26 165.42 12.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 110.31 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -155.48 156.81 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.363 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 19.8 mtmt -140.64 173.53 11.4 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.353 -0.842 . . . . 0.0 110.599 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.415 ' CB ' ' HD2' ' A' ' 65' ' ' LYS . 1.6 mtmm -158.53 62.23 0.43 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.843 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m120 45.11 82.6 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.661 -0.65 . . . . 0.0 111.195 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.91 14.78 33.06 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.608 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.415 ' HD2' ' CB ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -165.77 163.17 18.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.96 -1.318 . . . . 0.0 110.982 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.998 HD11 ' HA ' ' A' ' 108' ' ' LYS . 2.4 pt? -172.68 144.67 1.43 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.015 0.912 . . . . 0.0 111.356 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -139.01 173.33 11.67 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.175 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.607 HG13 ' HA ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -142.24 142.17 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.042 -1.036 . . . . 0.0 110.429 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.416 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 3.3 pp0? -97.66 132.35 43.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.398 -0.814 . . . . 0.0 109.641 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.549 HD13 ' HD2' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -113.49 132.63 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 110.457 -179.548 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 71' ' ' THR . 0.9 OUTLIER -89.54 125.2 35.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.679 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -103.15 134.22 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.901 . . . . 0.0 110.465 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -102.12 145.44 29.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.388 -0.82 . . . . 0.0 110.034 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 11.1 m170 50.61 87.39 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 110.141 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.2 p -57.21 -36.21 70.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.355 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -55.62 -32.8 63.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 110.353 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.599 ' O ' HG12 ' A' ' 119' ' ' VAL . 35.7 m0 -76.3 -60.67 2.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 110.378 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.661 HD11 HG13 ' A' ' 117' ' ' ILE . 2.1 tp -88.41 117.2 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.437 -0.789 . . . . 0.0 110.058 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.651 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -86.82 -24.59 24.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -0.803 . . . . 0.0 110.836 -179.341 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.98 177.89 48.25 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.606 -1.283 . . . . 0.0 109.955 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.402 ' HG2' ' HB ' ' A' ' 117' ' ' ILE . 1.1 mtt -152.94 162.42 41.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -1.148 . . . . 0.0 109.969 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 t -154.81 153.48 31.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.958 . . . . 0.0 110.01 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.816 HD11 ' CE2' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -151.77 147.21 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 110.896 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.478 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 61.07 10.65 2.98 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.488 -0.757 . . . . 0.0 111.944 179.204 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.75 2.16 34.59 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.313 -1.423 . . . . 0.0 111.39 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 83' ' ' ILE . 5.2 p80 -135.39 150.25 49.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.534 -1.568 . . . . 0.0 110.824 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -70.15 -164.23 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 110.437 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 9.6 pt-20 -106.79 170.24 8.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.857 . . . . 0.0 110.492 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.34 136.24 50.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.019 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -67.96 100.94 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.989 -1.07 . . . . 0.0 109.648 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 101' ' ' THR . 1.1 tt -96.26 -29.13 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.0 110.776 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 5.4 m -167.38 99.48 0.51 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.162 -0.961 . . . . 0.0 109.963 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -95.61 152.99 17.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.816 . . . . 0.0 110.041 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.79 73.66 1.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 110.172 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.57 -34.27 72.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.269 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -47.09 85.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.119 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -96.32 14.82 23.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.46 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 1.4 m-20 51.16 55.13 9.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.109 -0.995 . . . . 0.0 110.103 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 54.3 mt-10 -146.32 168.1 21.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.327 -0.858 . . . . 0.0 110.168 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 101' ' ' THR . 4.2 ttt180 -172.96 163.23 4.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.212 -0.93 . . . . 0.0 109.93 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.508 ' O ' HG22 ' A' ' 91' ' ' ILE . 62.9 m -139.96 153.98 47.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.863 . . . . 0.0 110.122 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.42 ' CB ' ' OE1' ' A' ' 88' ' ' GLU . 5.1 p -145.59 143.93 30.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.427 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.99 147.51 22.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.283 -0.886 . . . . 0.0 109.965 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.549 ' HD2' HD13 ' A' ' 70' ' ' ILE . 15.6 m-85 -128.02 135.84 50.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 110.683 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.445 ' C ' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -104.11 131.13 51.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.721 179.68 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.445 HG13 ' C ' ' A' ' 105' ' ' GLU . 24.0 m -149.22 159.12 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.14 -0.975 . . . . 0.0 110.558 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.8 t -50.44 -45.04 55.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 109.142 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.998 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.5 -165.43 0.85 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.658 -0.651 . . . . 0.0 109.485 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.86 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -149.99 71.48 1.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.073 -1.017 . . . . 0.0 110.548 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -146.17 55.49 1.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.404 -0.81 . . . . 0.0 110.177 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 142' ' ' PHE . . . 169.37 -108.27 0.29 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.452 ' HG3' HG23 ' A' ' 139' ' ' THR . 1.5 tmtt? -156.44 135.15 11.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.35 -1.088 . . . . 0.0 109.902 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.2 mt -128.97 147.27 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.124 -0.985 . . . . 0.0 110.291 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.89 119.95 20.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.952 . . . . 0.0 110.407 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -124.71 178.79 16.38 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 30.5 mttt -146.49 158.51 43.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -1.088 . . . . 0.0 109.842 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.661 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.55 146.91 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.069 -1.019 . . . . 0.0 110.581 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.651 ' C ' HG22 ' A' ' 79' ' ' THR . 1.4 m-20 -106.92 159.79 16.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.532 -0.73 . . . . 0.0 109.534 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.1 OUTLIER -136.24 151.63 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 0.0 110.286 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.16 103.91 3.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.385 -0.822 . . . . 0.0 110.513 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 65.4 mt -132.34 153.18 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 110.136 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.29 97.16 1.35 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.384 -0.823 . . . . 0.0 109.851 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -173.54 -179.73 1.91 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 110.165 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -103.16 108.01 19.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.096 -1.003 . . . . 0.0 110.295 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.474 ' O ' HG12 ' A' ' 125' ' ' VAL . 12.5 t -76.82 100.01 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.296 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.417 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 1.6 m120 62.65 42.08 8.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.222 -0.924 . . . . 0.0 110.519 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.1 36.49 24.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.08 106.21 4.48 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.155 -1.203 . . . . 0.0 110.12 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -51.18 115.19 1.89 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.695 1.366 . . . . 0.0 110.251 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -114.9 116.87 29.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 110.473 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.38 133.95 47.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.398 -0.814 . . . . 0.0 109.775 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.473 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 2.3 t80 -149.79 119.38 6.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.161 -0.962 . . . . 0.0 109.937 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -165.98 75.36 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.248 -0.908 . . . . 0.0 110.034 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.03 -165.24 2.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 110.448 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 1.6 p-80 -122.26 154.33 37.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 110.361 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 45.6 m-85 -154.94 135.06 13.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.31 -0.869 . . . . 0.0 110.033 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 138' ' ' ILE . 50.8 p30 -87.77 166.45 14.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.325 -0.859 . . . . 0.0 110.525 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 137' ' ' ASN . 5.9 pt -156.48 167.25 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.12 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.452 HG23 ' HG3' ' A' ' 112' ' ' LYS . 85.0 m -91.76 115.44 28.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.323 -0.861 . . . . 0.0 111.059 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.816 ' CE2' HD11 ' A' ' 83' ' ' ILE . 15.6 m-85 -90.62 95.79 10.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 109.578 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -87.71 101.94 14.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.05 -1.031 . . . . 0.0 110.742 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 36' ' ' TYR . 22.8 m-85 -93.26 138.87 31.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.31 -0.869 . . . . 0.0 110.251 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -132.38 99.48 4.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.11 -0.994 . . . . 0.0 110.333 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.766 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -159.77 -142.02 3.29 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.416 ' HG2' HD11 ' A' ' 109' ' ' LEU . 11.7 Cg_endo . . . . . 0 C--N 1.31 -1.485 0 O-C-N 123.598 1.315 . . . . 0.0 110.11 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 60.7 m-20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 120.904 0.383 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.25 141.05 13.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 110.569 -179.49 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -172.7 173.06 45.38 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.61 110.63 21.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.258 -1.142 . . . . 0.0 110.402 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.889 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.6 OUTLIER -95.61 155.34 16.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -0.915 . . . . 0.0 110.549 179.793 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.7 t-20 -81.86 135.69 35.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.111 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.895 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -167.09 159.52 13.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.864 -1.147 . . . . 0.0 110.969 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -154.69 -165.82 2.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.398 -0.814 . . . . 0.0 109.795 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.507 ' CG2' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -141.16 174.42 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 110.632 -179.914 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 50.6 m-85 -148.56 157.29 43.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.401 -0.812 . . . . 0.0 109.889 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.466 ' HG3' ' CG2' ' A' ' 43' ' ' THR . 12.8 tppt? -67.73 136.4 54.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 110.223 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.467 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -61.46 146.54 48.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.178 -0.951 . . . . 0.0 109.354 179.577 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 8.3 t30 72.02 2.83 4.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.851 -0.53 . . . . 0.0 110.79 -179.141 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.466 ' CG2' ' HG3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -136.62 -166.65 1.93 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.932 -1.105 . . . . 0.0 109.559 179.207 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.445 ' N ' ' OG1' ' A' ' 43' ' ' THR . 25.6 t30 -130.93 15.87 5.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 110.302 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.59 139.07 41.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 110.843 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.465 ' CG2' ' CB ' ' A' ' 50' ' ' ASN . 0.3 OUTLIER -70.43 134.76 48.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.075 179.141 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.462 ' OG ' HD12 ' A' ' 48' ' ' ILE . 4.7 t -129.28 -18.26 3.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.009 -1.077 . . . . 0.0 112.193 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.462 HD12 ' OG ' ' A' ' 47' ' ' SER . 1.1 mp -138.19 -49.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.773 -1.204 . . . . 0.0 110.976 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.94 8.5 10.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.537 -0.727 . . . . 0.0 111.475 -178.8 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.465 ' CB ' ' CG2' ' A' ' 46' ' ' THR . 0.5 OUTLIER -71.78 -33.93 69.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.901 -1.124 . . . . 0.0 110.492 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 71.5 m-20 -102.69 15.38 29.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.13 -0.981 . . . . 0.0 110.806 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.702 ' CD1' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -91.13 -18.01 25.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.047 -1.033 . . . . 0.0 110.866 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.507 ' CE1' ' CG2' ' A' ' 38' ' ' VAL . 39.2 p90 -118.3 127.88 54.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.15 -0.969 . . . . 0.0 110.865 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.532 ' CB ' HG21 ' A' ' 71' ' ' THR . 1.7 t30 -73.76 109.85 7.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.746 179.315 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.419 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 2.7 pttt -91.99 161.63 32.88 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.047 -1.033 . . . . 0.0 110.144 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 56.4 Cg_endo -79.54 -175.58 16.77 Favored 'Cis proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.513 -2.286 . . . . 0.0 110.585 -0.031 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.895 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.8 168.06 9.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 0.0 109.894 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.432 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -105.5 116.01 31.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 110.795 -179.798 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.502 ' HB2' HD23 ' A' ' 109' ' ' LEU . 3.9 p90 -96.3 160.96 14.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 0.0 109.355 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -154.72 124.62 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.942 -1.099 . . . . 0.0 110.967 -179.329 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.458 ' CD ' ' HE2' ' A' ' 108' ' ' LYS . 1.2 mtmt -137.62 129.29 28.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.349 -0.845 . . . . 0.0 110.173 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -108.37 63.63 0.61 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.903 . . . . 0.0 110.843 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 46.03 96.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.494 -0.754 . . . . 0.0 111.109 179.329 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.94 12.73 39.15 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.417 ' HB2' ' OH ' ' A' ' 67' ' ' TYR . 6.9 ptpt -171.25 156.8 4.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.166 -1.196 . . . . 0.0 109.735 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.753 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.05 143.28 6.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.034 -1.041 . . . . 0.0 111.517 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -140.26 -160.59 1.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.613 -0.679 . . . . 0.0 109.436 179.94 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -170.14 131.06 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.003 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.432 ' HG2' ' HB3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -98.46 141.98 30.65 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.917 . . . . 0.0 110.322 -179.948 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.1 OUTLIER -114.69 141.27 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.438 -0.789 . . . . 0.0 110.067 -179.872 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.532 HG21 ' CB ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -89.18 134.42 34.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.985 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.635 HG22 ' CE ' ' A' ' 81' ' ' MET . 3.0 t -104.36 124.87 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.867 . . . . 0.0 110.277 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.83 128.94 45.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.011 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.4 m80 62.72 113.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.311 -0.868 . . . . 0.0 110.107 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.2 t -76.47 -13.19 60.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.864 . . . . 0.0 110.677 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -84.0 -56.1 3.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.041 -1.037 . . . . 0.0 110.397 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.532 ' HA ' HD11 ' A' ' 121' ' ' ILE . 4.0 m0 -47.87 -68.07 0.22 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.325 -0.859 . . . . 0.0 110.646 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.752 HD11 HG13 ' A' ' 117' ' ' ILE . 0.6 OUTLIER -88.28 122.15 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.922 . . . . 0.0 110.041 -179.86 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.628 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.19 -27.42 23.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.847 . . . . 0.0 110.926 -179.204 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.18 -179.74 45.93 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.166 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.635 ' CE ' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -152.93 169.68 22.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.508 -0.995 . . . . 0.0 109.987 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -153.91 161.41 42.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.067 -1.021 . . . . 0.0 109.716 179.904 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.895 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -164.5 141.4 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 110.699 -179.672 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.48 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 0.4 OUTLIER 62.89 8.7 3.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.525 -0.734 . . . . 0.0 111.964 179.379 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.24 2.01 28.03 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.349 -1.405 . . . . 0.0 111.424 178.742 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.48 ' NE2' ' CB ' ' A' ' 84' ' ' GLU . 3.2 p80 -135.42 155.95 49.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.518 -1.577 . . . . 0.0 110.964 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -160.49 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.508 -0.745 . . . . 0.0 110.5 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -102.66 150.81 23.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.391 -0.818 . . . . 0.0 110.298 -179.863 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -99.89 125.55 45.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.599 179.519 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.532 HG22 HH21 ' A' ' 100' ' ' ARG . 1.1 pp -67.24 103.11 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.005 -1.059 . . . . 0.0 109.884 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.447 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -95.63 -28.91 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.461 -0.774 . . . . 0.0 110.851 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.5 p -167.05 105.1 0.56 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.96 -1.087 . . . . 0.0 109.982 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.465 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 13.2 ttmt -95.24 106.48 18.52 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.327 -0.858 . . . . 0.0 110.19 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -96.59 95.01 7.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.9 p -77.31 -17.75 58.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 110.434 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.73 -53.67 50.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.025 -1.047 . . . . 0.0 110.101 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -98.0 15.07 25.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -0.88 . . . . 0.0 110.358 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.0 64.93 1.57 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.15 -0.969 . . . . 0.0 110.174 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.93 170.98 15.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.424 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.532 HH21 HG22 ' A' ' 90' ' ' ILE . 6.6 mtp180 -162.18 164.6 27.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.496 -0.752 . . . . 0.0 109.91 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.447 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 94.6 m -140.68 152.12 45.11 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.29 -0.881 . . . . 0.0 109.618 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 1.7 p -143.54 138.84 29.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.989 -1.069 . . . . 0.0 110.65 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -91.69 138.2 31.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.366 -0.834 . . . . 0.0 109.975 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 38.2 m-85 -128.59 129.71 46.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.157 -0.964 . . . . 0.0 110.807 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -90.31 127.53 36.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.392 -0.817 . . . . 0.0 109.395 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.533 HG22 ' N ' ' A' ' 107' ' ' SER . 2.7 p -149.28 168.52 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.001 -1.062 . . . . 0.0 110.832 -179.25 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.533 ' N ' HG22 ' A' ' 106' ' ' VAL . 39.5 t -78.2 110.54 13.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.05 178.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.458 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 47.41 -158.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.46 -0.775 . . . . 0.0 109.86 -178.834 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.577 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -151.27 59.93 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.041 -1.037 . . . . 0.0 110.791 -179.678 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -146.22 56.96 1.19 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.239 -0.913 . . . . 0.0 110.31 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.33 178.96 48.66 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.417 ' CD ' HG23 ' A' ' 139' ' ' THR . 0.1 OUTLIER -81.57 148.32 29.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -1.135 . . . . 0.0 110.395 -179.916 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.1 mm -137.84 150.08 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 110.114 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -76.07 124.63 27.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 109.986 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.487 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -131.88 116.82 1.94 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 82' ' ' SER . 30.8 mtpt -95.44 159.22 15.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -1.106 . . . . 0.0 109.471 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.752 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -158.24 140.55 5.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 120.845 -1.16 . . . . 0.0 111.194 -179.836 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.628 ' C ' HG22 ' A' ' 79' ' ' THR . 15.0 m-20 -108.26 161.11 15.3 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.575 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -131.48 147.62 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.014 -1.054 . . . . 0.0 110.766 -179.434 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 22.6 t80 -152.12 106.45 3.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 110.281 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.532 HD11 ' HA ' ' A' ' 77' ' ' TRP . 2.4 mp -135.03 150.65 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.158 -0.964 . . . . 0.0 110.68 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 1.0 OUTLIER -160.94 96.8 1.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.46 -0.775 . . . . 0.0 109.863 179.856 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.421 ' OE2' HG12 ' A' ' 125' ' ' VAL . 0.9 OUTLIER -173.9 -168.38 0.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 110.508 -179.838 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 0.9 OUTLIER -97.9 84.73 3.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.863 . . . . 0.0 110.346 -179.874 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.421 HG12 ' OE2' ' A' ' 123' ' ' GLU . 16.0 m -77.52 136.62 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 50.39 28.01 3.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.812 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.32 34.21 41.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 4.1 mtpt -145.09 128.82 8.63 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.238 -1.154 . . . . 0.0 110.139 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.403 ' HD3' ' HE3' ' A' ' 124' ' ' LYS . 28.9 Cg_endo -68.95 110.5 2.4 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.658 1.346 . . . . 0.0 110.155 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.403 ' CE2' ' HB2' ' A' ' 132' ' ' TYR . 49.1 t80 -116.15 156.08 27.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.124 -0.985 . . . . 0.0 110.453 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.79 110.39 9.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 109.935 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.575 ' HE2' HG11 ' A' ' 119' ' ' VAL . 1.6 t80 -112.8 127.28 56.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 110.041 -179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -163.4 84.59 0.49 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 110.052 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.45 -169.8 3.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.511 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 4.0 p-80 -119.71 145.66 46.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 110.163 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 38.9 m-85 -155.16 -179.56 8.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 110.104 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.573 ' O ' HG23 ' A' ' 138' ' ' ILE . 2.0 p30 -151.88 172.9 15.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.8 pt -155.8 166.72 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.305 -0.872 . . . . 0.0 110.132 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.417 HG23 ' CD ' ' A' ' 112' ' ' LYS . 86.6 m -91.83 122.24 34.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 111.063 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.895 ' CD2' HD11 ' A' ' 83' ' ' ILE . 6.3 m-85 -90.02 162.5 15.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.302 -0.874 . . . . 0.0 109.625 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 101.31 2.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.055 -1.028 . . . . 0.0 110.819 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -91.34 133.85 35.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.299 -0.876 . . . . 0.0 109.518 179.227 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.44 ' C ' HD21 ' A' ' 34' ' ' LEU . 8.3 m120 -128.56 108.63 10.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 110.64 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.889 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -160.36 -145.5 4.3 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.562 ' HD2' HD11 ' A' ' 34' ' ' LEU . 11.0 Cg_endo . . . . . 0 C--N 1.307 -1.638 0 O-C-N 123.626 1.33 . . . . 0.0 110.063 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 8.8 m-20 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.907 0.384 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 p -160.02 159.05 31.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -0.995 . . . . 0.0 110.529 -179.607 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.51 176.19 35.21 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.94 105.96 18.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.283 -1.128 . . . . 0.0 110.369 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.829 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -95.82 157.26 15.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.128 -0.982 . . . . 0.0 110.847 -179.844 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -80.24 138.45 36.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.344 -0.848 . . . . 0.0 110.483 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.794 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -165.24 155.53 13.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.209 179.498 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -155.52 -177.4 6.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.0 110.101 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.746 ' O ' HG22 ' A' ' 46' ' ' THR . 2.2 m -140.21 116.74 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 0.0 110.356 179.511 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -92.35 169.56 10.47 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.421 -0.799 . . . . 0.0 110.38 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.457 ' CD ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -67.41 125.82 27.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.887 . . . . 0.0 109.716 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.493 ' O ' HG23 ' A' ' 43' ' ' THR . 0.5 OUTLIER -48.58 143.28 5.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.286 -0.884 . . . . 0.0 110.53 -179.46 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 18.6 t30 73.77 -2.47 2.76 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.038 -0.414 . . . . 0.0 111.468 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.47 -163.88 1.51 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.782 -1.199 . . . . 0.0 110.053 179.523 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -136.59 30.92 2.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.559 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -134.3 119.81 19.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.082 -1.011 . . . . 0.0 110.983 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.746 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -57.95 121.61 10.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.472 -0.767 . . . . 0.0 109.63 179.245 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.73 -19.18 3.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.767 -1.208 . . . . 0.0 112.227 -179.242 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.457 HD11 ' CD ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -138.92 -77.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.536 -1.353 . . . . 0.0 111.108 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -46.17 -25.67 0.64 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.702 -0.623 . . . . 0.0 111.269 -179.228 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.513 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 1.3 p30 -66.34 -14.65 62.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.988 -1.07 . . . . 0.0 110.917 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.63 15.27 29.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.083 -1.011 . . . . 0.0 111.182 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -138.79 13.4 2.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.831 -1.168 . . . . 0.0 111.002 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CE1' ' HA ' ' A' ' 50' ' ' ASN . 4.8 p90 -125.81 129.18 48.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.019 . . . . 0.0 110.4 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.41 157.11 37.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 110.297 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -148.27 155.4 42.93 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 110.062 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.407 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 56.8 Cg_endo -79.81 -174.97 15.52 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.762 -2.183 . . . . 0.0 110.351 -0.671 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.794 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.51 169.13 9.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -0.954 . . . . 0.0 110.164 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.44 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -103.15 115.84 31.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.498 -179.868 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.5 p90 -97.76 164.32 12.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.922 . . . . 0.0 109.916 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -155.45 129.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 110.275 179.903 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.431 ' HG2' ' HB2' ' A' ' 66' ' ' LEU . 1.2 mtmp? -140.05 112.74 7.99 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.485 -0.759 . . . . 0.0 110.196 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 62.23 2.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.109 -0.994 . . . . 0.0 110.593 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 46.03 99.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.604 -0.685 . . . . 0.0 111.63 179.287 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.05 -21.64 43.74 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.084 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.87 167.45 20.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -1.139 . . . . 0.0 110.35 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.711 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.1 pt? -171.62 145.46 2.02 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.553 179.318 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.566 ' C ' HG12 ' A' ' 68' ' ' VAL . 1.1 m-85 -142.45 -167.1 2.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.68 -0.637 . . . . 0.0 109.43 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.566 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -165.28 129.63 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.126 -0.984 . . . . 0.0 110.419 179.374 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.44 ' HG2' ' CB ' ' A' ' 58' ' ' LYS . 12.1 pt20 -99.57 132.52 44.85 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.832 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.5 HD12 ' CG2' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -117.04 130.66 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 110.195 -179.713 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.8 m -88.56 127.68 35.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.907 . . . . 0.0 109.797 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -102.01 141.9 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.829 . . . . 0.0 110.167 -179.663 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -99.72 148.48 24.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.323 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 7.9 m80 52.43 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.46 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.14 -29.82 61.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 0.0 110.104 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -53.3 14.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.395 -0.816 . . . . 0.0 110.118 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.773 ' O ' HG12 ' A' ' 119' ' ' VAL . 35.0 m0 -51.71 -70.43 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.344 -0.847 . . . . 0.0 110.286 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 78' ' ' ILE . 3.9 tt -88.23 116.91 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 109.927 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.701 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -87.3 -22.55 25.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -0.841 . . . . 0.0 110.937 -179.18 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.43 170.66 42.79 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.311 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.578 ' CG ' HD11 ' A' ' 78' ' ' ILE . 4.0 mtm -153.07 107.1 3.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.428 -1.042 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.84 163.91 17.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 110.136 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.708 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.5 OUTLIER -152.42 144.65 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.376 -0.827 . . . . 0.0 110.0 179.83 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.53 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 64.67 10.71 6.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.096 -1.002 . . . . 0.0 110.997 179.868 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.9 15.6 53.83 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.623 179.281 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.614 ' CE1' ' O ' ' A' ' 83' ' ' ILE . 3.2 p80 -135.08 159.47 41.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.821 -1.399 . . . . 0.0 110.546 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 176.71 4.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.403 -0.811 . . . . 0.0 111.008 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 7.4 pt-20 -104.02 170.25 8.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 0.0 110.508 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.7 OUTLIER -112.06 128.34 56.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 110.157 -179.927 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.71 103.56 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.097 -1.002 . . . . 0.0 109.586 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 101' ' ' THR . 1.4 tt -94.47 -27.24 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.344 -0.847 . . . . 0.0 110.872 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -167.03 100.86 0.54 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.184 -0.947 . . . . 0.0 109.808 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 21.5 ttmt -95.67 107.17 19.35 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.327 -0.858 . . . . 0.0 110.211 -179.607 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.47 68.3 2.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.027 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.94 -27.52 44.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.282 -0.886 . . . . 0.0 110.229 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.42 -47.44 84.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 0.0 110.126 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -96.71 17.54 16.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.263 -0.898 . . . . 0.0 110.435 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 52.7 57.98 5.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 110.247 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -148.28 174.42 12.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.164 -0.96 . . . . 0.0 110.527 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.442 ' O ' HG13 ' A' ' 72' ' ' VAL . 3.2 ttm180 -170.16 162.65 8.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.356 -0.84 . . . . 0.0 110.207 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.52 ' O ' HG22 ' A' ' 91' ' ' ILE . 91.0 m -142.13 153.78 44.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 109.801 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -145.8 144.93 30.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.96 -1.088 . . . . 0.0 110.927 -179.818 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -93.43 141.8 28.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.353 -0.842 . . . . 0.0 109.719 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.523 ' HB2' HG13 ' A' ' 68' ' ' VAL . 97.9 m-85 -130.16 141.63 50.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.006 . . . . 0.0 111.18 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.32 127.89 50.54 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.711 ' O ' HD21 ' A' ' 66' ' ' LEU . 2.6 p -149.89 149.59 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.036 -1.04 . . . . 0.0 111.351 -178.509 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 101.58 0.72 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.159 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.658 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 55.1 174.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 108.899 -177.919 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.96 70.66 1.11 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.782 -1.199 . . . . 0.0 111.004 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -147.32 64.39 1.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.469 -0.77 . . . . 0.0 110.191 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 177.54 -112.59 0.38 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.676 -1.25 . . . . 0.0 109.986 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.468 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.4 OUTLIER -157.35 137.58 12.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -1.165 . . . . 0.0 110.167 -179.628 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.518 HD13 HG21 ' A' ' 106' ' ' VAL . 12.0 mt -135.21 151.93 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.98 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -76.01 125.18 28.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.164 -0.96 . . . . 0.0 110.5 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.478 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -133.43 178.73 18.02 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 2.1 mtpp -142.34 166.89 23.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -1.186 . . . . 0.0 109.745 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.55 HG22 ' HA ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -158.83 140.59 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.877 -1.14 . . . . 0.0 110.751 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.701 ' C ' HG22 ' A' ' 79' ' ' THR . 1.2 m-20 -107.42 160.62 15.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.553 -0.717 . . . . 0.0 109.375 179.296 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -136.97 149.81 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.058 -1.026 . . . . 0.0 110.582 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.41 106.51 3.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.305 -0.872 . . . . 0.0 110.602 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 77' ' ' TRP . 3.0 mp -137.99 148.68 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -0.901 . . . . 0.0 110.258 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.9 95.69 1.19 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.351 -0.843 . . . . 0.0 109.738 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.47 -178.97 1.77 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.374 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -98.12 102.27 13.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 110.308 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.742 HG21 ' CD2' ' A' ' 130' ' ' PHE . 13.4 t -76.74 97.42 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 110.303 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.8 m120 57.48 50.84 10.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.268 -0.895 . . . . 0.0 110.423 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.9 36.63 57.35 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.434 ' HE3' ' CA ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -145.75 103.08 4.21 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.195 -1.179 . . . . 0.0 110.186 179.819 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -49.91 117.85 3.39 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.785 1.413 . . . . 0.0 110.227 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.742 ' CD2' HG21 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -111.81 110.3 20.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 110.453 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -106.08 107.48 18.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -0.886 . . . . 0.0 110.079 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.446 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 3.6 t80 -134.54 129.29 34.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.051 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -174.27 82.28 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.168 -0.957 . . . . 0.0 110.234 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -153.44 -160.54 1.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.169 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -122.5 148.46 45.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.257 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -155.14 -179.33 7.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.681 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.618 ' O ' HG23 ' A' ' 138' ' ' ILE . 46.2 p-10 -151.67 173.02 15.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 110.984 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.5 pt -157.58 172.39 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 110.356 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.468 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 59.9 m -91.66 124.06 35.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.346 -0.846 . . . . 0.0 110.56 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.708 ' CD2' HD11 ' A' ' 83' ' ' ILE . 31.5 m-85 -91.2 104.47 17.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.233 -0.917 . . . . 0.0 109.996 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -97.62 105.7 17.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.202 -0.936 . . . . 0.0 110.741 -179.703 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.42 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 67.7 m-85 -92.45 158.8 15.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.285 -0.884 . . . . 0.0 110.519 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.464 ' C ' HD21 ' A' ' 34' ' ' LEU . 18.9 m120 -145.49 104.0 3.87 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.094 -1.004 . . . . 0.0 110.479 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.829 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -164.34 -146.77 4.87 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.506 ' HD2' HD11 ' A' ' 34' ' ' LEU . 20.3 Cg_endo . . . . . 0 C--N 1.308 -1.605 0 O-C-N 123.802 1.422 . . . . 0.0 110.412 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 12.8 m-20 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 120.782 0.325 . . . . 0.0 110.308 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -159.36 155.23 26.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.037 -1.039 . . . . 0.0 110.589 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.79 171.76 35.66 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.67 111.14 21.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -1.12 . . . . 0.0 110.54 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.521 HD13 HD22 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -94.46 148.86 21.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 0.0 109.877 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.446 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 22.4 m-20 -79.56 137.94 37.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.224 -0.922 . . . . 0.0 110.199 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.732 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 1.8 p90 -166.57 164.01 17.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.187 -0.946 . . . . 0.0 110.83 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.25 -179.41 8.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.472 -0.768 . . . . 0.0 109.64 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.806 HG13 ' O ' ' A' ' 139' ' ' THR . 69.0 t -140.21 111.21 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.093 -1.004 . . . . 0.0 110.217 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -89.04 166.17 14.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.758 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.2 OUTLIER -67.18 125.15 25.15 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 110.109 -179.766 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.53 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -51.14 144.0 9.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 110.058 -179.906 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.9 OUTLIER 72.02 1.36 3.89 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.818 -0.551 . . . . 0.0 111.108 -179.536 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -135.66 -166.69 1.9 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.894 -1.129 . . . . 0.0 109.752 179.233 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -135.18 18.7 3.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.937 . . . . 0.0 110.196 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -136.19 126.41 26.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.114 -0.991 . . . . 0.0 111.088 -179.552 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.454 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -53.9 124.95 16.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -0.834 . . . . 0.0 108.903 178.951 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.3 -18.77 3.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.73 -1.231 . . . . 0.0 112.202 -178.705 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.3 mt -138.55 -78.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.751 -1.218 . . . . 0.0 110.776 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -45.99 -25.68 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.696 -0.627 . . . . 0.0 111.24 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.454 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -56.48 -18.12 10.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.037 -1.039 . . . . 0.0 111.073 -179.597 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -101.91 15.21 29.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.976 -1.078 . . . . 0.0 111.006 -179.316 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -141.87 10.74 2.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.935 -1.103 . . . . 0.0 111.031 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -118.69 115.44 24.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.091 -1.006 . . . . 0.0 110.136 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.31 152.36 42.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 110.408 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -147.2 158.26 44.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 109.848 179.896 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 58.7 Cg_endo -79.57 -175.65 16.9 Favored 'Cis proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.714 -2.203 . . . . 0.0 110.585 -0.367 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.732 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -102.47 164.05 11.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.062 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.447 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 1.4 mtpt -102.44 118.09 36.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.931 . . . . 0.0 110.524 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.514 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 27.2 p90 -97.3 164.47 12.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.862 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -156.31 117.03 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.033 -1.042 . . . . 0.0 110.632 -179.681 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.508 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -127.49 122.15 32.65 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.157 -0.965 . . . . 0.0 110.365 179.885 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 63' ' ' ASN . 1.7 mmmp? -101.46 61.97 0.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 0.0 110.155 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 62' ' ' LYS . 5.1 t-20 47.78 100.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.435 -0.791 . . . . 0.0 111.434 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.11 -15.53 57.83 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.207 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.461 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -144.28 169.36 18.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.009 -1.289 . . . . 0.0 110.532 179.827 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.699 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.6 pt? -169.58 144.26 2.91 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.367 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.541 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -137.47 -169.08 2.44 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.727 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -165.72 131.27 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 110.012 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.497 ' NE2' HG21 ' A' ' 101' ' ' THR . 0.0 OUTLIER -98.12 130.21 44.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 -179.932 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.587 HD11 ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -111.61 135.01 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.69 179.94 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.6 m -89.68 125.52 35.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.082 -1.011 . . . . 0.0 110.067 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.59 143.41 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 110.207 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -100.57 128.52 46.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.354 -0.841 . . . . 0.0 110.615 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 61.24 115.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 0.0 110.499 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -43.08 57.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.0 110.037 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -50.82 -39.37 53.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 109.99 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.497 ' O ' HG12 ' A' ' 119' ' ' VAL . 23.8 m0 -64.77 -73.45 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 110.062 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.31 119.13 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 109.987 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.827 HG22 ' O ' ' A' ' 118' ' ' ASP . 3.7 t -86.88 -21.65 26.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 111.001 -179.346 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 81' ' ' MET . . . -172.17 169.93 42.98 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.451 -1.356 . . . . 0.0 110.125 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 3.5 mtm -151.87 106.11 3.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -1.106 . . . . 0.0 110.04 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -86.58 158.48 19.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 109.863 179.66 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.757 HD11 ' CE1' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -156.25 135.63 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.5 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.5 ' HG3' HG12 ' A' ' 106' ' ' VAL . 0.6 OUTLIER 65.29 6.22 3.51 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.451 -0.781 . . . . 0.0 112.018 179.489 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.18 -0.57 22.51 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.332 -1.413 . . . . 0.0 111.328 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.474 ' NE2' ' HB3' ' A' ' 84' ' ' GLU . 2.6 p80 -131.72 158.08 42.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.557 -1.555 . . . . 0.0 110.881 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -70.55 -164.24 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.5 -0.75 . . . . 0.0 110.505 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 1.2 pm0 -104.61 164.07 12.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 110.544 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -115.38 133.96 55.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.913 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.427 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 1.2 pp -68.06 101.71 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.995 -1.065 . . . . 0.0 109.792 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 101' ' ' THR . 2.3 tt -95.71 -28.2 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.338 -0.851 . . . . 0.0 110.732 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.7 p -167.03 103.35 0.55 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 109.776 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -95.08 147.51 23.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.357 -0.84 . . . . 0.0 110.174 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.31 71.39 1.33 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 110.125 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.16 -32.7 62.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.372 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -42.78 99.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.224 -0.923 . . . . 0.0 110.16 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -95.98 10.38 37.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -0.904 . . . . 0.0 110.608 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 50.95 56.87 7.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.97 -1.081 . . . . 0.0 110.181 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -147.61 179.65 7.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.45 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -174.86 162.02 3.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.401 -0.812 . . . . 0.0 109.984 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.573 ' O ' HG22 ' A' ' 91' ' ' ILE . 82.8 m -140.61 156.02 46.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.331 -0.855 . . . . 0.0 109.552 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.45 ' OG ' HG22 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -143.23 140.02 30.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.982 -1.073 . . . . 0.0 110.82 -179.582 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -93.56 137.59 32.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.717 . . . . 0.0 110.194 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 81.7 m-85 -128.59 140.98 51.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.08 -1.012 . . . . 0.0 110.748 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.467 ' C ' HG13 ' A' ' 106' ' ' VAL . 2.0 tt0 -102.52 131.54 49.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.86 . . . . 0.0 109.335 179.109 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.699 ' O ' HD21 ' A' ' 66' ' ' LEU . 35.7 m -149.16 147.63 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.135 -0.978 . . . . 0.0 110.833 -179.203 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.51 108.25 1.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 109.141 179.12 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.672 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 54.39 176.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -0.95 . . . . 0.0 109.118 -178.646 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.521 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -148.9 72.09 1.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.968 -1.082 . . . . 0.0 110.792 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -145.59 44.58 1.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.471 -0.768 . . . . 0.0 109.984 179.66 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . -174.29 177.25 46.55 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.436 ' CD ' HG23 ' A' ' 139' ' ' THR . 0.6 OUTLIER -80.51 145.95 31.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.233 -1.157 . . . . 0.0 110.637 -179.701 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.418 ' N ' ' HE3' ' A' ' 112' ' ' LYS . 74.9 mt -136.17 150.75 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.35 -0.844 . . . . 0.0 109.781 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -76.48 132.26 39.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.06 -1.025 . . . . 0.0 110.428 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.437 ' HA3' ' CD2' ' A' ' 140' ' ' TYR . . . -132.94 169.84 22.36 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 82' ' ' SER . 22.4 mtmt -144.01 162.23 36.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.069 -1.253 . . . . 0.0 109.529 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.487 HG21 HG12 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -159.31 153.44 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.907 -1.121 . . . . 0.0 111.034 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.827 ' O ' HG22 ' A' ' 79' ' ' THR . 84.3 m-20 -115.31 154.23 29.52 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.63 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.502 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -129.48 143.76 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.058 -1.026 . . . . 0.0 110.55 -179.652 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.92 99.99 2.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -0.826 . . . . 0.0 110.118 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.7 mt -123.24 152.55 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.612 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.89 96.54 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.399 -0.813 . . . . 0.0 109.812 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -173.5 -170.67 0.62 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.945 . . . . 0.0 110.509 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.97 103.5 15.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 110.347 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 21.6 t -76.85 102.72 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 110.333 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 53.86 43.14 31.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.311 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.23 32.17 44.43 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 125' ' ' VAL . 5.2 mtmt -145.5 102.3 4.31 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.228 -1.16 . . . . 0.0 110.116 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -46.68 120.73 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.702 1.369 . . . . 0.0 110.517 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -124.95 148.51 48.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 0.0 110.058 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -134.69 106.35 6.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.271 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.502 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 4.7 t80 -110.62 131.48 55.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 110.098 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.29 88.04 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.895 . . . . 0.0 110.069 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.34 -168.33 2.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.268 -0.895 . . . . 0.0 110.288 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -117.65 141.67 48.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.974 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -155.51 -179.26 7.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 110.195 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.449 ' HA ' HG22 ' A' ' 117' ' ' ILE . 0.6 OUTLIER -151.18 176.38 11.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -0.951 . . . . 0.0 110.378 179.902 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.487 HG12 HG21 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -155.7 179.59 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 110.085 -179.761 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.806 ' O ' HG13 ' A' ' 38' ' ' VAL . 15.5 m -91.06 161.5 15.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.817 . . . . 0.0 111.086 -179.171 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.757 ' CE1' HD11 ' A' ' 83' ' ' ILE . 23.1 m-85 -147.82 98.81 3.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.575 -0.703 . . . . 0.0 109.3 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 10.9 tttt -116.86 110.19 18.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.244 -0.91 . . . . 0.0 110.955 -179.259 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -92.56 152.73 19.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.403 -0.811 . . . . 0.0 110.089 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 35' ' ' ASN . 3.4 m-80 -128.98 104.64 7.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.922 . . . . 0.0 110.214 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -153.26 -144.52 3.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.458 ' HD2' HD11 ' A' ' 109' ' ' LEU . 10.1 Cg_endo . . . . . 0 C--N 1.309 -1.55 0 O-C-N 123.608 1.32 . . . . 0.0 110.644 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.11 0.481 . . . . 0.0 110.209 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 p -159.74 129.85 5.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.408 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.52 177.8 48.33 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.45 105.54 17.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.205 -1.173 . . . . 0.0 110.221 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.762 HD13 HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -93.79 151.37 19.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.378 -0.826 . . . . 0.0 110.154 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.451 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 23.0 m120 -79.06 145.55 33.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.921 . . . . 0.0 110.14 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -163.92 156.01 17.07 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.189 -0.945 . . . . 0.0 110.177 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -155.44 -176.76 6.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 110.043 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.449 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -140.16 174.41 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.159 -0.963 . . . . 0.0 110.267 179.991 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.449 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 47.3 m-85 -147.96 160.19 43.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.416 -0.802 . . . . 0.0 110.153 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.81 121.33 15.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.859 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.532 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -48.75 148.97 1.91 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 -179.72 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 8.5 t30 72.47 1.43 3.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.968 -0.458 . . . . 0.0 111.085 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -136.05 -155.98 0.67 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.789 -1.195 . . . . 0.0 109.902 179.297 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -136.13 10.77 3.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.335 -0.853 . . . . 0.0 110.491 179.609 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -134.28 148.95 50.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.015 . . . . 0.0 110.845 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.438 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -79.83 138.44 37.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.319 179.547 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.97 -17.91 3.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.961 -1.087 . . . . 0.0 111.899 -179.041 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.5 mt -137.96 -71.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.764 -1.21 . . . . 0.0 110.709 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.519 ' HB1' ' HE2' ' A' ' 53' ' ' PHE . . . -46.11 -26.53 0.77 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.691 -0.631 . . . . 0.0 111.023 -179.426 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.414 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -59.7 -19.65 51.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.128 -0.983 . . . . 0.0 110.715 -179.595 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -102.32 14.82 30.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.97 -1.081 . . . . 0.0 110.868 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -128.79 6.15 5.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.984 -1.073 . . . . 0.0 111.075 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.519 ' HE2' ' HB1' ' A' ' 49' ' ' ALA . 33.8 m-85 -129.76 117.01 19.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 110.34 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -72.77 166.82 22.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.97 . . . . 0.0 110.301 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -148.18 159.57 39.32 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 110.011 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -82.48 -175.64 15.35 Favored 'Cis proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.648 -2.23 . . . . 0.0 110.394 -0.411 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.97 170.23 8.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 110.002 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.3 tmtm? -103.03 108.38 19.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 110.525 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.492 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 6.3 p90 -97.97 162.25 13.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 109.75 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -154.8 155.22 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.15 -0.969 . . . . 0.0 110.373 -179.665 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.7 mtpt -135.94 168.89 18.49 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.339 -0.851 . . . . 0.0 110.606 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.441 ' CB ' ' HG3' ' A' ' 65' ' ' LYS . 10.4 mttm -148.0 61.97 1.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 0.0 109.834 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.409 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 10.5 t-20 45.69 78.07 0.07 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.47 -0.769 . . . . 0.0 110.925 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.09 19.42 16.89 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HG3' ' CB ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -168.07 162.83 13.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.146 -1.208 . . . . 0.0 110.38 179.546 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.596 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.3 pt? -173.42 150.18 1.8 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.2 1.0 . . . . 0.0 111.74 178.706 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.592 ' C ' HG12 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -139.94 -164.83 1.77 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.023 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.592 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -170.17 144.01 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.0 110.692 179.356 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.419 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 9.2 pt20 -99.75 132.87 44.82 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.924 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -110.57 133.1 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.852 . . . . 0.0 109.8 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.532 ' O ' HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -89.27 123.08 33.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.145 -0.972 . . . . 0.0 110.26 -179.542 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.581 ' HB ' HG21 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -104.29 147.09 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.357 -0.839 . . . . 0.0 109.857 179.999 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -99.49 141.91 31.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 0.0 110.49 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 77' ' ' TRP . 9.6 m-70 53.62 92.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 m -52.35 -31.28 32.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 110.232 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -71.11 -45.53 63.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.219 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.466 ' CG ' ' HB3' ' A' ' 74' ' ' HIS . 45.6 m0 -55.64 -62.77 1.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.318 -0.864 . . . . 0.0 110.303 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.658 HD11 ' SD ' ' A' ' 81' ' ' MET . 0.5 OUTLIER -88.37 120.26 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.448 -0.783 . . . . 0.0 109.915 -179.727 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.675 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -89.16 -27.21 20.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.347 -0.846 . . . . 0.0 111.073 -179.217 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.57 172.02 43.78 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.258 -1.449 . . . . 0.0 110.535 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.658 ' SD ' HD11 ' A' ' 78' ' ' ILE . 1.8 mtp -153.05 110.95 3.6 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.522 -0.987 . . . . 0.0 109.859 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.419 ' O ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -86.56 123.04 31.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.975 -1.078 . . . . 0.0 110.031 179.947 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.7 HD12 ' CG ' ' A' ' 104' ' ' PHE . 1.7 mt -113.1 131.07 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 110.259 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 2.3 tm-20 69.62 5.51 5.23 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.493 -0.755 . . . . 0.0 110.99 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.25 23.89 10.86 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.728 -1.225 . . . . 0.0 111.0 178.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.47 ' C ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.39 162.37 34.6 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.673 -1.486 . . . . 0.0 110.149 179.359 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -175.68 1.18 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.96 . . . . 0.0 110.199 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.482 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 5.1 pt-20 -110.17 167.03 10.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 110.341 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 102' ' ' SER . 3.5 t-20 -114.09 130.7 56.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.361 -0.837 . . . . 0.0 109.918 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.401 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 1.1 pp -67.69 100.89 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 0.0 109.674 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.667 HG21 HG22 ' A' ' 101' ' ' THR . 2.4 tt -95.36 -23.3 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 110.566 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -167.06 100.18 0.53 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -94.54 142.5 27.37 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.914 -179.47 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.423 ' HB3' ' HB2' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -142.59 74.12 1.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 110.33 -179.747 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.0 p -65.07 -31.16 72.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.062 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.65 -50.07 72.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.852 . . . . 0.0 110.226 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -95.43 13.62 25.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.259 -0.9 . . . . 0.0 110.426 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.65 60.56 3.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 110.276 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 94' ' ' ASN . 23.4 mt-10 -147.54 150.41 34.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 0.0 110.418 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.405 ' O ' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -152.47 157.08 40.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.353 -0.842 . . . . 0.0 109.951 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.667 HG22 HG21 ' A' ' 91' ' ' ILE . 60.4 m -141.09 154.8 46.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.306 -0.871 . . . . 0.0 109.75 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 1.8 p -145.57 139.75 26.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.007 -1.058 . . . . 0.0 111.044 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 57.2 tt0 -93.06 138.65 31.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.46 -0.775 . . . . 0.0 109.429 179.399 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.7 ' CG ' HD12 ' A' ' 83' ' ' ILE . 93.5 m-85 -128.5 145.72 51.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.883 -1.136 . . . . 0.0 111.34 -179.234 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.519 ' C ' HG13 ' A' ' 106' ' ' VAL . 57.5 tt0 -105.72 130.41 53.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.42 -0.8 . . . . 0.0 109.048 178.953 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.596 ' O ' HD21 ' A' ' 66' ' ' LEU . 34.1 m -150.31 170.34 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.918 -1.113 . . . . 0.0 111.36 -178.71 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.3 m -74.59 111.02 9.36 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.509 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.523 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 45.7 -163.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.591 -0.693 . . . . 0.0 109.673 -178.355 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.762 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.03 56.88 0.9 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.911 -1.118 . . . . 0.0 110.871 -179.549 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -145.58 70.2 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 0.0 110.001 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.89 176.57 38.0 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.458 ' HE3' ' N ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -81.78 142.91 32.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -1.115 . . . . 0.0 110.34 -179.972 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.664 HD12 ' CD2' ' A' ' 142' ' ' PHE . 53.0 mt -137.34 153.52 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 110.041 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.38 128.3 34.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.231 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.452 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -138.62 123.25 2.56 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 10.5 mttm -96.76 163.74 12.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -1.175 . . . . 0.0 109.703 179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.431 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -159.22 133.18 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.879 -1.138 . . . . 0.0 111.171 179.895 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.675 ' C ' HG22 ' A' ' 79' ' ' THR . 93.6 m-20 -108.35 165.61 11.38 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.835 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -141.45 153.2 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.965 -1.085 . . . . 0.0 110.648 -179.644 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.421 ' CE1' ' OD2' ' A' ' 122' ' ' ASP . 6.4 t80 -151.82 109.63 3.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -0.806 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 46.2 mt -134.71 152.92 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.961 . . . . 0.0 110.349 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.421 ' OD2' ' CE1' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -160.48 98.07 1.24 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.389 -0.819 . . . . 0.0 109.622 179.602 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -173.2 -168.52 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 110.398 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 10.5 mttp -103.58 97.46 7.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 110.474 -179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.8 125.0 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.253 -0.905 . . . . 0.0 110.222 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 52.9 25.29 3.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.293 -0.879 . . . . 0.0 110.198 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 85.94 33.82 14.44 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 38.5 mtmt -144.61 134.43 11.66 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.313 -1.11 . . . . 0.0 110.0 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.47 127.85 25.21 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.631 1.332 . . . . 0.0 110.474 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -131.07 113.18 13.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.357 -0.84 . . . . 0.0 110.123 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.25 104.45 14.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.187 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.461 ' HB3' ' HB ' ' A' ' 121' ' ' ILE . 3.1 t80 -114.93 124.27 51.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.905 . . . . 0.0 109.943 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 48.2 p-10 -171.03 86.47 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.328 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -153.3 -168.95 3.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.905 . . . . 0.0 110.189 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.4 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.3 OUTLIER -119.8 148.61 43.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.336 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.4 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 12.4 m-85 -155.67 -178.56 7.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 0.0 110.245 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.442 ' O ' HG23 ' A' ' 138' ' ' ILE . 12.3 p30 -150.04 171.45 16.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.89 . . . . 0.0 110.275 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -156.46 166.21 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 0.0 110.413 -179.739 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.403 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 59.8 m -91.77 120.45 32.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 0.0 110.437 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.452 ' CD1' ' HA3' ' A' ' 115' ' ' GLY . 11.6 m-85 -90.38 161.82 15.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.59 102.7 2.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.908 . . . . 0.0 110.388 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.664 ' CD2' HD12 ' A' ' 113' ' ' ILE . 90.0 m-85 -91.72 154.91 18.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.922 . . . . 0.0 110.155 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 35' ' ' ASN . 15.2 m120 -143.0 98.45 3.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.716 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -153.62 -146.81 4.47 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo . . . . . 0 C--N 1.308 -1.581 0 O-C-N 123.776 1.408 . . . . 0.0 110.451 -179.922 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 9.8 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 120.766 0.317 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -160.14 159.76 32.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.021 -1.049 . . . . 0.0 110.911 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 165.24 172.73 33.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.37 115.21 25.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.156 -1.202 . . . . 0.0 110.381 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.552 HD13 HD22 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -95.88 141.72 28.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.134 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -78.99 135.88 37.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 109.924 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.444 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -165.71 171.67 12.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 110.715 -179.948 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -155.23 -176.78 6.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.442 -0.786 . . . . 0.0 110.081 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 46' ' ' THR . 1.4 m -141.27 108.37 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 0.0 109.94 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -93.2 162.64 13.94 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 110.637 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.437 ' CG ' HG21 ' A' ' 43' ' ' THR . 12.7 tppt? -67.52 140.81 57.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.599 -0.688 . . . . 0.0 110.043 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.46 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -64.57 147.75 52.21 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.011 -1.056 . . . . 0.0 109.247 179.413 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.1 t-20 70.95 3.04 4.47 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.701 -0.625 . . . . 0.0 110.746 -179.046 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -137.36 -168.28 2.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.911 -1.118 . . . . 0.0 109.446 179.182 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.441 ' N ' ' OG1' ' A' ' 43' ' ' THR . 65.3 t30 -128.55 12.29 6.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.931 -1.106 . . . . 0.0 110.491 179.69 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -136.29 133.04 36.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.055 -1.028 . . . . 0.0 110.467 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.626 HG21 ' CB ' ' A' ' 50' ' ' ASN . 6.0 t -63.56 139.43 58.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.088 -1.007 . . . . 0.0 109.068 179.154 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.402 ' HB3' ' HE3' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -129.39 -17.53 3.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 112.015 -179.013 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.7 mt -137.94 -50.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.785 -1.197 . . . . 0.0 110.845 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -57.74 -54.72 43.69 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.567 -0.708 . . . . 0.0 111.717 -178.854 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.626 ' CB ' HG21 ' A' ' 46' ' ' THR . 4.8 t-20 -47.47 -25.04 0.96 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.141 -0.974 . . . . 0.0 110.988 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -73.32 -2.44 22.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -0.988 . . . . 0.0 111.168 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -144.78 28.78 1.26 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.823 -1.173 . . . . 0.0 110.892 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.457 ' CE2' ' HB1' ' A' ' 49' ' ' ALA . 11.3 m-85 -130.97 109.47 10.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.944 . . . . 0.0 110.244 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -72.45 150.15 43.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.328 -0.857 . . . . 0.0 110.415 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.79 168.09 12.25 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.321 -0.862 . . . . 0.0 109.924 -179.994 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.436 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 44.6 Cg_endo -76.57 -175.66 17.04 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.692 -2.211 . . . . 0.0 110.683 -0.201 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.45 168.38 9.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 110.137 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.49 119.91 39.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.17 -0.956 . . . . 0.0 110.562 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.528 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 27.4 p90 -96.93 164.25 12.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 109.676 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.615 HG23 ' HD1' ' A' ' 67' ' ' TYR . 1.0 OUTLIER -156.37 116.4 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.951 -1.093 . . . . 0.0 111.165 -179.603 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.512 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -127.6 119.48 26.05 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.359 -0.838 . . . . 0.0 110.037 179.655 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.38 62.52 1.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.571 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.41 96.18 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.46 -0.775 . . . . 0.0 111.229 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.54 10.52 43.91 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.58 160.84 11.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.963 -1.316 . . . . 0.0 109.877 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.708 HD11 ' N ' ' A' ' 108' ' ' LYS . 1.7 pt? -166.18 141.78 4.76 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.636 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.615 ' HD1' HG23 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -139.64 -178.03 5.22 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.496 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -156.11 131.92 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.986 -1.071 . . . . 0.0 110.341 179.83 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 7.8 pt20 -97.3 133.12 42.33 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.291 -0.881 . . . . 0.0 109.936 179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -114.73 131.22 67.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.179 -0.951 . . . . 0.0 109.502 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 m -87.52 116.57 25.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.131 -0.981 . . . . 0.0 110.481 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.553 ' HB ' HD13 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -104.01 143.62 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.403 -0.811 . . . . 0.0 109.996 179.883 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -101.05 156.26 17.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.161 -0.962 . . . . 0.0 110.348 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.513 ' O ' HG22 ' A' ' 78' ' ' ILE . 17.0 m170 51.49 86.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 110.324 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.426 ' HB2' ' CD ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -65.36 -30.12 70.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 0.0 110.054 179.907 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -63.78 -34.5 78.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.88 . . . . 0.0 110.319 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.539 ' O ' HG13 ' A' ' 119' ' ' VAL . 27.4 m0 -77.74 -58.02 3.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.702 HD11 ' HG3' ' A' ' 81' ' ' MET . 8.8 tt -88.87 121.07 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.911 179.84 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 118' ' ' ASP . 1.0 OUTLIER -86.66 -24.83 25.13 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.248 -0.908 . . . . 0.0 110.867 -179.344 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.55 -179.19 48.75 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.308 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.702 ' HG3' HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -152.68 114.79 4.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.441 -1.035 . . . . 0.0 110.12 -179.989 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -85.78 156.34 20.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.146 -0.971 . . . . 0.0 110.406 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' A' ' 104' ' ' PHE . 1.4 mt -156.74 134.27 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.404 -0.81 . . . . 0.0 110.111 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 69.85 3.37 4.27 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.528 -0.732 . . . . 0.0 111.488 179.735 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.94 22.2 11.13 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.22 178.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.457 ' C ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.66 161.81 35.51 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.676 -1.485 . . . . 0.0 110.143 179.276 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -70.33 -169.54 0.31 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.127 -0.983 . . . . 0.0 110.475 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.23 169.71 8.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 110.259 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.05 128.66 49.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 110.236 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 90' ' ' ILE . 1.6 pp -68.33 101.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.773 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 101' ' ' THR . 1.5 tt -94.84 -28.32 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 110.441 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.8 m -166.39 98.88 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.901 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -95.31 106.38 18.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.455 -0.778 . . . . 0.0 110.017 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.1 101.87 13.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 110.227 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -78.96 -28.99 43.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 110.22 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.44 -51.04 69.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.15 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -96.2 15.75 20.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 110.41 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.66 23.23 3.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.115 -0.991 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -92.77 177.91 5.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 110.461 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.503 ' HB3' HG22 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -179.35 151.76 0.5 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.457 -0.777 . . . . 0.0 109.658 179.948 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.487 ' O ' HG22 ' A' ' 91' ' ' ILE . 86.1 m -141.46 158.03 44.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 110.257 -179.568 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.5 p -145.24 143.16 30.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -0.98 . . . . 0.0 110.452 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -93.26 143.44 26.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.29 -0.881 . . . . 0.0 110.031 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.47 ' CD2' HD12 ' A' ' 83' ' ' ILE . 30.3 m-85 -129.91 132.26 46.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.133 -0.98 . . . . 0.0 110.874 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.499 ' C ' HG13 ' A' ' 106' ' ' VAL . 16.4 mt-10 -92.31 128.92 38.34 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.308 -0.87 . . . . 0.0 109.624 179.409 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.553 ' O ' HD21 ' A' ' 66' ' ' LEU . 34.3 m -149.9 144.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.012 -1.055 . . . . 0.0 111.059 -179.327 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.36 109.8 1.71 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.928 . . . . 0.0 108.944 178.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.708 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 54.16 175.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 109.24 -178.585 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.552 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -149.98 71.45 1.08 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.006 -1.059 . . . . 0.0 110.871 -179.853 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 7.2 t30 -146.14 40.33 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.387 -0.821 . . . . 0.0 110.185 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . -169.42 -170.73 34.29 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.34 145.51 30.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -1.131 . . . . 0.0 110.476 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mm -137.65 138.14 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.432 -0.793 . . . . 0.0 109.971 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -76.16 123.07 25.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.185 -0.947 . . . . 0.0 110.361 -179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.463 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -134.86 175.79 20.36 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 38.9 mttt -144.7 176.85 9.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -1.182 . . . . 0.0 109.886 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.464 HG22 ' HA ' ' A' ' 137' ' ' ASN . 0.2 OUTLIER -158.47 144.45 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.922 -1.111 . . . . 0.0 111.157 179.926 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.712 ' O ' HG22 ' A' ' 79' ' ' THR . 1.1 m-20 -108.98 156.89 19.2 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.441 -0.787 . . . . 0.0 109.041 178.522 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 77' ' ' TRP . 2.6 t -141.72 151.86 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.016 -1.053 . . . . 0.0 110.705 -179.307 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.454 ' CZ ' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -151.14 104.37 3.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.436 -0.79 . . . . 0.0 110.268 179.97 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.491 HD12 ' CD2' ' A' ' 132' ' ' TYR . 5.0 mt -133.06 153.25 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.134 -0.979 . . . . 0.0 110.084 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.69 95.93 1.23 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 110.12 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.486 ' HG2' ' CE1' ' A' ' 130' ' ' PHE . 7.6 pt-20 -174.48 -155.77 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.445 ' HG2' ' CA ' ' A' ' 129' ' ' PRO . 9.3 mtmt -122.59 127.21 49.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.646 HG23 ' CD1' ' A' ' 130' ' ' PHE . 80.8 t -76.18 90.65 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.145 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 52.04 27.38 4.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 0.0 110.245 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 117.87 31.8 1.54 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 5.1 mtpt -145.29 90.9 5.97 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.219 -1.166 . . . . 0.0 110.066 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.445 ' CA ' ' HG2' ' A' ' 124' ' ' LYS . 27.6 Cg_exo -56.86 123.14 13.13 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.014 1.534 . . . . 0.0 110.314 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.646 ' CD1' HG23 ' A' ' 125' ' ' VAL . 14.7 p90 -147.7 132.69 18.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.221 -0.924 . . . . 0.0 110.262 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -103.94 132.54 50.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 110.027 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.491 ' CD2' HD12 ' A' ' 121' ' ' ILE . 4.1 t80 -125.63 130.96 52.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.377 -0.827 . . . . 0.0 110.003 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.454 ' OD2' ' CZ ' ' A' ' 120' ' ' TYR . 62.5 t0 -169.43 84.62 0.13 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -0.931 . . . . 0.0 110.008 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.72 -177.03 6.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.384 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.455 ' CD2' ' O ' ' A' ' 135' ' ' HIS . 28.4 p-80 -120.49 89.52 3.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 110.294 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -84.76 -179.41 7.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 109.813 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 10.3 p30 -151.21 168.24 25.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.037 -1.039 . . . . 0.0 110.876 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -156.66 178.88 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -0.81 . . . . 0.0 110.845 -179.707 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 140' ' ' TYR . 94.8 m -91.53 162.7 14.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.538 -0.727 . . . . 0.0 110.586 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.463 ' CE2' ' HA3' ' A' ' 115' ' ' GLY . 96.4 m-85 -145.4 105.25 4.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.373 -0.829 . . . . 0.0 109.717 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.4 OUTLIER -103.98 109.13 20.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 110.797 -179.484 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 110' ' ' ASN . 74.2 m-85 -91.79 145.84 24.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.603 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -133.81 109.17 8.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.035 -1.04 . . . . 0.0 110.63 -179.446 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.412 ' HA3' ' HD2' ' A' ' 145' ' ' PRO . . . -153.71 -135.47 2.13 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.429 ' HD2' ' CD1' ' A' ' 109' ' ' LEU . 6.1 Cg_endo . . . . . 0 C--N 1.312 -1.352 0 O-C-N 123.399 1.21 . . . . 0.0 110.025 179.743 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 6.7 m-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.983 0.42 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.72 153.86 23.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 110.325 -179.668 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.32 179.5 42.46 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.03 109.41 20.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.176 -1.19 . . . . 0.0 110.404 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.935 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.2 OUTLIER -94.36 151.69 19.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.397 -0.815 . . . . 0.0 109.955 179.926 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.497 ' H ' HD13 ' A' ' 34' ' ' LEU . 4.9 m120 -79.4 136.6 37.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.152 -0.967 . . . . 0.0 109.509 179.626 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.554 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -164.98 159.1 17.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.092 -1.005 . . . . 0.0 110.366 -179.852 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.37 -179.83 8.47 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.417 -0.802 . . . . 0.0 109.653 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.778 ' O ' HG22 ' A' ' 46' ' ' THR . 3.3 m -139.74 117.48 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.128 -0.982 . . . . 0.0 110.118 179.642 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -90.6 161.41 15.44 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.35 -0.843 . . . . 0.0 110.668 -179.629 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HZ2' HG22 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.05 135.42 52.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.605 -0.684 . . . . 0.0 110.243 -179.75 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.473 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -61.56 144.76 53.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 110.082 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.4 t-20 70.7 3.21 4.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.789 -0.57 . . . . 0.0 110.728 -179.204 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -139.0 -169.72 2.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.033 -1.042 . . . . 0.0 109.638 179.48 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.404 ' N ' ' OG1' ' A' ' 43' ' ' THR . 1.6 m120 -136.08 24.59 3.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.112 -0.992 . . . . 0.0 110.295 179.677 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -136.13 120.65 18.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 111.146 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.778 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -49.64 121.61 5.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.532 -0.73 . . . . 0.0 109.359 178.961 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.73 -18.83 3.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.833 -1.167 . . . . 0.0 112.293 -178.892 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.0 mt -138.99 -78.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.59 -1.319 . . . . 0.0 111.214 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.3 -26.65 0.54 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.634 -0.666 . . . . 0.0 111.508 -179.058 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.436 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -63.98 -16.33 61.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.029 -1.044 . . . . 0.0 110.765 -179.582 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -102.58 15.44 29.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.082 -1.011 . . . . 0.0 110.853 -179.65 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -130.38 12.14 5.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.072 -1.017 . . . . 0.0 111.014 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.427 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 23.8 m-85 -131.28 116.9 18.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.026 -1.046 . . . . 0.0 110.314 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.404 ' HB3' HG21 ' A' ' 71' ' ' THR . 12.9 t-20 -72.4 108.47 5.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.258 -0.901 . . . . 0.0 110.323 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.419 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -93.88 159.65 34.08 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 109.943 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 56.0 Cg_endo -78.76 -175.78 17.38 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.753 -2.186 . . . . 0.0 110.65 -0.261 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.554 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -102.1 171.56 7.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 109.984 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.418 ' HB2' ' HG3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -105.55 112.14 25.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.074 -1.016 . . . . 0.0 110.684 -179.706 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.757 ' CE1' HD23 ' A' ' 34' ' ' LEU . 11.1 p90 -96.95 167.1 11.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.217 -0.927 . . . . 0.0 109.965 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.513 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -156.39 120.96 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.172 -0.955 . . . . 0.0 110.981 179.941 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.1 mtmp? -137.77 127.36 25.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.282 -0.886 . . . . 0.0 110.078 179.614 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -108.59 62.33 0.61 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 110.425 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.68 103.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.434 -0.791 . . . . 0.0 111.343 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.28 -20.3 50.81 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.003 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.39 154.96 48.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.026 -1.279 . . . . 0.0 110.661 -179.677 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.802 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -157.02 142.99 17.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 111.195 179.446 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.532 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 4.0 m-85 -139.36 -172.85 3.45 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -163.39 130.06 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.95 -1.093 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.418 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 3.7 pt20 -98.59 136.28 38.91 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.589 179.293 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -114.76 132.61 63.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.15 -0.969 . . . . 0.0 110.172 -179.452 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.565 ' O ' HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.12 120.48 31.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.699 179.955 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.417 ' H ' HG13 ' A' ' 72' ' ' VAL . 0.8 OUTLIER -103.28 136.89 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 110.042 -179.72 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -99.92 147.15 25.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 110.335 -179.668 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 21.9 m80 58.1 92.12 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.433 -0.792 . . . . 0.0 110.231 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.77 -40.1 87.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 110.284 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.9 m170 -62.52 -27.7 69.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 110.266 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.661 ' O ' HG12 ' A' ' 119' ' ' VAL . 38.9 m0 -72.24 -73.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.998 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 78' ' ' ILE . 6.9 tt -88.06 116.47 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.378 -0.826 . . . . 0.0 109.316 179.552 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.769 HG22 ' C ' ' A' ' 118' ' ' ASP . 1.6 t -86.56 -21.4 26.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.284 -0.885 . . . . 0.0 111.615 -178.573 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 117' ' ' ILE . . . -173.52 168.74 41.74 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.307 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.474 ' HG3' HD11 ' A' ' 78' ' ' ILE . 1.8 mtm -153.17 105.21 2.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.375 -1.074 . . . . 0.0 109.993 179.717 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' LYS . 3.7 t -86.65 157.15 19.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 0.0 110.111 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.528 HG22 ' CE1' ' A' ' 86' ' ' HIS . 0.3 OUTLIER -153.88 151.75 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.132 179.805 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.521 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 1.3 mm-40 57.73 17.69 4.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.049 -1.032 . . . . 0.0 110.717 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.15 16.95 63.76 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.45 179.45 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.528 ' CE1' HG22 ' A' ' 83' ' ' ILE . 3.0 p80 -137.59 159.69 41.26 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.8 -1.412 . . . . 0.0 110.829 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -71.7 169.99 14.45 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.544 -0.723 . . . . 0.0 110.802 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -89.28 168.12 12.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.344 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 102' ' ' SER . 12.8 m120 -111.48 127.2 55.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.288 -0.882 . . . . 0.0 110.248 -179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pp -67.99 104.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.144 -0.973 . . . . 0.0 109.623 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 101' ' ' THR . 1.4 tt -95.89 -30.09 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 111.235 -179.15 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.7 p -166.86 101.75 0.56 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.936 -1.103 . . . . 0.0 110.49 -179.593 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.406 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 10.0 ttmt -96.69 146.75 24.59 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.422 -0.799 . . . . 0.0 109.972 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.55 110.12 5.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.153 -0.967 . . . . 0.0 110.31 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.0 m -81.49 -40.49 23.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.861 . . . . 0.0 110.411 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.72 -33.41 75.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.216 -0.928 . . . . 0.0 110.284 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 0.3 OUTLIER -96.05 -10.68 27.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 110.541 179.926 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 97' ' ' LYS . 1.2 t0 62.31 53.99 2.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.041 -1.037 . . . . 0.0 110.046 -179.883 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -146.98 179.42 7.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 110.429 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.406 ' HG3' ' CG ' ' A' ' 93' ' ' LYS . 9.8 ttm180 -172.04 159.92 5.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.978 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.521 ' O ' HG22 ' A' ' 91' ' ' ILE . 91.2 m -141.52 153.31 44.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 109.728 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 24.7 p -145.03 140.58 28.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.012 -1.055 . . . . 0.0 110.704 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -93.4 148.14 22.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 109.99 179.672 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.402 ' CD1' ' HB ' ' A' ' 83' ' ' ILE . 97.0 m-85 -128.8 150.38 50.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.141 -0.974 . . . . 0.0 110.721 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.403 ' OE2' ' N ' ' A' ' 106' ' ' VAL . 7.1 tp10 -110.99 123.88 51.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.381 -0.825 . . . . 0.0 109.792 179.626 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.676 ' O ' HD11 ' A' ' 66' ' ' LEU . 9.5 p -149.36 165.54 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.433 ' N ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -56.74 -41.27 77.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.133 -0.98 . . . . 0.0 109.795 179.604 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.457 ' CE ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -164.05 -146.23 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.353 179.403 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.866 HD22 ' HG ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -151.81 56.35 0.85 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.809 -1.182 . . . . 0.0 110.647 -179.403 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 145' ' ' PRO . 10.5 t-20 -146.59 93.74 2.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -0.87 . . . . 0.0 110.232 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 148.51 -119.68 1.1 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.462 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.0 OUTLIER -156.72 112.68 2.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -1.139 . . . . 0.0 110.264 -179.688 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mm -102.73 139.93 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.231 -0.918 . . . . 0.0 110.023 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.21 123.36 25.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.035 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -132.57 179.73 17.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 28.6 mtmm -144.29 166.29 25.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -1.131 . . . . 0.0 109.707 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.442 ' HB ' ' CG ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -158.73 144.06 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.933 -1.105 . . . . 0.0 110.721 179.991 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.769 ' C ' HG22 ' A' ' 79' ' ' THR . 5.8 m-20 -107.25 159.53 16.28 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.456 -0.778 . . . . 0.0 108.941 178.77 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -141.5 148.49 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.024 -1.047 . . . . 0.0 110.658 -179.464 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -152.09 104.02 2.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.381 -0.824 . . . . 0.0 110.045 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.439 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 44.4 mt -128.96 152.54 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 110.117 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -159.94 97.33 1.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 0.0 109.735 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -173.55 -169.11 0.48 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 110.304 -179.624 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 3.6 mmtm -112.01 102.61 10.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.87 . . . . 0.0 110.184 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.554 ' O ' HG12 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -76.69 118.22 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -0.877 . . . . 0.0 110.235 -179.903 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.94 26.77 6.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.365 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.65 5.52 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -145.38 107.35 4.44 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.202 -1.175 . . . . 0.0 110.139 179.809 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -51.13 109.8 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.694 1.365 . . . . 0.0 110.368 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 132' ' ' TYR . 11.3 t80 -110.02 146.25 35.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.175 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -133.62 99.18 4.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.284 -0.885 . . . . 0.0 110.214 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.447 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 2.5 t80 -115.12 129.1 56.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.125 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.62 81.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.953 . . . . 0.0 110.256 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -153.13 -165.28 2.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.16 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.42 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -118.3 143.43 46.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.109 -0.994 . . . . 0.0 110.29 179.866 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.42 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 32.2 m-85 -155.25 -179.47 8.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.381 -0.824 . . . . 0.0 109.826 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.512 ' O ' HG23 ' A' ' 138' ' ' ILE . 20.6 p30 -151.27 178.64 9.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 110.345 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 137' ' ' ASN . 0.5 OUTLIER -156.98 167.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 110.764 -179.73 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.462 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 94.1 m -91.75 121.25 33.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.46 -0.775 . . . . 0.0 110.37 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.493 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 43.2 m-85 -90.59 95.72 10.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.071 -1.018 . . . . 0.0 110.235 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.1 OUTLIER -91.92 104.26 16.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.458 -179.853 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' A' ' 140' ' ' TYR . 67.9 m-85 -92.93 158.75 15.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.325 -0.859 . . . . 0.0 110.295 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.451 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 10.3 m120 -139.72 97.36 3.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.105 -0.997 . . . . 0.0 110.651 -179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.935 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -161.91 -152.66 6.78 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.43 ' O ' ' CB ' ' A' ' 110' ' ' ASN . 18.8 Cg_endo . . . . . 0 C--N 1.309 -1.532 0 O-C-N 123.893 1.47 . . . . 0.0 110.241 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 13.3 m-20 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 59' ' ' TYR . 16.2 t -160.46 153.24 21.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.983 -1.073 . . . . 0.0 110.853 -179.5 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' CD2' ' A' ' 59' ' ' TYR . . . 171.18 176.76 40.55 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -91.76 109.5 20.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -1.158 . . . . 0.0 110.601 179.99 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.823 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -95.78 156.77 16.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.97 -1.081 . . . . 0.0 110.442 179.663 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.454 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 33.8 m-20 -79.92 139.83 36.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 110.246 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.647 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -165.84 160.66 17.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.945 . . . . 0.0 110.015 179.734 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -155.59 -175.8 5.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 0.0 110.447 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.689 HG12 ' O ' ' A' ' 139' ' ' THR . 0.0 OUTLIER -140.89 166.76 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.324 -0.86 . . . . 0.0 109.834 179.728 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.464 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 51.1 m-85 -147.56 161.55 40.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.084 -1.01 . . . . 0.0 110.545 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.556 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.1 OUTLIER -68.34 135.12 51.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.371 -0.831 . . . . 0.0 109.896 179.96 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.527 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -60.71 146.8 44.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.201 -179.82 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER 70.55 4.63 5.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.789 -0.569 . . . . 0.0 110.892 -179.453 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.556 HG21 ' HG2' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -135.18 -163.86 1.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.868 -1.145 . . . . 0.0 109.764 179.377 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.414 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.2 OUTLIER -130.34 11.73 5.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.461 179.637 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -135.27 148.89 49.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.025 -1.047 . . . . 0.0 110.592 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.568 HG21 ' HB2' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -78.32 137.27 37.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.504 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.54 -17.54 3.68 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.037 -179.075 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 60.5 mt -137.57 -69.73 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.708 -1.245 . . . . 0.0 110.868 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.447 ' O ' ' CD2' ' A' ' 53' ' ' PHE . . . -45.48 -26.5 0.58 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.627 -0.671 . . . . 0.0 111.241 -179.347 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.568 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -68.08 -9.13 43.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.076 -1.015 . . . . 0.0 110.823 -179.773 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.479 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 1.6 m-20 -99.26 14.8 28.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.029 -1.045 . . . . 0.0 110.852 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.479 ' CE2' ' HB2' ' A' ' 51' ' ' ASP . 36.6 m-85 -142.27 11.61 1.95 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.945 -1.097 . . . . 0.0 110.824 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 25.9 m-85 -132.62 107.46 8.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.06 -1.025 . . . . 0.0 110.584 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -72.72 167.91 19.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.14 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.418 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.42 164.73 22.91 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.955 . . . . 0.0 109.973 179.798 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 55.6 Cg_endo -78.23 -175.32 16.48 Favored 'Cis proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.565 -2.265 . . . . 0.0 110.588 -0.153 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.647 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -100.24 170.16 8.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 109.693 179.805 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.472 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -101.37 119.69 39.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 110.586 -179.644 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.52 ' CD1' ' HD2' ' A' ' 61' ' ' LYS . 13.7 p90 -97.81 162.97 13.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.118 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 1.9 tt -157.07 109.81 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.315 -0.866 . . . . 0.0 110.541 179.633 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.52 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -128.59 137.86 51.91 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.167 -0.958 . . . . 0.0 110.347 179.89 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.76 62.25 0.99 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 110.13 179.457 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 45.97 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.493 -0.754 . . . . 0.0 111.28 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.44 -8.42 58.6 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.458 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.19 158.54 44.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.916 -1.344 . . . . 0.0 110.428 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.769 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.2 pt? -169.49 148.54 3.79 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.156 -0.965 . . . . 0.0 111.233 179.191 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.787 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -140.73 -163.26 1.5 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.63 -0.669 . . . . 0.0 109.639 -179.638 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 67' ' ' TYR . 1.4 t -168.3 124.82 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 110.047 179.62 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.472 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -97.3 130.97 44.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.212 -0.93 . . . . 0.0 109.789 179.758 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.467 HG22 ' OG ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -111.48 141.54 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.83 . . . . 0.0 110.205 -179.344 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.5 m -89.69 123.52 33.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.794 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.892 HG12 HG21 ' A' ' 78' ' ' ILE . 1.4 t -102.3 131.8 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 110.358 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.47 143.85 30.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 110.382 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.576 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER 55.97 97.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.299 -0.875 . . . . 0.0 110.388 179.893 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -69.53 -18.03 63.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -0.932 . . . . 0.0 110.338 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.97 -47.37 18.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.255 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.53 ' O ' HG12 ' A' ' 119' ' ' VAL . 46.5 m0 -61.44 -59.33 5.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 110.569 -179.882 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.892 HG21 HG12 ' A' ' 72' ' ' VAL . 5.7 tt -88.67 122.69 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.09 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.596 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.99 -26.74 23.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.359 -0.838 . . . . 0.0 110.832 -179.368 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.9 180.0 47.58 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.625 -1.274 . . . . 0.0 109.921 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.593 ' HG3' HD11 ' A' ' 78' ' ' ILE . 25.8 mtm -151.6 163.31 39.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.338 -1.096 . . . . 0.0 110.118 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 116' ' ' LYS . 23.1 t -155.4 137.47 14.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.365 -0.834 . . . . 0.0 110.02 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 1.6 mt -136.23 141.28 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.263 -0.898 . . . . 0.0 110.362 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 72.67 -0.25 3.4 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.755 -0.591 . . . . 0.0 111.399 179.972 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.12 22.39 8.8 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.589 -1.291 . . . . 0.0 111.288 178.8 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.47 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.42 159.52 41.85 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.628 -1.513 . . . . 0.0 110.215 179.353 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -173.53 0.92 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.142 -0.974 . . . . 0.0 110.448 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 1.2 pt-20 -108.76 170.13 8.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.0 110.267 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 102' ' ' SER . 10.4 m120 -120.6 125.41 47.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.933 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -67.52 102.55 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.962 -1.086 . . . . 0.0 109.749 179.967 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.428 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.2 tt -94.87 -28.11 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 0.0 110.553 -179.354 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 23.7 m -166.48 96.1 0.56 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.411 -0.805 . . . . 0.0 109.829 -179.742 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -95.99 109.99 22.29 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 110.292 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.04 83.86 3.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 110.281 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.8 p -65.32 -30.99 71.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -0.929 . . . . 0.0 110.322 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.21 84.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.936 . . . . 0.0 110.09 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.81 17.49 15.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.3 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 49.59 60.39 3.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.239 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -147.33 177.98 8.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 110.242 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER 179.87 159.63 0.79 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.899 . . . . 0.0 110.072 -179.845 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.428 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 95.7 m -137.19 154.84 50.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.962 . . . . 0.0 109.808 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.467 ' OG ' HG22 ' A' ' 70' ' ' ILE . 3.7 p -145.11 139.45 27.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 110.712 -179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.5 tt0 -93.57 144.36 25.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 110.13 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 93.5 m-85 -128.94 146.7 50.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.19 -0.944 . . . . 0.0 110.534 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -101.88 129.84 48.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.364 -0.835 . . . . 0.0 109.607 179.439 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.769 ' O ' HD21 ' A' ' 66' ' ' LEU . 9.0 p -149.49 139.41 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.094 -1.004 . . . . 0.0 111.022 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.9 t -63.96 102.25 0.46 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.143 -0.973 . . . . 0.0 108.5 178.527 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.573 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 56.58 171.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 108.833 -177.968 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.429 ' H ' HD12 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -147.94 76.96 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.952 -1.093 . . . . 0.0 110.853 -179.427 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -146.01 64.17 1.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.447 -0.783 . . . . 0.0 109.846 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.08 -171.92 38.96 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.01 140.27 34.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.318 -1.107 . . . . 0.0 110.564 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.703 HD12 ' CD2' ' A' ' 142' ' ' PHE . 12.9 mt -136.0 150.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.321 -0.862 . . . . 0.0 109.739 179.623 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.33 127.46 32.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 -179.846 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -132.37 169.25 22.33 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -146.74 159.79 43.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -1.156 . . . . 0.0 110.096 179.981 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.401 ' O ' HD13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -157.99 143.66 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.105 -0.997 . . . . 0.0 110.591 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.596 ' C ' HG22 ' A' ' 79' ' ' THR . 13.8 m-20 -106.53 159.76 15.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.433 -0.792 . . . . 0.0 109.263 179.249 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.635 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -135.06 149.31 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.04 -1.037 . . . . 0.0 110.814 -179.582 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.412 ' HB2' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -151.72 107.63 3.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.46 -0.775 . . . . 0.0 109.859 179.715 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.474 HG12 ' HA ' ' A' ' 77' ' ' TRP . 28.6 mt -135.22 153.12 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.408 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.78 101.09 1.46 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.468 -0.77 . . . . 0.0 109.455 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -173.23 -165.14 0.26 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.235 -0.916 . . . . 0.0 110.442 -179.592 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.631 ' O ' HG23 ' A' ' 125' ' ' VAL . 8.0 ttmt -95.76 165.81 12.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.647 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 124' ' ' LYS . 6.8 t -158.41 93.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 65.53 30.5 10.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.386 -0.822 . . . . 0.0 109.603 -179.11 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.61 39.42 10.74 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -147.48 106.55 3.79 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.149 -1.206 . . . . 0.0 110.371 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.62 114.71 1.3 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.69 1.363 . . . . 0.0 109.953 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.464 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 10.5 t80 -97.78 141.36 30.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 110.451 -179.482 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -134.4 99.12 4.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 109.847 179.838 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.635 ' HE2' HG11 ' A' ' 119' ' ' VAL . 1.7 t80 -112.91 124.27 52.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.064 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.409 ' OD2' ' CZ ' ' A' ' 120' ' ' TYR . 53.7 t0 -170.24 84.39 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 109.926 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -154.16 -165.02 1.99 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 110.555 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.47 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 74.2 m-70 -117.87 152.32 35.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.852 . . . . 0.0 109.692 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.47 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 66.0 m-85 -155.11 -178.97 7.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.938 . . . . 0.0 110.331 -179.761 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.547 ' O ' HG23 ' A' ' 138' ' ' ILE . 2.1 p30 -150.16 164.93 34.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 110.166 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.2 pt -156.24 172.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.337 -0.852 . . . . 0.0 110.35 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.689 ' O ' HG12 ' A' ' 38' ' ' VAL . 10.9 m -91.76 162.28 14.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.412 -0.805 . . . . 0.0 110.576 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.463 ' CE1' ' CG1' ' A' ' 38' ' ' VAL . 12.0 m-85 -145.52 108.15 4.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.388 -0.82 . . . . 0.0 110.032 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.61 109.82 21.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.37 -0.831 . . . . 0.0 110.521 -179.726 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.703 ' CD2' HD12 ' A' ' 113' ' ' ILE . 80.8 m-85 -91.22 157.02 17.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.082 179.765 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.52 ' C ' HD21 ' A' ' 34' ' ' LEU . 32.3 m120 -138.83 98.37 3.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.197 -0.939 . . . . 0.0 110.398 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.823 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -157.76 -147.24 4.75 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo . . . . . 0 C--N 1.309 -1.526 0 O-C-N 123.807 1.424 . . . . 0.0 110.733 -179.87 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 4.8 m-20 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.972 0.415 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 p -159.13 158.67 33.32 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.272 -0.892 . . . . 0.0 110.779 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 171.5 171.84 37.01 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.91 108.5 19.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -1.216 . . . . 0.0 110.355 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.699 HD13 HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -94.45 152.52 18.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.0 109.995 179.855 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.463 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -78.82 139.57 38.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.139 -0.976 . . . . 0.0 110.425 -179.953 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.684 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -165.65 159.28 16.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.193 -0.942 . . . . 0.0 110.202 179.557 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -155.36 -171.63 3.87 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.338 -0.851 . . . . 0.0 109.699 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -140.85 172.06 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 110.231 179.781 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.421 ' HA ' HG23 ' A' ' 46' ' ' THR . 60.2 m-85 -147.52 157.24 43.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 110.09 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -67.58 139.33 56.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.226 -179.864 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.46 ' O ' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -63.64 147.04 52.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.942 179.853 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 28.3 t30 70.01 4.62 4.89 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.715 -0.616 . . . . 0.0 110.732 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.82 179.67 6.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.976 -1.078 . . . . 0.0 109.776 179.376 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -115.76 12.98 16.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 110.285 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.37 143.38 46.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.109 -0.994 . . . . 0.0 110.613 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.554 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -73.72 139.73 45.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.251 179.48 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -17.8 3.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.001 -1.062 . . . . 0.0 112.189 -178.768 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.54 HG22 ' N ' ' A' ' 49' ' ' ALA . 8.0 mt -137.46 -73.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.781 -1.2 . . . . 0.0 110.787 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.54 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -45.8 -26.13 0.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.612 -0.68 . . . . 0.0 111.14 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.501 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -60.02 -16.81 34.09 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.109 -0.995 . . . . 0.0 110.695 -179.83 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -102.33 15.54 28.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.031 -1.043 . . . . 0.0 111.009 -179.406 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 63.5 m-85 -133.27 7.63 3.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.839 -1.163 . . . . 0.0 111.384 -179.564 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 15.0 p90 -115.64 114.92 25.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.961 -1.087 . . . . 0.0 110.537 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -74.7 106.14 6.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.038 -1.039 . . . . 0.0 110.459 -179.682 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HB3' ' CE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -94.3 160.38 32.03 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 110.228 179.844 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.69 -175.38 15.97 Favored 'Cis proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.548 -2.272 . . . . 0.0 110.733 -0.453 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.684 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.71 164.99 11.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 109.899 179.694 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.11 117.55 34.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.134 -0.978 . . . . 0.0 110.993 -179.536 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 31.5 p90 -98.47 165.63 11.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.319 -0.863 . . . . 0.0 109.799 179.385 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -155.41 122.47 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.988 -1.07 . . . . 0.0 111.139 -179.739 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HE2' HD21 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -140.19 131.86 27.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.258 -0.901 . . . . 0.0 110.331 179.735 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 63' ' ' ASN . 7.1 tttt -111.37 62.08 0.61 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 0.0 110.455 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 62' ' ' LYS . 4.5 m120 49.85 101.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.365 -0.834 . . . . 0.0 111.223 179.578 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.65 -18.48 55.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -140.55 160.19 40.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.248 . . . . 0.0 110.273 179.849 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.747 HD22 ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -163.54 144.77 9.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 111.274 179.852 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 3.4 m-85 -141.57 -159.32 0.95 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.263 -0.898 . . . . 0.0 109.674 -179.771 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -169.92 165.28 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 110.322 179.613 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.414 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 2.0 pt20 -140.97 133.57 28.64 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.382 -0.824 . . . . 0.0 109.894 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.67 140.33 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 110.003 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.8 m -89.09 134.04 34.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.133 -0.979 . . . . 0.0 109.748 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.529 HG12 HG21 ' A' ' 78' ' ' ILE . 2.4 t -102.2 126.55 56.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.395 -0.816 . . . . 0.0 110.407 -179.507 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -99.5 127.9 45.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.263 -0.898 . . . . 0.0 110.046 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 63.32 69.93 0.55 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 109.871 -179.705 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.78 -27.49 63.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.467 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -55.99 -39.34 71.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 0.0 110.54 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.63 ' O ' HG13 ' A' ' 119' ' ' VAL . 24.8 m0 -81.2 -52.61 7.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.379 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.602 HD11 ' SD ' ' A' ' 81' ' ' MET . 20.3 tt -88.87 123.18 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 109.658 179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -87.08 -29.79 21.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.215 -0.928 . . . . 0.0 111.266 -179.001 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.95 175.07 47.28 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 118.998 -1.573 . . . . 0.0 110.701 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.602 ' SD ' HD11 ' A' ' 78' ' ' ILE . 5.2 mtt -152.3 110.49 3.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.654 -0.909 . . . . 0.0 109.784 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 116' ' ' LYS . 1.0 OUTLIER -85.88 157.26 20.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.095 -1.003 . . . . 0.0 110.359 -179.98 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.57 ' O ' ' CE1' ' A' ' 86' ' ' HIS . 1.0 OUTLIER -151.35 149.98 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.381 -0.825 . . . . 0.0 109.758 179.578 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.513 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 0.7 OUTLIER 61.77 14.09 5.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.124 -0.985 . . . . 0.0 110.783 -179.886 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.38 19.92 57.76 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.809 179.163 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.57 ' CE1' ' O ' ' A' ' 83' ' ' ILE . 2.4 p80 -137.47 161.24 36.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.72 -1.459 . . . . 0.0 110.692 179.591 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.76 174.33 7.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.468 -0.77 . . . . 0.0 110.838 -179.521 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 8.2 pt-20 -99.06 167.4 10.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 110.474 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -118.43 134.94 54.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.31 -0.869 . . . . 0.0 110.192 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.07 100.72 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 109.445 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 101' ' ' THR . 2.5 tt -96.32 -25.72 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 110.797 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -167.73 95.07 0.43 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.965 . . . . 0.0 110.138 -179.775 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.459 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 2.4 ttmt -96.34 144.03 26.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.83 93.62 2.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.129 -0.982 . . . . 0.0 110.331 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -76.81 -15.78 59.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.864 . . . . 0.0 110.357 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.83 -28.01 69.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 110.548 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -136.34 25.56 3.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.122 -0.986 . . . . 0.0 110.502 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.87 70.82 0.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.337 179.873 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -147.71 160.51 42.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.141 -0.975 . . . . 0.0 110.003 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.459 ' HG3' ' CG ' ' A' ' 93' ' ' LYS . 1.0 OUTLIER -168.92 162.87 11.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 110.356 -179.777 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.624 ' O ' HG22 ' A' ' 91' ' ' ILE . 57.9 m -142.05 157.81 44.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.45 -0.781 . . . . 0.0 109.229 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 2.0 p -143.9 137.04 27.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.821 -1.174 . . . . 0.0 110.616 -179.761 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -93.0 136.48 33.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.426 -0.796 . . . . 0.0 109.995 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 88.6 m-85 -129.68 144.38 51.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.1 -1.0 . . . . 0.0 110.904 -179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.46 ' C ' HG13 ' A' ' 106' ' ' VAL . 26.8 tt0 -101.11 127.96 47.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.481 -0.762 . . . . 0.0 109.091 179.041 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.636 ' O ' HD21 ' A' ' 66' ' ' LEU . 19.9 m -147.98 163.02 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.914 -1.117 . . . . 0.0 111.075 -178.84 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.67 109.55 7.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.292 -0.88 . . . . 0.0 108.658 178.629 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.459 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 48.84 -159.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.341 -0.85 . . . . 0.0 109.563 -178.577 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.699 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -150.59 60.72 0.94 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.974 -1.079 . . . . 0.0 111.103 -179.489 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 1.7 t30 -146.08 82.12 1.6 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.339 -0.85 . . . . 0.0 109.799 179.482 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.57 170.82 22.09 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.861 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.43 146.14 29.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -1.056 . . . . 0.0 110.458 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.427 HD12 ' CD2' ' A' ' 142' ' ' PHE . 82.6 mt -139.35 149.9 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.942 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.48 142.66 40.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.12 -0.988 . . . . 0.0 110.525 -179.699 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -147.72 127.84 2.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 82' ' ' SER . 10.8 mttt -94.67 168.2 10.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.346 -1.09 . . . . 0.0 109.787 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.423 HD12 ' CG ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -158.9 133.95 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.993 -1.067 . . . . 0.0 110.858 179.481 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.695 ' O ' HG22 ' A' ' 79' ' ' THR . 11.6 m-20 -107.47 163.32 13.15 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.482 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 77' ' ' TRP . 3.8 t -144.14 152.67 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.899 -1.126 . . . . 0.0 110.475 -179.268 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -151.21 113.73 4.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.427 -0.796 . . . . 0.0 110.523 179.915 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' A' ' 132' ' ' TYR . 2.7 mp -138.15 153.71 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.347 -0.845 . . . . 0.0 110.082 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.74 96.99 1.41 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.125 -0.985 . . . . 0.0 110.208 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.43 ' O ' ' CD1' ' A' ' 130' ' ' PHE . 0.4 OUTLIER -174.12 -170.69 0.56 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.395 -0.815 . . . . 0.0 110.151 -179.957 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.31 111.49 23.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.213 -0.929 . . . . 0.0 110.22 -179.875 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.759 HG23 ' CE1' ' A' ' 130' ' ' PHE . 2.7 t -77.12 107.6 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.34 179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.28 38.07 12.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.892 . . . . 0.0 110.495 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 91.72 39.02 5.66 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -144.82 90.07 6.44 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.337 -1.096 . . . . 0.0 109.998 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.03 121.48 9.37 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.97 1.51 . . . . 0.0 110.715 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.759 ' CE1' HG23 ' A' ' 125' ' ' VAL . 11.6 p90 -146.38 166.35 26.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.923 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.68 117.28 14.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 110.43 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.554 ' HB3' HD12 ' A' ' 121' ' ' ILE . 3.8 t80 -102.46 135.0 44.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.394 -0.817 . . . . 0.0 109.705 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -174.39 83.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 0.0 110.16 -179.915 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.91 -162.32 1.41 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.902 . . . . 0.0 110.622 179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -120.28 157.09 29.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.445 -0.785 . . . . 0.0 110.062 179.852 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 34.4 m-85 -155.15 -179.05 7.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.048 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -150.78 165.74 32.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 110.521 -179.884 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.462 HD11 ' HE2' ' A' ' 81' ' ' MET . 0.1 OUTLIER -156.38 159.34 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.464 -0.772 . . . . 0.0 109.815 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 19.9 m -91.61 119.9 31.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.18 -0.95 . . . . 0.0 110.655 -179.456 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.563 ' HA ' HG12 ' A' ' 38' ' ' VAL . 9.5 m-85 -90.39 165.73 13.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.322 -0.861 . . . . 0.0 109.909 179.518 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.89 103.92 1.9 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.467 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.427 ' CD2' HD12 ' A' ' 113' ' ' ILE . 96.4 m-85 -92.2 154.23 18.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.274 -0.891 . . . . 0.0 110.236 179.735 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 48.8 m-80 -141.78 96.9 3.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 110.497 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.592 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -150.86 -151.72 5.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.735 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.401 ' HD2' ' HA3' ' A' ' 144' ' ' GLY . 10.0 Cg_endo . . . . . 0 C--N 1.307 -1.652 0 O-C-N 123.733 1.386 . . . . 0.0 110.287 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 63.6 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.846 0.355 . . . . 0.0 110.386 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.39 150.44 19.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.052 -1.03 . . . . 0.0 110.727 -179.374 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.37 -136.87 3.39 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -149.22 110.5 4.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.162 -1.199 . . . . 0.0 110.348 -179.944 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.003 HD23 ' HB3' ' A' ' 59' ' ' TYR . 2.3 pp -95.06 156.08 16.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.434 -0.791 . . . . 0.0 110.365 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.612 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.4 t30 -79.33 141.69 36.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.37 -0.832 . . . . 0.0 110.068 179.749 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 1.6 p90 -164.01 162.81 23.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.068 -1.02 . . . . 0.0 110.682 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.36 -165.89 2.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.528 -0.732 . . . . 0.0 109.677 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.763 ' C ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -139.92 174.58 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.15 -0.969 . . . . 0.0 110.154 179.703 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.419 ' CE2' ' HG3' ' A' ' 141' ' ' LYS . 14.0 m-85 -147.62 147.29 29.87 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.203 -0.935 . . . . 0.0 109.961 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.466 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -67.58 130.36 42.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.366 -0.834 . . . . 0.0 110.26 -179.592 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.511 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -52.45 145.75 10.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -0.887 . . . . 0.0 110.386 -179.809 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.8 t30 72.79 0.26 3.59 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.884 -0.51 . . . . 0.0 111.074 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.38 -161.99 1.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.871 -1.143 . . . . 0.0 109.749 179.298 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.423 ' N ' ' OG1' ' A' ' 43' ' ' THR . 12.0 p-10 -135.58 15.47 3.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.188 -0.945 . . . . 0.0 110.214 179.592 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -135.14 128.13 31.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 0.0 110.767 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.763 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -57.58 136.35 56.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.45 179.509 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.747 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -128.34 -17.85 4.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.064 -1.023 . . . . 0.0 111.675 -179.194 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.747 HD12 ' HB3' ' A' ' 47' ' ' SER . 1.6 mp -137.78 -71.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.777 -1.202 . . . . 0.0 110.813 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.621 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -45.4 -26.14 0.51 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.693 -0.629 . . . . 0.0 111.27 -179.366 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.455 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -62.47 -13.02 25.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.06 -1.025 . . . . 0.0 111.044 -179.73 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -98.89 13.97 30.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.99 -1.069 . . . . 0.0 110.995 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -135.44 -1.55 2.55 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.907 -1.121 . . . . 0.0 111.574 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.621 ' CE2' ' HB1' ' A' ' 49' ' ' ALA . 16.2 m-30 -111.91 101.12 9.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.961 -1.087 . . . . 0.0 110.249 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.19 113.67 10.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.314 -0.866 . . . . 0.0 110.539 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.444 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 1.0 OUTLIER -93.53 166.67 15.5 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 109.942 179.739 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 60.2 Cg_endo -82.79 -175.55 14.97 Favored 'Cis proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.784 -2.174 . . . . 0.0 110.595 -0.494 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -104.25 162.67 13.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.286 -0.884 . . . . 0.0 109.641 179.467 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HG3' HG23 ' A' ' 33' ' ' THR . 15.1 mttt -98.85 114.73 27.45 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.226 -0.922 . . . . 0.0 110.254 -179.686 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 1.003 ' HB3' HD23 ' A' ' 34' ' ' LEU . 10.7 p90 -97.68 161.64 13.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.123 -0.985 . . . . 0.0 110.609 -179.863 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.594 HG23 ' HD1' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -154.86 127.77 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.9 . . . . 0.0 110.543 -179.632 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.453 ' CD ' ' HE2' ' A' ' 108' ' ' LYS . 2.4 mtmt -137.82 119.42 14.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.183 -0.948 . . . . 0.0 110.438 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -94.74 62.12 2.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.657 -179.998 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 0.1 OUTLIER 49.16 101.54 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.404 -0.81 . . . . 0.0 111.376 179.44 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.56 -21.93 41.97 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.357 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.444 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -135.28 154.5 51.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.175 -1.191 . . . . 0.0 110.138 179.61 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.838 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -156.37 135.99 12.43 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.159 0.98 . . . . 0.0 111.308 179.878 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.594 ' HD1' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -142.17 176.39 9.01 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.417 -0.802 . . . . 0.0 109.144 179.985 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.437 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -150.01 141.58 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.931 -1.106 . . . . 0.0 110.872 179.983 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 102' ' ' SER . 6.0 pt20 -100.09 134.98 42.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.461 -0.774 . . . . 0.0 109.513 179.209 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 101' ' ' THR . 1.1 mm -110.51 131.22 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.725 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.6 m -87.75 127.67 35.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.185 -0.947 . . . . 0.0 110.023 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.643 ' HB ' HD13 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -103.33 144.4 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.833 . . . . 0.0 110.045 -179.644 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -99.36 146.78 25.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.112 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 9.4 m80 53.94 84.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.078 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.8 p -50.35 -33.42 20.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.451 -179.845 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -41.17 74.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 110.384 -179.872 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.669 ' O ' HG12 ' A' ' 119' ' ' VAL . 31.5 m0 -61.15 -63.14 1.39 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 0.0 110.444 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.838 HD11 ' HG3' ' A' ' 81' ' ' MET . 16.4 tt -88.36 118.6 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.144 -0.973 . . . . 0.0 109.765 179.843 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.66 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.85 -23.67 25.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.87 . . . . 0.0 110.964 -179.2 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.38 173.83 44.9 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.447 -1.359 . . . . 0.0 110.153 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.838 ' HG3' HD11 ' A' ' 78' ' ' ILE . 1.2 mtm -153.32 113.58 3.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.339 -1.095 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.74 169.66 13.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.625 HG22 ' CE1' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -169.24 141.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -0.867 . . . . 0.0 110.048 179.785 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.645 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 1.1 tm-20 64.52 11.91 7.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.274 -0.891 . . . . 0.0 110.69 -179.806 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.77 17.45 61.66 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.336 179.528 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.645 ' CD2' ' HB3' ' A' ' 84' ' ' GLU . 2.6 p80 -137.75 160.19 39.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.971 -1.311 . . . . 0.0 110.576 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.91 162.15 29.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.418 -0.801 . . . . 0.0 110.492 -179.674 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.504 ' CB ' ' CE1' ' A' ' 104' ' ' PHE . 12.9 pt-20 -91.2 168.08 11.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.864 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -111.63 133.94 53.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.303 -179.964 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.8 pt -68.01 142.41 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.034 -1.041 . . . . 0.0 109.402 179.463 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.445 HG21 HG22 ' A' ' 101' ' ' THR . 3.0 tt -136.24 -29.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.151 -0.968 . . . . 0.0 111.43 -179.038 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 m -165.34 94.66 0.63 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.982 -1.074 . . . . 0.0 109.743 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -96.39 142.46 28.47 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.322 -0.861 . . . . 0.0 110.062 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.405 ' OD1' ' HB3' ' A' ' 97' ' ' LYS . 7.3 t-20 -141.74 91.57 2.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 72.6 p -71.14 -23.34 62.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 110.245 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.41 54.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.093 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.405 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 3.6 tttt -97.72 13.48 30.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.904 . . . . 0.0 110.413 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.29 62.45 2.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.034 -1.042 . . . . 0.0 110.166 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -147.89 137.29 22.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 0.0 110.43 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.454 ' HG3' ' N ' ' A' ' 101' ' ' THR . 3.2 ttt180 -144.1 162.0 37.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.435 -0.791 . . . . 0.0 109.983 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.454 ' N ' ' HG3' ' A' ' 100' ' ' ARG . 94.0 m -142.14 156.69 45.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 110.371 -179.781 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 2.4 p -145.29 145.35 31.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.183 -0.948 . . . . 0.0 110.271 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -91.55 144.21 25.78 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.296 -0.878 . . . . 0.0 110.041 -179.925 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.504 ' CE1' ' CB ' ' A' ' 88' ' ' GLU . 37.2 m-85 -130.13 135.82 48.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 110.846 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.06 126.19 38.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.34 -0.85 . . . . 0.0 109.424 179.182 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.457 ' O ' HD21 ' A' ' 66' ' ' LEU . 1.2 p -149.59 158.64 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.012 -1.055 . . . . 0.0 110.872 -179.101 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.4 p -69.87 108.88 4.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.937 . . . . 0.0 108.773 178.754 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.453 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 47.87 -153.51 0.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.366 -0.834 . . . . 0.0 109.488 -178.457 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.57 HD22 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.41 61.23 0.89 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.657 -1.277 . . . . 0.0 111.251 -179.093 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -147.37 94.35 2.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.961 . . . . 0.0 110.458 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.58 -123.78 1.61 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.464 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.2 OUTLIER -156.86 150.23 24.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.299 -1.118 . . . . 0.0 109.513 -179.676 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.417 ' N ' ' HG2' ' A' ' 112' ' ' LYS . 1.5 mm -138.53 129.16 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.134 -179.715 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -76.35 131.36 39.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.206 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -142.7 -162.66 9.36 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -146.31 172.45 13.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.224 -1.162 . . . . 0.0 109.741 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.617 HG21 HD13 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.8 140.41 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.115 -0.991 . . . . 0.0 110.477 179.972 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.66 ' C ' HG22 ' A' ' 79' ' ' THR . 23.2 m-20 -106.53 158.46 16.9 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.222 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -134.88 149.91 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.119 -0.988 . . . . 0.0 110.229 -179.749 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 3.3 t80 -151.27 106.8 3.36 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.646 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 77' ' ' TRP . 2.5 mp -137.43 152.67 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.43 -0.794 . . . . 0.0 109.777 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.31 106.65 1.54 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.289 -0.882 . . . . 0.0 109.723 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -172.28 -179.48 2.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 110.258 -179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -85.08 96.64 9.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 110.491 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 125' ' ' VAL . 2.5 t -76.45 106.78 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.996 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 64.15 26.2 13.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.174 -179.903 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.07 34.86 9.37 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.24 127.24 7.92 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.223 -1.163 . . . . 0.0 110.14 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -55.86 108.94 0.36 Allowed 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.504 1.265 . . . . 0.0 110.109 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 132' ' ' TYR . 52.0 t80 -114.93 144.24 43.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.363 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -135.44 118.07 15.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 110.243 -179.948 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.488 ' HD2' HD12 ' A' ' 121' ' ' ILE . 5.0 t80 -115.11 127.92 55.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.123 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.83 82.56 0.38 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.869 . . . . 0.0 109.925 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -154.29 -172.72 4.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 110.534 -179.763 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.459 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 5.9 p-80 -122.53 161.75 23.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.483 -0.761 . . . . 0.0 109.918 179.698 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.459 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 47.2 m-85 -155.38 140.63 17.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.169 -0.957 . . . . 0.0 110.337 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.645 ' O ' HG23 ' A' ' 138' ' ' ILE . 38.8 p30 -88.11 156.51 19.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.232 -0.917 . . . . 0.0 110.4 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 137' ' ' ASN . 4.2 pt -157.21 143.8 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 109.891 -179.945 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.644 ' O ' HG12 ' A' ' 38' ' ' VAL . 81.4 m -91.62 128.35 37.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.197 -0.94 . . . . 0.0 110.944 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.474 ' CE2' HG13 ' A' ' 83' ' ' ILE . 51.8 m-85 -90.8 159.99 16.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.793 179.102 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.419 ' HG3' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -146.67 102.41 3.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.368 -179.965 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -93.17 152.14 19.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.279 -0.888 . . . . 0.0 110.386 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.496 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 51.3 m-80 -144.22 95.61 2.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.154 -0.966 . . . . 0.0 110.393 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.466 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -152.19 -154.77 6.76 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.793 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.415 ' HG2' ' NZ ' ' A' ' 61' ' ' LYS . 11.4 Cg_endo . . . . . 0 C--N 1.305 -1.712 0 O-C-N 123.91 1.479 . . . . 0.0 110.644 -179.729 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.904 0.383 . . . . 0.0 110.281 . . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 t -161.31 140.81 10.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.86 . . . . 0.0 110.401 -179.647 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.0 179.38 47.36 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.28 111.99 22.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.317 -1.108 . . . . 0.0 110.051 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.878 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.9 OUTLIER -95.4 154.3 17.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -0.905 . . . . 0.0 110.8 -179.739 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.4 m-20 -81.91 139.08 34.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.336 179.071 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.619 ' CE2' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -166.89 160.36 14.34 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.948 -1.095 . . . . 0.0 110.859 -179.924 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.57 -167.12 2.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.572 -0.705 . . . . 0.0 109.721 179.695 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.517 HG23 HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -142.16 174.04 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.116 -0.99 . . . . 0.0 110.296 179.818 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.477 ' CE2' ' HG3' ' A' ' 141' ' ' LYS . 16.7 m-85 -147.73 152.69 38.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.838 . . . . 0.0 110.052 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 124.29 23.01 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.381 -0.824 . . . . 0.0 110.009 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.533 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -49.17 147.58 2.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.77 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 3.9 m120 72.33 0.79 3.72 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.934 -0.479 . . . . 0.0 110.91 -179.092 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.77 -160.38 1.05 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.818 -1.177 . . . . 0.0 109.729 179.092 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.4 ' N ' ' OG1' ' A' ' 43' ' ' THR . 3.2 t-20 -134.37 11.64 3.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 110.248 179.471 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -135.99 139.0 42.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.102 -0.999 . . . . 0.0 110.628 -179.685 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.517 HG21 HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -63.71 133.44 53.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.206 179.264 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -128.7 -17.6 4.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.89 -1.132 . . . . 0.0 111.964 -178.769 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.2 mt -137.54 -71.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.815 -1.178 . . . . 0.0 110.76 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -50.99 -22.53 2.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.499 -0.751 . . . . 0.0 111.027 -179.584 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.442 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -55.59 -19.32 9.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.128 -0.982 . . . . 0.0 110.77 -179.793 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -94.29 15.29 17.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.015 -1.053 . . . . 0.0 110.922 -179.44 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -141.61 16.27 2.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.908 -1.12 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -123.1 106.17 10.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.141 -0.975 . . . . 0.0 110.255 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.96 152.45 41.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.899 . . . . 0.0 110.607 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.426 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -147.3 162.56 31.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 0.0 109.838 179.692 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 56.2 Cg_endo -78.02 -176.68 19.18 Favored 'Cis proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.728 -2.197 . . . . 0.0 110.475 -0.127 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.619 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . . . -105.23 166.33 10.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 110.091 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -101.49 113.78 27.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 110.088 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 8.7 p90 -96.27 163.54 13.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.924 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.4 OUTLIER -154.74 154.19 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.181 -0.95 . . . . 0.0 110.205 -179.925 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 29.7 mtpt -136.52 170.43 16.07 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.157 -0.965 . . . . 0.0 110.854 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.44 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 9.4 mttt -155.06 62.91 0.64 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.439 -0.788 . . . . 0.0 110.032 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t30 48.61 86.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.397 -0.815 . . . . 0.0 111.091 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.63 24.21 33.92 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.616 179.021 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.44 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 6.4 ptpt -170.39 161.19 7.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.042 -1.27 . . . . 0.0 110.947 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.819 HD21 ' H ' ' A' ' 108' ' ' LYS . 1.6 pt? -172.19 149.49 2.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.1 0.952 . . . . 0.0 111.732 178.688 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -140.61 174.06 10.89 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.258 -179.268 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.42 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -148.57 143.04 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.988 -1.07 . . . . 0.0 110.15 179.561 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -99.69 133.65 43.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 110.329 179.87 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -113.12 141.08 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.796 179.823 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 m -89.13 130.21 35.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.875 . . . . 0.0 110.348 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.657 HG13 ' HE3' ' A' ' 81' ' ' MET . 1.7 t -102.94 125.63 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.904 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -100.32 140.24 34.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.497 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.546 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.6 OUTLIER 62.14 77.32 0.33 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.93 . . . . 0.0 110.315 179.87 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.8 m -65.47 -35.06 79.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 110.057 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -52.95 -38.28 61.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.314 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.523 ' CE2' ' CE1' ' A' ' 74' ' ' HIS . 44.6 m0 -82.18 -61.27 1.95 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.947 . . . . 0.0 110.381 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.72 ' HA ' HG12 ' A' ' 119' ' ' VAL . 7.8 tt -87.76 122.03 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.372 -0.83 . . . . 0.0 109.808 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.824 HG22 ' O ' ' A' ' 118' ' ' ASP . 1.3 t -87.6 -22.42 24.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.0 111.41 -178.87 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.79 176.98 47.68 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.303 -1.427 . . . . 0.0 110.381 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.657 ' HE3' HG13 ' A' ' 72' ' ' VAL . 2.1 mpp? -150.61 108.14 3.65 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.579 -0.954 . . . . 0.0 109.985 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.49 156.9 20.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.24 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.513 ' O ' ' CE1' ' A' ' 86' ' ' HIS . 3.9 mt -148.19 153.28 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 110.073 179.758 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.663 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 1.9 tm-20 61.96 14.81 6.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 0.0 110.709 179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.6 19.42 61.93 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.667 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.663 ' CD2' ' HB3' ' A' ' 84' ' ' GLU . 2.3 p80 -136.2 159.85 40.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.274 . . . . 0.0 110.272 179.608 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -71.44 162.95 28.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.82 . . . . 0.0 110.604 -179.436 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 81' ' ' MET . 4.0 pt-20 -90.79 170.09 10.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 179.878 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.39 126.92 55.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.289 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pp -67.86 103.64 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.142 -0.973 . . . . 0.0 109.465 179.578 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.464 HG21 HG22 ' A' ' 101' ' ' THR . 1.4 tt -94.38 -28.41 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 0.0 110.978 -179.061 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.3 m -166.91 100.21 0.55 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.044 -1.035 . . . . 0.0 110.12 -179.644 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.417 ' HG3' ' HG3' ' A' ' 100' ' ' ARG . 21.1 ttmt -95.72 102.64 14.46 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.396 -0.815 . . . . 0.0 110.041 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.47 94.3 7.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 110.211 -179.799 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 79.1 p -80.47 -17.34 51.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.356 -0.84 . . . . 0.0 110.368 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.48 -19.91 64.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.95 . . . . 0.0 110.11 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -136.44 22.44 3.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 110.105 179.887 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 52.74 67.97 0.9 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 0.0 110.093 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -147.72 176.23 10.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -0.898 . . . . 0.0 110.262 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.417 ' HG3' ' HG3' ' A' ' 93' ' ' LYS . 2.8 ttm180 -175.93 161.41 2.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.892 . . . . 0.0 110.189 -179.864 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.464 HG22 HG21 ' A' ' 91' ' ' ILE . 87.1 m -142.32 154.32 44.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.897 . . . . 0.0 109.814 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 22.4 p -145.88 142.01 28.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.034 -1.042 . . . . 0.0 110.759 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -92.74 146.16 23.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.456 -0.778 . . . . 0.0 109.716 179.472 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.425 ' CG ' HD12 ' A' ' 83' ' ' ILE . 46.4 m-85 -129.22 139.5 51.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.076 -1.015 . . . . 0.0 111.079 -179.398 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.471 ' C ' HG13 ' A' ' 106' ' ' VAL . 9.8 tt0 -105.75 122.06 45.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.462 -0.774 . . . . 0.0 109.225 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.471 HG13 ' C ' ' A' ' 105' ' ' GLU . 34.4 m -149.02 147.91 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.069 -1.019 . . . . 0.0 110.91 -178.928 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.6 m -63.8 106.64 1.03 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.327 -0.858 . . . . 0.0 109.117 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.819 ' H ' HD21 ' A' ' 66' ' ' LEU . 0.1 OUTLIER 50.45 -177.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.469 -0.77 . . . . 0.0 109.588 -178.729 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.727 HD22 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.42 82.49 1.36 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.907 -1.12 . . . . 0.0 111.191 -179.42 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -145.16 80.33 1.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.109 179.46 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.09 -113.61 0.61 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -157.11 152.93 27.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.161 -1.199 . . . . 0.0 110.055 179.847 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 57.4 mt -134.15 150.79 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 0.0 110.188 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -76.37 123.01 25.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.254 -0.904 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.458 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -128.83 177.75 17.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.8 mttt -143.45 171.79 13.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -1.079 . . . . 0.0 109.845 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.563 HD11 HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -158.13 138.83 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.073 -1.017 . . . . 0.0 110.543 -179.912 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.824 ' O ' HG22 ' A' ' 79' ' ' THR . 42.4 t0 -107.96 158.06 17.69 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 108.896 179.047 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.72 HG12 ' HA ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -145.34 152.7 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 0.0 110.781 -179.244 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 5.3 t80 -152.44 107.36 3.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.462 -0.774 . . . . 0.0 110.457 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.586 HD12 ' CB ' ' A' ' 132' ' ' TYR . 20.0 mt -127.74 153.31 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.185 -0.947 . . . . 0.0 110.454 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.55 96.96 1.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.866 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.444 ' HG2' ' CE1' ' A' ' 130' ' ' PHE . 6.7 pt-20 -173.88 -149.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 110.261 -179.654 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 0.1 OUTLIER -132.67 119.33 20.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.194 -0.941 . . . . 0.0 110.223 -179.947 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.679 HG23 ' CE1' ' A' ' 130' ' ' PHE . 38.7 t -76.77 90.58 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.222 -0.924 . . . . 0.0 110.369 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.58 46.07 23.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 110.505 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.23 36.16 5.02 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 0.1 OUTLIER -145.76 88.31 6.53 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.176 -1.19 . . . . 0.0 110.157 179.799 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -62.46 124.46 14.27 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.945 1.497 . . . . 0.0 110.274 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.679 ' CE1' HG23 ' A' ' 125' ' ' VAL . 6.2 p90 -154.25 161.86 41.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 110.183 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -135.42 106.18 6.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 110.17 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.586 ' CB ' HD12 ' A' ' 121' ' ' ILE . 3.6 t80 -91.79 131.31 37.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.01 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -166.68 89.63 0.37 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.917 . . . . 0.0 109.99 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 -177.06 6.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.152 -0.968 . . . . 0.0 110.593 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -118.22 93.06 3.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.372 -0.83 . . . . 0.0 109.758 179.753 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.407 ' CZ ' ' OH ' ' A' ' 132' ' ' TYR . 89.1 m-85 -85.55 -179.42 6.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.433 -0.792 . . . . 0.0 110.653 -179.476 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.601 ' O ' HG23 ' A' ' 138' ' ' ILE . 12.4 p30 -151.09 161.77 42.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 110.111 179.845 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.5 pt -156.81 163.35 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.093 -1.004 . . . . 0.0 110.692 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.425 HG23 ' HD2' ' A' ' 112' ' ' LYS . 86.0 m -91.97 121.6 33.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.386 -0.821 . . . . 0.0 110.736 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.484 ' CE2' HD11 ' A' ' 83' ' ' ILE . 55.4 m-85 -89.78 137.27 32.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -0.903 . . . . 0.0 109.407 179.088 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.477 ' HG3' ' CE2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -118.02 101.17 8.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.101 -1.0 . . . . 0.0 110.63 -179.725 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -92.6 130.3 38.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 0.0 109.83 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 8.9 m120 -129.55 103.84 7.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 110.453 -179.761 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.878 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -152.62 -147.85 4.71 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.427 ' HD2' HD11 ' A' ' 34' ' ' LEU . 9.8 Cg_endo . . . . . 0 C--N 1.309 -1.533 0 O-C-N 123.793 1.417 . . . . 0.0 110.601 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.273 0.559 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.17 150.32 12.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 110.111 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.519 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 3.9 t30 63.0 24.34 14.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 109.952 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 27' ' ' ASN . . . 178.87 53.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.411 -0.806 . . . . 0.0 110.092 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.3 -150.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.902 . . . . 0.0 110.347 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.8 OUTLIER 56.01 28.88 13.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.408 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.02 143.7 12.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 110.308 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.86 -178.77 43.94 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.96 103.47 16.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -1.155 . . . . 0.0 110.242 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.743 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -95.2 158.58 15.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 0.0 110.632 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' A' ' 143' ' ' ASN . 1.7 m120 -79.35 141.27 37.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 109.998 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.586 ' HE2' HD11 ' A' ' 70' ' ' ILE . 0.6 OUTLIER -164.94 157.23 15.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 110.209 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 141' ' ' LYS . 1.1 tt0 -155.66 -175.93 5.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 110.094 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 46' ' ' THR . 0.4 OUTLIER -140.31 172.47 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.941 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.408 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 39.1 m-85 -148.55 159.07 44.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 110.568 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.439 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.3 OUTLIER -67.56 128.22 35.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.477 -0.764 . . . . 0.0 109.882 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.479 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -55.41 146.51 19.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 0.0 110.089 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.1 t-20 71.44 2.3 4.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.861 -0.524 . . . . 0.0 111.235 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.75 -165.73 1.78 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.822 -1.174 . . . . 0.0 109.679 179.155 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -133.65 15.68 4.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 0.0 110.344 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -135.48 117.66 15.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.986 . . . . 0.0 110.579 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -50.45 131.3 24.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.201 -0.937 . . . . 0.0 109.264 179.274 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.54 -17.32 3.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.014 -1.054 . . . . 0.0 112.051 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.5 mt -136.93 -70.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.867 -1.145 . . . . 0.0 110.808 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.428 ' HB1' ' HE2' ' A' ' 53' ' ' PHE . . . -46.61 -26.31 0.88 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.597 -0.689 . . . . 0.0 110.943 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.453 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -63.39 -14.5 50.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -0.981 . . . . 0.0 110.803 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.413 ' C ' ' CG ' ' A' ' 52' ' ' TYR . 21.2 m-20 -95.24 14.85 20.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.074 -1.016 . . . . 0.0 110.832 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.413 ' CG ' ' C ' ' A' ' 51' ' ' ASP . 22.5 m-85 -142.91 15.73 1.93 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.992 -1.068 . . . . 0.0 110.737 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.428 ' HE2' ' HB1' ' A' ' 49' ' ' ALA . 19.4 m-85 -131.3 105.85 7.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.183 -0.948 . . . . 0.0 110.205 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.476 ' HB2' HG21 ' A' ' 71' ' ' THR . 22.7 m120 -72.3 169.76 15.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.947 . . . . 0.0 110.368 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.72 162.04 33.12 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.338 -0.851 . . . . 0.0 110.018 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.25 -175.8 16.46 Favored 'Cis proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.399 -2.334 . . . . 0.0 110.596 -0.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.58 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -103.5 171.3 7.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.325 -0.859 . . . . 0.0 109.885 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.438 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -105.2 116.25 31.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.001 . . . . 0.0 110.536 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.507 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 1.9 p90 -97.24 162.67 13.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.394 -0.816 . . . . 0.0 109.945 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -154.78 150.97 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.026 -1.046 . . . . 0.0 110.783 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 19.6 mtmt -134.39 173.65 11.4 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.247 -0.908 . . . . 0.0 110.737 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.457 ' HB2' ' CD ' ' A' ' 65' ' ' LYS . 4.5 mttm -153.27 62.21 0.76 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.508 -0.745 . . . . 0.0 109.703 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.1 m120 46.98 82.44 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.369 -0.832 . . . . 0.0 111.105 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.53 19.82 28.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.457 ' CD ' ' HB2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -168.84 162.62 11.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.045 -1.267 . . . . 0.0 111.181 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' A' ' 108' ' ' LYS . 2.6 pt? -172.66 154.89 3.15 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.009 0.909 . . . . 0.0 111.477 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 1.1 m-85 -137.98 -153.7 0.49 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.439 HG11 ' CE1' ' A' ' 142' ' ' PHE . 1.1 t -170.73 135.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.073 -1.017 . . . . 0.0 110.287 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.438 ' HG2' ' CB ' ' A' ' 58' ' ' LYS . 1.8 pt20 -97.51 131.24 44.31 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.39 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.586 HD11 ' HE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -110.68 143.69 20.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.253 -0.905 . . . . 0.0 110.108 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.476 HG21 ' HB2' ' A' ' 54' ' ' ASN . 0.5 OUTLIER -88.77 135.85 33.31 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.299 -0.876 . . . . 0.0 109.902 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.642 ' CG1' HG21 ' A' ' 78' ' ' ILE . 22.8 t -103.34 126.42 57.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.418 -0.802 . . . . 0.0 110.143 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -97.99 127.16 43.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.227 -0.921 . . . . 0.0 110.149 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 m80 55.04 99.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.827 . . . . 0.0 110.146 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.9 t -74.39 -35.75 63.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.189 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -51.57 -23.9 4.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.26 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.651 ' CD2' HBB2 ' A' ' 151' ' ' ZNH . 45.4 m0 -94.37 -53.53 3.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.48 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.642 HG21 ' CG1' ' A' ' 72' ' ' VAL . 13.6 tt -89.51 123.71 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.144 -0.973 . . . . 0.0 109.835 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -87.69 -27.02 22.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 110.982 -179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.56 -176.47 47.67 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.046 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.415 ' HE1' HG22 ' A' ' 72' ' ' VAL . 63.3 mtm -151.95 165.5 34.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.384 -1.068 . . . . 0.0 110.145 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -155.29 140.58 17.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.323 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.688 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -130.19 140.18 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 110.245 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 71.65 0.85 3.65 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.637 -0.664 . . . . 0.0 111.385 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.09 21.79 9.25 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.644 -1.265 . . . . 0.0 111.292 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.472 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.74 158.71 43.78 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.52 -1.577 . . . . 0.0 110.31 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.14 175.29 5.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 110.485 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -104.06 170.29 8.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.371 -0.831 . . . . 0.0 110.32 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -110.6 131.51 54.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 110.463 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 90' ' ' ILE . 1.4 pp -68.26 102.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 109.571 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.492 HG21 HG22 ' A' ' 101' ' ' THR . 1.1 tt -95.21 -30.89 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 111.092 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.7 m -167.22 95.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.028 -1.045 . . . . 0.0 110.327 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -96.77 105.07 17.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.397 -0.814 . . . . 0.0 109.977 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.67 105.36 17.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.236 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -32.03 44.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 0.0 110.235 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.59 -44.71 95.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 109.987 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -96.8 8.54 44.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 110.704 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.02 53.33 13.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.037 -1.039 . . . . 0.0 110.071 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.38 119.01 7.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 110.519 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.475 ' CG ' ' N ' ' A' ' 101' ' ' THR . 38.2 ttt180 -114.98 167.27 10.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.43 -0.794 . . . . 0.0 109.619 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.492 HG22 HG21 ' A' ' 91' ' ' ILE . 92.0 m -141.09 153.14 45.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.018 -1.051 . . . . 0.0 109.962 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.1 p -144.99 142.35 29.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.157 -0.964 . . . . 0.0 110.686 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.18 140.73 29.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.324 -0.86 . . . . 0.0 109.85 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -127.96 138.62 52.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.077 -1.014 . . . . 0.0 110.71 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.456 ' HG2' ' CD2' ' A' ' 67' ' ' TYR . 3.2 tm-20 -98.29 128.16 44.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.329 -0.857 . . . . 0.0 109.538 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.61 151.12 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 110.926 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -63.09 111.2 2.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -0.916 . . . . 0.0 109.195 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.792 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.21 -167.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.458 -0.776 . . . . 0.0 109.844 -178.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.468 HD22 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.25 70.98 1.05 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.96 -1.088 . . . . 0.0 110.86 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.573 ' OD1' HG23 ' A' ' 146' ' ' THR . 0.2 OUTLIER -146.2 67.48 1.19 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 0.0 110.243 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 164.53 -121.57 1.02 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -157.41 153.44 27.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -1.157 . . . . 0.0 110.115 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.1 mm -136.74 149.2 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.0 110.262 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -76.49 103.78 6.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 109.968 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -109.17 179.49 21.03 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.5 mttp -145.03 167.4 22.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -1.088 . . . . 0.0 109.824 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.443 HD11 ' HAC' ' A' ' 151' ' ' ZNH . 0.1 OUTLIER -158.07 153.17 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.016 -1.052 . . . . 0.0 110.792 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.652 ' O ' HG22 ' A' ' 79' ' ' THR . 59.9 m-20 -111.65 157.88 19.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.522 -0.737 . . . . 0.0 109.297 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.455 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.7 OUTLIER -141.61 151.57 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.999 -1.063 . . . . 0.0 110.528 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -151.51 117.07 5.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.411 -0.805 . . . . 0.0 110.069 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 77' ' ' TRP . 31.4 mt -141.05 151.97 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.188 -0.945 . . . . 0.0 110.484 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.57 95.79 1.12 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.465 -0.772 . . . . 0.0 109.668 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -173.14 163.6 4.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 110.431 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -87.34 112.94 22.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.374 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 130' ' ' PHE . 60.9 t -76.42 91.68 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.323 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.02 43.33 9.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.216 -0.927 . . . . 0.0 110.349 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.14 30.61 16.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -145.37 100.92 4.41 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.269 -1.136 . . . . 0.0 110.261 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -52.5 113.25 1.14 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.74 1.389 . . . . 0.0 110.286 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.466 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 3.3 t80 -112.39 120.13 40.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.0 110.391 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -103.95 142.67 34.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.338 -0.851 . . . . 0.0 110.077 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.455 ' HE2' HG11 ' A' ' 119' ' ' VAL . 2.5 t80 -156.67 121.23 4.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 109.988 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.429 ' HB3' ' CE1' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -168.01 86.66 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 110.367 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -153.43 -172.45 4.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 110.358 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -117.64 87.81 2.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 110.091 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -85.56 -178.39 6.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.328 -0.857 . . . . 0.0 110.242 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 138' ' ' ILE . 2.6 p30 -149.4 169.94 19.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 110.461 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.0 OUTLIER -157.11 163.79 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -0.918 . . . . 0.0 110.634 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.408 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 85.2 m -91.86 125.33 36.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.3 -0.875 . . . . 0.0 110.567 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.688 ' CD2' HD11 ' A' ' 83' ' ' ILE . 31.4 m-85 -90.13 154.02 20.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.601 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.0 OUTLIER -142.06 102.86 4.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.055 -1.028 . . . . 0.0 110.427 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.439 ' CE1' HG11 ' A' ' 68' ' ' VAL . 17.1 m-85 -92.26 153.51 19.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.524 ' C ' HD21 ' A' ' 34' ' ' LEU . 51.1 m-80 -142.62 97.91 3.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.446 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.743 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -155.21 -148.12 4.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.463 ' HD2' HD11 ' A' ' 34' ' ' LEU . 9.4 Cg_endo -58.57 -166.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.795 1.418 . . . . 0.0 110.436 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.573 HG23 ' OD1' ' A' ' 110' ' ' ASN . 1.2 p -149.84 -54.01 0.16 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.128 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -120.89 -76.71 0.58 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 110.244 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.6 t 56.25 59.4 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 110.406 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -157.98 28.79 0.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.882 . . . . 0.0 110.227 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.956 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.651 HBB2 ' CD2' ' A' ' 77' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.225 0.536 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -80.49 95.13 6.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.178 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 4.8 t-20 64.28 35.6 9.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -0.868 . . . . 0.0 110.089 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.86 79.44 1.73 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.406 -0.809 . . . . 0.0 110.234 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.38 -51.67 14.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 110.148 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER 53.2 34.5 17.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.239 -0.913 . . . . 0.0 110.337 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 p -160.67 148.06 15.78 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.195 -0.941 . . . . 0.0 110.331 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 171.2 174.35 38.9 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.93 107.73 19.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.282 -1.128 . . . . 0.0 110.568 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.699 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.7 OUTLIER -95.73 158.09 15.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.149 -0.97 . . . . 0.0 110.363 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 143' ' ' ASN . 2.1 m-20 -80.38 143.8 33.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 109.716 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.472 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 1.1 p90 -164.92 156.36 15.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.117 -0.989 . . . . 0.0 110.254 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.42 -175.76 5.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.314 -0.866 . . . . 0.0 109.958 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -140.31 175.17 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 110.031 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -149.08 160.57 43.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 110.404 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.426 ' HG3' ' HB2' ' A' ' 47' ' ' SER . 0.1 OUTLIER -67.94 119.97 13.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.369 -0.832 . . . . 0.0 109.418 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.546 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -48.71 146.15 3.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.241 -0.912 . . . . 0.0 110.169 -179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER 72.53 2.33 4.31 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.949 -0.47 . . . . 0.0 110.866 -179.328 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -135.34 -163.0 1.32 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.878 -1.138 . . . . 0.0 109.818 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.56 14.02 3.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 110.242 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -135.25 123.51 23.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 110.354 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.556 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -60.56 131.37 50.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.072 -1.018 . . . . 0.0 109.313 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.426 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -128.04 -17.14 4.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 111.781 -178.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.2 mt -137.25 -65.59 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.8 -1.188 . . . . 0.0 110.895 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HB1' ' HE2' ' A' ' 53' ' ' PHE . . . -50.03 -22.99 1.8 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.508 -0.745 . . . . 0.0 111.205 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.514 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.1 OUTLIER -70.58 -9.41 56.77 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.039 -1.038 . . . . 0.0 110.965 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.407 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 30.1 m-20 -102.47 14.9 30.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.928 -1.107 . . . . 0.0 110.959 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 51' ' ' ASP . 31.5 m-85 -136.47 4.98 2.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.001 -1.062 . . . . 0.0 111.097 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.579 ' HE2' ' HB1' ' A' ' 49' ' ' ALA . 19.8 m-85 -125.75 111.64 15.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.038 -1.039 . . . . 0.0 110.291 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -72.01 165.69 23.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.993 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.438 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -147.24 164.55 22.52 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.215 -0.928 . . . . 0.0 110.196 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.438 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 58.0 Cg_endo -80.84 -175.57 16.27 Favored 'Cis proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.338 -2.359 . . . . 0.0 110.666 -0.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.48 168.85 9.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -0.885 . . . . 0.0 109.676 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.441 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.89 121.33 41.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.031 -1.043 . . . . 0.0 110.783 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.511 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 9.2 p90 -98.26 158.73 15.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.327 -0.858 . . . . 0.0 109.873 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.8 OUTLIER -155.08 147.65 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.076 -1.015 . . . . 0.0 110.442 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 7.2 mttt -131.87 174.11 10.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.457 -0.777 . . . . 0.0 110.444 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . 2.6 mmtp -156.73 62.04 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.796 . . . . 0.0 109.731 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 m120 47.53 85.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.835 . . . . 0.0 110.992 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.73 17.45 48.5 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.555 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HD2' ' HB3' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -165.31 163.51 19.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.936 -1.332 . . . . 0.0 111.119 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.584 HD11 ' HA ' ' A' ' 108' ' ' LYS . 1.2 pt? -174.6 154.83 2.09 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.017 0.913 . . . . 0.0 110.964 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.565 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -139.48 -155.46 0.59 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -170.67 134.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.846 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.441 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -97.73 134.68 40.58 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.123 -0.986 . . . . 0.0 110.011 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 101' ' ' THR . 1.0 OUTLIER -113.2 139.53 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.437 -0.789 . . . . 0.0 110.069 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.31 133.67 34.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 110.022 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.842 HG13 HD13 ' A' ' 78' ' ' ILE . 5.2 t -102.6 125.51 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.44 -0.787 . . . . 0.0 109.831 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -99.21 126.93 45.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.13 -0.981 . . . . 0.0 110.416 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.599 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER 58.42 99.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 110.354 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.37 -25.55 59.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.168 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -59.39 -36.27 75.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.498 ' O ' HG12 ' A' ' 119' ' ' VAL . 46.5 m0 -82.77 -52.11 7.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.842 HD13 HG13 ' A' ' 72' ' ' VAL . 12.8 tt -89.3 122.66 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.869 . . . . 0.0 109.838 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.667 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.2 -25.46 24.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 110.878 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.77 178.05 48.41 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.499 -1.334 . . . . 0.0 110.243 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.706 ' SD ' HD11 ' A' ' 78' ' ' ILE . 89.6 mtp -150.92 160.26 44.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.996 . . . . 0.0 109.787 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -154.95 161.16 41.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 110.253 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.567 ' O ' ' CE1' ' A' ' 86' ' ' HIS . 1.3 mt -149.73 152.6 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 110.149 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.556 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 0.2 OUTLIER 62.77 12.51 5.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.093 -1.004 . . . . 0.0 111.058 179.706 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.17 20.42 52.8 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.436 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 83' ' ' ILE . 3.1 p80 -138.28 158.8 43.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.859 -1.377 . . . . 0.0 110.441 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.39 172.2 9.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.334 -0.854 . . . . 0.0 110.595 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.523 ' CB ' ' CZ ' ' A' ' 104' ' ' PHE . 4.4 pt-20 -100.54 170.53 8.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.342 -0.849 . . . . 0.0 110.373 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.3 129.49 53.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.347 -0.845 . . . . 0.0 110.483 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.76 101.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.111 -0.993 . . . . 0.0 109.569 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 101' ' ' THR . 1.1 tt -94.86 -26.38 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 110.857 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.501 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -167.04 100.31 0.54 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.229 -0.92 . . . . 0.0 109.655 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.406 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 16.4 ttmt -95.93 147.94 23.15 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 110.191 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -143.02 84.2 1.82 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -0.938 . . . . 0.0 110.3 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 p -71.21 -29.39 65.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 110.207 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.95 -52.57 62.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.339 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -96.31 15.84 20.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.0 110.5 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.42 62.54 2.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.117 -0.989 . . . . 0.0 110.547 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 94' ' ' ASN . 22.3 mt-10 -148.14 160.86 42.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.158 -0.964 . . . . 0.0 110.165 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 92' ' ' SER . 7.3 ttm180 -166.83 161.47 15.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 110.155 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.578 ' O ' HG22 ' A' ' 91' ' ' ILE . 74.3 m -143.07 152.0 41.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 109.61 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 18.2 p -146.33 143.46 29.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.988 -1.07 . . . . 0.0 110.871 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.82 147.96 22.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.374 -0.828 . . . . 0.0 109.693 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.523 ' CZ ' ' CB ' ' A' ' 88' ' ' GLU . 27.2 m-85 -130.16 135.79 48.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.088 -1.008 . . . . 0.0 111.117 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -97.19 125.17 41.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.393 -0.817 . . . . 0.0 109.117 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.478 ' O ' HD21 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -149.25 161.02 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 0.0 110.782 -178.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.433 ' N ' ' CG2' ' A' ' 106' ' ' VAL . 11.0 p -70.13 113.0 6.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 108.82 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.584 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 44.83 -164.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.673 -0.642 . . . . 0.0 109.964 -178.716 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -150.64 68.22 0.96 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.876 -1.14 . . . . 0.0 110.933 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -146.97 87.97 1.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.05 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 148.05 -125.76 2.18 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.47 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.1 OUTLIER -156.91 150.39 24.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -1.067 . . . . 0.0 109.723 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.461 ' CD1' HG23 ' A' ' 106' ' ' VAL . 2.4 mt -135.55 152.19 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.316 -0.865 . . . . 0.0 110.04 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -75.93 100.0 4.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.919 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.413 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -99.99 179.31 29.92 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 82' ' ' SER . 17.0 mtpt -146.13 158.31 43.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -1.121 . . . . 0.0 110.054 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.46 ' O ' HD13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -157.6 145.99 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.119 -0.988 . . . . 0.0 110.312 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.667 ' C ' HG22 ' A' ' 79' ' ' THR . 1.0 OUTLIER -108.32 161.17 15.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.366 -0.833 . . . . 0.0 109.596 179.508 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -136.48 150.77 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.119 -0.988 . . . . 0.0 110.766 -179.549 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -151.94 114.19 4.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.467 -0.771 . . . . 0.0 109.871 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 77' ' ' TRP . 15.8 mt -141.51 153.29 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.164 -0.96 . . . . 0.0 110.806 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -159.44 100.01 1.48 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.587 -0.695 . . . . 0.0 109.424 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -172.97 178.25 2.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.24 -0.912 . . . . 0.0 110.396 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -101.21 118.85 37.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.333 -0.854 . . . . 0.0 110.324 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.2 t -76.91 92.26 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.0 110.306 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.431 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 1.4 m120 57.39 36.18 26.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.878 . . . . 0.0 110.503 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.89 31.25 6.72 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.12 98.15 4.74 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.247 -1.149 . . . . 0.0 110.07 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -49.17 121.28 6.65 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.921 1.485 . . . . 0.0 110.327 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.516 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 2.0 t80 -126.32 124.63 40.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 110.195 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -103.61 140.59 37.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 110.351 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.467 ' HE2' HG11 ' A' ' 119' ' ' VAL . 2.5 t80 -150.85 123.22 8.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.091 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -175.83 87.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 109.935 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -153.58 -164.68 1.95 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.355 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.472 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -119.2 139.83 51.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.981 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 135' ' ' HIS . 47.5 m-85 -154.53 -179.82 8.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.93 . . . . 0.0 110.119 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.638 ' O ' HG23 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -152.39 178.89 9.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.161 -0.962 . . . . 0.0 110.51 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.638 HG23 ' O ' ' A' ' 137' ' ' ASN . 3.8 pt -157.13 170.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.885 . . . . 0.0 110.058 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.47 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 96.8 m -91.6 121.84 33.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 110.647 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.567 ' HA ' HG12 ' A' ' 38' ' ' VAL . 28.6 m-85 -89.44 155.58 19.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.575 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.0 OUTLIER -143.32 100.53 3.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.048 -1.033 . . . . 0.0 110.741 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.425 ' CE1' HG11 ' A' ' 68' ' ' VAL . 15.9 m-85 -91.7 129.14 37.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.652 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.472 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 56.1 m-80 -113.93 104.38 12.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.105 -0.997 . . . . 0.0 110.877 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.699 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -163.13 -159.03 10.15 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -62.66 140.52 81.31 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.982 1.517 . . . . 0.0 110.278 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 m -90.59 -42.54 10.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.928 . . . . 0.0 110.401 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -175.4 -43.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.189 -0.944 . . . . 0.0 110.28 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 148' ' ' VAL . 22.1 t 56.39 53.63 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 110.307 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.11 60.63 4.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.02 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.516 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.347 0.594 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.3 131.17 48.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.139 -0.975 . . . . 0.0 110.286 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.95 31.23 16.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.167 -0.958 . . . . 0.0 110.005 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.81 41.44 1.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.843 . . . . 0.0 110.277 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.55 -160.16 0.45 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 110.231 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER 56.69 27.33 12.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 110.419 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -158.91 134.6 8.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 110.246 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.96 178.27 48.74 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.29 105.4 17.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.181 -1.187 . . . . 0.0 110.382 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.839 HD13 HD22 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -94.27 154.25 17.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.345 -0.847 . . . . 0.0 109.744 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.475 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 12.4 t-20 -78.73 144.7 35.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.12 -0.988 . . . . 0.0 109.989 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -165.57 161.46 18.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.343 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.22 -173.44 4.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.425 -0.797 . . . . 0.0 109.746 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.78 HG23 HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.55 174.61 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.169 -0.957 . . . . 0.0 110.146 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.413 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 16.0 m-85 -147.47 151.37 36.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.377 -0.827 . . . . 0.0 109.839 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -67.43 127.12 31.51 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.419 -0.8 . . . . 0.0 110.066 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.477 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -52.94 146.98 9.9 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.091 -1.006 . . . . 0.0 109.493 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 12.5 t30 73.09 -1.17 3.14 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.944 -0.472 . . . . 0.0 110.914 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.95 -163.38 1.41 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.899 -1.126 . . . . 0.0 109.561 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.402 ' N ' ' OG1' ' A' ' 43' ' ' THR . 8.5 m120 -133.34 15.74 4.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 110.434 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -136.53 129.03 30.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.015 . . . . 0.0 110.681 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.78 HG21 HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -57.79 132.38 53.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.156 -0.965 . . . . 0.0 109.037 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.75 -16.8 4.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.102 -0.999 . . . . 0.0 112.035 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 49' ' ' ALA . 2.2 mt -136.62 -64.94 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.803 -1.185 . . . . 0.0 110.598 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.457 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -54.6 -20.79 8.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.428 -0.795 . . . . 0.0 110.727 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.456 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 0.1 OUTLIER -63.38 -17.84 63.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.309 -0.87 . . . . 0.0 110.76 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -102.47 15.45 29.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.139 -0.976 . . . . 0.0 110.992 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.477 ' CD2' HBC1 ' A' ' 151' ' ' ZNH . 66.9 m-85 -131.73 1.11 3.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.949 -1.094 . . . . 0.0 111.151 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -129.37 113.47 14.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.127 -0.983 . . . . 0.0 110.252 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -72.79 173.05 9.67 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.386 -0.821 . . . . 0.0 110.617 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.15 164.67 22.01 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.354 -0.841 . . . . 0.0 109.769 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -78.66 -174.84 15.55 Favored 'Cis proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.798 -2.167 . . . . 0.0 110.559 -0.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.22 164.38 11.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.879 . . . . 0.0 110.007 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.415 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 2.2 tptt -101.91 109.55 21.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.131 -0.981 . . . . 0.0 110.314 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.519 ' CD1' ' CB ' ' A' ' 34' ' ' LEU . 6.5 p90 -98.0 165.75 11.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.332 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.8 OUTLIER -155.6 157.81 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.296 -0.877 . . . . 0.0 110.537 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 3.1 mtmt -139.41 174.31 10.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.245 -0.909 . . . . 0.0 110.831 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . 7.2 mttm -159.03 62.21 0.41 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.418 -0.801 . . . . 0.0 109.878 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 48.97 84.0 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.441 -0.787 . . . . 0.0 111.232 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.68 24.42 28.12 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.736 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.76 ' C ' HD13 ' A' ' 66' ' ' LEU . 1.3 ptpp? -167.42 155.94 9.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.912 -1.346 . . . . 0.0 111.018 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.76 HD13 ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -160.12 155.56 25.34 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.201 1.0 . . . . 0.0 111.843 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 6.2 m-85 -142.58 -164.14 1.76 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 103' ' ' GLU . 1.1 t -170.47 135.98 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.998 -1.064 . . . . 0.0 110.554 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 102' ' ' SER . 4.7 pt20 -99.15 134.23 42.3 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 109.773 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -113.23 134.87 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 110.093 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.0 m -89.57 123.56 33.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 0.0 109.954 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -103.08 141.7 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.207 -0.933 . . . . 0.0 110.278 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -98.67 140.02 33.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.827 . . . . 0.0 110.207 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.2 m170 52.58 88.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 110.221 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.7 p -52.19 -25.91 10.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.378 -0.827 . . . . 0.0 110.298 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -65.37 -55.74 16.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 110.369 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.429 ' HA ' HG12 ' A' ' 121' ' ' ILE . 47.4 m0 -50.73 -59.56 3.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.19 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.79 HD11 ' CG ' ' A' ' 81' ' ' MET . 6.1 tt -88.46 118.04 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.312 -0.868 . . . . 0.0 109.894 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.61 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.6 -23.02 25.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.316 -0.865 . . . . 0.0 110.956 -179.186 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.07 176.1 47.93 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.019 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.79 ' CG ' HD11 ' A' ' 78' ' ' ILE . 56.6 mtp -152.57 157.79 41.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.376 -1.073 . . . . 0.0 110.07 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -155.11 140.51 17.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.94 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.848 HD11 ' CE2' ' A' ' 140' ' ' TYR . 0.4 OUTLIER -132.94 139.38 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.143 -0.973 . . . . 0.0 110.726 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 70.73 1.86 3.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.588 -0.695 . . . . 0.0 111.629 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.49 22.06 9.37 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.327 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.587 ' HE1' ' HD1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -137.88 159.64 41.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.685 -1.479 . . . . 0.0 110.059 179.217 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -70.16 -174.55 0.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.171 -0.956 . . . . 0.0 110.616 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -109.06 169.03 8.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 110.239 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 102' ' ' SER . 22.4 m120 -110.34 127.56 55.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.408 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 pp -67.08 102.89 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.062 -1.024 . . . . 0.0 109.661 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.456 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 0.9 OUTLIER -95.7 -31.5 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 111.007 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.427 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -167.24 100.4 0.52 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.036 -1.04 . . . . 0.0 110.162 -179.76 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -96.21 148.8 22.34 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.417 -0.802 . . . . 0.0 110.084 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -143.23 97.9 3.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 110.331 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.6 -32.56 58.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.049 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.89 -43.18 99.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 110.091 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.77 5.76 50.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 110.507 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.71 56.91 6.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.034 -1.041 . . . . 0.0 110.311 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -148.14 -177.32 5.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 110.357 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.544 ' O ' HG22 ' A' ' 72' ' ' VAL . 4.8 ttp180 175.22 160.06 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.855 . . . . 0.0 110.009 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.456 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 85.8 m -137.3 156.19 48.55 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.314 -0.866 . . . . 0.0 109.812 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 6.1 p -144.2 143.12 30.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.038 -1.038 . . . . 0.0 110.785 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.2 tt0 -92.92 150.15 20.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.816 . . . . 0.0 110.054 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.682 ' CD2' HD12 ' A' ' 83' ' ' ILE . 15.5 m-85 -129.71 154.44 47.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.94 . . . . 0.0 110.687 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.459 ' C ' HG13 ' A' ' 106' ' ' VAL . 0.5 OUTLIER -118.51 127.37 53.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.321 -0.862 . . . . 0.0 109.742 179.563 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.496 ' O ' HD21 ' A' ' 66' ' ' LEU . 29.0 m -149.88 -165.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.045 -1.034 . . . . 0.0 110.607 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -97.9 111.9 24.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.479 -0.763 . . . . 0.0 108.994 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 47.41 -166.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.48 -0.763 . . . . 0.0 109.554 -178.66 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.839 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.0 62.75 0.91 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.078 -1.014 . . . . 0.0 110.931 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -146.11 70.48 1.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 110.23 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 170.23 -125.07 1.19 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.2 OUTLIER -157.38 139.35 14.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.343 -1.092 . . . . 0.0 109.715 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.427 ' CA ' ' HE2' ' A' ' 112' ' ' LYS . 6.0 mt -135.25 149.83 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.24 -0.913 . . . . 0.0 110.237 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -76.57 123.18 25.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.908 . . . . 0.0 110.15 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.483 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -119.82 -177.65 16.23 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 12.3 mttt -145.12 158.86 43.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.327 -1.102 . . . . 0.0 110.111 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -157.77 143.64 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.454 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.61 ' C ' HG22 ' A' ' 79' ' ' THR . 0.9 OUTLIER -103.59 154.99 18.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.401 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.408 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -129.84 146.86 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.008 -1.057 . . . . 0.0 110.678 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.53 110.47 3.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.43 -0.794 . . . . 0.0 110.006 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.462 ' HB ' ' CB ' ' A' ' 132' ' ' TYR . 19.6 mt -139.92 153.71 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 110.573 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.0 95.1 1.26 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.498 -0.751 . . . . 0.0 109.436 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.476 ' O ' ' CD1' ' A' ' 130' ' ' PHE . 1.3 pt-20 -174.5 -164.73 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.387 -0.821 . . . . 0.0 109.928 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -113.63 115.04 27.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.101 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.972 HG23 ' CE1' ' A' ' 130' ' ' PHE . 3.1 t -76.61 94.56 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.264 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 59.42 39.13 22.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.337 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 91.89 34.69 7.13 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.72 90.71 6.31 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.226 -1.161 . . . . 0.0 110.061 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -57.3 133.75 59.31 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.126 1.593 . . . . 0.0 110.63 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.972 ' CE1' HG23 ' A' ' 125' ' ' VAL . 9.3 p90 -157.39 132.7 9.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.056 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -103.24 99.71 9.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.397 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.462 ' CB ' ' HB ' ' A' ' 121' ' ' ILE . 3.7 t80 -90.49 129.53 36.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.831 . . . . 0.0 109.703 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -170.45 83.58 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.091 -1.005 . . . . 0.0 110.27 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.84 -166.04 2.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.885 . . . . 0.0 110.327 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -118.34 151.7 37.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 109.858 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.411 ' HB3' HMD2 ' A' ' 151' ' ' ZNH . 16.7 m-85 -155.29 179.85 8.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.014 . . . . 0.0 110.405 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.574 ' O ' HG23 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -152.23 169.54 22.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.572 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.574 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.4 pt -156.65 161.63 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 110.214 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.478 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 66.4 m -91.82 125.85 36.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.865 . . . . 0.0 110.73 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.848 ' CE2' HD11 ' A' ' 83' ' ' ILE . 47.7 m-85 -90.59 164.93 14.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.905 . . . . 0.0 110.016 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.1 OUTLIER -147.98 103.3 3.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.954 . . . . 0.0 110.32 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -92.44 141.33 28.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.301 -0.874 . . . . 0.0 110.515 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 67.2 m-20 -133.12 98.43 4.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 110.022 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.523 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -160.52 -148.71 5.35 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -63.22 -174.01 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.773 1.407 . . . . 0.0 110.768 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.47 -42.74 0.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 110.038 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -142.82 -49.16 0.34 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 110.155 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 148' ' ' VAL . 30.4 t 56.01 29.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 110.322 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.55 24.67 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.291 -0.88 . . . . 0.0 110.19 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.915 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.477 HBC1 ' CD2' ' A' ' 52' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.286 0.565 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -131.85 142.21 49.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.164 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.78 27.99 17.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.262 -0.899 . . . . 0.0 109.88 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.08 114.17 10.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 0.0 110.24 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.74 -165.62 0.85 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.34 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 25.0 m-20 55.64 23.24 5.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.335 -0.853 . . . . 0.0 110.352 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.6 t -160.84 148.24 15.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 110.43 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.35 172.14 39.97 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.18 106.59 18.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -1.107 . . . . 0.0 110.229 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.782 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.8 OUTLIER -94.45 156.21 16.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.319 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -79.62 143.9 34.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 110.017 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.634 ' HE2' HD11 ' A' ' 70' ' ' ILE . 1.6 p90 -165.99 159.05 15.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 0.0 110.03 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -155.15 -175.14 5.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.926 . . . . 0.0 109.947 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 46' ' ' THR . 0.1 OUTLIER -141.43 174.5 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 110.476 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 18.6 m-85 -148.17 156.02 42.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -0.808 . . . . 0.0 109.926 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.542 ' HZ2' ' HA ' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -67.66 127.87 34.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.106 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.538 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -54.37 147.92 12.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 109.869 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 9.7 m-20 71.11 2.42 4.23 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.812 -0.555 . . . . 0.0 110.952 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -135.93 -162.26 1.25 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.849 -1.157 . . . . 0.0 109.666 179.087 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.413 ' N ' ' OG1' ' A' ' 43' ' ' THR . 16.5 m-80 -132.57 11.91 4.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 110.194 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -136.56 143.76 43.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 110.69 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -68.58 131.49 45.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.088 179.2 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.558 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -129.25 -17.52 3.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.962 -1.087 . . . . 0.0 112.137 -178.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.713 HG22 ' N ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -137.32 -71.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.789 -1.195 . . . . 0.0 110.581 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.713 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -48.87 -24.69 1.55 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.499 -0.751 . . . . 0.0 110.853 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.455 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -61.73 -20.64 63.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.121 -0.987 . . . . 0.0 110.784 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.41 ' OD2' ' ND2' ' A' ' 50' ' ' ASN . 2.1 m-20 -94.68 14.12 22.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.086 -1.009 . . . . 0.0 110.858 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.406 ' CD2' HBC1 ' A' ' 151' ' ' ZNH . 61.1 m-85 -141.3 9.51 2.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.062 . . . . 0.0 110.843 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -118.15 110.67 17.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.983 . . . . 0.0 110.171 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -72.77 155.67 39.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.298 -0.877 . . . . 0.0 110.693 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -147.52 163.27 28.58 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.333 -0.854 . . . . 0.0 109.833 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 50.5 Cg_endo -77.41 -175.27 16.4 Favored 'Cis proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.862 -2.141 . . . . 0.0 110.472 -0.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.513 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.09 -172.0 2.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 109.889 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.432 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -125.52 119.19 27.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.015 -1.053 . . . . 0.0 110.577 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 8.3 p90 -97.11 165.59 11.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 109.877 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.501 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -155.58 122.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.135 -0.978 . . . . 0.0 110.608 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.662 ' HD3' HD21 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -136.77 131.76 33.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.199 -0.938 . . . . 0.0 110.775 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' HB2' ' HD2' ' A' ' 65' ' ' LYS . 6.7 mttp -110.25 62.25 0.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 110.35 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 48.45 97.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.374 -0.829 . . . . 0.0 111.28 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.91 11.71 52.25 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.721 ' C ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -169.96 152.63 4.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.012 -1.287 . . . . 0.0 110.325 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.79 ' N ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -156.92 153.46 28.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.09 -1.006 . . . . 0.0 111.504 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 4.5 m-85 -142.94 -157.92 0.82 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.391 -0.818 . . . . 0.0 109.257 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -170.16 167.49 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.197 -0.939 . . . . 0.0 110.345 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.476 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -141.28 134.51 29.47 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.403 -0.81 . . . . 0.0 109.676 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.634 HD11 ' HE2' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -115.48 133.71 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 110.225 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.3 m -89.86 129.72 36.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.155 -0.966 . . . . 0.0 109.853 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.412 HG12 ' CE ' ' A' ' 81' ' ' MET . 1.0 OUTLIER -102.31 143.78 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 110.231 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -99.23 139.34 35.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.905 . . . . 0.0 110.254 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.655 ' O ' HG22 ' A' ' 78' ' ' ILE . 3.9 m-70 54.34 99.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 110.346 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.01 -35.32 78.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.885 . . . . 0.0 110.222 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -57.95 -35.98 71.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 110.196 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.681 ' O ' HG13 ' A' ' 119' ' ' VAL . 39.8 m0 -79.0 -51.04 10.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 110.213 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 74' ' ' HIS . 3.8 tp -89.27 120.55 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.875 . . . . 0.0 109.835 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.45 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.4 -34.56 20.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.406 -0.809 . . . . 0.0 110.706 -179.333 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.418 ' N ' ' CG2' ' A' ' 79' ' ' THR . . . -175.62 -179.63 46.25 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.532 -1.318 . . . . 0.0 109.989 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.442 ' CE ' HG21 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -152.41 166.31 32.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -1.091 . . . . 0.0 110.133 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -155.21 147.3 23.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.859 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.626 HD11 ' CD2' ' A' ' 140' ' ' TYR . 1.2 mt -142.37 143.11 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 110.627 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 72.3 -0.41 3.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.614 -0.678 . . . . 0.0 111.604 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.0 20.27 9.99 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.458 -1.354 . . . . 0.0 111.285 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.561 ' HE1' ' HD1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -137.02 161.41 36.13 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.735 -1.45 . . . . 0.0 110.199 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -172.16 0.6 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.006 -1.059 . . . . 0.0 110.739 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 0.1 OUTLIER -109.79 165.9 11.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 110.557 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.16 135.05 54.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.448 -0.783 . . . . 0.0 109.856 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.42 100.76 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.087 -1.008 . . . . 0.0 109.913 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.535 HG21 HG22 ' A' ' 101' ' ' THR . 1.2 tt -96.0 -28.56 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 110.285 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -166.32 96.08 0.57 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.232 -0.918 . . . . 0.0 109.794 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -95.36 102.4 14.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.427 -0.796 . . . . 0.0 110.073 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.38 95.75 7.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.365 -0.835 . . . . 0.0 110.352 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -37.96 53.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.928 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.55 -38.48 90.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.034 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -96.19 10.55 37.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.62 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 50.91 56.17 8.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.048 -1.033 . . . . 0.0 110.282 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -148.04 169.85 19.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.156 -0.965 . . . . 0.0 110.395 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.408 ' O ' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -166.62 157.63 12.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.333 -0.855 . . . . 0.0 109.954 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.535 HG22 HG21 ' A' ' 91' ' ' ILE . 86.8 m -141.98 158.38 43.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.396 -0.815 . . . . 0.0 109.759 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -145.04 142.97 30.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.045 -1.034 . . . . 0.0 110.728 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -92.98 138.77 31.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.363 -0.836 . . . . 0.0 109.943 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.561 ' HD1' ' HE1' ' A' ' 86' ' ' HIS . 88.6 m-85 -130.06 145.9 51.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.055 -1.028 . . . . 0.0 110.901 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.481 ' C ' HG13 ' A' ' 106' ' ' VAL . 3.2 tt0 -99.69 131.02 45.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.377 -0.827 . . . . 0.0 108.881 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 108' ' ' LYS . 22.9 m -149.09 162.28 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.849 -1.157 . . . . 0.0 111.285 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 60.4 p -69.44 112.32 5.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.0 OUTLIER 46.67 -157.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.51 -0.744 . . . . 0.0 109.418 -178.3 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.662 HD21 ' HD3' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -150.21 51.53 0.9 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.798 -1.189 . . . . 0.0 110.807 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -146.26 87.73 1.75 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.026 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.22 171.02 20.75 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.419 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 1.0 OUTLIER -81.63 144.01 31.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -1.169 . . . . 0.0 110.175 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mm -137.92 139.89 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.171 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -76.65 135.57 39.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 109.947 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -140.98 178.12 20.39 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 9.1 mtmm -143.6 158.06 43.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.426 -1.044 . . . . 0.0 109.837 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.56 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.7 142.62 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.959 -1.088 . . . . 0.0 110.592 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.45 ' C ' HG22 ' A' ' 79' ' ' THR . 40.5 m-20 -106.2 164.47 11.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -0.764 . . . . 0.0 109.798 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 77' ' ' TRP . 25.0 t -141.95 151.53 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 110.447 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -152.03 105.42 3.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.476 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.505 HG21 ' HE2' ' A' ' 130' ' ' PHE . 4.9 mt -125.46 152.79 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.243 -0.911 . . . . 0.0 110.073 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.73 102.41 1.33 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.798 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -173.7 -164.24 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 110.443 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 2.3 ttmt -99.92 103.11 14.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.294 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.667 ' O ' HG12 ' A' ' 125' ' ' VAL . 2.1 t -76.63 103.0 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 110.15 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 63.16 34.47 13.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.451 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.09 31.52 28.4 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -145.33 137.01 12.89 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.224 -1.162 . . . . 0.0 109.999 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.25 129.27 33.94 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.564 1.297 . . . . 0.0 109.838 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.679 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 8.7 t80 -129.14 118.1 21.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 110.583 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -105.2 137.78 42.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 109.847 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.483 ' CD2' HD12 ' A' ' 121' ' ' ILE . 6.3 t80 -157.17 123.62 4.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.212 -0.93 . . . . 0.0 110.006 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -173.35 87.55 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.905 . . . . 0.0 109.986 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.96 -161.46 1.29 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.892 . . . . 0.0 110.297 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -120.93 155.6 33.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.86 . . . . 0.0 110.256 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 32.4 m-85 -155.14 -179.26 7.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 109.831 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.563 ' O ' HG23 ' A' ' 138' ' ' ILE . 6.3 p30 -151.2 168.98 23.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 110.608 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.3 pt -156.85 163.27 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.365 -0.835 . . . . 0.0 110.13 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.419 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 90.8 m -91.9 122.11 34.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.224 -0.923 . . . . 0.0 110.54 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.626 ' CD2' HD11 ' A' ' 83' ' ' ILE . 49.2 m-85 -90.25 157.96 17.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -0.877 . . . . 0.0 110.235 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 104.74 3.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.225 -0.922 . . . . 0.0 110.178 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -91.39 158.35 16.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.237 -0.914 . . . . 0.0 110.277 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 29.7 m120 -143.13 99.56 3.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.782 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -157.52 -154.89 7.27 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.455 ' C ' HG23 ' A' ' 146' ' ' THR . 11.3 Cg_endo -60.36 -165.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.988 1.52 . . . . 0.0 110.537 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.455 HG23 ' C ' ' A' ' 145' ' ' PRO . 44.8 p -149.74 -47.83 0.13 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.378 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.75 -58.89 2.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 110.444 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 145' ' ' PRO . 12.2 t 57.12 54.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 110.229 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.58 75.72 8.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.293 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.964 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.679 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.294 0.569 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.7 136.39 40.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.242 -0.911 . . . . 0.0 110.158 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 56.87 27.77 13.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.381 -0.824 . . . . 0.0 109.762 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -149.36 47.25 0.97 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.477 -0.764 . . . . 0.0 110.367 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.13 -37.06 64.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.074 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 7.7 m-20 57.63 28.47 15.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 110.266 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 p -159.48 147.69 17.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 0.0 110.428 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.37 175.67 44.8 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.68 104.87 17.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -1.113 . . . . 0.0 110.39 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.583 HD13 HD22 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -95.27 159.12 15.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.328 -0.857 . . . . 0.0 110.434 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.455 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 16.3 m-20 -78.71 139.6 38.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.116 -0.99 . . . . 0.0 109.982 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.73 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -165.51 152.22 10.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.982 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -155.13 -173.2 4.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.0 110.237 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -140.97 178.65 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.878 . . . . 0.0 110.369 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 39.7 m-85 -148.18 156.72 42.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.446 -0.784 . . . . 0.0 109.68 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.27 122.78 18.62 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.937 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.58 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -49.86 148.89 2.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.934 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.4 t-20 71.52 2.82 4.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.879 -0.513 . . . . 0.0 110.771 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -135.12 -157.84 0.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.948 -1.095 . . . . 0.0 109.533 179.232 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.12 8.27 3.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 110.209 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -135.11 150.76 50.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.07 -1.019 . . . . 0.0 110.563 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.483 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -77.53 133.86 38.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.239 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.472 ' HB3' HD12 ' A' ' 48' ' ' ILE . 34.3 t -129.03 -17.21 3.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.024 -1.048 . . . . 0.0 111.954 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 47' ' ' SER . 3.3 mp -136.94 -69.45 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.7 -1.25 . . . . 0.0 110.623 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.484 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -49.42 -24.09 1.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.549 -0.72 . . . . 0.0 110.9 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.448 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -65.9 -13.41 59.63 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.083 -1.011 . . . . 0.0 110.957 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -99.27 15.36 26.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.016 -1.052 . . . . 0.0 110.957 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.49 ' CD1' HBC1 ' A' ' 151' ' ' ZNH . 58.1 m-85 -136.87 10.06 3.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.893 -1.129 . . . . 0.0 111.148 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.484 ' CE2' ' HB1' ' A' ' 49' ' ' ALA . 23.1 m-30 -120.83 104.78 10.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.093 -1.004 . . . . 0.0 110.242 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -72.59 106.35 4.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.193 -0.942 . . . . 0.0 110.114 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.466 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -93.53 167.71 13.4 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.255 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.466 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 53.1 Cg_endo -77.93 -175.82 17.47 Favored 'Cis proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.67 -2.221 . . . . 0.0 110.843 -0.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.73 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -103.2 171.51 7.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 109.977 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -104.21 117.17 33.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.01 . . . . 0.0 110.792 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.59 ' HB2' HD23 ' A' ' 109' ' ' LEU . 3.7 p90 -96.42 163.0 13.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 109.324 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.518 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -154.96 118.82 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.925 -1.109 . . . . 0.0 111.028 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HD3' HD21 ' A' ' 109' ' ' LEU . 1.4 mtmt -139.07 131.57 28.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.314 -0.866 . . . . 0.0 109.632 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.437 ' HB3' ' CE ' ' A' ' 65' ' ' LYS . 4.9 tttm -115.91 65.39 0.7 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.113 -0.992 . . . . 0.0 110.78 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 46.39 95.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.465 -0.772 . . . . 0.0 111.201 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.17 13.24 36.89 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.437 ' CE ' ' HB3' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -173.18 149.71 1.84 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.054 -1.262 . . . . 0.0 109.876 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.792 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -158.83 144.13 16.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.969 . . . . 0.0 111.261 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.518 ' HB2' HG23 ' A' ' 60' ' ' ILE . 3.3 m-85 -141.02 -161.79 1.27 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.537 -0.727 . . . . 0.0 109.663 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.54 HG11 ' CE1' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -170.18 163.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.213 -0.93 . . . . 0.0 109.933 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.744 ' C ' HD12 ' A' ' 70' ' ' ILE . 3.4 pt20 -141.61 144.63 34.31 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.171 -0.956 . . . . 0.0 110.58 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.744 HD12 ' C ' ' A' ' 69' ' ' GLN . 2.2 mp -116.68 147.47 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.509 -0.744 . . . . 0.0 109.856 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.6 m -89.19 134.68 33.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 0.0 109.887 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.564 HG12 HG21 ' A' ' 78' ' ' ILE . 2.4 t -102.31 119.63 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 0.0 110.332 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -100.11 137.32 38.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.212 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.528 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER 57.6 92.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.203 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 m -76.47 -25.49 54.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.155 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -60.4 -17.2 42.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.253 -0.904 . . . . 0.0 110.325 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.506 ' CD2' HBB2 ' A' ' 151' ' ' ZNH . 45.6 m0 -106.31 -51.45 2.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -0.956 . . . . 0.0 110.488 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.845 HD11 ' SD ' ' A' ' 81' ' ' MET . 11.4 tt -89.52 125.25 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 109.886 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.83 -33.46 19.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.398 -0.814 . . . . 0.0 110.765 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.4 ' N ' ' CG2' ' A' ' 79' ' ' THR . . . 178.06 -174.9 47.16 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.139 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.845 ' SD ' HD11 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -152.4 170.84 19.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -1.064 . . . . 0.0 110.259 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' LYS . 2.2 t -154.36 146.21 23.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 109.758 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.474 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 2.9 mt -140.95 144.44 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.619 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.474 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 71.33 2.29 4.19 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.632 -0.667 . . . . 0.0 111.204 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.33 21.47 13.14 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.73 -1.224 . . . . 0.0 111.103 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.509 ' HE1' ' HD1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -138.0 160.14 40.13 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.655 -1.497 . . . . 0.0 110.193 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.11 -174.28 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.042 -1.036 . . . . 0.0 110.544 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 8.3 pt-20 -109.97 170.06 8.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.357 -0.839 . . . . 0.0 110.309 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -120.13 130.59 54.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 0.0 110.266 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.402 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 pp -67.56 103.63 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.074 -1.016 . . . . 0.0 109.59 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.437 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -95.13 -27.69 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.366 -0.834 . . . . 0.0 110.971 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.0 m -167.26 94.64 0.46 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.146 -0.971 . . . . 0.0 109.898 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -97.35 147.97 23.64 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 110.284 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -142.85 101.18 3.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 109.973 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -74.21 -32.37 63.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 0.0 110.312 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.47 -44.8 95.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 110.171 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.55 -3.36 43.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 110.729 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t0 59.97 50.37 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.96 -1.088 . . . . 0.0 110.13 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -147.44 128.45 14.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 110.091 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.77 172.37 12.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 110.444 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.437 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 97.2 m -141.11 157.1 45.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.447 -0.783 . . . . 0.0 109.458 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -145.24 138.01 26.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.068 -1.02 . . . . 0.0 110.721 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -92.9 144.9 24.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.436 -0.79 . . . . 0.0 110.12 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.509 ' HD1' ' HE1' ' A' ' 86' ' ' HIS . 98.4 m-85 -130.76 145.5 51.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.142 -0.974 . . . . 0.0 110.845 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.48 ' C ' HG13 ' A' ' 106' ' ' VAL . 15.7 tt0 -95.59 126.59 40.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.338 -0.851 . . . . 0.0 109.295 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.48 HG13 ' C ' ' A' ' 105' ' ' GLU . 34.6 m -149.78 177.55 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.974 -1.079 . . . . 0.0 111.038 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.5 t -89.4 110.91 21.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.48 -0.763 . . . . 0.0 109.258 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.454 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 49.65 -158.3 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.652 -178.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.617 HD21 ' HD3' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -151.31 50.92 0.83 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.983 -1.073 . . . . 0.0 111.066 -179.118 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 145' ' ' PRO . 18.4 t-20 -144.85 84.35 1.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 110.137 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.43 170.44 19.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.405 ' O ' ' HE3' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -81.72 145.87 30.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.171 . . . . 0.0 110.416 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 mt -137.28 139.34 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 0.0 109.838 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -76.19 121.2 22.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.27 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -129.15 178.16 17.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -144.63 165.84 26.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -1.154 . . . . 0.0 109.456 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.563 HD12 ' HG3' ' A' ' 81' ' ' MET . 0.1 OUTLIER -157.79 150.52 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.869 -1.145 . . . . 0.0 111.171 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.514 ' O ' HG22 ' A' ' 79' ' ' THR . 1.1 m-20 -109.02 161.38 15.22 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.564 -0.71 . . . . 0.0 109.348 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.425 HG11 ' CE2' ' A' ' 132' ' ' TYR . 3.0 t -143.56 151.67 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.118 -0.989 . . . . 0.0 110.113 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 5.1 t80 -151.71 118.89 5.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 110.672 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 77' ' ' TRP . 30.2 mt -142.63 151.62 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.969 . . . . 0.0 110.145 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.39 95.65 1.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.348 -0.845 . . . . 0.0 109.615 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -173.28 166.26 4.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.259 -0.901 . . . . 0.0 110.414 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -90.25 113.72 25.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.114 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -76.52 90.36 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.2 50.13 3.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.907 . . . . 0.0 110.388 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.71 29.96 45.88 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.21 101.21 4.44 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.175 -1.191 . . . . 0.0 110.27 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.12 136.49 24.03 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.819 1.431 . . . . 0.0 110.293 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 5.8 t80 -136.63 114.71 11.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.174 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -103.43 130.35 50.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 110.112 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 1.6 t80 -145.21 113.84 6.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.763 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 15.8 t0 -162.81 92.15 0.77 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.929 . . . . 0.0 110.224 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -153.84 -169.75 3.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 110.433 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -119.63 86.29 2.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.318 -0.863 . . . . 0.0 110.022 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.43 ' CD1' HBD2 ' A' ' 151' ' ' ZNH . 43.2 m-85 -84.59 -178.96 7.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.255 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.611 ' O ' HG23 ' A' ' 138' ' ' ILE . 5.7 p30 -150.49 170.51 18.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 110.055 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.7 pt -156.92 165.63 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.076 -1.015 . . . . 0.0 110.754 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 98.8 m -91.76 117.91 30.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.499 -0.75 . . . . 0.0 110.33 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.571 ' HA ' HG12 ' A' ' 38' ' ' VAL . 30.6 m-85 -89.91 151.3 21.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 0.0 110.126 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -144.0 106.1 4.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.145 -0.972 . . . . 0.0 110.339 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.54 ' CE1' HG11 ' A' ' 68' ' ' VAL . 80.3 m-85 -91.46 148.6 22.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.91 . . . . 0.0 109.962 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.455 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 32.7 m-80 -131.1 105.03 7.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.271 -0.893 . . . . 0.0 110.508 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.441 ' HA3' HD21 ' A' ' 34' ' ' LEU . . . -160.72 -161.56 11.65 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.462 ' HD2' HD11 ' A' ' 34' ' ' LEU . 7.3 Cg_endo -54.89 -168.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.919 1.483 . . . . 0.0 110.291 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.2 20.45 0.96 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.256 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.69 -61.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 109.71 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' A' ' 145' ' ' PRO . 5.8 t 56.94 52.95 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.36 -0.838 . . . . 0.0 110.376 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.51 110.98 17.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.506 HBB2 ' CD2' ' A' ' 77' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.22 0.533 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -112.51 76.09 0.96 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.336 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 2.2 t-20 62.83 23.0 13.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.03 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -97.8 101.19 12.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -0.883 . . . . 0.0 110.288 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.89 -155.5 0.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 110.273 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 10.3 m-20 55.1 24.55 6.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.862 . . . . 0.0 110.516 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.1 t -159.23 171.36 20.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.083 -1.011 . . . . 0.0 110.889 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.98 177.64 27.62 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.05 107.12 18.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -1.128 . . . . 0.0 110.204 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.855 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -94.3 155.4 17.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 110.091 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.443 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 33.6 m-80 -79.92 138.62 37.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.77 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.674 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -166.0 159.24 15.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.117 -0.989 . . . . 0.0 110.117 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -155.76 -170.33 3.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -0.86 . . . . 0.0 110.247 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 46' ' ' THR . 0.1 OUTLIER -140.06 173.09 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 109.943 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -150.41 160.94 43.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.192 -0.943 . . . . 0.0 110.197 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -68.35 126.33 29.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.473 -0.767 . . . . 0.0 110.168 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.484 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -57.11 146.13 28.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 109.813 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 6.5 t30 72.93 -0.59 3.32 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.878 -0.514 . . . . 0.0 110.926 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -139.08 -168.62 2.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.976 -1.078 . . . . 0.0 109.556 179.484 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.422 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.9 OUTLIER -135.57 25.26 3.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.002 . . . . 0.0 110.558 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -135.37 123.69 23.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.147 -0.971 . . . . 0.0 111.035 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -52.54 122.1 8.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.46 -0.775 . . . . 0.0 109.313 179.046 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.59 -18.65 3.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.901 -1.125 . . . . 0.0 112.219 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.62 HG21 ' C1D' ' A' ' 151' ' ' ZNH . 1.4 mp -138.47 -76.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.621 -1.299 . . . . 0.0 110.971 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.603 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -45.07 -27.02 0.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.735 -0.603 . . . . 0.0 111.116 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.437 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -63.16 -13.64 39.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.075 -1.016 . . . . 0.0 110.689 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.465 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 31.3 m-20 -98.68 10.63 40.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.07 -1.019 . . . . 0.0 110.752 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 51' ' ' ASP . 16.6 m-85 -144.91 15.86 1.56 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.995 -1.066 . . . . 0.0 110.261 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.44 108.75 17.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 110.369 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -72.21 147.76 46.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.153 -0.967 . . . . 0.0 110.19 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.456 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 20.6 pttt -146.38 163.35 30.36 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 109.957 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 50.9 Cg_endo -76.07 -177.11 19.92 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.84 -2.15 . . . . 0.0 110.918 0.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.674 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.08 166.27 10.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.885 . . . . 0.0 110.005 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 1.2 mttm -103.39 112.44 25.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 0.0 110.364 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 1.9 p90 -95.83 163.33 13.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 109.682 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 1.1 tt -155.23 130.49 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.058 -1.026 . . . . 0.0 110.907 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -138.83 114.64 9.98 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.436 -0.79 . . . . 0.0 109.932 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HB2' ' HD2' ' A' ' 65' ' ' LYS . 40.4 mttt -97.32 62.19 1.74 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 110.654 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 46.08 99.3 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.544 -0.723 . . . . 0.0 111.616 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.8 -21.67 43.92 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.421 ' HD2' ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -133.16 166.09 23.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -1.182 . . . . 0.0 110.46 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.741 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.1 pt? -171.25 145.76 2.24 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.614 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.3 OUTLIER -141.41 -160.1 1.04 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -170.22 128.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.991 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.497 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 0.6 OUTLIER -98.79 132.49 44.11 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.033 -1.042 . . . . 0.0 109.704 179.735 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -112.62 128.16 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.85 . . . . 0.0 110.017 -179.662 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 m -88.57 126.74 35.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.06 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -102.92 144.74 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.79 143.94 28.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 0.0 110.357 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.624 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.3 OUTLIER 56.59 90.44 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.256 -0.902 . . . . 0.0 110.191 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -29.73 63.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.211 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -67.12 -53.08 34.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.848 . . . . 0.0 110.201 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.541 ' O ' HG12 ' A' ' 119' ' ' VAL . 46.8 m0 -57.72 -56.06 26.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.648 HD11 HG13 ' A' ' 117' ' ' ILE . 9.3 tp -87.69 116.58 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.443 -0.786 . . . . 0.0 109.928 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -86.37 -23.98 25.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.477 -0.764 . . . . 0.0 110.67 -179.254 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.16 179.48 47.52 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.3 mtt -151.52 165.79 33.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.395 -1.062 . . . . 0.0 109.796 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -154.56 148.84 26.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 110.215 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.917 HD12 ' CD2' ' A' ' 104' ' ' PHE . 2.3 mt -139.27 153.43 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 110.059 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.487 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 61.59 13.67 5.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.02 -1.05 . . . . 0.0 110.912 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.85 21.86 54.6 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.726 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.569 ' CE1' ' O ' ' A' ' 83' ' ' ILE . 2.3 p80 -136.81 162.72 32.43 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.751 -1.441 . . . . 0.0 110.677 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 171.47 10.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.345 -0.847 . . . . 0.0 111.023 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.481 ' CB ' ' CZ ' ' A' ' 104' ' ' PHE . 5.7 pt-20 -100.4 170.41 8.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.445 -0.784 . . . . 0.0 110.535 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 102' ' ' SER . 9.4 t-20 -108.38 138.14 45.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 109.975 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.4 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.1 pp -68.14 101.14 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.969 -1.082 . . . . 0.0 109.561 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.504 HG21 HG22 ' A' ' 101' ' ' THR . 0.4 OUTLIER -94.63 -31.95 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.352 -0.842 . . . . 0.0 110.978 -179.045 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.413 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 9.0 m -166.2 98.25 0.61 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.063 -1.023 . . . . 0.0 109.934 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -95.05 137.62 33.86 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.41 -0.806 . . . . 0.0 109.911 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -142.57 90.07 2.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.358 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -31.03 64.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.947 . . . . 0.0 109.979 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.81 -44.84 95.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 110.176 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -95.25 9.86 38.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 110.556 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 53.7 58.91 4.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.032 -1.043 . . . . 0.0 110.19 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -147.94 162.33 39.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 110.391 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.607 ' O ' HG22 ' A' ' 72' ' ' VAL . 1.2 mtp180 -164.71 149.42 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 109.961 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.504 HG22 HG21 ' A' ' 91' ' ' ILE . 52.4 m -142.04 154.87 45.3 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 109.986 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 24.8 p -146.91 146.67 30.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.981 . . . . 0.0 110.589 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -91.73 147.14 23.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.361 -0.837 . . . . 0.0 110.078 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.917 ' CD2' HD12 ' A' ' 83' ' ' ILE . 6.1 m-85 -130.14 140.14 50.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 110.846 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -97.34 126.82 42.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 108.991 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.741 ' O ' HD21 ' A' ' 66' ' ' LEU . 14.5 p -149.7 147.75 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.003 -1.06 . . . . 0.0 111.277 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.09 99.98 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.667 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 55.61 170.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.494 -0.754 . . . . 0.0 109.409 -178.191 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.408 ' H ' HD12 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -149.34 79.25 1.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.967 -1.083 . . . . 0.0 111.065 -179.191 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -146.41 71.89 1.26 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.827 . . . . 0.0 110.032 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.79 -101.48 0.19 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.453 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.3 OUTLIER -157.51 145.71 19.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -1.143 . . . . 0.0 110.156 -179.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mm -136.27 137.92 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 109.879 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.14 108.49 9.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 0.0 110.058 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -120.54 -176.36 15.62 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 5.3 mtmm -144.62 167.29 22.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.307 -1.113 . . . . 0.0 110.001 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.648 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.74 142.29 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.109 -0.995 . . . . 0.0 110.709 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.58 ' O ' HG22 ' A' ' 79' ' ' THR . 1.0 OUTLIER -104.7 155.92 18.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.438 -0.789 . . . . 0.0 109.679 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.2 OUTLIER -135.77 153.65 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 0.0 110.451 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 15.6 t80 -151.29 103.62 3.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.423 -0.798 . . . . 0.0 110.553 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 77' ' ' TRP . 75.3 mt -133.09 151.0 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 0.0 110.204 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -159.08 100.02 1.53 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.411 -0.806 . . . . 0.0 109.518 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -173.33 169.62 4.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 110.491 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 2.2 mttt -82.89 90.64 6.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.378 -0.826 . . . . 0.0 110.344 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.419 ' O ' ' CG1' ' A' ' 125' ' ' VAL . 2.0 p -77.43 134.66 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 110.156 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.58 25.47 1.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -0.881 . . . . 0.0 110.26 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.59 30.97 31.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 3.3 mtmm -144.62 139.11 15.13 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.238 -1.154 . . . . 0.0 110.017 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -62.49 119.7 6.91 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.709 1.373 . . . . 0.0 110.448 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 4.5 t80 -117.87 113.48 21.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 110.271 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -104.6 111.08 23.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.079 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.466 ' HE2' HG11 ' A' ' 119' ' ' VAL . 2.0 t80 -123.51 114.04 19.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 109.834 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -160.66 87.36 0.75 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.158 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -154.46 -173.01 4.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.868 . . . . 0.0 110.379 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -118.02 85.75 2.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.376 -0.827 . . . . 0.0 109.712 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -85.68 -179.05 6.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.28 -0.888 . . . . 0.0 110.362 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.595 ' O ' HG23 ' A' ' 138' ' ' ILE . 8.5 p30 -151.01 167.99 25.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 110.331 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.4 pt -157.28 177.19 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 110.499 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.453 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 20.7 m -91.57 121.2 33.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.903 . . . . 0.0 110.188 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.677 ' CD2' HD11 ' A' ' 83' ' ' ILE . 12.6 m-85 -89.51 99.96 12.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.58 154.84 24.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 110.244 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.4 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 14.9 m-85 -148.65 148.11 29.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.858 . . . . 0.0 109.919 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.443 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 23.6 m120 -138.99 98.13 3.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.88 . . . . 0.0 110.345 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.855 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -149.76 -148.83 4.85 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -66.5 -177.06 0.79 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.93 1.49 . . . . 0.0 110.463 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.45 -59.44 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 109.943 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.85 -148.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.867 . . . . 0.0 110.026 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.0 t 57.1 63.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 110.15 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.06 62.78 5.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.894 . . . . 0.0 110.241 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.62 ' C1D' HG21 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.187 0.517 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.65 133.48 38.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 110.167 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 62.41 22.7 13.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.951 . . . . 0.0 110.077 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -104.5 162.28 13.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.385 -0.822 . . . . 0.0 110.048 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.55 -172.5 2.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 110.283 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 2.5 m-20 54.54 24.66 5.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 110.087 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 p -158.86 146.01 17.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.948 . . . . 0.0 110.743 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -179.66 176.64 47.73 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.58 114.84 25.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.193 -1.181 . . . . 0.0 110.47 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.52 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 1.5 tt -94.79 148.25 22.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 110.319 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.1 t30 -80.64 139.8 36.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.96 . . . . 0.0 110.03 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.51 ' CD2' ' N ' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -167.11 174.18 8.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.026 -1.046 . . . . 0.0 110.658 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.51 ' N ' ' CD2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -155.58 -165.76 2.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.594 -0.691 . . . . 0.0 109.571 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.671 ' C ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.07 164.63 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.1 -1.0 . . . . 0.0 110.274 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -147.83 148.26 30.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.373 -0.83 . . . . 0.0 109.978 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.441 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -67.82 128.37 36.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 110.09 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.536 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -52.53 146.62 9.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.176 -0.953 . . . . 0.0 109.901 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.3 t30 71.74 1.54 3.93 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.851 -0.53 . . . . 0.0 111.161 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -135.24 -162.22 1.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.89 -1.131 . . . . 0.0 109.531 179.159 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.43 ' N ' ' OG1' ' A' ' 43' ' ' THR . 6.2 p30 -132.82 12.07 4.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 110.332 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -136.43 137.62 40.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.749 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.671 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -64.23 134.23 54.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.326 179.123 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.58 -17.25 3.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.904 -1.122 . . . . 0.0 112.159 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.0 mt -137.37 -50.75 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.61 -1.306 . . . . 0.0 111.184 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.0 5.34 11.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.385 -0.822 . . . . 0.0 111.512 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.447 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -73.5 -29.21 62.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.852 -1.155 . . . . 0.0 110.679 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -99.47 12.47 36.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.102 -0.999 . . . . 0.0 110.896 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -118.76 -18.84 8.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.009 -1.057 . . . . 0.0 110.451 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.414 ' CE2' HG12 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -101.43 113.86 27.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 109.848 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.14 155.21 40.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.967 . . . . 0.0 110.459 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -146.35 160.06 43.35 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.833 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 55.6 Cg_endo -78.29 -177.04 19.91 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.588 -2.255 . . . . 0.0 110.649 -0.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.86 170.4 7.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.143 -0.973 . . . . 0.0 110.095 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -104.32 119.47 39.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.789 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 29.1 p90 -97.01 165.81 11.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 109.525 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.677 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -154.95 124.04 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.937 -1.102 . . . . 0.0 110.937 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.479 ' HD3' HD21 ' A' ' 109' ' ' LEU . 1.2 mtmt -137.67 125.13 21.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.345 -0.847 . . . . 0.0 110.684 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -103.81 62.42 0.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.393 -0.817 . . . . 0.0 110.402 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 47.67 98.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.463 -0.773 . . . . 0.0 111.35 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.11 12.59 39.08 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.707 ' C ' HD13 ' A' ' 66' ' ' LEU . 3.5 ptpt -173.7 154.81 2.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.889 -1.359 . . . . 0.0 110.227 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.811 ' N ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -154.27 151.31 28.98 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.073 -1.017 . . . . 0.0 111.247 179.15 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.677 ' HB2' HG23 ' A' ' 60' ' ' ILE . 13.8 m-85 -141.92 -164.71 1.85 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.467 -0.771 . . . . 0.0 109.233 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.1 t -169.09 131.98 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.023 -1.048 . . . . 0.0 110.835 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -101.72 135.88 42.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.392 -0.817 . . . . 0.0 109.838 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.437 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -113.62 133.38 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.133 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -91.04 128.73 36.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.931 . . . . 0.0 110.422 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.541 HG11 ' CE ' ' A' ' 81' ' ' MET . 0.9 OUTLIER -104.86 142.24 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.906 . . . . 0.0 110.055 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -99.98 138.84 36.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.129 -0.982 . . . . 0.0 110.507 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 55.98 102.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.357 -0.839 . . . . 0.0 110.447 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.3 p -62.57 -43.73 98.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.125 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.76 -48.83 59.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.91 . . . . 0.0 110.146 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.46 ' O ' HG12 ' A' ' 119' ' ' VAL . 44.4 m0 -57.41 -67.69 0.3 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 110.323 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 78' ' ' ILE . 17.9 tt -87.83 117.98 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.39 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.618 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -85.9 -21.71 27.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.423 -0.798 . . . . 0.0 110.898 -178.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.09 177.13 47.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.541 ' CE ' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -152.29 159.22 43.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.432 -1.04 . . . . 0.0 109.884 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -155.84 151.33 27.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 0.0 109.932 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.527 HD12 ' CD2' ' A' ' 104' ' ' PHE . 3.9 mt -147.12 157.71 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 110.13 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.657 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 0.6 OUTLIER 62.48 14.52 7.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.611 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.23 21.23 61.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.657 ' CD2' ' HB3' ' A' ' 84' ' ' GLU . 2.1 p80 -136.77 160.17 39.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.035 -1.273 . . . . 0.0 110.563 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.85 163.68 27.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.393 -0.817 . . . . 0.0 110.403 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.524 ' CB ' ' CE1' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -92.22 170.27 9.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.158 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.67 134.81 51.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.184 -0.948 . . . . 0.0 110.066 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -67.4 101.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.957 . . . . 0.0 109.618 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.523 HG21 HG22 ' A' ' 101' ' ' THR . 0.7 OUTLIER -95.27 -29.89 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 111.001 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 3.5 m -167.15 94.94 0.47 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.035 -1.041 . . . . 0.0 110.048 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 18.2 ttmt -96.28 139.19 32.78 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.428 -0.795 . . . . 0.0 110.036 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.79 99.03 3.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.161 -0.962 . . . . 0.0 110.237 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 p -78.37 -32.37 48.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.1 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.12 99.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.879 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.06 10.68 36.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 0.0 110.549 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.54 58.11 5.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.978 -1.076 . . . . 0.0 110.011 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -146.43 165.04 30.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 110.265 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.471 ' CB ' ' CG2' ' A' ' 72' ' ' VAL . 2.8 mtp180 -168.73 154.42 6.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.368 -0.833 . . . . 0.0 109.903 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.523 HG22 HG21 ' A' ' 91' ' ' ILE . 78.2 m -141.76 154.66 45.41 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 109.839 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.452 ' HB2' ' CG ' ' A' ' 88' ' ' GLU . 99.7 p -144.84 139.14 27.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.981 . . . . 0.0 110.341 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -92.97 130.42 38.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.948 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.527 ' CD2' HD12 ' A' ' 83' ' ' ILE . 48.0 m-85 -114.43 147.74 38.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 110.451 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -105.17 135.15 47.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.342 -0.849 . . . . 0.0 110.052 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.3 m -149.36 158.97 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.36 -0.837 . . . . 0.0 109.891 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.4 p -53.17 -35.03 59.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.426 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.49 -150.96 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.596 -0.69 . . . . 0.0 109.184 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.479 HD21 ' HD3' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -148.56 54.18 1.01 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.849 -1.157 . . . . 0.0 110.567 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.529 ' CG ' HG22 ' A' ' 146' ' ' THR . 22.2 t-20 -145.28 57.64 1.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.22 -0.925 . . . . 0.0 110.222 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.44 176.97 44.14 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.419 ' CE ' HG23 ' A' ' 139' ' ' THR . 0.1 OUTLIER -81.6 146.66 29.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -1.183 . . . . 0.0 110.446 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.403 ' N ' ' O ' ' A' ' 140' ' ' TYR . 7.6 mm -136.36 129.43 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.841 . . . . 0.0 109.942 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -76.72 112.55 13.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.839 . . . . 0.0 110.367 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.432 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -121.09 -175.15 15.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 63.1 mttt -144.88 164.86 29.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -1.143 . . . . 0.0 110.035 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.632 HG21 HD11 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.98 145.76 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -0.948 . . . . 0.0 110.668 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.618 ' C ' HG22 ' A' ' 79' ' ' THR . 72.9 m-20 -107.26 155.7 19.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.496 -0.753 . . . . 0.0 109.492 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.2 OUTLIER -129.55 146.32 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.965 -1.084 . . . . 0.0 110.609 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.412 ' HB2' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -152.3 104.2 2.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.372 -0.83 . . . . 0.0 110.178 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.43 HD13 ' CBB' ' A' ' 151' ' ' ZNH . 46.4 mt -128.24 152.46 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.118 -0.989 . . . . 0.0 110.448 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.28 95.56 1.14 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.438 -0.789 . . . . 0.0 109.69 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -173.72 175.53 2.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.0 110.23 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -84.16 102.78 12.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 110.273 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.664 ' O ' HG12 ' A' ' 125' ' ' VAL . 2.1 t -76.68 103.39 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.091 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.66 43.51 7.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.049 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.37 33.53 56.25 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.28 109.46 4.59 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.278 -1.13 . . . . 0.0 110.193 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -47.42 113.5 0.76 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.66 1.347 . . . . 0.0 110.164 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.572 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 24.4 t80 -112.48 151.14 30.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.0 110.437 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.64 125.89 26.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.393 -0.817 . . . . 0.0 110.115 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.462 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 4.2 t80 -140.4 129.87 24.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 110.155 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 0.8 OUTLIER -176.3 88.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 110.037 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.35 -163.57 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 110.403 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -118.24 145.03 45.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 110.172 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -154.97 -179.03 7.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.095 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 8.9 p30 -150.27 169.85 20.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.187 -0.945 . . . . 0.0 110.558 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.632 HD11 HG21 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -156.53 173.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.608 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.419 HG23 ' CE ' ' A' ' 112' ' ' LYS . 24.6 m -91.82 162.77 14.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.473 -0.767 . . . . 0.0 110.526 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.432 ' CE2' ' HA3' ' A' ' 115' ' ' GLY . 97.0 m-85 -144.19 104.87 4.16 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.368 -0.832 . . . . 0.0 109.714 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.28 104.37 14.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 110.68 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.435 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 29.6 m-85 -91.66 135.27 34.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.896 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.413 ' H ' HD21 ' A' ' 34' ' ' LEU . 8.9 m120 -126.25 105.09 8.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.096 -1.003 . . . . 0.0 110.227 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.448 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -150.96 -149.8 5.14 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.44 ' C ' HG23 ' A' ' 146' ' ' THR . 1.7 Cg_endo -49.95 170.84 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.702 1.369 . . . . 0.0 110.907 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.529 HG22 ' CG ' ' A' ' 110' ' ' ASN . 46.8 p -149.3 -51.01 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.44 -0.787 . . . . 0.0 109.883 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.09 -59.76 1.96 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 110.102 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 149' ' ' ALA . 65.1 t 55.88 -102.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 0.0 110.247 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.49 ' N ' HG12 ' A' ' 148' ' ' VAL . . . -158.56 -58.69 0.07 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.008 -1.057 . . . . 0.0 110.173 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.974 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.572 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.239 0.543 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.9 130.46 36.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -0.937 . . . . 0.0 110.292 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 57.77 23.29 9.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.383 -0.823 . . . . 0.0 109.925 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.63 35.44 1.44 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.352 -0.843 . . . . 0.0 109.922 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.79 -60.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 110.308 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.4 OUTLIER 52.52 27.88 5.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.874 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -160.76 144.48 13.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.266 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.87 -175.99 42.6 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.39 105.62 17.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.34 -1.094 . . . . 0.0 110.395 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.649 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -94.8 154.49 17.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.0 110.31 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -80.13 137.86 36.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.335 -0.853 . . . . 0.0 110.037 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.717 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -165.96 161.91 17.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.04 -1.038 . . . . 0.0 110.273 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 141' ' ' LYS . 0.2 OUTLIER -156.11 -176.82 6.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 109.908 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.792 ' O ' HG22 ' A' ' 46' ' ' THR . 25.8 m -140.38 116.84 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.018 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -90.27 163.1 14.89 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.494 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.441 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.4 OUTLIER -67.36 126.84 30.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 109.942 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.494 ' O ' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -51.01 141.91 12.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.031 . . . . 0.0 109.943 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER 73.09 0.59 3.73 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.851 -0.53 . . . . 0.0 110.981 -179.408 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -136.83 -168.52 2.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.85 -1.156 . . . . 0.0 109.677 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -135.86 24.41 3.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.188 -0.945 . . . . 0.0 110.422 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -135.65 119.91 17.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.069 . . . . 0.0 111.101 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.792 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.7 OUTLIER -50.14 117.57 2.43 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.589 -0.694 . . . . 0.0 109.501 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.6 t -129.64 -18.98 3.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.811 -1.181 . . . . 0.0 112.18 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 49' ' ' ALA . 71.8 mt -138.54 -79.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.653 -1.28 . . . . 0.0 111.0 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.672 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -45.19 -26.93 0.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.738 -0.601 . . . . 0.0 111.159 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.458 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -67.68 -18.12 64.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.013 -1.055 . . . . 0.0 110.655 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -95.77 14.31 23.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 110.771 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.458 ' CD2' HBC1 ' A' ' 151' ' ' ZNH . 64.0 m-85 -134.49 2.71 3.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.062 -1.024 . . . . 0.0 111.109 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.443 ' CE1' ' SD ' ' A' ' 81' ' ' MET . 26.7 m-85 -123.37 120.49 33.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.959 -1.088 . . . . 0.0 110.298 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -72.47 160.04 32.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.346 -0.846 . . . . 0.0 110.569 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.73 164.36 24.31 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.895 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 53.5 Cg_endo -76.71 -175.71 17.18 Favored 'Cis proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.583 -0.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.717 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -103.4 169.17 8.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.958 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.75 110.32 22.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.198 -0.939 . . . . 0.0 109.998 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.618 ' CD2' HD13 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -96.02 161.8 13.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.328 -0.857 . . . . 0.0 109.91 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -155.3 151.09 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.095 -1.003 . . . . 0.0 110.997 -179.448 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 17.9 mtmt -134.53 173.86 11.19 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.331 -0.855 . . . . 0.0 110.595 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.479 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -158.26 63.51 0.44 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.364 -0.835 . . . . 0.0 110.153 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.0 m120 48.71 84.5 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 111.274 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.64 18.57 47.77 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.53 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.479 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 3.1 ptpt -165.83 162.86 18.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.964 -1.316 . . . . 0.0 111.294 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.83 HD21 ' H ' ' A' ' 108' ' ' LYS . 1.7 pt? -173.42 155.8 2.91 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.962 0.887 . . . . 0.0 111.205 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 1.1 m-85 -139.0 -159.4 0.95 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 67' ' ' TYR . 1.2 t -169.41 133.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.141 -0.974 . . . . 0.0 109.796 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 102' ' ' SER . 5.1 pt20 -97.42 136.17 38.24 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.106 -0.997 . . . . 0.0 109.866 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.435 ' O ' HG22 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -113.68 131.12 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 110.364 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m -88.76 123.89 33.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.637 HG12 ' HE1' ' A' ' 81' ' ' MET . 0.8 OUTLIER -103.29 136.77 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 110.499 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.8 144.6 29.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.365 -0.834 . . . . 0.0 110.007 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 58.33 89.08 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.178 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.2 p -55.22 -23.89 24.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.302 -0.874 . . . . 0.0 110.58 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -73.92 -55.64 5.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.976 . . . . 0.0 110.322 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.687 ' O ' HG12 ' A' ' 119' ' ' VAL . 42.2 m0 -48.91 -62.33 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 0.0 110.466 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.592 HG23 ' O ' ' A' ' 78' ' ' ILE . 6.4 tp -87.9 115.5 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.282 -0.886 . . . . 0.0 110.242 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.576 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.33 -26.68 23.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.389 -0.819 . . . . 0.0 110.83 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.5 176.86 45.34 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.637 ' HE1' HG12 ' A' ' 72' ' ' VAL . 33.6 mtm -151.92 160.13 43.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.358 -1.083 . . . . 0.0 110.063 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 116' ' ' LYS . 1.3 m -154.53 132.93 11.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.185 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.654 HD12 ' CG ' ' A' ' 104' ' ' PHE . 16.8 mt -130.17 141.96 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.354 -0.841 . . . . 0.0 110.321 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.463 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 1.1 tm-20 69.89 3.08 4.15 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.415 -0.803 . . . . 0.0 111.295 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.38 24.42 10.25 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.695 -1.241 . . . . 0.0 111.119 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.47 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.49 159.12 42.89 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.605 -1.526 . . . . 0.0 110.179 179.317 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -70.48 -178.44 1.76 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.347 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 0.6 OUTLIER -104.92 168.46 9.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 110.203 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.83 129.44 56.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.168 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.407 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.1 pp -67.98 101.23 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.139 -0.975 . . . . 0.0 109.484 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.548 HG21 HG22 ' A' ' 101' ' ' THR . 1.4 tt -93.19 -26.88 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.441 -0.787 . . . . 0.0 110.525 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.458 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -166.81 148.72 6.24 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.293 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.457 ' HG3' ' CG ' ' A' ' 100' ' ' ARG . 15.5 ttmt -141.98 149.32 39.9 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 110.019 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.74 91.34 2.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 0.0 110.466 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.4 p -73.33 -18.71 61.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 110.121 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.6 -28.46 69.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 110.379 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.55 23.24 3.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.253 -0.904 . . . . 0.0 110.249 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.54 79.72 0.11 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 0.0 110.432 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -148.14 167.15 25.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.457 ' CG ' ' HG3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -172.46 157.53 4.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 110.209 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.548 HG22 HG21 ' A' ' 91' ' ' ILE . 90.8 m -141.44 152.82 44.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.435 -0.791 . . . . 0.0 109.651 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 0.8 OUTLIER -145.24 145.22 31.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.084 -1.01 . . . . 0.0 110.694 -179.68 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -93.57 143.37 26.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.433 -0.792 . . . . 0.0 109.886 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.654 ' CG ' HD12 ' A' ' 83' ' ' ILE . 44.2 m-85 -127.36 127.58 44.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.976 . . . . 0.0 110.663 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.443 ' C ' HG13 ' A' ' 106' ' ' VAL . 2.7 tm-20 -93.27 125.2 37.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 109.792 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 105' ' ' GLU . 29.0 m -149.33 163.9 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.022 -1.049 . . . . 0.0 110.887 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p -80.21 105.03 11.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.388 -0.82 . . . . 0.0 109.348 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.83 ' H ' HD21 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 53.74 174.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 109.756 -178.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.542 HD21 ' HD2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -149.91 73.7 1.18 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.004 -1.06 . . . . 0.0 110.898 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.513 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -144.41 66.76 1.26 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.066 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.39 -108.64 0.31 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.86 146.34 19.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -1.145 . . . . 0.0 110.342 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.544 HD12 ' CE2' ' A' ' 142' ' ' PHE . 35.9 mt -137.38 142.8 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.357 -0.839 . . . . 0.0 110.157 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -76.3 125.42 29.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.218 -0.926 . . . . 0.0 110.137 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -131.56 -177.04 14.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.5 mtmm -142.38 161.0 39.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.364 -1.08 . . . . 0.0 109.678 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.483 HG21 HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -158.23 146.43 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.046 -1.034 . . . . 0.0 110.735 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.576 ' C ' HG22 ' A' ' 79' ' ' THR . 89.0 m-20 -110.12 159.68 17.13 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -133.63 147.05 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.09 -1.006 . . . . 0.0 110.17 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -152.03 113.14 4.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 110.684 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.617 HD11 ' HA ' ' A' ' 77' ' ' TRP . 2.6 mp -138.75 152.21 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 0.0 109.856 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.15 98.43 1.3 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.953 . . . . 0.0 110.015 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -174.03 178.68 2.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 110.18 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -93.06 107.69 19.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 110.175 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.42 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 56.0 t -75.84 90.58 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.826 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.42 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 63.7 53.04 2.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.277 -0.89 . . . . 0.0 110.012 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.33 36.95 48.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -145.04 97.48 4.84 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.296 -1.12 . . . . 0.0 110.366 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.99 110.15 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.863 1.454 . . . . 0.0 110.15 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.674 ' CE2' HMB2 ' A' ' 151' ' ' ZNH . 52.4 t80 -116.63 153.1 32.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.341 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -136.68 112.19 9.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 110.13 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.495 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 3.7 t80 -115.71 128.24 55.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.004 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -167.49 86.69 0.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.404 -0.81 . . . . 0.0 109.948 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -153.33 -169.19 3.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.898 . . . . 0.0 110.391 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.401 ' ND1' ' OD1' ' A' ' 118' ' ' ASP . 13.4 t60 -119.61 148.39 43.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 109.99 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -154.79 -179.66 8.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.882 . . . . 0.0 110.136 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.499 ' O ' HG23 ' A' ' 138' ' ' ILE . 42.9 p-10 -151.82 170.66 19.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.882 . . . . 0.0 110.261 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.672 HG21 ' HB2' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -157.76 168.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.917 . . . . 0.0 110.348 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 87.0 m -91.63 117.53 29.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.335 -0.853 . . . . 0.0 109.82 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.479 ' CD2' HG12 ' A' ' 83' ' ' ILE . 10.4 m-85 -88.91 106.51 18.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 110.326 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -86.69 159.59 19.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.318 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.544 ' CE2' HD12 ' A' ' 113' ' ' ILE . 41.4 m-85 -148.87 150.86 33.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.878 . . . . 0.0 110.125 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.56 ' C ' HD21 ' A' ' 34' ' ' LEU . 22.6 m120 -143.84 96.32 2.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 110.234 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.649 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -135.73 -140.01 4.1 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -49.38 134.17 31.53 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.711 1.374 . . . . 0.0 110.422 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.513 HG23 ' HB3' ' A' ' 110' ' ' ASN . 0.7 OUTLIER -149.28 -41.37 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.181 -0.949 . . . . 0.0 110.43 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.98 -72.76 0.67 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.917 . . . . 0.0 110.366 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.5 t 56.51 54.18 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.378 -0.826 . . . . 0.0 110.269 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.28 -19.99 41.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.307 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.814 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.674 HMB2 ' CE2' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.246 0.546 . . . . 0.0 110.201 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 25' ' ' SER . . . 56.36 80.63 0.14 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.289 -0.882 . . . . 0.0 110.171 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 0.1 OUTLIER 62.82 20.46 12.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.304 -0.873 . . . . 0.0 110.192 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 25' ' ' SER . . . -82.42 57.1 3.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 110.094 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.4 -35.05 63.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 110.376 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER 58.12 28.65 16.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.156 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.18 144.07 14.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.946 . . . . 0.0 110.264 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.61 -177.52 45.92 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.34 108.4 19.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.351 -1.087 . . . . 0.0 110.359 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.935 ' HG ' HD22 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -94.84 150.0 20.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.399 -0.813 . . . . 0.0 109.913 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.708 ' H ' HD13 ' A' ' 34' ' ' LEU . 5.1 m-80 -78.93 141.34 37.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.991 -1.068 . . . . 0.0 109.7 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -165.4 156.48 14.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 110.557 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 141' ' ' LYS . 5.2 tt0 -155.56 -175.85 5.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 0.0 109.946 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.659 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -141.63 173.22 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 110.449 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -147.79 161.07 41.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -0.805 . . . . 0.0 109.951 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.519 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.1 OUTLIER -67.53 132.73 48.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 0.0 109.879 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.512 ' CE2' ' ND2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -57.45 146.04 30.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 110.052 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.4 t30 71.07 2.89 4.43 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.801 -0.562 . . . . 0.0 111.055 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.519 HG21 ' HG2' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -135.64 -164.48 1.55 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.828 -1.17 . . . . 0.0 109.767 179.268 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.413 ' N ' ' OG1' ' A' ' 43' ' ' THR . 2.2 t-20 -131.81 14.21 4.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 110.296 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.81 135.55 41.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.069 -1.019 . . . . 0.0 110.401 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.531 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -68.07 133.48 49.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.403 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.48 -17.45 3.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.017 -1.052 . . . . 0.0 112.184 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.6 mt -136.92 -58.6 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.607 -1.308 . . . . 0.0 111.121 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.09 -10.04 27.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.472 -0.768 . . . . 0.0 111.424 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.461 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER -75.68 -18.15 59.72 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.843 -1.16 . . . . 0.0 110.787 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -102.06 15.41 29.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.0 110.731 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.434 ' CD2' HBC1 ' A' ' 151' ' ' ZNH . 49.4 m-85 -129.12 3.37 5.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.049 -1.032 . . . . 0.0 110.985 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -128.94 117.54 21.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.994 -1.066 . . . . 0.0 110.293 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -72.83 166.71 22.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.341 -0.849 . . . . 0.0 110.494 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -146.92 160.35 40.69 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.304 -0.873 . . . . 0.0 109.834 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.13 -175.36 16.49 Favored 'Cis proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.752 -2.186 . . . . 0.0 110.725 -0.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.44 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.77 170.23 8.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -0.895 . . . . 0.0 109.96 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.462 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -107.97 111.67 23.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.11 -0.994 . . . . 0.0 110.693 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.666 ' CD2' HD21 ' A' ' 109' ' ' LEU . 2.7 p90 -97.84 165.24 12.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.262 -0.899 . . . . 0.0 110.132 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -155.52 154.15 6.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.254 -0.904 . . . . 0.0 110.66 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -133.35 170.64 15.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.424 -0.798 . . . . 0.0 110.479 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.455 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 0.7 OUTLIER -152.75 62.33 0.79 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -0.83 . . . . 0.0 110.12 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 50.47 82.86 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.353 -0.842 . . . . 0.0 111.067 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.51 21.93 35.91 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.455 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 6.2 ptpt -167.15 163.71 15.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.021 -1.282 . . . . 0.0 110.768 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.952 HD11 ' HA ' ' A' ' 108' ' ' LYS . 1.5 pt? -173.73 154.19 2.39 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.009 0.909 . . . . 0.0 111.034 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.565 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -139.61 -155.52 0.6 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.779 -0.575 . . . . 0.0 109.475 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 103' ' ' GLU . 1.0 OUTLIER -170.67 135.88 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.195 -0.94 . . . . 0.0 110.536 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.462 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -99.29 133.73 43.18 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.29 -0.881 . . . . 0.0 109.657 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.2 OUTLIER -113.0 140.42 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.363 -0.836 . . . . 0.0 110.3 -179.502 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.5 m -89.23 129.9 35.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.754 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.724 HG12 HG21 ' A' ' 78' ' ' ILE . 2.5 t -103.47 128.25 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 110.544 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -100.92 134.97 43.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.304 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.515 ' O ' HG22 ' A' ' 78' ' ' ILE . 32.1 m170 54.76 94.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.345 -0.847 . . . . 0.0 110.245 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -27.85 61.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.942 . . . . 0.0 110.288 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -27.11 61.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.186 -0.946 . . . . 0.0 110.283 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.556 ' O ' HG12 ' A' ' 119' ' ' VAL . 38.4 m0 -92.48 -52.27 4.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.2 -0.938 . . . . 0.0 110.057 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.724 HG21 HG12 ' A' ' 72' ' ' VAL . 1.5 tt -88.65 119.15 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.293 -0.88 . . . . 0.0 109.392 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.629 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.98 -23.83 24.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.42 -0.8 . . . . 0.0 111.389 -178.66 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.49 -178.84 48.15 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.064 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.432 ' HE2' HG13 ' A' ' 72' ' ' VAL . 19.0 mtm -152.24 162.73 40.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.464 -1.021 . . . . 0.0 110.103 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -155.2 141.26 18.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 0.0 109.935 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.569 HD12 ' CG ' ' A' ' 104' ' ' PHE . 7.1 mt -135.75 140.47 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 110.589 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 71.16 1.99 4.05 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.528 -0.733 . . . . 0.0 111.442 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.79 21.79 10.85 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.536 -1.316 . . . . 0.0 111.233 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.64 ' HE1' ' HD1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -137.13 158.58 44.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.622 -1.517 . . . . 0.0 110.05 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -71.41 -177.6 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.141 -0.975 . . . . 0.0 110.337 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -109.95 170.21 8.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.322 -0.861 . . . . 0.0 110.182 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -115.4 134.73 54.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.294 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.48 102.29 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.976 . . . . 0.0 109.668 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.587 HG22 ' O ' ' A' ' 101' ' ' THR . 1.4 tt -95.51 -27.52 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 111.008 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.448 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -167.53 103.62 0.51 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.08 -1.013 . . . . 0.0 109.856 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -95.53 149.59 21.25 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.386 -0.821 . . . . 0.0 110.259 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.34 61.58 1.39 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 110.116 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 m -54.49 -30.58 53.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.214 -0.928 . . . . 0.0 110.148 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.09 -49.27 75.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.094 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -95.97 9.9 39.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.566 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.47 55.62 4.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.082 -1.011 . . . . 0.0 110.326 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -147.53 159.2 44.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.173 -0.954 . . . . 0.0 110.402 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.415 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.5 ttm180 -163.16 162.77 25.7 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.325 -0.86 . . . . 0.0 110.023 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.587 ' O ' HG22 ' A' ' 91' ' ' ILE . 85.7 m -141.07 152.71 45.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.944 . . . . 0.0 109.655 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.1 p -145.71 143.4 29.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.977 -1.077 . . . . 0.0 110.725 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 5.3 tt0 -93.07 143.87 25.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.381 -0.824 . . . . 0.0 109.843 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.64 ' HD1' ' HE1' ' A' ' 86' ' ' HIS . 42.4 m-85 -125.64 145.46 50.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.108 -0.995 . . . . 0.0 110.561 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.45 130.61 47.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.363 -0.835 . . . . 0.0 110.141 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.551 ' O ' HD21 ' A' ' 66' ' ' LEU . 12.5 p -148.9 150.56 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 110.292 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.34 -39.63 46.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.952 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.5 -157.56 0.33 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.445 -0.784 . . . . 0.0 109.591 179.168 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.935 HD22 ' HG ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -148.19 62.77 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.96 -1.087 . . . . 0.0 110.612 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.685 ' OD1' HG23 ' A' ' 146' ' ' THR . 28.4 t-20 -145.81 62.92 1.25 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 110.078 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.82 -179.97 33.15 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.05 145.28 30.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -1.14 . . . . 0.0 110.57 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.521 HD13 HG21 ' A' ' 106' ' ' VAL . 27.1 mt -137.77 149.71 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.888 . . . . 0.0 109.923 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -76.04 120.96 22.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.0 110.183 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.489 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -124.71 171.21 16.78 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 82' ' ' SER . 47.1 mttt -146.37 159.94 42.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.276 -1.132 . . . . 0.0 110.033 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.402 HG12 ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -158.12 144.35 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.155 -0.965 . . . . 0.0 110.317 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.629 ' C ' HG22 ' A' ' 79' ' ' THR . 11.9 m-20 -106.38 158.09 17.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.341 -0.849 . . . . 0.0 109.676 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.1 OUTLIER -131.89 150.99 34.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.243 -0.911 . . . . 0.0 109.771 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 16.8 t80 -151.74 100.26 2.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 0.0 110.543 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.434 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 54.7 mt -129.74 151.99 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 110.176 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.48 96.58 1.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.856 . . . . 0.0 110.012 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -173.76 -175.78 1.14 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.868 . . . . 0.0 110.394 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.91 104.15 16.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.338 -0.851 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.541 ' O ' HG12 ' A' ' 125' ' ' VAL . 11.9 t -76.6 95.68 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 110.072 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.13 44.44 10.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 110.128 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.85 30.09 44.71 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -145.34 107.79 4.48 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.295 -1.12 . . . . 0.0 110.233 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -52.12 108.31 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.684 1.36 . . . . 0.0 110.214 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.72 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 24.4 t80 -110.66 119.33 38.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 0.0 110.46 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -106.33 117.22 33.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 110.138 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.488 ' HE2' HG11 ' A' ' 119' ' ' VAL . 2.3 t80 -126.45 121.22 31.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 0.0 110.078 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 35.4 t70 -166.69 90.47 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 110.415 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.03 -165.1 2.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.145 -0.972 . . . . 0.0 110.392 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -120.87 86.11 2.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 109.997 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.415 ' HB3' HMD2 ' A' ' 151' ' ' ZNH . 31.6 m-85 -85.45 -179.17 6.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.881 . . . . 0.0 110.392 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.57 ' O ' HG23 ' A' ' 138' ' ' ILE . 46.2 p30 -151.28 171.05 18.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 110.29 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.4 pt -156.5 162.22 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 62.2 m -91.67 121.24 33.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 110.61 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.659 ' HA ' HG12 ' A' ' 38' ' ' VAL . 21.9 m-85 -90.2 155.16 19.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.835 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -144.77 99.82 3.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.518 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -91.6 144.03 25.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.37 -0.831 . . . . 0.0 109.825 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.436 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 5.3 m120 -132.96 100.96 5.05 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.158 -0.964 . . . . 0.0 110.51 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.917 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -163.21 -144.03 3.89 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.403 ' HG2' HD11 ' A' ' 109' ' ' LEU . 15.3 Cg_endo -63.28 138.31 65.62 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.779 1.41 . . . . 0.0 110.635 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.685 HG23 ' OD1' ' A' ' 110' ' ' ASN . 0.2 OUTLIER -91.86 -52.01 4.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.0 110.045 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.53 -48.98 0.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 110.303 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.53 HG12 ' N ' ' A' ' 149' ' ' ALA . 94.0 t 55.12 -102.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.219 -0.925 . . . . 0.0 110.158 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.53 ' N ' HG12 ' A' ' 148' ' ' VAL . . . -158.51 -41.11 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.961 -1.087 . . . . 0.0 110.159 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.939 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.72 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.319 0.58 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.401 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -141.38 75.81 1.52 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 110.194 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 9.5 t30 63.51 38.5 9.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.99 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.49 119.01 18.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.794 . . . . 0.0 110.297 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.93 -167.01 1.0 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.121 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.3 OUTLIER 52.07 28.35 5.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.948 . . . . 0.0 110.277 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.6 t -159.65 140.73 12.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 110.525 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 177.37 178.76 47.27 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.03 111.29 21.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -1.125 . . . . 0.0 110.389 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.512 ' CB ' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -94.16 151.12 19.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 109.665 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.444 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -79.06 131.5 36.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.178 -0.951 . . . . 0.0 110.538 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.907 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -166.11 158.14 14.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 111.034 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -155.53 -165.96 2.12 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.559 ' C ' HG23 ' A' ' 46' ' ' THR . 0.1 OUTLIER -141.22 175.08 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 110.36 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 54.3 m-85 -148.32 163.99 35.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.475 -0.766 . . . . 0.0 109.813 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.427 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -68.24 128.46 36.64 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 109.895 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.515 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -54.97 146.37 17.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 110.112 -179.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.0 t-20 71.87 2.93 4.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.922 -0.487 . . . . 0.0 110.941 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -136.23 -162.35 1.26 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.888 -1.133 . . . . 0.0 109.706 179.216 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.416 ' N ' ' OG1' ' A' ' 43' ' ' THR . 22.9 m120 -133.05 15.74 4.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 110.445 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.5 139.03 43.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.16 -0.963 . . . . 0.0 110.361 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.559 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -74.08 133.06 42.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.994 . . . . 0.0 109.379 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.76 -16.97 4.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.046 -1.033 . . . . 0.0 111.82 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.8 mt -137.11 -64.63 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.831 -1.168 . . . . 0.0 110.623 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.4 -18.09 6.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.495 -0.753 . . . . 0.0 111.163 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.46 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 0.1 OUTLIER -68.35 -10.87 57.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.926 -1.108 . . . . 0.0 110.847 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -102.38 12.8 36.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.879 -1.138 . . . . 0.0 110.843 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -136.29 6.44 3.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.012 -1.055 . . . . 0.0 110.667 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -114.22 98.47 6.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.957 . . . . 0.0 109.845 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -72.03 103.28 3.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.522 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HG3' ' N ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -93.05 165.06 19.38 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.204 -0.935 . . . . 0.0 109.879 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.446 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 50.1 Cg_endo -78.61 -176.36 18.53 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.468 -2.305 . . . . 0.0 110.524 -0.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.907 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -103.15 165.41 11.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.25 -0.906 . . . . 0.0 110.008 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.405 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.71 109.52 21.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 110.168 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.512 ' CD1' ' CB ' ' A' ' 34' ' ' LEU . 19.4 p90 -96.95 161.78 13.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.676 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -154.0 153.05 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.111 -0.993 . . . . 0.0 110.357 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -135.89 174.03 11.06 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.324 -0.86 . . . . 0.0 110.453 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.437 ' HB2' ' HD3' ' A' ' 65' ' ' LYS . 9.8 mtmt -159.48 62.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.344 -0.848 . . . . 0.0 110.108 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 48.97 87.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.449 -0.782 . . . . 0.0 111.193 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.59 25.15 33.69 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.087 -1.054 . . . . 0.0 110.558 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.437 ' HD3' ' HB2' ' A' ' 62' ' ' LYS . 6.8 ptpt -171.9 158.85 4.94 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.962 -1.317 . . . . 0.0 111.028 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' A' ' 108' ' ' LYS . 1.3 pt? -173.4 150.29 1.82 Allowed 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 122.068 0.937 . . . . 0.0 111.334 178.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.586 ' C ' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -140.03 -161.06 1.14 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.586 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -167.15 142.89 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.578 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 102' ' ' SER . 8.7 pt20 -101.12 134.8 43.6 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.906 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -113.75 138.85 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.902 . . . . 0.0 109.842 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.6 m -89.03 135.87 33.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 110.469 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.663 HG12 HG21 ' A' ' 78' ' ' ILE . 2.0 t -107.42 122.69 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.865 . . . . 0.0 110.201 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -100.23 143.07 30.85 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.107 -0.995 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.909 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.5 OUTLIER 62.03 74.53 0.44 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 110.029 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.4 m -64.35 -19.1 65.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.348 -0.845 . . . . 0.0 110.551 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.32 -45.11 57.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.089 -1.007 . . . . 0.0 110.315 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.414 ' CD2' HBB2 ' A' ' 151' ' ' ZNH . 40.3 m0 -77.19 -42.44 37.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 110.19 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.909 HG22 ' O ' ' A' ' 74' ' ' HIS . 6.1 tp -88.14 118.82 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -0.92 . . . . 0.0 109.3 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -85.55 -24.06 27.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 111.029 -178.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.48 -179.16 46.85 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.006 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.552 ' HE1' HG22 ' A' ' 72' ' ' VAL . 28.5 mtm -151.35 158.55 43.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.458 -1.025 . . . . 0.0 109.791 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.33 154.87 34.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.087 -1.008 . . . . 0.0 110.17 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.76 HD12 ' CD2' ' A' ' 104' ' ' PHE . 12.9 mt -141.96 155.36 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 110.195 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.628 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 58.79 16.55 4.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.013 . . . . 0.0 110.791 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.19 21.65 60.41 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.92 -1.133 . . . . 0.0 110.424 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.628 ' CD2' ' HB3' ' A' ' 84' ' ' GLU . 2.7 p80 -135.18 157.42 46.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.842 -1.387 . . . . 0.0 110.525 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 178.8 3.65 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.329 -0.857 . . . . 0.0 110.701 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.407 ' HG3' ' CB ' ' A' ' 102' ' ' SER . 2.7 pt-20 -108.5 166.65 10.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.362 -0.836 . . . . 0.0 110.221 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 102' ' ' SER . 1.4 t30 -105.22 130.89 53.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -0.919 . . . . 0.0 110.209 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.12 102.56 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -0.954 . . . . 0.0 110.081 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 101' ' ' THR . 1.3 tt -95.78 -26.83 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.88 . . . . 0.0 110.855 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -167.5 99.02 0.49 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.148 -0.97 . . . . 0.0 109.874 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.437 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 7.7 ttmm -95.7 103.78 15.67 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.382 -0.824 . . . . 0.0 110.178 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -96.33 95.01 7.78 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.0 110.293 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.3 -29.86 61.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 110.109 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.09 94.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 110.354 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -95.69 14.56 22.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.206 -0.934 . . . . 0.0 110.593 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.6 t0 50.16 57.42 6.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.033 -1.042 . . . . 0.0 110.263 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -146.84 -176.74 5.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.166 -0.959 . . . . 0.0 110.318 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 72' ' ' VAL . 4.9 ttm180 -176.75 162.45 2.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.438 -0.789 . . . . 0.0 109.989 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.636 ' O ' HG22 ' A' ' 91' ' ' ILE . 86.8 m -142.68 150.6 40.38 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.86 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 19.5 p -146.33 148.72 32.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.045 -1.034 . . . . 0.0 110.711 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -92.99 146.92 23.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.322 -0.862 . . . . 0.0 110.088 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.76 ' CD2' HD12 ' A' ' 83' ' ' ILE . 8.7 m-85 -131.15 144.15 51.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.109 -0.994 . . . . 0.0 110.76 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -99.37 128.42 45.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.882 . . . . 0.0 109.366 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.73 143.09 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 110.825 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.4 113.21 2.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.111 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.616 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 47.23 -163.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.539 -0.726 . . . . 0.0 109.69 -178.609 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.428 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.66 64.61 0.87 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.861 -1.149 . . . . 0.0 110.753 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -146.2 58.78 1.22 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 110.308 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.8 171.05 38.6 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.441 ' HE3' HG23 ' A' ' 139' ' ' THR . 1.6 tmtt? -81.6 147.48 29.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -1.152 . . . . 0.0 110.326 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.41 ' N ' ' HG2' ' A' ' 112' ' ' LYS . 1.4 mt -136.01 140.84 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.941 . . . . 0.0 110.021 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.24 112.32 12.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.129 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.479 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -111.21 178.24 19.45 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -145.04 161.54 39.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -1.115 . . . . 0.0 109.854 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.669 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.02 140.96 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.121 -0.987 . . . . 0.0 110.392 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.549 ' O ' HG22 ' A' ' 79' ' ' THR . 25.1 t0 -105.24 152.47 22.84 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.354 -0.841 . . . . 0.0 109.473 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.464 HG22 HD11 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -128.86 151.89 36.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.017 -1.052 . . . . 0.0 110.386 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.401 ' CB ' ' OG1' ' A' ' 79' ' ' THR . 27.0 t80 -151.39 100.63 2.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 110.621 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.483 HD12 ' CD2' ' A' ' 132' ' ' TYR . 4.3 mt -127.36 152.89 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.965 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -159.7 98.77 1.38 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.262 -0.899 . . . . 0.0 109.912 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 124' ' ' LYS . 12.5 pt-20 -173.75 -152.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 110.363 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.47 ' O ' HG23 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -101.98 167.05 10.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.329 -0.857 . . . . 0.0 110.423 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 125' ' ' VAL . 1.3 t -158.05 114.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 125' ' ' VAL . 36.9 t30 56.26 25.92 9.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.441 -0.787 . . . . 0.0 109.826 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 86.04 37.32 9.28 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 3.6 mtmm -148.92 145.91 20.59 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.11 -1.229 . . . . 0.0 110.189 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -66.83 130.31 22.89 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.861 1.453 . . . . 0.0 110.027 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.555 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 10.2 t80 -116.34 140.16 49.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.174 -0.954 . . . . 0.0 110.548 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.79 105.01 5.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.829 . . . . 0.0 109.943 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.483 ' CD2' HD12 ' A' ' 121' ' ' ILE . 4.0 t80 -120.71 128.57 53.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 110.046 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -170.82 88.45 0.12 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.089 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.44 -175.03 5.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.356 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -119.52 85.27 2.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 110.242 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.5 ' CD1' HBD2 ' A' ' 151' ' ' ZNH . 40.3 m-85 -86.26 -178.83 6.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.354 -0.842 . . . . 0.0 110.078 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.472 ' HA ' HG22 ' A' ' 117' ' ' ILE . 4.2 p30 -150.87 178.42 9.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 110.281 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -156.69 168.88 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.382 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.441 HG23 ' HE3' ' A' ' 112' ' ' LYS . 48.9 m -92.03 119.59 31.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.342 -0.849 . . . . 0.0 110.931 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.526 ' CE2' HD11 ' A' ' 83' ' ' ILE . 28.3 m-85 -90.92 162.86 14.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.258 -0.902 . . . . 0.0 110.026 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.01 99.89 2.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.057 -1.027 . . . . 0.0 110.702 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.405 ' HA ' ' HB2' ' A' ' 36' ' ' TYR . 61.7 m-85 -91.95 150.96 20.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.195 -0.94 . . . . 0.0 110.417 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -141.66 104.58 4.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -0.886 . . . . 0.0 110.449 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.424 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -157.28 -146.74 4.57 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.41 ' CD ' HD11 ' A' ' 109' ' ' LEU . 11.0 Cg_endo -58.91 -172.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.697 1.367 . . . . 0.0 110.671 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.65 -58.53 0.2 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.296 -0.877 . . . . 0.0 110.056 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -168.84 -63.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 110.216 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 148' ' ' VAL . 21.2 t 56.47 46.06 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.318 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.82 114.66 20.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.965 . . . . 0.0 110.176 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.955 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.555 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.203 0.525 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.66 87.15 1.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 110.252 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.64 26.88 16.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.9 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -114.27 177.9 4.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.863 . . . . 0.0 110.285 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 42.89 -164.0 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.364 0.602 . . . . 0.0 111.006 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 8.4 m-20 55.68 31.55 17.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 110.417 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' TYR . 1.5 p -160.98 156.01 24.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.024 -1.048 . . . . 0.0 110.711 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' CD2' ' A' ' 59' ' ' TYR . . . 164.24 171.88 31.03 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -91.88 107.77 19.45 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.235 -1.156 . . . . 0.0 110.538 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.65 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.6 OUTLIER -95.47 157.56 15.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.96 -1.088 . . . . 0.0 110.487 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.4 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 49.2 m-20 -80.17 143.68 33.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 110.142 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.5 OUTLIER -166.22 156.42 12.36 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.948 . . . . 0.0 110.096 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -155.6 -178.58 7.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -0.984 . . . . 0.0 110.444 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.753 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -140.14 170.33 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 0.0 109.959 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 47.3 m-85 -147.27 159.45 43.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.344 -0.847 . . . . 0.0 110.192 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.47 ' HE3' ' CB ' ' A' ' 47' ' ' SER . 9.4 tppt? -67.81 145.81 54.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.948 . . . . 0.0 109.979 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.62 140.91 53.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.074 -1.016 . . . . 0.0 110.311 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 61.59 26.26 16.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.925 . . . . 0.0 110.112 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.422 ' OG1' ' HG3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -133.14 -154.67 0.62 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.389 -0.819 . . . . 0.0 110.058 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -126.18 -28.62 3.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.18 -0.95 . . . . 0.0 110.741 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.433 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -134.93 172.92 12.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.068 -1.02 . . . . 0.0 110.973 -179.63 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.481 HG21 ' HB2' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -75.54 142.24 42.83 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.507 -0.745 . . . . 0.0 109.352 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.47 ' CB ' ' HE3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -129.62 -17.9 3.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.06 -1.025 . . . . 0.0 112.122 -178.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 49' ' ' ALA . 12.2 mt -137.63 -71.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.757 -1.215 . . . . 0.0 110.781 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.552 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -47.25 -24.98 0.83 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.704 -0.623 . . . . 0.0 111.242 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.481 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.1 OUTLIER -67.3 -13.99 62.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.995 -1.066 . . . . 0.0 110.89 -179.682 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.412 ' C ' ' CD1' ' A' ' 52' ' ' TYR . 27.3 m-20 -88.83 -11.11 45.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 110.785 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 0.6 OUTLIER -119.16 7.4 11.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.022 -1.049 . . . . 0.0 110.71 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.402 ' CE2' HG12 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -109.7 106.93 16.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.034 -1.041 . . . . 0.0 110.42 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -72.4 153.54 41.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.131 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.63 159.19 44.94 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.107 -0.996 . . . . 0.0 109.985 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 57.2 Cg_endo -78.97 -175.93 17.66 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.752 -2.187 . . . . 0.0 110.681 -0.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -104.23 173.38 6.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 110.251 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.477 ' CB ' ' CG ' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -103.59 120.61 41.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.887 . . . . 0.0 110.349 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.524 ' CD1' ' HD2' ' A' ' 61' ' ' LYS . 11.6 p90 -97.79 159.14 15.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.95 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.587 HG23 ' HD1' ' A' ' 67' ' ' TYR . 1.1 tt -155.85 114.5 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 110.469 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.524 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -128.1 127.88 43.87 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.153 -0.967 . . . . 0.0 110.549 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.06 62.11 0.69 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.402 -0.811 . . . . 0.0 110.128 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.4 OUTLIER 46.99 98.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.531 -0.73 . . . . 0.0 111.19 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.1 -11.65 58.72 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -145.64 162.82 36.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.028 -1.277 . . . . 0.0 110.296 179.629 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.693 HD11 ' N ' ' A' ' 108' ' ' LYS . 1.6 pt? -168.32 144.99 3.92 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.151 -0.968 . . . . 0.0 111.358 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.587 ' HD1' HG23 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -139.44 -160.69 1.09 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 67' ' ' TYR . 1.2 t -170.18 129.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.204 -0.935 . . . . 0.0 110.206 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.477 ' CG ' ' CB ' ' A' ' 58' ' ' LYS . 3.0 pp0? -96.37 126.54 41.64 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.229 -0.92 . . . . 0.0 109.254 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -108.73 139.33 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 110.283 -179.121 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m -88.31 141.7 28.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.359 -0.838 . . . . 0.0 109.425 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.555 HG12 HG21 ' A' ' 78' ' ' ILE . 0.7 OUTLIER -119.75 135.43 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 110.609 -179.227 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -101.18 131.2 47.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.336 -0.852 . . . . 0.0 109.815 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.415 ' O ' HG22 ' A' ' 78' ' ' ILE . 3.8 m-70 55.85 102.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.216 -0.928 . . . . 0.0 110.181 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -31.1 65.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.941 . . . . 0.0 110.537 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -54.11 -59.51 4.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.972 . . . . 0.0 110.178 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.642 ' HA ' HD11 ' A' ' 121' ' ' ILE . 20.0 m0 -53.35 -66.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.925 . . . . 0.0 110.31 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 78' ' ' ILE . 19.2 tt -88.76 118.69 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.249 -0.907 . . . . 0.0 109.746 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.692 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -87.47 -24.79 24.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 111.662 -178.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 81' ' ' MET . . . -174.54 175.45 46.82 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.553 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.429 ' SD ' HD11 ' A' ' 78' ' ' ILE . 2.9 mpp? -150.95 111.3 4.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.595 -0.944 . . . . 0.0 110.16 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -86.23 159.94 19.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.031 -1.043 . . . . 0.0 109.603 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.672 HD12 ' CD1' ' A' ' 104' ' ' PHE . 1.2 mt -151.14 122.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -0.902 . . . . 0.0 110.534 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.463 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 70.49 3.31 4.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.484 -0.76 . . . . 0.0 111.424 179.598 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.09 20.36 9.32 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.548 -1.311 . . . . 0.0 111.092 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.483 ' HE1' ' HD1' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -136.66 157.32 47.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.699 -1.471 . . . . 0.0 110.148 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -171.05 0.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.519 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -110.42 170.56 8.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 110.108 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 102' ' ' SER . 3.9 t-20 -119.12 121.11 39.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 110.156 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.401 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 pp -67.22 103.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.062 -1.024 . . . . 0.0 109.48 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.433 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.8 tt -94.32 -27.76 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.444 -0.785 . . . . 0.0 110.767 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.9 m -166.71 98.54 0.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.164 -0.96 . . . . 0.0 109.879 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.425 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 14.7 ttmt -96.05 106.54 18.73 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.403 -0.81 . . . . 0.0 110.315 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.84 95.26 7.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 0.0 110.038 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.2 p -74.91 -26.05 59.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.28 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.17 -49.2 76.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.128 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -96.05 13.82 25.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.925 . . . . 0.0 110.447 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 53.16 63.16 2.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.096 -1.003 . . . . 0.0 110.128 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.93 173.8 12.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.331 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 72' ' ' VAL . 3.5 ttm180 -169.37 165.16 10.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 0.0 110.236 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 70' ' ' ILE . 94.9 m -143.99 151.9 40.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -0.845 . . . . 0.0 109.903 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.492 ' HG ' ' HZ ' ' A' ' 104' ' ' PHE . 2.9 p -145.14 140.17 27.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.941 -1.1 . . . . 0.0 110.912 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.58 141.14 28.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 0.0 110.109 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.672 ' CD1' HD12 ' A' ' 83' ' ' ILE . 87.8 m-85 -131.45 145.41 51.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.131 -0.981 . . . . 0.0 110.851 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -104.33 130.36 52.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.316 -0.865 . . . . 0.0 109.471 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.624 ' O ' HD21 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -150.03 150.89 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.982 -1.074 . . . . 0.0 110.881 -179.194 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.1 t -66.13 113.2 4.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.189 -0.944 . . . . 0.0 109.027 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.693 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 51.88 -178.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.324 -178.621 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.584 ' H ' HD12 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -150.0 58.13 0.97 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 0.0 111.554 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 11.3 t30 -145.28 58.83 1.28 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.841 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.32 174.43 44.59 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 141.43 33.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -1.111 . . . . 0.0 110.659 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 72.6 mt -137.7 150.86 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.371 -0.831 . . . . 0.0 109.735 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -76.21 126.75 31.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.155 -0.966 . . . . 0.0 110.568 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -132.64 172.29 21.32 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 82' ' ' SER . 10.7 mttt -144.07 167.51 22.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.126 -1.22 . . . . 0.0 109.413 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.524 ' O ' HD13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -158.5 145.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.983 -1.073 . . . . 0.0 110.52 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.692 ' C ' HG22 ' A' ' 79' ' ' THR . 1.7 m-20 -108.2 160.34 15.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.429 -0.794 . . . . 0.0 109.225 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -134.41 147.85 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 110.642 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 3.5 t80 -151.34 109.86 3.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.426 -0.796 . . . . 0.0 110.569 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.642 HD11 ' HA ' ' A' ' 77' ' ' TRP . 2.3 mp -140.58 152.97 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.411 -0.805 . . . . 0.0 109.871 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -160.38 102.35 1.39 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.027 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -174.11 -170.72 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.454 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.74 109.4 21.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.85 . . . . 0.0 110.17 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.5 t -76.7 107.09 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.362 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 50.37 42.42 25.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.877 . . . . 0.0 110.423 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.82 37.19 11.97 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 36.7 mtmt -145.24 99.33 4.58 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.236 -1.155 . . . . 0.0 109.97 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 128' ' ' LYS . 9.6 Cg_endo -59.04 130.11 34.99 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.674 1.355 . . . . 0.0 110.392 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.84 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 0.1 OUTLIER -158.62 128.67 5.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 110.029 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -105.9 142.61 35.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.225 -0.922 . . . . 0.0 110.785 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.508 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 5.5 t80 -127.2 121.49 31.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.48 -0.763 . . . . 0.0 109.704 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -158.77 84.44 0.82 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.201 -0.937 . . . . 0.0 110.11 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.0 -169.62 3.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 110.419 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.443 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 13.4 p80 -120.28 159.29 25.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 110.309 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 57.4 m-85 -155.13 -178.82 7.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.347 -0.845 . . . . 0.0 109.907 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -150.66 161.2 43.06 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.039 -1.038 . . . . 0.0 110.885 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 137' ' ' ASN . 6.8 pt -155.59 173.34 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.544 -0.723 . . . . 0.0 109.642 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 43.3 m -91.79 116.36 28.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.162 -0.961 . . . . 0.0 111.089 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.753 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.4 m-85 -89.58 150.22 22.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 109.547 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.11 162.51 36.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.088 -1.007 . . . . 0.0 110.86 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.409 ' HB3' ' O ' ' A' ' 109' ' ' LEU . 26.9 m-85 -148.99 158.53 44.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.52 -0.738 . . . . 0.0 109.933 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.4 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 19.4 m120 -142.0 110.55 6.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.582 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.65 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -168.49 -145.95 4.78 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 11.3 Cg_endo -61.52 -177.25 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.75 1.395 . . . . 0.0 109.986 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.18 -56.92 0.2 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.154 -0.966 . . . . 0.0 110.305 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.72 -66.53 0.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.173 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.3 t 55.97 54.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.388 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.25 41.89 0.27 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.386 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.963 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.84 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.226 0.536 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.17 96.94 2.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 110.277 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 62.63 24.07 14.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.218 -0.926 . . . . 0.0 109.943 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.82 82.16 1.71 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 110.114 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.1 -161.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.154 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER 56.34 28.64 13.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.23 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -159.93 149.49 18.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.928 . . . . 0.0 110.292 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.7 176.83 39.21 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.95 103.05 15.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -1.13 . . . . 0.0 110.335 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.703 HD13 HD22 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -93.55 152.34 19.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 109.987 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.459 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 14.5 m-80 -78.35 144.86 35.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 110.125 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -165.09 156.96 15.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 110.058 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.1 -177.93 6.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.9 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.588 ' C ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.58 176.2 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.241 -0.912 . . . . 0.0 110.034 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 56.9 m-85 -148.67 161.91 40.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.413 -0.804 . . . . 0.0 109.954 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.2 OUTLIER -67.73 135.78 53.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 0.0 109.656 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.503 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -61.65 146.73 48.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 110.112 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER 70.54 4.58 5.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.793 -0.567 . . . . 0.0 110.723 -179.379 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -135.55 -164.52 1.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.92 -1.112 . . . . 0.0 109.576 179.286 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.422 ' N ' ' OG1' ' A' ' 43' ' ' THR . 6.3 m-80 -130.85 14.02 5.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 110.527 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -136.09 142.87 44.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.06 -1.025 . . . . 0.0 110.563 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.588 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -77.18 136.36 38.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.124 -0.985 . . . . 0.0 109.181 179.397 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.07 -17.78 3.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.01 -1.056 . . . . 0.0 112.048 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 51.8 mt -137.74 -68.81 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.79 -1.194 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -48.39 -24.5 1.26 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 111.201 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.531 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.1 OUTLIER -67.5 -14.15 62.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.961 -1.087 . . . . 0.0 110.891 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -102.19 15.16 29.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.056 -1.028 . . . . 0.0 110.902 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.445 ' CD2' HBC1 ' A' ' 151' ' ' ZNH . 95.7 m-85 -127.51 -5.49 5.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.963 -1.086 . . . . 0.0 111.177 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 11.5 m-30 -110.39 112.85 25.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.948 -1.095 . . . . 0.0 110.518 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -72.77 109.75 6.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.284 -0.885 . . . . 0.0 110.129 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.402 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -93.39 164.06 22.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 110.161 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.402 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 56.2 Cg_endo -79.62 -175.82 17.2 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.452 -2.311 . . . . 0.0 110.693 -0.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -103.77 165.62 10.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 110.098 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -104.36 113.27 26.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.178 -0.951 . . . . 0.0 110.345 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.524 ' HA ' HG23 ' A' ' 68' ' ' VAL . 9.3 p90 -98.21 166.45 11.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.22 -0.925 . . . . 0.0 110.308 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.8 OUTLIER -155.67 158.93 3.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.585 -179.736 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 18.0 mtmt -138.86 173.1 11.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 0.0 110.985 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.46 ' HB2' ' CD ' ' A' ' 65' ' ' LYS . 19.2 mtpt -155.53 62.15 0.61 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.577 -0.702 . . . . 0.0 109.535 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 47.96 84.3 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.539 -0.726 . . . . 0.0 111.177 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.06 19.45 36.31 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.809 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.758 ' C ' HD13 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -165.43 157.37 14.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.85 -1.383 . . . . 0.0 111.141 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.758 HD13 ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -160.47 155.92 25.15 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.169 0.985 . . . . 0.0 111.755 178.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 3.7 m-85 -141.89 -162.06 1.33 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.524 HG23 ' HA ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -170.68 138.88 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 120.97 -1.081 . . . . 0.0 110.712 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 7.0 pt20 -99.65 134.84 41.95 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.776 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -113.74 128.4 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.992 -179.739 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 71' ' ' THR . 0.9 OUTLIER -88.3 122.36 31.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.826 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -103.28 150.41 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.404 -0.81 . . . . 0.0 110.508 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -102.28 133.44 47.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.343 -0.848 . . . . 0.0 110.005 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 57.38 99.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.119 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.3 t -62.54 -44.06 97.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.879 . . . . 0.0 110.465 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -52.58 -38.35 59.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.915 . . . . 0.0 110.392 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.534 ' O ' HG12 ' A' ' 119' ' ' VAL . 45.5 m0 -68.46 -59.17 3.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -0.946 . . . . 0.0 110.243 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 78' ' ' ILE . 6.6 tp -88.44 118.04 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -0.918 . . . . 0.0 109.772 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.97 -25.38 24.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 110.99 -179.099 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.4 174.92 42.4 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.238 -1.458 . . . . 0.0 110.526 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -152.82 115.27 4.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.451 -1.029 . . . . 0.0 110.025 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.56 171.24 11.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 109.885 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.576 HD11 ' CZ ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -171.76 131.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.135 -0.978 . . . . 0.0 110.816 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HB3' ' NE2' ' A' ' 86' ' ' HIS . 0.9 OUTLIER 62.35 9.41 3.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.575 -0.703 . . . . 0.0 111.879 179.36 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.36 1.21 29.57 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.361 -1.399 . . . . 0.0 111.594 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.503 ' CD2' ' N ' ' A' ' 86' ' ' HIS . 3.3 p80 -135.6 154.17 51.43 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.577 -1.543 . . . . 0.0 110.847 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -167.17 0.17 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.454 -0.779 . . . . 0.0 110.421 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 8.1 pt-20 -107.68 170.22 8.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.193 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.34 134.32 55.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.246 -0.909 . . . . 0.0 110.396 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -67.83 103.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.126 -0.983 . . . . 0.0 109.514 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 92' ' ' SER . 2.0 tt -94.57 -29.49 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.865 . . . . 0.0 111.142 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.508 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -166.77 105.34 0.6 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.051 -1.03 . . . . 0.0 110.138 -179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.433 ' HG3' ' HG3' ' A' ' 100' ' ' ARG . 2.4 ttmm -96.07 108.82 21.29 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.394 -0.816 . . . . 0.0 110.244 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.54 86.71 4.2 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.067 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.07 -24.54 62.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.37 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.56 -53.47 54.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.078 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -97.46 19.2 13.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -0.881 . . . . 0.0 110.255 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 50.76 65.72 1.38 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 110.123 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -147.7 158.41 44.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.223 -0.923 . . . . 0.0 110.314 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.433 ' HG3' ' HG3' ' A' ' 93' ' ' LYS . 1.3 ttm180 -153.98 160.84 42.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -0.896 . . . . 0.0 110.038 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.501 ' O ' HG22 ' A' ' 91' ' ' ILE . 91.2 m -141.1 156.94 45.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.864 . . . . 0.0 109.856 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 84.7 p -145.65 143.41 29.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 110.699 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.08 135.98 33.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.354 -0.841 . . . . 0.0 109.912 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 39.1 m-85 -121.68 148.23 44.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.078 -1.014 . . . . 0.0 110.796 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.472 ' C ' HG13 ' A' ' 106' ' ' VAL . 3.9 mp0 -115.02 128.46 56.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.392 -0.818 . . . . 0.0 109.657 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.472 HG13 ' C ' ' A' ' 105' ' ' GLU . 35.0 m -149.62 -175.37 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.605 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.32 113.44 22.31 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.457 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 47.48 -158.6 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.46 -0.775 . . . . 0.0 109.343 -178.345 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.703 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.02 53.72 0.87 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.772 -1.205 . . . . 0.0 110.772 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.4 ' CB ' HG22 ' A' ' 146' ' ' THR . 2.7 t30 -145.87 84.29 1.66 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.994 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.41 166.51 15.14 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -81.87 144.0 31.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -1.12 . . . . 0.0 110.429 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.1 mt -137.06 146.61 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 110.089 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -76.68 130.64 38.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.325 -0.859 . . . . 0.0 110.385 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -138.82 176.55 20.81 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.6 mttt -143.06 164.41 30.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -1.122 . . . . 0.0 109.42 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.477 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -158.65 142.36 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.912 -1.117 . . . . 0.0 110.921 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.683 ' O ' HG22 ' A' ' 79' ' ' THR . 5.3 m-20 -112.08 162.77 15.04 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.551 -0.718 . . . . 0.0 109.182 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -140.76 153.63 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.137 -0.977 . . . . 0.0 110.37 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -151.82 107.31 3.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 110.541 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' A' ' 132' ' ' TYR . 7.7 mt -130.72 151.47 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.242 -0.911 . . . . 0.0 109.855 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -159.15 104.37 1.68 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.217 -0.927 . . . . 0.0 109.855 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -172.66 -158.73 0.11 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 110.304 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -119.83 108.01 13.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.368 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 125' ' ' VAL . 1.4 t -76.93 117.96 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.928 . . . . 0.0 110.223 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.48 29.06 2.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.396 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 90.98 35.77 7.0 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.49 116.52 5.46 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 110.125 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.12 135.36 30.39 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.638 1.336 . . . . 0.0 110.266 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.551 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 6.4 t80 -136.25 113.38 10.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 110.316 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -104.0 122.77 45.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 110.122 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.507 ' CD2' HD12 ' A' ' 121' ' ' ILE . 3.9 t80 -131.72 128.58 39.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 109.886 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 55.4 t0 -173.39 94.14 0.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.158 -0.964 . . . . 0.0 110.369 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.86 -175.0 5.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.256 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -120.55 86.43 2.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.941 . . . . 0.0 110.136 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.463 ' CD1' HBD2 ' A' ' 151' ' ' ZNH . 24.6 m-85 -84.48 -178.77 7.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.361 -0.837 . . . . 0.0 110.02 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 18.9 p30 -149.5 167.67 25.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 0.0 110.204 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.447 HG12 ' CG2' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -156.45 163.3 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 110.718 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.409 ' O ' HG12 ' A' ' 38' ' ' VAL . 81.9 m -92.15 125.41 36.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.489 -0.757 . . . . 0.0 110.406 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.576 ' CZ ' HD11 ' A' ' 83' ' ' ILE . 23.8 m-85 -90.39 165.11 14.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.204 -0.935 . . . . 0.0 110.371 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.21 101.54 1.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 110.315 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.427 ' CE1' HG11 ' A' ' 68' ' ' VAL . 59.3 m-85 -91.57 158.67 16.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.266 -0.897 . . . . 0.0 110.207 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.455 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 55.0 m-20 -143.46 96.98 3.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.223 -0.923 . . . . 0.0 110.604 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.597 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -154.23 -148.28 4.91 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.45 172.86 1.74 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.804 1.423 . . . . 0.0 110.631 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.4 HG22 ' CB ' ' A' ' 110' ' ' ASN . 9.2 p -149.89 -60.12 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.361 -0.837 . . . . 0.0 110.242 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -108.78 -27.87 9.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.315 -0.866 . . . . 0.0 110.378 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 148' ' ' VAL . 43.8 t 55.54 46.11 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.223 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.69 103.93 11.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 110.269 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.907 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.551 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.288 0.566 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -139.25 38.4 2.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.994 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 60.58 23.52 13.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 109.883 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.01 127.79 33.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 109.946 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 43.32 -163.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.704 -0.623 . . . . 0.0 110.802 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER 55.53 27.53 10.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.143 -0.973 . . . . 0.0 110.273 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 p -160.76 141.31 11.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.885 . . . . 0.0 110.347 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.25 -178.0 43.86 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.6 107.14 18.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.274 -1.133 . . . . 0.0 110.122 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.907 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -94.86 156.49 16.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.379 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 143' ' ' ASN . 2.8 m-20 -79.91 138.64 37.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.94 . . . . 0.0 110.369 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.687 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 1.2 p90 -164.91 150.75 10.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.349 -0.844 . . . . 0.0 110.006 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 38' ' ' VAL . 2.2 tt0 -155.02 156.46 35.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.869 . . . . 0.0 109.756 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.769 HG23 ' OG1' ' A' ' 46' ' ' THR . 28.1 m -101.08 174.71 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.17 -0.956 . . . . 0.0 110.638 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.471 ' HA ' ' CA ' ' A' ' 46' ' ' THR . 10.0 m-85 -148.12 156.18 42.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.516 -0.74 . . . . 0.0 109.746 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.433 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -67.59 133.59 49.68 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.221 -0.924 . . . . 0.0 109.592 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -63.73 147.14 52.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.991 -1.068 . . . . 0.0 109.864 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 5.5 t30 69.97 4.9 5.01 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.719 -0.613 . . . . 0.0 110.859 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.46 -167.23 2.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.94 -1.1 . . . . 0.0 109.718 179.422 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.411 ' N ' ' OG1' ' A' ' 43' ' ' THR . 24.7 m120 -130.56 14.34 5.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.109 -0.994 . . . . 0.0 110.426 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -135.03 116.86 15.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.083 -1.011 . . . . 0.0 110.402 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.769 ' OG1' HG23 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -54.65 134.42 47.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.991 -1.068 . . . . 0.0 108.972 179.327 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.73 -17.66 3.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.826 -1.171 . . . . 0.0 112.299 -178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.4 mt -137.78 -64.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.634 -1.291 . . . . 0.0 111.304 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.521 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -45.32 -27.92 0.74 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.619 -0.675 . . . . 0.0 111.43 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.456 ' CB ' ' CG2' ' A' ' 46' ' ' THR . 6.5 t-20 -71.91 -13.63 61.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.959 -1.088 . . . . 0.0 111.057 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.413 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 8.7 m-20 -90.05 14.95 11.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.063 -1.023 . . . . 0.0 110.863 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 51' ' ' ASP . 24.0 m-85 -143.05 11.56 1.79 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.042 -1.036 . . . . 0.0 110.856 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 24.0 m-85 -129.76 113.37 14.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 109.991 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -72.17 164.92 25.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.166 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -146.75 164.21 25.08 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 110.07 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.422 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 49.6 Cg_endo -79.53 -175.65 16.91 Favored 'Cis proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.332 -2.362 . . . . 0.0 110.558 -0.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.687 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.0 167.94 9.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.287 -0.883 . . . . 0.0 109.873 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -103.57 111.35 23.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.116 -0.99 . . . . 0.0 110.745 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.701 ' HA ' HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -96.35 162.85 13.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.001 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -154.28 155.93 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.085 -1.009 . . . . 0.0 110.528 -179.754 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.3 mtmp? -138.62 171.75 13.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.317 -0.865 . . . . 0.0 110.598 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.454 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . 12.1 mttp -162.03 61.66 0.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.394 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 60.91 91.66 0.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -0.839 . . . . 0.0 111.428 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.89 28.83 61.96 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.115 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.454 ' HD2' ' HB3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -170.59 162.71 8.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.892 -1.357 . . . . 0.0 111.207 179.434 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.865 HD21 ' H ' ' A' ' 108' ' ' LYS . 1.4 pt? -172.51 149.45 2.13 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 122.084 0.945 . . . . 0.0 111.38 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 1.2 m-85 -138.02 172.19 13.3 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.701 HG13 ' HA ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -142.72 142.09 26.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.933 -1.104 . . . . 0.0 110.441 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 102' ' ' SER . 6.3 pt20 -97.37 133.49 41.91 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.37 -0.831 . . . . 0.0 109.572 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.2 OUTLIER -111.99 138.55 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -0.82 . . . . 0.0 110.153 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 m -88.36 129.48 35.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.244 -0.91 . . . . 0.0 109.769 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.625 HG13 HD13 ' A' ' 78' ' ' ILE . 2.8 t -102.99 127.21 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 110.405 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -99.42 133.25 44.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 110.017 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.0 m80 54.8 98.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.158 -0.964 . . . . 0.0 110.063 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.3 p -64.15 -25.8 68.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.392 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -65.37 -56.85 10.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.48 ' O ' HG12 ' A' ' 119' ' ' VAL . 36.7 m0 -51.06 -65.11 0.61 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.21 -0.931 . . . . 0.0 110.177 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.631 HD11 ' HG3' ' A' ' 81' ' ' MET . 10.0 tt -89.27 120.79 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.331 -0.856 . . . . 0.0 109.845 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.668 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -86.93 -23.09 25.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 110.867 -179.341 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.99 -179.36 48.8 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.509 -1.329 . . . . 0.0 109.99 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.631 ' HG3' HD11 ' A' ' 78' ' ' ILE . 58.8 mtm -152.34 171.07 18.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -1.073 . . . . 0.0 110.292 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 116' ' ' LYS . 10.3 t -155.18 172.04 18.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.295 -0.878 . . . . 0.0 109.909 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.47 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -168.01 140.05 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.092 -1.005 . . . . 0.0 110.763 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.481 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 2.0 mt-10 61.94 10.23 3.46 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.477 -0.764 . . . . 0.0 111.749 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.67 0.51 30.66 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.362 -1.399 . . . . 0.0 111.093 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.481 ' NE2' ' CB ' ' A' ' 84' ' ' GLU . 3.6 p80 -132.56 154.55 49.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.645 -1.503 . . . . 0.0 110.519 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -162.41 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.516 -0.74 . . . . 0.0 110.173 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.491 ' CB ' ' CZ ' ' A' ' 104' ' ' PHE . 12.1 pt-20 -107.61 169.27 8.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 110.107 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -106.0 127.32 53.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.152 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.76 102.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.139 -0.976 . . . . 0.0 109.673 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 101' ' ' THR . 0.9 OUTLIER -94.74 -30.58 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 110.936 -179.201 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.409 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 54.4 p -167.15 103.89 0.54 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.091 -1.006 . . . . 0.0 109.986 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.456 ' HG3' ' CG ' ' A' ' 100' ' ' ARG . 21.4 ttmt -95.04 112.09 23.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 110.129 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -96.4 68.89 2.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.159 -0.963 . . . . 0.0 110.295 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.15 -29.05 56.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 110.266 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.51 -52.18 62.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.554 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -95.21 18.6 12.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -0.893 . . . . 0.0 110.552 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 51.0 61.32 3.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 110.21 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -147.14 169.89 18.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 110.024 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.456 ' CG ' ' HG3' ' A' ' 93' ' ' LYS . 0.8 OUTLIER -165.77 160.53 17.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.93 . . . . 0.0 110.328 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.502 ' O ' HG22 ' A' ' 91' ' ' ILE . 87.6 m -141.31 147.22 37.81 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.568 -0.708 . . . . 0.0 109.393 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 3.7 p -145.53 141.8 28.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.034 -1.041 . . . . 0.0 110.842 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 5.2 tt0 -92.49 145.48 24.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.531 -0.731 . . . . 0.0 109.682 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CZ ' ' CB ' ' A' ' 88' ' ' GLU . 30.4 m-85 -126.48 141.44 51.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.117 -0.989 . . . . 0.0 111.01 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.417 ' C ' HG13 ' A' ' 106' ' ' VAL . 38.0 tt0 -102.49 124.67 48.47 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.494 -0.754 . . . . 0.0 109.393 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.417 HG13 ' C ' ' A' ' 105' ' ' GLU . 16.6 m -149.45 138.03 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.016 -1.053 . . . . 0.0 111.038 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.68 101.53 0.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 108.945 178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.865 ' H ' HD21 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 53.65 176.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.378 -178.607 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.515 HD22 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.18 83.22 1.38 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.85 -1.156 . . . . 0.0 111.218 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.413 ' CB ' HG23 ' A' ' 146' ' ' THR . 13.6 t-20 -144.71 75.42 1.45 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.953 . . . . 0.0 110.15 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.32 -109.26 0.41 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HB3' ' HG2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -157.58 150.91 23.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -1.171 . . . . 0.0 110.437 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -136.14 147.02 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.436 -0.79 . . . . 0.0 109.827 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -75.83 114.26 14.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.997 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.94 179.21 16.57 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 27.1 mttp -144.08 160.69 40.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 0.0 109.9 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.675 HG21 HD11 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.29 146.45 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.975 . . . . 0.0 110.4 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.668 ' C ' HG22 ' A' ' 79' ' ' THR . 1.1 m-20 -105.57 156.3 18.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.414 -0.804 . . . . 0.0 109.405 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.583 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -131.97 146.0 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.159 -0.963 . . . . 0.0 110.44 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 1.1 t80 -151.6 109.3 3.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.37 -0.831 . . . . 0.0 110.246 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 54.8 mt -133.86 152.85 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.4 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 8.0 p-10 -160.46 95.28 1.11 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.81 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -174.26 -176.46 1.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 110.263 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -95.05 103.09 14.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 110.062 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.4 t -76.44 106.55 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.296 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.06 29.26 16.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 110.184 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.97 32.85 10.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.33 115.2 4.93 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.327 -1.102 . . . . 0.0 110.161 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -52.47 116.56 2.93 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.534 1.281 . . . . 0.0 110.187 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.473 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 5.7 t80 -116.0 122.51 45.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.691 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.83 122.02 44.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -0.879 . . . . 0.0 109.921 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.583 ' HE2' HG11 ' A' ' 119' ' ' VAL . 1.7 t80 -138.73 119.71 14.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.894 . . . . 0.0 110.169 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -168.53 85.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.127 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.25 -160.56 1.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.28 -0.887 . . . . 0.0 110.316 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.44 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -120.08 147.66 44.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.229 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 22.7 m-85 -155.68 -178.65 7.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.873 . . . . 0.0 109.997 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 9.7 p30 -149.82 169.18 21.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 0.0 110.671 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.675 HD11 HG21 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -156.18 162.61 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 110.322 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 49.6 m -91.86 118.21 30.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.321 -0.862 . . . . 0.0 110.932 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.484 ' HD1' HG12 ' A' ' 38' ' ' VAL . 13.2 m-85 -90.91 101.43 14.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.274 -0.891 . . . . 0.0 110.017 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.43 ' HG2' ' HB3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -87.74 103.49 15.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.087 -1.008 . . . . 0.0 110.526 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 140' ' ' TYR . 60.6 m-85 -92.67 153.28 19.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 110.186 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 5.2 m120 -141.52 103.2 4.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.153 -0.967 . . . . 0.0 110.331 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.907 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -156.46 -149.74 5.45 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.541 ' HD2' HD11 ' A' ' 34' ' ' LEU . 12.2 Cg_endo -62.76 -170.44 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.984 1.518 . . . . 0.0 110.43 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.413 HG23 ' CB ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -149.08 -42.6 0.14 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 110.105 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -144.75 -53.6 0.31 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.886 . . . . 0.0 109.905 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.8 t 56.55 51.75 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 110.272 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.67 107.39 14.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 0.0 110.121 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.891 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.519 HMD3 HG23 ' A' ' 138' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.274 0.559 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -171.92 61.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.142 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.0 t30 60.86 28.69 18.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.378 -0.826 . . . . 0.0 109.989 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.02 72.36 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -0.825 . . . . 0.0 109.968 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.05 -56.65 4.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 110.081 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 1.0 OUTLIER 56.16 33.67 22.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.119 -0.988 . . . . 0.0 110.41 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -160.43 139.82 10.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 110.486 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.93 178.05 43.58 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.58 109.03 19.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.293 -1.122 . . . . 0.0 110.252 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.819 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.6 OUTLIER -94.99 153.21 17.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.266 -0.896 . . . . 0.0 110.805 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -81.05 135.56 35.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.85 . . . . 0.0 110.243 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.933 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -166.47 161.77 16.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.993 -1.067 . . . . 0.0 110.129 179.379 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -155.12 -165.61 2.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 0.0 110.356 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 139' ' ' THR . 0.0 OUTLIER -139.06 169.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.419 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 31.3 m-85 -148.32 159.82 43.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.316 -0.865 . . . . 0.0 109.907 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.427 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.4 OUTLIER -67.97 135.74 52.83 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.336 -0.852 . . . . 0.0 109.734 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.467 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -64.52 146.89 53.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.074 -1.016 . . . . 0.0 109.762 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER 70.91 4.12 4.92 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.84 -0.537 . . . . 0.0 110.71 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.442 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -138.61 -167.53 2.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.944 -1.097 . . . . 0.0 109.498 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.442 ' N ' ' OG1' ' A' ' 43' ' ' THR . 37.4 m-80 -133.27 18.42 4.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.989 -1.069 . . . . 0.0 110.464 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -136.37 117.61 14.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.55 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.5 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -52.8 134.49 36.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.066 . . . . 0.0 109.261 179.352 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.35 -18.01 3.68 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.169 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.2 mt -138.1 -50.29 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.634 -1.291 . . . . 0.0 111.194 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HA ' ' HB3' ' A' ' 52' ' ' TYR . . . -80.95 7.71 10.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.49 -0.756 . . . . 0.0 111.532 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.459 ' O ' ' CE1' ' A' ' 53' ' ' PHE . 1.1 p-10 -69.32 -35.73 76.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.809 -1.182 . . . . 0.0 110.461 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -103.16 15.31 29.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.202 -0.936 . . . . 0.0 110.892 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.409 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -93.01 -8.38 43.14 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.966 -1.083 . . . . 0.0 111.021 -179.6 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.533 ' CE1' ' CG2' ' A' ' 38' ' ' VAL . 31.9 p90 -127.07 126.14 42.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.003 -1.061 . . . . 0.0 110.719 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.571 ' HB3' HG21 ' A' ' 71' ' ' THR . 19.7 t-20 -73.95 104.39 4.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.024 -1.047 . . . . 0.0 109.883 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 1.6 pttt -92.58 164.96 20.48 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 110.125 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.435 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 50.1 Cg_endo -77.92 -177.58 21.52 Favored 'Cis proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.519 -2.284 . . . . 0.0 110.569 -0.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.933 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -103.1 167.47 9.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.962 . . . . 0.0 110.25 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.461 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -102.95 114.51 28.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 110.09 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.0 p90 -96.98 162.21 13.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 110.056 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -154.97 155.13 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 110.311 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 24.6 mtmt -137.73 170.78 15.46 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.332 -0.855 . . . . 0.0 110.85 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.444 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -155.98 62.43 0.58 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.655 -0.653 . . . . 0.0 109.745 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.23 92.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.327 -0.858 . . . . 0.0 110.992 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.7 27.19 54.77 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.258 -0.972 . . . . 0.0 110.763 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.444 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 7.9 ptpt -171.81 158.51 4.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.972 -1.311 . . . . 0.0 111.0 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.868 HD21 ' H ' ' A' ' 108' ' ' LYS . 1.7 pt? -170.72 147.11 2.75 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.166 0.984 . . . . 0.0 111.615 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -138.32 171.37 14.49 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.473 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.83 143.27 24.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.975 -1.078 . . . . 0.0 109.971 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.461 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -97.0 135.67 38.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.24 -0.913 . . . . 0.0 110.087 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.2 OUTLIER -110.9 140.14 31.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.388 -0.82 . . . . 0.0 109.63 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.571 HG21 ' HB3' ' A' ' 54' ' ' ASN . 1.8 m -87.86 138.4 31.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.132 -0.98 . . . . 0.0 110.223 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.65 ' CG1' HG21 ' A' ' 78' ' ' ILE . 15.5 t -103.16 122.28 55.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.462 -0.774 . . . . 0.0 109.991 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.98 130.37 46.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 110.268 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.526 ' O ' HG22 ' A' ' 78' ' ' ILE . 4.8 t60 57.7 94.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.254 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t -71.79 -12.23 61.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.909 . . . . 0.0 110.593 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -74.64 -26.1 59.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.103 -0.998 . . . . 0.0 110.345 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.483 ' CE2' HBB2 ' A' ' 151' ' ' ZNH . 21.3 m0 -94.17 -47.34 6.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 0.0 110.39 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.65 HG21 ' CG1' ' A' ' 72' ' ' VAL . 6.8 tp -88.46 115.98 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.118 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.585 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -87.41 -23.06 24.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.356 -0.84 . . . . 0.0 110.442 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.55 178.17 48.54 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.463 ' HE3' ' HB3' ' A' ' 102' ' ' SER . 0.0 OUTLIER -152.9 161.14 42.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -1.074 . . . . 0.0 110.194 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 116' ' ' LYS . 2.4 t -155.12 149.67 26.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.032 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.568 HD12 ' CD2' ' A' ' 104' ' ' PHE . 4.8 mt -141.83 144.41 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 110.427 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 69.67 3.85 4.44 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.498 -0.751 . . . . 0.0 111.119 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.55 20.79 21.21 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.718 -1.23 . . . . 0.0 111.116 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.665 ' HE1' ' HD1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -137.04 163.31 31.05 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.713 -1.463 . . . . 0.0 110.174 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -177.69 1.85 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.108 -0.995 . . . . 0.0 110.31 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -110.01 169.61 8.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.347 -0.846 . . . . 0.0 110.209 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.64 124.95 53.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.948 . . . . 0.0 110.191 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pp -67.43 102.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 109.796 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 101' ' ' THR . 1.8 tt -95.19 -28.12 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.388 -0.82 . . . . 0.0 110.784 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 3.9 m -166.77 101.04 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.194 -0.941 . . . . 0.0 109.734 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -94.96 152.09 18.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.444 -0.785 . . . . 0.0 110.336 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -144.38 83.46 1.72 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 110.16 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 p -70.55 -27.05 63.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 110.326 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.59 -52.75 62.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 0.0 110.064 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.5 mtmm -96.21 17.75 15.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.311 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 51.97 60.27 3.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 110.249 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 94' ' ' ASN . 34.0 mt-10 -148.28 167.39 25.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 110.47 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.473 ' CG ' ' N ' ' A' ' 101' ' ' THR . 33.7 ttt180 -174.56 167.45 3.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.388 -0.82 . . . . 0.0 109.682 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.473 ' N ' ' CG ' ' A' ' 100' ' ' ARG . 94.9 m -141.44 153.95 45.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.962 . . . . 0.0 109.837 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.463 ' HB3' ' HE3' ' A' ' 81' ' ' MET . 83.6 p -145.38 141.1 28.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.112 -0.992 . . . . 0.0 110.68 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.32 146.65 23.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.896 . . . . 0.0 109.991 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.665 ' HD1' ' HE1' ' A' ' 86' ' ' HIS . 45.8 m-85 -129.14 147.74 51.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 0.0 110.675 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.489 ' C ' HG13 ' A' ' 106' ' ' VAL . 35.7 tt0 -105.53 125.83 51.43 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.384 -0.823 . . . . 0.0 109.789 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.489 HG13 ' C ' ' A' ' 105' ' ' GLU . 33.8 m -150.16 152.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.968 . . . . 0.0 110.956 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.2 m -71.95 105.93 4.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.276 -0.89 . . . . 0.0 109.291 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.868 ' H ' HD21 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 50.23 -178.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.494 -0.754 . . . . 0.0 109.734 -178.682 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.742 HD22 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -151.22 81.93 1.31 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.824 -1.172 . . . . 0.0 110.996 -179.385 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.422 ' CG ' HG23 ' A' ' 146' ' ' THR . 0.2 OUTLIER -145.61 67.71 1.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 110.191 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 162.57 -109.91 0.41 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.417 ' HB2' ' HG2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -157.19 148.1 21.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -1.118 . . . . 0.0 109.65 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 63.9 mt -136.27 150.74 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.902 . . . . 0.0 110.274 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.92 131.95 38.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.356 -0.84 . . . . 0.0 110.114 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -138.08 178.97 18.8 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 3.3 mtpp -144.6 164.46 30.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -1.179 . . . . 0.0 110.08 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.547 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.86 141.55 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.07 -1.019 . . . . 0.0 110.694 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.585 ' C ' HG22 ' A' ' 79' ' ' THR . 6.1 m-20 -104.12 152.46 22.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.268 -0.895 . . . . 0.0 109.72 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.2 OUTLIER -128.71 154.09 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.132 -0.98 . . . . 0.0 110.345 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -151.55 102.45 2.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.21 -0.931 . . . . 0.0 110.738 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.556 HD13 ' CBB' ' A' ' 151' ' ' ZNH . 3.8 mt -133.38 152.88 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.324 -0.86 . . . . 0.0 110.097 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.34 95.38 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.981 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 129' ' ' PRO . 19.1 pt-20 -174.81 -156.38 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 110.248 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.433 ' HG2' ' CA ' ' A' ' 129' ' ' PRO . 11.7 mttt -122.46 120.99 35.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.28 -0.887 . . . . 0.0 110.25 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.702 HG23 ' CE1' ' A' ' 130' ' ' PHE . 89.6 t -76.91 92.33 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 110.363 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.31 31.48 11.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.269 -0.895 . . . . 0.0 110.302 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.23 35.58 2.29 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 3.7 mtmt -145.43 85.44 7.94 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.358 -1.084 . . . . 0.0 110.124 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.433 ' CA ' ' HG2' ' A' ' 124' ' ' LYS . 11.3 Cg_endo -59.3 129.49 31.65 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.983 1.517 . . . . 0.0 110.287 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.702 ' CE1' HG23 ' A' ' 125' ' ' VAL . 7.6 p90 -156.14 139.85 16.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 110.452 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -105.36 131.9 52.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.391 -0.818 . . . . 0.0 110.007 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.497 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 5.9 t80 -131.47 129.92 41.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.0 110.138 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 16.6 t0 -174.44 89.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.343 -0.848 . . . . 0.0 110.064 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.83 -168.42 3.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 110.188 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.17 85.93 2.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.407 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.427 ' CD1' HAD1 ' A' ' 151' ' ' ZNH . 30.5 m-85 -85.01 -178.98 6.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 109.796 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.65 ' O ' HG23 ' A' ' 138' ' ' ILE . 29.2 p30 -150.42 168.98 22.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.025 -1.047 . . . . 0.0 110.654 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 137' ' ' ASN . 2.3 pt -157.83 173.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.324 -0.86 . . . . 0.0 110.784 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.76 ' O ' HG12 ' A' ' 38' ' ' VAL . 90.8 m -92.01 163.6 13.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.622 -0.674 . . . . 0.0 110.282 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.524 ' CD1' ' CG1' ' A' ' 38' ' ' VAL . 97.3 m-85 -141.79 100.49 3.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 109.643 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 2.0 mttt -82.5 108.95 16.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 110.833 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -92.17 140.65 29.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.99 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -129.64 96.04 4.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 110.339 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.819 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -149.14 -152.68 5.79 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -62.49 139.17 74.86 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.943 1.496 . . . . 0.0 110.356 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.422 HG23 ' CG ' ' A' ' 110' ' ' ASN . 0.3 OUTLIER -91.12 -36.37 14.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.473 -179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -133.82 -155.03 0.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 110.417 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.8 t 56.99 86.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 110.122 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.72 -22.21 37.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 0.0 110.223 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.556 ' CBB' HD13 ' A' ' 121' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.552 ' N ' ' HB2' ' A' ' 28' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.279 0.561 . . . . 0.0 110.252 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 25' ' ' SER . . . 60.64 103.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.375 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 t30 62.74 29.48 16.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.941 . . . . 0.0 109.994 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.552 ' HB2' ' N ' ' A' ' 25' ' ' SER . . . -65.38 100.03 0.45 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.9 -72.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.192 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 5.9 m-20 56.67 25.97 10.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.185 -0.947 . . . . 0.0 110.31 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.43 153.34 25.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.105 -0.997 . . . . 0.0 110.532 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.431 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 172.18 170.1 35.67 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.482 HG23 ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -88.25 111.08 21.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -1.117 . . . . 0.0 110.152 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.058 HD13 HD22 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -94.78 155.39 16.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 0.0 110.646 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 27.2 t30 -81.6 137.83 35.45 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.355 -0.84 . . . . 0.0 109.693 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.833 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -167.98 163.72 13.7 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.992 -1.067 . . . . 0.0 110.587 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.05 -168.33 2.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.37 -0.831 . . . . 0.0 109.823 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.748 ' O ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -139.82 -178.42 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.971 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.417 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 15.4 m-85 -149.22 150.71 33.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 110.047 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.413 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.5 OUTLIER -67.56 127.83 34.19 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.397 -0.814 . . . . 0.0 109.87 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.48 ' O ' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -55.9 147.27 19.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.142 -0.973 . . . . 0.0 109.921 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER 72.32 1.18 3.86 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.865 -0.522 . . . . 0.0 110.792 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.29 -166.49 1.94 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.873 -1.142 . . . . 0.0 109.559 179.192 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.408 ' N ' ' OG1' ' A' ' 43' ' ' THR . 23.0 m-80 -133.34 16.14 4.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -136.54 121.82 19.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.481 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.748 HG23 ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -51.15 132.25 28.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 109.226 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.459 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -128.98 -17.58 3.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.889 -1.132 . . . . 0.0 111.926 -178.746 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.459 HD12 ' HB3' ' A' ' 47' ' ' SER . 1.8 mp -137.5 -75.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.827 -1.17 . . . . 0.0 110.572 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 52' ' ' TYR . . . -47.48 -24.99 0.95 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.679 -0.638 . . . . 0.0 110.928 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.443 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.7 OUTLIER -46.65 -34.31 4.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.242 -0.911 . . . . 0.0 111.134 -179.597 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -102.19 15.76 28.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.044 -1.035 . . . . 0.0 110.986 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.52 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -99.25 -15.89 18.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.015 -1.053 . . . . 0.0 110.971 -179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.501 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 21.3 p90 -118.6 128.39 54.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.928 -1.108 . . . . 0.0 110.993 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -74.97 114.42 13.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.095 -1.003 . . . . 0.0 109.91 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.75 159.64 35.8 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.036 . . . . 0.0 109.994 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -81.45 -175.28 15.37 Favored 'Cis proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.643 -2.232 . . . . 0.0 110.667 -0.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.833 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.45 172.81 6.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.197 -0.939 . . . . 0.0 110.041 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HD2' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -106.31 116.6 32.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.25 -0.906 . . . . 0.0 111.076 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.48 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 6.9 p90 -98.14 161.77 13.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.237 -0.915 . . . . 0.0 109.523 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.537 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -155.42 122.08 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.951 -1.093 . . . . 0.0 111.034 -179.551 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.473 ' HD3' HD21 ' A' ' 109' ' ' LEU . 1.6 mtmt -139.39 131.52 28.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.0 110.212 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -109.21 62.42 0.6 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.196 -0.94 . . . . 0.0 110.441 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 62' ' ' LYS . 14.0 t-20 49.62 100.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.402 -0.811 . . . . 0.0 111.119 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.26 -17.96 56.17 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HB2' ' OH ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -140.43 152.8 45.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.154 -1.203 . . . . 0.0 110.201 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.812 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -155.07 142.81 19.87 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.938 0.875 . . . . 0.0 111.012 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.537 ' HB2' HG23 ' A' ' 60' ' ' ILE . 5.7 m-85 -140.03 -170.15 2.89 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.54 -0.725 . . . . 0.0 109.352 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -162.06 165.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.098 -1.001 . . . . 0.0 109.882 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 102' ' ' SER . 1.3 pt20 -140.45 143.66 35.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.198 -0.938 . . . . 0.0 110.472 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -115.56 128.51 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.335 -0.853 . . . . 0.0 110.258 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.7 m -88.83 124.33 34.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.482 HG11 ' CE ' ' A' ' 81' ' ' MET . 0.8 OUTLIER -102.68 138.93 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 110.386 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -101.0 135.03 43.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.325 -0.859 . . . . 0.0 110.238 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.439 ' O ' HG22 ' A' ' 78' ' ' ILE . 6.1 m80 60.4 102.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.295 -0.878 . . . . 0.0 110.036 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 t -64.47 -33.44 75.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.887 . . . . 0.0 110.377 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -52.49 -57.78 8.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 110.257 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.533 ' HA ' HD11 ' A' ' 121' ' ' ILE . 13.2 m0 -55.62 -62.52 1.63 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 110.382 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 78' ' ' ILE . 2.9 tp -88.78 114.01 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 109.97 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.79 -26.28 24.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 110.782 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.46 174.89 45.67 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.074 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.482 ' CE ' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -152.28 163.23 39.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -1.042 . . . . 0.0 109.962 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -155.66 167.62 29.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.824 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.601 HD11 ' CD1' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -164.62 154.13 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 110.033 179.825 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.454 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 59.74 15.02 4.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.049 -1.032 . . . . 0.0 110.859 179.725 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.28 23.23 55.14 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.031 -1.081 . . . . 0.0 110.976 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 83' ' ' ILE . 2.3 p80 -138.27 161.58 36.51 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.67 -1.488 . . . . 0.0 110.623 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.27 179.35 2.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.851 . . . . 0.0 110.971 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 2.1 pt-20 -99.39 170.13 8.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 110.663 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 102' ' ' SER . 2.2 t30 -116.78 133.73 55.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.476 -0.765 . . . . 0.0 109.468 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.589 HG22 ' NH2' ' A' ' 100' ' ' ARG . 1.1 pp -67.45 101.53 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.954 -1.092 . . . . 0.0 109.871 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.5 HG21 HG22 ' A' ' 101' ' ' THR . 0.5 OUTLIER -95.41 -31.22 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.838 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.418 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 11.0 m -166.73 95.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.109 -0.994 . . . . 0.0 110.009 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -95.9 95.3 8.15 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.478 -0.763 . . . . 0.0 110.156 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -97.09 91.25 5.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.175 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.73 -27.64 60.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 110.202 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.61 -45.37 93.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -0.936 . . . . 0.0 110.129 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.93 18.7 12.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.31 -0.869 . . . . 0.0 110.23 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 t0 50.48 61.75 3.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 110.043 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -148.09 166.72 26.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 110.515 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.589 ' NH2' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -168.93 147.71 4.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.453 -0.779 . . . . 0.0 109.533 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.5 HG22 HG21 ' A' ' 91' ' ' ILE . 62.9 m -141.55 158.22 44.12 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.163 -0.96 . . . . 0.0 109.867 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 81.3 p -145.06 143.45 30.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 110.375 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 1.5 tm-20 -92.6 141.26 28.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 110.2 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -123.81 148.65 46.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.279 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -98.3 132.29 43.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.37 -0.832 . . . . 0.0 110.075 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.558 HG13 HD21 ' A' ' 66' ' ' LEU . 8.9 p -149.08 166.88 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.202 -0.936 . . . . 0.0 110.245 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 106' ' ' VAL . 1.5 t -69.63 -35.3 75.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 109.846 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.461 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -164.5 -148.9 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.503 -0.748 . . . . 0.0 109.325 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 1.058 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.06 51.92 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.726 -1.234 . . . . 0.0 111.232 -179.577 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 12.9 t-20 -146.31 70.23 1.22 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.099 -1.001 . . . . 0.0 110.492 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 142' ' ' PHE . . . 172.12 -129.25 1.7 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.467 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.0 OUTLIER -156.65 140.87 16.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.323 -1.104 . . . . 0.0 109.839 -179.771 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.467 ' CD1' HG23 ' A' ' 106' ' ' VAL . 2.5 mt -135.33 153.87 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.164 -0.96 . . . . 0.0 110.019 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -76.2 137.08 39.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.076 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 83' ' ' ILE . . . -137.35 177.23 20.0 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 82' ' ' SER . 16.7 mttt -144.14 156.16 44.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -1.139 . . . . 0.0 109.76 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.585 ' O ' HD13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -157.73 151.16 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.006 -1.059 . . . . 0.0 110.578 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.621 ' O ' HG22 ' A' ' 79' ' ' THR . 0.9 OUTLIER -112.14 158.37 19.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.412 -0.805 . . . . 0.0 109.386 179.357 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.481 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -129.77 148.35 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -0.976 . . . . 0.0 110.053 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.78 102.24 2.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 110.769 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.649 HD13 HBB1 ' A' ' 151' ' ' ZNH . 2.6 mp -133.72 151.9 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -0.987 . . . . 0.0 110.162 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 1.2 p-10 -160.57 98.45 1.24 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.354 -0.842 . . . . 0.0 109.73 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -173.75 -156.95 0.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 110.553 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.586 ' O ' HG23 ' A' ' 125' ' ' VAL . 18.6 mtpt -91.27 165.22 13.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.416 -0.803 . . . . 0.0 110.608 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 124' ' ' LYS . 47.6 t -157.88 99.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 67.18 25.83 8.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.531 -0.731 . . . . 0.0 109.611 -178.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 86.53 34.25 12.18 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 0.6 OUTLIER -147.89 134.25 9.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.22 -1.165 . . . . 0.0 110.303 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 128' ' ' LYS . 20.5 Cg_exo -60.85 129.09 27.64 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.581 1.306 . . . . 0.0 110.141 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.759 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 46.2 t80 -121.01 145.8 47.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.167 -0.958 . . . . 0.0 110.385 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -136.08 118.21 15.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.211 -0.931 . . . . 0.0 110.146 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.494 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 3.7 t80 -129.73 131.47 46.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 109.804 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -177.37 87.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.04 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.66 -163.9 1.76 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 0.0 110.536 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.461 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 4.2 p80 -118.69 143.66 46.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.478 ' CD1' HBD2 ' A' ' 151' ' ' ZNH . 13.0 m-85 -154.85 -179.45 8.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 110.117 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.62 ' O ' HG23 ' A' ' 138' ' ' ILE . 1.7 p30 -152.1 172.11 16.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 0.0 110.584 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.62 HG23 ' O ' ' A' ' 137' ' ' ASN . 3.9 pt -157.17 162.93 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.844 . . . . 0.0 110.173 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.467 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 45.1 m -92.0 126.92 37.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 110.594 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.601 ' CD1' HD11 ' A' ' 83' ' ' ILE . 14.4 m-85 -89.48 154.23 20.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -0.949 . . . . 0.0 109.654 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -137.89 105.52 5.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.041 -1.037 . . . . 0.0 110.397 -179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.47 ' HB3' ' CA ' ' A' ' 109' ' ' LEU . 31.7 m-85 -91.99 134.72 34.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 0.0 110.374 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 8.7 m120 -132.11 103.56 6.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 0.0 110.311 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.898 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -164.71 -150.38 6.15 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.742 ' HD2' HD11 ' A' ' 34' ' ' LEU . 9.4 Cg_endo -57.56 -165.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.765 1.402 . . . . 0.0 110.457 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.2 p -149.54 -52.58 0.16 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -0.946 . . . . 0.0 110.09 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.62 -60.12 1.93 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.048 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.2 t 56.77 51.95 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.359 -0.838 . . . . 0.0 110.335 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.88 -5.4 58.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.2 -0.938 . . . . 0.0 110.67 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.987 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.759 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.3 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.262 0.553 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.6 65.75 0.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.908 . . . . 0.0 110.092 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 62.15 21.37 12.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.929 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.66 135.51 49.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.291 -0.88 . . . . 0.0 109.934 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 43.72 -160.54 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.71 -0.618 . . . . 0.0 110.419 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 25.4 m-20 54.66 31.33 15.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 110.196 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 59' ' ' TYR . 15.1 t -160.39 169.68 22.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 110.789 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.9 171.71 25.06 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.69 105.18 17.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.1 -1.235 . . . . 0.0 110.217 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.838 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -94.21 156.05 16.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 110.414 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.411 ' O ' ' N ' ' A' ' 143' ' ' ASN . 14.9 m-20 -79.86 140.83 36.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.214 -0.929 . . . . 0.0 109.738 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.664 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -165.91 158.18 14.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.98 . . . . 0.0 110.181 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -155.37 -168.89 2.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.258 -0.901 . . . . 0.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.473 ' C ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.07 173.97 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 109.796 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.402 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 27.6 m-85 -148.22 156.48 42.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 110.491 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 128.93 38.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.528 -0.732 . . . . 0.0 109.766 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.508 ' CE2' ' ND2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -58.18 148.26 27.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.098 -1.001 . . . . 0.0 109.879 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 11.0 m-20 71.08 2.44 4.24 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.816 -0.552 . . . . 0.0 110.961 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.96 -165.49 1.75 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.944 -1.098 . . . . 0.0 109.684 179.221 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' N ' ' OG1' ' A' ' 43' ' ' THR . 64.1 t30 -133.86 16.13 3.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 110.19 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -136.01 118.31 15.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 110.583 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.473 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -51.37 128.61 23.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.988 . . . . 0.0 109.099 179.247 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.49 -16.13 3.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.008 -1.058 . . . . 0.0 112.222 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.18 -64.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.792 -1.193 . . . . 0.0 110.907 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.49 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -52.39 -21.9 4.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.452 -0.78 . . . . 0.0 111.147 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -8.97 46.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.054 -1.029 . . . . 0.0 110.951 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.404 ' C ' ' CG ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -97.78 8.49 44.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.013 -1.055 . . . . 0.0 110.913 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.404 ' CG ' ' C ' ' A' ' 51' ' ' ASP . 7.1 m-85 -142.44 17.3 2.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.966 -1.084 . . . . 0.0 110.342 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -119.49 107.22 13.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.439 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -72.88 155.09 40.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 110.249 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.425 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -146.68 167.22 14.3 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.121 -0.987 . . . . 0.0 110.026 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.425 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 49.8 Cg_endo -77.06 -175.31 16.47 Favored 'Cis proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.681 -2.216 . . . . 0.0 110.481 -0.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.664 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -100.4 162.43 12.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 109.975 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.463 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . 0.5 OUTLIER -102.08 117.03 33.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.304 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.489 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.7 p90 -97.51 160.95 14.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 109.776 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.504 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -155.35 127.42 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.056 -1.028 . . . . 0.0 110.559 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HG2' ' CB ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -136.61 119.36 16.15 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.206 -0.934 . . . . 0.0 110.783 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.2 OUTLIER -96.01 62.05 2.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.384 -0.822 . . . . 0.0 110.393 179.62 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.403 ' O ' ' O ' ' A' ' 62' ' ' LYS . 41.3 t30 46.62 99.17 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.58 -0.7 . . . . 0.0 111.407 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.83 5.03 54.15 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.436 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.714 ' C ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.58 158.91 16.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.894 -1.357 . . . . 0.0 110.199 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.803 ' N ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -155.13 149.81 26.46 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 122.171 0.986 . . . . 0.0 111.199 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.519 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 5.0 m-85 -142.74 -164.71 1.89 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.388 -0.82 . . . . 0.0 109.242 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.441 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -170.56 134.12 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.082 -1.011 . . . . 0.0 110.102 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 0.3 OUTLIER -97.59 134.15 41.18 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.157 -0.965 . . . . 0.0 109.568 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.1 OUTLIER -112.81 137.64 45.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.864 -179.476 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.5 m -88.6 135.17 33.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 109.972 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.846 HG22 ' CE ' ' A' ' 81' ' ' MET . 3.4 t -102.38 123.98 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.283 -0.886 . . . . 0.0 109.943 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -98.31 126.85 43.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.247 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.637 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER 62.36 99.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 110.328 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -32.62 66.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 110.09 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -58.95 -41.63 87.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.16 -0.963 . . . . 0.0 110.041 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.656 ' O ' HG12 ' A' ' 119' ' ' VAL . 45.1 m0 -71.48 -62.11 1.53 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.375 -0.828 . . . . 0.0 110.128 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.642 HD12 HBC2 ' A' ' 151' ' ' ZNH . 9.9 tt -89.3 122.13 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 109.691 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.709 HG22 ' C ' ' A' ' 118' ' ' ASP . 1.0 OUTLIER -87.14 -23.25 24.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.385 -0.822 . . . . 0.0 111.114 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.409 ' O ' HG12 ' A' ' 117' ' ' ILE . . . -178.38 179.94 48.47 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.017 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.846 ' CE ' HG22 ' A' ' 72' ' ' VAL . 47.5 mtm -152.45 171.12 18.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.346 -1.09 . . . . 0.0 109.94 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -155.21 164.45 38.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.214 -0.929 . . . . 0.0 110.233 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.683 HD12 ' CG ' ' A' ' 104' ' ' PHE . 7.4 mt -155.59 135.54 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.542 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 1.6 tm-20 69.54 3.44 4.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.406 -0.808 . . . . 0.0 111.428 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.64 21.5 12.52 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.136 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.477 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -136.95 159.05 43.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.722 -1.458 . . . . 0.0 110.138 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -178.98 2.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.083 -1.011 . . . . 0.0 110.354 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.447 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 1.7 pt-20 -106.6 167.59 9.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.34 -0.85 . . . . 0.0 110.043 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.28 129.79 55.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 110.349 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.519 HD12 ' O ' ' A' ' 90' ' ' ILE . 1.4 pp -68.28 101.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.903 . . . . 0.0 109.671 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.55 HG21 HG22 ' A' ' 101' ' ' THR . 1.8 tt -95.3 -28.87 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.384 -0.822 . . . . 0.0 110.716 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.9 p -167.33 107.41 0.59 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.022 -1.049 . . . . 0.0 109.935 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.419 ' HA ' ' HG3' ' A' ' 100' ' ' ARG . 24.3 ttmt -95.41 110.33 22.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -0.869 . . . . 0.0 110.153 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.84 81.27 3.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 110.197 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.9 p -69.56 -26.56 64.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.254 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.62 -52.33 63.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.199 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -95.79 19.91 10.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 110.304 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 50.36 63.75 2.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 109.996 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -147.56 -177.98 6.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.858 . . . . 0.0 110.408 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.419 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 3.9 ttm180 -176.32 164.97 2.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.835 . . . . 0.0 109.715 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.55 HG22 HG21 ' A' ' 91' ' ' ILE . 93.3 m -142.6 154.86 44.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.158 -0.964 . . . . 0.0 109.755 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 p -145.53 144.25 30.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.905 -1.122 . . . . 0.0 110.721 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -92.69 140.34 29.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.299 -0.876 . . . . 0.0 109.792 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.683 ' CG ' HD12 ' A' ' 83' ' ' ILE . 32.6 m-85 -126.58 149.62 49.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.119 -0.988 . . . . 0.0 111.066 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.456 ' C ' HG13 ' A' ' 106' ' ' VAL . 1.6 tt0 -119.74 126.35 50.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.46 -0.775 . . . . 0.0 109.477 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.472 ' O ' HD21 ' A' ' 66' ' ' LEU . 22.9 m -149.97 -164.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.972 -1.08 . . . . 0.0 110.778 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.2 t -98.46 112.0 24.17 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.451 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.26 -165.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.521 -0.737 . . . . 0.0 109.661 -178.343 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.469 ' CD2' ' HB2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -151.91 60.2 0.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.87 -1.144 . . . . 0.0 111.188 -179.435 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.583 ' HB3' HG23 ' A' ' 146' ' ' THR . 8.1 t-20 -146.33 80.5 1.56 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.124 -0.985 . . . . 0.0 110.435 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.59 -117.19 0.75 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' CG ' ' CG2' ' A' ' 139' ' ' THR . 3.7 ttpt -157.52 145.27 18.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.346 -1.091 . . . . 0.0 110.041 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.6 mt -137.39 146.02 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.352 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -76.83 108.9 10.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.222 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.461 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -111.37 177.99 19.26 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 82' ' ' SER . 22.2 mttt -145.45 161.23 40.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -1.125 . . . . 0.0 109.89 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.455 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.8 147.15 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.095 -1.003 . . . . 0.0 110.682 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.709 ' C ' HG22 ' A' ' 79' ' ' THR . 39.6 m-20 -106.39 159.32 16.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.394 -0.816 . . . . 0.0 109.149 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -140.92 147.29 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.027 -1.045 . . . . 0.0 110.684 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -153.34 113.89 4.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -0.872 . . . . 0.0 110.711 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 43.9 mt -137.69 152.94 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.103 -0.998 . . . . 0.0 110.386 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -160.08 95.43 1.16 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.376 -0.828 . . . . 0.0 109.85 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -173.81 -173.95 0.9 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.885 . . . . 0.0 110.354 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -104.47 121.35 43.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 110.263 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.3 95.04 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.102 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.05 39.02 30.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.29 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 96.45 31.46 7.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -145.33 100.39 4.46 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.316 -1.108 . . . . 0.0 110.134 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -50.4 132.84 35.83 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.869 1.457 . . . . 0.0 110.191 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.486 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 2.9 t80 -139.39 127.79 22.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 110.301 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.21 136.99 43.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.143 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.444 ' HB3' ' HB ' ' A' ' 121' ' ' ILE . 1.8 t80 -153.22 123.94 7.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 110.188 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -177.08 86.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -153.09 -165.31 2.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.9 . . . . 0.0 110.249 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -119.35 140.13 50.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.891 . . . . 0.0 110.283 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.463 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 61.4 m-85 -154.6 -179.17 7.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.874 . . . . 0.0 109.871 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.508 ' ND2' ' CE2' ' A' ' 41' ' ' TYR . 40.0 p30 -151.1 176.59 11.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 110.787 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.49 HG21 ' HB2' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -156.35 171.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.476 -0.765 . . . . 0.0 109.673 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.478 ' CG2' ' CG ' ' A' ' 112' ' ' LYS . 26.1 m -91.76 118.04 30.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.976 . . . . 0.0 110.698 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.461 ' CD1' ' HA3' ' A' ' 115' ' ' GLY . 18.6 m-85 -89.68 108.11 19.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 109.61 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -97.48 161.67 13.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.723 -179.592 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -148.11 153.04 38.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.476 -0.765 . . . . 0.0 109.936 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 35' ' ' ASN . 21.0 m120 -138.74 101.8 4.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 110.419 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.838 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -159.46 -154.5 7.29 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.56 ' HD2' HD11 ' A' ' 34' ' ' LEU . 19.7 Cg_endo -64.44 -175.68 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.999 1.526 . . . . 0.0 110.707 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.583 HG23 ' HB3' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -149.13 -61.47 0.23 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.401 -0.812 . . . . 0.0 110.209 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' A' ' 148' ' ' VAL . 0.3 OUTLIER -98.3 -71.62 0.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.294 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.532 ' O ' HG12 ' A' ' 148' ' ' VAL . 38.6 t 56.18 42.85 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.357 -0.839 . . . . 0.0 110.078 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.74 86.77 6.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.361 -0.837 . . . . 0.0 110.255 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.642 HBC2 HD12 ' A' ' 78' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.138 0.494 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -106.53 116.46 31.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.086 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 0.1 OUTLIER 63.86 20.96 12.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.318 -0.864 . . . . 0.0 110.109 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.58 74.5 4.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 110.193 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.45 -153.97 0.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.335 -0.853 . . . . 0.0 110.213 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 2.1 m-20 54.99 30.24 13.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 110.187 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 p -159.58 147.87 17.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.019 . . . . 0.0 110.666 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.11 -179.33 45.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.04 119.68 28.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.176 -1.191 . . . . 0.0 110.26 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.87 HD11 ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -94.4 131.83 39.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.427 -0.796 . . . . 0.0 110.893 -179.471 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.445 ' N ' HD23 ' A' ' 34' ' ' LEU . 47.6 t30 -78.74 128.96 34.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.099 -1.0 . . . . 0.0 108.547 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.669 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -164.45 164.53 21.95 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.702 -1.249 . . . . 0.0 111.477 -178.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.98 -167.29 2.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.19 173.67 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.919 -1.113 . . . . 0.0 110.447 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -148.09 154.61 40.43 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.444 -0.785 . . . . 0.0 109.697 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.403 ' CE ' ' HA ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -66.99 140.58 57.73 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.334 -0.853 . . . . 0.0 109.771 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.507 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -63.28 147.16 51.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.993 . . . . 0.0 110.205 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.4 OUTLIER 69.0 5.98 5.37 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.673 -0.642 . . . . 0.0 110.681 -179.452 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.01 -167.42 2.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.027 -1.045 . . . . 0.0 109.344 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.44 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.9 OUTLIER -131.62 13.77 4.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.0 110.147 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -136.44 133.62 36.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.15 -0.969 . . . . 0.0 110.715 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.447 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -62.18 136.49 57.96 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.252 -0.905 . . . . 0.0 109.087 179.29 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.649 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -126.28 -17.96 5.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.917 -1.114 . . . . 0.0 111.81 -178.906 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.682 HG22 ' N ' ' A' ' 49' ' ' ALA . 1.2 mp -137.98 -74.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.897 -1.127 . . . . 0.0 110.532 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.682 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -45.13 -26.63 0.49 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.769 -0.582 . . . . 0.0 111.238 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.447 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -52.57 -23.64 6.78 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.094 -1.004 . . . . 0.0 111.102 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -102.73 15.41 29.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.969 -1.082 . . . . 0.0 111.026 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 52.7 m-85 -123.06 -10.64 8.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.039 -1.038 . . . . 0.0 110.967 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CZ ' ' CE ' ' A' ' 81' ' ' MET . 17.5 m-85 -119.52 115.33 23.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.063 -1.023 . . . . 0.0 110.309 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -72.24 169.47 16.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 110.6 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 161.96 33.76 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.428 -0.795 . . . . 0.0 109.76 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -83.6 -175.07 13.46 Favored 'Cis proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.592 -2.253 . . . . 0.0 110.728 -0.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.669 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -99.49 -171.46 2.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.369 -0.832 . . . . 0.0 109.752 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.413 ' HB2' ' NE2' ' A' ' 69' ' ' GLN . 3.8 mttp -127.63 121.16 29.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.055 -1.028 . . . . 0.0 110.372 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.527 ' HB3' HD12 ' A' ' 34' ' ' LEU . 38.6 p90 -96.36 161.28 14.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 0.0 109.893 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.638 HG23 ' HD1' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -155.19 121.03 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 110.609 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.517 ' CE ' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -130.88 117.91 19.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.089 -1.007 . . . . 0.0 110.654 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -93.61 61.57 3.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.25 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 49.62 101.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.555 -0.715 . . . . 0.0 111.431 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.1 56.99 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.466 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -142.49 158.62 43.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.056 -1.261 . . . . 0.0 110.08 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.853 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -158.86 138.28 11.59 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.988 0.899 . . . . 0.0 111.201 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.638 ' HD1' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.56 178.95 7.1 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.633 -0.667 . . . . 0.0 109.308 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.06 141.42 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 0.0 110.472 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 58' ' ' LYS . 11.2 pt20 -98.38 144.2 28.02 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 109.922 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.98 135.0 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.264 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 71' ' ' THR . 0.9 OUTLIER -89.51 123.84 33.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.883 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.653 HG12 HG21 ' A' ' 78' ' ' ILE . 1.3 t -103.21 131.21 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.928 . . . . 0.0 110.381 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -100.26 134.01 43.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.219 -0.926 . . . . 0.0 110.049 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.682 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER 62.14 116.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.3 -0.875 . . . . 0.0 110.036 -179.746 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.92 -25.26 24.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.177 -0.952 . . . . 0.0 110.638 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -59.66 4.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.994 . . . . 0.0 110.357 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.576 ' O ' HD11 ' A' ' 121' ' ' ILE . 39.8 m0 -53.58 -62.46 1.64 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.902 . . . . 0.0 110.436 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 74' ' ' HIS . 0.8 OUTLIER -88.34 120.38 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.954 . . . . 0.0 109.964 179.846 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.629 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.05 -23.25 25.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.392 -0.818 . . . . 0.0 110.758 -179.3 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.13 -177.01 47.25 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.52 ' CE ' ' CZ ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -151.18 168.16 25.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -1.076 . . . . 0.0 110.185 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 116' ' ' LYS . 3.2 t -154.33 137.87 15.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 109.845 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.898 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -132.27 140.01 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.345 -179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 73.35 -1.07 3.17 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.809 -0.557 . . . . 0.0 111.224 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.62 21.92 8.42 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.632 -1.27 . . . . 0.0 111.121 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.443 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.37 162.99 32.1 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.637 -1.508 . . . . 0.0 110.269 179.285 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -171.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 110.547 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -109.07 170.22 8.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.341 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.6 122.02 44.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.319 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pt -67.39 103.59 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.168 -0.958 . . . . 0.0 109.911 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 101' ' ' THR . 1.5 tt -95.66 -28.51 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.886 . . . . 0.0 110.964 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.6 p -167.53 105.21 0.52 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.033 -1.042 . . . . 0.0 110.081 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm -95.29 107.72 19.84 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.277 -0.889 . . . . 0.0 110.017 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.65 95.99 8.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 110.385 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.67 -29.65 56.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.099 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -47.78 82.37 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.305 -0.872 . . . . 0.0 110.078 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -95.85 12.24 30.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 110.419 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.9 t0 51.33 56.95 7.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.019 -1.051 . . . . 0.0 110.152 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -148.14 154.75 40.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.202 -0.936 . . . . 0.0 110.442 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -143.68 166.14 25.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 109.941 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.573 ' O ' HG22 ' A' ' 91' ' ' ILE . 87.0 m -141.35 150.69 42.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.382 -0.824 . . . . 0.0 109.636 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.9 p -145.31 141.48 28.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.036 -1.04 . . . . 0.0 110.733 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.04 144.1 25.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.842 . . . . 0.0 109.885 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -127.87 136.95 52.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.062 -1.024 . . . . 0.0 110.757 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.482 ' C ' HG13 ' A' ' 106' ' ' VAL . 3.5 mt-10 -93.13 127.48 38.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -0.883 . . . . 0.0 109.449 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.482 HG13 ' C ' ' A' ' 105' ' ' GLU . 35.3 m -149.68 171.36 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.017 -1.052 . . . . 0.0 110.954 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.79 110.47 18.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.33 -156.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 109.678 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.87 ' HB2' HD11 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -150.86 59.83 0.93 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.983 -1.073 . . . . 0.0 110.982 -179.267 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.526 ' HB2' HG23 ' A' ' 146' ' ' THR . 0.6 OUTLIER -146.12 104.19 3.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.293 -0.879 . . . . 0.0 110.337 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 134.35 -131.88 6.13 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.432 ' HB3' ' HG2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -157.0 152.42 26.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.299 -1.118 . . . . 0.0 110.0 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mt -135.78 145.24 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.882 . . . . 0.0 110.17 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -76.06 113.12 13.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.347 -0.845 . . . . 0.0 110.058 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.456 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -122.26 -170.4 13.69 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 82' ' ' SER . 4.1 mttp -147.66 171.95 14.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -1.155 . . . . 0.0 109.977 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -157.67 145.11 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -0.96 . . . . 0.0 110.453 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.629 ' O ' HG22 ' A' ' 79' ' ' THR . 7.7 m-20 -105.63 155.04 19.61 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.473 -0.767 . . . . 0.0 109.535 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -132.4 146.47 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 110.127 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -151.76 115.02 4.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.89 . . . . 0.0 110.55 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.576 HD11 ' O ' ' A' ' 77' ' ' TRP . 2.2 mp -141.51 152.57 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -0.95 . . . . 0.0 110.337 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.55 101.08 1.5 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 0.0 109.828 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -173.62 -176.93 1.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.378 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -97.61 105.18 17.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 110.391 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 128' ' ' LYS . 21.9 t -76.29 99.24 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.0 109.898 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 55.5 50.46 14.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.32 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.31 33.28 44.75 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.453 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -145.6 106.31 4.33 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.085 -1.244 . . . . 0.0 110.233 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 128' ' ' LYS . 9.2 Cg_endo -58.04 128.01 27.19 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.541 1.285 . . . . 0.0 110.108 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.621 ' CE2' HMB2 ' A' ' 151' ' ' ZNH . 54.6 t80 -127.13 148.05 50.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.355 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.3 99.07 4.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.364 -0.835 . . . . 0.0 109.837 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.492 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 3.0 t80 -102.0 131.14 48.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 109.894 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -166.37 77.48 0.22 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.227 -0.92 . . . . 0.0 110.229 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -153.83 -173.82 4.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.291 -0.881 . . . . 0.0 110.339 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.449 ' O ' ' CD2' ' A' ' 136' ' ' TYR . 6.1 p80 -119.79 162.53 18.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 110.11 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 135' ' ' HIS . 54.7 m-85 -155.09 137.34 14.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.964 . . . . 0.0 110.423 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.462 ' O ' HG23 ' A' ' 138' ' ' ILE . 28.1 p30 -88.63 159.23 17.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.315 -0.866 . . . . 0.0 110.267 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -156.69 155.92 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.269 -0.895 . . . . 0.0 110.051 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.2 m -91.81 123.06 34.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.265 -0.897 . . . . 0.0 111.074 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.898 ' CD2' HD11 ' A' ' 83' ' ' ILE . 62.7 m-85 -90.82 154.6 19.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.395 -0.816 . . . . 0.0 109.236 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -140.23 95.3 2.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.894 -1.129 . . . . 0.0 110.683 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 110' ' ' ASN . 23.4 m-85 -91.06 133.45 35.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.321 -0.862 . . . . 0.0 110.197 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.421 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 8.6 m120 -137.58 102.08 4.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 110.451 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.442 ' CA ' HD13 ' A' ' 109' ' ' LEU . . . -146.07 -142.11 3.72 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.429 ' HD2' ' HA3' ' A' ' 144' ' ' GLY . 1.9 Cg_endo -49.18 141.0 24.45 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.576 1.303 . . . . 0.0 110.756 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.526 HG23 ' HB2' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -150.49 30.44 0.67 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.166 179.714 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -121.85 -52.22 2.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 110.415 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.9 t 58.11 35.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.368 -0.832 . . . . 0.0 110.325 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.83 82.25 7.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.988 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.621 HMB2 ' CE2' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.276 0.56 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -98.83 55.61 1.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -0.897 . . . . 0.0 110.236 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 24.2 t30 63.23 22.07 13.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.909 . . . . 0.0 110.15 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -110.6 56.11 0.64 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 110.284 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 42.15 -162.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.761 -0.587 . . . . 0.0 111.076 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 1.1 m-20 54.87 29.85 12.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 110.373 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.6 p -161.81 150.4 15.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.841 . . . . 0.0 110.32 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 161.31 177.94 34.83 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.552 HG23 ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -88.18 104.9 17.14 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.358 -1.084 . . . . 0.0 110.321 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.783 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -94.61 158.6 15.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 110.499 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.448 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 3.6 m-20 -78.8 140.79 38.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.898 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.596 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -165.46 153.89 11.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 110.105 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.34 -177.06 6.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.235 -0.916 . . . . 0.0 110.352 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 140' ' ' TYR . 1.6 m -140.04 178.09 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.348 -0.845 . . . . 0.0 109.843 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -149.39 162.8 39.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 110.481 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.3 OUTLIER -68.15 123.73 21.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.362 -0.836 . . . . 0.0 109.79 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.502 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -53.26 144.94 14.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.977 . . . . 0.0 109.955 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 6.1 m120 71.62 1.52 3.91 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.857 -0.527 . . . . 0.0 111.1 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.98 -166.86 1.98 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.829 -1.169 . . . . 0.0 109.827 179.15 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.74 21.4 3.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 110.443 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -133.15 126.06 30.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.122 -0.986 . . . . 0.0 110.956 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.523 HG22 ' HB2' ' A' ' 50' ' ' ASN . 0.7 OUTLIER -55.11 118.48 4.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.601 -0.687 . . . . 0.0 109.686 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.51 -18.58 3.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.8 -1.188 . . . . 0.0 112.078 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.512 HG21 ' C1D' ' A' ' 151' ' ' ZNH . 70.0 mt -138.88 -76.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.789 -1.195 . . . . 0.0 111.122 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.504 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -46.0 -26.41 0.72 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.622 -0.674 . . . . 0.0 111.176 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.523 ' HB2' HG22 ' A' ' 46' ' ' THR . 16.9 t-20 -68.9 -13.4 62.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.075 -1.016 . . . . 0.0 110.792 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -102.59 15.13 30.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.974 -1.079 . . . . 0.0 111.123 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -136.42 11.33 3.24 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.008 -1.058 . . . . 0.0 110.808 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.437 ' HE2' ' HB1' ' A' ' 49' ' ' ALA . 25.2 m-85 -130.98 115.62 16.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.077 -1.014 . . . . 0.0 110.122 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -72.59 164.23 26.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.355 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.467 ' CD ' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -146.83 164.43 23.74 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.274 -0.891 . . . . 0.0 110.048 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.42 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 57.2 Cg_endo -78.86 -175.44 16.71 Favored 'Cis proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.438 -2.317 . . . . 0.0 110.45 -0.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.596 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.52 167.96 9.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.077 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.552 ' HD2' HG23 ' A' ' 33' ' ' THR . 0.9 OUTLIER -101.45 113.51 26.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.32 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CD2' HD21 ' A' ' 109' ' ' LEU . 1.7 p90 -97.06 161.95 13.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 110.004 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 1.0 OUTLIER -154.81 156.99 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.089 -1.007 . . . . 0.0 110.465 179.646 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 34.6 mtmt -140.34 170.23 16.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.179 -0.95 . . . . 0.0 111.058 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 12.5 mtmt -157.05 62.15 0.51 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.549 -0.719 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t30 51.05 87.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.344 -0.848 . . . . 0.0 111.26 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.83 24.91 39.96 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.696 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.753 ' C ' HD13 ' A' ' 66' ' ' LEU . 2.8 ptpt -167.56 153.3 7.46 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.914 -1.345 . . . . 0.0 110.941 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.768 ' N ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -158.78 151.17 21.61 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 122.347 1.07 . . . . 0.0 111.696 178.534 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 6.3 m-85 -143.85 170.41 15.94 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 58' ' ' LYS . 1.1 m -145.18 145.04 21.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.908 -1.12 . . . . 0.0 110.389 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.436 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 4.6 pt20 -97.84 132.77 43.15 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.355 -0.84 . . . . 0.0 109.593 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -112.38 137.57 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.942 -179.67 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.08 128.45 35.75 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.209 -0.932 . . . . 0.0 109.939 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.686 HG12 HG21 ' A' ' 78' ' ' ILE . 2.0 t -101.84 126.37 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.977 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 74' ' ' HIS . 21.6 m-20 -99.18 128.03 45.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.363 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.669 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER 64.23 113.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.85 . . . . 0.0 110.198 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.58 -38.31 23.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.202 -0.937 . . . . 0.0 110.257 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -55.35 -42.45 73.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.212 -0.93 . . . . 0.0 110.182 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.486 ' HA ' HG12 ' A' ' 121' ' ' ILE . 34.4 m0 -67.4 -64.32 0.88 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 110.282 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.686 HG21 HG12 ' A' ' 72' ' ' VAL . 17.9 tt -88.81 126.3 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.379 -0.826 . . . . 0.0 110.007 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.88 -24.81 23.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.441 -0.787 . . . . 0.0 110.975 -179.298 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' O ' HG12 ' A' ' 117' ' ' ILE . . . 178.16 -179.05 48.62 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.627 -1.273 . . . . 0.0 109.955 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.448 ' HG3' HD11 ' A' ' 78' ' ' ILE . 2.8 mtm -151.59 161.85 41.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.265 -1.138 . . . . 0.0 110.352 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -154.99 146.24 22.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.86 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.624 HD11 ' CD2' ' A' ' 140' ' ' TYR . 3.6 mt -139.17 142.77 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.903 . . . . 0.0 110.657 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 2.5 tm-20 72.26 -0.35 3.29 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.693 -0.63 . . . . 0.0 111.56 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.87 20.27 9.52 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.537 -1.316 . . . . 0.0 111.006 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.477 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.72 159.31 42.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.649 -1.5 . . . . 0.0 110.365 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -71.17 179.69 2.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 110.177 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -102.23 170.17 8.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.904 . . . . 0.0 110.083 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.2 129.7 56.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.938 . . . . 0.0 110.243 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.451 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 0.8 OUTLIER -67.65 102.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 109.767 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 101' ' ' THR . 1.5 tt -95.15 -25.86 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -0.861 . . . . 0.0 110.853 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.517 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -167.35 104.88 0.53 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.122 -0.986 . . . . 0.0 109.659 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -96.34 145.69 25.39 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.399 -0.813 . . . . 0.0 110.265 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.22 78.98 1.62 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 110.115 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.25 -25.88 67.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 110.327 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.16 64.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 110.112 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -96.57 17.3 16.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.392 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 t0 50.41 63.13 2.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.975 . . . . 0.0 110.013 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -147.15 162.28 39.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.335 -0.853 . . . . 0.0 110.346 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.447 ' O ' HG23 ' A' ' 72' ' ' VAL . 2.1 mtp180 -163.72 161.75 23.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.435 -0.791 . . . . 0.0 109.873 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.593 ' O ' HG22 ' A' ' 91' ' ' ILE . 86.9 m -142.42 150.37 40.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.655 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.5 p -145.42 143.6 30.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.052 -1.03 . . . . 0.0 110.76 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 2.0 tm-20 -93.4 147.33 23.04 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.374 -0.829 . . . . 0.0 109.838 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.577 ' CD2' HD12 ' A' ' 83' ' ' ILE . 19.1 m-85 -128.18 131.45 48.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.132 -0.98 . . . . 0.0 110.924 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.464 ' C ' HG13 ' A' ' 106' ' ' VAL . 15.5 tt0 -96.08 124.84 40.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.879 . . . . 0.0 109.474 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.496 ' O ' HD21 ' A' ' 66' ' ' LEU . 29.6 m -149.28 -171.71 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.051 -1.031 . . . . 0.0 110.665 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.9 111.96 23.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.442 -0.786 . . . . 0.0 109.144 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.479 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.69 -162.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.456 -0.777 . . . . 0.0 109.969 -178.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.522 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -149.84 56.92 0.97 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.015 -1.053 . . . . 0.0 110.644 -179.72 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.51 ' CB ' HG23 ' A' ' 146' ' ' THR . 19.2 t-20 -145.63 79.53 1.57 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.879 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.63 170.98 19.67 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.06 144.42 30.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -1.154 . . . . 0.0 110.482 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.486 HD12 ' CD2' ' A' ' 142' ' ' PHE . 5.3 mt -136.34 146.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 0.0 109.719 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.15 117.3 17.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.151 -0.968 . . . . 0.0 110.496 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.11 176.05 16.4 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 15.9 mttt -144.43 163.52 33.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -1.155 . . . . 0.0 109.945 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.417 ' HB ' ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -157.89 140.64 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 110.43 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.581 ' O ' HG22 ' A' ' 79' ' ' THR . 52.9 m-20 -101.56 154.35 18.93 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.366 -0.834 . . . . 0.0 109.254 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.654 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -133.4 151.05 32.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.999 -1.063 . . . . 0.0 110.781 -179.288 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -150.69 99.5 2.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.595 -0.69 . . . . 0.0 109.362 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.714 HD13 ' CBB' ' A' ' 151' ' ' ZNH . 20.1 mt -135.04 153.33 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.259 -0.9 . . . . 0.0 110.738 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -159.87 106.27 1.62 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.499 -0.75 . . . . 0.0 109.169 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.4 162.13 6.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.315 -0.866 . . . . 0.0 110.216 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 7.1 mtmt -89.78 113.88 25.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 110.495 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.4 t -76.92 96.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.341 -0.849 . . . . 0.0 110.218 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.22 29.74 13.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.595 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.95 32.94 5.69 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 46.6 mtmt -144.94 100.51 4.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.317 -1.107 . . . . 0.0 110.138 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.54 115.29 1.71 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.765 1.403 . . . . 0.0 110.468 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.661 ' CE2' HMB2 ' A' ' 151' ' ' ZNH . 8.2 t80 -111.95 125.63 54.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 110.17 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.2 139.39 37.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 110.147 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.654 ' HE2' HG11 ' A' ' 119' ' ' VAL . 1.6 t80 -153.43 113.83 3.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.809 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.403 ' O ' ' CG ' ' A' ' 134' ' ' HIS . 8.1 t0 -165.92 88.33 0.39 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.136 -0.977 . . . . 0.0 110.154 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.403 ' CG ' ' O ' ' A' ' 133' ' ' ASP . 74.1 m-70 -154.04 -168.26 2.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 110.282 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.6 85.46 2.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.796 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.476 ' HD2' HG21 ' A' ' 119' ' ' VAL . 25.0 m-85 -85.86 -178.57 6.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.825 . . . . 0.0 110.416 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 11.6 p30 -150.33 174.27 13.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.938 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.504 HG21 ' HB2' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -155.92 165.34 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.135 -0.978 . . . . 0.0 110.614 -179.655 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 61.8 m -91.81 113.82 26.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.406 -0.809 . . . . 0.0 110.525 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.674 ' HA ' HG12 ' A' ' 38' ' ' VAL . 27.6 m-85 -89.63 155.15 19.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.979 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.79 112.77 5.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.946 . . . . 0.0 110.523 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.486 ' CD2' HD12 ' A' ' 113' ' ' ILE . 27.2 m-85 -91.98 155.78 17.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 110.313 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.522 ' C ' HD21 ' A' ' 34' ' ' LEU . 27.2 m120 -140.03 96.93 3.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -0.979 . . . . 0.0 110.332 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.783 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -161.5 -151.95 6.47 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.497 ' HD2' HD11 ' A' ' 34' ' ' LEU . 15.1 Cg_endo -63.19 -172.09 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.889 1.468 . . . . 0.0 110.567 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.51 HG23 ' CB ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -149.37 -46.28 0.14 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.214 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -132.04 -48.58 0.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 110.082 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.2 t 56.37 54.17 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.1 25.74 0.26 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.188 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.714 ' CBB' HD13 ' A' ' 121' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.26 0.552 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.418 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -123.62 94.28 4.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.21 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 0.7 OUTLIER 63.95 40.09 7.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 0.0 110.037 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.36 150.11 37.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.381 -0.824 . . . . 0.0 110.445 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.02 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.368 -0.833 . . . . 0.0 110.197 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER 54.99 28.16 10.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.263 -0.898 . . . . 0.0 110.512 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.0 t -160.86 130.02 4.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.899 . . . . 0.0 110.29 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . -170.77 179.19 42.89 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.72 110.67 21.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.401 -1.058 . . . . 0.0 110.505 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.841 HD13 HD22 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -95.36 148.62 22.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 109.99 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.44 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -79.16 134.26 36.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.085 -1.01 . . . . 0.0 110.339 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.887 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -166.27 167.91 15.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.152 -0.968 . . . . 0.0 110.839 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.98 -172.93 4.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.542 -0.724 . . . . 0.0 109.764 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.707 ' O ' HG22 ' A' ' 46' ' ' THR . 0.6 OUTLIER -140.73 107.73 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.688 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.0 161.38 15.16 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.455 -0.778 . . . . 0.0 110.497 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.449 ' HD3' HD13 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -67.84 137.38 55.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.374 -0.829 . . . . 0.0 110.081 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.474 ' CD2' ' OD1' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -62.53 145.47 54.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.035 -1.041 . . . . 0.0 110.064 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 12.6 t30 70.42 3.49 4.5 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.763 -0.586 . . . . 0.0 110.771 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.423 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -139.25 -171.08 3.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.878 -1.139 . . . . 0.0 109.538 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.423 ' N ' ' OG1' ' A' ' 43' ' ' THR . 17.5 p30 -134.63 23.48 3.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.106 -0.996 . . . . 0.0 110.055 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.64 121.47 19.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 111.075 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.707 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -49.79 126.87 14.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.583 -0.698 . . . . 0.0 109.291 178.764 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.795 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -129.84 -19.36 3.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.74 -1.225 . . . . 0.0 112.449 -178.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 47' ' ' SER . 1.4 mp -139.45 -78.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.65 -1.281 . . . . 0.0 111.296 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.697 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -45.01 -26.42 0.43 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.853 -0.53 . . . . 0.0 111.337 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.478 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 4.7 p30 -60.92 -15.49 31.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.091 -1.006 . . . . 0.0 110.882 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.421 ' C ' ' CD1' ' A' ' 52' ' ' TYR . 6.2 m-20 -101.8 15.2 29.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.054 -1.029 . . . . 0.0 110.896 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.474 ' CD1' HBC1 ' A' ' 151' ' ' ZNH . 43.3 m-85 -140.08 10.39 2.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.004 -1.06 . . . . 0.0 110.554 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.417 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 30.7 m-85 -132.02 113.27 13.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 110.174 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.492 ' HB2' HG21 ' A' ' 71' ' ' THR . 0.8 OUTLIER -72.69 164.55 26.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.705 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -146.57 161.66 37.25 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.4 -0.812 . . . . 0.0 109.71 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.402 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 57.5 Cg_endo -79.93 -175.39 16.27 Favored 'Cis proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.522 -2.282 . . . . 0.0 110.396 -0.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.887 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.14 166.29 10.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.933 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.54 116.0 31.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.948 . . . . 0.0 110.465 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.514 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 28.9 p90 -97.1 163.87 12.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 109.823 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -155.11 151.0 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.109 -0.994 . . . . 0.0 110.558 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 28.1 mtmt -134.5 174.0 11.03 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -0.9 . . . . 0.0 110.945 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 9.5 mttt -155.93 62.33 0.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.4 -0.813 . . . . 0.0 110.021 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m120 53.97 85.86 0.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.338 -0.851 . . . . 0.0 111.188 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.43 23.58 50.36 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.203 -0.999 . . . . 0.0 110.705 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 62' ' ' LYS . 8.6 ptpt -166.12 161.17 16.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.814 -1.404 . . . . 0.0 110.951 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.786 HD11 ' HA ' ' A' ' 108' ' ' LYS . 2.5 pt? -173.11 158.0 3.59 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.152 0.977 . . . . 0.0 111.555 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.566 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -139.27 -153.84 0.49 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -170.17 135.16 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 110.026 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 5.1 pt20 -97.39 133.66 41.69 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.63 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -114.2 142.93 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 110.099 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.492 HG21 ' HB2' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -89.18 129.59 35.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 110.199 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.782 HG12 HG21 ' A' ' 78' ' ' ILE . 2.5 t -104.1 127.29 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 110.159 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.0 137.9 37.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 110.341 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.698 ' O ' HG22 ' A' ' 78' ' ' ILE . 63.4 m-70 52.42 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.339 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -73.52 -31.68 63.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 110.217 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -55.48 -36.93 67.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 110.31 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.481 ' CE2' HBB2 ' A' ' 151' ' ' ZNH . 11.4 m0 -83.6 -50.86 7.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 110.15 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.782 HG21 HG12 ' A' ' 72' ' ' VAL . 19.5 tt -89.75 125.34 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 109.942 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.612 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -87.1 -29.88 21.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 110.579 -179.577 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.15 -168.37 41.13 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.431 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.8 mtp -151.99 169.19 22.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -1.125 . . . . 0.0 110.469 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.36 131.62 11.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.871 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.3 mt -131.25 147.32 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.933 . . . . 0.0 110.344 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' OE1' ' CA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER 66.46 7.29 4.91 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.133 -0.979 . . . . 0.0 111.004 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.03 25.49 19.52 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.895 -1.145 . . . . 0.0 111.297 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.684 ' HE1' ' HD1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -139.48 161.29 37.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.638 -1.507 . . . . 0.0 110.482 179.262 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.41 -173.74 0.95 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.13 -0.981 . . . . 0.0 110.561 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 1.8 pt-20 -110.24 170.05 8.34 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.368 -0.832 . . . . 0.0 110.278 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.14 127.46 54.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.274 -0.891 . . . . 0.0 110.268 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.29 103.95 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 0.0 109.597 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.442 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.1 tt -95.92 -30.1 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 111.085 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.7 p -167.43 104.91 0.53 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.016 -1.052 . . . . 0.0 110.015 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -95.53 108.54 20.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 110.154 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 99' ' ' GLU . 3.9 t-20 -95.75 62.14 2.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.289 -0.882 . . . . 0.0 110.177 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.59 -21.93 30.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.297 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -18.69 62.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.211 -0.931 . . . . 0.0 110.288 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -136.31 22.19 3.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 110.278 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 55.89 64.42 1.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -0.868 . . . . 0.0 110.521 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 94' ' ' ASN . 15.6 mt-10 -148.18 -179.51 6.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.278 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 179.22 162.32 0.81 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.2 -0.938 . . . . 0.0 110.135 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.442 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 97.2 m -141.48 152.46 44.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 109.651 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 37.4 p -144.36 139.59 28.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.008 -1.057 . . . . 0.0 110.548 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.28 141.14 28.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.388 -0.82 . . . . 0.0 110.01 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.684 ' HD1' ' HE1' ' A' ' 86' ' ' HIS . 68.3 m-85 -129.0 138.26 51.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.157 -0.964 . . . . 0.0 110.669 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -99.0 130.66 45.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.272 -0.892 . . . . 0.0 109.616 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.0 p -149.42 152.12 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.02 -1.05 . . . . 0.0 110.86 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.6 m -63.68 106.41 0.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -0.931 . . . . 0.0 109.145 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.786 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 48.4 -174.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.494 -0.753 . . . . 0.0 110.062 -178.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.841 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.13 75.45 1.24 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.977 -1.077 . . . . 0.0 110.691 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -146.09 43.22 1.23 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.86 . . . . 0.0 110.246 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.64 -169.62 38.21 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 151.59 27.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -1.181 . . . . 0.0 110.437 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 140' ' ' TYR . 13.9 mm -136.31 132.35 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.418 -0.801 . . . . 0.0 109.884 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.68 103.03 6.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 0.0 110.191 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.57 175.85 15.94 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 18.9 mttt -147.88 177.46 9.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -1.14 . . . . 0.0 109.532 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.481 HG21 HD13 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -157.21 149.48 10.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.103 -0.998 . . . . 0.0 111.099 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.612 ' O ' HG22 ' A' ' 79' ' ' THR . 69.0 m-20 -106.83 156.14 18.99 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.452 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 2.2 t -140.45 149.44 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 110.142 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 2.1 t80 -151.01 116.36 5.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 0.0 110.381 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.498 HD12 ' CD2' ' A' ' 132' ' ' TYR . 3.9 mt -134.97 153.83 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.44 -0.788 . . . . 0.0 109.994 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.54 102.28 1.71 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.145 -0.972 . . . . 0.0 109.971 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -173.17 175.28 3.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.522 -0.736 . . . . 0.0 109.829 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 100.7 12.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.148 -0.97 . . . . 0.0 110.344 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.2 t -76.92 112.15 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.339 -0.851 . . . . 0.0 109.965 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 53.98 43.44 30.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 110.212 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.53 38.09 68.78 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -145.26 108.41 4.54 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.228 -1.16 . . . . 0.0 110.048 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -47.96 129.19 17.7 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.682 1.359 . . . . 0.0 110.377 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.645 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 36.6 t80 -135.38 139.91 44.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 110.132 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -135.08 121.45 20.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.0 110.262 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.498 ' CD2' HD12 ' A' ' 121' ' ' ILE . 3.2 t80 -114.2 141.45 47.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 109.617 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 3.7 p30 -175.99 81.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.085 -1.01 . . . . 0.0 110.298 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.19 178.77 9.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 0.0 110.589 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.406 ' ND1' ' N ' ' A' ' 135' ' ' HIS . 1.8 m80 -119.0 96.38 5.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.315 -0.866 . . . . 0.0 109.631 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.93 139.53 31.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 110.483 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.597 ' O ' HG23 ' A' ' 138' ' ' ILE . 25.4 p30 -88.72 159.72 17.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.327 -0.858 . . . . 0.0 110.157 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 137' ' ' ASN . 6.9 pt -156.35 166.28 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 110.1 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 88.6 m -91.76 161.27 14.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.359 -0.838 . . . . 0.0 110.572 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.457 ' CE2' HG13 ' A' ' 138' ' ' ILE . 19.3 m-85 -147.06 98.66 3.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.428 -0.795 . . . . 0.0 109.635 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -101.46 105.3 16.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.896 . . . . 0.0 110.874 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 140' ' ' TYR . 98.3 m-85 -92.2 140.34 29.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.889 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -124.02 98.67 5.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -0.99 . . . . 0.0 110.453 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.64 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -151.36 -148.67 4.87 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.418 ' HD2' HD11 ' A' ' 109' ' ' LEU . 10.3 Cg_endo -56.77 150.28 54.89 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.639 1.336 . . . . 0.0 110.077 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.4 p -90.5 -46.08 8.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.959 . . . . 0.0 110.313 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -155.29 -43.81 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.375 -0.828 . . . . 0.0 110.066 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 148' ' ' VAL . 17.5 t 56.36 41.9 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.207 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.19 75.55 8.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 110.17 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.921 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.645 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.218 0.532 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.12 101.52 3.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.288 -0.882 . . . . 0.0 110.267 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 1.6 t-20 63.34 35.46 12.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 110.077 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 27' ' ' ASN . . . -177.06 160.36 1.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 110.35 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.67 -160.61 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.231 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER 54.34 25.32 5.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.268 -0.895 . . . . 0.0 110.478 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.6 t -160.11 134.67 7.6 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 110.451 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.84 179.09 48.47 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.39 112.23 22.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -1.124 . . . . 0.0 110.335 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.86 HD13 HD22 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -94.73 146.83 23.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 110.431 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.412 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -80.7 133.15 35.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 109.779 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.749 ' CE2' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -165.88 162.69 18.45 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.154 -0.966 . . . . 0.0 110.716 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.47 -168.29 2.78 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.455 -0.778 . . . . 0.0 109.526 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.861 ' O ' HG22 ' A' ' 46' ' ' THR . 2.5 m -140.92 117.88 8.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.047 -1.033 . . . . 0.0 110.349 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -90.86 155.54 18.68 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.42 -0.8 . . . . 0.0 110.134 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.3 OUTLIER -67.44 126.83 30.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.401 -0.812 . . . . 0.0 110.111 -179.767 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.511 ' CD2' ' ND2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -56.96 147.37 24.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.913 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.8 t30 72.77 -0.01 3.5 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.963 -0.461 . . . . 0.0 110.811 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -138.73 -168.32 2.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.937 -1.102 . . . . 0.0 109.445 179.189 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.42 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.1 OUTLIER -136.28 25.27 3.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.014 -1.054 . . . . 0.0 110.357 179.667 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -135.62 118.63 16.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.057 -1.027 . . . . 0.0 111.354 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.861 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -48.82 120.64 3.97 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.849 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.66 -18.06 3.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.709 -1.244 . . . . 0.0 112.466 -178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.469 HG21 ' C1D' ' A' ' 151' ' ' ZNH . 95.3 mt -137.98 -76.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.624 -1.298 . . . . 0.0 111.279 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -50.28 -21.94 1.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.742 -0.599 . . . . 0.0 111.593 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.462 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 59.8 t30 -59.08 -32.92 70.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.039 . . . . 0.0 111.388 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.18 15.89 27.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.016 -1.053 . . . . 0.0 111.025 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.461 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -98.65 -17.55 18.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.02 -1.05 . . . . 0.0 111.069 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.501 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 9.3 p90 -127.0 134.3 50.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.0 -1.062 . . . . 0.0 111.037 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -74.78 113.88 12.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.904 . . . . 0.0 109.937 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.72 162.34 29.48 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.015 -1.053 . . . . 0.0 110.005 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -83.09 -175.46 14.6 Favored 'Cis proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.55 -2.271 . . . . 0.0 110.526 -0.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.749 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . . . -102.53 -171.61 1.99 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 0.0 110.176 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 2.2 ttmt -125.29 113.35 17.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 0.0 110.251 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.607 ' HA ' HG13 ' A' ' 68' ' ' VAL . 10.0 p90 -97.26 165.42 12.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 110.31 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -155.48 156.81 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.363 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 19.8 mtmt -140.64 173.53 11.4 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.353 -0.842 . . . . 0.0 110.599 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.415 ' CB ' ' HD2' ' A' ' 65' ' ' LYS . 1.6 mtmm -158.53 62.23 0.43 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.843 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m120 45.11 82.6 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.661 -0.65 . . . . 0.0 111.195 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.91 14.78 33.06 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.608 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.415 ' HD2' ' CB ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -165.77 163.17 18.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.96 -1.318 . . . . 0.0 110.982 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.998 HD11 ' HA ' ' A' ' 108' ' ' LYS . 2.4 pt? -172.68 144.67 1.43 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.015 0.912 . . . . 0.0 111.356 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -139.01 173.33 11.67 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.175 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.607 HG13 ' HA ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -142.24 142.17 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.042 -1.036 . . . . 0.0 110.429 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.416 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 3.3 pp0? -97.66 132.35 43.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.398 -0.814 . . . . 0.0 109.641 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.549 HD13 ' HD2' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -113.49 132.63 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 110.457 -179.548 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 71' ' ' THR . 0.9 OUTLIER -89.54 125.2 35.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.679 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -103.15 134.22 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.901 . . . . 0.0 110.465 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -102.12 145.44 29.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.388 -0.82 . . . . 0.0 110.034 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 11.1 m170 50.61 87.39 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 110.141 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.2 p -57.21 -36.21 70.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.355 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -55.62 -32.8 63.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 110.353 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.605 ' CE2' HBB2 ' A' ' 151' ' ' ZNH . 35.7 m0 -76.3 -60.67 2.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 110.378 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.661 HD11 HG13 ' A' ' 117' ' ' ILE . 2.1 tp -88.41 117.2 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.437 -0.789 . . . . 0.0 110.058 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.651 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -86.82 -24.59 24.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -0.803 . . . . 0.0 110.836 -179.341 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.98 177.89 48.25 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.606 -1.283 . . . . 0.0 109.955 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.402 ' HG2' ' HB ' ' A' ' 117' ' ' ILE . 1.1 mtt -152.94 162.42 41.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -1.148 . . . . 0.0 109.969 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 t -154.81 153.48 31.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.958 . . . . 0.0 110.01 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.816 HD11 ' CE2' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -151.77 147.21 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 110.896 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 61.07 10.65 2.98 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.488 -0.757 . . . . 0.0 111.944 179.204 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.75 2.16 34.59 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.313 -1.423 . . . . 0.0 111.39 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 83' ' ' ILE . 5.2 p80 -135.39 150.25 49.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.534 -1.568 . . . . 0.0 110.824 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -70.15 -164.23 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 110.437 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 9.6 pt-20 -106.79 170.24 8.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.857 . . . . 0.0 110.492 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.34 136.24 50.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.019 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -67.96 100.94 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.989 -1.07 . . . . 0.0 109.648 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 101' ' ' THR . 1.1 tt -96.26 -29.13 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.0 110.776 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 5.4 m -167.38 99.48 0.51 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.162 -0.961 . . . . 0.0 109.963 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -95.61 152.99 17.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.816 . . . . 0.0 110.041 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.79 73.66 1.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 110.172 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.57 -34.27 72.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.269 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -47.09 85.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.119 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -96.32 14.82 23.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.46 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 1.4 m-20 51.16 55.13 9.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.109 -0.995 . . . . 0.0 110.103 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 54.3 mt-10 -146.32 168.1 21.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.327 -0.858 . . . . 0.0 110.168 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 101' ' ' THR . 4.2 ttt180 -172.96 163.23 4.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.212 -0.93 . . . . 0.0 109.93 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.508 ' O ' HG22 ' A' ' 91' ' ' ILE . 62.9 m -139.96 153.98 47.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.863 . . . . 0.0 110.122 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.42 ' CB ' ' OE1' ' A' ' 88' ' ' GLU . 5.1 p -145.59 143.93 30.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.427 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.99 147.51 22.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.283 -0.886 . . . . 0.0 109.965 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.549 ' HD2' HD13 ' A' ' 70' ' ' ILE . 15.6 m-85 -128.02 135.84 50.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 110.683 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.445 ' C ' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -104.11 131.13 51.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.721 179.68 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.445 HG13 ' C ' ' A' ' 105' ' ' GLU . 24.0 m -149.22 159.12 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.14 -0.975 . . . . 0.0 110.558 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.8 t -50.44 -45.04 55.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 109.142 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.998 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.5 -165.43 0.85 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.658 -0.651 . . . . 0.0 109.485 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.86 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -149.99 71.48 1.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.073 -1.017 . . . . 0.0 110.548 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -146.17 55.49 1.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.404 -0.81 . . . . 0.0 110.177 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 142' ' ' PHE . . . 169.37 -108.27 0.29 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.452 ' HG3' HG23 ' A' ' 139' ' ' THR . 1.5 tmtt? -156.44 135.15 11.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.35 -1.088 . . . . 0.0 109.902 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.2 mt -128.97 147.27 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.124 -0.985 . . . . 0.0 110.291 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.89 119.95 20.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.952 . . . . 0.0 110.407 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -124.71 178.79 16.38 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 30.5 mttt -146.49 158.51 43.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -1.088 . . . . 0.0 109.842 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.661 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.55 146.91 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.069 -1.019 . . . . 0.0 110.581 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.651 ' C ' HG22 ' A' ' 79' ' ' THR . 1.4 m-20 -106.92 159.79 16.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.532 -0.73 . . . . 0.0 109.534 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.1 OUTLIER -136.24 151.63 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 0.0 110.286 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.16 103.91 3.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.385 -0.822 . . . . 0.0 110.513 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 65.4 mt -132.34 153.18 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 110.136 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.29 97.16 1.35 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.384 -0.823 . . . . 0.0 109.851 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -173.54 -179.73 1.91 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 110.165 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -103.16 108.01 19.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.096 -1.003 . . . . 0.0 110.295 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.474 ' O ' HG12 ' A' ' 125' ' ' VAL . 12.5 t -76.82 100.01 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.296 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.417 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 1.6 m120 62.65 42.08 8.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.222 -0.924 . . . . 0.0 110.519 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.1 36.49 24.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.08 106.21 4.48 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.155 -1.203 . . . . 0.0 110.12 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -51.18 115.19 1.89 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.695 1.366 . . . . 0.0 110.251 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.613 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 6.1 t80 -114.9 116.87 29.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 110.473 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.38 133.95 47.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.398 -0.814 . . . . 0.0 109.775 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.473 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 2.3 t80 -149.79 119.38 6.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.161 -0.962 . . . . 0.0 109.937 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -165.98 75.36 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.248 -0.908 . . . . 0.0 110.034 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.03 -165.24 2.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 110.448 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 1.6 p-80 -122.26 154.33 37.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 110.361 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 45.6 m-85 -154.94 135.06 13.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.31 -0.869 . . . . 0.0 110.033 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 138' ' ' ILE . 50.8 p30 -87.77 166.45 14.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.325 -0.859 . . . . 0.0 110.525 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 137' ' ' ASN . 5.9 pt -156.48 167.25 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.12 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.452 HG23 ' HG3' ' A' ' 112' ' ' LYS . 85.0 m -91.76 115.44 28.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.323 -0.861 . . . . 0.0 111.059 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.816 ' CE2' HD11 ' A' ' 83' ' ' ILE . 15.6 m-85 -90.62 95.79 10.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 109.578 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -87.71 101.94 14.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.05 -1.031 . . . . 0.0 110.742 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 36' ' ' TYR . 22.8 m-85 -93.26 138.87 31.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.31 -0.869 . . . . 0.0 110.251 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -132.38 99.48 4.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.11 -0.994 . . . . 0.0 110.333 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.766 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -159.77 -142.02 3.29 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.416 ' HG2' HD11 ' A' ' 109' ' ' LEU . 11.7 Cg_endo -61.54 133.73 47.33 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.598 1.315 . . . . 0.0 110.11 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.1 m -91.19 -52.12 4.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 110.165 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -165.02 29.28 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.852 . . . . 0.0 110.421 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.5 t 58.55 39.0 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.897 . . . . 0.0 110.358 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.13 56.73 3.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 0.0 110.295 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.979 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.613 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.229 0.538 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -170.3 134.58 1.19 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 110.33 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 6.2 t30 63.35 35.97 11.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.032 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.86 87.03 2.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.34 -0.85 . . . . 0.0 110.356 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.54 -164.58 0.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 110.236 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 60.7 m-20 53.29 27.97 6.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 110.341 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.25 141.05 13.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 110.569 -179.49 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -172.7 173.06 45.38 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.61 110.63 21.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.258 -1.142 . . . . 0.0 110.402 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.889 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.6 OUTLIER -95.61 155.34 16.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -0.915 . . . . 0.0 110.549 179.793 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.7 t-20 -81.86 135.69 35.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.111 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.895 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -167.09 159.52 13.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.864 -1.147 . . . . 0.0 110.969 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -154.69 -165.82 2.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.398 -0.814 . . . . 0.0 109.795 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.507 ' CG2' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -141.16 174.42 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 110.632 -179.914 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 50.6 m-85 -148.56 157.29 43.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.401 -0.812 . . . . 0.0 109.889 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.466 ' HG3' ' CG2' ' A' ' 43' ' ' THR . 12.8 tppt? -67.73 136.4 54.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 110.223 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.467 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -61.46 146.54 48.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.178 -0.951 . . . . 0.0 109.354 179.577 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 8.3 t30 72.02 2.83 4.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.851 -0.53 . . . . 0.0 110.79 -179.141 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.466 ' CG2' ' HG3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -136.62 -166.65 1.93 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.932 -1.105 . . . . 0.0 109.559 179.207 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.445 ' N ' ' OG1' ' A' ' 43' ' ' THR . 25.6 t30 -130.93 15.87 5.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 110.302 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.59 139.07 41.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 110.843 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.465 ' CG2' ' CB ' ' A' ' 50' ' ' ASN . 0.3 OUTLIER -70.43 134.76 48.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.075 179.141 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.462 ' OG ' HD12 ' A' ' 48' ' ' ILE . 4.7 t -129.28 -18.26 3.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.009 -1.077 . . . . 0.0 112.193 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.504 HG21 ' C1D' ' A' ' 151' ' ' ZNH . 1.1 mp -138.19 -49.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.773 -1.204 . . . . 0.0 110.976 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.94 8.5 10.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.537 -0.727 . . . . 0.0 111.475 -178.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.465 ' CB ' ' CG2' ' A' ' 46' ' ' THR . 0.5 OUTLIER -71.78 -33.93 69.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.901 -1.124 . . . . 0.0 110.492 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 71.5 m-20 -102.69 15.38 29.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.13 -0.981 . . . . 0.0 110.806 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.702 ' CD1' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -91.13 -18.01 25.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.047 -1.033 . . . . 0.0 110.866 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.507 ' CE1' ' CG2' ' A' ' 38' ' ' VAL . 39.2 p90 -118.3 127.88 54.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.15 -0.969 . . . . 0.0 110.865 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.532 ' CB ' HG21 ' A' ' 71' ' ' THR . 1.7 t30 -73.76 109.85 7.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.746 179.315 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.419 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 2.7 pttt -91.99 161.63 32.88 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.047 -1.033 . . . . 0.0 110.144 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 56.4 Cg_endo -79.54 -175.58 16.77 Favored 'Cis proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.513 -2.286 . . . . 0.0 110.585 -0.031 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.895 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.8 168.06 9.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 0.0 109.894 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.432 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -105.5 116.01 31.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 110.795 -179.798 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.502 ' HB2' HD23 ' A' ' 109' ' ' LEU . 3.9 p90 -96.3 160.96 14.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 0.0 109.355 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -154.72 124.62 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.942 -1.099 . . . . 0.0 110.967 -179.329 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.458 ' CD ' ' HE2' ' A' ' 108' ' ' LYS . 1.2 mtmt -137.62 129.29 28.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.349 -0.845 . . . . 0.0 110.173 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -108.37 63.63 0.61 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.903 . . . . 0.0 110.843 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 46.03 96.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.494 -0.754 . . . . 0.0 111.109 179.329 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.94 12.73 39.15 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' HB2' ' OH ' ' A' ' 67' ' ' TYR . 6.9 ptpt -171.25 156.8 4.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.166 -1.196 . . . . 0.0 109.735 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.753 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.05 143.28 6.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.034 -1.041 . . . . 0.0 111.517 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -140.26 -160.59 1.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.613 -0.679 . . . . 0.0 109.436 179.94 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -170.14 131.06 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.003 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.432 ' HG2' ' HB3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -98.46 141.98 30.65 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.917 . . . . 0.0 110.322 -179.948 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.1 OUTLIER -114.69 141.27 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.438 -0.789 . . . . 0.0 110.067 -179.872 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.532 HG21 ' CB ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -89.18 134.42 34.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.985 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.635 HG22 ' CE ' ' A' ' 81' ' ' MET . 3.0 t -104.36 124.87 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.867 . . . . 0.0 110.277 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.83 128.94 45.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.011 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.4 m80 62.72 113.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.311 -0.868 . . . . 0.0 110.107 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.2 t -76.47 -13.19 60.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.864 . . . . 0.0 110.677 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -84.0 -56.1 3.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.041 -1.037 . . . . 0.0 110.397 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.532 ' HA ' HD11 ' A' ' 121' ' ' ILE . 4.0 m0 -47.87 -68.07 0.22 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.325 -0.859 . . . . 0.0 110.646 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.752 HD11 HG13 ' A' ' 117' ' ' ILE . 0.6 OUTLIER -88.28 122.15 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.922 . . . . 0.0 110.041 -179.86 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.628 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.19 -27.42 23.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.847 . . . . 0.0 110.926 -179.204 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.18 -179.74 45.93 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.166 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.635 ' CE ' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -152.93 169.68 22.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.508 -0.995 . . . . 0.0 109.987 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -153.91 161.41 42.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.067 -1.021 . . . . 0.0 109.716 179.904 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.895 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -164.5 141.4 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 110.699 -179.672 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 0.4 OUTLIER 62.89 8.7 3.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.525 -0.734 . . . . 0.0 111.964 179.379 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.24 2.01 28.03 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.349 -1.405 . . . . 0.0 111.424 178.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.48 ' NE2' ' CB ' ' A' ' 84' ' ' GLU . 3.2 p80 -135.42 155.95 49.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.518 -1.577 . . . . 0.0 110.964 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -160.49 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.508 -0.745 . . . . 0.0 110.5 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -102.66 150.81 23.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.391 -0.818 . . . . 0.0 110.298 -179.863 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -99.89 125.55 45.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.599 179.519 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.532 HG22 HH21 ' A' ' 100' ' ' ARG . 1.1 pp -67.24 103.11 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.005 -1.059 . . . . 0.0 109.884 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.447 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -95.63 -28.91 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.461 -0.774 . . . . 0.0 110.851 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.5 p -167.05 105.1 0.56 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.96 -1.087 . . . . 0.0 109.982 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.465 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 13.2 ttmt -95.24 106.48 18.52 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.327 -0.858 . . . . 0.0 110.19 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -96.59 95.01 7.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.9 p -77.31 -17.75 58.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 110.434 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.73 -53.67 50.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.025 -1.047 . . . . 0.0 110.101 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -98.0 15.07 25.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -0.88 . . . . 0.0 110.358 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.0 64.93 1.57 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.15 -0.969 . . . . 0.0 110.174 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.93 170.98 15.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.424 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.532 HH21 HG22 ' A' ' 90' ' ' ILE . 6.6 mtp180 -162.18 164.6 27.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.496 -0.752 . . . . 0.0 109.91 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.447 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 94.6 m -140.68 152.12 45.11 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.29 -0.881 . . . . 0.0 109.618 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 1.7 p -143.54 138.84 29.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.989 -1.069 . . . . 0.0 110.65 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -91.69 138.2 31.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.366 -0.834 . . . . 0.0 109.975 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 38.2 m-85 -128.59 129.71 46.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.157 -0.964 . . . . 0.0 110.807 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -90.31 127.53 36.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.392 -0.817 . . . . 0.0 109.395 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.533 HG22 ' N ' ' A' ' 107' ' ' SER . 2.7 p -149.28 168.52 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.001 -1.062 . . . . 0.0 110.832 -179.25 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.533 ' N ' HG22 ' A' ' 106' ' ' VAL . 39.5 t -78.2 110.54 13.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.05 178.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.458 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 47.41 -158.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.46 -0.775 . . . . 0.0 109.86 -178.834 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.577 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -151.27 59.93 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.041 -1.037 . . . . 0.0 110.791 -179.678 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -146.22 56.96 1.19 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.239 -0.913 . . . . 0.0 110.31 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.33 178.96 48.66 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.417 ' CD ' HG23 ' A' ' 139' ' ' THR . 0.1 OUTLIER -81.57 148.32 29.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -1.135 . . . . 0.0 110.395 -179.916 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.1 mm -137.84 150.08 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 110.114 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -76.07 124.63 27.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 109.986 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.487 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -131.88 116.82 1.94 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 82' ' ' SER . 30.8 mtpt -95.44 159.22 15.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -1.106 . . . . 0.0 109.471 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.752 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -158.24 140.55 5.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 120.845 -1.16 . . . . 0.0 111.194 -179.836 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.628 ' C ' HG22 ' A' ' 79' ' ' THR . 15.0 m-20 -108.26 161.11 15.3 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.575 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -131.48 147.62 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.014 -1.054 . . . . 0.0 110.766 -179.434 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 22.6 t80 -152.12 106.45 3.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 110.281 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.666 HD13 HBB1 ' A' ' 151' ' ' ZNH . 2.4 mp -135.03 150.65 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.158 -0.964 . . . . 0.0 110.68 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 1.0 OUTLIER -160.94 96.8 1.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.46 -0.775 . . . . 0.0 109.863 179.856 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.421 ' OE2' HG12 ' A' ' 125' ' ' VAL . 0.9 OUTLIER -173.9 -168.38 0.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 110.508 -179.838 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 0.9 OUTLIER -97.9 84.73 3.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.863 . . . . 0.0 110.346 -179.874 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.421 HG12 ' OE2' ' A' ' 123' ' ' GLU . 16.0 m -77.52 136.62 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 50.39 28.01 3.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.812 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.32 34.21 41.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 4.1 mtpt -145.09 128.82 8.63 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.238 -1.154 . . . . 0.0 110.139 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.403 ' HD3' ' HE3' ' A' ' 124' ' ' LYS . 28.9 Cg_endo -68.95 110.5 2.4 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.658 1.346 . . . . 0.0 110.155 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.777 ' CE2' HMB2 ' A' ' 151' ' ' ZNH . 49.1 t80 -116.15 156.08 27.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.124 -0.985 . . . . 0.0 110.453 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.79 110.39 9.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 109.935 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.575 ' HE2' HG11 ' A' ' 119' ' ' VAL . 1.6 t80 -112.8 127.28 56.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 110.041 -179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -163.4 84.59 0.49 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 110.052 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.45 -169.8 3.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.511 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 4.0 p-80 -119.71 145.66 46.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 110.163 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 38.9 m-85 -155.16 -179.56 8.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 110.104 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.573 ' O ' HG23 ' A' ' 138' ' ' ILE . 2.0 p30 -151.88 172.9 15.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.8 pt -155.8 166.72 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.305 -0.872 . . . . 0.0 110.132 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.417 HG23 ' CD ' ' A' ' 112' ' ' LYS . 86.6 m -91.83 122.24 34.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 111.063 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.895 ' CD2' HD11 ' A' ' 83' ' ' ILE . 6.3 m-85 -90.02 162.5 15.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.302 -0.874 . . . . 0.0 109.625 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 101.31 2.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.055 -1.028 . . . . 0.0 110.819 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -91.34 133.85 35.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.299 -0.876 . . . . 0.0 109.518 179.227 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.44 ' C ' HD21 ' A' ' 34' ' ' LEU . 8.3 m120 -128.56 108.63 10.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 110.64 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.889 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -160.36 -145.5 4.3 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.562 ' HD2' HD11 ' A' ' 34' ' ' LEU . 11.0 Cg_endo -60.27 -169.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.626 1.33 . . . . 0.0 110.063 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.55 -43.5 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.0 110.231 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -110.9 -61.76 1.64 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.159 -0.963 . . . . 0.0 110.172 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 148' ' ' VAL . 50.2 t 55.57 48.97 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -0.833 . . . . 0.0 110.23 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.3 47.88 0.36 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 110.09 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.835 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.777 HMB2 ' CE2' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.204 0.526 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.405 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -132.27 133.43 44.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.914 . . . . 0.0 110.053 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 1.2 t-20 62.56 24.15 14.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.931 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.1 146.52 23.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.416 -0.803 . . . . 0.0 110.186 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.47 -160.11 0.45 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 110.189 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 8.8 m-20 56.94 27.37 13.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 110.259 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 p -160.02 159.05 31.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -0.995 . . . . 0.0 110.529 -179.607 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.51 176.19 35.21 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.94 105.96 18.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.283 -1.128 . . . . 0.0 110.369 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.829 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -95.82 157.26 15.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.128 -0.982 . . . . 0.0 110.847 -179.844 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -80.24 138.45 36.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.344 -0.848 . . . . 0.0 110.483 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.794 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -165.24 155.53 13.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.209 179.498 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -155.52 -177.4 6.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.0 110.101 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.746 ' O ' HG22 ' A' ' 46' ' ' THR . 2.2 m -140.21 116.74 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 0.0 110.356 179.511 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -92.35 169.56 10.47 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.421 -0.799 . . . . 0.0 110.38 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.457 ' CD ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -67.41 125.82 27.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.887 . . . . 0.0 109.716 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.493 ' O ' HG23 ' A' ' 43' ' ' THR . 0.5 OUTLIER -48.58 143.28 5.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.286 -0.884 . . . . 0.0 110.53 -179.46 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 18.6 t30 73.77 -2.47 2.76 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.038 -0.414 . . . . 0.0 111.468 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.47 -163.88 1.51 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.782 -1.199 . . . . 0.0 110.053 179.523 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -136.59 30.92 2.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.559 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -134.3 119.81 19.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.082 -1.011 . . . . 0.0 110.983 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.746 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -57.95 121.61 10.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.472 -0.767 . . . . 0.0 109.63 179.245 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.73 -19.18 3.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.767 -1.208 . . . . 0.0 112.227 -179.242 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.457 HD11 ' CD ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -138.92 -77.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.536 -1.353 . . . . 0.0 111.108 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -46.17 -25.67 0.64 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.702 -0.623 . . . . 0.0 111.269 -179.228 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.513 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 1.3 p30 -66.34 -14.65 62.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.988 -1.07 . . . . 0.0 110.917 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.63 15.27 29.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.083 -1.011 . . . . 0.0 111.182 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -138.79 13.4 2.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.831 -1.168 . . . . 0.0 111.002 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CE1' ' HA ' ' A' ' 50' ' ' ASN . 4.8 p90 -125.81 129.18 48.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.019 . . . . 0.0 110.4 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.41 157.11 37.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 110.297 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -148.27 155.4 42.93 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 110.062 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.407 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 56.8 Cg_endo -79.81 -174.97 15.52 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.762 -2.183 . . . . 0.0 110.351 -0.671 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.794 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.51 169.13 9.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -0.954 . . . . 0.0 110.164 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.44 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -103.15 115.84 31.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.498 -179.868 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.5 p90 -97.76 164.32 12.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.922 . . . . 0.0 109.916 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -155.45 129.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 110.275 179.903 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.431 ' HG2' ' HB2' ' A' ' 66' ' ' LEU . 1.2 mtmp? -140.05 112.74 7.99 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.485 -0.759 . . . . 0.0 110.196 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 62.23 2.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.109 -0.994 . . . . 0.0 110.593 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 46.03 99.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.604 -0.685 . . . . 0.0 111.63 179.287 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.05 -21.64 43.74 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.084 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.87 167.45 20.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -1.139 . . . . 0.0 110.35 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.711 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.1 pt? -171.62 145.46 2.02 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.553 179.318 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.566 ' C ' HG12 ' A' ' 68' ' ' VAL . 1.1 m-85 -142.45 -167.1 2.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.68 -0.637 . . . . 0.0 109.43 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.566 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -165.28 129.63 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.126 -0.984 . . . . 0.0 110.419 179.374 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.44 ' HG2' ' CB ' ' A' ' 58' ' ' LYS . 12.1 pt20 -99.57 132.52 44.85 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.832 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.5 HD12 ' CG2' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -117.04 130.66 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 110.195 -179.713 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.8 m -88.56 127.68 35.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.907 . . . . 0.0 109.797 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -102.01 141.9 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.829 . . . . 0.0 110.167 -179.663 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -99.72 148.48 24.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.323 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 7.9 m80 52.43 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.46 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.14 -29.82 61.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 0.0 110.104 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -53.3 14.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.395 -0.816 . . . . 0.0 110.118 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.773 ' O ' HG12 ' A' ' 119' ' ' VAL . 35.0 m0 -51.71 -70.43 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.344 -0.847 . . . . 0.0 110.286 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 78' ' ' ILE . 3.9 tt -88.23 116.91 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 109.927 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.701 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -87.3 -22.55 25.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -0.841 . . . . 0.0 110.937 -179.18 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.43 170.66 42.79 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.311 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.578 ' CG ' HD11 ' A' ' 78' ' ' ILE . 4.0 mtm -153.07 107.1 3.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.428 -1.042 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.84 163.91 17.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 110.136 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.708 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.5 OUTLIER -152.42 144.65 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.376 -0.827 . . . . 0.0 110.0 179.83 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.53 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 64.67 10.71 6.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.096 -1.002 . . . . 0.0 110.997 179.868 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.9 15.6 53.83 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.623 179.281 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.614 ' CE1' ' O ' ' A' ' 83' ' ' ILE . 3.2 p80 -135.08 159.47 41.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.821 -1.399 . . . . 0.0 110.546 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 176.71 4.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.403 -0.811 . . . . 0.0 111.008 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 7.4 pt-20 -104.02 170.25 8.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 0.0 110.508 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.7 OUTLIER -112.06 128.34 56.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 110.157 -179.927 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.71 103.56 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.097 -1.002 . . . . 0.0 109.586 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 101' ' ' THR . 1.4 tt -94.47 -27.24 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.344 -0.847 . . . . 0.0 110.872 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -167.03 100.86 0.54 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.184 -0.947 . . . . 0.0 109.808 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.431 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 21.5 ttmt -95.67 107.17 19.35 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.327 -0.858 . . . . 0.0 110.211 -179.607 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.47 68.3 2.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.027 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.94 -27.52 44.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.282 -0.886 . . . . 0.0 110.229 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.42 -47.44 84.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 0.0 110.126 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -96.71 17.54 16.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.263 -0.898 . . . . 0.0 110.435 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 52.7 57.98 5.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 110.247 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -148.28 174.42 12.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.164 -0.96 . . . . 0.0 110.527 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.442 ' O ' HG13 ' A' ' 72' ' ' VAL . 3.2 ttm180 -170.16 162.65 8.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.356 -0.84 . . . . 0.0 110.207 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.52 ' O ' HG22 ' A' ' 91' ' ' ILE . 91.0 m -142.13 153.78 44.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 109.801 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -145.8 144.93 30.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.96 -1.088 . . . . 0.0 110.927 -179.818 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -93.43 141.8 28.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.353 -0.842 . . . . 0.0 109.719 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.523 ' HB2' HG13 ' A' ' 68' ' ' VAL . 97.9 m-85 -130.16 141.63 50.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.006 . . . . 0.0 111.18 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.32 127.89 50.54 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.711 ' O ' HD21 ' A' ' 66' ' ' LEU . 2.6 p -149.89 149.59 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.036 -1.04 . . . . 0.0 111.351 -178.509 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 101.58 0.72 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.159 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.658 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 55.1 174.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 108.899 -177.919 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.96 70.66 1.11 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.782 -1.199 . . . . 0.0 111.004 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -147.32 64.39 1.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.469 -0.77 . . . . 0.0 110.191 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 177.54 -112.59 0.38 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.676 -1.25 . . . . 0.0 109.986 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.468 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.4 OUTLIER -157.35 137.58 12.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -1.165 . . . . 0.0 110.167 -179.628 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.518 HD13 HG21 ' A' ' 106' ' ' VAL . 12.0 mt -135.21 151.93 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.98 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -76.01 125.18 28.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.164 -0.96 . . . . 0.0 110.5 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.478 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -133.43 178.73 18.02 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 2.1 mtpp -142.34 166.89 23.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -1.186 . . . . 0.0 109.745 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.55 HG22 ' HA ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -158.83 140.59 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.877 -1.14 . . . . 0.0 110.751 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.701 ' C ' HG22 ' A' ' 79' ' ' THR . 1.2 m-20 -107.42 160.62 15.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.553 -0.717 . . . . 0.0 109.375 179.296 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -136.97 149.81 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.058 -1.026 . . . . 0.0 110.582 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.41 106.51 3.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.305 -0.872 . . . . 0.0 110.602 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.531 HD13 ' CBB' ' A' ' 151' ' ' ZNH . 3.0 mp -137.99 148.68 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -0.901 . . . . 0.0 110.258 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.9 95.69 1.19 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.351 -0.843 . . . . 0.0 109.738 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.47 -178.97 1.77 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.374 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -98.12 102.27 13.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 110.308 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.742 HG21 ' CD2' ' A' ' 130' ' ' PHE . 13.4 t -76.74 97.42 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 110.303 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.8 m120 57.48 50.84 10.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.268 -0.895 . . . . 0.0 110.423 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.9 36.63 57.35 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.434 ' HE3' ' CA ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -145.75 103.08 4.21 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.195 -1.179 . . . . 0.0 110.186 179.819 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -49.91 117.85 3.39 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.785 1.413 . . . . 0.0 110.227 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.742 ' CD2' HG21 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -111.81 110.3 20.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 110.453 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -106.08 107.48 18.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -0.886 . . . . 0.0 110.079 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.465 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 3.6 t80 -134.54 129.29 34.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.051 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -174.27 82.28 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.168 -0.957 . . . . 0.0 110.234 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -153.44 -160.54 1.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.169 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -122.5 148.46 45.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.257 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -155.14 -179.33 7.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.681 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.618 ' O ' HG23 ' A' ' 138' ' ' ILE . 46.2 p-10 -151.67 173.02 15.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 110.984 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.5 pt -157.58 172.39 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 110.356 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.468 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 59.9 m -91.66 124.06 35.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.346 -0.846 . . . . 0.0 110.56 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.708 ' CD2' HD11 ' A' ' 83' ' ' ILE . 31.5 m-85 -91.2 104.47 17.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.233 -0.917 . . . . 0.0 109.996 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -97.62 105.7 17.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.202 -0.936 . . . . 0.0 110.741 -179.703 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.42 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 67.7 m-85 -92.45 158.8 15.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.285 -0.884 . . . . 0.0 110.519 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.464 ' C ' HD21 ' A' ' 34' ' ' LEU . 18.9 m120 -145.49 104.0 3.87 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.094 -1.004 . . . . 0.0 110.479 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.829 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -164.34 -146.77 4.87 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.506 ' HD2' HD11 ' A' ' 34' ' ' LEU . 20.3 Cg_endo -66.48 122.43 9.87 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.802 1.422 . . . . 0.0 110.412 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.65 -34.48 15.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 110.21 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -154.64 -65.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.374 -0.829 . . . . 0.0 110.197 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 148' ' ' VAL . 11.7 t 57.31 40.3 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.367 -0.833 . . . . 0.0 110.379 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.72 59.85 4.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.957 . . . . 0.0 110.213 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.863 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.531 ' CBB' HD13 ' A' ' 121' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.233 0.54 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -158.55 145.3 17.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.174 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 0.6 OUTLIER 62.56 28.0 16.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.965 -179.872 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -107.59 106.98 17.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.421 -0.799 . . . . 0.0 110.186 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.74 -46.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.329 -0.857 . . . . 0.0 110.306 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 12.8 m-20 57.55 31.14 19.85 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.934 . . . . 0.0 110.308 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -159.36 155.23 26.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.037 -1.039 . . . . 0.0 110.589 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.79 171.76 35.66 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.67 111.14 21.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -1.12 . . . . 0.0 110.54 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.521 HD13 HD22 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -94.46 148.86 21.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 0.0 109.877 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.446 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 22.4 m-20 -79.56 137.94 37.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.224 -0.922 . . . . 0.0 110.199 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.732 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 1.8 p90 -166.57 164.01 17.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.187 -0.946 . . . . 0.0 110.83 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.25 -179.41 8.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.472 -0.768 . . . . 0.0 109.64 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.806 HG13 ' O ' ' A' ' 139' ' ' THR . 69.0 t -140.21 111.21 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.093 -1.004 . . . . 0.0 110.217 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -89.04 166.17 14.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.758 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.2 OUTLIER -67.18 125.15 25.15 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 110.109 -179.766 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.53 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -51.14 144.0 9.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 110.058 -179.906 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.9 OUTLIER 72.02 1.36 3.89 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.818 -0.551 . . . . 0.0 111.108 -179.536 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -135.66 -166.69 1.9 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.894 -1.129 . . . . 0.0 109.752 179.233 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -135.18 18.7 3.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.937 . . . . 0.0 110.196 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -136.19 126.41 26.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.114 -0.991 . . . . 0.0 111.088 -179.552 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.454 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -53.9 124.95 16.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -0.834 . . . . 0.0 108.903 178.951 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.3 -18.77 3.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.73 -1.231 . . . . 0.0 112.202 -178.705 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.3 mt -138.55 -78.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.751 -1.218 . . . . 0.0 110.776 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -45.99 -25.68 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.696 -0.627 . . . . 0.0 111.24 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.454 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -56.48 -18.12 10.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.037 -1.039 . . . . 0.0 111.073 -179.597 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -101.91 15.21 29.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.976 -1.078 . . . . 0.0 111.006 -179.316 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -141.87 10.74 2.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.935 -1.103 . . . . 0.0 111.031 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -118.69 115.44 24.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.091 -1.006 . . . . 0.0 110.136 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.31 152.36 42.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 110.408 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -147.2 158.26 44.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 109.848 179.896 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 58.7 Cg_endo -79.57 -175.65 16.9 Favored 'Cis proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.714 -2.203 . . . . 0.0 110.585 -0.367 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.732 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -102.47 164.05 11.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.062 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.447 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 1.4 mtpt -102.44 118.09 36.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.931 . . . . 0.0 110.524 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.514 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 27.2 p90 -97.3 164.47 12.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.862 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -156.31 117.03 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.033 -1.042 . . . . 0.0 110.632 -179.681 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.508 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -127.49 122.15 32.65 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.157 -0.965 . . . . 0.0 110.365 179.885 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 63' ' ' ASN . 1.7 mmmp? -101.46 61.97 0.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 0.0 110.155 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 62' ' ' LYS . 5.1 t-20 47.78 100.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.435 -0.791 . . . . 0.0 111.434 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.11 -15.53 57.83 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.207 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.461 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -144.28 169.36 18.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.009 -1.289 . . . . 0.0 110.532 179.827 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.699 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.6 pt? -169.58 144.26 2.91 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.367 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.541 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -137.47 -169.08 2.44 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.727 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -165.72 131.27 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 110.012 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.497 ' NE2' HG21 ' A' ' 101' ' ' THR . 0.0 OUTLIER -98.12 130.21 44.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 -179.932 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.587 HD11 ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -111.61 135.01 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.69 179.94 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.6 m -89.68 125.52 35.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.082 -1.011 . . . . 0.0 110.067 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.59 143.41 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 110.207 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -100.57 128.52 46.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.354 -0.841 . . . . 0.0 110.615 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 61.24 115.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 0.0 110.499 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -43.08 57.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.0 110.037 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -50.82 -39.37 53.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 109.99 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.499 ' HB3' HMC2 ' A' ' 151' ' ' ZNH . 23.8 m0 -64.77 -73.45 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 110.062 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.31 119.13 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 109.987 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.827 HG22 ' O ' ' A' ' 118' ' ' ASP . 3.7 t -86.88 -21.65 26.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 111.001 -179.346 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 81' ' ' MET . . . -172.17 169.93 42.98 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.451 -1.356 . . . . 0.0 110.125 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 3.5 mtm -151.87 106.11 3.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -1.106 . . . . 0.0 110.04 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -86.58 158.48 19.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 109.863 179.66 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.757 HD11 ' CE1' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -156.25 135.63 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.5 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.5 ' HG3' HG12 ' A' ' 106' ' ' VAL . 0.6 OUTLIER 65.29 6.22 3.51 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.451 -0.781 . . . . 0.0 112.018 179.489 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.18 -0.57 22.51 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.332 -1.413 . . . . 0.0 111.328 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.474 ' NE2' ' HB3' ' A' ' 84' ' ' GLU . 2.6 p80 -131.72 158.08 42.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.557 -1.555 . . . . 0.0 110.881 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -70.55 -164.24 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.5 -0.75 . . . . 0.0 110.505 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 1.2 pm0 -104.61 164.07 12.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 110.544 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -115.38 133.96 55.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.913 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.427 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 1.2 pp -68.06 101.71 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.995 -1.065 . . . . 0.0 109.792 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 101' ' ' THR . 2.3 tt -95.71 -28.2 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.338 -0.851 . . . . 0.0 110.732 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.7 p -167.03 103.35 0.55 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 109.776 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -95.08 147.51 23.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.357 -0.84 . . . . 0.0 110.174 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.31 71.39 1.33 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 110.125 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.16 -32.7 62.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.372 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -42.78 99.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.224 -0.923 . . . . 0.0 110.16 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -95.98 10.38 37.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -0.904 . . . . 0.0 110.608 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 50.95 56.87 7.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.97 -1.081 . . . . 0.0 110.181 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -147.61 179.65 7.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.45 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -174.86 162.02 3.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.401 -0.812 . . . . 0.0 109.984 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.573 ' O ' HG22 ' A' ' 91' ' ' ILE . 82.8 m -140.61 156.02 46.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.331 -0.855 . . . . 0.0 109.552 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.45 ' OG ' HG22 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -143.23 140.02 30.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.982 -1.073 . . . . 0.0 110.82 -179.582 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -93.56 137.59 32.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.717 . . . . 0.0 110.194 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 81.7 m-85 -128.59 140.98 51.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.08 -1.012 . . . . 0.0 110.748 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.467 ' C ' HG13 ' A' ' 106' ' ' VAL . 2.0 tt0 -102.52 131.54 49.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.86 . . . . 0.0 109.335 179.109 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.699 ' O ' HD21 ' A' ' 66' ' ' LEU . 35.7 m -149.16 147.63 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.135 -0.978 . . . . 0.0 110.833 -179.203 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.51 108.25 1.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 109.141 179.12 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.672 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 54.39 176.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -0.95 . . . . 0.0 109.118 -178.646 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.521 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -148.9 72.09 1.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.968 -1.082 . . . . 0.0 110.792 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -145.59 44.58 1.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.471 -0.768 . . . . 0.0 109.984 179.66 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . -174.29 177.25 46.55 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.436 ' CD ' HG23 ' A' ' 139' ' ' THR . 0.6 OUTLIER -80.51 145.95 31.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.233 -1.157 . . . . 0.0 110.637 -179.701 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.418 ' N ' ' HE3' ' A' ' 112' ' ' LYS . 74.9 mt -136.17 150.75 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.35 -0.844 . . . . 0.0 109.781 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -76.48 132.26 39.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.06 -1.025 . . . . 0.0 110.428 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.437 ' HA3' ' CD2' ' A' ' 140' ' ' TYR . . . -132.94 169.84 22.36 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 82' ' ' SER . 22.4 mtmt -144.01 162.23 36.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.069 -1.253 . . . . 0.0 109.529 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.487 HG21 HG12 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -159.31 153.44 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.907 -1.121 . . . . 0.0 111.034 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.827 ' O ' HG22 ' A' ' 79' ' ' THR . 84.3 m-20 -115.31 154.23 29.52 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.63 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.502 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -129.48 143.76 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.058 -1.026 . . . . 0.0 110.55 -179.652 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.92 99.99 2.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -0.826 . . . . 0.0 110.118 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.511 HD13 ' CBB' ' A' ' 151' ' ' ZNH . 20.7 mt -123.24 152.55 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.612 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.89 96.54 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.399 -0.813 . . . . 0.0 109.812 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -173.5 -170.67 0.62 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.945 . . . . 0.0 110.509 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.97 103.5 15.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 110.347 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 21.6 t -76.85 102.72 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 110.333 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 53.86 43.14 31.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.311 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.23 32.17 44.43 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 125' ' ' VAL . 5.2 mtmt -145.5 102.3 4.31 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.228 -1.16 . . . . 0.0 110.116 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -46.68 120.73 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.702 1.369 . . . . 0.0 110.517 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.82 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 35.8 t80 -124.95 148.51 48.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 0.0 110.058 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -134.69 106.35 6.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.271 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.504 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 4.7 t80 -110.62 131.48 55.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 110.098 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.29 88.04 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.895 . . . . 0.0 110.069 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.34 -168.33 2.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.268 -0.895 . . . . 0.0 110.288 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -117.65 141.67 48.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.974 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.459 ' CD1' HAD1 ' A' ' 151' ' ' ZNH . 30.6 m-85 -155.51 -179.26 7.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 110.195 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.449 ' HA ' HG22 ' A' ' 117' ' ' ILE . 0.6 OUTLIER -151.18 176.38 11.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -0.951 . . . . 0.0 110.378 179.902 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.487 HG12 HG21 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -155.7 179.59 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 110.085 -179.761 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.806 ' O ' HG13 ' A' ' 38' ' ' VAL . 15.5 m -91.06 161.5 15.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.817 . . . . 0.0 111.086 -179.171 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.757 ' CE1' HD11 ' A' ' 83' ' ' ILE . 23.1 m-85 -147.82 98.81 3.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.575 -0.703 . . . . 0.0 109.3 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 10.9 tttt -116.86 110.19 18.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.244 -0.91 . . . . 0.0 110.955 -179.259 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -92.56 152.73 19.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.403 -0.811 . . . . 0.0 110.089 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 35' ' ' ASN . 3.4 m-80 -128.98 104.64 7.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.922 . . . . 0.0 110.214 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -153.26 -144.52 3.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.458 ' HD2' HD11 ' A' ' 109' ' ' LEU . 10.1 Cg_endo -59.03 -173.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.608 1.32 . . . . 0.0 110.644 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 -42.41 0.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 110.414 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.402 ' O ' ' HB ' ' A' ' 148' ' ' VAL . 7.4 p-10 -160.77 -40.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 110.212 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 148' ' ' VAL . 29.5 t 56.25 43.59 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.836 . . . . 0.0 110.198 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.77 128.72 34.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.869 . . . . 0.0 110.15 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.993 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.82 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.27 0.557 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -144.61 54.15 1.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.002 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.5 m120 61.08 24.87 14.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 109.862 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.92 -179.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -0.845 . . . . 0.0 110.036 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.67 -69.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 0.0 110.356 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER 56.18 23.37 6.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.374 -0.829 . . . . 0.0 110.209 -179.854 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 p -159.74 129.85 5.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.408 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.52 177.8 48.33 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.45 105.54 17.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.205 -1.173 . . . . 0.0 110.221 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.762 HD13 HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -93.79 151.37 19.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.378 -0.826 . . . . 0.0 110.154 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.451 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 23.0 m120 -79.06 145.55 33.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.921 . . . . 0.0 110.14 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -163.92 156.01 17.07 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.189 -0.945 . . . . 0.0 110.177 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -155.44 -176.76 6.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 110.043 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.449 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -140.16 174.41 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.159 -0.963 . . . . 0.0 110.267 179.991 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.449 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 47.3 m-85 -147.96 160.19 43.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.416 -0.802 . . . . 0.0 110.153 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.81 121.33 15.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.859 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.532 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -48.75 148.97 1.91 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 -179.72 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 8.5 t30 72.47 1.43 3.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.968 -0.458 . . . . 0.0 111.085 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -136.05 -155.98 0.67 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.789 -1.195 . . . . 0.0 109.902 179.297 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -136.13 10.77 3.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.335 -0.853 . . . . 0.0 110.491 179.609 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -134.28 148.95 50.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.015 . . . . 0.0 110.845 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.438 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -79.83 138.44 37.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.319 179.547 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.97 -17.91 3.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.961 -1.087 . . . . 0.0 111.899 -179.041 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.5 mt -137.96 -71.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.764 -1.21 . . . . 0.0 110.709 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.519 ' HB1' ' HE2' ' A' ' 53' ' ' PHE . . . -46.11 -26.53 0.77 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.691 -0.631 . . . . 0.0 111.023 -179.426 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.414 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -59.7 -19.65 51.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.128 -0.983 . . . . 0.0 110.715 -179.595 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -102.32 14.82 30.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.97 -1.081 . . . . 0.0 110.868 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -128.79 6.15 5.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.984 -1.073 . . . . 0.0 111.075 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.519 ' HE2' ' HB1' ' A' ' 49' ' ' ALA . 33.8 m-85 -129.76 117.01 19.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 110.34 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -72.77 166.82 22.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.97 . . . . 0.0 110.301 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -148.18 159.57 39.32 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 110.011 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -82.48 -175.64 15.35 Favored 'Cis proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.648 -2.23 . . . . 0.0 110.394 -0.411 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.97 170.23 8.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 110.002 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.3 tmtm? -103.03 108.38 19.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 110.525 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.492 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 6.3 p90 -97.97 162.25 13.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 109.75 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -154.8 155.22 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.15 -0.969 . . . . 0.0 110.373 -179.665 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.7 mtpt -135.94 168.89 18.49 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.339 -0.851 . . . . 0.0 110.606 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.441 ' CB ' ' HG3' ' A' ' 65' ' ' LYS . 10.4 mttm -148.0 61.97 1.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 0.0 109.834 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.409 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 10.5 t-20 45.69 78.07 0.07 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.47 -0.769 . . . . 0.0 110.925 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.09 19.42 16.89 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HG3' ' CB ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -168.07 162.83 13.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.146 -1.208 . . . . 0.0 110.38 179.546 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.596 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.3 pt? -173.42 150.18 1.8 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.2 1.0 . . . . 0.0 111.74 178.706 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.592 ' C ' HG12 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -139.94 -164.83 1.77 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.023 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.592 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -170.17 144.01 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.0 110.692 179.356 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.419 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 9.2 pt20 -99.75 132.87 44.82 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.924 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -110.57 133.1 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.852 . . . . 0.0 109.8 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.532 ' O ' HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -89.27 123.08 33.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.145 -0.972 . . . . 0.0 110.26 -179.542 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.581 ' HB ' HG21 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -104.29 147.09 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.357 -0.839 . . . . 0.0 109.857 179.999 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -99.49 141.91 31.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 0.0 110.49 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 77' ' ' TRP . 9.6 m-70 53.62 92.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 m -52.35 -31.28 32.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 110.232 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -71.11 -45.53 63.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.219 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.466 ' CG ' ' HB3' ' A' ' 74' ' ' HIS . 45.6 m0 -55.64 -62.77 1.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.318 -0.864 . . . . 0.0 110.303 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.658 HD11 ' SD ' ' A' ' 81' ' ' MET . 0.5 OUTLIER -88.37 120.26 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.448 -0.783 . . . . 0.0 109.915 -179.727 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.675 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -89.16 -27.21 20.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.347 -0.846 . . . . 0.0 111.073 -179.217 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.57 172.02 43.78 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.258 -1.449 . . . . 0.0 110.535 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.658 ' SD ' HD11 ' A' ' 78' ' ' ILE . 1.8 mtp -153.05 110.95 3.6 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.522 -0.987 . . . . 0.0 109.859 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.419 ' O ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -86.56 123.04 31.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.975 -1.078 . . . . 0.0 110.031 179.947 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.7 HD12 ' CG ' ' A' ' 104' ' ' PHE . 1.7 mt -113.1 131.07 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 110.259 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 2.3 tm-20 69.62 5.51 5.23 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.493 -0.755 . . . . 0.0 110.99 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.25 23.89 10.86 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.728 -1.225 . . . . 0.0 111.0 178.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.47 ' C ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.39 162.37 34.6 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.673 -1.486 . . . . 0.0 110.149 179.359 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -175.68 1.18 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.96 . . . . 0.0 110.199 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.482 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 5.1 pt-20 -110.17 167.03 10.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 110.341 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 102' ' ' SER . 3.5 t-20 -114.09 130.7 56.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.361 -0.837 . . . . 0.0 109.918 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.401 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 1.1 pp -67.69 100.89 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 0.0 109.674 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.667 HG21 HG22 ' A' ' 101' ' ' THR . 2.4 tt -95.36 -23.3 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 110.566 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -167.06 100.18 0.53 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -94.54 142.5 27.37 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.914 -179.47 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.423 ' HB3' ' HB2' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -142.59 74.12 1.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 110.33 -179.747 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.0 p -65.07 -31.16 72.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.062 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.65 -50.07 72.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.852 . . . . 0.0 110.226 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -95.43 13.62 25.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.259 -0.9 . . . . 0.0 110.426 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.65 60.56 3.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 110.276 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 94' ' ' ASN . 23.4 mt-10 -147.54 150.41 34.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 0.0 110.418 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.405 ' O ' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -152.47 157.08 40.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.353 -0.842 . . . . 0.0 109.951 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.667 HG22 HG21 ' A' ' 91' ' ' ILE . 60.4 m -141.09 154.8 46.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.306 -0.871 . . . . 0.0 109.75 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 1.8 p -145.57 139.75 26.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.007 -1.058 . . . . 0.0 111.044 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 57.2 tt0 -93.06 138.65 31.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.46 -0.775 . . . . 0.0 109.429 179.399 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.7 ' CG ' HD12 ' A' ' 83' ' ' ILE . 93.5 m-85 -128.5 145.72 51.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.883 -1.136 . . . . 0.0 111.34 -179.234 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.519 ' C ' HG13 ' A' ' 106' ' ' VAL . 57.5 tt0 -105.72 130.41 53.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.42 -0.8 . . . . 0.0 109.048 178.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.596 ' O ' HD21 ' A' ' 66' ' ' LEU . 34.1 m -150.31 170.34 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.918 -1.113 . . . . 0.0 111.36 -178.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.3 m -74.59 111.02 9.36 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.509 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.523 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 45.7 -163.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.591 -0.693 . . . . 0.0 109.673 -178.355 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.762 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.03 56.88 0.9 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.911 -1.118 . . . . 0.0 110.871 -179.549 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -145.58 70.2 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 0.0 110.001 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.89 176.57 38.0 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.458 ' HE3' ' N ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -81.78 142.91 32.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -1.115 . . . . 0.0 110.34 -179.972 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.664 HD12 ' CD2' ' A' ' 142' ' ' PHE . 53.0 mt -137.34 153.52 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 110.041 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.38 128.3 34.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.231 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.452 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -138.62 123.25 2.56 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 10.5 mttm -96.76 163.74 12.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -1.175 . . . . 0.0 109.703 179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.431 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -159.22 133.18 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.879 -1.138 . . . . 0.0 111.171 179.895 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.675 ' C ' HG22 ' A' ' 79' ' ' THR . 93.6 m-20 -108.35 165.61 11.38 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -141.45 153.2 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.965 -1.085 . . . . 0.0 110.648 -179.644 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.421 ' CE1' ' OD2' ' A' ' 122' ' ' ASP . 6.4 t80 -151.82 109.63 3.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -0.806 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 46.2 mt -134.71 152.92 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.961 . . . . 0.0 110.349 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.421 ' OD2' ' CE1' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -160.48 98.07 1.24 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.389 -0.819 . . . . 0.0 109.622 179.602 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -173.2 -168.52 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 110.398 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 10.5 mttp -103.58 97.46 7.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 110.474 -179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.8 125.0 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.253 -0.905 . . . . 0.0 110.222 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 52.9 25.29 3.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.293 -0.879 . . . . 0.0 110.198 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 85.94 33.82 14.44 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 38.5 mtmt -144.61 134.43 11.66 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.313 -1.11 . . . . 0.0 110.0 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.47 127.85 25.21 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.631 1.332 . . . . 0.0 110.474 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.632 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 16.6 t80 -131.07 113.18 13.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.357 -0.84 . . . . 0.0 110.123 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.25 104.45 14.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.187 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.461 ' HB3' ' HB ' ' A' ' 121' ' ' ILE . 3.1 t80 -114.93 124.27 51.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.905 . . . . 0.0 109.943 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 48.2 p-10 -171.03 86.47 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.328 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -153.3 -168.95 3.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.905 . . . . 0.0 110.189 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.4 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.3 OUTLIER -119.8 148.61 43.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.336 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.495 ' CD1' HBD2 ' A' ' 151' ' ' ZNH . 12.4 m-85 -155.67 -178.56 7.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 0.0 110.245 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.442 ' O ' HG23 ' A' ' 138' ' ' ILE . 12.3 p30 -150.04 171.45 16.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.89 . . . . 0.0 110.275 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -156.46 166.21 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 0.0 110.413 -179.739 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.403 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 59.8 m -91.77 120.45 32.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 0.0 110.437 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.452 ' CD1' ' HA3' ' A' ' 115' ' ' GLY . 11.6 m-85 -90.38 161.82 15.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.59 102.7 2.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.908 . . . . 0.0 110.388 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.664 ' CD2' HD12 ' A' ' 113' ' ' ILE . 90.0 m-85 -91.72 154.91 18.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.922 . . . . 0.0 110.155 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 35' ' ' ASN . 15.2 m120 -143.0 98.45 3.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.716 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -153.62 -146.81 4.47 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.43 143.73 99.62 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.776 1.408 . . . . 0.0 110.451 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.5 p -90.94 -44.81 9.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.325 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -154.35 -46.6 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.228 -0.92 . . . . 0.0 110.143 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 15.4 t 56.88 48.17 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 110.281 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.59 82.81 7.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.186 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.979 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.632 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 58.2 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.291 0.567 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 25' ' ' SER . . . 179.59 172.2 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 63.39 29.27 15.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.068 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -140.68 105.63 4.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.419 -0.801 . . . . 0.0 110.213 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.61 -39.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.235 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 9.8 m-20 57.05 29.27 16.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.887 . . . . 0.0 110.439 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -160.14 159.76 32.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.021 -1.049 . . . . 0.0 110.911 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 165.24 172.73 33.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.37 115.21 25.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.156 -1.202 . . . . 0.0 110.381 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.552 HD13 HD22 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -95.88 141.72 28.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.134 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -78.99 135.88 37.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 109.924 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.444 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -165.71 171.67 12.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 110.715 -179.948 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -155.23 -176.78 6.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.442 -0.786 . . . . 0.0 110.081 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 46' ' ' THR . 1.4 m -141.27 108.37 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 0.0 109.94 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -93.2 162.64 13.94 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 110.637 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.437 ' CG ' HG21 ' A' ' 43' ' ' THR . 12.7 tppt? -67.52 140.81 57.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.599 -0.688 . . . . 0.0 110.043 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.46 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -64.57 147.75 52.21 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.011 -1.056 . . . . 0.0 109.247 179.413 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.1 t-20 70.95 3.04 4.47 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.701 -0.625 . . . . 0.0 110.746 -179.046 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -137.36 -168.28 2.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.911 -1.118 . . . . 0.0 109.446 179.182 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.441 ' N ' ' OG1' ' A' ' 43' ' ' THR . 65.3 t30 -128.55 12.29 6.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.931 -1.106 . . . . 0.0 110.491 179.69 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -136.29 133.04 36.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.055 -1.028 . . . . 0.0 110.467 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.626 HG21 ' CB ' ' A' ' 50' ' ' ASN . 6.0 t -63.56 139.43 58.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.088 -1.007 . . . . 0.0 109.068 179.154 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.402 ' HB3' ' HE3' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -129.39 -17.53 3.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 112.015 -179.013 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.7 mt -137.94 -50.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.785 -1.197 . . . . 0.0 110.845 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -57.74 -54.72 43.69 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.567 -0.708 . . . . 0.0 111.717 -178.854 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.626 ' CB ' HG21 ' A' ' 46' ' ' THR . 4.8 t-20 -47.47 -25.04 0.96 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.141 -0.974 . . . . 0.0 110.988 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -73.32 -2.44 22.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -0.988 . . . . 0.0 111.168 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -144.78 28.78 1.26 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.823 -1.173 . . . . 0.0 110.892 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.457 ' CE2' ' HB1' ' A' ' 49' ' ' ALA . 11.3 m-85 -130.97 109.47 10.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.944 . . . . 0.0 110.244 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -72.45 150.15 43.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.328 -0.857 . . . . 0.0 110.415 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.79 168.09 12.25 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.321 -0.862 . . . . 0.0 109.924 -179.994 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.436 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 44.6 Cg_endo -76.57 -175.66 17.04 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.692 -2.211 . . . . 0.0 110.683 -0.201 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.45 168.38 9.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 110.137 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.49 119.91 39.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.17 -0.956 . . . . 0.0 110.562 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.528 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 27.4 p90 -96.93 164.25 12.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 109.676 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.615 HG23 ' HD1' ' A' ' 67' ' ' TYR . 1.0 OUTLIER -156.37 116.4 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.951 -1.093 . . . . 0.0 111.165 -179.603 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.512 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -127.6 119.48 26.05 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.359 -0.838 . . . . 0.0 110.037 179.655 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.38 62.52 1.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.571 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.41 96.18 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.46 -0.775 . . . . 0.0 111.229 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.54 10.52 43.91 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.58 160.84 11.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.963 -1.316 . . . . 0.0 109.877 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.708 HD11 ' N ' ' A' ' 108' ' ' LYS . 1.7 pt? -166.18 141.78 4.76 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.636 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.615 ' HD1' HG23 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -139.64 -178.03 5.22 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.496 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -156.11 131.92 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.986 -1.071 . . . . 0.0 110.341 179.83 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 7.8 pt20 -97.3 133.12 42.33 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.291 -0.881 . . . . 0.0 109.936 179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -114.73 131.22 67.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.179 -0.951 . . . . 0.0 109.502 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 m -87.52 116.57 25.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.131 -0.981 . . . . 0.0 110.481 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.553 ' HB ' HD13 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -104.01 143.62 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.403 -0.811 . . . . 0.0 109.996 179.883 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -101.05 156.26 17.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.161 -0.962 . . . . 0.0 110.348 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.513 ' O ' HG22 ' A' ' 78' ' ' ILE . 17.0 m170 51.49 86.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 110.324 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.426 ' HB2' ' CD ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -65.36 -30.12 70.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 0.0 110.054 179.907 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -63.78 -34.5 78.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.88 . . . . 0.0 110.319 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.552 ' CD2' HBB2 ' A' ' 151' ' ' ZNH . 27.4 m0 -77.74 -58.02 3.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.702 HD11 ' HG3' ' A' ' 81' ' ' MET . 8.8 tt -88.87 121.07 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.911 179.84 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 118' ' ' ASP . 1.0 OUTLIER -86.66 -24.83 25.13 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.248 -0.908 . . . . 0.0 110.867 -179.344 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.55 -179.19 48.75 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.308 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.702 ' HG3' HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -152.68 114.79 4.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.441 -1.035 . . . . 0.0 110.12 -179.989 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -85.78 156.34 20.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.146 -0.971 . . . . 0.0 110.406 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' A' ' 104' ' ' PHE . 1.4 mt -156.74 134.27 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.404 -0.81 . . . . 0.0 110.111 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 69.85 3.37 4.27 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.528 -0.732 . . . . 0.0 111.488 179.735 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.94 22.2 11.13 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.22 178.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.457 ' C ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.66 161.81 35.51 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.676 -1.485 . . . . 0.0 110.143 179.276 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -70.33 -169.54 0.31 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.127 -0.983 . . . . 0.0 110.475 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.23 169.71 8.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 110.259 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.05 128.66 49.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 110.236 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 90' ' ' ILE . 1.6 pp -68.33 101.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.773 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 101' ' ' THR . 1.5 tt -94.84 -28.32 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 110.441 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.8 m -166.39 98.88 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.901 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -95.31 106.38 18.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.455 -0.778 . . . . 0.0 110.017 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.1 101.87 13.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 110.227 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -78.96 -28.99 43.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 110.22 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.44 -51.04 69.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.15 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -96.2 15.75 20.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 110.41 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.66 23.23 3.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.115 -0.991 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -92.77 177.91 5.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 110.461 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.503 ' HB3' HG22 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -179.35 151.76 0.5 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.457 -0.777 . . . . 0.0 109.658 179.948 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.487 ' O ' HG22 ' A' ' 91' ' ' ILE . 86.1 m -141.46 158.03 44.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 110.257 -179.568 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.5 p -145.24 143.16 30.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -0.98 . . . . 0.0 110.452 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -93.26 143.44 26.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.29 -0.881 . . . . 0.0 110.031 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.47 ' CD2' HD12 ' A' ' 83' ' ' ILE . 30.3 m-85 -129.91 132.26 46.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.133 -0.98 . . . . 0.0 110.874 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.499 ' C ' HG13 ' A' ' 106' ' ' VAL . 16.4 mt-10 -92.31 128.92 38.34 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.308 -0.87 . . . . 0.0 109.624 179.409 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.553 ' O ' HD21 ' A' ' 66' ' ' LEU . 34.3 m -149.9 144.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.012 -1.055 . . . . 0.0 111.059 -179.327 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.36 109.8 1.71 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.928 . . . . 0.0 108.944 178.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.708 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 54.16 175.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 109.24 -178.585 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.552 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -149.98 71.45 1.08 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.006 -1.059 . . . . 0.0 110.871 -179.853 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 7.2 t30 -146.14 40.33 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.387 -0.821 . . . . 0.0 110.185 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . -169.42 -170.73 34.29 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.34 145.51 30.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -1.131 . . . . 0.0 110.476 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mm -137.65 138.14 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.432 -0.793 . . . . 0.0 109.971 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -76.16 123.07 25.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.185 -0.947 . . . . 0.0 110.361 -179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.463 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -134.86 175.79 20.36 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 38.9 mttt -144.7 176.85 9.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -1.182 . . . . 0.0 109.886 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.464 HG22 ' HA ' ' A' ' 137' ' ' ASN . 0.2 OUTLIER -158.47 144.45 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.922 -1.111 . . . . 0.0 111.157 179.926 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.712 ' O ' HG22 ' A' ' 79' ' ' THR . 1.1 m-20 -108.98 156.89 19.2 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.441 -0.787 . . . . 0.0 109.041 178.522 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 77' ' ' TRP . 2.6 t -141.72 151.86 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.016 -1.053 . . . . 0.0 110.705 -179.307 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.454 ' CZ ' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -151.14 104.37 3.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.436 -0.79 . . . . 0.0 110.268 179.97 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.512 HD13 ' CBB' ' A' ' 151' ' ' ZNH . 5.0 mt -133.06 153.25 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.134 -0.979 . . . . 0.0 110.084 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.69 95.93 1.23 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 110.12 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.486 ' HG2' ' CE1' ' A' ' 130' ' ' PHE . 7.6 pt-20 -174.48 -155.77 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.445 ' HG2' ' CA ' ' A' ' 129' ' ' PRO . 9.3 mtmt -122.59 127.21 49.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.646 HG23 ' CD1' ' A' ' 130' ' ' PHE . 80.8 t -76.18 90.65 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.145 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 52.04 27.38 4.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 0.0 110.245 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 117.87 31.8 1.54 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 5.1 mtpt -145.29 90.9 5.97 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.219 -1.166 . . . . 0.0 110.066 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.445 ' CA ' ' HG2' ' A' ' 124' ' ' LYS . 27.6 Cg_exo -56.86 123.14 13.13 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.014 1.534 . . . . 0.0 110.314 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.646 ' CD1' HG23 ' A' ' 125' ' ' VAL . 14.7 p90 -147.7 132.69 18.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.221 -0.924 . . . . 0.0 110.262 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -103.94 132.54 50.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 110.027 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.491 ' CD2' HD12 ' A' ' 121' ' ' ILE . 4.1 t80 -125.63 130.96 52.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.377 -0.827 . . . . 0.0 110.003 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.454 ' OD2' ' CZ ' ' A' ' 120' ' ' TYR . 62.5 t0 -169.43 84.62 0.13 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -0.931 . . . . 0.0 110.008 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.72 -177.03 6.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.384 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.455 ' CD2' ' O ' ' A' ' 135' ' ' HIS . 28.4 p-80 -120.49 89.52 3.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 110.294 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -84.76 -179.41 7.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 109.813 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 10.3 p30 -151.21 168.24 25.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.037 -1.039 . . . . 0.0 110.876 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -156.66 178.88 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -0.81 . . . . 0.0 110.845 -179.707 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 140' ' ' TYR . 94.8 m -91.53 162.7 14.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.538 -0.727 . . . . 0.0 110.586 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.463 ' CE2' ' HA3' ' A' ' 115' ' ' GLY . 96.4 m-85 -145.4 105.25 4.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.373 -0.829 . . . . 0.0 109.717 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.4 OUTLIER -103.98 109.13 20.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 110.797 -179.484 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 110' ' ' ASN . 74.2 m-85 -91.79 145.84 24.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.603 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -133.81 109.17 8.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.035 -1.04 . . . . 0.0 110.63 -179.446 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.412 ' HA3' ' HD2' ' A' ' 145' ' ' PRO . . . -153.71 -135.47 2.13 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.49 ' C ' HG23 ' A' ' 146' ' ' THR . 6.1 Cg_endo -54.72 -173.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.399 1.21 . . . . 0.0 110.025 179.743 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.49 HG23 ' C ' ' A' ' 145' ' ' PRO . 62.9 p -150.18 -58.06 0.18 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 110.514 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -121.44 -65.29 1.15 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 110.417 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 148' ' ' VAL . 44.7 t 55.59 46.42 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 110.222 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.71 118.49 22.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.923 . . . . 0.0 110.295 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.951 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.552 HBB2 ' CD2' ' A' ' 77' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.301 0.572 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -150.5 80.67 1.35 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 110.276 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 62.2 28.8 17.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.961 . . . . 0.0 109.866 -179.843 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.9 -179.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.412 -0.805 . . . . 0.0 110.325 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.73 -68.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 110.199 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 6.7 m-20 54.58 27.41 8.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.093 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.72 153.86 23.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 110.325 -179.668 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.32 179.5 42.46 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.03 109.41 20.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.176 -1.19 . . . . 0.0 110.404 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.935 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.2 OUTLIER -94.36 151.69 19.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.397 -0.815 . . . . 0.0 109.955 179.926 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.497 ' H ' HD13 ' A' ' 34' ' ' LEU . 4.9 m120 -79.4 136.6 37.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.152 -0.967 . . . . 0.0 109.509 179.626 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.554 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -164.98 159.1 17.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.092 -1.005 . . . . 0.0 110.366 -179.852 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.37 -179.83 8.47 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.417 -0.802 . . . . 0.0 109.653 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.778 ' O ' HG22 ' A' ' 46' ' ' THR . 3.3 m -139.74 117.48 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.128 -0.982 . . . . 0.0 110.118 179.642 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -90.6 161.41 15.44 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.35 -0.843 . . . . 0.0 110.668 -179.629 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.533 ' HZ2' HG22 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.05 135.42 52.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.605 -0.684 . . . . 0.0 110.243 -179.75 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.473 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -61.56 144.76 53.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 110.082 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.4 t-20 70.7 3.21 4.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.789 -0.57 . . . . 0.0 110.728 -179.204 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -139.0 -169.72 2.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.033 -1.042 . . . . 0.0 109.638 179.48 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.404 ' N ' ' OG1' ' A' ' 43' ' ' THR . 1.6 m120 -136.08 24.59 3.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.112 -0.992 . . . . 0.0 110.295 179.677 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -136.13 120.65 18.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 111.146 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.778 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -49.64 121.61 5.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.532 -0.73 . . . . 0.0 109.359 178.961 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.73 -18.83 3.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.833 -1.167 . . . . 0.0 112.293 -178.892 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.0 mt -138.99 -78.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.59 -1.319 . . . . 0.0 111.214 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.3 -26.65 0.54 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.634 -0.666 . . . . 0.0 111.508 -179.058 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.436 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -63.98 -16.33 61.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.029 -1.044 . . . . 0.0 110.765 -179.582 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -102.58 15.44 29.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.082 -1.011 . . . . 0.0 110.853 -179.65 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.457 ' CD1' HMC3 ' A' ' 151' ' ' ZNH . 91.3 m-85 -130.38 12.14 5.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.072 -1.017 . . . . 0.0 111.014 -179.675 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.427 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 23.8 m-85 -131.28 116.9 18.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.026 -1.046 . . . . 0.0 110.314 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.404 ' HB3' HG21 ' A' ' 71' ' ' THR . 12.9 t-20 -72.4 108.47 5.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.258 -0.901 . . . . 0.0 110.323 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.419 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -93.88 159.65 34.08 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 109.943 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 56.0 Cg_endo -78.76 -175.78 17.38 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.753 -2.186 . . . . 0.0 110.65 -0.261 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.554 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -102.1 171.56 7.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 109.984 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.418 ' HB2' ' HG3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -105.55 112.14 25.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.074 -1.016 . . . . 0.0 110.684 -179.706 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.757 ' CE1' HD23 ' A' ' 34' ' ' LEU . 11.1 p90 -96.95 167.1 11.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.217 -0.927 . . . . 0.0 109.965 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.513 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -156.39 120.96 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.172 -0.955 . . . . 0.0 110.981 179.941 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.1 mtmp? -137.77 127.36 25.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.282 -0.886 . . . . 0.0 110.078 179.614 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -108.59 62.33 0.61 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 110.425 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.68 103.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.434 -0.791 . . . . 0.0 111.343 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.28 -20.3 50.81 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.003 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.39 154.96 48.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.026 -1.279 . . . . 0.0 110.661 -179.677 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.802 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -157.02 142.99 17.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 111.195 179.446 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.532 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 4.0 m-85 -139.36 -172.85 3.45 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -163.39 130.06 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.95 -1.093 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.418 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 3.7 pt20 -98.59 136.28 38.91 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.589 179.293 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -114.76 132.61 63.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.15 -0.969 . . . . 0.0 110.172 -179.452 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.565 ' O ' HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.12 120.48 31.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.699 179.955 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.417 ' H ' HG13 ' A' ' 72' ' ' VAL . 0.8 OUTLIER -103.28 136.89 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 110.042 -179.72 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -99.92 147.15 25.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 110.335 -179.668 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 21.9 m80 58.1 92.12 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.433 -0.792 . . . . 0.0 110.231 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.77 -40.1 87.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 110.284 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.9 m170 -62.52 -27.7 69.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 110.266 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.661 ' O ' HG12 ' A' ' 119' ' ' VAL . 38.9 m0 -72.24 -73.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.998 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 78' ' ' ILE . 6.9 tt -88.06 116.47 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.378 -0.826 . . . . 0.0 109.316 179.552 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.769 HG22 ' C ' ' A' ' 118' ' ' ASP . 1.6 t -86.56 -21.4 26.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.284 -0.885 . . . . 0.0 111.615 -178.573 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 117' ' ' ILE . . . -173.52 168.74 41.74 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.307 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.474 ' HG3' HD11 ' A' ' 78' ' ' ILE . 1.8 mtm -153.17 105.21 2.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.375 -1.074 . . . . 0.0 109.993 179.717 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' LYS . 3.7 t -86.65 157.15 19.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 0.0 110.111 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.528 HG22 ' CE1' ' A' ' 86' ' ' HIS . 0.3 OUTLIER -153.88 151.75 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.132 179.805 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.521 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 1.3 mm-40 57.73 17.69 4.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.049 -1.032 . . . . 0.0 110.717 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.15 16.95 63.76 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.45 179.45 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.528 ' CE1' HG22 ' A' ' 83' ' ' ILE . 3.0 p80 -137.59 159.69 41.26 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.8 -1.412 . . . . 0.0 110.829 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -71.7 169.99 14.45 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.544 -0.723 . . . . 0.0 110.802 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -89.28 168.12 12.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.344 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 102' ' ' SER . 12.8 m120 -111.48 127.2 55.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.288 -0.882 . . . . 0.0 110.248 -179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pp -67.99 104.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.144 -0.973 . . . . 0.0 109.623 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 101' ' ' THR . 1.4 tt -95.89 -30.09 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 111.235 -179.15 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.7 p -166.86 101.75 0.56 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.936 -1.103 . . . . 0.0 110.49 -179.593 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.406 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 10.0 ttmt -96.69 146.75 24.59 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.422 -0.799 . . . . 0.0 109.972 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.55 110.12 5.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.153 -0.967 . . . . 0.0 110.31 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.0 m -81.49 -40.49 23.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.861 . . . . 0.0 110.411 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.72 -33.41 75.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.216 -0.928 . . . . 0.0 110.284 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 0.3 OUTLIER -96.05 -10.68 27.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 110.541 179.926 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 97' ' ' LYS . 1.2 t0 62.31 53.99 2.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.041 -1.037 . . . . 0.0 110.046 -179.883 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -146.98 179.42 7.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 110.429 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.406 ' HG3' ' CG ' ' A' ' 93' ' ' LYS . 9.8 ttm180 -172.04 159.92 5.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.978 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.521 ' O ' HG22 ' A' ' 91' ' ' ILE . 91.2 m -141.52 153.31 44.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 109.728 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 24.7 p -145.03 140.58 28.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.012 -1.055 . . . . 0.0 110.704 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -93.4 148.14 22.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 109.99 179.672 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.402 ' CD1' ' HB ' ' A' ' 83' ' ' ILE . 97.0 m-85 -128.8 150.38 50.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.141 -0.974 . . . . 0.0 110.721 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.403 ' OE2' ' N ' ' A' ' 106' ' ' VAL . 7.1 tp10 -110.99 123.88 51.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.381 -0.825 . . . . 0.0 109.792 179.626 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.676 ' O ' HD11 ' A' ' 66' ' ' LEU . 9.5 p -149.36 165.54 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.433 ' N ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -56.74 -41.27 77.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.133 -0.98 . . . . 0.0 109.795 179.604 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.457 ' CE ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -164.05 -146.23 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.353 179.403 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.866 HD22 ' HG ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -151.81 56.35 0.85 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.809 -1.182 . . . . 0.0 110.647 -179.403 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 145' ' ' PRO . 10.5 t-20 -146.59 93.74 2.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -0.87 . . . . 0.0 110.232 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 148.51 -119.68 1.1 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.0 OUTLIER -156.72 112.68 2.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -1.139 . . . . 0.0 110.264 -179.688 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mm -102.73 139.93 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.231 -0.918 . . . . 0.0 110.023 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.21 123.36 25.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.035 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -132.57 179.73 17.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 28.6 mtmm -144.29 166.29 25.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -1.131 . . . . 0.0 109.707 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.442 ' HB ' ' CG ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -158.73 144.06 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.933 -1.105 . . . . 0.0 110.721 179.991 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.769 ' C ' HG22 ' A' ' 79' ' ' THR . 5.8 m-20 -107.25 159.53 16.28 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.456 -0.778 . . . . 0.0 108.941 178.77 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -141.5 148.49 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.024 -1.047 . . . . 0.0 110.658 -179.464 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -152.09 104.02 2.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.381 -0.824 . . . . 0.0 110.045 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.452 HD13 ' CBB' ' A' ' 151' ' ' ZNH . 44.4 mt -128.96 152.54 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 110.117 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -159.94 97.33 1.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 0.0 109.735 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -173.55 -169.11 0.48 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 110.304 -179.624 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 3.6 mmtm -112.01 102.61 10.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.87 . . . . 0.0 110.184 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.554 ' O ' HG12 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -76.69 118.22 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -0.877 . . . . 0.0 110.235 -179.903 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.94 26.77 6.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.365 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.65 5.52 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -145.38 107.35 4.44 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.202 -1.175 . . . . 0.0 110.139 179.809 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -51.13 109.8 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.694 1.365 . . . . 0.0 110.368 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.739 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 11.3 t80 -110.02 146.25 35.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.175 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -133.62 99.18 4.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.284 -0.885 . . . . 0.0 110.214 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.447 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 2.5 t80 -115.12 129.1 56.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.125 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.62 81.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.953 . . . . 0.0 110.256 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -153.13 -165.28 2.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.16 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.42 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -118.3 143.43 46.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.109 -0.994 . . . . 0.0 110.29 179.866 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.42 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 32.2 m-85 -155.25 -179.47 8.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.381 -0.824 . . . . 0.0 109.826 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.512 ' O ' HG23 ' A' ' 138' ' ' ILE . 20.6 p30 -151.27 178.64 9.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 110.345 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.533 HG22 ' HZ2' ' A' ' 40' ' ' LYS . 0.5 OUTLIER -156.98 167.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 110.764 -179.73 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.462 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 94.1 m -91.75 121.25 33.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.46 -0.775 . . . . 0.0 110.37 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.493 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 43.2 m-85 -90.59 95.72 10.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.071 -1.018 . . . . 0.0 110.235 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.1 OUTLIER -91.92 104.26 16.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.458 -179.853 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' A' ' 140' ' ' TYR . 67.9 m-85 -92.93 158.75 15.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.325 -0.859 . . . . 0.0 110.295 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.451 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 10.3 m120 -139.72 97.36 3.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.105 -0.997 . . . . 0.0 110.651 -179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.935 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -161.91 -152.66 6.78 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.43 ' O ' ' CB ' ' A' ' 110' ' ' ASN . 18.8 Cg_endo -64.92 -161.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.893 1.47 . . . . 0.0 110.241 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.7 p -148.44 -47.91 0.15 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.121 -0.987 . . . . 0.0 110.069 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.41 -49.59 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.315 -0.866 . . . . 0.0 110.016 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 148' ' ' VAL . 21.2 t 56.21 38.73 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.393 -0.817 . . . . 0.0 110.296 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.34 44.81 0.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.227 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.98 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.739 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.283 0.563 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.28 100.28 0.35 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.897 . . . . 0.0 110.122 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.93 22.7 13.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.288 -0.882 . . . . 0.0 110.009 -179.854 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -162.61 109.67 1.27 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 110.267 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.94 -49.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.362 -0.836 . . . . 0.0 110.124 -179.915 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 13.3 m-20 56.76 33.54 23.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 110.36 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 59' ' ' TYR . 16.2 t -160.46 153.24 21.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.983 -1.073 . . . . 0.0 110.853 -179.5 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' CD2' ' A' ' 59' ' ' TYR . . . 171.18 176.76 40.55 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -91.76 109.5 20.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -1.158 . . . . 0.0 110.601 179.99 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.823 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -95.78 156.77 16.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.97 -1.081 . . . . 0.0 110.442 179.663 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.454 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 33.8 m-20 -79.92 139.83 36.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 110.246 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.647 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -165.84 160.66 17.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.945 . . . . 0.0 110.015 179.734 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -155.59 -175.8 5.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 0.0 110.447 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.689 HG12 ' O ' ' A' ' 139' ' ' THR . 0.0 OUTLIER -140.89 166.76 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.324 -0.86 . . . . 0.0 109.834 179.728 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.464 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 51.1 m-85 -147.56 161.55 40.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.084 -1.01 . . . . 0.0 110.545 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.556 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.1 OUTLIER -68.34 135.12 51.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.371 -0.831 . . . . 0.0 109.896 179.96 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.527 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -60.71 146.8 44.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.201 -179.82 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER 70.55 4.63 5.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.789 -0.569 . . . . 0.0 110.892 -179.453 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.556 HG21 ' HG2' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -135.18 -163.86 1.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.868 -1.145 . . . . 0.0 109.764 179.377 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.414 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.2 OUTLIER -130.34 11.73 5.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.461 179.637 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -135.27 148.89 49.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.025 -1.047 . . . . 0.0 110.592 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.568 HG21 ' HB2' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -78.32 137.27 37.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.504 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.54 -17.54 3.68 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.037 -179.075 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 60.5 mt -137.57 -69.73 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.708 -1.245 . . . . 0.0 110.868 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.447 ' O ' ' CD2' ' A' ' 53' ' ' PHE . . . -45.48 -26.5 0.58 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.627 -0.671 . . . . 0.0 111.241 -179.347 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.568 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -68.08 -9.13 43.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.076 -1.015 . . . . 0.0 110.823 -179.773 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.479 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 1.6 m-20 -99.26 14.8 28.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.029 -1.045 . . . . 0.0 110.852 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.479 ' CE2' ' HB2' ' A' ' 51' ' ' ASP . 36.6 m-85 -142.27 11.61 1.95 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.945 -1.097 . . . . 0.0 110.824 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 25.9 m-85 -132.62 107.46 8.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.06 -1.025 . . . . 0.0 110.584 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -72.72 167.91 19.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.14 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.418 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.42 164.73 22.91 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.955 . . . . 0.0 109.973 179.798 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 55.6 Cg_endo -78.23 -175.32 16.48 Favored 'Cis proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.565 -2.265 . . . . 0.0 110.588 -0.153 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.647 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -100.24 170.16 8.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 109.693 179.805 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.472 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -101.37 119.69 39.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 110.586 -179.644 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.52 ' CD1' ' HD2' ' A' ' 61' ' ' LYS . 13.7 p90 -97.81 162.97 13.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.118 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 1.9 tt -157.07 109.81 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.315 -0.866 . . . . 0.0 110.541 179.633 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.52 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -128.59 137.86 51.91 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.167 -0.958 . . . . 0.0 110.347 179.89 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.76 62.25 0.99 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 110.13 179.457 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 45.97 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.493 -0.754 . . . . 0.0 111.28 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.44 -8.42 58.6 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.458 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.19 158.54 44.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.916 -1.344 . . . . 0.0 110.428 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.769 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.2 pt? -169.49 148.54 3.79 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.156 -0.965 . . . . 0.0 111.233 179.191 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.787 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -140.73 -163.26 1.5 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.63 -0.669 . . . . 0.0 109.639 -179.638 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 67' ' ' TYR . 1.4 t -168.3 124.82 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 110.047 179.62 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.472 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -97.3 130.97 44.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.212 -0.93 . . . . 0.0 109.789 179.758 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.467 HG22 ' OG ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -111.48 141.54 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.83 . . . . 0.0 110.205 -179.344 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.5 m -89.69 123.52 33.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.794 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.892 HG12 HG21 ' A' ' 78' ' ' ILE . 1.4 t -102.3 131.8 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 110.358 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.47 143.85 30.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 110.382 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.576 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER 55.97 97.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.299 -0.875 . . . . 0.0 110.388 179.893 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -69.53 -18.03 63.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -0.932 . . . . 0.0 110.338 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.97 -47.37 18.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.255 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.53 ' O ' HG12 ' A' ' 119' ' ' VAL . 46.5 m0 -61.44 -59.33 5.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 110.569 -179.882 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.892 HG21 HG12 ' A' ' 72' ' ' VAL . 5.7 tt -88.67 122.69 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.09 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.596 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.99 -26.74 23.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.359 -0.838 . . . . 0.0 110.832 -179.368 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.9 180.0 47.58 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.625 -1.274 . . . . 0.0 109.921 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.593 ' HG3' HD11 ' A' ' 78' ' ' ILE . 25.8 mtm -151.6 163.31 39.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.338 -1.096 . . . . 0.0 110.118 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 116' ' ' LYS . 23.1 t -155.4 137.47 14.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.365 -0.834 . . . . 0.0 110.02 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 1.6 mt -136.23 141.28 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.263 -0.898 . . . . 0.0 110.362 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 72.67 -0.25 3.4 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.755 -0.591 . . . . 0.0 111.399 179.972 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.12 22.39 8.8 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.589 -1.291 . . . . 0.0 111.288 178.8 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.47 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.42 159.52 41.85 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.628 -1.513 . . . . 0.0 110.215 179.353 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -173.53 0.92 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.142 -0.974 . . . . 0.0 110.448 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 1.2 pt-20 -108.76 170.13 8.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.0 110.267 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 102' ' ' SER . 10.4 m120 -120.6 125.41 47.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.933 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -67.52 102.55 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.962 -1.086 . . . . 0.0 109.749 179.967 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.428 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.2 tt -94.87 -28.11 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 0.0 110.553 -179.354 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 23.7 m -166.48 96.1 0.56 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.411 -0.805 . . . . 0.0 109.829 -179.742 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -95.99 109.99 22.29 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 110.292 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.04 83.86 3.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 110.281 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.8 p -65.32 -30.99 71.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -0.929 . . . . 0.0 110.322 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.21 84.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.936 . . . . 0.0 110.09 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.81 17.49 15.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.3 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 49.59 60.39 3.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.239 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -147.33 177.98 8.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 110.242 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER 179.87 159.63 0.79 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.899 . . . . 0.0 110.072 -179.845 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.428 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 95.7 m -137.19 154.84 50.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.962 . . . . 0.0 109.808 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.467 ' OG ' HG22 ' A' ' 70' ' ' ILE . 3.7 p -145.11 139.45 27.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 110.712 -179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.5 tt0 -93.57 144.36 25.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 110.13 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 93.5 m-85 -128.94 146.7 50.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.19 -0.944 . . . . 0.0 110.534 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -101.88 129.84 48.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.364 -0.835 . . . . 0.0 109.607 179.439 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.769 ' O ' HD21 ' A' ' 66' ' ' LEU . 9.0 p -149.49 139.41 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.094 -1.004 . . . . 0.0 111.022 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.9 t -63.96 102.25 0.46 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.143 -0.973 . . . . 0.0 108.5 178.527 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.573 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 56.58 171.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 108.833 -177.968 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.429 ' H ' HD12 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -147.94 76.96 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.952 -1.093 . . . . 0.0 110.853 -179.427 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -146.01 64.17 1.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.447 -0.783 . . . . 0.0 109.846 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.08 -171.92 38.96 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.01 140.27 34.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.318 -1.107 . . . . 0.0 110.564 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.703 HD12 ' CD2' ' A' ' 142' ' ' PHE . 12.9 mt -136.0 150.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.321 -0.862 . . . . 0.0 109.739 179.623 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.33 127.46 32.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 -179.846 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -132.37 169.25 22.33 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -146.74 159.79 43.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -1.156 . . . . 0.0 110.096 179.981 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.401 ' O ' HD13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -157.99 143.66 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.105 -0.997 . . . . 0.0 110.591 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.596 ' C ' HG22 ' A' ' 79' ' ' THR . 13.8 m-20 -106.53 159.76 15.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.433 -0.792 . . . . 0.0 109.263 179.249 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.635 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -135.06 149.31 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.04 -1.037 . . . . 0.0 110.814 -179.582 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.412 ' HB2' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -151.72 107.63 3.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.46 -0.775 . . . . 0.0 109.859 179.715 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.474 HG12 ' HA ' ' A' ' 77' ' ' TRP . 28.6 mt -135.22 153.12 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.408 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.78 101.09 1.46 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.468 -0.77 . . . . 0.0 109.455 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -173.23 -165.14 0.26 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.235 -0.916 . . . . 0.0 110.442 -179.592 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.631 ' O ' HG23 ' A' ' 125' ' ' VAL . 8.0 ttmt -95.76 165.81 12.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.647 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 124' ' ' LYS . 6.8 t -158.41 93.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 65.53 30.5 10.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.386 -0.822 . . . . 0.0 109.603 -179.11 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.61 39.42 10.74 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -147.48 106.55 3.79 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.149 -1.206 . . . . 0.0 110.371 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.62 114.71 1.3 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.69 1.363 . . . . 0.0 109.953 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.585 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 10.5 t80 -97.78 141.36 30.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 110.451 -179.482 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -134.4 99.12 4.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 109.847 179.838 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.635 ' HE2' HG11 ' A' ' 119' ' ' VAL . 1.7 t80 -112.91 124.27 52.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.064 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.409 ' OD2' ' CZ ' ' A' ' 120' ' ' TYR . 53.7 t0 -170.24 84.39 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 109.926 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -154.16 -165.02 1.99 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 110.555 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.47 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 74.2 m-70 -117.87 152.32 35.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.852 . . . . 0.0 109.692 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.47 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 66.0 m-85 -155.11 -178.97 7.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.938 . . . . 0.0 110.331 -179.761 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.547 ' O ' HG23 ' A' ' 138' ' ' ILE . 2.1 p30 -150.16 164.93 34.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 110.166 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.2 pt -156.24 172.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.337 -0.852 . . . . 0.0 110.35 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.689 ' O ' HG12 ' A' ' 38' ' ' VAL . 10.9 m -91.76 162.28 14.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.412 -0.805 . . . . 0.0 110.576 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.463 ' CE1' ' CG1' ' A' ' 38' ' ' VAL . 12.0 m-85 -145.52 108.15 4.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.388 -0.82 . . . . 0.0 110.032 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.61 109.82 21.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.37 -0.831 . . . . 0.0 110.521 -179.726 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.703 ' CD2' HD12 ' A' ' 113' ' ' ILE . 80.8 m-85 -91.22 157.02 17.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.082 179.765 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.52 ' C ' HD21 ' A' ' 34' ' ' LEU . 32.3 m120 -138.83 98.37 3.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.197 -0.939 . . . . 0.0 110.398 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.823 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -157.76 -147.24 4.75 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -71.99 152.15 56.91 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.807 1.424 . . . . 0.0 110.733 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 p -91.48 -24.31 19.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 110.076 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 108' ' ' LYS . 0.5 OUTLIER -165.24 -79.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.302 -0.874 . . . . 0.0 110.031 -179.914 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.0 t 56.89 35.94 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 110.344 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.51 -44.62 17.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.258 -0.901 . . . . 0.0 110.181 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.961 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.585 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.243 0.544 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.51 106.58 17.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 0.0 110.384 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 62.15 23.44 13.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.93 . . . . 0.0 110.02 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.84 65.58 8.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.359 -0.838 . . . . 0.0 110.089 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.39 -62.18 1.61 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.318 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 4.8 m-20 56.41 27.55 12.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.0 110.215 -179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 p -159.13 158.67 33.32 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.272 -0.892 . . . . 0.0 110.779 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 171.5 171.84 37.01 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.91 108.5 19.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -1.216 . . . . 0.0 110.355 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.699 HD13 HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -94.45 152.52 18.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.0 109.995 179.855 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.463 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -78.82 139.57 38.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.139 -0.976 . . . . 0.0 110.425 -179.953 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.684 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -165.65 159.28 16.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.193 -0.942 . . . . 0.0 110.202 179.557 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -155.36 -171.63 3.87 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.338 -0.851 . . . . 0.0 109.699 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -140.85 172.06 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 110.231 179.781 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.421 ' HA ' HG23 ' A' ' 46' ' ' THR . 60.2 m-85 -147.52 157.24 43.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 110.09 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -67.58 139.33 56.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.226 -179.864 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.46 ' O ' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -63.64 147.04 52.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.942 179.853 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 28.3 t30 70.01 4.62 4.89 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.715 -0.616 . . . . 0.0 110.732 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.82 179.67 6.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.976 -1.078 . . . . 0.0 109.776 179.376 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -115.76 12.98 16.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 110.285 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.37 143.38 46.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.109 -0.994 . . . . 0.0 110.613 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.554 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -73.72 139.73 45.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.251 179.48 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -17.8 3.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.001 -1.062 . . . . 0.0 112.189 -178.768 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.54 HG22 ' N ' ' A' ' 49' ' ' ALA . 8.0 mt -137.46 -73.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.781 -1.2 . . . . 0.0 110.787 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.54 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -45.8 -26.13 0.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.612 -0.68 . . . . 0.0 111.14 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.501 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -60.02 -16.81 34.09 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.109 -0.995 . . . . 0.0 110.695 -179.83 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -102.33 15.54 28.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.031 -1.043 . . . . 0.0 111.009 -179.406 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.482 ' CD1' HBC1 ' A' ' 151' ' ' ZNH . 63.5 m-85 -133.27 7.63 3.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.839 -1.163 . . . . 0.0 111.384 -179.564 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 15.0 p90 -115.64 114.92 25.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.961 -1.087 . . . . 0.0 110.537 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -74.7 106.14 6.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.038 -1.039 . . . . 0.0 110.459 -179.682 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HB3' ' CE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -94.3 160.38 32.03 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 110.228 179.844 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.69 -175.38 15.97 Favored 'Cis proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.548 -2.272 . . . . 0.0 110.733 -0.453 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.684 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.71 164.99 11.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 109.899 179.694 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.11 117.55 34.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.134 -0.978 . . . . 0.0 110.993 -179.536 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 31.5 p90 -98.47 165.63 11.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.319 -0.863 . . . . 0.0 109.799 179.385 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -155.41 122.47 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.988 -1.07 . . . . 0.0 111.139 -179.739 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HE2' HD21 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -140.19 131.86 27.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.258 -0.901 . . . . 0.0 110.331 179.735 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 63' ' ' ASN . 7.1 tttt -111.37 62.08 0.61 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 0.0 110.455 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 62' ' ' LYS . 4.5 m120 49.85 101.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.365 -0.834 . . . . 0.0 111.223 179.578 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.65 -18.48 55.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -140.55 160.19 40.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.248 . . . . 0.0 110.273 179.849 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.747 HD22 ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -163.54 144.77 9.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 111.274 179.852 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 3.4 m-85 -141.57 -159.32 0.95 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.263 -0.898 . . . . 0.0 109.674 -179.771 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -169.92 165.28 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 110.322 179.613 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.414 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 2.0 pt20 -140.97 133.57 28.64 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.382 -0.824 . . . . 0.0 109.894 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.67 140.33 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 110.003 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.8 m -89.09 134.04 34.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.133 -0.979 . . . . 0.0 109.748 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.529 HG12 HG21 ' A' ' 78' ' ' ILE . 2.4 t -102.2 126.55 56.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.395 -0.816 . . . . 0.0 110.407 -179.507 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -99.5 127.9 45.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.263 -0.898 . . . . 0.0 110.046 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 63.32 69.93 0.55 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 109.871 -179.705 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.78 -27.49 63.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.467 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -55.99 -39.34 71.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 0.0 110.54 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.63 ' O ' HG13 ' A' ' 119' ' ' VAL . 24.8 m0 -81.2 -52.61 7.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.379 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.602 HD11 ' SD ' ' A' ' 81' ' ' MET . 20.3 tt -88.87 123.18 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 109.658 179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -87.08 -29.79 21.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.215 -0.928 . . . . 0.0 111.266 -179.001 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.95 175.07 47.28 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 118.998 -1.573 . . . . 0.0 110.701 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.602 ' SD ' HD11 ' A' ' 78' ' ' ILE . 5.2 mtt -152.3 110.49 3.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.654 -0.909 . . . . 0.0 109.784 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 116' ' ' LYS . 1.0 OUTLIER -85.88 157.26 20.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.095 -1.003 . . . . 0.0 110.359 -179.98 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.57 ' O ' ' CE1' ' A' ' 86' ' ' HIS . 1.0 OUTLIER -151.35 149.98 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.381 -0.825 . . . . 0.0 109.758 179.578 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.513 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 0.7 OUTLIER 61.77 14.09 5.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.124 -0.985 . . . . 0.0 110.783 -179.886 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.38 19.92 57.76 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.809 179.163 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.57 ' CE1' ' O ' ' A' ' 83' ' ' ILE . 2.4 p80 -137.47 161.24 36.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.72 -1.459 . . . . 0.0 110.692 179.591 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.76 174.33 7.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.468 -0.77 . . . . 0.0 110.838 -179.521 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 8.2 pt-20 -99.06 167.4 10.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 110.474 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -118.43 134.94 54.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.31 -0.869 . . . . 0.0 110.192 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.07 100.72 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 109.445 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 101' ' ' THR . 2.5 tt -96.32 -25.72 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 110.797 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -167.73 95.07 0.43 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.965 . . . . 0.0 110.138 -179.775 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.459 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 2.4 ttmt -96.34 144.03 26.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.83 93.62 2.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.129 -0.982 . . . . 0.0 110.331 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -76.81 -15.78 59.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.864 . . . . 0.0 110.357 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.83 -28.01 69.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 110.548 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -136.34 25.56 3.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.122 -0.986 . . . . 0.0 110.502 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.87 70.82 0.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.337 179.873 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -147.71 160.51 42.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.141 -0.975 . . . . 0.0 110.003 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.459 ' HG3' ' CG ' ' A' ' 93' ' ' LYS . 1.0 OUTLIER -168.92 162.87 11.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 110.356 -179.777 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.624 ' O ' HG22 ' A' ' 91' ' ' ILE . 57.9 m -142.05 157.81 44.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.45 -0.781 . . . . 0.0 109.229 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 2.0 p -143.9 137.04 27.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.821 -1.174 . . . . 0.0 110.616 -179.761 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -93.0 136.48 33.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.426 -0.796 . . . . 0.0 109.995 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 88.6 m-85 -129.68 144.38 51.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.1 -1.0 . . . . 0.0 110.904 -179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.46 ' C ' HG13 ' A' ' 106' ' ' VAL . 26.8 tt0 -101.11 127.96 47.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.481 -0.762 . . . . 0.0 109.091 179.041 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.636 ' O ' HD21 ' A' ' 66' ' ' LEU . 19.9 m -147.98 163.02 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.914 -1.117 . . . . 0.0 111.075 -178.84 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.67 109.55 7.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.292 -0.88 . . . . 0.0 108.658 178.629 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.459 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 48.84 -159.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.341 -0.85 . . . . 0.0 109.563 -178.577 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.699 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -150.59 60.72 0.94 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.974 -1.079 . . . . 0.0 111.103 -179.489 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 1.7 t30 -146.08 82.12 1.6 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.339 -0.85 . . . . 0.0 109.799 179.482 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.57 170.82 22.09 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.861 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.43 146.14 29.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -1.056 . . . . 0.0 110.458 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.427 HD12 ' CD2' ' A' ' 142' ' ' PHE . 82.6 mt -139.35 149.9 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.942 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.48 142.66 40.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.12 -0.988 . . . . 0.0 110.525 -179.699 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -147.72 127.84 2.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 82' ' ' SER . 10.8 mttt -94.67 168.2 10.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.346 -1.09 . . . . 0.0 109.787 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.429 HD11 ' HAC' ' A' ' 151' ' ' ZNH . 0.3 OUTLIER -158.9 133.95 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.993 -1.067 . . . . 0.0 110.858 179.481 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.695 ' O ' HG22 ' A' ' 79' ' ' THR . 11.6 m-20 -107.47 163.32 13.15 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.482 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 77' ' ' TRP . 3.8 t -144.14 152.67 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.899 -1.126 . . . . 0.0 110.475 -179.268 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -151.21 113.73 4.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.427 -0.796 . . . . 0.0 110.523 179.915 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' A' ' 132' ' ' TYR . 2.7 mp -138.15 153.71 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.347 -0.845 . . . . 0.0 110.082 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.74 96.99 1.41 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.125 -0.985 . . . . 0.0 110.208 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.43 ' O ' ' CD1' ' A' ' 130' ' ' PHE . 0.4 OUTLIER -174.12 -170.69 0.56 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.395 -0.815 . . . . 0.0 110.151 -179.957 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.31 111.49 23.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.213 -0.929 . . . . 0.0 110.22 -179.875 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.759 HG23 ' CE1' ' A' ' 130' ' ' PHE . 2.7 t -77.12 107.6 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.34 179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.28 38.07 12.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.892 . . . . 0.0 110.495 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 91.72 39.02 5.66 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -144.82 90.07 6.44 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.337 -1.096 . . . . 0.0 109.998 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.03 121.48 9.37 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.97 1.51 . . . . 0.0 110.715 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.759 ' CE1' HG23 ' A' ' 125' ' ' VAL . 11.6 p90 -146.38 166.35 26.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.923 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.68 117.28 14.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 110.43 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.554 ' HB3' HD12 ' A' ' 121' ' ' ILE . 3.8 t80 -102.46 135.0 44.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.394 -0.817 . . . . 0.0 109.705 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -174.39 83.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 0.0 110.16 -179.915 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.91 -162.32 1.41 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.902 . . . . 0.0 110.622 179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -120.28 157.09 29.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.445 -0.785 . . . . 0.0 110.062 179.852 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 34.4 m-85 -155.15 -179.05 7.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.048 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -150.78 165.74 32.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 110.521 -179.884 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.462 HD11 ' HE2' ' A' ' 81' ' ' MET . 0.1 OUTLIER -156.38 159.34 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.464 -0.772 . . . . 0.0 109.815 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 19.9 m -91.61 119.9 31.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.18 -0.95 . . . . 0.0 110.655 -179.456 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.563 ' HA ' HG12 ' A' ' 38' ' ' VAL . 9.5 m-85 -90.39 165.73 13.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.322 -0.861 . . . . 0.0 109.909 179.518 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.89 103.92 1.9 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.467 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.427 ' CD2' HD12 ' A' ' 113' ' ' ILE . 96.4 m-85 -92.2 154.23 18.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.274 -0.891 . . . . 0.0 110.236 179.735 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 48.8 m-80 -141.78 96.9 3.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 110.497 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.592 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -150.86 -151.72 5.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.735 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.407 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 10.0 Cg_endo -58.96 178.13 0.29 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.733 1.386 . . . . 0.0 110.287 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.42 HG23 ' CB ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -148.61 -60.38 0.24 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.273 -0.892 . . . . 0.0 110.005 179.917 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.76 -63.12 1.36 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.095 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 148' ' ' VAL . 24.2 t 55.99 55.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 110.305 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.75 -22.57 37.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 110.255 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.997 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.482 HBC1 ' CD1' ' A' ' 52' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.326 0.584 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.46 78.96 0.73 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.937 . . . . 0.0 110.155 -179.991 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 t30 62.12 23.96 14.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.915 -179.763 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.46 90.01 4.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.377 -0.827 . . . . 0.0 110.245 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.87 -73.5 0.22 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.289 -0.882 . . . . 0.0 109.885 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 63.6 m-20 52.74 28.22 6.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 110.386 179.657 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.39 150.44 19.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.052 -1.03 . . . . 0.0 110.727 -179.374 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.37 -136.87 3.39 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -149.22 110.5 4.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.162 -1.199 . . . . 0.0 110.348 -179.944 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.003 HD23 ' HB3' ' A' ' 59' ' ' TYR . 2.3 pp -95.06 156.08 16.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.434 -0.791 . . . . 0.0 110.365 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.612 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.4 t30 -79.33 141.69 36.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.37 -0.832 . . . . 0.0 110.068 179.749 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 1.6 p90 -164.01 162.81 23.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.068 -1.02 . . . . 0.0 110.682 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.36 -165.89 2.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.528 -0.732 . . . . 0.0 109.677 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.763 ' C ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -139.92 174.58 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.15 -0.969 . . . . 0.0 110.154 179.703 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.419 ' CE2' ' HG3' ' A' ' 141' ' ' LYS . 14.0 m-85 -147.62 147.29 29.87 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.203 -0.935 . . . . 0.0 109.961 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.466 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -67.58 130.36 42.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.366 -0.834 . . . . 0.0 110.26 -179.592 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.511 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -52.45 145.75 10.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -0.887 . . . . 0.0 110.386 -179.809 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.8 t30 72.79 0.26 3.59 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.884 -0.51 . . . . 0.0 111.074 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.38 -161.99 1.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.871 -1.143 . . . . 0.0 109.749 179.298 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.423 ' N ' ' OG1' ' A' ' 43' ' ' THR . 12.0 p-10 -135.58 15.47 3.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.188 -0.945 . . . . 0.0 110.214 179.592 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -135.14 128.13 31.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 0.0 110.767 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.763 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -57.58 136.35 56.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.45 179.509 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.747 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -128.34 -17.85 4.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.064 -1.023 . . . . 0.0 111.675 -179.194 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.747 HD12 ' HB3' ' A' ' 47' ' ' SER . 1.6 mp -137.78 -71.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.777 -1.202 . . . . 0.0 110.813 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.621 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -45.4 -26.14 0.51 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.693 -0.629 . . . . 0.0 111.27 -179.366 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.455 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -62.47 -13.02 25.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.06 -1.025 . . . . 0.0 111.044 -179.73 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -98.89 13.97 30.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.99 -1.069 . . . . 0.0 110.995 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -135.44 -1.55 2.55 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.907 -1.121 . . . . 0.0 111.574 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.621 ' CE2' ' HB1' ' A' ' 49' ' ' ALA . 16.2 m-30 -111.91 101.12 9.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.961 -1.087 . . . . 0.0 110.249 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.19 113.67 10.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.314 -0.866 . . . . 0.0 110.539 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.444 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 1.0 OUTLIER -93.53 166.67 15.5 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 109.942 179.739 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 60.2 Cg_endo -82.79 -175.55 14.97 Favored 'Cis proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.784 -2.174 . . . . 0.0 110.595 -0.494 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -104.25 162.67 13.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.286 -0.884 . . . . 0.0 109.641 179.467 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HG3' HG23 ' A' ' 33' ' ' THR . 15.1 mttt -98.85 114.73 27.45 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.226 -0.922 . . . . 0.0 110.254 -179.686 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 1.003 ' HB3' HD23 ' A' ' 34' ' ' LEU . 10.7 p90 -97.68 161.64 13.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.123 -0.985 . . . . 0.0 110.609 -179.863 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.594 HG23 ' HD1' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -154.86 127.77 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.9 . . . . 0.0 110.543 -179.632 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.453 ' CD ' ' HE2' ' A' ' 108' ' ' LYS . 2.4 mtmt -137.82 119.42 14.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.183 -0.948 . . . . 0.0 110.438 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -94.74 62.12 2.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.657 -179.998 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 0.1 OUTLIER 49.16 101.54 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.404 -0.81 . . . . 0.0 111.376 179.44 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.56 -21.93 41.97 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.357 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.444 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -135.28 154.5 51.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.175 -1.191 . . . . 0.0 110.138 179.61 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.838 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -156.37 135.99 12.43 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.159 0.98 . . . . 0.0 111.308 179.878 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.594 ' HD1' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -142.17 176.39 9.01 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.417 -0.802 . . . . 0.0 109.144 179.985 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.437 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -150.01 141.58 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.931 -1.106 . . . . 0.0 110.872 179.983 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 102' ' ' SER . 6.0 pt20 -100.09 134.98 42.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.461 -0.774 . . . . 0.0 109.513 179.209 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 101' ' ' THR . 1.1 mm -110.51 131.22 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.725 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.6 m -87.75 127.67 35.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.185 -0.947 . . . . 0.0 110.023 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.643 ' HB ' HD13 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -103.33 144.4 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.833 . . . . 0.0 110.045 -179.644 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -99.36 146.78 25.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.112 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 9.4 m80 53.94 84.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.078 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.8 p -50.35 -33.42 20.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.451 -179.845 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -41.17 74.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 110.384 -179.872 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.669 ' O ' HG12 ' A' ' 119' ' ' VAL . 31.5 m0 -61.15 -63.14 1.39 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 0.0 110.444 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.838 HD11 ' HG3' ' A' ' 81' ' ' MET . 16.4 tt -88.36 118.6 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.144 -0.973 . . . . 0.0 109.765 179.843 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.66 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.85 -23.67 25.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.87 . . . . 0.0 110.964 -179.2 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.38 173.83 44.9 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.447 -1.359 . . . . 0.0 110.153 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.838 ' HG3' HD11 ' A' ' 78' ' ' ILE . 1.2 mtm -153.32 113.58 3.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.339 -1.095 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.74 169.66 13.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.625 HG22 ' CE1' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -169.24 141.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -0.867 . . . . 0.0 110.048 179.785 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.645 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 1.1 tm-20 64.52 11.91 7.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.274 -0.891 . . . . 0.0 110.69 -179.806 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.77 17.45 61.66 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.336 179.528 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.645 ' CD2' ' HB3' ' A' ' 84' ' ' GLU . 2.6 p80 -137.75 160.19 39.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.971 -1.311 . . . . 0.0 110.576 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.91 162.15 29.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.418 -0.801 . . . . 0.0 110.492 -179.674 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.504 ' CB ' ' CE1' ' A' ' 104' ' ' PHE . 12.9 pt-20 -91.2 168.08 11.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.864 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -111.63 133.94 53.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.303 -179.964 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.8 pt -68.01 142.41 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.034 -1.041 . . . . 0.0 109.402 179.463 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.445 HG21 HG22 ' A' ' 101' ' ' THR . 3.0 tt -136.24 -29.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.151 -0.968 . . . . 0.0 111.43 -179.038 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 m -165.34 94.66 0.63 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.982 -1.074 . . . . 0.0 109.743 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -96.39 142.46 28.47 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.322 -0.861 . . . . 0.0 110.062 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.405 ' OD1' ' HB3' ' A' ' 97' ' ' LYS . 7.3 t-20 -141.74 91.57 2.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 72.6 p -71.14 -23.34 62.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 110.245 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.41 54.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.093 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.405 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 3.6 tttt -97.72 13.48 30.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.904 . . . . 0.0 110.413 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.29 62.45 2.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.034 -1.042 . . . . 0.0 110.166 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -147.89 137.29 22.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 0.0 110.43 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.454 ' HG3' ' N ' ' A' ' 101' ' ' THR . 3.2 ttt180 -144.1 162.0 37.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.435 -0.791 . . . . 0.0 109.983 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.454 ' N ' ' HG3' ' A' ' 100' ' ' ARG . 94.0 m -142.14 156.69 45.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 110.371 -179.781 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 2.4 p -145.29 145.35 31.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.183 -0.948 . . . . 0.0 110.271 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -91.55 144.21 25.78 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.296 -0.878 . . . . 0.0 110.041 -179.925 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.504 ' CE1' ' CB ' ' A' ' 88' ' ' GLU . 37.2 m-85 -130.13 135.82 48.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 110.846 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.06 126.19 38.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.34 -0.85 . . . . 0.0 109.424 179.182 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.457 ' O ' HD21 ' A' ' 66' ' ' LEU . 1.2 p -149.59 158.64 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.012 -1.055 . . . . 0.0 110.872 -179.101 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.4 p -69.87 108.88 4.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.937 . . . . 0.0 108.773 178.754 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.453 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 47.87 -153.51 0.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.366 -0.834 . . . . 0.0 109.488 -178.457 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.57 HD22 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.41 61.23 0.89 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.657 -1.277 . . . . 0.0 111.251 -179.093 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -147.37 94.35 2.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.961 . . . . 0.0 110.458 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.58 -123.78 1.61 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.464 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.2 OUTLIER -156.86 150.23 24.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.299 -1.118 . . . . 0.0 109.513 -179.676 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.417 ' N ' ' HG2' ' A' ' 112' ' ' LYS . 1.5 mm -138.53 129.16 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.134 -179.715 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -76.35 131.36 39.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.206 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -142.7 -162.66 9.36 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -146.31 172.45 13.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.224 -1.162 . . . . 0.0 109.741 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.617 HG21 HD13 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.8 140.41 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.115 -0.991 . . . . 0.0 110.477 179.972 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.66 ' C ' HG22 ' A' ' 79' ' ' THR . 23.2 m-20 -106.53 158.46 16.9 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.222 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -134.88 149.91 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.119 -0.988 . . . . 0.0 110.229 -179.749 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 3.3 t80 -151.27 106.8 3.36 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.646 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.571 HD13 HBB1 ' A' ' 151' ' ' ZNH . 2.5 mp -137.43 152.67 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.43 -0.794 . . . . 0.0 109.777 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.31 106.65 1.54 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.289 -0.882 . . . . 0.0 109.723 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -172.28 -179.48 2.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 110.258 -179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -85.08 96.64 9.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 110.491 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 125' ' ' VAL . 2.5 t -76.45 106.78 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.996 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 64.15 26.2 13.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.174 -179.903 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.07 34.86 9.37 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.24 127.24 7.92 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.223 -1.163 . . . . 0.0 110.14 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -55.86 108.94 0.36 Allowed 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.504 1.265 . . . . 0.0 110.109 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.684 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 52.0 t80 -114.93 144.24 43.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.363 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -135.44 118.07 15.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 110.243 -179.948 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.495 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 5.0 t80 -115.11 127.92 55.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.123 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.83 82.56 0.38 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.869 . . . . 0.0 109.925 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -154.29 -172.72 4.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 110.534 -179.763 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.459 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 5.9 p-80 -122.53 161.75 23.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.483 -0.761 . . . . 0.0 109.918 179.698 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.459 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 47.2 m-85 -155.38 140.63 17.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.169 -0.957 . . . . 0.0 110.337 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.645 ' O ' HG23 ' A' ' 138' ' ' ILE . 38.8 p30 -88.11 156.51 19.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.232 -0.917 . . . . 0.0 110.4 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 137' ' ' ASN . 4.2 pt -157.21 143.8 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 109.891 -179.945 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.644 ' O ' HG12 ' A' ' 38' ' ' VAL . 81.4 m -91.62 128.35 37.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.197 -0.94 . . . . 0.0 110.944 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.474 ' CE2' HG13 ' A' ' 83' ' ' ILE . 51.8 m-85 -90.8 159.99 16.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.793 179.102 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.419 ' HG3' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -146.67 102.41 3.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.368 -179.965 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -93.17 152.14 19.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.279 -0.888 . . . . 0.0 110.386 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.496 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 51.3 m-80 -144.22 95.61 2.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.154 -0.966 . . . . 0.0 110.393 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.466 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -152.19 -154.77 6.76 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.793 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.415 ' HG2' ' NZ ' ' A' ' 61' ' ' LYS . 11.4 Cg_endo -61.15 178.39 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.91 1.479 . . . . 0.0 110.644 -179.729 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.7 p -149.49 -62.48 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 110.117 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 148' ' ' VAL . 34.8 m-20 -120.37 -60.81 1.65 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 110.169 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 148' ' ' VAL . 20.1 t 56.73 42.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 0.0 110.307 179.947 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.96 -47.26 12.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 0.0 110.264 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.972 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.684 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.29 0.567 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.53 88.3 2.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 110.241 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.91 32.23 17.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.267 -0.896 . . . . 0.0 109.954 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.47 118.35 19.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.851 . . . . 0.0 110.383 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 43.04 -164.78 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.667 -0.646 . . . . 0.0 111.044 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER 56.31 28.69 13.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.897 . . . . 0.0 110.281 -179.82 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 t -161.31 140.81 10.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.86 . . . . 0.0 110.401 -179.647 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.0 179.38 47.36 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.28 111.99 22.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.317 -1.108 . . . . 0.0 110.051 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.878 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.9 OUTLIER -95.4 154.3 17.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -0.905 . . . . 0.0 110.8 -179.739 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.4 m-20 -81.91 139.08 34.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.336 179.071 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.619 ' CE2' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -166.89 160.36 14.34 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.948 -1.095 . . . . 0.0 110.859 -179.924 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.57 -167.12 2.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.572 -0.705 . . . . 0.0 109.721 179.695 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.517 HG23 HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -142.16 174.04 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.116 -0.99 . . . . 0.0 110.296 179.818 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.477 ' CE2' ' HG3' ' A' ' 141' ' ' LYS . 16.7 m-85 -147.73 152.69 38.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.838 . . . . 0.0 110.052 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 124.29 23.01 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.381 -0.824 . . . . 0.0 110.009 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.533 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -49.17 147.58 2.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.77 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 3.9 m120 72.33 0.79 3.72 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.934 -0.479 . . . . 0.0 110.91 -179.092 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.77 -160.38 1.05 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.818 -1.177 . . . . 0.0 109.729 179.092 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.4 ' N ' ' OG1' ' A' ' 43' ' ' THR . 3.2 t-20 -134.37 11.64 3.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 110.248 179.471 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -135.99 139.0 42.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.102 -0.999 . . . . 0.0 110.628 -179.685 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.517 HG21 HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -63.71 133.44 53.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.206 179.264 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -128.7 -17.6 4.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.89 -1.132 . . . . 0.0 111.964 -178.769 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.2 mt -137.54 -71.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.815 -1.178 . . . . 0.0 110.76 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -50.99 -22.53 2.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.499 -0.751 . . . . 0.0 111.027 -179.584 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.442 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -55.59 -19.32 9.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.128 -0.982 . . . . 0.0 110.77 -179.793 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -94.29 15.29 17.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.015 -1.053 . . . . 0.0 110.922 -179.44 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -141.61 16.27 2.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.908 -1.12 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -123.1 106.17 10.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.141 -0.975 . . . . 0.0 110.255 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.96 152.45 41.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.899 . . . . 0.0 110.607 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.426 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -147.3 162.56 31.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 0.0 109.838 179.692 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 56.2 Cg_endo -78.02 -176.68 19.18 Favored 'Cis proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.728 -2.197 . . . . 0.0 110.475 -0.127 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.619 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . . . -105.23 166.33 10.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 110.091 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -101.49 113.78 27.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 110.088 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 8.7 p90 -96.27 163.54 13.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.924 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.4 OUTLIER -154.74 154.19 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.181 -0.95 . . . . 0.0 110.205 -179.925 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 29.7 mtpt -136.52 170.43 16.07 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.157 -0.965 . . . . 0.0 110.854 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.44 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 9.4 mttt -155.06 62.91 0.64 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.439 -0.788 . . . . 0.0 110.032 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t30 48.61 86.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.397 -0.815 . . . . 0.0 111.091 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.63 24.21 33.92 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.616 179.021 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.44 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 6.4 ptpt -170.39 161.19 7.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.042 -1.27 . . . . 0.0 110.947 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.819 HD21 ' H ' ' A' ' 108' ' ' LYS . 1.6 pt? -172.19 149.49 2.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.1 0.952 . . . . 0.0 111.732 178.688 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -140.61 174.06 10.89 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.258 -179.268 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.42 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -148.57 143.04 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.988 -1.07 . . . . 0.0 110.15 179.561 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -99.69 133.65 43.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 110.329 179.87 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -113.12 141.08 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.796 179.823 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 m -89.13 130.21 35.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.875 . . . . 0.0 110.348 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.657 HG13 ' HE3' ' A' ' 81' ' ' MET . 1.7 t -102.94 125.63 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.904 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -100.32 140.24 34.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.497 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.546 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.6 OUTLIER 62.14 77.32 0.33 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.93 . . . . 0.0 110.315 179.87 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.8 m -65.47 -35.06 79.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 110.057 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -52.95 -38.28 61.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.314 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.523 ' CE2' ' CE1' ' A' ' 74' ' ' HIS . 44.6 m0 -82.18 -61.27 1.95 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.947 . . . . 0.0 110.381 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.72 ' HA ' HG12 ' A' ' 119' ' ' VAL . 7.8 tt -87.76 122.03 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.372 -0.83 . . . . 0.0 109.808 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.824 HG22 ' O ' ' A' ' 118' ' ' ASP . 1.3 t -87.6 -22.42 24.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.0 111.41 -178.87 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.79 176.98 47.68 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.303 -1.427 . . . . 0.0 110.381 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.657 ' HE3' HG13 ' A' ' 72' ' ' VAL . 2.1 mpp? -150.61 108.14 3.65 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.579 -0.954 . . . . 0.0 109.985 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.49 156.9 20.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.24 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.513 ' O ' ' CE1' ' A' ' 86' ' ' HIS . 3.9 mt -148.19 153.28 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 110.073 179.758 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.663 ' HB3' ' CD2' ' A' ' 86' ' ' HIS . 1.9 tm-20 61.96 14.81 6.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 0.0 110.709 179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.6 19.42 61.93 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.667 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.663 ' CD2' ' HB3' ' A' ' 84' ' ' GLU . 2.3 p80 -136.2 159.85 40.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.274 . . . . 0.0 110.272 179.608 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -71.44 162.95 28.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.82 . . . . 0.0 110.604 -179.436 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 81' ' ' MET . 4.0 pt-20 -90.79 170.09 10.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 179.878 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.39 126.92 55.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.289 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pp -67.86 103.64 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.142 -0.973 . . . . 0.0 109.465 179.578 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.464 HG21 HG22 ' A' ' 101' ' ' THR . 1.4 tt -94.38 -28.41 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 0.0 110.978 -179.061 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.3 m -166.91 100.21 0.55 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.044 -1.035 . . . . 0.0 110.12 -179.644 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.417 ' HG3' ' HG3' ' A' ' 100' ' ' ARG . 21.1 ttmt -95.72 102.64 14.46 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.396 -0.815 . . . . 0.0 110.041 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.47 94.3 7.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 110.211 -179.799 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 79.1 p -80.47 -17.34 51.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.356 -0.84 . . . . 0.0 110.368 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.48 -19.91 64.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.95 . . . . 0.0 110.11 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -136.44 22.44 3.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 110.105 179.887 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 52.74 67.97 0.9 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 0.0 110.093 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -147.72 176.23 10.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -0.898 . . . . 0.0 110.262 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.417 ' HG3' ' HG3' ' A' ' 93' ' ' LYS . 2.8 ttm180 -175.93 161.41 2.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.892 . . . . 0.0 110.189 -179.864 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.464 HG22 HG21 ' A' ' 91' ' ' ILE . 87.1 m -142.32 154.32 44.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.897 . . . . 0.0 109.814 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 22.4 p -145.88 142.01 28.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.034 -1.042 . . . . 0.0 110.759 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -92.74 146.16 23.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.456 -0.778 . . . . 0.0 109.716 179.472 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.425 ' CG ' HD12 ' A' ' 83' ' ' ILE . 46.4 m-85 -129.22 139.5 51.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.076 -1.015 . . . . 0.0 111.079 -179.398 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.471 ' C ' HG13 ' A' ' 106' ' ' VAL . 9.8 tt0 -105.75 122.06 45.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.462 -0.774 . . . . 0.0 109.225 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.471 HG13 ' C ' ' A' ' 105' ' ' GLU . 34.4 m -149.02 147.91 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.069 -1.019 . . . . 0.0 110.91 -178.928 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.6 m -63.8 106.64 1.03 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.327 -0.858 . . . . 0.0 109.117 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.819 ' H ' HD21 ' A' ' 66' ' ' LEU . 0.1 OUTLIER 50.45 -177.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.469 -0.77 . . . . 0.0 109.588 -178.729 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.727 HD22 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.42 82.49 1.36 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.907 -1.12 . . . . 0.0 111.191 -179.42 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.468 ' CG ' HG23 ' A' ' 146' ' ' THR . 15.2 t-20 -145.16 80.33 1.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.109 179.46 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.09 -113.61 0.61 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -157.11 152.93 27.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.161 -1.199 . . . . 0.0 110.055 179.847 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 57.4 mt -134.15 150.79 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 0.0 110.188 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -76.37 123.01 25.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.254 -0.904 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.458 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -128.83 177.75 17.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.8 mttt -143.45 171.79 13.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -1.079 . . . . 0.0 109.845 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.563 HD11 HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -158.13 138.83 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.073 -1.017 . . . . 0.0 110.543 -179.912 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.824 ' O ' HG22 ' A' ' 79' ' ' THR . 42.4 t0 -107.96 158.06 17.69 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 108.896 179.047 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.72 HG12 ' HA ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -145.34 152.7 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 0.0 110.781 -179.244 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 5.3 t80 -152.44 107.36 3.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.462 -0.774 . . . . 0.0 110.457 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.586 HD12 ' CB ' ' A' ' 132' ' ' TYR . 20.0 mt -127.74 153.31 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.185 -0.947 . . . . 0.0 110.454 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.55 96.96 1.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.866 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.444 ' HG2' ' CE1' ' A' ' 130' ' ' PHE . 6.7 pt-20 -173.88 -149.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 110.261 -179.654 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 0.1 OUTLIER -132.67 119.33 20.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.194 -0.941 . . . . 0.0 110.223 -179.947 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.679 HG23 ' CE1' ' A' ' 130' ' ' PHE . 38.7 t -76.77 90.58 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.222 -0.924 . . . . 0.0 110.369 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.58 46.07 23.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 110.505 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.23 36.16 5.02 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 0.1 OUTLIER -145.76 88.31 6.53 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.176 -1.19 . . . . 0.0 110.157 179.799 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -62.46 124.46 14.27 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.945 1.497 . . . . 0.0 110.274 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.679 ' CE1' HG23 ' A' ' 125' ' ' VAL . 6.2 p90 -154.25 161.86 41.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 110.183 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -135.42 106.18 6.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 110.17 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.586 ' CB ' HD12 ' A' ' 121' ' ' ILE . 3.6 t80 -91.79 131.31 37.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.01 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -166.68 89.63 0.37 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.917 . . . . 0.0 109.99 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 -177.06 6.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.152 -0.968 . . . . 0.0 110.593 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -118.22 93.06 3.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.372 -0.83 . . . . 0.0 109.758 179.753 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.623 ' HB3' HMD2 ' A' ' 151' ' ' ZNH . 89.1 m-85 -85.55 -179.42 6.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.433 -0.792 . . . . 0.0 110.653 -179.476 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.601 ' O ' HG23 ' A' ' 138' ' ' ILE . 12.4 p30 -151.09 161.77 42.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 110.111 179.845 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.5 pt -156.81 163.35 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.093 -1.004 . . . . 0.0 110.692 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.425 HG23 ' HD2' ' A' ' 112' ' ' LYS . 86.0 m -91.97 121.6 33.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.386 -0.821 . . . . 0.0 110.736 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.484 ' CE2' HD11 ' A' ' 83' ' ' ILE . 55.4 m-85 -89.78 137.27 32.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -0.903 . . . . 0.0 109.407 179.088 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.477 ' HG3' ' CE2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -118.02 101.17 8.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.101 -1.0 . . . . 0.0 110.63 -179.725 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -92.6 130.3 38.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 0.0 109.83 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 8.9 m120 -129.55 103.84 7.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 110.453 -179.761 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.878 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -152.62 -147.85 4.71 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.427 ' HD2' HD11 ' A' ' 34' ' ' LEU . 9.8 Cg_endo -58.5 -172.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.793 1.417 . . . . 0.0 110.601 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.468 HG23 ' CG ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -149.15 -51.92 0.16 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.304 -0.873 . . . . 0.0 110.263 -179.921 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -131.23 -51.25 1.02 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.319 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 148' ' ' VAL . 16.5 t 56.83 32.42 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.368 -0.833 . . . . 0.0 110.324 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.31 30.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.273 -0.892 . . . . 0.0 110.261 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.976 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 151' ' ' ZNH . . . . . 0.623 HMD2 ' HB3' ' A' ' 136' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.849 0.357 . . . . 0.0 110.408 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.02 143.7 12.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 110.308 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.86 -178.77 43.94 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.96 103.47 16.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -1.155 . . . . 0.0 110.242 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.743 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -95.2 158.58 15.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 0.0 110.632 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' A' ' 143' ' ' ASN . 1.7 m120 -79.35 141.27 37.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 109.998 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.586 ' HE2' HD11 ' A' ' 70' ' ' ILE . 0.6 OUTLIER -164.94 157.23 15.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 110.209 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 141' ' ' LYS . 1.1 tt0 -155.66 -175.93 5.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 110.094 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 46' ' ' THR . 0.4 OUTLIER -140.31 172.47 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.941 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.408 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 39.1 m-85 -148.55 159.07 44.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 110.568 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.439 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.3 OUTLIER -67.56 128.22 35.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.477 -0.764 . . . . 0.0 109.882 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.479 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -55.41 146.51 19.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 0.0 110.089 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.1 t-20 71.44 2.3 4.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.861 -0.524 . . . . 0.0 111.235 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.75 -165.73 1.78 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.822 -1.174 . . . . 0.0 109.679 179.155 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -133.65 15.68 4.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 0.0 110.344 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -135.48 117.66 15.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.986 . . . . 0.0 110.579 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -50.45 131.3 24.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.201 -0.937 . . . . 0.0 109.264 179.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.54 -17.32 3.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.014 -1.054 . . . . 0.0 112.051 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.5 mt -136.93 -70.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.867 -1.145 . . . . 0.0 110.808 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.428 ' HB1' ' HE2' ' A' ' 53' ' ' PHE . . . -46.61 -26.31 0.88 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.597 -0.689 . . . . 0.0 110.943 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.453 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -63.39 -14.5 50.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -0.981 . . . . 0.0 110.803 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.413 ' C ' ' CG ' ' A' ' 52' ' ' TYR . 21.2 m-20 -95.24 14.85 20.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.074 -1.016 . . . . 0.0 110.832 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.413 ' CG ' ' C ' ' A' ' 51' ' ' ASP . 22.5 m-85 -142.91 15.73 1.93 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.992 -1.068 . . . . 0.0 110.737 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.428 ' HE2' ' HB1' ' A' ' 49' ' ' ALA . 19.4 m-85 -131.3 105.85 7.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.183 -0.948 . . . . 0.0 110.205 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.476 ' HB2' HG21 ' A' ' 71' ' ' THR . 22.7 m120 -72.3 169.76 15.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.947 . . . . 0.0 110.368 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.72 162.04 33.12 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.338 -0.851 . . . . 0.0 110.018 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.25 -175.8 16.46 Favored 'Cis proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.399 -2.334 . . . . 0.0 110.596 -0.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.58 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -103.5 171.3 7.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.325 -0.859 . . . . 0.0 109.885 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.438 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -105.2 116.25 31.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.001 . . . . 0.0 110.536 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.507 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 1.9 p90 -97.24 162.67 13.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.394 -0.816 . . . . 0.0 109.945 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -154.78 150.97 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.026 -1.046 . . . . 0.0 110.783 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 19.6 mtmt -134.39 173.65 11.4 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.247 -0.908 . . . . 0.0 110.737 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.457 ' HB2' ' CD ' ' A' ' 65' ' ' LYS . 4.5 mttm -153.27 62.21 0.76 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.508 -0.745 . . . . 0.0 109.703 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.1 m120 46.98 82.44 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.369 -0.832 . . . . 0.0 111.105 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.53 19.82 28.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.457 ' CD ' ' HB2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -168.84 162.62 11.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.045 -1.267 . . . . 0.0 111.181 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' A' ' 108' ' ' LYS . 2.6 pt? -172.66 154.89 3.15 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.009 0.909 . . . . 0.0 111.477 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 1.1 m-85 -137.98 -153.7 0.49 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.439 HG11 ' CE1' ' A' ' 142' ' ' PHE . 1.1 t -170.73 135.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.073 -1.017 . . . . 0.0 110.287 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.438 ' HG2' ' CB ' ' A' ' 58' ' ' LYS . 1.8 pt20 -97.51 131.24 44.31 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.39 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.586 HD11 ' HE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -110.68 143.69 20.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.253 -0.905 . . . . 0.0 110.108 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.476 HG21 ' HB2' ' A' ' 54' ' ' ASN . 0.5 OUTLIER -88.77 135.85 33.31 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.299 -0.876 . . . . 0.0 109.902 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.642 ' CG1' HG21 ' A' ' 78' ' ' ILE . 22.8 t -103.34 126.42 57.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.418 -0.802 . . . . 0.0 110.143 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -97.99 127.16 43.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.227 -0.921 . . . . 0.0 110.149 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 m80 55.04 99.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.827 . . . . 0.0 110.146 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.9 t -74.39 -35.75 63.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.189 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -51.57 -23.9 4.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.26 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.449 ' O ' HG12 ' A' ' 119' ' ' VAL . 45.4 m0 -94.37 -53.53 3.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.48 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.642 HG21 ' CG1' ' A' ' 72' ' ' VAL . 13.6 tt -89.51 123.71 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.144 -0.973 . . . . 0.0 109.835 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -87.69 -27.02 22.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 110.982 -179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.56 -176.47 47.67 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.046 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.415 ' HE1' HG22 ' A' ' 72' ' ' VAL . 63.3 mtm -151.95 165.5 34.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.384 -1.068 . . . . 0.0 110.145 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -155.29 140.58 17.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.323 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.688 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -130.19 140.18 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 110.245 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 71.65 0.85 3.65 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.637 -0.664 . . . . 0.0 111.385 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.09 21.79 9.25 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.644 -1.265 . . . . 0.0 111.292 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.472 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.74 158.71 43.78 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.52 -1.577 . . . . 0.0 110.31 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.14 175.29 5.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 110.485 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -104.06 170.29 8.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.371 -0.831 . . . . 0.0 110.32 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -110.6 131.51 54.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 110.463 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 90' ' ' ILE . 1.4 pp -68.26 102.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 109.571 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.492 HG21 HG22 ' A' ' 101' ' ' THR . 1.1 tt -95.21 -30.89 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 111.092 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.7 m -167.22 95.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.028 -1.045 . . . . 0.0 110.327 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -96.77 105.07 17.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.397 -0.814 . . . . 0.0 109.977 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.67 105.36 17.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.236 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -32.03 44.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 0.0 110.235 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.59 -44.71 95.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 109.987 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -96.8 8.54 44.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 110.704 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.02 53.33 13.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.037 -1.039 . . . . 0.0 110.071 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.38 119.01 7.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 110.519 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.475 ' CG ' ' N ' ' A' ' 101' ' ' THR . 38.2 ttt180 -114.98 167.27 10.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.43 -0.794 . . . . 0.0 109.619 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.492 HG22 HG21 ' A' ' 91' ' ' ILE . 92.0 m -141.09 153.14 45.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.018 -1.051 . . . . 0.0 109.962 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.1 p -144.99 142.35 29.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.157 -0.964 . . . . 0.0 110.686 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.18 140.73 29.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.324 -0.86 . . . . 0.0 109.85 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -127.96 138.62 52.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.077 -1.014 . . . . 0.0 110.71 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.456 ' HG2' ' CD2' ' A' ' 67' ' ' TYR . 3.2 tm-20 -98.29 128.16 44.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.329 -0.857 . . . . 0.0 109.538 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.61 151.12 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 110.926 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -63.09 111.2 2.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -0.916 . . . . 0.0 109.195 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.792 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.21 -167.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.458 -0.776 . . . . 0.0 109.844 -178.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.468 HD22 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.25 70.98 1.05 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.96 -1.088 . . . . 0.0 110.86 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.2 67.48 1.19 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 0.0 110.243 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 164.53 -121.57 1.02 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -157.41 153.44 27.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -1.157 . . . . 0.0 110.115 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.1 mm -136.74 149.2 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.0 110.262 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -76.49 103.78 6.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 109.968 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -109.17 179.49 21.03 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.5 mttp -145.03 167.4 22.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -1.088 . . . . 0.0 109.824 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -158.07 153.17 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.016 -1.052 . . . . 0.0 110.792 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.652 ' O ' HG22 ' A' ' 79' ' ' THR . 59.9 m-20 -111.65 157.88 19.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.522 -0.737 . . . . 0.0 109.297 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.455 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.7 OUTLIER -141.61 151.57 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.999 -1.063 . . . . 0.0 110.528 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -151.51 117.07 5.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.411 -0.805 . . . . 0.0 110.069 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 77' ' ' TRP . 31.4 mt -141.05 151.97 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.188 -0.945 . . . . 0.0 110.484 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.57 95.79 1.12 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.465 -0.772 . . . . 0.0 109.668 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -173.14 163.6 4.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 110.431 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -87.34 112.94 22.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.374 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 130' ' ' PHE . 60.9 t -76.42 91.68 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.323 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.02 43.33 9.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.216 -0.927 . . . . 0.0 110.349 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.14 30.61 16.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -145.37 100.92 4.41 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.269 -1.136 . . . . 0.0 110.261 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -52.5 113.25 1.14 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.74 1.389 . . . . 0.0 110.286 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.4 ' HB3' HG23 ' A' ' 125' ' ' VAL . 3.3 t80 -112.39 120.13 40.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.0 110.391 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -103.95 142.67 34.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.338 -0.851 . . . . 0.0 110.077 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.455 ' HE2' HG11 ' A' ' 119' ' ' VAL . 2.5 t80 -156.67 121.23 4.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 109.988 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.429 ' HB3' ' CE1' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -168.01 86.66 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 110.367 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -153.43 -172.45 4.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 110.358 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -117.64 87.81 2.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 110.091 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -85.56 -178.39 6.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.328 -0.857 . . . . 0.0 110.242 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 138' ' ' ILE . 2.6 p30 -149.4 169.94 19.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 110.461 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.0 OUTLIER -157.11 163.79 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -0.918 . . . . 0.0 110.634 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.408 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 85.2 m -91.86 125.33 36.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.3 -0.875 . . . . 0.0 110.567 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.688 ' CD2' HD11 ' A' ' 83' ' ' ILE . 31.4 m-85 -90.13 154.02 20.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.601 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.0 OUTLIER -142.06 102.86 4.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.055 -1.028 . . . . 0.0 110.427 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.439 ' CE1' HG11 ' A' ' 68' ' ' VAL . 17.1 m-85 -92.26 153.51 19.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.524 ' C ' HD21 ' A' ' 34' ' ' LEU . 51.1 m-80 -142.62 97.91 3.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.446 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.743 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -155.21 -148.12 4.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.463 ' HD2' HD11 ' A' ' 34' ' ' LEU . 9.4 Cg_endo . . . . . 0 C--N 1.309 -1.536 0 O-C-N 123.795 1.418 . . . . 0.0 110.436 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 120.918 0.39 . . . . 0.0 110.337 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 p -160.67 148.06 15.78 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.195 -0.941 . . . . 0.0 110.331 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 171.2 174.35 38.9 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.93 107.73 19.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.282 -1.128 . . . . 0.0 110.568 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.699 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.7 OUTLIER -95.73 158.09 15.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.149 -0.97 . . . . 0.0 110.363 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 143' ' ' ASN . 2.1 m-20 -80.38 143.8 33.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 109.716 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.472 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 1.1 p90 -164.92 156.36 15.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.117 -0.989 . . . . 0.0 110.254 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.42 -175.76 5.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.314 -0.866 . . . . 0.0 109.958 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -140.31 175.17 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 110.031 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -149.08 160.57 43.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 110.404 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.426 ' HG3' ' HB2' ' A' ' 47' ' ' SER . 0.1 OUTLIER -67.94 119.97 13.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.369 -0.832 . . . . 0.0 109.418 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.546 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -48.71 146.15 3.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.241 -0.912 . . . . 0.0 110.169 -179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER 72.53 2.33 4.31 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.949 -0.47 . . . . 0.0 110.866 -179.328 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -135.34 -163.0 1.32 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.878 -1.138 . . . . 0.0 109.818 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.56 14.02 3.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 110.242 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -135.25 123.51 23.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 110.354 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.556 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -60.56 131.37 50.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.072 -1.018 . . . . 0.0 109.313 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.426 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -128.04 -17.14 4.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 111.781 -178.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.2 mt -137.25 -65.59 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.8 -1.188 . . . . 0.0 110.895 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HB1' ' HE2' ' A' ' 53' ' ' PHE . . . -50.03 -22.99 1.8 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.508 -0.745 . . . . 0.0 111.205 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.514 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.1 OUTLIER -70.58 -9.41 56.77 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.039 -1.038 . . . . 0.0 110.965 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.407 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 30.1 m-20 -102.47 14.9 30.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.928 -1.107 . . . . 0.0 110.959 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 51' ' ' ASP . 31.5 m-85 -136.47 4.98 2.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.001 -1.062 . . . . 0.0 111.097 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.579 ' HE2' ' HB1' ' A' ' 49' ' ' ALA . 19.8 m-85 -125.75 111.64 15.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.038 -1.039 . . . . 0.0 110.291 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -72.01 165.69 23.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.993 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.438 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -147.24 164.55 22.52 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.215 -0.928 . . . . 0.0 110.196 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.438 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 58.0 Cg_endo -80.84 -175.57 16.27 Favored 'Cis proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.338 -2.359 . . . . 0.0 110.666 -0.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.48 168.85 9.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -0.885 . . . . 0.0 109.676 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.441 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.89 121.33 41.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.031 -1.043 . . . . 0.0 110.783 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.511 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 9.2 p90 -98.26 158.73 15.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.327 -0.858 . . . . 0.0 109.873 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.8 OUTLIER -155.08 147.65 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.076 -1.015 . . . . 0.0 110.442 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 7.2 mttt -131.87 174.11 10.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.457 -0.777 . . . . 0.0 110.444 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . 2.6 mmtp -156.73 62.04 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.796 . . . . 0.0 109.731 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 m120 47.53 85.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.835 . . . . 0.0 110.992 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.73 17.45 48.5 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.555 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HD2' ' HB3' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -165.31 163.51 19.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.936 -1.332 . . . . 0.0 111.119 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.584 HD11 ' HA ' ' A' ' 108' ' ' LYS . 1.2 pt? -174.6 154.83 2.09 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.017 0.913 . . . . 0.0 110.964 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.565 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -139.48 -155.46 0.59 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -170.67 134.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.846 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.441 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -97.73 134.68 40.58 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.123 -0.986 . . . . 0.0 110.011 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 101' ' ' THR . 1.0 OUTLIER -113.2 139.53 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.437 -0.789 . . . . 0.0 110.069 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.31 133.67 34.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 110.022 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.842 HG13 HD13 ' A' ' 78' ' ' ILE . 5.2 t -102.6 125.51 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.44 -0.787 . . . . 0.0 109.831 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -99.21 126.93 45.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.13 -0.981 . . . . 0.0 110.416 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.599 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER 58.42 99.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 110.354 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.37 -25.55 59.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.168 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -59.39 -36.27 75.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.498 ' O ' HG12 ' A' ' 119' ' ' VAL . 46.5 m0 -82.77 -52.11 7.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.842 HD13 HG13 ' A' ' 72' ' ' VAL . 12.8 tt -89.3 122.66 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.869 . . . . 0.0 109.838 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.667 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.2 -25.46 24.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 110.878 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.77 178.05 48.41 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.499 -1.334 . . . . 0.0 110.243 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.706 ' SD ' HD11 ' A' ' 78' ' ' ILE . 89.6 mtp -150.92 160.26 44.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.996 . . . . 0.0 109.787 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -154.95 161.16 41.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 110.253 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.493 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 1.3 mt -149.73 152.6 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 110.149 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.529 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 0.2 OUTLIER 62.77 12.51 5.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.093 -1.004 . . . . 0.0 111.058 179.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.17 20.42 52.8 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.436 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.529 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.2 p-80 -138.28 158.8 43.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.859 -1.377 . . . . 0.0 110.441 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.39 172.2 9.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.334 -0.854 . . . . 0.0 110.595 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.523 ' CB ' ' CZ ' ' A' ' 104' ' ' PHE . 4.4 pt-20 -100.54 170.53 8.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.342 -0.849 . . . . 0.0 110.373 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.3 129.49 53.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.347 -0.845 . . . . 0.0 110.483 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.76 101.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.111 -0.993 . . . . 0.0 109.569 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 101' ' ' THR . 1.1 tt -94.86 -26.38 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 110.857 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.501 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -167.04 100.31 0.54 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.229 -0.92 . . . . 0.0 109.655 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.406 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 16.4 ttmt -95.93 147.94 23.15 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 110.191 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -143.02 84.2 1.82 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -0.938 . . . . 0.0 110.3 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 p -71.21 -29.39 65.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 110.207 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.95 -52.57 62.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.339 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -96.31 15.84 20.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.0 110.5 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.42 62.54 2.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.117 -0.989 . . . . 0.0 110.547 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 94' ' ' ASN . 22.3 mt-10 -148.14 160.86 42.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.158 -0.964 . . . . 0.0 110.165 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 92' ' ' SER . 7.3 ttm180 -166.83 161.47 15.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 110.155 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.578 ' O ' HG22 ' A' ' 91' ' ' ILE . 74.3 m -143.07 152.0 41.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 109.61 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 18.2 p -146.33 143.46 29.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.988 -1.07 . . . . 0.0 110.871 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.82 147.96 22.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.374 -0.828 . . . . 0.0 109.693 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.523 ' CZ ' ' CB ' ' A' ' 88' ' ' GLU . 27.2 m-85 -130.16 135.79 48.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.088 -1.008 . . . . 0.0 111.117 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -97.19 125.17 41.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.393 -0.817 . . . . 0.0 109.117 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.478 ' O ' HD21 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -149.25 161.02 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 0.0 110.782 -178.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.433 ' N ' ' CG2' ' A' ' 106' ' ' VAL . 11.0 p -70.13 113.0 6.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 108.82 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.584 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 44.83 -164.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.673 -0.642 . . . . 0.0 109.964 -178.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -150.64 68.22 0.96 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.876 -1.14 . . . . 0.0 110.933 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -146.97 87.97 1.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.05 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 148.05 -125.76 2.18 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.47 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.1 OUTLIER -156.91 150.39 24.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -1.067 . . . . 0.0 109.723 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.461 ' CD1' HG23 ' A' ' 106' ' ' VAL . 2.4 mt -135.55 152.19 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.316 -0.865 . . . . 0.0 110.04 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -75.93 100.0 4.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.919 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.413 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -99.99 179.31 29.92 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 82' ' ' SER . 17.0 mtpt -146.13 158.31 43.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -1.121 . . . . 0.0 110.054 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.46 ' O ' HD13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -157.6 145.99 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.119 -0.988 . . . . 0.0 110.312 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.667 ' C ' HG22 ' A' ' 79' ' ' THR . 1.0 OUTLIER -108.32 161.17 15.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.366 -0.833 . . . . 0.0 109.596 179.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -136.48 150.77 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.119 -0.988 . . . . 0.0 110.766 -179.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -151.94 114.19 4.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.467 -0.771 . . . . 0.0 109.871 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 77' ' ' TRP . 15.8 mt -141.51 153.29 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.164 -0.96 . . . . 0.0 110.806 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -159.44 100.01 1.48 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.587 -0.695 . . . . 0.0 109.424 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -172.97 178.25 2.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.24 -0.912 . . . . 0.0 110.396 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -101.21 118.85 37.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.333 -0.854 . . . . 0.0 110.324 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.2 t -76.91 92.26 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.0 110.306 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.431 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 1.4 m120 57.39 36.18 26.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.878 . . . . 0.0 110.503 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.89 31.25 6.72 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.12 98.15 4.74 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.247 -1.149 . . . . 0.0 110.07 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -49.17 121.28 6.65 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.921 1.485 . . . . 0.0 110.327 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -126.32 124.63 40.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 110.195 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -103.61 140.59 37.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 110.351 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.467 ' HE2' HG11 ' A' ' 119' ' ' VAL . 2.5 t80 -150.85 123.22 8.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.091 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -175.83 87.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 109.935 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -153.58 -164.68 1.95 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.355 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.472 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -119.2 139.83 51.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.981 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 135' ' ' HIS . 47.5 m-85 -154.53 -179.82 8.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.93 . . . . 0.0 110.119 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.638 ' O ' HG23 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -152.39 178.89 9.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.161 -0.962 . . . . 0.0 110.51 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.638 HG23 ' O ' ' A' ' 137' ' ' ASN . 3.8 pt -157.13 170.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.885 . . . . 0.0 110.058 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.47 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 96.8 m -91.6 121.84 33.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 110.647 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.567 ' HA ' HG12 ' A' ' 38' ' ' VAL . 28.6 m-85 -89.44 155.58 19.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.575 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.0 OUTLIER -143.32 100.53 3.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.048 -1.033 . . . . 0.0 110.741 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.425 ' CE1' HG11 ' A' ' 68' ' ' VAL . 15.9 m-85 -91.7 129.14 37.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.652 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.472 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 56.1 m-80 -113.93 104.38 12.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.105 -0.997 . . . . 0.0 110.877 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.699 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -163.13 -159.03 10.15 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo . . . . . 0 C--N 1.305 -1.747 0 O-C-N 123.982 1.517 . . . . 0.0 110.278 179.922 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.014 0.435 . . . . 0.0 110.419 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -158.91 134.6 8.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 110.246 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.96 178.27 48.74 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.29 105.4 17.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.181 -1.187 . . . . 0.0 110.382 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.839 HD13 HD22 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -94.27 154.25 17.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.345 -0.847 . . . . 0.0 109.744 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.475 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 12.4 t-20 -78.73 144.7 35.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.12 -0.988 . . . . 0.0 109.989 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -165.57 161.46 18.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.343 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.22 -173.44 4.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.425 -0.797 . . . . 0.0 109.746 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.78 HG23 HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.55 174.61 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.169 -0.957 . . . . 0.0 110.146 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.413 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 16.0 m-85 -147.47 151.37 36.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.377 -0.827 . . . . 0.0 109.839 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -67.43 127.12 31.51 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.419 -0.8 . . . . 0.0 110.066 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.477 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -52.94 146.98 9.9 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.091 -1.006 . . . . 0.0 109.493 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 12.5 t30 73.09 -1.17 3.14 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.944 -0.472 . . . . 0.0 110.914 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.95 -163.38 1.41 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.899 -1.126 . . . . 0.0 109.561 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.402 ' N ' ' OG1' ' A' ' 43' ' ' THR . 8.5 m120 -133.34 15.74 4.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 110.434 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -136.53 129.03 30.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.015 . . . . 0.0 110.681 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.78 HG21 HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -57.79 132.38 53.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.156 -0.965 . . . . 0.0 109.037 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.75 -16.8 4.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.102 -0.999 . . . . 0.0 112.035 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 49' ' ' ALA . 2.2 mt -136.62 -64.94 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.803 -1.185 . . . . 0.0 110.598 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.457 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -54.6 -20.79 8.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.428 -0.795 . . . . 0.0 110.727 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.456 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 0.1 OUTLIER -63.38 -17.84 63.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.309 -0.87 . . . . 0.0 110.76 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -102.47 15.45 29.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.139 -0.976 . . . . 0.0 110.992 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -131.73 1.11 3.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.949 -1.094 . . . . 0.0 111.151 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -129.37 113.47 14.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.127 -0.983 . . . . 0.0 110.252 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -72.79 173.05 9.67 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.386 -0.821 . . . . 0.0 110.617 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.15 164.67 22.01 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.354 -0.841 . . . . 0.0 109.769 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -78.66 -174.84 15.55 Favored 'Cis proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.798 -2.167 . . . . 0.0 110.559 -0.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.22 164.38 11.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.879 . . . . 0.0 110.007 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.415 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 2.2 tptt -101.91 109.55 21.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.131 -0.981 . . . . 0.0 110.314 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.519 ' CD1' ' CB ' ' A' ' 34' ' ' LEU . 6.5 p90 -98.0 165.75 11.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.332 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.8 OUTLIER -155.6 157.81 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.296 -0.877 . . . . 0.0 110.537 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 3.1 mtmt -139.41 174.31 10.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.245 -0.909 . . . . 0.0 110.831 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . 7.2 mttm -159.03 62.21 0.41 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.418 -0.801 . . . . 0.0 109.878 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 48.97 84.0 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.441 -0.787 . . . . 0.0 111.232 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.68 24.42 28.12 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.736 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.76 ' C ' HD13 ' A' ' 66' ' ' LEU . 1.3 ptpp? -167.42 155.94 9.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.912 -1.346 . . . . 0.0 111.018 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.76 HD13 ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -160.12 155.56 25.34 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.201 1.0 . . . . 0.0 111.843 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 6.2 m-85 -142.58 -164.14 1.76 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 103' ' ' GLU . 1.1 t -170.47 135.98 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.998 -1.064 . . . . 0.0 110.554 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 102' ' ' SER . 4.7 pt20 -99.15 134.23 42.3 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 109.773 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -113.23 134.87 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 110.093 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.0 m -89.57 123.56 33.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 0.0 109.954 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -103.08 141.7 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.207 -0.933 . . . . 0.0 110.278 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -98.67 140.02 33.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.827 . . . . 0.0 110.207 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.2 m170 52.58 88.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 110.221 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.7 p -52.19 -25.91 10.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.378 -0.827 . . . . 0.0 110.298 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -65.37 -55.74 16.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 110.369 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.429 ' HA ' HG12 ' A' ' 121' ' ' ILE . 47.4 m0 -50.73 -59.56 3.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.19 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.79 HD11 ' CG ' ' A' ' 81' ' ' MET . 6.1 tt -88.46 118.04 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.312 -0.868 . . . . 0.0 109.894 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.61 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.6 -23.02 25.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.316 -0.865 . . . . 0.0 110.956 -179.186 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.07 176.1 47.93 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.019 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.79 ' CG ' HD11 ' A' ' 78' ' ' ILE . 56.6 mtp -152.57 157.79 41.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.376 -1.073 . . . . 0.0 110.07 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -155.11 140.51 17.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.94 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.848 HD11 ' CE2' ' A' ' 140' ' ' TYR . 0.4 OUTLIER -132.94 139.38 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.143 -0.973 . . . . 0.0 110.726 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 70.73 1.86 3.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.588 -0.695 . . . . 0.0 111.629 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.49 22.06 9.37 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.327 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.465 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.88 159.64 41.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.685 -1.479 . . . . 0.0 110.059 179.217 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -70.16 -174.55 0.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.171 -0.956 . . . . 0.0 110.616 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -109.06 169.03 8.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 110.239 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 102' ' ' SER . 22.4 m120 -110.34 127.56 55.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.408 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 pp -67.08 102.89 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.062 -1.024 . . . . 0.0 109.661 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.456 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 0.9 OUTLIER -95.7 -31.5 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 111.007 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.427 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -167.24 100.4 0.52 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.036 -1.04 . . . . 0.0 110.162 -179.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -96.21 148.8 22.34 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.417 -0.802 . . . . 0.0 110.084 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.23 97.9 3.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 110.331 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.6 -32.56 58.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.049 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.89 -43.18 99.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 110.091 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.77 5.76 50.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 110.507 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.71 56.91 6.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.034 -1.041 . . . . 0.0 110.311 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -148.14 -177.32 5.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 110.357 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.544 ' O ' HG22 ' A' ' 72' ' ' VAL . 4.8 ttp180 175.22 160.06 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.855 . . . . 0.0 110.009 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.456 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 85.8 m -137.3 156.19 48.55 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.314 -0.866 . . . . 0.0 109.812 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 6.1 p -144.2 143.12 30.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.038 -1.038 . . . . 0.0 110.785 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.2 tt0 -92.92 150.15 20.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.816 . . . . 0.0 110.054 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.682 ' CD2' HD12 ' A' ' 83' ' ' ILE . 15.5 m-85 -129.71 154.44 47.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.94 . . . . 0.0 110.687 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.459 ' C ' HG13 ' A' ' 106' ' ' VAL . 0.5 OUTLIER -118.51 127.37 53.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.321 -0.862 . . . . 0.0 109.742 179.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.496 ' O ' HD21 ' A' ' 66' ' ' LEU . 29.0 m -149.88 -165.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.045 -1.034 . . . . 0.0 110.607 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -97.9 111.9 24.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.479 -0.763 . . . . 0.0 108.994 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 47.41 -166.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.48 -0.763 . . . . 0.0 109.554 -178.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.839 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.0 62.75 0.91 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.078 -1.014 . . . . 0.0 110.931 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -146.11 70.48 1.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 110.23 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 170.23 -125.07 1.19 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.2 OUTLIER -157.38 139.35 14.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.343 -1.092 . . . . 0.0 109.715 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.427 ' CA ' ' HE2' ' A' ' 112' ' ' LYS . 6.0 mt -135.25 149.83 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.24 -0.913 . . . . 0.0 110.237 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -76.57 123.18 25.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.908 . . . . 0.0 110.15 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.483 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -119.82 -177.65 16.23 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 12.3 mttt -145.12 158.86 43.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.327 -1.102 . . . . 0.0 110.111 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -157.77 143.64 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.454 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.61 ' C ' HG22 ' A' ' 79' ' ' THR . 0.9 OUTLIER -103.59 154.99 18.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.401 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.408 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -129.84 146.86 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.008 -1.057 . . . . 0.0 110.678 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.53 110.47 3.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.43 -0.794 . . . . 0.0 110.006 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.462 ' HB ' ' CB ' ' A' ' 132' ' ' TYR . 19.6 mt -139.92 153.71 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 110.573 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.0 95.1 1.26 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.498 -0.751 . . . . 0.0 109.436 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.476 ' O ' ' CD1' ' A' ' 130' ' ' PHE . 1.3 pt-20 -174.5 -164.73 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.387 -0.821 . . . . 0.0 109.928 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -113.63 115.04 27.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.101 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.972 HG23 ' CE1' ' A' ' 130' ' ' PHE . 3.1 t -76.61 94.56 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.264 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.415 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 2.4 m120 59.42 39.13 22.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.337 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 91.89 34.69 7.13 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.72 90.71 6.31 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.226 -1.161 . . . . 0.0 110.061 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -57.3 133.75 59.31 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.126 1.593 . . . . 0.0 110.63 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.972 ' CE1' HG23 ' A' ' 125' ' ' VAL . 9.3 p90 -157.39 132.7 9.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.056 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -103.24 99.71 9.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.397 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.462 ' CB ' ' HB ' ' A' ' 121' ' ' ILE . 3.7 t80 -90.49 129.53 36.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.831 . . . . 0.0 109.703 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -170.45 83.58 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.091 -1.005 . . . . 0.0 110.27 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.84 -166.04 2.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.885 . . . . 0.0 110.327 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -118.34 151.7 37.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 109.858 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -155.29 179.85 8.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.014 . . . . 0.0 110.405 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.574 ' O ' HG23 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -152.23 169.54 22.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.572 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.574 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.4 pt -156.65 161.63 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 110.214 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.478 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 66.4 m -91.82 125.85 36.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.865 . . . . 0.0 110.73 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.848 ' CE2' HD11 ' A' ' 83' ' ' ILE . 47.7 m-85 -90.59 164.93 14.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.905 . . . . 0.0 110.016 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.1 OUTLIER -147.98 103.3 3.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.954 . . . . 0.0 110.32 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -92.44 141.33 28.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.301 -0.874 . . . . 0.0 110.515 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 67.2 m-20 -133.12 98.43 4.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 110.022 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.523 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -160.52 -148.71 5.35 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo . . . . . 0 C--N 1.308 -1.6 0 O-C-N 123.773 1.407 . . . . 0.0 110.768 -179.903 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 25.0 m-20 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 120.866 0.365 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.6 t -160.84 148.24 15.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 110.43 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.35 172.14 39.97 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.18 106.59 18.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -1.107 . . . . 0.0 110.229 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.782 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.8 OUTLIER -94.45 156.21 16.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.319 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -79.62 143.9 34.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 110.017 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.634 ' HE2' HD11 ' A' ' 70' ' ' ILE . 1.6 p90 -165.99 159.05 15.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 0.0 110.03 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -155.15 -175.14 5.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.926 . . . . 0.0 109.947 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 46' ' ' THR . 0.1 OUTLIER -141.43 174.5 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 110.476 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 18.6 m-85 -148.17 156.02 42.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -0.808 . . . . 0.0 109.926 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.542 ' HZ2' ' HA ' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -67.66 127.87 34.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.106 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.538 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -54.37 147.92 12.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 109.869 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 9.7 m-20 71.11 2.42 4.23 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.812 -0.555 . . . . 0.0 110.952 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -135.93 -162.26 1.25 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.849 -1.157 . . . . 0.0 109.666 179.087 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.413 ' N ' ' OG1' ' A' ' 43' ' ' THR . 16.5 m-80 -132.57 11.91 4.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 110.194 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -136.56 143.76 43.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 110.69 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -68.58 131.49 45.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.088 179.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.558 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -129.25 -17.52 3.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.962 -1.087 . . . . 0.0 112.137 -178.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.713 HG22 ' N ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -137.32 -71.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.789 -1.195 . . . . 0.0 110.581 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.713 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -48.87 -24.69 1.55 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.499 -0.751 . . . . 0.0 110.853 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.455 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -61.73 -20.64 63.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.121 -0.987 . . . . 0.0 110.784 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.41 ' OD2' ' ND2' ' A' ' 50' ' ' ASN . 2.1 m-20 -94.68 14.12 22.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.086 -1.009 . . . . 0.0 110.858 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -141.3 9.51 2.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.062 . . . . 0.0 110.843 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -118.15 110.67 17.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.983 . . . . 0.0 110.171 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -72.77 155.67 39.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.298 -0.877 . . . . 0.0 110.693 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -147.52 163.27 28.58 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.333 -0.854 . . . . 0.0 109.833 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 50.5 Cg_endo -77.41 -175.27 16.4 Favored 'Cis proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.862 -2.141 . . . . 0.0 110.472 -0.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.513 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.09 -172.0 2.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 109.889 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.432 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -125.52 119.19 27.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.015 -1.053 . . . . 0.0 110.577 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 8.3 p90 -97.11 165.59 11.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 109.877 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.501 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -155.58 122.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.135 -0.978 . . . . 0.0 110.608 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.662 ' HD3' HD21 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -136.77 131.76 33.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.199 -0.938 . . . . 0.0 110.775 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.404 ' HB2' ' HD2' ' A' ' 65' ' ' LYS . 6.7 mttp -110.25 62.25 0.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 110.35 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 48.45 97.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.374 -0.829 . . . . 0.0 111.28 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.91 11.71 52.25 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.721 ' C ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -169.96 152.63 4.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.012 -1.287 . . . . 0.0 110.325 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.79 ' N ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -156.92 153.46 28.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.09 -1.006 . . . . 0.0 111.504 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 4.5 m-85 -142.94 -157.92 0.82 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.391 -0.818 . . . . 0.0 109.257 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -170.16 167.49 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.197 -0.939 . . . . 0.0 110.345 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.432 ' HG2' ' HB3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -141.28 134.51 29.47 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.403 -0.81 . . . . 0.0 109.676 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.634 HD11 ' HE2' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -115.48 133.71 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 110.225 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.3 m -89.86 129.72 36.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.155 -0.966 . . . . 0.0 109.853 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.412 HG12 ' CE ' ' A' ' 81' ' ' MET . 1.0 OUTLIER -102.31 143.78 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 110.231 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -99.23 139.34 35.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.905 . . . . 0.0 110.254 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.655 ' O ' HG22 ' A' ' 78' ' ' ILE . 3.9 m-70 54.34 99.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 110.346 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.01 -35.32 78.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.885 . . . . 0.0 110.222 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -57.95 -35.98 71.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 110.196 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.681 ' O ' HG13 ' A' ' 119' ' ' VAL . 39.8 m0 -79.0 -51.04 10.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 110.213 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 74' ' ' HIS . 3.8 tp -89.27 120.55 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.875 . . . . 0.0 109.835 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.45 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.4 -34.56 20.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.406 -0.809 . . . . 0.0 110.706 -179.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.418 ' N ' ' CG2' ' A' ' 79' ' ' THR . . . -175.62 -179.63 46.25 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.532 -1.318 . . . . 0.0 109.989 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.442 ' CE ' HG21 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -152.41 166.31 32.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -1.091 . . . . 0.0 110.133 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -155.21 147.3 23.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.859 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.626 HD11 ' CD2' ' A' ' 140' ' ' TYR . 1.2 mt -142.37 143.11 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 110.627 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 72.3 -0.41 3.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.614 -0.678 . . . . 0.0 111.604 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.0 20.27 9.99 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.458 -1.354 . . . . 0.0 111.285 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.461 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.02 161.41 36.13 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.735 -1.45 . . . . 0.0 110.199 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -172.16 0.6 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.006 -1.059 . . . . 0.0 110.739 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 0.1 OUTLIER -109.79 165.9 11.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 110.557 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.16 135.05 54.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.448 -0.783 . . . . 0.0 109.856 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.42 100.76 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.087 -1.008 . . . . 0.0 109.913 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.535 HG21 HG22 ' A' ' 101' ' ' THR . 1.2 tt -96.0 -28.56 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 110.285 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -166.32 96.08 0.57 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.232 -0.918 . . . . 0.0 109.794 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -95.36 102.4 14.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.427 -0.796 . . . . 0.0 110.073 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.38 95.75 7.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.365 -0.835 . . . . 0.0 110.352 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -37.96 53.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.928 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.55 -38.48 90.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.034 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -96.19 10.55 37.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.62 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 50.91 56.17 8.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.048 -1.033 . . . . 0.0 110.282 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -148.04 169.85 19.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.156 -0.965 . . . . 0.0 110.395 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.408 ' O ' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -166.62 157.63 12.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.333 -0.855 . . . . 0.0 109.954 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.535 HG22 HG21 ' A' ' 91' ' ' ILE . 86.8 m -141.98 158.38 43.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.396 -0.815 . . . . 0.0 109.759 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -145.04 142.97 30.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.045 -1.034 . . . . 0.0 110.728 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -92.98 138.77 31.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.363 -0.836 . . . . 0.0 109.943 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.477 ' CZ ' ' HB2' ' A' ' 102' ' ' SER . 88.6 m-85 -130.06 145.9 51.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.055 -1.028 . . . . 0.0 110.901 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.481 ' C ' HG13 ' A' ' 106' ' ' VAL . 3.2 tt0 -99.69 131.02 45.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.377 -0.827 . . . . 0.0 108.881 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 108' ' ' LYS . 22.9 m -149.09 162.28 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.849 -1.157 . . . . 0.0 111.285 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 60.4 p -69.44 112.32 5.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.0 OUTLIER 46.67 -157.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.51 -0.744 . . . . 0.0 109.418 -178.3 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.662 HD21 ' HD3' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -150.21 51.53 0.9 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.798 -1.189 . . . . 0.0 110.807 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -146.26 87.73 1.75 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.026 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.22 171.02 20.75 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.419 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 1.0 OUTLIER -81.63 144.01 31.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -1.169 . . . . 0.0 110.175 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mm -137.92 139.89 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.171 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -76.65 135.57 39.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 109.947 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -140.98 178.12 20.39 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 9.1 mtmm -143.6 158.06 43.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.426 -1.044 . . . . 0.0 109.837 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.56 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.7 142.62 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.959 -1.088 . . . . 0.0 110.592 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.45 ' C ' HG22 ' A' ' 79' ' ' THR . 40.5 m-20 -106.2 164.47 11.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -0.764 . . . . 0.0 109.798 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 77' ' ' TRP . 25.0 t -141.95 151.53 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 110.447 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -152.03 105.42 3.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.476 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.505 HG21 ' HE2' ' A' ' 130' ' ' PHE . 4.9 mt -125.46 152.79 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.243 -0.911 . . . . 0.0 110.073 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.73 102.41 1.33 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.798 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -173.7 -164.24 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 110.443 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 2.3 ttmt -99.92 103.11 14.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.294 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.667 ' O ' HG12 ' A' ' 125' ' ' VAL . 2.1 t -76.63 103.0 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 110.15 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 63.16 34.47 13.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.451 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.09 31.52 28.4 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -145.33 137.01 12.89 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.224 -1.162 . . . . 0.0 109.999 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.25 129.27 33.94 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.564 1.297 . . . . 0.0 109.838 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.505 ' HE2' HG21 ' A' ' 121' ' ' ILE . 8.7 t80 -129.14 118.1 21.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 110.583 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -105.2 137.78 42.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 109.847 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.483 ' CD2' HD12 ' A' ' 121' ' ' ILE . 6.3 t80 -157.17 123.62 4.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.212 -0.93 . . . . 0.0 110.006 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -173.35 87.55 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.905 . . . . 0.0 109.986 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.96 -161.46 1.29 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.892 . . . . 0.0 110.297 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -120.93 155.6 33.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.86 . . . . 0.0 110.256 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 32.4 m-85 -155.14 -179.26 7.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 109.831 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.563 ' O ' HG23 ' A' ' 138' ' ' ILE . 6.3 p30 -151.2 168.98 23.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 110.608 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.3 pt -156.85 163.27 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.365 -0.835 . . . . 0.0 110.13 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.419 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 90.8 m -91.9 122.11 34.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.224 -0.923 . . . . 0.0 110.54 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.626 ' CD2' HD11 ' A' ' 83' ' ' ILE . 49.2 m-85 -90.25 157.96 17.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -0.877 . . . . 0.0 110.235 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 104.74 3.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.225 -0.922 . . . . 0.0 110.178 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -91.39 158.35 16.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.237 -0.914 . . . . 0.0 110.277 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 65.9 m-80 -143.13 99.56 3.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.782 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -157.52 -154.89 7.27 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.408 ' HD2' ' HA3' ' A' ' 144' ' ' GLY . 11.3 Cg_endo . . . . . 0 C--N 1.307 -1.624 0 O-C-N 123.988 1.52 . . . . 0.0 110.537 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 7.7 m-20 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.988 0.423 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 p -159.48 147.69 17.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 0.0 110.428 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.37 175.67 44.8 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.68 104.87 17.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -1.113 . . . . 0.0 110.39 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.583 HD13 HD22 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -95.27 159.12 15.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.328 -0.857 . . . . 0.0 110.434 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.455 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 16.3 m-20 -78.71 139.6 38.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.116 -0.99 . . . . 0.0 109.982 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.73 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -165.51 152.22 10.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.982 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -155.13 -173.2 4.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.0 110.237 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -140.97 178.65 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.878 . . . . 0.0 110.369 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 39.7 m-85 -148.18 156.72 42.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.446 -0.784 . . . . 0.0 109.68 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.27 122.78 18.62 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.937 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.58 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -49.86 148.89 2.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.934 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.4 t-20 71.52 2.82 4.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.879 -0.513 . . . . 0.0 110.771 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -135.12 -157.84 0.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.948 -1.095 . . . . 0.0 109.533 179.232 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.12 8.27 3.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 110.209 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -135.11 150.76 50.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.07 -1.019 . . . . 0.0 110.563 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.483 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -77.53 133.86 38.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.239 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.472 ' HB3' HD12 ' A' ' 48' ' ' ILE . 34.3 t -129.03 -17.21 3.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.024 -1.048 . . . . 0.0 111.954 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 47' ' ' SER . 3.3 mp -136.94 -69.45 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.7 -1.25 . . . . 0.0 110.623 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.484 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -49.42 -24.09 1.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.549 -0.72 . . . . 0.0 110.9 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.448 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -65.9 -13.41 59.63 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.083 -1.011 . . . . 0.0 110.957 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -99.27 15.36 26.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.016 -1.052 . . . . 0.0 110.957 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -136.87 10.06 3.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.893 -1.129 . . . . 0.0 111.148 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.484 ' CE2' ' HB1' ' A' ' 49' ' ' ALA . 23.1 m-30 -120.83 104.78 10.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.093 -1.004 . . . . 0.0 110.242 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -72.59 106.35 4.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.193 -0.942 . . . . 0.0 110.114 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.466 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -93.53 167.71 13.4 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.255 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.466 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 53.1 Cg_endo -77.93 -175.82 17.47 Favored 'Cis proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.67 -2.221 . . . . 0.0 110.843 -0.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.73 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -103.2 171.51 7.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 109.977 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -104.21 117.17 33.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.01 . . . . 0.0 110.792 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.59 ' HB2' HD23 ' A' ' 109' ' ' LEU . 3.7 p90 -96.42 163.0 13.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 109.324 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.518 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -154.96 118.82 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.925 -1.109 . . . . 0.0 111.028 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HD3' HD21 ' A' ' 109' ' ' LEU . 1.4 mtmt -139.07 131.57 28.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.314 -0.866 . . . . 0.0 109.632 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.437 ' HB3' ' CE ' ' A' ' 65' ' ' LYS . 4.9 tttm -115.91 65.39 0.7 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.113 -0.992 . . . . 0.0 110.78 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 46.39 95.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.465 -0.772 . . . . 0.0 111.201 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.17 13.24 36.89 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.437 ' CE ' ' HB3' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -173.18 149.71 1.84 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.054 -1.262 . . . . 0.0 109.876 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.792 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -158.83 144.13 16.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.969 . . . . 0.0 111.261 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.518 ' HB2' HG23 ' A' ' 60' ' ' ILE . 3.3 m-85 -141.02 -161.79 1.27 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.537 -0.727 . . . . 0.0 109.663 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.54 HG11 ' CE1' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -170.18 163.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.213 -0.93 . . . . 0.0 109.933 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.744 ' C ' HD12 ' A' ' 70' ' ' ILE . 3.4 pt20 -141.61 144.63 34.31 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.171 -0.956 . . . . 0.0 110.58 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.744 HD12 ' C ' ' A' ' 69' ' ' GLN . 2.2 mp -116.68 147.47 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.509 -0.744 . . . . 0.0 109.856 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.6 m -89.19 134.68 33.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 0.0 109.887 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.564 HG12 HG21 ' A' ' 78' ' ' ILE . 2.4 t -102.31 119.63 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 0.0 110.332 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -100.11 137.32 38.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.212 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.528 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER 57.6 92.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.203 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 m -76.47 -25.49 54.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.155 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -60.4 -17.2 42.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.253 -0.904 . . . . 0.0 110.325 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.45 ' HA ' HG12 ' A' ' 121' ' ' ILE . 45.6 m0 -106.31 -51.45 2.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -0.956 . . . . 0.0 110.488 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.845 HD11 ' SD ' ' A' ' 81' ' ' MET . 11.4 tt -89.52 125.25 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 109.886 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.83 -33.46 19.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.398 -0.814 . . . . 0.0 110.765 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.4 ' N ' ' CG2' ' A' ' 79' ' ' THR . . . 178.06 -174.9 47.16 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.139 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.845 ' SD ' HD11 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -152.4 170.84 19.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -1.064 . . . . 0.0 110.259 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' LYS . 2.2 t -154.36 146.21 23.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 109.758 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.474 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 2.9 mt -140.95 144.44 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.619 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.474 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 71.33 2.29 4.19 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.632 -0.667 . . . . 0.0 111.204 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.33 21.47 13.14 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.73 -1.224 . . . . 0.0 111.103 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.47 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.0 160.14 40.13 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.655 -1.497 . . . . 0.0 110.193 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.11 -174.28 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.042 -1.036 . . . . 0.0 110.544 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 8.3 pt-20 -109.97 170.06 8.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.357 -0.839 . . . . 0.0 110.309 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -120.13 130.59 54.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 0.0 110.266 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.402 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 pp -67.56 103.63 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.074 -1.016 . . . . 0.0 109.59 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.437 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -95.13 -27.69 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.366 -0.834 . . . . 0.0 110.971 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.0 m -167.26 94.64 0.46 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.146 -0.971 . . . . 0.0 109.898 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -97.35 147.97 23.64 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 110.284 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.85 101.18 3.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 109.973 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -74.21 -32.37 63.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 0.0 110.312 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.47 -44.8 95.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 110.171 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.55 -3.36 43.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 110.729 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t0 59.97 50.37 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.96 -1.088 . . . . 0.0 110.13 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -147.44 128.45 14.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 110.091 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.77 172.37 12.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 110.444 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.437 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 97.2 m -141.11 157.1 45.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.447 -0.783 . . . . 0.0 109.458 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -145.24 138.01 26.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.068 -1.02 . . . . 0.0 110.721 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -92.9 144.9 24.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.436 -0.79 . . . . 0.0 110.12 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 98.4 m-85 -130.76 145.5 51.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.142 -0.974 . . . . 0.0 110.845 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.48 ' C ' HG13 ' A' ' 106' ' ' VAL . 15.7 tt0 -95.59 126.59 40.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.338 -0.851 . . . . 0.0 109.295 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.48 HG13 ' C ' ' A' ' 105' ' ' GLU . 34.6 m -149.78 177.55 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.974 -1.079 . . . . 0.0 111.038 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.5 t -89.4 110.91 21.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.48 -0.763 . . . . 0.0 109.258 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.454 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 49.65 -158.3 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.652 -178.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.617 HD21 ' HD3' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -151.31 50.92 0.83 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.983 -1.073 . . . . 0.0 111.066 -179.118 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 145' ' ' PRO . 18.4 t-20 -144.85 84.35 1.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 110.137 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.43 170.44 19.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.405 ' O ' ' HE3' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -81.72 145.87 30.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.171 . . . . 0.0 110.416 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 mt -137.28 139.34 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 0.0 109.838 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -76.19 121.2 22.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.27 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -129.15 178.16 17.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -144.63 165.84 26.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -1.154 . . . . 0.0 109.456 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.563 HD12 ' HG3' ' A' ' 81' ' ' MET . 0.1 OUTLIER -157.79 150.52 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.869 -1.145 . . . . 0.0 111.171 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.514 ' O ' HG22 ' A' ' 79' ' ' THR . 1.1 m-20 -109.02 161.38 15.22 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.564 -0.71 . . . . 0.0 109.348 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.425 HG11 ' CE2' ' A' ' 132' ' ' TYR . 3.0 t -143.56 151.67 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.118 -0.989 . . . . 0.0 110.113 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 5.1 t80 -151.71 118.89 5.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 110.672 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 77' ' ' TRP . 30.2 mt -142.63 151.62 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.969 . . . . 0.0 110.145 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.39 95.65 1.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.348 -0.845 . . . . 0.0 109.615 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -173.28 166.26 4.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.259 -0.901 . . . . 0.0 110.414 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -90.25 113.72 25.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.114 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -76.52 90.36 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.2 50.13 3.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.907 . . . . 0.0 110.388 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.71 29.96 45.88 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.21 101.21 4.44 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.175 -1.191 . . . . 0.0 110.27 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.12 136.49 24.03 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.819 1.431 . . . . 0.0 110.293 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 5.8 t80 -136.63 114.71 11.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.174 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -103.43 130.35 50.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 110.112 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 1.6 t80 -145.21 113.84 6.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.763 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 15.8 t0 -162.81 92.15 0.77 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.929 . . . . 0.0 110.224 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -153.84 -169.75 3.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 110.433 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -119.63 86.29 2.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.318 -0.863 . . . . 0.0 110.022 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -84.59 -178.96 7.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.255 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.611 ' O ' HG23 ' A' ' 138' ' ' ILE . 5.7 p30 -150.49 170.51 18.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 110.055 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.7 pt -156.92 165.63 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.076 -1.015 . . . . 0.0 110.754 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 98.8 m -91.76 117.91 30.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.499 -0.75 . . . . 0.0 110.33 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.571 ' HA ' HG12 ' A' ' 38' ' ' VAL . 30.6 m-85 -89.91 151.3 21.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 0.0 110.126 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -144.0 106.1 4.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.145 -0.972 . . . . 0.0 110.339 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.54 ' CE1' HG11 ' A' ' 68' ' ' VAL . 80.3 m-85 -91.46 148.6 22.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.91 . . . . 0.0 109.962 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.455 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 32.7 m-80 -131.1 105.03 7.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.271 -0.893 . . . . 0.0 110.508 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.441 ' HA3' HD21 ' A' ' 34' ' ' LEU . . . -160.72 -161.56 11.65 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.462 ' HD2' HD11 ' A' ' 34' ' ' LEU . 7.3 Cg_endo . . . . . 0 C--N 1.305 -1.748 0 O-C-N 123.919 1.483 . . . . 0.0 110.291 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 10.3 m-20 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 120.764 0.316 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.1 t -159.23 171.36 20.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.083 -1.011 . . . . 0.0 110.889 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.98 177.64 27.62 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.05 107.12 18.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -1.128 . . . . 0.0 110.204 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.855 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -94.3 155.4 17.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 110.091 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.443 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 33.6 m-80 -79.92 138.62 37.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.77 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.674 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -166.0 159.24 15.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.117 -0.989 . . . . 0.0 110.117 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -155.76 -170.33 3.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -0.86 . . . . 0.0 110.247 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 46' ' ' THR . 0.1 OUTLIER -140.06 173.09 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 109.943 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -150.41 160.94 43.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.192 -0.943 . . . . 0.0 110.197 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -68.35 126.33 29.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.473 -0.767 . . . . 0.0 110.168 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.484 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -57.11 146.13 28.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 109.813 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 6.5 t30 72.93 -0.59 3.32 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.878 -0.514 . . . . 0.0 110.926 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -139.08 -168.62 2.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.976 -1.078 . . . . 0.0 109.556 179.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.422 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.9 OUTLIER -135.57 25.26 3.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.002 . . . . 0.0 110.558 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -135.37 123.69 23.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.147 -0.971 . . . . 0.0 111.035 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -52.54 122.1 8.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.46 -0.775 . . . . 0.0 109.313 179.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.59 -18.65 3.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.901 -1.125 . . . . 0.0 112.219 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.603 HG22 ' N ' ' A' ' 49' ' ' ALA . 1.4 mp -138.47 -76.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.621 -1.299 . . . . 0.0 110.971 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.603 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -45.07 -27.02 0.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.735 -0.603 . . . . 0.0 111.116 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.437 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -63.16 -13.64 39.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.075 -1.016 . . . . 0.0 110.689 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.465 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 31.3 m-20 -98.68 10.63 40.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.07 -1.019 . . . . 0.0 110.752 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 51' ' ' ASP . 16.6 m-85 -144.91 15.86 1.56 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.995 -1.066 . . . . 0.0 110.261 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.44 108.75 17.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 110.369 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -72.21 147.76 46.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.153 -0.967 . . . . 0.0 110.19 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.456 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 20.6 pttt -146.38 163.35 30.36 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 109.957 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 50.9 Cg_endo -76.07 -177.11 19.92 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.84 -2.15 . . . . 0.0 110.918 0.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.674 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.08 166.27 10.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.885 . . . . 0.0 110.005 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 1.2 mttm -103.39 112.44 25.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 0.0 110.364 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 1.9 p90 -95.83 163.33 13.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 109.682 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 1.1 tt -155.23 130.49 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.058 -1.026 . . . . 0.0 110.907 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -138.83 114.64 9.98 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.436 -0.79 . . . . 0.0 109.932 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HB2' ' HD2' ' A' ' 65' ' ' LYS . 40.4 mttt -97.32 62.19 1.74 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 110.654 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 46.08 99.3 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.544 -0.723 . . . . 0.0 111.616 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.8 -21.67 43.92 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.421 ' HD2' ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -133.16 166.09 23.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -1.182 . . . . 0.0 110.46 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.741 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.1 pt? -171.25 145.76 2.24 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.614 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.3 OUTLIER -141.41 -160.1 1.04 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -170.22 128.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.991 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.478 ' NE2' HG21 ' A' ' 101' ' ' THR . 0.0 OUTLIER -98.79 132.49 44.11 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.033 -1.042 . . . . 0.0 109.704 179.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -112.62 128.16 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.85 . . . . 0.0 110.017 -179.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 m -88.57 126.74 35.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.06 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -102.92 144.74 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.79 143.94 28.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 0.0 110.357 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.624 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.3 OUTLIER 56.59 90.44 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.256 -0.902 . . . . 0.0 110.191 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -29.73 63.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.211 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -67.12 -53.08 34.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.848 . . . . 0.0 110.201 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.541 ' O ' HG12 ' A' ' 119' ' ' VAL . 46.8 m0 -57.72 -56.06 26.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.648 HD11 HG13 ' A' ' 117' ' ' ILE . 9.3 tp -87.69 116.58 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.443 -0.786 . . . . 0.0 109.928 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -86.37 -23.98 25.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.477 -0.764 . . . . 0.0 110.67 -179.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.16 179.48 47.52 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.3 mtt -151.52 165.79 33.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.395 -1.062 . . . . 0.0 109.796 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -154.56 148.84 26.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 110.215 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.917 HD12 ' CD2' ' A' ' 104' ' ' PHE . 2.3 mt -139.27 153.43 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 110.059 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.512 ' HB2' ' CE1' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 61.59 13.67 5.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.02 -1.05 . . . . 0.0 110.912 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.85 21.86 54.6 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.726 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 2.1 p-80 -136.81 162.72 32.43 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.751 -1.441 . . . . 0.0 110.677 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 171.47 10.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.345 -0.847 . . . . 0.0 111.023 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.481 ' CB ' ' CZ ' ' A' ' 104' ' ' PHE . 5.7 pt-20 -100.4 170.41 8.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.445 -0.784 . . . . 0.0 110.535 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 102' ' ' SER . 9.4 t-20 -108.38 138.14 45.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 109.975 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.4 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.1 pp -68.14 101.14 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.969 -1.082 . . . . 0.0 109.561 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.504 HG21 HG22 ' A' ' 101' ' ' THR . 0.4 OUTLIER -94.63 -31.95 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.352 -0.842 . . . . 0.0 110.978 -179.045 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.413 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 9.0 m -166.2 98.25 0.61 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.063 -1.023 . . . . 0.0 109.934 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -95.05 137.62 33.86 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.41 -0.806 . . . . 0.0 109.911 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.57 90.07 2.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.358 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -31.03 64.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.947 . . . . 0.0 109.979 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.81 -44.84 95.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 110.176 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -95.25 9.86 38.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 110.556 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 53.7 58.91 4.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.032 -1.043 . . . . 0.0 110.19 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -147.94 162.33 39.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 110.391 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.607 ' O ' HG22 ' A' ' 72' ' ' VAL . 1.2 mtp180 -164.71 149.42 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 109.961 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.504 HG22 HG21 ' A' ' 91' ' ' ILE . 52.4 m -142.04 154.87 45.3 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 109.986 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 24.8 p -146.91 146.67 30.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.981 . . . . 0.0 110.589 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -91.73 147.14 23.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.361 -0.837 . . . . 0.0 110.078 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.917 ' CD2' HD12 ' A' ' 83' ' ' ILE . 6.1 m-85 -130.14 140.14 50.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 110.846 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -97.34 126.82 42.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 108.991 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.741 ' O ' HD21 ' A' ' 66' ' ' LEU . 14.5 p -149.7 147.75 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.003 -1.06 . . . . 0.0 111.277 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.09 99.98 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.667 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 55.61 170.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.494 -0.754 . . . . 0.0 109.409 -178.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.408 ' H ' HD12 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -149.34 79.25 1.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.967 -1.083 . . . . 0.0 111.065 -179.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -146.41 71.89 1.26 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.827 . . . . 0.0 110.032 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.79 -101.48 0.19 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.453 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.3 OUTLIER -157.51 145.71 19.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -1.143 . . . . 0.0 110.156 -179.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mm -136.27 137.92 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 109.879 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.14 108.49 9.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 0.0 110.058 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -120.54 -176.36 15.62 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 5.3 mtmm -144.62 167.29 22.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.307 -1.113 . . . . 0.0 110.001 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.648 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.74 142.29 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.109 -0.995 . . . . 0.0 110.709 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.58 ' O ' HG22 ' A' ' 79' ' ' THR . 1.0 OUTLIER -104.7 155.92 18.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.438 -0.789 . . . . 0.0 109.679 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.2 OUTLIER -135.77 153.65 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 0.0 110.451 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 15.6 t80 -151.29 103.62 3.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.423 -0.798 . . . . 0.0 110.553 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 77' ' ' TRP . 75.3 mt -133.09 151.0 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 0.0 110.204 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -159.08 100.02 1.53 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.411 -0.806 . . . . 0.0 109.518 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -173.33 169.62 4.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 110.491 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 2.2 mttt -82.89 90.64 6.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.378 -0.826 . . . . 0.0 110.344 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.419 ' O ' ' CG1' ' A' ' 125' ' ' VAL . 2.0 p -77.43 134.66 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 110.156 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.58 25.47 1.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -0.881 . . . . 0.0 110.26 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.59 30.97 31.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 3.3 mtmm -144.62 139.11 15.13 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.238 -1.154 . . . . 0.0 110.017 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -62.49 119.7 6.91 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.709 1.373 . . . . 0.0 110.448 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 4.5 t80 -117.87 113.48 21.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 110.271 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -104.6 111.08 23.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.079 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.466 ' HE2' HG11 ' A' ' 119' ' ' VAL . 2.0 t80 -123.51 114.04 19.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 109.834 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -160.66 87.36 0.75 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.158 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -154.46 -173.01 4.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.868 . . . . 0.0 110.379 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -118.02 85.75 2.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.376 -0.827 . . . . 0.0 109.712 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -85.68 -179.05 6.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.28 -0.888 . . . . 0.0 110.362 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.595 ' O ' HG23 ' A' ' 138' ' ' ILE . 8.5 p30 -151.01 167.99 25.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 110.331 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.4 pt -157.28 177.19 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 110.499 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.453 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 20.7 m -91.57 121.2 33.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.903 . . . . 0.0 110.188 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.677 ' CD2' HD11 ' A' ' 83' ' ' ILE . 12.6 m-85 -89.51 99.96 12.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.58 154.84 24.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 110.244 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.4 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 14.9 m-85 -148.65 148.11 29.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.858 . . . . 0.0 109.919 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.443 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 42.4 m-80 -138.99 98.13 3.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.88 . . . . 0.0 110.345 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.855 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -149.76 -148.83 4.85 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo . . . . . 0 C--N 1.307 -1.639 0 O-C-N 123.93 1.49 . . . . 0.0 110.463 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 2.5 m-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.921 0.391 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 p -158.86 146.01 17.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.948 . . . . 0.0 110.743 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -179.66 176.64 47.73 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.58 114.84 25.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.193 -1.181 . . . . 0.0 110.47 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.52 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 1.5 tt -94.79 148.25 22.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 110.319 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.1 t30 -80.64 139.8 36.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.96 . . . . 0.0 110.03 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.51 ' CD2' ' N ' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -167.11 174.18 8.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.026 -1.046 . . . . 0.0 110.658 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.51 ' N ' ' CD2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -155.58 -165.76 2.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.594 -0.691 . . . . 0.0 109.571 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.671 ' C ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.07 164.63 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.1 -1.0 . . . . 0.0 110.274 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -147.83 148.26 30.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.373 -0.83 . . . . 0.0 109.978 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.441 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -67.82 128.37 36.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 110.09 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.536 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -52.53 146.62 9.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.176 -0.953 . . . . 0.0 109.901 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.3 t30 71.74 1.54 3.93 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.851 -0.53 . . . . 0.0 111.161 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -135.24 -162.22 1.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.89 -1.131 . . . . 0.0 109.531 179.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.43 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.9 OUTLIER -132.82 12.07 4.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 110.332 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -136.43 137.62 40.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.749 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.671 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -64.23 134.23 54.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.326 179.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.58 -17.25 3.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.904 -1.122 . . . . 0.0 112.159 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.0 mt -137.37 -50.75 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.61 -1.306 . . . . 0.0 111.184 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.0 5.34 11.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.385 -0.822 . . . . 0.0 111.512 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.447 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -73.5 -29.21 62.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.852 -1.155 . . . . 0.0 110.679 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -99.47 12.47 36.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.102 -0.999 . . . . 0.0 110.896 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -118.76 -18.84 8.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.009 -1.057 . . . . 0.0 110.451 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.414 ' CE2' HG12 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -101.43 113.86 27.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 109.848 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.14 155.21 40.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.967 . . . . 0.0 110.459 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -146.35 160.06 43.35 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.833 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 55.6 Cg_endo -78.29 -177.04 19.91 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.588 -2.255 . . . . 0.0 110.649 -0.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.86 170.4 7.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.143 -0.973 . . . . 0.0 110.095 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -104.32 119.47 39.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.789 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 29.1 p90 -97.01 165.81 11.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 109.525 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.677 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -154.95 124.04 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.937 -1.102 . . . . 0.0 110.937 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.479 ' HD3' HD21 ' A' ' 109' ' ' LEU . 1.2 mtmt -137.67 125.13 21.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.345 -0.847 . . . . 0.0 110.684 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -103.81 62.42 0.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.393 -0.817 . . . . 0.0 110.402 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 47.67 98.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.463 -0.773 . . . . 0.0 111.35 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.11 12.59 39.08 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.707 ' C ' HD13 ' A' ' 66' ' ' LEU . 3.5 ptpt -173.7 154.81 2.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.889 -1.359 . . . . 0.0 110.227 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.811 ' N ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -154.27 151.31 28.98 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.073 -1.017 . . . . 0.0 111.247 179.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.677 ' HB2' HG23 ' A' ' 60' ' ' ILE . 13.8 m-85 -141.92 -164.71 1.85 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.467 -0.771 . . . . 0.0 109.233 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.1 t -169.09 131.98 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.023 -1.048 . . . . 0.0 110.835 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -101.72 135.88 42.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.392 -0.817 . . . . 0.0 109.838 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.437 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -113.62 133.38 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.133 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -91.04 128.73 36.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.931 . . . . 0.0 110.422 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.541 HG11 ' CE ' ' A' ' 81' ' ' MET . 0.9 OUTLIER -104.86 142.24 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.906 . . . . 0.0 110.055 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -99.98 138.84 36.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.129 -0.982 . . . . 0.0 110.507 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.449 ' CD2' ' CE2' ' A' ' 77' ' ' TRP . 2.3 t-80 55.98 102.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.357 -0.839 . . . . 0.0 110.447 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.3 p -62.57 -43.73 98.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.125 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.76 -48.83 59.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.91 . . . . 0.0 110.146 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.46 ' O ' HG12 ' A' ' 119' ' ' VAL . 44.4 m0 -57.41 -67.69 0.3 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 110.323 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 78' ' ' ILE . 17.9 tt -87.83 117.98 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.39 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.618 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -85.9 -21.71 27.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.423 -0.798 . . . . 0.0 110.898 -178.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.09 177.13 47.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.541 ' CE ' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -152.29 159.22 43.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.432 -1.04 . . . . 0.0 109.884 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -155.84 151.33 27.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 0.0 109.932 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.527 HD12 ' CD2' ' A' ' 104' ' ' PHE . 3.9 mt -147.12 157.71 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 110.13 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.523 ' HB2' ' CE1' ' A' ' 86' ' ' HIS . 0.6 OUTLIER 62.48 14.52 7.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.611 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.23 21.23 61.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.523 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 2.1 p-80 -136.77 160.17 39.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.035 -1.273 . . . . 0.0 110.563 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.85 163.68 27.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.393 -0.817 . . . . 0.0 110.403 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.524 ' CB ' ' CE1' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -92.22 170.27 9.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.158 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.67 134.81 51.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.184 -0.948 . . . . 0.0 110.066 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -67.4 101.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.957 . . . . 0.0 109.618 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.523 HG21 HG22 ' A' ' 101' ' ' THR . 0.7 OUTLIER -95.27 -29.89 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 111.001 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 3.5 m -167.15 94.94 0.47 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.035 -1.041 . . . . 0.0 110.048 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 18.2 ttmt -96.28 139.19 32.78 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.428 -0.795 . . . . 0.0 110.036 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.79 99.03 3.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.161 -0.962 . . . . 0.0 110.237 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 p -78.37 -32.37 48.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.1 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.12 99.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.879 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.06 10.68 36.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 0.0 110.549 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.54 58.11 5.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.978 -1.076 . . . . 0.0 110.011 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -146.43 165.04 30.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 110.265 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.471 ' CB ' ' CG2' ' A' ' 72' ' ' VAL . 2.8 mtp180 -168.73 154.42 6.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.368 -0.833 . . . . 0.0 109.903 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.523 HG22 HG21 ' A' ' 91' ' ' ILE . 78.2 m -141.76 154.66 45.41 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 109.839 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.452 ' HB2' ' CG ' ' A' ' 88' ' ' GLU . 99.7 p -144.84 139.14 27.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.981 . . . . 0.0 110.341 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -92.97 130.42 38.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.948 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.527 ' CD2' HD12 ' A' ' 83' ' ' ILE . 48.0 m-85 -114.43 147.74 38.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 110.451 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -105.17 135.15 47.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.342 -0.849 . . . . 0.0 110.052 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.3 m -149.36 158.97 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.36 -0.837 . . . . 0.0 109.891 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.4 p -53.17 -35.03 59.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.426 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.49 -150.96 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.596 -0.69 . . . . 0.0 109.184 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.479 HD21 ' HD3' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -148.56 54.18 1.01 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.849 -1.157 . . . . 0.0 110.567 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 22.2 t-20 -145.28 57.64 1.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.22 -0.925 . . . . 0.0 110.222 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.44 176.97 44.14 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.419 ' CE ' HG23 ' A' ' 139' ' ' THR . 0.1 OUTLIER -81.6 146.66 29.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -1.183 . . . . 0.0 110.446 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.403 ' N ' ' O ' ' A' ' 140' ' ' TYR . 7.6 mm -136.36 129.43 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.841 . . . . 0.0 109.942 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -76.72 112.55 13.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.839 . . . . 0.0 110.367 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.432 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -121.09 -175.15 15.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 63.1 mttt -144.88 164.86 29.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -1.143 . . . . 0.0 110.035 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.632 HG21 HD11 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.98 145.76 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -0.948 . . . . 0.0 110.668 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.618 ' C ' HG22 ' A' ' 79' ' ' THR . 72.9 m-20 -107.26 155.7 19.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.496 -0.753 . . . . 0.0 109.492 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.2 OUTLIER -129.55 146.32 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.965 -1.084 . . . . 0.0 110.609 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.412 ' HB2' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -152.3 104.2 2.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.372 -0.83 . . . . 0.0 110.178 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 46.4 mt -128.24 152.46 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.118 -0.989 . . . . 0.0 110.448 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.28 95.56 1.14 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.438 -0.789 . . . . 0.0 109.69 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -173.72 175.53 2.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.0 110.23 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -84.16 102.78 12.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 110.273 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.664 ' O ' HG12 ' A' ' 125' ' ' VAL . 2.1 t -76.68 103.39 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.091 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.66 43.51 7.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.049 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.37 33.53 56.25 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.28 109.46 4.59 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.278 -1.13 . . . . 0.0 110.193 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -47.42 113.5 0.76 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.66 1.347 . . . . 0.0 110.164 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -112.48 151.14 30.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.0 110.437 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.64 125.89 26.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.393 -0.817 . . . . 0.0 110.115 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.418 ' HE2' HG11 ' A' ' 119' ' ' VAL . 4.2 t80 -140.4 129.87 24.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 110.155 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 0.8 OUTLIER -176.3 88.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 110.037 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.35 -163.57 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 110.403 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -118.24 145.03 45.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 110.172 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -154.97 -179.03 7.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.095 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 8.9 p30 -150.27 169.85 20.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.187 -0.945 . . . . 0.0 110.558 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.632 HD11 HG21 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -156.53 173.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.608 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.419 HG23 ' CE ' ' A' ' 112' ' ' LYS . 24.6 m -91.82 162.77 14.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.473 -0.767 . . . . 0.0 110.526 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.432 ' CE2' ' HA3' ' A' ' 115' ' ' GLY . 97.0 m-85 -144.19 104.87 4.16 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.368 -0.832 . . . . 0.0 109.714 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.28 104.37 14.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 110.68 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.435 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 29.6 m-85 -91.66 135.27 34.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.896 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.413 ' H ' HD21 ' A' ' 34' ' ' LEU . 3.7 m-80 -126.25 105.09 8.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.096 -1.003 . . . . 0.0 110.227 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.448 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -150.96 -149.8 5.14 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.42 ' HD2' ' HA3' ' A' ' 144' ' ' GLY . 1.7 Cg_endo . . . . . 0 C--N 1.31 -1.478 0 O-C-N 123.702 1.369 . . . . 0.0 110.907 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.042 0.449 . . . . 0.0 109.874 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -160.76 144.48 13.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.266 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.87 -175.99 42.6 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.39 105.62 17.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.34 -1.094 . . . . 0.0 110.395 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.649 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -94.8 154.49 17.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.0 110.31 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -80.13 137.86 36.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.335 -0.853 . . . . 0.0 110.037 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.717 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -165.96 161.91 17.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.04 -1.038 . . . . 0.0 110.273 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 141' ' ' LYS . 0.2 OUTLIER -156.11 -176.82 6.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 109.908 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.792 ' O ' HG22 ' A' ' 46' ' ' THR . 25.8 m -140.38 116.84 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.018 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -90.27 163.1 14.89 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.494 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.441 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.4 OUTLIER -67.36 126.84 30.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 109.942 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.494 ' O ' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -51.01 141.91 12.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.031 . . . . 0.0 109.943 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER 73.09 0.59 3.73 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.851 -0.53 . . . . 0.0 110.981 -179.408 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -136.83 -168.52 2.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.85 -1.156 . . . . 0.0 109.677 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -135.86 24.41 3.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.188 -0.945 . . . . 0.0 110.422 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -135.65 119.91 17.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.069 . . . . 0.0 111.101 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.792 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.7 OUTLIER -50.14 117.57 2.43 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.589 -0.694 . . . . 0.0 109.501 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.6 t -129.64 -18.98 3.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.811 -1.181 . . . . 0.0 112.18 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 49' ' ' ALA . 71.8 mt -138.54 -79.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.653 -1.28 . . . . 0.0 111.0 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.672 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -45.19 -26.93 0.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.738 -0.601 . . . . 0.0 111.159 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.458 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -67.68 -18.12 64.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.013 -1.055 . . . . 0.0 110.655 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -95.77 14.31 23.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 110.771 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -134.49 2.71 3.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.062 -1.024 . . . . 0.0 111.109 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.443 ' CE1' ' SD ' ' A' ' 81' ' ' MET . 26.7 m-85 -123.37 120.49 33.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.959 -1.088 . . . . 0.0 110.298 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -72.47 160.04 32.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.346 -0.846 . . . . 0.0 110.569 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.73 164.36 24.31 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.895 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 53.5 Cg_endo -76.71 -175.71 17.18 Favored 'Cis proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.583 -0.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.717 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -103.4 169.17 8.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.958 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.75 110.32 22.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.198 -0.939 . . . . 0.0 109.998 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.618 ' CD2' HD13 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -96.02 161.8 13.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.328 -0.857 . . . . 0.0 109.91 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -155.3 151.09 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.095 -1.003 . . . . 0.0 110.997 -179.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 17.9 mtmt -134.53 173.86 11.19 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.331 -0.855 . . . . 0.0 110.595 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.479 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -158.26 63.51 0.44 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.364 -0.835 . . . . 0.0 110.153 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.0 m120 48.71 84.5 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 111.274 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.64 18.57 47.77 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.53 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.479 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 3.1 ptpt -165.83 162.86 18.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.964 -1.316 . . . . 0.0 111.294 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.83 HD21 ' H ' ' A' ' 108' ' ' LYS . 1.7 pt? -173.42 155.8 2.91 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.962 0.887 . . . . 0.0 111.205 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 1.1 m-85 -139.0 -159.4 0.95 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 67' ' ' TYR . 1.2 t -169.41 133.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.141 -0.974 . . . . 0.0 109.796 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 102' ' ' SER . 0.7 OUTLIER -97.42 136.17 38.24 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.106 -0.997 . . . . 0.0 109.866 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.435 ' O ' HG22 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -113.68 131.12 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 110.364 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m -88.76 123.89 33.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.637 HG12 ' HE1' ' A' ' 81' ' ' MET . 0.8 OUTLIER -103.29 136.77 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 110.499 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.8 144.6 29.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.365 -0.834 . . . . 0.0 110.007 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 58.33 89.08 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.178 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.2 p -55.22 -23.89 24.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.302 -0.874 . . . . 0.0 110.58 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -73.92 -55.64 5.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.976 . . . . 0.0 110.322 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.687 ' O ' HG12 ' A' ' 119' ' ' VAL . 42.2 m0 -48.91 -62.33 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 0.0 110.466 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.592 HG23 ' O ' ' A' ' 78' ' ' ILE . 6.4 tp -87.9 115.5 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.282 -0.886 . . . . 0.0 110.242 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.576 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.33 -26.68 23.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.389 -0.819 . . . . 0.0 110.83 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.5 176.86 45.34 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.637 ' HE1' HG12 ' A' ' 72' ' ' VAL . 33.6 mtm -151.92 160.13 43.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.358 -1.083 . . . . 0.0 110.063 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 116' ' ' LYS . 1.3 m -154.53 132.93 11.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.185 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.654 HD12 ' CG ' ' A' ' 104' ' ' PHE . 16.8 mt -130.17 141.96 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.354 -0.841 . . . . 0.0 110.321 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.463 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 1.1 tm-20 69.89 3.08 4.15 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.415 -0.803 . . . . 0.0 111.295 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.38 24.42 10.25 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.695 -1.241 . . . . 0.0 111.119 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.47 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.49 159.12 42.89 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.605 -1.526 . . . . 0.0 110.179 179.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -70.48 -178.44 1.76 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.347 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 0.6 OUTLIER -104.92 168.46 9.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 110.203 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.83 129.44 56.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.168 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.407 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.1 pp -67.98 101.23 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.139 -0.975 . . . . 0.0 109.484 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.548 HG21 HG22 ' A' ' 101' ' ' THR . 1.4 tt -93.19 -26.88 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.441 -0.787 . . . . 0.0 110.525 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.458 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -166.81 148.72 6.24 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.293 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.457 ' HG3' ' CG ' ' A' ' 100' ' ' ARG . 15.5 ttmt -141.98 149.32 39.9 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 110.019 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.74 91.34 2.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 0.0 110.466 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.4 p -73.33 -18.71 61.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 110.121 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.6 -28.46 69.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 110.379 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.55 23.24 3.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.253 -0.904 . . . . 0.0 110.249 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.54 79.72 0.11 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 0.0 110.432 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -148.14 167.15 25.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.457 ' CG ' ' HG3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -172.46 157.53 4.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 110.209 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.548 HG22 HG21 ' A' ' 91' ' ' ILE . 90.8 m -141.44 152.82 44.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.435 -0.791 . . . . 0.0 109.651 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 0.8 OUTLIER -145.24 145.22 31.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.084 -1.01 . . . . 0.0 110.694 -179.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -93.57 143.37 26.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.433 -0.792 . . . . 0.0 109.886 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.654 ' CG ' HD12 ' A' ' 83' ' ' ILE . 44.2 m-85 -127.36 127.58 44.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.976 . . . . 0.0 110.663 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.443 ' C ' HG13 ' A' ' 106' ' ' VAL . 2.7 tm-20 -93.27 125.2 37.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 109.792 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 105' ' ' GLU . 29.0 m -149.33 163.9 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.022 -1.049 . . . . 0.0 110.887 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p -80.21 105.03 11.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.388 -0.82 . . . . 0.0 109.348 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.83 ' H ' HD21 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 53.74 174.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 109.756 -178.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.542 HD21 ' HD2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -149.91 73.7 1.18 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.004 -1.06 . . . . 0.0 110.898 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.456 ' ND2' HD12 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -144.41 66.76 1.26 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.066 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.39 -108.64 0.31 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.86 146.34 19.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -1.145 . . . . 0.0 110.342 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.544 HD12 ' CE2' ' A' ' 142' ' ' PHE . 35.9 mt -137.38 142.8 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.357 -0.839 . . . . 0.0 110.157 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -76.3 125.42 29.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.218 -0.926 . . . . 0.0 110.137 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -131.56 -177.04 14.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.5 mtmm -142.38 161.0 39.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.364 -1.08 . . . . 0.0 109.678 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.483 HG21 HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -158.23 146.43 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.046 -1.034 . . . . 0.0 110.735 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.576 ' C ' HG22 ' A' ' 79' ' ' THR . 89.0 m-20 -110.12 159.68 17.13 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -133.63 147.05 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.09 -1.006 . . . . 0.0 110.17 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -152.03 113.14 4.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 110.684 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.617 HD11 ' HA ' ' A' ' 77' ' ' TRP . 2.6 mp -138.75 152.21 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 0.0 109.856 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.15 98.43 1.3 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.953 . . . . 0.0 110.015 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -174.03 178.68 2.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 110.18 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -93.06 107.69 19.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 110.175 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.42 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 56.0 t -75.84 90.58 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.826 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.42 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 63.7 53.04 2.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.277 -0.89 . . . . 0.0 110.012 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.33 36.95 48.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -145.04 97.48 4.84 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.296 -1.12 . . . . 0.0 110.366 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.99 110.15 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.863 1.454 . . . . 0.0 110.15 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -116.63 153.1 32.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.341 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -136.68 112.19 9.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 110.13 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.489 ' CE2' ' HB ' ' A' ' 119' ' ' VAL . 3.7 t80 -115.71 128.24 55.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.004 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -167.49 86.69 0.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.404 -0.81 . . . . 0.0 109.948 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -153.33 -169.19 3.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.898 . . . . 0.0 110.391 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.401 ' ND1' ' OD1' ' A' ' 118' ' ' ASP . 13.4 t60 -119.61 148.39 43.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 109.99 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -154.79 -179.66 8.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.882 . . . . 0.0 110.136 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.499 ' O ' HG23 ' A' ' 138' ' ' ILE . 42.9 p-10 -151.82 170.66 19.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.882 . . . . 0.0 110.261 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.672 HG21 ' HB2' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -157.76 168.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.917 . . . . 0.0 110.348 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 87.0 m -91.63 117.53 29.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.335 -0.853 . . . . 0.0 109.82 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.479 ' CD2' HG12 ' A' ' 83' ' ' ILE . 10.4 m-85 -88.91 106.51 18.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 110.326 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -86.69 159.59 19.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.318 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.544 ' CE2' HD12 ' A' ' 113' ' ' ILE . 41.4 m-85 -148.87 150.86 33.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.878 . . . . 0.0 110.125 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.56 ' C ' HD21 ' A' ' 34' ' ' LEU . 39.1 m-80 -143.84 96.32 2.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 110.234 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.649 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -135.73 -140.01 4.1 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.432 ' O ' ' ND2' ' A' ' 110' ' ' ASN . 39.2 Cg_exo . . . . . 0 C--N 1.309 -1.521 0 O-C-N 123.711 1.374 . . . . 0.0 110.422 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.027 0.442 . . . . 0.0 110.156 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.18 144.07 14.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.946 . . . . 0.0 110.264 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.61 -177.52 45.92 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.34 108.4 19.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.351 -1.087 . . . . 0.0 110.359 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.935 ' HG ' HD22 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -94.84 150.0 20.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.399 -0.813 . . . . 0.0 109.913 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.708 ' H ' HD13 ' A' ' 34' ' ' LEU . 5.1 m-80 -78.93 141.34 37.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.991 -1.068 . . . . 0.0 109.7 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -165.4 156.48 14.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 110.557 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 141' ' ' LYS . 5.2 tt0 -155.56 -175.85 5.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 0.0 109.946 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.659 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -141.63 173.22 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 110.449 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -147.79 161.07 41.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -0.805 . . . . 0.0 109.951 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.519 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.1 OUTLIER -67.53 132.73 48.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 0.0 109.879 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.512 ' CE2' ' ND2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -57.45 146.04 30.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 110.052 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.4 t30 71.07 2.89 4.43 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.801 -0.562 . . . . 0.0 111.055 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.519 HG21 ' HG2' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -135.64 -164.48 1.55 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.828 -1.17 . . . . 0.0 109.767 179.268 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.413 ' N ' ' OG1' ' A' ' 43' ' ' THR . 2.2 t-20 -131.81 14.21 4.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 110.296 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.81 135.55 41.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.069 -1.019 . . . . 0.0 110.401 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.531 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -68.07 133.48 49.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.403 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.48 -17.45 3.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.017 -1.052 . . . . 0.0 112.184 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.6 mt -136.92 -58.6 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.607 -1.308 . . . . 0.0 111.121 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.09 -10.04 27.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.472 -0.768 . . . . 0.0 111.424 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.461 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER -75.68 -18.15 59.72 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.843 -1.16 . . . . 0.0 110.787 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -102.06 15.41 29.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.0 110.731 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -129.12 3.37 5.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.049 -1.032 . . . . 0.0 110.985 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -128.94 117.54 21.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.994 -1.066 . . . . 0.0 110.293 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -72.83 166.71 22.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.341 -0.849 . . . . 0.0 110.494 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -146.92 160.35 40.69 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.304 -0.873 . . . . 0.0 109.834 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.13 -175.36 16.49 Favored 'Cis proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.752 -2.186 . . . . 0.0 110.725 -0.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.44 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.77 170.23 8.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -0.895 . . . . 0.0 109.96 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.462 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -107.97 111.67 23.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.11 -0.994 . . . . 0.0 110.693 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.666 ' CD2' HD21 ' A' ' 109' ' ' LEU . 2.7 p90 -97.84 165.24 12.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.262 -0.899 . . . . 0.0 110.132 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -155.52 154.15 6.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.254 -0.904 . . . . 0.0 110.66 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -133.35 170.64 15.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.424 -0.798 . . . . 0.0 110.479 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.455 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 0.7 OUTLIER -152.75 62.33 0.79 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -0.83 . . . . 0.0 110.12 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 50.47 82.86 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.353 -0.842 . . . . 0.0 111.067 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.51 21.93 35.91 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.455 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 6.2 ptpt -167.15 163.71 15.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.021 -1.282 . . . . 0.0 110.768 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.952 HD11 ' HA ' ' A' ' 108' ' ' LYS . 1.5 pt? -173.73 154.19 2.39 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.009 0.909 . . . . 0.0 111.034 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.565 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -139.61 -155.52 0.6 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.779 -0.575 . . . . 0.0 109.475 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 103' ' ' GLU . 1.0 OUTLIER -170.67 135.88 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.195 -0.94 . . . . 0.0 110.536 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.462 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -99.29 133.73 43.18 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.29 -0.881 . . . . 0.0 109.657 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.2 OUTLIER -113.0 140.42 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.363 -0.836 . . . . 0.0 110.3 -179.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.5 m -89.23 129.9 35.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.754 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.724 HG12 HG21 ' A' ' 78' ' ' ILE . 2.5 t -103.47 128.25 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 110.544 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -100.92 134.97 43.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.304 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.515 ' O ' HG22 ' A' ' 78' ' ' ILE . 32.1 m170 54.76 94.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.345 -0.847 . . . . 0.0 110.245 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -27.85 61.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.942 . . . . 0.0 110.288 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -27.11 61.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.186 -0.946 . . . . 0.0 110.283 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.556 ' O ' HG12 ' A' ' 119' ' ' VAL . 38.4 m0 -92.48 -52.27 4.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.2 -0.938 . . . . 0.0 110.057 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.724 HG21 HG12 ' A' ' 72' ' ' VAL . 1.5 tt -88.65 119.15 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.293 -0.88 . . . . 0.0 109.392 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.629 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.98 -23.83 24.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.42 -0.8 . . . . 0.0 111.389 -178.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.49 -178.84 48.15 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.064 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.432 ' HE2' HG13 ' A' ' 72' ' ' VAL . 19.0 mtm -152.24 162.73 40.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.464 -1.021 . . . . 0.0 110.103 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -155.2 141.26 18.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 0.0 109.935 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.569 HD12 ' CG ' ' A' ' 104' ' ' PHE . 7.1 mt -135.75 140.47 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 110.589 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 71.16 1.99 4.05 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.528 -0.733 . . . . 0.0 111.442 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.79 21.79 10.85 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.536 -1.316 . . . . 0.0 111.233 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.13 158.58 44.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.622 -1.517 . . . . 0.0 110.05 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -71.41 -177.6 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.141 -0.975 . . . . 0.0 110.337 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -109.95 170.21 8.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.322 -0.861 . . . . 0.0 110.182 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -115.4 134.73 54.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.294 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.48 102.29 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.976 . . . . 0.0 109.668 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.587 HG22 ' O ' ' A' ' 101' ' ' THR . 1.4 tt -95.51 -27.52 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 111.008 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.448 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -167.53 103.62 0.51 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.08 -1.013 . . . . 0.0 109.856 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -95.53 149.59 21.25 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.386 -0.821 . . . . 0.0 110.259 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.411 ' ND2' ' HD2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -143.34 61.58 1.39 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 110.116 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 m -54.49 -30.58 53.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.214 -0.928 . . . . 0.0 110.148 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.09 -49.27 75.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.094 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.411 ' HD2' ' ND2' ' A' ' 94' ' ' ASN . 9.4 mttt -95.97 9.9 39.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.566 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.47 55.62 4.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.082 -1.011 . . . . 0.0 110.326 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -147.53 159.2 44.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.173 -0.954 . . . . 0.0 110.402 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.415 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.5 ttm180 -163.16 162.77 25.7 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.325 -0.86 . . . . 0.0 110.023 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.587 ' O ' HG22 ' A' ' 91' ' ' ILE . 85.7 m -141.07 152.71 45.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.944 . . . . 0.0 109.655 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.1 p -145.71 143.4 29.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.977 -1.077 . . . . 0.0 110.725 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 5.3 tt0 -93.07 143.87 25.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.381 -0.824 . . . . 0.0 109.843 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.569 ' CG ' HD12 ' A' ' 83' ' ' ILE . 42.4 m-85 -125.64 145.46 50.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.108 -0.995 . . . . 0.0 110.561 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.45 130.61 47.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.363 -0.835 . . . . 0.0 110.141 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.551 ' O ' HD21 ' A' ' 66' ' ' LEU . 12.5 p -148.9 150.56 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 110.292 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.34 -39.63 46.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.952 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.5 -157.56 0.33 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.445 -0.784 . . . . 0.0 109.591 179.168 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.935 HD22 ' HG ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -148.19 62.77 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.96 -1.087 . . . . 0.0 110.612 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -145.81 62.92 1.25 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 110.078 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.82 -179.97 33.15 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.05 145.28 30.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -1.14 . . . . 0.0 110.57 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.521 HD13 HG21 ' A' ' 106' ' ' VAL . 27.1 mt -137.77 149.71 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.888 . . . . 0.0 109.923 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -76.04 120.96 22.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.0 110.183 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.489 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -124.71 171.21 16.78 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 82' ' ' SER . 47.1 mttt -146.37 159.94 42.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.276 -1.132 . . . . 0.0 110.033 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.402 HG12 ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -158.12 144.35 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.155 -0.965 . . . . 0.0 110.317 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.629 ' C ' HG22 ' A' ' 79' ' ' THR . 11.9 m-20 -106.38 158.09 17.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.341 -0.849 . . . . 0.0 109.676 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.1 OUTLIER -131.89 150.99 34.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.243 -0.911 . . . . 0.0 109.771 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 16.8 t80 -151.74 100.26 2.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 0.0 110.543 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.434 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 54.7 mt -129.74 151.99 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 110.176 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.48 96.58 1.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.856 . . . . 0.0 110.012 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -173.76 -175.78 1.14 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.868 . . . . 0.0 110.394 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.91 104.15 16.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.338 -0.851 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.541 ' O ' HG12 ' A' ' 125' ' ' VAL . 11.9 t -76.6 95.68 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 110.072 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.13 44.44 10.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 110.128 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.85 30.09 44.71 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -145.34 107.79 4.48 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.295 -1.12 . . . . 0.0 110.233 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -52.12 108.31 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.684 1.36 . . . . 0.0 110.214 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.527 ' HB3' HG23 ' A' ' 125' ' ' VAL . 24.4 t80 -110.66 119.33 38.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 0.0 110.46 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -106.33 117.22 33.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 110.138 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.488 ' HE2' HG11 ' A' ' 119' ' ' VAL . 2.3 t80 -126.45 121.22 31.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 0.0 110.078 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 35.4 t70 -166.69 90.47 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 110.415 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.03 -165.1 2.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.145 -0.972 . . . . 0.0 110.392 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -120.87 86.11 2.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 109.997 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -85.45 -179.17 6.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.881 . . . . 0.0 110.392 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.57 ' O ' HG23 ' A' ' 138' ' ' ILE . 46.2 p30 -151.28 171.05 18.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 110.29 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.4 pt -156.5 162.22 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 62.2 m -91.67 121.24 33.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 110.61 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.659 ' HA ' HG12 ' A' ' 38' ' ' VAL . 21.9 m-85 -90.2 155.16 19.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.835 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -144.77 99.82 3.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.518 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -91.6 144.03 25.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.37 -0.831 . . . . 0.0 109.825 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 5.4 m-80 -132.96 100.96 5.05 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.158 -0.964 . . . . 0.0 110.51 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.917 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -163.21 -144.03 3.89 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.403 ' HG2' HD11 ' A' ' 109' ' ' LEU . 15.3 Cg_endo . . . . . 0 C--N 1.309 -1.521 0 O-C-N 123.779 1.41 . . . . 0.0 110.635 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.944 0.402 . . . . 0.0 110.277 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.6 t -159.65 140.73 12.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 110.525 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 177.37 178.76 47.27 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.03 111.29 21.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -1.125 . . . . 0.0 110.389 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.512 ' CB ' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -94.16 151.12 19.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 109.665 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.444 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -79.06 131.5 36.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.178 -0.951 . . . . 0.0 110.538 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.907 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -166.11 158.14 14.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 111.034 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -155.53 -165.96 2.12 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.559 ' C ' HG23 ' A' ' 46' ' ' THR . 0.1 OUTLIER -141.22 175.08 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 110.36 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 54.3 m-85 -148.32 163.99 35.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.475 -0.766 . . . . 0.0 109.813 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.427 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -68.24 128.46 36.64 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 109.895 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.515 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -54.97 146.37 17.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 110.112 -179.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.0 t-20 71.87 2.93 4.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.922 -0.487 . . . . 0.0 110.941 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -136.23 -162.35 1.26 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.888 -1.133 . . . . 0.0 109.706 179.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.416 ' N ' ' OG1' ' A' ' 43' ' ' THR . 22.9 m120 -133.05 15.74 4.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 110.445 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.5 139.03 43.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.16 -0.963 . . . . 0.0 110.361 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.559 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -74.08 133.06 42.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.994 . . . . 0.0 109.379 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.76 -16.97 4.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.046 -1.033 . . . . 0.0 111.82 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.8 mt -137.11 -64.63 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.831 -1.168 . . . . 0.0 110.623 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.4 -18.09 6.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.495 -0.753 . . . . 0.0 111.163 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.46 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 0.1 OUTLIER -68.35 -10.87 57.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.926 -1.108 . . . . 0.0 110.847 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -102.38 12.8 36.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.879 -1.138 . . . . 0.0 110.843 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -136.29 6.44 3.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.012 -1.055 . . . . 0.0 110.667 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -114.22 98.47 6.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.957 . . . . 0.0 109.845 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -72.03 103.28 3.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.522 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HG3' ' N ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -93.05 165.06 19.38 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.204 -0.935 . . . . 0.0 109.879 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.446 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 50.1 Cg_endo -78.61 -176.36 18.53 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.468 -2.305 . . . . 0.0 110.524 -0.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.907 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -103.15 165.41 11.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.25 -0.906 . . . . 0.0 110.008 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.405 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.71 109.52 21.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 110.168 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.512 ' CD1' ' CB ' ' A' ' 34' ' ' LEU . 19.4 p90 -96.95 161.78 13.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.676 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -154.0 153.05 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.111 -0.993 . . . . 0.0 110.357 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -135.89 174.03 11.06 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.324 -0.86 . . . . 0.0 110.453 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.437 ' HB2' ' HD3' ' A' ' 65' ' ' LYS . 9.8 mtmt -159.48 62.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.344 -0.848 . . . . 0.0 110.108 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 48.97 87.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.449 -0.782 . . . . 0.0 111.193 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.59 25.15 33.69 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.087 -1.054 . . . . 0.0 110.558 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.437 ' HD3' ' HB2' ' A' ' 62' ' ' LYS . 6.8 ptpt -171.9 158.85 4.94 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.962 -1.317 . . . . 0.0 111.028 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' A' ' 108' ' ' LYS . 1.3 pt? -173.4 150.29 1.82 Allowed 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 122.068 0.937 . . . . 0.0 111.334 178.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.586 ' C ' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -140.03 -161.06 1.14 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.586 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -167.15 142.89 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.578 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 102' ' ' SER . 8.7 pt20 -101.12 134.8 43.6 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.906 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -113.75 138.85 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.902 . . . . 0.0 109.842 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.6 m -89.03 135.87 33.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 110.469 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.663 HG12 HG21 ' A' ' 78' ' ' ILE . 2.0 t -107.42 122.69 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.865 . . . . 0.0 110.201 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -100.23 143.07 30.85 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.107 -0.995 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.909 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.5 OUTLIER 62.03 74.53 0.44 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 110.029 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.4 m -64.35 -19.1 65.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.348 -0.845 . . . . 0.0 110.551 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.32 -45.11 57.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.089 -1.007 . . . . 0.0 110.315 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -77.19 -42.44 37.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 110.19 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.909 HG22 ' O ' ' A' ' 74' ' ' HIS . 6.1 tp -88.14 118.82 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -0.92 . . . . 0.0 109.3 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -85.55 -24.06 27.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 111.029 -178.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.48 -179.16 46.85 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.006 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.552 ' HE1' HG22 ' A' ' 72' ' ' VAL . 28.5 mtm -151.35 158.55 43.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.458 -1.025 . . . . 0.0 109.791 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.33 154.87 34.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.087 -1.008 . . . . 0.0 110.17 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.76 HD12 ' CD2' ' A' ' 104' ' ' PHE . 12.9 mt -141.96 155.36 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 110.195 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.53 ' HB2' ' CE1' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 58.79 16.55 4.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.013 . . . . 0.0 110.791 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.19 21.65 60.41 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.92 -1.133 . . . . 0.0 110.424 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.53 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 2.2 p-80 -135.18 157.42 46.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.842 -1.387 . . . . 0.0 110.525 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 178.8 3.65 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.329 -0.857 . . . . 0.0 110.701 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.407 ' HG3' ' CB ' ' A' ' 102' ' ' SER . 2.7 pt-20 -108.5 166.65 10.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.362 -0.836 . . . . 0.0 110.221 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 102' ' ' SER . 1.4 t30 -105.22 130.89 53.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -0.919 . . . . 0.0 110.209 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.12 102.56 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -0.954 . . . . 0.0 110.081 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 101' ' ' THR . 1.3 tt -95.78 -26.83 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.88 . . . . 0.0 110.855 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -167.5 99.02 0.49 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.148 -0.97 . . . . 0.0 109.874 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.437 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 7.7 ttmm -95.7 103.78 15.67 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.382 -0.824 . . . . 0.0 110.178 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.33 95.01 7.78 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.0 110.293 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.3 -29.86 61.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 110.109 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.09 94.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 110.354 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -95.69 14.56 22.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.206 -0.934 . . . . 0.0 110.593 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.6 t0 50.16 57.42 6.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.033 -1.042 . . . . 0.0 110.263 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -146.84 -176.74 5.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.166 -0.959 . . . . 0.0 110.318 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 72' ' ' VAL . 4.9 ttm180 -176.75 162.45 2.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.438 -0.789 . . . . 0.0 109.989 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.636 ' O ' HG22 ' A' ' 91' ' ' ILE . 86.8 m -142.68 150.6 40.38 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.86 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 19.5 p -146.33 148.72 32.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.045 -1.034 . . . . 0.0 110.711 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -92.99 146.92 23.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.322 -0.862 . . . . 0.0 110.088 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.76 ' CD2' HD12 ' A' ' 83' ' ' ILE . 8.7 m-85 -131.15 144.15 51.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.109 -0.994 . . . . 0.0 110.76 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -99.37 128.42 45.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.882 . . . . 0.0 109.366 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.73 143.09 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 110.825 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.4 113.21 2.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.111 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.616 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 47.23 -163.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.539 -0.726 . . . . 0.0 109.69 -178.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.428 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.66 64.61 0.87 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.861 -1.149 . . . . 0.0 110.753 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -146.2 58.78 1.22 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 110.308 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.8 171.05 38.6 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.441 ' HE3' HG23 ' A' ' 139' ' ' THR . 1.6 tmtt? -81.6 147.48 29.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -1.152 . . . . 0.0 110.326 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.41 ' N ' ' HG2' ' A' ' 112' ' ' LYS . 1.4 mt -136.01 140.84 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.941 . . . . 0.0 110.021 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.24 112.32 12.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.129 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.479 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -111.21 178.24 19.45 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -145.04 161.54 39.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -1.115 . . . . 0.0 109.854 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.669 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.02 140.96 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.121 -0.987 . . . . 0.0 110.392 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.549 ' O ' HG22 ' A' ' 79' ' ' THR . 25.1 t0 -105.24 152.47 22.84 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.354 -0.841 . . . . 0.0 109.473 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.464 HG22 HD11 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -128.86 151.89 36.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.017 -1.052 . . . . 0.0 110.386 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.401 ' CB ' ' OG1' ' A' ' 79' ' ' THR . 27.0 t80 -151.39 100.63 2.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 110.621 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.483 HD12 ' CD2' ' A' ' 132' ' ' TYR . 4.3 mt -127.36 152.89 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.965 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -159.7 98.77 1.38 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.262 -0.899 . . . . 0.0 109.912 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 124' ' ' LYS . 12.5 pt-20 -173.75 -152.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 110.363 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.47 ' O ' HG23 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -101.98 167.05 10.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.329 -0.857 . . . . 0.0 110.423 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 125' ' ' VAL . 1.3 t -158.05 114.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 125' ' ' VAL . 3.0 t-20 56.26 25.92 9.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.441 -0.787 . . . . 0.0 109.826 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 86.04 37.32 9.28 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 3.6 mtmm -148.92 145.91 20.59 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.11 -1.229 . . . . 0.0 110.189 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -66.83 130.31 22.89 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.861 1.453 . . . . 0.0 110.027 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 10.2 t80 -116.34 140.16 49.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.174 -0.954 . . . . 0.0 110.548 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.79 105.01 5.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.829 . . . . 0.0 109.943 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.483 ' CD2' HD12 ' A' ' 121' ' ' ILE . 4.0 t80 -120.71 128.57 53.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 110.046 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -170.82 88.45 0.12 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.089 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.44 -175.03 5.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.356 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -119.52 85.27 2.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 110.242 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.402 ' HD2' HG21 ' A' ' 119' ' ' VAL . 40.3 m-85 -86.26 -178.83 6.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.354 -0.842 . . . . 0.0 110.078 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.472 ' HA ' HG22 ' A' ' 117' ' ' ILE . 4.2 p30 -150.87 178.42 9.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 110.281 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -156.69 168.88 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.382 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.441 HG23 ' HE3' ' A' ' 112' ' ' LYS . 48.9 m -92.03 119.59 31.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.342 -0.849 . . . . 0.0 110.931 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.526 ' CE2' HD11 ' A' ' 83' ' ' ILE . 28.3 m-85 -90.92 162.86 14.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.258 -0.902 . . . . 0.0 110.026 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.01 99.89 2.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.057 -1.027 . . . . 0.0 110.702 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.405 ' HA ' ' HB2' ' A' ' 36' ' ' TYR . 61.7 m-85 -91.95 150.96 20.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.195 -0.94 . . . . 0.0 110.417 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.423 ' ND2' ' N ' ' A' ' 143' ' ' ASN . 2.3 m-80 -141.66 104.58 4.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -0.886 . . . . 0.0 110.449 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.424 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -157.28 -146.74 4.57 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.41 ' CD ' HD11 ' A' ' 109' ' ' LEU . 11.0 Cg_endo . . . . . 0 C--N 1.309 -1.552 0 O-C-N 123.697 1.367 . . . . 0.0 110.671 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 8.4 m-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.706 0.289 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' TYR . 1.5 p -160.98 156.01 24.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.024 -1.048 . . . . 0.0 110.711 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' CD2' ' A' ' 59' ' ' TYR . . . 164.24 171.88 31.03 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -91.88 107.77 19.45 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.235 -1.156 . . . . 0.0 110.538 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.65 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.6 OUTLIER -95.47 157.56 15.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.96 -1.088 . . . . 0.0 110.487 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.4 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 49.2 m-20 -80.17 143.68 33.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 110.142 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.5 OUTLIER -166.22 156.42 12.36 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.948 . . . . 0.0 110.096 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -155.6 -178.58 7.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -0.984 . . . . 0.0 110.444 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.753 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -140.14 170.33 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 0.0 109.959 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 47.3 m-85 -147.27 159.45 43.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.344 -0.847 . . . . 0.0 110.192 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.47 ' HE3' ' CB ' ' A' ' 47' ' ' SER . 9.4 tppt? -67.81 145.81 54.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.948 . . . . 0.0 109.979 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.62 140.91 53.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.074 -1.016 . . . . 0.0 110.311 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 61.59 26.26 16.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.925 . . . . 0.0 110.112 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.422 ' OG1' ' HG3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -133.14 -154.67 0.62 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.389 -0.819 . . . . 0.0 110.058 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -126.18 -28.62 3.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.18 -0.95 . . . . 0.0 110.741 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.433 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -134.93 172.92 12.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.068 -1.02 . . . . 0.0 110.973 -179.63 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.481 HG21 ' HB2' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -75.54 142.24 42.83 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.507 -0.745 . . . . 0.0 109.352 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.47 ' CB ' ' HE3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -129.62 -17.9 3.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.06 -1.025 . . . . 0.0 112.122 -178.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 49' ' ' ALA . 12.2 mt -137.63 -71.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.757 -1.215 . . . . 0.0 110.781 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.552 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -47.25 -24.98 0.83 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.704 -0.623 . . . . 0.0 111.242 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.481 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.1 OUTLIER -67.3 -13.99 62.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.995 -1.066 . . . . 0.0 110.89 -179.682 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.412 ' C ' ' CD1' ' A' ' 52' ' ' TYR . 27.3 m-20 -88.83 -11.11 45.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 110.785 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 0.6 OUTLIER -119.16 7.4 11.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.022 -1.049 . . . . 0.0 110.71 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.402 ' CE2' HG12 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -109.7 106.93 16.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.034 -1.041 . . . . 0.0 110.42 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -72.4 153.54 41.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.131 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.63 159.19 44.94 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.107 -0.996 . . . . 0.0 109.985 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 57.2 Cg_endo -78.97 -175.93 17.66 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.752 -2.187 . . . . 0.0 110.681 -0.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -104.23 173.38 6.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 110.251 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.477 ' CB ' ' CG ' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -103.59 120.61 41.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.887 . . . . 0.0 110.349 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.524 ' CD1' ' HD2' ' A' ' 61' ' ' LYS . 11.6 p90 -97.79 159.14 15.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.95 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.587 HG23 ' HD1' ' A' ' 67' ' ' TYR . 1.1 tt -155.85 114.5 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 110.469 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.524 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -128.1 127.88 43.87 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.153 -0.967 . . . . 0.0 110.549 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.06 62.11 0.69 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.402 -0.811 . . . . 0.0 110.128 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.4 OUTLIER 46.99 98.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.531 -0.73 . . . . 0.0 111.19 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.1 -11.65 58.72 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -145.64 162.82 36.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.028 -1.277 . . . . 0.0 110.296 179.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.693 HD11 ' N ' ' A' ' 108' ' ' LYS . 1.6 pt? -168.32 144.99 3.92 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.151 -0.968 . . . . 0.0 111.358 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.587 ' HD1' HG23 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -139.44 -160.69 1.09 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 67' ' ' TYR . 1.2 t -170.18 129.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.204 -0.935 . . . . 0.0 110.206 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.477 ' CG ' ' CB ' ' A' ' 58' ' ' LYS . 3.0 pp0? -96.37 126.54 41.64 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.229 -0.92 . . . . 0.0 109.254 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -108.73 139.33 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 110.283 -179.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m -88.31 141.7 28.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.359 -0.838 . . . . 0.0 109.425 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.555 HG12 HG21 ' A' ' 78' ' ' ILE . 0.7 OUTLIER -119.75 135.43 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 110.609 -179.227 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -101.18 131.2 47.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.336 -0.852 . . . . 0.0 109.815 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.415 ' O ' HG22 ' A' ' 78' ' ' ILE . 3.8 m-70 55.85 102.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.216 -0.928 . . . . 0.0 110.181 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -31.1 65.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.941 . . . . 0.0 110.537 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -54.11 -59.51 4.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.972 . . . . 0.0 110.178 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.642 ' HA ' HD11 ' A' ' 121' ' ' ILE . 20.0 m0 -53.35 -66.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.925 . . . . 0.0 110.31 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 78' ' ' ILE . 19.2 tt -88.76 118.69 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.249 -0.907 . . . . 0.0 109.746 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.692 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -87.47 -24.79 24.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 111.662 -178.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 81' ' ' MET . . . -174.54 175.45 46.82 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.553 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.429 ' SD ' HD11 ' A' ' 78' ' ' ILE . 2.9 mpp? -150.95 111.3 4.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.595 -0.944 . . . . 0.0 110.16 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -86.23 159.94 19.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.031 -1.043 . . . . 0.0 109.603 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.672 HD12 ' CD1' ' A' ' 104' ' ' PHE . 1.2 mt -151.14 122.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -0.902 . . . . 0.0 110.534 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.463 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 70.49 3.31 4.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.484 -0.76 . . . . 0.0 111.424 179.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.09 20.36 9.32 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.548 -1.311 . . . . 0.0 111.092 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.477 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -136.66 157.32 47.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.699 -1.471 . . . . 0.0 110.148 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -171.05 0.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.519 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -110.42 170.56 8.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 110.108 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 102' ' ' SER . 3.9 t-20 -119.12 121.11 39.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 110.156 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.401 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 pp -67.22 103.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.062 -1.024 . . . . 0.0 109.48 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.433 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.8 tt -94.32 -27.76 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.444 -0.785 . . . . 0.0 110.767 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.9 m -166.71 98.54 0.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.164 -0.96 . . . . 0.0 109.879 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.425 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 14.7 ttmt -96.05 106.54 18.73 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.403 -0.81 . . . . 0.0 110.315 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.84 95.26 7.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 0.0 110.038 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.2 p -74.91 -26.05 59.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.28 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.17 -49.2 76.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.128 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -96.05 13.82 25.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.925 . . . . 0.0 110.447 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 53.16 63.16 2.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.096 -1.003 . . . . 0.0 110.128 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.93 173.8 12.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.331 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 72' ' ' VAL . 3.5 ttm180 -169.37 165.16 10.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 0.0 110.236 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 70' ' ' ILE . 94.9 m -143.99 151.9 40.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -0.845 . . . . 0.0 109.903 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.492 ' HG ' ' HZ ' ' A' ' 104' ' ' PHE . 2.9 p -145.14 140.17 27.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.941 -1.1 . . . . 0.0 110.912 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.58 141.14 28.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 0.0 110.109 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.672 ' CD1' HD12 ' A' ' 83' ' ' ILE . 87.8 m-85 -131.45 145.41 51.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.131 -0.981 . . . . 0.0 110.851 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -104.33 130.36 52.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.316 -0.865 . . . . 0.0 109.471 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.624 ' O ' HD21 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -150.03 150.89 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.982 -1.074 . . . . 0.0 110.881 -179.194 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.1 t -66.13 113.2 4.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.189 -0.944 . . . . 0.0 109.027 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.693 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 51.88 -178.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.324 -178.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.584 ' H ' HD12 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -150.0 58.13 0.97 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 0.0 111.554 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 11.3 t30 -145.28 58.83 1.28 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.841 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.32 174.43 44.59 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 141.43 33.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -1.111 . . . . 0.0 110.659 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 72.6 mt -137.7 150.86 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.371 -0.831 . . . . 0.0 109.735 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -76.21 126.75 31.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.155 -0.966 . . . . 0.0 110.568 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -132.64 172.29 21.32 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 82' ' ' SER . 10.7 mttt -144.07 167.51 22.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.126 -1.22 . . . . 0.0 109.413 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.524 ' O ' HD13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -158.5 145.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.983 -1.073 . . . . 0.0 110.52 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.692 ' C ' HG22 ' A' ' 79' ' ' THR . 1.7 m-20 -108.2 160.34 15.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.429 -0.794 . . . . 0.0 109.225 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -134.41 147.85 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 110.642 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 3.5 t80 -151.34 109.86 3.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.426 -0.796 . . . . 0.0 110.569 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.642 HD11 ' HA ' ' A' ' 77' ' ' TRP . 2.3 mp -140.58 152.97 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.411 -0.805 . . . . 0.0 109.871 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -160.38 102.35 1.39 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.027 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -174.11 -170.72 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.454 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.74 109.4 21.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.85 . . . . 0.0 110.17 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.5 t -76.7 107.09 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.362 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.4 m120 50.37 42.42 25.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.877 . . . . 0.0 110.423 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.82 37.19 11.97 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 36.7 mtmt -145.24 99.33 4.58 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.236 -1.155 . . . . 0.0 109.97 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 128' ' ' LYS . 9.6 Cg_endo -59.04 130.11 34.99 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.674 1.355 . . . . 0.0 110.392 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -158.62 128.67 5.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 110.029 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -105.9 142.61 35.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.225 -0.922 . . . . 0.0 110.785 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.497 ' CE2' ' HB ' ' A' ' 119' ' ' VAL . 5.5 t80 -127.2 121.49 31.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.48 -0.763 . . . . 0.0 109.704 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -158.77 84.44 0.82 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.201 -0.937 . . . . 0.0 110.11 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.0 -169.62 3.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 110.419 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.443 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 13.5 p-80 -120.28 159.29 25.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 110.309 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 57.4 m-85 -155.13 -178.82 7.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.347 -0.845 . . . . 0.0 109.907 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -150.66 161.2 43.06 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.039 -1.038 . . . . 0.0 110.885 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 137' ' ' ASN . 6.8 pt -155.59 173.34 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.544 -0.723 . . . . 0.0 109.642 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 43.3 m -91.79 116.36 28.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.162 -0.961 . . . . 0.0 111.089 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.753 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.4 m-85 -89.58 150.22 22.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 109.547 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.11 162.51 36.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.088 -1.007 . . . . 0.0 110.86 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.409 ' HB3' ' O ' ' A' ' 109' ' ' LEU . 26.9 m-85 -148.99 158.53 44.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.52 -0.738 . . . . 0.0 109.933 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.4 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 32.8 m-80 -142.0 110.55 6.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.582 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.65 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -168.49 -145.95 4.78 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 11.3 Cg_endo . . . . . 0 C--N 1.309 -1.531 0 O-C-N 123.75 1.395 . . . . 0.0 109.986 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.009 0.433 . . . . 0.0 110.23 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -159.93 149.49 18.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.928 . . . . 0.0 110.292 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.7 176.83 39.21 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.95 103.05 15.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -1.13 . . . . 0.0 110.335 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.703 HD13 HD22 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -93.55 152.34 19.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 109.987 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.459 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 14.5 m-80 -78.35 144.86 35.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 110.125 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -165.09 156.96 15.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 110.058 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.1 -177.93 6.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.9 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.588 ' C ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.58 176.2 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.241 -0.912 . . . . 0.0 110.034 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 56.9 m-85 -148.67 161.91 40.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.413 -0.804 . . . . 0.0 109.954 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.2 OUTLIER -67.73 135.78 53.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 0.0 109.656 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.503 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -61.65 146.73 48.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 110.112 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 3.3 t-20 70.54 4.58 5.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.793 -0.567 . . . . 0.0 110.723 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -135.55 -164.52 1.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.92 -1.112 . . . . 0.0 109.576 179.286 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.422 ' N ' ' OG1' ' A' ' 43' ' ' THR . 6.3 m-80 -130.85 14.02 5.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 110.527 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -136.09 142.87 44.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.06 -1.025 . . . . 0.0 110.563 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.588 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -77.18 136.36 38.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.124 -0.985 . . . . 0.0 109.181 179.397 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.07 -17.78 3.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.01 -1.056 . . . . 0.0 112.048 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 51.8 mt -137.74 -68.81 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.79 -1.194 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -48.39 -24.5 1.26 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 111.201 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.531 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.1 OUTLIER -67.5 -14.15 62.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.961 -1.087 . . . . 0.0 110.891 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -102.19 15.16 29.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.056 -1.028 . . . . 0.0 110.902 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -127.51 -5.49 5.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.963 -1.086 . . . . 0.0 111.177 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 11.5 m-30 -110.39 112.85 25.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.948 -1.095 . . . . 0.0 110.518 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -72.77 109.75 6.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.284 -0.885 . . . . 0.0 110.129 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.402 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -93.39 164.06 22.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 110.161 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.402 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 56.2 Cg_endo -79.62 -175.82 17.2 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.452 -2.311 . . . . 0.0 110.693 -0.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -103.77 165.62 10.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 110.098 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -104.36 113.27 26.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.178 -0.951 . . . . 0.0 110.345 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.524 ' HA ' HG23 ' A' ' 68' ' ' VAL . 9.3 p90 -98.21 166.45 11.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.22 -0.925 . . . . 0.0 110.308 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.8 OUTLIER -155.67 158.93 3.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.585 -179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 18.0 mtmt -138.86 173.1 11.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 0.0 110.985 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.46 ' HB2' ' CD ' ' A' ' 65' ' ' LYS . 19.2 mtpt -155.53 62.15 0.61 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.577 -0.702 . . . . 0.0 109.535 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 47.96 84.3 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.539 -0.726 . . . . 0.0 111.177 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.06 19.45 36.31 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.809 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.758 ' C ' HD13 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -165.43 157.37 14.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.85 -1.383 . . . . 0.0 111.141 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.758 HD13 ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -160.47 155.92 25.15 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.169 0.985 . . . . 0.0 111.755 178.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 3.7 m-85 -141.89 -162.06 1.33 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.524 HG23 ' HA ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -170.68 138.88 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 120.97 -1.081 . . . . 0.0 110.712 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 1.2 pt20 -99.65 134.84 41.95 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.776 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -113.74 128.4 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.992 -179.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 71' ' ' THR . 0.9 OUTLIER -88.3 122.36 31.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.826 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -103.28 150.41 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.404 -0.81 . . . . 0.0 110.508 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -102.28 133.44 47.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.343 -0.848 . . . . 0.0 110.005 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 57.38 99.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.119 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.3 t -62.54 -44.06 97.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.879 . . . . 0.0 110.465 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -52.58 -38.35 59.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.915 . . . . 0.0 110.392 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.534 ' O ' HG12 ' A' ' 119' ' ' VAL . 45.5 m0 -68.46 -59.17 3.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -0.946 . . . . 0.0 110.243 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 78' ' ' ILE . 6.6 tp -88.44 118.04 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -0.918 . . . . 0.0 109.772 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.97 -25.38 24.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 110.99 -179.099 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.4 174.92 42.4 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.238 -1.458 . . . . 0.0 110.526 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -152.82 115.27 4.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.451 -1.029 . . . . 0.0 110.025 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.56 171.24 11.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 109.885 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.576 HD11 ' CZ ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -171.76 131.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.135 -0.978 . . . . 0.0 110.816 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HB3' ' NE2' ' A' ' 86' ' ' HIS . 0.9 OUTLIER 62.35 9.41 3.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.575 -0.703 . . . . 0.0 111.879 179.36 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.36 1.21 29.57 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.361 -1.399 . . . . 0.0 111.594 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.503 ' CD2' ' N ' ' A' ' 86' ' ' HIS . 3.3 p80 -135.6 154.17 51.43 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.577 -1.543 . . . . 0.0 110.847 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -167.17 0.17 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.454 -0.779 . . . . 0.0 110.421 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 8.1 pt-20 -107.68 170.22 8.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.193 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.34 134.32 55.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.246 -0.909 . . . . 0.0 110.396 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -67.83 103.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.126 -0.983 . . . . 0.0 109.514 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 92' ' ' SER . 2.0 tt -94.57 -29.49 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.865 . . . . 0.0 111.142 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.508 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -166.77 105.34 0.6 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.051 -1.03 . . . . 0.0 110.138 -179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.433 ' HG3' ' HG3' ' A' ' 100' ' ' ARG . 2.4 ttmm -96.07 108.82 21.29 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.394 -0.816 . . . . 0.0 110.244 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.54 86.71 4.2 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.067 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.07 -24.54 62.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.37 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.56 -53.47 54.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.078 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -97.46 19.2 13.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -0.881 . . . . 0.0 110.255 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 50.76 65.72 1.38 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 110.123 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -147.7 158.41 44.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.223 -0.923 . . . . 0.0 110.314 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.433 ' HG3' ' HG3' ' A' ' 93' ' ' LYS . 1.3 ttm180 -153.98 160.84 42.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -0.896 . . . . 0.0 110.038 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.501 ' O ' HG22 ' A' ' 91' ' ' ILE . 91.2 m -141.1 156.94 45.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.864 . . . . 0.0 109.856 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 84.7 p -145.65 143.41 29.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 110.699 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.08 135.98 33.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.354 -0.841 . . . . 0.0 109.912 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 39.1 m-85 -121.68 148.23 44.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.078 -1.014 . . . . 0.0 110.796 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.472 ' C ' HG13 ' A' ' 106' ' ' VAL . 3.9 mp0 -115.02 128.46 56.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.392 -0.818 . . . . 0.0 109.657 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.472 HG13 ' C ' ' A' ' 105' ' ' GLU . 35.0 m -149.62 -175.37 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.605 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.32 113.44 22.31 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.457 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 47.48 -158.6 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.46 -0.775 . . . . 0.0 109.343 -178.345 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.703 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.02 53.72 0.87 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.772 -1.205 . . . . 0.0 110.772 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -145.87 84.29 1.66 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.994 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.41 166.51 15.14 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -81.87 144.0 31.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -1.12 . . . . 0.0 110.429 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.1 mt -137.06 146.61 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 110.089 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -76.68 130.64 38.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.325 -0.859 . . . . 0.0 110.385 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -138.82 176.55 20.81 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.6 mttt -143.06 164.41 30.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -1.122 . . . . 0.0 109.42 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.477 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -158.65 142.36 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.912 -1.117 . . . . 0.0 110.921 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.683 ' O ' HG22 ' A' ' 79' ' ' THR . 5.3 m-20 -112.08 162.77 15.04 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.551 -0.718 . . . . 0.0 109.182 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -140.76 153.63 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.137 -0.977 . . . . 0.0 110.37 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -151.82 107.31 3.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 110.541 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' A' ' 132' ' ' TYR . 7.7 mt -130.72 151.47 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.242 -0.911 . . . . 0.0 109.855 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -159.15 104.37 1.68 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.217 -0.927 . . . . 0.0 109.855 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -172.66 -158.73 0.11 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 110.304 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -119.83 108.01 13.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.368 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 125' ' ' VAL . 1.4 t -76.93 117.96 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.928 . . . . 0.0 110.223 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.48 29.06 2.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.396 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 90.98 35.77 7.0 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.49 116.52 5.46 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 110.125 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.12 135.36 30.39 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.638 1.336 . . . . 0.0 110.266 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -136.25 113.38 10.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 110.316 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -104.0 122.77 45.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 110.122 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.507 ' CD2' HD12 ' A' ' 121' ' ' ILE . 3.9 t80 -131.72 128.58 39.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 109.886 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 55.4 t0 -173.39 94.14 0.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.158 -0.964 . . . . 0.0 110.369 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.86 -175.0 5.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.256 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.55 86.43 2.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.941 . . . . 0.0 110.136 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -84.48 -178.77 7.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.361 -0.837 . . . . 0.0 110.02 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 18.9 p30 -149.5 167.67 25.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 0.0 110.204 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.447 HG12 ' CG2' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -156.45 163.3 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 110.718 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.409 ' O ' HG12 ' A' ' 38' ' ' VAL . 81.9 m -92.15 125.41 36.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.489 -0.757 . . . . 0.0 110.406 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.576 ' CZ ' HD11 ' A' ' 83' ' ' ILE . 23.8 m-85 -90.39 165.11 14.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.204 -0.935 . . . . 0.0 110.371 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.21 101.54 1.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 110.315 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.427 ' CE1' HG11 ' A' ' 68' ' ' VAL . 59.3 m-85 -91.57 158.67 16.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.266 -0.897 . . . . 0.0 110.207 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.455 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 55.0 m-20 -143.46 96.98 3.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.223 -0.923 . . . . 0.0 110.604 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.597 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -154.23 -148.28 4.91 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo . . . . . 0 C--N 1.31 -1.491 0 O-C-N 123.804 1.423 . . . . 0.0 110.631 -179.786 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.932 0.396 . . . . 0.0 110.273 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 p -160.76 141.31 11.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.885 . . . . 0.0 110.347 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.25 -178.0 43.86 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.6 107.14 18.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.274 -1.133 . . . . 0.0 110.122 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.907 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -94.86 156.49 16.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.379 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 143' ' ' ASN . 2.8 m-20 -79.91 138.64 37.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.94 . . . . 0.0 110.369 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.687 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 1.2 p90 -164.91 150.75 10.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.349 -0.844 . . . . 0.0 110.006 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 38' ' ' VAL . 2.2 tt0 -155.02 156.46 35.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.869 . . . . 0.0 109.756 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.769 HG23 ' OG1' ' A' ' 46' ' ' THR . 28.1 m -101.08 174.71 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.17 -0.956 . . . . 0.0 110.638 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.471 ' HA ' ' CA ' ' A' ' 46' ' ' THR . 10.0 m-85 -148.12 156.18 42.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.516 -0.74 . . . . 0.0 109.746 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.433 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -67.59 133.59 49.68 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.221 -0.924 . . . . 0.0 109.592 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -63.73 147.14 52.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.991 -1.068 . . . . 0.0 109.864 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 5.5 t30 69.97 4.9 5.01 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.719 -0.613 . . . . 0.0 110.859 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.46 -167.23 2.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.94 -1.1 . . . . 0.0 109.718 179.422 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.411 ' N ' ' OG1' ' A' ' 43' ' ' THR . 24.7 m120 -130.56 14.34 5.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.109 -0.994 . . . . 0.0 110.426 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -135.03 116.86 15.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.083 -1.011 . . . . 0.0 110.402 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.769 ' OG1' HG23 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -54.65 134.42 47.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.991 -1.068 . . . . 0.0 108.972 179.327 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.73 -17.66 3.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.826 -1.171 . . . . 0.0 112.299 -178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.4 mt -137.78 -64.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.634 -1.291 . . . . 0.0 111.304 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.521 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -45.32 -27.92 0.74 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.619 -0.675 . . . . 0.0 111.43 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.456 ' CB ' ' CG2' ' A' ' 46' ' ' THR . 6.5 t-20 -71.91 -13.63 61.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.959 -1.088 . . . . 0.0 111.057 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.413 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 8.7 m-20 -90.05 14.95 11.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.063 -1.023 . . . . 0.0 110.863 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 51' ' ' ASP . 24.0 m-85 -143.05 11.56 1.79 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.042 -1.036 . . . . 0.0 110.856 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 24.0 m-85 -129.76 113.37 14.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 109.991 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -72.17 164.92 25.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.166 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -146.75 164.21 25.08 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 110.07 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.422 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 49.6 Cg_endo -79.53 -175.65 16.91 Favored 'Cis proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.332 -2.362 . . . . 0.0 110.558 -0.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.687 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.0 167.94 9.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.287 -0.883 . . . . 0.0 109.873 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -103.57 111.35 23.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.116 -0.99 . . . . 0.0 110.745 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.701 ' HA ' HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -96.35 162.85 13.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.001 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -154.28 155.93 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.085 -1.009 . . . . 0.0 110.528 -179.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.3 mtmp? -138.62 171.75 13.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.317 -0.865 . . . . 0.0 110.598 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.454 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . 12.1 mttp -162.03 61.66 0.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.394 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 60.91 91.66 0.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -0.839 . . . . 0.0 111.428 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.89 28.83 61.96 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.115 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.454 ' HD2' ' HB3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -170.59 162.71 8.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.892 -1.357 . . . . 0.0 111.207 179.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.865 HD21 ' H ' ' A' ' 108' ' ' LYS . 1.4 pt? -172.51 149.45 2.13 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 122.084 0.945 . . . . 0.0 111.38 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 1.2 m-85 -138.02 172.19 13.3 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.701 HG13 ' HA ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -142.72 142.09 26.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.933 -1.104 . . . . 0.0 110.441 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 102' ' ' SER . 6.3 pt20 -97.37 133.49 41.91 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.37 -0.831 . . . . 0.0 109.572 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.2 OUTLIER -111.99 138.55 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -0.82 . . . . 0.0 110.153 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 m -88.36 129.48 35.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.244 -0.91 . . . . 0.0 109.769 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.625 HG13 HD13 ' A' ' 78' ' ' ILE . 2.8 t -102.99 127.21 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 110.405 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -99.42 133.25 44.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 110.017 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.0 m80 54.8 98.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.158 -0.964 . . . . 0.0 110.063 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.3 p -64.15 -25.8 68.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.392 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -65.37 -56.85 10.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.48 ' O ' HG12 ' A' ' 119' ' ' VAL . 36.7 m0 -51.06 -65.11 0.61 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.21 -0.931 . . . . 0.0 110.177 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.631 HD11 ' HG3' ' A' ' 81' ' ' MET . 10.0 tt -89.27 120.79 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.331 -0.856 . . . . 0.0 109.845 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.668 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -86.93 -23.09 25.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 110.867 -179.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.99 -179.36 48.8 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.509 -1.329 . . . . 0.0 109.99 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.631 ' HG3' HD11 ' A' ' 78' ' ' ILE . 58.8 mtm -152.34 171.07 18.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -1.073 . . . . 0.0 110.292 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 116' ' ' LYS . 10.3 t -155.18 172.04 18.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.295 -0.878 . . . . 0.0 109.909 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.47 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -168.01 140.05 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.092 -1.005 . . . . 0.0 110.763 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.481 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 2.0 mt-10 61.94 10.23 3.46 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.477 -0.764 . . . . 0.0 111.749 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.67 0.51 30.66 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.362 -1.399 . . . . 0.0 111.093 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.481 ' NE2' ' CB ' ' A' ' 84' ' ' GLU . 3.6 p80 -132.56 154.55 49.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.645 -1.503 . . . . 0.0 110.519 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -162.41 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.516 -0.74 . . . . 0.0 110.173 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.491 ' CB ' ' CZ ' ' A' ' 104' ' ' PHE . 12.1 pt-20 -107.61 169.27 8.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 110.107 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -106.0 127.32 53.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.152 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.76 102.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.139 -0.976 . . . . 0.0 109.673 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 101' ' ' THR . 0.9 OUTLIER -94.74 -30.58 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 110.936 -179.201 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.409 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 54.4 p -167.15 103.89 0.54 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.091 -1.006 . . . . 0.0 109.986 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.456 ' HG3' ' CG ' ' A' ' 100' ' ' ARG . 21.4 ttmt -95.04 112.09 23.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 110.129 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.4 68.89 2.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.159 -0.963 . . . . 0.0 110.295 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.15 -29.05 56.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 110.266 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.51 -52.18 62.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.554 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -95.21 18.6 12.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -0.893 . . . . 0.0 110.552 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 51.0 61.32 3.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 110.21 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -147.14 169.89 18.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 110.024 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.456 ' CG ' ' HG3' ' A' ' 93' ' ' LYS . 0.8 OUTLIER -165.77 160.53 17.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.93 . . . . 0.0 110.328 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.502 ' O ' HG22 ' A' ' 91' ' ' ILE . 87.6 m -141.31 147.22 37.81 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.568 -0.708 . . . . 0.0 109.393 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 3.7 p -145.53 141.8 28.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.034 -1.041 . . . . 0.0 110.842 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 5.2 tt0 -92.49 145.48 24.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.531 -0.731 . . . . 0.0 109.682 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CZ ' ' CB ' ' A' ' 88' ' ' GLU . 30.4 m-85 -126.48 141.44 51.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.117 -0.989 . . . . 0.0 111.01 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.417 ' C ' HG13 ' A' ' 106' ' ' VAL . 38.0 tt0 -102.49 124.67 48.47 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.494 -0.754 . . . . 0.0 109.393 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.417 HG13 ' C ' ' A' ' 105' ' ' GLU . 16.6 m -149.45 138.03 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.016 -1.053 . . . . 0.0 111.038 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.68 101.53 0.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 108.945 178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.865 ' H ' HD21 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 53.65 176.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.378 -178.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.515 HD22 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.18 83.22 1.38 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.85 -1.156 . . . . 0.0 111.218 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 145' ' ' PRO . 13.6 t-20 -144.71 75.42 1.45 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.953 . . . . 0.0 110.15 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.32 -109.26 0.41 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HB3' ' HG2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -157.58 150.91 23.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -1.171 . . . . 0.0 110.437 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -136.14 147.02 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.436 -0.79 . . . . 0.0 109.827 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -75.83 114.26 14.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.997 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.94 179.21 16.57 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 27.1 mttp -144.08 160.69 40.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 0.0 109.9 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.675 HG21 HD11 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.29 146.45 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.975 . . . . 0.0 110.4 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.668 ' C ' HG22 ' A' ' 79' ' ' THR . 1.1 m-20 -105.57 156.3 18.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.414 -0.804 . . . . 0.0 109.405 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.583 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -131.97 146.0 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.159 -0.963 . . . . 0.0 110.44 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 1.1 t80 -151.6 109.3 3.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.37 -0.831 . . . . 0.0 110.246 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 54.8 mt -133.86 152.85 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.4 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 8.0 p-10 -160.46 95.28 1.11 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.81 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -174.26 -176.46 1.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 110.263 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -95.05 103.09 14.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 110.062 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.4 t -76.44 106.55 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.296 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.06 29.26 16.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 110.184 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.97 32.85 10.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.33 115.2 4.93 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.327 -1.102 . . . . 0.0 110.161 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -52.47 116.56 2.93 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.534 1.281 . . . . 0.0 110.187 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.473 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 5.7 t80 -116.0 122.51 45.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.691 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.83 122.02 44.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -0.879 . . . . 0.0 109.921 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.583 ' HE2' HG11 ' A' ' 119' ' ' VAL . 1.7 t80 -138.73 119.71 14.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.894 . . . . 0.0 110.169 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -168.53 85.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.127 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.25 -160.56 1.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.28 -0.887 . . . . 0.0 110.316 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.44 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -120.08 147.66 44.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.229 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 22.7 m-85 -155.68 -178.65 7.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.873 . . . . 0.0 109.997 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 9.7 p30 -149.82 169.18 21.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 0.0 110.671 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.675 HD11 HG21 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -156.18 162.61 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 110.322 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 49.6 m -91.86 118.21 30.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.321 -0.862 . . . . 0.0 110.932 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.484 ' HD1' HG12 ' A' ' 38' ' ' VAL . 13.2 m-85 -90.91 101.43 14.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.274 -0.891 . . . . 0.0 110.017 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.43 ' HG2' ' HB3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -87.74 103.49 15.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.087 -1.008 . . . . 0.0 110.526 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 140' ' ' TYR . 60.6 m-85 -92.67 153.28 19.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 110.186 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 9.8 m-80 -141.52 103.2 4.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.153 -0.967 . . . . 0.0 110.331 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.907 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -156.46 -149.74 5.45 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.541 ' HD2' HD11 ' A' ' 34' ' ' LEU . 12.2 Cg_endo . . . . . 0 C--N 1.309 -1.533 0 O-C-N 123.984 1.518 . . . . 0.0 110.43 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.933 0.397 . . . . 0.0 110.41 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -160.43 139.82 10.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 110.486 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.93 178.05 43.58 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.58 109.03 19.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.293 -1.122 . . . . 0.0 110.252 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.819 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.6 OUTLIER -94.99 153.21 17.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.266 -0.896 . . . . 0.0 110.805 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -81.05 135.56 35.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.85 . . . . 0.0 110.243 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.933 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -166.47 161.77 16.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.993 -1.067 . . . . 0.0 110.129 179.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -155.12 -165.61 2.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 0.0 110.356 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 139' ' ' THR . 0.0 OUTLIER -139.06 169.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.419 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 31.3 m-85 -148.32 159.82 43.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.316 -0.865 . . . . 0.0 109.907 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.427 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.4 OUTLIER -67.97 135.74 52.83 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.336 -0.852 . . . . 0.0 109.734 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.467 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -64.52 146.89 53.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.074 -1.016 . . . . 0.0 109.762 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 5.2 t-20 70.91 4.12 4.92 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.84 -0.537 . . . . 0.0 110.71 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.442 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -138.61 -167.53 2.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.944 -1.097 . . . . 0.0 109.498 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.442 ' N ' ' OG1' ' A' ' 43' ' ' THR . 37.4 m-80 -133.27 18.42 4.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.989 -1.069 . . . . 0.0 110.464 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -136.37 117.61 14.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.55 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.5 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -52.8 134.49 36.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.066 . . . . 0.0 109.261 179.352 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.35 -18.01 3.68 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.169 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.2 mt -138.1 -50.29 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.634 -1.291 . . . . 0.0 111.194 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HA ' ' HB3' ' A' ' 52' ' ' TYR . . . -80.95 7.71 10.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.49 -0.756 . . . . 0.0 111.532 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.459 ' O ' ' CE1' ' A' ' 53' ' ' PHE . 1.1 p-10 -69.32 -35.73 76.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.809 -1.182 . . . . 0.0 110.461 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -103.16 15.31 29.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.202 -0.936 . . . . 0.0 110.892 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.409 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -93.01 -8.38 43.14 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.966 -1.083 . . . . 0.0 111.021 -179.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.533 ' CE1' ' CG2' ' A' ' 38' ' ' VAL . 31.9 p90 -127.07 126.14 42.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.003 -1.061 . . . . 0.0 110.719 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.571 ' HB3' HG21 ' A' ' 71' ' ' THR . 19.7 t-20 -73.95 104.39 4.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.024 -1.047 . . . . 0.0 109.883 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 1.6 pttt -92.58 164.96 20.48 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 110.125 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.435 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 50.1 Cg_endo -77.92 -177.58 21.52 Favored 'Cis proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.519 -2.284 . . . . 0.0 110.569 -0.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.933 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -103.1 167.47 9.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.962 . . . . 0.0 110.25 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.461 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -102.95 114.51 28.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 110.09 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.0 p90 -96.98 162.21 13.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 110.056 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -154.97 155.13 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 110.311 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 24.6 mtmt -137.73 170.78 15.46 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.332 -0.855 . . . . 0.0 110.85 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.444 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -155.98 62.43 0.58 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.655 -0.653 . . . . 0.0 109.745 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.23 92.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.327 -0.858 . . . . 0.0 110.992 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.7 27.19 54.77 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.258 -0.972 . . . . 0.0 110.763 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.444 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 7.9 ptpt -171.81 158.51 4.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.972 -1.311 . . . . 0.0 111.0 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.868 HD21 ' H ' ' A' ' 108' ' ' LYS . 1.7 pt? -170.72 147.11 2.75 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.166 0.984 . . . . 0.0 111.615 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -138.32 171.37 14.49 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.473 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.83 143.27 24.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.975 -1.078 . . . . 0.0 109.971 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.461 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -97.0 135.67 38.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.24 -0.913 . . . . 0.0 110.087 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.2 OUTLIER -110.9 140.14 31.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.388 -0.82 . . . . 0.0 109.63 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.571 HG21 ' HB3' ' A' ' 54' ' ' ASN . 1.8 m -87.86 138.4 31.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.132 -0.98 . . . . 0.0 110.223 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.65 ' CG1' HG21 ' A' ' 78' ' ' ILE . 15.5 t -103.16 122.28 55.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.462 -0.774 . . . . 0.0 109.991 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.98 130.37 46.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 110.268 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.526 ' O ' HG22 ' A' ' 78' ' ' ILE . 4.8 t60 57.7 94.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.254 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t -71.79 -12.23 61.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.909 . . . . 0.0 110.593 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -74.64 -26.1 59.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.103 -0.998 . . . . 0.0 110.345 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.481 ' O ' HG12 ' A' ' 119' ' ' VAL . 21.3 m0 -94.17 -47.34 6.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 0.0 110.39 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.65 HG21 ' CG1' ' A' ' 72' ' ' VAL . 6.8 tp -88.46 115.98 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.118 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.585 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -87.41 -23.06 24.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.356 -0.84 . . . . 0.0 110.442 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.55 178.17 48.54 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.463 ' HE3' ' HB3' ' A' ' 102' ' ' SER . 0.0 OUTLIER -152.9 161.14 42.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -1.074 . . . . 0.0 110.194 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 116' ' ' LYS . 2.4 t -155.12 149.67 26.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.032 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.568 HD12 ' CD2' ' A' ' 104' ' ' PHE . 4.8 mt -141.83 144.41 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 110.427 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 69.67 3.85 4.44 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.498 -0.751 . . . . 0.0 111.119 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.55 20.79 21.21 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.718 -1.23 . . . . 0.0 111.116 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.457 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.04 163.31 31.05 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.713 -1.463 . . . . 0.0 110.174 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -177.69 1.85 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.108 -0.995 . . . . 0.0 110.31 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -110.01 169.61 8.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.347 -0.846 . . . . 0.0 110.209 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.64 124.95 53.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.948 . . . . 0.0 110.191 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pp -67.43 102.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 109.796 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 101' ' ' THR . 1.8 tt -95.19 -28.12 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.388 -0.82 . . . . 0.0 110.784 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 3.9 m -166.77 101.04 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.194 -0.941 . . . . 0.0 109.734 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -94.96 152.09 18.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.444 -0.785 . . . . 0.0 110.336 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -144.38 83.46 1.72 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 110.16 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 p -70.55 -27.05 63.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 110.326 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.59 -52.75 62.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 0.0 110.064 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.5 mtmm -96.21 17.75 15.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.311 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 51.97 60.27 3.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 110.249 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 94' ' ' ASN . 34.0 mt-10 -148.28 167.39 25.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 110.47 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.473 ' CG ' ' N ' ' A' ' 101' ' ' THR . 33.7 ttt180 -174.56 167.45 3.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.388 -0.82 . . . . 0.0 109.682 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.473 ' N ' ' CG ' ' A' ' 100' ' ' ARG . 94.9 m -141.44 153.95 45.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.962 . . . . 0.0 109.837 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.463 ' HB3' ' HE3' ' A' ' 81' ' ' MET . 83.6 p -145.38 141.1 28.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.112 -0.992 . . . . 0.0 110.68 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.32 146.65 23.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.896 . . . . 0.0 109.991 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.568 ' CD2' HD12 ' A' ' 83' ' ' ILE . 45.8 m-85 -129.14 147.74 51.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 0.0 110.675 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.489 ' C ' HG13 ' A' ' 106' ' ' VAL . 35.7 tt0 -105.53 125.83 51.43 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.384 -0.823 . . . . 0.0 109.789 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.489 HG13 ' C ' ' A' ' 105' ' ' GLU . 33.8 m -150.16 152.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.968 . . . . 0.0 110.956 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.2 m -71.95 105.93 4.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.276 -0.89 . . . . 0.0 109.291 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.868 ' H ' HD21 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 50.23 -178.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.494 -0.754 . . . . 0.0 109.734 -178.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.742 HD22 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -151.22 81.93 1.31 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.824 -1.172 . . . . 0.0 110.996 -179.385 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.61 67.71 1.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 110.191 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 162.57 -109.91 0.41 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.417 ' HB2' ' HG2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -157.19 148.1 21.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -1.118 . . . . 0.0 109.65 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 63.9 mt -136.27 150.74 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.902 . . . . 0.0 110.274 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.92 131.95 38.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.356 -0.84 . . . . 0.0 110.114 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -138.08 178.97 18.8 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 3.3 mtpp -144.6 164.46 30.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -1.179 . . . . 0.0 110.08 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.547 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.86 141.55 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.07 -1.019 . . . . 0.0 110.694 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.585 ' C ' HG22 ' A' ' 79' ' ' THR . 6.1 m-20 -104.12 152.46 22.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.268 -0.895 . . . . 0.0 109.72 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.2 OUTLIER -128.71 154.09 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.132 -0.98 . . . . 0.0 110.345 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -151.55 102.45 2.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.21 -0.931 . . . . 0.0 110.738 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 3.8 mt -133.38 152.88 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.324 -0.86 . . . . 0.0 110.097 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.34 95.38 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.981 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 129' ' ' PRO . 19.1 pt-20 -174.81 -156.38 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 110.248 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.433 ' HG2' ' CA ' ' A' ' 129' ' ' PRO . 11.7 mttt -122.46 120.99 35.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.28 -0.887 . . . . 0.0 110.25 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.702 HG23 ' CE1' ' A' ' 130' ' ' PHE . 89.6 t -76.91 92.33 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 110.363 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.31 31.48 11.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.269 -0.895 . . . . 0.0 110.302 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.23 35.58 2.29 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 3.7 mtmt -145.43 85.44 7.94 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.358 -1.084 . . . . 0.0 110.124 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.433 ' CA ' ' HG2' ' A' ' 124' ' ' LYS . 11.3 Cg_endo -59.3 129.49 31.65 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.983 1.517 . . . . 0.0 110.287 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.702 ' CE1' HG23 ' A' ' 125' ' ' VAL . 7.6 p90 -156.14 139.85 16.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 110.452 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -105.36 131.9 52.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.391 -0.818 . . . . 0.0 110.007 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.445 ' HB3' ' HB ' ' A' ' 121' ' ' ILE . 5.9 t80 -131.47 129.92 41.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.0 110.138 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 16.6 t0 -174.44 89.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.343 -0.848 . . . . 0.0 110.064 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.83 -168.42 3.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 110.188 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.17 85.93 2.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.407 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -85.01 -178.98 6.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 109.796 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.65 ' O ' HG23 ' A' ' 138' ' ' ILE . 29.2 p30 -150.42 168.98 22.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.025 -1.047 . . . . 0.0 110.654 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 137' ' ' ASN . 2.3 pt -157.83 173.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.324 -0.86 . . . . 0.0 110.784 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.76 ' O ' HG12 ' A' ' 38' ' ' VAL . 90.8 m -92.01 163.6 13.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.622 -0.674 . . . . 0.0 110.282 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.524 ' CD1' ' CG1' ' A' ' 38' ' ' VAL . 97.3 m-85 -141.79 100.49 3.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 109.643 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 2.0 mttt -82.5 108.95 16.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 110.833 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -92.17 140.65 29.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.99 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -129.64 96.04 4.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 110.339 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.819 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -149.14 -152.68 5.79 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo . . . . . 0 C--N 1.308 -1.582 0 O-C-N 123.943 1.496 . . . . 0.0 110.356 -179.908 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 5.9 m-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.969 0.414 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.43 153.34 25.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.105 -0.997 . . . . 0.0 110.532 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.431 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 172.18 170.1 35.67 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.482 HG23 ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -88.25 111.08 21.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -1.117 . . . . 0.0 110.152 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.058 HD13 HD22 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -94.78 155.39 16.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 0.0 110.646 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 3.0 t-20 -81.6 137.83 35.45 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.355 -0.84 . . . . 0.0 109.693 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.833 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -167.98 163.72 13.7 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.992 -1.067 . . . . 0.0 110.587 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.05 -168.33 2.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.37 -0.831 . . . . 0.0 109.823 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.748 ' O ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -139.82 -178.42 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.971 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.417 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 15.4 m-85 -149.22 150.71 33.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 110.047 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.413 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.5 OUTLIER -67.56 127.83 34.19 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.397 -0.814 . . . . 0.0 109.87 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.48 ' O ' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -55.9 147.27 19.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.142 -0.973 . . . . 0.0 109.921 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER 72.32 1.18 3.86 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.865 -0.522 . . . . 0.0 110.792 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.29 -166.49 1.94 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.873 -1.142 . . . . 0.0 109.559 179.192 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.408 ' N ' ' OG1' ' A' ' 43' ' ' THR . 23.0 m-80 -133.34 16.14 4.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -136.54 121.82 19.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.481 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.748 HG23 ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -51.15 132.25 28.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 109.226 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.459 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -128.98 -17.58 3.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.889 -1.132 . . . . 0.0 111.926 -178.746 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.459 HD12 ' HB3' ' A' ' 47' ' ' SER . 1.8 mp -137.5 -75.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.827 -1.17 . . . . 0.0 110.572 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 52' ' ' TYR . . . -47.48 -24.99 0.95 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.679 -0.638 . . . . 0.0 110.928 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.443 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.7 OUTLIER -46.65 -34.31 4.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.242 -0.911 . . . . 0.0 111.134 -179.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -102.19 15.76 28.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.044 -1.035 . . . . 0.0 110.986 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.52 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -99.25 -15.89 18.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.015 -1.053 . . . . 0.0 110.971 -179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.501 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 21.3 p90 -118.6 128.39 54.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.928 -1.108 . . . . 0.0 110.993 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -74.97 114.42 13.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.095 -1.003 . . . . 0.0 109.91 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.75 159.64 35.8 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.036 . . . . 0.0 109.994 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -81.45 -175.28 15.37 Favored 'Cis proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.643 -2.232 . . . . 0.0 110.667 -0.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.833 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.45 172.81 6.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.197 -0.939 . . . . 0.0 110.041 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HD2' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -106.31 116.6 32.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.25 -0.906 . . . . 0.0 111.076 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.48 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 6.9 p90 -98.14 161.77 13.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.237 -0.915 . . . . 0.0 109.523 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.537 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -155.42 122.08 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.951 -1.093 . . . . 0.0 111.034 -179.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.473 ' HD3' HD21 ' A' ' 109' ' ' LEU . 1.6 mtmt -139.39 131.52 28.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.0 110.212 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -109.21 62.42 0.6 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.196 -0.94 . . . . 0.0 110.441 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 62' ' ' LYS . 14.0 t-20 49.62 100.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.402 -0.811 . . . . 0.0 111.119 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.26 -17.96 56.17 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HB2' ' OH ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -140.43 152.8 45.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.154 -1.203 . . . . 0.0 110.201 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.812 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -155.07 142.81 19.87 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.938 0.875 . . . . 0.0 111.012 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.537 ' HB2' HG23 ' A' ' 60' ' ' ILE . 5.7 m-85 -140.03 -170.15 2.89 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.54 -0.725 . . . . 0.0 109.352 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -162.06 165.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.098 -1.001 . . . . 0.0 109.882 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 102' ' ' SER . 1.3 pt20 -140.45 143.66 35.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.198 -0.938 . . . . 0.0 110.472 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -115.56 128.51 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.335 -0.853 . . . . 0.0 110.258 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.7 m -88.83 124.33 34.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.482 HG11 ' CE ' ' A' ' 81' ' ' MET . 0.8 OUTLIER -102.68 138.93 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 110.386 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -101.0 135.03 43.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.325 -0.859 . . . . 0.0 110.238 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.439 ' O ' HG22 ' A' ' 78' ' ' ILE . 6.1 m80 60.4 102.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.295 -0.878 . . . . 0.0 110.036 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 t -64.47 -33.44 75.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.887 . . . . 0.0 110.377 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -52.49 -57.78 8.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 110.257 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.533 ' HA ' HD11 ' A' ' 121' ' ' ILE . 13.2 m0 -55.62 -62.52 1.63 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 110.382 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 78' ' ' ILE . 2.9 tp -88.78 114.01 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 109.97 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.79 -26.28 24.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 110.782 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.46 174.89 45.67 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.074 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.482 ' CE ' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -152.28 163.23 39.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -1.042 . . . . 0.0 109.962 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -155.66 167.62 29.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.824 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.601 HD11 ' CD1' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -164.62 154.13 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 110.033 179.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.521 ' HB2' ' CE1' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 59.74 15.02 4.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.049 -1.032 . . . . 0.0 110.859 179.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.28 23.23 55.14 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.031 -1.081 . . . . 0.0 110.976 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.521 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 2.0 p-80 -138.27 161.58 36.51 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.67 -1.488 . . . . 0.0 110.623 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.27 179.35 2.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.851 . . . . 0.0 110.971 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 2.1 pt-20 -99.39 170.13 8.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 110.663 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 102' ' ' SER . 2.2 t30 -116.78 133.73 55.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.476 -0.765 . . . . 0.0 109.468 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.589 HG22 ' NH2' ' A' ' 100' ' ' ARG . 1.1 pp -67.45 101.53 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.954 -1.092 . . . . 0.0 109.871 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.5 HG21 HG22 ' A' ' 101' ' ' THR . 0.5 OUTLIER -95.41 -31.22 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.838 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.418 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 11.0 m -166.73 95.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.109 -0.994 . . . . 0.0 110.009 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -95.9 95.3 8.15 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.478 -0.763 . . . . 0.0 110.156 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.09 91.25 5.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.175 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.73 -27.64 60.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 110.202 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.61 -45.37 93.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -0.936 . . . . 0.0 110.129 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.93 18.7 12.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.31 -0.869 . . . . 0.0 110.23 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 t0 50.48 61.75 3.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 110.043 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -148.09 166.72 26.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 110.515 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.589 ' NH2' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -168.93 147.71 4.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.453 -0.779 . . . . 0.0 109.533 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.5 HG22 HG21 ' A' ' 91' ' ' ILE . 62.9 m -141.55 158.22 44.12 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.163 -0.96 . . . . 0.0 109.867 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 81.3 p -145.06 143.45 30.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 110.375 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 1.5 tm-20 -92.6 141.26 28.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 110.2 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -123.81 148.65 46.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.279 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -98.3 132.29 43.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.37 -0.832 . . . . 0.0 110.075 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.558 HG13 HD21 ' A' ' 66' ' ' LEU . 8.9 p -149.08 166.88 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.202 -0.936 . . . . 0.0 110.245 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 106' ' ' VAL . 1.5 t -69.63 -35.3 75.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 109.846 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.461 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -164.5 -148.9 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.503 -0.748 . . . . 0.0 109.325 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 1.058 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.06 51.92 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.726 -1.234 . . . . 0.0 111.232 -179.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 12.9 t-20 -146.31 70.23 1.22 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.099 -1.001 . . . . 0.0 110.492 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 142' ' ' PHE . . . 172.12 -129.25 1.7 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.467 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.0 OUTLIER -156.65 140.87 16.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.323 -1.104 . . . . 0.0 109.839 -179.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.467 ' CD1' HG23 ' A' ' 106' ' ' VAL . 2.5 mt -135.33 153.87 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.164 -0.96 . . . . 0.0 110.019 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -76.2 137.08 39.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.076 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 83' ' ' ILE . . . -137.35 177.23 20.0 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 82' ' ' SER . 16.7 mttt -144.14 156.16 44.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -1.139 . . . . 0.0 109.76 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.585 ' O ' HD13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -157.73 151.16 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.006 -1.059 . . . . 0.0 110.578 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.621 ' O ' HG22 ' A' ' 79' ' ' THR . 0.9 OUTLIER -112.14 158.37 19.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.412 -0.805 . . . . 0.0 109.386 179.357 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.481 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -129.77 148.35 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -0.976 . . . . 0.0 110.053 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.78 102.24 2.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 110.769 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.533 HD11 ' HA ' ' A' ' 77' ' ' TRP . 2.6 mp -133.72 151.9 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -0.987 . . . . 0.0 110.162 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 1.2 p-10 -160.57 98.45 1.24 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.354 -0.842 . . . . 0.0 109.73 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -173.75 -156.95 0.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 110.553 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.586 ' O ' HG23 ' A' ' 125' ' ' VAL . 18.6 mtpt -91.27 165.22 13.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.416 -0.803 . . . . 0.0 110.608 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 124' ' ' LYS . 47.6 t -157.88 99.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 67.18 25.83 8.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.531 -0.731 . . . . 0.0 109.611 -178.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 86.53 34.25 12.18 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 0.6 OUTLIER -147.89 134.25 9.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.22 -1.165 . . . . 0.0 110.303 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 128' ' ' LYS . 20.5 Cg_exo -60.85 129.09 27.64 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.581 1.306 . . . . 0.0 110.141 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' A' ' 132' ' ' TYR . 46.2 t80 -121.01 145.8 47.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.167 -0.958 . . . . 0.0 110.385 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -136.08 118.21 15.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.211 -0.931 . . . . 0.0 110.146 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.485 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . 3.7 t80 -129.73 131.47 46.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 109.804 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -177.37 87.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.04 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.66 -163.9 1.76 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 0.0 110.536 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.461 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 4.2 p80 -118.69 143.66 46.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 135' ' ' HIS . 13.0 m-85 -154.85 -179.45 8.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 110.117 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.62 ' O ' HG23 ' A' ' 138' ' ' ILE . 1.7 p30 -152.1 172.11 16.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 0.0 110.584 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.62 HG23 ' O ' ' A' ' 137' ' ' ASN . 3.9 pt -157.17 162.93 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.844 . . . . 0.0 110.173 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.467 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 45.1 m -92.0 126.92 37.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 110.594 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.601 ' CD1' HD11 ' A' ' 83' ' ' ILE . 14.4 m-85 -89.48 154.23 20.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -0.949 . . . . 0.0 109.654 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -137.89 105.52 5.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.041 -1.037 . . . . 0.0 110.397 -179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.47 ' HB3' ' CA ' ' A' ' 109' ' ' LEU . 31.7 m-85 -91.99 134.72 34.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 0.0 110.374 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 4.2 m-80 -132.11 103.56 6.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 0.0 110.311 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.898 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -164.71 -150.38 6.15 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.742 ' HD2' HD11 ' A' ' 34' ' ' LEU . 9.4 Cg_endo . . . . . 0 C--N 1.308 -1.601 0 O-C-N 123.765 1.402 . . . . 0.0 110.457 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 25.4 m-20 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 120.816 0.341 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 59' ' ' TYR . 15.1 t -160.39 169.68 22.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 110.789 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.9 171.71 25.06 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.69 105.18 17.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.1 -1.235 . . . . 0.0 110.217 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.838 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -94.21 156.05 16.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 110.414 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.411 ' O ' ' N ' ' A' ' 143' ' ' ASN . 14.9 m-20 -79.86 140.83 36.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.214 -0.929 . . . . 0.0 109.738 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.664 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -165.91 158.18 14.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.98 . . . . 0.0 110.181 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -155.37 -168.89 2.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.258 -0.901 . . . . 0.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.473 ' C ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.07 173.97 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 109.796 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.402 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 27.6 m-85 -148.22 156.48 42.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 110.491 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 128.93 38.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.528 -0.732 . . . . 0.0 109.766 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.508 ' CE2' ' ND2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -58.18 148.26 27.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.098 -1.001 . . . . 0.0 109.879 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 11.0 m-20 71.08 2.44 4.24 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.816 -0.552 . . . . 0.0 110.961 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.96 -165.49 1.75 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.944 -1.098 . . . . 0.0 109.684 179.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.409 ' N ' ' OG1' ' A' ' 43' ' ' THR . 64.1 t30 -133.86 16.13 3.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 110.19 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -136.01 118.31 15.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 110.583 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.473 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -51.37 128.61 23.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.988 . . . . 0.0 109.099 179.247 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.49 -16.13 3.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.008 -1.058 . . . . 0.0 112.222 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.18 -64.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.792 -1.193 . . . . 0.0 110.907 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.49 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -52.39 -21.9 4.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.452 -0.78 . . . . 0.0 111.147 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -8.97 46.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.054 -1.029 . . . . 0.0 110.951 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.404 ' C ' ' CG ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -97.78 8.49 44.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.013 -1.055 . . . . 0.0 110.913 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.404 ' CG ' ' C ' ' A' ' 51' ' ' ASP . 7.1 m-85 -142.44 17.3 2.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.966 -1.084 . . . . 0.0 110.342 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -119.49 107.22 13.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.439 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -72.88 155.09 40.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 110.249 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.425 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -146.68 167.22 14.3 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.121 -0.987 . . . . 0.0 110.026 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.425 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 49.8 Cg_endo -77.06 -175.31 16.47 Favored 'Cis proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.681 -2.216 . . . . 0.0 110.481 -0.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.664 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -100.4 162.43 12.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 109.975 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.463 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . 0.5 OUTLIER -102.08 117.03 33.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.304 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.489 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.7 p90 -97.51 160.95 14.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 109.776 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.504 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -155.35 127.42 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.056 -1.028 . . . . 0.0 110.559 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HG2' ' CB ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -136.61 119.36 16.15 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.206 -0.934 . . . . 0.0 110.783 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.2 OUTLIER -96.01 62.05 2.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.384 -0.822 . . . . 0.0 110.393 179.62 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.403 ' O ' ' O ' ' A' ' 62' ' ' LYS . 41.3 t30 46.62 99.17 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.58 -0.7 . . . . 0.0 111.407 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.83 5.03 54.15 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.436 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.714 ' C ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.58 158.91 16.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.894 -1.357 . . . . 0.0 110.199 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.803 ' N ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -155.13 149.81 26.46 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 122.171 0.986 . . . . 0.0 111.199 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.519 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 5.0 m-85 -142.74 -164.71 1.89 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.388 -0.82 . . . . 0.0 109.242 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.441 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -170.56 134.12 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.082 -1.011 . . . . 0.0 110.102 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.463 ' HG2' ' HB3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -97.59 134.15 41.18 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.157 -0.965 . . . . 0.0 109.568 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.1 OUTLIER -112.81 137.64 45.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.864 -179.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.5 m -88.6 135.17 33.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 109.972 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.846 HG22 ' CE ' ' A' ' 81' ' ' MET . 3.4 t -102.38 123.98 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.283 -0.886 . . . . 0.0 109.943 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -98.31 126.85 43.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.247 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.637 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER 62.36 99.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 110.328 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -32.62 66.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 110.09 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -58.95 -41.63 87.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.16 -0.963 . . . . 0.0 110.041 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.656 ' O ' HG12 ' A' ' 119' ' ' VAL . 45.1 m0 -71.48 -62.11 1.53 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.375 -0.828 . . . . 0.0 110.128 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 74' ' ' HIS . 9.9 tt -89.3 122.13 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 109.691 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.709 HG22 ' C ' ' A' ' 118' ' ' ASP . 1.0 OUTLIER -87.14 -23.25 24.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.385 -0.822 . . . . 0.0 111.114 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.409 ' O ' HG12 ' A' ' 117' ' ' ILE . . . -178.38 179.94 48.47 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.017 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.846 ' CE ' HG22 ' A' ' 72' ' ' VAL . 47.5 mtm -152.45 171.12 18.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.346 -1.09 . . . . 0.0 109.94 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -155.21 164.45 38.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.214 -0.929 . . . . 0.0 110.233 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.683 HD12 ' CG ' ' A' ' 104' ' ' PHE . 7.4 mt -155.59 135.54 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.542 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 1.6 tm-20 69.54 3.44 4.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.406 -0.808 . . . . 0.0 111.428 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.64 21.5 12.52 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.136 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.477 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -136.95 159.05 43.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.722 -1.458 . . . . 0.0 110.138 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -178.98 2.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.083 -1.011 . . . . 0.0 110.354 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.447 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 1.7 pt-20 -106.6 167.59 9.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.34 -0.85 . . . . 0.0 110.043 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.28 129.79 55.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 110.349 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.519 HD12 ' O ' ' A' ' 90' ' ' ILE . 1.4 pp -68.28 101.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.903 . . . . 0.0 109.671 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.55 HG21 HG22 ' A' ' 101' ' ' THR . 1.8 tt -95.3 -28.87 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.384 -0.822 . . . . 0.0 110.716 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.9 p -167.33 107.41 0.59 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.022 -1.049 . . . . 0.0 109.935 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.419 ' HA ' ' HG3' ' A' ' 100' ' ' ARG . 24.3 ttmt -95.41 110.33 22.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -0.869 . . . . 0.0 110.153 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.84 81.27 3.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 110.197 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.9 p -69.56 -26.56 64.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.254 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.62 -52.33 63.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.199 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -95.79 19.91 10.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 110.304 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 50.36 63.75 2.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 109.996 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -147.56 -177.98 6.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.858 . . . . 0.0 110.408 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.419 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 3.9 ttm180 -176.32 164.97 2.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.835 . . . . 0.0 109.715 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.55 HG22 HG21 ' A' ' 91' ' ' ILE . 93.3 m -142.6 154.86 44.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.158 -0.964 . . . . 0.0 109.755 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 p -145.53 144.25 30.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.905 -1.122 . . . . 0.0 110.721 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -92.69 140.34 29.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.299 -0.876 . . . . 0.0 109.792 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.683 ' CG ' HD12 ' A' ' 83' ' ' ILE . 32.6 m-85 -126.58 149.62 49.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.119 -0.988 . . . . 0.0 111.066 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.456 ' C ' HG13 ' A' ' 106' ' ' VAL . 1.6 tt0 -119.74 126.35 50.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.46 -0.775 . . . . 0.0 109.477 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.472 ' O ' HD21 ' A' ' 66' ' ' LEU . 22.9 m -149.97 -164.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.972 -1.08 . . . . 0.0 110.778 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.2 t -98.46 112.0 24.17 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.451 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.26 -165.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.521 -0.737 . . . . 0.0 109.661 -178.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.469 ' CD2' ' HB2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -151.91 60.2 0.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.87 -1.144 . . . . 0.0 111.188 -179.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -146.33 80.5 1.56 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.124 -0.985 . . . . 0.0 110.435 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.59 -117.19 0.75 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.478 ' CG ' ' CG2' ' A' ' 139' ' ' THR . 3.7 ttpt -157.52 145.27 18.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.346 -1.091 . . . . 0.0 110.041 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.6 mt -137.39 146.02 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.352 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -76.83 108.9 10.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.222 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.461 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -111.37 177.99 19.26 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 82' ' ' SER . 22.2 mttt -145.45 161.23 40.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -1.125 . . . . 0.0 109.89 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.455 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.8 147.15 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.095 -1.003 . . . . 0.0 110.682 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.709 ' C ' HG22 ' A' ' 79' ' ' THR . 39.6 m-20 -106.39 159.32 16.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.394 -0.816 . . . . 0.0 109.149 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -140.92 147.29 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.027 -1.045 . . . . 0.0 110.684 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -153.34 113.89 4.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -0.872 . . . . 0.0 110.711 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 43.9 mt -137.69 152.94 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.103 -0.998 . . . . 0.0 110.386 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -160.08 95.43 1.16 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.376 -0.828 . . . . 0.0 109.85 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -173.81 -173.95 0.9 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.885 . . . . 0.0 110.354 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -104.47 121.35 43.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 110.263 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.3 95.04 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.102 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.05 39.02 30.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.29 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 96.45 31.46 7.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -145.33 100.39 4.46 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.316 -1.108 . . . . 0.0 110.134 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -50.4 132.84 35.83 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.869 1.457 . . . . 0.0 110.191 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -139.39 127.79 22.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 110.301 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.21 136.99 43.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.143 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.444 ' HB3' ' HB ' ' A' ' 121' ' ' ILE . 1.8 t80 -153.22 123.94 7.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 110.188 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -177.08 86.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -153.09 -165.31 2.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.9 . . . . 0.0 110.249 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -119.35 140.13 50.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.891 . . . . 0.0 110.283 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.463 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 61.4 m-85 -154.6 -179.17 7.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.874 . . . . 0.0 109.871 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.508 ' ND2' ' CE2' ' A' ' 41' ' ' TYR . 40.0 p30 -151.1 176.59 11.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 110.787 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.49 HG21 ' HB2' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -156.35 171.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.476 -0.765 . . . . 0.0 109.673 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.478 ' CG2' ' CG ' ' A' ' 112' ' ' LYS . 26.1 m -91.76 118.04 30.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.976 . . . . 0.0 110.698 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.461 ' CD1' ' HA3' ' A' ' 115' ' ' GLY . 18.6 m-85 -89.68 108.11 19.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 109.61 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -97.48 161.67 13.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.723 -179.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -148.11 153.04 38.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.476 -0.765 . . . . 0.0 109.936 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 35' ' ' ASN . 31.4 m-80 -138.74 101.8 4.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 110.419 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.838 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -159.46 -154.5 7.29 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.56 ' HD2' HD11 ' A' ' 34' ' ' LEU . 19.7 Cg_endo . . . . . 0 C--N 1.307 -1.635 0 O-C-N 123.999 1.526 . . . . 0.0 110.707 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 2.1 m-20 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.921 0.391 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 p -159.58 147.87 17.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.019 . . . . 0.0 110.666 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.11 -179.33 45.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.04 119.68 28.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.176 -1.191 . . . . 0.0 110.26 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.87 HD11 ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -94.4 131.83 39.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.427 -0.796 . . . . 0.0 110.893 -179.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.445 ' N ' HD23 ' A' ' 34' ' ' LEU . 47.6 t30 -78.74 128.96 34.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.099 -1.0 . . . . 0.0 108.547 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.669 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -164.45 164.53 21.95 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.702 -1.249 . . . . 0.0 111.477 -178.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.98 -167.29 2.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.19 173.67 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.919 -1.113 . . . . 0.0 110.447 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -148.09 154.61 40.43 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.444 -0.785 . . . . 0.0 109.697 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.403 ' CE ' ' HA ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -66.99 140.58 57.73 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.334 -0.853 . . . . 0.0 109.771 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.507 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -63.28 147.16 51.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.993 . . . . 0.0 110.205 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.4 OUTLIER 69.0 5.98 5.37 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.673 -0.642 . . . . 0.0 110.681 -179.452 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.01 -167.42 2.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.027 -1.045 . . . . 0.0 109.344 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.44 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.9 OUTLIER -131.62 13.77 4.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.0 110.147 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -136.44 133.62 36.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.15 -0.969 . . . . 0.0 110.715 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.447 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -62.18 136.49 57.96 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.252 -0.905 . . . . 0.0 109.087 179.29 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.649 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -126.28 -17.96 5.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.917 -1.114 . . . . 0.0 111.81 -178.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.682 HG22 ' N ' ' A' ' 49' ' ' ALA . 1.2 mp -137.98 -74.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.897 -1.127 . . . . 0.0 110.532 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.682 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -45.13 -26.63 0.49 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.769 -0.582 . . . . 0.0 111.238 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.447 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -52.57 -23.64 6.78 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.094 -1.004 . . . . 0.0 111.102 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -102.73 15.41 29.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.969 -1.082 . . . . 0.0 111.026 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 52.7 m-85 -123.06 -10.64 8.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.039 -1.038 . . . . 0.0 110.967 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CZ ' ' CE ' ' A' ' 81' ' ' MET . 17.5 m-85 -119.52 115.33 23.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.063 -1.023 . . . . 0.0 110.309 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -72.24 169.47 16.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 110.6 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 161.96 33.76 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.428 -0.795 . . . . 0.0 109.76 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -83.6 -175.07 13.46 Favored 'Cis proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.592 -2.253 . . . . 0.0 110.728 -0.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.669 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -99.49 -171.46 2.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.369 -0.832 . . . . 0.0 109.752 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.413 ' HB2' ' NE2' ' A' ' 69' ' ' GLN . 3.8 mttp -127.63 121.16 29.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.055 -1.028 . . . . 0.0 110.372 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.527 ' HB3' HD12 ' A' ' 34' ' ' LEU . 38.6 p90 -96.36 161.28 14.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 0.0 109.893 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.638 HG23 ' HD1' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -155.19 121.03 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 110.609 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.517 ' CE ' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -130.88 117.91 19.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.089 -1.007 . . . . 0.0 110.654 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -93.61 61.57 3.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.25 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 49.62 101.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.555 -0.715 . . . . 0.0 111.431 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.1 56.99 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.466 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -142.49 158.62 43.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.056 -1.261 . . . . 0.0 110.08 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.853 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -158.86 138.28 11.59 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.988 0.899 . . . . 0.0 111.201 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.638 ' HD1' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.56 178.95 7.1 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.633 -0.667 . . . . 0.0 109.308 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.06 141.42 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 0.0 110.472 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 58' ' ' LYS . 11.2 pt20 -98.38 144.2 28.02 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 109.922 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.98 135.0 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.264 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 71' ' ' THR . 0.9 OUTLIER -89.51 123.84 33.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.883 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.653 HG12 HG21 ' A' ' 78' ' ' ILE . 1.3 t -103.21 131.21 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.928 . . . . 0.0 110.381 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -100.26 134.01 43.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.219 -0.926 . . . . 0.0 110.049 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.682 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER 62.14 116.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.3 -0.875 . . . . 0.0 110.036 -179.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.92 -25.26 24.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.177 -0.952 . . . . 0.0 110.638 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -59.66 4.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.994 . . . . 0.0 110.357 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.576 ' O ' HD11 ' A' ' 121' ' ' ILE . 39.8 m0 -53.58 -62.46 1.64 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.902 . . . . 0.0 110.436 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 74' ' ' HIS . 0.8 OUTLIER -88.34 120.38 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.954 . . . . 0.0 109.964 179.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.629 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.05 -23.25 25.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.392 -0.818 . . . . 0.0 110.758 -179.3 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.13 -177.01 47.25 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.52 ' CE ' ' CZ ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -151.18 168.16 25.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -1.076 . . . . 0.0 110.185 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 116' ' ' LYS . 3.2 t -154.33 137.87 15.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 109.845 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.898 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -132.27 140.01 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.345 -179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 73.35 -1.07 3.17 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.809 -0.557 . . . . 0.0 111.224 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.62 21.92 8.42 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.632 -1.27 . . . . 0.0 111.121 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.443 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.37 162.99 32.1 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.637 -1.508 . . . . 0.0 110.269 179.285 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -171.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 110.547 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -109.07 170.22 8.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.341 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.6 122.02 44.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.319 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pt -67.39 103.59 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.168 -0.958 . . . . 0.0 109.911 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 101' ' ' THR . 1.5 tt -95.66 -28.51 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.886 . . . . 0.0 110.964 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.6 p -167.53 105.21 0.52 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.033 -1.042 . . . . 0.0 110.081 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm -95.29 107.72 19.84 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.277 -0.889 . . . . 0.0 110.017 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.65 95.99 8.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 110.385 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.67 -29.65 56.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.099 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -47.78 82.37 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.305 -0.872 . . . . 0.0 110.078 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -95.85 12.24 30.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 110.419 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.9 t0 51.33 56.95 7.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.019 -1.051 . . . . 0.0 110.152 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -148.14 154.75 40.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.202 -0.936 . . . . 0.0 110.442 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -143.68 166.14 25.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 109.941 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.573 ' O ' HG22 ' A' ' 91' ' ' ILE . 87.0 m -141.35 150.69 42.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.382 -0.824 . . . . 0.0 109.636 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.9 p -145.31 141.48 28.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.036 -1.04 . . . . 0.0 110.733 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.04 144.1 25.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.842 . . . . 0.0 109.885 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -127.87 136.95 52.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.062 -1.024 . . . . 0.0 110.757 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.482 ' C ' HG13 ' A' ' 106' ' ' VAL . 3.5 mt-10 -93.13 127.48 38.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -0.883 . . . . 0.0 109.449 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.482 HG13 ' C ' ' A' ' 105' ' ' GLU . 35.3 m -149.68 171.36 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.017 -1.052 . . . . 0.0 110.954 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.79 110.47 18.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.33 -156.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 109.678 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.87 ' HB2' HD11 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -150.86 59.83 0.93 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.983 -1.073 . . . . 0.0 110.982 -179.267 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER -146.12 104.19 3.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.293 -0.879 . . . . 0.0 110.337 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 134.35 -131.88 6.13 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.432 ' HB3' ' HG2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -157.0 152.42 26.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.299 -1.118 . . . . 0.0 110.0 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mt -135.78 145.24 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.882 . . . . 0.0 110.17 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -76.06 113.12 13.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.347 -0.845 . . . . 0.0 110.058 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.456 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -122.26 -170.4 13.69 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 82' ' ' SER . 4.1 mttp -147.66 171.95 14.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -1.155 . . . . 0.0 109.977 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -157.67 145.11 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -0.96 . . . . 0.0 110.453 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.629 ' O ' HG22 ' A' ' 79' ' ' THR . 7.7 m-20 -105.63 155.04 19.61 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.473 -0.767 . . . . 0.0 109.535 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -132.4 146.47 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 110.127 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -151.76 115.02 4.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.89 . . . . 0.0 110.55 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.576 HD11 ' O ' ' A' ' 77' ' ' TRP . 2.2 mp -141.51 152.57 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -0.95 . . . . 0.0 110.337 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.55 101.08 1.5 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 0.0 109.828 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -173.62 -176.93 1.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.378 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -97.61 105.18 17.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 110.391 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 128' ' ' LYS . 21.9 t -76.29 99.24 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.0 109.898 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 55.5 50.46 14.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.32 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.31 33.28 44.75 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.453 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -145.6 106.31 4.33 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.085 -1.244 . . . . 0.0 110.233 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 128' ' ' LYS . 9.2 Cg_endo -58.04 128.01 27.19 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.541 1.285 . . . . 0.0 110.108 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -127.13 148.05 50.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.355 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.3 99.07 4.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.364 -0.835 . . . . 0.0 109.837 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.492 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 3.0 t80 -102.0 131.14 48.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 109.894 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -166.37 77.48 0.22 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.227 -0.92 . . . . 0.0 110.229 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -153.83 -173.82 4.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.291 -0.881 . . . . 0.0 110.339 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.449 ' O ' ' CD2' ' A' ' 136' ' ' TYR . 6.1 p80 -119.79 162.53 18.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 110.11 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 135' ' ' HIS . 54.7 m-85 -155.09 137.34 14.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.964 . . . . 0.0 110.423 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.462 ' O ' HG23 ' A' ' 138' ' ' ILE . 28.1 p30 -88.63 159.23 17.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.315 -0.866 . . . . 0.0 110.267 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -156.69 155.92 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.269 -0.895 . . . . 0.0 110.051 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.2 m -91.81 123.06 34.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.265 -0.897 . . . . 0.0 111.074 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.898 ' CD2' HD11 ' A' ' 83' ' ' ILE . 62.7 m-85 -90.82 154.6 19.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.395 -0.816 . . . . 0.0 109.236 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -140.23 95.3 2.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.894 -1.129 . . . . 0.0 110.683 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 110' ' ' ASN . 23.4 m-85 -91.06 133.45 35.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.321 -0.862 . . . . 0.0 110.197 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.421 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 3.6 m-80 -137.58 102.08 4.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 110.451 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.442 ' CA ' HD13 ' A' ' 109' ' ' LEU . . . -146.07 -142.11 3.72 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.429 ' HD2' ' HA3' ' A' ' 144' ' ' GLY . 1.9 Cg_endo . . . . . 0 C--N 1.312 -1.369 0 O-C-N 123.576 1.303 . . . . 0.0 110.756 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 1.1 m-20 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.852 0.358 . . . . 0.0 110.373 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.6 p -161.81 150.4 15.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.841 . . . . 0.0 110.32 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 161.31 177.94 34.83 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.552 HG23 ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -88.18 104.9 17.14 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.358 -1.084 . . . . 0.0 110.321 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.783 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -94.61 158.6 15.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 110.499 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.448 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 3.6 m-20 -78.8 140.79 38.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.898 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.596 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -165.46 153.89 11.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 110.105 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.34 -177.06 6.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.235 -0.916 . . . . 0.0 110.352 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 140' ' ' TYR . 1.6 m -140.04 178.09 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.348 -0.845 . . . . 0.0 109.843 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -149.39 162.8 39.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 110.481 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.3 OUTLIER -68.15 123.73 21.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.362 -0.836 . . . . 0.0 109.79 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.502 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -53.26 144.94 14.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.977 . . . . 0.0 109.955 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 6.1 m120 71.62 1.52 3.91 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.857 -0.527 . . . . 0.0 111.1 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.98 -166.86 1.98 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.829 -1.169 . . . . 0.0 109.827 179.15 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.74 21.4 3.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 110.443 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -133.15 126.06 30.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.122 -0.986 . . . . 0.0 110.956 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.523 HG22 ' HB2' ' A' ' 50' ' ' ASN . 0.7 OUTLIER -55.11 118.48 4.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.601 -0.687 . . . . 0.0 109.686 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.51 -18.58 3.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.8 -1.188 . . . . 0.0 112.078 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.0 mt -138.88 -76.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.789 -1.195 . . . . 0.0 111.122 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.504 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -46.0 -26.41 0.72 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.622 -0.674 . . . . 0.0 111.176 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.523 ' HB2' HG22 ' A' ' 46' ' ' THR . 16.9 t-20 -68.9 -13.4 62.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.075 -1.016 . . . . 0.0 110.792 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -102.59 15.13 30.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.974 -1.079 . . . . 0.0 111.123 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -136.42 11.33 3.24 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.008 -1.058 . . . . 0.0 110.808 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.437 ' HE2' ' HB1' ' A' ' 49' ' ' ALA . 25.2 m-85 -130.98 115.62 16.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.077 -1.014 . . . . 0.0 110.122 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -72.59 164.23 26.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.355 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.467 ' CD ' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -146.83 164.43 23.74 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.274 -0.891 . . . . 0.0 110.048 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.42 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 57.2 Cg_endo -78.86 -175.44 16.71 Favored 'Cis proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.438 -2.317 . . . . 0.0 110.45 -0.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.596 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.52 167.96 9.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.077 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.552 ' HD2' HG23 ' A' ' 33' ' ' THR . 0.9 OUTLIER -101.45 113.51 26.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.32 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CD2' HD21 ' A' ' 109' ' ' LEU . 1.7 p90 -97.06 161.95 13.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 110.004 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 1.0 OUTLIER -154.81 156.99 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.089 -1.007 . . . . 0.0 110.465 179.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 34.6 mtmt -140.34 170.23 16.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.179 -0.95 . . . . 0.0 111.058 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 12.5 mtmt -157.05 62.15 0.51 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.549 -0.719 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t30 51.05 87.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.344 -0.848 . . . . 0.0 111.26 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.83 24.91 39.96 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.696 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.753 ' C ' HD13 ' A' ' 66' ' ' LEU . 2.8 ptpt -167.56 153.3 7.46 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.914 -1.345 . . . . 0.0 110.941 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.768 ' N ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -158.78 151.17 21.61 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 122.347 1.07 . . . . 0.0 111.696 178.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 6.3 m-85 -143.85 170.41 15.94 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 58' ' ' LYS . 1.1 m -145.18 145.04 21.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.908 -1.12 . . . . 0.0 110.389 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.436 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 4.6 pt20 -97.84 132.77 43.15 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.355 -0.84 . . . . 0.0 109.593 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -112.38 137.57 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.942 -179.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.08 128.45 35.75 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.209 -0.932 . . . . 0.0 109.939 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.686 HG12 HG21 ' A' ' 78' ' ' ILE . 2.0 t -101.84 126.37 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.977 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 74' ' ' HIS . 21.6 m-20 -99.18 128.03 45.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.363 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.669 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER 64.23 113.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.85 . . . . 0.0 110.198 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.58 -38.31 23.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.202 -0.937 . . . . 0.0 110.257 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -55.35 -42.45 73.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.212 -0.93 . . . . 0.0 110.182 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.486 ' HA ' HG12 ' A' ' 121' ' ' ILE . 34.4 m0 -67.4 -64.32 0.88 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 110.282 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.686 HG21 HG12 ' A' ' 72' ' ' VAL . 17.9 tt -88.81 126.3 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.379 -0.826 . . . . 0.0 110.007 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.88 -24.81 23.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.441 -0.787 . . . . 0.0 110.975 -179.298 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.402 ' O ' HG12 ' A' ' 117' ' ' ILE . . . 178.16 -179.05 48.62 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.627 -1.273 . . . . 0.0 109.955 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.448 ' HG3' HD11 ' A' ' 78' ' ' ILE . 2.8 mtm -151.59 161.85 41.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.265 -1.138 . . . . 0.0 110.352 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -154.99 146.24 22.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.86 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.624 HD11 ' CD2' ' A' ' 140' ' ' TYR . 3.6 mt -139.17 142.77 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.903 . . . . 0.0 110.657 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 2.5 tm-20 72.26 -0.35 3.29 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.693 -0.63 . . . . 0.0 111.56 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.87 20.27 9.52 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.537 -1.316 . . . . 0.0 111.006 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.477 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.72 159.31 42.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.649 -1.5 . . . . 0.0 110.365 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -71.17 179.69 2.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 110.177 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -102.23 170.17 8.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.904 . . . . 0.0 110.083 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.2 129.7 56.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.938 . . . . 0.0 110.243 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.451 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 0.8 OUTLIER -67.65 102.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 109.767 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 101' ' ' THR . 1.5 tt -95.15 -25.86 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -0.861 . . . . 0.0 110.853 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.517 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -167.35 104.88 0.53 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.122 -0.986 . . . . 0.0 109.659 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -96.34 145.69 25.39 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.399 -0.813 . . . . 0.0 110.265 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.22 78.98 1.62 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 110.115 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.25 -25.88 67.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 110.327 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.16 64.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 110.112 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -96.57 17.3 16.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.392 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 t0 50.41 63.13 2.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.975 . . . . 0.0 110.013 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -147.15 162.28 39.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.335 -0.853 . . . . 0.0 110.346 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.447 ' O ' HG23 ' A' ' 72' ' ' VAL . 2.1 mtp180 -163.72 161.75 23.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.435 -0.791 . . . . 0.0 109.873 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.593 ' O ' HG22 ' A' ' 91' ' ' ILE . 86.9 m -142.42 150.37 40.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.655 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.5 p -145.42 143.6 30.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.052 -1.03 . . . . 0.0 110.76 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 2.0 tm-20 -93.4 147.33 23.04 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.374 -0.829 . . . . 0.0 109.838 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.577 ' CD2' HD12 ' A' ' 83' ' ' ILE . 19.1 m-85 -128.18 131.45 48.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.132 -0.98 . . . . 0.0 110.924 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.464 ' C ' HG13 ' A' ' 106' ' ' VAL . 15.5 tt0 -96.08 124.84 40.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.879 . . . . 0.0 109.474 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.496 ' O ' HD21 ' A' ' 66' ' ' LEU . 29.6 m -149.28 -171.71 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.051 -1.031 . . . . 0.0 110.665 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.9 111.96 23.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.442 -0.786 . . . . 0.0 109.144 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.479 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.69 -162.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.456 -0.777 . . . . 0.0 109.969 -178.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.522 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -149.84 56.92 0.97 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.015 -1.053 . . . . 0.0 110.644 -179.72 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -145.63 79.53 1.57 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.879 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.63 170.98 19.67 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.06 144.42 30.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -1.154 . . . . 0.0 110.482 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.486 HD12 ' CD2' ' A' ' 142' ' ' PHE . 5.3 mt -136.34 146.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 0.0 109.719 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.15 117.3 17.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.151 -0.968 . . . . 0.0 110.496 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.11 176.05 16.4 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 15.9 mttt -144.43 163.52 33.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -1.155 . . . . 0.0 109.945 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.417 ' HB ' ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -157.89 140.64 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 110.43 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.581 ' O ' HG22 ' A' ' 79' ' ' THR . 52.9 m-20 -101.56 154.35 18.93 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.366 -0.834 . . . . 0.0 109.254 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.654 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -133.4 151.05 32.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.999 -1.063 . . . . 0.0 110.781 -179.288 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -150.69 99.5 2.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.595 -0.69 . . . . 0.0 109.362 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.501 HD12 ' CD2' ' A' ' 132' ' ' TYR . 20.1 mt -135.04 153.33 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.259 -0.9 . . . . 0.0 110.738 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -159.87 106.27 1.62 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.499 -0.75 . . . . 0.0 109.169 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.4 162.13 6.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.315 -0.866 . . . . 0.0 110.216 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 7.1 mtmt -89.78 113.88 25.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 110.495 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.4 t -76.92 96.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.341 -0.849 . . . . 0.0 110.218 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.22 29.74 13.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.595 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.95 32.94 5.69 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 46.6 mtmt -144.94 100.51 4.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.317 -1.107 . . . . 0.0 110.138 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.54 115.29 1.71 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.765 1.403 . . . . 0.0 110.468 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 8.2 t80 -111.95 125.63 54.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 110.17 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.2 139.39 37.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 110.147 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.654 ' HE2' HG11 ' A' ' 119' ' ' VAL . 1.6 t80 -153.43 113.83 3.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.809 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.403 ' O ' ' CG ' ' A' ' 134' ' ' HIS . 8.1 t0 -165.92 88.33 0.39 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.136 -0.977 . . . . 0.0 110.154 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.403 ' CG ' ' O ' ' A' ' 133' ' ' ASP . 74.1 m-70 -154.04 -168.26 2.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 110.282 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.6 85.46 2.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.796 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.476 ' HD2' HG21 ' A' ' 119' ' ' VAL . 25.0 m-85 -85.86 -178.57 6.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.825 . . . . 0.0 110.416 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 11.6 p30 -150.33 174.27 13.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.938 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.504 HG21 ' HB2' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -155.92 165.34 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.135 -0.978 . . . . 0.0 110.614 -179.655 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 61.8 m -91.81 113.82 26.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.406 -0.809 . . . . 0.0 110.525 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.674 ' HA ' HG12 ' A' ' 38' ' ' VAL . 27.6 m-85 -89.63 155.15 19.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.979 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.79 112.77 5.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.946 . . . . 0.0 110.523 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.486 ' CD2' HD12 ' A' ' 113' ' ' ILE . 27.2 m-85 -91.98 155.78 17.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 110.313 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.522 ' C ' HD21 ' A' ' 34' ' ' LEU . 61.3 m-80 -140.03 96.93 3.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -0.979 . . . . 0.0 110.332 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.783 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -161.5 -151.95 6.47 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.497 ' HD2' HD11 ' A' ' 34' ' ' LEU . 15.1 Cg_endo . . . . . 0 C--N 1.307 -1.625 0 O-C-N 123.889 1.468 . . . . 0.0 110.567 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 120.807 0.337 . . . . 0.0 110.512 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.0 t -160.86 130.02 4.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.899 . . . . 0.0 110.29 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . -170.77 179.19 42.89 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.72 110.67 21.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.401 -1.058 . . . . 0.0 110.505 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.841 HD13 HD22 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -95.36 148.62 22.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 109.99 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.44 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -79.16 134.26 36.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.085 -1.01 . . . . 0.0 110.339 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.887 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -166.27 167.91 15.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.152 -0.968 . . . . 0.0 110.839 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.98 -172.93 4.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.542 -0.724 . . . . 0.0 109.764 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.707 ' O ' HG22 ' A' ' 46' ' ' THR . 0.6 OUTLIER -140.73 107.73 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.688 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.0 161.38 15.16 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.455 -0.778 . . . . 0.0 110.497 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.449 ' HD3' HD13 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -67.84 137.38 55.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.374 -0.829 . . . . 0.0 110.081 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.474 ' CD2' ' OD1' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -62.53 145.47 54.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.035 -1.041 . . . . 0.0 110.064 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 12.6 t30 70.42 3.49 4.5 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.763 -0.586 . . . . 0.0 110.771 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.423 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -139.25 -171.08 3.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.878 -1.139 . . . . 0.0 109.538 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.423 ' N ' ' OG1' ' A' ' 43' ' ' THR . 17.5 p30 -134.63 23.48 3.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.106 -0.996 . . . . 0.0 110.055 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.64 121.47 19.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 111.075 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.707 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -49.79 126.87 14.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.583 -0.698 . . . . 0.0 109.291 178.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.795 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -129.84 -19.36 3.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.74 -1.225 . . . . 0.0 112.449 -178.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 47' ' ' SER . 1.4 mp -139.45 -78.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.65 -1.281 . . . . 0.0 111.296 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.697 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -45.01 -26.42 0.43 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.853 -0.53 . . . . 0.0 111.337 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.478 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 4.7 p30 -60.92 -15.49 31.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.091 -1.006 . . . . 0.0 110.882 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.421 ' C ' ' CD1' ' A' ' 52' ' ' TYR . 6.2 m-20 -101.8 15.2 29.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.054 -1.029 . . . . 0.0 110.896 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 43.3 m-85 -140.08 10.39 2.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.004 -1.06 . . . . 0.0 110.554 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.417 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 30.7 m-85 -132.02 113.27 13.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 110.174 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.492 ' HB2' HG21 ' A' ' 71' ' ' THR . 0.8 OUTLIER -72.69 164.55 26.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.705 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -146.57 161.66 37.25 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.4 -0.812 . . . . 0.0 109.71 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.402 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 57.5 Cg_endo -79.93 -175.39 16.27 Favored 'Cis proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.522 -2.282 . . . . 0.0 110.396 -0.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.887 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.14 166.29 10.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.933 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.54 116.0 31.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.948 . . . . 0.0 110.465 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.514 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 28.9 p90 -97.1 163.87 12.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 109.823 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -155.11 151.0 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.109 -0.994 . . . . 0.0 110.558 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 28.1 mtmt -134.5 174.0 11.03 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -0.9 . . . . 0.0 110.945 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 9.5 mttt -155.93 62.33 0.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.4 -0.813 . . . . 0.0 110.021 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m120 53.97 85.86 0.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.338 -0.851 . . . . 0.0 111.188 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.43 23.58 50.36 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.203 -0.999 . . . . 0.0 110.705 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 62' ' ' LYS . 8.6 ptpt -166.12 161.17 16.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.814 -1.404 . . . . 0.0 110.951 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.786 HD11 ' HA ' ' A' ' 108' ' ' LYS . 2.5 pt? -173.11 158.0 3.59 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.152 0.977 . . . . 0.0 111.555 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.566 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -139.27 -153.84 0.49 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -170.17 135.16 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 110.026 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 5.1 pt20 -97.39 133.66 41.69 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.63 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -114.2 142.93 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 110.099 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.492 HG21 ' HB2' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -89.18 129.59 35.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 110.199 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.782 HG12 HG21 ' A' ' 78' ' ' ILE . 2.5 t -104.1 127.29 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 110.159 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.0 137.9 37.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 110.341 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.698 ' O ' HG22 ' A' ' 78' ' ' ILE . 63.4 m-70 52.42 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.339 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -73.52 -31.68 63.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 110.217 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -55.48 -36.93 67.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 110.31 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -83.6 -50.86 7.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 110.15 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.782 HG21 HG12 ' A' ' 72' ' ' VAL . 19.5 tt -89.75 125.34 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 109.942 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.612 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -87.1 -29.88 21.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 110.579 -179.577 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.15 -168.37 41.13 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.431 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.8 mtp -151.99 169.19 22.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -1.125 . . . . 0.0 110.469 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.36 131.62 11.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.871 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.3 mt -131.25 147.32 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.933 . . . . 0.0 110.344 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' OE1' ' CA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER 66.46 7.29 4.91 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.133 -0.979 . . . . 0.0 111.004 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.03 25.49 19.52 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.895 -1.145 . . . . 0.0 111.297 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.47 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -139.48 161.29 37.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.638 -1.507 . . . . 0.0 110.482 179.262 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.41 -173.74 0.95 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.13 -0.981 . . . . 0.0 110.561 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 1.8 pt-20 -110.24 170.05 8.34 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.368 -0.832 . . . . 0.0 110.278 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.14 127.46 54.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.274 -0.891 . . . . 0.0 110.268 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.29 103.95 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 0.0 109.597 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.442 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.1 tt -95.92 -30.1 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 111.085 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.7 p -167.43 104.91 0.53 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.016 -1.052 . . . . 0.0 110.015 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -95.53 108.54 20.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 110.154 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -95.75 62.14 2.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.289 -0.882 . . . . 0.0 110.177 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.59 -21.93 30.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.297 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -18.69 62.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.211 -0.931 . . . . 0.0 110.288 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -136.31 22.19 3.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 110.278 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 55.89 64.42 1.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -0.868 . . . . 0.0 110.521 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 94' ' ' ASN . 15.6 mt-10 -148.18 -179.51 6.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.278 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 179.22 162.32 0.81 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.2 -0.938 . . . . 0.0 110.135 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.442 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 97.2 m -141.48 152.46 44.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 109.651 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 37.4 p -144.36 139.59 28.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.008 -1.057 . . . . 0.0 110.548 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.28 141.14 28.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.388 -0.82 . . . . 0.0 110.01 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' A' ' 88' ' ' GLU . 68.3 m-85 -129.0 138.26 51.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.157 -0.964 . . . . 0.0 110.669 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -99.0 130.66 45.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.272 -0.892 . . . . 0.0 109.616 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.0 p -149.42 152.12 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.02 -1.05 . . . . 0.0 110.86 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.6 m -63.68 106.41 0.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -0.931 . . . . 0.0 109.145 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.786 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 48.4 -174.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.494 -0.753 . . . . 0.0 110.062 -178.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.841 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.13 75.45 1.24 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.977 -1.077 . . . . 0.0 110.691 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -146.09 43.22 1.23 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.86 . . . . 0.0 110.246 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.64 -169.62 38.21 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 151.59 27.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -1.181 . . . . 0.0 110.437 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 140' ' ' TYR . 13.9 mm -136.31 132.35 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.418 -0.801 . . . . 0.0 109.884 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.68 103.03 6.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 0.0 110.191 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.57 175.85 15.94 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 18.9 mttt -147.88 177.46 9.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -1.14 . . . . 0.0 109.532 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.481 HG21 HD13 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -157.21 149.48 10.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.103 -0.998 . . . . 0.0 111.099 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.612 ' O ' HG22 ' A' ' 79' ' ' THR . 69.0 m-20 -106.83 156.14 18.99 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.452 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 2.2 t -140.45 149.44 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 110.142 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 2.1 t80 -151.01 116.36 5.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 0.0 110.381 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.498 HD12 ' CD2' ' A' ' 132' ' ' TYR . 3.9 mt -134.97 153.83 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.44 -0.788 . . . . 0.0 109.994 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.54 102.28 1.71 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.145 -0.972 . . . . 0.0 109.971 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -173.17 175.28 3.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.522 -0.736 . . . . 0.0 109.829 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 100.7 12.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.148 -0.97 . . . . 0.0 110.344 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.2 t -76.92 112.15 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.339 -0.851 . . . . 0.0 109.965 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 53.98 43.44 30.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 110.212 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.53 38.09 68.78 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -145.26 108.41 4.54 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.228 -1.16 . . . . 0.0 110.048 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -47.96 129.19 17.7 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.682 1.359 . . . . 0.0 110.377 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -135.38 139.91 44.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 110.132 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -135.08 121.45 20.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.0 110.262 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.498 ' CD2' HD12 ' A' ' 121' ' ' ILE . 3.2 t80 -114.2 141.45 47.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 109.617 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 3.7 p30 -175.99 81.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.085 -1.01 . . . . 0.0 110.298 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.19 178.77 9.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 0.0 110.589 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.406 ' ND1' ' N ' ' A' ' 135' ' ' HIS . 1.8 m80 -119.0 96.38 5.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.315 -0.866 . . . . 0.0 109.631 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.93 139.53 31.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 110.483 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.597 ' O ' HG23 ' A' ' 138' ' ' ILE . 25.4 p30 -88.72 159.72 17.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.327 -0.858 . . . . 0.0 110.157 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 137' ' ' ASN . 6.9 pt -156.35 166.28 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 110.1 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 88.6 m -91.76 161.27 14.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.359 -0.838 . . . . 0.0 110.572 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.457 ' CE2' HG13 ' A' ' 138' ' ' ILE . 19.3 m-85 -147.06 98.66 3.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.428 -0.795 . . . . 0.0 109.635 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -101.46 105.3 16.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.896 . . . . 0.0 110.874 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 140' ' ' TYR . 98.3 m-85 -92.2 140.34 29.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.889 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.458 ' ND2' ' N ' ' A' ' 143' ' ' ASN . 2.1 m-80 -124.02 98.67 5.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -0.99 . . . . 0.0 110.453 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.64 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -151.36 -148.67 4.87 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.418 ' HD2' HD11 ' A' ' 109' ' ' LEU . 10.3 Cg_endo . . . . . 0 C--N 1.309 -1.548 0 O-C-N 123.639 1.336 . . . . 0.0 110.077 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.962 0.41 . . . . 0.0 110.478 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.6 t -160.11 134.67 7.6 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 110.451 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.84 179.09 48.47 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.39 112.23 22.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -1.124 . . . . 0.0 110.335 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.86 HD13 HD22 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -94.73 146.83 23.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 110.431 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.412 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -80.7 133.15 35.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 109.779 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.749 ' CE2' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -165.88 162.69 18.45 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.154 -0.966 . . . . 0.0 110.716 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.47 -168.29 2.78 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.455 -0.778 . . . . 0.0 109.526 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.861 ' O ' HG22 ' A' ' 46' ' ' THR . 2.5 m -140.92 117.88 8.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.047 -1.033 . . . . 0.0 110.349 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -90.86 155.54 18.68 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.42 -0.8 . . . . 0.0 110.134 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.3 OUTLIER -67.44 126.83 30.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.401 -0.812 . . . . 0.0 110.111 -179.767 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.511 ' CD2' ' ND2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -56.96 147.37 24.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.913 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.8 t30 72.77 -0.01 3.5 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.963 -0.461 . . . . 0.0 110.811 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -138.73 -168.32 2.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.937 -1.102 . . . . 0.0 109.445 179.189 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.42 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.1 OUTLIER -136.28 25.27 3.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.014 -1.054 . . . . 0.0 110.357 179.667 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -135.62 118.63 16.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.057 -1.027 . . . . 0.0 111.354 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.861 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -48.82 120.64 3.97 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.66 -18.06 3.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.709 -1.244 . . . . 0.0 112.466 -178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 95.3 mt -137.98 -76.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.624 -1.298 . . . . 0.0 111.279 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -50.28 -21.94 1.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.742 -0.599 . . . . 0.0 111.593 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.462 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 59.8 t30 -59.08 -32.92 70.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.039 . . . . 0.0 111.388 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.18 15.89 27.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.016 -1.053 . . . . 0.0 111.025 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.461 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -98.65 -17.55 18.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.02 -1.05 . . . . 0.0 111.069 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.501 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 9.3 p90 -127.0 134.3 50.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.0 -1.062 . . . . 0.0 111.037 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.78 113.88 12.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.904 . . . . 0.0 109.937 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.72 162.34 29.48 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.015 -1.053 . . . . 0.0 110.005 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -83.09 -175.46 14.6 Favored 'Cis proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.55 -2.271 . . . . 0.0 110.526 -0.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.749 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . . . -102.53 -171.61 1.99 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 0.0 110.176 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 2.2 ttmt -125.29 113.35 17.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 0.0 110.251 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.607 ' HA ' HG13 ' A' ' 68' ' ' VAL . 10.0 p90 -97.26 165.42 12.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 110.31 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -155.48 156.81 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.363 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 19.8 mtmt -140.64 173.53 11.4 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.353 -0.842 . . . . 0.0 110.599 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.415 ' CB ' ' HD2' ' A' ' 65' ' ' LYS . 1.6 mtmm -158.53 62.23 0.43 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.843 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m120 45.11 82.6 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.661 -0.65 . . . . 0.0 111.195 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.91 14.78 33.06 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.608 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.415 ' HD2' ' CB ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -165.77 163.17 18.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.96 -1.318 . . . . 0.0 110.982 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.998 HD11 ' HA ' ' A' ' 108' ' ' LYS . 2.4 pt? -172.68 144.67 1.43 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.015 0.912 . . . . 0.0 111.356 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -139.01 173.33 11.67 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.175 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.607 HG13 ' HA ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -142.24 142.17 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.042 -1.036 . . . . 0.0 110.429 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.416 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 3.3 pp0? -97.66 132.35 43.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.398 -0.814 . . . . 0.0 109.641 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.549 HD13 ' HD2' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -113.49 132.63 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 110.457 -179.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 71' ' ' THR . 0.9 OUTLIER -89.54 125.2 35.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.679 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -103.15 134.22 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.901 . . . . 0.0 110.465 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -102.12 145.44 29.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.388 -0.82 . . . . 0.0 110.034 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 11.1 m170 50.61 87.39 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 110.141 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.2 p -57.21 -36.21 70.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.355 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -55.62 -32.8 63.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 110.353 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.599 ' O ' HG12 ' A' ' 119' ' ' VAL . 35.7 m0 -76.3 -60.67 2.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 110.378 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.661 HD11 HG13 ' A' ' 117' ' ' ILE . 2.1 tp -88.41 117.2 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.437 -0.789 . . . . 0.0 110.058 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.651 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -86.82 -24.59 24.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -0.803 . . . . 0.0 110.836 -179.341 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.98 177.89 48.25 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.606 -1.283 . . . . 0.0 109.955 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.402 ' HG2' ' HB ' ' A' ' 117' ' ' ILE . 1.1 mtt -152.94 162.42 41.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -1.148 . . . . 0.0 109.969 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 t -154.81 153.48 31.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.958 . . . . 0.0 110.01 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.816 HD11 ' CE2' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -151.77 147.21 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 110.896 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.478 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 61.07 10.65 2.98 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.488 -0.757 . . . . 0.0 111.944 179.204 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.75 2.16 34.59 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.313 -1.423 . . . . 0.0 111.39 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 83' ' ' ILE . 5.2 p80 -135.39 150.25 49.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.534 -1.568 . . . . 0.0 110.824 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -70.15 -164.23 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 110.437 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 9.6 pt-20 -106.79 170.24 8.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.857 . . . . 0.0 110.492 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.34 136.24 50.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.019 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -67.96 100.94 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.989 -1.07 . . . . 0.0 109.648 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 101' ' ' THR . 1.1 tt -96.26 -29.13 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.0 110.776 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 5.4 m -167.38 99.48 0.51 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.162 -0.961 . . . . 0.0 109.963 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -95.61 152.99 17.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.816 . . . . 0.0 110.041 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.79 73.66 1.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 110.172 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.57 -34.27 72.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.269 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -47.09 85.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.119 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -96.32 14.82 23.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.46 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 1.4 m-20 51.16 55.13 9.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.109 -0.995 . . . . 0.0 110.103 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 54.3 mt-10 -146.32 168.1 21.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.327 -0.858 . . . . 0.0 110.168 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 101' ' ' THR . 4.2 ttt180 -172.96 163.23 4.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.212 -0.93 . . . . 0.0 109.93 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.508 ' O ' HG22 ' A' ' 91' ' ' ILE . 62.9 m -139.96 153.98 47.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.863 . . . . 0.0 110.122 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.42 ' CB ' ' OE1' ' A' ' 88' ' ' GLU . 5.1 p -145.59 143.93 30.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.427 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.99 147.51 22.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.283 -0.886 . . . . 0.0 109.965 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.549 ' HD2' HD13 ' A' ' 70' ' ' ILE . 15.6 m-85 -128.02 135.84 50.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 110.683 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.445 ' C ' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -104.11 131.13 51.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.721 179.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.445 HG13 ' C ' ' A' ' 105' ' ' GLU . 24.0 m -149.22 159.12 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.14 -0.975 . . . . 0.0 110.558 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.8 t -50.44 -45.04 55.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 109.142 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.998 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.5 -165.43 0.85 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.658 -0.651 . . . . 0.0 109.485 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.86 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -149.99 71.48 1.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.073 -1.017 . . . . 0.0 110.548 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -146.17 55.49 1.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.404 -0.81 . . . . 0.0 110.177 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 142' ' ' PHE . . . 169.37 -108.27 0.29 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.452 ' HG3' HG23 ' A' ' 139' ' ' THR . 1.5 tmtt? -156.44 135.15 11.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.35 -1.088 . . . . 0.0 109.902 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.2 mt -128.97 147.27 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.124 -0.985 . . . . 0.0 110.291 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.89 119.95 20.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.952 . . . . 0.0 110.407 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -124.71 178.79 16.38 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 30.5 mttt -146.49 158.51 43.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -1.088 . . . . 0.0 109.842 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.661 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.55 146.91 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.069 -1.019 . . . . 0.0 110.581 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.651 ' C ' HG22 ' A' ' 79' ' ' THR . 1.4 m-20 -106.92 159.79 16.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.532 -0.73 . . . . 0.0 109.534 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.1 OUTLIER -136.24 151.63 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 0.0 110.286 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.16 103.91 3.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.385 -0.822 . . . . 0.0 110.513 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 65.4 mt -132.34 153.18 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 110.136 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.29 97.16 1.35 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.384 -0.823 . . . . 0.0 109.851 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -173.54 -179.73 1.91 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 110.165 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -103.16 108.01 19.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.096 -1.003 . . . . 0.0 110.295 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.474 ' O ' HG12 ' A' ' 125' ' ' VAL . 12.5 t -76.82 100.01 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.296 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.417 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 1.6 m120 62.65 42.08 8.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.222 -0.924 . . . . 0.0 110.519 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.1 36.49 24.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.08 106.21 4.48 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.155 -1.203 . . . . 0.0 110.12 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -51.18 115.19 1.89 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.695 1.366 . . . . 0.0 110.251 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -114.9 116.87 29.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 110.473 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.38 133.95 47.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.398 -0.814 . . . . 0.0 109.775 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.473 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 2.3 t80 -149.79 119.38 6.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.161 -0.962 . . . . 0.0 109.937 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -165.98 75.36 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.248 -0.908 . . . . 0.0 110.034 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.03 -165.24 2.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 110.448 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 1.6 p-80 -122.26 154.33 37.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 110.361 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 45.6 m-85 -154.94 135.06 13.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.31 -0.869 . . . . 0.0 110.033 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 138' ' ' ILE . 50.8 p30 -87.77 166.45 14.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.325 -0.859 . . . . 0.0 110.525 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 137' ' ' ASN . 5.9 pt -156.48 167.25 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.12 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.452 HG23 ' HG3' ' A' ' 112' ' ' LYS . 85.0 m -91.76 115.44 28.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.323 -0.861 . . . . 0.0 111.059 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.816 ' CE2' HD11 ' A' ' 83' ' ' ILE . 15.6 m-85 -90.62 95.79 10.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 109.578 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -87.71 101.94 14.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.05 -1.031 . . . . 0.0 110.742 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 36' ' ' TYR . 22.8 m-85 -93.26 138.87 31.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.31 -0.869 . . . . 0.0 110.251 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.469 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 17.4 m-80 -132.38 99.48 4.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.11 -0.994 . . . . 0.0 110.333 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.766 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -159.77 -142.02 3.29 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.416 ' HG2' HD11 ' A' ' 109' ' ' LEU . 11.7 Cg_endo . . . . . 0 C--N 1.31 -1.485 0 O-C-N 123.598 1.315 . . . . 0.0 110.11 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 60.7 m-20 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 120.904 0.383 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.25 141.05 13.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 110.569 -179.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -172.7 173.06 45.38 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.61 110.63 21.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.258 -1.142 . . . . 0.0 110.402 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.889 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.6 OUTLIER -95.61 155.34 16.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -0.915 . . . . 0.0 110.549 179.793 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.7 t-20 -81.86 135.69 35.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.111 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.895 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -167.09 159.52 13.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.864 -1.147 . . . . 0.0 110.969 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -154.69 -165.82 2.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.398 -0.814 . . . . 0.0 109.795 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.507 ' CG2' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -141.16 174.42 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 110.632 -179.914 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 50.6 m-85 -148.56 157.29 43.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.401 -0.812 . . . . 0.0 109.889 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.466 ' HG3' ' CG2' ' A' ' 43' ' ' THR . 12.8 tppt? -67.73 136.4 54.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 110.223 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.467 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -61.46 146.54 48.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.178 -0.951 . . . . 0.0 109.354 179.577 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 8.3 t30 72.02 2.83 4.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.851 -0.53 . . . . 0.0 110.79 -179.141 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.466 ' CG2' ' HG3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -136.62 -166.65 1.93 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.932 -1.105 . . . . 0.0 109.559 179.207 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.445 ' N ' ' OG1' ' A' ' 43' ' ' THR . 25.6 t30 -130.93 15.87 5.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 110.302 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.59 139.07 41.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 110.843 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.465 ' CG2' ' CB ' ' A' ' 50' ' ' ASN . 0.3 OUTLIER -70.43 134.76 48.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.075 179.141 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.462 ' OG ' HD12 ' A' ' 48' ' ' ILE . 4.7 t -129.28 -18.26 3.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.009 -1.077 . . . . 0.0 112.193 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.462 HD12 ' OG ' ' A' ' 47' ' ' SER . 1.1 mp -138.19 -49.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.773 -1.204 . . . . 0.0 110.976 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.94 8.5 10.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.537 -0.727 . . . . 0.0 111.475 -178.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.465 ' CB ' ' CG2' ' A' ' 46' ' ' THR . 0.5 OUTLIER -71.78 -33.93 69.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.901 -1.124 . . . . 0.0 110.492 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 71.5 m-20 -102.69 15.38 29.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.13 -0.981 . . . . 0.0 110.806 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.702 ' CD1' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -91.13 -18.01 25.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.047 -1.033 . . . . 0.0 110.866 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.507 ' CE1' ' CG2' ' A' ' 38' ' ' VAL . 39.2 p90 -118.3 127.88 54.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.15 -0.969 . . . . 0.0 110.865 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.532 ' CB ' HG21 ' A' ' 71' ' ' THR . 1.7 t30 -73.76 109.85 7.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.746 179.315 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.419 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 2.7 pttt -91.99 161.63 32.88 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.047 -1.033 . . . . 0.0 110.144 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 56.4 Cg_endo -79.54 -175.58 16.77 Favored 'Cis proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.513 -2.286 . . . . 0.0 110.585 -0.031 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.895 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.8 168.06 9.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 0.0 109.894 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.432 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -105.5 116.01 31.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 110.795 -179.798 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.502 ' HB2' HD23 ' A' ' 109' ' ' LEU . 3.9 p90 -96.3 160.96 14.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 0.0 109.355 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -154.72 124.62 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.942 -1.099 . . . . 0.0 110.967 -179.329 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.458 ' CD ' ' HE2' ' A' ' 108' ' ' LYS . 1.2 mtmt -137.62 129.29 28.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.349 -0.845 . . . . 0.0 110.173 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -108.37 63.63 0.61 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.903 . . . . 0.0 110.843 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 46.03 96.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.494 -0.754 . . . . 0.0 111.109 179.329 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.94 12.73 39.15 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.417 ' HB2' ' OH ' ' A' ' 67' ' ' TYR . 6.9 ptpt -171.25 156.8 4.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.166 -1.196 . . . . 0.0 109.735 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.753 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.05 143.28 6.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.034 -1.041 . . . . 0.0 111.517 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -140.26 -160.59 1.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.613 -0.679 . . . . 0.0 109.436 179.94 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -170.14 131.06 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.003 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.432 ' HG2' ' HB3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -98.46 141.98 30.65 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.917 . . . . 0.0 110.322 -179.948 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.1 OUTLIER -114.69 141.27 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.438 -0.789 . . . . 0.0 110.067 -179.872 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.532 HG21 ' CB ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -89.18 134.42 34.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.985 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.635 HG22 ' CE ' ' A' ' 81' ' ' MET . 3.0 t -104.36 124.87 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.867 . . . . 0.0 110.277 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.83 128.94 45.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.011 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.4 m80 62.72 113.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.311 -0.868 . . . . 0.0 110.107 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.2 t -76.47 -13.19 60.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.864 . . . . 0.0 110.677 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -84.0 -56.1 3.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.041 -1.037 . . . . 0.0 110.397 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.532 ' HA ' HD11 ' A' ' 121' ' ' ILE . 4.0 m0 -47.87 -68.07 0.22 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.325 -0.859 . . . . 0.0 110.646 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.752 HD11 HG13 ' A' ' 117' ' ' ILE . 0.6 OUTLIER -88.28 122.15 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.922 . . . . 0.0 110.041 -179.86 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.628 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.19 -27.42 23.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.847 . . . . 0.0 110.926 -179.204 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.18 -179.74 45.93 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.166 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.635 ' CE ' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -152.93 169.68 22.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.508 -0.995 . . . . 0.0 109.987 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -153.91 161.41 42.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.067 -1.021 . . . . 0.0 109.716 179.904 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.895 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -164.5 141.4 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 110.699 -179.672 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.48 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 0.4 OUTLIER 62.89 8.7 3.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.525 -0.734 . . . . 0.0 111.964 179.379 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.24 2.01 28.03 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.349 -1.405 . . . . 0.0 111.424 178.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.48 ' NE2' ' CB ' ' A' ' 84' ' ' GLU . 3.2 p80 -135.42 155.95 49.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.518 -1.577 . . . . 0.0 110.964 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -160.49 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.508 -0.745 . . . . 0.0 110.5 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -102.66 150.81 23.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.391 -0.818 . . . . 0.0 110.298 -179.863 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -99.89 125.55 45.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.599 179.519 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.532 HG22 HH21 ' A' ' 100' ' ' ARG . 1.1 pp -67.24 103.11 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.005 -1.059 . . . . 0.0 109.884 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.447 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -95.63 -28.91 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.461 -0.774 . . . . 0.0 110.851 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.5 p -167.05 105.1 0.56 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.96 -1.087 . . . . 0.0 109.982 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.465 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 13.2 ttmt -95.24 106.48 18.52 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.327 -0.858 . . . . 0.0 110.19 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -96.59 95.01 7.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.9 p -77.31 -17.75 58.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 110.434 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.73 -53.67 50.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.025 -1.047 . . . . 0.0 110.101 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -98.0 15.07 25.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -0.88 . . . . 0.0 110.358 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.0 64.93 1.57 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.15 -0.969 . . . . 0.0 110.174 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.93 170.98 15.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.424 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.532 HH21 HG22 ' A' ' 90' ' ' ILE . 6.6 mtp180 -162.18 164.6 27.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.496 -0.752 . . . . 0.0 109.91 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.447 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 94.6 m -140.68 152.12 45.11 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.29 -0.881 . . . . 0.0 109.618 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 1.7 p -143.54 138.84 29.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.989 -1.069 . . . . 0.0 110.65 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -91.69 138.2 31.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.366 -0.834 . . . . 0.0 109.975 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 38.2 m-85 -128.59 129.71 46.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.157 -0.964 . . . . 0.0 110.807 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -90.31 127.53 36.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.392 -0.817 . . . . 0.0 109.395 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.533 HG22 ' N ' ' A' ' 107' ' ' SER . 2.7 p -149.28 168.52 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.001 -1.062 . . . . 0.0 110.832 -179.25 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.533 ' N ' HG22 ' A' ' 106' ' ' VAL . 39.5 t -78.2 110.54 13.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.05 178.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.458 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 47.41 -158.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.46 -0.775 . . . . 0.0 109.86 -178.834 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.577 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -151.27 59.93 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.041 -1.037 . . . . 0.0 110.791 -179.678 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -146.22 56.96 1.19 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.239 -0.913 . . . . 0.0 110.31 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.33 178.96 48.66 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.417 ' CD ' HG23 ' A' ' 139' ' ' THR . 0.1 OUTLIER -81.57 148.32 29.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -1.135 . . . . 0.0 110.395 -179.916 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.1 mm -137.84 150.08 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 110.114 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -76.07 124.63 27.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 109.986 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.487 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -131.88 116.82 1.94 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 82' ' ' SER . 30.8 mtpt -95.44 159.22 15.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -1.106 . . . . 0.0 109.471 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.752 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -158.24 140.55 5.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 120.845 -1.16 . . . . 0.0 111.194 -179.836 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.628 ' C ' HG22 ' A' ' 79' ' ' THR . 15.0 m-20 -108.26 161.11 15.3 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.575 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -131.48 147.62 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.014 -1.054 . . . . 0.0 110.766 -179.434 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 22.6 t80 -152.12 106.45 3.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 110.281 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.532 HD11 ' HA ' ' A' ' 77' ' ' TRP . 2.4 mp -135.03 150.65 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.158 -0.964 . . . . 0.0 110.68 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 1.0 OUTLIER -160.94 96.8 1.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.46 -0.775 . . . . 0.0 109.863 179.856 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.421 ' OE2' HG12 ' A' ' 125' ' ' VAL . 0.9 OUTLIER -173.9 -168.38 0.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 110.508 -179.838 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 0.9 OUTLIER -97.9 84.73 3.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.863 . . . . 0.0 110.346 -179.874 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.421 HG12 ' OE2' ' A' ' 123' ' ' GLU . 16.0 m -77.52 136.62 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 50.39 28.01 3.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.812 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.32 34.21 41.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 4.1 mtpt -145.09 128.82 8.63 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.238 -1.154 . . . . 0.0 110.139 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.403 ' HD3' ' HE3' ' A' ' 124' ' ' LYS . 28.9 Cg_endo -68.95 110.5 2.4 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.658 1.346 . . . . 0.0 110.155 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.403 ' CE2' ' HB2' ' A' ' 132' ' ' TYR . 49.1 t80 -116.15 156.08 27.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.124 -0.985 . . . . 0.0 110.453 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.79 110.39 9.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 109.935 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.575 ' HE2' HG11 ' A' ' 119' ' ' VAL . 1.6 t80 -112.8 127.28 56.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 110.041 -179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -163.4 84.59 0.49 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 110.052 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.45 -169.8 3.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.511 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.468 ' CD2' ' O ' ' A' ' 135' ' ' HIS . 0.7 OUTLIER -119.71 145.66 46.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 110.163 179.889 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 38.9 m-85 -155.16 -179.56 8.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 110.104 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.573 ' O ' HG23 ' A' ' 138' ' ' ILE . 2.0 p30 -151.88 172.9 15.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.8 pt -155.8 166.72 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.305 -0.872 . . . . 0.0 110.132 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.417 HG23 ' CD ' ' A' ' 112' ' ' LYS . 86.6 m -91.83 122.24 34.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 111.063 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.895 ' CD2' HD11 ' A' ' 83' ' ' ILE . 6.3 m-85 -90.02 162.5 15.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.302 -0.874 . . . . 0.0 109.625 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 101.31 2.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.055 -1.028 . . . . 0.0 110.819 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -91.34 133.85 35.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.299 -0.876 . . . . 0.0 109.518 179.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.44 ' C ' HD21 ' A' ' 34' ' ' LEU . 2.9 m-80 -128.56 108.63 10.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 110.64 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.889 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -160.36 -145.5 4.3 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.562 ' HD2' HD11 ' A' ' 34' ' ' LEU . 11.0 Cg_endo . . . . . 0 C--N 1.307 -1.638 0 O-C-N 123.626 1.33 . . . . 0.0 110.063 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 8.8 m-20 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.907 0.384 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 p -160.02 159.05 31.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -0.995 . . . . 0.0 110.529 -179.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.51 176.19 35.21 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.94 105.96 18.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.283 -1.128 . . . . 0.0 110.369 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.829 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -95.82 157.26 15.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.128 -0.982 . . . . 0.0 110.847 -179.844 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -80.24 138.45 36.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.344 -0.848 . . . . 0.0 110.483 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.794 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -165.24 155.53 13.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.209 179.498 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -155.52 -177.4 6.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.0 110.101 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.746 ' O ' HG22 ' A' ' 46' ' ' THR . 2.2 m -140.21 116.74 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 0.0 110.356 179.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -92.35 169.56 10.47 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.421 -0.799 . . . . 0.0 110.38 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.457 ' CD ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -67.41 125.82 27.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.887 . . . . 0.0 109.716 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.493 ' O ' HG23 ' A' ' 43' ' ' THR . 0.5 OUTLIER -48.58 143.28 5.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.286 -0.884 . . . . 0.0 110.53 -179.46 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 18.6 t30 73.77 -2.47 2.76 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.038 -0.414 . . . . 0.0 111.468 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.47 -163.88 1.51 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.782 -1.199 . . . . 0.0 110.053 179.523 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -136.59 30.92 2.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.559 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -134.3 119.81 19.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.082 -1.011 . . . . 0.0 110.983 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.746 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -57.95 121.61 10.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.472 -0.767 . . . . 0.0 109.63 179.245 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.73 -19.18 3.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.767 -1.208 . . . . 0.0 112.227 -179.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.457 HD11 ' CD ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -138.92 -77.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.536 -1.353 . . . . 0.0 111.108 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -46.17 -25.67 0.64 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.702 -0.623 . . . . 0.0 111.269 -179.228 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.513 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 1.3 p30 -66.34 -14.65 62.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.988 -1.07 . . . . 0.0 110.917 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.63 15.27 29.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.083 -1.011 . . . . 0.0 111.182 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -138.79 13.4 2.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.831 -1.168 . . . . 0.0 111.002 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CE1' ' HA ' ' A' ' 50' ' ' ASN . 4.8 p90 -125.81 129.18 48.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.019 . . . . 0.0 110.4 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -73.41 157.11 37.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 110.297 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -148.27 155.4 42.93 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 110.062 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.407 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 56.8 Cg_endo -79.81 -174.97 15.52 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.762 -2.183 . . . . 0.0 110.351 -0.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.794 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.51 169.13 9.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -0.954 . . . . 0.0 110.164 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.44 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -103.15 115.84 31.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.498 -179.868 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.5 p90 -97.76 164.32 12.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.922 . . . . 0.0 109.916 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -155.45 129.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 110.275 179.903 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.431 ' HG2' ' HB2' ' A' ' 66' ' ' LEU . 1.2 mtmp? -140.05 112.74 7.99 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.485 -0.759 . . . . 0.0 110.196 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 62.23 2.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.109 -0.994 . . . . 0.0 110.593 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 46.03 99.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.604 -0.685 . . . . 0.0 111.63 179.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.05 -21.64 43.74 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.084 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.87 167.45 20.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -1.139 . . . . 0.0 110.35 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.711 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.1 pt? -171.62 145.46 2.02 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.553 179.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.566 ' C ' HG12 ' A' ' 68' ' ' VAL . 1.1 m-85 -142.45 -167.1 2.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.68 -0.637 . . . . 0.0 109.43 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.566 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -165.28 129.63 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.126 -0.984 . . . . 0.0 110.419 179.374 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.44 ' HG2' ' CB ' ' A' ' 58' ' ' LYS . 12.1 pt20 -99.57 132.52 44.85 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.832 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.5 HD12 ' CG2' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -117.04 130.66 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 110.195 -179.713 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.8 m -88.56 127.68 35.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.907 . . . . 0.0 109.797 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -102.01 141.9 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.829 . . . . 0.0 110.167 -179.663 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -99.72 148.48 24.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.323 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 7.9 m80 52.43 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.46 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.14 -29.82 61.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 0.0 110.104 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -53.3 14.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.395 -0.816 . . . . 0.0 110.118 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.773 ' O ' HG12 ' A' ' 119' ' ' VAL . 35.0 m0 -51.71 -70.43 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.344 -0.847 . . . . 0.0 110.286 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 78' ' ' ILE . 3.9 tt -88.23 116.91 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 109.927 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.701 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -87.3 -22.55 25.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -0.841 . . . . 0.0 110.937 -179.18 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.43 170.66 42.79 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.311 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.578 ' CG ' HD11 ' A' ' 78' ' ' ILE . 4.0 mtm -153.07 107.1 3.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.428 -1.042 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.84 163.91 17.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 110.136 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.708 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.5 OUTLIER -152.42 144.65 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.376 -0.827 . . . . 0.0 110.0 179.83 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.491 ' HB3' ' CE1' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 64.67 10.71 6.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.096 -1.002 . . . . 0.0 110.997 179.868 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.9 15.6 53.83 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.623 179.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 83' ' ' ILE . 2.2 p-80 -135.08 159.47 41.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.821 -1.399 . . . . 0.0 110.546 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 176.71 4.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.403 -0.811 . . . . 0.0 111.008 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 7.4 pt-20 -104.02 170.25 8.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 0.0 110.508 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.7 OUTLIER -112.06 128.34 56.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 110.157 -179.927 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.71 103.56 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.097 -1.002 . . . . 0.0 109.586 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 101' ' ' THR . 1.4 tt -94.47 -27.24 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.344 -0.847 . . . . 0.0 110.872 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -167.03 100.86 0.54 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.184 -0.947 . . . . 0.0 109.808 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 21.5 ttmt -95.67 107.17 19.35 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.327 -0.858 . . . . 0.0 110.211 -179.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.47 68.3 2.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.027 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.94 -27.52 44.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.282 -0.886 . . . . 0.0 110.229 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.42 -47.44 84.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 0.0 110.126 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -96.71 17.54 16.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.263 -0.898 . . . . 0.0 110.435 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 52.7 57.98 5.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 110.247 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -148.28 174.42 12.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.164 -0.96 . . . . 0.0 110.527 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.442 ' O ' HG13 ' A' ' 72' ' ' VAL . 3.2 ttm180 -170.16 162.65 8.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.356 -0.84 . . . . 0.0 110.207 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.52 ' O ' HG22 ' A' ' 91' ' ' ILE . 91.0 m -142.13 153.78 44.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 109.801 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -145.8 144.93 30.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.96 -1.088 . . . . 0.0 110.927 -179.818 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -93.43 141.8 28.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.353 -0.842 . . . . 0.0 109.719 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.523 ' HB2' HG13 ' A' ' 68' ' ' VAL . 97.9 m-85 -130.16 141.63 50.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.006 . . . . 0.0 111.18 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.32 127.89 50.54 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.711 ' O ' HD21 ' A' ' 66' ' ' LEU . 2.6 p -149.89 149.59 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.036 -1.04 . . . . 0.0 111.351 -178.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 101.58 0.72 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.159 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.658 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 55.1 174.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 108.899 -177.919 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.96 70.66 1.11 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.782 -1.199 . . . . 0.0 111.004 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -147.32 64.39 1.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.469 -0.77 . . . . 0.0 110.191 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 177.54 -112.59 0.38 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.676 -1.25 . . . . 0.0 109.986 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.468 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.4 OUTLIER -157.35 137.58 12.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -1.165 . . . . 0.0 110.167 -179.628 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.518 HD13 HG21 ' A' ' 106' ' ' VAL . 12.0 mt -135.21 151.93 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.98 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -76.01 125.18 28.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.164 -0.96 . . . . 0.0 110.5 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.478 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -133.43 178.73 18.02 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 2.1 mtpp -142.34 166.89 23.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -1.186 . . . . 0.0 109.745 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.55 HG22 ' HA ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -158.83 140.59 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.877 -1.14 . . . . 0.0 110.751 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.701 ' C ' HG22 ' A' ' 79' ' ' THR . 1.2 m-20 -107.42 160.62 15.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.553 -0.717 . . . . 0.0 109.375 179.296 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -136.97 149.81 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.058 -1.026 . . . . 0.0 110.582 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.41 106.51 3.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.305 -0.872 . . . . 0.0 110.602 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 77' ' ' TRP . 3.0 mp -137.99 148.68 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -0.901 . . . . 0.0 110.258 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.9 95.69 1.19 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.351 -0.843 . . . . 0.0 109.738 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.47 -178.97 1.77 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.374 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -98.12 102.27 13.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 110.308 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.742 HG21 ' CD2' ' A' ' 130' ' ' PHE . 13.4 t -76.74 97.42 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 110.303 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.8 m120 57.48 50.84 10.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.268 -0.895 . . . . 0.0 110.423 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.9 36.63 57.35 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.434 ' HE3' ' CA ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -145.75 103.08 4.21 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.195 -1.179 . . . . 0.0 110.186 179.819 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -49.91 117.85 3.39 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.785 1.413 . . . . 0.0 110.227 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.742 ' CD2' HG21 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -111.81 110.3 20.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 110.453 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -106.08 107.48 18.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -0.886 . . . . 0.0 110.079 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.446 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 3.6 t80 -134.54 129.29 34.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.051 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -174.27 82.28 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.168 -0.957 . . . . 0.0 110.234 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -153.44 -160.54 1.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.169 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -122.5 148.46 45.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.257 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -155.14 -179.33 7.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.681 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.618 ' O ' HG23 ' A' ' 138' ' ' ILE . 46.2 p-10 -151.67 173.02 15.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 110.984 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.5 pt -157.58 172.39 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 110.356 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.468 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 59.9 m -91.66 124.06 35.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.346 -0.846 . . . . 0.0 110.56 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.708 ' CD2' HD11 ' A' ' 83' ' ' ILE . 31.5 m-85 -91.2 104.47 17.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.233 -0.917 . . . . 0.0 109.996 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -97.62 105.7 17.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.202 -0.936 . . . . 0.0 110.741 -179.703 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -92.45 158.8 15.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.285 -0.884 . . . . 0.0 110.519 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.464 ' C ' HD21 ' A' ' 34' ' ' LEU . 38.2 m-80 -145.49 104.0 3.87 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.094 -1.004 . . . . 0.0 110.479 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.829 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -164.34 -146.77 4.87 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.506 ' HD2' HD11 ' A' ' 34' ' ' LEU . 20.3 Cg_endo . . . . . 0 C--N 1.308 -1.605 0 O-C-N 123.802 1.422 . . . . 0.0 110.412 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 12.8 m-20 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 120.782 0.325 . . . . 0.0 110.308 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -159.36 155.23 26.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.037 -1.039 . . . . 0.0 110.589 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.79 171.76 35.66 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.67 111.14 21.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -1.12 . . . . 0.0 110.54 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.521 HD13 HD22 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -94.46 148.86 21.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 0.0 109.877 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.446 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 22.4 m-20 -79.56 137.94 37.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.224 -0.922 . . . . 0.0 110.199 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.732 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 1.8 p90 -166.57 164.01 17.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.187 -0.946 . . . . 0.0 110.83 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.25 -179.41 8.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.472 -0.768 . . . . 0.0 109.64 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.806 HG13 ' O ' ' A' ' 139' ' ' THR . 69.0 t -140.21 111.21 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.093 -1.004 . . . . 0.0 110.217 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -89.04 166.17 14.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.758 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.2 OUTLIER -67.18 125.15 25.15 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 110.109 -179.766 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.53 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -51.14 144.0 9.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 110.058 -179.906 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.9 OUTLIER 72.02 1.36 3.89 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.818 -0.551 . . . . 0.0 111.108 -179.536 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -135.66 -166.69 1.9 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.894 -1.129 . . . . 0.0 109.752 179.233 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -135.18 18.7 3.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.937 . . . . 0.0 110.196 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -136.19 126.41 26.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.114 -0.991 . . . . 0.0 111.088 -179.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.454 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -53.9 124.95 16.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -0.834 . . . . 0.0 108.903 178.951 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.3 -18.77 3.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.73 -1.231 . . . . 0.0 112.202 -178.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.3 mt -138.55 -78.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.751 -1.218 . . . . 0.0 110.776 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -45.99 -25.68 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.696 -0.627 . . . . 0.0 111.24 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.454 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -56.48 -18.12 10.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.037 -1.039 . . . . 0.0 111.073 -179.597 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -101.91 15.21 29.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.976 -1.078 . . . . 0.0 111.006 -179.316 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -141.87 10.74 2.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.935 -1.103 . . . . 0.0 111.031 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -118.69 115.44 24.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.091 -1.006 . . . . 0.0 110.136 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.31 152.36 42.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 110.408 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -147.2 158.26 44.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 109.848 179.896 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 58.7 Cg_endo -79.57 -175.65 16.9 Favored 'Cis proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.714 -2.203 . . . . 0.0 110.585 -0.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.732 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -102.47 164.05 11.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.062 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.447 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 1.4 mtpt -102.44 118.09 36.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.931 . . . . 0.0 110.524 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.514 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 27.2 p90 -97.3 164.47 12.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.862 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -156.31 117.03 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.033 -1.042 . . . . 0.0 110.632 -179.681 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.508 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -127.49 122.15 32.65 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.157 -0.965 . . . . 0.0 110.365 179.885 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 63' ' ' ASN . 1.7 mmmp? -101.46 61.97 0.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 0.0 110.155 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 62' ' ' LYS . 5.1 t-20 47.78 100.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.435 -0.791 . . . . 0.0 111.434 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.11 -15.53 57.83 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.461 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -144.28 169.36 18.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.009 -1.289 . . . . 0.0 110.532 179.827 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.699 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.6 pt? -169.58 144.26 2.91 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.367 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.541 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -137.47 -169.08 2.44 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.727 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -165.72 131.27 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 110.012 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.497 ' NE2' HG21 ' A' ' 101' ' ' THR . 0.0 OUTLIER -98.12 130.21 44.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 -179.932 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.587 HD11 ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -111.61 135.01 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.69 179.94 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.6 m -89.68 125.52 35.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.082 -1.011 . . . . 0.0 110.067 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.59 143.41 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 110.207 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -100.57 128.52 46.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.354 -0.841 . . . . 0.0 110.615 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 61.24 115.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 0.0 110.499 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -43.08 57.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.0 110.037 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -50.82 -39.37 53.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 109.99 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.497 ' O ' HG12 ' A' ' 119' ' ' VAL . 23.8 m0 -64.77 -73.45 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 110.062 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.31 119.13 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 109.987 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.827 HG22 ' O ' ' A' ' 118' ' ' ASP . 3.7 t -86.88 -21.65 26.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 111.001 -179.346 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 81' ' ' MET . . . -172.17 169.93 42.98 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.451 -1.356 . . . . 0.0 110.125 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 3.5 mtm -151.87 106.11 3.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -1.106 . . . . 0.0 110.04 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -86.58 158.48 19.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 109.863 179.66 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.757 HD11 ' CE1' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -156.25 135.63 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.5 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.5 ' HG3' HG12 ' A' ' 106' ' ' VAL . 0.6 OUTLIER 65.29 6.22 3.51 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.451 -0.781 . . . . 0.0 112.018 179.489 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.18 -0.57 22.51 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.332 -1.413 . . . . 0.0 111.328 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.474 ' NE2' ' HB3' ' A' ' 84' ' ' GLU . 2.6 p80 -131.72 158.08 42.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.557 -1.555 . . . . 0.0 110.881 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -70.55 -164.24 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.5 -0.75 . . . . 0.0 110.505 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 1.2 pm0 -104.61 164.07 12.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 110.544 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -115.38 133.96 55.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.913 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.427 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 1.2 pp -68.06 101.71 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.995 -1.065 . . . . 0.0 109.792 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 101' ' ' THR . 2.3 tt -95.71 -28.2 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.338 -0.851 . . . . 0.0 110.732 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.7 p -167.03 103.35 0.55 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 109.776 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -95.08 147.51 23.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.357 -0.84 . . . . 0.0 110.174 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.31 71.39 1.33 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 110.125 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.16 -32.7 62.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.372 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -42.78 99.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.224 -0.923 . . . . 0.0 110.16 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -95.98 10.38 37.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -0.904 . . . . 0.0 110.608 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 50.95 56.87 7.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.97 -1.081 . . . . 0.0 110.181 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -147.61 179.65 7.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.45 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -174.86 162.02 3.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.401 -0.812 . . . . 0.0 109.984 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.573 ' O ' HG22 ' A' ' 91' ' ' ILE . 82.8 m -140.61 156.02 46.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.331 -0.855 . . . . 0.0 109.552 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.45 ' OG ' HG22 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -143.23 140.02 30.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.982 -1.073 . . . . 0.0 110.82 -179.582 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -93.56 137.59 32.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.717 . . . . 0.0 110.194 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 81.7 m-85 -128.59 140.98 51.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.08 -1.012 . . . . 0.0 110.748 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.467 ' C ' HG13 ' A' ' 106' ' ' VAL . 2.0 tt0 -102.52 131.54 49.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.86 . . . . 0.0 109.335 179.109 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.699 ' O ' HD21 ' A' ' 66' ' ' LEU . 35.7 m -149.16 147.63 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.135 -0.978 . . . . 0.0 110.833 -179.203 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.51 108.25 1.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 109.141 179.12 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.672 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 54.39 176.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -0.95 . . . . 0.0 109.118 -178.646 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.521 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -148.9 72.09 1.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.968 -1.082 . . . . 0.0 110.792 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -145.59 44.58 1.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.471 -0.768 . . . . 0.0 109.984 179.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . -174.29 177.25 46.55 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.436 ' CD ' HG23 ' A' ' 139' ' ' THR . 0.6 OUTLIER -80.51 145.95 31.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.233 -1.157 . . . . 0.0 110.637 -179.701 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.418 ' N ' ' HE3' ' A' ' 112' ' ' LYS . 74.9 mt -136.17 150.75 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.35 -0.844 . . . . 0.0 109.781 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -76.48 132.26 39.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.06 -1.025 . . . . 0.0 110.428 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.437 ' HA3' ' CD2' ' A' ' 140' ' ' TYR . . . -132.94 169.84 22.36 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 82' ' ' SER . 22.4 mtmt -144.01 162.23 36.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.069 -1.253 . . . . 0.0 109.529 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.487 HG21 HG12 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -159.31 153.44 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.907 -1.121 . . . . 0.0 111.034 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.827 ' O ' HG22 ' A' ' 79' ' ' THR . 84.3 m-20 -115.31 154.23 29.52 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.502 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -129.48 143.76 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.058 -1.026 . . . . 0.0 110.55 -179.652 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.92 99.99 2.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -0.826 . . . . 0.0 110.118 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.7 mt -123.24 152.55 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.612 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.89 96.54 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.399 -0.813 . . . . 0.0 109.812 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -173.5 -170.67 0.62 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.945 . . . . 0.0 110.509 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.97 103.5 15.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 110.347 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 21.6 t -76.85 102.72 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 110.333 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.8 m120 53.86 43.14 31.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.311 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.23 32.17 44.43 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 125' ' ' VAL . 5.2 mtmt -145.5 102.3 4.31 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.228 -1.16 . . . . 0.0 110.116 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -46.68 120.73 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.702 1.369 . . . . 0.0 110.517 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -124.95 148.51 48.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 0.0 110.058 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -134.69 106.35 6.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.271 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.502 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 4.7 t80 -110.62 131.48 55.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 110.098 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.29 88.04 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.895 . . . . 0.0 110.069 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.34 -168.33 2.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.268 -0.895 . . . . 0.0 110.288 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -117.65 141.67 48.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.974 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -155.51 -179.26 7.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 110.195 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.449 ' HA ' HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -151.18 176.38 11.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -0.951 . . . . 0.0 110.378 179.902 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.487 HG12 HG21 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -155.7 179.59 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 110.085 -179.761 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.806 ' O ' HG13 ' A' ' 38' ' ' VAL . 15.5 m -91.06 161.5 15.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.817 . . . . 0.0 111.086 -179.171 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.757 ' CE1' HD11 ' A' ' 83' ' ' ILE . 23.1 m-85 -147.82 98.81 3.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.575 -0.703 . . . . 0.0 109.3 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 10.9 tttt -116.86 110.19 18.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.244 -0.91 . . . . 0.0 110.955 -179.259 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -92.56 152.73 19.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.403 -0.811 . . . . 0.0 110.089 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 35' ' ' ASN . 3.4 m-80 -128.98 104.64 7.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.922 . . . . 0.0 110.214 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -153.26 -144.52 3.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.458 ' HD2' HD11 ' A' ' 109' ' ' LEU . 10.1 Cg_endo . . . . . 0 C--N 1.309 -1.55 0 O-C-N 123.608 1.32 . . . . 0.0 110.644 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.11 0.481 . . . . 0.0 110.209 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 p -159.74 129.85 5.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.408 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.52 177.8 48.33 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.45 105.54 17.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.205 -1.173 . . . . 0.0 110.221 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.762 HD13 HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -93.79 151.37 19.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.378 -0.826 . . . . 0.0 110.154 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.451 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 23.0 m120 -79.06 145.55 33.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.921 . . . . 0.0 110.14 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.476 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 1.5 p90 -163.92 156.01 17.07 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.189 -0.945 . . . . 0.0 110.177 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -155.44 -176.76 6.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 110.043 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.449 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -140.16 174.41 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.159 -0.963 . . . . 0.0 110.267 179.991 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.449 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 47.3 m-85 -147.96 160.19 43.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.416 -0.802 . . . . 0.0 110.153 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.81 121.33 15.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.859 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.532 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -48.75 148.97 1.91 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 -179.72 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 8.5 t30 72.47 1.43 3.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.968 -0.458 . . . . 0.0 111.085 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -136.05 -155.98 0.67 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.789 -1.195 . . . . 0.0 109.902 179.297 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -136.13 10.77 3.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.335 -0.853 . . . . 0.0 110.491 179.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -134.28 148.95 50.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.015 . . . . 0.0 110.845 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.438 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -79.83 138.44 37.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.319 179.547 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.97 -17.91 3.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.961 -1.087 . . . . 0.0 111.899 -179.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.5 mt -137.96 -71.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.764 -1.21 . . . . 0.0 110.709 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.519 ' HB1' ' HE2' ' A' ' 53' ' ' PHE . . . -46.11 -26.53 0.77 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.691 -0.631 . . . . 0.0 111.023 -179.426 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.414 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -59.7 -19.65 51.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.128 -0.983 . . . . 0.0 110.715 -179.595 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -102.32 14.82 30.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.97 -1.081 . . . . 0.0 110.868 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -128.79 6.15 5.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.984 -1.073 . . . . 0.0 111.075 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.519 ' HE2' ' HB1' ' A' ' 49' ' ' ALA . 33.8 m-85 -129.76 117.01 19.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 110.34 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -72.77 166.82 22.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.97 . . . . 0.0 110.301 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -148.18 159.57 39.32 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 110.011 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -82.48 -175.64 15.35 Favored 'Cis proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.648 -2.23 . . . . 0.0 110.394 -0.411 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.97 170.23 8.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 110.002 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.3 tmtm? -103.03 108.38 19.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 110.525 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.492 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 6.3 p90 -97.97 162.25 13.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 109.75 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -154.8 155.22 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.15 -0.969 . . . . 0.0 110.373 -179.665 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.7 mtpt -135.94 168.89 18.49 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.339 -0.851 . . . . 0.0 110.606 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.441 ' CB ' ' HG3' ' A' ' 65' ' ' LYS . 10.4 mttm -148.0 61.97 1.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 0.0 109.834 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.409 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 10.5 t-20 45.69 78.07 0.07 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.47 -0.769 . . . . 0.0 110.925 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.09 19.42 16.89 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HG3' ' CB ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -168.07 162.83 13.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.146 -1.208 . . . . 0.0 110.38 179.546 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.596 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.3 pt? -173.42 150.18 1.8 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.2 1.0 . . . . 0.0 111.74 178.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.592 ' C ' HG12 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -139.94 -164.83 1.77 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.023 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.592 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -170.17 144.01 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.0 110.692 179.356 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.419 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 1.6 pt20 -99.75 132.87 44.82 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.924 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -110.57 133.1 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.852 . . . . 0.0 109.8 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.532 ' O ' HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -89.27 123.08 33.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.145 -0.972 . . . . 0.0 110.26 -179.542 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.581 ' HB ' HG21 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -104.29 147.09 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.357 -0.839 . . . . 0.0 109.857 179.999 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -99.49 141.91 31.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 0.0 110.49 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 77' ' ' TRP . 9.6 m-70 53.62 92.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 m -52.35 -31.28 32.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 110.232 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -71.11 -45.53 63.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.219 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.466 ' CG ' ' HB3' ' A' ' 74' ' ' HIS . 45.6 m0 -55.64 -62.77 1.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.318 -0.864 . . . . 0.0 110.303 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.658 HD11 ' SD ' ' A' ' 81' ' ' MET . 0.5 OUTLIER -88.37 120.26 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.448 -0.783 . . . . 0.0 109.915 -179.727 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.675 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -89.16 -27.21 20.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.347 -0.846 . . . . 0.0 111.073 -179.217 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.57 172.02 43.78 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.258 -1.449 . . . . 0.0 110.535 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.658 ' SD ' HD11 ' A' ' 78' ' ' ILE . 1.8 mtp -153.05 110.95 3.6 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.522 -0.987 . . . . 0.0 109.859 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.419 ' O ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -86.56 123.04 31.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.975 -1.078 . . . . 0.0 110.031 179.947 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.7 HD12 ' CG ' ' A' ' 104' ' ' PHE . 1.7 mt -113.1 131.07 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 110.259 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 2.3 tm-20 69.62 5.51 5.23 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.493 -0.755 . . . . 0.0 110.99 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.25 23.89 10.86 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.728 -1.225 . . . . 0.0 111.0 178.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.47 ' C ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.39 162.37 34.6 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.673 -1.486 . . . . 0.0 110.149 179.359 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -175.68 1.18 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.96 . . . . 0.0 110.199 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.482 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 5.1 pt-20 -110.17 167.03 10.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 110.341 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 102' ' ' SER . 3.5 t-20 -114.09 130.7 56.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.361 -0.837 . . . . 0.0 109.918 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.401 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 1.1 pp -67.69 100.89 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 0.0 109.674 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.667 HG21 HG22 ' A' ' 101' ' ' THR . 2.4 tt -95.36 -23.3 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 110.566 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -167.06 100.18 0.53 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -94.54 142.5 27.37 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.914 -179.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.423 ' HB3' ' HB2' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -142.59 74.12 1.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 110.33 -179.747 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.0 p -65.07 -31.16 72.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.062 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.65 -50.07 72.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.852 . . . . 0.0 110.226 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -95.43 13.62 25.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.259 -0.9 . . . . 0.0 110.426 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.65 60.56 3.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 110.276 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 94' ' ' ASN . 23.4 mt-10 -147.54 150.41 34.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 0.0 110.418 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.405 ' O ' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -152.47 157.08 40.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.353 -0.842 . . . . 0.0 109.951 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.667 HG22 HG21 ' A' ' 91' ' ' ILE . 60.4 m -141.09 154.8 46.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.306 -0.871 . . . . 0.0 109.75 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 1.8 p -145.57 139.75 26.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.007 -1.058 . . . . 0.0 111.044 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 57.2 tt0 -93.06 138.65 31.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.46 -0.775 . . . . 0.0 109.429 179.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.7 ' CG ' HD12 ' A' ' 83' ' ' ILE . 93.5 m-85 -128.5 145.72 51.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.883 -1.136 . . . . 0.0 111.34 -179.234 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.519 ' C ' HG13 ' A' ' 106' ' ' VAL . 57.5 tt0 -105.72 130.41 53.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.42 -0.8 . . . . 0.0 109.048 178.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.596 ' O ' HD21 ' A' ' 66' ' ' LEU . 34.1 m -150.31 170.34 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.918 -1.113 . . . . 0.0 111.36 -178.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.3 m -74.59 111.02 9.36 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.523 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 45.7 -163.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.591 -0.693 . . . . 0.0 109.673 -178.355 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.762 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.03 56.88 0.9 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.911 -1.118 . . . . 0.0 110.871 -179.549 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -145.58 70.2 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 0.0 110.001 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.89 176.57 38.0 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.458 ' HE3' ' N ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -81.78 142.91 32.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -1.115 . . . . 0.0 110.34 -179.972 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.664 HD12 ' CD2' ' A' ' 142' ' ' PHE . 53.0 mt -137.34 153.52 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 110.041 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.38 128.3 34.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.231 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.452 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -138.62 123.25 2.56 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 10.5 mttm -96.76 163.74 12.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -1.175 . . . . 0.0 109.703 179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.431 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -159.22 133.18 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.879 -1.138 . . . . 0.0 111.171 179.895 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.675 ' C ' HG22 ' A' ' 79' ' ' THR . 93.6 m-20 -108.35 165.61 11.38 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -141.45 153.2 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.965 -1.085 . . . . 0.0 110.648 -179.644 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.421 ' CE1' ' OD2' ' A' ' 122' ' ' ASP . 6.4 t80 -151.82 109.63 3.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -0.806 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 46.2 mt -134.71 152.92 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.961 . . . . 0.0 110.349 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.421 ' OD2' ' CE1' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -160.48 98.07 1.24 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.389 -0.819 . . . . 0.0 109.622 179.602 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -173.2 -168.52 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 110.398 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 10.5 mttp -103.58 97.46 7.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 110.474 -179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.8 125.0 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.253 -0.905 . . . . 0.0 110.222 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 52.9 25.29 3.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.293 -0.879 . . . . 0.0 110.198 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 85.94 33.82 14.44 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 38.5 mtmt -144.61 134.43 11.66 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.313 -1.11 . . . . 0.0 110.0 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.47 127.85 25.21 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.631 1.332 . . . . 0.0 110.474 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -131.07 113.18 13.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.357 -0.84 . . . . 0.0 110.123 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.25 104.45 14.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.187 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.461 ' HB3' ' HB ' ' A' ' 121' ' ' ILE . 3.1 t80 -114.93 124.27 51.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.905 . . . . 0.0 109.943 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 48.2 p-10 -171.03 86.47 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.328 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -153.3 -168.95 3.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.905 . . . . 0.0 110.189 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.4 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.3 OUTLIER -119.8 148.61 43.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.336 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.4 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 12.4 m-85 -155.67 -178.56 7.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 0.0 110.245 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.442 ' O ' HG23 ' A' ' 138' ' ' ILE . 12.3 p30 -150.04 171.45 16.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.89 . . . . 0.0 110.275 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -156.46 166.21 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 0.0 110.413 -179.739 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.403 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 59.8 m -91.77 120.45 32.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 0.0 110.437 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.452 ' CD1' ' HA3' ' A' ' 115' ' ' GLY . 11.6 m-85 -90.38 161.82 15.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.59 102.7 2.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.908 . . . . 0.0 110.388 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.664 ' CD2' HD12 ' A' ' 113' ' ' ILE . 90.0 m-85 -91.72 154.91 18.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.922 . . . . 0.0 110.155 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 22.8 m-80 -143.0 98.45 3.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.716 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -153.62 -146.81 4.47 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo . . . . . 0 C--N 1.308 -1.581 0 O-C-N 123.776 1.408 . . . . 0.0 110.451 -179.922 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 9.8 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 120.766 0.317 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -160.14 159.76 32.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.021 -1.049 . . . . 0.0 110.911 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 165.24 172.73 33.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.37 115.21 25.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.156 -1.202 . . . . 0.0 110.381 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.552 HD13 HD22 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -95.88 141.72 28.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.134 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -78.99 135.88 37.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 109.924 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.444 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -165.71 171.67 12.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 110.715 -179.948 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -155.23 -176.78 6.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.442 -0.786 . . . . 0.0 110.081 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 46' ' ' THR . 1.4 m -141.27 108.37 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 0.0 109.94 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -93.2 162.64 13.94 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 110.637 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.437 ' CG ' HG21 ' A' ' 43' ' ' THR . 12.7 tppt? -67.52 140.81 57.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.599 -0.688 . . . . 0.0 110.043 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.46 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -64.57 147.75 52.21 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.011 -1.056 . . . . 0.0 109.247 179.413 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.1 t-20 70.95 3.04 4.47 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.701 -0.625 . . . . 0.0 110.746 -179.046 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -137.36 -168.28 2.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.911 -1.118 . . . . 0.0 109.446 179.182 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.441 ' N ' ' OG1' ' A' ' 43' ' ' THR . 65.3 t30 -128.55 12.29 6.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.931 -1.106 . . . . 0.0 110.491 179.69 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -136.29 133.04 36.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.055 -1.028 . . . . 0.0 110.467 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.626 HG21 ' CB ' ' A' ' 50' ' ' ASN . 6.0 t -63.56 139.43 58.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.088 -1.007 . . . . 0.0 109.068 179.154 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.402 ' HB3' ' HE3' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -129.39 -17.53 3.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 112.015 -179.013 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.7 mt -137.94 -50.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.785 -1.197 . . . . 0.0 110.845 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -57.74 -54.72 43.69 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.567 -0.708 . . . . 0.0 111.717 -178.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.626 ' CB ' HG21 ' A' ' 46' ' ' THR . 4.8 t-20 -47.47 -25.04 0.96 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.141 -0.974 . . . . 0.0 110.988 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -73.32 -2.44 22.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -0.988 . . . . 0.0 111.168 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -144.78 28.78 1.26 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.823 -1.173 . . . . 0.0 110.892 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.457 ' CE2' ' HB1' ' A' ' 49' ' ' ALA . 11.3 m-85 -130.97 109.47 10.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.944 . . . . 0.0 110.244 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -72.45 150.15 43.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.328 -0.857 . . . . 0.0 110.415 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.79 168.09 12.25 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.321 -0.862 . . . . 0.0 109.924 -179.994 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.436 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 44.6 Cg_endo -76.57 -175.66 17.04 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.692 -2.211 . . . . 0.0 110.683 -0.201 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.45 168.38 9.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 110.137 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.49 119.91 39.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.17 -0.956 . . . . 0.0 110.562 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.528 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 27.4 p90 -96.93 164.25 12.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 109.676 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.615 HG23 ' HD1' ' A' ' 67' ' ' TYR . 1.0 OUTLIER -156.37 116.4 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.951 -1.093 . . . . 0.0 111.165 -179.603 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.512 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -127.6 119.48 26.05 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.359 -0.838 . . . . 0.0 110.037 179.655 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.38 62.52 1.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.571 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.41 96.18 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.46 -0.775 . . . . 0.0 111.229 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.54 10.52 43.91 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.58 160.84 11.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.963 -1.316 . . . . 0.0 109.877 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.708 HD11 ' N ' ' A' ' 108' ' ' LYS . 1.7 pt? -166.18 141.78 4.76 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.636 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.615 ' HD1' HG23 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -139.64 -178.03 5.22 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.496 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -156.11 131.92 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.986 -1.071 . . . . 0.0 110.341 179.83 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 7.8 pt20 -97.3 133.12 42.33 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.291 -0.881 . . . . 0.0 109.936 179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -114.73 131.22 67.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.179 -0.951 . . . . 0.0 109.502 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 m -87.52 116.57 25.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.131 -0.981 . . . . 0.0 110.481 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.553 ' HB ' HD13 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -104.01 143.62 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.403 -0.811 . . . . 0.0 109.996 179.883 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -101.05 156.26 17.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.161 -0.962 . . . . 0.0 110.348 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.513 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.4 OUTLIER 51.49 86.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 110.324 179.895 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.426 ' HB2' ' CD ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -65.36 -30.12 70.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 0.0 110.054 179.907 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -63.78 -34.5 78.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.88 . . . . 0.0 110.319 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.539 ' O ' HG13 ' A' ' 119' ' ' VAL . 27.4 m0 -77.74 -58.02 3.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.702 HD11 ' HG3' ' A' ' 81' ' ' MET . 8.8 tt -88.87 121.07 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.911 179.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 118' ' ' ASP . 1.0 OUTLIER -86.66 -24.83 25.13 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.248 -0.908 . . . . 0.0 110.867 -179.344 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.55 -179.19 48.75 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.308 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.702 ' HG3' HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -152.68 114.79 4.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.441 -1.035 . . . . 0.0 110.12 -179.989 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -85.78 156.34 20.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.146 -0.971 . . . . 0.0 110.406 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' A' ' 104' ' ' PHE . 1.4 mt -156.74 134.27 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.404 -0.81 . . . . 0.0 110.111 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 69.85 3.37 4.27 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.528 -0.732 . . . . 0.0 111.488 179.735 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.94 22.2 11.13 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.22 178.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.457 ' C ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.66 161.81 35.51 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.676 -1.485 . . . . 0.0 110.143 179.276 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -70.33 -169.54 0.31 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.127 -0.983 . . . . 0.0 110.475 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.23 169.71 8.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 110.259 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.05 128.66 49.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 110.236 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 90' ' ' ILE . 1.6 pp -68.33 101.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.773 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 101' ' ' THR . 1.5 tt -94.84 -28.32 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 110.441 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.8 m -166.39 98.88 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.901 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -95.31 106.38 18.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.455 -0.778 . . . . 0.0 110.017 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.1 101.87 13.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 110.227 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -78.96 -28.99 43.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 110.22 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.44 -51.04 69.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.15 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -96.2 15.75 20.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 110.41 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.66 23.23 3.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.115 -0.991 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -92.77 177.91 5.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 110.461 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.503 ' HB3' HG22 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -179.35 151.76 0.5 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.457 -0.777 . . . . 0.0 109.658 179.948 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.487 ' O ' HG22 ' A' ' 91' ' ' ILE . 86.1 m -141.46 158.03 44.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 110.257 -179.568 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.5 p -145.24 143.16 30.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -0.98 . . . . 0.0 110.452 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -93.26 143.44 26.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.29 -0.881 . . . . 0.0 110.031 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.47 ' CD2' HD12 ' A' ' 83' ' ' ILE . 30.3 m-85 -129.91 132.26 46.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.133 -0.98 . . . . 0.0 110.874 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.499 ' C ' HG13 ' A' ' 106' ' ' VAL . 16.4 mt-10 -92.31 128.92 38.34 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.308 -0.87 . . . . 0.0 109.624 179.409 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.553 ' O ' HD21 ' A' ' 66' ' ' LEU . 34.3 m -149.9 144.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.012 -1.055 . . . . 0.0 111.059 -179.327 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.36 109.8 1.71 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.928 . . . . 0.0 108.944 178.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.708 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 54.16 175.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 109.24 -178.585 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.552 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -149.98 71.45 1.08 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.006 -1.059 . . . . 0.0 110.871 -179.853 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 7.2 t30 -146.14 40.33 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.387 -0.821 . . . . 0.0 110.185 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . -169.42 -170.73 34.29 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.34 145.51 30.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -1.131 . . . . 0.0 110.476 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mm -137.65 138.14 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.432 -0.793 . . . . 0.0 109.971 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -76.16 123.07 25.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.185 -0.947 . . . . 0.0 110.361 -179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.463 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -134.86 175.79 20.36 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 38.9 mttt -144.7 176.85 9.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -1.182 . . . . 0.0 109.886 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.464 HG22 ' HA ' ' A' ' 137' ' ' ASN . 0.2 OUTLIER -158.47 144.45 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.922 -1.111 . . . . 0.0 111.157 179.926 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.712 ' O ' HG22 ' A' ' 79' ' ' THR . 1.1 m-20 -108.98 156.89 19.2 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.441 -0.787 . . . . 0.0 109.041 178.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 77' ' ' TRP . 2.6 t -141.72 151.86 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.016 -1.053 . . . . 0.0 110.705 -179.307 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.454 ' CZ ' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -151.14 104.37 3.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.436 -0.79 . . . . 0.0 110.268 179.97 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.491 HD12 ' CD2' ' A' ' 132' ' ' TYR . 5.0 mt -133.06 153.25 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.134 -0.979 . . . . 0.0 110.084 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.69 95.93 1.23 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 110.12 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.486 ' HG2' ' CE1' ' A' ' 130' ' ' PHE . 7.6 pt-20 -174.48 -155.77 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.445 ' HG2' ' CA ' ' A' ' 129' ' ' PRO . 9.3 mtmt -122.59 127.21 49.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.646 HG23 ' CD1' ' A' ' 130' ' ' PHE . 80.8 t -76.18 90.65 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.145 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.7 m120 52.04 27.38 4.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 0.0 110.245 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 117.87 31.8 1.54 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 5.1 mtpt -145.29 90.9 5.97 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.219 -1.166 . . . . 0.0 110.066 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.445 ' CA ' ' HG2' ' A' ' 124' ' ' LYS . 27.6 Cg_exo -56.86 123.14 13.13 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.014 1.534 . . . . 0.0 110.314 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.646 ' CD1' HG23 ' A' ' 125' ' ' VAL . 14.7 p90 -147.7 132.69 18.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.221 -0.924 . . . . 0.0 110.262 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -103.94 132.54 50.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 110.027 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.491 ' CD2' HD12 ' A' ' 121' ' ' ILE . 4.1 t80 -125.63 130.96 52.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.377 -0.827 . . . . 0.0 110.003 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.454 ' OD2' ' CZ ' ' A' ' 120' ' ' TYR . 62.5 t0 -169.43 84.62 0.13 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -0.931 . . . . 0.0 110.008 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.72 -177.03 6.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.384 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.455 ' CD2' ' O ' ' A' ' 135' ' ' HIS . 28.4 p-80 -120.49 89.52 3.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 110.294 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -84.76 -179.41 7.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 109.813 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 10.3 p30 -151.21 168.24 25.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.037 -1.039 . . . . 0.0 110.876 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -156.66 178.88 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -0.81 . . . . 0.0 110.845 -179.707 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 140' ' ' TYR . 94.8 m -91.53 162.7 14.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.538 -0.727 . . . . 0.0 110.586 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.463 ' CE2' ' HA3' ' A' ' 115' ' ' GLY . 96.4 m-85 -145.4 105.25 4.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.373 -0.829 . . . . 0.0 109.717 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.4 OUTLIER -103.98 109.13 20.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 110.797 -179.484 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 110' ' ' ASN . 74.2 m-85 -91.79 145.84 24.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.603 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' A' ' 143' ' ' ASN . 2.6 m-80 -133.81 109.17 8.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.035 -1.04 . . . . 0.0 110.63 -179.446 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.412 ' HA3' ' HD2' ' A' ' 145' ' ' PRO . . . -153.71 -135.47 2.13 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.429 ' HD2' ' CD1' ' A' ' 109' ' ' LEU . 6.1 Cg_endo . . . . . 0 C--N 1.312 -1.352 0 O-C-N 123.399 1.21 . . . . 0.0 110.025 179.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 6.7 m-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.983 0.42 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.72 153.86 23.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 110.325 -179.668 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.32 179.5 42.46 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.03 109.41 20.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.176 -1.19 . . . . 0.0 110.404 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.935 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.2 OUTLIER -94.36 151.69 19.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.397 -0.815 . . . . 0.0 109.955 179.926 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.497 ' H ' HD13 ' A' ' 34' ' ' LEU . 2.8 m-80 -79.4 136.6 37.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.152 -0.967 . . . . 0.0 109.509 179.626 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.554 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -164.98 159.1 17.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.092 -1.005 . . . . 0.0 110.366 -179.852 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.37 -179.83 8.47 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.417 -0.802 . . . . 0.0 109.653 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.778 ' O ' HG22 ' A' ' 46' ' ' THR . 3.3 m -139.74 117.48 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.128 -0.982 . . . . 0.0 110.118 179.642 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -90.6 161.41 15.44 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.35 -0.843 . . . . 0.0 110.668 -179.629 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HZ2' HG22 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.05 135.42 52.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.605 -0.684 . . . . 0.0 110.243 -179.75 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.473 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -61.56 144.76 53.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 110.082 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.4 t-20 70.7 3.21 4.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.789 -0.57 . . . . 0.0 110.728 -179.204 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -139.0 -169.72 2.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.033 -1.042 . . . . 0.0 109.638 179.48 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.404 ' N ' ' OG1' ' A' ' 43' ' ' THR . 1.6 m120 -136.08 24.59 3.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.112 -0.992 . . . . 0.0 110.295 179.677 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -136.13 120.65 18.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 111.146 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.778 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -49.64 121.61 5.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.532 -0.73 . . . . 0.0 109.359 178.961 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.73 -18.83 3.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.833 -1.167 . . . . 0.0 112.293 -178.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.0 mt -138.99 -78.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.59 -1.319 . . . . 0.0 111.214 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.3 -26.65 0.54 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.634 -0.666 . . . . 0.0 111.508 -179.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.436 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -63.98 -16.33 61.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.029 -1.044 . . . . 0.0 110.765 -179.582 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -102.58 15.44 29.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.082 -1.011 . . . . 0.0 110.853 -179.65 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -130.38 12.14 5.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.072 -1.017 . . . . 0.0 111.014 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.427 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 23.8 m-85 -131.28 116.9 18.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.026 -1.046 . . . . 0.0 110.314 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.404 ' HB3' HG21 ' A' ' 71' ' ' THR . 12.9 t-20 -72.4 108.47 5.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.258 -0.901 . . . . 0.0 110.323 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.419 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -93.88 159.65 34.08 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 109.943 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 56.0 Cg_endo -78.76 -175.78 17.38 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.753 -2.186 . . . . 0.0 110.65 -0.261 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.554 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -102.1 171.56 7.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 109.984 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.418 ' HB2' ' HG3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -105.55 112.14 25.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.074 -1.016 . . . . 0.0 110.684 -179.706 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.757 ' CE1' HD23 ' A' ' 34' ' ' LEU . 11.1 p90 -96.95 167.1 11.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.217 -0.927 . . . . 0.0 109.965 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.513 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -156.39 120.96 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.172 -0.955 . . . . 0.0 110.981 179.941 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.1 mtmp? -137.77 127.36 25.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.282 -0.886 . . . . 0.0 110.078 179.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -108.59 62.33 0.61 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 110.425 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.68 103.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.434 -0.791 . . . . 0.0 111.343 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.28 -20.3 50.81 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.003 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.39 154.96 48.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.026 -1.279 . . . . 0.0 110.661 -179.677 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.802 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -157.02 142.99 17.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 111.195 179.446 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.532 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 4.0 m-85 -139.36 -172.85 3.45 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -163.39 130.06 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.95 -1.093 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.418 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 3.7 pt20 -98.59 136.28 38.91 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.589 179.293 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -114.76 132.61 63.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.15 -0.969 . . . . 0.0 110.172 -179.452 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.565 ' O ' HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.12 120.48 31.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.699 179.955 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.417 ' H ' HG13 ' A' ' 72' ' ' VAL . 0.8 OUTLIER -103.28 136.89 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 110.042 -179.72 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -99.92 147.15 25.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 110.335 -179.668 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.447 ' CD2' ' CZ3' ' A' ' 77' ' ' TRP . 62.0 m-70 58.1 92.12 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.433 -0.792 . . . . 0.0 110.231 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.77 -40.1 87.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 110.284 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.9 m170 -62.52 -27.7 69.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 110.266 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.661 ' O ' HG12 ' A' ' 119' ' ' VAL . 38.9 m0 -72.24 -73.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.998 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 78' ' ' ILE . 6.9 tt -88.06 116.47 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.378 -0.826 . . . . 0.0 109.316 179.552 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.769 HG22 ' C ' ' A' ' 118' ' ' ASP . 1.6 t -86.56 -21.4 26.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.284 -0.885 . . . . 0.0 111.615 -178.573 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 117' ' ' ILE . . . -173.52 168.74 41.74 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.307 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.474 ' HG3' HD11 ' A' ' 78' ' ' ILE . 1.8 mtm -153.17 105.21 2.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.375 -1.074 . . . . 0.0 109.993 179.717 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' LYS . 3.7 t -86.65 157.15 19.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 0.0 110.111 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.486 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.3 OUTLIER -153.88 151.75 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.132 179.805 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.524 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 1.3 mm-40 57.73 17.69 4.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.049 -1.032 . . . . 0.0 110.717 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.15 16.95 63.76 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.45 179.45 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.524 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.2 p-80 -137.59 159.69 41.26 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.8 -1.412 . . . . 0.0 110.829 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -71.7 169.99 14.45 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.544 -0.723 . . . . 0.0 110.802 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -89.28 168.12 12.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.344 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 102' ' ' SER . 12.8 m120 -111.48 127.2 55.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.288 -0.882 . . . . 0.0 110.248 -179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pp -67.99 104.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.144 -0.973 . . . . 0.0 109.623 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 101' ' ' THR . 1.4 tt -95.89 -30.09 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 111.235 -179.15 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.7 p -166.86 101.75 0.56 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.936 -1.103 . . . . 0.0 110.49 -179.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.406 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 10.0 ttmt -96.69 146.75 24.59 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.422 -0.799 . . . . 0.0 109.972 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.55 110.12 5.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.153 -0.967 . . . . 0.0 110.31 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.0 m -81.49 -40.49 23.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.861 . . . . 0.0 110.411 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.72 -33.41 75.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.216 -0.928 . . . . 0.0 110.284 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 0.3 OUTLIER -96.05 -10.68 27.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 110.541 179.926 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 97' ' ' LYS . 1.2 t0 62.31 53.99 2.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.041 -1.037 . . . . 0.0 110.046 -179.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -146.98 179.42 7.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 110.429 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.406 ' HG3' ' CG ' ' A' ' 93' ' ' LYS . 9.8 ttm180 -172.04 159.92 5.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.978 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.521 ' O ' HG22 ' A' ' 91' ' ' ILE . 91.2 m -141.52 153.31 44.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 109.728 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 24.7 p -145.03 140.58 28.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.012 -1.055 . . . . 0.0 110.704 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -93.4 148.14 22.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 109.99 179.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.402 ' CD1' ' HB ' ' A' ' 83' ' ' ILE . 97.0 m-85 -128.8 150.38 50.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.141 -0.974 . . . . 0.0 110.721 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.403 ' OE2' ' N ' ' A' ' 106' ' ' VAL . 7.1 tp10 -110.99 123.88 51.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.381 -0.825 . . . . 0.0 109.792 179.626 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.676 ' O ' HD11 ' A' ' 66' ' ' LEU . 9.5 p -149.36 165.54 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.433 ' N ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -56.74 -41.27 77.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.133 -0.98 . . . . 0.0 109.795 179.604 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.457 ' CE ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -164.05 -146.23 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.353 179.403 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.866 HD22 ' HG ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -151.81 56.35 0.85 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.809 -1.182 . . . . 0.0 110.647 -179.403 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 145' ' ' PRO . 10.5 t-20 -146.59 93.74 2.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -0.87 . . . . 0.0 110.232 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 148.51 -119.68 1.1 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.462 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.0 OUTLIER -156.72 112.68 2.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -1.139 . . . . 0.0 110.264 -179.688 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mm -102.73 139.93 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.231 -0.918 . . . . 0.0 110.023 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.21 123.36 25.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.035 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -132.57 179.73 17.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 28.6 mtmm -144.29 166.29 25.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -1.131 . . . . 0.0 109.707 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.442 ' HB ' ' CG ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -158.73 144.06 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.933 -1.105 . . . . 0.0 110.721 179.991 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.769 ' C ' HG22 ' A' ' 79' ' ' THR . 5.8 m-20 -107.25 159.53 16.28 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.456 -0.778 . . . . 0.0 108.941 178.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -141.5 148.49 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.024 -1.047 . . . . 0.0 110.658 -179.464 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -152.09 104.02 2.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.381 -0.824 . . . . 0.0 110.045 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.439 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 44.4 mt -128.96 152.54 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 110.117 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -159.94 97.33 1.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 0.0 109.735 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -173.55 -169.11 0.48 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 110.304 -179.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 3.6 mmtm -112.01 102.61 10.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.87 . . . . 0.0 110.184 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.554 ' O ' HG12 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -76.69 118.22 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -0.877 . . . . 0.0 110.235 -179.903 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.94 26.77 6.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.365 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.65 5.52 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -145.38 107.35 4.44 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.202 -1.175 . . . . 0.0 110.139 179.809 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -51.13 109.8 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.694 1.365 . . . . 0.0 110.368 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 132' ' ' TYR . 11.3 t80 -110.02 146.25 35.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.175 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -133.62 99.18 4.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.284 -0.885 . . . . 0.0 110.214 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.447 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 2.5 t80 -115.12 129.1 56.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.125 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.62 81.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.953 . . . . 0.0 110.256 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -153.13 -165.28 2.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.16 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.42 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -118.3 143.43 46.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.109 -0.994 . . . . 0.0 110.29 179.866 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.42 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 32.2 m-85 -155.25 -179.47 8.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.381 -0.824 . . . . 0.0 109.826 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.512 ' O ' HG23 ' A' ' 138' ' ' ILE . 20.6 p30 -151.27 178.64 9.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 110.345 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 137' ' ' ASN . 0.5 OUTLIER -156.98 167.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 110.764 -179.73 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.462 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 94.1 m -91.75 121.25 33.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.46 -0.775 . . . . 0.0 110.37 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.493 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 43.2 m-85 -90.59 95.72 10.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.071 -1.018 . . . . 0.0 110.235 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.1 OUTLIER -91.92 104.26 16.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.458 -179.853 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' A' ' 140' ' ' TYR . 67.9 m-85 -92.93 158.75 15.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.325 -0.859 . . . . 0.0 110.295 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.456 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 20.7 m-80 -139.72 97.36 3.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.105 -0.997 . . . . 0.0 110.651 -179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.935 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -161.91 -152.66 6.78 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.43 ' O ' ' CB ' ' A' ' 110' ' ' ASN . 18.8 Cg_endo . . . . . 0 C--N 1.309 -1.532 0 O-C-N 123.893 1.47 . . . . 0.0 110.241 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 13.3 m-20 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 59' ' ' TYR . 16.2 t -160.46 153.24 21.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.983 -1.073 . . . . 0.0 110.853 -179.5 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' CD2' ' A' ' 59' ' ' TYR . . . 171.18 176.76 40.55 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -91.76 109.5 20.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -1.158 . . . . 0.0 110.601 179.99 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.823 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -95.78 156.77 16.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.97 -1.081 . . . . 0.0 110.442 179.663 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.454 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 33.8 m-20 -79.92 139.83 36.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 110.246 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.647 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -165.84 160.66 17.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.945 . . . . 0.0 110.015 179.734 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -155.59 -175.8 5.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 0.0 110.447 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.689 HG12 ' O ' ' A' ' 139' ' ' THR . 0.0 OUTLIER -140.89 166.76 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.324 -0.86 . . . . 0.0 109.834 179.728 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.464 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 51.1 m-85 -147.56 161.55 40.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.084 -1.01 . . . . 0.0 110.545 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.556 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.1 OUTLIER -68.34 135.12 51.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.371 -0.831 . . . . 0.0 109.896 179.96 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.527 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -60.71 146.8 44.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.201 -179.82 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER 70.55 4.63 5.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.789 -0.569 . . . . 0.0 110.892 -179.453 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.556 HG21 ' HG2' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -135.18 -163.86 1.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.868 -1.145 . . . . 0.0 109.764 179.377 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.414 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.1 OUTLIER -130.34 11.73 5.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.461 179.637 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -135.27 148.89 49.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.025 -1.047 . . . . 0.0 110.592 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.568 HG21 ' HB2' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -78.32 137.27 37.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.504 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.54 -17.54 3.68 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.037 -179.075 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 60.5 mt -137.57 -69.73 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.708 -1.245 . . . . 0.0 110.868 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.447 ' O ' ' CD2' ' A' ' 53' ' ' PHE . . . -45.48 -26.5 0.58 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.627 -0.671 . . . . 0.0 111.241 -179.347 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.568 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -68.08 -9.13 43.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.076 -1.015 . . . . 0.0 110.823 -179.773 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.479 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 1.6 m-20 -99.26 14.8 28.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.029 -1.045 . . . . 0.0 110.852 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.479 ' CE2' ' HB2' ' A' ' 51' ' ' ASP . 36.6 m-85 -142.27 11.61 1.95 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.945 -1.097 . . . . 0.0 110.824 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 25.9 m-85 -132.62 107.46 8.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.06 -1.025 . . . . 0.0 110.584 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -72.72 167.91 19.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.14 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.418 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.42 164.73 22.91 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.955 . . . . 0.0 109.973 179.798 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 55.6 Cg_endo -78.23 -175.32 16.48 Favored 'Cis proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.565 -2.265 . . . . 0.0 110.588 -0.153 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.647 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -100.24 170.16 8.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 109.693 179.805 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.472 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -101.37 119.69 39.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 110.586 -179.644 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.52 ' CD1' ' HD2' ' A' ' 61' ' ' LYS . 13.7 p90 -97.81 162.97 13.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.118 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 1.9 tt -157.07 109.81 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.315 -0.866 . . . . 0.0 110.541 179.633 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.52 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -128.59 137.86 51.91 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.167 -0.958 . . . . 0.0 110.347 179.89 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.76 62.25 0.99 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 110.13 179.457 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 45.97 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.493 -0.754 . . . . 0.0 111.28 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.44 -8.42 58.6 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.458 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.19 158.54 44.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.916 -1.344 . . . . 0.0 110.428 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.769 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.2 pt? -169.49 148.54 3.79 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.156 -0.965 . . . . 0.0 111.233 179.191 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.787 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -140.73 -163.26 1.5 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.63 -0.669 . . . . 0.0 109.639 -179.638 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 67' ' ' TYR . 1.4 t -168.3 124.82 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 110.047 179.62 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.472 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -97.3 130.97 44.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.212 -0.93 . . . . 0.0 109.789 179.758 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.467 HG22 ' OG ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -111.48 141.54 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.83 . . . . 0.0 110.205 -179.344 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.5 m -89.69 123.52 33.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.794 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.892 HG12 HG21 ' A' ' 78' ' ' ILE . 1.4 t -102.3 131.8 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 110.358 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.47 143.85 30.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 110.382 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.576 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER 55.97 97.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.299 -0.875 . . . . 0.0 110.388 179.893 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -69.53 -18.03 63.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -0.932 . . . . 0.0 110.338 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.97 -47.37 18.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.255 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.53 ' O ' HG12 ' A' ' 119' ' ' VAL . 46.5 m0 -61.44 -59.33 5.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 110.569 -179.882 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.892 HG21 HG12 ' A' ' 72' ' ' VAL . 5.7 tt -88.67 122.69 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.09 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.596 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.99 -26.74 23.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.359 -0.838 . . . . 0.0 110.832 -179.368 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.9 180.0 47.58 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.625 -1.274 . . . . 0.0 109.921 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.593 ' HG3' HD11 ' A' ' 78' ' ' ILE . 25.8 mtm -151.6 163.31 39.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.338 -1.096 . . . . 0.0 110.118 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 116' ' ' LYS . 23.1 t -155.4 137.47 14.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.365 -0.834 . . . . 0.0 110.02 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 1.6 mt -136.23 141.28 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.263 -0.898 . . . . 0.0 110.362 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 72.67 -0.25 3.4 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.755 -0.591 . . . . 0.0 111.399 179.972 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.12 22.39 8.8 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.589 -1.291 . . . . 0.0 111.288 178.8 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.47 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.42 159.52 41.85 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.628 -1.513 . . . . 0.0 110.215 179.353 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -173.53 0.92 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.142 -0.974 . . . . 0.0 110.448 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 1.2 pt-20 -108.76 170.13 8.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.0 110.267 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 102' ' ' SER . 10.4 m120 -120.6 125.41 47.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.933 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -67.52 102.55 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.962 -1.086 . . . . 0.0 109.749 179.967 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.428 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.2 tt -94.87 -28.11 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 0.0 110.553 -179.354 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 23.7 m -166.48 96.1 0.56 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.411 -0.805 . . . . 0.0 109.829 -179.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -95.99 109.99 22.29 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 110.292 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.04 83.86 3.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 110.281 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.8 p -65.32 -30.99 71.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -0.929 . . . . 0.0 110.322 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.21 84.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.936 . . . . 0.0 110.09 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.81 17.49 15.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.3 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 49.59 60.39 3.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.239 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -147.33 177.98 8.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 110.242 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER 179.87 159.63 0.79 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.899 . . . . 0.0 110.072 -179.845 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.428 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 95.7 m -137.19 154.84 50.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.962 . . . . 0.0 109.808 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.467 ' OG ' HG22 ' A' ' 70' ' ' ILE . 3.7 p -145.11 139.45 27.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 110.712 -179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.5 tt0 -93.57 144.36 25.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 110.13 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 93.5 m-85 -128.94 146.7 50.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.19 -0.944 . . . . 0.0 110.534 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -101.88 129.84 48.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.364 -0.835 . . . . 0.0 109.607 179.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.769 ' O ' HD21 ' A' ' 66' ' ' LEU . 9.0 p -149.49 139.41 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.094 -1.004 . . . . 0.0 111.022 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.9 t -63.96 102.25 0.46 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.143 -0.973 . . . . 0.0 108.5 178.527 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.573 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 56.58 171.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 108.833 -177.968 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.429 ' H ' HD12 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -147.94 76.96 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.952 -1.093 . . . . 0.0 110.853 -179.427 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -146.01 64.17 1.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.447 -0.783 . . . . 0.0 109.846 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.08 -171.92 38.96 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.01 140.27 34.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.318 -1.107 . . . . 0.0 110.564 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.703 HD12 ' CD2' ' A' ' 142' ' ' PHE . 12.9 mt -136.0 150.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.321 -0.862 . . . . 0.0 109.739 179.623 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.33 127.46 32.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 -179.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -132.37 169.25 22.33 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -146.74 159.79 43.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -1.156 . . . . 0.0 110.096 179.981 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.401 ' O ' HD13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -157.99 143.66 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.105 -0.997 . . . . 0.0 110.591 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.596 ' C ' HG22 ' A' ' 79' ' ' THR . 13.8 m-20 -106.53 159.76 15.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.433 -0.792 . . . . 0.0 109.263 179.249 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.635 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -135.06 149.31 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.04 -1.037 . . . . 0.0 110.814 -179.582 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.412 ' HB2' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -151.72 107.63 3.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.46 -0.775 . . . . 0.0 109.859 179.715 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.474 HG12 ' HA ' ' A' ' 77' ' ' TRP . 28.6 mt -135.22 153.12 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.408 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.78 101.09 1.46 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.468 -0.77 . . . . 0.0 109.455 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -173.23 -165.14 0.26 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.235 -0.916 . . . . 0.0 110.442 -179.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.631 ' O ' HG23 ' A' ' 125' ' ' VAL . 8.0 ttmt -95.76 165.81 12.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.647 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 124' ' ' LYS . 6.8 t -158.41 93.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 65.53 30.5 10.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.386 -0.822 . . . . 0.0 109.603 -179.11 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.61 39.42 10.74 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -147.48 106.55 3.79 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.149 -1.206 . . . . 0.0 110.371 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.62 114.71 1.3 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.69 1.363 . . . . 0.0 109.953 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.464 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 10.5 t80 -97.78 141.36 30.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 110.451 -179.482 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -134.4 99.12 4.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 109.847 179.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.635 ' HE2' HG11 ' A' ' 119' ' ' VAL . 1.7 t80 -112.91 124.27 52.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.064 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.409 ' OD2' ' CZ ' ' A' ' 120' ' ' TYR . 53.7 t0 -170.24 84.39 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 109.926 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -154.16 -165.02 1.99 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 110.555 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.47 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 74.2 m-70 -117.87 152.32 35.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.852 . . . . 0.0 109.692 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.47 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 66.0 m-85 -155.11 -178.97 7.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.938 . . . . 0.0 110.331 -179.761 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.547 ' O ' HG23 ' A' ' 138' ' ' ILE . 2.1 p30 -150.16 164.93 34.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 110.166 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.2 pt -156.24 172.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.337 -0.852 . . . . 0.0 110.35 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.689 ' O ' HG12 ' A' ' 38' ' ' VAL . 10.9 m -91.76 162.28 14.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.412 -0.805 . . . . 0.0 110.576 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.463 ' CE1' ' CG1' ' A' ' 38' ' ' VAL . 12.0 m-85 -145.52 108.15 4.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.388 -0.82 . . . . 0.0 110.032 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.61 109.82 21.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.37 -0.831 . . . . 0.0 110.521 -179.726 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.703 ' CD2' HD12 ' A' ' 113' ' ' ILE . 80.8 m-85 -91.22 157.02 17.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.082 179.765 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.52 ' C ' HD21 ' A' ' 34' ' ' LEU . 59.1 m-80 -138.83 98.37 3.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.197 -0.939 . . . . 0.0 110.398 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.823 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -157.76 -147.24 4.75 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo . . . . . 0 C--N 1.309 -1.526 0 O-C-N 123.807 1.424 . . . . 0.0 110.733 -179.87 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 4.8 m-20 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.972 0.415 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 p -159.13 158.67 33.32 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.272 -0.892 . . . . 0.0 110.779 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 171.5 171.84 37.01 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.91 108.5 19.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -1.216 . . . . 0.0 110.355 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.699 HD13 HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -94.45 152.52 18.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.0 109.995 179.855 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.463 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -78.82 139.57 38.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.139 -0.976 . . . . 0.0 110.425 -179.953 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.684 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -165.65 159.28 16.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.193 -0.942 . . . . 0.0 110.202 179.557 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -155.36 -171.63 3.87 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.338 -0.851 . . . . 0.0 109.699 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -140.85 172.06 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 110.231 179.781 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.421 ' HA ' HG23 ' A' ' 46' ' ' THR . 60.2 m-85 -147.52 157.24 43.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 110.09 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -67.58 139.33 56.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.226 -179.864 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.46 ' O ' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -63.64 147.04 52.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.942 179.853 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 28.3 t30 70.01 4.62 4.89 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.715 -0.616 . . . . 0.0 110.732 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.82 179.67 6.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.976 -1.078 . . . . 0.0 109.776 179.376 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -115.76 12.98 16.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 110.285 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.37 143.38 46.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.109 -0.994 . . . . 0.0 110.613 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.554 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -73.72 139.73 45.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.251 179.48 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -17.8 3.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.001 -1.062 . . . . 0.0 112.189 -178.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.54 HG22 ' N ' ' A' ' 49' ' ' ALA . 8.0 mt -137.46 -73.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.781 -1.2 . . . . 0.0 110.787 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.54 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -45.8 -26.13 0.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.612 -0.68 . . . . 0.0 111.14 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.501 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -60.02 -16.81 34.09 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.109 -0.995 . . . . 0.0 110.695 -179.83 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -102.33 15.54 28.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.031 -1.043 . . . . 0.0 111.009 -179.406 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 63.5 m-85 -133.27 7.63 3.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.839 -1.163 . . . . 0.0 111.384 -179.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 15.0 p90 -115.64 114.92 25.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.961 -1.087 . . . . 0.0 110.537 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -74.7 106.14 6.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.038 -1.039 . . . . 0.0 110.459 -179.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HB3' ' CE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -94.3 160.38 32.03 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 110.228 179.844 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.69 -175.38 15.97 Favored 'Cis proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.548 -2.272 . . . . 0.0 110.733 -0.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.684 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.71 164.99 11.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 109.899 179.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.11 117.55 34.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.134 -0.978 . . . . 0.0 110.993 -179.536 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 31.5 p90 -98.47 165.63 11.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.319 -0.863 . . . . 0.0 109.799 179.385 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -155.41 122.47 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.988 -1.07 . . . . 0.0 111.139 -179.739 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HE2' HD21 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -140.19 131.86 27.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.258 -0.901 . . . . 0.0 110.331 179.735 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 63' ' ' ASN . 7.1 tttt -111.37 62.08 0.61 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 0.0 110.455 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 62' ' ' LYS . 4.5 m120 49.85 101.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.365 -0.834 . . . . 0.0 111.223 179.578 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.65 -18.48 55.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -140.55 160.19 40.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.248 . . . . 0.0 110.273 179.849 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.747 HD22 ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -163.54 144.77 9.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 111.274 179.852 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 3.4 m-85 -141.57 -159.32 0.95 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.263 -0.898 . . . . 0.0 109.674 -179.771 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -169.92 165.28 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 110.322 179.613 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.414 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 2.0 pt20 -140.97 133.57 28.64 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.382 -0.824 . . . . 0.0 109.894 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.67 140.33 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 110.003 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.8 m -89.09 134.04 34.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.133 -0.979 . . . . 0.0 109.748 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.529 HG12 HG21 ' A' ' 78' ' ' ILE . 2.4 t -102.2 126.55 56.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.395 -0.816 . . . . 0.0 110.407 -179.507 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -99.5 127.9 45.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.263 -0.898 . . . . 0.0 110.046 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 63.32 69.93 0.55 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 109.871 -179.705 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.78 -27.49 63.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.467 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -55.99 -39.34 71.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 0.0 110.54 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.63 ' O ' HG13 ' A' ' 119' ' ' VAL . 24.8 m0 -81.2 -52.61 7.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.379 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.602 HD11 ' SD ' ' A' ' 81' ' ' MET . 20.3 tt -88.87 123.18 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 109.658 179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -87.08 -29.79 21.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.215 -0.928 . . . . 0.0 111.266 -179.001 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.95 175.07 47.28 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 118.998 -1.573 . . . . 0.0 110.701 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.602 ' SD ' HD11 ' A' ' 78' ' ' ILE . 5.2 mtt -152.3 110.49 3.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.654 -0.909 . . . . 0.0 109.784 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 116' ' ' LYS . 1.0 OUTLIER -85.88 157.26 20.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.095 -1.003 . . . . 0.0 110.359 -179.98 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.485 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 1.0 OUTLIER -151.35 149.98 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.381 -0.825 . . . . 0.0 109.758 179.578 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.526 ' HB2' ' CE1' ' A' ' 86' ' ' HIS . 0.7 OUTLIER 61.77 14.09 5.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.124 -0.985 . . . . 0.0 110.783 -179.886 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.38 19.92 57.76 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.809 179.163 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.526 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 2.1 p-80 -137.47 161.24 36.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.72 -1.459 . . . . 0.0 110.692 179.591 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.76 174.33 7.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.468 -0.77 . . . . 0.0 110.838 -179.521 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 8.2 pt-20 -99.06 167.4 10.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 110.474 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -118.43 134.94 54.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.31 -0.869 . . . . 0.0 110.192 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.07 100.72 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 109.445 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 101' ' ' THR . 2.5 tt -96.32 -25.72 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 110.797 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -167.73 95.07 0.43 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.965 . . . . 0.0 110.138 -179.775 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.459 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 2.4 ttmt -96.34 144.03 26.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.83 93.62 2.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.129 -0.982 . . . . 0.0 110.331 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -76.81 -15.78 59.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.864 . . . . 0.0 110.357 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.83 -28.01 69.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 110.548 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -136.34 25.56 3.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.122 -0.986 . . . . 0.0 110.502 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.87 70.82 0.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.337 179.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -147.71 160.51 42.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.141 -0.975 . . . . 0.0 110.003 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.459 ' HG3' ' CG ' ' A' ' 93' ' ' LYS . 1.0 OUTLIER -168.92 162.87 11.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 110.356 -179.777 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.624 ' O ' HG22 ' A' ' 91' ' ' ILE . 57.9 m -142.05 157.81 44.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.45 -0.781 . . . . 0.0 109.229 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 2.0 p -143.9 137.04 27.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.821 -1.174 . . . . 0.0 110.616 -179.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -93.0 136.48 33.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.426 -0.796 . . . . 0.0 109.995 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 88.6 m-85 -129.68 144.38 51.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.1 -1.0 . . . . 0.0 110.904 -179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.46 ' C ' HG13 ' A' ' 106' ' ' VAL . 26.8 tt0 -101.11 127.96 47.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.481 -0.762 . . . . 0.0 109.091 179.041 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.636 ' O ' HD21 ' A' ' 66' ' ' LEU . 19.9 m -147.98 163.02 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.914 -1.117 . . . . 0.0 111.075 -178.84 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.67 109.55 7.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.292 -0.88 . . . . 0.0 108.658 178.629 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.459 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 48.84 -159.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.341 -0.85 . . . . 0.0 109.563 -178.577 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.699 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -150.59 60.72 0.94 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.974 -1.079 . . . . 0.0 111.103 -179.489 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -146.08 82.12 1.6 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.339 -0.85 . . . . 0.0 109.799 179.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.57 170.82 22.09 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.43 146.14 29.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -1.056 . . . . 0.0 110.458 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.427 HD12 ' CD2' ' A' ' 142' ' ' PHE . 82.6 mt -139.35 149.9 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.942 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.48 142.66 40.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.12 -0.988 . . . . 0.0 110.525 -179.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -147.72 127.84 2.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 82' ' ' SER . 10.8 mttt -94.67 168.2 10.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.346 -1.09 . . . . 0.0 109.787 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.423 HD12 ' CG ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -158.9 133.95 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.993 -1.067 . . . . 0.0 110.858 179.481 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.695 ' O ' HG22 ' A' ' 79' ' ' THR . 11.6 m-20 -107.47 163.32 13.15 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 77' ' ' TRP . 3.8 t -144.14 152.67 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.899 -1.126 . . . . 0.0 110.475 -179.268 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -151.21 113.73 4.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.427 -0.796 . . . . 0.0 110.523 179.915 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' A' ' 132' ' ' TYR . 2.7 mp -138.15 153.71 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.347 -0.845 . . . . 0.0 110.082 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.74 96.99 1.41 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.125 -0.985 . . . . 0.0 110.208 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.43 ' O ' ' CD1' ' A' ' 130' ' ' PHE . 0.4 OUTLIER -174.12 -170.69 0.56 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.395 -0.815 . . . . 0.0 110.151 -179.957 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.31 111.49 23.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.213 -0.929 . . . . 0.0 110.22 -179.875 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.759 HG23 ' CE1' ' A' ' 130' ' ' PHE . 2.7 t -77.12 107.6 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.34 179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.28 38.07 12.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.892 . . . . 0.0 110.495 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 91.72 39.02 5.66 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -144.82 90.07 6.44 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.337 -1.096 . . . . 0.0 109.998 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.03 121.48 9.37 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.97 1.51 . . . . 0.0 110.715 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.759 ' CE1' HG23 ' A' ' 125' ' ' VAL . 11.6 p90 -146.38 166.35 26.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.923 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.68 117.28 14.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 110.43 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.554 ' HB3' HD12 ' A' ' 121' ' ' ILE . 3.8 t80 -102.46 135.0 44.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.394 -0.817 . . . . 0.0 109.705 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -174.39 83.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 0.0 110.16 -179.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.91 -162.32 1.41 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.902 . . . . 0.0 110.622 179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -120.28 157.09 29.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.445 -0.785 . . . . 0.0 110.062 179.852 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 34.4 m-85 -155.15 -179.05 7.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.048 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -150.78 165.74 32.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 110.521 -179.884 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.462 HD11 ' HE2' ' A' ' 81' ' ' MET . 0.1 OUTLIER -156.38 159.34 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.464 -0.772 . . . . 0.0 109.815 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 19.9 m -91.61 119.9 31.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.18 -0.95 . . . . 0.0 110.655 -179.456 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.563 ' HA ' HG12 ' A' ' 38' ' ' VAL . 9.5 m-85 -90.39 165.73 13.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.322 -0.861 . . . . 0.0 109.909 179.518 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.89 103.92 1.9 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.467 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.427 ' CD2' HD12 ' A' ' 113' ' ' ILE . 96.4 m-85 -92.2 154.23 18.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.274 -0.891 . . . . 0.0 110.236 179.735 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 48.8 m-80 -141.78 96.9 3.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 110.497 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.592 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -150.86 -151.72 5.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.735 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.401 ' HD2' ' HA3' ' A' ' 144' ' ' GLY . 10.0 Cg_endo . . . . . 0 C--N 1.307 -1.652 0 O-C-N 123.733 1.386 . . . . 0.0 110.287 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 63.6 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.846 0.355 . . . . 0.0 110.386 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.39 150.44 19.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.052 -1.03 . . . . 0.0 110.727 -179.374 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.37 -136.87 3.39 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -149.22 110.5 4.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.162 -1.199 . . . . 0.0 110.348 -179.944 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.003 HD23 ' HB3' ' A' ' 59' ' ' TYR . 2.3 pp -95.06 156.08 16.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.434 -0.791 . . . . 0.0 110.365 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.612 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.4 t30 -79.33 141.69 36.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.37 -0.832 . . . . 0.0 110.068 179.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 1.6 p90 -164.01 162.81 23.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.068 -1.02 . . . . 0.0 110.682 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.36 -165.89 2.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.528 -0.732 . . . . 0.0 109.677 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.763 ' C ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -139.92 174.58 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.15 -0.969 . . . . 0.0 110.154 179.703 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.419 ' CE2' ' HG3' ' A' ' 141' ' ' LYS . 14.0 m-85 -147.62 147.29 29.87 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.203 -0.935 . . . . 0.0 109.961 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.466 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -67.58 130.36 42.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.366 -0.834 . . . . 0.0 110.26 -179.592 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.511 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -52.45 145.75 10.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -0.887 . . . . 0.0 110.386 -179.809 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.8 t30 72.79 0.26 3.59 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.884 -0.51 . . . . 0.0 111.074 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.38 -161.99 1.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.871 -1.143 . . . . 0.0 109.749 179.298 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.423 ' N ' ' OG1' ' A' ' 43' ' ' THR . 12.0 p-10 -135.58 15.47 3.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.188 -0.945 . . . . 0.0 110.214 179.592 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -135.14 128.13 31.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 0.0 110.767 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.763 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -57.58 136.35 56.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.45 179.509 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.747 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -128.34 -17.85 4.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.064 -1.023 . . . . 0.0 111.675 -179.194 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.747 HD12 ' HB3' ' A' ' 47' ' ' SER . 1.6 mp -137.78 -71.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.777 -1.202 . . . . 0.0 110.813 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.621 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -45.4 -26.14 0.51 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.693 -0.629 . . . . 0.0 111.27 -179.366 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.455 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -62.47 -13.02 25.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.06 -1.025 . . . . 0.0 111.044 -179.73 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -98.89 13.97 30.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.99 -1.069 . . . . 0.0 110.995 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -135.44 -1.55 2.55 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.907 -1.121 . . . . 0.0 111.574 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.621 ' CE2' ' HB1' ' A' ' 49' ' ' ALA . 16.2 m-30 -111.91 101.12 9.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.961 -1.087 . . . . 0.0 110.249 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.19 113.67 10.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.314 -0.866 . . . . 0.0 110.539 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.444 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 1.0 OUTLIER -93.53 166.67 15.5 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 109.942 179.739 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 60.2 Cg_endo -82.79 -175.55 14.97 Favored 'Cis proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.784 -2.174 . . . . 0.0 110.595 -0.494 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -104.25 162.67 13.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.286 -0.884 . . . . 0.0 109.641 179.467 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HG3' HG23 ' A' ' 33' ' ' THR . 15.1 mttt -98.85 114.73 27.45 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.226 -0.922 . . . . 0.0 110.254 -179.686 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 1.003 ' HB3' HD23 ' A' ' 34' ' ' LEU . 10.7 p90 -97.68 161.64 13.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.123 -0.985 . . . . 0.0 110.609 -179.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.594 HG23 ' HD1' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -154.86 127.77 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.9 . . . . 0.0 110.543 -179.632 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.453 ' CD ' ' HE2' ' A' ' 108' ' ' LYS . 2.4 mtmt -137.82 119.42 14.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.183 -0.948 . . . . 0.0 110.438 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -94.74 62.12 2.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.657 -179.998 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 0.1 OUTLIER 49.16 101.54 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.404 -0.81 . . . . 0.0 111.376 179.44 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.56 -21.93 41.97 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.357 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.444 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -135.28 154.5 51.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.175 -1.191 . . . . 0.0 110.138 179.61 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.838 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -156.37 135.99 12.43 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.159 0.98 . . . . 0.0 111.308 179.878 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.594 ' HD1' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -142.17 176.39 9.01 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.417 -0.802 . . . . 0.0 109.144 179.985 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.437 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -150.01 141.58 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.931 -1.106 . . . . 0.0 110.872 179.983 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 102' ' ' SER . 6.0 pt20 -100.09 134.98 42.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.461 -0.774 . . . . 0.0 109.513 179.209 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 101' ' ' THR . 1.1 mm -110.51 131.22 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.725 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.6 m -87.75 127.67 35.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.185 -0.947 . . . . 0.0 110.023 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.643 ' HB ' HD13 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -103.33 144.4 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.833 . . . . 0.0 110.045 -179.644 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -99.36 146.78 25.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.112 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 53.94 84.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.078 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.8 p -50.35 -33.42 20.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.451 -179.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -41.17 74.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 110.384 -179.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.669 ' O ' HG12 ' A' ' 119' ' ' VAL . 31.5 m0 -61.15 -63.14 1.39 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 0.0 110.444 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.838 HD11 ' HG3' ' A' ' 81' ' ' MET . 16.4 tt -88.36 118.6 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.144 -0.973 . . . . 0.0 109.765 179.843 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.66 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.85 -23.67 25.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.87 . . . . 0.0 110.964 -179.2 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.38 173.83 44.9 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.447 -1.359 . . . . 0.0 110.153 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.838 ' HG3' HD11 ' A' ' 78' ' ' ILE . 1.2 mtm -153.32 113.58 3.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.339 -1.095 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.74 169.66 13.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.474 HG13 ' CE2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -169.24 141.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -0.867 . . . . 0.0 110.048 179.785 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.523 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 1.1 tm-20 64.52 11.91 7.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.274 -0.891 . . . . 0.0 110.69 -179.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.77 17.45 61.66 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.336 179.528 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.523 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.2 p-80 -137.75 160.19 39.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.971 -1.311 . . . . 0.0 110.576 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.91 162.15 29.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.418 -0.801 . . . . 0.0 110.492 -179.674 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.504 ' CB ' ' CE1' ' A' ' 104' ' ' PHE . 12.9 pt-20 -91.2 168.08 11.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.864 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -111.63 133.94 53.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.303 -179.964 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.8 pt -68.01 142.41 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.034 -1.041 . . . . 0.0 109.402 179.463 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.445 HG21 HG22 ' A' ' 101' ' ' THR . 3.0 tt -136.24 -29.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.151 -0.968 . . . . 0.0 111.43 -179.038 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 m -165.34 94.66 0.63 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.982 -1.074 . . . . 0.0 109.743 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -96.39 142.46 28.47 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.322 -0.861 . . . . 0.0 110.062 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.405 ' OD1' ' HB3' ' A' ' 97' ' ' LYS . 7.3 t-20 -141.74 91.57 2.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 72.6 p -71.14 -23.34 62.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 110.245 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.41 54.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.093 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.405 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 3.6 tttt -97.72 13.48 30.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.904 . . . . 0.0 110.413 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.29 62.45 2.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.034 -1.042 . . . . 0.0 110.166 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -147.89 137.29 22.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 0.0 110.43 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.454 ' HG3' ' N ' ' A' ' 101' ' ' THR . 3.2 ttt180 -144.1 162.0 37.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.435 -0.791 . . . . 0.0 109.983 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.454 ' N ' ' HG3' ' A' ' 100' ' ' ARG . 94.0 m -142.14 156.69 45.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 110.371 -179.781 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 2.4 p -145.29 145.35 31.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.183 -0.948 . . . . 0.0 110.271 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -91.55 144.21 25.78 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.296 -0.878 . . . . 0.0 110.041 -179.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.504 ' CE1' ' CB ' ' A' ' 88' ' ' GLU . 37.2 m-85 -130.13 135.82 48.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 110.846 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.06 126.19 38.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.34 -0.85 . . . . 0.0 109.424 179.182 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.457 ' O ' HD21 ' A' ' 66' ' ' LEU . 1.2 p -149.59 158.64 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.012 -1.055 . . . . 0.0 110.872 -179.101 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.4 p -69.87 108.88 4.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.937 . . . . 0.0 108.773 178.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.453 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 47.87 -153.51 0.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.366 -0.834 . . . . 0.0 109.488 -178.457 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.57 HD22 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.41 61.23 0.89 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.657 -1.277 . . . . 0.0 111.251 -179.093 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -147.37 94.35 2.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.961 . . . . 0.0 110.458 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.58 -123.78 1.61 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.464 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.2 OUTLIER -156.86 150.23 24.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.299 -1.118 . . . . 0.0 109.513 -179.676 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.417 ' N ' ' HG2' ' A' ' 112' ' ' LYS . 1.5 mm -138.53 129.16 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.134 -179.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -76.35 131.36 39.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.206 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -142.7 -162.66 9.36 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -146.31 172.45 13.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.224 -1.162 . . . . 0.0 109.741 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.617 HG21 HD13 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.8 140.41 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.115 -0.991 . . . . 0.0 110.477 179.972 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.66 ' C ' HG22 ' A' ' 79' ' ' THR . 23.2 m-20 -106.53 158.46 16.9 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.222 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -134.88 149.91 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.119 -0.988 . . . . 0.0 110.229 -179.749 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 3.3 t80 -151.27 106.8 3.36 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.646 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 77' ' ' TRP . 2.5 mp -137.43 152.67 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.43 -0.794 . . . . 0.0 109.777 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.31 106.65 1.54 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.289 -0.882 . . . . 0.0 109.723 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -172.28 -179.48 2.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 110.258 -179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -85.08 96.64 9.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 110.491 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 125' ' ' VAL . 2.5 t -76.45 106.78 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.996 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 64.15 26.2 13.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.174 -179.903 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.07 34.86 9.37 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.24 127.24 7.92 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.223 -1.163 . . . . 0.0 110.14 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -55.86 108.94 0.36 Allowed 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.504 1.265 . . . . 0.0 110.109 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 132' ' ' TYR . 52.0 t80 -114.93 144.24 43.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.363 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -135.44 118.07 15.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 110.243 -179.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.488 ' HD2' HD12 ' A' ' 121' ' ' ILE . 5.0 t80 -115.11 127.92 55.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.123 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.83 82.56 0.38 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.869 . . . . 0.0 109.925 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -154.29 -172.72 4.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 110.534 -179.763 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.459 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 5.9 p-80 -122.53 161.75 23.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.483 -0.761 . . . . 0.0 109.918 179.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.459 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 47.2 m-85 -155.38 140.63 17.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.169 -0.957 . . . . 0.0 110.337 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.645 ' O ' HG23 ' A' ' 138' ' ' ILE . 38.8 p30 -88.11 156.51 19.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.232 -0.917 . . . . 0.0 110.4 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 137' ' ' ASN . 4.2 pt -157.21 143.8 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 109.891 -179.945 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.644 ' O ' HG12 ' A' ' 38' ' ' VAL . 81.4 m -91.62 128.35 37.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.197 -0.94 . . . . 0.0 110.944 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.474 ' CE2' HG13 ' A' ' 83' ' ' ILE . 51.8 m-85 -90.8 159.99 16.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.793 179.102 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.419 ' HG3' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -146.67 102.41 3.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.368 -179.965 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -93.17 152.14 19.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.279 -0.888 . . . . 0.0 110.386 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.496 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 51.3 m-80 -144.22 95.61 2.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.154 -0.966 . . . . 0.0 110.393 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.466 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -152.19 -154.77 6.76 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.793 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.415 ' HG2' ' NZ ' ' A' ' 61' ' ' LYS . 11.4 Cg_endo . . . . . 0 C--N 1.305 -1.712 0 O-C-N 123.91 1.479 . . . . 0.0 110.644 -179.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.904 0.383 . . . . 0.0 110.281 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 t -161.31 140.81 10.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.86 . . . . 0.0 110.401 -179.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.0 179.38 47.36 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.28 111.99 22.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.317 -1.108 . . . . 0.0 110.051 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.878 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.9 OUTLIER -95.4 154.3 17.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -0.905 . . . . 0.0 110.8 -179.739 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.4 m-20 -81.91 139.08 34.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.336 179.071 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.619 ' CE2' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -166.89 160.36 14.34 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.948 -1.095 . . . . 0.0 110.859 -179.924 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.57 -167.12 2.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.572 -0.705 . . . . 0.0 109.721 179.695 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.517 HG23 HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -142.16 174.04 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.116 -0.99 . . . . 0.0 110.296 179.818 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.477 ' CE2' ' HG3' ' A' ' 141' ' ' LYS . 16.7 m-85 -147.73 152.69 38.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.838 . . . . 0.0 110.052 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 124.29 23.01 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.381 -0.824 . . . . 0.0 110.009 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.533 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -49.17 147.58 2.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.77 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 3.9 m120 72.33 0.79 3.72 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.934 -0.479 . . . . 0.0 110.91 -179.092 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.77 -160.38 1.05 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.818 -1.177 . . . . 0.0 109.729 179.092 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.4 ' N ' ' OG1' ' A' ' 43' ' ' THR . 3.2 t-20 -134.37 11.64 3.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 110.248 179.471 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -135.99 139.0 42.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.102 -0.999 . . . . 0.0 110.628 -179.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.517 HG21 HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -63.71 133.44 53.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.206 179.264 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -128.7 -17.6 4.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.89 -1.132 . . . . 0.0 111.964 -178.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.2 mt -137.54 -71.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.815 -1.178 . . . . 0.0 110.76 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -50.99 -22.53 2.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.499 -0.751 . . . . 0.0 111.027 -179.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.442 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -55.59 -19.32 9.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.128 -0.982 . . . . 0.0 110.77 -179.793 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -94.29 15.29 17.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.015 -1.053 . . . . 0.0 110.922 -179.44 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -141.61 16.27 2.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.908 -1.12 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -123.1 106.17 10.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.141 -0.975 . . . . 0.0 110.255 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.96 152.45 41.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.899 . . . . 0.0 110.607 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.426 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -147.3 162.56 31.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 0.0 109.838 179.692 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 56.2 Cg_endo -78.02 -176.68 19.18 Favored 'Cis proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.728 -2.197 . . . . 0.0 110.475 -0.127 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.619 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . . . -105.23 166.33 10.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 110.091 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -101.49 113.78 27.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 110.088 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 8.7 p90 -96.27 163.54 13.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.924 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.4 OUTLIER -154.74 154.19 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.181 -0.95 . . . . 0.0 110.205 -179.925 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 29.7 mtpt -136.52 170.43 16.07 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.157 -0.965 . . . . 0.0 110.854 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.44 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 9.4 mttt -155.06 62.91 0.64 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.439 -0.788 . . . . 0.0 110.032 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t30 48.61 86.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.397 -0.815 . . . . 0.0 111.091 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.63 24.21 33.92 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.616 179.021 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.44 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 6.4 ptpt -170.39 161.19 7.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.042 -1.27 . . . . 0.0 110.947 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.819 HD21 ' H ' ' A' ' 108' ' ' LYS . 1.6 pt? -172.19 149.49 2.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.1 0.952 . . . . 0.0 111.732 178.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -140.61 174.06 10.89 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.258 -179.268 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.42 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -148.57 143.04 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.988 -1.07 . . . . 0.0 110.15 179.561 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -99.69 133.65 43.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 110.329 179.87 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -113.12 141.08 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.796 179.823 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 m -89.13 130.21 35.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.875 . . . . 0.0 110.348 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.657 HG13 ' HE3' ' A' ' 81' ' ' MET . 1.7 t -102.94 125.63 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.904 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -100.32 140.24 34.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.497 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.546 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.6 OUTLIER 62.14 77.32 0.33 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.93 . . . . 0.0 110.315 179.87 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.8 m -65.47 -35.06 79.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 110.057 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -52.95 -38.28 61.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.314 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.523 ' CE2' ' CE1' ' A' ' 74' ' ' HIS . 44.6 m0 -82.18 -61.27 1.95 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.947 . . . . 0.0 110.381 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.72 ' HA ' HG12 ' A' ' 119' ' ' VAL . 7.8 tt -87.76 122.03 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.372 -0.83 . . . . 0.0 109.808 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.824 HG22 ' O ' ' A' ' 118' ' ' ASP . 1.3 t -87.6 -22.42 24.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.0 111.41 -178.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.79 176.98 47.68 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.303 -1.427 . . . . 0.0 110.381 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.657 ' HE3' HG13 ' A' ' 72' ' ' VAL . 2.1 mpp? -150.61 108.14 3.65 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.579 -0.954 . . . . 0.0 109.985 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.49 156.9 20.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.24 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.484 HD11 ' CE2' ' A' ' 140' ' ' TYR . 3.9 mt -148.19 153.28 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 110.073 179.758 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.524 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 1.9 tm-20 61.96 14.81 6.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 0.0 110.709 179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.6 19.42 61.93 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.524 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.2 p-80 -136.2 159.85 40.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.274 . . . . 0.0 110.272 179.608 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -71.44 162.95 28.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.82 . . . . 0.0 110.604 -179.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 81' ' ' MET . 4.0 pt-20 -90.79 170.09 10.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 179.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.39 126.92 55.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.289 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pp -67.86 103.64 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.142 -0.973 . . . . 0.0 109.465 179.578 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.464 HG21 HG22 ' A' ' 101' ' ' THR . 1.4 tt -94.38 -28.41 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 0.0 110.978 -179.061 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.3 m -166.91 100.21 0.55 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.044 -1.035 . . . . 0.0 110.12 -179.644 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.417 ' HG3' ' HG3' ' A' ' 100' ' ' ARG . 21.1 ttmt -95.72 102.64 14.46 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.396 -0.815 . . . . 0.0 110.041 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.47 94.3 7.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 110.211 -179.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 79.1 p -80.47 -17.34 51.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.356 -0.84 . . . . 0.0 110.368 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.48 -19.91 64.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.95 . . . . 0.0 110.11 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -136.44 22.44 3.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 110.105 179.887 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 52.74 67.97 0.9 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 0.0 110.093 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -147.72 176.23 10.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -0.898 . . . . 0.0 110.262 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.417 ' HG3' ' HG3' ' A' ' 93' ' ' LYS . 2.8 ttm180 -175.93 161.41 2.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.892 . . . . 0.0 110.189 -179.864 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.464 HG22 HG21 ' A' ' 91' ' ' ILE . 87.1 m -142.32 154.32 44.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.897 . . . . 0.0 109.814 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 22.4 p -145.88 142.01 28.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.034 -1.042 . . . . 0.0 110.759 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -92.74 146.16 23.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.456 -0.778 . . . . 0.0 109.716 179.472 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.425 ' CG ' HD12 ' A' ' 83' ' ' ILE . 46.4 m-85 -129.22 139.5 51.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.076 -1.015 . . . . 0.0 111.079 -179.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.471 ' C ' HG13 ' A' ' 106' ' ' VAL . 9.8 tt0 -105.75 122.06 45.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.462 -0.774 . . . . 0.0 109.225 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.471 HG13 ' C ' ' A' ' 105' ' ' GLU . 34.4 m -149.02 147.91 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.069 -1.019 . . . . 0.0 110.91 -178.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.6 m -63.8 106.64 1.03 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.327 -0.858 . . . . 0.0 109.117 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.819 ' H ' HD21 ' A' ' 66' ' ' LEU . 0.1 OUTLIER 50.45 -177.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.469 -0.77 . . . . 0.0 109.588 -178.729 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.727 HD22 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.42 82.49 1.36 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.907 -1.12 . . . . 0.0 111.191 -179.42 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -145.16 80.33 1.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.109 179.46 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.09 -113.61 0.61 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -157.11 152.93 27.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.161 -1.199 . . . . 0.0 110.055 179.847 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 57.4 mt -134.15 150.79 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 0.0 110.188 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -76.37 123.01 25.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.254 -0.904 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.458 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -128.83 177.75 17.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.8 mttt -143.45 171.79 13.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -1.079 . . . . 0.0 109.845 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.563 HD11 HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -158.13 138.83 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.073 -1.017 . . . . 0.0 110.543 -179.912 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.824 ' O ' HG22 ' A' ' 79' ' ' THR . 42.4 t0 -107.96 158.06 17.69 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 108.896 179.047 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.72 HG12 ' HA ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -145.34 152.7 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 0.0 110.781 -179.244 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 5.3 t80 -152.44 107.36 3.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.462 -0.774 . . . . 0.0 110.457 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.586 HD12 ' CB ' ' A' ' 132' ' ' TYR . 20.0 mt -127.74 153.31 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.185 -0.947 . . . . 0.0 110.454 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.55 96.96 1.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.866 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.444 ' HG2' ' CE1' ' A' ' 130' ' ' PHE . 6.7 pt-20 -173.88 -149.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 110.261 -179.654 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 0.1 OUTLIER -132.67 119.33 20.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.194 -0.941 . . . . 0.0 110.223 -179.947 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.679 HG23 ' CE1' ' A' ' 130' ' ' PHE . 38.7 t -76.77 90.58 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.222 -0.924 . . . . 0.0 110.369 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.58 46.07 23.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 110.505 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.23 36.16 5.02 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 0.1 OUTLIER -145.76 88.31 6.53 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.176 -1.19 . . . . 0.0 110.157 179.799 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -62.46 124.46 14.27 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.945 1.497 . . . . 0.0 110.274 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.679 ' CE1' HG23 ' A' ' 125' ' ' VAL . 6.2 p90 -154.25 161.86 41.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 110.183 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -135.42 106.18 6.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 110.17 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.586 ' CB ' HD12 ' A' ' 121' ' ' ILE . 3.6 t80 -91.79 131.31 37.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.01 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -166.68 89.63 0.37 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.917 . . . . 0.0 109.99 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 -177.06 6.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.152 -0.968 . . . . 0.0 110.593 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -118.22 93.06 3.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.372 -0.83 . . . . 0.0 109.758 179.753 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.407 ' CZ ' ' OH ' ' A' ' 132' ' ' TYR . 89.1 m-85 -85.55 -179.42 6.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.433 -0.792 . . . . 0.0 110.653 -179.476 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.601 ' O ' HG23 ' A' ' 138' ' ' ILE . 12.4 p30 -151.09 161.77 42.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 110.111 179.845 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.5 pt -156.81 163.35 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.093 -1.004 . . . . 0.0 110.692 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.425 HG23 ' HD2' ' A' ' 112' ' ' LYS . 86.0 m -91.97 121.6 33.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.386 -0.821 . . . . 0.0 110.736 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.484 ' CE2' HD11 ' A' ' 83' ' ' ILE . 55.4 m-85 -89.78 137.27 32.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -0.903 . . . . 0.0 109.407 179.088 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.477 ' HG3' ' CE2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -118.02 101.17 8.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.101 -1.0 . . . . 0.0 110.63 -179.725 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -92.6 130.3 38.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 0.0 109.83 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 3.7 m-80 -129.55 103.84 7.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 110.453 -179.761 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.878 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -152.62 -147.85 4.71 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.427 ' HD2' HD11 ' A' ' 34' ' ' LEU . 9.8 Cg_endo . . . . . 0 C--N 1.309 -1.533 0 O-C-N 123.793 1.417 . . . . 0.0 110.601 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.273 0.559 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -163.17 150.32 12.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 110.111 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.519 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 3.9 t30 63.0 24.34 14.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.874 . . . . 0.0 109.952 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 27' ' ' ASN . . . 178.87 53.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.411 -0.806 . . . . 0.0 110.092 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.3 -150.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.902 . . . . 0.0 110.347 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.8 OUTLIER 56.01 28.88 13.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.408 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.02 143.7 12.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 110.308 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.86 -178.77 43.94 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.96 103.47 16.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -1.155 . . . . 0.0 110.242 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.743 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -95.2 158.58 15.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 0.0 110.632 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' A' ' 143' ' ' ASN . 1.7 m120 -79.35 141.27 37.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 109.998 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.586 ' HE2' HD11 ' A' ' 70' ' ' ILE . 0.6 OUTLIER -164.94 157.23 15.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 110.209 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 141' ' ' LYS . 1.1 tt0 -155.66 -175.93 5.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 110.094 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 46' ' ' THR . 0.4 OUTLIER -140.31 172.47 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.941 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.408 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 39.1 m-85 -148.55 159.07 44.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 110.568 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.439 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.3 OUTLIER -67.56 128.22 35.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.477 -0.764 . . . . 0.0 109.882 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.479 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -55.41 146.51 19.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 0.0 110.089 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.472 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.1 t-20 71.44 2.3 4.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.861 -0.524 . . . . 0.0 111.235 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.75 -165.73 1.78 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.822 -1.174 . . . . 0.0 109.679 179.155 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -133.65 15.68 4.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.134 -0.979 . . . . 0.0 110.344 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -135.48 117.66 15.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.986 . . . . 0.0 110.579 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -50.45 131.3 24.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.201 -0.937 . . . . 0.0 109.264 179.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.54 -17.32 3.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.014 -1.054 . . . . 0.0 112.051 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 67.5 mt -136.93 -70.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.867 -1.145 . . . . 0.0 110.808 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.428 ' HB1' ' HE2' ' A' ' 53' ' ' PHE . . . -46.61 -26.31 0.88 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.597 -0.689 . . . . 0.0 110.943 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.453 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -63.39 -14.5 50.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -0.981 . . . . 0.0 110.803 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.413 ' C ' ' CG ' ' A' ' 52' ' ' TYR . 21.2 m-20 -95.24 14.85 20.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.074 -1.016 . . . . 0.0 110.832 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.413 ' CG ' ' C ' ' A' ' 51' ' ' ASP . 22.5 m-85 -142.91 15.73 1.93 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.992 -1.068 . . . . 0.0 110.737 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.428 ' HE2' ' HB1' ' A' ' 49' ' ' ALA . 19.4 m-85 -131.3 105.85 7.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.183 -0.948 . . . . 0.0 110.205 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.476 ' HB2' HG21 ' A' ' 71' ' ' THR . 22.7 m120 -72.3 169.76 15.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.186 -0.947 . . . . 0.0 110.368 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.72 162.04 33.12 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.338 -0.851 . . . . 0.0 110.018 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.25 -175.8 16.46 Favored 'Cis proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.399 -2.334 . . . . 0.0 110.596 -0.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.58 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -103.5 171.3 7.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.325 -0.859 . . . . 0.0 109.885 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.438 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -105.2 116.25 31.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.001 . . . . 0.0 110.536 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.507 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 1.9 p90 -97.24 162.67 13.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.394 -0.816 . . . . 0.0 109.945 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -154.78 150.97 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.026 -1.046 . . . . 0.0 110.783 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 19.6 mtmt -134.39 173.65 11.4 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.247 -0.908 . . . . 0.0 110.737 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.457 ' HB2' ' CD ' ' A' ' 65' ' ' LYS . 4.5 mttm -153.27 62.21 0.76 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.508 -0.745 . . . . 0.0 109.703 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.1 m120 46.98 82.44 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.369 -0.832 . . . . 0.0 111.105 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.53 19.82 28.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.457 ' CD ' ' HB2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -168.84 162.62 11.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.045 -1.267 . . . . 0.0 111.181 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' A' ' 108' ' ' LYS . 2.6 pt? -172.66 154.89 3.15 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.009 0.909 . . . . 0.0 111.477 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 1.1 m-85 -137.98 -153.7 0.49 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.439 HG11 ' CE1' ' A' ' 142' ' ' PHE . 1.1 t -170.73 135.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.073 -1.017 . . . . 0.0 110.287 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.438 ' HG2' ' CB ' ' A' ' 58' ' ' LYS . 1.8 pt20 -97.51 131.24 44.31 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.39 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.586 HD11 ' HE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -110.68 143.69 20.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.253 -0.905 . . . . 0.0 110.108 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.476 HG21 ' HB2' ' A' ' 54' ' ' ASN . 0.5 OUTLIER -88.77 135.85 33.31 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.299 -0.876 . . . . 0.0 109.902 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.642 ' CG1' HG21 ' A' ' 78' ' ' ILE . 22.8 t -103.34 126.42 57.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.418 -0.802 . . . . 0.0 110.143 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -97.99 127.16 43.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.227 -0.921 . . . . 0.0 110.149 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 m80 55.04 99.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.827 . . . . 0.0 110.146 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.9 t -74.39 -35.75 63.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 110.189 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -51.57 -23.9 4.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.26 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.651 ' CD2' HBB2 ' A' ' 151' ' ' ZNH . 45.4 m0 -94.37 -53.53 3.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.48 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.642 HG21 ' CG1' ' A' ' 72' ' ' VAL . 13.6 tt -89.51 123.71 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.144 -0.973 . . . . 0.0 109.835 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -87.69 -27.02 22.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 110.982 -179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.56 -176.47 47.67 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.046 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.415 ' HE1' HG22 ' A' ' 72' ' ' VAL . 63.3 mtm -151.95 165.5 34.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.384 -1.068 . . . . 0.0 110.145 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -155.29 140.58 17.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.323 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.688 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -130.19 140.18 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 110.245 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 71.65 0.85 3.65 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.637 -0.664 . . . . 0.0 111.385 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.09 21.79 9.25 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.644 -1.265 . . . . 0.0 111.292 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.472 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.74 158.71 43.78 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.52 -1.577 . . . . 0.0 110.31 179.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.14 175.29 5.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 110.485 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -104.06 170.29 8.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.371 -0.831 . . . . 0.0 110.32 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -110.6 131.51 54.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 110.463 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 90' ' ' ILE . 1.4 pp -68.26 102.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 109.571 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.492 HG21 HG22 ' A' ' 101' ' ' THR . 1.1 tt -95.21 -30.89 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 111.092 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.7 m -167.22 95.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.028 -1.045 . . . . 0.0 110.327 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -96.77 105.07 17.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.397 -0.814 . . . . 0.0 109.977 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.67 105.36 17.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.236 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -32.03 44.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 0.0 110.235 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.59 -44.71 95.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.925 . . . . 0.0 109.987 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -96.8 8.54 44.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 110.704 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.02 53.33 13.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.037 -1.039 . . . . 0.0 110.071 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.38 119.01 7.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 110.519 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.475 ' CG ' ' N ' ' A' ' 101' ' ' THR . 38.2 ttt180 -114.98 167.27 10.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.43 -0.794 . . . . 0.0 109.619 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.492 HG22 HG21 ' A' ' 91' ' ' ILE . 92.0 m -141.09 153.14 45.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.018 -1.051 . . . . 0.0 109.962 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.1 p -144.99 142.35 29.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.157 -0.964 . . . . 0.0 110.686 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.18 140.73 29.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.324 -0.86 . . . . 0.0 109.85 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -127.96 138.62 52.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.077 -1.014 . . . . 0.0 110.71 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.456 ' HG2' ' CD2' ' A' ' 67' ' ' TYR . 3.2 tm-20 -98.29 128.16 44.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.329 -0.857 . . . . 0.0 109.538 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.61 151.12 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 110.926 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -63.09 111.2 2.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.235 -0.916 . . . . 0.0 109.195 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.792 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.21 -167.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.458 -0.776 . . . . 0.0 109.844 -178.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.468 HD22 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.25 70.98 1.05 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.96 -1.088 . . . . 0.0 110.86 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.573 ' OD1' HG23 ' A' ' 146' ' ' THR . 0.2 OUTLIER -146.2 67.48 1.19 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 0.0 110.243 179.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 164.53 -121.57 1.02 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -157.41 153.44 27.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -1.157 . . . . 0.0 110.115 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.1 mm -136.74 149.2 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.0 110.262 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -76.49 103.78 6.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 109.968 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -109.17 179.49 21.03 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.5 mttp -145.03 167.4 22.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -1.088 . . . . 0.0 109.824 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.443 HD11 ' HAC' ' A' ' 151' ' ' ZNH . 0.1 OUTLIER -158.07 153.17 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.016 -1.052 . . . . 0.0 110.792 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.652 ' O ' HG22 ' A' ' 79' ' ' THR . 59.9 m-20 -111.65 157.88 19.93 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.522 -0.737 . . . . 0.0 109.297 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.455 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.7 OUTLIER -141.61 151.57 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.999 -1.063 . . . . 0.0 110.528 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -151.51 117.07 5.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.411 -0.805 . . . . 0.0 110.069 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 77' ' ' TRP . 31.4 mt -141.05 151.97 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.188 -0.945 . . . . 0.0 110.484 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.57 95.79 1.12 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.465 -0.772 . . . . 0.0 109.668 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -173.14 163.6 4.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.335 -0.853 . . . . 0.0 110.431 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -87.34 112.94 22.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 110.374 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 130' ' ' PHE . 60.9 t -76.42 91.68 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.323 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 62.02 43.33 9.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.216 -0.927 . . . . 0.0 110.349 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.14 30.61 16.52 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -145.37 100.92 4.41 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.269 -1.136 . . . . 0.0 110.261 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -52.5 113.25 1.14 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.74 1.389 . . . . 0.0 110.286 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.466 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 3.3 t80 -112.39 120.13 40.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.0 110.391 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -103.95 142.67 34.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.338 -0.851 . . . . 0.0 110.077 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.455 ' HE2' HG11 ' A' ' 119' ' ' VAL . 2.5 t80 -156.67 121.23 4.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 109.988 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.429 ' HB3' ' CE1' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -168.01 86.66 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 110.367 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -153.43 -172.45 4.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 110.358 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -117.64 87.81 2.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 110.091 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -85.56 -178.39 6.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.328 -0.857 . . . . 0.0 110.242 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 138' ' ' ILE . 2.6 p30 -149.4 169.94 19.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 110.461 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.0 OUTLIER -157.11 163.79 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -0.918 . . . . 0.0 110.634 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.408 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 85.2 m -91.86 125.33 36.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.3 -0.875 . . . . 0.0 110.567 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.688 ' CD2' HD11 ' A' ' 83' ' ' ILE . 31.4 m-85 -90.13 154.02 20.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.601 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.0 OUTLIER -142.06 102.86 4.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.055 -1.028 . . . . 0.0 110.427 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.439 ' CE1' HG11 ' A' ' 68' ' ' VAL . 17.1 m-85 -92.26 153.51 19.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.524 ' C ' HD21 ' A' ' 34' ' ' LEU . 51.1 m-80 -142.62 97.91 3.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.446 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.743 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -155.21 -148.12 4.91 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.463 ' HD2' HD11 ' A' ' 34' ' ' LEU . 9.4 Cg_endo -58.57 -166.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.795 1.418 . . . . 0.0 110.436 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.573 HG23 ' OD1' ' A' ' 110' ' ' ASN . 1.2 p -149.84 -54.01 0.16 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.128 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -120.89 -76.71 0.58 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.908 . . . . 0.0 110.244 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.6 t 56.25 59.4 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 0.0 110.406 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -157.98 28.79 0.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.882 . . . . 0.0 110.227 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.956 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.651 HBB2 ' CD2' ' A' ' 77' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.225 0.536 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -80.49 95.13 6.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.178 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 4.8 t-20 64.28 35.6 9.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -0.868 . . . . 0.0 110.089 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.86 79.44 1.73 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.406 -0.809 . . . . 0.0 110.234 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.38 -51.67 14.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 110.148 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER 53.2 34.5 17.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.239 -0.913 . . . . 0.0 110.337 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.7 p -160.67 148.06 15.78 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.195 -0.941 . . . . 0.0 110.331 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 171.2 174.35 38.9 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.93 107.73 19.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.282 -1.128 . . . . 0.0 110.568 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.699 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.7 OUTLIER -95.73 158.09 15.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.149 -0.97 . . . . 0.0 110.363 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 143' ' ' ASN . 2.1 m-20 -80.38 143.8 33.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 0.0 109.716 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.472 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 1.1 p90 -164.92 156.36 15.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.117 -0.989 . . . . 0.0 110.254 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.42 -175.76 5.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.314 -0.866 . . . . 0.0 109.958 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -140.31 175.17 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 110.031 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -149.08 160.57 43.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 110.404 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.426 ' HG3' ' HB2' ' A' ' 47' ' ' SER . 0.1 OUTLIER -67.94 119.97 13.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.369 -0.832 . . . . 0.0 109.418 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.546 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -48.71 146.15 3.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.241 -0.912 . . . . 0.0 110.169 -179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER 72.53 2.33 4.31 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.949 -0.47 . . . . 0.0 110.866 -179.328 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -135.34 -163.0 1.32 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.878 -1.138 . . . . 0.0 109.818 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.56 14.02 3.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.35 -0.844 . . . . 0.0 110.242 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -135.25 123.51 23.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 110.354 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.556 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -60.56 131.37 50.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.072 -1.018 . . . . 0.0 109.313 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.426 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -128.04 -17.14 4.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 111.781 -178.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.2 mt -137.25 -65.59 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.8 -1.188 . . . . 0.0 110.895 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HB1' ' HE2' ' A' ' 53' ' ' PHE . . . -50.03 -22.99 1.8 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.508 -0.745 . . . . 0.0 111.205 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.514 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.1 OUTLIER -70.58 -9.41 56.77 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.039 -1.038 . . . . 0.0 110.965 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.407 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 30.1 m-20 -102.47 14.9 30.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.928 -1.107 . . . . 0.0 110.959 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 51' ' ' ASP . 31.5 m-85 -136.47 4.98 2.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.001 -1.062 . . . . 0.0 111.097 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.579 ' HE2' ' HB1' ' A' ' 49' ' ' ALA . 19.8 m-85 -125.75 111.64 15.14 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.038 -1.039 . . . . 0.0 110.291 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -72.01 165.69 23.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.993 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.438 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -147.24 164.55 22.52 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.215 -0.928 . . . . 0.0 110.196 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.438 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 58.0 Cg_endo -80.84 -175.57 16.27 Favored 'Cis proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.338 -2.359 . . . . 0.0 110.666 -0.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.48 168.85 9.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -0.885 . . . . 0.0 109.676 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.441 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.89 121.33 41.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.031 -1.043 . . . . 0.0 110.783 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.511 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 9.2 p90 -98.26 158.73 15.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.327 -0.858 . . . . 0.0 109.873 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.8 OUTLIER -155.08 147.65 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.076 -1.015 . . . . 0.0 110.442 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 7.2 mttt -131.87 174.11 10.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.457 -0.777 . . . . 0.0 110.444 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . 2.6 mmtp -156.73 62.04 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.796 . . . . 0.0 109.731 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 m120 47.53 85.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.835 . . . . 0.0 110.992 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.73 17.45 48.5 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.555 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HD2' ' HB3' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -165.31 163.51 19.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.936 -1.332 . . . . 0.0 111.119 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.584 HD11 ' HA ' ' A' ' 108' ' ' LYS . 1.2 pt? -174.6 154.83 2.09 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.017 0.913 . . . . 0.0 110.964 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.565 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -139.48 -155.46 0.59 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -170.67 134.51 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.846 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.441 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -97.73 134.68 40.58 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.123 -0.986 . . . . 0.0 110.011 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 101' ' ' THR . 1.0 OUTLIER -113.2 139.53 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.437 -0.789 . . . . 0.0 110.069 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.31 133.67 34.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 110.022 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.842 HG13 HD13 ' A' ' 78' ' ' ILE . 5.2 t -102.6 125.51 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.44 -0.787 . . . . 0.0 109.831 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -99.21 126.93 45.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.13 -0.981 . . . . 0.0 110.416 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.599 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER 58.42 99.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 110.354 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.37 -25.55 59.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.168 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -59.39 -36.27 75.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.498 ' O ' HG12 ' A' ' 119' ' ' VAL . 46.5 m0 -82.77 -52.11 7.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 110.208 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.842 HD13 HG13 ' A' ' 72' ' ' VAL . 12.8 tt -89.3 122.66 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.309 -0.869 . . . . 0.0 109.838 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.667 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.2 -25.46 24.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 110.878 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.77 178.05 48.41 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.499 -1.334 . . . . 0.0 110.243 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.706 ' SD ' HD11 ' A' ' 78' ' ' ILE . 89.6 mtp -150.92 160.26 44.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.996 . . . . 0.0 109.787 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -154.95 161.16 41.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 110.253 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.493 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 1.3 mt -149.73 152.6 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 110.149 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.529 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 0.2 OUTLIER 62.77 12.51 5.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.093 -1.004 . . . . 0.0 111.058 179.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.17 20.42 52.8 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.436 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.529 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.2 p-80 -138.28 158.8 43.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.859 -1.377 . . . . 0.0 110.441 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.39 172.2 9.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.334 -0.854 . . . . 0.0 110.595 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.523 ' CB ' ' CZ ' ' A' ' 104' ' ' PHE . 4.4 pt-20 -100.54 170.53 8.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.342 -0.849 . . . . 0.0 110.373 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.3 129.49 53.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.347 -0.845 . . . . 0.0 110.483 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.76 101.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.111 -0.993 . . . . 0.0 109.569 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 101' ' ' THR . 1.1 tt -94.86 -26.38 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 110.857 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.501 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -167.04 100.31 0.54 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.229 -0.92 . . . . 0.0 109.655 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.406 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 16.4 ttmt -95.93 147.94 23.15 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 110.191 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -143.02 84.2 1.82 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -0.938 . . . . 0.0 110.3 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 p -71.21 -29.39 65.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 110.207 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.95 -52.57 62.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.339 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -96.31 15.84 20.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.0 110.5 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.42 62.54 2.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.117 -0.989 . . . . 0.0 110.547 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 94' ' ' ASN . 22.3 mt-10 -148.14 160.86 42.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.158 -0.964 . . . . 0.0 110.165 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 92' ' ' SER . 7.3 ttm180 -166.83 161.47 15.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 110.155 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.578 ' O ' HG22 ' A' ' 91' ' ' ILE . 74.3 m -143.07 152.0 41.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 109.61 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 18.2 p -146.33 143.46 29.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.988 -1.07 . . . . 0.0 110.871 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.82 147.96 22.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.374 -0.828 . . . . 0.0 109.693 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.523 ' CZ ' ' CB ' ' A' ' 88' ' ' GLU . 27.2 m-85 -130.16 135.79 48.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.088 -1.008 . . . . 0.0 111.117 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -97.19 125.17 41.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.393 -0.817 . . . . 0.0 109.117 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.478 ' O ' HD21 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -149.25 161.02 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 0.0 110.782 -178.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.433 ' N ' ' CG2' ' A' ' 106' ' ' VAL . 11.0 p -70.13 113.0 6.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 108.82 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.584 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 44.83 -164.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.673 -0.642 . . . . 0.0 109.964 -178.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -150.64 68.22 0.96 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.876 -1.14 . . . . 0.0 110.933 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -146.97 87.97 1.71 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 110.05 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 148.05 -125.76 2.18 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.47 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.1 OUTLIER -156.91 150.39 24.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -1.067 . . . . 0.0 109.723 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.461 ' CD1' HG23 ' A' ' 106' ' ' VAL . 2.4 mt -135.55 152.19 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.316 -0.865 . . . . 0.0 110.04 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -75.93 100.0 4.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.919 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.413 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -99.99 179.31 29.92 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 82' ' ' SER . 17.0 mtpt -146.13 158.31 43.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -1.121 . . . . 0.0 110.054 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.46 ' O ' HD13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -157.6 145.99 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.119 -0.988 . . . . 0.0 110.312 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.667 ' C ' HG22 ' A' ' 79' ' ' THR . 1.0 OUTLIER -108.32 161.17 15.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.366 -0.833 . . . . 0.0 109.596 179.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -136.48 150.77 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.119 -0.988 . . . . 0.0 110.766 -179.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -151.94 114.19 4.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.467 -0.771 . . . . 0.0 109.871 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 77' ' ' TRP . 15.8 mt -141.51 153.29 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.164 -0.96 . . . . 0.0 110.806 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -159.44 100.01 1.48 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.587 -0.695 . . . . 0.0 109.424 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -172.97 178.25 2.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.24 -0.912 . . . . 0.0 110.396 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -101.21 118.85 37.8 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.333 -0.854 . . . . 0.0 110.324 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.2 t -76.91 92.26 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.0 110.306 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.431 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 1.4 m120 57.39 36.18 26.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.878 . . . . 0.0 110.503 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.89 31.25 6.72 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.12 98.15 4.74 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.247 -1.149 . . . . 0.0 110.07 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -49.17 121.28 6.65 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.921 1.485 . . . . 0.0 110.327 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.516 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 2.0 t80 -126.32 124.63 40.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 110.195 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -103.61 140.59 37.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 110.351 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.467 ' HE2' HG11 ' A' ' 119' ' ' VAL . 2.5 t80 -150.85 123.22 8.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.091 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -175.83 87.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 109.935 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -153.58 -164.68 1.95 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.355 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.472 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -119.2 139.83 51.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.981 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.472 ' CD1' ' O ' ' A' ' 135' ' ' HIS . 47.5 m-85 -154.53 -179.82 8.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.93 . . . . 0.0 110.119 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.638 ' O ' HG23 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -152.39 178.89 9.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.161 -0.962 . . . . 0.0 110.51 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.638 HG23 ' O ' ' A' ' 137' ' ' ASN . 3.8 pt -157.13 170.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.885 . . . . 0.0 110.058 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.47 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 96.8 m -91.6 121.84 33.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.157 -0.964 . . . . 0.0 110.647 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.567 ' HA ' HG12 ' A' ' 38' ' ' VAL . 28.6 m-85 -89.44 155.58 19.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.575 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.0 OUTLIER -143.32 100.53 3.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.048 -1.033 . . . . 0.0 110.741 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.425 ' CE1' HG11 ' A' ' 68' ' ' VAL . 15.9 m-85 -91.7 129.14 37.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 109.652 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.472 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 56.1 m-80 -113.93 104.38 12.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.105 -0.997 . . . . 0.0 110.877 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.699 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -163.13 -159.03 10.15 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -62.66 140.52 81.31 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.982 1.517 . . . . 0.0 110.278 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 m -90.59 -42.54 10.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.928 . . . . 0.0 110.401 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -175.4 -43.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.189 -0.944 . . . . 0.0 110.28 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.421 ' O ' HG12 ' A' ' 148' ' ' VAL . 22.1 t 56.39 53.63 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 110.307 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.11 60.63 4.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.02 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.516 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.347 0.594 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.3 131.17 48.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.139 -0.975 . . . . 0.0 110.286 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.95 31.23 16.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.167 -0.958 . . . . 0.0 110.005 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.81 41.44 1.43 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.843 . . . . 0.0 110.277 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.55 -160.16 0.45 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 110.231 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER 56.69 27.33 12.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 110.419 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -158.91 134.6 8.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 110.246 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.96 178.27 48.74 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.29 105.4 17.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.181 -1.187 . . . . 0.0 110.382 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.839 HD13 HD22 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -94.27 154.25 17.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.345 -0.847 . . . . 0.0 109.744 179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.475 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 12.4 t-20 -78.73 144.7 35.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.12 -0.988 . . . . 0.0 109.989 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -165.57 161.46 18.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.343 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.22 -173.44 4.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.425 -0.797 . . . . 0.0 109.746 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.78 HG23 HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.55 174.61 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.169 -0.957 . . . . 0.0 110.146 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.413 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 16.0 m-85 -147.47 151.37 36.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.377 -0.827 . . . . 0.0 109.839 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -67.43 127.12 31.51 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.419 -0.8 . . . . 0.0 110.066 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.477 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -52.94 146.98 9.9 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.091 -1.006 . . . . 0.0 109.493 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 12.5 t30 73.09 -1.17 3.14 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.944 -0.472 . . . . 0.0 110.914 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.95 -163.38 1.41 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.899 -1.126 . . . . 0.0 109.561 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.402 ' N ' ' OG1' ' A' ' 43' ' ' THR . 8.5 m120 -133.34 15.74 4.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 110.434 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -136.53 129.03 30.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.015 . . . . 0.0 110.681 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.78 HG21 HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -57.79 132.38 53.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.156 -0.965 . . . . 0.0 109.037 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.75 -16.8 4.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.102 -0.999 . . . . 0.0 112.035 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 49' ' ' ALA . 2.2 mt -136.62 -64.94 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.803 -1.185 . . . . 0.0 110.598 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.457 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -54.6 -20.79 8.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.428 -0.795 . . . . 0.0 110.727 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.456 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 0.1 OUTLIER -63.38 -17.84 63.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.309 -0.87 . . . . 0.0 110.76 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -102.47 15.45 29.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.139 -0.976 . . . . 0.0 110.992 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.477 ' CD2' HBC1 ' A' ' 151' ' ' ZNH . 66.9 m-85 -131.73 1.11 3.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.949 -1.094 . . . . 0.0 111.151 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -129.37 113.47 14.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.127 -0.983 . . . . 0.0 110.252 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -72.79 173.05 9.67 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.386 -0.821 . . . . 0.0 110.617 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.15 164.67 22.01 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.354 -0.841 . . . . 0.0 109.769 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -78.66 -174.84 15.55 Favored 'Cis proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.798 -2.167 . . . . 0.0 110.559 -0.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.22 164.38 11.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.879 . . . . 0.0 110.007 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.415 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 2.2 tptt -101.91 109.55 21.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.131 -0.981 . . . . 0.0 110.314 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.519 ' CD1' ' CB ' ' A' ' 34' ' ' LEU . 6.5 p90 -98.0 165.75 11.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.332 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.8 OUTLIER -155.6 157.81 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.296 -0.877 . . . . 0.0 110.537 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 3.1 mtmt -139.41 174.31 10.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.245 -0.909 . . . . 0.0 110.831 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . 7.2 mttm -159.03 62.21 0.41 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.418 -0.801 . . . . 0.0 109.878 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 48.97 84.0 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.441 -0.787 . . . . 0.0 111.232 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.68 24.42 28.12 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.736 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.76 ' C ' HD13 ' A' ' 66' ' ' LEU . 1.3 ptpp? -167.42 155.94 9.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.912 -1.346 . . . . 0.0 111.018 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.76 HD13 ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -160.12 155.56 25.34 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.201 1.0 . . . . 0.0 111.843 178.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 6.2 m-85 -142.58 -164.14 1.76 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 103' ' ' GLU . 1.1 t -170.47 135.98 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.998 -1.064 . . . . 0.0 110.554 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 102' ' ' SER . 4.7 pt20 -99.15 134.23 42.3 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 109.773 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -113.23 134.87 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 110.093 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.0 m -89.57 123.56 33.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 0.0 109.954 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -103.08 141.7 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.207 -0.933 . . . . 0.0 110.278 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -98.67 140.02 33.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.827 . . . . 0.0 110.207 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.2 m170 52.58 88.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 110.221 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 95.7 p -52.19 -25.91 10.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.378 -0.827 . . . . 0.0 110.298 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -65.37 -55.74 16.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 110.369 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.429 ' HA ' HG12 ' A' ' 121' ' ' ILE . 47.4 m0 -50.73 -59.56 3.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.19 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.79 HD11 ' CG ' ' A' ' 81' ' ' MET . 6.1 tt -88.46 118.04 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.312 -0.868 . . . . 0.0 109.894 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.61 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.6 -23.02 25.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.316 -0.865 . . . . 0.0 110.956 -179.186 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.07 176.1 47.93 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.57 -1.3 . . . . 0.0 110.019 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.79 ' CG ' HD11 ' A' ' 78' ' ' ILE . 56.6 mtp -152.57 157.79 41.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.376 -1.073 . . . . 0.0 110.07 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -155.11 140.51 17.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.94 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.848 HD11 ' CE2' ' A' ' 140' ' ' TYR . 0.4 OUTLIER -132.94 139.38 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.143 -0.973 . . . . 0.0 110.726 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 70.73 1.86 3.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.588 -0.695 . . . . 0.0 111.629 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.49 22.06 9.37 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.327 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.465 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.88 159.64 41.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.685 -1.479 . . . . 0.0 110.059 179.217 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -70.16 -174.55 0.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.171 -0.956 . . . . 0.0 110.616 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -109.06 169.03 8.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 110.239 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 102' ' ' SER . 22.4 m120 -110.34 127.56 55.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.408 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 pp -67.08 102.89 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.062 -1.024 . . . . 0.0 109.661 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.456 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 0.9 OUTLIER -95.7 -31.5 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 111.007 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.427 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 0.8 OUTLIER -167.24 100.4 0.52 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.036 -1.04 . . . . 0.0 110.162 -179.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -96.21 148.8 22.34 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.417 -0.802 . . . . 0.0 110.084 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.23 97.9 3.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 110.331 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.6 -32.56 58.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.049 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.89 -43.18 99.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 110.091 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.77 5.76 50.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 110.507 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.71 56.91 6.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.034 -1.041 . . . . 0.0 110.311 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -148.14 -177.32 5.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 110.357 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.544 ' O ' HG22 ' A' ' 72' ' ' VAL . 4.8 ttp180 175.22 160.06 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.855 . . . . 0.0 110.009 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.456 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 85.8 m -137.3 156.19 48.55 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.314 -0.866 . . . . 0.0 109.812 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 6.1 p -144.2 143.12 30.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.038 -1.038 . . . . 0.0 110.785 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.2 tt0 -92.92 150.15 20.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.816 . . . . 0.0 110.054 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.682 ' CD2' HD12 ' A' ' 83' ' ' ILE . 15.5 m-85 -129.71 154.44 47.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.94 . . . . 0.0 110.687 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.459 ' C ' HG13 ' A' ' 106' ' ' VAL . 0.5 OUTLIER -118.51 127.37 53.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.321 -0.862 . . . . 0.0 109.742 179.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.496 ' O ' HD21 ' A' ' 66' ' ' LEU . 29.0 m -149.88 -165.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.045 -1.034 . . . . 0.0 110.607 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.7 t -97.9 111.9 24.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.479 -0.763 . . . . 0.0 108.994 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 47.41 -166.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.48 -0.763 . . . . 0.0 109.554 -178.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.839 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.0 62.75 0.91 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.078 -1.014 . . . . 0.0 110.931 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -146.11 70.48 1.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.91 . . . . 0.0 110.23 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 170.23 -125.07 1.19 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.2 OUTLIER -157.38 139.35 14.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.343 -1.092 . . . . 0.0 109.715 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.427 ' CA ' ' HE2' ' A' ' 112' ' ' LYS . 6.0 mt -135.25 149.83 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.24 -0.913 . . . . 0.0 110.237 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -76.57 123.18 25.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.908 . . . . 0.0 110.15 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.483 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -119.82 -177.65 16.23 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 12.3 mttt -145.12 158.86 43.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.327 -1.102 . . . . 0.0 110.111 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -157.77 143.64 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.454 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.61 ' C ' HG22 ' A' ' 79' ' ' THR . 0.9 OUTLIER -103.59 154.99 18.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.401 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.408 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -129.84 146.86 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.008 -1.057 . . . . 0.0 110.678 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.53 110.47 3.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.43 -0.794 . . . . 0.0 110.006 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.462 ' HB ' ' CB ' ' A' ' 132' ' ' TYR . 19.6 mt -139.92 153.71 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 110.573 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.0 95.1 1.26 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.498 -0.751 . . . . 0.0 109.436 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.476 ' O ' ' CD1' ' A' ' 130' ' ' PHE . 1.3 pt-20 -174.5 -164.73 0.18 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.387 -0.821 . . . . 0.0 109.928 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -113.63 115.04 27.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.101 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.972 HG23 ' CE1' ' A' ' 130' ' ' PHE . 3.1 t -76.61 94.56 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.264 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.415 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 2.4 m120 59.42 39.13 22.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.337 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 91.89 34.69 7.13 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.72 90.71 6.31 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.226 -1.161 . . . . 0.0 110.061 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -57.3 133.75 59.31 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.126 1.593 . . . . 0.0 110.63 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.972 ' CE1' HG23 ' A' ' 125' ' ' VAL . 9.3 p90 -157.39 132.7 9.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 110.056 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -103.24 99.71 9.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.397 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.462 ' CB ' ' HB ' ' A' ' 121' ' ' ILE . 3.7 t80 -90.49 129.53 36.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.831 . . . . 0.0 109.703 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -170.45 83.58 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.091 -1.005 . . . . 0.0 110.27 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.84 -166.04 2.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.885 . . . . 0.0 110.327 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -118.34 151.7 37.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 109.858 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.411 ' HB3' HMD2 ' A' ' 151' ' ' ZNH . 16.7 m-85 -155.29 179.85 8.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.078 -1.014 . . . . 0.0 110.405 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.574 ' O ' HG23 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -152.23 169.54 22.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 110.572 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.574 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.4 pt -156.65 161.63 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 110.214 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.478 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 66.4 m -91.82 125.85 36.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.865 . . . . 0.0 110.73 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.848 ' CE2' HD11 ' A' ' 83' ' ' ILE . 47.7 m-85 -90.59 164.93 14.02 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.905 . . . . 0.0 110.016 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.1 OUTLIER -147.98 103.3 3.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.954 . . . . 0.0 110.32 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -92.44 141.33 28.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.301 -0.874 . . . . 0.0 110.515 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.458 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 67.2 m-20 -133.12 98.43 4.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.172 -0.955 . . . . 0.0 110.022 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.523 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -160.52 -148.71 5.35 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -63.22 -174.01 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.773 1.407 . . . . 0.0 110.768 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.47 -42.74 0.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 110.038 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -142.82 -49.16 0.34 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 110.155 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 148' ' ' VAL . 30.4 t 56.01 29.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 110.322 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.55 24.67 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.291 -0.88 . . . . 0.0 110.19 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.915 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.477 HBC1 ' CD2' ' A' ' 52' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.286 0.565 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -131.85 142.21 49.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.164 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.78 27.99 17.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.262 -0.899 . . . . 0.0 109.88 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.08 114.17 10.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 0.0 110.24 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.74 -165.62 0.85 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.34 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 25.0 m-20 55.64 23.24 5.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.335 -0.853 . . . . 0.0 110.352 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.6 t -160.84 148.24 15.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 110.43 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.35 172.14 39.97 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.18 106.59 18.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -1.107 . . . . 0.0 110.229 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.782 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.8 OUTLIER -94.45 156.21 16.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.319 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -79.62 143.9 34.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 110.017 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.634 ' HE2' HD11 ' A' ' 70' ' ' ILE . 1.6 p90 -165.99 159.05 15.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 0.0 110.03 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -155.15 -175.14 5.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.219 -0.926 . . . . 0.0 109.947 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 46' ' ' THR . 0.1 OUTLIER -141.43 174.5 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 110.476 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 18.6 m-85 -148.17 156.02 42.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -0.808 . . . . 0.0 109.926 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.542 ' HZ2' ' HA ' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -67.66 127.87 34.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.106 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.538 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -54.37 147.92 12.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 109.869 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 9.7 m-20 71.11 2.42 4.23 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.812 -0.555 . . . . 0.0 110.952 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -135.93 -162.26 1.25 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.849 -1.157 . . . . 0.0 109.666 179.087 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.413 ' N ' ' OG1' ' A' ' 43' ' ' THR . 16.5 m-80 -132.57 11.91 4.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 110.194 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -136.56 143.76 43.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -0.996 . . . . 0.0 110.69 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -68.58 131.49 45.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.088 179.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.558 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -129.25 -17.52 3.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.962 -1.087 . . . . 0.0 112.137 -178.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.713 HG22 ' N ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -137.32 -71.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.789 -1.195 . . . . 0.0 110.581 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.713 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -48.87 -24.69 1.55 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.499 -0.751 . . . . 0.0 110.853 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.455 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -61.73 -20.64 63.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.121 -0.987 . . . . 0.0 110.784 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.41 ' OD2' ' ND2' ' A' ' 50' ' ' ASN . 2.1 m-20 -94.68 14.12 22.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.086 -1.009 . . . . 0.0 110.858 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.406 ' CD2' HBC1 ' A' ' 151' ' ' ZNH . 61.1 m-85 -141.3 9.51 2.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.062 . . . . 0.0 110.843 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -118.15 110.67 17.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.128 -0.983 . . . . 0.0 110.171 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -72.77 155.67 39.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.298 -0.877 . . . . 0.0 110.693 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -147.52 163.27 28.58 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.333 -0.854 . . . . 0.0 109.833 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 50.5 Cg_endo -77.41 -175.27 16.4 Favored 'Cis proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.862 -2.141 . . . . 0.0 110.472 -0.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.513 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.09 -172.0 2.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 109.889 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.432 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -125.52 119.19 27.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.015 -1.053 . . . . 0.0 110.577 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 8.3 p90 -97.11 165.59 11.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.86 . . . . 0.0 109.877 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.501 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -155.58 122.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.135 -0.978 . . . . 0.0 110.608 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.662 ' HD3' HD21 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -136.77 131.76 33.83 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.199 -0.938 . . . . 0.0 110.775 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' HB2' ' HD2' ' A' ' 65' ' ' LYS . 6.7 mttp -110.25 62.25 0.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 110.35 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 48.45 97.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.374 -0.829 . . . . 0.0 111.28 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.91 11.71 52.25 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.721 ' C ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -169.96 152.63 4.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.012 -1.287 . . . . 0.0 110.325 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.79 ' N ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -156.92 153.46 28.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.09 -1.006 . . . . 0.0 111.504 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 4.5 m-85 -142.94 -157.92 0.82 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.391 -0.818 . . . . 0.0 109.257 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -170.16 167.49 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.197 -0.939 . . . . 0.0 110.345 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.432 ' HG2' ' HB3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -141.28 134.51 29.47 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.403 -0.81 . . . . 0.0 109.676 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.634 HD11 ' HE2' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -115.48 133.71 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 110.225 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.3 m -89.86 129.72 36.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.155 -0.966 . . . . 0.0 109.853 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.412 HG12 ' CE ' ' A' ' 81' ' ' MET . 1.0 OUTLIER -102.31 143.78 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 110.231 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -99.23 139.34 35.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.905 . . . . 0.0 110.254 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.655 ' O ' HG22 ' A' ' 78' ' ' ILE . 3.9 m-70 54.34 99.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 110.346 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.01 -35.32 78.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.885 . . . . 0.0 110.222 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -57.95 -35.98 71.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 110.196 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.681 ' O ' HG13 ' A' ' 119' ' ' VAL . 39.8 m0 -79.0 -51.04 10.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 110.213 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 74' ' ' HIS . 3.8 tp -89.27 120.55 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.875 . . . . 0.0 109.835 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.45 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.4 -34.56 20.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.406 -0.809 . . . . 0.0 110.706 -179.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.418 ' N ' ' CG2' ' A' ' 79' ' ' THR . . . -175.62 -179.63 46.25 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.532 -1.318 . . . . 0.0 109.989 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.442 ' CE ' HG21 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -152.41 166.31 32.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -1.091 . . . . 0.0 110.133 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -155.21 147.3 23.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.859 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.626 HD11 ' CD2' ' A' ' 140' ' ' TYR . 1.2 mt -142.37 143.11 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 110.627 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 72.3 -0.41 3.28 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.614 -0.678 . . . . 0.0 111.604 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.0 20.27 9.99 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.458 -1.354 . . . . 0.0 111.285 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.461 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.02 161.41 36.13 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.735 -1.45 . . . . 0.0 110.199 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -172.16 0.6 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.006 -1.059 . . . . 0.0 110.739 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 0.1 OUTLIER -109.79 165.9 11.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 110.557 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.16 135.05 54.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.448 -0.783 . . . . 0.0 109.856 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.42 100.76 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.087 -1.008 . . . . 0.0 109.913 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.535 HG21 HG22 ' A' ' 101' ' ' THR . 1.2 tt -96.0 -28.56 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.406 -0.809 . . . . 0.0 110.285 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.7 m -166.32 96.08 0.57 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.232 -0.918 . . . . 0.0 109.794 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -95.36 102.4 14.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.427 -0.796 . . . . 0.0 110.073 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.38 95.75 7.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.365 -0.835 . . . . 0.0 110.352 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -37.96 53.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.928 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.55 -38.48 90.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.034 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -96.19 10.55 37.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.62 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 50.91 56.17 8.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.048 -1.033 . . . . 0.0 110.282 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -148.04 169.85 19.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.156 -0.965 . . . . 0.0 110.395 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.408 ' O ' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -166.62 157.63 12.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.333 -0.855 . . . . 0.0 109.954 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.535 HG22 HG21 ' A' ' 91' ' ' ILE . 86.8 m -141.98 158.38 43.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.396 -0.815 . . . . 0.0 109.759 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -145.04 142.97 30.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.045 -1.034 . . . . 0.0 110.728 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -92.98 138.77 31.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.363 -0.836 . . . . 0.0 109.943 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.477 ' CZ ' ' HB2' ' A' ' 102' ' ' SER . 88.6 m-85 -130.06 145.9 51.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.055 -1.028 . . . . 0.0 110.901 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.481 ' C ' HG13 ' A' ' 106' ' ' VAL . 3.2 tt0 -99.69 131.02 45.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.377 -0.827 . . . . 0.0 108.881 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 108' ' ' LYS . 22.9 m -149.09 162.28 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.849 -1.157 . . . . 0.0 111.285 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 60.4 p -69.44 112.32 5.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.51 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.0 OUTLIER 46.67 -157.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.51 -0.744 . . . . 0.0 109.418 -178.3 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.662 HD21 ' HD3' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -150.21 51.53 0.9 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.798 -1.189 . . . . 0.0 110.807 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -146.26 87.73 1.75 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.026 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.22 171.02 20.75 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.419 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 1.0 OUTLIER -81.63 144.01 31.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -1.169 . . . . 0.0 110.175 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mm -137.92 139.89 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.191 -0.943 . . . . 0.0 110.171 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -76.65 135.57 39.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 109.947 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -140.98 178.12 20.39 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 9.1 mtmm -143.6 158.06 43.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.426 -1.044 . . . . 0.0 109.837 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.56 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.7 142.62 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.959 -1.088 . . . . 0.0 110.592 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.45 ' C ' HG22 ' A' ' 79' ' ' THR . 40.5 m-20 -106.2 164.47 11.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -0.764 . . . . 0.0 109.798 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 77' ' ' TRP . 25.0 t -141.95 151.53 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 110.447 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -152.03 105.42 3.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 110.476 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.505 HG21 ' HE2' ' A' ' 130' ' ' PHE . 4.9 mt -125.46 152.79 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.243 -0.911 . . . . 0.0 110.073 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.73 102.41 1.33 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.798 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -173.7 -164.24 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 110.443 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 2.3 ttmt -99.92 103.11 14.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 110.294 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.667 ' O ' HG12 ' A' ' 125' ' ' VAL . 2.1 t -76.63 103.0 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 110.15 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 63.16 34.47 13.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.451 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.09 31.52 28.4 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -145.33 137.01 12.89 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.224 -1.162 . . . . 0.0 109.999 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.25 129.27 33.94 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.564 1.297 . . . . 0.0 109.838 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.679 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 8.7 t80 -129.14 118.1 21.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 110.583 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -105.2 137.78 42.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 109.847 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.483 ' CD2' HD12 ' A' ' 121' ' ' ILE . 6.3 t80 -157.17 123.62 4.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.212 -0.93 . . . . 0.0 110.006 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -173.35 87.55 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.905 . . . . 0.0 109.986 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.96 -161.46 1.29 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.892 . . . . 0.0 110.297 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -120.93 155.6 33.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.325 -0.86 . . . . 0.0 110.256 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 32.4 m-85 -155.14 -179.26 7.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 109.831 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.563 ' O ' HG23 ' A' ' 138' ' ' ILE . 6.3 p30 -151.2 168.98 23.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 110.608 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.3 pt -156.85 163.27 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.365 -0.835 . . . . 0.0 110.13 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.419 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 90.8 m -91.9 122.11 34.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.224 -0.923 . . . . 0.0 110.54 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.626 ' CD2' HD11 ' A' ' 83' ' ' ILE . 49.2 m-85 -90.25 157.96 17.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -0.877 . . . . 0.0 110.235 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 104.74 3.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.225 -0.922 . . . . 0.0 110.178 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -91.39 158.35 16.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.237 -0.914 . . . . 0.0 110.277 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 65.9 m-80 -143.13 99.56 3.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.782 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -157.52 -154.89 7.27 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.455 ' C ' HG23 ' A' ' 146' ' ' THR . 11.3 Cg_endo -60.36 -165.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.988 1.52 . . . . 0.0 110.537 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.455 HG23 ' C ' ' A' ' 145' ' ' PRO . 44.8 p -149.74 -47.83 0.13 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.378 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.75 -58.89 2.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 110.444 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 145' ' ' PRO . 12.2 t 57.12 54.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 110.229 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.58 75.72 8.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.293 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.964 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.679 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.294 0.569 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.7 136.39 40.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.242 -0.911 . . . . 0.0 110.158 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 56.87 27.77 13.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.381 -0.824 . . . . 0.0 109.762 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -149.36 47.25 0.97 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.477 -0.764 . . . . 0.0 110.367 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.13 -37.06 64.19 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.074 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 7.7 m-20 57.63 28.47 15.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 110.266 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 p -159.48 147.69 17.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 0.0 110.428 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.37 175.67 44.8 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.68 104.87 17.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.307 -1.113 . . . . 0.0 110.39 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.583 HD13 HD22 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -95.27 159.12 15.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.328 -0.857 . . . . 0.0 110.434 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.455 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 16.3 m-20 -78.71 139.6 38.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.116 -0.99 . . . . 0.0 109.982 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.73 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -165.51 152.22 10.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 109.982 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -155.13 -173.2 4.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.0 110.237 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -140.97 178.65 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.878 . . . . 0.0 110.369 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 39.7 m-85 -148.18 156.72 42.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.446 -0.784 . . . . 0.0 109.68 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.27 122.78 18.62 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.937 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.58 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -49.86 148.89 2.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.934 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.4 t-20 71.52 2.82 4.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.879 -0.513 . . . . 0.0 110.771 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -135.12 -157.84 0.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.948 -1.095 . . . . 0.0 109.533 179.232 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.12 8.27 3.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.39 -0.819 . . . . 0.0 110.209 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -135.11 150.76 50.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.07 -1.019 . . . . 0.0 110.563 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.483 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -77.53 133.86 38.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.239 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.472 ' HB3' HD12 ' A' ' 48' ' ' ILE . 34.3 t -129.03 -17.21 3.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.024 -1.048 . . . . 0.0 111.954 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 47' ' ' SER . 3.3 mp -136.94 -69.45 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.7 -1.25 . . . . 0.0 110.623 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.484 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -49.42 -24.09 1.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.549 -0.72 . . . . 0.0 110.9 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.448 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -65.9 -13.41 59.63 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.083 -1.011 . . . . 0.0 110.957 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -99.27 15.36 26.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.016 -1.052 . . . . 0.0 110.957 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.49 ' CD1' HBC1 ' A' ' 151' ' ' ZNH . 58.1 m-85 -136.87 10.06 3.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.893 -1.129 . . . . 0.0 111.148 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.484 ' CE2' ' HB1' ' A' ' 49' ' ' ALA . 23.1 m-30 -120.83 104.78 10.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.093 -1.004 . . . . 0.0 110.242 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -72.59 106.35 4.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.193 -0.942 . . . . 0.0 110.114 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.466 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -93.53 167.71 13.4 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.255 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.466 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 53.1 Cg_endo -77.93 -175.82 17.47 Favored 'Cis proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.67 -2.221 . . . . 0.0 110.843 -0.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.73 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -103.2 171.51 7.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.345 -0.847 . . . . 0.0 109.977 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -104.21 117.17 33.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.083 -1.01 . . . . 0.0 110.792 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.59 ' HB2' HD23 ' A' ' 109' ' ' LEU . 3.7 p90 -96.42 163.0 13.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 109.324 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.518 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -154.96 118.82 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.925 -1.109 . . . . 0.0 111.028 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HD3' HD21 ' A' ' 109' ' ' LEU . 1.4 mtmt -139.07 131.57 28.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.314 -0.866 . . . . 0.0 109.632 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.437 ' HB3' ' CE ' ' A' ' 65' ' ' LYS . 4.9 tttm -115.91 65.39 0.7 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.113 -0.992 . . . . 0.0 110.78 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 46.39 95.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.465 -0.772 . . . . 0.0 111.201 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.17 13.24 36.89 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.437 ' CE ' ' HB3' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -173.18 149.71 1.84 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.054 -1.262 . . . . 0.0 109.876 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.792 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -158.83 144.13 16.26 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.149 -0.969 . . . . 0.0 111.261 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.518 ' HB2' HG23 ' A' ' 60' ' ' ILE . 3.3 m-85 -141.02 -161.79 1.27 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.537 -0.727 . . . . 0.0 109.663 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.54 HG11 ' CE1' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -170.18 163.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.213 -0.93 . . . . 0.0 109.933 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.744 ' C ' HD12 ' A' ' 70' ' ' ILE . 3.4 pt20 -141.61 144.63 34.31 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.171 -0.956 . . . . 0.0 110.58 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.744 HD12 ' C ' ' A' ' 69' ' ' GLN . 2.2 mp -116.68 147.47 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.509 -0.744 . . . . 0.0 109.856 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.6 m -89.19 134.68 33.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 0.0 109.887 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.564 HG12 HG21 ' A' ' 78' ' ' ILE . 2.4 t -102.31 119.63 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 0.0 110.332 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -100.11 137.32 38.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.212 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.528 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER 57.6 92.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 110.203 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 m -76.47 -25.49 54.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.155 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -60.4 -17.2 42.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.253 -0.904 . . . . 0.0 110.325 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.506 ' CD2' HBB2 ' A' ' 151' ' ' ZNH . 45.6 m0 -106.31 -51.45 2.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -0.956 . . . . 0.0 110.488 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.845 HD11 ' SD ' ' A' ' 81' ' ' MET . 11.4 tt -89.52 125.25 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 109.886 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.83 -33.46 19.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.398 -0.814 . . . . 0.0 110.765 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.4 ' N ' ' CG2' ' A' ' 79' ' ' THR . . . 178.06 -174.9 47.16 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.139 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.845 ' SD ' HD11 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -152.4 170.84 19.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -1.064 . . . . 0.0 110.259 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' LYS . 2.2 t -154.36 146.21 23.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 109.758 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.474 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 2.9 mt -140.95 144.44 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.113 -0.992 . . . . 0.0 110.619 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.474 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 71.33 2.29 4.19 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.632 -0.667 . . . . 0.0 111.204 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.33 21.47 13.14 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.73 -1.224 . . . . 0.0 111.103 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.47 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.0 160.14 40.13 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.655 -1.497 . . . . 0.0 110.193 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.11 -174.28 0.96 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.042 -1.036 . . . . 0.0 110.544 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 8.3 pt-20 -109.97 170.06 8.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.357 -0.839 . . . . 0.0 110.309 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -120.13 130.59 54.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 0.0 110.266 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.402 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 pp -67.56 103.63 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.074 -1.016 . . . . 0.0 109.59 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.437 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -95.13 -27.69 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.366 -0.834 . . . . 0.0 110.971 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.0 m -167.26 94.64 0.46 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.146 -0.971 . . . . 0.0 109.898 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -97.35 147.97 23.64 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 110.284 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.85 101.18 3.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 109.973 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -74.21 -32.37 63.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 0.0 110.312 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.47 -44.8 95.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 110.171 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.55 -3.36 43.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.931 . . . . 0.0 110.729 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t0 59.97 50.37 6.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.96 -1.088 . . . . 0.0 110.13 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -147.44 128.45 14.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 0.0 110.091 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.77 172.37 12.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 110.444 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.437 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 97.2 m -141.11 157.1 45.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.447 -0.783 . . . . 0.0 109.458 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -145.24 138.01 26.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.068 -1.02 . . . . 0.0 110.721 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -92.9 144.9 24.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.436 -0.79 . . . . 0.0 110.12 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 98.4 m-85 -130.76 145.5 51.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.142 -0.974 . . . . 0.0 110.845 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.48 ' C ' HG13 ' A' ' 106' ' ' VAL . 15.7 tt0 -95.59 126.59 40.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.338 -0.851 . . . . 0.0 109.295 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.48 HG13 ' C ' ' A' ' 105' ' ' GLU . 34.6 m -149.78 177.55 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.974 -1.079 . . . . 0.0 111.038 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.5 t -89.4 110.91 21.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.48 -0.763 . . . . 0.0 109.258 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.454 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 49.65 -158.3 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.652 -178.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.617 HD21 ' HD3' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -151.31 50.92 0.83 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.983 -1.073 . . . . 0.0 111.066 -179.118 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 145' ' ' PRO . 18.4 t-20 -144.85 84.35 1.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 110.137 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.43 170.44 19.59 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.405 ' O ' ' HE3' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -81.72 145.87 30.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.171 . . . . 0.0 110.416 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 mt -137.28 139.34 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 0.0 109.838 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -76.19 121.2 22.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.27 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -129.15 178.16 17.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -144.63 165.84 26.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -1.154 . . . . 0.0 109.456 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.563 HD12 ' HG3' ' A' ' 81' ' ' MET . 0.1 OUTLIER -157.79 150.52 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.869 -1.145 . . . . 0.0 111.171 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.514 ' O ' HG22 ' A' ' 79' ' ' THR . 1.1 m-20 -109.02 161.38 15.22 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.564 -0.71 . . . . 0.0 109.348 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.425 HG11 ' CE2' ' A' ' 132' ' ' TYR . 3.0 t -143.56 151.67 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.118 -0.989 . . . . 0.0 110.113 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 5.1 t80 -151.71 118.89 5.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 110.672 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 77' ' ' TRP . 30.2 mt -142.63 151.62 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.969 . . . . 0.0 110.145 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.39 95.65 1.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.348 -0.845 . . . . 0.0 109.615 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -173.28 166.26 4.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.259 -0.901 . . . . 0.0 110.414 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -90.25 113.72 25.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.114 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -76.52 90.36 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 110.23 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.2 50.13 3.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.907 . . . . 0.0 110.388 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.71 29.96 45.88 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.21 101.21 4.44 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.175 -1.191 . . . . 0.0 110.27 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.12 136.49 24.03 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.819 1.431 . . . . 0.0 110.293 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 5.8 t80 -136.63 114.71 11.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.174 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -103.43 130.35 50.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 110.112 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 1.6 t80 -145.21 113.84 6.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.763 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 15.8 t0 -162.81 92.15 0.77 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.929 . . . . 0.0 110.224 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -153.84 -169.75 3.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 110.433 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -119.63 86.29 2.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.318 -0.863 . . . . 0.0 110.022 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.43 ' CD1' HBD2 ' A' ' 151' ' ' ZNH . 43.2 m-85 -84.59 -178.96 7.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.255 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.611 ' O ' HG23 ' A' ' 138' ' ' ILE . 5.7 p30 -150.49 170.51 18.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 110.055 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.7 pt -156.92 165.63 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.076 -1.015 . . . . 0.0 110.754 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 98.8 m -91.76 117.91 30.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.499 -0.75 . . . . 0.0 110.33 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.571 ' HA ' HG12 ' A' ' 38' ' ' VAL . 30.6 m-85 -89.91 151.3 21.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.182 -0.949 . . . . 0.0 110.126 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -144.0 106.1 4.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.145 -0.972 . . . . 0.0 110.339 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.54 ' CE1' HG11 ' A' ' 68' ' ' VAL . 80.3 m-85 -91.46 148.6 22.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.91 . . . . 0.0 109.962 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.455 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 32.7 m-80 -131.1 105.03 7.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.271 -0.893 . . . . 0.0 110.508 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.441 ' HA3' HD21 ' A' ' 34' ' ' LEU . . . -160.72 -161.56 11.65 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.462 ' HD2' HD11 ' A' ' 34' ' ' LEU . 7.3 Cg_endo -54.89 -168.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.919 1.483 . . . . 0.0 110.291 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.2 20.45 0.96 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.256 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.69 -61.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 109.71 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' A' ' 145' ' ' PRO . 5.8 t 56.94 52.95 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.36 -0.838 . . . . 0.0 110.376 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.51 110.98 17.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 110.137 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.506 HBB2 ' CD2' ' A' ' 77' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.22 0.533 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -112.51 76.09 0.96 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.336 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 2.2 t-20 62.83 23.0 13.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.03 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -97.8 101.19 12.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -0.883 . . . . 0.0 110.288 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.89 -155.5 0.23 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 110.273 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 10.3 m-20 55.1 24.55 6.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.862 . . . . 0.0 110.516 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.1 t -159.23 171.36 20.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.083 -1.011 . . . . 0.0 110.889 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.98 177.64 27.62 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.05 107.12 18.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -1.128 . . . . 0.0 110.204 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.855 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -94.3 155.4 17.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 110.091 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.443 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 33.6 m-80 -79.92 138.62 37.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.77 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.674 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -166.0 159.24 15.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.117 -0.989 . . . . 0.0 110.117 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -155.76 -170.33 3.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -0.86 . . . . 0.0 110.247 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 46' ' ' THR . 0.1 OUTLIER -140.06 173.09 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 109.943 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -150.41 160.94 43.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.192 -0.943 . . . . 0.0 110.197 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -68.35 126.33 29.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.473 -0.767 . . . . 0.0 110.168 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.484 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -57.11 146.13 28.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 109.813 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 6.5 t30 72.93 -0.59 3.32 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.878 -0.514 . . . . 0.0 110.926 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -139.08 -168.62 2.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.976 -1.078 . . . . 0.0 109.556 179.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.422 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.9 OUTLIER -135.57 25.26 3.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.002 . . . . 0.0 110.558 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -135.37 123.69 23.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.147 -0.971 . . . . 0.0 111.035 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -52.54 122.1 8.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.46 -0.775 . . . . 0.0 109.313 179.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.59 -18.65 3.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.901 -1.125 . . . . 0.0 112.219 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.62 HG21 ' C1D' ' A' ' 151' ' ' ZNH . 1.4 mp -138.47 -76.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.621 -1.299 . . . . 0.0 110.971 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.603 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -45.07 -27.02 0.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.735 -0.603 . . . . 0.0 111.116 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.437 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -63.16 -13.64 39.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.075 -1.016 . . . . 0.0 110.689 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.465 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 31.3 m-20 -98.68 10.63 40.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.07 -1.019 . . . . 0.0 110.752 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 51' ' ' ASP . 16.6 m-85 -144.91 15.86 1.56 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.995 -1.066 . . . . 0.0 110.261 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.44 108.75 17.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 110.369 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -72.21 147.76 46.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.153 -0.967 . . . . 0.0 110.19 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.456 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 20.6 pttt -146.38 163.35 30.36 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.146 -0.971 . . . . 0.0 109.957 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 50.9 Cg_endo -76.07 -177.11 19.92 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.84 -2.15 . . . . 0.0 110.918 0.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.674 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.08 166.27 10.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.885 . . . . 0.0 110.005 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 1.2 mttm -103.39 112.44 25.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 0.0 110.364 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 1.9 p90 -95.83 163.33 13.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 109.682 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 1.1 tt -155.23 130.49 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.058 -1.026 . . . . 0.0 110.907 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 66' ' ' LEU . 0.7 OUTLIER -138.83 114.64 9.98 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.436 -0.79 . . . . 0.0 109.932 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HB2' ' HD2' ' A' ' 65' ' ' LYS . 40.4 mttt -97.32 62.19 1.74 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 110.654 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 46.08 99.3 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.544 -0.723 . . . . 0.0 111.616 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.8 -21.67 43.92 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.421 ' HD2' ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -133.16 166.09 23.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -1.182 . . . . 0.0 110.46 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.741 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.1 pt? -171.25 145.76 2.24 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.614 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.3 OUTLIER -141.41 -160.1 1.04 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -170.22 128.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 109.991 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.478 ' NE2' HG21 ' A' ' 101' ' ' THR . 0.0 OUTLIER -98.79 132.49 44.11 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.033 -1.042 . . . . 0.0 109.704 179.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -112.62 128.16 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.85 . . . . 0.0 110.017 -179.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 m -88.57 126.74 35.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 110.06 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -102.92 144.74 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -98.79 143.94 28.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 0.0 110.357 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.624 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.3 OUTLIER 56.59 90.44 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.256 -0.902 . . . . 0.0 110.191 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -29.73 63.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 110.211 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -67.12 -53.08 34.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.344 -0.848 . . . . 0.0 110.201 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.541 ' O ' HG12 ' A' ' 119' ' ' VAL . 46.8 m0 -57.72 -56.06 26.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.648 HD11 HG13 ' A' ' 117' ' ' ILE . 9.3 tp -87.69 116.58 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.443 -0.786 . . . . 0.0 109.928 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -86.37 -23.98 25.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.477 -0.764 . . . . 0.0 110.67 -179.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.16 179.48 47.52 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 17.3 mtt -151.52 165.79 33.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.395 -1.062 . . . . 0.0 109.796 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -154.56 148.84 26.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 110.215 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.917 HD12 ' CD2' ' A' ' 104' ' ' PHE . 2.3 mt -139.27 153.43 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 110.059 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.512 ' HB2' ' CE1' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 61.59 13.67 5.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.02 -1.05 . . . . 0.0 110.912 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.85 21.86 54.6 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 120.008 -1.091 . . . . 0.0 110.726 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 2.1 p-80 -136.81 162.72 32.43 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.751 -1.441 . . . . 0.0 110.677 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 171.47 10.89 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.345 -0.847 . . . . 0.0 111.023 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.481 ' CB ' ' CZ ' ' A' ' 104' ' ' PHE . 5.7 pt-20 -100.4 170.41 8.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.445 -0.784 . . . . 0.0 110.535 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 102' ' ' SER . 9.4 t-20 -108.38 138.14 45.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.41 -0.806 . . . . 0.0 109.975 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.4 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.1 pp -68.14 101.14 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.969 -1.082 . . . . 0.0 109.561 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.504 HG21 HG22 ' A' ' 101' ' ' THR . 0.4 OUTLIER -94.63 -31.95 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.352 -0.842 . . . . 0.0 110.978 -179.045 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.413 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 9.0 m -166.2 98.25 0.61 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.063 -1.023 . . . . 0.0 109.934 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -95.05 137.62 33.86 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.41 -0.806 . . . . 0.0 109.911 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.57 90.07 2.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.358 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -31.03 64.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.947 . . . . 0.0 109.979 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.81 -44.84 95.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 110.176 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -95.25 9.86 38.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 110.556 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 53.7 58.91 4.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.032 -1.043 . . . . 0.0 110.19 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -147.94 162.33 39.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 110.391 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.607 ' O ' HG22 ' A' ' 72' ' ' VAL . 1.2 mtp180 -164.71 149.42 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 109.961 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.504 HG22 HG21 ' A' ' 91' ' ' ILE . 52.4 m -142.04 154.87 45.3 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 109.986 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 24.8 p -146.91 146.67 30.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.981 . . . . 0.0 110.589 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -91.73 147.14 23.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.361 -0.837 . . . . 0.0 110.078 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.917 ' CD2' HD12 ' A' ' 83' ' ' ILE . 6.1 m-85 -130.14 140.14 50.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 110.846 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -97.34 126.82 42.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 0.0 108.991 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.741 ' O ' HD21 ' A' ' 66' ' ' LEU . 14.5 p -149.7 147.75 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.003 -1.06 . . . . 0.0 111.277 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.09 99.98 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.667 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 55.61 170.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.494 -0.754 . . . . 0.0 109.409 -178.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.408 ' H ' HD12 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -149.34 79.25 1.39 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.967 -1.083 . . . . 0.0 111.065 -179.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -146.41 71.89 1.26 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.827 . . . . 0.0 110.032 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.79 -101.48 0.19 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.453 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.3 OUTLIER -157.51 145.71 19.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -1.143 . . . . 0.0 110.156 -179.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mm -136.27 137.92 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 109.879 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.14 108.49 9.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 0.0 110.058 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -120.54 -176.36 15.62 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 5.3 mtmm -144.62 167.29 22.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.307 -1.113 . . . . 0.0 110.001 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.648 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.74 142.29 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.109 -0.995 . . . . 0.0 110.709 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.58 ' O ' HG22 ' A' ' 79' ' ' THR . 1.0 OUTLIER -104.7 155.92 18.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.438 -0.789 . . . . 0.0 109.679 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.2 OUTLIER -135.77 153.65 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 0.0 110.451 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 15.6 t80 -151.29 103.62 3.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.423 -0.798 . . . . 0.0 110.553 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 77' ' ' TRP . 75.3 mt -133.09 151.0 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.225 -0.922 . . . . 0.0 110.204 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -159.08 100.02 1.53 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.411 -0.806 . . . . 0.0 109.518 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -173.33 169.62 4.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 110.491 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 2.2 mttt -82.89 90.64 6.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.378 -0.826 . . . . 0.0 110.344 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.419 ' O ' ' CG1' ' A' ' 125' ' ' VAL . 2.0 p -77.43 134.66 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 110.156 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.58 25.47 1.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.29 -0.881 . . . . 0.0 110.26 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.59 30.97 31.39 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 3.3 mtmm -144.62 139.11 15.13 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.238 -1.154 . . . . 0.0 110.017 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -62.49 119.7 6.91 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.709 1.373 . . . . 0.0 110.448 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 4.5 t80 -117.87 113.48 21.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 110.271 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -104.6 111.08 23.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.079 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.466 ' HE2' HG11 ' A' ' 119' ' ' VAL . 2.0 t80 -123.51 114.04 19.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.212 -0.93 . . . . 0.0 109.834 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -160.66 87.36 0.75 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.158 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -154.46 -173.01 4.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.868 . . . . 0.0 110.379 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -118.02 85.75 2.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.376 -0.827 . . . . 0.0 109.712 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -85.68 -179.05 6.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.28 -0.888 . . . . 0.0 110.362 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.595 ' O ' HG23 ' A' ' 138' ' ' ILE . 8.5 p30 -151.01 167.99 25.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 110.331 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.4 pt -157.28 177.19 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 110.499 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.453 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 20.7 m -91.57 121.2 33.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.903 . . . . 0.0 110.188 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.677 ' CD2' HD11 ' A' ' 83' ' ' ILE . 12.6 m-85 -89.51 99.96 12.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.58 154.84 24.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 110.244 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.4 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 14.9 m-85 -148.65 148.11 29.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.858 . . . . 0.0 109.919 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.443 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 42.4 m-80 -138.99 98.13 3.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.88 . . . . 0.0 110.345 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.855 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -149.76 -148.83 4.85 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -66.5 -177.06 0.79 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.93 1.49 . . . . 0.0 110.463 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.45 -59.44 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 109.943 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.85 -148.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.867 . . . . 0.0 110.026 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.0 t 57.1 63.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 110.15 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.06 62.78 5.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.894 . . . . 0.0 110.241 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.62 ' C1D' HG21 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.187 0.517 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.65 133.48 38.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 110.167 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 62.41 22.7 13.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.951 . . . . 0.0 110.077 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -104.5 162.28 13.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.385 -0.822 . . . . 0.0 110.048 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.55 -172.5 2.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 110.283 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 2.5 m-20 54.54 24.66 5.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 110.087 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 p -158.86 146.01 17.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.948 . . . . 0.0 110.743 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -179.66 176.64 47.73 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.58 114.84 25.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.193 -1.181 . . . . 0.0 110.47 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.52 ' HB2' ' CD1' ' A' ' 59' ' ' TYR . 1.5 tt -94.79 148.25 22.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 110.319 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.1 t30 -80.64 139.8 36.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.96 . . . . 0.0 110.03 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.51 ' CD2' ' N ' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -167.11 174.18 8.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.026 -1.046 . . . . 0.0 110.658 179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.51 ' N ' ' CD2' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -155.58 -165.76 2.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.594 -0.691 . . . . 0.0 109.571 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.671 ' C ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.07 164.63 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.1 -1.0 . . . . 0.0 110.274 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -147.83 148.26 30.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.373 -0.83 . . . . 0.0 109.978 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.441 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -67.82 128.37 36.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 110.09 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.536 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -52.53 146.62 9.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.176 -0.953 . . . . 0.0 109.901 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.3 t30 71.74 1.54 3.93 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.851 -0.53 . . . . 0.0 111.161 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -135.24 -162.22 1.24 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.89 -1.131 . . . . 0.0 109.531 179.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.43 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.9 OUTLIER -132.82 12.07 4.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 110.332 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -136.43 137.62 40.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.749 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.671 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -64.23 134.23 54.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.326 179.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.58 -17.25 3.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.904 -1.122 . . . . 0.0 112.159 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.0 mt -137.37 -50.75 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.61 -1.306 . . . . 0.0 111.184 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -79.0 5.34 11.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.385 -0.822 . . . . 0.0 111.512 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.447 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -73.5 -29.21 62.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.852 -1.155 . . . . 0.0 110.679 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -99.47 12.47 36.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.102 -0.999 . . . . 0.0 110.896 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -118.76 -18.84 8.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.009 -1.057 . . . . 0.0 110.451 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.414 ' CE2' HG12 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -101.43 113.86 27.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 109.848 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.14 155.21 40.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.967 . . . . 0.0 110.459 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -146.35 160.06 43.35 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.833 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 55.6 Cg_endo -78.29 -177.04 19.91 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.588 -2.255 . . . . 0.0 110.649 -0.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.86 170.4 7.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.143 -0.973 . . . . 0.0 110.095 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -104.32 119.47 39.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.789 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 29.1 p90 -97.01 165.81 11.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 109.525 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.677 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -154.95 124.04 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.937 -1.102 . . . . 0.0 110.937 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.479 ' HD3' HD21 ' A' ' 109' ' ' LEU . 1.2 mtmt -137.67 125.13 21.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.345 -0.847 . . . . 0.0 110.684 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -103.81 62.42 0.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.393 -0.817 . . . . 0.0 110.402 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 47.67 98.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.463 -0.773 . . . . 0.0 111.35 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.11 12.59 39.08 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.707 ' C ' HD13 ' A' ' 66' ' ' LEU . 3.5 ptpt -173.7 154.81 2.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.889 -1.359 . . . . 0.0 110.227 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.811 ' N ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -154.27 151.31 28.98 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.073 -1.017 . . . . 0.0 111.247 179.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.677 ' HB2' HG23 ' A' ' 60' ' ' ILE . 13.8 m-85 -141.92 -164.71 1.85 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.467 -0.771 . . . . 0.0 109.233 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.1 t -169.09 131.98 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.023 -1.048 . . . . 0.0 110.835 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -101.72 135.88 42.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.392 -0.817 . . . . 0.0 109.838 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.437 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -113.62 133.38 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.295 -0.878 . . . . 0.0 110.133 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -91.04 128.73 36.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.931 . . . . 0.0 110.422 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.541 HG11 ' CE ' ' A' ' 81' ' ' MET . 0.9 OUTLIER -104.86 142.24 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.906 . . . . 0.0 110.055 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -99.98 138.84 36.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.129 -0.982 . . . . 0.0 110.507 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.449 ' CD2' ' CE2' ' A' ' 77' ' ' TRP . 2.3 t-80 55.98 102.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.357 -0.839 . . . . 0.0 110.447 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.3 p -62.57 -43.73 98.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 110.125 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.76 -48.83 59.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.91 . . . . 0.0 110.146 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.46 ' O ' HG12 ' A' ' 119' ' ' VAL . 44.4 m0 -57.41 -67.69 0.3 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.247 -0.908 . . . . 0.0 110.323 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 78' ' ' ILE . 17.9 tt -87.83 117.98 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.39 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.618 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -85.9 -21.71 27.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.423 -0.798 . . . . 0.0 110.898 -178.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.09 177.13 47.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.541 ' CE ' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -152.29 159.22 43.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.432 -1.04 . . . . 0.0 109.884 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -155.84 151.33 27.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.289 -0.882 . . . . 0.0 109.932 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.527 HD12 ' CD2' ' A' ' 104' ' ' PHE . 3.9 mt -147.12 157.71 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.26 -0.9 . . . . 0.0 110.13 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.523 ' HB2' ' CE1' ' A' ' 86' ' ' HIS . 0.6 OUTLIER 62.48 14.52 7.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.611 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.23 21.23 61.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.523 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 2.1 p-80 -136.77 160.17 39.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.035 -1.273 . . . . 0.0 110.563 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.85 163.68 27.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.393 -0.817 . . . . 0.0 110.403 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.524 ' CB ' ' CE1' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -92.22 170.27 9.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.158 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.67 134.81 51.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.184 -0.948 . . . . 0.0 110.066 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -67.4 101.03 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.957 . . . . 0.0 109.618 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.523 HG21 HG22 ' A' ' 101' ' ' THR . 0.7 OUTLIER -95.27 -29.89 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 111.001 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 3.5 m -167.15 94.94 0.47 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.035 -1.041 . . . . 0.0 110.048 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 18.2 ttmt -96.28 139.19 32.78 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.428 -0.795 . . . . 0.0 110.036 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.79 99.03 3.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.161 -0.962 . . . . 0.0 110.237 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 p -78.37 -32.37 48.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.1 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.12 99.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.879 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.06 10.68 36.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 0.0 110.549 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.54 58.11 5.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.978 -1.076 . . . . 0.0 110.011 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -146.43 165.04 30.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 110.265 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.471 ' CB ' ' CG2' ' A' ' 72' ' ' VAL . 2.8 mtp180 -168.73 154.42 6.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.368 -0.833 . . . . 0.0 109.903 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.523 HG22 HG21 ' A' ' 91' ' ' ILE . 78.2 m -141.76 154.66 45.41 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.357 -0.839 . . . . 0.0 109.839 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.452 ' HB2' ' CG ' ' A' ' 88' ' ' GLU . 99.7 p -144.84 139.14 27.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.13 -0.981 . . . . 0.0 110.341 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -92.97 130.42 38.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.948 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.527 ' CD2' HD12 ' A' ' 83' ' ' ILE . 48.0 m-85 -114.43 147.74 38.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 110.451 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -105.17 135.15 47.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.342 -0.849 . . . . 0.0 110.052 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.3 m -149.36 158.97 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.36 -0.837 . . . . 0.0 109.891 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.4 p -53.17 -35.03 59.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.426 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.49 -150.96 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.596 -0.69 . . . . 0.0 109.184 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.479 HD21 ' HD3' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -148.56 54.18 1.01 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.849 -1.157 . . . . 0.0 110.567 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.529 ' CG ' HG22 ' A' ' 146' ' ' THR . 22.2 t-20 -145.28 57.64 1.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.22 -0.925 . . . . 0.0 110.222 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.44 176.97 44.14 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.419 ' CE ' HG23 ' A' ' 139' ' ' THR . 0.1 OUTLIER -81.6 146.66 29.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -1.183 . . . . 0.0 110.446 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.403 ' N ' ' O ' ' A' ' 140' ' ' TYR . 7.6 mm -136.36 129.43 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.841 . . . . 0.0 109.942 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -76.72 112.55 13.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.839 . . . . 0.0 110.367 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.432 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -121.09 -175.15 15.09 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 63.1 mttt -144.88 164.86 29.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -1.143 . . . . 0.0 110.035 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.632 HG21 HD11 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.98 145.76 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.184 -0.948 . . . . 0.0 110.668 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.618 ' C ' HG22 ' A' ' 79' ' ' THR . 72.9 m-20 -107.26 155.7 19.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.496 -0.753 . . . . 0.0 109.492 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.2 OUTLIER -129.55 146.32 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.965 -1.084 . . . . 0.0 110.609 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.412 ' HB2' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -152.3 104.2 2.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.372 -0.83 . . . . 0.0 110.178 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.43 HD13 ' CBB' ' A' ' 151' ' ' ZNH . 46.4 mt -128.24 152.46 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.118 -0.989 . . . . 0.0 110.448 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.28 95.56 1.14 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.438 -0.789 . . . . 0.0 109.69 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -173.72 175.53 2.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.0 110.23 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -84.16 102.78 12.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.221 -0.924 . . . . 0.0 110.273 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.664 ' O ' HG12 ' A' ' 125' ' ' VAL . 2.1 t -76.68 103.39 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 110.091 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.66 43.51 7.38 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.049 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.37 33.53 56.25 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.28 109.46 4.59 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.278 -1.13 . . . . 0.0 110.193 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -47.42 113.5 0.76 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.66 1.347 . . . . 0.0 110.164 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.572 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 24.4 t80 -112.48 151.14 30.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.0 110.437 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.64 125.89 26.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.393 -0.817 . . . . 0.0 110.115 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.462 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 4.2 t80 -140.4 129.87 24.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.298 -0.876 . . . . 0.0 110.155 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 0.8 OUTLIER -176.3 88.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 0.0 110.037 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.35 -163.57 1.71 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 110.403 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -118.24 145.03 45.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 110.172 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -154.97 -179.03 7.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.095 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 8.9 p30 -150.27 169.85 20.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.187 -0.945 . . . . 0.0 110.558 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.632 HD11 HG21 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -156.53 173.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.608 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.419 HG23 ' CE ' ' A' ' 112' ' ' LYS . 24.6 m -91.82 162.77 14.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.473 -0.767 . . . . 0.0 110.526 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.432 ' CE2' ' HA3' ' A' ' 115' ' ' GLY . 97.0 m-85 -144.19 104.87 4.16 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.368 -0.832 . . . . 0.0 109.714 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.28 104.37 14.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 110.68 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.435 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 29.6 m-85 -91.66 135.27 34.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.896 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.413 ' H ' HD21 ' A' ' 34' ' ' LEU . 3.7 m-80 -126.25 105.09 8.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.096 -1.003 . . . . 0.0 110.227 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.448 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -150.96 -149.8 5.14 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.44 ' C ' HG23 ' A' ' 146' ' ' THR . 1.7 Cg_endo -49.95 170.84 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.702 1.369 . . . . 0.0 110.907 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.529 HG22 ' CG ' ' A' ' 110' ' ' ASN . 46.8 p -149.3 -51.01 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.44 -0.787 . . . . 0.0 109.883 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.09 -59.76 1.96 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 110.102 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 149' ' ' ALA . 65.1 t 55.88 -102.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 0.0 110.247 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.49 ' N ' HG12 ' A' ' 148' ' ' VAL . . . -158.56 -58.69 0.07 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.008 -1.057 . . . . 0.0 110.173 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.974 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.572 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.239 0.543 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.9 130.46 36.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.201 -0.937 . . . . 0.0 110.292 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 57.77 23.29 9.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.383 -0.823 . . . . 0.0 109.925 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.63 35.44 1.44 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.352 -0.843 . . . . 0.0 109.922 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.79 -60.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 110.308 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.4 OUTLIER 52.52 27.88 5.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.874 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -160.76 144.48 13.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.266 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.87 -175.99 42.6 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.39 105.62 17.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.34 -1.094 . . . . 0.0 110.395 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.649 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -94.8 154.49 17.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.0 110.31 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -80.13 137.86 36.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.335 -0.853 . . . . 0.0 110.037 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.717 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -165.96 161.91 17.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.04 -1.038 . . . . 0.0 110.273 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 141' ' ' LYS . 0.2 OUTLIER -156.11 -176.82 6.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 109.908 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.792 ' O ' HG22 ' A' ' 46' ' ' THR . 25.8 m -140.38 116.84 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.018 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -90.27 163.1 14.89 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.494 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.441 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.4 OUTLIER -67.36 126.84 30.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 109.942 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.494 ' O ' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -51.01 141.91 12.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.031 . . . . 0.0 109.943 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER 73.09 0.59 3.73 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.851 -0.53 . . . . 0.0 110.981 -179.408 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -136.83 -168.52 2.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.85 -1.156 . . . . 0.0 109.677 179.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -135.86 24.41 3.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.188 -0.945 . . . . 0.0 110.422 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -135.65 119.91 17.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.069 . . . . 0.0 111.101 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.792 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.7 OUTLIER -50.14 117.57 2.43 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.589 -0.694 . . . . 0.0 109.501 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.6 t -129.64 -18.98 3.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.811 -1.181 . . . . 0.0 112.18 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 49' ' ' ALA . 71.8 mt -138.54 -79.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.653 -1.28 . . . . 0.0 111.0 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.672 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -45.19 -26.93 0.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.738 -0.601 . . . . 0.0 111.159 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.458 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -67.68 -18.12 64.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.013 -1.055 . . . . 0.0 110.655 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -95.77 14.31 23.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 110.771 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.458 ' CD2' HBC1 ' A' ' 151' ' ' ZNH . 64.0 m-85 -134.49 2.71 3.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.062 -1.024 . . . . 0.0 111.109 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.443 ' CE1' ' SD ' ' A' ' 81' ' ' MET . 26.7 m-85 -123.37 120.49 33.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.959 -1.088 . . . . 0.0 110.298 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -72.47 160.04 32.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.346 -0.846 . . . . 0.0 110.569 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.73 164.36 24.31 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.895 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 53.5 Cg_endo -76.71 -175.71 17.18 Favored 'Cis proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.655 -2.227 . . . . 0.0 110.583 -0.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.717 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -103.4 169.17 8.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.958 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.75 110.32 22.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.198 -0.939 . . . . 0.0 109.998 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.618 ' CD2' HD13 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -96.02 161.8 13.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.328 -0.857 . . . . 0.0 109.91 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -155.3 151.09 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.095 -1.003 . . . . 0.0 110.997 -179.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 17.9 mtmt -134.53 173.86 11.19 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.331 -0.855 . . . . 0.0 110.595 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.479 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -158.26 63.51 0.44 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.364 -0.835 . . . . 0.0 110.153 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.0 m120 48.71 84.5 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 111.274 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.64 18.57 47.77 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.53 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.479 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 3.1 ptpt -165.83 162.86 18.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.964 -1.316 . . . . 0.0 111.294 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.83 HD21 ' H ' ' A' ' 108' ' ' LYS . 1.7 pt? -173.42 155.8 2.91 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.962 0.887 . . . . 0.0 111.205 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 1.1 m-85 -139.0 -159.4 0.95 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 67' ' ' TYR . 1.2 t -169.41 133.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.141 -0.974 . . . . 0.0 109.796 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 102' ' ' SER . 0.7 OUTLIER -97.42 136.17 38.24 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.106 -0.997 . . . . 0.0 109.866 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.435 ' O ' HG22 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -113.68 131.12 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 110.364 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m -88.76 123.89 33.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.637 HG12 ' HE1' ' A' ' 81' ' ' MET . 0.8 OUTLIER -103.29 136.77 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 110.499 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -100.8 144.6 29.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.365 -0.834 . . . . 0.0 110.007 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 58.33 89.08 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.204 -0.935 . . . . 0.0 110.178 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.2 p -55.22 -23.89 24.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.302 -0.874 . . . . 0.0 110.58 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -73.92 -55.64 5.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.138 -0.976 . . . . 0.0 110.322 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.687 ' O ' HG12 ' A' ' 119' ' ' VAL . 42.2 m0 -48.91 -62.33 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -0.914 . . . . 0.0 110.466 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.592 HG23 ' O ' ' A' ' 78' ' ' ILE . 6.4 tp -87.9 115.5 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.282 -0.886 . . . . 0.0 110.242 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.576 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.33 -26.68 23.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.389 -0.819 . . . . 0.0 110.83 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.5 176.86 45.34 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.637 ' HE1' HG12 ' A' ' 72' ' ' VAL . 33.6 mtm -151.92 160.13 43.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.358 -1.083 . . . . 0.0 110.063 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 116' ' ' LYS . 1.3 m -154.53 132.93 11.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.185 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.654 HD12 ' CG ' ' A' ' 104' ' ' PHE . 16.8 mt -130.17 141.96 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.354 -0.841 . . . . 0.0 110.321 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.463 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 1.1 tm-20 69.89 3.08 4.15 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.415 -0.803 . . . . 0.0 111.295 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.38 24.42 10.25 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.695 -1.241 . . . . 0.0 111.119 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.47 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.49 159.12 42.89 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.605 -1.526 . . . . 0.0 110.179 179.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -70.48 -178.44 1.76 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 0.0 110.347 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 0.6 OUTLIER -104.92 168.46 9.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 110.203 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.83 129.44 56.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.168 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.407 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.1 pp -67.98 101.23 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.139 -0.975 . . . . 0.0 109.484 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.548 HG21 HG22 ' A' ' 101' ' ' THR . 1.4 tt -93.19 -26.88 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.441 -0.787 . . . . 0.0 110.525 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.458 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -166.81 148.72 6.24 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.293 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.457 ' HG3' ' CG ' ' A' ' 100' ' ' ARG . 15.5 ttmt -141.98 149.32 39.9 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 110.019 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.74 91.34 2.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 0.0 110.466 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.4 p -73.33 -18.71 61.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.171 -0.955 . . . . 0.0 110.121 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.6 -28.46 69.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 110.379 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.55 23.24 3.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.253 -0.904 . . . . 0.0 110.249 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.54 79.72 0.11 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 0.0 110.432 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -148.14 167.15 25.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.142 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.457 ' CG ' ' HG3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -172.46 157.53 4.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 110.209 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.548 HG22 HG21 ' A' ' 91' ' ' ILE . 90.8 m -141.44 152.82 44.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.435 -0.791 . . . . 0.0 109.651 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 88' ' ' GLU . 0.8 OUTLIER -145.24 145.22 31.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.084 -1.01 . . . . 0.0 110.694 -179.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -93.57 143.37 26.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.433 -0.792 . . . . 0.0 109.886 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.654 ' CG ' HD12 ' A' ' 83' ' ' ILE . 44.2 m-85 -127.36 127.58 44.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.976 . . . . 0.0 110.663 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.443 ' C ' HG13 ' A' ' 106' ' ' VAL . 2.7 tm-20 -93.27 125.2 37.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 109.792 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.443 HG13 ' C ' ' A' ' 105' ' ' GLU . 29.0 m -149.33 163.9 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.022 -1.049 . . . . 0.0 110.887 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p -80.21 105.03 11.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.388 -0.82 . . . . 0.0 109.348 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.83 ' H ' HD21 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 53.74 174.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.34 -0.85 . . . . 0.0 109.756 -178.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.542 HD21 ' HD2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -149.91 73.7 1.18 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.004 -1.06 . . . . 0.0 110.898 -179.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.513 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.1 OUTLIER -144.41 66.76 1.26 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.066 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.39 -108.64 0.31 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.86 146.34 19.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.253 -1.145 . . . . 0.0 110.342 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.544 HD12 ' CE2' ' A' ' 142' ' ' PHE . 35.9 mt -137.38 142.8 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.357 -0.839 . . . . 0.0 110.157 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -76.3 125.42 29.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.218 -0.926 . . . . 0.0 110.137 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -131.56 -177.04 14.67 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.5 mtmm -142.38 161.0 39.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.364 -1.08 . . . . 0.0 109.678 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.483 HG21 HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -158.23 146.43 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.046 -1.034 . . . . 0.0 110.735 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.576 ' C ' HG22 ' A' ' 79' ' ' THR . 89.0 m-20 -110.12 159.68 17.13 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -133.63 147.05 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.09 -1.006 . . . . 0.0 110.17 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -152.03 113.14 4.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 110.684 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.617 HD11 ' HA ' ' A' ' 77' ' ' TRP . 2.6 mp -138.75 152.21 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 0.0 109.856 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.15 98.43 1.3 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.953 . . . . 0.0 110.015 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -174.03 178.68 2.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 110.18 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -93.06 107.69 19.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 110.175 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.42 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 56.0 t -75.84 90.58 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.826 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.42 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 63.7 53.04 2.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.277 -0.89 . . . . 0.0 110.012 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.33 36.95 48.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -145.04 97.48 4.84 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.296 -1.12 . . . . 0.0 110.366 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.99 110.15 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.863 1.454 . . . . 0.0 110.15 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.674 ' CE2' HMB2 ' A' ' 151' ' ' ZNH . 52.4 t80 -116.63 153.1 32.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.341 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -136.68 112.19 9.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 110.13 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.495 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 3.7 t80 -115.71 128.24 55.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.004 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -167.49 86.69 0.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.404 -0.81 . . . . 0.0 109.948 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -153.33 -169.19 3.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.898 . . . . 0.0 110.391 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.401 ' ND1' ' OD1' ' A' ' 118' ' ' ASP . 13.4 t60 -119.61 148.39 43.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 109.99 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -154.79 -179.66 8.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.882 . . . . 0.0 110.136 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.499 ' O ' HG23 ' A' ' 138' ' ' ILE . 42.9 p-10 -151.82 170.66 19.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.882 . . . . 0.0 110.261 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.672 HG21 ' HB2' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -157.76 168.86 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.917 . . . . 0.0 110.348 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 87.0 m -91.63 117.53 29.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.335 -0.853 . . . . 0.0 109.82 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.479 ' CD2' HG12 ' A' ' 83' ' ' ILE . 10.4 m-85 -88.91 106.51 18.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 110.326 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -86.69 159.59 19.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.318 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.544 ' CE2' HD12 ' A' ' 113' ' ' ILE . 41.4 m-85 -148.87 150.86 33.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.878 . . . . 0.0 110.125 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.56 ' C ' HD21 ' A' ' 34' ' ' LEU . 39.1 m-80 -143.84 96.32 2.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 110.234 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.649 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -135.73 -140.01 4.1 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.432 ' O ' ' ND2' ' A' ' 110' ' ' ASN . 39.2 Cg_exo -49.38 134.17 31.53 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.711 1.374 . . . . 0.0 110.422 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.513 HG23 ' HB3' ' A' ' 110' ' ' ASN . 0.7 OUTLIER -149.28 -41.37 0.14 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.181 -0.949 . . . . 0.0 110.43 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.98 -72.76 0.67 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.917 . . . . 0.0 110.366 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.5 t 56.51 54.18 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.378 -0.826 . . . . 0.0 110.269 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.28 -19.99 41.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.247 -0.908 . . . . 0.0 110.307 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.814 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.674 HMB2 ' CE2' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.246 0.546 . . . . 0.0 110.201 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 25' ' ' SER . . . 56.36 80.63 0.14 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.289 -0.882 . . . . 0.0 110.171 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 0.1 OUTLIER 62.82 20.46 12.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.304 -0.873 . . . . 0.0 110.192 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 25' ' ' SER . . . -82.42 57.1 3.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 110.094 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.4 -35.05 63.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 110.376 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER 58.12 28.65 16.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.156 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.18 144.07 14.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.946 . . . . 0.0 110.264 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.61 -177.52 45.92 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.34 108.4 19.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.351 -1.087 . . . . 0.0 110.359 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.935 ' HG ' HD22 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -94.84 150.0 20.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.399 -0.813 . . . . 0.0 109.913 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.708 ' H ' HD13 ' A' ' 34' ' ' LEU . 5.1 m-80 -78.93 141.34 37.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.991 -1.068 . . . . 0.0 109.7 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -165.4 156.48 14.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 110.557 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 141' ' ' LYS . 5.2 tt0 -155.56 -175.85 5.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 0.0 109.946 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.659 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -141.63 173.22 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 110.449 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -147.79 161.07 41.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -0.805 . . . . 0.0 109.951 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.519 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.1 OUTLIER -67.53 132.73 48.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 0.0 109.879 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.512 ' CE2' ' ND2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -57.45 146.04 30.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 110.052 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.4 t30 71.07 2.89 4.43 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.801 -0.562 . . . . 0.0 111.055 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.519 HG21 ' HG2' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -135.64 -164.48 1.55 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.828 -1.17 . . . . 0.0 109.767 179.268 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.413 ' N ' ' OG1' ' A' ' 43' ' ' THR . 2.2 t-20 -131.81 14.21 4.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 110.296 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.81 135.55 41.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.069 -1.019 . . . . 0.0 110.401 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.531 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -68.07 133.48 49.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.403 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.48 -17.45 3.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.017 -1.052 . . . . 0.0 112.184 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.6 mt -136.92 -58.6 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.607 -1.308 . . . . 0.0 111.121 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.09 -10.04 27.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.472 -0.768 . . . . 0.0 111.424 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.461 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 0.0 OUTLIER -75.68 -18.15 59.72 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.843 -1.16 . . . . 0.0 110.787 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -102.06 15.41 29.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.0 110.731 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.434 ' CD2' HBC1 ' A' ' 151' ' ' ZNH . 49.4 m-85 -129.12 3.37 5.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.049 -1.032 . . . . 0.0 110.985 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -128.94 117.54 21.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.994 -1.066 . . . . 0.0 110.293 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -72.83 166.71 22.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.341 -0.849 . . . . 0.0 110.494 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -146.92 160.35 40.69 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.304 -0.873 . . . . 0.0 109.834 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.13 -175.36 16.49 Favored 'Cis proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.752 -2.186 . . . . 0.0 110.725 -0.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.44 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.77 170.23 8.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -0.895 . . . . 0.0 109.96 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.462 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -107.97 111.67 23.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.11 -0.994 . . . . 0.0 110.693 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.666 ' CD2' HD21 ' A' ' 109' ' ' LEU . 2.7 p90 -97.84 165.24 12.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.262 -0.899 . . . . 0.0 110.132 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -155.52 154.15 6.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.254 -0.904 . . . . 0.0 110.66 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -133.35 170.64 15.17 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.424 -0.798 . . . . 0.0 110.479 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.455 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 0.7 OUTLIER -152.75 62.33 0.79 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -0.83 . . . . 0.0 110.12 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 50.47 82.86 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.353 -0.842 . . . . 0.0 111.067 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.51 21.93 35.91 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.455 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 6.2 ptpt -167.15 163.71 15.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.021 -1.282 . . . . 0.0 110.768 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.952 HD11 ' HA ' ' A' ' 108' ' ' LYS . 1.5 pt? -173.73 154.19 2.39 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.009 0.909 . . . . 0.0 111.034 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.565 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -139.61 -155.52 0.6 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.779 -0.575 . . . . 0.0 109.475 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 103' ' ' GLU . 1.0 OUTLIER -170.67 135.88 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.195 -0.94 . . . . 0.0 110.536 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.462 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -99.29 133.73 43.18 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.29 -0.881 . . . . 0.0 109.657 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.2 OUTLIER -113.0 140.42 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.363 -0.836 . . . . 0.0 110.3 -179.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.5 m -89.23 129.9 35.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.754 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.724 HG12 HG21 ' A' ' 78' ' ' ILE . 2.5 t -103.47 128.25 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 110.544 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -100.92 134.97 43.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.304 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.515 ' O ' HG22 ' A' ' 78' ' ' ILE . 32.1 m170 54.76 94.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.345 -0.847 . . . . 0.0 110.245 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -27.85 61.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.942 . . . . 0.0 110.288 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -27.11 61.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.186 -0.946 . . . . 0.0 110.283 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.556 ' O ' HG12 ' A' ' 119' ' ' VAL . 38.4 m0 -92.48 -52.27 4.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.2 -0.938 . . . . 0.0 110.057 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.724 HG21 HG12 ' A' ' 72' ' ' VAL . 1.5 tt -88.65 119.15 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.293 -0.88 . . . . 0.0 109.392 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.629 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.98 -23.83 24.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.42 -0.8 . . . . 0.0 111.389 -178.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.49 -178.84 48.15 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.064 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.432 ' HE2' HG13 ' A' ' 72' ' ' VAL . 19.0 mtm -152.24 162.73 40.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.464 -1.021 . . . . 0.0 110.103 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -155.2 141.26 18.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 0.0 109.935 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.569 HD12 ' CG ' ' A' ' 104' ' ' PHE . 7.1 mt -135.75 140.47 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 110.589 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 71.16 1.99 4.05 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.528 -0.733 . . . . 0.0 111.442 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.79 21.79 10.85 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.536 -1.316 . . . . 0.0 111.233 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.13 158.58 44.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.622 -1.517 . . . . 0.0 110.05 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -71.41 -177.6 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.141 -0.975 . . . . 0.0 110.337 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -109.95 170.21 8.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.322 -0.861 . . . . 0.0 110.182 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -115.4 134.73 54.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.294 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.48 102.29 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.139 -0.976 . . . . 0.0 109.668 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.587 HG22 ' O ' ' A' ' 101' ' ' THR . 1.4 tt -95.51 -27.52 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 111.008 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.448 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.5 OUTLIER -167.53 103.62 0.51 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.08 -1.013 . . . . 0.0 109.856 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -95.53 149.59 21.25 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.386 -0.821 . . . . 0.0 110.259 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.411 ' ND2' ' HD2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -143.34 61.58 1.39 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 110.116 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 m -54.49 -30.58 53.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.214 -0.928 . . . . 0.0 110.148 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.09 -49.27 75.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.094 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.411 ' HD2' ' ND2' ' A' ' 94' ' ' ASN . 9.4 mttt -95.97 9.9 39.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.566 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.47 55.62 4.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.082 -1.011 . . . . 0.0 110.326 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -147.53 159.2 44.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.173 -0.954 . . . . 0.0 110.402 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.415 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.5 ttm180 -163.16 162.77 25.7 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.325 -0.86 . . . . 0.0 110.023 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.587 ' O ' HG22 ' A' ' 91' ' ' ILE . 85.7 m -141.07 152.71 45.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.944 . . . . 0.0 109.655 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.1 p -145.71 143.4 29.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.977 -1.077 . . . . 0.0 110.725 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 5.3 tt0 -93.07 143.87 25.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.381 -0.824 . . . . 0.0 109.843 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.569 ' CG ' HD12 ' A' ' 83' ' ' ILE . 42.4 m-85 -125.64 145.46 50.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.108 -0.995 . . . . 0.0 110.561 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.45 130.61 47.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.363 -0.835 . . . . 0.0 110.141 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.551 ' O ' HD21 ' A' ' 66' ' ' LEU . 12.5 p -148.9 150.56 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.266 -0.896 . . . . 0.0 110.292 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.34 -39.63 46.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.952 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.5 -157.56 0.33 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.445 -0.784 . . . . 0.0 109.591 179.168 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.935 HD22 ' HG ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -148.19 62.77 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.96 -1.087 . . . . 0.0 110.612 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.685 ' OD1' HG23 ' A' ' 146' ' ' THR . 28.4 t-20 -145.81 62.92 1.25 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 110.078 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.82 -179.97 33.15 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.05 145.28 30.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -1.14 . . . . 0.0 110.57 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.521 HD13 HG21 ' A' ' 106' ' ' VAL . 27.1 mt -137.77 149.71 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.888 . . . . 0.0 109.923 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -76.04 120.96 22.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.156 -0.965 . . . . 0.0 110.183 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.489 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -124.71 171.21 16.78 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 82' ' ' SER . 47.1 mttt -146.37 159.94 42.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.276 -1.132 . . . . 0.0 110.033 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.402 HG12 ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -158.12 144.35 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.155 -0.965 . . . . 0.0 110.317 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.629 ' C ' HG22 ' A' ' 79' ' ' THR . 11.9 m-20 -106.38 158.09 17.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.341 -0.849 . . . . 0.0 109.676 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.1 OUTLIER -131.89 150.99 34.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.243 -0.911 . . . . 0.0 109.771 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 16.8 t80 -151.74 100.26 2.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.924 . . . . 0.0 110.543 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.434 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 54.7 mt -129.74 151.99 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 110.176 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.48 96.58 1.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.856 . . . . 0.0 110.012 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -173.76 -175.78 1.14 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.868 . . . . 0.0 110.394 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.91 104.15 16.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.338 -0.851 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.541 ' O ' HG12 ' A' ' 125' ' ' VAL . 11.9 t -76.6 95.68 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 110.072 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.13 44.44 10.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 110.128 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.85 30.09 44.71 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -145.34 107.79 4.48 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.295 -1.12 . . . . 0.0 110.233 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -52.12 108.31 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.684 1.36 . . . . 0.0 110.214 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.72 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 24.4 t80 -110.66 119.33 38.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 0.0 110.46 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -106.33 117.22 33.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 110.138 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.488 ' HE2' HG11 ' A' ' 119' ' ' VAL . 2.3 t80 -126.45 121.22 31.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 0.0 110.078 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 35.4 t70 -166.69 90.47 0.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 110.415 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.03 -165.1 2.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.145 -0.972 . . . . 0.0 110.392 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -120.87 86.11 2.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 0.0 109.997 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.415 ' HB3' HMD2 ' A' ' 151' ' ' ZNH . 31.6 m-85 -85.45 -179.17 6.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.881 . . . . 0.0 110.392 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.57 ' O ' HG23 ' A' ' 138' ' ' ILE . 46.2 p30 -151.28 171.05 18.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 110.29 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.4 pt -156.5 162.22 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.2 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 62.2 m -91.67 121.24 33.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.276 -0.89 . . . . 0.0 110.61 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.659 ' HA ' HG12 ' A' ' 38' ' ' VAL . 21.9 m-85 -90.2 155.16 19.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.933 . . . . 0.0 109.835 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -144.77 99.82 3.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.518 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -91.6 144.03 25.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.37 -0.831 . . . . 0.0 109.825 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 5.4 m-80 -132.96 100.96 5.05 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.158 -0.964 . . . . 0.0 110.51 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.917 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -163.21 -144.03 3.89 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.403 ' HG2' HD11 ' A' ' 109' ' ' LEU . 15.3 Cg_endo -63.28 138.31 65.62 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.779 1.41 . . . . 0.0 110.635 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.685 HG23 ' OD1' ' A' ' 110' ' ' ASN . 0.2 OUTLIER -91.86 -52.01 4.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.0 110.045 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.53 -48.98 0.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 110.303 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.53 HG12 ' N ' ' A' ' 149' ' ' ALA . 94.0 t 55.12 -102.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.219 -0.925 . . . . 0.0 110.158 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.53 ' N ' HG12 ' A' ' 148' ' ' VAL . . . -158.51 -41.11 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.961 -1.087 . . . . 0.0 110.159 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.939 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.72 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.319 0.58 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.401 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -141.38 75.81 1.52 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 110.194 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 9.5 t30 63.51 38.5 9.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.283 -0.886 . . . . 0.0 109.99 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.49 119.01 18.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.429 -0.794 . . . . 0.0 110.297 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.93 -167.01 1.0 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.246 -0.909 . . . . 0.0 110.121 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.3 OUTLIER 52.07 28.35 5.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.948 . . . . 0.0 110.277 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.6 t -159.65 140.73 12.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 110.525 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.407 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 177.37 178.76 47.27 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.03 111.29 21.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -1.125 . . . . 0.0 110.389 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.512 ' CB ' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -94.16 151.12 19.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 109.665 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.444 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -79.06 131.5 36.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.178 -0.951 . . . . 0.0 110.538 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.907 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -166.11 158.14 14.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 111.034 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -155.53 -165.96 2.12 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.559 ' C ' HG23 ' A' ' 46' ' ' THR . 0.1 OUTLIER -141.22 175.08 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 110.36 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 54.3 m-85 -148.32 163.99 35.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.475 -0.766 . . . . 0.0 109.813 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.427 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -68.24 128.46 36.64 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 109.895 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.515 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -54.97 146.37 17.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 110.112 -179.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.0 t-20 71.87 2.93 4.49 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.922 -0.487 . . . . 0.0 110.941 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -136.23 -162.35 1.26 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.888 -1.133 . . . . 0.0 109.706 179.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.416 ' N ' ' OG1' ' A' ' 43' ' ' THR . 22.9 m120 -133.05 15.74 4.2 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 110.445 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.5 139.03 43.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.16 -0.963 . . . . 0.0 110.361 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.559 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -74.08 133.06 42.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.994 . . . . 0.0 109.379 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.76 -16.97 4.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.046 -1.033 . . . . 0.0 111.82 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.8 mt -137.11 -64.63 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.831 -1.168 . . . . 0.0 110.623 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.4 -18.09 6.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.495 -0.753 . . . . 0.0 111.163 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.46 ' HB2' ' CG2' ' A' ' 46' ' ' THR . 0.1 OUTLIER -68.35 -10.87 57.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.926 -1.108 . . . . 0.0 110.847 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -102.38 12.8 36.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.879 -1.138 . . . . 0.0 110.843 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -136.29 6.44 3.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.012 -1.055 . . . . 0.0 110.667 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -114.22 98.47 6.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.957 . . . . 0.0 109.845 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -72.03 103.28 3.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.522 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HG3' ' N ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -93.05 165.06 19.38 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.204 -0.935 . . . . 0.0 109.879 179.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.446 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 50.1 Cg_endo -78.61 -176.36 18.53 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.468 -2.305 . . . . 0.0 110.524 -0.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.907 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -103.15 165.41 11.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.25 -0.906 . . . . 0.0 110.008 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.405 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -101.71 109.52 21.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 110.168 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.512 ' CD1' ' CB ' ' A' ' 34' ' ' LEU . 19.4 p90 -96.95 161.78 13.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.676 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -154.0 153.05 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.111 -0.993 . . . . 0.0 110.357 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -135.89 174.03 11.06 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.324 -0.86 . . . . 0.0 110.453 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.437 ' HB2' ' HD3' ' A' ' 65' ' ' LYS . 9.8 mtmt -159.48 62.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.344 -0.848 . . . . 0.0 110.108 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 48.97 87.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.449 -0.782 . . . . 0.0 111.193 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.59 25.15 33.69 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.087 -1.054 . . . . 0.0 110.558 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.437 ' HD3' ' HB2' ' A' ' 62' ' ' LYS . 6.8 ptpt -171.9 158.85 4.94 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.962 -1.317 . . . . 0.0 111.028 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' A' ' 108' ' ' LYS . 1.3 pt? -173.4 150.29 1.82 Allowed 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 122.068 0.937 . . . . 0.0 111.334 178.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.586 ' C ' HG12 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -140.03 -161.06 1.14 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.586 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -167.15 142.89 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.578 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 102' ' ' SER . 8.7 pt20 -101.12 134.8 43.6 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.906 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -113.75 138.85 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.256 -0.902 . . . . 0.0 109.842 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.6 m -89.03 135.87 33.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 110.469 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.663 HG12 HG21 ' A' ' 78' ' ' ILE . 2.0 t -107.42 122.69 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.865 . . . . 0.0 110.201 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -100.23 143.07 30.85 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.107 -0.995 . . . . 0.0 110.403 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.909 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.5 OUTLIER 62.03 74.53 0.44 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 110.029 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.4 m -64.35 -19.1 65.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.348 -0.845 . . . . 0.0 110.551 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.32 -45.11 57.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.089 -1.007 . . . . 0.0 110.315 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.414 ' CD2' HBB2 ' A' ' 151' ' ' ZNH . 40.3 m0 -77.19 -42.44 37.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.281 -0.887 . . . . 0.0 110.19 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.909 HG22 ' O ' ' A' ' 74' ' ' HIS . 6.1 tp -88.14 118.82 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -0.92 . . . . 0.0 109.3 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -85.55 -24.06 27.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 111.029 -178.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.48 -179.16 46.85 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.006 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.552 ' HE1' HG22 ' A' ' 72' ' ' VAL . 28.5 mtm -151.35 158.55 43.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.458 -1.025 . . . . 0.0 109.791 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.33 154.87 34.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.087 -1.008 . . . . 0.0 110.17 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.76 HD12 ' CD2' ' A' ' 104' ' ' PHE . 12.9 mt -141.96 155.36 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.355 -0.841 . . . . 0.0 110.195 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.53 ' HB2' ' CE1' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 58.79 16.55 4.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.013 . . . . 0.0 110.791 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.19 21.65 60.41 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.92 -1.133 . . . . 0.0 110.424 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.53 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 2.2 p-80 -135.18 157.42 46.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.842 -1.387 . . . . 0.0 110.525 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 178.8 3.65 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.329 -0.857 . . . . 0.0 110.701 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.407 ' HG3' ' CB ' ' A' ' 102' ' ' SER . 2.7 pt-20 -108.5 166.65 10.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.362 -0.836 . . . . 0.0 110.221 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 102' ' ' SER . 1.4 t30 -105.22 130.89 53.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -0.919 . . . . 0.0 110.209 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.12 102.56 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -0.954 . . . . 0.0 110.081 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 101' ' ' THR . 1.3 tt -95.78 -26.83 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.88 . . . . 0.0 110.855 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -167.5 99.02 0.49 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.148 -0.97 . . . . 0.0 109.874 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.437 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 7.7 ttmm -95.7 103.78 15.67 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.382 -0.824 . . . . 0.0 110.178 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.33 95.01 7.78 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.0 110.293 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.3 -29.86 61.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 110.109 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.09 94.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.901 . . . . 0.0 110.354 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -95.69 14.56 22.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.206 -0.934 . . . . 0.0 110.593 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.6 t0 50.16 57.42 6.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.033 -1.042 . . . . 0.0 110.263 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -146.84 -176.74 5.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.166 -0.959 . . . . 0.0 110.318 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 72' ' ' VAL . 4.9 ttm180 -176.75 162.45 2.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.438 -0.789 . . . . 0.0 109.989 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.636 ' O ' HG22 ' A' ' 91' ' ' ILE . 86.8 m -142.68 150.6 40.38 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.86 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 19.5 p -146.33 148.72 32.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.045 -1.034 . . . . 0.0 110.711 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -92.99 146.92 23.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.322 -0.862 . . . . 0.0 110.088 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.76 ' CD2' HD12 ' A' ' 83' ' ' ILE . 8.7 m-85 -131.15 144.15 51.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.109 -0.994 . . . . 0.0 110.76 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -99.37 128.42 45.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.882 . . . . 0.0 109.366 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.73 143.09 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 110.825 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.4 113.21 2.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.111 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.616 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 47.23 -163.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.539 -0.726 . . . . 0.0 109.69 -178.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.428 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.66 64.61 0.87 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.861 -1.149 . . . . 0.0 110.753 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -146.2 58.78 1.22 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 110.308 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.8 171.05 38.6 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.441 ' HE3' HG23 ' A' ' 139' ' ' THR . 1.6 tmtt? -81.6 147.48 29.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -1.152 . . . . 0.0 110.326 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.41 ' N ' ' HG2' ' A' ' 112' ' ' LYS . 1.4 mt -136.01 140.84 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.941 . . . . 0.0 110.021 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.24 112.32 12.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.129 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.479 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -111.21 178.24 19.45 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -145.04 161.54 39.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -1.115 . . . . 0.0 109.854 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.669 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.02 140.96 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.121 -0.987 . . . . 0.0 110.392 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.549 ' O ' HG22 ' A' ' 79' ' ' THR . 25.1 t0 -105.24 152.47 22.84 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.354 -0.841 . . . . 0.0 109.473 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.464 HG22 HD11 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -128.86 151.89 36.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.017 -1.052 . . . . 0.0 110.386 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.401 ' CB ' ' OG1' ' A' ' 79' ' ' THR . 27.0 t80 -151.39 100.63 2.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 110.621 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.483 HD12 ' CD2' ' A' ' 132' ' ' TYR . 4.3 mt -127.36 152.89 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.965 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -159.7 98.77 1.38 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.262 -0.899 . . . . 0.0 109.912 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 124' ' ' LYS . 12.5 pt-20 -173.75 -152.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 110.363 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.47 ' O ' HG23 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -101.98 167.05 10.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.329 -0.857 . . . . 0.0 110.423 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 125' ' ' VAL . 1.3 t -158.05 114.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 125' ' ' VAL . 3.0 t-20 56.26 25.92 9.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.441 -0.787 . . . . 0.0 109.826 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 86.04 37.32 9.28 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 3.6 mtmm -148.92 145.91 20.59 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.11 -1.229 . . . . 0.0 110.189 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -66.83 130.31 22.89 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.861 1.453 . . . . 0.0 110.027 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.555 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 10.2 t80 -116.34 140.16 49.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.174 -0.954 . . . . 0.0 110.548 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.79 105.01 5.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.829 . . . . 0.0 109.943 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.483 ' CD2' HD12 ' A' ' 121' ' ' ILE . 4.0 t80 -120.71 128.57 53.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 110.046 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -170.82 88.45 0.12 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.089 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.44 -175.03 5.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -0.894 . . . . 0.0 110.356 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -119.52 85.27 2.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 110.242 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.5 ' CD1' HBD2 ' A' ' 151' ' ' ZNH . 40.3 m-85 -86.26 -178.83 6.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.354 -0.842 . . . . 0.0 110.078 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.472 ' HA ' HG22 ' A' ' 117' ' ' ILE . 4.2 p30 -150.87 178.42 9.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 110.281 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -156.69 168.88 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.382 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.441 HG23 ' HE3' ' A' ' 112' ' ' LYS . 48.9 m -92.03 119.59 31.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.342 -0.849 . . . . 0.0 110.931 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.526 ' CE2' HD11 ' A' ' 83' ' ' ILE . 28.3 m-85 -90.92 162.86 14.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.258 -0.902 . . . . 0.0 110.026 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.01 99.89 2.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.057 -1.027 . . . . 0.0 110.702 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.405 ' HA ' ' HB2' ' A' ' 36' ' ' TYR . 61.7 m-85 -91.95 150.96 20.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.195 -0.94 . . . . 0.0 110.417 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.423 ' ND2' ' N ' ' A' ' 143' ' ' ASN . 2.3 m-80 -141.66 104.58 4.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -0.886 . . . . 0.0 110.449 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.424 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -157.28 -146.74 4.57 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.41 ' CD ' HD11 ' A' ' 109' ' ' LEU . 11.0 Cg_endo -58.91 -172.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.697 1.367 . . . . 0.0 110.671 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.65 -58.53 0.2 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.296 -0.877 . . . . 0.0 110.056 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -168.84 -63.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 110.216 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 148' ' ' VAL . 21.2 t 56.47 46.06 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.318 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.82 114.66 20.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.965 . . . . 0.0 110.176 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.955 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.555 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.203 0.525 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.66 87.15 1.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 110.252 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.64 26.88 16.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.9 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -114.27 177.9 4.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.863 . . . . 0.0 110.285 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 42.89 -164.0 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.364 0.602 . . . . 0.0 111.006 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 8.4 m-20 55.68 31.55 17.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.249 -0.907 . . . . 0.0 110.417 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' TYR . 1.5 p -160.98 156.01 24.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.024 -1.048 . . . . 0.0 110.711 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' CD2' ' A' ' 59' ' ' TYR . . . 164.24 171.88 31.03 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -91.88 107.77 19.45 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.235 -1.156 . . . . 0.0 110.538 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.65 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.6 OUTLIER -95.47 157.56 15.84 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.96 -1.088 . . . . 0.0 110.487 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.4 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 49.2 m-20 -80.17 143.68 33.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 110.142 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 0.5 OUTLIER -166.22 156.42 12.36 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.948 . . . . 0.0 110.096 179.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -155.6 -178.58 7.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -0.984 . . . . 0.0 110.444 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.753 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -140.14 170.33 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 0.0 109.959 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 47.3 m-85 -147.27 159.45 43.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.344 -0.847 . . . . 0.0 110.192 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.47 ' HE3' ' CB ' ' A' ' 47' ' ' SER . 9.4 tppt? -67.81 145.81 54.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.948 . . . . 0.0 109.979 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.62 140.91 53.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.074 -1.016 . . . . 0.0 110.311 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 61.59 26.26 16.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.925 . . . . 0.0 110.112 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.422 ' OG1' ' HG3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -133.14 -154.67 0.62 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.389 -0.819 . . . . 0.0 110.058 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -126.18 -28.62 3.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.18 -0.95 . . . . 0.0 110.741 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.433 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -134.93 172.92 12.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.068 -1.02 . . . . 0.0 110.973 -179.63 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.481 HG21 ' HB2' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -75.54 142.24 42.83 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.507 -0.745 . . . . 0.0 109.352 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.47 ' CB ' ' HE3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -129.62 -17.9 3.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.06 -1.025 . . . . 0.0 112.122 -178.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 49' ' ' ALA . 12.2 mt -137.63 -71.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.757 -1.215 . . . . 0.0 110.781 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.552 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -47.25 -24.98 0.83 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.704 -0.623 . . . . 0.0 111.242 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.481 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.1 OUTLIER -67.3 -13.99 62.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.995 -1.066 . . . . 0.0 110.89 -179.682 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.412 ' C ' ' CD1' ' A' ' 52' ' ' TYR . 27.3 m-20 -88.83 -11.11 45.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.071 -1.018 . . . . 0.0 110.785 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 0.6 OUTLIER -119.16 7.4 11.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.022 -1.049 . . . . 0.0 110.71 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.402 ' CE2' HG12 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -109.7 106.93 16.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.034 -1.041 . . . . 0.0 110.42 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -72.4 153.54 41.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.131 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.63 159.19 44.94 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.107 -0.996 . . . . 0.0 109.985 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 57.2 Cg_endo -78.97 -175.93 17.66 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.752 -2.187 . . . . 0.0 110.681 -0.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . -104.23 173.38 6.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 110.251 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.477 ' CB ' ' CG ' ' A' ' 69' ' ' GLN . 0.4 OUTLIER -103.59 120.61 41.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.887 . . . . 0.0 110.349 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.524 ' CD1' ' HD2' ' A' ' 61' ' ' LYS . 11.6 p90 -97.79 159.14 15.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.95 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.587 HG23 ' HD1' ' A' ' 67' ' ' TYR . 1.1 tt -155.85 114.5 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 110.469 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.524 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -128.1 127.88 43.87 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.153 -0.967 . . . . 0.0 110.549 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.06 62.11 0.69 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.402 -0.811 . . . . 0.0 110.128 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' A' ' 63' ' ' ASN . 0.4 OUTLIER 46.99 98.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.531 -0.73 . . . . 0.0 111.19 179.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.1 -11.65 58.72 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -145.64 162.82 36.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.028 -1.277 . . . . 0.0 110.296 179.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.693 HD11 ' N ' ' A' ' 108' ' ' LYS . 1.6 pt? -168.32 144.99 3.92 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.151 -0.968 . . . . 0.0 111.358 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.587 ' HD1' HG23 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -139.44 -160.69 1.09 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 67' ' ' TYR . 1.2 t -170.18 129.63 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.204 -0.935 . . . . 0.0 110.206 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.477 ' CG ' ' CB ' ' A' ' 58' ' ' LYS . 3.0 pp0? -96.37 126.54 41.64 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.229 -0.92 . . . . 0.0 109.254 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -108.73 139.33 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 110.283 -179.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m -88.31 141.7 28.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.359 -0.838 . . . . 0.0 109.425 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.555 HG12 HG21 ' A' ' 78' ' ' ILE . 0.7 OUTLIER -119.75 135.43 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 110.609 -179.227 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -101.18 131.2 47.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.336 -0.852 . . . . 0.0 109.815 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.415 ' O ' HG22 ' A' ' 78' ' ' ILE . 3.8 m-70 55.85 102.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.216 -0.928 . . . . 0.0 110.181 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -31.1 65.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.941 . . . . 0.0 110.537 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -54.11 -59.51 4.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.972 . . . . 0.0 110.178 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.642 ' HA ' HD11 ' A' ' 121' ' ' ILE . 20.0 m0 -53.35 -66.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.925 . . . . 0.0 110.31 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 78' ' ' ILE . 19.2 tt -88.76 118.69 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.249 -0.907 . . . . 0.0 109.746 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.692 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -87.47 -24.79 24.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 111.662 -178.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 81' ' ' MET . . . -174.54 175.45 46.82 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.553 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.429 ' SD ' HD11 ' A' ' 78' ' ' ILE . 2.9 mpp? -150.95 111.3 4.17 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.595 -0.944 . . . . 0.0 110.16 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -86.23 159.94 19.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.031 -1.043 . . . . 0.0 109.603 179.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.672 HD12 ' CD1' ' A' ' 104' ' ' PHE . 1.2 mt -151.14 122.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -0.902 . . . . 0.0 110.534 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.463 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 70.49 3.31 4.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.484 -0.76 . . . . 0.0 111.424 179.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.09 20.36 9.32 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.548 -1.311 . . . . 0.0 111.092 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.477 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -136.66 157.32 47.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.699 -1.471 . . . . 0.0 110.148 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -171.05 0.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.519 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -110.42 170.56 8.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.39 -0.819 . . . . 0.0 110.108 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 102' ' ' SER . 3.9 t-20 -119.12 121.11 39.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 110.156 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.401 ' O ' ' CG1' ' A' ' 90' ' ' ILE . 1.2 pp -67.22 103.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.062 -1.024 . . . . 0.0 109.48 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.433 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.8 tt -94.32 -27.76 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.444 -0.785 . . . . 0.0 110.767 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.9 m -166.71 98.54 0.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.164 -0.96 . . . . 0.0 109.879 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.425 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 14.7 ttmt -96.05 106.54 18.73 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.403 -0.81 . . . . 0.0 110.315 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.84 95.26 7.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 0.0 110.038 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.2 p -74.91 -26.05 59.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.28 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.17 -49.2 76.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.128 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -96.05 13.82 25.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.925 . . . . 0.0 110.447 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 53.16 63.16 2.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.096 -1.003 . . . . 0.0 110.128 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.93 173.8 12.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.331 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 72' ' ' VAL . 3.5 ttm180 -169.37 165.16 10.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 0.0 110.236 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 70' ' ' ILE . 94.9 m -143.99 151.9 40.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -0.845 . . . . 0.0 109.903 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.492 ' HG ' ' HZ ' ' A' ' 104' ' ' PHE . 2.9 p -145.14 140.17 27.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.941 -1.1 . . . . 0.0 110.912 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.58 141.14 28.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 0.0 110.109 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.672 ' CD1' HD12 ' A' ' 83' ' ' ILE . 87.8 m-85 -131.45 145.41 51.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.131 -0.981 . . . . 0.0 110.851 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -104.33 130.36 52.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.316 -0.865 . . . . 0.0 109.471 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.624 ' O ' HD21 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -150.03 150.89 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.982 -1.074 . . . . 0.0 110.881 -179.194 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.1 t -66.13 113.2 4.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.189 -0.944 . . . . 0.0 109.027 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.693 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 51.88 -178.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.324 -178.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.584 ' H ' HD12 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -150.0 58.13 0.97 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 0.0 111.554 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 11.3 t30 -145.28 58.83 1.28 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.841 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.32 174.43 44.59 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.97 141.43 33.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -1.111 . . . . 0.0 110.659 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 72.6 mt -137.7 150.86 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.371 -0.831 . . . . 0.0 109.735 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -76.21 126.75 31.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.155 -0.966 . . . . 0.0 110.568 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -132.64 172.29 21.32 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 82' ' ' SER . 10.7 mttt -144.07 167.51 22.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.126 -1.22 . . . . 0.0 109.413 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.524 ' O ' HD13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -158.5 145.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.983 -1.073 . . . . 0.0 110.52 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.692 ' C ' HG22 ' A' ' 79' ' ' THR . 1.7 m-20 -108.2 160.34 15.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.429 -0.794 . . . . 0.0 109.225 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -134.41 147.85 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 110.642 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 3.5 t80 -151.34 109.86 3.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.426 -0.796 . . . . 0.0 110.569 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.642 HD11 ' HA ' ' A' ' 77' ' ' TRP . 2.3 mp -140.58 152.97 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.411 -0.805 . . . . 0.0 109.871 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -160.38 102.35 1.39 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.027 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -174.11 -170.72 0.56 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.454 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.74 109.4 21.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.85 . . . . 0.0 110.17 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.5 t -76.7 107.09 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 110.362 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.4 m120 50.37 42.42 25.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.296 -0.877 . . . . 0.0 110.423 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.82 37.19 11.97 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 36.7 mtmt -145.24 99.33 4.58 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.236 -1.155 . . . . 0.0 109.97 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 128' ' ' LYS . 9.6 Cg_endo -59.04 130.11 34.99 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.674 1.355 . . . . 0.0 110.392 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.84 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 0.1 OUTLIER -158.62 128.67 5.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 110.029 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -105.9 142.61 35.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.225 -0.922 . . . . 0.0 110.785 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.508 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 5.5 t80 -127.2 121.49 31.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.48 -0.763 . . . . 0.0 109.704 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -158.77 84.44 0.82 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.201 -0.937 . . . . 0.0 110.11 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.0 -169.62 3.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 110.419 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.443 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 13.5 p-80 -120.28 159.29 25.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 110.309 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 57.4 m-85 -155.13 -178.82 7.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.347 -0.845 . . . . 0.0 109.907 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -150.66 161.2 43.06 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.039 -1.038 . . . . 0.0 110.885 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 137' ' ' ASN . 6.8 pt -155.59 173.34 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.544 -0.723 . . . . 0.0 109.642 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 43.3 m -91.79 116.36 28.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.162 -0.961 . . . . 0.0 111.089 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.753 ' HA ' HG12 ' A' ' 38' ' ' VAL . 7.4 m-85 -89.58 150.22 22.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 109.547 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.11 162.51 36.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.088 -1.007 . . . . 0.0 110.86 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.409 ' HB3' ' O ' ' A' ' 109' ' ' LEU . 26.9 m-85 -148.99 158.53 44.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.52 -0.738 . . . . 0.0 109.933 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.4 ' HB2' ' CB ' ' A' ' 35' ' ' ASN . 32.8 m-80 -142.0 110.55 6.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.582 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.65 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -168.49 -145.95 4.78 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 110' ' ' ASN . 11.3 Cg_endo -61.52 -177.25 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.75 1.395 . . . . 0.0 109.986 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.18 -56.92 0.2 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.154 -0.966 . . . . 0.0 110.305 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.72 -66.53 0.36 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.173 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.3 t 55.97 54.87 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 110.388 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.25 41.89 0.27 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.386 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.963 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.84 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.226 0.536 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.17 96.94 2.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 110.277 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 62.63 24.07 14.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.218 -0.926 . . . . 0.0 109.943 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.82 82.16 1.71 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.332 -0.855 . . . . 0.0 110.114 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.1 -161.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.154 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER 56.34 28.64 13.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 110.23 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -159.93 149.49 18.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.216 -0.928 . . . . 0.0 110.292 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.7 176.83 39.21 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.95 103.05 15.32 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -1.13 . . . . 0.0 110.335 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.703 HD13 HD22 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -93.55 152.34 19.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 109.987 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.459 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 14.5 m-80 -78.35 144.86 35.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 110.125 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -165.09 156.96 15.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 110.058 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.1 -177.93 6.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -0.904 . . . . 0.0 109.9 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.588 ' C ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.58 176.2 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.241 -0.912 . . . . 0.0 110.034 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 56.9 m-85 -148.67 161.91 40.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.413 -0.804 . . . . 0.0 109.954 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.2 OUTLIER -67.73 135.78 53.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 0.0 109.656 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.503 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -61.65 146.73 48.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 110.112 -179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 3.3 t-20 70.54 4.58 5.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.793 -0.567 . . . . 0.0 110.723 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -135.55 -164.52 1.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.92 -1.112 . . . . 0.0 109.576 179.286 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.422 ' N ' ' OG1' ' A' ' 43' ' ' THR . 6.3 m-80 -130.85 14.02 5.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 110.527 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -136.09 142.87 44.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.06 -1.025 . . . . 0.0 110.563 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.588 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -77.18 136.36 38.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.124 -0.985 . . . . 0.0 109.181 179.397 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.07 -17.78 3.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.01 -1.056 . . . . 0.0 112.048 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 51.8 mt -137.74 -68.81 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.79 -1.194 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -48.39 -24.5 1.26 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 111.201 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.531 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.1 OUTLIER -67.5 -14.15 62.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.961 -1.087 . . . . 0.0 110.891 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -102.19 15.16 29.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.056 -1.028 . . . . 0.0 110.902 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.445 ' CD2' HBC1 ' A' ' 151' ' ' ZNH . 95.7 m-85 -127.51 -5.49 5.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.963 -1.086 . . . . 0.0 111.177 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 11.5 m-30 -110.39 112.85 25.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.948 -1.095 . . . . 0.0 110.518 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -72.77 109.75 6.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.284 -0.885 . . . . 0.0 110.129 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.402 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -93.39 164.06 22.56 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 110.161 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.402 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 56.2 Cg_endo -79.62 -175.82 17.2 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.452 -2.311 . . . . 0.0 110.693 -0.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -103.77 165.62 10.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 110.098 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -104.36 113.27 26.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.178 -0.951 . . . . 0.0 110.345 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.524 ' HA ' HG23 ' A' ' 68' ' ' VAL . 9.3 p90 -98.21 166.45 11.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.22 -0.925 . . . . 0.0 110.308 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.8 OUTLIER -155.67 158.93 3.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.585 -179.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 18.0 mtmt -138.86 173.1 11.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 0.0 110.985 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.46 ' HB2' ' CD ' ' A' ' 65' ' ' LYS . 19.2 mtpt -155.53 62.15 0.61 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.577 -0.702 . . . . 0.0 109.535 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 47.96 84.3 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.539 -0.726 . . . . 0.0 111.177 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.06 19.45 36.31 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 120.149 -1.024 . . . . 0.0 110.809 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.758 ' C ' HD13 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -165.43 157.37 14.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.85 -1.383 . . . . 0.0 111.141 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.758 HD13 ' C ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -160.47 155.92 25.15 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.169 0.985 . . . . 0.0 111.755 178.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 67' ' ' TYR . 3.7 m-85 -141.89 -162.06 1.33 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.524 HG23 ' HA ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -170.68 138.88 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 120.97 -1.081 . . . . 0.0 110.712 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 1.2 pt20 -99.65 134.84 41.95 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.776 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -113.74 128.4 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.992 -179.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 71' ' ' THR . 0.9 OUTLIER -88.3 122.36 31.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.826 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -103.28 150.41 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.404 -0.81 . . . . 0.0 110.508 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -102.28 133.44 47.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.343 -0.848 . . . . 0.0 110.005 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 57.38 99.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.119 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.3 t -62.54 -44.06 97.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.879 . . . . 0.0 110.465 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -52.58 -38.35 59.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.915 . . . . 0.0 110.392 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.534 ' O ' HG12 ' A' ' 119' ' ' VAL . 45.5 m0 -68.46 -59.17 3.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -0.946 . . . . 0.0 110.243 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 78' ' ' ILE . 6.6 tp -88.44 118.04 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.231 -0.918 . . . . 0.0 109.772 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.97 -25.38 24.33 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 110.99 -179.099 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.4 174.92 42.4 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.238 -1.458 . . . . 0.0 110.526 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -152.82 115.27 4.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.451 -1.029 . . . . 0.0 110.025 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.56 171.24 11.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 109.885 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.576 HD11 ' CZ ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -171.76 131.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.135 -0.978 . . . . 0.0 110.816 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HB3' ' NE2' ' A' ' 86' ' ' HIS . 0.9 OUTLIER 62.35 9.41 3.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.575 -0.703 . . . . 0.0 111.879 179.36 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.36 1.21 29.57 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.361 -1.399 . . . . 0.0 111.594 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.503 ' CD2' ' N ' ' A' ' 86' ' ' HIS . 3.3 p80 -135.6 154.17 51.43 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.577 -1.543 . . . . 0.0 110.847 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -167.17 0.17 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.454 -0.779 . . . . 0.0 110.421 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 8.1 pt-20 -107.68 170.22 8.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.193 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.34 134.32 55.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.246 -0.909 . . . . 0.0 110.396 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -67.83 103.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.126 -0.983 . . . . 0.0 109.514 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 92' ' ' SER . 2.0 tt -94.57 -29.49 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.865 . . . . 0.0 111.142 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.508 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -166.77 105.34 0.6 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.051 -1.03 . . . . 0.0 110.138 -179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.433 ' HG3' ' HG3' ' A' ' 100' ' ' ARG . 2.4 ttmm -96.07 108.82 21.29 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.394 -0.816 . . . . 0.0 110.244 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.54 86.71 4.2 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.067 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.07 -24.54 62.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.275 -0.891 . . . . 0.0 110.37 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.56 -53.47 54.22 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -0.941 . . . . 0.0 110.078 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -97.46 19.2 13.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -0.881 . . . . 0.0 110.255 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 50.76 65.72 1.38 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 110.123 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -147.7 158.41 44.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.223 -0.923 . . . . 0.0 110.314 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.433 ' HG3' ' HG3' ' A' ' 93' ' ' LYS . 1.3 ttm180 -153.98 160.84 42.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -0.896 . . . . 0.0 110.038 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.501 ' O ' HG22 ' A' ' 91' ' ' ILE . 91.2 m -141.1 156.94 45.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.317 -0.864 . . . . 0.0 109.856 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 84.7 p -145.65 143.41 29.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 110.699 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.08 135.98 33.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.354 -0.841 . . . . 0.0 109.912 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 39.1 m-85 -121.68 148.23 44.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.078 -1.014 . . . . 0.0 110.796 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.472 ' C ' HG13 ' A' ' 106' ' ' VAL . 3.9 mp0 -115.02 128.46 56.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.392 -0.818 . . . . 0.0 109.657 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.472 HG13 ' C ' ' A' ' 105' ' ' GLU . 35.0 m -149.62 -175.37 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.605 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.32 113.44 22.31 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.457 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 47.48 -158.6 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.46 -0.775 . . . . 0.0 109.343 -178.345 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.703 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.02 53.72 0.87 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.772 -1.205 . . . . 0.0 110.772 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.4 ' CB ' HG22 ' A' ' 146' ' ' THR . 2.7 t30 -145.87 84.29 1.66 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.994 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.41 166.51 15.14 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -81.87 144.0 31.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -1.12 . . . . 0.0 110.429 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 81.1 mt -137.06 146.61 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 110.089 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -76.68 130.64 38.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.325 -0.859 . . . . 0.0 110.385 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -138.82 176.55 20.81 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.6 mttt -143.06 164.41 30.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -1.122 . . . . 0.0 109.42 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.477 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -158.65 142.36 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.912 -1.117 . . . . 0.0 110.921 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.683 ' O ' HG22 ' A' ' 79' ' ' THR . 5.3 m-20 -112.08 162.77 15.04 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.551 -0.718 . . . . 0.0 109.182 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -140.76 153.63 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.137 -0.977 . . . . 0.0 110.37 -179.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -151.82 107.31 3.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 110.541 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' A' ' 132' ' ' TYR . 7.7 mt -130.72 151.47 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.242 -0.911 . . . . 0.0 109.855 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -159.15 104.37 1.68 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.217 -0.927 . . . . 0.0 109.855 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -172.66 -158.73 0.11 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 110.304 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -119.83 108.01 13.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.368 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 125' ' ' VAL . 1.4 t -76.93 117.96 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.214 -0.928 . . . . 0.0 110.223 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.48 29.06 2.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.396 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 90.98 35.77 7.0 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.49 116.52 5.46 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.191 -1.182 . . . . 0.0 110.125 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.12 135.36 30.39 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.638 1.336 . . . . 0.0 110.266 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.551 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 6.4 t80 -136.25 113.38 10.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 110.316 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -104.0 122.77 45.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 110.122 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.507 ' CD2' HD12 ' A' ' 121' ' ' ILE . 3.9 t80 -131.72 128.58 39.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 109.886 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 55.4 t0 -173.39 94.14 0.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.158 -0.964 . . . . 0.0 110.369 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.86 -175.0 5.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.256 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.55 86.43 2.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -0.941 . . . . 0.0 110.136 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.463 ' CD1' HBD2 ' A' ' 151' ' ' ZNH . 24.6 m-85 -84.48 -178.77 7.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.361 -0.837 . . . . 0.0 110.02 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 18.9 p30 -149.5 167.67 25.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 0.0 110.204 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.447 HG12 ' CG2' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -156.45 163.3 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 110.718 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.409 ' O ' HG12 ' A' ' 38' ' ' VAL . 81.9 m -92.15 125.41 36.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.489 -0.757 . . . . 0.0 110.406 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.576 ' CZ ' HD11 ' A' ' 83' ' ' ILE . 23.8 m-85 -90.39 165.11 14.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.204 -0.935 . . . . 0.0 110.371 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.21 101.54 1.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 110.315 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.427 ' CE1' HG11 ' A' ' 68' ' ' VAL . 59.3 m-85 -91.57 158.67 16.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.266 -0.897 . . . . 0.0 110.207 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.455 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 55.0 m-20 -143.46 96.98 3.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.223 -0.923 . . . . 0.0 110.604 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.597 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -154.23 -148.28 4.91 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.45 172.86 1.74 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.804 1.423 . . . . 0.0 110.631 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.4 HG22 ' CB ' ' A' ' 110' ' ' ASN . 9.2 p -149.89 -60.12 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.361 -0.837 . . . . 0.0 110.242 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -108.78 -27.87 9.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.315 -0.866 . . . . 0.0 110.378 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 148' ' ' VAL . 43.8 t 55.54 46.11 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.223 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.69 103.93 11.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 110.269 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.907 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.551 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.288 0.566 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -139.25 38.4 2.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.994 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 60.58 23.52 13.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 109.883 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.01 127.79 33.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 109.946 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 43.32 -163.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.704 -0.623 . . . . 0.0 110.802 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER 55.53 27.53 10.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.143 -0.973 . . . . 0.0 110.273 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 p -160.76 141.31 11.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.885 . . . . 0.0 110.347 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.25 -178.0 43.86 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.6 107.14 18.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.274 -1.133 . . . . 0.0 110.122 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.907 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -94.86 156.49 16.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.27 -0.894 . . . . 0.0 110.379 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 143' ' ' ASN . 2.8 m-20 -79.91 138.64 37.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.195 -0.94 . . . . 0.0 110.369 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.687 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 1.2 p90 -164.91 150.75 10.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.349 -0.844 . . . . 0.0 110.006 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 38' ' ' VAL . 2.2 tt0 -155.02 156.46 35.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.869 . . . . 0.0 109.756 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.769 HG23 ' OG1' ' A' ' 46' ' ' THR . 28.1 m -101.08 174.71 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.17 -0.956 . . . . 0.0 110.638 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.471 ' HA ' ' CA ' ' A' ' 46' ' ' THR . 10.0 m-85 -148.12 156.18 42.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.516 -0.74 . . . . 0.0 109.746 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.433 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -67.59 133.59 49.68 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.221 -0.924 . . . . 0.0 109.592 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.465 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -63.73 147.14 52.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.991 -1.068 . . . . 0.0 109.864 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 5.5 t30 69.97 4.9 5.01 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.719 -0.613 . . . . 0.0 110.859 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.46 -167.23 2.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.94 -1.1 . . . . 0.0 109.718 179.422 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.411 ' N ' ' OG1' ' A' ' 43' ' ' THR . 24.7 m120 -130.56 14.34 5.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.109 -0.994 . . . . 0.0 110.426 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -135.03 116.86 15.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.083 -1.011 . . . . 0.0 110.402 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.769 ' OG1' HG23 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -54.65 134.42 47.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.991 -1.068 . . . . 0.0 108.972 179.327 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.73 -17.66 3.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.826 -1.171 . . . . 0.0 112.299 -178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.4 mt -137.78 -64.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.634 -1.291 . . . . 0.0 111.304 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.521 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -45.32 -27.92 0.74 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.619 -0.675 . . . . 0.0 111.43 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.456 ' CB ' ' CG2' ' A' ' 46' ' ' THR . 6.5 t-20 -71.91 -13.63 61.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.959 -1.088 . . . . 0.0 111.057 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.413 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 8.7 m-20 -90.05 14.95 11.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.063 -1.023 . . . . 0.0 110.863 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 51' ' ' ASP . 24.0 m-85 -143.05 11.56 1.79 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.042 -1.036 . . . . 0.0 110.856 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 24.0 m-85 -129.76 113.37 14.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 109.991 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -72.17 164.92 25.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.166 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -146.75 164.21 25.08 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 110.07 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.422 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 49.6 Cg_endo -79.53 -175.65 16.91 Favored 'Cis proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.332 -2.362 . . . . 0.0 110.558 -0.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.687 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.0 167.94 9.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.287 -0.883 . . . . 0.0 109.873 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -103.57 111.35 23.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.116 -0.99 . . . . 0.0 110.745 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.701 ' HA ' HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -96.35 162.85 13.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.001 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -154.28 155.93 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.085 -1.009 . . . . 0.0 110.528 -179.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.3 mtmp? -138.62 171.75 13.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.317 -0.865 . . . . 0.0 110.598 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.454 ' HB3' ' HD2' ' A' ' 65' ' ' LYS . 12.1 mttp -162.03 61.66 0.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.394 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 60.91 91.66 0.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -0.839 . . . . 0.0 111.428 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.89 28.83 61.96 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.115 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.454 ' HD2' ' HB3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -170.59 162.71 8.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.892 -1.357 . . . . 0.0 111.207 179.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.865 HD21 ' H ' ' A' ' 108' ' ' LYS . 1.4 pt? -172.51 149.45 2.13 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 122.084 0.945 . . . . 0.0 111.38 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 1.2 m-85 -138.02 172.19 13.3 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.701 HG13 ' HA ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -142.72 142.09 26.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.933 -1.104 . . . . 0.0 110.441 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 102' ' ' SER . 6.3 pt20 -97.37 133.49 41.91 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.37 -0.831 . . . . 0.0 109.572 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.2 OUTLIER -111.99 138.55 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -0.82 . . . . 0.0 110.153 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 m -88.36 129.48 35.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.244 -0.91 . . . . 0.0 109.769 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.625 HG13 HD13 ' A' ' 78' ' ' ILE . 2.8 t -102.99 127.21 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 110.405 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -99.42 133.25 44.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.0 110.017 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.0 m80 54.8 98.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.158 -0.964 . . . . 0.0 110.063 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.3 p -64.15 -25.8 68.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.392 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -65.37 -56.85 10.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.48 ' O ' HG12 ' A' ' 119' ' ' VAL . 36.7 m0 -51.06 -65.11 0.61 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.21 -0.931 . . . . 0.0 110.177 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.631 HD11 ' HG3' ' A' ' 81' ' ' MET . 10.0 tt -89.27 120.79 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.331 -0.856 . . . . 0.0 109.845 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.668 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -86.93 -23.09 25.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 110.867 -179.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.99 -179.36 48.8 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.509 -1.329 . . . . 0.0 109.99 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.631 ' HG3' HD11 ' A' ' 78' ' ' ILE . 58.8 mtm -152.34 171.07 18.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -1.073 . . . . 0.0 110.292 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 116' ' ' LYS . 10.3 t -155.18 172.04 18.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.295 -0.878 . . . . 0.0 109.909 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.47 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -168.01 140.05 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.092 -1.005 . . . . 0.0 110.763 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.481 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 2.0 mt-10 61.94 10.23 3.46 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.477 -0.764 . . . . 0.0 111.749 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.67 0.51 30.66 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.362 -1.399 . . . . 0.0 111.093 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.481 ' NE2' ' CB ' ' A' ' 84' ' ' GLU . 3.6 p80 -132.56 154.55 49.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.645 -1.503 . . . . 0.0 110.519 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -162.41 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.516 -0.74 . . . . 0.0 110.173 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.491 ' CB ' ' CZ ' ' A' ' 104' ' ' PHE . 12.1 pt-20 -107.61 169.27 8.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 110.107 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -106.0 127.32 53.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.152 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.76 102.6 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.139 -0.976 . . . . 0.0 109.673 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 101' ' ' THR . 0.9 OUTLIER -94.74 -30.58 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 110.936 -179.201 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.409 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 54.4 p -167.15 103.89 0.54 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.091 -1.006 . . . . 0.0 109.986 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.456 ' HG3' ' CG ' ' A' ' 100' ' ' ARG . 21.4 ttmt -95.04 112.09 23.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 110.129 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.4 68.89 2.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.159 -0.963 . . . . 0.0 110.295 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.15 -29.05 56.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 110.266 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.51 -52.18 62.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.554 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -95.21 18.6 12.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -0.893 . . . . 0.0 110.552 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 51.0 61.32 3.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 110.21 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -147.14 169.89 18.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 110.024 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.456 ' CG ' ' HG3' ' A' ' 93' ' ' LYS . 0.8 OUTLIER -165.77 160.53 17.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.211 -0.93 . . . . 0.0 110.328 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.502 ' O ' HG22 ' A' ' 91' ' ' ILE . 87.6 m -141.31 147.22 37.81 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.568 -0.708 . . . . 0.0 109.393 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 3.7 p -145.53 141.8 28.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.034 -1.041 . . . . 0.0 110.842 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 5.2 tt0 -92.49 145.48 24.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.531 -0.731 . . . . 0.0 109.682 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CZ ' ' CB ' ' A' ' 88' ' ' GLU . 30.4 m-85 -126.48 141.44 51.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.117 -0.989 . . . . 0.0 111.01 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.417 ' C ' HG13 ' A' ' 106' ' ' VAL . 38.0 tt0 -102.49 124.67 48.47 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.494 -0.754 . . . . 0.0 109.393 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.417 HG13 ' C ' ' A' ' 105' ' ' GLU . 16.6 m -149.45 138.03 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.016 -1.053 . . . . 0.0 111.038 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.68 101.53 0.07 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 108.945 178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.865 ' H ' HD21 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 53.65 176.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.378 -178.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.515 HD22 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.18 83.22 1.38 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.85 -1.156 . . . . 0.0 111.218 -179.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.413 ' CB ' HG23 ' A' ' 146' ' ' THR . 13.6 t-20 -144.71 75.42 1.45 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.953 . . . . 0.0 110.15 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.32 -109.26 0.41 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HB3' ' HG2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -157.58 150.91 23.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -1.171 . . . . 0.0 110.437 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -136.14 147.02 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.436 -0.79 . . . . 0.0 109.827 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -75.83 114.26 14.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.997 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.94 179.21 16.57 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 27.1 mttp -144.08 160.69 40.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 0.0 109.9 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.675 HG21 HD11 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.29 146.45 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -0.975 . . . . 0.0 110.4 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.668 ' C ' HG22 ' A' ' 79' ' ' THR . 1.1 m-20 -105.57 156.3 18.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.414 -0.804 . . . . 0.0 109.405 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.583 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -131.97 146.0 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.159 -0.963 . . . . 0.0 110.44 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 1.1 t80 -151.6 109.3 3.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.37 -0.831 . . . . 0.0 110.246 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 54.8 mt -133.86 152.85 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.4 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 8.0 p-10 -160.46 95.28 1.11 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.81 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -174.26 -176.46 1.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 110.263 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -95.05 103.09 14.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 110.062 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.4 t -76.44 106.55 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 110.296 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.06 29.26 16.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 110.184 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.97 32.85 10.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.33 115.2 4.93 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.327 -1.102 . . . . 0.0 110.161 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -52.47 116.56 2.93 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.534 1.281 . . . . 0.0 110.187 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.473 ' CZ ' ' HB2' ' A' ' 132' ' ' TYR . 5.7 t80 -116.0 122.51 45.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.691 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.83 122.02 44.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -0.879 . . . . 0.0 109.921 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.583 ' HE2' HG11 ' A' ' 119' ' ' VAL . 1.7 t80 -138.73 119.71 14.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.27 -0.894 . . . . 0.0 110.169 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -168.53 85.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.127 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.25 -160.56 1.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.28 -0.887 . . . . 0.0 110.316 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.44 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -120.08 147.66 44.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.229 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 22.7 m-85 -155.68 -178.65 7.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.302 -0.873 . . . . 0.0 109.997 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 9.7 p30 -149.82 169.18 21.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 0.0 110.671 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.675 HD11 HG21 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -156.18 162.61 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 110.322 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 49.6 m -91.86 118.21 30.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.321 -0.862 . . . . 0.0 110.932 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.484 ' HD1' HG12 ' A' ' 38' ' ' VAL . 13.2 m-85 -90.91 101.43 14.19 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.274 -0.891 . . . . 0.0 110.017 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.43 ' HG2' ' HB3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -87.74 103.49 15.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.087 -1.008 . . . . 0.0 110.526 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 140' ' ' TYR . 60.6 m-85 -92.67 153.28 19.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 110.186 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 9.8 m-80 -141.52 103.2 4.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.153 -0.967 . . . . 0.0 110.331 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.907 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -156.46 -149.74 5.45 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.541 ' HD2' HD11 ' A' ' 34' ' ' LEU . 12.2 Cg_endo -62.76 -170.44 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.984 1.518 . . . . 0.0 110.43 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.413 HG23 ' CB ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -149.08 -42.6 0.14 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 110.105 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -144.75 -53.6 0.31 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.283 -0.886 . . . . 0.0 109.905 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.8 t 56.55 51.75 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 110.272 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.67 107.39 14.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 0.0 110.121 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.891 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.519 HMD3 HG23 ' A' ' 138' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.274 0.559 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -171.92 61.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.142 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.0 t30 60.86 28.69 18.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.378 -0.826 . . . . 0.0 109.989 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.02 72.36 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -0.825 . . . . 0.0 109.968 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.05 -56.65 4.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 110.081 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 1.0 OUTLIER 56.16 33.67 22.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.119 -0.988 . . . . 0.0 110.41 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -160.43 139.82 10.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 110.486 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.93 178.05 43.58 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.58 109.03 19.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.293 -1.122 . . . . 0.0 110.252 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.819 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.6 OUTLIER -94.99 153.21 17.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.266 -0.896 . . . . 0.0 110.805 -179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -81.05 135.56 35.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.85 . . . . 0.0 110.243 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.933 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -166.47 161.77 16.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.993 -1.067 . . . . 0.0 110.129 179.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -155.12 -165.61 2.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 0.0 110.356 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 139' ' ' THR . 0.0 OUTLIER -139.06 169.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 110.238 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.419 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 31.3 m-85 -148.32 159.82 43.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.316 -0.865 . . . . 0.0 109.907 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.427 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.4 OUTLIER -67.97 135.74 52.83 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.336 -0.852 . . . . 0.0 109.734 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.467 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -64.52 146.89 53.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.074 -1.016 . . . . 0.0 109.762 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 5.2 t-20 70.91 4.12 4.92 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.84 -0.537 . . . . 0.0 110.71 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.442 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -138.61 -167.53 2.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.944 -1.097 . . . . 0.0 109.498 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.442 ' N ' ' OG1' ' A' ' 43' ' ' THR . 37.4 m-80 -133.27 18.42 4.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.989 -1.069 . . . . 0.0 110.464 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -136.37 117.61 14.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.55 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.5 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -52.8 134.49 36.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.066 . . . . 0.0 109.261 179.352 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.35 -18.01 3.68 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.169 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.2 mt -138.1 -50.29 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.634 -1.291 . . . . 0.0 111.194 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HA ' ' HB3' ' A' ' 52' ' ' TYR . . . -80.95 7.71 10.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.49 -0.756 . . . . 0.0 111.532 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.459 ' O ' ' CE1' ' A' ' 53' ' ' PHE . 1.1 p-10 -69.32 -35.73 76.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.809 -1.182 . . . . 0.0 110.461 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -103.16 15.31 29.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.202 -0.936 . . . . 0.0 110.892 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.409 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -93.01 -8.38 43.14 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.966 -1.083 . . . . 0.0 111.021 -179.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.533 ' CE1' ' CG2' ' A' ' 38' ' ' VAL . 31.9 p90 -127.07 126.14 42.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.003 -1.061 . . . . 0.0 110.719 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.571 ' HB3' HG21 ' A' ' 71' ' ' THR . 19.7 t-20 -73.95 104.39 4.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.024 -1.047 . . . . 0.0 109.883 179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 1.6 pttt -92.58 164.96 20.48 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 110.125 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.435 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 50.1 Cg_endo -77.92 -177.58 21.52 Favored 'Cis proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.519 -2.284 . . . . 0.0 110.569 -0.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.933 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -103.1 167.47 9.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.962 . . . . 0.0 110.25 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.461 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -102.95 114.51 28.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 110.09 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.0 p90 -96.98 162.21 13.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 110.056 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -154.97 155.13 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 110.311 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 24.6 mtmt -137.73 170.78 15.46 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.332 -0.855 . . . . 0.0 110.85 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.444 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -155.98 62.43 0.58 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.655 -0.653 . . . . 0.0 109.745 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.23 92.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.327 -0.858 . . . . 0.0 110.992 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.7 27.19 54.77 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.258 -0.972 . . . . 0.0 110.763 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.444 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 7.9 ptpt -171.81 158.51 4.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.972 -1.311 . . . . 0.0 111.0 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.868 HD21 ' H ' ' A' ' 108' ' ' LYS . 1.7 pt? -170.72 147.11 2.75 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.166 0.984 . . . . 0.0 111.615 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -138.32 171.37 14.49 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.473 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.83 143.27 24.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.975 -1.078 . . . . 0.0 109.971 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.461 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -97.0 135.67 38.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.24 -0.913 . . . . 0.0 110.087 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.2 OUTLIER -110.9 140.14 31.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.388 -0.82 . . . . 0.0 109.63 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.571 HG21 ' HB3' ' A' ' 54' ' ' ASN . 1.8 m -87.86 138.4 31.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.132 -0.98 . . . . 0.0 110.223 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.65 ' CG1' HG21 ' A' ' 78' ' ' ILE . 15.5 t -103.16 122.28 55.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.462 -0.774 . . . . 0.0 109.991 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.98 130.37 46.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 110.268 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.526 ' O ' HG22 ' A' ' 78' ' ' ILE . 4.8 t60 57.7 94.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.254 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t -71.79 -12.23 61.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.909 . . . . 0.0 110.593 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -74.64 -26.1 59.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.103 -0.998 . . . . 0.0 110.345 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.483 ' CE2' HBB2 ' A' ' 151' ' ' ZNH . 21.3 m0 -94.17 -47.34 6.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 0.0 110.39 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.65 HG21 ' CG1' ' A' ' 72' ' ' VAL . 6.8 tp -88.46 115.98 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 110.118 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.585 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -87.41 -23.06 24.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.356 -0.84 . . . . 0.0 110.442 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.55 178.17 48.54 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.463 ' HE3' ' HB3' ' A' ' 102' ' ' SER . 0.0 OUTLIER -152.9 161.14 42.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -1.074 . . . . 0.0 110.194 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 116' ' ' LYS . 2.4 t -155.12 149.67 26.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.032 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.568 HD12 ' CD2' ' A' ' 104' ' ' PHE . 4.8 mt -141.83 144.41 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 110.427 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 69.67 3.85 4.44 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.498 -0.751 . . . . 0.0 111.119 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.55 20.79 21.21 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.718 -1.23 . . . . 0.0 111.116 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.457 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.04 163.31 31.05 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.713 -1.463 . . . . 0.0 110.174 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -177.69 1.85 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.108 -0.995 . . . . 0.0 110.31 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -110.01 169.61 8.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.347 -0.846 . . . . 0.0 110.209 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.64 124.95 53.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.948 . . . . 0.0 110.191 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pp -67.43 102.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 109.796 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 101' ' ' THR . 1.8 tt -95.19 -28.12 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.388 -0.82 . . . . 0.0 110.784 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 3.9 m -166.77 101.04 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.194 -0.941 . . . . 0.0 109.734 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -94.96 152.09 18.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.444 -0.785 . . . . 0.0 110.336 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -144.38 83.46 1.72 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 110.16 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 p -70.55 -27.05 63.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 110.326 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.59 -52.75 62.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 0.0 110.064 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.5 mtmm -96.21 17.75 15.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.311 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 51.97 60.27 3.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -0.994 . . . . 0.0 110.249 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 94' ' ' ASN . 34.0 mt-10 -148.28 167.39 25.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 110.47 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.473 ' CG ' ' N ' ' A' ' 101' ' ' THR . 33.7 ttt180 -174.56 167.45 3.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.388 -0.82 . . . . 0.0 109.682 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.473 ' N ' ' CG ' ' A' ' 100' ' ' ARG . 94.9 m -141.44 153.95 45.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.962 . . . . 0.0 109.837 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.463 ' HB3' ' HE3' ' A' ' 81' ' ' MET . 83.6 p -145.38 141.1 28.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.112 -0.992 . . . . 0.0 110.68 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.32 146.65 23.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.896 . . . . 0.0 109.991 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.568 ' CD2' HD12 ' A' ' 83' ' ' ILE . 45.8 m-85 -129.14 147.74 51.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 0.0 110.675 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.489 ' C ' HG13 ' A' ' 106' ' ' VAL . 35.7 tt0 -105.53 125.83 51.43 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.384 -0.823 . . . . 0.0 109.789 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.489 HG13 ' C ' ' A' ' 105' ' ' GLU . 33.8 m -150.16 152.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.968 . . . . 0.0 110.956 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.2 m -71.95 105.93 4.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.276 -0.89 . . . . 0.0 109.291 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.868 ' H ' HD21 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 50.23 -178.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.494 -0.754 . . . . 0.0 109.734 -178.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.742 HD22 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -151.22 81.93 1.31 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.824 -1.172 . . . . 0.0 110.996 -179.385 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.422 ' CG ' HG23 ' A' ' 146' ' ' THR . 0.2 OUTLIER -145.61 67.71 1.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 110.191 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 162.57 -109.91 0.41 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.417 ' HB2' ' HG2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -157.19 148.1 21.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -1.118 . . . . 0.0 109.65 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 63.9 mt -136.27 150.74 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.902 . . . . 0.0 110.274 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.92 131.95 38.81 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.356 -0.84 . . . . 0.0 110.114 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -138.08 178.97 18.8 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 3.3 mtpp -144.6 164.46 30.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -1.179 . . . . 0.0 110.08 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.547 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.86 141.55 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.07 -1.019 . . . . 0.0 110.694 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.585 ' C ' HG22 ' A' ' 79' ' ' THR . 6.1 m-20 -104.12 152.46 22.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.268 -0.895 . . . . 0.0 109.72 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.2 OUTLIER -128.71 154.09 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.132 -0.98 . . . . 0.0 110.345 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -151.55 102.45 2.88 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.21 -0.931 . . . . 0.0 110.738 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.556 HD13 ' CBB' ' A' ' 151' ' ' ZNH . 3.8 mt -133.38 152.88 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.324 -0.86 . . . . 0.0 110.097 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.34 95.38 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.981 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 129' ' ' PRO . 19.1 pt-20 -174.81 -156.38 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.286 -0.884 . . . . 0.0 110.248 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.433 ' HG2' ' CA ' ' A' ' 129' ' ' PRO . 11.7 mttt -122.46 120.99 35.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.28 -0.887 . . . . 0.0 110.25 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.702 HG23 ' CE1' ' A' ' 130' ' ' PHE . 89.6 t -76.91 92.33 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 110.363 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.31 31.48 11.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.269 -0.895 . . . . 0.0 110.302 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.23 35.58 2.29 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 3.7 mtmt -145.43 85.44 7.94 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.358 -1.084 . . . . 0.0 110.124 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.433 ' CA ' ' HG2' ' A' ' 124' ' ' LYS . 11.3 Cg_endo -59.3 129.49 31.65 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.983 1.517 . . . . 0.0 110.287 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.702 ' CE1' HG23 ' A' ' 125' ' ' VAL . 7.6 p90 -156.14 139.85 16.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 110.452 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -105.36 131.9 52.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.391 -0.818 . . . . 0.0 110.007 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.497 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 5.9 t80 -131.47 129.92 41.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.0 110.138 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 16.6 t0 -174.44 89.56 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.343 -0.848 . . . . 0.0 110.064 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.83 -168.42 3.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 110.188 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.17 85.93 2.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.407 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.427 ' CD1' HAD1 ' A' ' 151' ' ' ZNH . 30.5 m-85 -85.01 -178.98 6.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.862 . . . . 0.0 109.796 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.65 ' O ' HG23 ' A' ' 138' ' ' ILE . 29.2 p30 -150.42 168.98 22.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.025 -1.047 . . . . 0.0 110.654 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 137' ' ' ASN . 2.3 pt -157.83 173.69 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.324 -0.86 . . . . 0.0 110.784 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.76 ' O ' HG12 ' A' ' 38' ' ' VAL . 90.8 m -92.01 163.6 13.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.622 -0.674 . . . . 0.0 110.282 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.524 ' CD1' ' CG1' ' A' ' 38' ' ' VAL . 97.3 m-85 -141.79 100.49 3.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 109.643 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 2.0 mttt -82.5 108.95 16.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 110.833 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -92.17 140.65 29.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.99 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -129.64 96.04 4.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 110.339 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.819 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -149.14 -152.68 5.79 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -62.49 139.17 74.86 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.943 1.496 . . . . 0.0 110.356 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.422 HG23 ' CG ' ' A' ' 110' ' ' ASN . 0.3 OUTLIER -91.12 -36.37 14.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.473 -179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -133.82 -155.03 0.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 110.417 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.8 t 56.99 86.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 110.122 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.72 -22.21 37.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 0.0 110.223 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.556 ' CBB' HD13 ' A' ' 121' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.552 ' N ' ' HB2' ' A' ' 28' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.279 0.561 . . . . 0.0 110.252 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 25' ' ' SER . . . 60.64 103.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.375 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 t30 62.74 29.48 16.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.941 . . . . 0.0 109.994 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.552 ' HB2' ' N ' ' A' ' 25' ' ' SER . . . -65.38 100.03 0.45 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.9 -72.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.192 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 5.9 m-20 56.67 25.97 10.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.185 -0.947 . . . . 0.0 110.31 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.43 153.34 25.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.105 -0.997 . . . . 0.0 110.532 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.431 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 172.18 170.1 35.67 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.482 HG23 ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -88.25 111.08 21.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -1.117 . . . . 0.0 110.152 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.058 HD13 HD22 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -94.78 155.39 16.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 0.0 110.646 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 3.0 t-20 -81.6 137.83 35.45 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.355 -0.84 . . . . 0.0 109.693 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.833 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -167.98 163.72 13.7 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.992 -1.067 . . . . 0.0 110.587 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.05 -168.33 2.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.37 -0.831 . . . . 0.0 109.823 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.748 ' O ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -139.82 -178.42 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.971 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.417 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 15.4 m-85 -149.22 150.71 33.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.319 -0.863 . . . . 0.0 110.047 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.413 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.5 OUTLIER -67.56 127.83 34.19 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.397 -0.814 . . . . 0.0 109.87 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.48 ' O ' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -55.9 147.27 19.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.142 -0.973 . . . . 0.0 109.921 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER 72.32 1.18 3.86 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.865 -0.522 . . . . 0.0 110.792 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.29 -166.49 1.94 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.873 -1.142 . . . . 0.0 109.559 179.192 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.408 ' N ' ' OG1' ' A' ' 43' ' ' THR . 23.0 m-80 -133.34 16.14 4.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -136.54 121.82 19.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.481 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.748 HG23 ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -51.15 132.25 28.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 109.226 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.459 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -128.98 -17.58 3.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.889 -1.132 . . . . 0.0 111.926 -178.746 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.459 HD12 ' HB3' ' A' ' 47' ' ' SER . 1.8 mp -137.5 -75.61 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.827 -1.17 . . . . 0.0 110.572 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 52' ' ' TYR . . . -47.48 -24.99 0.95 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.679 -0.638 . . . . 0.0 110.928 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.443 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.7 OUTLIER -46.65 -34.31 4.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.242 -0.911 . . . . 0.0 111.134 -179.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -102.19 15.76 28.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.044 -1.035 . . . . 0.0 110.986 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.52 ' CE1' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -99.25 -15.89 18.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.015 -1.053 . . . . 0.0 110.971 -179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.501 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 21.3 p90 -118.6 128.39 54.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.928 -1.108 . . . . 0.0 110.993 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -74.97 114.42 13.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.095 -1.003 . . . . 0.0 109.91 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.75 159.64 35.8 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.036 . . . . 0.0 109.994 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -81.45 -175.28 15.37 Favored 'Cis proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.643 -2.232 . . . . 0.0 110.667 -0.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.833 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.45 172.81 6.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.197 -0.939 . . . . 0.0 110.041 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HD2' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -106.31 116.6 32.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.25 -0.906 . . . . 0.0 111.076 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.48 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 6.9 p90 -98.14 161.77 13.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.237 -0.915 . . . . 0.0 109.523 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.537 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -155.42 122.08 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.951 -1.093 . . . . 0.0 111.034 -179.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.473 ' HD3' HD21 ' A' ' 109' ' ' LEU . 1.6 mtmt -139.39 131.52 28.06 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.0 110.212 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -109.21 62.42 0.6 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.196 -0.94 . . . . 0.0 110.441 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 62' ' ' LYS . 14.0 t-20 49.62 100.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.402 -0.811 . . . . 0.0 111.119 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.26 -17.96 56.17 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HB2' ' OH ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -140.43 152.8 45.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.154 -1.203 . . . . 0.0 110.201 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.812 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -155.07 142.81 19.87 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.938 0.875 . . . . 0.0 111.012 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.537 ' HB2' HG23 ' A' ' 60' ' ' ILE . 5.7 m-85 -140.03 -170.15 2.89 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.54 -0.725 . . . . 0.0 109.352 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -162.06 165.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.098 -1.001 . . . . 0.0 109.882 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 102' ' ' SER . 1.3 pt20 -140.45 143.66 35.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.198 -0.938 . . . . 0.0 110.472 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -115.56 128.51 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.335 -0.853 . . . . 0.0 110.258 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.7 m -88.83 124.33 34.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.482 HG11 ' CE ' ' A' ' 81' ' ' MET . 0.8 OUTLIER -102.68 138.93 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.0 110.386 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -101.0 135.03 43.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.325 -0.859 . . . . 0.0 110.238 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.439 ' O ' HG22 ' A' ' 78' ' ' ILE . 6.1 m80 60.4 102.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.295 -0.878 . . . . 0.0 110.036 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 t -64.47 -33.44 75.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.887 . . . . 0.0 110.377 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -52.49 -57.78 8.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 110.257 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.533 ' HA ' HD11 ' A' ' 121' ' ' ILE . 13.2 m0 -55.62 -62.52 1.63 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 110.382 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 78' ' ' ILE . 2.9 tp -88.78 114.01 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 109.97 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.79 -26.28 24.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 110.782 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.46 174.89 45.67 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.074 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.482 ' CE ' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -152.28 163.23 39.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -1.042 . . . . 0.0 109.962 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -155.66 167.62 29.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.824 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.601 HD11 ' CD1' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -164.62 154.13 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 110.033 179.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.521 ' HB2' ' CE1' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 59.74 15.02 4.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.049 -1.032 . . . . 0.0 110.859 179.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.28 23.23 55.14 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.031 -1.081 . . . . 0.0 110.976 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.521 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 2.0 p-80 -138.27 161.58 36.51 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.67 -1.488 . . . . 0.0 110.623 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.27 179.35 2.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.851 . . . . 0.0 110.971 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 2.1 pt-20 -99.39 170.13 8.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 110.663 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 102' ' ' SER . 2.2 t30 -116.78 133.73 55.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.476 -0.765 . . . . 0.0 109.468 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.589 HG22 ' NH2' ' A' ' 100' ' ' ARG . 1.1 pp -67.45 101.53 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.954 -1.092 . . . . 0.0 109.871 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.5 HG21 HG22 ' A' ' 101' ' ' THR . 0.5 OUTLIER -95.41 -31.22 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.838 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.418 ' N ' ' CG2' ' A' ' 91' ' ' ILE . 11.0 m -166.73 95.21 0.52 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.109 -0.994 . . . . 0.0 110.009 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -95.9 95.3 8.15 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.478 -0.763 . . . . 0.0 110.156 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.09 91.25 5.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.175 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.73 -27.64 60.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 110.202 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.61 -45.37 93.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -0.936 . . . . 0.0 110.129 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.93 18.7 12.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.31 -0.869 . . . . 0.0 110.23 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 t0 50.48 61.75 3.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 110.043 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -148.09 166.72 26.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 110.515 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.589 ' NH2' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -168.93 147.71 4.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.453 -0.779 . . . . 0.0 109.533 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.5 HG22 HG21 ' A' ' 91' ' ' ILE . 62.9 m -141.55 158.22 44.12 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.163 -0.96 . . . . 0.0 109.867 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 81.3 p -145.06 143.45 30.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 110.375 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 1.5 tm-20 -92.6 141.26 28.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 110.2 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -123.81 148.65 46.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.279 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -98.3 132.29 43.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.37 -0.832 . . . . 0.0 110.075 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.558 HG13 HD21 ' A' ' 66' ' ' LEU . 8.9 p -149.08 166.88 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.202 -0.936 . . . . 0.0 110.245 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 106' ' ' VAL . 1.5 t -69.63 -35.3 75.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 109.846 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.461 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -164.5 -148.9 0.12 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.503 -0.748 . . . . 0.0 109.325 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 1.058 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.06 51.92 0.91 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.726 -1.234 . . . . 0.0 111.232 -179.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 12.9 t-20 -146.31 70.23 1.22 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.099 -1.001 . . . . 0.0 110.492 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 142' ' ' PHE . . . 172.12 -129.25 1.7 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.467 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.0 OUTLIER -156.65 140.87 16.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.323 -1.104 . . . . 0.0 109.839 -179.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.467 ' CD1' HG23 ' A' ' 106' ' ' VAL . 2.5 mt -135.33 153.87 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.164 -0.96 . . . . 0.0 110.019 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -76.2 137.08 39.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.076 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 83' ' ' ILE . . . -137.35 177.23 20.0 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 82' ' ' SER . 16.7 mttt -144.14 156.16 44.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -1.139 . . . . 0.0 109.76 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.585 ' O ' HD13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -157.73 151.16 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.006 -1.059 . . . . 0.0 110.578 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.621 ' O ' HG22 ' A' ' 79' ' ' THR . 0.9 OUTLIER -112.14 158.37 19.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.412 -0.805 . . . . 0.0 109.386 179.357 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.481 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -129.77 148.35 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -0.976 . . . . 0.0 110.053 -179.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.78 102.24 2.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 110.769 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.649 HD13 HBB1 ' A' ' 151' ' ' ZNH . 2.6 mp -133.72 151.9 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -0.987 . . . . 0.0 110.162 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 1.2 p-10 -160.57 98.45 1.24 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.354 -0.842 . . . . 0.0 109.73 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -173.75 -156.95 0.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 110.553 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.586 ' O ' HG23 ' A' ' 125' ' ' VAL . 18.6 mtpt -91.27 165.22 13.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.416 -0.803 . . . . 0.0 110.608 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 124' ' ' LYS . 47.6 t -157.88 99.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 67.18 25.83 8.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.531 -0.731 . . . . 0.0 109.611 -178.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 86.53 34.25 12.18 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 0.6 OUTLIER -147.89 134.25 9.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.22 -1.165 . . . . 0.0 110.303 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 128' ' ' LYS . 20.5 Cg_exo -60.85 129.09 27.64 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.581 1.306 . . . . 0.0 110.141 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.759 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 46.2 t80 -121.01 145.8 47.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.167 -0.958 . . . . 0.0 110.385 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -136.08 118.21 15.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.211 -0.931 . . . . 0.0 110.146 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.494 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 3.7 t80 -129.73 131.47 46.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 109.804 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -177.37 87.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -0.971 . . . . 0.0 110.04 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.66 -163.9 1.76 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 0.0 110.536 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.461 ' O ' ' CD1' ' A' ' 136' ' ' TYR . 4.2 p80 -118.69 143.66 46.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.279 -0.888 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.478 ' CD1' HBD2 ' A' ' 151' ' ' ZNH . 13.0 m-85 -154.85 -179.45 8.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 110.117 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.62 ' O ' HG23 ' A' ' 138' ' ' ILE . 1.7 p30 -152.1 172.11 16.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 0.0 110.584 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.62 HG23 ' O ' ' A' ' 137' ' ' ASN . 3.9 pt -157.17 162.93 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.844 . . . . 0.0 110.173 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.467 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 45.1 m -92.0 126.92 37.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.3 -0.875 . . . . 0.0 110.594 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.601 ' CD1' HD11 ' A' ' 83' ' ' ILE . 14.4 m-85 -89.48 154.23 20.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -0.949 . . . . 0.0 109.654 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -137.89 105.52 5.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.041 -1.037 . . . . 0.0 110.397 -179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.47 ' HB3' ' CA ' ' A' ' 109' ' ' LEU . 31.7 m-85 -91.99 134.72 34.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 0.0 110.374 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 4.2 m-80 -132.11 103.56 6.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 0.0 110.311 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.898 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -164.71 -150.38 6.15 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.742 ' HD2' HD11 ' A' ' 34' ' ' LEU . 9.4 Cg_endo -57.56 -165.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.765 1.402 . . . . 0.0 110.457 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.2 p -149.54 -52.58 0.16 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -0.946 . . . . 0.0 110.09 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.62 -60.12 1.93 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.048 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.2 t 56.77 51.95 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.359 -0.838 . . . . 0.0 110.335 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.88 -5.4 58.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.2 -0.938 . . . . 0.0 110.67 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.987 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.759 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.3 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.262 0.553 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.6 65.75 0.08 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.908 . . . . 0.0 110.092 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 62.15 21.37 12.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.929 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.66 135.51 49.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.291 -0.88 . . . . 0.0 109.934 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 43.72 -160.54 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.71 -0.618 . . . . 0.0 110.419 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 25.4 m-20 54.66 31.33 15.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 110.196 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 59' ' ' TYR . 15.1 t -160.39 169.68 22.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 110.789 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.9 171.71 25.06 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.69 105.18 17.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.1 -1.235 . . . . 0.0 110.217 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.838 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -94.21 156.05 16.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 0.0 110.414 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.411 ' O ' ' N ' ' A' ' 143' ' ' ASN . 14.9 m-20 -79.86 140.83 36.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.214 -0.929 . . . . 0.0 109.738 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.664 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -165.91 158.18 14.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.98 . . . . 0.0 110.181 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -155.37 -168.89 2.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.258 -0.901 . . . . 0.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.473 ' C ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -140.07 173.97 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 109.796 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.402 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 27.6 m-85 -148.22 156.48 42.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 110.491 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 128.93 38.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.528 -0.732 . . . . 0.0 109.766 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.508 ' CE2' ' ND2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -58.18 148.26 27.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.098 -1.001 . . . . 0.0 109.879 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 11.0 m-20 71.08 2.44 4.24 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.816 -0.552 . . . . 0.0 110.961 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.96 -165.49 1.75 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.944 -1.098 . . . . 0.0 109.684 179.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' N ' ' OG1' ' A' ' 43' ' ' THR . 64.1 t30 -133.86 16.13 3.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 110.19 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -136.01 118.31 15.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 110.583 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.473 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -51.37 128.61 23.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.988 . . . . 0.0 109.099 179.247 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.49 -16.13 3.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.008 -1.058 . . . . 0.0 112.222 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.18 -64.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.792 -1.193 . . . . 0.0 110.907 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.49 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -52.39 -21.9 4.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.452 -0.78 . . . . 0.0 111.147 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -8.97 46.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.054 -1.029 . . . . 0.0 110.951 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.404 ' C ' ' CG ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -97.78 8.49 44.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.013 -1.055 . . . . 0.0 110.913 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.404 ' CG ' ' C ' ' A' ' 51' ' ' ASP . 7.1 m-85 -142.44 17.3 2.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.966 -1.084 . . . . 0.0 110.342 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -119.49 107.22 13.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.439 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -72.88 155.09 40.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 110.249 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.425 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -146.68 167.22 14.3 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.121 -0.987 . . . . 0.0 110.026 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.425 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 49.8 Cg_endo -77.06 -175.31 16.47 Favored 'Cis proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.681 -2.216 . . . . 0.0 110.481 -0.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.664 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -100.4 162.43 12.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 109.975 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.463 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . 0.5 OUTLIER -102.08 117.03 33.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 110.304 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.489 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.7 p90 -97.51 160.95 14.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 109.776 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.504 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -155.35 127.42 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.056 -1.028 . . . . 0.0 110.559 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HG2' ' CB ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER -136.61 119.36 16.15 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.206 -0.934 . . . . 0.0 110.783 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.2 OUTLIER -96.01 62.05 2.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.384 -0.822 . . . . 0.0 110.393 179.62 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.403 ' O ' ' O ' ' A' ' 62' ' ' LYS . 41.3 t30 46.62 99.17 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.58 -0.7 . . . . 0.0 111.407 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.83 5.03 54.15 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.436 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.714 ' C ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.58 158.91 16.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.894 -1.357 . . . . 0.0 110.199 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.803 ' N ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -155.13 149.81 26.46 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 122.171 0.986 . . . . 0.0 111.199 178.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.519 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 5.0 m-85 -142.74 -164.71 1.89 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.388 -0.82 . . . . 0.0 109.242 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.441 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -170.56 134.12 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.082 -1.011 . . . . 0.0 110.102 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.463 ' HG2' ' HB3' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -97.59 134.15 41.18 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.157 -0.965 . . . . 0.0 109.568 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.1 OUTLIER -112.81 137.64 45.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.864 -179.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.5 m -88.6 135.17 33.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 109.972 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.846 HG22 ' CE ' ' A' ' 81' ' ' MET . 3.4 t -102.38 123.98 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.283 -0.886 . . . . 0.0 109.943 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -98.31 126.85 43.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 0.0 110.247 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.637 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER 62.36 99.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 110.328 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -32.62 66.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 110.09 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -58.95 -41.63 87.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.16 -0.963 . . . . 0.0 110.041 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.656 ' O ' HG12 ' A' ' 119' ' ' VAL . 45.1 m0 -71.48 -62.11 1.53 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.375 -0.828 . . . . 0.0 110.128 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.642 HD12 HBC2 ' A' ' 151' ' ' ZNH . 9.9 tt -89.3 122.13 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 109.691 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.709 HG22 ' C ' ' A' ' 118' ' ' ASP . 1.0 OUTLIER -87.14 -23.25 24.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.385 -0.822 . . . . 0.0 111.114 -179.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.409 ' O ' HG12 ' A' ' 117' ' ' ILE . . . -178.38 179.94 48.47 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.017 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.846 ' CE ' HG22 ' A' ' 72' ' ' VAL . 47.5 mtm -152.45 171.12 18.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.346 -1.09 . . . . 0.0 109.94 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -155.21 164.45 38.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.214 -0.929 . . . . 0.0 110.233 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.683 HD12 ' CG ' ' A' ' 104' ' ' PHE . 7.4 mt -155.59 135.54 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 110.542 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 1.6 tm-20 69.54 3.44 4.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.406 -0.808 . . . . 0.0 111.428 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.64 21.5 12.52 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.136 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.477 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -136.95 159.05 43.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.722 -1.458 . . . . 0.0 110.138 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -178.98 2.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.083 -1.011 . . . . 0.0 110.354 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.447 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 1.7 pt-20 -106.6 167.59 9.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.34 -0.85 . . . . 0.0 110.043 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.28 129.79 55.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 110.349 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.519 HD12 ' O ' ' A' ' 90' ' ' ILE . 1.4 pp -68.28 101.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.903 . . . . 0.0 109.671 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.55 HG21 HG22 ' A' ' 101' ' ' THR . 1.8 tt -95.3 -28.87 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.384 -0.822 . . . . 0.0 110.716 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 26.9 p -167.33 107.41 0.59 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.022 -1.049 . . . . 0.0 109.935 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.419 ' HA ' ' HG3' ' A' ' 100' ' ' ARG . 24.3 ttmt -95.41 110.33 22.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -0.869 . . . . 0.0 110.153 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.84 81.27 3.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 110.197 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.9 p -69.56 -26.56 64.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.254 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.62 -52.33 63.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.199 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -95.79 19.91 10.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 110.304 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 50.36 63.75 2.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 109.996 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -147.56 -177.98 6.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.858 . . . . 0.0 110.408 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.419 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 3.9 ttm180 -176.32 164.97 2.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.835 . . . . 0.0 109.715 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.55 HG22 HG21 ' A' ' 91' ' ' ILE . 93.3 m -142.6 154.86 44.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.158 -0.964 . . . . 0.0 109.755 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 p -145.53 144.25 30.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.905 -1.122 . . . . 0.0 110.721 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -92.69 140.34 29.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.299 -0.876 . . . . 0.0 109.792 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.683 ' CG ' HD12 ' A' ' 83' ' ' ILE . 32.6 m-85 -126.58 149.62 49.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.119 -0.988 . . . . 0.0 111.066 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.456 ' C ' HG13 ' A' ' 106' ' ' VAL . 1.6 tt0 -119.74 126.35 50.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.46 -0.775 . . . . 0.0 109.477 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.472 ' O ' HD21 ' A' ' 66' ' ' LEU . 22.9 m -149.97 -164.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.972 -1.08 . . . . 0.0 110.778 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.2 t -98.46 112.0 24.17 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.451 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.26 -165.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.521 -0.737 . . . . 0.0 109.661 -178.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.469 ' CD2' ' HB2' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -151.91 60.2 0.86 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.87 -1.144 . . . . 0.0 111.188 -179.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.583 ' HB3' HG23 ' A' ' 146' ' ' THR . 8.1 t-20 -146.33 80.5 1.56 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.124 -0.985 . . . . 0.0 110.435 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.59 -117.19 0.75 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' CG ' ' CG2' ' A' ' 139' ' ' THR . 3.7 ttpt -157.52 145.27 18.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.346 -1.091 . . . . 0.0 110.041 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.6 mt -137.39 146.02 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.352 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -76.83 108.9 10.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.222 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.461 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -111.37 177.99 19.26 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 82' ' ' SER . 22.2 mttt -145.45 161.23 40.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -1.125 . . . . 0.0 109.89 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.455 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.8 147.15 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.095 -1.003 . . . . 0.0 110.682 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.709 ' C ' HG22 ' A' ' 79' ' ' THR . 39.6 m-20 -106.39 159.32 16.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.394 -0.816 . . . . 0.0 109.149 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -140.92 147.29 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.027 -1.045 . . . . 0.0 110.684 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -153.34 113.89 4.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -0.872 . . . . 0.0 110.711 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 43.9 mt -137.69 152.94 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.103 -0.998 . . . . 0.0 110.386 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -160.08 95.43 1.16 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.376 -0.828 . . . . 0.0 109.85 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -173.81 -173.95 0.9 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.885 . . . . 0.0 110.354 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -104.47 121.35 43.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 110.263 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.3 95.04 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.102 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.05 39.02 30.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 110.29 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 96.45 31.46 7.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -145.33 100.39 4.46 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.316 -1.108 . . . . 0.0 110.134 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -50.4 132.84 35.83 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.869 1.457 . . . . 0.0 110.191 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.486 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 2.9 t80 -139.39 127.79 22.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 110.301 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.21 136.99 43.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.143 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.444 ' HB3' ' HB ' ' A' ' 121' ' ' ILE . 1.8 t80 -153.22 123.94 7.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 110.188 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -177.08 86.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.21 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -153.09 -165.31 2.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.9 . . . . 0.0 110.249 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.4 OUTLIER -119.35 140.13 50.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.891 . . . . 0.0 110.283 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.463 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 61.4 m-85 -154.6 -179.17 7.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.874 . . . . 0.0 109.871 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.508 ' ND2' ' CE2' ' A' ' 41' ' ' TYR . 40.0 p30 -151.1 176.59 11.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.129 -0.982 . . . . 0.0 110.787 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.49 HG21 ' HB2' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -156.35 171.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.476 -0.765 . . . . 0.0 109.673 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.478 ' CG2' ' CG ' ' A' ' 112' ' ' LYS . 26.1 m -91.76 118.04 30.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.976 . . . . 0.0 110.698 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.461 ' CD1' ' HA3' ' A' ' 115' ' ' GLY . 18.6 m-85 -89.68 108.11 19.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 109.61 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -97.48 161.67 13.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.723 -179.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -148.11 153.04 38.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.476 -0.765 . . . . 0.0 109.936 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 35' ' ' ASN . 31.4 m-80 -138.74 101.8 4.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 110.419 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.838 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -159.46 -154.5 7.29 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.56 ' HD2' HD11 ' A' ' 34' ' ' LEU . 19.7 Cg_endo -64.44 -175.68 0.35 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.999 1.526 . . . . 0.0 110.707 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.583 HG23 ' HB3' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -149.13 -61.47 0.23 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.401 -0.812 . . . . 0.0 110.209 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' A' ' 148' ' ' VAL . 0.3 OUTLIER -98.3 -71.62 0.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 0.0 110.294 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.532 ' O ' HG12 ' A' ' 148' ' ' VAL . 38.6 t 56.18 42.85 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.357 -0.839 . . . . 0.0 110.078 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.74 86.77 6.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.361 -0.837 . . . . 0.0 110.255 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.642 HBC2 HD12 ' A' ' 78' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.138 0.494 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -106.53 116.46 31.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.086 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 0.1 OUTLIER 63.86 20.96 12.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.318 -0.864 . . . . 0.0 110.109 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.58 74.5 4.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 110.193 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.45 -153.97 0.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.335 -0.853 . . . . 0.0 110.213 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 2.1 m-20 54.99 30.24 13.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 110.187 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 p -159.58 147.87 17.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.019 . . . . 0.0 110.666 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.11 -179.33 45.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.04 119.68 28.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.176 -1.191 . . . . 0.0 110.26 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.87 HD11 ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -94.4 131.83 39.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.427 -0.796 . . . . 0.0 110.893 -179.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.445 ' N ' HD23 ' A' ' 34' ' ' LEU . 47.6 t30 -78.74 128.96 34.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.099 -1.0 . . . . 0.0 108.547 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.669 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -164.45 164.53 21.95 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.702 -1.249 . . . . 0.0 111.477 -178.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.98 -167.29 2.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.19 173.67 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.919 -1.113 . . . . 0.0 110.447 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -148.09 154.61 40.43 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.444 -0.785 . . . . 0.0 109.697 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.403 ' CE ' ' HA ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -66.99 140.58 57.73 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.334 -0.853 . . . . 0.0 109.771 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.507 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -63.28 147.16 51.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.993 . . . . 0.0 110.205 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.4 OUTLIER 69.0 5.98 5.37 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.673 -0.642 . . . . 0.0 110.681 -179.452 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.01 -167.42 2.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.027 -1.045 . . . . 0.0 109.344 179.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.44 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.9 OUTLIER -131.62 13.77 4.93 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.0 110.147 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -136.44 133.62 36.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.15 -0.969 . . . . 0.0 110.715 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.447 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -62.18 136.49 57.96 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.252 -0.905 . . . . 0.0 109.087 179.29 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.649 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -126.28 -17.96 5.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.917 -1.114 . . . . 0.0 111.81 -178.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.682 HG22 ' N ' ' A' ' 49' ' ' ALA . 1.2 mp -137.98 -74.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.897 -1.127 . . . . 0.0 110.532 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.682 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -45.13 -26.63 0.49 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.769 -0.582 . . . . 0.0 111.238 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.447 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -52.57 -23.64 6.78 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.094 -1.004 . . . . 0.0 111.102 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -102.73 15.41 29.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.969 -1.082 . . . . 0.0 111.026 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 52.7 m-85 -123.06 -10.64 8.13 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.039 -1.038 . . . . 0.0 110.967 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CZ ' ' CE ' ' A' ' 81' ' ' MET . 17.5 m-85 -119.52 115.33 23.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.063 -1.023 . . . . 0.0 110.309 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -72.24 169.47 16.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 110.6 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 161.96 33.76 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.428 -0.795 . . . . 0.0 109.76 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -83.6 -175.07 13.46 Favored 'Cis proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.592 -2.253 . . . . 0.0 110.728 -0.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.669 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -99.49 -171.46 2.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.369 -0.832 . . . . 0.0 109.752 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.413 ' HB2' ' NE2' ' A' ' 69' ' ' GLN . 3.8 mttp -127.63 121.16 29.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.055 -1.028 . . . . 0.0 110.372 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.527 ' HB3' HD12 ' A' ' 34' ' ' LEU . 38.6 p90 -96.36 161.28 14.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 0.0 109.893 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.638 HG23 ' HD1' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -155.19 121.03 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 110.609 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.517 ' CE ' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -130.88 117.91 19.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.089 -1.007 . . . . 0.0 110.654 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -93.61 61.57 3.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.25 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 49.62 101.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.555 -0.715 . . . . 0.0 111.431 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.1 56.99 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.466 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -142.49 158.62 43.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.056 -1.261 . . . . 0.0 110.08 179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.853 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -158.86 138.28 11.59 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.988 0.899 . . . . 0.0 111.201 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.638 ' HD1' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.56 178.95 7.1 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.633 -0.667 . . . . 0.0 109.308 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.06 141.42 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 0.0 110.472 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 58' ' ' LYS . 11.2 pt20 -98.38 144.2 28.02 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 109.922 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.98 135.0 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.264 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 71' ' ' THR . 0.9 OUTLIER -89.51 123.84 33.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.883 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.653 HG12 HG21 ' A' ' 78' ' ' ILE . 1.3 t -103.21 131.21 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.928 . . . . 0.0 110.381 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -100.26 134.01 43.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.219 -0.926 . . . . 0.0 110.049 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.682 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER 62.14 116.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.3 -0.875 . . . . 0.0 110.036 -179.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.92 -25.26 24.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.177 -0.952 . . . . 0.0 110.638 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.51 -59.66 4.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.994 . . . . 0.0 110.357 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.576 ' O ' HD11 ' A' ' 121' ' ' ILE . 39.8 m0 -53.58 -62.46 1.64 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.902 . . . . 0.0 110.436 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 74' ' ' HIS . 0.8 OUTLIER -88.34 120.38 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.954 . . . . 0.0 109.964 179.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.629 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.05 -23.25 25.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.392 -0.818 . . . . 0.0 110.758 -179.3 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.13 -177.01 47.25 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.52 ' CE ' ' CZ ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -151.18 168.16 25.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -1.076 . . . . 0.0 110.185 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 116' ' ' LYS . 3.2 t -154.33 137.87 15.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.949 . . . . 0.0 109.845 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.898 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -132.27 140.01 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 110.345 -179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 73.35 -1.07 3.17 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.809 -0.557 . . . . 0.0 111.224 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.62 21.92 8.42 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.632 -1.27 . . . . 0.0 111.121 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.443 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.37 162.99 32.1 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.637 -1.508 . . . . 0.0 110.269 179.285 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -171.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 110.547 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -109.07 170.22 8.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.401 -0.812 . . . . 0.0 110.341 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.6 122.02 44.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.319 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pt -67.39 103.59 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.168 -0.958 . . . . 0.0 109.911 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 101' ' ' THR . 1.5 tt -95.66 -28.51 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.886 . . . . 0.0 110.964 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.6 p -167.53 105.21 0.52 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.033 -1.042 . . . . 0.0 110.081 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm -95.29 107.72 19.84 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.277 -0.889 . . . . 0.0 110.017 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.65 95.99 8.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 110.385 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.67 -29.65 56.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.099 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -47.78 82.37 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.305 -0.872 . . . . 0.0 110.078 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -95.85 12.24 30.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 110.419 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.9 t0 51.33 56.95 7.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.019 -1.051 . . . . 0.0 110.152 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -148.14 154.75 40.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.202 -0.936 . . . . 0.0 110.442 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -143.68 166.14 25.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 109.941 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.573 ' O ' HG22 ' A' ' 91' ' ' ILE . 87.0 m -141.35 150.69 42.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.382 -0.824 . . . . 0.0 109.636 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.9 p -145.31 141.48 28.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.036 -1.04 . . . . 0.0 110.733 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.04 144.1 25.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.842 . . . . 0.0 109.885 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -127.87 136.95 52.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.062 -1.024 . . . . 0.0 110.757 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.482 ' C ' HG13 ' A' ' 106' ' ' VAL . 3.5 mt-10 -93.13 127.48 38.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -0.883 . . . . 0.0 109.449 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.482 HG13 ' C ' ' A' ' 105' ' ' GLU . 35.3 m -149.68 171.36 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.017 -1.052 . . . . 0.0 110.954 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.79 110.47 18.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 50.33 -156.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 109.678 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.87 ' HB2' HD11 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -150.86 59.83 0.93 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.983 -1.073 . . . . 0.0 110.982 -179.267 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.526 ' HB2' HG23 ' A' ' 146' ' ' THR . 0.6 OUTLIER -146.12 104.19 3.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.293 -0.879 . . . . 0.0 110.337 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 134.35 -131.88 6.13 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.432 ' HB3' ' HG2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -157.0 152.42 26.58 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.299 -1.118 . . . . 0.0 110.0 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mt -135.78 145.24 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.882 . . . . 0.0 110.17 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -76.06 113.12 13.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.347 -0.845 . . . . 0.0 110.058 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.456 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -122.26 -170.4 13.69 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 82' ' ' SER . 4.1 mttp -147.66 171.95 14.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -1.155 . . . . 0.0 109.977 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -157.67 145.11 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -0.96 . . . . 0.0 110.453 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.629 ' O ' HG22 ' A' ' 79' ' ' THR . 7.7 m-20 -105.63 155.04 19.61 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.473 -0.767 . . . . 0.0 109.535 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.565 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -132.4 146.47 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 110.127 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -151.76 115.02 4.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.89 . . . . 0.0 110.55 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.576 HD11 ' O ' ' A' ' 77' ' ' TRP . 2.2 mp -141.51 152.57 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.18 -0.95 . . . . 0.0 110.337 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.55 101.08 1.5 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 0.0 109.828 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -173.62 -176.93 1.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.378 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -97.61 105.18 17.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 110.391 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 128' ' ' LYS . 21.9 t -76.29 99.24 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.0 109.898 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 55.5 50.46 14.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.321 -0.862 . . . . 0.0 110.32 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.31 33.28 44.75 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.453 ' HA ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -145.6 106.31 4.33 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.085 -1.244 . . . . 0.0 110.233 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 128' ' ' LYS . 9.2 Cg_endo -58.04 128.01 27.19 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.541 1.285 . . . . 0.0 110.108 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.621 ' CE2' HMB2 ' A' ' 151' ' ' ZNH . 54.6 t80 -127.13 148.05 50.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.893 . . . . 0.0 110.355 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.3 99.07 4.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.364 -0.835 . . . . 0.0 109.837 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.492 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 3.0 t80 -102.0 131.14 48.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 109.894 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -166.37 77.48 0.22 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.227 -0.92 . . . . 0.0 110.229 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -153.83 -173.82 4.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.291 -0.881 . . . . 0.0 110.339 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.449 ' O ' ' CD2' ' A' ' 136' ' ' TYR . 6.1 p80 -119.79 162.53 18.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 110.11 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.449 ' CD2' ' O ' ' A' ' 135' ' ' HIS . 54.7 m-85 -155.09 137.34 14.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.964 . . . . 0.0 110.423 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.462 ' O ' HG23 ' A' ' 138' ' ' ILE . 28.1 p30 -88.63 159.23 17.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.315 -0.866 . . . . 0.0 110.267 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -156.69 155.92 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.269 -0.895 . . . . 0.0 110.051 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 29.2 m -91.81 123.06 34.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.265 -0.897 . . . . 0.0 111.074 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.898 ' CD2' HD11 ' A' ' 83' ' ' ILE . 62.7 m-85 -90.82 154.6 19.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.395 -0.816 . . . . 0.0 109.236 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HG2' ' HB3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -140.23 95.3 2.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.894 -1.129 . . . . 0.0 110.683 -179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 110' ' ' ASN . 23.4 m-85 -91.06 133.45 35.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.321 -0.862 . . . . 0.0 110.197 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.421 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 3.6 m-80 -137.58 102.08 4.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 110.451 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.442 ' CA ' HD13 ' A' ' 109' ' ' LEU . . . -146.07 -142.11 3.72 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.429 ' HD2' ' HA3' ' A' ' 144' ' ' GLY . 1.9 Cg_endo -49.18 141.0 24.45 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.576 1.303 . . . . 0.0 110.756 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.526 HG23 ' HB2' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -150.49 30.44 0.67 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.166 179.714 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -121.85 -52.22 2.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 110.415 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.9 t 58.11 35.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.368 -0.832 . . . . 0.0 110.325 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.83 82.25 7.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.159 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.988 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.621 HMB2 ' CE2' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.276 0.56 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -98.83 55.61 1.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -0.897 . . . . 0.0 110.236 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 24.2 t30 63.23 22.07 13.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.909 . . . . 0.0 110.15 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -110.6 56.11 0.64 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 110.284 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 42.15 -162.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.761 -0.587 . . . . 0.0 111.076 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 1.1 m-20 54.87 29.85 12.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 110.373 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.6 p -161.81 150.4 15.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.841 . . . . 0.0 110.32 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 161.31 177.94 34.83 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.552 HG23 ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -88.18 104.9 17.14 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.358 -1.084 . . . . 0.0 110.321 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.783 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -94.61 158.6 15.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 110.499 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.448 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 3.6 m-20 -78.8 140.79 38.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.898 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.596 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -165.46 153.89 11.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 110.105 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.34 -177.06 6.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.235 -0.916 . . . . 0.0 110.352 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 140' ' ' TYR . 1.6 m -140.04 178.09 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.348 -0.845 . . . . 0.0 109.843 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -149.39 162.8 39.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 110.481 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.3 OUTLIER -68.15 123.73 21.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.362 -0.836 . . . . 0.0 109.79 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.502 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -53.26 144.94 14.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.136 -0.977 . . . . 0.0 109.955 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 6.1 m120 71.62 1.52 3.91 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.857 -0.527 . . . . 0.0 111.1 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.98 -166.86 1.98 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.829 -1.169 . . . . 0.0 109.827 179.15 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.74 21.4 3.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 110.443 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -133.15 126.06 30.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.122 -0.986 . . . . 0.0 110.956 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.523 HG22 ' HB2' ' A' ' 50' ' ' ASN . 0.7 OUTLIER -55.11 118.48 4.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.601 -0.687 . . . . 0.0 109.686 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.51 -18.58 3.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.8 -1.188 . . . . 0.0 112.078 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.512 HG21 ' C1D' ' A' ' 151' ' ' ZNH . 70.0 mt -138.88 -76.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.789 -1.195 . . . . 0.0 111.122 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.504 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -46.0 -26.41 0.72 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.622 -0.674 . . . . 0.0 111.176 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.523 ' HB2' HG22 ' A' ' 46' ' ' THR . 16.9 t-20 -68.9 -13.4 62.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.075 -1.016 . . . . 0.0 110.792 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -102.59 15.13 30.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.974 -1.079 . . . . 0.0 111.123 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -136.42 11.33 3.24 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.008 -1.058 . . . . 0.0 110.808 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.437 ' HE2' ' HB1' ' A' ' 49' ' ' ALA . 25.2 m-85 -130.98 115.62 16.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.077 -1.014 . . . . 0.0 110.122 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -72.59 164.23 26.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.355 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.467 ' CD ' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -146.83 164.43 23.74 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.274 -0.891 . . . . 0.0 110.048 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.42 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 57.2 Cg_endo -78.86 -175.44 16.71 Favored 'Cis proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.438 -2.317 . . . . 0.0 110.45 -0.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.596 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.52 167.96 9.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.077 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.552 ' HD2' HG23 ' A' ' 33' ' ' THR . 0.9 OUTLIER -101.45 113.51 26.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.32 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CD2' HD21 ' A' ' 109' ' ' LEU . 1.7 p90 -97.06 161.95 13.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 110.004 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 1.0 OUTLIER -154.81 156.99 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.089 -1.007 . . . . 0.0 110.465 179.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 34.6 mtmt -140.34 170.23 16.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.179 -0.95 . . . . 0.0 111.058 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 12.5 mtmt -157.05 62.15 0.51 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.549 -0.719 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t30 51.05 87.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.344 -0.848 . . . . 0.0 111.26 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.83 24.91 39.96 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.696 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.753 ' C ' HD13 ' A' ' 66' ' ' LEU . 2.8 ptpt -167.56 153.3 7.46 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.914 -1.345 . . . . 0.0 110.941 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.768 ' N ' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -158.78 151.17 21.61 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 122.347 1.07 . . . . 0.0 111.696 178.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 6.3 m-85 -143.85 170.41 15.94 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 58' ' ' LYS . 1.1 m -145.18 145.04 21.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.908 -1.12 . . . . 0.0 110.389 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.436 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 4.6 pt20 -97.84 132.77 43.15 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.355 -0.84 . . . . 0.0 109.593 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -112.38 137.57 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.942 -179.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.08 128.45 35.75 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.209 -0.932 . . . . 0.0 109.939 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.686 HG12 HG21 ' A' ' 78' ' ' ILE . 2.0 t -101.84 126.37 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.977 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.414 ' O ' ' CB ' ' A' ' 74' ' ' HIS . 21.6 m-20 -99.18 128.03 45.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.363 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.669 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER 64.23 113.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.85 . . . . 0.0 110.198 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.58 -38.31 23.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.202 -0.937 . . . . 0.0 110.257 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -55.35 -42.45 73.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.212 -0.93 . . . . 0.0 110.182 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.486 ' HA ' HG12 ' A' ' 121' ' ' ILE . 34.4 m0 -67.4 -64.32 0.88 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.349 -0.844 . . . . 0.0 110.282 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.686 HG21 HG12 ' A' ' 72' ' ' VAL . 17.9 tt -88.81 126.3 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.379 -0.826 . . . . 0.0 110.007 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.88 -24.81 23.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.441 -0.787 . . . . 0.0 110.975 -179.298 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' O ' HG12 ' A' ' 117' ' ' ILE . . . 178.16 -179.05 48.62 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.627 -1.273 . . . . 0.0 109.955 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.448 ' HG3' HD11 ' A' ' 78' ' ' ILE . 2.8 mtm -151.59 161.85 41.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.265 -1.138 . . . . 0.0 110.352 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -154.99 146.24 22.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.86 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.624 HD11 ' CD2' ' A' ' 140' ' ' TYR . 3.6 mt -139.17 142.77 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.903 . . . . 0.0 110.657 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 2.5 tm-20 72.26 -0.35 3.29 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.693 -0.63 . . . . 0.0 111.56 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.87 20.27 9.52 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.537 -1.316 . . . . 0.0 111.006 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.477 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.72 159.31 42.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.649 -1.5 . . . . 0.0 110.365 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -71.17 179.69 2.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 110.177 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -102.23 170.17 8.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.904 . . . . 0.0 110.083 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.2 129.7 56.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.938 . . . . 0.0 110.243 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.451 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 0.8 OUTLIER -67.65 102.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 109.767 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 101' ' ' THR . 1.5 tt -95.15 -25.86 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -0.861 . . . . 0.0 110.853 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.517 ' HB2' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -167.35 104.88 0.53 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.122 -0.986 . . . . 0.0 109.659 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -96.34 145.69 25.39 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.399 -0.813 . . . . 0.0 110.265 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.22 78.98 1.62 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.924 . . . . 0.0 110.115 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.25 -25.88 67.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 110.327 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.16 64.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 110.112 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -96.57 17.3 16.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.392 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 t0 50.41 63.13 2.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.975 . . . . 0.0 110.013 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -147.15 162.28 39.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.335 -0.853 . . . . 0.0 110.346 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.447 ' O ' HG23 ' A' ' 72' ' ' VAL . 2.1 mtp180 -163.72 161.75 23.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.435 -0.791 . . . . 0.0 109.873 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.593 ' O ' HG22 ' A' ' 91' ' ' ILE . 86.9 m -142.42 150.37 40.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.655 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.5 p -145.42 143.6 30.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.052 -1.03 . . . . 0.0 110.76 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 2.0 tm-20 -93.4 147.33 23.04 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.374 -0.829 . . . . 0.0 109.838 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.577 ' CD2' HD12 ' A' ' 83' ' ' ILE . 19.1 m-85 -128.18 131.45 48.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.132 -0.98 . . . . 0.0 110.924 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.464 ' C ' HG13 ' A' ' 106' ' ' VAL . 15.5 tt0 -96.08 124.84 40.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.879 . . . . 0.0 109.474 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.496 ' O ' HD21 ' A' ' 66' ' ' LEU . 29.6 m -149.28 -171.71 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.051 -1.031 . . . . 0.0 110.665 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.9 111.96 23.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.442 -0.786 . . . . 0.0 109.144 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.479 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER 46.69 -162.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.456 -0.777 . . . . 0.0 109.969 -178.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.522 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -149.84 56.92 0.97 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.015 -1.053 . . . . 0.0 110.644 -179.72 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.51 ' CB ' HG23 ' A' ' 146' ' ' THR . 19.2 t-20 -145.63 79.53 1.57 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.879 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.63 170.98 19.67 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.06 144.42 30.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.238 -1.154 . . . . 0.0 110.482 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.486 HD12 ' CD2' ' A' ' 142' ' ' PHE . 5.3 mt -136.34 146.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 0.0 109.719 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.15 117.3 17.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.151 -0.968 . . . . 0.0 110.496 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.11 176.05 16.4 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 15.9 mttt -144.43 163.52 33.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.237 -1.155 . . . . 0.0 109.945 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.417 ' HB ' ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -157.89 140.64 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 110.43 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.581 ' O ' HG22 ' A' ' 79' ' ' THR . 52.9 m-20 -101.56 154.35 18.93 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.366 -0.834 . . . . 0.0 109.254 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.654 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -133.4 151.05 32.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.999 -1.063 . . . . 0.0 110.781 -179.288 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -150.69 99.5 2.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.595 -0.69 . . . . 0.0 109.362 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.714 HD13 ' CBB' ' A' ' 151' ' ' ZNH . 20.1 mt -135.04 153.33 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.259 -0.9 . . . . 0.0 110.738 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -159.87 106.27 1.62 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.499 -0.75 . . . . 0.0 109.169 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.4 162.13 6.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.315 -0.866 . . . . 0.0 110.216 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 7.1 mtmt -89.78 113.88 25.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 110.495 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.4 t -76.92 96.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.341 -0.849 . . . . 0.0 110.218 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.22 29.74 13.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.595 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.95 32.94 5.69 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 46.6 mtmt -144.94 100.51 4.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.317 -1.107 . . . . 0.0 110.138 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.54 115.29 1.71 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.765 1.403 . . . . 0.0 110.468 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.661 ' CE2' HMB2 ' A' ' 151' ' ' ZNH . 8.2 t80 -111.95 125.63 54.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.298 -0.876 . . . . 0.0 110.17 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.2 139.39 37.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 110.147 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.654 ' HE2' HG11 ' A' ' 119' ' ' VAL . 1.6 t80 -153.43 113.83 3.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.809 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.403 ' O ' ' CG ' ' A' ' 134' ' ' HIS . 8.1 t0 -165.92 88.33 0.39 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.136 -0.977 . . . . 0.0 110.154 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.403 ' CG ' ' O ' ' A' ' 133' ' ' ASP . 74.1 m-70 -154.04 -168.26 2.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 110.282 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.6 85.46 2.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.796 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.476 ' HD2' HG21 ' A' ' 119' ' ' VAL . 25.0 m-85 -85.86 -178.57 6.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.825 . . . . 0.0 110.416 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 11.6 p30 -150.33 174.27 13.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.938 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.504 HG21 ' HB2' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -155.92 165.34 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.135 -0.978 . . . . 0.0 110.614 -179.655 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 61.8 m -91.81 113.82 26.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.406 -0.809 . . . . 0.0 110.525 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.674 ' HA ' HG12 ' A' ' 38' ' ' VAL . 27.6 m-85 -89.63 155.15 19.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.979 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.79 112.77 5.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.946 . . . . 0.0 110.523 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.486 ' CD2' HD12 ' A' ' 113' ' ' ILE . 27.2 m-85 -91.98 155.78 17.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 110.313 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.522 ' C ' HD21 ' A' ' 34' ' ' LEU . 61.3 m-80 -140.03 96.93 3.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -0.979 . . . . 0.0 110.332 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.783 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -161.5 -151.95 6.47 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.497 ' HD2' HD11 ' A' ' 34' ' ' LEU . 15.1 Cg_endo -63.19 -172.09 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.889 1.468 . . . . 0.0 110.567 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.51 HG23 ' CB ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -149.37 -46.28 0.14 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.214 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -132.04 -48.58 0.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.924 . . . . 0.0 110.082 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 16.2 t 56.37 54.17 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.1 25.74 0.26 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.188 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.714 ' CBB' HD13 ' A' ' 121' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.26 0.552 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.418 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -123.62 94.28 4.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.21 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 0.7 OUTLIER 63.95 40.09 7.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 0.0 110.037 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.36 150.11 37.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.381 -0.824 . . . . 0.0 110.445 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.02 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.368 -0.833 . . . . 0.0 110.197 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER 54.99 28.16 10.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.263 -0.898 . . . . 0.0 110.512 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.0 t -160.86 130.02 4.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.899 . . . . 0.0 110.29 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . -170.77 179.19 42.89 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.72 110.67 21.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.401 -1.058 . . . . 0.0 110.505 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.841 HD13 HD22 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -95.36 148.62 22.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 109.99 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.44 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -79.16 134.26 36.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.085 -1.01 . . . . 0.0 110.339 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.887 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -166.27 167.91 15.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.152 -0.968 . . . . 0.0 110.839 179.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.98 -172.93 4.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.542 -0.724 . . . . 0.0 109.764 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.707 ' O ' HG22 ' A' ' 46' ' ' THR . 0.6 OUTLIER -140.73 107.73 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.688 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.0 161.38 15.16 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.455 -0.778 . . . . 0.0 110.497 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.449 ' HD3' HD13 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -67.84 137.38 55.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.374 -0.829 . . . . 0.0 110.081 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.474 ' CD2' ' OD1' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -62.53 145.47 54.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.035 -1.041 . . . . 0.0 110.064 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 12.6 t30 70.42 3.49 4.5 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.763 -0.586 . . . . 0.0 110.771 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.423 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -139.25 -171.08 3.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.878 -1.139 . . . . 0.0 109.538 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.423 ' N ' ' OG1' ' A' ' 43' ' ' THR . 17.5 p30 -134.63 23.48 3.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.106 -0.996 . . . . 0.0 110.055 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.64 121.47 19.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 111.075 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.707 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -49.79 126.87 14.87 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.583 -0.698 . . . . 0.0 109.291 178.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.795 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -129.84 -19.36 3.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.74 -1.225 . . . . 0.0 112.449 -178.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 47' ' ' SER . 1.4 mp -139.45 -78.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.65 -1.281 . . . . 0.0 111.296 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.697 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -45.01 -26.42 0.43 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.853 -0.53 . . . . 0.0 111.337 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.478 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 4.7 p30 -60.92 -15.49 31.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.091 -1.006 . . . . 0.0 110.882 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.421 ' C ' ' CD1' ' A' ' 52' ' ' TYR . 6.2 m-20 -101.8 15.2 29.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.054 -1.029 . . . . 0.0 110.896 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.474 ' CD1' HBC1 ' A' ' 151' ' ' ZNH . 43.3 m-85 -140.08 10.39 2.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.004 -1.06 . . . . 0.0 110.554 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.417 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 30.7 m-85 -132.02 113.27 13.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 110.174 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.492 ' HB2' HG21 ' A' ' 71' ' ' THR . 0.8 OUTLIER -72.69 164.55 26.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.218 -0.926 . . . . 0.0 110.705 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -146.57 161.66 37.25 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.4 -0.812 . . . . 0.0 109.71 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.402 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 57.5 Cg_endo -79.93 -175.39 16.27 Favored 'Cis proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.522 -2.282 . . . . 0.0 110.396 -0.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.887 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.14 166.29 10.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.933 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.54 116.0 31.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.948 . . . . 0.0 110.465 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.514 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 28.9 p90 -97.1 163.87 12.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.214 -0.929 . . . . 0.0 109.823 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.9 OUTLIER -155.11 151.0 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.109 -0.994 . . . . 0.0 110.558 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 28.1 mtmt -134.5 174.0 11.03 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -0.9 . . . . 0.0 110.945 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 9.5 mttt -155.93 62.33 0.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.4 -0.813 . . . . 0.0 110.021 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m120 53.97 85.86 0.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.338 -0.851 . . . . 0.0 111.188 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.43 23.58 50.36 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.203 -0.999 . . . . 0.0 110.705 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 62' ' ' LYS . 8.6 ptpt -166.12 161.17 16.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.814 -1.404 . . . . 0.0 110.951 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.786 HD11 ' HA ' ' A' ' 108' ' ' LYS . 2.5 pt? -173.11 158.0 3.59 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 122.152 0.977 . . . . 0.0 111.555 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.566 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -139.27 -153.84 0.49 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -170.17 135.16 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 110.026 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 5.1 pt20 -97.39 133.66 41.69 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.63 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -114.2 142.93 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 110.099 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.492 HG21 ' HB2' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -89.18 129.59 35.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 110.199 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.782 HG12 HG21 ' A' ' 78' ' ' ILE . 2.5 t -104.1 127.29 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 110.159 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.0 137.9 37.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 110.341 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.698 ' O ' HG22 ' A' ' 78' ' ' ILE . 63.4 m-70 52.42 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 110.339 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -73.52 -31.68 63.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 110.217 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -55.48 -36.93 67.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 110.31 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.481 ' CE2' HBB2 ' A' ' 151' ' ' ZNH . 11.4 m0 -83.6 -50.86 7.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 110.15 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.782 HG21 HG12 ' A' ' 72' ' ' VAL . 19.5 tt -89.75 125.34 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 109.942 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.612 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -87.1 -29.88 21.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 110.579 -179.577 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.15 -168.37 41.13 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.431 ' HA ' ' HA ' ' A' ' 117' ' ' ILE . 2.8 mtp -151.99 169.19 22.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -1.125 . . . . 0.0 110.469 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.36 131.62 11.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.871 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.3 mt -131.25 147.32 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.933 . . . . 0.0 110.344 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' OE1' ' CA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER 66.46 7.29 4.91 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.133 -0.979 . . . . 0.0 111.004 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.03 25.49 19.52 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.895 -1.145 . . . . 0.0 111.297 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.47 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -139.48 161.29 37.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.638 -1.507 . . . . 0.0 110.482 179.262 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.41 -173.74 0.95 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.13 -0.981 . . . . 0.0 110.561 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 1.8 pt-20 -110.24 170.05 8.34 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.368 -0.832 . . . . 0.0 110.278 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.14 127.46 54.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.274 -0.891 . . . . 0.0 110.268 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.29 103.95 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 0.0 109.597 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.442 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.1 tt -95.92 -30.1 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 111.085 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.7 p -167.43 104.91 0.53 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.016 -1.052 . . . . 0.0 110.015 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -95.53 108.54 20.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 110.154 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -95.75 62.14 2.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.289 -0.882 . . . . 0.0 110.177 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.59 -21.93 30.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.297 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -18.69 62.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.211 -0.931 . . . . 0.0 110.288 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -136.31 22.19 3.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 110.278 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 55.89 64.42 1.73 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -0.868 . . . . 0.0 110.521 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 94' ' ' ASN . 15.6 mt-10 -148.18 -179.51 6.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.278 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 179.22 162.32 0.81 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.2 -0.938 . . . . 0.0 110.135 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.442 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 97.2 m -141.48 152.46 44.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 0.0 109.651 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 37.4 p -144.36 139.59 28.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.008 -1.057 . . . . 0.0 110.548 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.28 141.14 28.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.388 -0.82 . . . . 0.0 110.01 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' A' ' 88' ' ' GLU . 68.3 m-85 -129.0 138.26 51.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.157 -0.964 . . . . 0.0 110.669 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -99.0 130.66 45.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.272 -0.892 . . . . 0.0 109.616 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.0 p -149.42 152.12 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.02 -1.05 . . . . 0.0 110.86 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.6 m -63.68 106.41 0.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -0.931 . . . . 0.0 109.145 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.786 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 48.4 -174.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.494 -0.753 . . . . 0.0 110.062 -178.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.841 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.13 75.45 1.24 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.977 -1.077 . . . . 0.0 110.691 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -146.09 43.22 1.23 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.86 . . . . 0.0 110.246 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.64 -169.62 38.21 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 151.59 27.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -1.181 . . . . 0.0 110.437 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 140' ' ' TYR . 13.9 mm -136.31 132.35 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.418 -0.801 . . . . 0.0 109.884 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.68 103.03 6.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 0.0 110.191 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -119.57 175.85 15.94 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 18.9 mttt -147.88 177.46 9.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -1.14 . . . . 0.0 109.532 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.481 HG21 HD13 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -157.21 149.48 10.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.103 -0.998 . . . . 0.0 111.099 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.612 ' O ' HG22 ' A' ' 79' ' ' THR . 69.0 m-20 -106.83 156.14 18.99 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.452 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 2.2 t -140.45 149.44 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 110.142 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 2.1 t80 -151.01 116.36 5.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 0.0 110.381 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.498 HD12 ' CD2' ' A' ' 132' ' ' TYR . 3.9 mt -134.97 153.83 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.44 -0.788 . . . . 0.0 109.994 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.54 102.28 1.71 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.145 -0.972 . . . . 0.0 109.971 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -173.17 175.28 3.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.522 -0.736 . . . . 0.0 109.829 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 100.7 12.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.148 -0.97 . . . . 0.0 110.344 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.2 t -76.92 112.15 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.339 -0.851 . . . . 0.0 109.965 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 53.98 43.44 30.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 110.212 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.53 38.09 68.78 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -145.26 108.41 4.54 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.228 -1.16 . . . . 0.0 110.048 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -47.96 129.19 17.7 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.682 1.359 . . . . 0.0 110.377 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.645 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 36.6 t80 -135.38 139.91 44.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 110.132 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -135.08 121.45 20.38 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.255 -0.903 . . . . 0.0 110.262 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.498 ' CD2' HD12 ' A' ' 121' ' ' ILE . 3.2 t80 -114.2 141.45 47.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 109.617 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 119' ' ' VAL . 3.7 p30 -175.99 81.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.085 -1.01 . . . . 0.0 110.298 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.19 178.77 9.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 0.0 110.589 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.406 ' ND1' ' N ' ' A' ' 135' ' ' HIS . 1.8 m80 -119.0 96.38 5.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.315 -0.866 . . . . 0.0 109.631 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.93 139.53 31.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 110.483 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.597 ' O ' HG23 ' A' ' 138' ' ' ILE . 25.4 p30 -88.72 159.72 17.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.327 -0.858 . . . . 0.0 110.157 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 137' ' ' ASN . 6.9 pt -156.35 166.28 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 110.1 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 88.6 m -91.76 161.27 14.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.359 -0.838 . . . . 0.0 110.572 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.457 ' CE2' HG13 ' A' ' 138' ' ' ILE . 19.3 m-85 -147.06 98.66 3.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.428 -0.795 . . . . 0.0 109.635 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -101.46 105.3 16.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.896 . . . . 0.0 110.874 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 140' ' ' TYR . 98.3 m-85 -92.2 140.34 29.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.889 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.458 ' ND2' ' N ' ' A' ' 143' ' ' ASN . 2.1 m-80 -124.02 98.67 5.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.116 -0.99 . . . . 0.0 110.453 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.64 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -151.36 -148.67 4.87 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.418 ' HD2' HD11 ' A' ' 109' ' ' LEU . 10.3 Cg_endo -56.77 150.28 54.89 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.639 1.336 . . . . 0.0 110.077 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.4 p -90.5 -46.08 8.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.959 . . . . 0.0 110.313 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -155.29 -43.81 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.375 -0.828 . . . . 0.0 110.066 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 148' ' ' VAL . 17.5 t 56.36 41.9 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.377 -0.827 . . . . 0.0 110.207 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.19 75.55 8.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 110.17 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.921 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.645 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.218 0.532 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.12 101.52 3.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.288 -0.882 . . . . 0.0 110.267 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 1.6 t-20 63.34 35.46 12.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 110.077 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 27' ' ' ASN . . . -177.06 160.36 1.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 110.35 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.67 -160.61 0.46 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.231 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER 54.34 25.32 5.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.268 -0.895 . . . . 0.0 110.478 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.6 t -160.11 134.67 7.6 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 110.451 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.84 179.09 48.47 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.39 112.23 22.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -1.124 . . . . 0.0 110.335 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.86 HD13 HD22 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -94.73 146.83 23.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.949 . . . . 0.0 110.431 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.412 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -80.7 133.15 35.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.857 . . . . 0.0 109.779 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.749 ' CE2' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -165.88 162.69 18.45 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.154 -0.966 . . . . 0.0 110.716 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.47 -168.29 2.78 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.455 -0.778 . . . . 0.0 109.526 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.861 ' O ' HG22 ' A' ' 46' ' ' THR . 2.5 m -140.92 117.88 8.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.047 -1.033 . . . . 0.0 110.349 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -90.86 155.54 18.68 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.42 -0.8 . . . . 0.0 110.134 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.3 OUTLIER -67.44 126.83 30.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.401 -0.812 . . . . 0.0 110.111 -179.767 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.511 ' CD2' ' ND2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -56.96 147.37 24.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.913 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.8 t30 72.77 -0.01 3.5 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.963 -0.461 . . . . 0.0 110.811 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -138.73 -168.32 2.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.937 -1.102 . . . . 0.0 109.445 179.189 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.42 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.1 OUTLIER -136.28 25.27 3.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.014 -1.054 . . . . 0.0 110.357 179.667 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -135.62 118.63 16.37 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.057 -1.027 . . . . 0.0 111.354 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.861 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -48.82 120.64 3.97 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.66 -18.06 3.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.709 -1.244 . . . . 0.0 112.466 -178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.469 HG21 ' C1D' ' A' ' 151' ' ' ZNH . 95.3 mt -137.98 -76.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.624 -1.298 . . . . 0.0 111.279 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -50.28 -21.94 1.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.742 -0.599 . . . . 0.0 111.593 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.462 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 59.8 t30 -59.08 -32.92 70.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.039 . . . . 0.0 111.388 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.18 15.89 27.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.016 -1.053 . . . . 0.0 111.025 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.461 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -98.65 -17.55 18.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.02 -1.05 . . . . 0.0 111.069 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.501 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 9.3 p90 -127.0 134.3 50.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.0 -1.062 . . . . 0.0 111.037 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.78 113.88 12.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.904 . . . . 0.0 109.937 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.72 162.34 29.48 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.015 -1.053 . . . . 0.0 110.005 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -83.09 -175.46 14.6 Favored 'Cis proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.55 -2.271 . . . . 0.0 110.526 -0.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.749 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . . . -102.53 -171.61 1.99 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 0.0 110.176 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 2.2 ttmt -125.29 113.35 17.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.137 -0.977 . . . . 0.0 110.251 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.607 ' HA ' HG13 ' A' ' 68' ' ' VAL . 10.0 p90 -97.26 165.42 12.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.256 -0.903 . . . . 0.0 110.31 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.7 OUTLIER -155.48 156.81 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.204 -0.935 . . . . 0.0 110.363 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 19.8 mtmt -140.64 173.53 11.4 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.353 -0.842 . . . . 0.0 110.599 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.415 ' CB ' ' HD2' ' A' ' 65' ' ' LYS . 1.6 mtmm -158.53 62.23 0.43 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.843 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m120 45.11 82.6 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.661 -0.65 . . . . 0.0 111.195 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.91 14.78 33.06 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.901 -1.142 . . . . 0.0 110.608 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.415 ' HD2' ' CB ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -165.77 163.17 18.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.96 -1.318 . . . . 0.0 110.982 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.998 HD11 ' HA ' ' A' ' 108' ' ' LYS . 2.4 pt? -172.68 144.67 1.43 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.015 0.912 . . . . 0.0 111.356 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -139.01 173.33 11.67 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.175 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.607 HG13 ' HA ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -142.24 142.17 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.042 -1.036 . . . . 0.0 110.429 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.416 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 3.3 pp0? -97.66 132.35 43.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.398 -0.814 . . . . 0.0 109.641 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.549 HD13 ' HD2' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -113.49 132.63 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 110.457 -179.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 71' ' ' THR . 0.9 OUTLIER -89.54 125.2 35.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.679 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -103.15 134.22 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.901 . . . . 0.0 110.465 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -102.12 145.44 29.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.388 -0.82 . . . . 0.0 110.034 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 11.1 m170 50.61 87.39 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 110.141 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.2 p -57.21 -36.21 70.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 110.355 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -55.62 -32.8 63.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 110.353 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.605 ' CE2' HBB2 ' A' ' 151' ' ' ZNH . 35.7 m0 -76.3 -60.67 2.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 110.378 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.661 HD11 HG13 ' A' ' 117' ' ' ILE . 2.1 tp -88.41 117.2 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.437 -0.789 . . . . 0.0 110.058 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.651 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -86.82 -24.59 24.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -0.803 . . . . 0.0 110.836 -179.341 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.98 177.89 48.25 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.606 -1.283 . . . . 0.0 109.955 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.402 ' HG2' ' HB ' ' A' ' 117' ' ' ILE . 1.1 mtt -152.94 162.42 41.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -1.148 . . . . 0.0 109.969 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 t -154.81 153.48 31.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.958 . . . . 0.0 110.01 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.816 HD11 ' CE2' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -151.77 147.21 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 110.896 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 61.07 10.65 2.98 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.488 -0.757 . . . . 0.0 111.944 179.204 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.75 2.16 34.59 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.313 -1.423 . . . . 0.0 111.39 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 83' ' ' ILE . 5.2 p80 -135.39 150.25 49.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.534 -1.568 . . . . 0.0 110.824 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -70.15 -164.23 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 110.437 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 9.6 pt-20 -106.79 170.24 8.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.328 -0.857 . . . . 0.0 110.492 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.34 136.24 50.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.019 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pt -67.96 100.94 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.989 -1.07 . . . . 0.0 109.648 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 101' ' ' THR . 1.1 tt -96.26 -29.13 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.0 110.776 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 5.4 m -167.38 99.48 0.51 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.162 -0.961 . . . . 0.0 109.963 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.5 ttmm -95.61 152.99 17.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.816 . . . . 0.0 110.041 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.79 73.66 1.41 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 110.172 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.57 -34.27 72.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.269 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -47.09 85.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 110.119 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -96.32 14.82 23.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 110.46 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 1.4 m-20 51.16 55.13 9.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.109 -0.995 . . . . 0.0 110.103 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 54.3 mt-10 -146.32 168.1 21.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.327 -0.858 . . . . 0.0 110.168 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 101' ' ' THR . 4.2 ttt180 -172.96 163.23 4.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.212 -0.93 . . . . 0.0 109.93 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.508 ' O ' HG22 ' A' ' 91' ' ' ILE . 62.9 m -139.96 153.98 47.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.32 -0.863 . . . . 0.0 110.122 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.42 ' CB ' ' OE1' ' A' ' 88' ' ' GLU . 5.1 p -145.59 143.93 30.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 110.427 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.99 147.51 22.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.283 -0.886 . . . . 0.0 109.965 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.549 ' HD2' HD13 ' A' ' 70' ' ' ILE . 15.6 m-85 -128.02 135.84 50.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 110.683 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.445 ' C ' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -104.11 131.13 51.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.721 179.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.445 HG13 ' C ' ' A' ' 105' ' ' GLU . 24.0 m -149.22 159.12 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.14 -0.975 . . . . 0.0 110.558 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.8 t -50.44 -45.04 55.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 109.142 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.998 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.5 -165.43 0.85 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.658 -0.651 . . . . 0.0 109.485 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.86 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -149.99 71.48 1.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.073 -1.017 . . . . 0.0 110.548 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -146.17 55.49 1.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.404 -0.81 . . . . 0.0 110.177 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 142' ' ' PHE . . . 169.37 -108.27 0.29 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.452 ' HG3' HG23 ' A' ' 139' ' ' THR . 1.5 tmtt? -156.44 135.15 11.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.35 -1.088 . . . . 0.0 109.902 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.2 mt -128.97 147.27 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.124 -0.985 . . . . 0.0 110.291 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.89 119.95 20.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.952 . . . . 0.0 110.407 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -124.71 178.79 16.38 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 30.5 mttt -146.49 158.51 43.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -1.088 . . . . 0.0 109.842 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.661 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -157.55 146.91 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.069 -1.019 . . . . 0.0 110.581 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.651 ' C ' HG22 ' A' ' 79' ' ' THR . 1.4 m-20 -106.92 159.79 16.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.532 -0.73 . . . . 0.0 109.534 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.1 OUTLIER -136.24 151.63 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 0.0 110.286 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.16 103.91 3.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.385 -0.822 . . . . 0.0 110.513 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 65.4 mt -132.34 153.18 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 110.136 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.29 97.16 1.35 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.384 -0.823 . . . . 0.0 109.851 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -173.54 -179.73 1.91 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 110.165 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -103.16 108.01 19.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.096 -1.003 . . . . 0.0 110.295 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.474 ' O ' HG12 ' A' ' 125' ' ' VAL . 12.5 t -76.82 100.01 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.296 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.417 ' ND2' ' N ' ' A' ' 126' ' ' ASN . 1.6 m120 62.65 42.08 8.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.222 -0.924 . . . . 0.0 110.519 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.1 36.49 24.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.08 106.21 4.48 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.155 -1.203 . . . . 0.0 110.12 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -51.18 115.19 1.89 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.695 1.366 . . . . 0.0 110.251 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.613 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 6.1 t80 -114.9 116.87 29.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 110.473 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.38 133.95 47.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.398 -0.814 . . . . 0.0 109.775 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.473 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 2.3 t80 -149.79 119.38 6.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.161 -0.962 . . . . 0.0 109.937 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -165.98 75.36 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.248 -0.908 . . . . 0.0 110.034 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.03 -165.24 2.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 110.448 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 1.6 p-80 -122.26 154.33 37.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 110.361 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 45.6 m-85 -154.94 135.06 13.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.31 -0.869 . . . . 0.0 110.033 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 138' ' ' ILE . 50.8 p30 -87.77 166.45 14.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.325 -0.859 . . . . 0.0 110.525 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 137' ' ' ASN . 5.9 pt -156.48 167.25 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.12 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.452 HG23 ' HG3' ' A' ' 112' ' ' LYS . 85.0 m -91.76 115.44 28.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.323 -0.861 . . . . 0.0 111.059 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.816 ' CE2' HD11 ' A' ' 83' ' ' ILE . 15.6 m-85 -90.62 95.79 10.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 109.578 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -87.71 101.94 14.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.05 -1.031 . . . . 0.0 110.742 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 36' ' ' TYR . 22.8 m-85 -93.26 138.87 31.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.31 -0.869 . . . . 0.0 110.251 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.469 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 17.4 m-80 -132.38 99.48 4.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.11 -0.994 . . . . 0.0 110.333 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.766 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -159.77 -142.02 3.29 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.416 ' HG2' HD11 ' A' ' 109' ' ' LEU . 11.7 Cg_endo -61.54 133.73 47.33 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.598 1.315 . . . . 0.0 110.11 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.1 m -91.19 -52.12 4.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 110.165 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -165.02 29.28 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.852 . . . . 0.0 110.421 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.5 t 58.55 39.0 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.897 . . . . 0.0 110.358 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.13 56.73 3.27 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 0.0 110.295 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.979 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.613 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.229 0.538 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -170.3 134.58 1.19 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 110.33 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 6.2 t30 63.35 35.97 11.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 0.0 110.032 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.86 87.03 2.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.34 -0.85 . . . . 0.0 110.356 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.54 -164.58 0.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 110.236 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 60.7 m-20 53.29 27.97 6.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.866 . . . . 0.0 110.341 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.25 141.05 13.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 110.569 -179.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -172.7 173.06 45.38 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.61 110.63 21.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.258 -1.142 . . . . 0.0 110.402 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.889 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.6 OUTLIER -95.61 155.34 16.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -0.915 . . . . 0.0 110.549 179.793 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.7 t-20 -81.86 135.69 35.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.111 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.895 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -167.09 159.52 13.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.864 -1.147 . . . . 0.0 110.969 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -154.69 -165.82 2.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.398 -0.814 . . . . 0.0 109.795 -179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.507 ' CG2' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -141.16 174.42 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 110.632 -179.914 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 50.6 m-85 -148.56 157.29 43.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.401 -0.812 . . . . 0.0 109.889 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.466 ' HG3' ' CG2' ' A' ' 43' ' ' THR . 12.8 tppt? -67.73 136.4 54.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 110.223 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.467 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -61.46 146.54 48.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.178 -0.951 . . . . 0.0 109.354 179.577 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 8.3 t30 72.02 2.83 4.46 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.851 -0.53 . . . . 0.0 110.79 -179.141 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.466 ' CG2' ' HG3' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -136.62 -166.65 1.93 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.932 -1.105 . . . . 0.0 109.559 179.207 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.445 ' N ' ' OG1' ' A' ' 43' ' ' THR . 25.6 t30 -130.93 15.87 5.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 110.302 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.59 139.07 41.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 110.843 -179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.465 ' CG2' ' CB ' ' A' ' 50' ' ' ASN . 0.3 OUTLIER -70.43 134.76 48.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.075 179.141 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.462 ' OG ' HD12 ' A' ' 48' ' ' ILE . 4.7 t -129.28 -18.26 3.67 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.009 -1.077 . . . . 0.0 112.193 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.504 HG21 ' C1D' ' A' ' 151' ' ' ZNH . 1.1 mp -138.19 -49.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.773 -1.204 . . . . 0.0 110.976 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.94 8.5 10.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.537 -0.727 . . . . 0.0 111.475 -178.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.465 ' CB ' ' CG2' ' A' ' 46' ' ' THR . 0.5 OUTLIER -71.78 -33.93 69.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.901 -1.124 . . . . 0.0 110.492 -179.976 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 71.5 m-20 -102.69 15.38 29.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.13 -0.981 . . . . 0.0 110.806 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.702 ' CD1' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -91.13 -18.01 25.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.047 -1.033 . . . . 0.0 110.866 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.507 ' CE1' ' CG2' ' A' ' 38' ' ' VAL . 39.2 p90 -118.3 127.88 54.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.15 -0.969 . . . . 0.0 110.865 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.532 ' CB ' HG21 ' A' ' 71' ' ' THR . 1.7 t30 -73.76 109.85 7.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.746 179.315 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.419 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 2.7 pttt -91.99 161.63 32.88 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.047 -1.033 . . . . 0.0 110.144 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 56.4 Cg_endo -79.54 -175.58 16.77 Favored 'Cis proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.513 -2.286 . . . . 0.0 110.585 -0.031 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.895 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -101.8 168.06 9.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 0.0 109.894 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.432 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -105.5 116.01 31.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 110.795 -179.798 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.502 ' HB2' HD23 ' A' ' 109' ' ' LEU . 3.9 p90 -96.3 160.96 14.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 0.0 109.355 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 0.6 OUTLIER -154.72 124.62 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.942 -1.099 . . . . 0.0 110.967 -179.329 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.458 ' CD ' ' HE2' ' A' ' 108' ' ' LYS . 1.2 mtmt -137.62 129.29 28.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.349 -0.845 . . . . 0.0 110.173 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -108.37 63.63 0.61 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.903 . . . . 0.0 110.843 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 46.03 96.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.494 -0.754 . . . . 0.0 111.109 179.329 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.94 12.73 39.15 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' HB2' ' OH ' ' A' ' 67' ' ' TYR . 6.9 ptpt -171.25 156.8 4.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.166 -1.196 . . . . 0.0 109.735 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.753 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -165.05 143.28 6.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.034 -1.041 . . . . 0.0 111.517 -179.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -140.26 -160.59 1.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.613 -0.679 . . . . 0.0 109.436 179.94 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -170.14 131.06 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.003 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.432 ' HG2' ' HB3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -98.46 141.98 30.65 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.232 -0.917 . . . . 0.0 110.322 -179.948 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.1 OUTLIER -114.69 141.27 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.438 -0.789 . . . . 0.0 110.067 -179.872 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.532 HG21 ' CB ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -89.18 134.42 34.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.985 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.635 HG22 ' CE ' ' A' ' 81' ' ' MET . 3.0 t -104.36 124.87 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.312 -0.867 . . . . 0.0 110.277 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.83 128.94 45.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -0.929 . . . . 0.0 110.011 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.4 m80 62.72 113.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.311 -0.868 . . . . 0.0 110.107 -179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.2 t -76.47 -13.19 60.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.864 . . . . 0.0 110.677 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -84.0 -56.1 3.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.041 -1.037 . . . . 0.0 110.397 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.532 ' HA ' HD11 ' A' ' 121' ' ' ILE . 4.0 m0 -47.87 -68.07 0.22 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.325 -0.859 . . . . 0.0 110.646 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.752 HD11 HG13 ' A' ' 117' ' ' ILE . 0.6 OUTLIER -88.28 122.15 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.922 . . . . 0.0 110.041 -179.86 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.628 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -87.19 -27.42 23.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.847 . . . . 0.0 110.926 -179.204 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.18 -179.74 45.93 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.166 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.635 ' CE ' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -152.93 169.68 22.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.508 -0.995 . . . . 0.0 109.987 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -153.91 161.41 42.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.067 -1.021 . . . . 0.0 109.716 179.904 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.895 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -164.5 141.4 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 110.699 -179.672 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' CB ' ' NE2' ' A' ' 86' ' ' HIS . 0.4 OUTLIER 62.89 8.7 3.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.525 -0.734 . . . . 0.0 111.964 179.379 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.24 2.01 28.03 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.349 -1.405 . . . . 0.0 111.424 178.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.48 ' NE2' ' CB ' ' A' ' 84' ' ' GLU . 3.2 p80 -135.42 155.95 49.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.518 -1.577 . . . . 0.0 110.964 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -160.49 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.508 -0.745 . . . . 0.0 110.5 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 0.9 OUTLIER -102.66 150.81 23.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.391 -0.818 . . . . 0.0 110.298 -179.863 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -99.89 125.55 45.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.907 . . . . 0.0 109.599 179.519 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.532 HG22 HH21 ' A' ' 100' ' ' ARG . 1.1 pp -67.24 103.11 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.005 -1.059 . . . . 0.0 109.884 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.447 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.4 tt -95.63 -28.91 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.461 -0.774 . . . . 0.0 110.851 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.5 p -167.05 105.1 0.56 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.96 -1.087 . . . . 0.0 109.982 -179.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.465 ' HG3' ' CD ' ' A' ' 100' ' ' ARG . 13.2 ttmt -95.24 106.48 18.52 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.327 -0.858 . . . . 0.0 110.19 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -96.59 95.01 7.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.9 p -77.31 -17.75 58.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 110.434 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.73 -53.67 50.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.025 -1.047 . . . . 0.0 110.101 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -98.0 15.07 25.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.291 -0.88 . . . . 0.0 110.358 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.0 64.93 1.57 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.15 -0.969 . . . . 0.0 110.174 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.93 170.98 15.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.424 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.532 HH21 HG22 ' A' ' 90' ' ' ILE . 6.6 mtp180 -162.18 164.6 27.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.496 -0.752 . . . . 0.0 109.91 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.447 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 94.6 m -140.68 152.12 45.11 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.29 -0.881 . . . . 0.0 109.618 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 1.7 p -143.54 138.84 29.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.989 -1.069 . . . . 0.0 110.65 -179.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -91.69 138.2 31.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.366 -0.834 . . . . 0.0 109.975 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 38.2 m-85 -128.59 129.71 46.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.157 -0.964 . . . . 0.0 110.807 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -90.31 127.53 36.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.392 -0.817 . . . . 0.0 109.395 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.533 HG22 ' N ' ' A' ' 107' ' ' SER . 2.7 p -149.28 168.52 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.001 -1.062 . . . . 0.0 110.832 -179.25 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.533 ' N ' HG22 ' A' ' 106' ' ' VAL . 39.5 t -78.2 110.54 13.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.05 178.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.458 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 47.41 -158.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.46 -0.775 . . . . 0.0 109.86 -178.834 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.577 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -151.27 59.93 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.041 -1.037 . . . . 0.0 110.791 -179.678 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -146.22 56.96 1.19 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.239 -0.913 . . . . 0.0 110.31 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.33 178.96 48.66 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.417 ' CD ' HG23 ' A' ' 139' ' ' THR . 0.1 OUTLIER -81.57 148.32 29.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -1.135 . . . . 0.0 110.395 -179.916 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 32.1 mm -137.84 150.08 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 110.114 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -76.07 124.63 27.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 109.986 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.487 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -131.88 116.82 1.94 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 82' ' ' SER . 30.8 mtpt -95.44 159.22 15.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -1.106 . . . . 0.0 109.471 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.752 HG13 HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -158.24 140.55 5.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 120.845 -1.16 . . . . 0.0 111.194 -179.836 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.628 ' C ' HG22 ' A' ' 79' ' ' THR . 15.0 m-20 -108.26 161.11 15.3 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.575 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -131.48 147.62 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.014 -1.054 . . . . 0.0 110.766 -179.434 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 22.6 t80 -152.12 106.45 3.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 110.281 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.666 HD13 HBB1 ' A' ' 151' ' ' ZNH . 2.4 mp -135.03 150.65 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.158 -0.964 . . . . 0.0 110.68 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 1.0 OUTLIER -160.94 96.8 1.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.46 -0.775 . . . . 0.0 109.863 179.856 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.421 ' OE2' HG12 ' A' ' 125' ' ' VAL . 0.9 OUTLIER -173.9 -168.38 0.41 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 110.508 -179.838 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 0.9 OUTLIER -97.9 84.73 3.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.863 . . . . 0.0 110.346 -179.874 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.421 HG12 ' OE2' ' A' ' 123' ' ' GLU . 16.0 m -77.52 136.62 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 50.39 28.01 3.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.812 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 77.32 34.21 41.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 4.1 mtpt -145.09 128.82 8.63 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.238 -1.154 . . . . 0.0 110.139 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.403 ' HD3' ' HE3' ' A' ' 124' ' ' LYS . 28.9 Cg_endo -68.95 110.5 2.4 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.658 1.346 . . . . 0.0 110.155 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.777 ' CE2' HMB2 ' A' ' 151' ' ' ZNH . 49.1 t80 -116.15 156.08 27.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.124 -0.985 . . . . 0.0 110.453 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.79 110.39 9.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 109.935 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.575 ' HE2' HG11 ' A' ' 119' ' ' VAL . 1.6 t80 -112.8 127.28 56.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 110.041 -179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -163.4 84.59 0.49 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 110.052 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.45 -169.8 3.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.511 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.468 ' CD2' ' O ' ' A' ' 135' ' ' HIS . 0.7 OUTLIER -119.71 145.66 46.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 110.163 179.889 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.434 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 38.9 m-85 -155.16 -179.56 8.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 110.104 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.573 ' O ' HG23 ' A' ' 138' ' ' ILE . 2.0 p30 -151.88 172.9 15.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.8 pt -155.8 166.72 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.305 -0.872 . . . . 0.0 110.132 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.417 HG23 ' CD ' ' A' ' 112' ' ' LYS . 86.6 m -91.83 122.24 34.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 111.063 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.895 ' CD2' HD11 ' A' ' 83' ' ' ILE . 6.3 m-85 -90.02 162.5 15.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.302 -0.874 . . . . 0.0 109.625 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 101.31 2.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.055 -1.028 . . . . 0.0 110.819 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -91.34 133.85 35.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.299 -0.876 . . . . 0.0 109.518 179.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.44 ' C ' HD21 ' A' ' 34' ' ' LEU . 2.9 m-80 -128.56 108.63 10.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 110.64 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.889 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -160.36 -145.5 4.3 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.562 ' HD2' HD11 ' A' ' 34' ' ' LEU . 11.0 Cg_endo -60.27 -169.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.626 1.33 . . . . 0.0 110.063 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.55 -43.5 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.0 110.231 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -110.9 -61.76 1.64 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.159 -0.963 . . . . 0.0 110.172 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 148' ' ' VAL . 50.2 t 55.57 48.97 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -0.833 . . . . 0.0 110.23 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.3 47.88 0.36 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 110.09 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.835 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.777 HMB2 ' CE2' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.204 0.526 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.405 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -132.27 133.43 44.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.914 . . . . 0.0 110.053 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 1.2 t-20 62.56 24.15 14.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.931 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.1 146.52 23.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.416 -0.803 . . . . 0.0 110.186 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.47 -160.11 0.45 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 110.189 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 8.8 m-20 56.94 27.37 13.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 110.259 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 p -160.02 159.05 31.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -0.995 . . . . 0.0 110.529 -179.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.51 176.19 35.21 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.94 105.96 18.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.283 -1.128 . . . . 0.0 110.369 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.829 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -95.82 157.26 15.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.128 -0.982 . . . . 0.0 110.847 -179.844 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -80.24 138.45 36.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.344 -0.848 . . . . 0.0 110.483 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.794 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -165.24 155.53 13.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.209 179.498 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -155.52 -177.4 6.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.0 110.101 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.746 ' O ' HG22 ' A' ' 46' ' ' THR . 2.2 m -140.21 116.74 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 0.0 110.356 179.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -92.35 169.56 10.47 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.421 -0.799 . . . . 0.0 110.38 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.457 ' CD ' HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -67.41 125.82 27.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.887 . . . . 0.0 109.716 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.493 ' O ' HG23 ' A' ' 43' ' ' THR . 0.5 OUTLIER -48.58 143.28 5.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.286 -0.884 . . . . 0.0 110.53 -179.46 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 18.6 t30 73.77 -2.47 2.76 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.038 -0.414 . . . . 0.0 111.468 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.47 -163.88 1.51 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.782 -1.199 . . . . 0.0 110.053 179.523 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -136.59 30.92 2.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 110.559 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -134.3 119.81 19.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.082 -1.011 . . . . 0.0 110.983 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.746 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -57.95 121.61 10.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.472 -0.767 . . . . 0.0 109.63 179.245 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.73 -19.18 3.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.767 -1.208 . . . . 0.0 112.227 -179.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.457 HD11 ' CD ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -138.92 -77.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.536 -1.353 . . . . 0.0 111.108 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -46.17 -25.67 0.64 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.702 -0.623 . . . . 0.0 111.269 -179.228 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.513 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 1.3 p30 -66.34 -14.65 62.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.988 -1.07 . . . . 0.0 110.917 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.63 15.27 29.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.083 -1.011 . . . . 0.0 111.182 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -138.79 13.4 2.7 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.831 -1.168 . . . . 0.0 111.002 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.513 ' CE1' ' HA ' ' A' ' 50' ' ' ASN . 4.8 p90 -125.81 129.18 48.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.019 . . . . 0.0 110.4 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -73.41 157.11 37.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 110.297 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -148.27 155.4 42.93 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 110.062 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.407 ' HB2' ' O ' ' A' ' 34' ' ' LEU . 56.8 Cg_endo -79.81 -174.97 15.52 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.762 -2.183 . . . . 0.0 110.351 -0.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.794 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.51 169.13 9.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -0.954 . . . . 0.0 110.164 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.44 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -103.15 115.84 31.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.498 -179.868 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 3.5 p90 -97.76 164.32 12.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.922 . . . . 0.0 109.916 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -155.45 129.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 110.275 179.903 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.431 ' HG2' ' HB2' ' A' ' 66' ' ' LEU . 1.2 mtmp? -140.05 112.74 7.99 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.485 -0.759 . . . . 0.0 110.196 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 62.23 2.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.109 -0.994 . . . . 0.0 110.593 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 46.03 99.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.604 -0.685 . . . . 0.0 111.63 179.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.05 -21.64 43.74 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.084 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.87 167.45 20.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -1.139 . . . . 0.0 110.35 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.711 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.1 pt? -171.62 145.46 2.02 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.553 179.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.566 ' C ' HG12 ' A' ' 68' ' ' VAL . 1.1 m-85 -142.45 -167.1 2.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.68 -0.637 . . . . 0.0 109.43 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.566 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -165.28 129.63 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.126 -0.984 . . . . 0.0 110.419 179.374 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.44 ' HG2' ' CB ' ' A' ' 58' ' ' LYS . 12.1 pt20 -99.57 132.52 44.85 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.832 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.5 HD12 ' CG2' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -117.04 130.66 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 110.195 -179.713 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.8 m -88.56 127.68 35.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.907 . . . . 0.0 109.797 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -102.01 141.9 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.829 . . . . 0.0 110.167 -179.663 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -99.72 148.48 24.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.323 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 7.9 m80 52.43 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.317 -0.865 . . . . 0.0 110.46 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.14 -29.82 61.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 0.0 110.104 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -53.3 14.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.395 -0.816 . . . . 0.0 110.118 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.773 ' O ' HG12 ' A' ' 119' ' ' VAL . 35.0 m0 -51.71 -70.43 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.344 -0.847 . . . . 0.0 110.286 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 78' ' ' ILE . 3.9 tt -88.23 116.91 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.375 -0.828 . . . . 0.0 109.927 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.701 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -87.3 -22.55 25.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -0.841 . . . . 0.0 110.937 -179.18 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.43 170.66 42.79 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.311 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.578 ' CG ' HD11 ' A' ' 78' ' ' ILE . 4.0 mtm -153.07 107.1 3.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.428 -1.042 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.84 163.91 17.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 110.136 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.708 HD11 ' CD2' ' A' ' 140' ' ' TYR . 0.5 OUTLIER -152.42 144.65 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.376 -0.827 . . . . 0.0 110.0 179.83 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.491 ' HB3' ' CE1' ' A' ' 86' ' ' HIS . 0.0 OUTLIER 64.67 10.71 6.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.096 -1.002 . . . . 0.0 110.997 179.868 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.9 15.6 53.83 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.623 179.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 83' ' ' ILE . 2.2 p-80 -135.08 159.47 41.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.821 -1.399 . . . . 0.0 110.546 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 176.71 4.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.403 -0.811 . . . . 0.0 111.008 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 7.4 pt-20 -104.02 170.25 8.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 0.0 110.508 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.7 OUTLIER -112.06 128.34 56.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 110.157 -179.927 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.71 103.56 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.097 -1.002 . . . . 0.0 109.586 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 101' ' ' THR . 1.4 tt -94.47 -27.24 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.344 -0.847 . . . . 0.0 110.872 -179.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -167.03 100.86 0.54 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.184 -0.947 . . . . 0.0 109.808 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.431 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 21.5 ttmt -95.67 107.17 19.35 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.327 -0.858 . . . . 0.0 110.211 -179.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.47 68.3 2.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 110.027 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.94 -27.52 44.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.282 -0.886 . . . . 0.0 110.229 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.42 -47.44 84.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 0.0 110.126 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -96.71 17.54 16.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.263 -0.898 . . . . 0.0 110.435 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 52.7 57.98 5.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 110.247 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -148.28 174.42 12.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.164 -0.96 . . . . 0.0 110.527 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.442 ' O ' HG13 ' A' ' 72' ' ' VAL . 3.2 ttm180 -170.16 162.65 8.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.356 -0.84 . . . . 0.0 110.207 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.52 ' O ' HG22 ' A' ' 91' ' ' ILE . 91.0 m -142.13 153.78 44.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 109.801 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 0.7 OUTLIER -145.8 144.93 30.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.96 -1.088 . . . . 0.0 110.927 -179.818 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -93.43 141.8 28.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.353 -0.842 . . . . 0.0 109.719 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.523 ' HB2' HG13 ' A' ' 68' ' ' VAL . 97.9 m-85 -130.16 141.63 50.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.006 . . . . 0.0 111.18 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.32 127.89 50.54 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.711 ' O ' HD21 ' A' ' 66' ' ' LEU . 2.6 p -149.89 149.59 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.036 -1.04 . . . . 0.0 111.351 -178.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 101.58 0.72 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.159 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.658 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 55.1 174.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.368 -0.832 . . . . 0.0 108.899 -177.919 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.96 70.66 1.11 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.782 -1.199 . . . . 0.0 111.004 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -147.32 64.39 1.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.469 -0.77 . . . . 0.0 110.191 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 177.54 -112.59 0.38 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.676 -1.25 . . . . 0.0 109.986 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.468 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.4 OUTLIER -157.35 137.58 12.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -1.165 . . . . 0.0 110.167 -179.628 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.518 HD13 HG21 ' A' ' 106' ' ' VAL . 12.0 mt -135.21 151.93 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.98 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -76.01 125.18 28.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.164 -0.96 . . . . 0.0 110.5 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.478 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -133.43 178.73 18.02 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 2.1 mtpp -142.34 166.89 23.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -1.186 . . . . 0.0 109.745 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.55 HG22 ' HA ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -158.83 140.59 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.877 -1.14 . . . . 0.0 110.751 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.701 ' C ' HG22 ' A' ' 79' ' ' THR . 1.2 m-20 -107.42 160.62 15.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.553 -0.717 . . . . 0.0 109.375 179.296 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -136.97 149.81 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.058 -1.026 . . . . 0.0 110.582 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.41 106.51 3.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.305 -0.872 . . . . 0.0 110.602 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.531 HD13 ' CBB' ' A' ' 151' ' ' ZNH . 3.0 mp -137.99 148.68 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -0.901 . . . . 0.0 110.258 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.9 95.69 1.19 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.351 -0.843 . . . . 0.0 109.738 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.47 -178.97 1.77 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.374 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -98.12 102.27 13.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 110.308 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.742 HG21 ' CD2' ' A' ' 130' ' ' PHE . 13.4 t -76.74 97.42 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 110.303 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.8 m120 57.48 50.84 10.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.268 -0.895 . . . . 0.0 110.423 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.9 36.63 57.35 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.434 ' HE3' ' CA ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -145.75 103.08 4.21 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.195 -1.179 . . . . 0.0 110.186 179.819 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -49.91 117.85 3.39 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.785 1.413 . . . . 0.0 110.227 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.742 ' CD2' HG21 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -111.81 110.3 20.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 110.453 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -106.08 107.48 18.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -0.886 . . . . 0.0 110.079 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.465 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 3.6 t80 -134.54 129.29 34.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.051 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -174.27 82.28 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.168 -0.957 . . . . 0.0 110.234 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -153.44 -160.54 1.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.169 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -122.5 148.46 45.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.257 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -155.14 -179.33 7.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.681 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.618 ' O ' HG23 ' A' ' 138' ' ' ILE . 46.2 p-10 -151.67 173.02 15.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 110.984 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.5 pt -157.58 172.39 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 110.356 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.468 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 59.9 m -91.66 124.06 35.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.346 -0.846 . . . . 0.0 110.56 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.708 ' CD2' HD11 ' A' ' 83' ' ' ILE . 31.5 m-85 -91.2 104.47 17.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.233 -0.917 . . . . 0.0 109.996 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -97.62 105.7 17.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.202 -0.936 . . . . 0.0 110.741 -179.703 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -92.45 158.8 15.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.285 -0.884 . . . . 0.0 110.519 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.464 ' C ' HD21 ' A' ' 34' ' ' LEU . 38.2 m-80 -145.49 104.0 3.87 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.094 -1.004 . . . . 0.0 110.479 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.829 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -164.34 -146.77 4.87 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.506 ' HD2' HD11 ' A' ' 34' ' ' LEU . 20.3 Cg_endo -66.48 122.43 9.87 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.802 1.422 . . . . 0.0 110.412 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.65 -34.48 15.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 110.21 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -154.64 -65.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.374 -0.829 . . . . 0.0 110.197 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 148' ' ' VAL . 11.7 t 57.31 40.3 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.367 -0.833 . . . . 0.0 110.379 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.72 59.85 4.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.957 . . . . 0.0 110.213 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.863 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.531 ' CBB' HD13 ' A' ' 121' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.233 0.54 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 27' ' ' ASN . . . -158.55 145.3 17.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.174 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 26' ' ' ALA . 0.6 OUTLIER 62.56 28.0 16.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.965 -179.872 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -107.59 106.98 17.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.421 -0.799 . . . . 0.0 110.186 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.74 -46.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.329 -0.857 . . . . 0.0 110.306 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 12.8 m-20 57.55 31.14 19.85 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.934 . . . . 0.0 110.308 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -159.36 155.23 26.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.037 -1.039 . . . . 0.0 110.589 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.79 171.76 35.66 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.67 111.14 21.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -1.12 . . . . 0.0 110.54 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.521 HD13 HD22 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -94.46 148.86 21.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 0.0 109.877 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.446 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 22.4 m-20 -79.56 137.94 37.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.224 -0.922 . . . . 0.0 110.199 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.732 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 1.8 p90 -166.57 164.01 17.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.187 -0.946 . . . . 0.0 110.83 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.25 -179.41 8.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.472 -0.768 . . . . 0.0 109.64 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.806 HG13 ' O ' ' A' ' 139' ' ' THR . 69.0 t -140.21 111.21 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.093 -1.004 . . . . 0.0 110.217 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -89.04 166.17 14.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.758 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 0.2 OUTLIER -67.18 125.15 25.15 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.383 -0.823 . . . . 0.0 110.109 -179.766 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.53 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -51.14 144.0 9.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 110.058 -179.906 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 0.9 OUTLIER 72.02 1.36 3.89 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.818 -0.551 . . . . 0.0 111.108 -179.536 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -135.66 -166.69 1.9 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.894 -1.129 . . . . 0.0 109.752 179.233 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -135.18 18.7 3.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.937 . . . . 0.0 110.196 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -136.19 126.41 26.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.114 -0.991 . . . . 0.0 111.088 -179.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.454 ' HB ' ' CB ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -53.9 124.95 16.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.366 -0.834 . . . . 0.0 108.903 178.951 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.3 -18.77 3.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.73 -1.231 . . . . 0.0 112.202 -178.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.3 mt -138.55 -78.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.751 -1.218 . . . . 0.0 110.776 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.456 ' HB2' HG21 ' A' ' 138' ' ' ILE . . . -45.99 -25.68 0.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.696 -0.627 . . . . 0.0 111.24 -179.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.454 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -56.48 -18.12 10.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.037 -1.039 . . . . 0.0 111.073 -179.597 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -101.91 15.21 29.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.976 -1.078 . . . . 0.0 111.006 -179.316 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -141.87 10.74 2.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.935 -1.103 . . . . 0.0 111.031 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -118.69 115.44 24.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.091 -1.006 . . . . 0.0 110.136 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.31 152.36 42.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 110.408 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.1 OUTLIER -147.2 158.26 44.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 109.848 179.896 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 58.7 Cg_endo -79.57 -175.65 16.9 Favored 'Cis proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.714 -2.203 . . . . 0.0 110.585 -0.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.732 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -102.47 164.05 11.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.062 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.447 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 1.4 mtpt -102.44 118.09 36.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.931 . . . . 0.0 110.524 -179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.514 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 27.2 p90 -97.3 164.47 12.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.862 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -156.31 117.03 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.033 -1.042 . . . . 0.0 110.632 -179.681 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.508 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -127.49 122.15 32.65 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.157 -0.965 . . . . 0.0 110.365 179.885 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 63' ' ' ASN . 1.7 mmmp? -101.46 61.97 0.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -0.847 . . . . 0.0 110.155 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 62' ' ' LYS . 5.1 t-20 47.78 100.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.435 -0.791 . . . . 0.0 111.434 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.11 -15.53 57.83 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.461 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -144.28 169.36 18.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.009 -1.289 . . . . 0.0 110.532 179.827 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.699 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.6 pt? -169.58 144.26 2.91 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.367 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.541 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -137.47 -169.08 2.44 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.727 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -165.72 131.27 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 110.012 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.497 ' NE2' HG21 ' A' ' 101' ' ' THR . 0.0 OUTLIER -98.12 130.21 44.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.268 -0.895 . . . . 0.0 110.186 -179.932 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.587 HD11 ' CE2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -111.61 135.01 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.69 179.94 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.6 m -89.68 125.52 35.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.082 -1.011 . . . . 0.0 110.067 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.59 143.41 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 110.207 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -100.57 128.52 46.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.354 -0.841 . . . . 0.0 110.615 -179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 61.24 115.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 0.0 110.499 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -43.08 57.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.0 110.037 179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -50.82 -39.37 53.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 109.99 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.499 ' HB3' HMC2 ' A' ' 151' ' ' ZNH . 23.8 m0 -64.77 -73.45 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.334 -0.854 . . . . 0.0 110.062 179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.31 119.13 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 109.987 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.827 HG22 ' O ' ' A' ' 118' ' ' ASP . 3.7 t -86.88 -21.65 26.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.31 -0.869 . . . . 0.0 111.001 -179.346 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 81' ' ' MET . . . -172.17 169.93 42.98 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.451 -1.356 . . . . 0.0 110.125 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 3.5 mtm -151.87 106.11 3.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -1.106 . . . . 0.0 110.04 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -86.58 158.48 19.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 109.863 179.66 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.757 HD11 ' CE1' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -156.25 135.63 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.5 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.5 ' HG3' HG12 ' A' ' 106' ' ' VAL . 0.6 OUTLIER 65.29 6.22 3.51 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.451 -0.781 . . . . 0.0 112.018 179.489 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.18 -0.57 22.51 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.332 -1.413 . . . . 0.0 111.328 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.474 ' NE2' ' HB3' ' A' ' 84' ' ' GLU . 2.6 p80 -131.72 158.08 42.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.557 -1.555 . . . . 0.0 110.881 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -70.55 -164.24 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.5 -0.75 . . . . 0.0 110.505 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 1.2 pm0 -104.61 164.07 12.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 110.544 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -115.38 133.96 55.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.913 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.427 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 1.2 pp -68.06 101.71 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.995 -1.065 . . . . 0.0 109.792 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 101' ' ' THR . 2.3 tt -95.71 -28.2 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.338 -0.851 . . . . 0.0 110.732 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.7 p -167.03 103.35 0.55 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.092 -1.005 . . . . 0.0 109.776 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -95.08 147.51 23.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.357 -0.84 . . . . 0.0 110.174 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.31 71.39 1.33 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 110.125 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.16 -32.7 62.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.372 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.57 -42.78 99.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.224 -0.923 . . . . 0.0 110.16 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt -95.98 10.38 37.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -0.904 . . . . 0.0 110.608 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 50.95 56.87 7.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.97 -1.081 . . . . 0.0 110.181 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -147.61 179.65 7.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.45 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -174.86 162.02 3.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.401 -0.812 . . . . 0.0 109.984 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.573 ' O ' HG22 ' A' ' 91' ' ' ILE . 82.8 m -140.61 156.02 46.39 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.331 -0.855 . . . . 0.0 109.552 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.45 ' OG ' HG22 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -143.23 140.02 30.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.982 -1.073 . . . . 0.0 110.82 -179.582 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -93.56 137.59 32.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.717 . . . . 0.0 110.194 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 81.7 m-85 -128.59 140.98 51.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.08 -1.012 . . . . 0.0 110.748 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.467 ' C ' HG13 ' A' ' 106' ' ' VAL . 2.0 tt0 -102.52 131.54 49.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.86 . . . . 0.0 109.335 179.109 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.699 ' O ' HD21 ' A' ' 66' ' ' LEU . 35.7 m -149.16 147.63 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.135 -0.978 . . . . 0.0 110.833 -179.203 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.51 108.25 1.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 109.141 179.12 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.672 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 54.39 176.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -0.95 . . . . 0.0 109.118 -178.646 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.521 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -148.9 72.09 1.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.968 -1.082 . . . . 0.0 110.792 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -145.59 44.58 1.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.471 -0.768 . . . . 0.0 109.984 179.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . -174.29 177.25 46.55 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.436 ' CD ' HG23 ' A' ' 139' ' ' THR . 0.6 OUTLIER -80.51 145.95 31.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.233 -1.157 . . . . 0.0 110.637 -179.701 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.418 ' N ' ' HE3' ' A' ' 112' ' ' LYS . 74.9 mt -136.17 150.75 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.35 -0.844 . . . . 0.0 109.781 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -76.48 132.26 39.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.06 -1.025 . . . . 0.0 110.428 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.437 ' HA3' ' CD2' ' A' ' 140' ' ' TYR . . . -132.94 169.84 22.36 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 82' ' ' SER . 22.4 mtmt -144.01 162.23 36.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.069 -1.253 . . . . 0.0 109.529 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.487 HG21 HG12 ' A' ' 138' ' ' ILE . 0.3 OUTLIER -159.31 153.44 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.907 -1.121 . . . . 0.0 111.034 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.827 ' O ' HG22 ' A' ' 79' ' ' THR . 84.3 m-20 -115.31 154.23 29.52 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.502 ' HB ' ' CD2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -129.48 143.76 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.058 -1.026 . . . . 0.0 110.55 -179.652 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.92 99.99 2.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.379 -0.826 . . . . 0.0 110.118 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.511 HD13 ' CBB' ' A' ' 151' ' ' ZNH . 20.7 mt -123.24 152.55 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.612 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.89 96.54 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.399 -0.813 . . . . 0.0 109.812 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -173.5 -170.67 0.62 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.945 . . . . 0.0 110.509 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.97 103.5 15.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 110.347 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 21.6 t -76.85 102.72 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 0.0 110.333 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.8 m120 53.86 43.14 31.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.311 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.23 32.17 44.43 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 125' ' ' VAL . 5.2 mtmt -145.5 102.3 4.31 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.228 -1.16 . . . . 0.0 110.116 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -46.68 120.73 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.702 1.369 . . . . 0.0 110.517 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.82 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 35.8 t80 -124.95 148.51 48.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 0.0 110.058 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -134.69 106.35 6.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 110.271 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.504 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 4.7 t80 -110.62 131.48 55.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.307 -0.871 . . . . 0.0 110.098 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -170.29 88.04 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.895 . . . . 0.0 110.069 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.34 -168.33 2.98 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.268 -0.895 . . . . 0.0 110.288 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -117.65 141.67 48.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.974 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.459 ' CD1' HAD1 ' A' ' 151' ' ' ZNH . 30.6 m-85 -155.51 -179.26 7.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 110.195 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.449 ' HA ' HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -151.18 176.38 11.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -0.951 . . . . 0.0 110.378 179.902 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.487 HG12 HG21 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -155.7 179.59 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 110.085 -179.761 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.806 ' O ' HG13 ' A' ' 38' ' ' VAL . 15.5 m -91.06 161.5 15.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.817 . . . . 0.0 111.086 -179.171 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.757 ' CE1' HD11 ' A' ' 83' ' ' ILE . 23.1 m-85 -147.82 98.81 3.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.575 -0.703 . . . . 0.0 109.3 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 10.9 tttt -116.86 110.19 18.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.244 -0.91 . . . . 0.0 110.955 -179.259 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -92.56 152.73 19.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.403 -0.811 . . . . 0.0 110.089 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 35' ' ' ASN . 3.4 m-80 -128.98 104.64 7.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.922 . . . . 0.0 110.214 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -153.26 -144.52 3.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.458 ' HD2' HD11 ' A' ' 109' ' ' LEU . 10.1 Cg_endo -59.03 -173.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.608 1.32 . . . . 0.0 110.644 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 -42.41 0.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 110.414 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.402 ' O ' ' HB ' ' A' ' 148' ' ' VAL . 7.4 p-10 -160.77 -40.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 110.212 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 148' ' ' VAL . 29.5 t 56.25 43.59 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.836 . . . . 0.0 110.198 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.77 128.72 34.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.869 . . . . 0.0 110.15 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.993 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.82 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.27 0.557 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -144.61 54.15 1.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.002 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.5 m120 61.08 24.87 14.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 109.862 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.92 -179.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -0.845 . . . . 0.0 110.036 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.67 -69.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 0.0 110.356 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.6 OUTLIER 56.18 23.37 6.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.374 -0.829 . . . . 0.0 110.209 -179.854 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 p -159.74 129.85 5.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.408 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.52 177.8 48.33 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.45 105.54 17.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.205 -1.173 . . . . 0.0 110.221 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.762 HD13 HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -93.79 151.37 19.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.378 -0.826 . . . . 0.0 110.154 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.451 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 23.0 m120 -79.06 145.55 33.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.921 . . . . 0.0 110.14 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.476 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 1.5 p90 -163.92 156.01 17.07 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.189 -0.945 . . . . 0.0 110.177 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -155.44 -176.76 6.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 110.043 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.449 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -140.16 174.41 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.159 -0.963 . . . . 0.0 110.267 179.991 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.449 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 47.3 m-85 -147.96 160.19 43.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.416 -0.802 . . . . 0.0 110.153 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.81 121.33 15.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.859 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.532 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -48.75 148.97 1.91 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 -179.72 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 8.5 t30 72.47 1.43 3.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.968 -0.458 . . . . 0.0 111.085 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -136.05 -155.98 0.67 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.789 -1.195 . . . . 0.0 109.902 179.297 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -136.13 10.77 3.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.335 -0.853 . . . . 0.0 110.491 179.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -134.28 148.95 50.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.015 . . . . 0.0 110.845 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.438 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -79.83 138.44 37.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.319 179.547 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.97 -17.91 3.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.961 -1.087 . . . . 0.0 111.899 -179.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.5 mt -137.96 -71.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.764 -1.21 . . . . 0.0 110.709 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.519 ' HB1' ' HE2' ' A' ' 53' ' ' PHE . . . -46.11 -26.53 0.77 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.691 -0.631 . . . . 0.0 111.023 -179.426 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.414 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -59.7 -19.65 51.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.128 -0.983 . . . . 0.0 110.715 -179.595 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -102.32 14.82 30.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.97 -1.081 . . . . 0.0 110.868 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -128.79 6.15 5.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.984 -1.073 . . . . 0.0 111.075 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.519 ' HE2' ' HB1' ' A' ' 49' ' ' ALA . 33.8 m-85 -129.76 117.01 19.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 110.34 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -72.77 166.82 22.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.97 . . . . 0.0 110.301 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -148.18 159.57 39.32 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.291 -0.881 . . . . 0.0 110.011 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -82.48 -175.64 15.35 Favored 'Cis proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.648 -2.23 . . . . 0.0 110.394 -0.411 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.97 170.23 8.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 110.002 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 2.3 tmtm? -103.03 108.38 19.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 110.525 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.492 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 6.3 p90 -97.97 162.25 13.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 109.75 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -154.8 155.22 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.15 -0.969 . . . . 0.0 110.373 -179.665 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.7 mtpt -135.94 168.89 18.49 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.339 -0.851 . . . . 0.0 110.606 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.441 ' CB ' ' HG3' ' A' ' 65' ' ' LYS . 10.4 mttm -148.0 61.97 1.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 0.0 109.834 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.409 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 10.5 t-20 45.69 78.07 0.07 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.47 -0.769 . . . . 0.0 110.925 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.09 19.42 16.89 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HG3' ' CB ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -168.07 162.83 13.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.146 -1.208 . . . . 0.0 110.38 179.546 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.596 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.3 pt? -173.42 150.18 1.8 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 122.2 1.0 . . . . 0.0 111.74 178.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.592 ' C ' HG12 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -139.94 -164.83 1.77 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.023 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.592 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -170.17 144.01 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.0 110.692 179.356 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.419 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 1.6 pt20 -99.75 132.87 44.82 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.924 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -110.57 133.1 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.336 -0.852 . . . . 0.0 109.8 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.532 ' O ' HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -89.27 123.08 33.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.145 -0.972 . . . . 0.0 110.26 -179.542 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.581 ' HB ' HG21 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -104.29 147.09 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.357 -0.839 . . . . 0.0 109.857 179.999 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -99.49 141.91 31.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 0.0 110.49 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 77' ' ' TRP . 9.6 m-70 53.62 92.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.3 m -52.35 -31.28 32.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 110.232 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -71.11 -45.53 63.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.219 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.466 ' CG ' ' HB3' ' A' ' 74' ' ' HIS . 45.6 m0 -55.64 -62.77 1.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.318 -0.864 . . . . 0.0 110.303 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.658 HD11 ' SD ' ' A' ' 81' ' ' MET . 0.5 OUTLIER -88.37 120.26 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.448 -0.783 . . . . 0.0 109.915 -179.727 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.675 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -89.16 -27.21 20.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.347 -0.846 . . . . 0.0 111.073 -179.217 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.57 172.02 43.78 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.258 -1.449 . . . . 0.0 110.535 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.658 ' SD ' HD11 ' A' ' 78' ' ' ILE . 1.8 mtp -153.05 110.95 3.6 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.522 -0.987 . . . . 0.0 109.859 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.419 ' O ' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -86.56 123.04 31.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.975 -1.078 . . . . 0.0 110.031 179.947 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.7 HD12 ' CG ' ' A' ' 104' ' ' PHE . 1.7 mt -113.1 131.07 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.211 -0.931 . . . . 0.0 110.259 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 2.3 tm-20 69.62 5.51 5.23 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.493 -0.755 . . . . 0.0 110.99 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.25 23.89 10.86 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.728 -1.225 . . . . 0.0 111.0 178.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.47 ' C ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.39 162.37 34.6 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.673 -1.486 . . . . 0.0 110.149 179.359 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -175.68 1.18 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.96 . . . . 0.0 110.199 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.482 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 5.1 pt-20 -110.17 167.03 10.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 110.341 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 102' ' ' SER . 3.5 t-20 -114.09 130.7 56.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.361 -0.837 . . . . 0.0 109.918 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.401 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 1.1 pp -67.69 100.89 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 0.0 109.674 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.667 HG21 HG22 ' A' ' 101' ' ' THR . 2.4 tt -95.36 -23.3 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 110.566 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -167.06 100.18 0.53 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -94.54 142.5 27.37 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.914 -179.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.423 ' HB3' ' HB2' ' A' ' 99' ' ' GLU . 0.1 OUTLIER -142.59 74.12 1.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 110.33 -179.747 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.0 p -65.07 -31.16 72.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -0.877 . . . . 0.0 110.062 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.65 -50.07 72.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.852 . . . . 0.0 110.226 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -95.43 13.62 25.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.259 -0.9 . . . . 0.0 110.426 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.65 60.56 3.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 110.276 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 94' ' ' ASN . 23.4 mt-10 -147.54 150.41 34.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 0.0 110.418 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.405 ' O ' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -152.47 157.08 40.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.353 -0.842 . . . . 0.0 109.951 -179.844 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.667 HG22 HG21 ' A' ' 91' ' ' ILE . 60.4 m -141.09 154.8 46.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.306 -0.871 . . . . 0.0 109.75 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 1.8 p -145.57 139.75 26.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.007 -1.058 . . . . 0.0 111.044 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 57.2 tt0 -93.06 138.65 31.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.46 -0.775 . . . . 0.0 109.429 179.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.7 ' CG ' HD12 ' A' ' 83' ' ' ILE . 93.5 m-85 -128.5 145.72 51.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.883 -1.136 . . . . 0.0 111.34 -179.234 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.519 ' C ' HG13 ' A' ' 106' ' ' VAL . 57.5 tt0 -105.72 130.41 53.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.42 -0.8 . . . . 0.0 109.048 178.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.596 ' O ' HD21 ' A' ' 66' ' ' LEU . 34.1 m -150.31 170.34 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.918 -1.113 . . . . 0.0 111.36 -178.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.3 m -74.59 111.02 9.36 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.523 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 45.7 -163.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.591 -0.693 . . . . 0.0 109.673 -178.355 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.762 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.03 56.88 0.9 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.911 -1.118 . . . . 0.0 110.871 -179.549 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -145.58 70.2 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 0.0 110.001 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.89 176.57 38.0 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.458 ' HE3' ' N ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -81.78 142.91 32.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -1.115 . . . . 0.0 110.34 -179.972 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.664 HD12 ' CD2' ' A' ' 142' ' ' PHE . 53.0 mt -137.34 153.52 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.243 -0.911 . . . . 0.0 110.041 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.38 128.3 34.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.231 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.452 ' HA3' ' CD1' ' A' ' 140' ' ' TYR . . . -138.62 123.25 2.56 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 10.5 mttm -96.76 163.74 12.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.202 -1.175 . . . . 0.0 109.703 179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.431 ' CG2' HG12 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -159.22 133.18 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.879 -1.138 . . . . 0.0 111.171 179.895 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.675 ' C ' HG22 ' A' ' 79' ' ' THR . 93.6 m-20 -108.35 165.61 11.38 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -141.45 153.2 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.965 -1.085 . . . . 0.0 110.648 -179.644 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.421 ' CE1' ' OD2' ' A' ' 122' ' ' ASP . 6.4 t80 -151.82 109.63 3.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -0.806 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 132' ' ' TYR . 46.2 mt -134.71 152.92 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.961 . . . . 0.0 110.349 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.421 ' OD2' ' CE1' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -160.48 98.07 1.24 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.389 -0.819 . . . . 0.0 109.622 179.602 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -173.2 -168.52 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 110.398 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 10.5 mttp -103.58 97.46 7.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 110.474 -179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.6 t -76.8 125.0 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.253 -0.905 . . . . 0.0 110.222 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 52.9 25.29 3.83 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.293 -0.879 . . . . 0.0 110.198 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 85.94 33.82 14.44 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 38.5 mtmt -144.61 134.43 11.66 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.313 -1.11 . . . . 0.0 110.0 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.47 127.85 25.21 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.631 1.332 . . . . 0.0 110.474 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.632 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 16.6 t80 -131.07 113.18 13.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.357 -0.84 . . . . 0.0 110.123 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.25 104.45 14.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 110.187 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.461 ' HB3' ' HB ' ' A' ' 121' ' ' ILE . 3.1 t80 -114.93 124.27 51.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.905 . . . . 0.0 109.943 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 48.2 p-10 -171.03 86.47 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.328 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -153.3 -168.95 3.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.905 . . . . 0.0 110.189 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.4 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.3 OUTLIER -119.8 148.61 43.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 110.336 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.495 ' CD1' HBD2 ' A' ' 151' ' ' ZNH . 12.4 m-85 -155.67 -178.56 7.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 0.0 110.245 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.442 ' O ' HG23 ' A' ' 138' ' ' ILE . 12.3 p30 -150.04 171.45 16.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.89 . . . . 0.0 110.275 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -156.46 166.21 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 0.0 110.413 -179.739 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.403 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 59.8 m -91.77 120.45 32.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 0.0 110.437 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.452 ' CD1' ' HA3' ' A' ' 115' ' ' GLY . 11.6 m-85 -90.38 161.82 15.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.268 -0.895 . . . . 0.0 110.164 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.59 102.7 2.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.908 . . . . 0.0 110.388 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.664 ' CD2' HD12 ' A' ' 113' ' ' ILE . 90.0 m-85 -91.72 154.91 18.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.922 . . . . 0.0 110.155 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 22.8 m-80 -143.0 98.45 3.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.716 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -153.62 -146.81 4.47 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.43 143.73 99.62 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.776 1.408 . . . . 0.0 110.451 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.5 p -90.94 -44.81 9.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.325 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -154.35 -46.6 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.228 -0.92 . . . . 0.0 110.143 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 15.4 t 56.88 48.17 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 110.281 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.59 82.81 7.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.186 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.979 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.632 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 58.2 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.291 0.567 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 25' ' ' SER . . . 179.59 172.2 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.39 29.27 15.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.068 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -140.68 105.63 4.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.419 -0.801 . . . . 0.0 110.213 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.61 -39.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.235 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 9.8 m-20 57.05 29.27 16.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.887 . . . . 0.0 110.439 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -160.14 159.76 32.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.021 -1.049 . . . . 0.0 110.911 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 165.24 172.73 33.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.37 115.21 25.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.156 -1.202 . . . . 0.0 110.381 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.552 HD13 HD22 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -95.88 141.72 28.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.134 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -78.99 135.88 37.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 109.924 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.444 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -165.71 171.67 12.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 110.715 -179.948 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -155.23 -176.78 6.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.442 -0.786 . . . . 0.0 110.081 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 46' ' ' THR . 1.4 m -141.27 108.37 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 0.0 109.94 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -93.2 162.64 13.94 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 110.637 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.437 ' CG ' HG21 ' A' ' 43' ' ' THR . 12.7 tppt? -67.52 140.81 57.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.599 -0.688 . . . . 0.0 110.043 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.46 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -64.57 147.75 52.21 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.011 -1.056 . . . . 0.0 109.247 179.413 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 2.1 t-20 70.95 3.04 4.47 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.701 -0.625 . . . . 0.0 110.746 -179.046 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -137.36 -168.28 2.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.911 -1.118 . . . . 0.0 109.446 179.182 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.441 ' N ' ' OG1' ' A' ' 43' ' ' THR . 65.3 t30 -128.55 12.29 6.38 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.931 -1.106 . . . . 0.0 110.491 179.69 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -136.29 133.04 36.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.055 -1.028 . . . . 0.0 110.467 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.626 HG21 ' CB ' ' A' ' 50' ' ' ASN . 6.0 t -63.56 139.43 58.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.088 -1.007 . . . . 0.0 109.068 179.154 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.402 ' HB3' ' HE3' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -129.39 -17.53 3.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 112.015 -179.013 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.7 mt -137.94 -50.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.785 -1.197 . . . . 0.0 110.845 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.457 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -57.74 -54.72 43.69 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.567 -0.708 . . . . 0.0 111.717 -178.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.626 ' CB ' HG21 ' A' ' 46' ' ' THR . 4.8 t-20 -47.47 -25.04 0.96 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.141 -0.974 . . . . 0.0 110.988 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -73.32 -2.44 22.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -0.988 . . . . 0.0 111.168 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -144.78 28.78 1.26 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.823 -1.173 . . . . 0.0 110.892 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.457 ' CE2' ' HB1' ' A' ' 49' ' ' ALA . 11.3 m-85 -130.97 109.47 10.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.944 . . . . 0.0 110.244 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -72.45 150.15 43.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.328 -0.857 . . . . 0.0 110.415 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.79 168.09 12.25 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.321 -0.862 . . . . 0.0 109.924 -179.994 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.436 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 44.6 Cg_endo -76.57 -175.66 17.04 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.692 -2.211 . . . . 0.0 110.683 -0.201 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.45 168.38 9.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 110.137 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.49 119.91 39.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.17 -0.956 . . . . 0.0 110.562 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.528 ' CD2' ' HB2' ' A' ' 34' ' ' LEU . 27.4 p90 -96.93 164.25 12.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 109.676 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.615 HG23 ' HD1' ' A' ' 67' ' ' TYR . 1.0 OUTLIER -156.37 116.4 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.951 -1.093 . . . . 0.0 111.165 -179.603 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.512 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -127.6 119.48 26.05 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.359 -0.838 . . . . 0.0 110.037 179.655 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.38 62.52 1.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.571 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.41 96.18 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.46 -0.775 . . . . 0.0 111.229 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.54 10.52 43.91 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.58 160.84 11.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.963 -1.316 . . . . 0.0 109.877 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.708 HD11 ' N ' ' A' ' 108' ' ' LYS . 1.7 pt? -166.18 141.78 4.76 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.636 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.615 ' HD1' HG23 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -139.64 -178.03 5.22 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.496 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 68' ' ' VAL . 0.9 OUTLIER -156.11 131.92 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.986 -1.071 . . . . 0.0 110.341 179.83 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.427 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 7.8 pt20 -97.3 133.12 42.33 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.291 -0.881 . . . . 0.0 109.936 179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -114.73 131.22 67.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.179 -0.951 . . . . 0.0 109.502 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 m -87.52 116.57 25.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.131 -0.981 . . . . 0.0 110.481 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.553 ' HB ' HD13 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -104.01 143.62 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.403 -0.811 . . . . 0.0 109.996 179.883 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -101.05 156.26 17.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.161 -0.962 . . . . 0.0 110.348 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.513 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.4 OUTLIER 51.49 86.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 110.324 179.895 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.426 ' HB2' ' CD ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -65.36 -30.12 70.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.227 -0.921 . . . . 0.0 110.054 179.907 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -63.78 -34.5 78.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.88 . . . . 0.0 110.319 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.552 ' CD2' HBB2 ' A' ' 151' ' ' ZNH . 27.4 m0 -77.74 -58.02 3.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.702 HD11 ' HG3' ' A' ' 81' ' ' MET . 8.8 tt -88.87 121.07 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.911 179.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 118' ' ' ASP . 1.0 OUTLIER -86.66 -24.83 25.13 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.248 -0.908 . . . . 0.0 110.867 -179.344 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.55 -179.19 48.75 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.308 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.702 ' HG3' HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -152.68 114.79 4.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.441 -1.035 . . . . 0.0 110.12 -179.989 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -85.78 156.34 20.64 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.146 -0.971 . . . . 0.0 110.406 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' A' ' 104' ' ' PHE . 1.4 mt -156.74 134.27 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.404 -0.81 . . . . 0.0 110.111 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 69.85 3.37 4.27 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.528 -0.732 . . . . 0.0 111.488 179.735 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.94 22.2 11.13 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.22 178.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.457 ' C ' ' CD2' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -137.66 161.81 35.51 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.676 -1.485 . . . . 0.0 110.143 179.276 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -70.33 -169.54 0.31 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.127 -0.983 . . . . 0.0 110.475 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.23 169.71 8.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.329 -0.857 . . . . 0.0 110.259 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.05 128.66 49.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 110.236 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 90' ' ' ILE . 1.6 pp -68.33 101.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.773 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 101' ' ' THR . 1.5 tt -94.84 -28.32 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 110.441 -179.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.8 m -166.39 98.88 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.901 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -95.31 106.38 18.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.455 -0.778 . . . . 0.0 110.017 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.1 101.87 13.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 110.227 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 p -78.96 -28.99 43.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 110.22 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.44 -51.04 69.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.15 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -96.2 15.75 20.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 110.41 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.66 23.23 3.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.115 -0.991 . . . . 0.0 110.202 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -92.77 177.91 5.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.917 . . . . 0.0 110.461 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.503 ' HB3' HG22 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -179.35 151.76 0.5 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.457 -0.777 . . . . 0.0 109.658 179.948 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.487 ' O ' HG22 ' A' ' 91' ' ' ILE . 86.1 m -141.46 158.03 44.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 110.257 -179.568 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.5 p -145.24 143.16 30.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.131 -0.98 . . . . 0.0 110.452 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -93.26 143.44 26.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.29 -0.881 . . . . 0.0 110.031 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.47 ' CD2' HD12 ' A' ' 83' ' ' ILE . 30.3 m-85 -129.91 132.26 46.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.133 -0.98 . . . . 0.0 110.874 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.499 ' C ' HG13 ' A' ' 106' ' ' VAL . 16.4 mt-10 -92.31 128.92 38.34 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.308 -0.87 . . . . 0.0 109.624 179.409 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.553 ' O ' HD21 ' A' ' 66' ' ' LEU . 34.3 m -149.9 144.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.012 -1.055 . . . . 0.0 111.059 -179.327 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.36 109.8 1.71 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.928 . . . . 0.0 108.944 178.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.708 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 54.16 175.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 109.24 -178.585 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.552 HD22 HD13 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -149.98 71.45 1.08 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.006 -1.059 . . . . 0.0 110.871 -179.853 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 7.2 t30 -146.14 40.33 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.387 -0.821 . . . . 0.0 110.185 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . -169.42 -170.73 34.29 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.34 145.51 30.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -1.131 . . . . 0.0 110.476 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mm -137.65 138.14 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.432 -0.793 . . . . 0.0 109.971 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -76.16 123.07 25.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.185 -0.947 . . . . 0.0 110.361 -179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.463 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -134.86 175.79 20.36 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 38.9 mttt -144.7 176.85 9.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -1.182 . . . . 0.0 109.886 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.464 HG22 ' HA ' ' A' ' 137' ' ' ASN . 0.2 OUTLIER -158.47 144.45 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.922 -1.111 . . . . 0.0 111.157 179.926 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.712 ' O ' HG22 ' A' ' 79' ' ' THR . 1.1 m-20 -108.98 156.89 19.2 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.441 -0.787 . . . . 0.0 109.041 178.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 77' ' ' TRP . 2.6 t -141.72 151.86 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.016 -1.053 . . . . 0.0 110.705 -179.307 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.454 ' CZ ' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -151.14 104.37 3.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.436 -0.79 . . . . 0.0 110.268 179.97 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.512 HD13 ' CBB' ' A' ' 151' ' ' ZNH . 5.0 mt -133.06 153.25 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.134 -0.979 . . . . 0.0 110.084 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.69 95.93 1.23 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 110.12 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.486 ' HG2' ' CE1' ' A' ' 130' ' ' PHE . 7.6 pt-20 -174.48 -155.77 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.445 ' HG2' ' CA ' ' A' ' 129' ' ' PRO . 9.3 mtmt -122.59 127.21 49.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.646 HG23 ' CD1' ' A' ' 130' ' ' PHE . 80.8 t -76.18 90.65 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.145 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.7 m120 52.04 27.38 4.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 0.0 110.245 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 117.87 31.8 1.54 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 5.1 mtpt -145.29 90.9 5.97 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.219 -1.166 . . . . 0.0 110.066 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.445 ' CA ' ' HG2' ' A' ' 124' ' ' LYS . 27.6 Cg_exo -56.86 123.14 13.13 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.014 1.534 . . . . 0.0 110.314 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.646 ' CD1' HG23 ' A' ' 125' ' ' VAL . 14.7 p90 -147.7 132.69 18.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.221 -0.924 . . . . 0.0 110.262 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -103.94 132.54 50.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 110.027 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.491 ' CD2' HD12 ' A' ' 121' ' ' ILE . 4.1 t80 -125.63 130.96 52.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.377 -0.827 . . . . 0.0 110.003 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.454 ' OD2' ' CZ ' ' A' ' 120' ' ' TYR . 62.5 t0 -169.43 84.62 0.13 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -0.931 . . . . 0.0 110.008 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.72 -177.03 6.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.384 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.455 ' CD2' ' O ' ' A' ' 135' ' ' HIS . 28.4 p-80 -120.49 89.52 3.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 110.294 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -84.76 -179.41 7.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 109.813 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 10.3 p30 -151.21 168.24 25.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.037 -1.039 . . . . 0.0 110.876 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 137' ' ' ASN . 0.4 OUTLIER -156.66 178.88 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -0.81 . . . . 0.0 110.845 -179.707 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 140' ' ' TYR . 94.8 m -91.53 162.7 14.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.538 -0.727 . . . . 0.0 110.586 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.463 ' CE2' ' HA3' ' A' ' 115' ' ' GLY . 96.4 m-85 -145.4 105.25 4.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.373 -0.829 . . . . 0.0 109.717 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.4 OUTLIER -103.98 109.13 20.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 110.797 -179.484 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 110' ' ' ASN . 74.2 m-85 -91.79 145.84 24.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.603 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' A' ' 143' ' ' ASN . 2.6 m-80 -133.81 109.17 8.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.035 -1.04 . . . . 0.0 110.63 -179.446 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.412 ' HA3' ' HD2' ' A' ' 145' ' ' PRO . . . -153.71 -135.47 2.13 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.49 ' C ' HG23 ' A' ' 146' ' ' THR . 6.1 Cg_endo -54.72 -173.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.399 1.21 . . . . 0.0 110.025 179.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.49 HG23 ' C ' ' A' ' 145' ' ' PRO . 62.9 p -150.18 -58.06 0.18 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 110.514 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -121.44 -65.29 1.15 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 110.417 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 148' ' ' VAL . 44.7 t 55.59 46.42 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 0.0 110.222 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.71 118.49 22.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.923 . . . . 0.0 110.295 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.951 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.552 HBB2 ' CD2' ' A' ' 77' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.301 0.572 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -150.5 80.67 1.35 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 110.276 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 62.2 28.8 17.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.961 . . . . 0.0 109.866 -179.843 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.9 -179.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.412 -0.805 . . . . 0.0 110.325 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.73 -68.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 110.199 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 6.7 m-20 54.58 27.41 8.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.093 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.72 153.86 23.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 110.325 -179.668 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.32 179.5 42.46 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.03 109.41 20.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.176 -1.19 . . . . 0.0 110.404 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.935 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.2 OUTLIER -94.36 151.69 19.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.397 -0.815 . . . . 0.0 109.955 179.926 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.497 ' H ' HD13 ' A' ' 34' ' ' LEU . 2.8 m-80 -79.4 136.6 37.01 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.152 -0.967 . . . . 0.0 109.509 179.626 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.554 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -164.98 159.1 17.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.092 -1.005 . . . . 0.0 110.366 -179.852 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.37 -179.83 8.47 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.417 -0.802 . . . . 0.0 109.653 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.778 ' O ' HG22 ' A' ' 46' ' ' THR . 3.3 m -139.74 117.48 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.128 -0.982 . . . . 0.0 110.118 179.642 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -90.6 161.41 15.44 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.35 -0.843 . . . . 0.0 110.668 -179.629 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.533 ' HZ2' HG22 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -68.05 135.42 52.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.605 -0.684 . . . . 0.0 110.243 -179.75 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.473 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -61.56 144.76 53.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 110.082 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.4 t-20 70.7 3.21 4.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.789 -0.57 . . . . 0.0 110.728 -179.204 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -139.0 -169.72 2.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.033 -1.042 . . . . 0.0 109.638 179.48 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.404 ' N ' ' OG1' ' A' ' 43' ' ' THR . 1.6 m120 -136.08 24.59 3.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.112 -0.992 . . . . 0.0 110.295 179.677 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -136.13 120.65 18.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 111.146 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.778 HG22 ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -49.64 121.61 5.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.532 -0.73 . . . . 0.0 109.359 178.961 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.73 -18.83 3.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.833 -1.167 . . . . 0.0 112.293 -178.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.0 mt -138.99 -78.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.59 -1.319 . . . . 0.0 111.214 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -45.3 -26.65 0.54 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.634 -0.666 . . . . 0.0 111.508 -179.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.436 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -63.98 -16.33 61.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.029 -1.044 . . . . 0.0 110.765 -179.582 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -102.58 15.44 29.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.082 -1.011 . . . . 0.0 110.853 -179.65 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.457 ' CD1' HMC3 ' A' ' 151' ' ' ZNH . 91.3 m-85 -130.38 12.14 5.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.072 -1.017 . . . . 0.0 111.014 -179.675 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.427 ' CZ ' ' SD ' ' A' ' 81' ' ' MET . 23.8 m-85 -131.28 116.9 18.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.026 -1.046 . . . . 0.0 110.314 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.404 ' HB3' HG21 ' A' ' 71' ' ' THR . 12.9 t-20 -72.4 108.47 5.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.258 -0.901 . . . . 0.0 110.323 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.419 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -93.88 159.65 34.08 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 109.943 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 56.0 Cg_endo -78.76 -175.78 17.38 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.753 -2.186 . . . . 0.0 110.65 -0.261 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.554 ' HB2' ' CE1' ' A' ' 36' ' ' TYR . . . -102.1 171.56 7.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 109.984 179.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.418 ' HB2' ' HG3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -105.55 112.14 25.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.074 -1.016 . . . . 0.0 110.684 -179.706 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.757 ' CE1' HD23 ' A' ' 34' ' ' LEU . 11.1 p90 -96.95 167.1 11.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.217 -0.927 . . . . 0.0 109.965 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.513 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -156.39 120.96 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.172 -0.955 . . . . 0.0 110.981 179.941 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 1.1 mtmp? -137.77 127.36 25.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.282 -0.886 . . . . 0.0 110.078 179.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -108.59 62.33 0.61 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -0.875 . . . . 0.0 110.425 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.68 103.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.434 -0.791 . . . . 0.0 111.343 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.28 -20.3 50.81 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.003 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.39 154.96 48.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.026 -1.279 . . . . 0.0 110.661 -179.677 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.802 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -157.02 142.99 17.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 111.195 179.446 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.532 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 4.0 m-85 -139.36 -172.85 3.45 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.2 t -163.39 130.06 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.95 -1.093 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.418 ' HG3' ' HB2' ' A' ' 58' ' ' LYS . 3.7 pt20 -98.59 136.28 38.91 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.589 179.293 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -114.76 132.61 63.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.15 -0.969 . . . . 0.0 110.172 -179.452 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.565 ' O ' HG22 ' A' ' 71' ' ' THR . 0.7 OUTLIER -90.12 120.48 31.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.699 179.955 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.417 ' H ' HG13 ' A' ' 72' ' ' VAL . 0.8 OUTLIER -103.28 136.89 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 110.042 -179.72 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -99.92 147.15 25.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 110.335 -179.668 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.447 ' CD2' ' CZ3' ' A' ' 77' ' ' TRP . 62.0 m-70 58.1 92.12 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.433 -0.792 . . . . 0.0 110.231 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.77 -40.1 87.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 110.284 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.9 m170 -62.52 -27.7 69.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.219 -0.926 . . . . 0.0 110.266 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.661 ' O ' HG12 ' A' ' 119' ' ' VAL . 38.9 m0 -72.24 -73.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.998 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 78' ' ' ILE . 6.9 tt -88.06 116.47 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.378 -0.826 . . . . 0.0 109.316 179.552 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.769 HG22 ' C ' ' A' ' 118' ' ' ASP . 1.6 t -86.56 -21.4 26.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.284 -0.885 . . . . 0.0 111.615 -178.573 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 117' ' ' ILE . . . -173.52 168.74 41.74 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.307 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.474 ' HG3' HD11 ' A' ' 78' ' ' ILE . 1.8 mtm -153.17 105.21 2.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.375 -1.074 . . . . 0.0 109.993 179.717 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' LYS . 3.7 t -86.65 157.15 19.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 0.0 110.111 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.486 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 0.3 OUTLIER -153.88 151.75 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.132 179.805 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.524 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 1.3 mm-40 57.73 17.69 4.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.049 -1.032 . . . . 0.0 110.717 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.15 16.95 63.76 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.45 179.45 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.524 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.2 p-80 -137.59 159.69 41.26 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.8 -1.412 . . . . 0.0 110.829 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -71.7 169.99 14.45 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.544 -0.723 . . . . 0.0 110.802 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -89.28 168.12 12.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.277 -0.889 . . . . 0.0 110.344 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' A' ' 102' ' ' SER . 12.8 m120 -111.48 127.2 55.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.288 -0.882 . . . . 0.0 110.248 -179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pp -67.99 104.24 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.144 -0.973 . . . . 0.0 109.623 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 101' ' ' THR . 1.4 tt -95.89 -30.09 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 111.235 -179.15 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.7 p -166.86 101.75 0.56 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.936 -1.103 . . . . 0.0 110.49 -179.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.406 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 10.0 ttmt -96.69 146.75 24.59 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.422 -0.799 . . . . 0.0 109.972 179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.55 110.12 5.76 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.153 -0.967 . . . . 0.0 110.31 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.0 m -81.49 -40.49 23.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.323 -0.861 . . . . 0.0 110.411 -179.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.72 -33.41 75.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.216 -0.928 . . . . 0.0 110.284 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 0.3 OUTLIER -96.05 -10.68 27.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 110.541 179.926 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 97' ' ' LYS . 1.2 t0 62.31 53.99 2.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.041 -1.037 . . . . 0.0 110.046 -179.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -146.98 179.42 7.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 110.429 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.406 ' HG3' ' CG ' ' A' ' 93' ' ' LYS . 9.8 ttm180 -172.04 159.92 5.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.978 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.521 ' O ' HG22 ' A' ' 91' ' ' ILE . 91.2 m -141.52 153.31 44.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 109.728 -179.914 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 24.7 p -145.03 140.58 28.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.012 -1.055 . . . . 0.0 110.704 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -93.4 148.14 22.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.311 -0.868 . . . . 0.0 109.99 179.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.402 ' CD1' ' HB ' ' A' ' 83' ' ' ILE . 97.0 m-85 -128.8 150.38 50.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.141 -0.974 . . . . 0.0 110.721 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.403 ' OE2' ' N ' ' A' ' 106' ' ' VAL . 7.1 tp10 -110.99 123.88 51.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.381 -0.825 . . . . 0.0 109.792 179.626 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.676 ' O ' HD11 ' A' ' 66' ' ' LEU . 9.5 p -149.36 165.54 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 110.157 -179.508 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.433 ' N ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -56.74 -41.27 77.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.133 -0.98 . . . . 0.0 109.795 179.604 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.457 ' CE ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -164.05 -146.23 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.353 179.403 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.866 HD22 ' HG ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -151.81 56.35 0.85 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.809 -1.182 . . . . 0.0 110.647 -179.403 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 145' ' ' PRO . 10.5 t-20 -146.59 93.74 2.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -0.87 . . . . 0.0 110.232 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 141' ' ' LYS . . . 148.51 -119.68 1.1 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.0 OUTLIER -156.72 112.68 2.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -1.139 . . . . 0.0 110.264 -179.688 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mm -102.73 139.93 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.231 -0.918 . . . . 0.0 110.023 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.21 123.36 25.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.922 . . . . 0.0 110.035 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' A' ' 140' ' ' TYR . . . -132.57 179.73 17.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 28.6 mtmm -144.29 166.29 25.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -1.131 . . . . 0.0 109.707 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.442 ' HB ' ' CG ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -158.73 144.06 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.933 -1.105 . . . . 0.0 110.721 179.991 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.769 ' C ' HG22 ' A' ' 79' ' ' THR . 5.8 m-20 -107.25 159.53 16.28 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.456 -0.778 . . . . 0.0 108.941 178.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -141.5 148.49 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.024 -1.047 . . . . 0.0 110.658 -179.464 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -152.09 104.02 2.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.381 -0.824 . . . . 0.0 110.045 179.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.452 HD13 ' CBB' ' A' ' 151' ' ' ZNH . 44.4 mt -128.96 152.54 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 110.117 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -159.94 97.33 1.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 0.0 109.735 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -173.55 -169.11 0.48 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 110.304 -179.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 3.6 mmtm -112.01 102.61 10.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.87 . . . . 0.0 110.184 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.554 ' O ' HG12 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -76.69 118.22 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -0.877 . . . . 0.0 110.235 -179.903 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.94 26.77 6.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.365 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.19 42.65 5.52 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -145.38 107.35 4.44 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.202 -1.175 . . . . 0.0 110.139 179.809 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -51.13 109.8 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.694 1.365 . . . . 0.0 110.368 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.739 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 11.3 t80 -110.02 146.25 35.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.175 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -133.62 99.18 4.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.284 -0.885 . . . . 0.0 110.214 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.447 ' CD2' ' HB ' ' A' ' 119' ' ' VAL . 2.5 t80 -115.12 129.1 56.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.125 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.62 81.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.176 -0.953 . . . . 0.0 110.256 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -153.13 -165.28 2.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.16 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.42 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -118.3 143.43 46.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.109 -0.994 . . . . 0.0 110.29 179.866 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.42 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 32.2 m-85 -155.25 -179.47 8.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.381 -0.824 . . . . 0.0 109.826 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.512 ' O ' HG23 ' A' ' 138' ' ' ILE . 20.6 p30 -151.27 178.64 9.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 110.345 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.533 HG22 ' HZ2' ' A' ' 40' ' ' LYS . 0.5 OUTLIER -156.98 167.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 110.764 -179.73 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.462 ' CG2' ' HG3' ' A' ' 112' ' ' LYS . 94.1 m -91.75 121.25 33.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.46 -0.775 . . . . 0.0 110.37 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.493 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 43.2 m-85 -90.59 95.72 10.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.071 -1.018 . . . . 0.0 110.235 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 0.1 OUTLIER -91.92 104.26 16.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 110.458 -179.853 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' A' ' 140' ' ' TYR . 67.9 m-85 -92.93 158.75 15.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.325 -0.859 . . . . 0.0 110.295 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.456 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 20.7 m-80 -139.72 97.36 3.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.105 -0.997 . . . . 0.0 110.651 -179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.935 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -161.91 -152.66 6.78 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.43 ' O ' ' CB ' ' A' ' 110' ' ' ASN . 18.8 Cg_endo -64.92 -161.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.893 1.47 . . . . 0.0 110.241 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.7 p -148.44 -47.91 0.15 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.121 -0.987 . . . . 0.0 110.069 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.41 -49.59 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.315 -0.866 . . . . 0.0 110.016 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 148' ' ' VAL . 21.2 t 56.21 38.73 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.393 -0.817 . . . . 0.0 110.296 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.34 44.81 0.31 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.227 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.98 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.739 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.283 0.563 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -169.28 100.28 0.35 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.897 . . . . 0.0 110.122 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.93 22.7 13.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.288 -0.882 . . . . 0.0 110.009 -179.854 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -162.61 109.67 1.27 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 110.267 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.94 -49.86 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.362 -0.836 . . . . 0.0 110.124 -179.915 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 13.3 m-20 56.76 33.54 23.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 110.36 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 59' ' ' TYR . 16.2 t -160.46 153.24 21.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.983 -1.073 . . . . 0.0 110.853 -179.5 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' CD2' ' A' ' 59' ' ' TYR . . . 171.18 176.76 40.55 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -91.76 109.5 20.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.231 -1.158 . . . . 0.0 110.601 179.99 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.823 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -95.78 156.77 16.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.97 -1.081 . . . . 0.0 110.442 179.663 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.454 ' CB ' ' HB2' ' A' ' 143' ' ' ASN . 33.8 m-20 -79.92 139.83 36.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 110.246 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.647 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -165.84 160.66 17.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.945 . . . . 0.0 110.015 179.734 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -155.59 -175.8 5.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 0.0 110.447 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.689 HG12 ' O ' ' A' ' 139' ' ' THR . 0.0 OUTLIER -140.89 166.76 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.324 -0.86 . . . . 0.0 109.834 179.728 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.464 ' CD1' ' O ' ' A' ' 38' ' ' VAL . 51.1 m-85 -147.56 161.55 40.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.084 -1.01 . . . . 0.0 110.545 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.556 ' HG2' HG21 ' A' ' 43' ' ' THR . 0.1 OUTLIER -68.34 135.12 51.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.371 -0.831 . . . . 0.0 109.896 179.96 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.527 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -60.71 146.8 44.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.201 -179.82 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.0 OUTLIER 70.55 4.63 5.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.789 -0.569 . . . . 0.0 110.892 -179.453 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.556 HG21 ' HG2' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -135.18 -163.86 1.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.868 -1.145 . . . . 0.0 109.764 179.377 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.414 ' N ' ' OG1' ' A' ' 43' ' ' THR . 0.1 OUTLIER -130.34 11.73 5.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.461 179.637 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -135.27 148.89 49.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.025 -1.047 . . . . 0.0 110.592 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.568 HG21 ' HB2' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -78.32 137.27 37.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.504 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.54 -17.54 3.68 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.037 -179.075 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 60.5 mt -137.57 -69.73 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.708 -1.245 . . . . 0.0 110.868 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.447 ' O ' ' CD2' ' A' ' 53' ' ' PHE . . . -45.48 -26.5 0.58 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.627 -0.671 . . . . 0.0 111.241 -179.347 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.568 ' HB2' HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -68.08 -9.13 43.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.076 -1.015 . . . . 0.0 110.823 -179.773 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.479 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 1.6 m-20 -99.26 14.8 28.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.029 -1.045 . . . . 0.0 110.852 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.479 ' CE2' ' HB2' ' A' ' 51' ' ' ASP . 36.6 m-85 -142.27 11.61 1.95 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.945 -1.097 . . . . 0.0 110.824 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 25.9 m-85 -132.62 107.46 8.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.06 -1.025 . . . . 0.0 110.584 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -72.72 167.91 19.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.14 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.418 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -146.42 164.73 22.91 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.955 . . . . 0.0 109.973 179.798 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 55.6 Cg_endo -78.23 -175.32 16.48 Favored 'Cis proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.565 -2.265 . . . . 0.0 110.588 -0.153 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.647 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -100.24 170.16 8.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.287 -0.883 . . . . 0.0 109.693 179.805 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.472 ' HB2' ' CG ' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -101.37 119.69 39.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 110.586 -179.644 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.52 ' CD1' ' HD2' ' A' ' 61' ' ' LYS . 13.7 p90 -97.81 162.97 13.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.118 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 1.9 tt -157.07 109.81 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.315 -0.866 . . . . 0.0 110.541 179.633 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.52 ' HD2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -128.59 137.86 51.91 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.167 -0.958 . . . . 0.0 110.347 179.89 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.76 62.25 0.99 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 110.13 179.457 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 45.97 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.493 -0.754 . . . . 0.0 111.28 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.44 -8.42 58.6 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.458 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.19 158.54 44.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.916 -1.344 . . . . 0.0 110.428 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.769 HD21 ' O ' ' A' ' 106' ' ' VAL . 1.2 pt? -169.49 148.54 3.79 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.156 -0.965 . . . . 0.0 111.233 179.191 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.787 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -140.73 -163.26 1.5 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.63 -0.669 . . . . 0.0 109.639 -179.638 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 67' ' ' TYR . 1.4 t -168.3 124.82 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 110.047 179.62 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.472 ' CG ' ' HB2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -97.3 130.97 44.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.212 -0.93 . . . . 0.0 109.789 179.758 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.467 HG22 ' OG ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -111.48 141.54 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.83 . . . . 0.0 110.205 -179.344 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.5 m -89.69 123.52 33.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.794 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.892 HG12 HG21 ' A' ' 78' ' ' ILE . 1.4 t -102.3 131.8 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 110.358 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.47 143.85 30.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 110.382 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.576 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.1 OUTLIER 55.97 97.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.299 -0.875 . . . . 0.0 110.388 179.893 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 m -69.53 -18.03 63.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.209 -0.932 . . . . 0.0 110.338 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.97 -47.37 18.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.255 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.53 ' O ' HG12 ' A' ' 119' ' ' VAL . 46.5 m0 -61.44 -59.33 5.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 110.569 -179.882 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.892 HG21 HG12 ' A' ' 72' ' ' VAL . 5.7 tt -88.67 122.69 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.09 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.596 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.99 -26.74 23.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.359 -0.838 . . . . 0.0 110.832 -179.368 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.9 180.0 47.58 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.625 -1.274 . . . . 0.0 109.921 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.593 ' HG3' HD11 ' A' ' 78' ' ' ILE . 25.8 mtm -151.6 163.31 39.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.338 -1.096 . . . . 0.0 110.118 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 116' ' ' LYS . 23.1 t -155.4 137.47 14.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.365 -0.834 . . . . 0.0 110.02 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 1.6 mt -136.23 141.28 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.263 -0.898 . . . . 0.0 110.362 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER 72.67 -0.25 3.4 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.755 -0.591 . . . . 0.0 111.399 179.972 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.12 22.39 8.8 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.589 -1.291 . . . . 0.0 111.288 178.8 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.47 ' CD2' ' O ' ' A' ' 86' ' ' HIS . 0.1 OUTLIER -138.42 159.52 41.85 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.628 -1.513 . . . . 0.0 110.215 179.353 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -173.53 0.92 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.142 -0.974 . . . . 0.0 110.448 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 1.2 pt-20 -108.76 170.13 8.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.0 110.267 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 102' ' ' SER . 10.4 m120 -120.6 125.41 47.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.933 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' A' ' 90' ' ' ILE . 0.6 OUTLIER -67.52 102.55 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.962 -1.086 . . . . 0.0 109.749 179.967 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.428 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.2 tt -94.87 -28.11 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -0.865 . . . . 0.0 110.553 -179.354 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 100' ' ' ARG . 23.7 m -166.48 96.1 0.56 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.411 -0.805 . . . . 0.0 109.829 -179.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -95.99 109.99 22.29 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 110.292 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.04 83.86 3.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 0.0 110.281 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.8 p -65.32 -30.99 71.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.213 -0.929 . . . . 0.0 110.322 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.21 84.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.936 . . . . 0.0 110.09 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.81 17.49 15.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.3 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 49.59 60.39 3.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.239 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -147.33 177.98 8.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 110.242 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER 179.87 159.63 0.79 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.899 . . . . 0.0 110.072 -179.845 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.428 ' HB ' ' CG2' ' A' ' 91' ' ' ILE . 95.7 m -137.19 154.84 50.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.962 . . . . 0.0 109.808 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.467 ' OG ' HG22 ' A' ' 70' ' ' ILE . 3.7 p -145.11 139.45 27.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 110.712 -179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 3.5 tt0 -93.57 144.36 25.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 110.13 179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 93.5 m-85 -128.94 146.7 50.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.19 -0.944 . . . . 0.0 110.534 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -101.88 129.84 48.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.364 -0.835 . . . . 0.0 109.607 179.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.769 ' O ' HD21 ' A' ' 66' ' ' LEU . 9.0 p -149.49 139.41 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.094 -1.004 . . . . 0.0 111.022 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.9 t -63.96 102.25 0.46 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.143 -0.973 . . . . 0.0 108.5 178.527 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.573 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 56.58 171.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 108.833 -177.968 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.429 ' H ' HD12 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -147.94 76.96 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.952 -1.093 . . . . 0.0 110.853 -179.427 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -146.01 64.17 1.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.447 -0.783 . . . . 0.0 109.846 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.08 -171.92 38.96 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.01 140.27 34.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.318 -1.107 . . . . 0.0 110.564 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.703 HD12 ' CD2' ' A' ' 142' ' ' PHE . 12.9 mt -136.0 150.11 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.321 -0.862 . . . . 0.0 109.739 179.623 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.33 127.46 32.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 -179.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -132.37 169.25 22.33 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -146.74 159.79 43.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -1.156 . . . . 0.0 110.096 179.981 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.401 ' O ' HD13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -157.99 143.66 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.105 -0.997 . . . . 0.0 110.591 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.596 ' C ' HG22 ' A' ' 79' ' ' THR . 13.8 m-20 -106.53 159.76 15.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.433 -0.792 . . . . 0.0 109.263 179.249 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.635 HG11 ' HE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -135.06 149.31 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.04 -1.037 . . . . 0.0 110.814 -179.582 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.412 ' HB2' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -151.72 107.63 3.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.46 -0.775 . . . . 0.0 109.859 179.715 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.474 HG12 ' HA ' ' A' ' 77' ' ' TRP . 28.6 mt -135.22 153.12 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.408 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.78 101.09 1.46 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.468 -0.77 . . . . 0.0 109.455 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -173.23 -165.14 0.26 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.235 -0.916 . . . . 0.0 110.442 -179.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.631 ' O ' HG23 ' A' ' 125' ' ' VAL . 8.0 ttmt -95.76 165.81 12.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.647 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 124' ' ' LYS . 6.8 t -158.41 93.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 65.53 30.5 10.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.386 -0.822 . . . . 0.0 109.603 -179.11 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.61 39.42 10.74 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -147.48 106.55 3.79 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.149 -1.206 . . . . 0.0 110.371 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.62 114.71 1.3 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.69 1.363 . . . . 0.0 109.953 179.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.585 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 10.5 t80 -97.78 141.36 30.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 110.451 -179.482 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -134.4 99.12 4.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.45 -0.781 . . . . 0.0 109.847 179.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.635 ' HE2' HG11 ' A' ' 119' ' ' VAL . 1.7 t80 -112.91 124.27 52.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.064 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.409 ' OD2' ' CZ ' ' A' ' 120' ' ' TYR . 53.7 t0 -170.24 84.39 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 0.0 109.926 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -154.16 -165.02 1.99 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 110.555 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.47 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 74.2 m-70 -117.87 152.32 35.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.852 . . . . 0.0 109.692 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.47 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 66.0 m-85 -155.11 -178.97 7.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.938 . . . . 0.0 110.331 -179.761 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.547 ' O ' HG23 ' A' ' 138' ' ' ILE . 2.1 p30 -150.16 164.93 34.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 110.166 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.2 pt -156.24 172.83 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.337 -0.852 . . . . 0.0 110.35 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.689 ' O ' HG12 ' A' ' 38' ' ' VAL . 10.9 m -91.76 162.28 14.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.412 -0.805 . . . . 0.0 110.576 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.463 ' CE1' ' CG1' ' A' ' 38' ' ' VAL . 12.0 m-85 -145.52 108.15 4.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.388 -0.82 . . . . 0.0 110.032 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.61 109.82 21.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.37 -0.831 . . . . 0.0 110.521 -179.726 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.703 ' CD2' HD12 ' A' ' 113' ' ' ILE . 80.8 m-85 -91.22 157.02 17.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 110.082 179.765 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.52 ' C ' HD21 ' A' ' 34' ' ' LEU . 59.1 m-80 -138.83 98.37 3.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.197 -0.939 . . . . 0.0 110.398 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.823 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -157.76 -147.24 4.75 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -71.99 152.15 56.91 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.807 1.424 . . . . 0.0 110.733 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 p -91.48 -24.31 19.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 110.076 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 108' ' ' LYS . 0.5 OUTLIER -165.24 -79.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.302 -0.874 . . . . 0.0 110.031 -179.914 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.0 t 56.89 35.94 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 110.344 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.51 -44.62 17.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.258 -0.901 . . . . 0.0 110.181 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.961 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.585 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.243 0.544 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.51 106.58 17.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 0.0 110.384 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 62.15 23.44 13.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.93 . . . . 0.0 110.02 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.84 65.58 8.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.359 -0.838 . . . . 0.0 110.089 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.39 -62.18 1.61 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.318 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 4.8 m-20 56.41 27.55 12.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.0 110.215 -179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 p -159.13 158.67 33.32 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.272 -0.892 . . . . 0.0 110.779 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' O ' ' CD1' ' A' ' 59' ' ' TYR . . . 171.5 171.84 37.01 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.91 108.5 19.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.133 -1.216 . . . . 0.0 110.355 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.699 HD13 HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -94.45 152.52 18.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.0 109.995 179.855 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.463 ' N ' ' HG ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -78.82 139.57 38.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.139 -0.976 . . . . 0.0 110.425 -179.953 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.684 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -165.65 159.28 16.28 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.193 -0.942 . . . . 0.0 110.202 179.557 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -155.36 -171.63 3.87 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.338 -0.851 . . . . 0.0 109.699 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -140.85 172.06 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.968 . . . . 0.0 110.231 179.781 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.421 ' HA ' HG23 ' A' ' 46' ' ' THR . 60.2 m-85 -147.52 157.24 43.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 110.09 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.4 OUTLIER -67.58 139.33 56.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.226 -179.864 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.46 ' O ' HG23 ' A' ' 43' ' ' THR . 0.2 OUTLIER -63.64 147.04 52.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.942 179.853 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 28.3 t30 70.01 4.62 4.89 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.715 -0.616 . . . . 0.0 110.732 -179.384 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -137.82 179.67 6.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.976 -1.078 . . . . 0.0 109.776 179.376 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -115.76 12.98 16.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 110.285 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.37 143.38 46.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.109 -0.994 . . . . 0.0 110.613 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.554 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -73.72 139.73 45.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.251 179.48 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -17.8 3.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.001 -1.062 . . . . 0.0 112.189 -178.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.54 HG22 ' N ' ' A' ' 49' ' ' ALA . 8.0 mt -137.46 -73.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.781 -1.2 . . . . 0.0 110.787 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.54 ' N ' HG22 ' A' ' 48' ' ' ILE . . . -45.8 -26.13 0.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.612 -0.68 . . . . 0.0 111.14 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.501 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -60.02 -16.81 34.09 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.109 -0.995 . . . . 0.0 110.695 -179.83 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -102.33 15.54 28.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.031 -1.043 . . . . 0.0 111.009 -179.406 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.482 ' CD1' HBC1 ' A' ' 151' ' ' ZNH . 63.5 m-85 -133.27 7.63 3.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.839 -1.163 . . . . 0.0 111.384 -179.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' A' ' 53' ' ' PHE . 15.0 p90 -115.64 114.92 25.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.961 -1.087 . . . . 0.0 110.537 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -74.7 106.14 6.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.038 -1.039 . . . . 0.0 110.459 -179.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HB3' ' CE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -94.3 160.38 32.03 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 110.228 179.844 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.69 -175.38 15.97 Favored 'Cis proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.548 -2.272 . . . . 0.0 110.733 -0.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.684 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -101.71 164.99 11.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 109.899 179.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.11 117.55 34.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.134 -0.978 . . . . 0.0 110.993 -179.536 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 31.5 p90 -98.47 165.63 11.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.319 -0.863 . . . . 0.0 109.799 179.385 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -155.41 122.47 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.988 -1.07 . . . . 0.0 111.139 -179.739 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HE2' HD21 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -140.19 131.86 27.28 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.258 -0.901 . . . . 0.0 110.331 179.735 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 63' ' ' ASN . 7.1 tttt -111.37 62.08 0.61 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 0.0 110.455 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 62' ' ' LYS . 4.5 m120 49.85 101.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.365 -0.834 . . . . 0.0 111.223 179.578 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.65 -18.48 55.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -140.55 160.19 40.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.078 -1.248 . . . . 0.0 110.273 179.849 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.747 HD22 ' C ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -163.54 144.77 9.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 111.274 179.852 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 3.4 m-85 -141.57 -159.32 0.95 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.263 -0.898 . . . . 0.0 109.674 -179.771 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -169.92 165.28 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 110.322 179.613 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.414 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 2.0 pt20 -140.97 133.57 28.64 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.382 -0.824 . . . . 0.0 109.894 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.67 140.33 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 110.003 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.8 m -89.09 134.04 34.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.133 -0.979 . . . . 0.0 109.748 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.529 HG12 HG21 ' A' ' 78' ' ' ILE . 2.4 t -102.2 126.55 56.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.395 -0.816 . . . . 0.0 110.407 -179.507 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -99.5 127.9 45.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.263 -0.898 . . . . 0.0 110.046 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 63.32 69.93 0.55 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 109.871 -179.705 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.78 -27.49 63.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.467 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -55.99 -39.34 71.7 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.135 -0.978 . . . . 0.0 110.54 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.63 ' O ' HG13 ' A' ' 119' ' ' VAL . 24.8 m0 -81.2 -52.61 7.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.379 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.602 HD11 ' SD ' ' A' ' 81' ' ' MET . 20.3 tt -88.87 123.18 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 0.0 109.658 179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -87.08 -29.79 21.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.215 -0.928 . . . . 0.0 111.266 -179.001 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.95 175.07 47.28 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 118.998 -1.573 . . . . 0.0 110.701 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.602 ' SD ' HD11 ' A' ' 78' ' ' ILE . 5.2 mtt -152.3 110.49 3.7 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.654 -0.909 . . . . 0.0 109.784 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 116' ' ' LYS . 1.0 OUTLIER -85.88 157.26 20.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.095 -1.003 . . . . 0.0 110.359 -179.98 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.485 ' O ' ' CD2' ' A' ' 86' ' ' HIS . 1.0 OUTLIER -151.35 149.98 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.381 -0.825 . . . . 0.0 109.758 179.578 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.526 ' HB2' ' CE1' ' A' ' 86' ' ' HIS . 0.7 OUTLIER 61.77 14.09 5.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.124 -0.985 . . . . 0.0 110.783 -179.886 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.38 19.92 57.76 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.809 179.163 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.526 ' CE1' ' HB2' ' A' ' 84' ' ' GLU . 2.1 p-80 -137.47 161.24 36.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.72 -1.459 . . . . 0.0 110.692 179.591 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.76 174.33 7.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.468 -0.77 . . . . 0.0 110.838 -179.521 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 8.2 pt-20 -99.06 167.4 10.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 110.474 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -118.43 134.94 54.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.31 -0.869 . . . . 0.0 110.192 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.07 100.72 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 109.445 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 101' ' ' THR . 2.5 tt -96.32 -25.72 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 110.797 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -167.73 95.07 0.43 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.965 . . . . 0.0 110.138 -179.775 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.459 ' CG ' ' HG3' ' A' ' 100' ' ' ARG . 2.4 ttmt -96.34 144.03 26.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.83 93.62 2.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.129 -0.982 . . . . 0.0 110.331 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -76.81 -15.78 59.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.864 . . . . 0.0 110.357 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.83 -28.01 69.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 110.548 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -136.34 25.56 3.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.122 -0.986 . . . . 0.0 110.502 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.87 70.82 0.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.217 -0.927 . . . . 0.0 110.337 179.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -147.71 160.51 42.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.141 -0.975 . . . . 0.0 110.003 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.459 ' HG3' ' CG ' ' A' ' 93' ' ' LYS . 1.0 OUTLIER -168.92 162.87 11.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 110.356 -179.777 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.624 ' O ' HG22 ' A' ' 91' ' ' ILE . 57.9 m -142.05 157.81 44.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.45 -0.781 . . . . 0.0 109.229 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . 2.0 p -143.9 137.04 27.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.821 -1.174 . . . . 0.0 110.616 -179.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -93.0 136.48 33.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.426 -0.796 . . . . 0.0 109.995 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 88' ' ' GLU . 88.6 m-85 -129.68 144.38 51.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.1 -1.0 . . . . 0.0 110.904 -179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.46 ' C ' HG13 ' A' ' 106' ' ' VAL . 26.8 tt0 -101.11 127.96 47.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.481 -0.762 . . . . 0.0 109.091 179.041 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.636 ' O ' HD21 ' A' ' 66' ' ' LEU . 19.9 m -147.98 163.02 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.914 -1.117 . . . . 0.0 111.075 -178.84 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.67 109.55 7.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.292 -0.88 . . . . 0.0 108.658 178.629 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.459 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 48.84 -159.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.341 -0.85 . . . . 0.0 109.563 -178.577 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.699 HD22 HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -150.59 60.72 0.94 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.974 -1.079 . . . . 0.0 111.103 -179.489 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.42 ' CB ' HG23 ' A' ' 146' ' ' THR . 16.0 t-20 -146.08 82.12 1.6 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.339 -0.85 . . . . 0.0 109.799 179.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.57 170.82 22.09 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.43 146.14 29.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -1.056 . . . . 0.0 110.458 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.427 HD12 ' CD2' ' A' ' 142' ' ' PHE . 82.6 mt -139.35 149.9 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.942 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.48 142.66 40.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.12 -0.988 . . . . 0.0 110.525 -179.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -147.72 127.84 2.74 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 82' ' ' SER . 10.8 mttt -94.67 168.2 10.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.346 -1.09 . . . . 0.0 109.787 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.429 HD11 ' HAC' ' A' ' 151' ' ' ZNH . 0.3 OUTLIER -158.9 133.95 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.993 -1.067 . . . . 0.0 110.858 179.481 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.695 ' O ' HG22 ' A' ' 79' ' ' THR . 11.6 m-20 -107.47 163.32 13.15 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 77' ' ' TRP . 3.8 t -144.14 152.67 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.899 -1.126 . . . . 0.0 110.475 -179.268 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -151.21 113.73 4.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.427 -0.796 . . . . 0.0 110.523 179.915 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' A' ' 132' ' ' TYR . 2.7 mp -138.15 153.71 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.347 -0.845 . . . . 0.0 110.082 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.74 96.99 1.41 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.125 -0.985 . . . . 0.0 110.208 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.43 ' O ' ' CD1' ' A' ' 130' ' ' PHE . 0.4 OUTLIER -174.12 -170.69 0.56 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.395 -0.815 . . . . 0.0 110.151 -179.957 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.31 111.49 23.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.213 -0.929 . . . . 0.0 110.22 -179.875 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.759 HG23 ' CE1' ' A' ' 130' ' ' PHE . 2.7 t -77.12 107.6 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.34 179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.28 38.07 12.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.892 . . . . 0.0 110.495 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 91.72 39.02 5.66 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -144.82 90.07 6.44 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.337 -1.096 . . . . 0.0 109.998 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.03 121.48 9.37 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.97 1.51 . . . . 0.0 110.715 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.759 ' CE1' HG23 ' A' ' 125' ' ' VAL . 11.6 p90 -146.38 166.35 26.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.923 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.68 117.28 14.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 110.43 -179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.554 ' HB3' HD12 ' A' ' 121' ' ' ILE . 3.8 t80 -102.46 135.0 44.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.394 -0.817 . . . . 0.0 109.705 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -174.39 83.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 0.0 110.16 -179.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.91 -162.32 1.41 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.902 . . . . 0.0 110.622 179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.467 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -120.28 157.09 29.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.445 -0.785 . . . . 0.0 110.062 179.852 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 34.4 m-85 -155.15 -179.05 7.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.048 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -150.78 165.74 32.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 110.521 -179.884 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.462 HD11 ' HE2' ' A' ' 81' ' ' MET . 0.1 OUTLIER -156.38 159.34 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.464 -0.772 . . . . 0.0 109.815 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 19.9 m -91.61 119.9 31.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.18 -0.95 . . . . 0.0 110.655 -179.456 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.563 ' HA ' HG12 ' A' ' 38' ' ' VAL . 9.5 m-85 -90.39 165.73 13.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.322 -0.861 . . . . 0.0 109.909 179.518 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.89 103.92 1.9 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.467 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.427 ' CD2' HD12 ' A' ' 113' ' ' ILE . 96.4 m-85 -92.2 154.23 18.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.274 -0.891 . . . . 0.0 110.236 179.735 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 48.8 m-80 -141.78 96.9 3.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -0.903 . . . . 0.0 110.497 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.592 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -150.86 -151.72 5.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.735 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.407 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 10.0 Cg_endo -58.96 178.13 0.29 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.733 1.386 . . . . 0.0 110.287 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.42 HG23 ' CB ' ' A' ' 110' ' ' ASN . 0.1 OUTLIER -148.61 -60.38 0.24 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.273 -0.892 . . . . 0.0 110.005 179.917 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.76 -63.12 1.36 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.095 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 148' ' ' VAL . 24.2 t 55.99 55.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 110.305 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.75 -22.57 37.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 110.255 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.997 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.482 HBC1 ' CD1' ' A' ' 52' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.326 0.584 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.46 78.96 0.73 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.937 . . . . 0.0 110.155 -179.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 t30 62.12 23.96 14.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.915 -179.763 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.46 90.01 4.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.377 -0.827 . . . . 0.0 110.245 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.87 -73.5 0.22 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.289 -0.882 . . . . 0.0 109.885 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 63.6 m-20 52.74 28.22 6.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.916 . . . . 0.0 110.386 179.657 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.39 150.44 19.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.052 -1.03 . . . . 0.0 110.727 -179.374 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.37 -136.87 3.39 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -149.22 110.5 4.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.162 -1.199 . . . . 0.0 110.348 -179.944 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.003 HD23 ' HB3' ' A' ' 59' ' ' TYR . 2.3 pp -95.06 156.08 16.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.434 -0.791 . . . . 0.0 110.365 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.612 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.4 t30 -79.33 141.69 36.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.37 -0.832 . . . . 0.0 110.068 179.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 57' ' ' ALA . 1.6 p90 -164.01 162.81 23.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.068 -1.02 . . . . 0.0 110.682 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.36 -165.89 2.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.528 -0.732 . . . . 0.0 109.677 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.763 ' C ' HG23 ' A' ' 46' ' ' THR . 0.0 OUTLIER -139.92 174.58 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.15 -0.969 . . . . 0.0 110.154 179.703 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.419 ' CE2' ' HG3' ' A' ' 141' ' ' LYS . 14.0 m-85 -147.62 147.29 29.87 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.203 -0.935 . . . . 0.0 109.961 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.466 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -67.58 130.36 42.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.366 -0.834 . . . . 0.0 110.26 -179.592 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.511 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -52.45 145.75 10.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -0.887 . . . . 0.0 110.386 -179.809 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 1.8 t30 72.79 0.26 3.59 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.884 -0.51 . . . . 0.0 111.074 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.38 -161.99 1.22 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.871 -1.143 . . . . 0.0 109.749 179.298 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.423 ' N ' ' OG1' ' A' ' 43' ' ' THR . 12.0 p-10 -135.58 15.47 3.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.188 -0.945 . . . . 0.0 110.214 179.592 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -135.14 128.13 31.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 0.0 110.767 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.763 HG23 ' C ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -57.58 136.35 56.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.45 179.509 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.747 ' HB3' HD12 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -128.34 -17.85 4.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.064 -1.023 . . . . 0.0 111.675 -179.194 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.747 HD12 ' HB3' ' A' ' 47' ' ' SER . 1.6 mp -137.78 -71.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.777 -1.202 . . . . 0.0 110.813 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.621 ' HB1' ' CE2' ' A' ' 53' ' ' PHE . . . -45.4 -26.14 0.51 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.693 -0.629 . . . . 0.0 111.27 -179.366 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.455 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -62.47 -13.02 25.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.06 -1.025 . . . . 0.0 111.044 -179.73 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -98.89 13.97 30.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.99 -1.069 . . . . 0.0 110.995 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -135.44 -1.55 2.55 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.907 -1.121 . . . . 0.0 111.574 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.621 ' CE2' ' HB1' ' A' ' 49' ' ' ALA . 16.2 m-30 -111.91 101.12 9.46 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.961 -1.087 . . . . 0.0 110.249 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.19 113.67 10.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.314 -0.866 . . . . 0.0 110.539 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.444 ' CB ' ' HA ' ' A' ' 56' ' ' PRO . 1.0 OUTLIER -93.53 166.67 15.5 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 109.942 179.739 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HA ' ' CB ' ' A' ' 55' ' ' LYS . 60.2 Cg_endo -82.79 -175.55 14.97 Favored 'Cis proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.784 -2.174 . . . . 0.0 110.595 -0.494 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 36' ' ' TYR . . . -104.25 162.67 13.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.286 -0.884 . . . . 0.0 109.641 179.467 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.474 ' HG3' HG23 ' A' ' 33' ' ' THR . 15.1 mttt -98.85 114.73 27.45 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.226 -0.922 . . . . 0.0 110.254 -179.686 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 1.003 ' HB3' HD23 ' A' ' 34' ' ' LEU . 10.7 p90 -97.68 161.64 13.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.123 -0.985 . . . . 0.0 110.609 -179.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.594 HG23 ' HD1' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -154.86 127.77 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.9 . . . . 0.0 110.543 -179.632 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.453 ' CD ' ' HE2' ' A' ' 108' ' ' LYS . 2.4 mtmt -137.82 119.42 14.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.183 -0.948 . . . . 0.0 110.438 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -94.74 62.12 2.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.657 -179.998 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 0.1 OUTLIER 49.16 101.54 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.404 -0.81 . . . . 0.0 111.376 179.44 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.56 -21.93 41.97 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.357 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.444 ' N ' ' CD ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -135.28 154.5 51.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.175 -1.191 . . . . 0.0 110.138 179.61 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.838 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -156.37 135.99 12.43 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.159 0.98 . . . . 0.0 111.308 179.878 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.594 ' HD1' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -142.17 176.39 9.01 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.417 -0.802 . . . . 0.0 109.144 179.985 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.437 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -150.01 141.58 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.931 -1.106 . . . . 0.0 110.872 179.983 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 102' ' ' SER . 6.0 pt20 -100.09 134.98 42.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.461 -0.774 . . . . 0.0 109.513 179.209 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 101' ' ' THR . 1.1 mm -110.51 131.22 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.725 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.6 m -87.75 127.67 35.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.185 -0.947 . . . . 0.0 110.023 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.643 ' HB ' HD13 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -103.33 144.4 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.368 -0.833 . . . . 0.0 110.045 -179.644 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -99.36 146.78 25.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.112 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 53.94 84.17 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.078 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.8 p -50.35 -33.42 20.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.451 -179.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.08 -41.17 74.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 110.384 -179.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.669 ' O ' HG12 ' A' ' 119' ' ' VAL . 31.5 m0 -61.15 -63.14 1.39 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 0.0 110.444 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.838 HD11 ' HG3' ' A' ' 81' ' ' MET . 16.4 tt -88.36 118.6 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.144 -0.973 . . . . 0.0 109.765 179.843 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.66 HG22 ' C ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -86.85 -23.67 25.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.87 . . . . 0.0 110.964 -179.2 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.38 173.83 44.9 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.447 -1.359 . . . . 0.0 110.153 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.838 ' HG3' HD11 ' A' ' 78' ' ' ILE . 1.2 mtm -153.32 113.58 3.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.339 -1.095 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.74 169.66 13.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.474 HG13 ' CE2' ' A' ' 140' ' ' TYR . 0.1 OUTLIER -169.24 141.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -0.867 . . . . 0.0 110.048 179.785 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.523 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 1.1 tm-20 64.52 11.91 7.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.274 -0.891 . . . . 0.0 110.69 -179.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.77 17.45 61.66 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.336 179.528 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.523 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.2 p-80 -137.75 160.19 39.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.971 -1.311 . . . . 0.0 110.576 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.91 162.15 29.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.418 -0.801 . . . . 0.0 110.492 -179.674 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.504 ' CB ' ' CE1' ' A' ' 104' ' ' PHE . 12.9 pt-20 -91.2 168.08 11.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.864 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -111.63 133.94 53.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 110.303 -179.964 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.8 pt -68.01 142.41 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.034 -1.041 . . . . 0.0 109.402 179.463 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.445 HG21 HG22 ' A' ' 101' ' ' THR . 3.0 tt -136.24 -29.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.151 -0.968 . . . . 0.0 111.43 -179.038 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 m -165.34 94.66 0.63 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.982 -1.074 . . . . 0.0 109.743 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -96.39 142.46 28.47 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.322 -0.861 . . . . 0.0 110.062 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.405 ' OD1' ' HB3' ' A' ' 97' ' ' LYS . 7.3 t-20 -141.74 91.57 2.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 72.6 p -71.14 -23.34 62.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 110.245 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.41 54.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.093 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.405 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 3.6 tttt -97.72 13.48 30.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.904 . . . . 0.0 110.413 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.29 62.45 2.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.034 -1.042 . . . . 0.0 110.166 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -147.89 137.29 22.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 0.0 110.43 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.454 ' HG3' ' N ' ' A' ' 101' ' ' THR . 3.2 ttt180 -144.1 162.0 37.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.435 -0.791 . . . . 0.0 109.983 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.454 ' N ' ' HG3' ' A' ' 100' ' ' ARG . 94.0 m -142.14 156.69 45.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 110.371 -179.781 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 2.4 p -145.29 145.35 31.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.183 -0.948 . . . . 0.0 110.271 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -91.55 144.21 25.78 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.296 -0.878 . . . . 0.0 110.041 -179.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.504 ' CE1' ' CB ' ' A' ' 88' ' ' GLU . 37.2 m-85 -130.13 135.82 48.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 110.846 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.06 126.19 38.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.34 -0.85 . . . . 0.0 109.424 179.182 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.457 ' O ' HD21 ' A' ' 66' ' ' LEU . 1.2 p -149.59 158.64 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.012 -1.055 . . . . 0.0 110.872 -179.101 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.4 p -69.87 108.88 4.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.937 . . . . 0.0 108.773 178.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.453 ' HE2' ' CD ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 47.87 -153.51 0.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.366 -0.834 . . . . 0.0 109.488 -178.457 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.57 HD22 HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.41 61.23 0.89 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.657 -1.277 . . . . 0.0 111.251 -179.093 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -147.37 94.35 2.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.961 . . . . 0.0 110.458 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.58 -123.78 1.61 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.464 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 0.2 OUTLIER -156.86 150.23 24.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.299 -1.118 . . . . 0.0 109.513 -179.676 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.417 ' N ' ' HG2' ' A' ' 112' ' ' LYS . 1.5 mm -138.53 129.16 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.134 -179.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -76.35 131.36 39.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 110.206 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -142.7 -162.66 9.36 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -146.31 172.45 13.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.224 -1.162 . . . . 0.0 109.741 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.617 HG21 HD13 ' A' ' 138' ' ' ILE . 0.0 OUTLIER -157.8 140.41 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.115 -0.991 . . . . 0.0 110.477 179.972 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.66 ' C ' HG22 ' A' ' 79' ' ' THR . 23.2 m-20 -106.53 158.46 16.9 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.222 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -134.88 149.91 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.119 -0.988 . . . . 0.0 110.229 -179.749 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 3.3 t80 -151.27 106.8 3.36 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.646 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.571 HD13 HBB1 ' A' ' 151' ' ' ZNH . 2.5 mp -137.43 152.67 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.43 -0.794 . . . . 0.0 109.777 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.31 106.65 1.54 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.289 -0.882 . . . . 0.0 109.723 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -172.28 -179.48 2.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 110.258 -179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -85.08 96.64 9.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 110.491 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 125' ' ' VAL . 2.5 t -76.45 106.78 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.996 179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER 64.15 26.2 13.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.174 -179.903 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.07 34.86 9.37 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.24 127.24 7.92 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.223 -1.163 . . . . 0.0 110.14 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -55.86 108.94 0.36 Allowed 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.504 1.265 . . . . 0.0 110.109 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.684 ' CZ ' HMB2 ' A' ' 151' ' ' ZNH . 52.0 t80 -114.93 144.24 43.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.363 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -135.44 118.07 15.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 110.243 -179.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.495 ' OH ' ' NA ' ' A' ' 151' ' ' ZNH . 5.0 t80 -115.11 127.92 55.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.123 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.83 82.56 0.38 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.869 . . . . 0.0 109.925 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -154.29 -172.72 4.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 110.534 -179.763 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.459 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 5.9 p-80 -122.53 161.75 23.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.483 -0.761 . . . . 0.0 109.918 179.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.459 ' CG ' ' O ' ' A' ' 135' ' ' HIS . 47.2 m-85 -155.38 140.63 17.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.169 -0.957 . . . . 0.0 110.337 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.645 ' O ' HG23 ' A' ' 138' ' ' ILE . 38.8 p30 -88.11 156.51 19.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.232 -0.917 . . . . 0.0 110.4 -179.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 137' ' ' ASN . 4.2 pt -157.21 143.8 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 109.891 -179.945 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.644 ' O ' HG12 ' A' ' 38' ' ' VAL . 81.4 m -91.62 128.35 37.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.197 -0.94 . . . . 0.0 110.944 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.474 ' CE2' HG13 ' A' ' 83' ' ' ILE . 51.8 m-85 -90.8 159.99 16.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.793 179.102 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.419 ' HG3' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -146.67 102.41 3.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.183 -0.948 . . . . 0.0 110.368 -179.965 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -93.17 152.14 19.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.279 -0.888 . . . . 0.0 110.386 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.496 ' ND2' ' HA ' ' A' ' 36' ' ' TYR . 51.3 m-80 -144.22 95.61 2.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.154 -0.966 . . . . 0.0 110.393 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.466 ' HA3' HD13 ' A' ' 109' ' ' LEU . . . -152.19 -154.77 6.76 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.793 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.415 ' HG2' ' NZ ' ' A' ' 61' ' ' LYS . 11.4 Cg_endo -61.15 178.39 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.91 1.479 . . . . 0.0 110.644 -179.729 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.7 p -149.49 -62.48 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.856 . . . . 0.0 110.117 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 148' ' ' VAL . 34.8 m-20 -120.37 -60.81 1.65 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 110.169 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 148' ' ' VAL . 20.1 t 56.73 42.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 0.0 110.307 179.947 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.96 -47.26 12.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 0.0 110.264 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.972 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.684 HMB2 ' CZ ' ' A' ' 130' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.29 0.567 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -127.53 88.3 2.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 110.241 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.91 32.23 17.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.267 -0.896 . . . . 0.0 109.954 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.47 118.35 19.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.338 -0.851 . . . . 0.0 110.383 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 43.04 -164.78 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.667 -0.646 . . . . 0.0 111.044 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 0.5 OUTLIER 56.31 28.69 13.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.897 . . . . 0.0 110.281 -179.82 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 t -161.31 140.81 10.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.86 . . . . 0.0 110.401 -179.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.0 179.38 47.36 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.28 111.99 22.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.317 -1.108 . . . . 0.0 110.051 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.878 HD11 ' HA3' ' A' ' 144' ' ' GLY . 0.9 OUTLIER -95.4 154.3 17.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -0.905 . . . . 0.0 110.8 -179.739 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.4 m-20 -81.91 139.08 34.85 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.336 179.071 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.619 ' CE2' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -166.89 160.36 14.34 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.948 -1.095 . . . . 0.0 110.859 -179.924 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.57 -167.12 2.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.572 -0.705 . . . . 0.0 109.721 179.695 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.517 HG23 HG21 ' A' ' 46' ' ' THR . 0.0 OUTLIER -142.16 174.04 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.116 -0.99 . . . . 0.0 110.296 179.818 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.477 ' CE2' ' HG3' ' A' ' 141' ' ' LYS . 16.7 m-85 -147.73 152.69 38.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.838 . . . . 0.0 110.052 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 124.29 23.01 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.381 -0.824 . . . . 0.0 110.009 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.533 ' O ' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -49.17 147.58 2.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.77 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 41' ' ' TYR . 3.9 m120 72.33 0.79 3.72 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.934 -0.479 . . . . 0.0 110.91 -179.092 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -136.77 -160.38 1.05 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.818 -1.177 . . . . 0.0 109.729 179.092 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.4 ' N ' ' OG1' ' A' ' 43' ' ' THR . 3.2 t-20 -134.37 11.64 3.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 110.248 179.471 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -135.99 139.0 42.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.102 -0.999 . . . . 0.0 110.628 -179.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.517 HG21 HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -63.71 133.44 53.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.206 179.264 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -128.7 -17.6 4.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.89 -1.132 . . . . 0.0 111.964 -178.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.2 mt -137.54 -71.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.815 -1.178 . . . . 0.0 110.76 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -50.99 -22.53 2.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.499 -0.751 . . . . 0.0 111.027 -179.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.442 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -55.59 -19.32 9.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.128 -0.982 . . . . 0.0 110.77 -179.793 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -94.29 15.29 17.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.015 -1.053 . . . . 0.0 110.922 -179.44 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -141.61 16.27 2.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.908 -1.12 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -123.1 106.17 10.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.141 -0.975 . . . . 0.0 110.255 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.96 152.45 41.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.899 . . . . 0.0 110.607 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.426 ' HA ' ' C ' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -147.3 162.56 31.98 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 0.0 109.838 179.692 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 55' ' ' LYS . 56.2 Cg_endo -78.02 -176.68 19.18 Favored 'Cis proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.728 -2.197 . . . . 0.0 110.475 -0.127 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.619 ' HB2' ' CE2' ' A' ' 36' ' ' TYR . . . -105.23 166.33 10.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 110.091 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -101.49 113.78 27.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 110.088 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 8.7 p90 -96.27 163.54 13.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.924 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 0.4 OUTLIER -154.74 154.19 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.181 -0.95 . . . . 0.0 110.205 -179.925 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 29.7 mtpt -136.52 170.43 16.07 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.157 -0.965 . . . . 0.0 110.854 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.44 ' HB3' ' CD ' ' A' ' 65' ' ' LYS . 9.4 mttt -155.06 62.91 0.64 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.439 -0.788 . . . . 0.0 110.032 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t30 48.61 86.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.397 -0.815 . . . . 0.0 111.091 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.63 24.21 33.92 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.616 179.021 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.44 ' CD ' ' HB3' ' A' ' 62' ' ' LYS . 6.4 ptpt -170.39 161.19 7.94 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.042 -1.27 . . . . 0.0 110.947 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.819 HD21 ' H ' ' A' ' 108' ' ' LYS . 1.6 pt? -172.19 149.49 2.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.1 0.952 . . . . 0.0 111.732 178.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -140.61 174.06 10.89 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.258 -179.268 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.42 HG12 ' C ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -148.57 143.04 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.988 -1.07 . . . . 0.0 110.15 179.561 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -99.69 133.65 43.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.192 -0.943 . . . . 0.0 110.329 179.87 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -113.12 141.08 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.796 179.823 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 m -89.13 130.21 35.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.875 . . . . 0.0 110.348 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.657 HG13 ' HE3' ' A' ' 81' ' ' MET . 1.7 t -102.94 125.63 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.904 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -100.32 140.24 34.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.497 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.546 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.6 OUTLIER 62.14 77.32 0.33 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.93 . . . . 0.0 110.315 179.87 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.8 m -65.47 -35.06 79.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 110.057 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -52.95 -38.28 61.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.314 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.523 ' CE2' ' CE1' ' A' ' 74' ' ' HIS . 44.6 m0 -82.18 -61.27 1.95 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.947 . . . . 0.0 110.381 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.72 ' HA ' HG12 ' A' ' 119' ' ' VAL . 7.8 tt -87.76 122.03 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.372 -0.83 . . . . 0.0 109.808 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.824 HG22 ' O ' ' A' ' 118' ' ' ASP . 1.3 t -87.6 -22.42 24.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -0.897 . . . . 0.0 111.41 -178.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.79 176.98 47.68 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.303 -1.427 . . . . 0.0 110.381 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.657 ' HE3' HG13 ' A' ' 72' ' ' VAL . 2.1 mpp? -150.61 108.14 3.65 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.579 -0.954 . . . . 0.0 109.985 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -85.49 156.9 20.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.24 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.484 HD11 ' CE2' ' A' ' 140' ' ' TYR . 3.9 mt -148.19 153.28 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 110.073 179.758 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.524 ' CB ' ' CE1' ' A' ' 86' ' ' HIS . 1.9 tm-20 61.96 14.81 6.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 0.0 110.709 179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.6 19.42 61.93 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.524 ' CE1' ' CB ' ' A' ' 84' ' ' GLU . 2.2 p-80 -136.2 159.85 40.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.274 . . . . 0.0 110.272 179.608 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -71.44 162.95 28.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.82 . . . . 0.0 110.604 -179.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 81' ' ' MET . 4.0 pt-20 -90.79 170.09 10.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 110.17 179.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.39 126.92 55.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.289 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 pp -67.86 103.64 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.142 -0.973 . . . . 0.0 109.465 179.578 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.464 HG21 HG22 ' A' ' 101' ' ' THR . 1.4 tt -94.38 -28.41 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 0.0 110.978 -179.061 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.3 m -166.91 100.21 0.55 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.044 -1.035 . . . . 0.0 110.12 -179.644 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.417 ' HG3' ' HG3' ' A' ' 100' ' ' ARG . 21.1 ttmt -95.72 102.64 14.46 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.396 -0.815 . . . . 0.0 110.041 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.47 94.3 7.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 110.211 -179.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 79.1 p -80.47 -17.34 51.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.356 -0.84 . . . . 0.0 110.368 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.48 -19.91 64.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.95 . . . . 0.0 110.11 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -136.44 22.44 3.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 110.105 179.887 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 52.74 67.97 0.9 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.31 -0.869 . . . . 0.0 110.093 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -147.72 176.23 10.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -0.898 . . . . 0.0 110.262 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.417 ' HG3' ' HG3' ' A' ' 93' ' ' LYS . 2.8 ttm180 -175.93 161.41 2.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.892 . . . . 0.0 110.189 -179.864 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.464 HG22 HG21 ' A' ' 91' ' ' ILE . 87.1 m -142.32 154.32 44.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.897 . . . . 0.0 109.814 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 69' ' ' GLN . 22.4 p -145.88 142.01 28.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.034 -1.042 . . . . 0.0 110.759 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -92.74 146.16 23.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.456 -0.778 . . . . 0.0 109.716 179.472 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.425 ' CG ' HD12 ' A' ' 83' ' ' ILE . 46.4 m-85 -129.22 139.5 51.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.076 -1.015 . . . . 0.0 111.079 -179.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.471 ' C ' HG13 ' A' ' 106' ' ' VAL . 9.8 tt0 -105.75 122.06 45.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.462 -0.774 . . . . 0.0 109.225 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.471 HG13 ' C ' ' A' ' 105' ' ' GLU . 34.4 m -149.02 147.91 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.069 -1.019 . . . . 0.0 110.91 -178.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.6 m -63.8 106.64 1.03 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.327 -0.858 . . . . 0.0 109.117 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.819 ' H ' HD21 ' A' ' 66' ' ' LEU . 0.1 OUTLIER 50.45 -177.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.469 -0.77 . . . . 0.0 109.588 -178.729 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.727 HD22 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -150.42 82.49 1.36 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.907 -1.12 . . . . 0.0 111.191 -179.42 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.468 ' CG ' HG23 ' A' ' 146' ' ' THR . 15.2 t-20 -145.16 80.33 1.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.109 179.46 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.09 -113.61 0.61 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 0.0 OUTLIER -157.11 152.93 27.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.161 -1.199 . . . . 0.0 110.055 179.847 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 57.4 mt -134.15 150.79 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 0.0 110.188 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -76.37 123.01 25.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.254 -0.904 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.458 ' HA3' ' CE1' ' A' ' 140' ' ' TYR . . . -128.83 177.75 17.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 137' ' ' ASN . 8.8 mttt -143.45 171.79 13.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -1.079 . . . . 0.0 109.845 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.563 HD11 HG13 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -158.13 138.83 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.073 -1.017 . . . . 0.0 110.543 -179.912 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.824 ' O ' HG22 ' A' ' 79' ' ' THR . 42.4 t0 -107.96 158.06 17.69 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.425 -0.797 . . . . 0.0 108.896 179.047 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.72 HG12 ' HA ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -145.34 152.7 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 0.0 110.781 -179.244 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 132' ' ' TYR . 5.3 t80 -152.44 107.36 3.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.462 -0.774 . . . . 0.0 110.457 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.586 HD12 ' CB ' ' A' ' 132' ' ' TYR . 20.0 mt -127.74 153.31 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.185 -0.947 . . . . 0.0 110.454 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -159.55 96.96 1.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.866 179.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.444 ' HG2' ' CE1' ' A' ' 130' ' ' PHE . 6.7 pt-20 -173.88 -149.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 110.261 -179.654 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 128' ' ' LYS . 0.1 OUTLIER -132.67 119.33 20.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.194 -0.941 . . . . 0.0 110.223 -179.947 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.679 HG23 ' CE1' ' A' ' 130' ' ' PHE . 38.7 t -76.77 90.58 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.222 -0.924 . . . . 0.0 110.369 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 49.58 46.07 23.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 110.505 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.23 36.16 5.02 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 124' ' ' LYS . 0.1 OUTLIER -145.76 88.31 6.53 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.176 -1.19 . . . . 0.0 110.157 179.799 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -62.46 124.46 14.27 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.945 1.497 . . . . 0.0 110.274 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.679 ' CE1' HG23 ' A' ' 125' ' ' VAL . 6.2 p90 -154.25 161.86 41.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 110.183 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -135.42 106.18 6.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 110.17 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.586 ' CB ' HD12 ' A' ' 121' ' ' ILE . 3.6 t80 -91.79 131.31 37.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 110.01 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -166.68 89.63 0.37 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.917 . . . . 0.0 109.99 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 -177.06 6.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.152 -0.968 . . . . 0.0 110.593 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -118.22 93.06 3.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.372 -0.83 . . . . 0.0 109.758 179.753 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.623 ' HB3' HMD2 ' A' ' 151' ' ' ZNH . 89.1 m-85 -85.55 -179.42 6.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.433 -0.792 . . . . 0.0 110.653 -179.476 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.601 ' O ' HG23 ' A' ' 138' ' ' ILE . 12.4 p30 -151.09 161.77 42.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 110.111 179.845 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 137' ' ' ASN . 1.5 pt -156.81 163.35 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.093 -1.004 . . . . 0.0 110.692 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.425 HG23 ' HD2' ' A' ' 112' ' ' LYS . 86.0 m -91.97 121.6 33.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.386 -0.821 . . . . 0.0 110.736 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.484 ' CE2' HD11 ' A' ' 83' ' ' ILE . 55.4 m-85 -89.78 137.27 32.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -0.903 . . . . 0.0 109.407 179.088 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.477 ' HG3' ' CE2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -118.02 101.17 8.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.101 -1.0 . . . . 0.0 110.63 -179.725 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -92.6 130.3 38.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 0.0 109.83 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 3.7 m-80 -129.55 103.84 7.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 110.453 -179.761 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.878 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -152.62 -147.85 4.71 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.427 ' HD2' HD11 ' A' ' 34' ' ' LEU . 9.8 Cg_endo -58.5 -172.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.793 1.417 . . . . 0.0 110.601 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.468 HG23 ' CG ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER -149.15 -51.92 0.16 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.304 -0.873 . . . . 0.0 110.263 -179.921 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -131.23 -51.25 1.02 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.319 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 148' ' ' VAL . 16.5 t 56.83 32.42 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.368 -0.833 . . . . 0.0 110.324 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -158.31 30.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.273 -0.892 . . . . 0.0 110.261 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.976 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' ZNH . . . . . 0.623 HMD2 ' HB3' ' A' ' 136' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_